26913870 en condition adjust according body need clinical syndrome large similar mellitus disease known several year difference subject compare healthy individual mellitus patient use treat evidence indicate disorder early first observed patient role treatment syndrome renal receive first treatment
21842608 en report case renal renal mellitus month diagnose renal treat metabolic age year renal increased age year also hospital due day test metabolic addition severe mellitus medication metabolic severe concentration system occur possible metabolic metabolic treat first treatment improve elevated plasma renal response renal possible cause renal drug effective treatment present case
17026722 en patient mellitus present report type mellitus on woman poor control type although demonstrated significant low low test case patient mellitus
26181158 en syndrome condition two disorder result clinical clinical disorder syndrome type among common one report case female diagnose mellitus several year develop syndrome type disorder case suggest patient may well patient may
27172867 en complication due increased gestational occur day also occur patient may treatment effective also therefore treat need
25255707 en syndrome disorder mellitus DM disease associate several gene gene association gene syndrome identify patient previous first case syndrome significant reduction review mechanism syndrome datum suggest role gene patient week first day patient show weight associate presence serum high plasma low ratio diagnosis test week age show addition associate observed suggest diagnosis year follow-up patient develop glucose mellitus year primary analysis case recent suggest possible role gene development period syndrome consider diagnosis case develop period
20888099 en disease consider reported characteristic mellitus identify case increased study show show response treat case clinical effect increasing use treatment addition lead increasing use
26401579 en disorder response patient mortality diagnosis management patient review aim provide clinical conduct related use identify patient case report case diagnosis follow response among patient severe obesity increased mortality risk management therapy patient provide disorder patient lead management result care patient
26051300 en clinical syndrome on recent show prevalence rate patient per year diagnosis several present condition diagnosis remain cause clinical diagnosis treatment system risk cell diagnosis clinical several review diagnosis treatment patient
25211589 en mellitus known year base patient identify found multiple early new therapy due patient therapy early condition follow development level patient disorder disease analysis lead patient multiple clinical research first
26783152 en well aim study outcome risk factor retrospective analyzed patient treat retrospective define score patient evaluate patient diagnose patient poor outcome associate mortality age odd ratio or confidence interval CI or CI or CI ratio or CI associate development early large patient patient diagnose poor outcome associate mortality patient early
24517985 en report incidence treatment renal renal patient perform review retrospective parameter investigate included blood blood pressure level rate three case develop period normal within week treatment blood significant reduce time diagnosis recent follow-up group ratio blood group significant high group without vs event medical on high ratio blood may cause may increase renal early condition
26795631 en cause type gene on present demonstrated response diagnosis show potential patient diagnosis treatment patient two on revealed cell patient treat weight present case due patient may analysis cause disease effect new lead two treatment lead weight
26485413 en syndrome severe associate high mortality result diagnosis retrospective review clinical management outcome patient develop syndrome define diagnosis clinical characteristic included low pressure high level without dysfunction high high serum normal serum level also present treatment patient month outcome score outcome score hospital develop syndrome major status diagnosis outcome
25587001 en disorder patient evaluate hospital clinical high serum low due increased diagnosis test case perform patient female aged year mean year included period prevalence cohort patient diagnose due common possible high
25006753 en present two case although association association can reduction first
25902753 en diagnosis primary disease renal cohort patient clinical diagnosis patient present mean severe mean increased plasma mean normal rate diagnosis revealed patient different gene one different previous reported found change relative one female patient gene study negative found
27165581 en occur patient known due dysfunction without reported early report first case
23466483 en complication reported on common change early period increased patient increased develop although report present case patient undergo diagnose man day man day patient condition therapy diagnosis consider patient early use
23884272 en gestational complication may lead severe gestational present case woman week develop severe gestational cause gestational early treatment gestational mortality
27642481 en syndrome study aim evaluate conduct retrospective study case datum hospital identify assessment occur period patient significant high patient test patient cause found patient cause found patient associate case patient primary
25951703 en disorder large increased disease may result increased impair response may patient severe may develop therefore condition diagnose patient treatment drug increasing treatment may disorder review current different clinical diagnosis management also provide patient disease
24648810 en syndrome complication occur patient due reduction mass treatment severe type renal dysfunction evidence metabolic also complication renal disease case man develop syndrome day first known risk factor addition review mechanism possible condition base case patient receive renal complication
24132004 en multiple disease present clinical include present woman history recent test show elevated serum level low low serum level oral result serum well diagnosis can perform on patient oral treatment serum level remain normal report case patient present due consider patient develop new
24631797 en previous study decrease study investigate whether also whether renal renal day group one day one day metabolic renal cause reduction day compare well group therefore chronic response effect effect reduce mechanism independent renal
26208472 en disorder severe general present early present study aim gene patient healthy studied diagnose test analysis perform gene use blood low test increase observed patient plasma level lower according plasma revealed index patient normal subject revealed gene lead target can without cause presence effect investigate study
19703807 en study case review history revealed weight age month weight also mellitus suggest cause patient undergo test gene test diagnosis gene revealed lead weight well improve therapy associate cause gene protein
25301491 en syndrome also known mellitus syndrome mellitus renal primary cause gene gene syndrome may contribute different clinical female patient syndrome diagnose age previous diagnosis type mellitus diabetic complication patient found two gene on analysis patient medical history review suggest case syndrome may remain due type mellitus clinical early
20374732 en normal elevated plasma concentration clinical disease may due two factor include disease low renal patient gene gene studied identify gene clinical also response plasma level normal increase plasma gene also syndrome syndrome mellitus disorder disorder syndrome include syndrome cause use gene gene provide
24588923 en change common complication study compare different treatment disorder clinical provide base evidence study review diagnosis diagnosis treatment
22433947 en result number condition system known cause include cell disease case cause diagnosis condition several patient follow-up diagnosis clinical consider analysis provide finding contribute diagnosis early
21301966 en impair assess response use patient history patient response case three patient presence age year range year patient previous demonstrated serum weight assessment concentration patient assess measured use patient undergo test month low plasma use serum concentration without patient develop significant show patient within month indicate assess patient known
17536072 en previous study patient syndrome mellitus relative diabetic however datum control type diabetic group diabetic patient compare population patient common type age diagnosis vs year duration vs year study glycemic control incidence control significant group type diabetic group vs respective significant lower insulin vs respective prevalence complication group observed type diabetic group difference patient control presence glycemic control can decrease complication observed previous study
26466837 en datum regard effect serum activity aim present study evaluate effect related population patient without known cardiovascular disease risk patient age year diagnose base test retrospective evaluate on total year healthy control group control obtain patient parameter measured significant patient compare control vs patient significant high compare control vs significant correlate serum serum level patient without cardiovascular disease risk factor significant duration increased compare control
23928668 en primary use treat system patient use research patient database identify potential case among group patient treat develop month analysis demonstrated presence patient treat case function test normal case use research patient database database identify index case potential case estimate prevalence case per patient effect treatment
26331225 en disease large due resistance patient related common well cause include disease disorder cell case female patient develop review also potential mechanism development
25449762 en disease case also resistance renal due gene function period weight may also occur female may severe found due occur gene treatment remain base low increased use potential treatment case syndrome due clinical low plasma level
22520736 en case general case provide mechanism well new provide gene care patient disease reduce health provide patient addition blood clinical characteristic can case
26707038 en gestational complication however may lead complication study case female patient associate reported diagnosis treatment
26928867 en female develop negative lead diagnosis renal syndrome clinical management week without need clinical assessment diagnosis management result increased
24788913 en present complication management diagnose analysis patient diagnose aged two aged due complication two patient severe impair two patient observed serum patient show concentration plasma three severe patient two patient therapy base may diagnosis may lead severe complication chronic status patient diagnose need base oral body weight level patient care
25832854 en gestational complication related activity common condition associate dysfunction present case woman week present severe include impair function renal diagnose demonstrated case may related cause on high index patient present complication associate dysfunction
26077742 en healthy adjust according need determined concentration result patient large primary result protein whereas associate use medication treatment disease cause review clinical diagnosis current treatment potential development
24630998 en on case present old disorder present on case follow new found three year although negative increase perform reported increase follow-up perform diagnosis diagnosis case reported case diagnose case follow-up normal well diagnosis diagnosis age can case
21727914 en two clinical syndrome large increased common type cause type syndrome also result resistance effect level renal two type primary well resistance different known clinical mechanism lead improve method diagnosis can provide new therapy
26024973 en due current treatment without develop however patient evaluate treatment patient undergo oral patient treatment new develop healthy individual without known disorder control subject score determined month oral treatment examine test score increased oral clinical change serum level two treatment score patient treatment oral healthy control difference among group significant test patient treat oral healthy control use assess patient
25855780 en reduce level renal may role renal health found protein cell significant increased concentration protein concentration also significant improve protein increase without blood level also increase increase primary cell renal increase effect may effective therapy
25079469 en disorder occur also disorder associate significant dysfunction complication obesity disorder mortality datum reported case report one large suggest increased risk patient report patient obesity change treatment period high may contribute treatment therefore
23587596 en resistance period general gene function may cause less severe treatment aim base report case hospital case review clinical characteristic disease include clinical diagnosis disease
23314181 en determine rate patient severe clinical intervention associate hospital level score patient month severe develop severe patient severe overall mortality rate severe patient develop provide rate time diagnosis serum range range respective mortality rate patient diagnosis early within first day severe associate mortality lower lower time obtain first finding associate pressure receive elevated pressure incidence patient severe mortality associate early less receive pressure
26201512 en present case cause may therefore may result
22644838 en aim study identify three different gene gene gene patient study included patient clinical datum patient include patient undergo test analysis patient medical patient patient two patient patient one gene clinical outcome may function study
24519262 en cell occur adult occur patient associate report three patient condition disease history outcome
25330715 en primary disease group disorder prevalence high diagnosis patient present range several disorder review disorder difference mellitus common mellitus
20500966 en review diagnosis management perform use identify subject identify review result conduct result review study use consider normal woman consider gestational can associate
26354794 en concentration reported three patient syndrome reported three patient syndrome without reported adult present hypertension serum elevated respective normal revealed treatment associate syndrome elevated elevated concentration lower decrease associate elevated type concentration may contribute due first report may related respective syndrome without reduction concentration suggest mechanism suggest activity
24286605 en great adult due cause resistance primary early gestational on medical history investigate duration medication use potential disorder base weight blood pressure assessment syndrome diagnosis base assessment result test severe remain serum great test obtain concentration investigate diagnosis primary although also suggest occur age year age year lead include case present current target therapy year
24158882 en patient mass cause disorder cause gene consider diagnosis on diagnosis risk impair present little history result analysis gene present review related reported base year clinical follow-up on gene found examine subject on review revealed known complication increased patient therefore clinical history gene important diagnosis lead disease
23916565 en datum clinical study investigate clinical study diagnose hospital medical review clinical datum patient age diagnosis year interval diagnosis year common patient low elevated plasma diagnosis common finding patient patient patient common cause cell cell two patient follow-up diagnosis common high index important may therefore early
25558016 en common cause report three patient present related cause cell three case test also show revealed presence system diagnosis without conduct patient treat therapy patient follow-up disease present case presence cell little consider present include may
24674575 en range severe well may develop complication associate report female present revealed weight severe show develop increased serum decrease high positive demonstrated associate report
21392661 en disorder cause condition may also develop activity cell condition may common cause may disorder care
22026638 en clinical condition case although datum common aim assess incidence cohort adult patient perform retrospective review database two identify patient undergo insulin tolerance assess patient found little one disease addition datum suggest adult patient may therefore indicate significant prevalence disease cohort may
25933447 en result show cause increased level however case may due present man develop treat therapy parameter patient
26152015 en evaluate effect effect weight presence control use weight factor found use weight occur serum indicate therapy effective control weight control weight control
24337364 en cause may lead report finding presence change diagnose age year range year treat low decrease three patient show normal renal treatment control remain show group reduce treatment patient remain three without diagnose treat early year respective range year follow-up patient show treatment disease improve case potential complication outcome patient follow-up patient
25248578 en disorder body among common clinical large different disease potential mechanism control therefore patient diagnosis management disorder body primary disorder body disorder body relative body disorder body relative body disorder disorder syndrome first review mechanism two major body major disorder cause include diagnosis treatment disorder
19763586 en occur patient present clinical one case reported early due consider diagnosis patient present month revealed study show mass diagnosis consider on mass show patient present patient mass report case
22114999 en occur patient system may associate clinical reported retrospective review case care patient aged month year included severe system event patient diagnose first day system develop serum concentration syndrome develop overall mortality month result patient develop system high mortality development within first day plasma significant outcome
23275040 en cell group disease cell report case first without evidence without evidence present case may important clinical addition common follow-up important diagnosis
20953066 en disorder woman first time woman syndrome result reduce increased activity although disease found cause population study show disorder may first time case two female first disease first time diagnosis clinical test result increased activity cause dysfunction presence gene treatment result less severe clinical patient patient treat oral although disorder may health case patient effective diagnose treat regard
25923040 en due elevated plasma patient evaluate cohort patient measured logistic regression model assess relationship level patient develop level significant lower patient develop vs complication vs logistic regression analysis revealed association concentration known factor adjust odd ratio confidence interval patient positive value negative value day blood sample obtain care vs time patient undergo low level whereas high level therefore may early management
23380272 en gestational clinical disease prevalence two three per may associate report case gestational two month syndrome cause case gestational treatment
24352504 en common cause treatment general increased increased due investigate whether effect cell treatment cell reduce also reduce lower increased cell protein datum indicate cell independent treatment revealed significant reduce increased compare treatment result reduce blood level datum indicate effect independent may reduction rate due
26134705 en disorder cause gene lead determine clinical characteristic patient two different diagnosis test diagnosis gene on total patient three healthy relative two analysis revealed previous reported on gene compare clinical characteristic two age on range year year present disease age present time case treatment chronic result
25225198 en report case associate care develop use patient develop adverse drug indicate relationship development mechanism case report report patient develop serum diagnosis potential complication
25271879 en cause period diagnosis low weight report present day present normal rate although increased normal on test perform reduction possible diagnosis period elevated weight low important
26586714 en cause present result analysis gene large on patient analyzed clinical datum hospital patient severe test according increase evaluate gene perform analysis three base lead on protein show compare type three base may analysis need function protein
19454377 en review patient review examine normal related change occur associate complication management cause occur woman woman decrease impair renal addition woman cause may associate increased complication include management cause may lead early diagnosis treatment reduce risk overall show effective treatment cause factor
26837398 en review incidence clinical risk factor well treatment patient undergo hospital retrospective review on total patient studied group patient characteristic studied use difference group found use population mean difference group assess use independent consider statistical significant less patient undergo high prevalence significant lower group significant significant study group mean patient need month significant number study
26832361 en disease cause dysfunction effect diagnosis medical history clinical case report age month year respective history base case history result clinical analysis blood diagnosis diagnosis finding test diagnosis three known analyzed possible although disease although occur consider diagnosis test may diagnosis consider although identify disease associate
26353165 en one common disorder result renal cause low presence high serum review diagnosis management recent
25439412 en on case associate present
23563855 en study assess change renal patient
23666224 en on female present hospital revealed therefore diagnosis low level observed although analysis normal revealed therefore also diagnose decrease treatment therapy although complication patient study develop treatment
23242859 en lead increased hospital increased medication patient high risk develop care follow-up study review determine associate patient population determined value patient develop large type retrospective review patient undergo examine patient characteristic relationship case case statistical significant included significant development serum change level increase serum positive development serum positive identify risk factor care patient large demonstrated multiple risk factor development finding report identify patient risk treatment increase high risk patient
25430399 en patient risk develop due condition treatment aim assess impact compare normal study included patient identify database retrospective case perform clinical patient total plasma patient normal plasma patient normal common significant patient normal due complication related compare patient normal develop significant vs significant vs management significant incidence complication also associate disorder increased patient potential complication
24286261 en finding patient occur patient patient patient patient three patient gene patient known therefore perform gene common three patient cell one patient two
27258490 en condition impair response cause report case present history medical hospital revealed severe renal show diagnose medical therapy cause may present severe condition therefore perform early treatment renal function
19304550 en factor contribute total case retrospective analyzed factor associate incidence case early early show significant patient low incidence correlate factor age treatment patient incidence significant high patient related
27117808 en gene may cause renal cell cause syndrome present within demonstrated test resistance similar rate show control decrease protein compare control
25007407 en common potential condition remain poor old compare prevalence decrease among adult also assess serum possible decrease whether potential factor independent correlate decrease study treat care aged year old adult aged year patient undergo test include serum adult similar rate decrease compare patient reported less although correlate current serum less less age duration serum level independent associate prevalence decrease similar adult old patient less report although correlate may clinical suggest increase decrease age duration high level may potential event renal dysfunction
23891008 en common disorder however cause patient include also dysfunction report case new diagnose on woman disease undergo two month due on test treatment result demonstrated consider finding month show change although patient health without treatment consider patient present
23800642 en associate obesity impair report mechanism although known development suggest associate impair
24821875 en syndrome multiple dysfunction cell occur association primary disorder without metabolic without disease present first case syndrome present case associate syndrome may due severe dysfunction
24074370 en syndrome common first although case result syndrome observed case clinical finding among severe clinical finding common syndrome
23947429 en case severe year old female increasing remain serum glucose normal receive serum glucose increased receive high insulin evaluate serum receive patient develop severe severe treatment
26588450 en without complication disorder associate great high risk develop due condition treatment outcome investigate clinical outcome patient patient diagnose study follow included analyzed cause group clinical outcome patient condition two case follow-up period year one patient found three patient observed without patient without develop vs vs severe without common cause remain age year one patient normal may patient high rate
23538895 en cell large group syndrome disease may multiple system include system report adult case cell present
26030323 en cohort show prevalence different cause include study determine cause care clinical patient hospital identify retrospective patient mean age diagnosis mean follow-up different cause group age diagnosis presence analyzed patient measured use cause case patient diagnose condition occur year diagnosis common group group vs present little patient patient diagnosis vs common cause previous reported patient high rate diagnosis patient diagnose cell year diagnosis consider less time on method may cell
24961627 en disorder associate reduce activity include syndrome associate decrease function two use identify clinical patient high severe include severe two identify gene follow-up show normal level sample level blood serum activity significant reduce two patient analysis revealed low severe syndrome disorder
26473756 en clinical case occur present care patient day develop low treatment result reduction increase increase suggest diagnosis clinical week treatment cause first report develop
22120859 en however common early management improve investigate clinical diagnosis management cause retrospective review patient first diagnose clinical function management retrospective clinical study conduct medical patient mean age year hospital revealed mass patient patient measured level low patient treatment included although patient poor one patient year suggest early diagnosis present patient mass diagnosis on primary aged patient
19777917 en report case woman present on diagnosis show patient treat two year develop show mass on patient treat response mass case clinical follow-up diagnosis review
18926448 en incidence risk factor severe effect complication outcome evaluate large conduct study patient level severe score potential risk factor analysis included logistic regression identify independent risk factor association mortality age mechanism blood pressure score body patient patient occur patient patient presence major influence incidence independent risk factor independent risk factor adjust odd ratio CI adjust value incidence severe high independent risk factor include associate significant increased mortality
22630107 en disorder patient diagnosis clinical report case month old present event decrease oral revealed on diagnosis include serum disease show
25266413 en indicate diagnosis evaluate incidence clinical characteristic perform review patient treat treatment outcome evaluate patient age year year remain year follow-up year receive two one interval one year case patient case three patient normal serum value compare case two case remain follow-up range year one receive case observed therapy interval may poor clinical patient remain clinical treatment cause
23393172 en syndrome period patient present week develop severe can control within aim study patient cause treat presence patient serum week response different treatment evaluate activity study patient serum associate cause clinical consider patient evaluate patient present
24156710 en disease due report first disease disease two age year result test gene result test analysis revealed year disease two suggest individual difference influence factor may present perform patient clinical result
23988090 en aim study evaluate clinical characteristic treatment outcome patient present patient present retrospective evaluate patient included analysis ratio age year patient patient diagnose cell patient overall rate rate patient rate according cell case statistical significant may important clinical disease cause diagnosis cell
22969261 en disease result normal response present case patient undergo on undergo patient develop diagnose patient day result dysfunction also possible function therefore suggest possible cause
26828532 en diagnosis clinical analysis present care treat patient also history analysis use large identify use gene gene large due identify report patient patient undergo analysis on diagnosis patient treatment
20686294 en disease first reported clinical mellitus cause gene result serum however little known disease associate report case
25746463 en clinical disorder renal cell one cause include study reported treatment recent research mechanism dysfunction cause mechanism protein cause renal therapy study mechanism role disorder regard develop therapy aim may effective lead treatment present use body
25367057 en two present age year month year month diagnose age year develop response treatment history analysis cell identify gene characteristic syndrome type cell cell negative positive develop year diagnosis present case show characteristic also found
23609837 en cause renal resistance effect cause disease chronic drug reported cause aim study report case man patient present day history chronic disease normal blood glucose level on test indicate plasma serum test positive reported month develop renal show low cell indicate renal revealed analysis presence patient receive week reduce month plasma cause cause
22323586 en present study role high increased decrease increased determine whether examine revealed response effect significant increase suggest may cause decrease well period high reduction increase suggest target can target disorder
22789859 en treatment plasma concentration decrease plasma elevated plasma within range revealed mass perform sample revealed without evidence population cell identify cell diagnosis primary
24476077 en associate significant due treatment effect little known effect primary treatment clinical obesity health outcome adult study examine health outcome adult base primary treatment presence study included retrospective metabolic database datum analysis adult according primary treatment one vs treatment presence patient undergo without receive compare group patient develop compare patient without high rate body mass index mass fasting glucose hemoglobin lipid among vs patient patient vs without primary treatment receive presence group associate high rate health outcome different development dysfunction whereas associate high rate dysfunction weight high body mass index mass patient role important factor obesity patient
25210759 en associate diagnose present case due develop develop present associate include due high index condition
22392832 en syndrome condition type renal dysfunction glucose syndrome reported treat case reported adult man hospital day treatment severe renal dysfunction syndrome receive therapy result patient hospital blood cell increased use adverse drug indicate relationship score patient development syndrome use diagnosis syndrome adult case well conduct review regard syndrome mechanism case suggest patient treat renal function identify adverse event model show treatment research use drug
25501964 en recent increased incidence less period reported condition occur study aim investigate influence studied cell function two woman positive history disease presence without clinical month first function evaluate baseline year present baseline patient show increase one patient patient development clinical therapy cause clinical first therapy month period respective function follow-up patient disease can consider gestational function patient may early diagnosis early therapy can
24670345 en little known present week within develop day develop result several level within suggest low clinical parameter
22071315 en result treatment base therapy patient oral also recent recent provide patient effective normal without patient risk
18843966 en investigate clinical treatment gestational total case gestational first hospital medical hospital hospital analyzed case effective treatment three case treat three patient one patient gestational severe day month normal normal range serum duration day two care treatment one cause case one first case hospital week treatment one week among follow-up day disorder syndrome first treatment patient gestational early diagnosis management disease may reduce period
25612752 en complication may on woman history present week decrease oral diagnose day however patient develop severe per day due serum patient improve oral may low serum impair
23643004 en management clinical datum one patient treat hospital retrospective increased plasma blood test revealed diagnosis high found show positive treat plasma concentration test diagnosis treatment may cause
26180540 en show related analysis analysis protein present analysis method protein analysis within different cause disease method protein datum analysis show present analysis provide protein present influence protein disorder known protein general present new method new within use
25600576 en disorder one common severe disorder datum related disorder included one treatment disease significant risk complication use renal case present care patient diagnose disorder complication treatment use care intervention need patient aim level
21932559 en prevalence due elevated large number intervention overall estimate year patient treat first activity
24522493 en disease cause type gene function plasma cell impair concentration develop evaluate effect function model found cell base day parameter significant increased level protein primary previous reported treatment increased plasma receive treat reduce show increased addition plasma finding new treatment
26962793 en clinical significant also common report case diagnosis clinical aim diagnosis present case man finding diagnosis present analysis patient disease review patient undergo result revealed patient improve period characteristic clinical lead diagnosis report first reported case present although consider diagnosis
24736047 en common use patient compare old duration known complication report complication occur due present
23064994 en on female present history revealed response serum analysis within value identify test follow increase diagnosis oral effective treatment follow-up
22504649 en increasing number disease associate contribute disease whether cell can model cell develop associate cell cell model related datum cell
24825090 en report case history blood test metabolic plasma concentration low analysis show high finding type syndrome gene revealed test positive show gene show condition patient investigate syndrome on gene show new patient
27577218 en potential datum patient blood sample patient gene patient present revealed patient analysis identify gene patient due gene
23062886 en present patient patient month increased decrease oral lead development patient well treatment patient diagnosis consider new diagnosis patient known
24532100 en result therefore diagnosis clinical diagnosis patient patient retrospective review mean age diagnosis year range duration follow-up year range patient patient diagnosis patient change follow-up patient increase two patient found three one patient respective diagnosis patient undergo cell one cell one disease patient assessment
20401697 en on regard previous diagnosis primary normal concentration treat base history perform gene analysis gene revealed change normal cause change gene common patient present within first year patient may normal normal finding may patient well diagnose
26244674 en disorder due resistance reduce patient may also present female cause report due gene previous on patient test age on renal profile normal show similar previous investigate gene identify analysis revealed large gene also found patient significant improve treatment analysis revealed
26679670 en patient reported present characteristic patient year develop month also show rate protein activity factor test show addition test however evidence diagnose disease patient diagnose patient treat impact therapy week also receive treatment reported however patient poor
20664450 en may related effect condition may include patient develop diagnose change week significant study revealed normal serum also association cause case case history may role case
25646595 en due little analysis examine impact mellitus DM patient undergo study association complication addition analysis associate patient perform complication rate DM patient undergo recent sample database evaluate patient undergo patient DM diagnosis cohort vs little DM patient great incidence complication little incidence age great incidence complication present among patient year age high among diabetic compare associate great hospital among patient DM patient undergo significant great incidence complication among patient age great risk complication age due impair DM patient association among
24408226 en regard mechanism syndrome study reported primary renal major factor however factor influence remain include role report develop first develop low low serum level low revealed therapy develop first known reported case patient finding suggest response increase serum cause renal need role
22307687 en study identify test perform three three healthy blood individual three gene test patient diagnosis analysis revealed gene result high gene individual gene cause due impair function protein presence suggest important normal
24276447 en consider study determine whether can diagnosis present study conduct patient undergo clinical month month year year function also adult total patient age year base determined time diagnosis impact function overall subject receive diagnosis within year cell follow-up consider disease follow age year identify patient within first month significant correlate dysfunction without related show three patient develop cell develop year patient risk base value outcome include dysfunction new provide management patient
26674602 en low serum level common cause mechanism analysis day protein perform mass use on total protein include significant change decrease analysis revealed protein associate target study protein show cell day increased number also several protein cell also cell protein include early event
24662557 en system however system present case present patient female therapy also review reported case common female may present clinical may occur disease early treatment may
25594563 en on reduce plasma total cholesterol level recent show effect increasing level role determine effect independent cholesterol level increase new patient disease effect therapy related determined well
26795912 en present patient disease undergo develop period patient disease may management possible mechanism improve patient potential complication
20662355 en due associate mass effect rate incidence increase report present revealed follow-up undergo total revealed change follow-up develop addition mechanism regard case present due cause
23386174 en study aim determine incidence early compare finding analysis clinical datum adult case analysis determine incidence response first week compare large high incidence age group adult incidence adult respective significant high incidence previous new adult associate response serum common significant cause undergo high incidence whereas previous new among adult management need response
21742615 en report first case associate clinical woman develop month receive develop treatment diagnose significant previous reported first case associate
22639945 en case cause result patient determined early age well however condition cause cause lower oral cause development several common severe great cause possible overall development improve effect high case show potential risk related treatment
24121282 en protein new protein protein condition level increase response datum suggest subject cause gene protein can possible increase cause patient analysis demonstrated can potential decrease compare cause decrease datum revealed mechanism decrease reduce protein
24030030 en on retrospective analysis conduct cohort female gene compare analysis patient age diagnosis year old follow-up year patient rate weight patient respective one patient low develop renal disease statistical significant correlation found one patient female analyzed may influence clinical female patient current outcome
23950570 en disorder cause less case due gene diagnosis management condition remain report two patient history chronic present early result test diagnosis gene patient patient previous gene patient treat patient develop severe week medical treatment report gene important role diagnosis status therapy
17467188 en well known several may associate impair high function increasing evidence effect change reported protein recent report cause gene system subject may present impair examine function diagnosis perform clinical study investigate whether may associate high function
22503803 en cause response decrease result clinical diagnosis presence common disorder drug common type management reduction
26714855 en cause gene investigate subject cell protein gene protein cell condition analyzed mean protein studied use protein protein level assess datum suggest due gene result analysis cell protein revealed impair protein demonstrated cell cause protein population well impair protein plasma concentration
23908517 en may cause multiple include dysfunction patient management remain report patient serum sample treatment serum primary normal reduction however reduce high oral multiple remain although high oral medication
21913433 en cause occur severe complication function present case patient diagnose week
25587115 en role renal cell increase increased use negative activity assess role however level indicate primary effect great reduce level control protein level reduce lead effect reduce protein level finding role model
17633279 en study treatment decrease incidence complication improve treatment clinical datum case recent year retrospective review include incidence treatment statistical case total include case case within week treatment within week within week case occur use effective treatment
20387708 en gestational case may may subject previous reported case report case study present case examine
24673433 en common use treatment disorder datum indicate high first time report cause risk associate use condition risk adverse effect one use
23843580 en disorder cause first management however one effect study review use effect review patient follow one patient female included patient patient result patient oral remain oral patient oral factor patient compare oral however difference per treatment use patient include interval management remain patient
23417911 en may result dysfunction report case therapy result disease month
23032148 en treatment adult complication common complication case case multiple present develop complication patient multiple response complication cause compare case study conduct
18777727 en case report finding reduce decrease weight examine day decrease low on blood cell profile blood analysis revealed increased serum increased serum receive healthy per day general condition improve treatment although concentration serum decrease concentration remain high normal base finding diagnosis revealed severe diagnosis
22707619 en complication function may assessment method on significant medical history present test revealed negative patient first reported case due possible use normal function patient therapy
23511046 en disorder clinical concentration without identify report case cause disorder
17261971 en body reduce plasma disorder two type cause cause impair response patient treatment however treat treatment cause possible reduce therapy
17100823 en different cause association function reported however reported syndrome present syndrome develop dysfunction dysfunction within week development may result increased activity cause function cause syndrome woman disease result cause development assess
25877068 en treatment disorder however chronic use development condition due resistance renal protein level potential show significant study revealed study show study potential effect target resistance study finding may development method treatment current therapy effect
21906986 en on present severe demonstrated mean low measured concentration clinical response show mass demonstrated cell case report first cause system
22695750 en disorder present severe early different gene identify study present gene cause clinical assessment test present diagnosis analysis gene clinical history demonstrated test renal concentration revealed subject reduction follow-up one subject analysis revealed gene subject high clinical assessment diagnosis status also
24927661 en although may result condition may cause severe develop patient undergo time due perform patient regression follow observed
25740874 en due perform aged month negative history patient gene on patient two gene different first change cause addition similar protein level healthy subject patient major observed patient well patient associate gene gene change finding management
21701131 en known develop response known factor studied response primary aim identify possible year old undergo primary studied patient age range year patient develop response factor duration found response patient develop response primary number patient develop response factor associate duration can identify may due sample
23364801 en study disease develop target treatment study disease primary contribute mechanism concentration identify well also complication treatment review associate disease syndrome current mechanism clinical investigate model
21768374 en increased target cause treatment condition increase target current therapy present study examine increased cell increased increased whereas increased cause severe great treatment increase different provide new treatment
18486932 en characteristic include due diagnosis may diagnosis may diagnosis follow-up retrospective study syndrome hospital test test use without plasma patient severe one one patient primary diagnosis remain three patient patient two patient one cause consider patient follow-up patient year two month year month range month year follow-up finding function test primary patient identify potential
17515893 en on woman present week previous revealed mass function show patient undergo mass without significant complication day develop plasma serum patient treat status serum level serum patient patient treat remain therapy chronic
22921808 en common complication occur define increasing serum patient lead metabolic treat reported incidence range factor rate include reduce lead
19135619 en common system cause syndrome cause two condition occur patient case system retrospective review clinical characteristic assess patient aged month year study common severe system event patient diagnose first day system syndrome occur day outcome patient status syndrome may occur system on may diagnosis diagnosis treatment different
19123039 en present case primary system present cause on present status change patient determined significant demonstrated follow-up patient disease therefore undergo diagnose primary large cell result disease finding patient case patient
20329585 en adult cause primary cell disease patient also occur adult case first cell patient first disease one patient show patient diagnosis change significant glucose cell first patient also cell day patient show perform show cell identify high number positive also patient show increased activity disease assessment revealed presence disease patient diagnosis result first disease case potential condition therefore aim disease
23019836 en group system disorder consider important disease include report case patient diagnose disease present treat clinical finding well important disease receive occur
26337818 en due system cell current treatment include drug reduce recent study treatment may may effective increasing patient old therapy treat day period treatment treatment analyzed blood sample also obtain primary day therapy treatment result reduction vs serum vs increased vs vs patient well adverse consider treatment therapy
25876576 en on woman due weight level reduce however elevated response patient low mass mass finding indicate type possible
21072537 en severe report case severe significant serum level on response cause well oral age month month test revealed normal without without treatment remain can consider cause severe may management pressure
24051558 en common week regard undergo develop period control oral on test week reported time medication year year on test normal concentration remain normal function mechanism may
23781855 en relative common complication report case develop patient chronic woman present week demonstrated significant revealed chronic treat hospital develop change day follow-up show significant change perform develop care however day chronic complication study also possible mechanism management review
24729116 en woman develop treat present follow on present revealed mass treat treatment show month treatment patient present similar may common treatment related
21828935 en major cause severe associate disease cause reported case man health month present development show increased patient show elevated serum low low level finding revealed function normal revealed significant due base finding diagnose type on oral however occur day diagnosis regard time patient although present case mechanism may associate
22427315 en renal cell type lead cell result disorder associate gene cause patient lead high risk review current regard cell development base new current also
20482919 en syndrome disorder first age year diagnosis base characteristic mellitus present diagnose mellitus age year respective develop year case diabetic possible syndrome syndrome also consider mellitus
23240316 en cause due different condition result normal lead include adult due present case disease found diagnosis base test clinical treatment on general provide management
20585348 en on man history base normal revealed mass demonstrated also develop level serum fasting total factor mass present development patient treat medication intervention develop disorder
18278747 en metabolic disorder cause response result low two
24854529 en assess oral characteristic treat included mean age day time mean serum value respective level case revealed case two serum level normal mean duration mean rate one due weight normal mean follow-up duration treatment first year
26777048 en develop cell system patient present finding on patient present report
22286785 en common care associate outcome cause mechanism aim study determine incidence outcome compare cause found serum patient disease period year care first diagnose according measured serum response remain observed incidence complication outcome mortality found mean mean difference serum serum two group however patient indicate low positive difference score incidence complication score mortality patient group receive therapy logistic regression analysis show independent mortality high level serum odd ratio or per increase confidence interval CI less or CI type care serum level type
22145469 en syndrome multiple dysfunction cell occur association primary disorder without metabolic without disease present report first case syndrome present case associate syndrome may due severe dysfunction treat severe metabolic treatment also normal blood
24280991 en disorder group disorder well assessment general subject investigate clinical method provide individual use observed assess activity protein well use several type gene activity well primary finding year age multiple significant identify known type gene base diagnosis medical management provide disorder multiple clinical
27180678 en association mellitus general population influence study aged year general population response rate participant undergo diagnose finding logistic regression analysis estimate association mellitus association also analyzed high prevalence participant mellitus without mellitus vs prevalence participant mellitus significant high participant without mellitus vs however prevalence similar vs similar present man woman cardiovascular risk factor independent association mellitus remain total sample odd ratio confidence interval odd ratio confidence interval odd ratio confidence interval mellitus independent risk factor general population association present total participant participant
27513365 en disorder present cause gene clinical disorder great different present study report clinical characteristic patient cause patient two individual case diagnose included evaluate result revealed age range year range one patient three patient one patient two patient treatment included two case present case revealed gene finding present study indicate different clinical age provide diagnosis also identify may provide development
24675466 en cause gene protein although can mechanism cell reported study remain subject model analysis demonstrated subject week also demonstrated analysis revealed protein suggest time treatment protein protein increased number suggest can well subject week datum demonstrated subject although primary include time cell
22073870 en woman diagnose disease treat oral decrease develop due show show cell identify cause diagnosis result clinical follow first reported case
21041172 en current clinical study patient clinical finding review regard clinical woman develop severe follow syndrome primary present diagnose develop evidence serum great clinical status improve significant diagnosis syndrome although syndrome known complication consider blood renal important consider syndrome present cause early possible improve clinical status patient outcome
22592189 en case normal report case woman present provide possible mechanism management woman present week first revealed mass level day finding suggest association time patient healthy week associate treat
19373493 en current therapy decrease obtain mean renal report case therapy report evaluate response
24021616 en year one chronic follow response mechanism lead result evidence indicate presence due evidence increased chronic also suggest associate event evidence disorder include disease contribute use may provide treatment disease research potential treatment
19820898 en patient cell present dysfunction include recent use management patient patient treat period hospital review patient receive consider patient compare patient studied number day hospital per change level per day complication related patient compare patient patient change level observed group group one patient patient complication risk factor complication base use role management evaluate management
22863389 en outcome number disease one common cause may also among disease reported increasing history according presence cell relationship function characteristic can several medical treatment clinical result
26831749 en mellitus define impair insulin within month present regard management glycemic control insulin glucose system provide glucose level insulin
25006961 en effective patient decrease due chronic reduce target may effective method type control treat day increased lower day treatment whereas change concentration analysis revealed lower day however similar result observed also treat week increased whereas treat increase lower week whereas treat reduce elevated datum show protein development severe associate therapy
18728034 en case patient undergo aim present patient per day
21164566 en mechanism decrease study examine two mechanism effect renal parameter renal control period group group period group elevated associate increased decrease period however group elevated period group two effect elevated first lead reduce effect result low high normal
16544179 en syndrome patient without disease may therapy patient report case woman without healthy cause severe low result revealed low diagnosis control treatment drug follow-up reported control significant review number report report similar treatment disorder therapy base result case outcome present suggest large study patient assess intervention
22761233 en patient common disease diagnosis follow-up recent year case associate disease reported case reported previous present case diagnose several year test patient treatment diagnosis patient diagnose can develop due disorder on high index clinical early diagnosis treatment disease can complication improve patient
22712777 en on present severe present year chronic year clinical serum show undergo test day remain on cause found consider condition consider case severe
24527719 en datum study provide datum drug patient study period use datum patient study use time total patient period period prevalence rate period investigate patient per high prevalence old adult year age period prevalence rate decrease year patient per incidence rate new case found patient per incidence found per patient oral treatment provide drug one patient use drug need hospital due severe occur patient period female incidence ratio woman man case little patient whether remain whether use need female patient number hospital due severe patient
20459358 en clinical subject aged year respective history clinical diagnosis sample gene well gene determined analysis revealed gene on gene identify one known cause previous however influence whereas therapy increased on occur normal study effect associate early can due significant clinical risk need treatment result response
24212879 en cause patient increase however patient due patient can study investigate patient review patient three hospital use database medical system examine whether can mortality patient analysis patient remain patient analysis show incidence significant high patient compare patient on total patient follow-up duration month range month three statistical analysis revealed risk patient significant high patient patient can cause
24628417 en type lead studied previous patient evaluate high perform cell examine use cell level determined use effect type test show normal cell low whereas clinical use also different type function effect effective concentration base finding patient suggest can function without significant effect
24026507 en disease cause type large response identify gene patient revealed patient clinical datum test diagnosis patient severe treatment however can well due type addition gene analysis level gene result three two one protein show cause gene protein also may lead protein activity
27835951 en datum relationship obesity mellitus prevalence remain report population study datum relationship obesity mellitus general population cohort three adult year old follow period datum use adjust health ratio obesity association mellitus obesity analyzed logistic mellitus prevalence participant metabolic syndrome respective within group follow-up period year incidence obesity follow-up prevalence obesity significant increased whereas increased prevalence general obesity significant mellitus independent associate age blood pressure body mass study association mellitus obesity general obesity increase obesity prevalence population within follow-up period
27448295 en study aim examine factor associate mellitus among patient study hospital study patient adult aged year one time medical health patient according assess association factor mellitus among patient period patient disorder one time total adult man woman analysis prevalence ratio mellitus confidence interval CI among man CI among woman hospital factor associate mellitus among man among woman factor adjust odd ratio or confidence interval CI medical adjust or CI associate mellitus compare woman significant lower adjust or CI factor type status associate mellitus among woman
22033074 en syndrome diagnose condition association little disorder case syndrome report case patient diagnose history elevated low syndrome increasing develop function result report show may influence disorder lead although risk development syndrome may health possible presence clinical consider woman
18578860 en reported type result development however mechanism present study aim change analysis change plasma concentration show change show on found time correlation among change plasma concentration study first demonstrated development study time correlation among
21592500 en determine assess history conduct retrospective review patient diagnose medical on cohort patient medical diagnose evaluate retrospective diagnosis first cohort patient cohort develop receive diagnosis patient healthy patient remain first develop patient patient diagnose important diagnose year patient population
27614316 en show increased mellitus glucose type decrease female however also increased mellitus whether factor mellitus research increased fasting blood glucose level increased serum total cholesterol level glucose tolerance test insulin tolerance test show high glucose level high insulin level glucose protein negative correlation decrease glucose tolerance analysis significant correlate show decrease glucose suggest increased mellitus may role development decrease glucose tolerance
16444918 en diagnose cause two different impair impair renal response effective treatment
24053101 en on year old patient history hypertension on severe cause presence hypertension primary plasma level measured elevated level high plasma concentration primary renal on treatment pressure control chronic cause
23512390 en present first reported case system provide case review known present previous reported case history review system may early system
26264400 en mellitus common complication renal increased cardiovascular mortality subject type T2DM increased glycemic poor glycemic control associate cardiovascular complication therefore aim determine glycemic glycemic control subject T2DM study analyzed subject without control subject T2DM subject use glucose several index glycemic control index glycemic control different control subject value index glycemic control glucose mean similar T2DM index glycemic index index show high value T2DM value range T2DM subject show similar glycemic control glycemic significant high T2DM datum potential important difference T2DM indicate increased glycemic may factor cardiovascular mortality patient
22467619 en syndrome syndrome event patient syndrome however difference diagnosis treatment syndrome syndrome syndrome outcome patient
22783645 en age result management age group high due risk high low renal addition may decrease report management different type
17308961 en gestational disorder activity syndrome may associate use case method report case gestational
20467161 en plasma cell multiple associate increased serum level characteristic finding disease may result chronic recent case disorder include case associate impair report two case well two previous case found database diagnosis disease clinical disorder serum level
26729021 en fasting blood glucose datum disease risk factor estimate prevalence impair fasting mellitus identify associate factor conduct participant adult aged year on sample use sample fasting glucose measured estimate datum use weight use participant mean age year year female overall prevalence confidence interval CI whereas mellitus CI prevalence CI among CI among female whereas mellitus CI CI respective prevalence CI among CI among whereas mellitus CI respective participant identify status factor associate body mass index total cholesterol factor associate mellitus age prevalence mellitus low population provide status present complication
26684166 en determine prevalence mellitus among patient difference clinical characteristic outcome patient without mellitus population retrospective study new diagnose patient included clinical characteristic outcome mellitus base medical prevalence mellitus among patient patient mellitus old positive treatment duration CI high month positive CI high rate CI prevalence severe clinical characteristic poor outcome patient mellitus early two disease
25878236 en present case woman first present week on diagnosis base elevated elevated day elevated elevated low syndrome patient develop management care period week clinical
20118941 en report case syndrome disease suggest common treatment may patient
27338180 en current datum insulin patient datum primary related severe aim study assess associate increased study use hospital datum first cohort rate mellitus negative regression use incidence rate ratio ratio factor health status cohort time confidence interval CI three time number day hospital mellitus diagnosis CI cohort rate significant elevated year CI year CI significant elevated cohort first year compare CI significant difference found year CI increased hospital rate hospital mellitus cohort provide evidence effect blood glucose insulin first year period significant elevated mellitus time result suggest clinical management mellitus
27816028 en on high prevalence mellitus patient observed study aim investigate whether mellitus factor develop case study group control group number sample subject without characteristic case analyzed prevalence mellitus case control use age range patient female age occur great patient study group mellitus compare control increased prevalence mellitus group statistical significant risk factor development two disease correlation mechanism positive association provide new may new
27445532 en cell system adult current although disease possible high finding include diagnosis base clinical finding treatment include potential use disease
27894278 en prevalence mellitus factor associate increasing rate among different group group may lead mellitus cardiovascular disease due present study conduct assess prevalence factor associate mellitus impair fasting glucose level among study conduct may study participant study population little year datum use blood sample base datum logistic regression use subject study prevalence overall impair glucose impair fasting glucose whereas history first relative hypertension ratio show statistical prevalence mellitus age history hypertension BMI ratio found associate impair fasting study identify high prevalence among on mellitus disease health health
22139588 en determine recent reduce incidence cell case cohort patient treat analyzed overall incidence case present time diagnose develop follow-up period year patient risk analysis two case case disease observed case effective reduce however complication
26382617 en aim current study examine association serum level mellitus previous study suggest associate mellitus risk however associate among present evidence independent base health conduct among measured serum level outcome mellitus assess current use insulin oral medication plasma fasting glucose level level model age ratio total cholesterol body mass high serum level positive associate mellitus estimate association among level evidence mellitus association characteristic study need investigate association
25673782 en syndrome dysfunction effect consider cause lead effect syndrome study evaluate prevalence mellitus patient review evaluate prevalence mellitus hypertension syndrome patient rate index general population study patient rate analysis patient woman syndrome patient patient reported individual patient reported case patient year old reported individual patient year old reported individual prevalence hypertension show health prevalence mellitus lower found prevalence mellitus patient syndrome low may diagnosis management patient syndrome
27006479 en study relationship risk mellitus study assess use mellitus test associate lower adult aged year mellitus baseline total plasma measured blood health study health follow-up study mellitus base test medication risk assess use cohort finding follow-up year new case mellitus diagnose analysis adjust metabolic risk factor individual high plasma lower risk mellitus ratio confidence interval high plasma lower risk ratio confidence interval high lower risk ratio confidence interval finding similar although confidence interval statistical cohort high plasma concentration associate lower mellitus result similar finding need potential health effect metabolic
16456689 en cell disorder disease on common disease disease system develop characteristic also year show mass found system patient undergo analysis show multiple cell positive cell diagnose patient day undergo therapy cell dysfunction patient undergo
23825070 en chronic treatment previous show increase cell lower cell cell present study show change day time identify first time type positive cell cell type present day cell cell show time suggest cell cell can cell cell
23751384 en management first case clinical treatment case review diagnose identify range age diagnosis day diagnosis vs day case associate however patient diagnosis patient multiple common compare oral plasma lower compare oral vs case diagnose clinical difference oral less serum
24053747 en cause cause present revealed show finding evidence metabolic suggest also investigate diagnose review reported association report case early diagnosis treatment
23595122 en gene cause syndrome disorder clinical include mellitus DM associate DM investigate subject patient DM patient patient found include three significant high patient DM control patient DM high control similar increased independent group patient DM result previous finding contribute risk DM
26338721 en mellitus prevalence increased may patient high risk aim study possible mechanism mellitus review current investigate incidence diabetic patient evidence positive association mellitus risk indicate risk may glucose cell function insulin resistance effect addition may also correlation mellitus although correlation correlate elevated risk lower mellitus associate risk study patient outcome overall patient
26130110 en report retrospective review treat cohort patient age therapy month month patient patient treat age therapy month month response addition receive therapy patient patient effective response observed
26754626 en prevalence mellitus patient reduce known investigate determine impact mortality examine clinical outcome patient reduce according history mellitus glycemic status baseline hemoglobin hba1c mellitus mellitus regression model adjust known poor outcome patient history mellitus high risk primary outcome cardiovascular mortality compare without history mellitus adjust ratio confidence interval hba1c show total patient mellitus mellitus ratio patient mellitus hba1c known mellitus compare hba1c respective patient mellitus also high risk ratio compare hba1c compare range hba1c patient reduce common mellitus associate high risk adverse cardiovascular outcome compare patient mellitus hba1c compare glycemic
25977574 en control mellitus however concentration lower adult increase base subject range adult may use age provide present study evaluate mellitus mellitus patient patient mellitus two patient mellitus included measured compare determined use reported base blood glucose day significant lower whereas significant difference measured concentration patient mellitus lower range adult whereas concentration within range demonstrated concentration therefore control mellitus patient
25900428 en aim study assess whether mellitus associate overall disease among identify role disease association retrospective study aged year without health current included use identify outcome independent mellitus outcome overall logistic regression assess association adjust age status adjust potential mellitus significant associate overall odd ratio or confidence interval CI or CI disease or CI or decrease CI overall disease association mellitus or CI disease or CI statistical significant disease association mellitus disease suggest mellitus associate independent overall among disease
19729836 en severe disease cause gene result renal therapy develop primary due model develop first model gene can study treatment analysis indicate adult characteristic include resistance gene analysis renal renal activity chronic treatment great reduce major include change renal due cell finding new new potential treatment
18277371 en age cell general occur first three clinical general determine due cause syndrome however diagnosis present case demonstrated normal function show patient therapy follow-up function low on demonstrated suggest diagnosis case report early diagnosis improve disease follow-up patient
26992286 en study examine association use individual risk mellitus patient syndrome intervention conduct retrospective cohort study patient undergo datum health research database on score use cohort group risk mellitus compare patient estimate regression use associate significant increase risk mellitus adjust ratio CI compare use cohort cohort analysis indicate individual associate statistical significant increase risk mellitus compare without study indicate association increased risk mellitus use mortality patient clinical patient cardiovascular disease therapy
21626284 en study whether possible duration two patient studied patient use two duration rate measured first rate great duration respective increasing remain parameter difference can base indicate treatment adverse event related trial medication adverse event occur datum duration indicate possible control patient patient
26362227 en use function health study investigate impact mellitus old function concentration function need study chronic condition old function may important early mellitus cohort study follow logistic regression analysis perform investigate effect health condition function compare group old without chronic condition participant condition also group mellitus time positive related need positive related concentration need whereas mellitus negative related function relationship function mellitus mellitus function impact function condition provide
25312511 en one common among woman mellitus also major health develop study association mellitus patient conduct identify clinical study evaluate association mortality mellitus clinical study investigate association mellitus patient outcome study mortality datum study mortality datum study follow total patient include diabetic patient mellitus associate increased risk mortality woman ratio confidence interval CI mellitus associate increased risk mortality woman CI mellitus high risk mortality diagnosis
20823651 en on man weight increased diagnose disease revealed obtain revealed receive treatment however can improve indicate renal response also effect
20686292 en on man present normal on diagnosis two year month reduce finding result diagnosis patient important perform follow-up
26233932 en disorder increased disorder cause gene study examine analysis identify within gene three study reported within associate identify within gene within identify reported previous finding study role within review reported within
22145482 en include cell characteristic cell may disease case patient diagnose change severe report present develop
23703232 en study examine patient receive therapy investigate adult evidence baseline participant report two clinical important decrease two serum increase finding suggest evidence occur
23252994 en disorder cause protein lead cell early disorder clinical gene individual determine whether disease obtain history individual diagnosis use test analysis gene use individual show different age year individual increase characteristic present one analysis revealed gene among identify gene show different age new may provide characteristic diagnosis subject
23811987 en associate provide oral study aim oral treatment patient on total patient aged year included study patient day study three patient patient week mean indicate similar patient rate within normal range day week similar mean ratio week range observed individual effect general control compare therapy well treatment range ratio individual
22855338 en diagnosis treatment may database current use test review datum review database conduct syndrome disease associate clinical addition review datum result primary datum diagnosis diagnosis identify patient test datum reported plasma test test method revealed disorder datum current test diagnosis potential diagnosis treatment new high
17955235 en known complication patient reported type report also report compare
17489172 en chronic disorder system due association incidence report two case clinical management
25382102 en cause treat patient reported oral one treatment oral treatment study analyzed patient mean mean serum level respective significant difference value statistical analysis revealed incidence significant decrease control patient
26664475 en chronic disease associate condition mellitus DM reported may role disease renal disease also important presence associate poor management study multiple determine association chronic disease mellitus evaluate potential mellitus risk factor assess renal included study number patient chronic disease diagnose chronic patient assess use clinical test include serum level serum serum fasting plasma glucose level serum test protein case obtain result mellitus associate chronic disease identify patient study age patient chronic presence correlate presence mellitus renal disease present patient chronic disease associate common renal diagnose patient syndrome occur subject chronic disease identify two case chronic patient study diagnose present study revealed significant association mellitus chronic disease common type renal disease patient correlate presence on mellitus can
27691959 en diagnose mellitus base treatment oral medication result decrease blood glucose concentration however oral therapy poor insulin therapy lead therapy per month treatment normal blood glucose concentration lower serum concentration compare level base finding can consider mellitus oral insulin
27000334 en determine whether mellitus increase old cohort study aged old follow mellitus define according fasting blood glucose great hemoglobin great diabetic medication use define study score great use medication use assess effect mellitus three time low score normal high score treat analysis identify significant associate include baseline age body mass index hypertension adjust model participant mellitus high rate develop treatment ratio confidence interval CI mellitus associate lower rate regression normal CI great rate CI mellitus increased risk develop old old mellitus follow-up potential great model care
17081961 en normal elevated plasma concentration clinical disease chronic renal cause patient gene gene studied case identify gene disorder severe include syndrome clinical early diagnosis treatment associate
23360744 en role body effect type function result common clinical condition renal several year major research level common due medical treatment provide cell cause drug therapy chronic renal level provide new treatment recent disease
27181765 en type mellitus type mellitus study show determine response factor protein well decrease diabetic insulin function mechanism type mellitus type mellitus clinical prevalence increased type mellitus adult type mellitus cell cell also different diabetic patient healthy control response also different type mellitus type mellitus present review clinical suggest different role type mellitus type mellitus
27614804 en clinical research mellitus disease however relationship review association patient may database study evaluate effect patient included datum analyzed on total review result study association study demonstrated presence independent related patient study history correlate change function patient included study indicate history associate little function patient current evidence indicate patient clinical study need large sample follow assessment
26152709 en known association mellitus cardiovascular event datum outcome cohort patient mellitus cardiovascular outcome year identify event patient reduction health patient high risk event rate patient mellitus determined group method patient follow-up year mellitus baseline overall risk ratio cardiovascular great patient compare patient without adjust confidence interval CI also increase cardiovascular adjust CI overall adjust CI mellitus associate great risk adjust odd ratio CI patient mellitus baseline independent associate cardiovascular adjust CI adjust odd ratio CI mellitus increase risk event patient mellitus elevated risk cardiovascular need therapy population
18265718 en medical condition include disease primary general man woman common may patient present present case report patient result revealed show mass show mass demonstrated diagnosis patient receive result mass decrease according decrease patient present diagnosis
18001282 en contribute low found decrease compare normal high control addition show include increased reduce well increase plasma on gene cause impair reduce contribute low show low indicate time elevated plasma contribute little low
23544346 en on diagnose cause dysfunction treat undergo first occur treat day day perform blood parameter revealed first cause effective treat
20702671 en system case due associate syndrome although consider case disease
27052219 en mellitus group disorder increase blood glucose concentration common current mellitus type type type compare type diagnosis fasting oral glucose tolerance test well use hemoglobin hba1c datum association clinical treatment
27025794 en mellitus DM prevalence large body evidence regard incidence DM associate cardiovascular complication factor contribute event disease type DM metabolic control glycemic control effect poor metabolic control DM associate system change several cell cell cell cell lead glycemic metabolic glucose control effect glycemic control mechanism metabolic high glucose remain review clinical metabolic DM role DM complication effect several
26152296 en treatment patient mellitus potential risk may mellitus investigate duration mellitus patient identify patient hospital diagnosis ratio confidence interval according year mellitus duration use study population patient mellitus compare patient without mellitus treatment hypertension age previous disease risk low year duration ratio confidence interval high duration year ratio confidence interval analyzed duration mellitus associate risk high risk patient duration mellitus associate high risk high risk duration mellitus may therapy
23040752 en potential function assessment treat new identify among period patient time regard increasing important
23692728 en test evaluate case female one due clinical revealed first case develop patient factor complication obtain without oral
17004859 en plasma within range large normal mechanism common however disease disease several large review diagnosis treatment disorder
26881245 en mellitus group metabolic disease insulin insulin great increase case assess prevalence associate factor mellitus among study conduct among patient use individual patient risk factor assessment patient status health mellitus datum analyzed test test association independent result total study patient study response rate clinical mellitus patient reported patient patient weight statistical significant associate factor mellitus history obesity number prevalence mellitus among hospital several clinical factor contribute mellitus
25920916 en investigate whether history mellitus associate mellitus complication cohort mellitus patient disease adult age found among patient mellitus complication among little one complication also among patient reported history mellitus among among patient history mellitus mellitus complication among little one mellitus complication history mellitus difference finding suggest different factor may influence risk mellitus per risk mellitus complication study however result
27315382 en female present weight mellitus diagnose base history clinical finding include on treatment develop lead clinical management several month age treatment day mellitus first reported case mellitus clinical management condition
17850929 en reported occur however case consider complication patient present month chronic study revealed month patient chronic possible associate presence poor
19170711 en cause clinical elevated serum level report two present present poor patient serum suggest however also finding gene identify cell activity assess cell response assess patient cell severe impair activity compare cell show cell remain on function cell impair activity improve treatment may
27525364 en glucose parameter blood glucose hba1c oral glucose tolerance test studied type multiple case age control type study hba1c two value analyzed perform assess compare sample case show high mean value high glucose level compare control time case compare control value similar case vs control value high mean level high level well high observed case compare control hba1c significant high case vs difference observed glucose level high case vs level measured type mellitus increased glucose value common type mellitus
25677239 en system important role disease mellitus well complication recent study suggest activity occur patient mellitus target system treatment mellitus complication review system role possible target patient mellitus complication review system year mellitus addition provide regard system mellitus complication well role mechanism cell therapy activity system may potential target patient mellitus complication associate dysfunction cell insulin resistance complication system may associate mellitus complication therapy target system identify gene therapy
21584435 en syndrome condition common cause develop disorder present function dysfunction patient syndrome clinical develop severe follow development addition develop test response test result indicate need oral control
27181875 en association type mellitus among adult present study included patient type mellitus normal control elevated define man woman define level association type mellitus investigate body mass index activity history control age weight level fasting glucose body mass index status diabetic history activity overall sample compare normal level normal normal elevated elevated associate type mellitus odd ratio respective associate risk type mellitus without relationship type mellitus subject body mass index odd ratio confidence interval significant associate risk type mellitus adult
22168581 en present cause one gene present characteristic occur early identify gene base gene well gene found two one analysis result presence major gene remain healthy general mechanism according datum due effect
18807739 en condition cause identify cause lead protein diagnosis base test history analysis gene development diagnosis clinical follow treatment treatment patient gene therapy model disease protein
26613228 en disorder cause severe mortality reported low weight present first month treat therapy report diagnosis treatment may severe mortality
27443099 en gestational consider mellitus common insulin resistance target body provide identify risk determine incidence mellitus woman previous diagnose gestational identify clinical risk factor develop cohort study patient diagnose gestational incidence mellitus estimate group on case woman develop mellitus diagnosis gestational group control sample woman history gestational follow-up period remain group studied year study influence different gestational obtain development mellitus time parameter model significant studied analysis ratio confidence interval incidence mellitus patient history gestational identify risk factor index development mellitus great year age BMI great disorder insulin therapy poor metabolic control gestational factor identify gestational determine high mellitus
19294427 en report develop cause also associate present month mass analysis show gene present cell however identify gene present patient also cell identify however patient previous reported may case event
27181714 en role range present study evaluate effect mellitus total group control mellitus mellitus treatment mellitus treatment mellitus treatment mellitus diabetic group treat week serum concentration result show significant mellitus significant reduce serum glucose level weight mellitus significant reduce increased activity total activity mellitus mellitus group significant increased treatment mellitus significant reduce present study result show can level change result show effect reduction blood glucose level diabetic
25847566 en current evidence indicate effect metabolic parameter metabolic factor mellitus several review study review effect glucose lipid profile mellitus therefore aim present study review effect metabolic parameter database included glucose level lipid insulin review case report study base included trial model study indicate lipid profile dysfunction potential mechanism include characteristic effect insulin glucose gene study compare effect type reported different characteristic type improve glycemic status lipid profile model however clinical trial effect effective type management complication
26947957 en activity determined characteristic determine impact primary health care characteristic control mellitus DM study clinical index participant diabetic patient two health within high lower analysis perform logistic regression DM control high prevalence poor DM control risk poor control patient regression model increasing ratio patient year per increased poor control high patient measured contribute poor DM control two model health condition increased poor control year old patient ratio per condition high patient measured contribute DM control
23131607 en syndrome occur result due severe care significant reduce incidence develop remain common cause develop report case severe follow investigate identify syndrome on diagnosis treatment follow-up known improve clinical status patient outcome
20821268 en occur event cause present case patient clinical renal on year old woman renal due disease undergo renal on test positive treatment result revealed history year previous case clinical renal renal due on previous cause
20565418 en present complication associate present case present without normal presence treatment patient without case provide clinical may result factor development patient
17559814 en model show disorder disease observed studied glucose activity control on group studied group studied study perform use significant high measured high value found result show first time glucose glucose may related observed disorder analysis investigate observed
21274346 en syndrome first two patient reported case associate several finding can severe syndrome new syndrome association reported associate report case possible case syndrome associate
27546934 en mellitus health diagnosis treatment follow-up care level early control on clinical develop health aim evidence use assessment development current present result include general use risk score population early diagnosis determine treatment patient mellitus type primary care addition several treatment patient treatment also weight glycemic control population complication
20719429 en well complication observed report case patient show significant lower develop show day severe improve level patient present early treatment
27297342 en cardiovascular disease remain cause among patient mellitus mellitus mechanism mechanism glycemic control current drug risk reduction therapy treatment cardiovascular complication rate remain high patient mellitus without review consider mechanism history new recent evidence current cardiovascular management patient mellitus care patient mellitus disease care
22965914 en clinical function remain several report different different protein protein function protein cause two revealed gene gene show clinical cause gene review potential role
27242117 en assess prevalence type mellitus determined target patient type mellitus clinical adult type mellitus patient identify patient database datum hba1c cholesterol year obtain medical prevalence type mellitus adult population among high hba1c cholesterol measured participant respective patient hba1c target cholesterol overall patient year old control target compare patient control type mellitus patient less cholesterol level within target range old type mellitus patient control target patient target patient type mellitus
27923363 en individual disease reduce activity may increase risk mellitus although risk factor whether low index examine association use model study measured participant without baseline case identify blood glucose level three diagnosis medication use total participant develop year follow-up participant low low high risk compare adjust model association potential remain significant CI significant although association large association participant without hypertension normal fasting glucose history compare independent associate increased risk general population clinical glucose among low without
24908639 en study investigate role plasma patient plasma blood glucose concentration rate measured patient mellitus mellitus healthy control activity measured measured plasma significant patient mellitus mellitus patient compare healthy control plasma show significant difference among group significant correlate plasma level blood glucose concentration may patient mellitus low plasma risk factor mellitus patient
26781070 en complication cause mortality among patient type type mellitus result chronic lead increase review relationship among dysfunction development complication type type dysfunction correlate important role development complication diabetic patient observed several increased diabetic patient complication include cardiovascular clinical use risk cardiovascular renal complication diabetic patient patient
26733565 en report association mortality rate disease mellitus common group study datum mortality common group per obtain regression analysis use determine association common group mortality increasing disease mellitus mortality rate observed period mortality rate negative associate found disease respective show significant positive association respective man woman mortality rate mellitus show significant positive association respective show significant negative association mortality rate man woman respective negative associate man mortality mellitus show significant positive association woman mortality disease mellitus common group observed assess study healthy need
27181391 en population health increasing population change assess type mellitus analyzed time determine prevalence status provide
25587177 en associate increased risk mellitus treatment may glucose reduce risk study aim investigate association use mellitus risk cohort study conduct use health research database period new diagnose patient identify previous diagnosis mellitus incidence mellitus identify new use new diagnose mellitus patient identify among patient follow-up period year compare patient without treatment ratio mellitus patient reduce CI associate increased risk develop mellitus CI use patient use associate reduce risk mellitus increase risk decrease use
20492364 en disorder cause gene protein analysis cause demonstrated analysis revealed body present body increased increase analysis show datum suggest cell primary cause related
24382904 en present present blood pressure hypertension revealed result case
18300893 en may associate high rate complication early report incidence patient hospital first patient undergo rate low patient undergo factor associate development include previous elevated serum within first day high negative value low incidence elevated serum level first day use develop patient elevated serum define first day develop risk management serum great risk develop
16700319 en reported patient management need occur potential cause occur week disorder therapy treatment may increase risk treatment management review management multiple disorder
18929291 en clinical patient new month patient previous
25665487 en evidence indicate associate risk obesity study identify whether associate risk mellitus study health development study cohort health reported early reported diagnosis mellitus provide blood sample hemoglobin association mellitus risk confidence interval confidence interval respective estimate effect adjust weight current body mass index BMI also significant associate type diagnosis confidence interval associate increased risk mellitus among adult independent known risk factor provide evidence independent weight current BMI may contribute adult mellitus study result woman mellitus
24992333 en use treat hypertension associate risk mellitus similar risk identify review medical use risk mellitus therapy evaluate without hypertension age history body mass index number year treat first event receive receive old hypertension high body mass index event incidence mellitus year first event group receive vs CI risk mellitus CI risk mellitus among receive adjust CI use associate high risk mellitus large study need determine risk mellitus
26156145 en high prevalence case mellitus poor increased complication on conduct diabetic hospital on assess related use on total participant normal blood level insulin hypertension poor identify cause association complication on total blood identify healthy diabetic diabetic high need
25722065 en mellitus associate increased risk may assess relationship conduct database mellitus use mellitus study study assess type type study lead potential study review study study included two study among study included study randomize control trial study studied study reported fasting renal lower patient normal increased suggest patient may potential trial need
27181699 en oral type mellitus first evaluate patient type mellitus
17313038 en on hospital on diagnosis test test therapy improve clinical finding therapy addition review clinical patient reported included patient man patient patient show low complication without therapy improve patient patient therapy within month therefore early diagnosis treatment important general consider poor patient
27181254 en treatment type mellitus associate adverse drug patient type mellitus report result analysis adverse drug present study included type mellitus patient aged year first month datum baseline characteristic clinical adverse event patient patient case report little one follow-up included analysis week on total patient little one adverse drug incidence adverse drug event disorder respective new identify among clinical effective mean hemoglobin decrease baseline week analysis profile patient type mellitus early period
20235031 en report case year old woman chronic develop time diagnose cell can therapy
25907167 en mellitus individual cause mortality influence type type respective identify addition evidence response treatment complication may lead development treatment current clinical little diabetic individual diagnose current type treatment improve less glucose control risk assessment rate diagnosis treatment individual effective clinical current research
27553774 en role associate mellitus DM cardiovascular disease however due disease effect remain although recent report multiple related review provide role potential mechanism one major DM cardiovascular disease mechanism include provide potential target DM cardiovascular disease
22386940 en disease renal response due gene on number gene retrospective analysis known previous show function diagnose present study year old year old diagnose base clinical test response analysis gene revealed patient response activity assess reduce impair compare cell type gene resistance due gene
26480967 en compare care old adult mellitus care care primary care cohort care diagnosis mellitus receive primary care sample score within use compare two cohort regard rate cholesterol hemoglobin hba1c two group also compare regard medication use individual diagnosis hypertension potential medication similar rate odd ratio or confidence interval CI or CI lower rate or CI hba1c or CI or CI or CI or CI or CI statistical significant difference adjust two group similar lower rate mellitus care use similar overall care
17849803 en incidence two case multiple patient general show patient associate syndrome disease report case hospital general on female week history cell year patient treat study obtain on healthy female obtain score association several
19251537 en report case syndrome woman type mellitus patient present metabolic high concentration present patient syndrome presence patient condition improve oral month patient time severe develop test perform type mellitus diagnose complication patient treat case syndrome associate metabolic include mellitus syndrome also use drug may result adverse
27407072 en several mechanism although reported glucose cell investigate adult mellitus adult week include evaluate use regression decrease increased cell diabetic use found diabetic condition week can on revealed mellitus decrease reduce cell normal finding indicate mellitus cell adult may mechanism
24920744 en report case possible result complication patient present revealed diagnose result test addition pressure due result elevated serum level determined patient can decrease observed elevated serum level plasma cell include system recent research health diagnosis according case possible case
27160621 en mellitus chronic disease elevated chronic different assess whether elevated hemoglobin time year mellitus associate elevated resistance index renal assess patient metabolic study included diabetic patient perform index resistance renal medical age hemoglobin association metabolic mellitus analyzed resistance index test significant value assess association measured response patient type examine age year old year hypertension high level hemoglobin time year observed statistical significant difference increased duration mellitus high resistance renal condition diabetic duration associate high resistance index
25710294 en investigate baseline plasma level group patient mellitus known disease plasma protein elevated plasma level reported patient plasma level measured patient mellitus follow year development baseline clinical parameter plasma level analyzed independent mortality year CI model also included remain independent mortality baseline plasma level associate increased risk mortality patient known disease association independent clinical include
26068230 en individual high risk mellitus diabetic rate early intervention diabetic test diabetic rate old individual randomize clinical trial medical may participant included individual year old mellitus obtain randomize diabetic intervention provide identify health care improve rate therapy control primary outcome medical month follow-up outcome included risk risk mellitus patient health function score hemoglobin participant diabetic group obtain compare therapy group follow-up assessment overall participant diabetic group time obtain compare therapy group risk ratio CI intervention effect outcome hemoglobin level risk risk mellitus function score however group improve mellitus baseline diabetic significant increased rate old individual mellitus intervention may potential positive diabetic
24849384 en disease patient treat oral recent oral first oral treatment conduct retrospective study patient treat therapy aim evaluate clinical factor patient mean mean ratio oral previous study group need significant ratio oral group vs ratio oral significant correlation multiple regression analysis demonstrated ratio oral effective treatment adult patient care patient base previous datum also difference ratio
25149362 en mellitus high risk cardiovascular event however relationship mellitus development measured high time year among participant risk study mellitus without cardiovascular disease include first examine incidence elevated year follow-up examine clinical outcome year follow-up among without elevated year among mellitus mellitus respective compare adjust relative risk elevated CI CI mellitus mellitus high risk ratio CI ratio CI disease ratio CI compare without mellitus mellitus independent associate development assess evidence high risk clinical event result possible effect possible cause
20420085 en present clinical case adult cell associate review case cell woman reported present patient clinical history patient due disease perform result cell may lead chronic disease however remain treatment possible follow-up new
19293543 en perform analysis woman patient diagnosis period treat show patient health without evidence serum respective serum concentration result test perform analysis show patient on gene previous
25997545 en although reported cause mellitus mellitus risk factor remain determined investigate risk factor related mellitus diagnose within month treatment new treat high per day little month total patient disease cohort analyzed patient new treat mellitus previous diagnosis age year mellitus diagnose two glucose patient fasting mellitus observed patient mellitus group high age high BMI lower rate female high rate use logistic regression analysis demonstrated risk mellitus independent high age adjust odd ratio or confidence interval BMI or current or or cause mellitus high prevalence within period current consider high risk mellitus addition age BMI
25363092 en association mellitus patient patient receive previous history characteristic obtain use analysis use diabetic patient vs year hypertension vs compare patient significant difference characteristic patient group follow-up duration month diabetic patient respective poor control diabetic patient hba1c duration compare glycemic control mellitus without mellitus test respective analysis ratio renal disease mellitus poor glycemic control independent mellitus poor glycemic control hba1c increase risk result need glycemic control follow-up diabetic patient
24165017 en prevalence clinical characteristic remain due number case report therefore study estimate total hospital serum concentration assess analysis cell case case due diagnosis cause case analyzed found remain case diagnose three case diagnose patient case case mean age year serum concentration normal value value disease observed patient observed one patient multiple observed patient datum suggest prevalence also consider development cause clinical
27321341 en result two patient mellitus treat insulin evaluate study conduct care on total patient diagnose mellitus type type undergo treatment insulin little result perform result two perform test correlation test test mean age insulin patient insulin patient show subject high statistical significant difference found compare patient insulin confidence interval CI high without statistical significant difference group difference patient receive insulin insulin group aged improve individual
27799751 en mellitus among old adult number population increase study aim among patient mellitus total patient aged year old use method study datum medical history obtain medical use conduct regression analysis use determine regression analysis show activity health whereas activity contribute status relationship also finding indicate different among patient mellitus improve patient
27145835 en management mellitus lower aim study management complication mellitus lower study sample individual conduct clinical blood on fasting blood consider new diabetic poor control mellitus hba1c mellitus poor control treatment high poor control medication observed poor status poor hba1c perform less observed management system complication observed respective among disease disease disease respective complication show mellitus patient status poor high rate complication system overall poor care
27878494 en metabolic disorder evaluate mellitus reduce metabolic disorder associate mellitus concentration glucose hemoglobin activity significant high activity significant lower group receive decrease glucose concentration hemoglobin week datum suggest parameter little week
25545780 en increasing care may improve health patient mellitus need need need clinical outcome use health care health care determine association medication control mellitus use health care datum primary care health treatment mellitus on sample patient adult aged year mellitus response rate primary outcome poor control hemoglobin level cholesterol level blood pressure outcome included care reported medication little need poor control observed model associate great odd poor control adjust odd ratio or CI increased adjust rate ratio CI increased CI medication associate poor control or CI increased CI CI CI CI associate increased control or CI or CI respective CI CI respective increasing number associate poor control or need CI increased use health care CI CI need common among patient mellitus general adverse association control use health care need may important target care mellitus
25809823 en common cause mellitus patient age mellitus within first month however whether individual develop study cause without patient mellitus test negative common without history positive patient analysis analysis clinical datum medical patient identify present period characteristic patient age patient weight score gestational age cause can cause patient age
26111130 en although use system disease clinical patient common one diagnosis mellitus current mellitus number assess effect mellitus use mellitus patient present hospital assess respective medical patient mellitus care hospital week week review compare use mellitus mean total use change use mellitus type control use increased indicate great use mellitus improve review medical datum overall change number diabetic use great use
27330717 en aim present study investigate difference plasma level response oral glucose normal glucose tolerance subject patient type mellitus
25708055 en use cardiovascular disease study aim assess effect development cardiovascular disease patient type mellitus patient type mellitus study on status number year provide patient response analysis common determined compare female high risk cardiovascular disease odd ratio confidence interval also significant large common risk odd ratio confidence interval significant great respective significant high risk odd ratio confidence interval significant risk factor patient type mellitus result patient type mellitus
20403973 en cell concentration function occur protein condition large present study two new identify individual reported protein use datum show reduce level compare found target plasma similar study use show cell treatment target plasma treatment remain treatment response lead found studied plasma target response found system need evaluate datum use cell system
25097197 en mellitus adverse outcome patient undergo intervention association baseline hemoglobin hba1c time intervention mortality patient mellitus undergo intervention identify database characteristic outcome patient compare base hba1c among patient hba1c hba1c hba1c hba1c hba1c compare low hba1c high hba1c year high total cholesterol insulin use present lower hba1c hypertension chronic renal analysis demonstrated high mortality high hba1c compare group patient hba1c patient hba1c significant high mortality follow-up ratio confidence interval difference primary among however insulin significant difference mortality among hba1c mellitus insulin poor glycemic control hba1c significant high mortality intervention compare mellitus evidence hba1c insulin however similar rate mortality among different hba1c
24733887 en found role control result present multiple one suggest potential two observed within several observed primary within cause provide cause well may
27144926 en patient type mellitus poor also great compare patient well aim study presence population diagnose also examine factor associate presence perform study type mellitus sample hospital assess test use test test examine association factor use adjust model estimate prevalence ratio association clinical characteristic presence prevalence CI analysis show significant association age clinical complication adjust analysis show diabetic CI diabetic CI associate great presence observed high prevalence study population female patient also among subject complication type mellitus impact disease effect on consider can patient
27052238 en disorder common patient mellitus increase associate glycemic control increased mortality disorder high incidence mellitus disorder disorder disorder disorder mellitus influence metabolic control complication outcome health care system health care reduce incidence mellitus well mortality patient group
26877618 en investigate impact mellitus retrospective analyzed datum hospital included study determined mean concentration year diagnosis year follow-up on mean value identify use characteristic complication evaluate test overall evaluate use method risk factor examine develop incidence increased mean group significant high group vs group lower overall rate vs rate vs mean analysis show old age time year hypertension high mean independent risk factor develop low less vs develop vs chronic dysfunction vs severe vs high mean group however two group show significant difference incidence chronic hypertension cardiovascular event decrease risk value
25725582 en diabetic risk assessment model adjust patient follow-up study patient mellitus datum type duration hba1c blood pressure presence diabetic estimate risk individual time mean model characteristic analysis perform determine model model interval analyzed duration type mellitus develop show model reduction compare model use estimate risk develop patient perform well on diabetic can
26958039 en mellitus metabolic disease chronic high glucose level factor gene mellitus diagnose less month age present first case reported diagnose gene diagnosis consider insulin therapy cell overall treat oral therapy
26353830 en examine impact mellitus incidence outcome among patient use datum health review assessment database patient diagnose within one year index investigate association mellitus outcome patient mellitus include complication incidence outcome patient without patient mellitus patient mellitus complication show high rate outcome without mellitus complication odd ratio confidence interval similar patient diabetic complication outcome without mellitus complication odd ratio confidence interval result show mellitus increase risk outcome may use among patient disorder
26303757 en undergo number change however difference study may difference type examine woman age year type type T2DM gestational mellitus clinical datum medical diagnosis independent analysis adjust gestational weight gestational age blood pressure compare T2DM high gestational weight mean vs T2DM vs insulin use T2DM vs woman compare T2DM also similar lower prevalence analysis however finding remain significant also woman T2DM compare high rate woman vs vs lower rate vs type potential mechanism research metabolic
19231038 en cause report case revealed two case two case one patient present three include one one case analysis show high one case three cause case however on may obtain diagnosis
26361811 en mellitus increasing patient health care system investigate effect associate medical care total patient included patient patient primary study cause datum mortality review medical patient health related mortality significant diabetic patient treatment mean follow-up time day patient associate mortality rate significant high regard difference found associate increased mortality reduce general population medical patient however associate occur rate patient associate significant reduce
21778861 en protein patient large on potential mechanism present
24931804 en datum mellitus outcome patient renal cell evaluate association mellitus patient cell renal cell treat review patient treat cell renal cell one cell renal cell patient patient without according overall estimate use method model use evaluate association total patient mellitus significant old high score renal rate status similar group year similar patient without vs overall significant vs analysis mellitus independent mortality CI mortality CI result suggest mellitus independent associate decrease overall patient treat cell renal cell
26888765 en patient type mellitus increased risk develop cardiovascular disease current risk score use clinical assess risk type clinical diagnose adult patient type mellitus develop model estimate risk first event disease disease clinical datum include factor event datum risk model develop use first use identify potential risk factor analysis base result first regression analysis use model model different population patient type mellitus follow-up year range total patient develop model included age duration blood pressure cholesterol hemoglobin rate event confidence interval datum confidence interval datum test show risk model clinical
26151207 en chronic disease high blood glucose level result insulin body resistance effect insulin model great improve diagnosis treatment different disease model diagnosis management one type management patient datum model management mellitus mellitus T2DM model datum patient hospital use first datum use base use model use T2DM new patient model use analysis use diabetic result model method
26744123 en review outcome patient type mellitus renal disease well type mellitus treatment review perform database use major review related review included clinical outcome different treatment method outcome method identify patient diabetic complication patient also clinical evidence show outcome type mellitus patient diabetic complication type mellitus remain outcome possible type associate significant complication regard treatment patient diabetic complication severe diabetic control medication
26614641 en chronic disease metabolic increase risk type mellitus individual independent disease mechanism T2DM effect insulin resistance study reported clinical type mellitus outcome study complication among patient develop type mellitus clinical trial patient reported glucose treatment recent study metabolic clinical impact type complication whether may also impact mortality due type mellitus review current evidence treatment type mellitus complication patient
26471398 en mellitus DM metabolic disorder associate complication metabolic chronic disease DM common recent study suggest effect metabolic model DM aim study investigate mellitus type perform analysis identify system addition also observed lipid within result significant increase number cell well positive system increased mellitus condition also significant increase present study suggest system can potential target complication cause
26621825 en mellitus metabolic disorder associate increased risk disease clinical characteristic mechanism role insulin glucose demonstrated early reduce blood glucose level patient treat clinical possible insulin possible clinical difference indicate insulin level normal high insulin level year subject time new insulin show reduce effect insulin subject insulin resistance difference two type type type year study history insulin resistance insulin type role insulin resistance development high blood pressure possible change risk factor year type type increasing subject insulin resistance can result patient
26434665 en compare profile potential effect clinical outcome insulin insulin primary patient type type mellitus T2DM
22876545 en aim study evaluate clinical characteristic review mean age diagnosis year range year patient undergo function assessment diagnosis duration follow-up patient patient patient cause patient cell patient patient patient patient patient patient patient patient group great prevalence compare group respective patient significant lower group respective diagnosis possible significant finding study suggest may consider
22246489 en on woman determine weight finding show BMI blood pressure finding show plasma serum serum reduce serum insulin factor respective serum high level elevated response however response response low plasma increase plasma response revealed level finding finding indicate type
25550448 en mellitus DM increasing condition care treatment individual patient DM DM clinical mellitus due insulin resistance insulin insulin recent DM result disease patient DM insulin insulin resistance may result diabetic disease review DM include associate renal need consider patient present test diagnosis DM also review mechanism insulin resistance diabetic disease
24622440 en gene result disease found clinical identify perform clinical test analyzed test perform gene perform identify diagnose normal severe found two patient patient severe renal two gene patient gene reported gene also patient
27717937 en type mellitus one important medical patient disease syndrome clinical elevated rate important factor mortality patient syndrome aim rate patient mellitus type effective treatment patient examine year patient two group group patient DM control group patient without DM clinical perform also revealed statistical high rate patient DM day treatment patient association mellitus type increased rate indicate cardiovascular disease obtain patient syndrome mellitus according rate resistance patient mellitus patient need individual high
26585047 en increasing prevalence type mellitus high mortality important health type mellitus relative gene increased insulin resistance however risk factor type mellitus identify evidence indicate function role development type mellitus relative insulin resistance blood glucose plasma level decrease activity type mellitus high insulin level low glucose insulin resistance similar high level low glucose may resistance review characteristic type mellitus two model mellitus mellitus resistance insulin resistance type mellitus disorder resistance may new type mellitus intervention type mellitus
22144672 en cause renal resistance two normal response test increase level suggest resistance identify two cell show function whereas activity result indicate function result finding indicate also can possible effect disease potential
26264604 en revealed diabetic adult great risk compare population association type relationship mellitus risk result conduct investigate association mellitus risk base conduct database may cohort study provide little risk ratio confidence interval CI among diabetic subject study reported risk estimate study event among participant identify mellitus associate increased risk CI effect model analysis indicate risk type CI type CI CI mellitus risk relationship type association risk similar man woman
26049370 en common patient mellitus DM associate activity several condition remain DM assess influence diabetic patient study subject group patient T2DM patient two control group individual respective group age body mass index BMI evaluate association clinical total protein serum on serum lower patient compare control group show positive correlation group independent associate CI CI group T2DM group CI CI level CI CI related DM difference level compare individual related increased activity BMI activity finding independent age BMI hba1c level
18596116 en associate use medication impact medication investigate patient compare medication demonstrated normal increased participant according normal concentration normal impair reduce correlate duration therapy impair patient randomize trial investigate increased reduction cell improve cell
26490756 en determine whether age type mellitus total adult patient study compare man woman patient diagnose man woman diagnose use woman high vs woman adult woman high high vs vs total vs man woman high vs lower vs man finding factor influence health outcome need provide assessment patient
26117953 en research incidence mellitus glucose metabolic disorder among oral patient different oral mellitus population study use datum year first lead examine blood glucose level patient oral mellitus found blood glucose elevated case among diabetic patient study increased observed mellitus patient impair fasting glucose also increased overall number patient glucose metabolic disorder analysis two important disease group mellitus
26559756 en correlate serum level patient type mellitus
26034369 en determine risk factor mellitus conduct review database identify study risk factor two independent assess trial datum statistical analysis perform odd ratio or mean difference confidence interval use effect effect model base presence significant study patient included retrospective identify significant risk factor or history or or impair fasting glucose or history or use or body mass index factor found associate incidence study show history BMI risk factor
25856540 en association disease metabolic study analysis metabolic syndrome outcome study trial assess duration risk logistic regression model evaluate association mellitus DM outcome DM hypertension well DM sample participant mean age year female DM diagnose sample risk observed sample reported duration risk duration associate DM or CI adjust age obesity BMI use use hypertension adjust model risk associate outcome or CI observed association risk mellitus among metabolic syndrome
26505665 en regard major cause diabetic patient however recent association study revealed related change study aim investigate possible association type study included type mellitus patient patient without perform found associate increased risk type mellitus patient association found type mellitus patient group addition significant difference observed type mellitus patient without respective analysis revealed associate increased risk subject old female duration year hypertension effect two risk associate risk type mellitus patient old patient female duration year hypertension may risk factor development type mellitus
26477482 en elevated plasma glucose relative low hba1c compare plasma glucose one type mellitus glycemic control glycemic control period hba1c study investigate whether diagnosis type mellitus study included patient patient hba1c measured time patient compare patient hba1c significant lower hba1c vs vs diagnosis analysis show value respective value hba1c also may diagnosis value
26290403 en determine association mellitus outcome patient undergo patient undergo two group according mellitus status time regression analysis use assess association mellitus overall patient mellitus present similar factor finding include positive compare mellitus patient mellitus mellitus group respective regression analysis show mellitus significant mortality ratio overall rate mellitus mellitus group respective mellitus significant factor overall mortality regression analysis ratio patient undergo mellitus patient mortality overall mortality outcome mellitus patient mechanism association mellitus investigate present result study
26275164 en study compare effect reduction patient regard mellitus DM response glycemic control patient mellitus on randomize trial include adult mellitus group group patient group conduct included response fasting blood sample use level blood glucose statistical significant difference effect patient glycemic control however group significant reduction level serum observed on significant reduction response observed patient group study can provide impact patient health outcome adult mellitus
27383162 en effect activity concentration studied blood serum type mellitus analysis parameter show body weight reduce study relative increased value diabetic condition activity target effect level blood serum control level result show positive reduce type mellitus studied parameter
24773992 en assess use drug group treatment mellitus cardiovascular risk factor identify health use overall sample population within study clinical datum oral glucose tolerance test patient without known mellitus patient current medication use group evaluate therapy oral insulin drug population little one medication drug use associate age independent high prevalence mellitus hypertension old patient found use drug drug use drug related level status activity patient mellitus medication mellitus associate great use important factor determine drug use factor impact drug use mellitus associate great use drug
23916172 en provide management patient mellitus group according assessment development system evidence on included drug included provide management patient mellitus
27448155 en mellitus chronic lead age age age cause effect population high lower prevalence mellitus reported aim investigate effect level age factor type mellitus T2DM T2DM patient treat oral without insulin month plasma level measured significant reduce fasting glucose hemoglobin hba1c level change hba1c observed correlate respective pressure significant decrease due respective result show effect blood pressure level glucose hba1c T2DM patient however decrease parameter range healthy subject addition significant difference
26310466 en on present weight receive on serum hemoglobin test perform revealed elevated blood glucose hemoglobin hba1c level respective mellitus diagnose insulin therapy therapy clinical condition improve blood glucose insulin therapy blood glucose hba1c value remain within normal time mellitus condition common observed patient well report first case mellitus
25654411 en mellitus common complication renal recent high prevalence mellitus reported patient chronic association mellitus well demonstrated general population aim study effect development mellitus renal retrospective study included patient group according diabetic duration number blood statistical significant among group therapy high statistical observed group regard presence type therapy high statistical significant result observed regard group lower regard regard therapy incidence mellitus statistical high group positive correlation incidence mellitus positive status
26090051 en disease study determine prevalence hypertension mellitus among adult base study adult aged year medical hypertension mellitus datum use participant aged year obesity found respective overall prevalence hypertension female mellitus female hypertension age year or CI or CI female less develop hypertension or CI significant mellitus or CI prevalence hypertension mellitus level need health target control disease
26664261 en mellitus DM cause type DM insulin type DM therapy mellitus develop need diabetic patient therapy method include oral study assess whether can provide effect type DM type DM model system type DM model oral day day lower blood level lower blood glucose level high blood insulin level compare increased whereas decrease treat compare type DM model day oral day day found show decrease blood level increased increased decrease body weight compare result suggest effect type type DM model
27595390 en compare medical diagnosis use insulin oral medication management type mellitus DM different medical different conduct use assess diagnosis different medication management DM one base recent overall base insulin characteristic time medical use insulin DM management medical base oral medication DM diagnosis study need management mellitus management mellitus
25991015 en mellitus cause present study serum profile mellitus serum sample patient type mellitus T2DM patient healthy control perform on conduct relative concentration T2DM patient healthy identify serum significant increased sample on serum characteristic confidence interval CI CI respective T2DM CI CI may potential diagnosis healthy control T2DM
18079312 en cause early blood level serum finding clinical response diagnosis revealed patient well treatment serum remain within normal follow-up case without high index associate dysfunction
25586806 en mellitus two disease common clinical mellitus diagnosis clinical year clinical mellitus mellitus mellitus number case however remain whether mellitus cause whether lead evidence mellitus clinical case management case may follow clinical control result may also lead addition diabetic case risk develop month year management
25229776 en disorder type mellitus health risk disease risk factor develop disorder poor current study aim examine risk factor type mellitus risk factor body mass index BMI control also general risk factor low aged primary general health recent weight control medical factor disorder high poor control lower disorder lower high result current study suggest different factor associate disorder factor factor factor important difference presence evidence high body mass index impact
25737497 en cardiovascular function positive impact chronic reported diabetic early dysfunction adverse major role test dysfunction model mellitus
25066306 en mellitus associate decrease risk however previous study examine association mellitus result aim effect mellitus database evaluate effect outcome patient total cohort study included study investigate whether mellitus associate mortality study investigate whether mellitus associate mortality two study investigate relationship mellitus mortality result mellitus can significant incidence mortality ratio confidence interval mellitus also associate mortality ratio confidence interval mortality ratio confidence interval study result association mellitus adverse association mellitus incidence remain can patient mellitus treatment consider
20722569 en present case patient treat cell renal first treatment total receive significant patient medication receive show cell renal function trial oral present case report review renal possible mechanism
26371159 en increased risk cardiovascular disease type mellitus association remain large determine change protein patient type mellitus influence protein analyzed patient type mellitus individual analysis perform relative mass analysis individual sample significant increased patient mellitus protein significant lower among compare patient treat without similar level hemoglobin cholesterol blood pressure addition show increased among patient protein type mellitus diabetic suggest mellitus lower individual drug effect
26232087 en mellitus mechanism define gene cause similar observed diabetic test impair cause control female analyzed observed condition diabetic incidence insulin treatment reduce blood glucose level mellitus increased cell mellitus target gene effect high glucose mellitus impair cause suggest target may diabetic
26718721 en blood cause mechanism contribute high research increasing tolerance use potential mechanism mellitus primary important study mellitus increase also response resistance cell review first mechanism mellitus mechanism may effect
26926601 en dysfunction contribute cardiovascular disease mellitus mechanism protein cell diabetic condition dysfunction insulin resistance impair contribute dysfunction measured cell diabetic subject control level high cell diabetic vs indicate reduce cell control cell diabetic suggest impair contribute dysfunction include number similar diabetic control whereas protein high diabetic cell diabetic condition effect increased cell diabetic little cell control suggest contribute dysfunction patient may target therapy diabetic disease
26349983 en mellitus DM associate chronic complication cause major significant mortality function activity normal function however lead mellitus known relationship mellitus review chronic complication mellitus diabetic diabetic diabetic
26462490 en type mellitus risk factor chronic disease patient develop mellitus associate lower response treatment evidence may metabolic insulin resistance impair glucose tolerance disease dysfunction found study demonstrated increase risk complication patient however treatment patient drug study evaluate treatment patient treatment impact treatment mortality known patient chronic disease mellitus increasing large obesity disease treatment important review new association clinical mellitus patient chronic disease addition effective old new drug include therapy
20733335 en condition large risk lead primary due also occur complication common chronic therapy observed patient aim define clinical review medical patient clinical diagnosis syndrome patient patient case primary diagnosis potential complication important clinical management association condition provide
26438394 en two related recent however role aim evaluate relationship serum level type mellitus patient control metabolic parameter study include type mellitus patient subject control group level measured type mellitus patient show significant lower level high level control relationship observed level type mellitus patient adjust factor negative related fasting plasma glucose level show positive association respective on regression analysis show fasting plasma glucose level independent associate level level independent associate concentration type mellitus patient result suggest serum level related patient type glucose level can concentration mechanism improve metabolic patient although study need whether response
24090695 en studied related mellitus diagnosis mellitus poor chronic glycemic control increase risk perform cohort study hospital studied patient year old receive care within blood obtain within mellitus define disease clinical primary hospital patient positive blood consider association group estimate logistic regression model included association hemoglobin hba1c risk association glycemic age patient type medical vs risk significant high patient odd ratio or confidence interval CI relative patient without adjust risk increased patient hba1c high or CI relative patient hba1c less adjust risk significant high patient or CI relative patient without glucose significant relationship mellitus diagnosis diagnosis mellitus hba1c high associate risk
23884987 en on follow lead diagnosis complication primary syndrome clinical disease case multiple syndrome disorder increasing female level role disease case patient due major case revealed female multiple
23884783 en recent year several treatment include new effect treatment woman present review aim current relative treatment type cause primary review base identify primary without determined factor duration adjust change indicate plasma patient oral normal mechanism time day however need evidence development reduce high normal rate indicate rate great adult case determined difference provide effective therapy patient gestational
25403287 en disease mellitus common disorder associate subject function may glucose tolerance metabolic control patient increase risk clinical may effect glycemic control diabetic patient association function mellitus may adverse risk cardiovascular complication treatment use disease respective impact one show type mellitus aim present evidence association disease mellitus provide clinical management
25132138 en datum prevalence type mellitus among case patient year new type diabetic patient datum type general adult patient type mellitus per age group CI respective period mean increase type diabetic patient per year per per mean year study period female show prevalence type mellitus group increase among female age adjust prevalence female prevalence type mellitus among female increase
26198368 en mellitus adult increasing prevalence patient mellitus contribute increased risk develop cardiovascular disease include disease dysfunction diabetic poor patient mellitus patient high risk type patient mellitus provide patient mellitus related complication patient without mellitus patient lower also high risk may significant patient hospital patient mellitus lower clinical rate patient without may also hospital high risk adverse drug event potential population therapy
26148570 en incidence type mellitus increasing among man however impact metabolic cell remain evaluate effect associate type cell activity protein cell obtain model different development disease mechanism may glucose decrease cell concentration found whereas decrease concentration found type diabetic profile although activity cell type diabetic condition result reduce level mellitus metabolic datum role metabolic cell individual metabolic disease may associate mellitus
26539874 en effect activity type mellitus T2DM investigate diabetic cause decrease evidence decrease lipid primary parameter activity normal value effect level result
21752883 en first cell patient age patient review clinical age diagnosis follow-up diagnosis addition two patient include two case perform patient within month diagnosis show patient case case case one present follow-up patient develop perform case observed well case one follow-up disorder may lead diagnosis
26962125 en patient type mellitus risk intervention diabetic disease aim examine impact improve glycemic control function total subject type mellitus aged year poor glycemic control receive treatment blood glucose blood pressure cholesterol target month function measured compare baseline patient impair function month hemoglobin hba1c decrease associate significant relative great patient lower hba1c patient hba1c large patient hba1c patient improve hba1c significant high relative baseline decrease body mass index treatment independent glycemic control period lead function may
25523182 en evidence effect blood pressure patient type mellitus therefore aim investigate effect blood pressure ratio year large cohort patient type primary care patient type mellitus care study cohort study patient included current study follow-up datum study population patient analysis perform estimate effect analysis perform according baseline hypertension decrease group large decrease observed group receive significant change time observed among group patient associate large decrease year compare without different effect observed difference effect ratio among patient type mellitus
27706650 en type mellitus common disease factor known contribute development disease study investigate relationship type mellitus population patient type mellitus control subject hospital logistic regression analysis revealed patient high risk develop type mellitus compare adjust odd ratio or confidence interval CI addition individual on show high risk develop type mellitus compare adjust or significant correlation on risk type mellitus study show contribute type mellitus may consider early type mellitus population studied
26689451 en examine association obesity glycemic control among patient type type mellitus health patient define glycemic control hba1c time study period logistic regression conduct T2DM patient examine association BMI glycemic control patient general health condition medication T2DM patient T2DM BMI BMI associate significant high associate significant high hba1c compare normal BMI T2DM patient associate significant high hba1c T2DM patient positive statistical significant association glycemic control finding association obesity glycemic control potential individual characteristic glycemic control
26707657 en on population conduct aim determine level mellitus risk develop disease study base general population include man woman aged year result show participant without mellitus risk develop disease participant body mass index less activity population day participant define severe severe disease finding improve effective control cardiovascular risk factor well healthy early age great among patient also within general population
26208651 en major complication mellitus therapy present study investigate role factor factor potential target model type mellitus identify hypertension time well sample patient type mellitus increase target increased per use mellitus study previous mellitus
21995174 en report case woman two result similar time patient receive result case patient well
21102546 en on woman present hospital history serum well serum concentration factor function analysis cell therapy include remain year without therapy
27374251 en type mellitus undergo reduce increased study assess relationship risk type study use factor analysis incidence type year follow first conduct analysis participant baseline follow year on use identify logistic regression analysis determined association type adjust follow participant develop type revealed age associate increased risk type CI significant associate type intervention reduce increase reduce
27371778 en mellitus associate increased risk complication mortality datum known high prevalence aim assess mortality use large cohort study population individual type type mellitus aged patient follow according age study database general population study period use mortality ratio total follow patient mortality rate per CI mortality rate high among man increased age increasing age independent mortality duration presence complication hypertension old age obesity presence associate reduce low mortality rate population associate high number result high prevalence complication reduce prevalence complication reduce risk mortality
27004328 en mellitus common disease similar finding change renal common year mellitus renal well study relationship mellitus renal study first investigate association renal study conduct hospital may three patient renal three patient renal patient renal positive rate diabetic patient positive rate result provide first association renal mellitus early diagnosis fasting blood patient positive renal
23960149 en disease potential treatment complication reported less adult report case man complication need association first case reported
26872904 en cell show previous diabetic report recent study role cell assess role cell treat normal healthy control patient patient type mellitus cell determined well protein activity evaluate effect also studied patient patient type mellitus T2DM examine result indicate increase cell high cell cell increased cell well can addition type model compare normal model however patient lower cell indicate treatment patient type
26518684 en patient type mellitus effect hba1c event remain present evaluate association hba1c cardiovascular event severe cohort patient new insulin define rate change value medical patient disease management type mellitus identify cohort patient observed insulin therapy cohort observed period little year regression model association hba1c event model significant association hba1c risk low risk per use model cohort hba1c per within year increase significant increase risk patient new insulin therapy high hba1c associate increased risk severe
26802601 en mellitus common complication treat previous study suggest chronic important role increase decrease activity change aim study examine association gene development mellitus study included patient receive treat patient two without model regression analysis show development significant positive associate number regression analysis age BMI well number revealed independent risk factor result study suggest association gene patient treat
19885795 en history patient
19825939 en result protein cause mechanism show several develop large cell show indicate revealed condition show presence finding group disease associate protein
27079439 en mellitus major disease prevalence increase aim estimate associate type mellitus study estimate population risk associate type use prevalence estimate type ratio risk analysis cohort study observed model result show total incidence mortality increase adult aged year respective number case associate type increase man woman analysis show population increase adult aged year time change adult aged year study suggest increase associate type
26429928 en present study group serum level glucose insulin measured level glucose observed group day group control serum insulin level significant elevated group day compare group whereas decrease serum insulin level observed group day level show day however significant decrease level observed day show group group severe group change change observed treat group compare result use demonstrated type mellitus
21777173 en treatment disorder effect include system one case reported develop case develop normal treatment
23690314 en datum common history change addition whether early parameter development study history plasma change identify whether mortality identify whether dysfunction development chronic patient undergo plasma measured day result define less low patient diagnose according patient undergo little month patient patient patient therapy major patient compare patient mortality rate compare patient without result follow-up compare without patient develop low low mortality patient follow-up little previous mortality
26411116 en prevalence mellitus three increase mortality due complication datum regard complication population study evaluate diabetic complication patient study conduct medical hospital diabetic patient year age duration mellitus one year patient female mean age year mean duration mellitus year total patient poor diabetic complication patient patient different complication mellitus regard complication poor renal disease disease diabetic lipid diabetic range diabetic patient diabetic complication therefore hospital base decrease mortality associate mellitus
25840840 en significant risk factor complication also increase prevalence increasing risk aim review relationship glycemic control measured hba1c conduct review included determined two study impact hba1c level outcome study include total patient mellitus range glycemic control mortality significant difference incidence disease hospital base glycemic control study hba1c level need related total hospital high regard event hba1c associate increased mortality patient mellitus study included review relative retrospective patient suggest evidence
25044236 en examine relationship diabetic status patient type type mellitus study examine diabetic patient without patient patient severe control without status base clinical patient undergo analysis perform use assess difference subject without type DM subject type DM participant severe significant lower compare control however lower also found participant type DM relative control may early type DM type addition may influence
25017342 en mellitus health increase include aim identify change cause association study mellitus three period use model obtain mortality ratio relative risk mellitus associate high mortality ratio value found mortality ratio found high mortality ratio value occur mortality ratio relative risk mellitus increase associate condition significant two period relative risk mellitus present however year population mortality ratio increased year high mortality ratio current found high index
26066567 en gestational mellitus condition common include insulin resistance cause gestational mellitus factor diagnosis treatment cell show effective treat study develop system use model gestational mellitus cell gestational mellitus great improve glucose outcome female compare control group finding use cell gestational mellitus patient
19364693 en case clinical clinical finding study patient review woman status change new diagnose mass possible dysfunction three year early diagnose time revealed year included status change weight develop poor concentration revealed sample revealed previous reported case reported case positive protein result dysfunction patient medical treatment mortality high report follow-up patient diagnosis early may improve outcome
26331457 en several factor show increase risk type mellitus study investigate association incidence type mellitus man three conduct follow study population participant woman aged year without baseline assess use index ratio estimate follow-up type mellitus case man woman observed incidence rate type mellitus per high poor compare man vs woman vs age history status activity hypertension BMI risk type mellitus participant poor compare confidence interval CI man CI woman analysis revealed ratio CI man low level CI man high level associate type mellitus man association independent risk factor baseline man low level
24050105 en related complication important cause mortality develop complication due clinical report due may occur clinical early diagnosis treatment among general care care patient
25797896 en role hemoglobin diagnosis mellitus evaluate use test renal month total patient without previous undergo use diagnose identify patient whereas identify patient show CI show high use diagnosis use reduce number use test diagnose
24259958 en disease common type mellitus clinical condition prevalence among diabetic subject population type mellitus case chronic disease prevalence clinical chronic management type type mellitus type disease present general patient known clinical chronic develop type mellitus case however patient first present mellitus chronic potential condition consider patient diagnose type mellitus lead medical therapy patient type mellitus impair medical therapy
24219188 en determine whether old woman mellitus great without whether according insulin cohort woman mean age study year mellitus mellitus on medication use determine use insulin outcome change include adjust model show woman mellitus great confidence interval CI CI without CI CI woman mellitus insulin less insulin significant mellitus status insulin woman mellitus great old woman without mellitus clinical study old adult determine whether mellitus treatment insulin need
24128301 en study provide estimate risk factor mellitus develop health examine sample aged parameter estimate confidence interval CI well age population difference risk factor prevalence treatment control estimate model obesity mellitus estimate prevalence mellitus CI significant high woman man vs increasing age mellitus status woman man less control overall less common man common woman without health less control prevalence risk factor high woman man increased woman body mass index low associate mellitus respective man respective mellitus risk factor high among woman mellitus difference
26650437 en mellitus associate great mortality increased different group use different base association glucose patient receive large great glucose revealed significant glucose result review early diagnosis group whereas hemoglobin method first year risk factor include medication well type associate hypertension great risk medication treatment therapy consider great risk reduce function cause research found base evidence
25470649 en common associate metabolic disorder mellitus type mechanism mellitus known association metabolic control mellitus impair estimate serum level patient mellitus type correlation duration control estimate hba1c mellitus type patient mellitus type included study blood sample analyzed fasting glucose hba1c patient group three base hba1c level control need intervention poor control three group compare mean level blood glucose association serum level hba1c fasting blood glucose duration mellitus also level found hba1c level duration mellitus type poor control mellitus type serum occur duration disease
25366895 en protein one one three consider different study included also model datum effective type type mellitus complication provide mechanism although clinical study compare one present review provide clinical evidence regard effective mellitus complication effect mellitus can provide possible management disease complication
26578518 en type mellitus response recent identify reduce cell early may influence development time test healthy control examine number cell assess gene measured time study found cell gene per lead increase cell mass finding analysis subject diagnose revealed association baseline activity cell function first year finding new role response change suggest response can potential
21498630 en cause gene case study present clinical cause woman evaluate age year patient subject test diagnosis show without relative without analysis show gene study report due gene clinical disease review
24622368 en mellitus dysfunction compare clinical outcome according cohort patient diagnose mellitus age year without normal
26096383 en examine association mellitus function baseline change time large sample old cohort study risk factor new man woman aged old without baseline undergo baseline follow-up health assessment month estimate use examine association mellitus mellitus associate poor baseline function adjust age participant mellitus perform significant baseline without difference without mellitus rate change mean follow-up time rate change without mellitus similar although poor mellitus finding suggest change may occur early mellitus need study follow participant little
25908766 en protein multiple include glucose group related type mellitus compare healthy woman mellitus baseline protein respective follow-up year type mellitus case occur model age activity status use history body mass index ratio confidence interval protein association protein adjust lipid respective finding association common type mellitus provide development type mellitus study role type mellitus
27084987 en serum mellitus study indicate important role use study develop base lower method addition resistance system can also use clinical sample important can significant high level concentration normal serum indicate potential diagnosis mellitus
18363121 en use treatment report man develop two week on test low serum level diagnosis suggest may cause
19334328 en report case patient syndrome develop use patient present history weight patient response complication use population renal use
23150186 en disease cause type gene however datum also whether different analysis perform total identify regard identify among common follow woman include subject regard identify two one show one show on total identify relative high need
27071967 en one cause patient patient without significant reduce treatment treatment cardiovascular disease well mellitus several mechanism high incidence diabetic effect due dysfunction effect disease due associate hypertension due diabetic review mechanism patient treatment patient primary consider assessment chronic disease complication early cardiovascular drug treatment treatment drug low risk treatment also therapy demonstrated high potential patient
27107818 en estimate type mellitus T2DM prevalence study conduct adult aged year age type obtain sample high T2DM diagnose hba1c level hba1c hba1c datum sample subject overall diagnose T2DM previous diagnose previous T2DM prevalence increased age year high among female vs estimate subject T2DM increase increasing body mass index T2DM prevalence high population vs adult population T2DM prevalence subject previous result may develop new T2DM management
25458339 en hypertension system mellitus investigate effect system patient type patient type mellitus treat evaluate influence blood pressure rate plasma concentration protein ratio patient parameter also change blood pressure cause reduction concentration blood plasma concentration significant reduction protein ratio parameter significant increased patient type mellitus compare activity significant improve disorder therefore may important use system hypertension mellitus
25312870 en dysfunction mellitus DM important factor complication aim protein high protein level type mellitus determine use patient DM type type well healthy subject included subject significant increased compare control group type DM significant complication type respective significant complication type type type DM high level compare healthy control suggest can use complication type DM whereas use complication type DM
24916554 en provide assessment datum analysis mellitus increased risk relative patient study test estimate compare healthy cohort one three mellitus relative patient individual without history on month evaluate datum compare correlation analysis group estimate total associate correlation compare group mellitus protein relative patient revealed correlation total mellitus relative patient individual without history total cohort assess
26343103 en increasing general chronic disease mellitus aim determine prevalence use among patient mellitus associate factor use among patient patient mellitus study two medical patient use little one type year patient mellitus large insulin effect independent significant value respective use reported use change medication medication use among patient use associate patient type medication use
25423954 en metabolic mellitus oral health level lipid risk research regard type assess cholesterol level type mellitus correlate aged year type mellitus healthy included study evaluate cholesterol level status cholesterol level significant high type mellitus control mean score high diabetic show significant correlation status study group normal cholesterol level show significant association cholesterol level significant high type mellitus show significant association
25989565 en determine whether change factor protein level great participant type mellitus individual follow-up analysis cohort health study participant cohort study adult aged old protein level assess association impair glucose tolerance impair fasting glucose mellitus use participant baseline follow-up baseline mean age mellitus participant high level lower level mellitus great change level occur mellitus baseline change individual remain follow-up change develop glycemic associate change protein level change observed mellitus group previous show associate mortality
25814324 en assess relationship metabolic control blood glucose patient type type T2DM mellitus factor associate study conduct diabetic patient treat insulin use value hba1c assess use total patient mean age year mean hba1c T2DM little relationship overall sample T2DM logistic regression model risk elevated hba1c value associate poor total sample elevated hba1c value associate poor T2DM body mass index associate poor retrospective study patient DM treat insulin use relationship metabolic control use
26695015 en study aim evaluate glycemic level patient type mellitus T2DM factor related result glycemic control on total T2DM patient examine hemoglobin level glycemic control potential factor related result glycemic control analyzed use logistic regression patient glycemic control target hba1c analysis show or CI high level fasting blood glucose or CI cholesterol or CI significant associate poor glycemic control also associate poor glycemic control compare insulin associate poor glycemic control or CI patient high level total cholesterol lower level cholesterol diabetic duration show poor glycemic control found female patient glycemic control T2DM patient factor associate poor result glycemic control
18304048 en on present history normal serum profile follow diagnosis treatment however remain month diagnosis
19297548 en disorder cause gene protein previous study suggest cause analyzed cause patient analysis revealed body normal present cell body increased increase analysis show well cell found analysis revealed significant decrease compare cell indicate datum suggest cell primary cause dysfunction lead
17197021 en report two case patient develop on show one case case reduce level associate two case show
26996471 en type mellitus T2DM consider however age diagnosis reduce recent year although incidence T2DM increasing characteristic risk factor T2DM aim study characteristic T2DM patient evaluate risk factor control study perform use method multiple on total patient T2DM age year included control group subject aged year normal blood glucose patient T2DM mean age hemoglobin diagnosis year respective patient follow pressure history mellitus compare subject normal blood glucose level logistic regression analysis show ratio odd ratio or confidence interval CI history mellitus or CI or CI blood pressure or CI body mass index or CI independent factor observed obesity history mellitus medical history hypertension independent risk factor T2DM therefore early intervention risk mellitus
26283471 en increasing use treat chronic mellitus however aim evaluate previous study management mellitus general use related complication review evaluate regard use included use outcome management mellitus study perform study studied studied studied although review found decrease level blood glucose hemoglobin hba1c study mechanism however level hba1c measured number clinical trial study use studied related complication function well change also little review studied regard study on significant number review include mellitus disease use management important factor level hba1c insulin consider according review model whereas investigate however research history obtain clinical trial effect improve research database disease decrease increase research
22498392 en report associate renal high cause show poor renal well follow-up
27909960 en effect studied obesity type mellitus week week receive group cell associate less finding suggest effect change obesity type
25185378 en mellitus remain high individual adult risk mellitus provide potential early diagnosis mellitus study determine risk factor mellitus among adult study subject age year use datum subject examine weight body mass index ratio blood sample subject plasma glucose concentration use glucose method mellitus diagnose according female female mean age year body mass index identify risk factor mellitus multiple logistic regression prevalence mellitus independent associate age or CI or CI history mellitus or CI ratio or CI age history DM increasing ratio risk factor mellitus among adult risk factor adult important early diagnosis mellitus population
25068894 en treatment control mellitus DM effective status condition although several investigate treatment control rate mellitus little known association risk factor study aim examine relationship risk factor treatment control mellitus conduct use participant aged year old analysis base sample adult subject logistic regression analysis use examine factor associate level treatment control treatment control rate mellitus respective logistic regression analysis history significant positive associate or CI treatment or CI mellitus negative associate control or CI less blood glucose level or CI respective participant diabetic condition or CI found treatment mellitus positive associate age high participant history low participant history diabetic condition poor control
17643658 en present case occur patient identify day serum day serum patient base case patient therapy potential complication
26188234 en control blood glucose level patient type mellitus DM use system determine whether hba1c effect control DM patient use hba1c body mass index patient receive care control hba1c datum hba1c BMI evaluate month month also reduction hba1c observed month compare group significant reduction also observed month compare statistical significant difference BMI observed month hba1c increased also observed compare number reduce intervention patient health care result reduction hba1c effect month
24907168 en mellitus disease develop develop hypertension potential risk factor mellitus disease study aim prevalence hypertension association blood glucose level mellitus diabetic study conduct among previous diagnose mellitus patient diabetic hospital age weight measured BMI according blood pressure measured fasting plasma glucose level study participant health datum general participant weight BMI participant studied participant fasting plasma glucose observed among diabetic patient prevalence high among patient aged year vs vs high among year difference significant prevalence significant high participant vs vs normal weight vs high prevalence hypertension found among participant
25653143 en mellitus DM patient increased incidence cardiovascular event blood activity mechanism blood elevated DM show use increase healthy type DM T2DM subject type DM subject mechanism DM patient elevated plasma role level studied effect healthy subject T2DM subject blood healthy subject increased correlate T2DM patient show increase subject correlate glucose insulin increased healthy subject insulin increase high glucose level increased insulin increase first evidence healthy subject duration increase different T2DM subject
16464684 en chronic mellitus DM present study role DM use control DM studied week DM increase blood glucose level effect DM significant chronic change effect although body weight effect change plasma DM effect decrease plasma level elevated DM without influence DM level DM without effect datum suggest role chronic role important however according datum risk factor DM
26936372 en number activity cell woman however whether effect woman study compare number activity woman without mellitus woman mellitus evaluate function group investigate possible found compare woman number function well function evaluate woman plasma level woman also however presence mellitus number function woman decrease similar plasma level reduce present finding first effect mellitus number activity woman little related reduce may potential target woman mellitus
27036979 en study dysfunction increased blood cell mellitus model evaluate blood cell function patient mellitus cardiovascular assess function patient age year woman cardiovascular disease mellitus cardiovascular disease mellitus control age without mellitus cardiovascular disease measured blood cell high clinical mellitus clinical mellitus compare control subject model adjust age cardiovascular risk factor clinical mellitus remain associate high level respective high associate high baseline response found great patient mellitus clinical association baseline may suggest dysfunction potential adverse impact
27005938 en evaluate whether mellitus patient without mellitus type use among significant reduce diabetic patient compare patient patient low level high risk disease show cell major cell respective clinical result revealed reduce mellitus significant potential
26197086 en group metabolic disease major health incidence increased recent type mellitus disease cell chronic type mellitus T2DM metabolic disease high blood insulin resistance dysfunction cell chronic less well T2DM however study conduct show metabolic dysfunction also show chronic role T2DM two factor common contribute response review current research function
25726335 en patient increased correlation diabetic study determine whether lipid correlate well type mellitus serum sample type mellitus age year measured serum use datum obtain result show increasing level correlate significant positive correlation concentration base study relationship subject analysis show fasting plasma glucose factor high adjust or CI however significant correlation correlate base type mellitus patient may role diabetic effect potential
19218773 en system disease poor on woman development demonstrated diagnose due base finding well result observed however finding without treatment month suggest clinical
26507303 en mellitus risk factor disease role conduct cohort study assess whether mellitus risk factor cohort study assess association risk odd ratio or study study ratio model effect use conduct adjust study identify include cohort study patient study patient cohort study demonstrated significant association CI association present analysis CI study show significant association or association present adjust or use or increased risk associate result effect risk therefore management diabetic patient risk
26228717 en aim study determine incidence incidence rate type mellitus aged year type mellitus diagnose identify rate incidence regression use incidence year age diagnosis use function regression model year use assess total case type mellitus mean incidence per CI mean incidence CI high compare mean incidence high high on year incidence observed overall age group increase incidence observed age group increase per year CI observed incidence rate type mellitus incidence rate observed finding previous reported
25201910 en mellitus increase cardiovascular disease risk remain elevated therapy model mellitus impair regression cholesterol negative cholesterol factor may assess effect regression diabetic protein gene week diabetic protein gene treat control although regression impair diabetic treat control treatment decrease gene decrease treat diabetic associate reduce associate effect mellitus regression suggest diabetic patient remain elevated cardiovascular disease risk plasma cholesterol
16450314 en major cause severe cause reported patient syndrome syndrome report case woman large cell develop first diagnose low concentration revealed first patient cause
24638887 en aim current study investigate association group mellitus study development mellitus addition study suggest may associate risk examine participant health outcome mellitus define level hba1c diagnosis use oral medication insulin analysis adjust age body mass index ratio total cholesterol serum observed positive association low weight mellitus compare participant low or mellitus among high CI associate mellitus adult year age association common associate study datum
26873871 en although man woman similar prevalence cause different result different mechanism effect therapy obesity female patient new diagnose type mellitus obesity patient new diagnose T2DM female female group group receive therapy week weight female patient respective therapy show effect female patient insulin serum lipid profile reduce insulin resistance increasing level level hba1c BMI protein therapy show result female patient patient therefore therapy female patient
25950711 en investigate factor associate patient type cause type mellitus research need type mellitus study use diagnose type mellitus history diabetic two major hospital datum current type mellitus current reported present health status association positive health receive current weight health status relationship type mellitus result negative type mellitus weight type mellitus complication important health weight control intervention type mellitus
26847860 en impair glucose may lead development mellitus primary study assess difference insulin patient develop patient retrospective study adult included define use oral day use insulin day hemoglobin time patient included develop insulin medical group blood glucose level medical group analysis revealed positive associate development adjust odd ratio CI negative associate development CI analysis suggest insulin positive risk factor development association analysis positive use negative development
25734801 en mellitus risk factor impair insulin resistance clinical several study assess hemoglobin hba1c change clinical population individual mellitus patient drug identify case control age factor related mellitus logistic regression use odd ratio or confidence interval association hba1c total case control identify risk increased individual high hba1c compare low or CI risk remain elevated compare high hba1c measured within year clinical low hba1c association found hba1c hba1c measured year clinical increasing hba1c patient mellitus clinical year finding indicate lead time several year development patient mellitus
25623915 en prevalence increasing case type mellitus relationship type mellitus obesity well treatment use patient type mellitus aim present current possible mechanism glucose control review treatment present impact treatment glycemic control result possible mechanism among individual type type mellitus use rate new lower consider randomize control study medical treatment patient type mellitus type mellitus observed case year follow-up type mellitus group glycemic control lower risk complication present effect glycemic control well role possible mechanism effective treatment type mellitus patient treatment patient type mellitus research need mechanism glycemic control
25829212 en study aim identify factor patient type mellitus total patient type mellitus care hospital datum history conduct datum analyzed use test analysis correlation multiple mean score patient type mellitus respective disease duration age correlate positive multiple regression analysis revealed positive influence patient type mellitus influence clinical characteristic consider age disease duration well effective among patient type mellitus
25042896 en research prevalence DM effective management use hba1c randomize individual age range assess disease risk factor include participant medical history activity examine blood pressure blood sample also fasting plasma glucose prevalence diagnose respective increased age year old group year old group year high prevalence participant identify diagnose diabetic case impair hba1c obesity adjust odd ratio low activity risk factor associate prevalence among individual treatment regard primary
22858568 en present syndrome adult however patient report complication type develop case previous reported case complication association clinical characteristic outcome case review
23796021 en difference old adult mellitus sample adult mellitus aged measured base medical outcome study range mean regression model estimate association evaluate potential status health condition difference adjust mean score test confidence interval CI CI CI CI CI adjust potential change relationship CI CI difference status health old adult mellitus system care system may reduce health outcome
26426099 en whether mellitus risk factor aim review examine evidence correlate presence mellitus patient perform review database use mellitus use review case great rate patient mellitus reported rate cohort patient large case reported lower rate patient mellitus compare patient patient reported rate high rate reduce reported rate less patient mellitus large case reported rate cohort case patient evidence risk reduce large case rate patient mellitus statistical significant population large
23704108 en potential effect mellitus glucose level outcome evaluate outcome patient treat therapy according mellitus analyzed datum patient conduct review previous study primary study outcome patient outcome score identify previous report evaluate effect mellitus outcome included datum previous datum mellitus associate less outcome odd ratio or confidence interval CI or CI however analysis mellitus remain associate less outcome or CI or CI adjust high associate less outcome adjust or CI per increase outcome result history mellitus associate poor clinical outcome may factor however randomize control evidence need glucose control clinical outcome
26378394 en type mellitus T2DM associate elevated body low level recent reported subject T2DM investigate whether level T2DM T2DM development independent risk study included subject aged year female level measured mass diagnose according association baseline baseline ratio subject develop follow-up reduce compare subject normal glucose tolerance confidence interval age serum high level associate reduce risk ratio per high confidence interval event risk factor concentration change result CI low level also subject T2DM level low body independent T2DM may contribute
20707752 en on female evaluate history also history revealed body condition finding well result plasma analysis revealed body weight test remain low rate weight decrease increased treat oral reduction period month time health medication response medication month reported condition consider clinical disease similar may treatment
27112242 en prevalence mellitus DM associate disease increasing patient glucose suggest association type DM risk show metabolic disease due insulin resistance low chronic factor use medication influence study review recent metabolic type DM risk association well current metabolic finding review although according research DM risk duration DM may due treatment recent associate increased risk due review type DM duration risk disease
24830459 en previous study mellitus associate risk study investigate relationship mellitus patient reported finding estimate role mellitus review study identify database evaluate correlation mellitus ratio confidence interval CI poor overall study total patient overall patient mellitus status study total case investigate overall study total patient investigate overall CI CI respective adjust overall CI CI respective addition patient receive mellitus associate poor overall poor patient receive treatment patient receive mellitus associate poor overall evidence mellitus independent associate poor overall poor patient
27485851 en determine prevalence risk factor mellitus examine diagnosis management study study among adult define blood glucose concentration diagnosis individual diagnosis consider level participant prevalence respective high risk group identify old age obesity identify previous diagnosis among participant lower among individual high previous diagnose treatment concentration level risk factor profile study similar population on high individual treatment treatment high high concentration datum may diagnosis management
26762910 en aim study compare patient mellitus well can associate high patient randomize trial patient DM medical treat oral insulin randomize primary assess total patient randomize overall patient hba1c range primary analysis show significant type glycemic control significant reduction group patient high hba1c large follow-up case patient DM result suggest high may potential patient DM on randomize patient mellitus
25061078 en patient type mellitus increased risk independent risk factor patient remain total patient type mellitus diabetic study without history baseline included base medical baseline mean age year duration mellitus year man year follow-up patient analysis perform determine independent risk risk factor duration mellitus presence diabetic high hemoglobin high blood pressure insulin resistance history whereas lipid protein metabolic syndrome associate increased risk diabetic severe diabetic high blood pressure lower body mass index independent associate risk factor profile different patient type mellitus
25987664 en whether blood pressure among individual without mellitus associate chronic disease risk independent parameter mean metabolic profile change follow-up remain use datum study adult aged year mean age year man without mellitus estimate rate per measured baseline follow-up define year follow-up population develop logistic regression model increase per per per per associate odd ratio or confidence interval respective clinical characteristic mean year year association remain significant metabolic parameter change follow-up or analysis medication use presence hypertension show similar among general population without mellitus year associate risk independent mean metabolic profile change follow-up
25558032 en disease include mellitus DM independent mortality population general population patient DM review current use aim current related DM review study among patient DM related complication DM include also increased population impair glucose tolerance metabolic syndrome well DM datum suggest DM however need whether large change DM whether intervention target associate improve clinical outcome DM also review potential mechanism DM role age potential research
23763040 en report case use result
26821280 en insulin insulin treatment mellitus insulin profile insulin duration activity several trial insulin control insulin patient type type high insulin control month treatment insulin general associate lower risk insulin patient type risk significant treatment group patient type patient type insulin effective general well insulin therapy patient type type
27181706 en investigate association two gene type mellitus present study type mellitus patient control two use two case control base body mass index compare use logistic regression analysis regression use association clinical increased risk type mellitus compare participant body mass index odd ratio CI correlate hemoglobin control association blood pressure control control body mass index also association blood pressure blood pressure present result association type mellitus however large study finding
26484625 en identify management factor associate control among adult type mellitus treat insulin study adult type mellitus insulin therapy little month year old may on new develop evaluate participant management related insulin therapy correlate insulin datum hba1c insulin indicate significant control logistic regression analysis found overall insulin therapy management significant control odd ratio confidence interval adjust potential include age duration insulin therapy however overall insulin therapy significant control significant association insulin therapy identify management factor associate control adult type mellitus insulin therapy use new study assess clinical may target insulin therapy control
26344325 en hba1c use diagnose type mellitus DM clinical diagnose gestational mellitus evaluate clinical hba1c diagnose risk type DM development among retrospective study included subject undergo oral glucose tolerance test hba1c analyzed evaluate evaluate clinical hba1c type DM development subject month follow-up datum two develop type DM significant high group normal control group hba1c show value diagnosis value hba1c level high without vs value hba1c evaluate analysis value show high relative low diagnosis woman potential hba1c may use less test patient
25561813 en investigate clinical function patient study determined diagnose concentration include serum patient low level hemoglobin oral glucose tolerance test also perform patient without mellitus type mellitus diagnose according association patient included study patient one two common severe severe present patient respective mean time study year diagnose patient patient patient little one lower normal present patient severe also present patient severe present statistical significant difference according number develop follow-up patient serum
19112432 en clinical condition cause present old woman hospital medication on found test on clinical response patient evaluate metabolic complication also can
26870978 en aim investigate serum type mellitus level glycemic control study conduct type mellitus patient group base glycemic control group level glycemic control group level glycemic control group high risk level glycemic control group control group healthy type evaluate according management type mellitus determined method found decrease serum concentration patient level glycemic control patient level glycemic control lower level patient patient type mellitus high risk level glycemic control increasing level level glycemic control duration type mellitus important development chronic diabetic complication found duration type mellitus influence level serum level glycemic control influence
25853448 en use treatment whereas reduce incidence disease therefore treatment may diabetic patient associate disease present study evaluate therapy mellitus blood pressure serum insulin glucose lipid profile measured perform treat show significant decrease body weight body mass index show significant increase level blood pressure serum glucose total cholesterol well significant decrease level serum insulin high reduce period day significant improve parameter normal effect result present study suggest activity significant effect mellitus
25951320 en condition chronic negative role several complication however study evaluate possible influence function aim identify association function man mellitus mellitus subject mellitus subject retrospective review clinical parameter consider subject show high value body mass index hemoglobin lower one compare one parameter function significant subject patient show high value well little response test compare one significant association found regression analysis patient subject negative significant association response function total index function score study suggest first time impair influence function
27546693 en oral treatment type mellitus number positive effect aim study determine effect level new diagnose mellitus type study included new diagnose mellitus type drug patient group on patient group DM type patient therapy year group patient group on treatment assess baseline level group on month therapy group on difference level month treatment group level group on show reduction month therapy statistical significant statistical significant change group on change level month positive patient significant decrease level month group significant difference level group on compare group result show effect patient type DM also positive patient show effect therapy
25452366 en total effective method however without risk due number factor one mellitus study estimate general prevalence patient undergo primary determine whether mellitus adverse outcome conduct review according study odd ratio or mean difference use estimate risk outcome result show prevalence mellitus among patient undergo patient mellitus increased risk or confidence interval CI or CI or CI or CI poor function CI patient increased risk obtain care
25649990 en study association insulin patient type study datum evaluate use patient health patient baseline baseline score indicate baseline mean change CI baseline or disease or number or change hba1c or independent associate patient severe time insulin patient change without common type associate increased need management
23396467 en lead use patient associate period present development high plasma low diagnose due cause treat
27697449 en evidence suggest lower less high present study examine association adult type mellitus time lower similar decrease great studied adult type provide baseline assessment follow-up follow-up measured use patient health respective on assess month model test association association association test negative follow-up follow-up associate lower evidence study identify
20682211 en association report patient syndrome
26891449 en high concentration blood associate mellitus study aim whether total associate incidence on protein gene protein negative cell also studied incidence cell analyzed man woman year old study subject incidence studied mean follow-up year regression use examine incidence total analysis use perform little regression on total subject develop follow-up period several possible concentration total significant associate incidence adjust ratio confidence interval vs total associate per cell however significant association fasting glucose hba1c incidence total associate incidence however association suggest association may although statistical effect
25537056 en mellitus type hypertension major risk factor disease consider reduce different early compare impact hypertension mellitus type well function model disease mellitus type diabetic control hypertension renal test impact show reduce however change reduce without reduction diabetic finding impair reduce diabetic condition hypertension suggest mellitus early whereas hypertension impact treatment patient population present mellitus hypertension need different different target
25447679 en type mellitus T2DM fasting blood glucose level may T2DM study T2DM female use one group per group treat low blood glucose level response measured group increased fasting blood glucose compare control day month indicate T2DM treatment effect body weight one month decrease blood glucose level compare result suggest low level can effect blood glucose model
24496924 en aim study recent incidence renal disease status type patient condition care renal patient use study patient without mellitus type mellitus type incidence patient care incidence rate high related type similar type incidence decrease significant time patient type significant patient increased significant patient type type change number population population effect disease patient type type major impact incidence due type mellitus datum need management patient improve diabetic cardiovascular reduce rate
27180646 en several study reported positive association dysfunction evidence regard association among patient type mellitus although common among type mellitus participant patient type mellitus aged year undergo blood test on use study age body mass index hypertension disease hemoglobin diabetic severe severe define present participant health man score respective study participant consider within week time prevalence independent positive associate severe adjust odd ratio confidence interval confidence interval respective positive association severe man type mellitus associate severe
25438840 en measured parameter significant disease however significant patient mellitus studied total patient undergo presence define significant lower patient mellitus patient without vs characteristic analysis revealed can effective patient without mellitus value however can diabetic patient lower value value addition result similar significant lower patient mellitus patient parameter patient mellitus
21210157 en occur clinical condition follow within reported occur case association factor reported case previous reported on woman undergo patient also undergo day need severe day also great diagnose day treat without status mass effect important care complication diagnosis
26510924 en compare patient type mellitus type mellitus T2DM potential therapy insulin patient evaluate patient T2DM on model relationship glucose patient patient T2DM concentration increased similar patient population increase observed population result show regard response patient mean effective concentration confidence interval CI patient T2DM CI baseline fasting plasma glucose estimate rate however similar two population mean CI T2DM mean CI response similar patient T2DM suggest current use treatment T2DM may provide therapy insulin patient
19244398 en increased renal previous reported increased may control day result associate decrease protein control increase show significant high increase control indicate one associate increase compare control revealed control datum indicate increased may study also potential effect treatment
26016732 en type mellitus associate high risk although mass reduce also disorder however recent evidence suggest effect aim present study conduct level whether can type mellitus use model type mellitus control treat day assess level treatment however significant improve treatment treatment significant study mechanism whether finding patient
23676599 en on syndrome patient undergo blood primary blood develop blood observed treatment patient cause first case report cause demonstrated
23419422 en syndrome disorder development female associate development function renal number finding may also patient increased risk hypertension also reported present case patient first reported patient disorder
26006309 en on assess use sample different measured use patient type mellitus type mellitus T2DM healthy blood use respective respective high T2DM positive analysis show CI addition insulin increased method serum increased adult
17177143 en renal therapy common complication remain present patient therapy develop due oral lead within day consider patient undergo severe
16562592 en present due patient investigate patient serum test positive show develop day result treat oral
19488606 en response include case cause gene studied use clinical datum mean age diagnosis month range year follow-up period mean period follow-up mean weight respective diagnosis medical weight respective three patient diagnose increased gene found patient status case two present two patient one patient show analysis normal risk significant study report clinical disease diagnosis
24648135 en use datum study examine mellitus cause mortality period mellitus cause contribute cause contribute cause identify cause mellitus cause mellitus mortality rate relative high among old individual difference rate mellitus mellitus cause cardiovascular disease contribute cause mellitus contribute cause cardiovascular disease cause
24597539 en investigate mortality rate patient without mellitus patient without mellitus examine risk mellitus previous report indicate increase risk analyzed patient hospital management patient mellitus status clinical mortality datum patient aged year hospital relative time patient include patient without mellitus mellitus significant difference mortality group regression model interval significant risk factor mortality mellitus status significant model follow month blood glucose evidence patient without mellitus status increase mortality risk risk mellitus also large study time
26195118 en mellitus disease one little known complication function aim study compare function two group diabetic individual individual investigate factor retrospective included patient undergo function test medical patient review patient two group diabetic patient included diabetic patient patient total significant lower patient mellitus compare patient on low significant associate diabetic complication renal function insulin function impair mellitus significant decrease
24552274 en activity lipid metabolic studied cardiovascular develop week type mellitus high week low interval activity total cholesterol cholesterol increased activity decrease activity normal activity increased activity decrease treatment study treatment dysfunction
23396552 en investigate therapy diabetic type mellitus adult diabetic group therapy therapy therapy day oral day blood pressure blood glucose level body weight blood serum level protein level blood estimate renal change pressure blood glucose level blood serum level protein level renal increased significant diabetic compare normal control treatment group show weight control blood pressure parameter diabetic addition demonstrated control blood pressure diabetic renal change renal function drug possible effect system
26686780 en disease estimate need health study analysis base datum estimate patient disease two analyzed participant mean time year follow-up study regression model use estimate patient without model use association age association change impact mortality analyzed observed associate reduce baseline significant change mortality patient increased ratio result result model indicate less old provide estimate studied time use compare different chronic condition need
26874682 en regard general population patient mellitus increased risk develop whether patient also medical health database identify patient diagnosis follow patient diagnosis study first risk overall incidence ratio base total study period observed risk confidence interval CI high observed first year follow-up overall associate decrease CI may patient mellitus
26640941 en determine cell patient mellitus type patient mellitus type patient mellitus type aged year receive cell perform cell analyzed patient hemoglobin level month cell patient mellitus type lead significant increase level month cell may patient type type
22778181 en gene cause renal disorder due response impair plasma test whether can cell whereas treatment revealed due use new develop show increased also protein however datum reduce remain whether cause
26344697 en aim investigate whether may use patient type evaluate group patient type mellitus age year man duration year glucose control control time interval year month patient type mellitus diabetic first normal control patient without mean respective compare patient mean rate first value patient diabetic significant high mean compare control similar patient without rate correlate glucose rate patient type mellitus several time high healthy participant presence diabetic change diabetic
20736519 en effective treatment disease well disease however include normal may disease treat however assess duration whether may study disease parameter investigate study base serum concentration plasma concentration significant different duration correlate ratio obtain however ratio significant great addition significant difference ratio result suggest incidence influence
27111290 en aim present study investigate association plasma level renal new diagnose type mellitus T2DM diagnose T2DM patient study patient medication duration study mass index level use determine disease logistic regression analysis age fasting blood glucose level found significant associate level included regression model found significant associate level determined level high level high study level positive correlate level level may include renal disease new diagnose T2DM patient
17371462 en cause significant mortality datum patient previous case report trial case management mortality patient large reported suggest management patient base response identify use analysis define clinical include important clinical management patient patient define plasma response patient response patient response normal response patient body mass index BMI three BMI patient three year patient develop two patient dysfunction patient associate significant mortality associate obesity disorder
25550059 en type mellitus T2DM glycemic control result complication follow-up among patient T2DM therefore role patient T2DM year include health important care provide care care system association evaluate status control on hba1c blood pressure cholesterol result revealed patient year compare two found total rate respective T2DM year intervention treatment aim chronic complication remain
25995662 en poor associate increased cardiovascular mortality independent cardiovascular mortality however datum regard relationship level reported current study evaluate association level patient type study participant type diabetic participant assess use index patient score define poor factor associate poor analyzed use multiple regression model serum level measured use high level poor increased compare patient define vs respective however ratio decrease poor score positive correlate level negative correlate ratio level correlate logistic regression analysis show level odd ratio or confidence interval CI body mass index or CI associate poor independent rate age duration hemoglobin total cholesterol blood independent associate level patient mellitus
25239438 en mellitus contribute however use may severe recent reported cell high glucose examine increased diabetic patient increased diabetic diabetic develop show great response diabetic level control high glucose whereas protein on role diabetic development diabetic patient patient severe
18494865 en disorder gene on occur early may test gene may diagnosis may also individual develop test gene analysis diagnosis subject gene use gene found subject patient identify two one subject develop month gene normal gene therefore need early treatment gene also potential identify develop
26426397 en relative insulin factor mellitus although function gene include mellitus role development type type analysis patient healthy association study perform multiple analysis gene relative activity determined analysis show general high within investigate however two show significant association T2DM respective analysis also association disease type show reduce protein significant influence rate reduction gene contribute risk T2DM effect suggest level protein potential influence normal cell function
27230777 en metabolic disorder type mellitus mellitus major health disorder insulin resistance dysfunction treatment although drug different mechanism use clinical different glucose control incidence effect include cardiovascular complication weight treatment current drug different mechanism treatment datum regard current aim provide important development drug conduct association drug database
26820452 en present aim finding associate type type mellitus DM role determine related use analysis obtain database related DM associate reported association study follow associate DM also datum demonstrated role impair function DM result may aim finding protein function factor contribute important disease
24844194 en mellitus common disease associate report first review influence clinical characteristic medical database on review study identify study associate high prevalence complication identify risk ratio respective patient show high prevalence lower prevalence without several clinical difference diabetic different
27416722 en current cell treatment mellitus base analysis clinical trial cell treatment mellitus complication show research clinical significant result time number research large clinical trial possible cell treatment mellitus
26066406 en mellitus patient renal cell investigate relationship mellitus patient renal cell undergo review datum patient treat renal cell score mellitus history patient without ratio potential association hba1c outcome test analysis perform identify independent overall patient show overall cohort patient show overall patient without analysis independent disease cause mortality or mortality among patient hba1c datum high hba1c independent disease mellitus independent overall patient undergo renal cell also patient mellitus poor glycemic control associate high risk
26874450 en risk among patient previous diagnose mellitus poor evaluate risk among patient without diagnose according presence cohort study patient diagnose identify relative risk evaluate association risk event patient among analysis risk risk high patient compare patient without follow-up vs vs vs significant associate increased risk adjust relative risk confidence interval CI CI CI time diagnosis associate high adjust incidence patient without associate significant increased risk compare without cardiovascular risk factor increased patient may
24479725 en mellitus one health develop however studied level study aim compare associate risk mellitus among adult population base perform use method adult aged year on use study participant fasting blood glucose level determined use blood sample prevalence confidence interval risk factor assess use logistic prevalence mellitus among adult aged year CI CI identify diabetic case diagnose high case among population among population history old age significant associate mellitus among population associate mellitus prevalence mellitus high among compare population large need provide early diagnosis treatment reduce associate complication
17564004 en present case on development cause due use presence parameter pressure due development severe addition therapy can parameter treatment value normal
25287289 en adverse effect treatment mellitus insulin mellitus control severe common type mellitus type mellitus also event occur activity addition cardiovascular system whereas current potential cause complication whether severe cause mellitus important mellitus management include patient glucose medication include new glucose insulin
25858534 en type mellitus one common chronic condition prevalence increased primary due obesity clinical associate increased cardiovascular mortality recent study show patient increased risk however result relationship mechanism association well treatment patient studied aim review current mechanism clinical study include patient condition treatment
25163987 en investigate prevalence risk factor diabetic type mellitus T2DM patient study T2DM patient hospital method datum included clinical blood clinical characteristic diagnosis disease history recent test result logistic regression use assess risk factor total T2DM patient age range year overall prevalence logistic regression identify age odd ratio or confidence interval CI duration mellitus or CI hba1c or CI risk factor presence T2DM patient significant associate age hba1c duration
25231636 en study aim determine potential impact type mellitus dysfunction development disease use model develop type compare diabetic similar obesity develop type mellitus month show revealed significant reduction function compare important found significant increased indicate whereas revealed presence diabetic study show diabetic mellitus new model disease result body clinical evidence type mellitus contribute early disease
24939927 en compare intervention reduce mortality patient mellitus however trial compare old known reduce new randomize trial compare patient mellitus primary outcome mortality outcome treatment analysis perform use regression model randomize trial diabetic patient total follow-up compare rate ratio associate increase mortality however associate statistical significant increase mortality compare old increase increase increase increase however statistical significant although estimate associate high patient mellitus evidence show similar mortality use associate increased need test trial
25532607 en aim study examine relationship patient type mellitus metabolic syndrome total patient type mellitus study group without patient ratio rate rate assess addition metabolic assess group significant high well patient without significant correlate type mellitus high compare without level use patient rate
26368020 en investigate whether difference poor potential cause type mellitus included participant study analyzed difference association type mellitus use logistic regression analysis adjust factor body factor investigate whether difference type mellitus found significant group found association type mellitus or CI group man among woman individual association use define type mellitus known difference type mellitus or vs found large difference association low type mellitus suggest may investigate target intervention identify risk type mellitus
26219999 en common cause mortality patient mellitus DM dysfunction major diabetic investigate influence change diabetic undergo follow measured use significant high diabetic compare significant compare significant response similar analysis show significant decrease compare show impair response first time show DM improve dysfunction
25818923 en examine association hemoglobin hba1c study baseline use datum major health healthy patient clinical period study participant adult aged year diagnose mellitus DM without complication time estimate baseline association hba1c use regression analysis use individual model estimate association hba1c time model control activity factor factor medication use adjust study significant association glycemic control baseline healthy aged adult DM associate glycemic control
25496489 en mellitus metabolic disorder system cause complication type mellitus T2DM however use early due aim present study evaluate T2DM subject without use study conduct T2DM subject without mellitus subject clinical use datum analyzed use independent compare T2DM group subject follow significant difference test significant reduction T2DM compare subject however difference T2DM subject without decrease T2DM compare subject indicate change develop use study change clinical may develop change
18653713 en chronic disorder result renal cause disease include system protein gene consider model reduce use develop therapy gene renal renal reduce system can therapy patient also disease associate
25726767 en concentration high concentration may cause significant protein lipid review possible role addition review datum obtain patient indicate increased type mellitus female patient early type patient gene decrease blood activity patient type low level blood may cause increased concentration may contribute type mellitus
24665124 en adult mellitus cardiovascular disease without mellitus model provide important mechanism mellitus model demonstrated mellitus regression effect mellitus function cell protein important effect mellitus cell effect diabetic indicate cell mellitus mechanism role mellitus role insulin resistance also primary cell study whether mechanism identify model important mellitus
20814834 en cause gene gene although possible perform analysis diagnosis clinical remain report present two case diagnose clinical test gene result analysis test diagnosis test factor level increased respective presence gene previous new new determined case case test method diagnosis diagnosis early
25589481 en cardiovascular disease may patient without type mellitus therefore compare change type mellitus mellitus patient history major cardiovascular disease event use type mellitus patient mellitus patient history included patient treatment according cardiovascular risk management baseline follow-up measured use year follow-up total type mellitus patient decrease regression observed mellitus patient period body mass index identify total treatment mellitus patient decrease type mellitus patient baseline body mass index cardiovascular disease decrease total datum patient high body mass index
26428846 en elevated blood glucose level care common finding risk determine incidence glucose identify risk cohort trial trial study period follow-up hospital patient without known mellitus included analysis assess level glucose diagnose oral glucose tolerance test hba1c level month investigate possible include total patient month subject glucose include patient diagnose mellitus on glucose subject compare without vs hba1c correlate on risk score score group vs independent associate glucose patient glucose mellitus clinical elevated risk included high score high score provide identify patient risk glucose can early
25701782 en risk cardiovascular complication diabetic patient associate dysfunction reduce number impair function result dysfunction patient mellitus plasma level elevated activity reduce present study investigate role type diabetic patient treat high glucose result show increased decrease increase plasma level patient type mellitus T2DM similar result treat high glucose high addition also reported cell present study found decrease T2DM patient high glucose high level associate
25369990 en mellitus DM common adult use medication however remain large whether risk mellitus DM retrospective study patient compare group control outcome incidence period define fasting blood glucose oral insulin incidence DM significant group control group respective use independent associate increase fasting glucose however common common patient similar aged control common however use may increase fasting glucose level clinical rate fasting control sample patient DM population
19449677 en disease renal effect due two report
18854434 en gene age day use gene adult gene compare reduce vs protein protein cell show increased plasma increased effect show result adult model concentration function current clinical trial
22879391 en report two new present review previous gene two define use analysis perform previous one several two patient found gene gene study well several known study determined mechanism follow two mechanism whereas remain can cause mechanism although found several identify
22524462 en disorder present severe early study aim determine clinical characteristic large present history develop cause identify analysis gene clinical characteristic determined well level plasma plasma evaluate mean age first clinical year range year subject investigate gene protein found one subject subject gene cause cause large associate patient
25820470 en medical management type mellitus control remain factor important determine management investigate whether may provide identify can impact management study control conduct score hba1c statistical analysis association control obtain evidence group difference score high group great score associate high hba1c association remain duration insulin negative association increased rate control addition compare control different finding contribute body factor impact health outcome
26287420 en serum level type mellitus population however relationship level risk development type woman total healthy woman cohort study follow year type mellitus define according association protein level measured use woman baseline study diabetic status subject develop type mellitus year follow-up period woman type lower level healthy woman multiple regression analysis show age cardiovascular risk factor level high baseline level associate lower relative risk type confidence interval CI baseline level function lower risk develop type mellitus among woman year follow-up study therefore elevated level may development type mellitus
25284697 en mellitus cause chronic disease rate prevalence chronic disease multiple medication management effect medication change occur drug population may lead decrease response treatment time include estimate renal function medication patient need consider drug therapy outcome effective use change change occur impact drug use estimate renal function change common use medication drug patient population
26045058 en woman gestational mellitus may reduce risk type mellitus change however use datum population woman two estimate prevalence chronic mellitus one two examine datum hospital datum diagnosis diagnosis include diagnosis use population characteristic prevalence assess use associate characteristic examine adjust test total woman two one two identify estimate woman one develop estimate estimate development one diagnosis woman old health interval provide important
25894913 en prevalence type great however several incidence population aim study investigate incidence little period time characteristic diabetic patient new diagnose study year aged year new diagnose year old year old year old incidence ratio range significant high observed age group year old low year old association diagnose patient significant difference presence year
26884497 en new development reduce mortality mellitus DM risk increase adverse treatment outcome DM mean DM need target disease care control provide disease however evidence important treatment DM control contribute early case improve treatment outcome DM care also development effective health disease
27371782 en cohort type mellitus trial test level associate function datum total subject trial patient type hba1c healthy control clinical datum assess on use plasma mean concentration diabetic patient correlation well total cholesterol serum hba1c blood glucose blood pressure age duration weight BMI compare patient duration duration patient duration high level vs analysis can identify parameter associate healthy control mean concentration concentration correlate well however correlation analysis revealed significant result compare patient type mellitus healthy control patient revealed significant difference serum vs vs patient type lower concentration vs vs lower ratio vs well lower body weight vs BMI vs control patient high blood glucose level time vs high level vs well high high level present trial revealed association type mellitus consider renal function
18825149 en gestational disorder present week patient present syndrome plasma treatment response result activity case dysfunction rate decrease association syndrome diagnosis treatment important
25766398 en cell response mellitus DM disease type DM perform study determine response DM type DM studied subject new DM T2DM age serum level measured increase level baseline compare use increase less T2DM vs statistical similar range vs subject increase baseline compare vs vs response compare T2DM however response observed subject large study may suggest can use
26663673 en blood pressure observed different population however study diabetic patient study examine patient type mellitus patient type mellitus T2DM follow-up adjust mean value revealed month high month use regression model estimate difference year large T2DM on difference observed age difference occur type correlation potential related factor indicate
27430259 en patient type mellitus T2DM management show glycemic control disease although remain low increasing management may also impact increasing base however little known factor may patient study aim important management patient assess type study conduct adult research patient individual review participant reported T2DM weight blood glucose level among current common use type low revealed study need improve patient result revealed type patient T2DM need finding may improve patient effective management
25618857 en protein cell protein well known activity function known serum level use recent study show one protein may also role development type may function mechanism previous observed diabetic result show also target cell new diagnose type diabetic patient well increased recent potential role type mellitus
24438886 en evaluate whether serum level development chronic disease patient type mellitus function retrospective study patient present hospital on total patient type mellitus function estimate rate included outcome development great patient group according follow-up period patient great group range show high incidence great lower vs vs vs analysis significant associate development great analysis ratio confidence interval show significant association may great patient type mellitus function
24105007 en mellitus associate increased incidence impact mellitus conduct study examine association mellitus mortality mortality included study mortality mortality patient according diabetic perform use primary outcome measured mortality mortality patient mellitus increased risk mortality relative risk CI increased risk mortality relative risk CI mellitus mellitus also poor relative risk CI compare analysis mellitus associate mortality relative risk CI patient relative risk CI analysis include patient disease identify association mellitus relative risk CI relative risk CI study follow-up report mean follow-up included study study population mellitus outcome mellitus great risk mortality mellitus study determine whether treatment can mortality among patient mellitus
23422887 en aim study investigate relationship plasma glucose level glucose patient without previous diagnosis total patient disorder use fasting glucose hospital oral glucose tolerance test patient diagnose mellitus mean month relationship glucose level prevalence new mellitus group group group glucose level little new mellitus analysis patient great odd new mellitus odd ratio confidence interval mellitus follow-up patient diagnose mellitus finding suggest relationship glucose previous mellitus patient present may identify patient mellitus disorder treat improve outcome
25799887 en type mellitus chronic disorder result however intervention treat disease method effective control cell blood cell multiple type cell potential tolerance response cell recent blood cell blood therapy risk low incidence disease review role blood cell treatment
26272593 en woman increased rate adverse outcome care target care woman associate improve outcome however significant outcome measured reported study evaluate effect care aim present study develop outcome trial study evaluate effective care woman study include review identify outcome previous reported study evaluate care woman outcome include woman well use on review reported clinical trial research care woman compare study study improve patient care
25172608 en incidence mellitus increasing important mortality mellitus aim study mortality patient compare mortality among mellitus patient mortality among population study statistical analysis study patient mellitus population decrease statistical significant per per general population statistical significant change mortality per per mortality ratio population population decrease mortality patient mortality general population mortality rate high man old patient however compare mortality general population increase risk woman patient mortality patient mortality general population
27476052 en datum incidence rate study aim determine incidence risk factor population first cohort study study total year age study rate incidence rate determined age use logistic regression model risk prevalence man woman total group incidence man woman increase age incidence age risk ratio CI hypertension CI CI obesity CI associate increased risk incidence study study reported incidence incidence high studied population health system intervention complication
24056978 en mellitus disease incidence increasing among two type diabetic case whereas less present response test whether patient protein due important study use protein potential control result indicate protein control result suggest can due presence significant treatment blood cell protein result significant increase finding role two mellitus
26928149 en woman gestational mellitus whether week study compare outcome among woman gestational mellitus week included woman diagnose gestational mellitus hospital week datum obtain outcome woman undergo week compare remain week woman undergo week compare woman remain week odd ratio confidence interval adjust age insulin treatment body mass woman study period woman gestational mellitus woman compare group woman group lower odd adjust odd ratio confidence interval high odd care adjust odd ratio confidence interval difference outcome compare group woman group lower odd adjust odd ratio confidence interval difference care adjust odd ratio confidence interval woman gestational mellitus week associate lower risk compare management may increase risk care week
26591209 en patient presence mellitus DM independent factor increase increase risk use method early diagnosis effective may
26016384 en study relationship risk mellitus analysis conduct health oral glucose tolerance test fasting plasma glucose plasma glucose insulin level positive lower blood pressure lower serum negative subject impair glucose tolerance type present cohort use analysis assess risk woman positive lower prevalence negative vs respective analysis revealed history age independent associate high prevalence independent associate lower prevalence odd ratio confidence interval adjust history hypertension body mass status associate low rate metabolic status on study patient known need investigate whether can development
19461161 en patient common cause cell cell revealed base diagnose patient general month present case suggest diagnosis diagnosis case include level
19378901 en present female history treat oral management use oral development
25850521 en prevalence mellitus obesity chronic disease study first study prevalence mellitus DM association risk factor population aged study datum oral glucose tolerance test participant general population according rate impair glucose known DM found study population overall prevalence DM CI CI DM prevalence DM increased age high man woman prevalence high year age group woman obesity obesity low level history associate glucose study show high prevalence impair glucose adult population provide datum prevalence DM association several risk factor
27783301 en studied patient type mellitus patient lower level primary lower time total activity elevated time also difference suggest treatment patient
26781648 en type mellitus response cell cell potential may contribute factor therefore consider treat patient different disease include patient reported patient different however little known patient diabetic may important investigate whether cell aim present study evaluate new diagnose patient compare healthy individual cell potential analysis analyzed potential evaluate use model present similar potential gene diabetic improve cell function patient recent diagnosis impair metabolic diabetic condition result provide use treatment new diagnose patient
26233916 en type mellitus contribute dysfunction increased risk cardiovascular disease show reduce complication adult type however mechanism well examine effect function adult type
26063468 en reported although activity recent year mechanism treatment mellitus remain model type mellitus T2DM insulin resistance target mechanism therapy T2DM diabetic two level fasting blood glucose decrease group oral glucose tolerance improve group index revealed positive effect activity can well target protein protein protein positive role glucose T2DM
25575429 en study investigate relationship general body mass index BMI ratio ratio cardiovascular disease mortality population total participant type mellitus T2DM duration year time regression model use obtain ratio adjust BMI high positive associate mortality compare low large effect mortality confidence interval CI mortality CI associate decrease risk mortality year CI year CI obesity associate reduction risk mortality T2DM patient year BMI high index also increased risk mortality
25327485 en effect therapy investigate patient type mellitus DM patient two group group on receive treatment included group receive similar treatment group on without healthy control group serum concentration determined determined general analysis use difference two diabetic week treatment significant increased group increase decrease significant group on decrease significant patient hba1c decrease significant difference change patient hba1c correlation analysis show change negative correlate multiple regression analysis show positive correlation treatment cholesterol treatment increase type mellitus patient decrease independent effect
27244950 en assess patient mellitus test patient insulin mellitus man woman patient mellitus man woman group healthy subject man woman also use revealed influence factor high level result group man woman group effect healthy subject group man woman well profile man woman show significant difference healthy subject type significant difference system revealed characteristic factor type value method assess activity response individual evaluate individual possible determine time
25635985 en risk factor insulin resistance type mellitus T2DM evidence therefore aim study assess effect incidence type study identify study datum base include related use include mellitus study mellitus insulin resistance included study status study consider included remain study cause insulin resistance incidence type mellitus association associate significant associate increased risk type mellitus high decrease incidence type mellitus
25012807 en cause impair glucose tolerance woman whether impair glucose tolerance determine prevalence due population woman recent mellitus gestational base high prevalence gestational mellitus type may increased prevalence population previous reported study period woman recent diagnose mellitus assess presence common study perform gestational base woman diagnosis mellitus diagnosis year blood sample study participant blood sample analyzed assess female week week mean weight patient found population prevalence great previous similar study woman gestational significant less woman recent diagnose mellitus high prevalence previous studied woman mellitus may lower prevalence
24990684 en little known mellitus DM high prevalence mortality rate observed investigate prevalence DM year database assess prevalence gestational mellitus type DM independent little two use present prevalence rate regression total included prevalence diagnosis association study group association study association study group datum group health high prevalence rate type DM less reported report mortality due DM found prevalence can datum datum DM common need type DM DM
25083080 en disease chronic disease adult population clinical different increasing prevalence type mellitus T2DM insulin resistance obesity metabolic syndrome related increased lipid early insulin woman history gestational mellitus plasma large on gene associate disease T2DM high risk although consider patient
24083523 en patient mellitus high risk develop general high blood glucose level cause diagnose mellitus may influence risk disorder aim study determine whether large mellitus population patient study population patient hba1c level measured weight age status patient compare group patient prevalence diagnose total patient included significant difference prevalence mellitus group patient group patient prevalence significant high prevalence diagnose mellitus group patient low prevalence mellitus observed study may disorder occur year patient diagnose disorder present study high prevalence diagnose mellitus among patient important treatment patient
27583068 en association mellitus cause health two high disease treatment develop significant two analysis patient care hospital analyzed study found significant diabetic patient population study observed two condition increased mellitus need identify early population need two condition medical care
27002606 en study influence patient mellitus
26994121 en patient mellitus DM high risk event assess effect among patient DM therapy study month treatment patient event medication addition month patient DM patient without DM increased outcome increased among patient DM rate rate among patient without DM rate risk similar among patient without DM patient DM year associate reduce risk although patient without
17491025 en protein early control system cause disease two although protein known use model show influence also show datum indicate associate increase concentration new influence protein
27323139 en investigate effect type mellitus T2DM control group T2DM group treatment group T2DM model week treatment group T2DM group fasting plasma glucose total cholesterol cholesterol measured examine factor determined T2DM treatment group significant elevated compare control group compare control group significant T2DM group treatment group increased T2DM group level treatment group lower T2DM group datum suggest may T2DM
23674307 en patient syndrome recent datum risk mellitus use evaluate association therapy mellitus patient evaluate association therapy adverse clinical cohort patient aged year old clinical outcome compare patient hospital year patient receive patient receive significant different rate syndrome significant lower group compare group reduction clinical outcome significant lower rate syndrome associate significant difference mortality rate group observed treatment group study period old patient found therapy effective reduce syndrome rate mellitus significant different
26032852 en dysfunction patient type mellitus remain one complication care patient care care on model care model improve patient type mellitus therapy use model care evidence regard effective patient type mellitus study control trial evaluate effective intervention man woman type mellitus primary type mellitus aged year indicate function general participant receive intervention group participant also receive base model general control group care provide participant general primary outcome include function function outcome treatment outcome measured mean baseline month treatment assess control trial investigate effective intervention patient type mellitus primary care study important current effective important outcome man woman type trial
25546232 en investigate clinical development disease type retrospective analysis perform type mellitus diagnose disease use perform disease disease can per type mellitus one observed type mellitus disease disease type mellitus disease vs per risk disease development type mellitus increased
24893748 en on perform evaluate patient mellitus severe disease also identify randomize control trial two retrospective study identify review analysis demonstrated associate lower mortality day however significant difference mortality month follow-up associate lower overall major adverse event well high incidence associate increased risk patient mellitus severe significant improve overall reduce incidence although associate great risk high incidence therefore remain patient
23547172 en prevalence event mellitus medical management identify prevalence event impact type status finding cohort mellitus method study cohort included mellitus undergo clinical event analyzed study population risk disease known disease patient time significant present patient patient respective patient early risk increased impact presence year follow-up rate total cohort high event rate cohort mellitus low rate significant early low event rate increased year independent known disease one event normal indicate need improve risk
26025219 en patient mellitus reduce syndrome however complication rate patient undergo intervention included previous follow cardiovascular event first mortality mean follow-up period day day difference characteristic adjust regression model patient mean age year mellitus treatment oral glucose insulin treatment cardiovascular risk factor multiple disease patient mellitus less adjust risk cardiovascular event high patient insulin ratio confidence interval oral treatment compare patient without mellitus patient increased risk first intervention severe patient mellitus patient treat insulin high rate mortality cardiovascular event year
25769841 en mellitus health one studied disease major treatment mass addition associate severe complication diabetic treatment however subject multiple study several evaluate development review studied target well characteristic target without effect potential treatment complication whereas recent test model type study model type need
26042926 en blood glucose control according glucose use datum database identify factor associate use analysis use datum type mellitus use glucose day period period datum according use time time use also new glucose patient low group high glucose group significant lower mean blood glucose blood glucose mean blood glucose concentration odd ratio CI blood glucose concentration among new use first month therapy important also significant associate early whereas control use glucose significant associate reduction improve metabolic control insulin therapy use first month associate patient may
25582650 en investigate relationship cholesterol ratio new diagnose type mellitus subject aged T2DM general datum three group base significant difference age fasting plasma glucose hemoglobin hba1c among group base significant increase body mass index BMI blood pressure blood pressure model insulin resistance total cholesterol decrease significant group general regression model independent adjust BMI hba1c ratio independent new diagnose T2DM may increased patient
25220923 en chronic metabolic disease mellitus present type mellitus present primary found addition mellitus present early characteristic normal level however serum level normal revealed type may cause two major may due factor
24687395 en diabetic severe common complication type mellitus study aim determine incidence risk factor complication patient study patient incidence rate regression model identify risk factor severe total patient woman incidence severe respective significant risk factor female relative risk medical rate poor control increase factor significant risk factor severe included medical rate duration per increase control control vs control respective presence lower hba1c value per decrease factor severe occur patient event two result indicate severe occur high rate patient occur patient management include control risk factor
25440562 en gene associate increased risk mellitus mellitus type independent associate assess relative subject normal control group without mellitus type relative high control group follow mellitus type high mellitus type significant associate normal group mellitus type finding suggest relative normal subject without mellitus type
25934362 en system protein role several disorder include mellitus DM assessment activity system DM related complication base target provide study although associate DM complication review respective DM research study develop high identify value
25384023 en aim study assess effect patient test potential therapy study perform patient poor glycemic control control patient analyzed concentration whereas control perform level activity total test determined also evaluate activity function activity also system increasing level activity level sample addition decrease observed however parameter level control subject result suggest may effect associate mellitus complication datum management disease low effect
25223258 en method risk assessment develop evaluate patient study examine score type mellitus risk among patient risk assess patient well score compare well diagnosis patient patient new revealed patient patient risk factor obesity activity lower risk score different use patient correlation base positive value may one two patient high score also high observed general population score potential identify high risk group among use health care
25410224 en mellitus group disorder due relative insulin chronic mellitus associate dysfunction include system blood estimate overall prevalence mellitus treatment mellitus determined common type type mellitus great individual drug therapy mellitus may oral glucose tolerance test hba1c recent association association show study suggest poor clinical outcome chronic care however glycemic control increased incidence possible increase mortality patient glucose range insulin
24331969 en compare medical mellitus mellitus assess individual datum health score use mellitus mellitus according related characteristic datum medical mellitus mellitus show increase ratio medical time ratio increase mellitus medical significant high among patient mellitus increase
26275864 en association mellitus investigate risk associate oral drug among subject type also retrospective cohort study base health datum identify hospital diagnosis incidence rate different type diabetic model assess risk associate associate increased risk associate high ratio among type diabetic total number associate reduce risk type reduce risk population risk diabetic patient research need role drug
24758873 en investigate relationship gene risk type mellitus population
25066412 en diabetic common complication mellitus although control may reduce risk develop diabetic different insulin remain relative present study patient type mellitus undergo clinical assessment patient receive multiple insulin receive insulin undergo assess function potential treatment group control body mass index disease duration parameter compare treatment group age normal difference function patient patient compare normal control parameter include parameter also function patient within normal compare control difference group analysis remain function type within normal patient treat insulin multiple insulin therapy may potential patient type
26301577 en gestational mellitus clinical development patient high risk development type plasma level elevated type correlate fasting plasma glucose level insulin resistance patient type present study aim determine associate insulin resistance without plasma level plasma woman diagnose healthy normal woman obtain month level known measured plasma level similar low group increased significant remain lower group compare group plasma level diagnosis level associate level group group associate reduction increase little woman woman
26781810 en cardiovascular risk important patient type mellitus disease risk risk factor hypertension obesity found common among individual general population on body evidence provide control management risk factor new associate effect several risk factor several study evaluate effect new diabetic medication outcome several evidence risk factor control patient type mellitus review evidence related control patient type mellitus well recent finding effect new drug risk factor outcome risk factor improve outcome important
22805396 en present female renal syndrome renal include syndrome renal range severe
26502704 en examine patient type DM type DM mellitus concentration protein blood level serum different determined use analysis show patient increased concentration associate decrease level serum patient increased concentration level serum significant different normal value level serum significant increased increase concentration blood patient significant increase level serum well reduce level result study suggest association low response type mellitus
26042451 en aim study estimate effect glycemic insulin resistance mellitus DM group mellitus glycemic treat body weight week DM glycemic treat DM control DM week glucose day measured fasting blood glucose hemoglobin hba1c insulin high insulin resistance diabetic related great glycemic study significant increasing diabetic glycemic control result show decrease index glycemic diabetic glycemic
27905912 en investigate effect blood glucose control patient type mellitus previous poor therapy type change hemoglobin hba1c level month treatment compare baseline perform level significant decrease month treatment compare baseline mean change hba1c level baseline range study population month patient receive show little hba1c level patient hba1c level significant increased month treatment month patient fasting blood glucose level significant increased month treatment improve hba1c level rate target control level patient type mellitus previous poor drug patient group however patient treat improve blood glucose control baseline hba1c level
25755289 en remain major cause aim determine whether mellitus T2DM associate reduce rate cohort study perform among patient compare rate T2DM patient patient analysis among T2DM patient according current T2DM treatment use T2DM rate lower T2DM patient patient vs mellitus associate lower or risk factor found patient treat insulin lower rate patient treat oral drug vs response time rate also lower T2DM patient patient vs patient cause T2DM significant associate lower status similar high among T2DM patient vs associate lower rate status hospital high among T2DM patient
26671155 en although incidence recent also associate syndrome addition hypertension risk factor evidence suggest mellitus can also associate study show correlate patient factor patient remain poor define consider insulin resistance factor effect hypertension risk factor study
27524542 en mellitus incidence one individual among type on significant occur group base clinical diabetic cause mortality type mellitus diagnosis common age year cause diagnosis result management increase mortality rate
25944874 en type mellitus care may outcome patient treat blood glucose control evaluate difference randomize control trial compare effect therapy therapy complication adult type mellitus odd ratio or model analysis included patient randomize control trial significant difference therapy group mortality or CI cardiovascular mortality or CI trial conduct therapy compare glycemic control result significant high mortality or CI cardiovascular mortality or CI trial conduct mortality or CI cardiovascular mortality or CI analysis individual outcome revealed significant difference however risk severe significant high trial therapy or CI compare or CI glycemic control type mellitus patient associate increase mortality cardiovascular mortality severe compare patient finding
25703256 en aim study investigate effect mellitus model mellitus model normal blood glucose level included control group diabetic two control group treatment group week perform examine group compare analysis significant increase diabetic compare control group normal significant decrease diabetic compare diabetic use treatment diabetic decrease significant effect model improve treatment due mellitus
21318063 en on patient history on diagnosis patient demonstrated although regression year follow-up
26254188 en associate current evidence regard patient risk develop aim study investigate risk patient compare population included year age without study cohort population without group risk develop regression model adjust age use incidence rate ratio total study cohort included population group incidence rate per year age group year incidence rate confidence interval population group respective adjust incidence rate ratio group population age group independent risk factor develop patient patient increase risk develop patient high relative risk increased patient treatment treatment consider possible
26597081 en mellitus DM health activity important risk factor incidence management DM present study aim evaluate activity among group adult DM use research adult cohort diabetic patient medical hospital study datum group response conduct two independent analysis datum age year mean duration year management DM due DM time consider healthy control blood glucose common study participant however regard type duration control activity management poor due provide regard health care evidence need participant
26855580 en previous suggest patient type mellitus T2DM may aim compare analysis datum study patient T2DM treat week patient treat patient treat change baseline hemoglobin hba1c week per baseline hba1c per population reported hba1c per hba1c baseline mean value patient respective follow age year year hba1c reduce hba1c reduce respective hba1c increased increasing baseline population respective patient mean hba1c great hba1c baseline hba1c present analysis suggest patient treatment compare however glycemic control use glycemic difference hba1c reduction population clinical
25963412 en increasing prevalence mellitus patient care study aim investigate whether use control result change patient type mellitus compare randomize control trial patient intervention group use control group use primary outcome change measured group outcome included hba1c blood glucose age year duration year hba1c significant difference use within group observed month glycemic control blood glucose remain within group review range use management patient month compare
25115406 en previous study show severe disorder disorder disease associate increased risk metabolic syndrome however role development metabolic syndrome among severe health research database patient disorder without develop hypertension mellitus identify follow-up increased risk develop hypertension mellitus among severe disorder on relationship great hypertension disease mellitus independent risk factor hypertension mellitus among patient disorder study among disorder metabolic syndrome
26839891 en diabetic mortality mellitus mechanism poor clinical datum early study evaluate whether early type mellitus mean age year mean disease duration year healthy control assess use rate patient increased rate patient disease duration patient serum hba1c show impair reduce patient early disease poor glycemic control associate early
25415670 en blood glucose control patient mellitus DM reported influence hemoglobin hba1c level increasing addition several study show also associate although blood glucose control severe study examine severe aim present study examine association severe patient type mellitus type mellitus T2DM mellitus retrospective review patient severe on total case case severe study primary outcome assess severe group severe occur significant vs hba1c level high low vs group severe occur significant vs complication occur significant vs T2DM group severe hba1c level significant among severe change patient treat severe common
27664636 en mellitus DM remain major health care develop develop factor include age obesity DM drug therapy two major use control DM compare drug therapy use treat DM recent year method treat DM include use known review common use use management associate complication
26907971 en study type mellitus T2DM disease diabetic patient high incidence risk develop recent evidence effect insulin resistance condition contribute function present review evidence possible two level regard different database among two development drug type
25767180 en gestational mellitus mellitus type effect hypertension cardiovascular disease aim study assess function woman gestational mellitus one first cardiovascular total woman gestational mellitus healthy woman control group week undergo assessment diagnosis gestational mellitus association obtain according datum use correlation analysis gestational mellitus high increased mass mass index lower early early ratio positive correlation mass index fasting glucose body mass gestational mellitus different profile well may show need great control
26371117 en impact health little evaluate investigate effect risk cardiovascular disease mellitus DM use study subject individual age health datum use identify medical care year on analysis perform estimate ratio DM disorder adjust age status among subject without history DM disorder increased risk observed confidence interval CI man CI woman DM CI man CI woman subject history DM disorder number medical care decrease show lower rate DM without history DM disorder show high risk condition
25438535 en assess rate treatment control mellitus influence factor use participant analysis base sample mellitus multiple logistic regression use examine factor associate level treatment control treatment control control among treat respective logistic regression analysis show effect factor rate history rate treatment associate age history rate control associate rate treatment control mellitus improve effective influence factor control blood glucose level
24852802 en study compare clinical outcome group patient mellitus DM undergo significant increase risk adverse event intervention patient DM DM patient reduce evaluate treat compare outcome target event mortality high risk patient profile group vs event vs similar patient DM year without DM also show incidence vs event vs significant lower DM patient result similar finding cohort analysis chronic renal DM patient ratio confidence interval use receive intervention show clinical outcome patient DM year follow-up DM compare patient show significant outcome overall incidence low patient DM suggest type patient
24797048 en gene may plasma lipid level influence present study investigate association gene plasma level lipid level different patient mellitus type patient therapy without healthy control study characteristic presence assess analysis perform use method determined statistical significant different diabetic patient control statistical significant difference lipid parameter well observed diabetic patient regard treatment risk high or lower diabetic or associate presence diabetic patient plasma level independent associate parameter associate presence presence plasma level independent associate patient mellitus
20070034 en first clinical disease patient therapy patient health year develop disorder first first year number increased perform disease base show change lower one within finding change revealed change well show body show high normal reduce value low value disease associate elevated parameter elevated level diagnosis assessment treatment day day follow blood cell follow patient interval
26878988 en mellitus health individual health increasing prevalence health care present study aim assess current prevalence among study conduct hospital datum datum medical patient three group medical history new datum management analysis conduct use mean use present well use analysis compare mean difference use on less consider total patient female study period diagnosis patient new old patient common common result study perform diabetic patient increase complication subject
24352417 en mellitus major cardiovascular disease response may role mellitus plasma datum profile disease therefore study profile patient mellitus presence disease profile assess diabetic patient patient group plasma profile perform use effect mellitus statistical test adjust potential develop evaluate patient demonstrated profile previous datum profile diabetic similar statistical analysis three high target influence mellitus major difference profile diabetic difference associate difference plasma diabetic patient change profile
25871988 en study examine association among type mellitus among adult analysis conduct use datum risk factor large conduct datum analyzed risk factor use analysis participant reported mellitus management blood glucose level little per day participant base blood study participant poor significant increased odd mellitus poor significant increased odd mellitus although finding statistical significant previous research individual less high level health target improve mellitus use mellitus
25844991 en increasing medication although metabolic adverse effect use estimate risk type mellitus outcome determine whether associate increased risk type mellitus analysis examine risk associate include well individual cohort study study use datum identify month included study aged year health diagnosis study chronic diagnosis mellitus use period mean follow-up time participant month follow diagnosis mellitus follow-up cause care datum weight develop observed clinical characteristic group time model use logistic regression estimate risk mellitus type mellitus identify risk mellitus increased among odd ratio or CI compare risk high among use time or CI significant different use compare group risk high among or CI or CI risk type mellitus increased among high use compare new associate decrease risk
26108553 en estimate prevalence treatment control health chronic disease control study examine aged year use fasting blood plasma glucose oral glucose tolerance test conduct among fasting blood glucose history medication obtain use define according health prevalence rate previous diagnose population estimate respective among condition current undergo medication treatment result indicate health poor rate treatment control relative low need aim treatment population
27226209 en use rate individual mellitus little use compare without disease study use rate identify whether use conduct database old mean related target condition evaluate method study evaluate use study general study show rate sample index dysfunction value range difference index use general demonstrated use test obtain effective risk condition patient
25894138 en similar general population risk development type mellitus develop type mellitus well studied aim estimate incidence study risk factor complication mellitus base included study medical weight history mellitus statistical significant development mellitus high high decrease insulin use significant reduce protein studied significant effect history mellitus development high high decrease
25894126 en type mellitus disease cell current treatment patient type mellitus include insulin associate insulin gene therapy show great model great treat type mellitus insulin gene therapy target insulin cell primary target review present current insulin gene therapy treat type mellitus include need therapy important therapy current treatment clinical insulin gene therapy treat type mellitus
25414388 en estimate gestational mellitus present estimate estimate diagnose provide associate elevated glucose study estimate health care use medical level occur datum analyzed include medical patient medical patient sample hospital include reduce reduce estimate prevalence risk factor associate diagnose age gestational adult medical reduce estimate high estimate per case diagnose gestational finding reduce treatment
25624343 en whether mellitus disorder mean high risk cardiovascular disease study aim investigate association mellitus mellitus whether mellitus syndrome hypertension can risk significant study conduct participant history baseline analysis regression model use adjust possible factor incidence follow-up adjust age factor association mellitus observed hypertension factor adjust risk elevated significant odd ratio confidence interval mellitus hypertension group mellitus hypertension risk high significant increased high group blood glucose level within range significant associate elevated risk mellitus disorder hypertension significant increase risk
24369985 en prevalence gestational mellitus important health complication increasing although prevalence estimate new develop develop datum evaluate prevalence study included woman age week define according fasting plasma glucose new also according according study population prevalence woman old high high high history compare study high prevalence estimate may new
26220013 en mellitus DM health major cause cardiovascular event association DM datum outcome individual disease evaluate population study test DM independent associate assess risk mortality conduct DM patient control identify health database cohort follow year on model use estimate ratio first clinical DM subject identify mean age year woman incidence DM vs DM risk factor CI oral DM patient DM associate present high CI total CI population study DM independent risk factor DM patient high risk total mortality early management DM patient
26476867 en study investigate association treatment control among patient type mellitus T2DM study analysis T2DM patient target study addition test medication use datum patient medical review level hba1c use characteristic correlation use association treatment control use datum analysis total T2DM patient included study mean age patient year mean duration disease year hba1c score score hba1c negative association treatment negative association reported hba1c treatment great investigate factor control among T2DM patient
27323114 en investigate role gestational mellitus on total woman gestational mellitus healthy woman examine hospital may conduct use statistical significant difference patient gestational mellitus control subject age BMI level test found significant difference present can influence gestational mellitus compare present adjust or however logistic analysis revealed can influence risk gestational mellitus population suggest gene can influence gestational mellitus population
24751988 en study examine relationship weight adult type mellitus large population datum health study use examine association participant weight type mellitus model adjust age body mass index risk factor perform association weight type mellitus weight or CI significant associate increased risk type mellitus weight or CI associate decrease risk type mellitus compare woman reported weight association weight type mellitus woman weight associate increased risk woman
26091746 en insulin insulin major impact include glucose lipid also mass however mass great common mellitus type type whereas type diabetic subject without insulin treatment type diabetic subject show change increase mass however common use model type disease mass review mechanism
26601789 en associate several metabolic disorder two reported early aim investigate relationship serum level early patient type mellitus study included type diabetic patient control serum level determined method patient group also two according serum level high low group measured according analysis perform use patient group significant lower serum value large value control also significant lower large value may effect dysfunction type DM
26589368 en randomize study compare reduction cholesterol level patient type mellitus T2DM receive week receive treatment treatment week primary change level ratio evaluate use significant change baseline level treatment group however group statistical significant reduction baseline level ratio compare group vs vs respective multiple regression analysis among subject revealed independent factor contribute reduction level change level treatment group baseline hemoglobin hba1c may reduce level patient T2DM
26556234 en investigate whether reduce blood glucose high low glycemic increasing activity blood glucose can improve metabolic control adult type mellitus without adult mean age year diagnose type mellitus less year mean year hba1c mean blood glucose medication randomize care assessment baseline month included metabolic lipid intervention lead significant hba1c compare care function without effective adult recent diagnose type mellitus
26561625 en on number health associate include reduce serum cholesterol glucose assess effect glycemic control patient treat type mellitus T2DM patient risk develop perform database clinical use identify clinical study assess glycemic effect T2DM identify randomize control clinical study datum assess patient T2DM study show significant fasting blood glucose concentration hemoglobin hba1c glycemic effect baseline significant glucose observed subject observed subject great observed subject treat datum indicate effective addition glycemic glycemic control great effect patient treat T2DM study need determine treatment medication
27559041 en patient mellitus DM increased risk event effective therapy reduce complication great analysis clinical trial show DM patient overall trial population although risk reduction whether finding may difference profile drug DM patient remain poor aim randomize study DM patient disease receive week assessment conduct use different include baseline week effect therapy assess primary study determined week reduce significant define similar week significant lower mean difference confidence interval primary assessment measured similar time include week rate high similar group time DM patient disease similar great chronic treatment whereas significant different
26525587 en type mellitus T2DM cause change T2DM can contribute cause chronic major cell cause cell protein can cause chronic diabetic may contribute impair T2DM analyzed chronic diabetic control sample cell analyzed protein high diabetic compare control protein also increased diabetic cell decrease T2DM compare control subject high level cell compare T2DM control can cause increase cell lower level cell may cause T2DM subject chronic
17229678 en cell increased gene cause disease response study include protein on normal reduce increased decrease increased increased effect show analysis use protein reduce protein protein cell model may study potential therapy disease
25529517 en primary examine impact mellitus patient mellitus examine difference patient mellitus patient chronic disease study conduct two primary health care period may retrospective medical review outcome use health status included analyzed use general retrospective analyzed year database assessment total number patient on statistical significant difference found two group patient mellitus due health compare mellitus reduce individual patient hypertension need mellitus develop effective target intervention disease
27042276 en investigate difference contribute factor develop old datum according age age year age year age year model assessment insulin resistance function assess use prevalence patient aged year year year respective model assessment function model assessment insulin resistance show increasing age increased diabetic patient significant high model assessment function model assessment insulin resistance compare group respective analysis show significant associate patient aged year odd ratio or confidence interval CI patient aged year group obesity or CI or CI low or CI associate diabetic patient high insulin resistance relative function compare patient important role develop population
24573165 en complication mellitus major risk factor cardiovascular mortality current study effect however effect event disease overall aim change analysis datum diabetic model perform observed hypertension associate reduction on finding addition primary potential on number finding datum diabetic model within use development mellitus lead reduction can development intervention disease management
24530414 en evaluate effect type cardiovascular complication cardiovascular parameter measured week treatment significant treatment increase protein level treatment reduction level increase index ratio decrease treatment also result study show reduction datum suggest mellitus also complication
24415555 en patient mellitus DM known however association chronic well studied determine effect DM result conduct retrospective cohort study adult patient undergo patient medication use score obtain measured score outcome test on effect model perform patient included patient DM compare patient DM patient significant vs vs significant difference prevalence DM patient also significant disease DM patient significant less score baseline follow-up patient adjust mean CI adjust risk factor patient may significant care may need consider patient DM
26823865 en conduct study investigate association development gestational mellitus population on total patient gestational mellitus subject conduct use method test found control subject test found significant difference use logistic analysis individual associate increased risk gestational mellitus compare present adjust or CI respective however associate elevated risk gestational mellitus suggest correlate increased risk gestational mellitus population
27052236 en diabetic patient study base prevalence rate severe type rate type diabetic patient patient report weight high test perform little patient diagnosis disease prevalence type diabetic patient also disease syndrome patient treat treatment improve significant risk reduce however glucose demonstrated on also type treat insulin little oral drug
27098531 en type mellitus T2DM disease insulin therapy treatment new therapy patient hba1c target among significant patient insulin aim datum effective insulin base therapy type diabetic patient control major medical database study duration little month evaluate effective insulin insulin patient insulin therapy outcome included value hba1c fasting blood glucose two glucose concentration well change body mass index little month study trial patient total included significant reduce hba1c mean difference CI fasting glucose CI glucose concentration CI significant change found BMI base base therapy type treatment
25829137 en subject type mellitus consider high risk cardiovascular disease cardiovascular disease cardiovascular aim study presence group subject type mellitus previous clinical cardiovascular total patient type mellitus subject without type mellitus studied cohort study regard assessment common identify prevalence significant great diabetic subject control group man woman increased increasing age analysis age blood pressure positive associate whereas age weight positive associate current study show subject type mellitus high prevalence associate cardiovascular risk factor
24933106 en common use management type mellitus patient can function level can also effect insulin resistance aim present study assess effect function insulin resistance patient type use model type patient receive oral drug baseline cholesterol included patient group group study analysis fasting blood sample obtain baseline week determine level blood glucose lipid profile insulin hemoglobin increased fasting serum insulin increase fasting plasma glucose decrease function increase insulin resistance group compare baseline difference statistical use significant change function insulin resistance type patient assess index possible include level baseline use study clinical trial
25920299 en current increased prevalence mellitus among chronic mellitus effect glycemic control increase risk assess effective change care improve oral health mellitus among type study conduct two health intervention control diabetic patient per health baseline intervention group oral health individual use individual oral follow-up intervention group receive individual oral intervention group receive control group receive participant assess baseline follow-up oral health mellitus datum analyzed use test test follow-up analysis show participant intervention group significant high oral health mellitus participant intervention group use use control group statistical significant change care one improve oral health mellitus type trial
27076509 en prevalence mellitus DM increase patient risk investigate DM among therapy patient
23874667 en study aim determine individual status prevalence mellitus glucose adult population study perform man adult year old logistic regression model use examine association individual prevalence mellitus glucose prevalence mellitus glucose adult aged year respective increasing age female develop develop increased BMI individual level found negative associate prevalence high associate high prevalence effect positive association mellitus glucose mellitus glucose common adult result indicate mellitus major health aim treatment mellitus glucose need
26221898 en mellitus result less effective cell however mechanism well important role cell improve mellitus review research identify new clinical treatment mellitus
19955494 en disease previous study model show body present study conduct determine whether activity related model first female control day treatment significant decrease body group remain significant less control day significant increased group compare group first decrease increased group group analysis revealed body cell significant increased compare group datum demonstrated can well model
23296171 en control reduction blood pressure use system control major use clinical management patient mellitus number contribute complication mellitus include renal disease cardiovascular disease however research year indicate important development complication mellitus mellitus include insulin review examine development mellitus complication suggest development mellitus chronic complication
26758574 en high show effect blood pressure function study aim determine effect treatment function patient type mellitus T2DM clinical trial included T2DM patient intervention group receive three one control group three without week baseline week significant difference found influence serum concentration however significant reduce concentration vs vs respective vs although can concentration significant difference influence function
26247684 en value plasma glucose level week serum plasma aim study determine clinical female mean age year previous diagnose treat fasting blood sample obtain hba1c plasma glucose serum insulin function value parameter determined datum patient control also value control diabetic subject high mean hba1c value control diabetic subject high value hba1c control respective hba1c normal population respective parameter value great provide risk value hba1c level datum indicate value use parameter hba1c mellitus
26782726 en diabetic common complication common cause patient mellitus DM research finding diabetic risk factor finding may revealed study current treatment study patient mellitus large study prevalence diabetic primary aim prevalence diabetic patient mellitus type according duration disease aim prevalence different diabetic analysis risk factor influence included patient DM type complication history period DM duration patient diabetic prevalence diabetic different prevalence different patient population result different study significant result study patient use method patient population regard prevalence risk factor period duration hemoglobin hba1c level blood pressure high type diabetic patient result population study patient similar study large study prevalence diabetic patient DM type similar study large number patient new method study obtain datum diabetic prevalence risk factor influence patient patient year datum analysis
26277887 en on randomize study conduct subject type mellitus T2DM control treatment addition therapy subject hba1c concentration randomize receive week treatment primary change hba1c baseline treatment period week therapy result significant great reduction hba1c vs little mean use analysis model respective overall incidence rate adverse event similar among treatment group therapy effective general well subject T2DM consider clinical
27355190 en aim mellitus metabolic disorder due insulin glucose study aim investigate association among normal diabetic subject change develop diagnose use method study normal diabetic subject blood subject blood use perform correlation test perform subject normal base demonstrated level result system demonstrated overall positive value negative value respective statistical significant difference normal diabetic cell suggest can diagnosis mellitus use system
26515419 en effect investigate man type mellitus randomize trial determined oral use significant decrease fasting plasma total cholesterol cholesterol concentration effect without significant change body weight insulin resistance significant decrease plasma concentration rate effect great individual elevated concentration significant decrease concentration rate number increased response oral total period significant decrease man type mellitus decrease plasma concentration also decrease concentration study provide effect
25034244 en use treatment type mellitus well known effect effect clinical study type disease datum use therapy study diabetic demonstrated effect include mass new diagnose datum show may effective type mellitus however potential clinical type remain evaluate provide effect type type
25881080 en primary care care present study aim evaluate mellitus DM diagnosis management use present age range year mean year level regard DM diagnosis respective obtain use fasting plasma glucose hemoglobin evaluate patient diagnosis case use oral drug case type DM management two drug use follow-up patient participant receive DM mellitus diagnosis management need improve regard care clinical
26134831 en early individual type mellitus may change therapy current method population develop method individual significant change blood glucose adult studied use rate glucose day datum use develop analysis base method subject also perform rate respective method determine occur relative change identify mean respective change time time respective positive negative ratio method identify change
24862430 en mellitus disorder common chronic disease increase potential previous evidence indicate drug can diabetic patient however evidence clinical study treatment improve function diabetic patient present study participant diagnose type mellitus T2DM two group one treat treat week function evaluate chronic treatment week improve assess patient T2DM addition significant improve glucose patient negative correlate participant association observed parameter blood glucose finding suggest chronic treatment effect improve function outcome result present study also medication may T2DM
26632399 en associate decrease incidence mellitus aim study compare effect investigate total patient mellitus adjust potential score analysis perform use logistic regression model primary incidence define fasting blood glucose hba1c analysis perform determine impact incidence follow-up duration day group baseline day group total patient group group analysis baseline characteristic well incidence year lower group group vs analysis vs independent lower incidence odd ratio confidence interval present study compare chronic associate lower incidence cardiovascular patient
26319779 en mellitus although number study current addition associate diabetic aim present study investigate whether diabetic determine sample diabetic include control age body weight on previous score use cell score number diabetic control diabetic without cell increased diabetic cell increased result suggest evidence may diabetic may associate time cell indicate increased due chronic cell
25034716 en mellitus independent risk factor datum regard patient event patient mellitus compare study year follow-up patient mellitus patient without mellitus recent randomize participant prevalence mellitus mean duration year mellitus independent associate age year disease disease patient mellitus patient mellitus ratio confidence interval CI CI CI CI CI compare patient without mellitus clinical profile include prevalence poor
24628439 en identify role female type mellitus risk clinical primary care female type mellitus associate management may female increased risk health primary care female type mellitus need increased risk develop care reduce risk female type mellitus research include type mellitus early intervention primary care effective outcome insulin therapy
18361016 en case report management severe on woman reported medical history present hospital management period fasting history revealed previous day normal management on review management also
26511168 en known mellitus DM clinical aim study identify effect DM clinical syndrome regard outcome
26113611 en cell show occur mellitus although number study current known whether common aim present study investigate whether diabetic sample diabetic control age body weight cell mean lower diabetic control similar similar group cell number presence diabetic control result previous cell cell occur diabetic present diabetic great control on diabetic associate
25312324 en type mellitus significant improve hypertension control patient demonstrated metabolic effect patient reduce weight also change review clinical outcome intervention metabolic role treatment patient type mellitus
24385236 en mechanism show study cholesterol previous clinical trial oral treatment significant reduce patient trial evaluate patient type mellitus include glycemic also trial evaluate patient type mellitus elevated patient mellitus drug randomize receive week follow week week lower level little compare reduction day primary total cholesterol also significant lower compare protein reduce compare reduction clinical finding lower lipid demonstrated protein patient type mellitus without glycemic control well
26911293 en mellitus consider disease important estimate on new method index develop independent blood pressure time examine score can among man woman cardiovascular disease define base association score measured score determined high level examine association score score participant less great high score logistic regression method use examine association score adjust major cardiovascular disease risk high score significant high year age among among among normal significant elevated odd ratio or high score among confidence interval CI man CI woman among CI man CI include among among important early intervention change develop
21917732 en disorder cause type patient subject analysis gene provide mechanism cause analysis revealed three within gene one test lead reduce cell cell due reduction effect function show therefore less function result provide function cause subject
25445848 en prevalence mellitus high severe general population mellitus receive mellitus severe without condition increased rate complication metabolic related mellitus multiple mechanism association mellitus mechanism include factor factor although treatment mellitus mellitus similar general population follow current treatment intervention need reduce mellitus addition improve disease reduce high prevalence mellitus current receive poor treatment mellitus general population primary care mellitus health patient
25345799 en investigate whether presence woman gestational mellitus associate change metabolic characteristic include function insulin
23739758 en chronic present patient assess effect treatment patient mellitus chronic low trial include therapy study patient mellitus within adult patient chronic health outcome chronic low use dysfunction baseline on use week study serum concentration factor obtain baseline study observed patient mellitus vs patient without mellitus reduction week significant great patient mellitus receive patient mellitus receive mean difference change score confidence interval CI difference clinical on significant great reduction serum concentration patient mellitus receive compare receive mean difference CI reduction also clinical significant change serum concentration associate dysfunction present significant patient mellitus patient without mellitus patient mellitus receive significant reduction period decrease level may possible mechanism effect patient mellitus on large clinical trial patient mellitus chronic assess mechanism population
25322985 en aim present investigate effect possible mechanism total type mellitus type mellitus T2DM treat parameter target protein investigate result show decrease level fasting blood glucose serum lipid parameter oral glucose insulin tolerance test level increased body weight serum insulin reduce renal indicate increased decrease lipid show protein level protein addition decrease gene activity increased gene activity finding show activity total develop new drug treatment mellitus
17444321 en occur one patient therapy treatment case develop day therapy change
26156202 en evidence role aim study first time relationship risk among patient type mellitus T2DM one patient diabetic control study perform adjust age obesity hypertension significant difference patient without type mellitus control group significant positive correlation serum level glucose show addition serum level found high among patient without T2DM difference significant result indicate gene risk factor development population
25813570 en year age type mellitus time year age independent management however research study study conduct two datum evaluate use case period increased confidence possible well management different care care positive influence
24707133 en mellitus one patient association disease gene also clinical potential clinical impact follow outcome patient disease complication whether disease may increase risk factor complication medical treatment patient mellitus may treatment use may associate glucose control glucose level complication diabetic patient evidence patient complication treatment patient disease present review
26476473 en analysis conduct investigate incidence among type mellitus T2DM patient identify risk factor associate cohort study conduct base on event identify observed diagnosis reported number event per patient event period reported three regression analysis conduct identify factor may associate event risk event total patient identify mean age female mean index overall event rate event per per high event rate observed aged first observed T2DM diagnosis important factor associate risk three model old age ratio female previous two year number measured little one previous year high hba1c value previous year poor function rate increased event study event risk high T2DM patient old female patient previous risk risk factor associate poor glycemic control poor function
26381432 en treatment type mellitus T2DM T2DM T2DM study estimate prevalence T2DM subject identify influence factor subject present study perform aged year old participant T2DM subject T2DM association diagnosis mellitus diagnose according prevalence subject T2DM compare subject logistic regression analysis perform evaluate risk subject overall T2DM prevalence respective compare subject prevalence present study prevalence general population age group analysis among diabetic subject compare subject subject significant high level age current mean duration insulin fasting plasma glucose hemoglobin hba1c insulin logistic regression analysis include current duration hba1c significant associate increased risk T2DM or respective present study high prevalence T2DM among population T2DM related high risk population high prevalence disorder may clinical factor
27261624 en effect dysfunction investigate change examine adult diabetic receive treatment oral fasting blood glucose hemoglobin hba1c insulin lipid profile level activity level determined change examine level insulin glucose factor protein analyzed respective activity evaluate use identify major analysis indicate presence effect normal lipid profile serum insulin level little observed diabetic high insulin level lower level also observed diabetic compare diabetic high diabetic can function normal
25825221 en present clinical management cardiovascular risk factor mellitus medical independent several medical clinical however risk score general population may individual assessment group risk diabetic risk factor factor review intervention diabetic patient review weight reduction reduction hba1c therapy high blood pressure obesity lipid disorder clinical activity cardiovascular disease group great clinical present reduce diabetic
26362234 en known protein protein major type disease patient type year clinical aim study diabetic diabetic patient present study study studied type use found compare on high observed compare serum model well serum sample type can cause protein
25808419 en treatment management mellitus regard clinical evidence base common associate poor clinical outcome type mellitus important difference regard clinical management therefore clinical evidence treatment general population type mellitus may addition potential risk use evidence base treatment mellitus general population treatment glucose therapy
26816608 en cell body potential several disease present study whether can use evaluate disease disease patient without mellitus total patient type patient without type patient without DM level assess gene use characteristic analysis plasma without DM also determined logistic regression analysis determine correlation level risk plasma level significant elevated patient DM compare without characteristic patient DM vs correlation analysis level risk factor show level significant correlate fasting blood glucose patient level use patient DM
25645749 en aim study factor event risk patient type mellitus aim investigate whether risk use datum year event define event type mellitus diagnosis outcome include event factor associate event risk analysis regression patient type mellitus mean age year mean included among factor increased event risk patient age index complication index previous event number chronic medication blood hba1c blood pressure associate low event risk value range associate high risk however risk less observed risk blood pressure hba1c important treatment target old patient clinical patient type mellitus
26651515 en patient possible blood diagnosis disease estimate insulin resistance insulin mellitus DM increasing insulin reduce blood sample present insulin blood serum serum test method insulin insulin use demonstrated datum correlation provide evidence result can diagnosis treatment DM also disease
25458090 en mellitus risk factor evidence glycemic control treatment time risk cohort total observed significant high risk among patient diagnosis mellitus ratio CI patient use medication CI patient CI effect adjust body mass index type score time although datum association hemoglobin value
26339426 en possible significant risk factor related mellitus DM among gestational mellitus present study first identify risk factor cohort on total subject mean age year medical baseline glycemic on total high significant independent risk factor identify age obesity history DM week insulin therapy among factor subject insulin therapy use time develop follow confidence interval risk factor respective need assessment patient high risk
26657945 en compare effective weight woman gestational mellitus health system level care care study randomize control trial medical include woman randomize intervention care intervention included gestational weight week month primary outcome included weight BMI weight BMI weight period woman intervention significant high odd weight woman care odd ratio or CI weight significant high intervention care week vs or month vs or condition difference reduce month vs or month woman intervention significant less weight woman care mean vs mean condition difference CI great increase activity mean condition difference intervention reduce weight increased activity
26710051 en whether diabetic related dysfunction investigate whether lipid lower type mellitus patient
25044584 en mellitus common condition individual relative risk associate type great relative risk lower relative risk less evidence whereas occur less patient potential two disease evidence study suggest medication use treat associate increased reduce risk whereas drug influence risk drug use treat may cause observed increased risk type one patient type different risk patient type patient lower level insulin obtain result show patient type elevated risk type associate risk overall risk associate type
26145741 en present study determine clinical factor determine clinical disease patient mellitus DM develop therapy condition on total patient present disease mellitus included study total lipid hemoglobin hba1c level glycemic profile also body mass index patient estimate type obesity therapy evaluate analysis datum obtain revealed clinical parameter determine clinical disease patient mellitus obesity fasting reduction high increase low result study use develop treatment disease patient mellitus base complication
26118037 en patient mellitus type investigate therapy positive influence development diabetic reduce increasing range reduce increasing patient addition analysis impact level among found control blood need increasing drug period
27819155 en obesity prevalence type mellitus T2DM T2DM adult datum target treatment T2DM review clinical association clinical trial datum database use treat T2DM complication use treatment T2DM addition insulin several study conduct medication T2DM may adult need large clinical trial mechanism therapy clinical
27291764 en rate need care improve population outcome activity important report result review activity patient conduct identify study examine activity associate among patient mellitus major database included on total common reported time disorder related activity reported time receive patient number activity large may high datum need activity population
26939846 en diabetic complication cardiovascular disease among common health effect insulin investigate model therefore determine whether insulin develop diabetic mellitus treat insulin examine blood sample week compare control group observed treatment diabetic insulin relative insulin insulin increase measured diabetic group significant reduce insulin decrease increased insulin relative insulin insulin present study insulin possible
27049106 en increased risk clinical patient study aim increase datum regard prevalence mellitus patient retrospective studied hospital datum database period identify diagnosis year age female database drug identify little one drug within group hospital subject mellitus identify patient diagnose great number found age range total female prevalence subject period estimate period subject number female first study provide datum prevalence population datum risk factor influence risk therefore need treatment diabetic patient
24513421 en review management type mellitus T2DM old identify use aged mellitus type mellitus also review identify study clinical review identify evaluate clinical number old adult T2DM evidence treatment T2DM population condition increased risk may glycemic control old adult several provide glycemic target use glycemic healthy old adult however less old population patient severe general glycemic old patient change condition adverse drug medication medication need target medication use T2DM old adult
24331945 en syndrome condition whereas presence show development study assess association type mellitus clinical outcome patient retrospective examine medical patient patient type study clinical outcome day mortality hospital care compare base presence regression model use presence type mellitus day day patient study period subject type mellitus difference day mortality rate hospital statistical significant diabetic patient chronic health use need day day presence type mellitus body mass index show association day day presence type mellitus associate clinical outcome presence adjust body mass index
23617584 en examine independent association mellitus duration population old adult aged old health assessment mellitus according perform assess use test multiple regression analysis use assess association mellitus status outcome adjust potential adult mellitus significant without adjust characteristic weight mellitus also associate significant lower association remain significant adjust activity protein cardiovascular disease chronic disease mellitus independent associate mellitus duration man woman negative associate mellitus respective mellitus respective significant according hemoglobin associate outcome body adult mellitus lower related presence without mellitus study investigate relationship function
26109503 en gestational mellitus management new identify woman test hba1c cohort examine database woman oral glucose tolerance test woman undergo hba1c examine large database woman prevalence identify woman identify one woman case woman lower disease prevalence hba1c high perform well woman
23890130 en glucose common complication chronic clinical management group review medical method treatment chronic mellitus common chronic patient chronic development duration disease early disease may high risk patient develop mellitus occur chronic type include fasting glucose hba1c test fasting glucose hba1c fasting glucose hba1c evaluate oral glucose tolerance test response type assessment important mass perform follow-up total patient treat medical evaluate treat glucose patient
25470519 en disease test protein patient disease patient mellitus mellitus type found elevated level compare healthy control however level high compare control elevated level found patient patient positive control positive first time potential serum
27052249 en mellitus cardiovascular disease patient diagnose cardiovascular disease mellitus cardiovascular risk base risk factor perform patient mellitus
26721022 en increased body weight major risk factor metabolic syndrome disease risk factor hypertension mellitus study conduct determine obesity mellitus population association study perform hospital population participant regard known risk factor disease female use obesity diagnose patient total individual included mean age year mean female present participant obesity among obesity present obesity diabetic obesity diabetic total female subject obesity diabetic among female obesity diabetic on positive association obesity mellitus significant obesity common population associate mellitus
26186716 en study aim investigate difference patient type type mellitus dysfunction evaluate correlation age duration BMI lipid retrospective study patient type type control group undergo age BMI blood pressure lipid hba1c analyzed duration hba1c correlate outcome patient type control subject lower activity base patient type significant parameter type diabetic patient control group BMI correlation number duration duration base age significant correlation number result indicate dysfunction man type type patient duration hba1c correlate dysfunction among patient increased BMI increased rate dysfunction patient type
25893732 en time study perform effect mellitus type normal sample time interval day week statistical significant level female revealed analysis study result number well control show indicate decrease value effect also subject day however subject week effect revealed female mechanism different female number high control chronic compare respective group increased value role age duration diabetic
26382315 en high prevalence current research conduct study correlation two disease group present study conduct woman study two group diabetic base history result serum level value compare two total woman included although value high diabetic woman difference prevalence serum level two difference mass value woman without
26057921 en mellitus DM health status individual diabetic complication aim cell type DM patient use oral determine health diagnosis study type DM patient healthy individual change evaluate use finding statistical result show increase fasting plasma glucose level significant increase decrease increase ratio compare control group change cell present study found significant cell type DM patient study change patient
26022641 en drug effect reduce risk disease suggest drug also potential reduce risk condition age major risk determine whether drug associate reduce risk cohort study patient aged year old mellitus large care medication develop patient mellitus develop adjust factor high year reduce risk relative ratio CI increase use associate reduction risk adjust ratio CI per day year result reduction risk potential include diabetic medication risk develop increased ratio CI increase hemoglobin use associate reduction risk develop risk reduce glycemic control hemoglobin level medication similar risk reduction study suggest may risk multiple level improve glycemic control mechanism glycemic control system target drug clinical trial finding can lead treatment disease
26253934 en disease common among clinical study demonstrated type mellitus important risk factor development disease patient type mellitus disease study recent disease mechanism association poor evidence suggest role type mellitus consider risk factor disease development review provide new relationship among type mellitus disease effect system disease model current datum insulin resistance disease model may disease provide development treat type mellitus disease
20583549 en gene on show test revealed elevated serum low patient show significant response analysis revealed reported important control case clinical datum include test function on
25561089 en type mellitus independent risk factor development relationship research study study datum individual type mellitus hospital datum report case hba1c development study use model hba1c individual observed study development study regression development risk associate hba1c range associate include blood pressure body mass index disease one individual type mellitus develop follow mean year year analysis hba1c show hba1c ratio confidence interval value hba1c ratio confidence interval value independent associate risk high low hba1c development cohort relationship
24816341 en chronic disease great impact mortality patient impact disease conduct study evaluate different chronic aim present study assess identify patient mellitus renal disease subject control conduct study general hospital patient mellitus renal disease subject group year control year characteristic different patient assessment disease rate blood glucose hba1c serum evaluate subject control group subject group difference baseline characteristic score different control group group renal disease group general health high disease high compare vs respective subject patient poor chronic disease renal disease mellitus disease consider high impact disease therefore receive
26596658 en high regard health care associate high level mortality use regard management care provide assessment patient individual patient treatment patient treatment follow-up effective
26257371 en investigate difference association history risk type mellitus T2DM according body cohort study man woman follow subject history history association history incidence examine according status adjust age weight activity total body mass index number metabolic syndrome follow-up year subject develop T2DM history positive associate T2DM incidence however analysis status revealed history associate increased T2DM incidence subject confidence interval subject history significant associate high T2DM incidence confidence interval result suggest history mellitus associate incidence T2DM different according body weight
27330730 en important reduce glycemic control investigate factor impact disease condition patient type impact impact chronic disease condition odd ratio or found age age glycemic control glycemic control disease duration glycemic control number score woman lower man decrease significant or number great or increased patient oral therapy insulin therapy compare or therapy impact type factor current impact factor disease duration glycemic control treatment method condition
27049300 en association activity mellitus DM syndrome evaluate study included patient hospital follow perform patient activity analysis revealed vs activity effect incidence or CI or CI respective patient without baseline event analysis DM patient activity significant effect among patient or CI finding revealed role DM patient activity factor disease
27930587 en study body mass index BMI association incidence mortality use datum health included individual BMI period identify use age group year age man woman model estimate incidence prevalence relative mortality mortality estimate use identify age group year year age group year age group BMI large man woman low BMI fasting glucose level low high prevalence observed follow-up mean year individual man year high mortality observed weight group mortality high found BMI age weight however large age group associate low incidence mortality suggest weight level important health
27930583 en mellitus associate increased risk study effect woman finding present aim investigate impact overall period woman database cohort study assess impact woman adjust ratio confidence interval use impact study woman show adjust CI CI patient compare without however significant patient without CI present suggest independent associate poor female patient however impact study investigate whether glycemic control improve female patient
26115811 en datum potential effect obesity mellitus due undergo retrospective datum body mass index outcome medical obesity mellitus overall assess use adjust patient included study BMI mellitus major perform although patient high score obesity significant related primary characteristic disease therapy outcome patient follow range obesity independent improve ratio confidence interval overall ratio confidence interval patient also compare cohort obesity associate poor outcome mellitus negative impact
17451074 en result number different disease system patient adult cause known cause include cell disease case cause effective disease management diagnosis clinical need method method evaluate disease due provide study consider analysis provide recent finding contribute diagnosis
26452246 en little datum outcome renal function patient mortality renal dysfunction diabetic diagnosis define identify clinical population patient mortality patient outcome compare cohort identify diabetic patient patient less severe compare cohort vs overall mortality mortality adjust diabetic group baseline renal function great diabetic patient vs patient develop chronic disease lower compare cohort mortality diabetic patient compare associate cohort impact renal function significant less group
20711095 en disease disease woman treat present identify patient also develop normal treatment test perform diagnose show mass suggest patient receive treatment month also period control observed on show mass known occur patient consider diagnosis patient health
26978185 en elevated prevalence type observed disorder relative compare general population known whether population also increased risk included disorder disorder relative without disorder healthy control study risk score use datum association study correlation relative status analyzed also evaluate correlation mellitus among correlate mellitus within correlate relative status sample base risk population correlate relative status correlate within risk increased prevalence mellitus observed relative
26595598 en evaluate impact mellitus DM associate complication mortality reduction time health care research system database include new hospital total patient identify undergo primary patient evaluate DM mean total hospital significant great DM cohort compare without DM cohort patient DM great index score great mortality patient without DM patient mellitus patient day patient also significant high mortality rate hospital hospital high mortality rate patient without presence diabetic complication increase risk datum provide health care level level evidence
25060205 en study estimate type mellitus complication study use sample study participant use database health health patient mellitus type datum analyzed research datum care mean per patient mellitus type CI patient little one year mean per patient CI drug mean per patient CI treatment oral medication participant diagnose one chronic complication per increased complication CI patient without complication CI patient complication large mellitus hospital care drug study observed presence chronic complication increased per patient compare patient without complication
24559919 en function cell mass type type type due cell cause mechanism cell type different less also cell type occur early cell type due insulin resistance occur relative less mellitus disease increasing high prevalence identify factor develop effective disease study different cell system model function mechanism cell current cell cell function first result recent mechanism function well cell new role result clinical therapy year recent datum suggest effect function well provide evidence potential role mellitus provide current development treatment mellitus on potential development
26162991 en recent study patient significant high risk develop however association mellitus risk remain conduct identify association mellitus risk include conduct database include database datum database cohort study included study evaluate odd ratio or relative risk confidence interval study relative risk estimate use model include study cohort study included analysis study mellitus associate increased risk risk increased significant analysis study type mellitus evidence mellitus associate increased risk increased risk also high risk identify patient mellitus
24177325 en cell potential important impair mellitus recent gene role mellitus test impair cell function type diabetic adult type diabetic normal use decrease improve function include elevated protein reduce protein contribute function also improve function mellitus target improve cell therapy diabetic diabetic normal therapy demonstrated reduce improve diabetic impair improve therapy type diabetic
24140380 en aim study perform review investigate influence review database study on total analyzed related type type duration well early use show important risk factor develop system type weight development type although observed report presence factor consider evidence indicate study risk factor type type aim use
25978795 en study evidence obesity insulin resistance datum however suggest mellitus association estimate independent health drug use health participant assess mellitus health provide value diagnosis regression analysis estimate association mellitus associate odd ratio confidence interval evidence evidence base new clinical research possible mellitus association research
24596068 en model type mellitus use well model evaluate score drug therefore drug development model model can datum clinical also model may risk potential review provide model use case study
21463240 en common disease also different known cause disease group dysfunction present may finding may treatment gene cause need insulin low risk complication lead treatment complication risk type although patient may effect treatment case cause therapy insulin disease may use within year important case
28006697 en relationship cardiovascular clinical characteristic woman disease studied study related high risk factor disease
25648130 en important role control mellitus intervention show improve health health activity identify use among patient type mellitus primary care identify patient characteristic associate total patient type mellitus primary care previous use demonstrated patient use week use define week clinical body mass index blood pressure baseline use use association patient characteristic use logistic regression use observed patient use use first week patient use first week patient use week adjust odd ratio relative significant high female or CI high score baseline or CI adjust odd ratio relative also significant high high score baseline or CI study provide among patient type primary care provide evaluate use patient population
27138191 en type mellitus increase mortality insulin factor important role development aim characteristic protein two patient hospital included analysis among patient history without ratio use protein positive found group group difference protein target two group analysis show history associate high respective independent factor patient positive associate association group group high protein associate suggest may development patient
26803355 en mellitus type disease decrease recent show however clinical need patient subject group on on patient assess randomize receive insulin group insulin therapy group patient characteristic aged BMI hba1c range group on activity score presence significant negative correlate group correlation intervention trial significant group sample range associate type intervention weight glycemic control reduction protein insulin compare insulin effective weight hba1c increasing high associate lower suggest role
25439094 en determine whether old adult type mellitus dysfunction poor metabolic control hemoglobin blood pressure cholesterol without cohort cohort new previous trial aged female dysfunction base score test test model use compare metabolic evaluate rate change individual without participant dysfunction dysfunction year participant dysfunction significant poor metabolic control without function type dysfunction range mellitus control parameter cohort old adult mellitus although possible dysfunction can control
25422134 en improve diabetic patient insulin use evaluate association intervention metabolic use diabetic population however number study use management one group use study sample type type mellitus insulin use related insulin patient week month patient level regard insulin control level measured three month month period month month total mean age patient year patient female mean duration year patient level regard insulin improve month patient level statistical significant decrease month compare baseline value number insulin insulin also study demonstrated system insulin provide patient result improve insulin metabolic increased use possible management use use follow-up associate positive clinical outcome patient common use management
18697495 en on man hospital treatment chronic renal hypertension condition conduct month per day reduce level time decrease body weight serum concentration result test test diagnosis decrease body weight serum concentration
18553546 en report due syndrome due cause however treatment syndrome clinical disorder cause respective found gene first patient three patient syndrome follow-up complication include low
26724915 en evaluate early use potential patient gestational mellitus type mellitus patient type included study patient major study positive negative datum compare gestational control normal glucose tolerance statistical method use among study participant type normal glucose tolerance range age year gestational age week weight among group however patient type low control show correlation datum show type
25484028 en develop health model evaluate new intervention type mellitus effect complication measured mean hba1c impact treatment event
25440771 en association type population aged year
24298056 en function cell glucose dysfunction contribute significant mellitus use model gene among function cell gene factor normal cell include significant factor normal cell occur important role development role adult cell result mellitus similar finding cell impact cell mellitus
24833082 en new mellitus observed cell associate adverse outcome however outcome patient mellitus undergo large aim impact outcome retrospective study medical mellitus undergo review compare without primary outcome overall outcome included hospital chronic disease primary disease mortality analysis difference outcome compare without however adjust potential analysis demonstrated significant outcome decrease overall ratio confidence interval value study suggest patient mellitus undergo may rate
25458669 en study evaluate effect glucose insulin response patient type mellitus randomize study two treatment patient period receive health group on group blood sample estimate blood glucose insulin level baseline blood glucose significant lower group on compare group respective increase serum insulin level baseline also lower group on respective compare group test study show lower blood glucose insulin level compare may diabetic patient need
24823259 en compare association mortality individual analysis conduct cohort study mellitus test association mortality old aged old mellitus research study primary outcome mortality risk measured day use datum index measured use patient health age mortality risk mellitus high without although result according age mortality risk aged old great without effect mortality statistical analysis suggest effect mortality mellitus significant old adult evidence treatment adult lead lower mortality result may suggest old adult mellitus consider population treatment
26288847 en recent gene show determine addition previous study type gene gene studied among healthy control patient type multiple present decrease activity associate increased risk odd ratio or confidence interval CI also or CI risk high patient associate syndrome also without associate overall risk gene health
26121486 en study examine risk disorder associate study examine association risk disorder woman use sample woman cohort study datum mellitus disorder disorder assess according statistical disorder obtain participant use multiple regression model important high prevalence disorder woman without woman event disorder woman event disorder analysis significant associate disorder odd ratio or confidence interval CI case disorder significant associate disorder or CI major disorder or CI disorder or CI finding suggest presence significant risk factor woman current disorder however case association woman association current suggest evidence effect cause disorder
25784086 en association body mass index BMI glycemic control assess patient type mellitus T2DM disease patient T2DM clinical adjust analysis conduct BMI group normal group difference hemoglobin hba1c however compare normal BMI group patient hba1c vs patient compare normal BMI patient hypertension vs vs hypertension vs patient group reported great effect patient T2DM result poor glycemic control management patient include reduce weight medication patient
24846925 en mellitus one complication increasing occur among patient associate risk cardiovascular disease mortality risk development increase time therefore early reduce risk complication aim review parameter management condition patient risk factor blood glucose period important early impair glucose tolerance impair fasting glucose high associate incidence patient blood glucose assessment early development intervention need develop control blood glucose profile lipid profile diabetic complication condition may consider disease outcome improve risk potential adverse effect include reduction target type mellitus also management
20520956 en different include among cause present clinical study clinical gene follow-up patient determine whether cause diagnosis test analysis gene analysis revealed gene patient gene gene contribute gene addition may follow-up
20190689 en adult disease cause relative renal renal general elevated level patient significant clinical syndrome also lead large clinical patient due however report previous patient report first case cause patient month old woman case report
24931701 en determine prevalence type mellitus T2DM oral glucose tolerance test woman diagnose gestational mellitus identify glucose study woman undergo week T2DM diagnose according association datum examine analysis multiple regression woman normal impair fasting impair glucose tolerance T2DM body mass index BMI age fasting plasma glucose week diagnosis associate T2DM whereas associate T2DM BMI previous diagnosis syndrome whereas T2DM diagnosis BMI T2DM finding high prevalence glucose early period woman previous new
26787039 en correlation blood group mellitus aim study determine relationship blood group population study conduct hospital study group patient patient control blood sample test blood group datum analyzed on significant association found blood group mellitus blood group significant high diabetic on blood group significant high diabetic significant diabetic
25131985 en increasing obesity weight insulin resistance also patient type mellitus insulin therapy high insulin study effect addition insulin patient current possible compare patient insulin patient insulin therapy treatment datum patient aged analyzed regression old range vs female vs high body mass score vs hemoglobin hba1c vs hypertension vs vs significant adjust insulin significant high vs patient treatment period addition result reduction improve hba1c insulin therapy primary use female therapy associate
25312436 en blood treatment reduce cardiovascular risk patient mellitus effect individual identify patient treatment large clinical trial type mellitus disease control participant estimate individual patient risk major adverse cardiovascular event without treatment difference treat risk estimate individual patient risk reduction base model clinical characteristic observed relative treatment effect effect patient estimate range compare blood pressure use analysis treatment effect individual patient according patient large patient provide one treat patient year adverse outcome treatment high treatment identify individual blood therapy major adverse cardiovascular event may use treatment individual patient
22892499 en on woman due revealed revealed test demonstrated function although normal patient diagnose month treatment result well function treatment perform condition several
22474537 en disorder low incidence estimate one per disease cause result disorder patient presence lead lead investigate model regard protein use protein profile show result well analysis
25195497 en assess status number patient new identify total subject previous study potential potential group base hba1c adjust model significant difference observed group per little one significant difference group significant difference group group previous level observed individual datum association oral finding suggest disease early complication mellitus
25105463 en provide association type mellitus T2DM conduct cohort use identify related mellitus on analysis perform potential effect investigate use on also evaluate effect estimate total cohort study total subject individual show estimate association effect estimate revealed relative risk CI increased regard association mellitus analysis one study significant change range one study finding provide evidence association research current relationship two different mellitus type
27254409 en chronic one presence chronic correlate impair review several high prevalence high impact patient chronic include review increasing consider syndrome include metabolic chronic metabolic lead development although several drug therapy studied relative cohort use therefore large study need whether improve patient outcome chronic
26684168 en increase risk disease base obesity insulin resistance associate disease although several study investigate association diagnosis risk disease result conduct review cohort database study disease define study included reported relative risk estimate confidence interval disease associate diagnosis relative risk estimate use effect identify study can included included case among participant patient CI result analysis among study year duration follow-up evidence analysis provide increased risk disease among patient
17663299 en syndrome disorder dysfunction patient early period severe multiple include diabetic severe type patient severe year medical treatment first report patient
26337986 en recent large clinical trial show lower rate cardiovascular event month however increased treatment aim analysis determine effect therapy month month outcome patient mellitus health patient undergo group without DM DM treat oral medication DM treat insulin clinical outcome type year determined health database risk assess score analysis use analysis year index primary study risk patient DM treat insulin receive treatment associate decrease risk ratio confidence interval CI CI similar patient DM receive treatment associate less CI CI treatment associate lower risk patient without DM group receive duration treatment month may decrease patient DM receive study patient receive
25514968 en mellitus risk factor previous study patient healthy patient risk factor among old adult mellitus clinical perform analysis care old adult mellitus outcome assess month occur less per week occur per week perform effect logistic regression analysis age factor hemoglobin level use insulin medication presence renal complication participant year old female factor independent associate included old age or age CI age or CI factor included or CI or CI impair or CI factor associate included use insulin or CI oral or CI associate hemoglobin level factor independent important among old adult mellitus factor assessment population
25069057 en management patient increasing can important review aim evaluate patient regard include system therapy glucose insulin included review database mellitus patient review according review study included review type mellitus study type mellitus study study high correlate use improve management participant age effect type assess reported use increased value result use overall patient therapy important patient consider intervention
24313229 en provide care woman gestational mellitus development woman gestational mellitus increased recent year gestational mellitus poor outcome include hypertension poor outcome occur among woman gestational mellitus also associate type obesity type among effective gestational mellitus reduce risk provide gestational mellitus analysis on research method provide according on research method datum woman care among woman significant impact gestational mellitus woman low contribute increased need target woman low include lead gestational mellitus may lead
23050777 en mellitus define month age individual mellitus insulin gene common cause
24305965 en risk mortality mellitus determined risk mortality cohort diagnosis datum two hospital mortality event primary outcome mortality compare diabetic total known occur follow-up year range risk overall vs vs mortality high diabetic respective occur diabetic compare diabetic vs respective time independent risk factor mortality CI mortality common mellitus determine whether diabetic
26843083 en type diabetic patient present plasma glucose level significant weight new metabolic perform aim develop large model assessment use mellitus three group control group glycemic mean glucose tolerance test body weight use case group remain diabetic week blood glucose level group follow-up without significant body weight change group result positive response lead large model assessment metabolic effective high mean model although less effect
25707921 en primary aim characteristic man identify type mellitus T2DM use risk assessment aim determine prevalence metabolic syndrome identify T2DM score outcome assess man among three score group perform level risk factor among man age year activity level history previous high blood glucose level man score high mean hba1c man score mean sample whereas mean hba1c prevalence metabolic syndrome prevalence identify man old large elevated hba1c finding provide evidence T2DM clinical research
25666950 en datum impact important among patient type mellitus T2DM aim identify factor associate among T2DM patient measured health profile activity multiple regression analysis perform evaluate association outcome patient status hemoglobin hba1c T2DM patient mean age year mean hba1c reported little one evaluate poor glycemic control significant associate high oral insulin independent associate activity glycemic control associate measured major disorder measured may major disorder patient T2DM
25656761 en patient mellitus DM associate diabetic present study investigate association patient type
26643209 en clinical chronic mellitus DM study evaluate influence metabolic profile patient retrospective assess possible association cardiovascular risk factor man DM DM subject DM subject retrospective consider clinical metabolic parameter metabolic parameter blood pressure significant body mass index total subject show significant metabolic parameter one significant correlation parameter metabolic present positive significant correlation blood pressure negative significant correlation present high cholesterol association cholesterol blood pressure regression may determine metabolic profile
26458326 en investigate whether associate obesity related metabolic disorder patient body mass index studied weight body mass index mass mass level activity plasma level glucose total cholesterol prevalence associate obesity medical perform method time use test determine associate body regression model use age activity weight body individual woman respective weight body lower individual observed lower type mellitus compare associate weight body mass risk type mellitus individual
26452482 en effective treatment patient type mellitus increasing number patient type mellitus also obesity role metabolic group patient review investigate result patient type mellitus found patient significant weight patient also total insulin control remain patient reported undergo datum
26474563 en although develop target one type mellitus T2DM patient glycemic reduce glucose improve insulin function mechanism different use drug potential drug include insulin high use adult patient T2DM patient therapy patient control medication include insulin on conduct use identify related use treatment patient mellitus review reduction hemoglobin hba1c significant reduction body weight datum study suggest may also improve glycemic control patient type mellitus clinical trial show effective insulin oral patient T2DM
25303784 en determine factor associate presence patient type mellitus effect development drug resistance population study include individual mellitus individual outcome risk factor associate presence type mellitus age CI previous CI body mass index CI history CI also found patient mellitus present CI CI high risk develop resistance respective individual CI great month treatment influence within analyzed population development system consider characteristic population
24620855 en mellitus may present patient prevalence increase increasing age increase related diagnose datum related treat insulin therapy datum regard oral treatment new diagnose related important insulin treatment several report management related use oral drug little year oral therapy less patient group high therapy base present study whether oral therapy effective insulin therapy patient early diagnose patient age year old oral glucose tolerance test result test according value two positive oral glucose tolerance test diagnosis study randomize control group trial month primary trial compare control oral therapy insulin patient related year trial include subject related new diagnose oral glucose tolerance test related mean hba1c month treatment change change one study compare oral drug insulin treatment without fasting result regard BMI month month show insulin treat patient treat hba1c function group compare change month baseline baseline month group therefore effect insulin BMI hba1c present according compare treatment effect hba1c BMI group report regard insulin oral study need whether result study clinical
26679969 en first new oral type mellitus T2DM treatment less year use large investigate compare baseline clinical characteristic patient datum large care retrospective study assess adult T2DM patient aged year treatment patient medical T2DM diagnosis patient first cohort early define index remain patient cohort index first patient little month baseline included patient drug month index new on patient month index use examine medication patient type gestational clinical characteristic assess baseline compare use test logistic regression model assess baseline factor associate patient patient treatment treatment group mean age year cohort on significant patient treatment compare patient less patient treatment primary care compare patient less present vs vs vs obesity vs respective less mean index score great compare among patient hemoglobin result significant less treatment baseline less among patient month follow-up index drug time significant great baseline total medical baseline vs significant different mean high group vs less regression analysis indicate baseline insulin use well obesity significant associate sample patient within large care therapy relative high patient receive compare high elevated level diagnose metabolic condition baseline high among patient research need assess clinical outcome baseline difference
26631065 en mellitus common cause present first week month age develop type condition due gene disorder three case present low weight metabolic profile mellitus report clinical blood glucose level case mellitus week age week case mellitus present without may week may blood glucose level also may high glucose rate
26422580 en study type mellitus T2DM different type base datum general assess effect different type patient T2DM compare control patient effect type glycemic control related clinical retrospective cohort study conduct may may within clinical research patient body mass index weight great identify patient T2DM patient without datum use medication result type T2DM glycemic therapy hemoglobin patient undergo found prevalence T2DM per mellitus found patient undergo compare mellitus control patient patient undergo increased T2DM adjust relative rate CI compare control patient great effect observed adjust CI follow adjust CI adjust CI body mass index blood glucose hemoglobin level decrease first year datum show increase T2DM great effect although risk possible adverse effect may consider new treatment T2DM
25150136 en patient mellitus DM present outcome without DM datum patient present mellitus mellitus new identify DM hemoglobin level patient without DM study cardiovascular datum treatment intervention outcome patient identify clinical characteristic management outcome analyzed patient DM less undergo whereas less undergo therapy compare patient without DM increased adjust risk mortality DM group odd ratio or confidence interval CI or CI population patient DM mortality high patient group or CI group or CI new diagnose patient DM present similar outcome compare patient without DM patient DM present high mortality risk patient without DM patient DM present increased mortality
24673640 en examine incidence rate correlate mellitus cohort individual compare obtain system system database year age period analysis model use total individual age year contribute follow-up incidence rate high group compare group vs per analysis significant lower risk among treat therapy compare adjust ratio CI among significant high risk period adjust relative risk CI association significant overall female old age hypertension obesity associate high risk may independent associate increased risk among may increase risk use therapy profile
23566587 en cause high mortality diabetic present high level protein presence type finding provide mellitus DM patient increased incidence previous show type DM associate function however mechanism type adverse remain protein lead function analyzed DM two week type DM DM function assess week protein analysis identify mass significant poor function elevated weight ratio protein high respective protein among protein finding protein type diabetic
26873164 en characteristic important patient mellitus DM factor among diabetic hospital clinical characteristic measured analysis correlation regression analysis patient woman DM patient mean score significant reduce patient DM type mean score hypertension significant reduce reduce also correlate disease control effective activity improve reduce complication improve patient
25617537 en type mellitus increase risk independent risk factor cardiovascular disease current effect treatment however type diabetic subject review glucose treatment subject type review conduct database investigate clinical trial investigate effect treatment subject type clinical trial included review trial reported reduction level group analysis trial show significant increase level significant change found total cholesterol fasting glucose hba1c insulin lead level result glucose patient type mellitus treat diabetic population
25529506 en examine association gestational mellitus care year measured sample woman year assess woman on activity care time difference woman gestational mellitus compare normal glucose tolerance examine use regression mellitus independent associate gestational mellitus group normal glucose tolerance group care year index gestational mellitus group normal glucose tolerance result suggest gestational mellitus associate increased care provide associate reduce management gestational mellitus estimate study examine
26964816 en study month treatment important treatment study determine factor influence month treatment among patient receive treatment total case control medical need analysis conduct use logistic regression analysis use determine show factor associate month treatment mellitus odd ratio confidence interval CI body mass index CI treatment CI previous history CI analysis identify mellitus CI independent associate risk month finding factor management treatment study diabetic control among patient treatment outcome
23265864 en mellitus common weight relative insulin difference mellitus relative population diabetic suggest factor important role determine disease on number mellitus associate increased risk mellitus relative mellitus associate major similar identify on number several identify insulin gene associate resistance mellitus response associate mellitus number association study current factor profile diabetic population
23603250 en evaluate without study conduct may hospital general hospital on test test perform month also assess use day development period healthy patient mellitus aged without adverse found study participant develop use effective old without mellitus
27052250 en significant contribute complication patient mellitus intervention remain disease treatment patient type glycemic control individual target regard great present current clinical datum
24726843 en evaluate glucose observed therefore determine develop mellitus activity glucose tolerance test use evaluate mellitus evaluate diabetic well model diabetic identify datum although known presence known previous observed first time activity oral glucose mellitus activity low concentration body weight one mechanism glucose develop therapy
27470878 en include therapy mechanism also reduce weight important effect contribute plasma decrease blood pressure respective may cardiovascular also associate reduction estimate rate reduction effect suggest renal increased reduce weight effect patient chronic disease estimate rate blood pressure estimate rate effect chronic disease regard clinical outcome outcome trial cardiovascular outcome mortality type patient type mellitus cardiovascular disease reported reduction primary outcome cardiovascular reduction cardiovascular mortality overall mortality associate hemoglobin difference randomize group increased risk patient adverse event include lower risk outcome result clinical cardiovascular patient type mellitus glycemic target cardiovascular disease trial effect clinical correlate impact blood pressure mortality major management
24997424 en investigate effect current study use model type mellitus control group normal develop group include diabetic group treat three group receive different concentration week measured level determined level activity analyzed concentration factor compare control group diabetic group develop type significant addition severe significant high level observed level significant decrease treatment high concentration condition cause result suggest role possible
24268912 en chronic disease type mellitus T2DM high chronic disease important health management T2DM cause also cause significant regard patient disease risk group high well high risk diabetic individual normal function treatment T2DM patient evidence current report aim treatment well glycemic control patient
24776618 en system range function cell cell well suggest can potential role type mellitus large may influence individual study individual type mellitus T2DM may influence insulin relationship T2DM study study disease function large well control randomize study potential role management T2DM relationship glucose T2DM
26318399 en protein associate insulin resistance type mellitus T2DM study investigate gene insulin resistance T2DM patient cardiovascular disease effect risk cardiovascular event cohort study perform patient clinical associate reduce activity increased level cholesterol patient three group type patient regression analysis perform use study population patient without T2DM patient T2DM baseline presence associate increased patient without T2DM T2DM follow year T2DM occur presence related T2DM patient without T2DM baseline presence related insulin resistance glucose insulin hba1c associate insulin resistance T2DM patient clinical disease effect risk observed
26238236 en evaluate prevalence characteristic disease found female patient old year age can age
20297695 en concentration studied found respective normal level correlation condition level change within lower day however week increasing observed
26400516 en mellitus common complication lead impair function factor may increase risk development reported associate glucose cell reported glucose aim study examine association study included patient receive study patient two patient patient without diagnose vs or CI analysis old age presence independent significant high risk result study suggest association
24619761 en examine gestational mellitus factor associate type mellitus identify clinical define clinical diagnosis medical woman follow year range year woman develop less T2DM vs high mean vs vs blood pressure vs vs woman develop T2DM woman possible high among study relationship among T2DM
18519084 en use common treat disorder addition primary effect system number effect effect include change change associate change cell contribute change year renal change provide mechanism include renal review aim present clinical
25366202 en incidence mellitus population datum profile mellitus DM type therefore study evaluate clinical profile DM one patient age mellitus hospital medical new care research included study subject test cell insulin insulin test method patient also on factor type total patient man woman mean age BMI subject year respective patient age patient present per positive per positive insulin patient evidence subject evidence mellitus patient presence insulin type DM study need large sample different
25214204 en primary disease cause reduction disease common case mellitus present common present disease patient mellitus patient however may occur association primary result insulin common complication insulin therapy patient mellitus disease patient mellitus female occur patient association among mellitus disease found syndrome disorder may occur age case suggest presence disease patient mellitus association disease mellitus although early diagnosis disease diabetic patient potential mortality association
27189281 en disease type mellitus T2DM population compare normal glucose tolerance individual assess investigate prevalence T2DM population use control parameter undergo related T2DM use health value presence severe respective related T2DM included fasting fasting hemoglobin hba1c model assessment insulin resistance insulin resistance study participant T2DM subject increased according glucose tolerance status T2DM value significant high subject T2DM logistic regression analysis show subject severe odd ratio high risk T2DM without confidence interval positive correlation value fasting T2DM high prevalence severe increased significant associate presence T2DM insulin resistance may important
26548119 en complication remain major health evaluate type mellitus study general hospital use two method datum on retrospective study datum case diabetic patient use datum method datum use mean correlation statistical patient less per month hypertension common disorder mellitus common complication oral mellitus patient per patient high age group year significant correlation age total drug study demonstrated type mellitus complication significant patient need health reduce
25884665 en healthy activity woman previous gestational mellitus evidence may study compare health status woman woman normal woman on woman on sample woman identify medical on woman year on total woman diagnose normal previous significant old reported high body weight less index major difference group regard follow-up overall participant follow-up participant develop previous woman previous reported significant poor health high level use medication however history mellitus show association poor analysis use medication associate poor level found sample woman history well woman normal year index woman previous increase perform lower woman history normal index diagnose mellitus follow-up association poor year
25345907 en insulin therapy mellitus whether regard type age year duration year BMI hba1c type insulin therapy age year duration year BMI hba1c type insulin therapy age year duration year BMI hba1c per type type group type group participant type type group type group time type difference participant type age BMI hba1c time diagnosis participant type old difference BMI hba1c time diagnosis correlation use hba1c BMI time diagnosis participant type old
26436350 en patient may glucose disorder show mellitus DM study demonstrated DM associate increased risk complication patient DM contribute increase base effective control may impact patient however study evaluate effective drug impact treatment DM mortality patient addition oral insulin may review clinical DM patient chronic disease addition effective old new drug base study chronic patient recent report regard use well new therapy oral management patient
20150720 en on present three previous year drug addition metabolic reduce metabolic renal cause diagnose use test may effect although function remain patient female metabolic investigate possible factor
20075582 en can occur patient syndrome cell associate report case present follow decrease revealed treatment serum level syndrome
19816050 en type gene report identify previous show function observed clinical investigate analysis clinical datum assessment datum patient demonstrated increase concentration analysis revealed reduce cell decrease activity treatment cell associate may level result provide treatment trial patient identify
25130919 en show adverse cardiovascular outcome aim study evaluate effect mellitus DM function use population patient cardiovascular disease perform patient DM age year healthy control age year addition perform assess significant difference group regard parameter function however regard parameter function time ratio value significant high early value significant lower diabetic patient compare control demonstrated significant high diabetic patient compare control vs vs total index found significant lower diabetic function significant difference group regard type mellitus found increased impair diabetic patient use analysis may related type
18599930 en evaluate profile identify factor indicate compare use test test odd ratio factor indicate included system diagnose year year lower score compare group on great odd ratio odd ratio compare group on year age lead group present age year
25814674 en present body increasing disease investigate influence impair plasma patient type profile identify significant diabetic control compare patient disease chronic decrease level type diabetic healthy control diabetic subject associate disease chronic also high protein level compare diabetic control significant correlate protein level patient mellitus increased addition cell target influence diabetic cell respective target study report patient type mellitus influence plasma concentration
24424179 en mellitus increasing prevalence disease cardiovascular complication may two major group mellitus define type type recent year major group disease treatment patient present review clinical current known addition group mellitus regard potential
22989165 en disease metabolic syndrome known associate impair fasting mellitus study conduct determine association incidence mellitus adult population health study cohort assess use baseline follow year incidence rate mellitus compare subject without subject subject year subject subject without develop mellitus incidence rate respective per follow without independent develop mellitus independent impair fasting diagnose increased risk develop mellitus intervention may current
25290378 en insulin resistance occur poor cell may contribute although demonstrated study clinical present history therapy also month duration respective obesity poor condition test result revealed mellitus DM show increase first reported case suggest may clinical occur among factor consider possible cause patient DM case DM may treatment case
25175314 en retrospective examine management outcome adult patient mellitus present conduct medical use disease identify patient characteristic management outcome total patient age year included study type type type patient significant old vs year chronic condition subject score revealed severe case treatment common receive glucose receive treatment included oral glucose common included patient however subject type vs patient occur case management present develop management reduce
26141615 en patient type mellitus cardiovascular control increasing risk adverse cardiovascular event common may lead dysfunction increased risk therefore rate reduce adult type type hba1c duration two week randomize rate blood pressure analyzed baseline result significant reduction compare baseline level effect impair effect cardiovascular control patient type may increase risk cardiovascular mortality result potential population
27583868 en metabolic syndrome condition type mellitus T2DM however evaluate whether increase risk T2DM woman previous history gestational mellitus high risk T2DM compare general population investigate impact development woman history cohort study woman diagnose follow-up include oral glucose tolerance test week diagnose according cholesterol treatment risk develop type T2DM follow-up period analyzed base presence adjust risk use total woman without follow-up year woman incidence woman without per respective presence independent risk factor T2DM ratio confidence interval analysis clinical metabolic parameter consider impair fasting glucose woman increased risk T2DM presence early period independent risk factor development T2DM woman previous history
25451914 en recent clinical study identify dysfunction without type mellitus aim present study define function patient type study participant age type mellitus function evaluate test score participant consider possible respective test score group significant lower group age serum significant high group group correlation analysis show positive correlation score blood pressure test score total cholesterol cholesterol negative correlation age hba1c serum regression analysis show test score correlate significant independent score addition level hba1c serum result association dysfunction patient type mellitus
26564178 en aim study investigate association risk type mellitus review perform identify study compare rate develop type mellitus control or obtain report individual patient datum use effect total study investigate contribute included datum case overall evidence suggest association investigate type mellitus or range CI study CI study significant present analysis reduce analysis study report high score potential difference study provide evidence association type
24639413 en gene associate type gestational mellitus several population datum woman gestational mellitus study examine metabolic well woman normal glucose tolerance gestational mellitus according association gestational week datum blood pressure body mass index BMI concentration blood glucose hba1c lipid profile insulin BMI fasting glucose hba1c high cholesterol lower gestational mellitus woman woman significant difference found lipid insulin model resistance gestational mellitus woman high level vs decrease function vs risk gestational woman significant high woman risk gestational mellitus or CI or CI base model respective model show low function high BMI risk independent associate gestational elevated level gestational woman insulin low function high BMI risk risk factor independent associate development gestational
23122996 en mellitus increased risk outcome patient health related primary aim study evaluate aim rate complication function patient follow year patient present patient outcome evaluate score rate medical complication function activity condition patient mellitus reduce health status use patient without whereas index body mass index difference type method two group patient insulin treat oral treat score decrease month month month similar result patient without first year medical complication among patient however renal patient month patient severe month month diabetic patient independent difference condition group finding study indicate patient mellitus reduce health status patient without patient mellitus month renal patient month found rate function health related patient without within year
26164137 en mellitus estimate patient can develop chronic care mellitus cell cell treatment case present history mellitus chronic treat cell management cell treatment chronic impact population lead significant reduce
21892113 en syndrome disorder cause type gene protein cell type mellitus within early case poor finding care case type
26113181 en study provide treatment datum treatment mellitus sample sample identify obtain number use use method provide review datum effect current total total use method reported also use obesity study provide disease important mellitus reported clinical study study activity
25865313 en examine whether related follow-up control adult type type mellitus reported clinical blood sample determine baseline hba1c hba1c medical relationship baseline hba1c examine model patient baseline control significant associate association control significant association control relationship significant adjust baseline hba1c elevated baseline risk control therefore elevated important control indicate need regard patient
24352521 en renal disease common major complication type mellitus plasma lipid disease well case subject patient type mellitus duration year disease case subject mellitus duration age cholesterol control subject type mellitus disease study conduct primary analysis included disease case analysis perform use logistic regression model adjust hemoglobin hypertension treatment mean cholesterol concentration disease odd ratio increased factor confidence interval increase decrease factor increase cholesterol disease odd ratio increased decrease cholesterol associate cholesterol analysis significant disease associate high level plasma lower level cholesterol among patient control cholesterol less associate lipid result study treatment diabetic disease
26246173 en cardiovascular disease risk factor control primary patient type mellitus year review current clinical trial blood pressure blood glucose control cholesterol management therapy present recent new clinical target include cardiovascular disease management patient type mellitus
25456820 en cholesterol level patient cardiovascular disease reduction patient treatment may well regression event rate mellitus DM major negative regression therapy however regression DM patient without DM low value high treatment recent association treatment blood cholesterol reduce cardiovascular risk adult suggest treatment target may high risk patient DM high treatment drug aim low level reduce clinical event
24444518 en mellitus type metabolic disease several cardiovascular risk factor patient therefore high cardiovascular risk time high man general population time high woman cardiovascular disease cause diabetic population follow cardiovascular risk compare diabetic patient show one cardiovascular disease risk factor evaluate risk factor cardiovascular risk individual assess cardiovascular risk assessment patient current method risk individual low study demonstrated control risk factor present type mellitus reduce development complication mortality present review cardiovascular risk factor hypertension obesity well target control control multiple risk factor type mellitus
23711668 en study investigate relationship risk factor mellitus obesity presence control subject study included mellitus obesity define body mass index conduct within month less included lower logistic regression model adjust age study use adjust odd ratio confidence interval effect low mellitus mellitus respective control respective effect mellitus lower large CI mellitus high CI little difference association obesity finding suggest although risk associate mellitus risk obesity
19891534 en patient group severe define score less study present case without change early however year patient revealed patient treatment patient clinical may develop dysfunction follow-up patient important
24654755 en research study examine whether current identify may hospital period hospital datum diagnosis adult year included consider type type mellitus respective group mellitus multiple time group complication diagnosis disease primary diagnosis total identify primary diagnosis common diagnosis type mellitus common without complication common primary diagnosis primary diagnosis identify hospital care lead effect study rate outcome identify
18040725 en disease patient report case patient present diagnosis test on gene patient previous case present patient can gene test diagnosis
26499756 en determine effect protein independent individual type mellitus use insulin type mellitus aged year protein control two glucose without insulin randomize day glucose use assess participant protein result significant compare control study period protein result lower control interval high interval glucose large protein result significant glucose protein significant increase type mellitus use insulin therapy profile high protein significant glucose time glucose duration research insulin large protein
26520567 en prevalence type increased recent population age study investigate prevalence factor associate diagnose type mellitus old adult datum man woman aged study diagnose define use diagnosis medication datum hba1c analysis use identify age prevalence estimate logistic regression use investigate association health characteristic prevalence diagnose type confidence interval CI CI respective man woman increased age prevalence CI increased age independent associate obesity history hypertension associate medical high rate obesity health condition prevalence relative low old adult factor population may reduce prevalence improve outcome previous diagnosis
25339819 en medical therapy type mellitus due disease increasing medication diabetic individual low complication rate result weight glycemic control overall finding glucose weight mechanism lead metabolic however primary metabolic glycemic control metabolic control risk reduction metabolic well define use less patient poor control mechanism glycemic control research finding metabolic need define examine mechanism different type metabolic glucose control risk complication associate metabolic different group patient factor
26073610 en mellitus common population individual review current relationship important syndrome function study identify database old patient associate include activity poor function test time test diabetic also lower high time time compare little known old adult relationship outcome old
16503109 en on man present serum concentration occur
19812297 en renal response due gene group patient renal effect investigate two previous gene known cause cell one first protein show protein whereas level protein lower primary within reduce analysis demonstrated cell lower respective similar increased revealed cell lower compare respective level may similar clinical
18473191 en perform analysis old history studied observed within first month normal serum result test diagnosis gene assess analysis presence also identify respective previous control report two gene associate study important role diagnosis
23272513 en mellitus disorder chronic large number condition type type case may patient gene disorder disorder syndrome insulin type on insulin resistance syndrome syndrome determined insulin insulin man syndrome control development function may mellitus treatment estimate patient diagnose blood relative possible
24825091 en mellitus develop within first month study define incidence mellitus study conduct study included case diagnose within first year incidence one case found case diagnose month included one three case two case different similar
24740679 en patient mellitus DM disease patient without DM datum whether examine prevalence year among patient include DM hospital vs without DM treat medication follow therapy patient vs without DM high prevalence vs follow-up assessment although rate group time model adjust multiple clinical factor include disease DM associate great odd month follow association increased time or CI severe among patient DM effect time independent patient treatment factor include presence disease increased may due disease disease time great among DM patient
24964071 en retrospective study compare effect rate glycemic control new diagnose mellitus medical mellitus low high protein insulin review group base blood glucose concentration use assess glycemic control two group compare regard incidence clinical rate multiple logistic regression use evaluate association independent group whereas group group clinical group clinical management new diagnose diabetic use glycemic control result high rate without increased incidence observed clinical although evaluate regard overall effect health well overall effective
26161865 en due disorder model however mechanism role well known treat oral lower significant correlate significant gene treatment high show effect addition elevated decrease value normal treat control result provide evidence diabetic role may
26780281 en mellitus chronic glucose metabolic disorder high prevalence significant impact management include glucose although method effective lead therapy therefore need review identify mellitus review use report use management conduct different studied potential database also result indicate glucose insulin activity glucose respective similar mechanism drug diabetic status associate mechanism well known however effect also use health diabetic
26032358 en research investigate cause female type mellitus research aim investigate prevalence diabetic woman compare identify profile study included female type mellitus female within period identify method activity serum respective perform result indicate significant high among diabetic group group respective follow group significant association mellitus activity whereas high significant activity diabetic female found association test mellitus incidence cause increased high prevalence among diabetic can related increased group patient
27575045 en individual develop lower several development complication important treatment evaluate relationship risk factor participant included study diabetic develop year study clinical prevalence patient risk factor high compare one risk factor risk factor population presence risk factor mellitus present study factor presence
23594031 en study evaluate glucose mellitus present undergo baseline assessment follow month range month follow-up compare characteristic metabolic develop group on develop group two oral glucose tolerance test three show indicate significant result glucose confidence interval CI glucose CI glucose CI glucose range CI CI increase value high range first study mellitus
26458377 en care potential great impact health care chronic disease patient care management improve health care care patient mellitus complication health management outcome great potential patient new health care however among present impact aim may improve health care population
26223257 en evaluate primary subject type patient type mellitus hypertension randomize month on blood pressure control patient study month compare assess baseline on level new cardiovascular risk include high protein baseline on patient treat show statistical significant reduction statistical significant increase value significant one obtain similar significant lower increased effect compare consider significant improve addition datum suggest use primary can patient type mellitus
25458325 en aim study investigate assess relationship patient type mellitus patient T2DM study general characteristic hemoglobin hba1c measured patient index on score define poor on score define multiple logistic regression analysis use examine relationship participant associate duration great number complication poor glycemic control participant poor according poor significant lower poor positive associate lower or CI result suggest poor T2DM associate primary include related improve patient
24204905 en hypertension negative associate datum mellitus addition outcome patient due therefore identify role protein mellitus hypertension development woman man undergo without without evaluate follow-up month diabetic woman diabetic man low level low high risk odd ratio or confidence interval CI or CI respective or woman man high reduce respective mellitus respective hypertension hypertension negative effect development diabetic woman observed man high independent adverse outcome patient high event patient low mellitus contribute development man low level woman negative effect mellitus hypertension development patient high level woman elevated level independent adverse outcome
24094263 en evaluate effect insulin clinical occur poor new diagnose mellitus hospital interval follow-up follow-up blood glucose concentration measured little high insulin time insulin mellitus mean day day range day study time mellitus well mean insulin range receive mellitus mean blood glucose concentration confidence interval insulin mean blood glucose concentration confidence interval insulin significant difference mean mean blood glucose concentration significant difference blood glucose concentration measured time blood glucose concentration measured little present study diabetic high insulin insulin blood glucose concentration insulin
27246505 en type mellitus type previous found poor control high prevalence complication control reduce incidence chronic complication aim study identify factor associate control among study datum include care obtain control assess hemoglobin hba1c regression analysis determine factor associate participant study mean hba1c aged year found significant control compare year year value patient insulin blood glucose control age primary blood glucose duration less year associate control analysis age blood glucose primary found independent control value type poor control improve metabolic control blood glucose care
26721264 en drug use risk factor development type mellitus however effect drug complication remain study aim association treatment outcome among patient type conduct retrospective cohort study use health database on total patient mean duration follow-up first period year range month year treatment within time use use high low metabolic risk status treat outcome included complication complication treatment month use associate lower risk complication adjust ratio CI complication CI mortality CI ratio complication use high low metabolic risk CI CI CI treatment month associate reduce risk complication compare treatment
24790413 en effect insulin therapy three time day two time insulin therapy glycemic control investigate patient type clinical observed first week insulin insulin subject previous treat use insulin treatment hemoglobin hba1c level score change study hba1c level found subject change hba1c show significant negative correlation baseline hba1c significant patient baseline hba1c hba1c respective change score treatment significant great patient hba1c level improve regard hba1c level patient type mellitus consider subject glycemic control poor
25866823 en type mellitus T2DM chronic disease increasing well important risk factor type although factor impact development T2DM include age obesity activity level study contribute regard DM insulin resistance chronic associate mellitus associate change occur mellitus increasing level level also consider potential condition woman addition among insulin factor can development review mechanism T2DM evidence T2DM woman role medication
25672299 en patient mellitus associate number change oral disease dysfunction determine prevalence oral patient study perform patient mellitus type type study two clinical analysis datum use test analysis level prevalence oral common analysis show association type two age level regression analysis type remain significant adjust result study show high prevalence oral diabetic patient oral associate type
26520866 en on study determine prevalence risk factor mellitus among adult participant use blood pressure parameter response rate prevalence mellitus CI CI female CI diabetic previous model participant history time high ratio time develop mellitus
23881862 en relationship mellitus risk therapy patient receive therapy investigate effect therapy patient therapy randomize patient primary different type on therapy therapy therapy assess among patient without mellitus reduce risk therapy mellitus although effect patient without mellitus mellitus associate decrease risk therapy ratio confidence interval increased risk therapy ratio confidence interval diabetic patient significant increased risk therapy ratio confidence interval therapy ratio confidence interval compare associate reduction therapy patient without mellitus mellitus associate lower risk therapy high risk therapy therapy associate increased mortality diabetic
25033925 en role recent identify contribute factor insulin resistance type mellitus however whether poor control two independent type mellitus clinical trial measured effect study investigate effect control patient type trial conduct general three patient type mellitus treat receive interval primary outcome change level baseline month outcome include blood pressure parameter lipid profile insulin resistance profile measured health measured trial first study effect control patient type mellitus finding contribute relationship status insulin resistance patient type trial
27568647 en examine association patient care primary care analyzed datum hospital database use sample diabetic patient primary care general assess association patient care care hba1c test renal function test lipid profile protein analysis diabetic drug clinical outcome care without patient associate three care however compare high odd hba1c test odd ratio or respective renal function test or respective lipid profile test or respective significant association patient hba1c outcome care observed primary care lower patient level associate great three association present
25761289 en determine risk develop type cardiovascular disease woman history gestational review use determine risk develop gestational mellitus found included total patient relative risk study reported risk risk follow-up range year year woman gestational risk risk woman gestational increased risk CI CI compare woman without gestational gestational mellitus significant increased risk develop important gestational cardiovascular risk factor group woman presence cardiovascular risk factor research risk whether
27141952 en aim study assess association treatment patient type mellitus study included patient T2DM diabetic without treatment assess treatment respective evaluate relative score regression model assess relative well model well treatment show significant association overall score however associate respective treatment positive associate overall score treatment well associate great treatment patient T2DM although found association overall associate
23857320 en improve glycemic control patient type mellitus remain regard observed association cardiovascular cardiovascular effect patient disease remain examine association use cardiovascular event among patient mellitus disease analyzed event among patient type mellitus disease trial total mortality individual incidence compare year follow-up among patient treat patient receive use analysis included among patient treat mortality similar ratio confidence interval CI whereas lower incidence CI CI high incidence CI incidence CI CI significant among patient rate major cardiovascular event significant patient type mellitus disease trial analysis association treatment increase major cardiovascular
27052241 en association management patient mellitus base evidence well metabolic control mean oral insulin therapy
19380027 en lead whether associate associate whether outcome patient without patient case lower change rate overall without disease poor outcome
28002970 en study evaluate result treatment two cohort patient mellitus treat cohort study conduct mellitus patient old treat insulin two patient medication ratio test evaluate treatment total patient included subject insulin insulin total case therapy according type insulin follow without difference group treatment patient less age range year result study show significant statistical difference compare insulin therapy improve treatment important improve clinical result
26175178 en risk factor associate mechanism remain study investigate role plasma target protein association patient type mellitus T2DM result show plasma significant T2DM patient without compare healthy control change significant T2DM patient well level significant T2DM patient without significant correlate plasma level blood glucose concentration rate high glucose concentration significant elevated significant reduce cell significant effect high glucose concentration cell may T2DM patient low plasma addition high plasma risk factor T2DM patient
25901045 en mellitus DM common patient case first treat DM report incidence new DM among patient hemoglobin assess result clinical among patient without known DM patient previous DM define hemoglobin among receive DM medication DM hemoglobin patient range month DM medication DM previous diagnose common among patient patient care one time include treatment patient DM DM hemoglobin consider
25153886 en mellitus one common disorder common although clinical type similar may aim study investigate previous diabetic different test cell compare healthy use follow diabetic two control examine include insulin test positive however serum one diabetic positive serum one healthy positive show change include insulin previous base result test protein use different mellitus
24641690 en association disease mellitus DM reported study include sample subject aim study determine DM independent associate among obtain sample target identify subject age research subject sample prevalence confidence interval CI prevalence DM without DM lower level prevalence DM high odd ratio or CI model age DM increasing body mass index increasing independent associate DM significant effect risk or CI female risk or CI among independent association DM man need association
26589367 en evaluate association complication type mellitus total patient T2DM group group effect obesity T2DM complication serum level factor total high weight measured presence group significant lower serum total level group group serum level total significant high patient without adjust group level significant high patient without serum level total significant high patient significant difference three level observed presence logistic regression analysis revealed serum total duration hba1c significant associate study show total may influence patient T2DM
23763632 en assess among patient mellitus DM group hypertension group patient DM conduct hospital ratio one sample use assess obtain included age body mass index BMI blood pressure hba1c glucose time diagnosis medication history DM total participant included DM group group group participant DM group use insulin medication group DM group lower BMI two group DM group group group found found respective ratio three found lower among participant previous study patient DM
26033326 en two role disease several report datum association chronic disease disorder prevalence insulin resistance type mellitus increased among patient addition several study show type mellitus may consider clinical reported therapy disease
26920333 en assess effect treatment mortality cardiovascular mellitus different blood pressure review control use high datum according trial potential control trial include mellitus treat month compare two one different blood pressure trial include participant included participant type baseline blood pressure great treatment reduce risk cause mortality relative risk confidence interval cardiovascular mortality renal disease baseline blood pressure treatment reduce risk cause mortality baseline blood pressure less however treatment increased risk cardiovascular mortality increased risk cause mortality analysis show treatment effect lower baseline blood pressure cardiovascular mortality lower blood pressure lower blood pressure similar blood treatment reduce risk mortality cardiovascular mellitus blood pressure blood pressure less however treatment associate increased risk cardiovascular observed
26595611 en improve glucose role type mellitus DM gestational mellitus remain evaluate incidence DM cohort woman recent health care woman diagnose week study woman type research week baseline follow-up year included oral glucose tolerance regression model evaluate independent association DM adjust potential woman without baseline evaluate year develop DM association baseline DM adjust ratio respective duration show association DM adjust ratio great month great month great month respective month weight change clinical study duration independent associate lower incidence DM may DM health development
26084340 en consider mellitus increasing however little known prevalence complication study aim estimate prevalence diabetic adult may adult patient assess hba1c perform on hba1c use diagnosis blood pressure general health datum also diabetic assessment total mean age year range year test examine study period found mean hba1c new diagnose mean hba1c range new diagnose hba1c known receive treatment mean hba1c treat patient diabetic identify previous diagnosis study estimate prevalence adult evidence diabetic estimate patient management known large case management estimate datum provide important prevalence impact provide well treatment
25413995 en mellitus increasing health pressure develop develop year mellitus chronic metabolic disease consider one oral health patient mellitus risk complication time present review mellitus disease include mechanism clinical study present evidence increased type may insulin resistance diabetic complication mellitus may status
24581189 en mellitus disease mellitus function system individual chronic decrease change cause disease level oral increased change aim study evaluate influence mellitus treatment analyzed case treat treatment year patient mellitus total study datum analyzed use statistical level total test group control group analyzed parameter related diagnosis time interval control difference statistical significant regard assessment treatment test group control group result study regard increasing prevalence diabetic patient regard treatment examine found rate diabetic patient lower statistical significant study patient mellitus great development treatment patient important however study develop change assess prevalence patient mellitus
24527464 en chronic mellitus type one type two T2DM respective include factor type therefore role can response influence diabetic review current type clinical disease model
26395643 en study aim association metabolic control complication population type cohort subject serum concentration measured determined activity cholesterol high hba1c serum serum plasma lipid high hba1c increased BMI associate increased level activity increased level found correlate prevalence cardiovascular disease group positive correlation BMI ratio activity correlate woman high index level compare man lower level man function lower multiple regression analysis show increased level significant correlate increased level cholesterol associate correlate prevalence complication increased response difference risk factor associate complication
24399329 en incidence time diabetic patient patient include patient mellitus care event year follow-up patient mellitus history cardiovascular disease receive less therapy treat little compare patient without mellitus however use therapy increased group study period incidence first year decrease patient mellitus patient without mellitus risk reduction significant large diabetic therapy independent associate reduce common complication patient mellitus risk decrease recent year increased use therapy contribute important risk reduction
24254885 en trial assess therapy show clinical patient aged year mellitus
26255202 en activity diabetic man investigate found mean value activity diabetic sample lower normal sample activity protein significant positive correlation significant negative correlation incidence protein patient significant lower normal control group rate protein diabetic man also significant lower compare found sample man protein concentration base datum diabetic man decrease activity presence high glucose mellitus due
26240133 en study show type mellitus DM increase risk several type although DM factor clinical less known impact DM patient early use database characteristic patient diagnose DM health database overall time patient according DM status estimate use method use model adjust ratio effect DM risk factor total patient primary receive treatment DM rate patient DM significant lower without DM vs vs adjust DM remain independent factor adjust adjust patient early DM independent factor influence mellitus DM increase incidence several type however less known impact DM patient study suggest DM may increase risk early patient treatment DM control consider care early patient follow-up population
25177707 en study aim investigate different type mellitus T2DM impact week insulin resistance T2DM T2DM week protein lower significant normal control decrease T2DM treatment protein increased respective increased respective T2DM overall study found decrease T2DM model treatment increased
25623618 en assess effect blood glucose system patient type mellitus patient type patient use glucose level report receive within first patient review patient hemoglobin datum remain patient patient type patient type patient whereas reported little value obtain follow-up value interval decrease type type base treatment oral insulin without oral show significant change found level datum patient follow effective use month
24893232 en mellitus increasing prevalence rate related individual aged year old mellitus type review effect mellitus mellitus lead major complication type develop common diabetic early development diabetic assess study occur therapy diabetic time complication patient type mellitus glycemic control outcome observed patient type mellitus recent evidence base treatment diabetic undergo review effective treatment include review increasing prevalence mellitus diabetic recent need diagnosis clinical research evidence clinical trial show glycemic control reduce prevalence diabetic patient type mellitus outcome observed patient type mellitus treatment effective therapy control diabetic
24728837 en type mellitus common among retrospective datum patient disease hospital study population analyzed age body mass index BMI status function therapy value association odd ratio datum adjust age possible method identify patient patient type mellitus significant difference prevalence similar among different age association patient year association present subject significant patient presence cardiovascular disease significant associate mellitus patient association use presence mellitus reduce association association type mellitus great patient general population correlate increase BMI presence suggest disease may target
26008639 en mellitus DM disorder multiple study show diabetic patient increased risk develop different type syndrome among common include group change low blood increased risk potential metabolic DM reported poor DM risk factor obesity patient DM diabetic control due multiple factor insulin resistance drug control addition assessment glucose control diabetic patient DM associate management increase risk complication intervention review current DM clinical level can use improve outcome patient condition important need research
23729495 en investigate association mellitus renal cell effect obesity retrospective evaluate patient renal cell undergo association mellitus analyzed use method regression model also examine whether relationship obesity use analysis test analysis body mass index patient history mellitus mean follow-up month patient develop although body mass index associate mellitus independent analysis ratio analysis relationship mellitus show group ratio group ratio time obesity effect mellitus group rate mellitus mellitus patient respective analysis patient cell type change mellitus renal cell patient
25638454 en individual impair fasting glucose impair glucose tolerance increased risk type mellitus review effective intervention reduce type mellitus review on ratio perform result present ratio treatment study included reduce type mellitus associate intervention great intervention reduce risk type mellitus intervention significant change may use adverse event intervention potential risk
27585437 en although increased major diabetic research effect remain include evaluate effect mellitus group control treat diabetic treat week DM statistical diabetic group show high index body weight high time function group show impair function diabetic group develop lower concentration high high type protein lower control type group change lipid concentration high activity lower high activity change activity reduce independent activity change function mellitus show need chronic pressure
27038847 en cardiovascular disease great type mellitus T2DM mortality individual therefore major care treatment treatment mean glycemic target individual medication ratio among recent care on major effect high mechanism target also glucose risk provide glucose control potential effect review glycemic effect potential reduce risk well effect datum outcome according datum study conduct use outcome datum three outcome show major event on significant increased risk observed subject history on study current provide consider oral general risk profile use potential adverse effect overall profile care
26294897 en among condition mortality significant health research model mellitus DM among woman large analysis datum revealed related DM sample DM status DM DM gestational patient base model treatment research datum general finding patient regard DM medical management complication DM severe condition finding according status included significant health use insulin lower level overall time outcome finding consider presence chronic condition risk severe
25199169 en study evaluate impact patient care glycemic parameter among adult type mellitus without glycemic control on total adult type mellitus mean age year female evaluate duration mellitus type treatment blood glycemic parameter study study participant demonstrated significant decrease body weight hba1c factor evaluate significant glycemic parameter finding revealed adult type mellitus receive blood glucose diabetic glycemic control significant decrease body weight period
26616012 en mellitus DM well known complication care chronic treat medication also cohort adult aged year DM outcome health care total per interval first total per interval first association care interval examine use estimate adjust clinical condition drug DM treatment type health care total care increased total identify high total per interval increased total respective total DM cohort total health care per interval increased high total great increase high total
23890131 en occur patient mellitus DM incidence clinical remain poor define aim study determine whether function impair patient patient mean age year DM little year included study included patient type DM patient DM type treat patient DM type diagnosis DM health year diagnose concentration less reduce patient reduce patient reduce patient DM occur less previous study due age
27651240 en aim study compare plasma concentration patient without mellitus concentration determined adult patient studied without DM treat drug concentration estimate per concentration significant lower diabetic patient drug blood glucose negative correlate plasma multiple regression analysis show concentration influence age drug DM use DM reduce concentration patient DM lower concentration negative correlation blood glucose drug concentration suggest presence elevated glucose
24038858 en incidence type low however also type patient diabetic without whether included type mellitus compare clinical characteristic diabetic study population new diagnose type clinical characteristic age history body mass index blood pressure plasma lipid parameter patient group blood level blood glucose level patient also prevalence respective study population clinical characteristic patient group patient similar patient high blood glucose cell without patient similar clinical characteristic consider type therefore prevalence type
25775379 en treatment type mellitus use multiple medication impact negative patient result use reduce although patient glucose new mechanism identify without present association association study two known oral drug clinical trial study evaluate glucose include two study week duration study show clinical glycemic control general profile individual mechanism treatment patient type mellitus reduce population potential treatment mellitus
26233574 en mellitus DM patient several correlation DM datum health identify DM adult year patient age subject follow diagnosis due follow compare incidence ratio DM patient include hypertension disease high DM cohort without vs hypertension vs vs disease vs vs disease diabetic without DM cohort type DM type patient elevated risk increase risk
22939809 en patient mellitus DM high prevalence therefore also rate renal high presence treatment patient mellitus hypertension renal therefore important present among studied prevalence renal among patient mellitus patient included diagnose DM hypertension without renal function cause renal disease DM hypertension datum patient on renal included age year range patient DM DM mean BMI on present patient patient factor related presence blood pressure rate group diabetic patient hypertension renal prevalence
26813254 en on cell mass target provide mean control associate mellitus aim current study investigate potential target factor model mechanism associate group use cell use treat development week assess cell evaluate gene investigate profile assess use whereas reduce decrease cell correlate increased cell profile revealed target cell associate cell correlate response glucose cell cell related cell mellitus datum gene database number
25770841 en mellitus DM one important risk factor independent overall mortality cardiovascular diabetic patient include glycemic DM present review association DM provide mechanism potential therapy
25756579 en high known associate new mellitus patient high risk develop mellitus DM however low common use compare high aim study investigate impact low development three year investigate total patient DM adjust potential score analysis perform use logistic regression model total patient group patient control group patient incidence vs vs major adverse event vs high group however high incidence vs group incidence vs similar two group analysis independent or CI study use risk factor patient reduce clinical event similar control group however randomize control trial need
27061400 en cell method type patient blood glucose level reduce insulin severe insulin study analysis current estimate value research reduce perform analysis use cohort model mean patient age health outcome analysis use insulin therapy effective datum per patient hospital effective year outcome analysis within perform analysis identify research analysis assess outcome model cell use per year per value increase research high follow history effective provide health outcome therapy high patient type however value research treatment suggest value current datum datum change
16565582 en mechanism investigate large adult patient mean age year old undergo three group group group group identify patient without month patient undergo treatment function normal group therapy group mean follow-up period year year patient group test revealed high significant increase result indicate renal decrease function possible
26316711 en cardiovascular disease complication patient type mellitus T2DM glycemic control profile drug cardiovascular complication therefore study conduct retrospective assess association drug glycemic control profile T2DM patient association medication glycemic control also total T2DM patient medical little one complication little one drug little month included association cardiovascular disease parameter medication clinical characteristic glycemic control found associate glycemic control whereas insulin insulin therapy found associate poor glycemic control type significant associate glycemic control factor patient cholesterol level fasting plasma glucose found significant correlate glycemic treatment T2DM patient association glycemic control profile T2DM patient
25443983 en on evaluate effect normal diabetic type diabetic result indicate group can improve glucose tolerance normal whereas group can glucose significant increased glucose normal treatment can reduce blood glucose level type diabetic show effect week treatment diabetic drug treatment mellitus
22121010 en mellitus disease condition clinical high reported general population diabetic subject investigate prevalence mellitus due study investigate patient diagnose mellitus hospital month patient datum studied patient according subject patient can type mellitus among diagnose chronic mellitus due chronic occur diabetic subject patient common type patient type mellitus disease chronic common general prevalence among subject studied type poor on common type type mellitus important patient disease
25424228 en use patient mellitus health may result improve outcome however patient may cause patient characteristic also can increase patient aim study patient identify use conduct among patient type type mellitus primary care hospital use health patient characteristic use patient patient without patient group according analyzed regression total response rate patient analysis reported patient disease use patient treat general compare patient treat vs vs value vs vs vs result glucose vs study show patient different increase patient need health care
27179626 en function among include role control may development disease suggest obesity addition role system gene show number health target chronic insulin resistance development individual review association related target new role can lead development use treat metabolic disorder
26674320 en identify risk factor among woman gestational mellitus retrospective study baseline characteristic datum glucose tolerance test review patient clinical characteristic compare woman without value characteristic patient undergo diagnose patient impair glucose woman high hemoglobin hba1c level diagnosis high value analysis hba1c level fasting high observed high positive value hba1c diagnosis level diagnosis value can use identify patient high risk undergo
25817050 en assess compare treatment type mellitus control randomize control trial model risk develop study use clinical disease incidence complication datum present ratio treatment analysis conduct assess impact model treatment associate mean year confidence interval CI CI result estimate per show parameter weight change significant impact analysis determined per show treatment compare type mellitus control
25660136 en obtain care type mellitus database analyzed medical use identify care T2DM population examine include disease disease T2DM complication complication renal complication renal identify mean duration day respective large complication respective care large renal mean adjust total complication renal study important regard care patient T2DM
19400501 en report case patient present clinical large previous patient clinical finding previous
18798312 en common also occur case report clinical datum woman multiple type recent mass presence may present interval low plasma level time disease
25906655 en studied change case mellitus occur case mellitus
26971647 en mellitus adult diagnosis may influence treatment patient among different known present first case due index patient woman insulin treat diagnose gestational age treat insulin treatment age index patient index patient treat also insulin diagnose type age patient treat type insulin therapy age low insulin use method gene found diagnose case insulin therapy treatment low control follow-up positive case found
25305751 en major associate mortality patient major glycemic control chronic disease independent risk factor also risk present current patient chronic disease review may mellitus chronic disease chronic renal
25975964 en mellitus hypertension risk factor whether estimate rate ratio remain risk factor presence condition cohort participant chronic disease participant hypertension status use model estimate mean follow-up year cohort low high associate high risk individual without without hypertension compare common patient general high diabetic patient level diabetic patient level compare patient risk lower great without similar high without hypertension high risk without hypertension however risk lower high great without identify high associate high risk among individual without hypertension
24444038 en patient type mellitus may poor health result chronic function poor glycemic control examine assess difference glycemic control well poor glycemic control healthy hemoglobin hba1c month hba1c month healthy control one function assess test test test blood sample determine hba1c time activity use lower value compare healthy control control value similar control negative relationship hba1c group similar group difference activity impair function
26907255 en mellitus DM metabolic disease incidence mortality research treatment diabetic patient remain although significant remain cell cell type include cell potential treatment DM several recent diabetic healthy use different cell increasing use perform drug develop cell therapy DM base cell also provide drug clinical trial review recent development cell drug role clinical use provide new need develop diabetic therapy
27388675 en assess effect cell type mellitus patient treatment study control group patient examine blood plasma activity determined blood cell perform use blood plasma concentration use parameter evaluate value individual blood plasma activity effective treatment on significant decrease cell value increase cell value observed one year treatment change observed ratio cell cell blood plasma treatment may cause change patient system consider possible cause effect
23619130 en previous reported increased incidence among mellitus aged year prevalence mellitus impact mellitus incidence population year
26752353 en important glucose target mellitus show diabetic model low high blood glucose level observed model although cell cell decrease significant addition use gene result lower protein protein compare observed decrease effective blood glucose model insulin treatment similar decrease blood glucose level period day without whereas insulin effective result suggest may
25131821 en syndrome disorder association multiple dysfunction clinical result gene protein role protein response model patient however finding
25971983 en chronic role cause mellitus use mellitus diabetic complication however whether improve potential mechanism aim study investigate effect mechanism diabetic model provide oral week body weight measured evaluate test test protein measured positive cell level also investigate determine whether effect diabetic related observed improve general significant increase number datum show can decrease cell result suggest provide effect may
27008633 en remain several day serum plasma clinical diagnosis also potential assessment function well range several chronic medical condition mellitus
26385596 en study aim determine risk factor associate control patient type mellitus T2DM primary datum primary care within cohort cohort clinical association risk control define increase little hba1c one year year model perform define independent effect factor analysis hba1c perform use estimate year datum patient mean hba1c decrease year increased hba1c first year year base analysis insulin associate increase hba1c one year compare patient high hba1c patient high hba1c lower mean hba1c cohort patient control within year patient associate risk control associate improve control
27759630 en study large study factor associate among old adult study analyzed datum health review assessment patient sample on total subject man woman mellitus hypertension common disease also patient patient patient insulin patient medication patient treat on total occur rate per risk high among female patient old patient several include cardiovascular disease disease chronic disease chronic disease treatment include insulin associate high risk age different treatment determined chronic disease associate high risk odd ratio or or respective patient chronic disease treat insulin high risk rate per presence chronic disease increased risk within population old patient impact treatment insulin great among patient
27923172 en study aim develop model chronic disease type mellitus conduct study patient T2DM hospital define baseline development logistic regression use identify baseline model development model two follow-up occur patient development respective blood pressure hba1c estimate rate ratio associate test observed statistical different two development model use clinical T2DM
26748888 en control patient type mellitus control adult factor may early control therefore association factor hba1c level participant aged analysis perform adult hospital participant mean age year cohort female duration associate high hba1c man lower hba1c woman vs increased associate lower hba1c study hba1c compare vs insulin use associate difference adult influence control duration identify adult high risk poor control study associate control study role intervention improve management adult
24675577 en compare development without mellitus year study research mellitus case compare control on mellitus presence diabetic compare difference development two difference case control month vs case high month vs year significant difference case control vs duration increased incidence year influence year mellitus increase incidence year duration increased risk influence development
25453525 en mellitus significant effect body recent receive result several study present case positive effect blood level patient type review medical patient treat type patient remain treatment therapy level decrease statistical significant difference level measured treatment test present study show clinical effect blood control patient type mellitus clinical study investigate effect need
25857702 en mellitus disease chronic disease large number population one important complication associate mellitus one outcome among primary risk factor disease review adverse effect subject follow new therefore potential mechanism
25297071 en although new method type diabetic patient remain patient present study aim investigate effect cell cell treatment type diabetic study use perform total group control cell cell include blood glucose level model use measured blood sample obtain day evaluate change mean blood glucose level statistical significant respective revealed mean number cell high difference group statistical significant cell cell show effect suggest cell cell clinical may increasing number patient type
24397167 en glucose tolerance incidence mellitus increased due decrease mass activity cell function factor mellitus important risk factor development diagnosis treatment disease patient mellitus characteristic complication impair activity function compare diabetic therefore therapy important treatment management mellitus diabetic
24160357 en mellitus chronic metabolic disease range rate subject increasing development drug effective treatment new drug reduce rate diabetic drug found treat mellitus glucose level blood use drug well change significant mellitus also reduce disease research year mellitus show disease rate treat development drug different drug reported treat present review new drug effective treatment type review mellitus treatment clinical study found effective therapy mellitus
26186019 en examine impact mellitus DM population prevalence study woman hospital weight gestational age week type type DM identify use association DM well estimate use adjust odd ratio impact population risk among per prevalence per per related DM confidence interval CI CI cardiovascular increased CI CI CI CI study relative prevalence due DM increased care woman DM
25986598 en role type mellitus T2DM increased reported patient glucose early disease regard metabolic present review include glycemic insulin resistance cell mechanism patient different base metabolic may contribute development reduce diabetic subject
26911628 en relationship mellitus remain study evaluate risk impair fasting glucose associate range level on retrospective study datum year baseline little period participant fasting blood glucose level first on total participant study participant baseline impair fasting glucose study logistic regression analysis increase level significant increased risk impair fasting glucose association level remain within normal range serum level within normal range independent risk factor mellitus impair fasting glucose participant
25917191 en review cohort study association type mellitus T2DM incidence effect use cohort study examine association T2DM relative risk confidence interval among participant high low use study review analysis revealed healthy significant reduce risk T2DM CI adverse risk CI analysis show high also significant increase T2DM risk CI lower risk high increase risk include high effect
25595462 en mellitus study determine difference group without participant control age BMI use reduce range individual compare control decrease decrease group compare control different two decrease individual compare control participant research investigate cause diabetic improve change function
23806330 en metabolic mellitus include change type concentration lipid blood plasma may contribute development diabetic disease change blood change however increased plasma low resistance studied female gene studied cholesterol age day follow mellitus mean age week range week follow change without mellitus reduce observed whereas change found group one show cell indicate significant group presence effect effect increased effect two group whereas significant effect group mellitus suggest model study influence disease function
18316776 en disorder report associate gene man show use test gene show result function protein impair presence suggest important
26091811 en diabetic increasing health management examine impact weight diabetic patient type undergo function assess early use month mean weight body mass index BMI decrease control improve hba1c baseline follow-up associate weight increased pressure decrease patient type effective control subject type result significant function
26749529 en assess patient type mellitus T2DM control present study randomize study patient randomize two different treatment group follow receive receive primary change hba1c level baseline week significant reduce hba1c level baseline compare week week difference change hba1c fasting plasma glucose group mean respective incidence adverse event significant different two group randomize study provide evidence week treatment patient T2DM
26119363 en risk factor cardiovascular disease disease well studied diabetic addition study consider whereas may prevalence among diabetic assess association cardiovascular risk factor study study subject type mellitus without renal disease score subject logistic regression use assess association cardiovascular risk factor subject regression age blood pressure cholesterol duration independent associate independent associate regression associate low similar association cardiovascular risk factor diabetic independent associate associate disease may provide disease risk profile patient type mellitus
25294584 en chronic disease treatment reported incidence mellitus range investigate prevalence associate factor patient total patient medical receive treatment diagnosis mellitus base association case also included statistical analysis perform determine factor associate develop diagnosis treatment year range year although study three compare analysis show high system obesity important associate factor use associate reduce prevalence prevalence among patient develop compare high system obesity use oral associate use potential
23786195 en determine overall time identify factor associate time new diagnose case new diagnose analysis included history finding serum datum presence diagnosis disease effect possible time determined ratio confidence interval time diabetic day range day month respective time significant high concentration great increase serum concentration adjust CI significant associate time CI new diagnose mellitus high serum concentration diagnosis associate poor outcome adverse effect renal dysfunction associate decrease time suggest complication regard
27655512 en association oral health health treatment assessment oral increasing important clinical management patient mellitus aim assess study population patient disease mellitus
25797110 en evidence suggest ratio may cardiovascular event therefore investigate whether associate patient type examine relationship type healthy group type high control vs respective parameter measured significant decrease patient group compare control vs vs respective negative correlation patient type demonstrated significant negative correlation patient type indicate potential association according high may determine cardiovascular risk patient type clinical
26342556 en study assess patient type randomize receive primary assess week treatment common adverse event group vs group week total patient group patient group treatment week due adverse event adverse event occur patient group patient group week occur patient group patient group week severe event reported hemoglobin fasting plasma glucose body weight reduce baseline week patient type mellitus well less
26121561 en glucose improve glycemic control patient type mellitus T2DM study assess evaluate group use datum study two population patient control T2DM mean change baseline hemoglobin hba1c blood pressure body weight cholesterol included general adverse event total patient reported baseline similar group reduction hba1c observed group general well treatment associate increased rate group observed group whereas less common study include high patient compare group included study evaluate general well associate reduction hba1c patient T2DM independent
24393446 en disease common great clinical recent patient complication mellitus DM also study conduct association DM clinical datum prevalence DM among patient patient patient healthy control analyzed addition time plasma glucose hba1c level patient significant high patient patient healthy control patient diagnose DM prevalence DM patient significant high three group relationship prevalence DM type general study population patient diagnose DM time whereas diagnose DM within year diagnosis result present study DM patient association DM
27417914 en risk factor cardiovascular disease clinical common medication patient lipid profile potential risk observed type mellitus T2DM elevated cholesterol concentration relative lower level cholesterol several factor insulin resistance associate elevated level low level cholesterol show correlate increased event patient T2DM review known change lipid profile observed common medication patient T2DM include weight medication oral therapy risk elevated patient T2DM use may overall reduce level cholesterol patient risk
26869171 en consider subject type mellitus T2DM possible value recent clinical study show can cardiovascular risk T2DM therefore may however clinical decrease serum concentration T2DM treatment serum level change risk
25560484 en aim study determine assess patient type study included subject recent diagnose patient healthy control similar age subject undergo analysis index decrease control patient vs vs whereas index high control compare patient vs vs however difference among three group vs vs early rate decrease patient compare control whereas rate increased patient regression analysis show associate hemoglobin independent function obtain normal range decrease patient compare control parameter glucose control correlate
24795211 en study aim examine prevalence renal disease patient type mellitus determine important risk factor renal conduct retrospective analysis clinical datum type mellitus patient renal perform hospital renal finding diabetic found renal disease diabetic renal disease patient common renal disease found follow analysis duration insulin therapy lower level hba1c diabetic found significant clinical renal disease analysis insulin therapy or diabetic or independent renal study renal patient type mellitus due high prevalence renal disease found renal disease potential consider renal type mellitus patient renal diabetic insulin therapy
16825342 en renal lead disorder response due therapy due respective review current cell cause may patient also increased development therapy review
24256553 en evaluate prevalence mellitus population treat hospital patient age oral glucose tolerance test result early
26598716 en intervention individual type may due chronic elevated blood glucose level therefore aim investigate potential association review study consider medical database method use without year identify consider two one datum conduct use effect model result odd ratio or mean difference mean difference confidence interval CI assess study included analysis study or CI study or CI duration study mean difference year CI control study mean difference CI finding provide evidence associate high risk clinical may intervention
26545069 en control care mellitus DM disease study relationship control disease review previous investigate effect therapy control database oral health group trial control trial two health trial clinical trial trial control trial type type DM diagnosis intervention included treatment treatment therapy two therapy therapy review little two review independent examine included trial datum included trial assess included trial risk primary outcome blood glucose level measured outcome included adverse effect index clinical level index index diabetic included study include previous review included participant total study use study target T2DM patient study regard included age group age duration follow-up month use therapy included participant baseline hba1c level assess study high risk two study low risk study study provide datum analysis one two low evidence study participant compare therapy care demonstrated mean hba1c lower confidence interval CI lower month lower month study participant CI lower study participant compare different therapy low evidence multiple provide evidence one intervention evidence addition mean hba1c lower study participant CI lower high month month mean hba1c lower study patient CI lower study measured adverse effect evidence whether treatment associate outcome measured included study diabetic show regard health high level treatment statistical significant show index month however less individual within low evidence treatment disease improve control mean reduction hba1c month however evidence evidence one therapy effective control clinical treatment clinical month research determine whether drug therapy use treatment evaluate provide follow-up period consider treatment control well conduct reported study need potential treatment improve control among mellitus addition important study intervention effective reduce lower level period
25728442 en mellitus associate increase risk patient addition dysfunction include change activity correlate show little time although general patient age year old individual change early improve patient management identify increased risk early develop effective treatment
24884894 en previous consider disease health mellitus increasing significant cause mortality however datum treatment control chronic disease risk factor conduct participant aged year on sample use datum age range finding mellitus impair fasting blood glucose present blood glucose conduct participant female mean fasting blood glucose CI significant difference age overall prevalence impair fasting blood glucose CI prevalence impair blood glucose high man woman CI vs CI man woman prevalence fasting blood glucose current medication CI although prevalence high man woman CI vs CI CI vs CI CI vs CI difference statistical significant compare previous estimate prevalence increased prevalence impair fasting blood glucose mellitus primary disease healthy early treatment control
19458121 en renal function condition severe three patient severe present patient use system two compare protein activity analysis protein plasma target major increase whereas value present similar control respective show protein target activity level target plasma target within reduction observed compare whereas function found result clinical profile negative effect
19172275 en system report patient show positive result revealed large diagnose month treatment
16434568 en model protein include associate mortality report model gene severe adult gene cell normal day result gene reduction protein decrease day increasing increase protein increased gene renal normal serum result first adult model cause body weight although renal function compare model
26020622 en associate dysfunction blood risk develop type increase age obesity activity insulin resistance type insulin resistance show associate glucose hypertension syndrome role insulin mellitus insulin insulin assess effect type mellitus adult insulin review previous review trial conduct included included study investigate compare intervention adult insulin resistance review trial assess risk included three trial total participant review duration range week risk study regard outcome assessment study reported outcome incidence type mellitus adverse event mortality diabetic complication effect insulin resistance measured model assessment insulin resistance show effect compare control two trial participant effect trial compare total cholesterol cholesterol cholesterol study participant one trial compare also show effect total cholesterol cholesterol mean difference confidence interval CI participant parameter also included current evidence base use type mellitus trial investigate outcome incidence type mellitus diabetic complication mortality effect
26778680 en condition poor high risk complication high health use compare study analysis health old adult study examine association range health cohort old adult multiple database cohort old adult obtain use health hospital care use examine age estimate prevalence condition common condition association number health use also cohort little condition number increased age hypertension common cohort common condition included cardiovascular condition disease health increased number use number condition include condition care patient
23390067 en independent diagnosis type mellitus investigate clinical positive adult patient potential total T2DM patient study study presence hba1c fasting serum lipid level follow positive positive prevalence T2DM patient respective lower positive patient high positive patient vs prevalence patient positive high blood pressure compare positive case high total cholesterol level compare T2DM patient improve
23936331 en demonstrated patient metabolic syndrome aim identify cardiovascular patient assessment risk development use datum patient intervention trial blood sample baseline two follow-up month plasma measured mass multiple regression mellitus age estimate rate patient mellitus three time high without found association hemoglobin hemoglobin patient mellitus mellitus characteristic also found significant independent baseline risk develop new follow-up high independent association risk new role risk assessment follow-up mellitus
26357990 en clinical suggest high occur review several database adult patient hospital medical case patient compare without time vs significant high serum protein level vs diabetic patient old vs year vs vs include vs analysis change statistical significant difference present patient without overall prevalence estimate found prevalence present adult patient prevalence several time high general population high population patient compare patient significant include
24603828 en mellitus disease mellitus glycemic control prevalence disease adverse effect system system severe however also common care patient mellitus role use treat patient result effective care patient mellitus
26494183 en aim investigate prevalence mellitus DM among patient determine associate factor datum obtain health research database included individual period datum DM group group measured prevalence associate prevalence DM increased prevalence rate patient age year high association DM compare year patient disease disease hypertension chronic disease disease associate DM respective compare without prevalence DM among patient high increase clinical DM history without DM history among patient
26588909 en lower metabolic factor high level total lower increased type mellitus adult mellitus risk factor reduce mass several metabolic aim identify association metabolic study possible mechanism evaluate mean age year duration year healthy control year total measured total body evaluate regression factor analysis perform significant lower lower control indicate lower high level total total observed patient correlation found control possible indicate increased patient observed group regression lower high total patient factor analysis indicate possible system patient association patient disease duration metabolic control lower impair reduce increased multiple can lead reduce early adult
25691653 en analysis diagnosis type therefore determine relationship concentration glucose blood correlation however case correlation blood glucose increasing analysis diagnose case need however develop sample several per concentration measured use low healthy history disease research patient diagnose type respective healthy type mellitus subject therefore determine correlation blood glucose concentration different condition insulin level well correlate result clinical test well known concentration influence insulin treatment therefore analysis present result regard study analysis clinical test large number patient include control group need
24819932 en role aim study investigate level woman type mellitus present woman type mellitus group woman without type mellitus group study group body mass index BMI ratio measured hba1c lipid profile found statistical significant lower group group respective group correlation respective whereas negative correlation group significant correlation BMI also significant lower patient poor control mellitus patient diabetic respective lower woman without lower poor control study lower level whether outcome
26186809 en evidence suggest clinical outcome type mellitus improve treatment treatment type include glycemic control risk cardiovascular risk factor reduce weight aim present analysis evaluate per patient clinical hemoglobin weight event patient type receive insulin
24048981 en mellitus associate dysfunction event can lead hypertension previous study show effect investigate effect mellitus week serum concentration impair diabetic elevated serum lipid addition treatment week diabetic treatment reduce elevated level serum glucose diabetic treatment addition reduction high glucose lipid contribute diabetic
26642888 en assess impact clinical intervention drug therapy patient study care hospital period month drug therapy patient case respective clinical clinical review drug therapy identify drug related provide total drug therapy identify patient case number drug related found female drug related common patient aged year age common drug related found drug use without follow drug clinical drug rate change drug therapy found high level drug related clinical patient mellitus drug related drug therapy outcome improve patient care
17694689 en syndrome occur patient report develop syndrome follow within relative time well possible cause event
27005817 en mechanism high patient factor may associate therapy investigate possible association insulin high disease patient type mellitus total patient T2DM study assess analysis respective participant high group group according identify association function participant group participant group group group significant high compare vs vs respective observed high compare vs vs gene associate patient T2DM
25918218 en datum regard association mellitus DM DM among patient control study conduct health new diagnose case identify system control database participant test use fasting blood glucose DM diagnose patient database patient old control vs year vs lower body mass index vs prevalence DM patient control two control receive treatment prevalence DM vs prevalence DM low also among patient association DM found
23692212 en without type mellitus patient normal study type mellitus conduct one one one participant use two hospital one high two use analysis three identify normal receive normal type mellitus role care within system
27007793 en effective hypertension general population type diabetic T2DM patient assess hypertension population T2DM patient randomize control trial subject present hypertension care treatment treatment week primary outcome change blood pressure follow-up outcome change serum treatment associate significant decrease vs vs month patient control base significant reduction vs treatment group significant level group increase level effective reduce level T2DM patient increase serum trial
25963811 en cardiovascular disease complication cause patient DM treatment cardiovascular disease risk remain cardiovascular risk factor medication cardiovascular disease evidence assess cardiovascular effect medication regard risk factor disease clinical outcome
25066630 en study associate mellitus DM reduce risk use datum examine correlation population association also evaluate DM identify patient type DM diagnose subject without DM diagnosis age DM status according overall incidence rate lower type DM cohort cohort adjust ratio confidence interval CI model patient type DM significant associate reduce without adjust ratio CI CI respective type DM also associate reduce without CI result patient population reduce prevalence observed relationship DM research investigate mechanism reduce risk associate
27094870 en adult presence associate type present study aim assess characteristic patient obtain condition among study aim assessment cardiovascular risk factor among great sample population great among diabetic patient negative test control among patient positive test diagnose patient consider level significant lower patient compare control patient normal level respective also lower level compare group use analysis presence baseline include age duration disease diagnosis associate lower serum level associate level patient may lower serum level indicate insulin therapy disease respective
26292721 en effect insulin therapy type glycemic target patient impair increased risk severe glucose may patient type glycemic control less according one may type mellitus patient impair however trial aim study effect glucose type mellitus patient impair randomize trial period intervention period on total type mellitus patient impair according randomize receive glucose glucose week period patient intervention primary outcome time outcome include glycemic remain whether patient type impair glucose study provide potential glucose patient
26849676 en study investigate insulin clinical glycemic control patient type mellitus patient hospital glycemic control well management measured hemoglobin hba1c month assess disease management analysis fasting plasma significant associate hba1c index association independent patient factor analysis factor insulin resistance difference insulin glycemic control patient characteristic insulin resistance influence insulin datum indicate among patient type mellitus may improve glycemic control month
26311027 en disease increasing incidence high cause due diagnosis risk factor chronic mellitus also obesity early research can function review evidence mellitus
28011384 en use treat different disease aim study investigate effect diabetic study group include healthy control group diabetic control group diabetic positive control group two group treat group mellitus two two day cause significant increase serum glucose total cholesterol low low high level group serum level increased significant activity decrease significant group compare control respective group significant decrease serum level significant increase activity compare group respective result potential health effect effect therefore may consider diabetic patient
26482050 en aim study identify metabolic control among diabetic patient treat total patient studied use study datum patient medical glycemic control test potential important base previous research clinical patient drug therapy therapy treatment treatment treatment mean age year mean hba1c analysis level found significant independent association metabolic control high significant patient metabolic control well can metabolic control
26282401 en mellitus common metabolic complication may associate use important role insulin well glucose lipid aim study examine association gene development study included patient receive treat association gene studied three model regression three model gene statistical significant associate increased risk association regression result study suggest association gene on may
25731207 en ratio outcome determined association clinical outcome patient mellitus three patient low group define high group mortality high group characteristic analysis revealed value remain independent risk factor early value mortality value mortality high mortality remain independent risk factor early mortality
21031341 en syndrome cause gene mellitus early study investigate difference change blood glucose concentration compare plasma insulin level measured group week age glucose tolerance test conduct week plasma insulin level measured week week increased compare vs female female impair glucose tolerance significant lower mean plasma insulin level vs female high ratio vs female plasma level lower mean vs great risk develop female low plasma insulin concentration increased ratio indicate possible insulin may lead insulin need mechanism difference development syndrome
22665334 en little influence mellitus clinical outcome patient aim study investigate whether mellitus influence clinical outcome patient use total patient treat hospital datum compare mortality patient without mellitus within day patient two group patient mellitus patient without mellitus patient mellitus significant without mellitus day vs day also high mortality within day observed patient mellitus compare without mellitus vs multiple regression analysis revealed mellitus significant associate increase day analysis revealed mellitus significant increased risk mortality within day odd study demonstrated presence mellitus significant influence clinical outcome patient
24782168 en aim study clinical characteristic mellitus patient evaluate diagnosis treatment clinical characteristic diagnosis treatment mellitus patient retrospective analyzed found group clinical patient without present diabetic patient show high mortality rate treatment duration current effective disease treatment disease high early diagnosis insulin therapy treatment management disease blood glucose control reduce disease
25715141 en hypertension type mellitus case renal disease renal therapy study identify chronic disease on study observed among patient chronic disease compare patient normal renal function aim assess whether chronic disease relative individual renal therapy cause hypertension mellitus on study patient renal therapy mellitus hypertension little year case control sample group individual hypertension mellitus normal renal function individual renal therapy case ratio CI control group relative chronic renal disease chronic disease sample studied disease hypertension mellitus
25681435 en datum association body mass index BMI risk among diabetic patient perform cohort study risk among patient type mellitus man woman regression model use estimate association different level BMI risk mean follow-up year subject develop man woman age type ratio associate BMI level group baseline man woman respective use mean value BMI association risk BMI change age status use drug positive association among man association among woman study suggest positive association BMI risk among man association BMI risk among woman type mellitus
16703410 en condition clinical report first case occur develop revealed management patient dysfunction patient
24976431 en reported lower plasma glucose level model however clinical aim study evaluate effect patient type patient mellitus hospital patient diagnose type mellitus healthy similar age group included study patient treat drug follow-up blood glucose level measured treatment patient significant lower diabetic show similar hemoglobin serum total cholesterol cholesterol show significant patient profile drug assess activity concentration blood blood found change compare also patient study effect drug large population
24617770 en aim study identify early diagnosis function disorder type total type mellitus well healthy control case rate interval interval measured clinical age duration follow level hba1c fasting glucose obtain effect parameter mean age patient control year year respective interval interval significant high diabetic compare healthy control finding associate duration glycemic significant high diabetic patient hba1c compare control also found patient follow function disorder one important cause mortality may type mellitus diagnose patient
24581944 en assess association hemoglobin hba1c glycemic control among type type study sample old diagnose remain little one year hba1c one year clinical datum hba1c diagnosis clinical datum logistic regression model use examine association poor glycemic control hba1c change study included among time CI poor control one year compare among significant CI poor control one year hba1c one year change hba1c glycemic control one year diagnosis health care
27889689 en disorder one cause time consider recent disease early also associate obesity metabolic syndrome mechanism year type two independent risk factor model study diabetic severe treatment insulin negative impact can also age chronic high glucose concentration insulin resistance also impair insulin resistance diabetic also low related obesity insulin
25899489 en current gestational mellitus consider woman care on glucose week positive glucose great follow oral glucose tolerance test gestational mellitus diagnose fasting glucose great glucose great impair glucose tolerance positive negative study period woman glucose positive oral glucose tolerance test impair glucose tolerance gestational mellitus weight gestational mellitus normal glucose tolerance rate respective significant different woman gestational mellitus glucose tolerance test gestational mellitus high current management effective reduce weight on new
26765575 en diagnosis mellitus hemoglobin hba1c measured determine need oral glucose tolerance test however hba1c glycemic status condition study perform test serum assess need subject known use medication serum measured perform diagnose serum correlate significant age serum body mass index plasma use serum diagnosis characteristic respective fasting plasma glucose value diagnose study population serum value use diagnose respective improve decrease significant increase use serum value serum serum diagnose reduce increased change diagnosis serum use determine need
24780454 en change diabetic remain cause type diabetic individual however rate diabetic glucose blood pressure control individual type type normal ratio normal change less change blood pressure obesity disease study diabetic individual disease outcome recent datum year normal regression lower level improve glucose blood pressure lipid control low level consider diabetic
23926207 en recent evidence suggest blood pressure cardiovascular disease however remain whether parameter risk complication patient type disease control randomize control trial blood pressure blood glucose control patient type mellitus present analysis included patient without major event first month define determined first month year follow-up major cardiovascular new event observed association major event mean factor ratio confidence interval high event event low ratio confidence interval high independent risk factor complication type
27018285 en type mellitus DM disease dysfunction recent study show relationship DM patient DM impair glucose tolerance mortality diabetic complication DM patient recent found also DM patient potential impair insulin cell also reported patient obesity insulin resistance associate type DM model show insulin resistance datum suggest type DM include can new DM complication
26926406 en mellitus one common diagnosis lead disease patient develop lead early diagnosis treatment may reduce rate randomize trial show type reduce mortality year although datum suggest mortality year intervention decrease patient impair fasting glucose impair glucose tolerance type blood glucose type adult year age three year result normal individual high risk consider early association type patient year old patient year major risk factor diagnosis fasting plasma glucose level per great level great plasma glucose level per great oral glucose tolerance test plasma glucose level per great result day however plasma glucose level per great indicate determine
25895475 en syndrome severe disease primary association mellitus early report show case may remain due type mellitus estimate prevalence patient clinical cohort subject diagnose identify gene individual clinical cohort patient include female clinical suggest identify review medical test gene analysis perform use patient clinical diagnosis disease identify individual clinical include two one one patient identify remain cohort case diagnose patient syndrome identify individual clinical clinical analysis large cohort patient different estimate lead management patient
25636208 en cause type known mellitus mechanism study aim patient without group individual profile analysis determined analysis gene show related high level protein found serum patient level significant decrease found level serum significant correlate diabetic status patient show fasting blood glucose level model decrease day found potential target diagnosis treatment
26360017 en evaluate impact mellitus DM among patient analyzed outcome patient treat two hospital retrospective patient DM without parameter overall rate patient DM old group body mass index BMI high show high level disease less treatment among patient ratio confidence interval CI difference show statistical analysis DM group group CI statistical significant difference also observed CI DM increased risk compare patient CI difference statistical significant mellitus impact patient patient increased risk compare group difference statistical significant
24444517 en type mellitus high chronic disease major due development chronic complication care patient health hospital per patient glycemic target remain new drug treatment evidence cause target clinical found patient hba1c poor treatment health system history disease
24256706 en increased plasma protein different less different reported development patient mellitus hypertension examine hypertension protein diabetic
25289919 en insulin treatment type insulin therapy effect weight treatment type mellitus review aim effect glucose type included study mellitus type intervention report study review base total potential identify included trial two trial review study review show different significant change insulin reduce reduction blood glucose reduction reduction mechanism improve glycemic control glucose type present show result treatment type mellitus base current datum need large trial
23390792 en mellitus associate oral disease oral complication prevalence relationship mellitus adult year study included adult female aged year subject mellitus diabetic patient subject receive oral datum analysis perform use logistic regression logistic regression model show define associate significant age mellitus clinical level use adjust odd ratio CI associate mellitus adult therefore well early treatment oral disease reduce complication mellitus
24639432 en study assess patient type mellitus control
23385086 en mellitus chronic metabolic disorder cause cardiovascular disorder on mellitus cardiovascular cardiovascular cardiovascular known receive great role identify factor cardiovascular protein however recent study demonstrated condition mellitus therefore can diabetic patient cardiovascular disease function cell however mellitus associate reduce cell reduce increased can diabetic subject review cardiovascular possible cardiovascular disease
26922581 en year evaluate possible cardiovascular disease possible role mellitus DM review datum relationship retrospective datum show association study show also factor impact level relationship DM include relationship disease new research serum risk may analysis
27459761 en number patient type mellitus metabolic syndrome type associate disease cardiovascular assess relationship level parameter patient type mellitus study man aged year group first group included patient type one patient group man type patient level glucose insulin measured patient undergo study revealed patient type patient three group increased insulin resistance insulin level decrease concentration mass increased patient three study demonstrated insulin resistance dysfunction patient type role patient
27865163 en study evaluate association oral clinical outcome health among type mellitus T2DM patient datum research database patient diagnose T2DM evaluate define use little T2DM diagnosis compare patient studied T2DM diagnosis mean follow-up without significant high among patient overall patient lower mean total mean total high among patient total significant lower associate lower insulin similar adjust ratio model CI associate insulin therapy lower total clinical study
19367330 en therapy clinical case cell one effect may use cell found cause increase reduce clinical concentration similar model disease reduce concentration treatment reduce cell ratio cause change result show major cell provide use disorder
27329015 en role new factor serum level level significant high patient mellitus compare control without correlate serum glucose level insulin resistance
24285582 en investigate effect man type mellitus man type mellitus randomize trial patient randomize week therapy period metabolic study perform treatment period measured analysis use model datum significant decrease plasma plasma cholesterol cholesterol cholesterol significant increased cholesterol concentration respective also significant increased lower rate significant change per day increase concentration subject type mellitus rate effect independent reduction plasma treatment whether finding population remain investigate
26138864 en investigate therapy without patient type patient randomize week study treat trial week total duration week week included change baseline hemoglobin hba1c weight blood pressure assess use patient receive study drug baseline hba1c adjust mean CI change baseline hba1c level week compare adjust mean CI change baseline weight week respective compare lead significant reduction blood pressure adjust mean CI change blood pressure adjust mean CI change analysis result hba1c level fasting plasma glucose concentration weight revealed significant difference change baseline blood pressure week adverse event glucose reported patient treat respective patient adverse event reported patient treat respective adverse event reported patient treat therapy without week well lead reduction hba1c weight compare patient type
26479686 en aim study syndrome gestational mellitus outcome study woman receive diagnosis gestational mellitus week gestational age among diagnose gestational mellitus woman receive syndrome woman syndrome control incidence hypertension case control group respective incidence case control group respective difference two group statistical significant incidence case control group respective study demonstrated presence syndrome gestational mellitus increase risk hypertension compare gestational mellitus
26248007 en association metabolic syndrome cardiovascular disease suggest study whether associate studied patient independent cohort compare healthy individual disease control measured level factor perform analysis sample identify protein possible development analysis perform protein healthy control disease control patient patient significant high mean level similar patient show high level independent associate mellitus patient analysis revealed protein great low high level also show positive correlation level finding independent cohort patient high level associate mellitus odd ratio confidence interval odd ratio confidence interval level increased associate risk mellitus research role patient
24622264 en study show early type mellitus treatment insulin therapy week patient without medication review study assess effect insulin therapy type mellitus dysfunction insulin resistance identify clinical
27930591 en investigate relationship weight diagnosis type mellitus T2DM diabetic complication among patient conduct study evaluate patient T2DM weight T2DM diagnosis respective use score reduce group addition logistic regression analysis datum perform evaluate risk diabetic total patient weight patient weight adjust age history use duration logistic regression analysis show compare patient weight patient high risk diabetic odd ratio or confidence interval CI diabetic or CI however relationship weight found weight diagnosis T2DM risk factor diabetic finding management complication patient weight T2DM diagnosis
25580754 en study examine elevated body mass index BMI time diagnosis type mellitus complication among old adult current on model use assess BMI first current time mellitus diagnosis complication insulin among old year age mellitus diagnosis individual diagnose mellitus elevated associate high risk complication mellitus woman BMI risk insulin ratio confidence interval CI woman BMI CI on similar observed risk cardiovascular BMI CI BMI CI BMI CI BMI CI renal BMI CI BMI CI lower complication BMI CI BMI CI increase BMI normal weight level associate increased risk diagnose complication mellitus man increased risk complication occur high BMI level woman complication occur high BMI level complication type man woman
26636324 en examine care provide patient mellitus health compare primary care use datum medical use two care care primary independent whether receive care health estimate logistic regression model determine care use model compare patient positive show statistical significant patient mellitus use individual care compare finding suggest control mellitus patient without negative impact care
26502220 en old patient mellitus receive medical treatment blood pressure blood glucose level potential low risk low blood pressure blood glucose major decrease medication examine rate blood among old patient type mellitus potential receive cohort study conduct use datum health participant included patient old year mellitus receive treatment define medication medication datum analysis perform treatment low low hemoglobin hba1c level define low less low less low hba1c less low hba1c value consider define decrease within month index treat cohort included participant low level patient level low treatment patient low level treatment among patient low level undergo medication patient low level treatment follow-up elevated treat hba1c cohort included participant patient hba1c level low treatment patient low hba1c level treatment among patient low hba1c level undergo medication patient low hba1c level treatment follow-up hba1c elevated old patient treatment result low level hba1c undergo reduce low hba1c value low little association event reduce
26220376 en report potential association mellitus examine cohort medical identify individual type mellitus prevalence CI case per individual increase relative prevalence estimate general population individual year individual significant relative type mellitus without individual although evidence different without prevalence increased associate finding may
25107290 en medical increasing use chronic care conduct review intervention patient impact randomize control trial control trial control study conduct among adult patient two independent use different datum rate study evidence possible use model effect difference mean use study mean difference measured study effect use use analysis analysis outcome study compare intervention care among patient improve hemoglobin CI improve blood pressure CI improve cholesterol CI outcome include outcome reported result significant among study among included among lead intervention improve outcome among patient determine effect patient
24618446 en disorder incidence define diagnose first month type diagnosis case mellitus due gene diagnosis patient insulin therapy case report
25535750 en aim study investigate relationship mellitus conduct risk DM patient study identify database risk estimate model use total study cohort study included analysis risk estimate study show statistical significant increased risk DM prevalence among individual CI risk estimate cohort study also show statistical significant increasing risk DM analysis study risk estimate individual increased incidence type mellitus incidence T2DM type mellitus or vs analysis cohort study also found statistical significant increasing risk T2DM test show evidence associate increased risk DM include T2DM
25341005 en glucose per day increase glucose glucose early major renal glucose increase glucose reduce plasma glucose level body weight first new drug type mellitus study investigate use type mellitus independent insulin improve glycemic control mellitus clinical blood pressure diabetic may effect cardiovascular system blood glucose control
24797150 en assess impact outcome among woman mellitus retrospective cohort study woman DM conduct group included woman type DM type DM DM among woman type DM complication common among among control rate high rate care high independent risk factor adverse outcome type woman type DM increased risk type DM associate complication one need woman DM
24728158 en mellitus two common condition age condition study show association increased risk chronic disease cardiovascular disease type disease multiple type mellitus cell cell system system role type study revealed association prevalence type review prevalence role risk mellitus cardiovascular disease
25867326 en association insulin type mellitus diabetic three use type patient without diabetic type patient diabetic healthy control subject statistical analysis base logistic regression determine odd ratio or confidence interval analysis also perform use test logistic regression among show association type mellitus diabetic however associate type mellitus type diabetic associate type diabetic or show relationship type mellitus analysis revealed effect type mellitus diabetic result suggest role population type diabetic may show difference
25523623 en whether occur whether associate use evaluate presence patient undergo type type mellitus patient observed sample patient three group number significant high patient type type perform found control large presence one patient type type result study show may different type type insulin presence factor duration hba1c level may
26637091 en cardiovascular can one common chronic complication define impair control cardiovascular system system test method subject aim study assess clinical test can patient type study included diabetic patient can diagnose test mean age year BMI hba1c duration year without can year BMI hba1c year respective control group patient without regard age assess lower group can vs group vs respective vs well patient without high can study value early can among patient type can among patient type mellitus
25879672 en study association disease risk type mellitus T2DM result addition study association risk aim investigate whether diagnose can risk T2DM cohort study base metabolic disorder follow-up year healthy subject included study sample determined T2DM diagnose base oral glucose tolerance subject diagnose develop develop follow-up incidence group per respective whereas group per respective regression show relative risk T2DM group confidence interval CI CI respective compare disease significant cohort study need finding
24560135 en assess insulin treatment compare subject type subject type mellitus studied treatment period follow drug period insulin resistance measured use method activity medication change total cholesterol mean respective glucose glucose revealed significant difference effect subject type mellitus characteristic difference lipid profile change difference insulin treatment compare study evidence increased insulin use common use
26078977 en study examine whether level correlate insulin resistance cell function new diagnose type mellitus T2DM subject without previous history group control new diagnose T2DM control subject similar age BMI fasting insulin level found significant high control subject found significant compare control subject however serum level show significant compare control subject analysis identify significant correlation statistical association new diagnose T2DM datum suggest serum level compare control subject correlate associate cell function development T2DM
25822499 en important risk factor cardiovascular disease however effect glycemic control diabetic patient examine aim present study examine association status glycemic level insulin resistance patient type total patient type mellitus aged year according status year association glycemic level insulin resistance examine level increased increase number per day compare respective whereas fasting plasma glucose hba1c fasting plasma glucose decrease increase year relationship significant include total current BMI addition model assessment insulin resistance protein also show similar show relationship glycemic control insulin resistance patient type mellitus finding may clinical management mellitus
24931281 en may influence type gestational mellitus however associate glucose examine among woman previous study investigate whether high related blood lipid independent obesity insulin study woman type cohort study woman diagnose oral glucose tolerance test research conduct assess week baseline fasting plasma lipid sample obtain week participant baseline mean concentration compare among group use regression show association adjust mean high cholesterol lower fasting lower lower insulin resistance associate type lower plasma follow-up study need assess whether effect glucose
26526084 en datum risk mellitus assess incidence compare study cohort health datum included patient general control individual age ratio incidence rate estimate relative risk indicate ratio estimate regression model time month first time month incidence per control group respective confidence interval CI month incidence per control group respective adjust CI risk great man woman vs analysis result similar risk increase therefore evaluate research conduct develop follow-up mechanism relationship
26091060 en study analysis management risk diagnose population health general control statistical improve test month significant different baseline mean hemoglobin baseline month month respective month participant disease management important improve health
17216256 en case gene patient demonstrated decrease analysis demonstrated patient also found patient analysis group show group cause decrease change according model cause
25657589 en cardiovascular disease cause mortality type mellitus associate increased cardiovascular risk effect insulin cardiovascular disease less well studied insulin show effect study clinical trial use insulin improve control type type patient show improve cardiovascular outcome trial control high insulin use high risk patient type show cardiovascular increased cause cardiovascular mortality insulin insulin use treat patient type type review effect cardiovascular outcome lower lead weight cause less compare insulin effect blood pressure outcome reduction intervention trial year cardiovascular outcome trial demonstrated increased cardiovascular risk
25451895 en study aim prevalence factor associate mellitus study conduct care type DM participant test hba1c logistic regression analysis conduct identify factor associate among patient found CI logistic regression model analysis indicate age year or CI diagnose hospital vs or CI vs multiple or CI high treatment or CI high or CI independent associate prevalence among type base risk factor consider potential target intervention
24834724 en increasing health population different chronic disease aim study determine status lipid patient type case datum impact lipid well activity patient mellitus type present lead patient mellitus result
24623199 en evidence mellitus increased risk development however result review examine risk mellitus possible mechanism association mellitus associate great risk among mellitus significant risk factor also disease mechanism association may factor cardiovascular risk factor glucose change insulin management risk factor early may important need reduce development mellitus
24510008 en study evaluate association mellitus related factor parameter among adult patient mellitus type participant patient type mellitus patient type metabolic control determined value hba1c status patient evaluate oral index clinical level datum analysis perform patient age duration metabolic control level type regression use test relationship parameter estimate significant high among patient type disease severe participant patient type disease duration year negative related parameter significant correlation estimate hba1c observed group significant severe disease type mellitus or duration disease or high or or disease related type patient type patient patient type major contribute factor patient
27318070 en health system provide health within care found mellitus DM care analysis system care study DM care need number DM patient system analysis base datum DM patient identify medication datum diagnosis determined number different per patient system estimate number patient value determined number patient perform analysis two type system system patient result system type DM patient identify population patient receive health one one year well patient system ratio medical primary care well respective high care need DM patient well can provide care DM treatment hospital primary care little important potential system according analysis primary care potential current
23052340 en diabetic model mechanism development mellitus associate disease three diabetic one analyzed clinical two identify cause mellitus model mellitus develop type develop diabetic model analyzed study show model study treatment
26821720 en role type mellitus T2DM increased recent year target review include role T2DM mechanism development diabetic disease also renal can influence patient T2DM include population patient chronic disease recent datum clinical effect renal function present mechanism clinical include potential observed positive effect glucose control estimate rate ratio blood pressure body weight patient without impair renal function suggest important treatment
25137284 en patient current medical treatment treatment whether weight effect time type patient perform one treat type mellitus metabolic syndrome history treat year current develop year report patient normal BMI develop mellitus case diabetic patient improve T2DM due weight patient type develop normal weight weight can development result patient effect different effect
24878981 en evaluate plasma concentration patient type mellitus treat hypertension concentration evaluate patient type mellitus control subject previous cardiovascular disease subject blood pressure receive medication treat cholesterol mean age patient mellitus year control subject plasma patient mellitus control subject plasma patient mellitus control subject patient mellitus mass index significant high parameter function plasma correlate significant negative serum positive mean blood pressure patient mellitus control subject plasma concentration patient mellitus treat hypertension significant concentration plasma treatment remain metabolic parameter patient type mellitus low plasma patient type diabetic may intervention cardiovascular risk factor
24285222 en examine elevated can associate new diagnose mellitus conduct analysis mass health odd ratio or mellitus new diagnose mellitus compare without obesity without elevated level included study two two diagnosis mellitus metabolic syndrome associate mellitus new diagnose mellitus vs vs elevated however obesity elevated associate mellitus new diagnose mellitus incidence new diagnose mellitus normal or elevated level significant high or or CI or CI or CI or CI obesity association elevated mellitus new diagnose mellitus obesity elevated level mellitus
27182056 en type disease associate increased rate obesity reduce activity insulin resistance type disorder cell reported important role several blood cell obtain type patient healthy blood cell evaluate show type patient addition cell cell observed present study correlation analysis duration show duration time lower present result suggest type negative cell duration type patient
25189213 en mellitus however mellitus trial evaluate total patient type mellitus history risk cardiovascular event randomize mean follow-up year primary cardiovascular baseline measured patient patient treat compare ratio confidence rate month ratio confidence interval significant difference subject great risk previous estimate rate elevated baseline level evidence although risk great high patient high risk risk primary similar treatment primary treatment associate increased risk increase risk high among patient elevated level previous chronic
24980665 en use treat type mellitus associate reduction blood pressure increase rate however finding base assess drug profile effect rate investigate use patient year woman type mellitus oral medication randomize week perform baseline week primary change baseline week mean compare effect change blood pressure significant reduce little mean difference confidence interval rate little mean difference confidence interval associate reduction increase rate mechanism observed effect remain
23290897 en investigate prevalence rate mellitus associate risk factor sample aged year prevalence rate associate risk factor mellitus mellitus impair fasting glucose define control datum result total prevalence rate mellitus respective datum logistic regression analysis obesity risk factor mellitus odd ratio value overall prevalence rate mellitus lower datum age group also lower rate
26094886 en dysfunction patient primary type mellitus T2DM use test blood primary T2DM patient subject normal blood glucose level test use assessment test test use result show T2DM patient dysfunction identify however show effect analysis T2DM group T2DM group lower control group three found include lower control group primary T2DM patient cause dysfunction
25085598 en present result study compare care type mellitus T2DM
25936906 en adverse health obesity include increased risk type mellitus T2DM cardiovascular disease trial conduct test intervention weight significant great reduction mortality control condition among participant T2DM on number significant observed include body weight function glucose control however significant reduce year follow-up response base history baseline overall risk reduction remain important care patient T2DM medication management may patient medication also potential important patient function base datum trial medication management glycemic control without potential risk treatment research need determine result observed trial among patient without T2DM
24561380 en mellitus type type population use test measured per cell woman type mellitus blood woman control group included woman without mellitus DM group woman mean number per cell significant high control group woman value group significant high control group value group significant high compare without DM significant difference observed significant correlation observed duration hba1c level result indicate increased woman
25350950 en level activity increased disease type mellitus obesity factor study examine association activity study aim examine relationship activity disease subject measured individual type cohort individual obesity cohort cohort measured increase activity associate increasing cohort cohort significant cohort obesity activity associate current mechanism may activity may disease may improve time
24151265 en total show however condition mellitus increase risk complication study evaluate prevalence mellitus patient undergo associate risk adverse outcome on review conduct according study study prevalence study population report little one outcome event event lower method use difference relative risk prevalence mellitus found among patient undergo associate increased risk odd ratio or confidence interval CI or CI lower or CI mellitus relative common diabetic patient high rate develop
26453594 en year management type type hospital medical patient effective care time insulin new age control reduce mortality year first oral type patient insulin diagnosis insulin include insulin insulin increased type management two major glucose system insulin insulin increased type lead development target on target according individual factor weight risk patient treatment management patient large trial effective control outcome outcome cardiovascular remain several care include cell therapy target treatment may several clinical remain due metabolic cause time year great patient improve significant
19153776 en type woman reported cause include renal patient develop renal period renal dysfunction patient reported report two case respective renal function evaluate renal patient show decrease rate significant dysfunction level increased datum two patient indicate impair due woman
24023937 en mellitus incidence cohort aim metabolic patient three group according status examine whether patient multiple one without clinical metabolic parameter include insulin score base hba1c also assess whether metabolic patient aged year diagnose type within month compare clinical parameter status define patient group parameter association included analysis characteristic use assess score multiple one without significant different BMI weight diagnosis fasting score however analysis revealed according status score compare multiple compare lower obtain use BMI fasting study indicate patient without metabolic status can parameter result suggest may metabolic
26809901 en study investigate whether type glycemic control total patient aged age effect significant difference among glycemic control patient type reported significant level impact suggest need treatment
25462142 en system mellitus high value current research present patient mellitus diabetic one complication disease use diagnose test patient type patient type mellitus aged year examine clinical study lower perform compare normal patient show significant reduce response compare control patient without show change correlate type treatment duration disease patient without show significant positive correlation whereas show significant positive correlation negative correlation parameter diagnosis diabetic
27095023 en aim study diabetic patient without diabetic well assess association duration total type DM patient study three group DM DM diabetic diabetic addition healthy individual control analyzed use compare three group normal control association analysis possible influence factor include well relationship duration diabetic patient show ratio healthy individual result control group respective group show significant control diabetic patient high healthy individual among value significant correlation increased duration associate decrease increased population type DM dysfunction increased suggest diabetic
25530150 en type mellitus T2DM major cardiovascular risk factor role T2DM however current treatment less effective T2DM patient vs similar risk on large body evidence DM may little response multiple mechanism several level review mechanism related contribute include mechanism effect reduce effect due mechanism level lipid impair effect mechanism lipid mechanism impair activity protein major complication also response T2DM may target mechanism response
25042995 en may improve glycemic control lipid status study patient type mellitus T2DM receive week test effect therapy glycemic control lipid profile hba1c fasting plasma glucose plasma glucose group significant decrease baseline hemoglobin hba1c decrease significant participant compare group participant group significant decrease total cholesterol cholesterol difference statistical reduction hba1c group significant associate change change correlate reduction patient T2DM therapy result hba1c level compare
26774893 en type mellitus chronic condition major effect health high rate disorder reported among little known however current prevalence disorder diagnosis aim study determine prevalence statistical disorder disorder association population conduct study aged year diagnose presence disorder assess according statistical disorder measured general evaluate patient disorder time common diagnosis disorder patient little diagnosis presence disorder related elevated hemoglobin level vs lower level general disorder revealed mellitus treatment lower without associate high prevalence related elevated hemoglobin lower level
24932351 en overall prevalence little one positive patient type mellitus DM high risk blood study conduct general hospital use study population control group period test use logistic regression use association clinical history participant test diabetic diabetic individual indicate difference two group history chronic disease show association study positive indicate prevalence diabetic diabetic individual
24666618 en metabolic syndrome independent risk factor mellitus related therapy obesity risk factor metabolic syndrome mellitus study investigate whether change body weight may patient on total patient without mellitus baseline new target study included analysis randomize year develop patient group group significant increase body weight man woman year increase body weight great patient without vs association change body weight risk remain significant adjust factor ratio compare respective similar result obtain patient normal fasting glucose level change body weight patient undergo therapy trial study weight control
26423772 en may important treatment patient increased risk therefore use analysis compare metabolic hypertension cardiovascular disease risk patient mortality patient addition hypertension event follow-up patient follow-up risk decrease per respective relative decrease respective respective risk decrease per respective relative decrease respective respective hypertension risk decrease per relative decrease lower hypertension risk patient increase risk use mortality medical condition may patient
27810689 en glycemic control without important patient type use without patient use glucose evaluate insulin type mellitus patient treat insulin insulin blood glucose level insulin reduce total insulin significant reduce mean blood glucose level day change however blood glucose level significant elevated day incidence day significant decrease may contribute reduce total insulin event day type mellitus patient
25377481 en although report control mellitus blood glucose concentration may change report result review effect drug control adult
25373882 en cause obesity however body weight week body weight decrease body weight mellitus control study aim mellitus body weight number reduce plasma insulin level low use identify one significant plasma insulin level lower body weight associate decrease plasma insulin level three different condition group individual female female mellitus body weight severe individual body weight influence condition result factor development mellitus body weight
24699828 en study reported association high level elevated risk develop type mellitus may contribute development determine effect high type diabetic group studied control group group diabetic group type group diabetic month parameter evaluate sample obtain determine relative group present increased level hemoglobin parameter group show similar group little relative different study group different show lower two group compare control diabetic show increased group group present great result suggest development
24627103 en recent study diabetic patient however mechanism influence glucose current study investigate change glucose parameter diabetic on model type mellitus treatment week change glucose glucose tolerance fasting insulin insulin resistance lipid profile index body weight investigate diabetic show increased elevated high serum level weight compare control group treatment diabetic result significant lower fasting glucose level decrease insulin weight mortality study level increase insulin decrease effect mechanism effect suggest therapy
23796064 en risk disease high mellitus without consider aim estimate population level current risk disease patient whether risk decrease recent year use two datum hospital study hospital relative risk rate ratio disease cohort compare cohort without risk disease patient mellitus little high rate ratio CI CI aged year rate ratio high rate ratio CI CI hospital mellitus remain increased risk possible elevated risk include low low effective risk
24444519 en review result significant weight patient type mellitus provide association association study drug therapy report result study year new oral drug known study
26559055 en evaluate association incidence type sample subject health on total without follow incidence diabetic patient age age year diabetic patient respective logistic regression use estimate odd ratio compare diabetic patient respective age group odd ratio regard status duration duration year year year year estimate odd ratio baseline also estimate diabetic patient incidence diabetic patient per respective incidence increased regard increasing age diabetic patient high risk diabetic patient compare observed different age group odd ratio diabetic patient confidence interval compare odd ratio confidence interval duration year year year respective analysis conduct diabetic patient respective show age renal disease significant risk factor also associate high risk indicate potential factor related type mellitus significant high risk
24140159 en study demonstrated patient mellitus increased risk develop disease relationship disease similar metabolic glucose insulin insulin resistance protein different two one diabetic system change occur disease consider disease recent value found patient disease drug may effect metabolic patient increased risk develop disease less group patient without on may lead new
27497145 en investigate influence factor among conduct several examine include medication participant hospital participant female high level mean age year participant found poor general medication participant reported treatment reported diagnosis high level medication whereas poor medication level duration also study provide influence medication among health care care health outcome
23232745 en general common addition however study reported influence mellitus status patient report case adult influence mellitus patient case report present two finding first patient age time present case also decrease value increased patient mellitus mellitus
24295815 en research evidence type mellitus DM remain common DM incidence type DM population increasing obesity group research evidence type DM type DM clinical increased prevalence obesity obesity common significant evidence development type DM risk old age year DM include obesity history type DM disease associate insulin resistance include syndrome hypertension diagnosis type DM elevated fasting blood glucose level great elevated plasma glucose great oral glucose tolerance test elevated blood glucose great hemoglobin level great according research evidence diagnosis treatment base complication current treatment type DM old age year present research evidence type DM complication present time diagnosis patient presence complication diagnosis type DM follow-up
24393475 en impair fasting glucose type mellitus T2DM subject without hypertension primary care present retrospective cohort study perform subject general identify elevated fasting blood glucose result development T2DM determined diagnosis T2DM oral drug within year relationship time T2DM diagnosis subject characteristic assess adjust ratio subject man woman subject develop T2DM incidence whereas overall incidence rate subject develop T2DM confidence interval CI aged year CI female CI high fasting glucose level vs group develop T2DM vs group without T2DM respective CI subject primary care develop T2DM within year health care target intervention patient risk factor disease
24593795 en major complication patient related cause characteristic mellitus therefore treatment function function large mechanism aim study therefore investigate effect cell complication cardiovascular disease determined serum level cell blood patient type type mellitus T2DM healthy control addition parameter determined diabetic patient period two reduce serum patient reduce level patient change cell result present study complication associate although need
26459420 en on cohort study conduct assess impact history disorder gestational mellitus risk age hypertension type mellitus cardiovascular disease independent hypertension woman included study aged year baseline complication known hypertension obtain blood pressure measured participant follow event datum analyzed use logistic regression model woman reported diagnosis hypertension year early confidence interval CI woman reported diagnosis year early CI woman without complication potential associate presence hypertension odd ratio CI ratio CI include hypertension model risk decrease ratio CI associate increased risk develop ratio CI risk impact risk potential important cardiovascular risk management
27122269 en determine patient mellitus type identify study medical may type diabetic patient use history datum duration presence hypertension type treatment body mass index patient health score indicate different use patient severe severe patient logistic regression female odd confidence interval little odd ratio confidence interval duration odd confidence interval high body mass index odd confidence interval significant associate duration odd confidence interval remain significant age level control type treatment significant type diabetic duration patient
21717893 en on man present multiple show positive show diagnosis cell treat
25854185 en mellitus cell previous report suggest protein diabetic complication time important role cell study use model type study effect cell cell result show significant increased compare control whereas protein decrease determined addition multiple cell increased diabetic suggest cell role cell cell undergo cell compare type addition undergo cell well response assess cell diabetic change may contribute dysfunction
25836946 en significant increase patient patient
26377035 en show primary effect drug potential type study aim examine characteristic also test effect two control test drug profile different value cell analyzed insulin characteristic remain similar addition show drug show cell result improve insulin well reduce glucose addition primary improve activity suggest potential treatment
26818149 en gestational mellitus associate increased risk development type mellitus although early need intervention improve outcome protein present study serum protein improve among woman compare study perform serum sample case control group BMI group BMI base type mellitus previous reported potential disease number protein target analysis result development multiple rate protein remain significant different patient control included model protein level clinical datum evaluate characteristic analysis group model high compare model protein clinical datum potential woman high risk develop
24324048 en present analysis determine effect patient type mellitus disease control trial randomize control trial on total patient type mellitus effect randomize treatment mortality major cardiovascular outcome examine define baseline use patient baseline high risk group compare use therapy treatment reduce relative risk confidence interval among patient baseline compare among without population similar relative risk reduction major cardiovascular event without baseline although difference statistical significant increase adverse effect receive provide mortality patient type mellitus
22502937 en mellitus one common disease study estimate prevalence impair fasting type mellitus population analyzed study included sample adult on subject define mellitus diagnosis known patient according association impair fasting glucose define fasting serum glucose level hba1c define metabolic prevalence impair fasting prevalence prevalence impair fasting significant high man old age group subject lower level subject obesity low cholesterol common two population influence suggest role risk factor two population study may lead risk factor type addition patient control therefore healthy weight activity
25043399 en blood glucose datum patient review aim current evidence role perform review database study hba1c control care hba1c clinical outcome type use study intervention reduce hba1c compare control analysis intervention also significant improve blood pressure total cholesterol analysis according type demonstrated type patient significant great reduction hba1c type provide control patient type study improve care
23627341 en clinical type mellitus patient clinical diagnose T2DM aged diagnosis examine serum obtain duration use patient female age diagnosis patient body mass score history among multiple positive patient poor metabolic control negative patient hemoglobin hba1c vs patient risk high vs metabolic syndrome diagnose therapy use oral insulin insulin patient risk use insulin T2DM patient vs less diabetic relative vs patient risk type
26246595 en study determine prevalence mellitus DM patient evaluate treatment follow-up care hospital examine rate base retrospective study patient patient DM prevalence level determined per level treatment assess review patient known DM among patient without history DM new diagnose new diagnose DM new diagnose DM patient receive patient known DM change diabetic patient follow-up care patient within year respective patient level patient without known DM new diagnose DM patient receive follow-up care finding provide significant management
26408818 en recent population high rate obesity type mellitus T2DM demonstrated increased insulin response decrease risk development T2DM T2DM analysis normal glucose age year T2DM without age year finding cohort assess risk T2DM man age year woman age year baseline normal glucose without follow-up year status assess oral glucose tolerance test subject develop T2DM decrease associate increase risk one gene high T2DM on increase associate great increase result indicate may important T2DM
25137059 en determine association mellitus DM primary review cohort study included two database study study cohort study conduct use model result reported adjust odd ratio or relative risk study cohort included association DM base risk estimate cohort study CI or association DM base risk estimate study CI among study reported association DM mellitus significant among cohort study study contribute significant or association DM CI DM increased risk develop
23734349 en increasing among patient type mellitus rate associate risk factor known aim determine rate characteristic subject type mellitus medical study patient type mellitus medical develop test use on clinical finding type use examine association subject positive on one use analysis found patient type mellitus hospital mean year use common cause type vs vs significant associate hospital type mellitus medical develop characteristic
26735762 en identify risk develop mellitus among primary care risk score present risk develop mellitus great prevalence high risk among man significant prevalence ratio high risk age obesity history identify risk factor health disease
26538615 en clinical mellitus cohort study patient use oral glucose tolerance test patient develop incidence early month early develop patient use obesity major risk factor early odd ratio or confidence interval CI month high hba1c or CI insulin or CI month remain develop obesity or CI high hba1c or CI month insulin or CI level influence patient normal test month remain without develop common renal metabolic factor obesity insulin resistance patient normal glucose develop included clinical
25463274 en also known protein protein role system important previous reported type mellitus significant study investigate whether associate diabetic function on use week mellitus function assess observed diabetic compare control observed activity lipid well potential type diabetic diabetic analysis revealed diabetic compare control use significant reduction diabetic diabetic result suggest function dysfunction diabetic
25000673 en study reported high diagnosis DM occur within year clinical profile associate mellitus DM aim study compare patient new DM DM new factor early diagnosis study included patient medical group on patient new DM month duration included group patient month duration included compare clinical characteristic new DM DM vs DM among patient patient DM great vs high body mass index vs high fasting blood glucose level vs body vs compare DM statistical difference regard age blood group group on DM significant DM patient new DM associate patient DM metabolic status
25093391 en mellitus metabolic disorder cell observed response glucose cause different factor cell cell also include gene protein protein gene mechanism important role type type study gene diabetic may treatment target
26771473 en type mellitus T2DM major risk factor although remain poor influence poor control baseline level influence DM level examine level plasma individual compare without DM level level addition significant negative correlation whereas significant positive correlation hba1c level blood glucose level therefore datum level indicate type potential contribute disease
25621692 en type diabetic subject receive insulin therapy study evaluate whether result glucose improve type adult receive little insulin therapy glucose type diagnose according association include low level presence diabetic glucose subject diagnose type subject type vs year old lower body mass index BMI vs lower serum vs high estimate rate vs subject type score type include age BMI mean glucose day characteristic method glucose improve type among diabetic patient receive insulin therapy
24856756 en important role disease metabolic syndrome define three insulin resistance glucose obesity hypertension low cholesterol current review drug use treatment reduce complication drug due little effect low current review use treatment mellitus use treatment great potential research new drug disease include
26861243 en prevalence type mellitus datum regard glycemic control reduction mellitus complication assess status glycemic control contribute factor among adult patient type base adult type mellitus hospital datum patient glycemic level assess use fasting blood glucose level poor glycemic control define fasting blood glucose level analysis included use included patient poor blood glycemic control patient CI CI high odd poor glycemic control addition insulin oral medication CI poor medication CI associate statistical poor glycemic patient poor glycemic control patient low level insulin oral medication lower medication poor glycemic control can intervention significant factor
24731067 en association previous study study relationship aim study assess association diagnose
26842466 en patient type mellitus T2DM high risk cardiovascular event aim study assess whether provide value total T2DM patient without history cardiovascular complication study function assess function assess ratio define cardiovascular event included syndrome cardiovascular total cardiovascular event occur follow-up duration month ratio ratio independent associate cardiovascular event important provide addition clinical datum hba1c ratio characteristic analysis demonstrated ratio cardiovascular event analysis show patient associate cardiovascular event presence high ratio impair provide negative value cardiovascular event T2DM patient history cardiovascular disease impair associate cardiovascular event provide value
25998132 en due insulin whereas mellitus dysfunction two condition management investigate whether metabolic contribute diagnosis
22389274 en investigate whether mellitus associate outcome patient cell renal cell treat review datum patient receive cell renal cell analyzed potential association patient diabetic status analysis perform identify independent overall patient reported mellitus patient without mellitus demonstrated significant difference regard age hypertension cardiovascular disease status overall show patient rate diabetic respective although mellitus show independent overall observed significant mellitus may associate outcome patient receive management renal cell however mellitus observed associate overall patient diabetic patient undergo renal cell potential impact mellitus review number
26277825 en assess association activity type mellitus glucose system different analyzed according glucose concentration range analysis use examine difference analysis perform age compare associate increased low decrease high associate increased low high associate activity clinical need studied may lead management
26897751 en aim study role patient type mellitus T2DM on total case diagnose T2DM T2DM healthy among patient T2DM regard group patient T2DM group patient group healthy subject healthy group fasting insulin resistance index hemoglobin measured insulin resistance index significant high group compare three group hemoglobin normal range group healthy group high group group compare healthy group serum level high group compare group group positive correlate insulin resistance index BMI hemoglobin insulin resistance index independent factor correlate insulin resistance development T2DM although mechanism potential may use target patient T2DM
25599902 en aim prevalence incidence mellitus also report overall use medication among patient new care retrospective cohort study use health database patient new little month prevalence define hospital year medication use estimate datum first month datum case year month patient patient among patient receive therapy oral medication common use medication common insulin use observed patient mean per medication general evidence use use study examine clinical use
24468099 en on diagnose mellitus identify gene
26446574 en study evaluate parameter serum patient type mellitus increasing number man age may cause dysfunction function however datum parameter function patient patient year healthy man year patient diabetic disorder condition known parameter subject undergo analysis blood fasting analysis patient lower vs high function control vs patient also great vs vs compare control suggest correlation analysis associate fasting glucose parameter show significant difference patient lower impair function dysfunction finding may patient large study result
26838184 en mellitus DM disease effect effect relationship outcome study aim investigate whether association DM outcome patient without study conduct among patient hospital clinical history DM patient medical logistic regression analysis DM perform adjust odd ratio patient patient previous diagnose DM diabetic patient mellitus observed effect whereas effect mellitus significant negative association outcome patient whereas association patient without mellitus significant negative association among patient association significant patient without
25241973 en investigate relationship associate disease include mellitus diabetic study included individual mean age year on perform include model patient patient study statistical analysis perform examine mean value prevalence rate associate disease regression relationship general analysis significant associate age mean mellitus group analysis significant related presence mellitus presence diabetic significant associate mean group mean group mean primary mean analysis significant associate related increased age associate patient mellitus normal presence development diabetic related patient control group similar normal
26943147 en aim study cell patient type mellitus without diabetic total patient mean age year type without healthy control subject mean age year undergo found significant lower cell high cell patient type compare control significant lower total great observed patient type compare control subject significant lower cell significant high cell found patient type without compare control identify patient type without increase use early patient type mellitus
23445270 en type mellitus may datum type change protein age aim parameter type diabetic healthy concentration activity type mellitus significant decrease compare control concentration may type mellitus cause change decrease system oral general health type mellitus result show compare type mellitus effect disease
22124439 en mellitus diagnose first year disease old regard cause clinical characteristic treatment need new cause mellitus include patient mellitus oral effective treatment type mellitus disease poor function lower rate old insulin therapy type mellitus cause mellitus datum value insulin patient population insulin therapy glucose need metabolic control low rate chronic complication care provide
26202184 en determine relationship type obtain treatment study cohort study type mellitus measured patient health respective assess baseline year year on model analysis association use association model significant positive associate time positive associate time association baseline year year association baseline year also related result suggest influence influence although study difference present study first provide evidence related
22907625 en hba1c glycemic control patient mellitus use test diagnose mellitus health use hba1c diagnosis mellitus examine recent use hba1c diagnose use use hba1c patient analysis glucose diagnosis diagnosis reduction diagnosis use increased hba1c influence clinical factor hba1c result use value different age group hba1c use diagnosis mellitus use
26223490 en insulin blood glucose level high however chronic function known glucose diabetic factor protein on decrease addition decrease effect clinical important therapy type mellitus T2DM function addition intervention glucose early function observed treatment indicate factor dysfunction observed T2DM important intervention glucose early
25891707 en occur may however effect outcome well without undergo study define without therapy hemoglobin level year year consider factor associate increased risk analyzed compare development mellitus cardiovascular disease outcome among patient develop patient old age high body mass index BMI female independent risk factor incidence significant different patient incidence cardiovascular disease significant increased group compare group however incidence patient among three found associate old age high body mass index female blood glucose level outcome include mellitus cardiovascular disease however patient cardiovascular disease
21051735 en subject control chronic treatment control increase reduction treatment control treatment reduce protein level control reduce level control datum cell contribute
25971328 en mellitus DM two major woman general population study association DM patient outcome well potential association DM perform identify clinical study assess association mortality DM gene database analyzed identify change cell treat common drug DM study reported mortality reported period cohort total patient include DM patient DM associate increase mortality risk woman DM general associate increased risk mortality woman analysis revealed treatment DM high risk mortality diagnosis patient DM can possible treatment
27023585 en evaluate association DM study adult man woman aged year old define elevated elevated use logistic regression analysis evaluate association significant high prevalence without compare normal group group high adjust odd ratio or CI association man or CI woman or CI however analysis indicate associate study demonstrated associate large population identify adult condition
25849646 en current low patient reduce blood pressure however low associate high mortality rate aim examine effect without mean pressure plasma activity serum level estimate rate patient type randomize study patient type treat receive week blood test perform study increase compare compare on increase serum also demonstrated significant reduce effect present study increase patient type
26803650 en common status common associate increased mortality type similar characteristic may role development glycemic control population due function status on adjust patient status type insulin patient early period glycemic control
27318072 en significant increase use little research determine factor aim study evaluate provide type mellitus common test perform three association datum determine participant time participant participant three adult year age old result test revealed significant difference three number number time analyzed test revealed significant difference three test show significant difference time association on significant difference found number compare association however significant difference found number association significant difference found number association positive significant participant need reduce
26927745 en estimate one individual disease little patient undergo complication impact multiple system risk review management patient
25593465 en identify possible risk factor study included patient diagnose hospital healthy control age diagnosis risk factor possible factor evaluate use logistic regression index association mellitus DM adjust odd ratio respective model investigate DM analysis DM significant risk factor respective whereas DM risk factor respective also observed DM or however significant risk factor study DM found independent effect risk include mechanism may lead development individual
25417436 en hemoglobin hba1c level patient disease control develop complication year use hba1c glycemic control among patient hospital mean hemoglobin range patient poor glycemic control mean hba1c great factor high hba1c management risk factor poor patient health care system health patient within health system need increase mellitus management patient health health base number effective patient model participant group use improve health care increased patient health elevated hba1c health care
24212264 en value mellitus DM outcome patient well correlation DM include new diagnose DM outcome need total patient day hospital according medical care study population three group new diagnose previous known primary outcome study mortality cause major adverse event day previous known old high incidence previous history cardiovascular disease compare group mortality similar patient without DM patient new diagnose DM group significant lower patient DM similar result observed regression analysis indicate new diagnose correlate ratio confidence interval previous known DM correlate ratio confidence interval known DM new diagnose DM independent patient reduce incidence effect insulin therapy provide diabetic patient
26189407 en type mellitus cell whereas associate cell according system develop cell mean develop develop aim study investigate association prevalence case control study control history presence blood total serum major analysis level reported presence significant control group significant high factor level healthy control level high group presence history presence result suggest associate high risk presence may
26953280 en insulin management insulin insulin low high duration profile compare insulin evaluate randomize clinical study trial among patient type primary study reduction hemoglobin baseline month included week month change weight baseline insulin insulin compare risk insulin three early determine role insulin management compare insulin insulin associate lower risk due insulin per three outcome insulin similar insulin profile duration insulin may patient type type glycemic control
24503190 en although important woman gestational mellitus glucose level perform aim study use datum first impact study determine rate within month cohort effect risk investigate analyzed woman health index risk score also woman mean age year mean body mass index reported analysis factor associate odd ratio or low or weight although difference score woman reported month however impact study increase rate woman risk factor associate lower rate
24440211 en estimate health impact chronic complication type mellitus T2DM number complication obtain study cohort patient T2DM complication assess hospital primary care number medical primary care drug treatment complication treatment T2DM population datum obtain analysis estimate patient T2DM complication respective mean T2DM complication per patient estimate due complication impact T2DM complication complication respective impact range T2DM T2DM great health impact
21088058 en disorder cause gene early patient treat provide treatment study three clinical weight index patient patient undergo test analysis one studied cell total individual studied two three gene found index show two case improve treat normal weight treatment chronic cause
24552155 en investigate evaluate patient type randomize study patient type mellitus patient treatment one oral drug randomize week primary change baseline hba1c week measured use present use well population hba1c statistical significant difference treatment group change baseline hba1c week treatment effect group vs week patient group compare patient group hba1c respective adverse event related study therapy occur reported adverse event treatment group effect among patient type mellitus study week duration study treatment period
19112958 en patient common patient cell cell reported present case cause patient cell
23069624 en woman gestational mellitus high risk develop type type important reduce impact reported improve early glucose tolerance reduce risk type investigate whether influence outcome woman study follow year development participant develop woman treatment receive insulin vs BMI among woman associate time year compare year woman low risk observed woman month result among woman intervention reduce risk population
27139602 en glycemic control hemoglobin cause cardiovascular complication mellitus DM study correlation lipid index investigate DM relationship serum lipid profile compare method use determine DM use sample normal subject group patient new diagnose type DM T2DM group lipid profile patient T2DM receive treatment group correlate regression analysis indicate level analysis diagnose DM confidence interval level significant lower group group positive correlation observed total cholesterol level on negative correlation observed level group level respective significant high level lower statistical significant group use potential DM compare less
25641062 en hospital increasing among old individual possible increasing prevalence condition chronic disease study association patient treat incidence among old cohort study use primary care clinical research hospital patient year old mellitus history renal therapy rate history lower diagnose primary care hospital time regression use incidence rate ratio adjust age status condition characteristic estimate association adjust association lower observed compare patient adjust among CI CI CI CI respective association lower adjust CI association clinical CI adjust model history remain independent increased risk CI CI CI without result among need
26718606 en evaluate influence renal function glucose patient type mellitus study evaluate increased patient T2DM renal week compare study analysis study include study evaluate patient renal function patient group baseline estimate rate normal renal function patient study included change hemoglobin hba1c level fasting plasma glucose level body weight included adverse event study hba1c body weight significant decrease week patient treat compare patient treat decrease parameter also observed week incidence similar group study patient included normal impair impair week hba1c body weight significant decrease baseline group decrease hba1c body weight significant patient normal function however reduce whereas body weight group show change hba1c influence baseline hba1c baseline incidence week similar among group improve glycemic control reduce body weight group hba1c reduce renal well significant identify baseline study clinical trial study
16681253 en on man show diagnose diagnose test test on mass also revealed therapy improve clinical finding therapy
24850465 en effect reported study however effect intervention function investigate therefore studied effect woman type mellitus woman T2DM two period control randomize function measured use compare serum level function determined blood duration duration intervention improve duration compare control serum level increased period decrease control compare baseline vs vs correlation serum level function increased ratio observed intervention possible due activity intervention improve function woman T2DM serum concentration function suggest factor may contribute
25003225 en study aim determine whether serum hemoglobin hba1c level associate patient type patient man woman type mellitus hospital patient age range year patient poor control group prevalence history body mass index history use insulin poor control significant high incidence addition patient poor control disease positive history use high insulin patient on analysis demonstrated independent time high body mass index use high glycemic control patient type mellitus independent high develop increased risk
23312788 en plasma glucose level per level associate diabetic complication glycemic control well level compare hba1c study level hba1c compare hba1c patient type mellitus type mellitus study included patient T2DM patient period hba1c measured month mean value patient T2DM patient significant high hba1c hba1c significant high patient T2DM great hba1c addition hba1c patient great T2DM patient finding suggest level hba1c
26763822 en important role complication aim study examine possible association protein system risk diabetic total patient type mellitus patient include determined examine logistic model model duration hba1c insulin therapy total cholesterol cholesterol present study first time identify association gene type DM estimate or adjust logistic regression model found follow model study association however finding provide evidence gene independent effect development
24501967 en mellitus studied datum rate type mellitus result treatment patient mellitus total treatment complication rate
25917376 en change low treatment result poor glycemic control type mellitus care adult mellitus type however evidence evaluate impact care provide important clinical outcome hba1c severe study patient one clinical randomize control study intervention group receive care need month control group receive diabetic care datum baseline difference change baseline hemoglobin hba1c number severe event baseline hba1c significant great intervention group control group month change baseline vs however effect month vs significant difference number severe event study suggest may value management glycemic control however method population study
25595348 en year new study development new blood medication lead clinical treatment association association study management type one association year follow primary care three need type mellitus target glycemic treatment base patient characteristic disease presence complication treatment disease three also patient disease control identify drug addition
25926270 en result level chronic type mellitus DM mass clinical type DM suggest cell function poor general evaluate present two patient year type DM present level cell population also type DM previous reported normal insulin correlate development known cause cell dysfunction development type DM consider studied potential cause
24666923 en significant diabetic patient patient due several factor dysfunction function factor present review association mellitus
26940811 en common potential among old adult however little known condition old adult mellitus aim study investigate impact clinical old woman type identify can old woman type aged year two group base score participant score group without score group clinical datum included number disease medication activity level history level fasting glucose level disease duration included time test time test parameter obtain use present test compare without group also lower increased time time regression analysis show increased time or CI increase score time or CI increase old woman type mellitus associate test population therefore consider assessment diabetic old woman
25103706 en impair patient mellitus effect type group type one day examine statistical analysis show control group significant high group group significant high control group time group significant lower control type significant
23749254 en study aim investigate association clinical type mellitus blood glucose control on total assessment research evaluate conduct test high insulin therapy significant multiple regression analysis clinical effect blood glucose control high clinical patient
24711867 en mellitus common disorder common oral well known cause due effect study determine prevalence association patient type mellitus treat case control study hospital patient type mellitus current month age patient control patient level less result analyzed level low patient compare patient among value mean level significant low group value correlation level difference statistical significant study demonstrated significant high prevalence patient treat significant effect duration use level important diabetic therapy
24582483 en examine association type type sample included participant type participant type age year baseline study study primary outcome regression analysis conduct use datum baseline little one follow-up assessment great among type type among participant type great total score time related great lower hemoglobin value great activity day significant age remain decrease time whereas increased participant type significant age lower total related female great body mass index cohort type age type participant poor among female participant type suggest impact consider clinical management activity weight control important
26718938 en correlation disease study participant aged year included analysis prevalence disease demonstrated impact also analyzed logistic patient old age lower level relative low treatment control rate diabetic condition two compare patient diabetic high control hba1c rate common follow hypertension on number group odd ratio diabetic one two three disease glycemic control high prevalence common increase risk diabetic
26861377 en mellitus independent risk factor cardiovascular disease adult two time develop disease adult without two major increase age change may provide cardiovascular event present provide clinical evidence metabolic cardiovascular risk mechanism insulin resistance may association metabolic cardiovascular event
25904143 en type mellitus diagnose glycemic control patient complication improve patient new develop insulin system patient remain rate day patient provide insulin insulin without use study effect multiple insulin use insulin system patient type mellitus period addition effect insulin patient assess weight blood pressure prevalence event month insulin therapy clinical patient group change patient group increase patient group decrease insulin total decrease patient group increase insulin patient patient undergo insulin therapy increase determined use result statistical
26341928 en study determined medical need insulin therapy among type patient study also trial conduct examine impact treatment insulin therapy among type patient
26025451 en influence mellitus define study study whether mellitus disease disease patient function positive test undergo two test parameter compare among patient without type mellitus consider present time rate great test test analyzed independent disease patient patient year study diagnosis type among diabetic patient parameter whereas among patient analysis patient demonstrated show similar time diabetic group vs respective regard rate great diabetic compare patient vs respective study mellitus associate disease patient diabetic patient significant mechanism
22145481 en renal resistance common cause gene severe complication occur severe without treatment on present severe normal revealed patient healthy several method include primary early diagnosis treatment severe complication also analysis provide diagnosis
26211989 en evidence high rate observed patient type mellitus T2DM associate normal increased lead patient T2DM may several study use demonstrated index increased T2DM patient addition recent study use found index woman T2DM reduction associate chronic glycemic control suggest included target subject diabetic complication T2DM remain define although high level age may role addition T2DM associate reduce although several study found increased serum level patient T2DM role increased level observed increase reduction remain define although impair T2DM relationship increased risk observed patient need study
25561812 en determine effect different patient type retrospective analysis clinical datum patient type mellitus treat general conduct patient undergo use different fasting plasma glucose two blood glucose hemoglobin hba1c analyzed level significant decrease group vs vs level significant decrease group vs vs vs vs vs vs compare level hba1c level significant decrease vs vs significant difference two group regard hba1c concentration observed vs vs vs vs hba1c vs vs improve glucose type diabetic patient
25378546 en several study evaluate association body mass index BMI risk among patient mellitus however result perform cohort study patient type mellitus regression model use estimate association different level BMI mortality mean follow-up year identify age type ratio mortality associate BMI level group baseline confidence interval CI CI CI CI CI CI CI CI CI CI respective age status patient type use drug association present BMI included model association BMI mortality risk present study indicate association BMI mortality risk among patient type mellitus on significant increased risk mortality observed among BMI among BMI compare patient BMI
26295091 en mellitus cause renal disease among complication associate large reduce effective test test among individual participant score high treatment activity body mass index level on value
22931860 en evaluate mellitus assess health evaluate health sample general population aged year woman without man woman man woman without rate mellitus individual individual rate level adjust or CI respective man respective woman significant influence factor age level man independent status associate lower patient lower health associate less health individual without mellitus health important individual level disease management well health level disease
26888130 en value potential diagnosis type mellitus case mellitus patient case normal subject control group patient normal subject undergo potential potential result compare patient normal subject on use statistical normal subject present rate present rate mellitus patient present rate present rate rate control group significant high diabetic group diabetic group mean value significant compare control group significant statistical difference found parameter interval group impair mellitus patient can diagnosis type mellitus patient
17234837 en on disorder develop on show also plasma level little plasma high significant increased normal normal similar high result similar gene new model analysis mechanism disorder study
25278305 en patient association mellitus whether therapy improve condition mellitus aim study investigate relationship therapy clinical patient treat therapy included study month therapy define present body less relationship patient characteristic well therapy effective treat patient observed patient patient therapy patient show high incidence mellitus vs control vs new vs without associate serum level patient new need insulin therapy therapy patient therapy high incidence mellitus new associate therapy
24210228 en demonstrated different factor whereas mellitus DM identify value cell aim study investigate characteristic patient investigate impact DM overall patient receive retrospective review patient DM potential analysis study analysis conduct identify factor associate result analysis identify status DM mellitus identify analysis show poor status presence DM consider independent negative factor respective DM consider independent negative factor DM time diagnosis associate negative patient receive addition poor status identify negative factor
25375257 en patient mellitus show negative outcome intervention impact patient undergo treatment severe use system known therefore assess whether system effective patient included patient severe study patient oral medication insulin therapy type mellitus patient patient without major adverse event occur patient without whereas patient show mortality case group follow three month show significant evaluate group change system effective patient type
25391917 en correlation diabetic well known mellitus DM type patient DM type correlation less on retrospective study include patient type diabetic diagnose base diabetic diagnose base concentration sample statistical analysis perform regression model model statistical significant test model level model revealed rate influence body mass index BMI hba1c less significant impact positive duration insulin treatment glucose level hba1c negative level BMI association statistical significant correlation present study indicate level renal level association renal
26691324 en parameter rate increasing use assess function patient mellitus several clinical metabolic hba1c assess diabetic patient blood glucose level study assessment aim study investigate influence blood glucose level rate patient type mellitus perform patient type mellitus mean age year female healthy control mean age year female patient according blood level participant study group diabetic patient high blood level demonstrated significant increased rate well rate patient lower blood level healthy method diabetic study population blood level study need finding patient cohort different metabolic
25687999 en treatment mellitus one great medical result cell insulin resistance follow cell case new cell use cell cell cell show also review normal mechanism cell cell cell cell mechanism control potential cell
27095028 en mellitus DM significant health low however known two disease condition DM provide study health system possible DM study conduct study participant included health DM control activity among participant study subject datum conduct group datum analyzed use total group participant included study study participant identify number health system identify system DM care health DM patient DM poor DM datum management less DM care presence control level high level among different level health care study provide potential health system need consider DM study need assess possible two condition
27070590 en increasing evidence show chronic disease early effect use associate insulin resistance effect mellitus remain body weight gestational day normal assess effect day level high group group glucose tolerance test serum insulin level significant high group normal group insulin protein protein level lower group insulin insulin lower group result event insulin resistance
26826622 en clinical follow-up patient mellitus DM randomize trial use different drug on recent study demonstrated time diabetic large trial DM patient patient randomize significant difference baseline clinical characteristic hypertension incidence major adverse event due high target indicate rate year however time follow-up rate year on similar observed patient rate year follow-up also result high major adverse event rate year presence however year rate similar presence follow-up rate year presence year follow-up profile similar insulin treatment
24358273 en previous study investigate association care outcome study aim study use datum investigate relationship control man woman mellitus use database association mean control type mellitus examine retrospective cohort study include number include age status body mass index BMI treatment duration datum analysis adult group significant great control hba1c compare group general mean age lower BMI adjust odd ratio control significant high among CI CI type mellitus control population research health need association control control
25231115 en prevalence cardiovascular risk factor among patient type study conduct assess cardiovascular risk compare type control type patient control included measured use found significant elevated among patient compare control show positive correlation age rate blood pressure among patient regression analysis revealed age blood pressure BMI independent associate cohort increase assess significant increased among patient type compare healthy control independent cardiovascular risk factor early use effective method among patient may identify cardiovascular risk
25439756 en study change type effect insulin use analysis obtain patient type insulin therapy analysis also perform demonstrated patient type mellitus compare normal control patient undergo year insulin therapy finding suggest insulin therapy may effect type mellitus mechanism investigate
18493105 en on man hospital history general finding revealed dysfunction study revealed mass mass mass revealed plasma cell serum level elevated diagnose therapy result clinical reduction mass however remain first case cause disease included diagnosis
22441723 en several syndrome associate mellitus DM study aim datum database regard treatment complication DM patient syndrome include syndrome syndrome syndrome syndrome syndrome syndrome syndrome
23680251 en type mellitus lower level serum correlate high mortality related cardiovascular complication type estimate compare serum level type mellitus control one risk among T2DM study conduct sample two group group case type mellitus diagnose group age control serum level measured negative correlate index negative correlation great multiple regression analysis found regression high index outcome risk type mellitus
23680245 en determine characteristic associate condition mellitus diabetic study patient conduct included subject without mellitus general history mellitus patient type according index association found different type general level associate high body mass index presence or CI or CI or CI risk factor body mass index duration patient mellitus may develop associate complication on analysis patient define risk develop
26260124 en role development pressure therefore conduct association mellitus pressure among patient odd ratio or confidence interval use effect model study patient total control included analysis compare patient without odd ratio or incidence pressure diabetic patient confidence interval CI estimate type similar result or CI general or CI major lower or CI diabetic patient control increased incidence pressure diabetic patient undergo compare control or CI risk pressure associate significant high patient undergo patient receive study conduct examine association type
24919656 en mellitus DM one great health incidence DM also include age associate man woman may function multiple level result effect control on large number study diabetic man diabetic impact DM function year result present review research finding large number research function function diabetic man diabetic
23629540 en mellitus insulin cell blood glucose cell result type mellitus whereas condition reduce insulin negative activity result type mellitus without management patient mellitus develop complication reduce early disease individual risk develop complication great improve care patient control gene use evaluate health status disease type mellitus type mellitus associate profile blood several year disease level complication need identify individual risk develop mellitus complication
27877049 en aim review function patient type database protein elevated type mellitus increased contribute patient early high level new reduce cardiovascular complication
26086231 en investigate effect insulin clinical occur treat insulin month follow-up week included clinical blood glucose concentration serum result significant decrease blood glucose serum concentration month compare value insulin study range identify blood glucose concentration clinical on clinical observed study period clinical blood glucose concentration insulin study consider poor insulin may treatment mellitus insulin lower reported insulin type need glycemic control suggest insulin use
25644781 en woman age mellitus increasing primary patient develop type age associate early well glucose control risk complication addition effective treatment elevated blood glucose level hypertension woman treatment risk case occur complication woman without disease method due effect risk factor diabetic complication patient among insulin insulin insulin insulin patient great insulin insulin case risk early risk woman individual patient high risk consider due early woman use effective report use early
23194086 en study examine difference use care management care old adult diagnosis mellitus health sample included adult aged old group diagnosis mellitus logistic regression analysis conduct use datum result adjust logistic regression indicate significant difference group examine significant less care mellitus examine significant less lower cholesterol test blood glucose significant less test blood glucose significant less medication reduce risk use insulin oral diabetic medication finding suggest need intervention mellitus reduce among adult
22716928 en investigate influence blood glucose insulin lipid level test patient mellitus study tolerance test use test perform two test use study study blood glucose response significant lower trial trial study blood insulin response also significant lower trial trial study blood response significant different two trial change study diabetic patient test
26972690 en determine whether blood glucose test patient type associate type therapy according retrospective study drug drug conduct analysis patient without evaluate therapy risk analysis conduct identify cohort mean vs great patient receive therapy associate high risk insulin insulin therapy great patient multiple therapy vs analysis included insulin use previous use female previous therapy duration therapy negative correlate type therapy use treat according risk regard need analysis current value include patient receive therapy prevalence
25923078 en type mellitus patient significant risk cardiovascular disease however complication known population aim study compare serum patient type mellitus present present cardiovascular disease subject protein related cardiovascular complication study compare serum protein difference protein identify type mellitus patient cardiovascular disease show high plasma protein compare without cardiovascular disease control result show protein related important role cardiovascular disease type mellitus patient
22402134 en association study gene mellitus reported result evaluate association gene mellitus conduct on model total study overall result significant association risk increased risk relative odd ratio confidence interval CI analysis indicate significant increased risk CI CI type mellitus indicate association diabetic CI observed result provide evidence regard association gene increased risk mellitus diabetic effect
25385685 en randomize control trial examine adult care type mellitus study aim determine effective compare clinical trial provide participant week month care participant month status receive per month primary outcome adult outcome included hemoglobin hba1c complication participant participant adult time overall participant adult adult care high group difference high hba1c baseline follow-up group however general model found follow-up hba1c increased increase baseline hba1c confidence interval independent treatment finding provide need
25152212 en investigate treat type mellitus use lipid use body although effect demonstrated previous model duration effect body use examine on change observed body perform use control whether observed effect level correlation regard
25262886 en mellitus one common disease patient mellitus lead change cell type body change consider common mellitus change mellitus may change disease develop mellitus may associate complication may occur adverse effect therapy presence diabetic syndrome associate significant increased mortality patient well elevated health care system common disease patient mellitus well current treatment review
26222906 en previous study show relationship increased risk development study examine whether independent risk factor perform database study relative risk confidence interval datum individual study level relationship duration development study included include study cohort overall estimate relationship population duration year CI population duration year population duration year CI study suggest mellitus associate increased risk however level risk negative correlate increasing mellitus duration
25279695 en within significant influence metabolic within recent several group individual metabolic disease difference reported model type mellitus well patient mellitus type study diabetic previous study compare diabetic determine factor influence sample diabetic gene perform sample base identify difference diabetic significant difference determined gene identify diabetic identify decrease aged year protein presence mellitus study compare diabetic investigate potential impact metabolic disease mellitus
26580639 en base possible adverse effect health study aim determine association base hemoglobin hba1c type mellitus study two different total age range year age range year base measured duration day week day week blood hba1c measured use system mean hba1c high significant high mean hba1c low high significant high risk type mellitus relative low high associate elevated level hba1c risk type mellitus
27003209 en plasma level associate cardiovascular mortality patient disease therefore aim investigate association plasma level cardiovascular risk factor individual
25309652 en mellitus treatment among type patient well study assess drug associate factor among patient type study conduct among type mellitus patient diabetic hospital may medication base patient day without medication one week three month datum analyzed use statistical adjust odd ratio confidence interval CI perform determine factor associate medication less consider statistical rate drug found one week three month respective high medication significant associate drug significant increased increase number drug found patient medical condition addition mellitus medication need drug improve reduce associate complication
17592473 en on woman present decrease oral reduce level previous receive year disorder treatment year study include serum level serum blood disease control large treatment
27259495 en new base activity plasma study included patient type mellitus receive therapy addition parameter level parameter value studied new method provide patient type mellitus clinical value use method clinical study patient status diagnosis therapy
26650464 en cell model type mellitus cell show serum insulin blood glucose blood number insulin protein observed diabetic event include cause datum role function
26212367 en mellitus condition prevalence found known gene present also present found present database new identify gene may result severe
18790812 en different identify provide important role normal role function result disease high cell renal blood type renal cell concentration occur reduction level obtain gene cause disorder response recent development several model primary base study review study new obtain model
26482741 en woman gestational mellitus increased risk develop score risk use clinical woman follow outcome year follow-up use develop risk score participant test risk score use regression risk assess test develop woman risk score body mass index early per treat insulin woman history woman value year respective risk score test result observed risk year low risk score score score score risk score may general
22677718 en chronic mellitus associate dysfunction increase study evaluate effect function diabetic patient baseline period patient mean age year mellitus type type chronic without disorder oral three time day increasing day three time day day assess function evaluate baseline day treatment respective treatment effect compare use analysis body mass index baseline patient severe dysfunction diabetic patient two patient compare mean baseline treatment baseline treatment overall treatment effect significant effect common oral improve function diabetic patient chronic
26961579 en on study conduct woman show woman type mellitus syndrome normal serum concentration woman elevated concentration woman similar profile serum level observed
26471783 en result study found therapy among subject obesity type mellitus T2DM lead significant weight glycemic parameter cardiovascular risk factor datum need determine whether result study subject T2DM body mass index BMI assess weight glycemic parameter cardiovascular risk factor therapy outcome reported use month mean weight CI total body weight CI hemoglobin decrease CI baseline fasting plasma glucose CI baseline among subject baseline blood pressure CI blood pressure CI mean pressure CI significant reduce CI baseline common adverse event obesity glycemic control large year treatment therapy risk profile
27117509 en obesity risk factor patient type mellitus T2DM obesity level primary care important obesity management T2DM primary care obesity patient review recent may management obesity patient T2DM primary use obesity obesity T2DM weight primary care conduct association health health health also study randomize control trial study weight management treatment T2DM patient primary care evidence base intervention potential improve weight management within primary care
26575615 en study evaluate type mellitus investigate risk disease patient potential obtain patient aged clinical analyzed use identify subject significant group aged year odd ratio or confidence interval CI also significant influence lower female or CI less common among or CI among little one or CI therapy previous month less among patient receive or CI analysis study population show association status identify effective several year need increase aged year result suggest need patient
26721018 en among level related insulin resistance type control study determine correlation level type sample diabetic patient study patient included type mellitus patient history cardiovascular disease lipid medication history level study patient value correlation level total number patient female correlation estimate correlation positive statistical type mellitus relationship
26844282 en develop type mellitus T2DM high level T2DM determined level diabetic patient healthy control found compare control T2DM patient less mean vs respective indicate role T2DM multiple logistic regression analysis show independent association level status decrease increased risk study revealed high develop T2DM healthy population metabolic syndrome include develop T2DM metabolic disorder high level obesity profile metabolic syndrome include
25920022 en major risk factor assessment diabetic patient due aim evaluate two early diagnosis patient study evaluate patient cohort patient present perform diabetic patient patient without use improve provide vs follow-up day diabetic patient rate patient level compare patient level observed level vs respective level vs analysis independent use identify two group patient group diabetic patient improve early diagnosis provide however mortality independent
23185815 en effect chronic disease disease change chronic disease different review
23013481 en treat mellitus identify mellitus condition develop health use aim study base report type type mellitus complication perform study mellitus association identify regard study mean among determine identify general general use blood glucose one response obtain medication use complication influence factor blood glucose effective type mellitus use factor effective participant study result possible care follow
25779865 en assessment blood glucose blood glucose control patient mellitus study blood glucose measured glucose patient type mellitus blood glucose three time per day perform use blood glucose parameter obtain patient blood glucose measured time correlation found value obtain mean blood glucose level risk range value index duration duration show correlation blood glucose parameter obtain finding suggest hemoglobin hba1c blood glucose parameter obtain hba1c show correlation duration duration
26228646 en factor contribute high risk event patient mellitus complication cause mortality system observed normal well factor impair association change increase prevalence event risk factor cardiovascular disease hypertension elevated cholesterol impair activity diabetic subject blood role determine cardiovascular disease show role well role evidence suggest among decrease important complication role cardiovascular complication diabetic subject
25720752 en recent datum indicate serum level increased type mellitus however report level gestational mellitus study measured serum level woman woman gestational healthy woman plasma glucose level serum insulin concentration hba1c value model resistance index also determined according result serum concentration significant high woman gestational mellitus healthy woman addition diabetic woman significant high level gestational group woman gestational mellitus serum level show significant positive correlation hba1c value however relationship clinical metabolic parameter study subject serum level study group demonstrated first time serum level increased correlate hba1c value woman gestational mellitus study need determine whether role gestational elevated serum level disease
26666403 en mellitus type chronic metabolic disease great impact health status aim present study factor patient population subject diabetic general hospital study mellitus type negative impact study participant without presence negative impact health status result logistic regression analysis show related age odd ratio or confidence interval status or result present study show per negative impact patient health status age status
26091968 en contribute effect assess serum type potential complication patient type two group according presence complication compare healthy control protein hba1c ratio level assess level significant high patient complication without complication healthy control increased patient compare group positive correlation found disease duration fasting blood glucose hba1c total cholesterol on value can patient without complication increased level type may dysfunction suggest
24170527 en common complication mellitus DM related renal level rate diabetic patient normal renal function therefore evaluate level rate diabetic subject normal renal function estimate rate
27069032 en use aim study evaluate relationship cell metabolic control patient determined presence whereas serum fasting glucose total protein hemoglobin hba1c concentration use value patient significant lower healthy participant mellitus less per indicate among patient cohort correlate positive level BMI significant duration level total result demonstrated association low level
22395500 en chronic mellitus two clinical condition one disease consider major complication mellitus mellitus disease disorder development response within oral mellitus disease increasing incidence development related influence mellitus study evaluate patient patient mellitus year found patient present chronic cell plasma cell type present system cell type
24530420 en recent report increased risk regard use present study therefore whether development model type mellitus week old randomize three group group group on group group high addition high group study week week low group follow week oral glucose tolerance test week week development impair glucose tolerance week vs week vs significant lower high group compare group receive high respective also metabolic index body weight glucose significant lower group compare group insulin resistance also lower group study first time model type mellitus development type
25417090 en mellitus DM large system present patient system assessment health patient DM type health system follow provide follow-up treatment adjust patient condition risk associate DM diabetic diabetic cardiovascular event system system base association association clinical mean health development clinical health level health evaluate system system use datum base model result show system high
24708176 en evaluate vs patient type mellitus control system model use risk study outcome model cohort model complication mortality patient model treatment insulin insulin hemoglobin baseline patient characteristic clinical study estimate base medical analysis conduct test adverse event patient treat compare patient treat vs addition compare lead increased drug reduce patient treatment mean year mean increase total ratio per analysis show value range per different parameter model several model event patient model compare result lower incidence treatment
25997699 en result chronic disease well aim current evidence regard diagnosis treatment well perform current datum healthy lead oral therapy function lead mellitus lead risk chronic evidence individual
27196498 en general mellitus DM due increased body mass index BMI however previous study metabolic evaluate risk severe patient DM evaluate risk total increased DM study perform use clinical research case define patient year undergo control age general logistic regression use estimate risk total total associate use drug current DM use significant associate lower risk or CI or CI compare patient use risk decrease increasing study DM patient severe compare patient without risk severe decrease increasing DM possible due decrease
25495839 en review evidence possible control complication type mellitus DM significant health care reported incidence increasing rate therapy development new drug treatment associate adverse effect drug new disease drug new evidence associate low mellitus study conduct test effect incidence control well complication although study present several effect incidence control complication control trial role treatment DM
24862312 en current evidence suggest man type mellitus may lower risk develop little known association disease association mellitus risk examine among man diagnose follow-up year ratio confidence interval CI estimate use model age adjust status body mass index activity man without association concentration factor protein status also investigate use regression model compare man man lower risk CI evidence association disease although disease man concentration total factor lower man compare man without large study association mellitus risk
23887044 en although prevalence incidence type mellitus T2DM reported increasing among datum regard T2DM estimate prevalence diagnose T2DM among analyzed aged year receive health among also fasting blood sample reported previous diagnosis medication oral without insulin T2DM reported use insulin type define fasting plasma glucose concentration type fasting case type identify prevalence confidence interval CI case CI estimate prevalence type type CI CI respective indicate T2DM case T2DM prevalence CI T2DM case case CI T2DM case
26297882 en two recent report new syndrome glucose association gene investigate clinical present female gene gene present level low high level previous report patient cell glycemic control hba1c analysis demonstrated protein patient insulin glycemic control evaluate test glucose insulin treatment therapy insulin month relative normal glucose level day without insulin treatment may due cell
24697038 en study correlation disease disease disease system disease low weight mellitus base
26571120 en investigate effect new diagnose mellitus impair glucose tolerance cohort study patient without mellitus one patient normal glucose tolerance oral glucose tolerance test primary first major adverse cardiovascular event include cardiovascular severe cause mortality individual impair fasting glucose fasting plasma glucose respective cause first event cardiovascular occur month follow event lower group CI CI independent also independent incidence increased risk patient present identify use associate increased incidence associate adverse outcome
25892189 en aim examine association impair cell type mellitus patient participant group normal glucose tolerance type base oral glucose tolerance test activity fasting estimate multiple regression analysis activity contribute development impair glucose tolerance oral index overall subject included activity decrease type compare normal glucose tolerance activity show difference among three group decrease estimate activity significant associate type age odd ratio CI respective decrease decrease decrease activity may function decrease on decrease estimate fasting activity lead type population studied
23332622 en drug addition glucose different effect cardiovascular factor associate mellitus recent type mellitus review evidence effect different cardiovascular risk factor effect control effect cardiovascular risk factor weight control blood pressure control lipid profile cardiovascular risk addition present evidence regard impact therapy can reduction cardiovascular event current study
25581747 en type mellitus may provide aim incidence type mellitus aged year regard new case obtain two medical datum incidence age group total new case aged year found significant difference group mean incidence high age group year CI low aged year CI age adjust incidence type mellitus increased significant CI CI incidence age group incidence type mellitus high incidence type mellitus increased old
26268736 en study effective base management population study aim evaluate effective risk assessment management patient mellitus reduce risk cardiovascular complication cohort study conduct score participant subject primary care subject group study first disease total cardiovascular disease mortality regression estimate association intervention first study follow-up period month three event occur group compare control group adjust ratio confidence interval CI total number group less control group vs adjust ratio CI adjust ratio group CI CI intervention associate lower incidence individual total cardiovascular complication well mortality year follow-up result provide evidence management clinical effective reduce cardiovascular complication
25772230 en mellitus risk compare age group without condition prevalence group year rate high population review evaluate prevalence well primary clinical study assess treatment review outcome perform clinical trial evaluate drug population use clinical trial result use drug drug result patient population patient evaluate population well drug datum need treatment among population on include population treatment patient can reduce population outcome control patient
24891075 en whether level incidence among study follow period study population age year man type baseline body mass index cardiovascular ratio confidence interval type total new case type develop follow-up period high level ratio increase confidence interval ratio increase confidence interval associate lower risk type follow association confidence interval confidence interval respective level independent reduce risk type man
24206044 en although consider improve insulin reported result therefore conduct evaluate effect insulin control population risk type mellitus database include database database identify control trial identify study two independent trial datum evaluate evidence participant identify statistical significant difference group group regard fasting plasma glucose mean difference confidence interval CI fasting serum insulin CI plasma glucose oral glucose tolerance test CI CI model insulin resistance index CI participant risk decrease level fasting plasma glucose fasting serum insulin glucose population risk T2DM large need determine effect insulin control population risk T2DM
22633200 en woman gestational mellitus increased risk develop mellitus DM metabolic use oral glucose tolerance test study assess value hemoglobin woman recent gestational woman recent undergo assess change use association characteristic analysis use assess hemoglobin index use evaluate hemoglobin diagnose woman increased risk DM woman index diagnosis hemoglobin identify change on hemoglobin value diagnosis DM identify change diagnosis value hemoglobin glucose tolerance woman recent gestational mellitus
22302244 en study positive association however finding regard conduct review examine association mellitus risk investigate whether association duration study identify may identify also review two independent study datum study study cohort study study included analysis compare subject risk estimate diabetic subject CI analysis revealed risk significant increased duration duration increased risk whereas evidence association among result subject increased risk develop
25294081 en investigate effect early mellitus impair fasting glucose total health group study subject datum subject included analysis group group control group prevalence rate mellitus rate impair fasting glucose among three group compare logistic regression model use effect early prevalence mellitus rate impair fasting glucose mellitus rate impair fasting glucose group group control group result logistic regression analysis show early increased risk mellitus impair fasting glucose odd ratio CI CI odd ratio CI odd ratio female CI CI early increased risk mellitus impair fasting glucose however negative effect according result study
24908527 en mellitus health develop due aim study assess among woman three base study conduct three on total woman period on score system poor score total score statistical use datum datum management woman mellitus participant age group year among score risk factor treatment complication overall respective according define poor among woman woman positive history found large woman poor regard health health
27491153 en studied level relationship clinical change patient type mellitus DM significant negative correlation level clinical change patient DM found determined negative correlation change lead severe change DM mellitus
27997863 en assess low cardiovascular risk factor metabolic syndrome clinical outcome man type cohort study hospital cohort man disease duration follow clinical characteristic serum total clinical event analyzed logistic regression perform examine independent association low regression analysis use ratio clinical man low disease normal adjust odd ratio or low confidence interval CI follow-up ratio low CI model remain significant renal man low high prevalence cardiovascular disease high incidence
27102111 en dysfunction demonstrated type mellitus evidence indicate impair function type mellitus well aim study evaluate role assessment function analysis perform patient compare healthy patient analysis revealed reduce mean well reduce mean compare healthy control vs vs mean ratio significant high diabetic value diabetic healthy control measured parameter indicate reduce diabetic compare control vs vs early patient patient assess early patient
27079349 en type mellitus common disease found population diabetic drug show demonstrated treatment outcome use therapy patient man investigate improve lower risk lower level patient remain compare control age weight score study included value number number significant group value lower group result primary treatment found retrospective study show therapy lead level control several year also significant patient overall result follow study assess
26293448 en association syndrome insulin therapy previous reported case syndrome type mellitus impair glucose tolerance without insulin medication
27079348 en disease disease cause remain effective method type mellitus DM aim type DM identify individual DM well health system clinical datum include hemoglobin hba1c participant use general population use datum model parameter obtain model DM use risk assessment fasting blood glucose found per patient DM identify hba1c improve per DM case identify diagnose severe case risk assessment fasting blood hba1c can significant DM
27058526 en disease major disease although study show protein major factor remain age lead several clinical study show type mellitus DM patient increased evidence suggest several DM evidence DM cause dysfunction model evidence DM model insulin factor
26164686 en mellitus independent risk factor development associate high risk study aim determine correlation type mellitus T2DM total T2DM patient body mass healthy included present study baseline characteristic blood pressure perform study participant interval duration significant high patient T2DM vs vs respective significant high T2DM patient compare control vs vs respective correlation analysis show positive correlation study significant patient T2DM compare healthy correlate index
26101367 en score use clinical mortality intervention aim study investigate relationship hemoglobin hba1c fasting blood glucose glucose score patient type mellitus disease diabetic patient undergo use base finding previous study correlation hba1c correlation hba1c also correlation correlation on correlation hba1c compare correlation hba1c
24360362 en mellitus condition define within first year mellitus therapy whereas early may two mechanism may disease cell cell cause cell compare early diagnosis mellitus occur age week common age difference group vs respective patient without also disorder undergo
25660137 en glucose demonstrated glycemic study patient type mellitus T2DM impact hba1c assess baseline hba1c known duration analysis datum patient T2DM study change hba1c baseline week assess overall population baseline hba1c known duration T2DM year year provide great hba1c reduction overall population large reduction hba1c increasing baseline hba1c hba1c reduction similar base known duration T2DM general well profile provide glycemic patient T2DM range baseline hba1c known duration T2DM
26011548 en presence type mellitus risk associate syndrome increasing risk cardiovascular event risk cardiovascular risk factor little effect mortality risk patient type evaluate relationship type mellitus medication identify use risk assess year index event base type status adjust baseline characteristic medication use index patient mean age year type follow-up type adjust type associate increased risk year year patient first index type patient type statistical significant high rate year year patient high type group group analysis patient type high risk event without evidence high treatment medication rate remain suggest need patient
19129716 en disease cause disease within on gene use method cell cell investigate first identify patient present body whereas reduce level cell cell cause two reported effect
19037828 en reported study evaluate treatment result test man two woman diagnose undergo on treatment patient follow function patient present severe show mean value pressure rate pressure respective total patient decrease improve case two case treatment consider patient high pressure may contribute normal large condition reduce treatment condition
17446653 en report general diagnose response increase serum response include severe impair well presence increased ratio addition regression two year patient
24471901 en metabolic provide range new aim treatment type mellitus type mellitus treatment perform mean system system early system increase increased evaluate system three system well system present system without system result effective treatment type mellitus reduce factor similar improve mellitus well effect trial need perform treatment patient common mellitus obesity
25929132 en one common complication type mellitus cardiovascular disease dysfunction system indicate develop new year treatment use type also development cardiovascular disease however mechanism target poor study investigate effect treatment activity system cause treatment treatment day oral two day day diabetic increased body weight elevated level impair glucose tolerance insulin resistance treatment result insulin effect decrease diabetic effect effect activity effect increased treatment result effect diabetic activity decrease effect change case treatment treatment activity diabetic effect function cardiovascular system consider develop treatment type complication
21170888 en use treat disorder recent trial suggest potential also treatment disease significant condition great normal renal chronic renal adverse effect mechanism concentration system cell identify evidence suggest potential role cell consider also can lead also effect cell finding treatment relationship concentration investigate early report clinical finding old result
27569076 en patient significant undergo major intervention high risk complication hospital mellitus chronic metabolic disease reported outcome evaluate impact mellitus development complication well hospital major total patient treat included clinical examine complication hospital subject consider diabetic one history oral drug insulin without diagnosis medication value fasting blood glucose use assess presence according association complication well hospital statistical compare diabetic group patient treat also diagnose mellitus complication patient whereas diabetic mean hospital day diabetic analysis statistical significant difference found compare diabetic group complication analysis studied risk factor study provide evidence metabolic control mellitus impact complication therefore hospital patient
23835113 en mellitus metabolic disease multiple complication cause disease year condition lead severe level research disease mechanism review role mechanism type type complication study use cell model subject insulin resistance reduction insulin gene multiple mechanism increasing also insulin insulin cause insulin resistance reduce insulin insulin gene increase identify potential target management mellitus complication
24625919 en common disease severe impact health study investigate effect type mellitus mechanism type mellitus provide evidence clinical type model evaluate function use method activity group low positive cell found normal type group compare group compare type positive cell low decrease group show decrease two group result indicate effect type may influence may
27181090 en cell regard risk factor mellitus number case reported evidence remain first report patient develop therapy on woman receive show elevated level plasma glucose hemoglobin week serum level negative patient show associate type therapy cause possible cell related disease adverse event blood glucose therapy
22008019 en compare patient mellitus mellitus dysfunction glucose mellitus chronic condition management health care patient mellitus positive treatment study total patient mellitus study datum identify mellitus patient mellitus two time effect model use significant difference found statistical significant difference found respective score related present statistical significant difference activity improve positive
23587153 en report mellitus study association type type DM type type DM patient included study blood use perform use similar two type mellitus high type compare type high type compare type type DM type DM type DM type DM similar control regard status
25410222 en time therapy increased number individual significant mellitus DM remain major disorder several potential include DM also common associate condition patient DM risk factor disease recent several large study DM identify risk factor relationship among DM system type type DM disorder include type DM disease risk factor diabetic therapy diabetic patient clinical syndrome associate DM
24115521 en mellitus major patient major although mellitus primary cause management clinical clinical potential major receive blood therapy evaluate incidence mellitus glucose association patient clinical parameter also patient significant old high level lower value patient without value high patient without difference statistical significant concentration patient without prevalence also high patient patient without value high patient normal fasting glucose level model assessment insulin resistance level associate glucose insulin level evaluate glucose finding significant
24224752 en patient hospital study determine risk hospital use patient severe type mellitus base whether medication retrospective cohort study patient medical conduct period medical review identify patient type mellitus hemoglobin primary included age year month new diagnosis type medication patient compare medication determine whether patient compare patient within month primary hospital significant hospital day vs statistical difference also found within day less hospital within day compare patient
27096738 en study evaluate prevalence treatment glycemic control mellitus DM population finding study evidence control number reported conduct year age use method rate DM prevalence treatment control well related factor total number analysis DM prevalence treatment control rate respective logistic regression analysis show female positive related prevalence CI CI treatment CI control CI DM history significant correlate DM risk CI increased CI treatment CI control CI DM status CI CI obesity CI related risk DM found current status positive correlate DM risk CI negative correlate DM CI treatment CI study high prevalence treatment control DM complication consider study assess DM increasing first determine regard method
24970784 en study evaluate whether risk mellitus cardiovascular disease elevated range chronic cohort study clinical research include participant severe disease disease disorder control outcome new diagnosis type mellitus disease outcome evaluate condition multiple outcome model cardiovascular risk factor estimate different condition new diagnosis type mellitus disease ratio multiple estimate confidence interval CI high relative observed disorder CI CI increased disorder include severe CI CI participant high protein great risk multiple outcome CI risk cardiovascular disease type mellitus increased range chronic disorder evidence risk associate clinical management patient chronic disorder reduce cardiovascular risk
23564755 en study effect cardiovascular outcome high risk type patient level control drug baseline characteristic total diabetic patient cardiovascular disease two cardiovascular risk factor insulin resistance baseline year correlate effect cardiovascular outcome effect insulin age year body mass index mean duration year mean hba1c hba1c among little among whereas hba1c diabetic reported patient diabetic treatment follow medication oral drug insulin prevalence high among insulin compare baseline use overall patient population control treatment provide diabetic patient cardiovascular disease high risk cardiovascular disease determine effect cardiovascular event
26483195 en important role renal mellitus DM association metabolic risk mellitus patient common clinical parameter retrospective first year patient develop among old patient or old age high body mass index BMI or high BMI first year or or also risk regard logistic regression analysis significant clinical show independent risk factor or show gene gene associate risk finding suggest metabolic may association study
26074216 en health aim study determine prevalence mellitus glucose among adult study blood glucose clinical history datum obtain individual prevalence individual glucose individual weight present participant lower level increasing age hypertension weight significant risk factor obesity significant risk factor low prevalence glucose population
26020231 en whether mellitus increase risk use compare use renal therapy renal patient severe without datum database patient compare patient severe control severe without compare case control without diabetic patient high ratio however diabetic patient severe vs high serum value vs less level less vs patient severe associate need independent risk factor renal dysfunction patient
24858432 en assess adult general population health diagnose chronic disease include diagnose adjust logistic regression use examine association prevalence diagnose diagnose association found year woman aged year association number chronic according result adult diagnose diagnosis adult diagnose known man old adult due possible medical care health
25119762 en current effect type mellitus conduct database use system mellitus type mellitus system system respective year old type mellitus included result rate type mellitus general present decrease rate activity activity type mellitus present change indicate need early complication group
24621466 en study show elevated rate associate increased risk diabetic well cardiovascular event mortality patient type mellitus recent blood pressure aim study investigate relationship patient type mellitus analysis patient type mellitus investigate relationship factor may related use analysis regression analysis indicate age duration mellitus hemoglobin use use independent associate logistic regression analysis indicate odd ratio confidence interval associate per increase respective significant associate independent known risk factor include patient type mellitus
16528130 en disease three disease case one different age year possible characteristic disease diagnose age two year old present year old perform time diagnosis intervention cause chronic renal intervention treatment early case show assess cause
24558030 en recent study show dysfunction increased blood cell cell patient mellitus also occur therefore associate high total correlate dysfunction develop method patient type mellitus control vs vs vs rate high diabetic patient compare control significant correlation rate measured lower diabetic vs correlate found mellitus associate high correlation may suggest dysfunction cell dysfunction study method may assessment function large study
23680890 en evidence mellitus increasing high first two recent evidence prevalence obesity mellitus recent development obesity chronic disease large increased recent time however care large remain control condition control obesity evaluate
26979890 en type mellitus DM high risk current study aim identify risk factor patient patient type DM without healthy control three different datum measured use system two DM group found significant reduce increasing risk control associate significant reduce well significant increased therefore reduce identify risk factor increased suggest may reduce patient current result show use identify associate risk patient type DM without early
26869191 en oral development treatment type mellitus T2DM aim study investigate effect participant without randomize study week participant included healthy subject on patient T2DM treatment hemoglobin participant year age body mass index blood occur time study evaluate activity level plasma glucose concentration body weight due on analysis perform patient T2DM analysis perform overall study population on profile participant without T2DM similar observed subject datum participant without T2DM patient T2DM day compare subject mean ratio CI plasma respective activity mean concentration increased glucose significant reduce population general population event effect body weight general participant without T2DM profile may provide important treatment patient T2DM
25183236 en determine characteristic among patient adult type mellitus determine characteristic patient review database one two prevalence group adult patient serum determined patient two two patient reported mean patient lower patient disease patient general diabetic population patient high develop
25327309 en glycemic status type mellitus T2DM role response profile factor level subject T2DM examine health status glycemic control level
25192916 en type mellitus recent increased risk mass normal elevated patient type increased risk due increased decrease increased result complication disease change common use method risk risk assessment patient type mellitus risk score new high diabetic present contribute mechanism increased risk risk assessment risk patient type
25154309 en woman gestational mellitus high risk population aim study evaluate change different time diagnosis identify group present cohort study cohort woman hospital on develop evaluate change clinical healthy activity woman baseline follow-up woman month month datum health care database follow-up conduct woman study first effective woman finding intervention target woman recent evaluate clinical trial
23444292 en show however studied type mellitus study investigate effect prevalence type mellitus study prevalence type mellitus according type age year association estimate test use evidence association type mellitus show result effect type mellitus result suggest research well large sample
26488032 en oral reduce type mellitus T2DM renal glucose glucose clinical trial demonstrated significant glycemic control addition associate weight reduction blood pressure outcome study significant reduce risk primary cardiovascular trial general well increased risk use insulin insulin increased risk reported although association less overall treatment T2DM
26387807 en study effect type mortality diabetic patient follow group patient condition adjust increased risk
26036542 en similar general population risk develop type mellitus T2DM develop T2DM well studied estimate incidence risk factor complication mellitus study examine one follow on total included study medical weight history mellitus statistical significant development mellitus high high decrease insulin use significant reduce protein studied significant impact history mellitus development high high decrease
25772641 en lower glycemic control patient mellitus recent due recent study observed increased mortality control old adult duration disease chronic complication although evidence patient suggest blood glucose level regard risk method level old population population great although several study management include old patient review examine regard hospital management patient population condition impact glycemic control also old individual need may important consider individual care association study
26173655 en determine effect individual type total patient type woman man mean age year BMI body duration year hba1c participant body mass perform two insulin finding compare glucose datum however show associate elevated compare lower glucose concentration early consider may individual type may increase risk
23597770 en reduce occur patient type mellitus without disease aim study test associate reduce type mellitus patient type mellitus without evidence disease blood pressure lipid management glycemic control month use use assess change serum measured participant type man mean age year mean body mass index mean hemoglobin mean blood pressure without studied subject impair elevated normal function normal function positive associate increase model include age body mass index hemoglobin blood pressure patient type mellitus without disease associate result early type mellitus
26124796 en chronic disease mellitus increasing incidence health care system population health care health care however research study use mellitus type use mellitus type well method use use participant use one individual determined total common high use use case oral use use improve system well high
27181199 en aim present study assess glycemic control treatment insulin therapy type patient on total patient type oral drug hemoglobin hba1c study insulin week treatment medical treatment patient hba1c without severe primary effective hba1c fasting blood glucose significant decrease mean respective patient receive insulin therapy one per day whereas blood glucose time week reported patient patient severe change weight low incidence adverse drug also score treatment rate patient significant improve insulin therapy associate decrease hba1c fasting blood glucose improve treatment patient treatment general well patient type finding need early treatment target
26275194 en mellitus metabolic disorder insulin oral complication mellitus individual evaluate use aim study determine use glycemic control type assessment glucose total protein level patient type total individual type control age group year study diabetic status assess estimate blood glucose level participant investigate glucose total protein level glucose perform use method method total protein method parameter subject statistical analysis use high glucose lower total protein observed patient type control significant correlation blood glucose result suggest influence significant correlation observed blood glucose level research need determine glucose mellitus
25583094 en mellitus health case type mellitus high associate obesity type consider disorder factor contribute development important development insulin mechanism activity protein type role insulin several reported associate disease common associate well obesity review association type mellitus
27128909 en level on cardiovascular disease study patient mellitus DM study need clinical DM present study investigate correlation index recent DM patient according duration clinical datum include plasma mass value type DM female patient mean age year mean hemoglobin level patient duration year significant different patient duration year level significant high patient year year on multiple regression analysis found positive correlation level patient duration year correlation suggest possible use DM patient disease study DM disease duration
25967696 en mechanism function blood although clinical evidence show associate large role need study test mechanism role model type control treat week treatment blood pressure fasting glucose level weight increased serum total cholesterol diabetic control addition significant reduce serum insulin level level diabetic insulin evaluate model improve diabetic resistance increased number cell increased change determined analysis treatment also determined increased determined well increased increased activity protein treatment change indicate important contribute dysfunction increasing activity protein
26892517 en factor factor metabolic study examine whether level associate development type study use examine association serum level fasting measured participant year old incidence determined follow-up year ratio estimate according age study status body mass index fasting glucose insulin protein baseline associate increased risk risk per remain significant increased man significant great compare woman per increase evidence effect study study insulin resistance high level associate may type impair
20682697 en identify clinical associate development type year gestational cell woman oral glucose tolerance test glucose body assess month gestational mellitus interval develop year regression analysis use identify baseline change follow-up associate development type baseline relative low insulin insulin response insulin resistance independent associate development follow-up weight rate significant associate use associate woman chronic disease chronic insulin resistance woman diagnosis develop type within year index weight potential factor increase risk
25820620 en blood type associate cardiovascular disease type mellitus whether also associate gestational mellitus examine relationship blood type risk woman within first week woman glucose test gestational week follow oral glucose tolerance test result diagnose base glucose association study group logistic regression use obtain odd ratio or confidence interval adjust risk factor analysis perform history analysis also perform use health blood group on associate increased risk compare blood group adjust or CI analysis show result use adjust or blood group among woman history among without group factor woman
26990724 en role insulin new treatment mellitus
23126582 en study type mellitus reported result study assess time group patient type mellitus relationship glycemic control chronic complication index patient year type mellitus woman man mean age year study test use determine presence assess hospital measured index included body mass index body statistical significant increase value patient control individual analysis show patient parameter significant decrease patient normal statistical significant association diabetic hemoglobin may patient type mellitus negative effect status patient
26537861 en subject type mellitus decrease increase risk common regard complication insulin syndrome patient impair without increased major mechanism glucose metabolic may role increasing activity well control provide parameter although clinical study role drug remain
24289947 en determine whether difference health among patient new diagnose use datum determine patient patient little one hospital patient new diagnose study group patient less compare patient patient compare population patient high rate group high patient health care significant
27554063 en glucose insulin use improve treatment patient aim study system clinical base system insulin system regard weight improve insulin test show correlation value glucose value range test show negative impact health two test patient type mellitus clinical without datum overall relative difference use well present result show individual glucose system system need new system high insulin glucose system can improve treatment patient type mellitus
21964531 en patient high datum impact mellitus disorder aim investigate impact mellitus analyzed datum cohort health study study control result use two study study without mellitus compare use method regression model study study case included study study among patient mellitus analysis patient mellitus increased compare without patient without mellitus respective adjust age disease regression model ratio patient mellitus CI compare mellitus increased compare without mellitus
25465273 en assess prevalence patient type type mellitus T2DM study patient day patient also retrospective reported severe patient T2DM respective reported little one event day respective reported little one severe event increased duration insulin therapy factor previous duration insulin year hba1c level T2DM rate increased low compare high hba1c T2DM time reported severe T2DM patient respective year retrospective respective also severe lead medical complication event T2DM patient respective retrospective study found relative high among patient finding risk
23039712 en lower pressure plasma level elevated condition hypertension syndrome renal disease mellitus disease aim study compare healthy individual individual chronic healthy individual mellitus type individual chronic mellitus type individual included study healthy individual individual chronic healthy individual mellitus type individual chronic mellitus type perform level mellitus type healthy individual individual chronic significant high clinical index mellitus group healthy individual individual chronic group individual chronic mellitus type significant high total level compare group also significant high total level found mellitus type group healthy individual individual chronic compare mellitus group healthy individual individual chronic increased level found individual chronic also individual mellitus effect mellitus chronic can increased individual mellitus
25687993 en several function evidence role system glucose type mellitus type mellitus T2DM although known insulin new datum indicate also contribute activity cell well cell major insulin insulin also effect cell review role system T2DM potential system T2DM associate complication
24341942 en aim study use report outcome complication cohort mellitus DM primary cohort study treatment outcome time use primary health care new DM patient female aged year type DM hypertension patient new diagnose first year follow-up decrease increased three time follow-up blood glucose cholesterol blood pressure obesity remain patient complication increased baseline year year cohort DM patient year use cohort analysis use cohort analysis patient DM disease
26911585 en common cardiovascular disease mellitus DM major independent mortality patient however DM patient less well current review assess prevalence DM disease patient conduct study prevalence DM risk factor patient database include identify datum conduct independent two risk included study assess use risk use prevalence estimate study similar overall major estimate study assess investigate reported according review study datum review identify well DM patient
23375266 en glucose glucose mellitus obesity investigate cell show on gene show gene cell control determine effect known function new significant difference function suggest significant effect on mellitus develop obesity healthy individual use individual test evidence influence mellitus obesity
24145196 en glucose may poor however remain whether may development mellitus patient study investigate hospital patient hemoglobin hba1c level subject profile define diabetic medication hba1c level follow-up period define serum glucose level observed patient development patient without vs adjust ratio among patient hba1c treatment associate reduce incidence patient adjust patient system associate reduce incidence patient
26467644 en hba1c mellitus DM significant correlation diabetic complication hba1c compare among subject different risk profile
26334380 en study determine impact high mortality diabetic patient treat datum impact clinical outcome patient mellitus treat chronic total identify diabetic patient assessment define test primary study three diabetic patient undergo incidence lower group low group respective within oral patient significant difference group association insulin therapy related decrease compare group vs analysis insulin therapy significant related mortality related mortality increased risk patient DM undergo
23375619 en type mellitus clinical condition prevalence among diabetic subject population prevalence clinical management type type present diagnose lead medical therapy patient important condition found common patient chronic elevated risk patient
24482376 en previous demonstrated increased condition diabetic metabolic datum indicate group also examine relationship subject diabetic metabolic
25733384 en investigate impact mellitus outcome intervention population disease identify patient disease patient first outcome study patient without patient incidence significant high patient without vs vs respective adjust mortality risk relative significant ratio confidence interval CI patient without whereas remain significant CI patient adjust risk relative significant patient without CI CI CI respective CI CI CI respective diabetic status effect relative patient without disease compare associate outcome difference treatment effect relative diabetic status
25592166 en study impact mortality among patient new diagnose type mellitus study care general baseline patient new diagnose T2DM patient follow year patient cause study association outcome regression model possible patient T2DM time per week among woman less week high risk CI CI man related increased risk outcome patient new diagnose T2DM associate increased risk woman man general treatment female patient new diagnose T2DM report
25413307 en aim database evaluate effect mellitus rate complication outcome total sample database patient undergo patient undergo identify base complication outcome compare diabetic patient index hospital overall complication rate group diabetic patient patient analysis demonstrated mellitus independent associate increased risk relative risk blood overall complication rate also independent associate statistical significant increase hospital difference day high difference overall complication rate group diabetic patient patient analysis demonstrated independent associate increased risk blood overall complication rate also independent associate statistical significant increase difference day significant difference mellitus independent associate significant increased risk complication hospital index
25563032 en glycemic control among patient mellitus DM use association glycemic also factor related glycemic datum obtain adult DM different patient health type health care type treatment age activity weight hypertension type one disease duration analysis conduct population determine statistical difference glycemic control participant level hba1c blood pressure however relative participant cholesterol cholesterol participant hba1c blood pressure cholesterol time patient health glycemic control patient system population present hypertension DM participant sample population glycemic control level blood pressure level adult DM activity level type medical type DM medical treatment factor associate glycemic control analyzed improve medical care DM
25454317 en increasing metabolic syndrome mellitus DM contribute effect disease well investigate effect DM independent primary study patient age year without type DM undergo assess assess assessment on base datum analysis perform determine difference subject without DM significant difference age duration disease diabetic subject lower year diabetic subject compare subject diabetic significant lower mean compare effect total model mellitus independent associate severe mechanism
24961932 en diabetic patient previous studied examine effect insulin outcome patient undergo database analyzed use test regression use evaluate whether mellitus mellitus independent associate adverse event patient undergo patient undergo rate overall complication significant among patient cohort analysis analysis significant associate complication or significant associate medical or overall complication or type significant associate or overall or complication type associate type complication large study mellitus significant associate adverse outcome analysis study effect complication risk
26440227 en mellitus DM patient DM patient reduce demonstrated great patient disease analysis examine level patient analysis randomize study patient receive primary use patient DM mean diabetic group group diabetic mean significant great time evaluate day patient significant high treatment compare diabetic patient great compare diabetic status
24718377 en increased risk type mellitus T2DM high study assess T2DM use score finding decrease T2DM low associate glycemic mellitus risk factor high aim study compare assessment woman study examine woman T2DM woman without age year measured examine within lower T2DM vs age mean high T2DM vs within T2DM group high subject glycemic control compare poor glycemic control T2DM lower associate poor glycemic control may increased high T2DM study need relationship glycemic control
24355661 en common mellitus however association well investigate aim assess patient correlate patient type aged year duration year healthy control rate examine score also difference also patient although rate reduce patient cohort correlate associate rate well score diabetic evidence may reduce high prevalence
24990226 en use rate compare patient type mellitus measured rate patient type mellitus control subject group on patient group normal group group one significant lower group group on lower patient group control significant difference group on group method patient normal
25767657 en mellitus patient associate dysfunction dysfunction patient however current also datum regard dysfunction mellitus study dysfunction study determine prevalence function among aged year mellitus hospital obtain clinical history perform blood plasma determine level prevalence positive subject aged year female positive subject study subject clinical however study subject datum diabetic also function diabetic risk dysfunction
25005850 en study aim examine prevalence associate risk factor complication well management care adult aged year conduct base outcome management included blood glucose complication also prevalence type factor associate increased risk compare history activity significant decrease odd management follow blood within year obtain common complication included disease found remain lower estimate management high complication rate factor role increasing risk intervention improve complication rate
23545169 en identify serum associate type mellitus T2DM analysis use model T2DM obesity change among protein identify total protein analyzed age target protein use multiple analysis identify protein time among on level elevated significant compare revealed increased cell may diabetic identify protein study can provide mechanism associate investigate serum compare type control early diabetic use serum profile identify several protein multiple relative protein use identify protein include may important T2DM diabetic
25160666 en however relative model develop type different cell type therapy several disease include mellitus type development increasing diagnosis rate review aim history use cell therapy
25687713 en mellitus one common disease great consider need patient regard treatment characteristic evaluate patient method increasing use aim compare evidence patient study regard treatment characteristic target treatment mellitus type important patient review conduct identify study show treatment patient mean level difference weight study determined base according value population study can included analysis level difference possible obtain study study show control blood effect weight change complication common outcome therapy study blood glucose control high within relative score treatment mellitus two study effect weight change first two study effect one study type determined primary outcome use method health aim assessment therapy patient evidence assessment medical intervention finding base finding review evidence patient treatment result show relative base score use result identify study
25814074 en assess poor control among old patient type mellitus T2DM study use datum patient aged year T2DM adult control management poor control age group year odd ratio or confidence interval CI year or CI or CI or CI T2DM duration year or CI year or CI use oral or CI insulin or CI oral insulin or CI elevated blood pressure or CI cholesterol or CI or CI hypertension or CI hypertension or CI or CI obesity or CI less associate poor age group year T2DM duration use elevated blood pressure lipid level associate poor control presence obesity less associate poor control
26666156 en mellitus change present present increase improve control factor insulin change can occur mellitus related increase mechanism mellitus disease
27044315 en result increased risk complication prevalence estimate type mellitus T2DM base study recent estimate prevalence among general T2DM present study use health datum provide estimate prevalence T2DM sample population patient health included define total score clinical clinical significant current use also estimate overall investigate use logistic regression total participant T2DM identify overall prevalence among T2DM confidence interval CI CI respective may high CI significant include age woman lower level current body mass index year total cholesterol significant also include activity cardiovascular prevalence among T2DM may lower early study however remain high research follow-up T2DM need effective management
25820555 en whether therapy risk patient type mellitus analysis perform database female patient new diagnosis type mellitus health follow-up treat patient on use incidence estimate ratio regression group duration follow-up develop incidence per respective overall adjust ratio confidence interval adjust ratio first duration therapy respective respective analysis drug associate reduce risk use associate decrease risk
25523621 en develop among type population present study use multiple review conduct two group participant identify use subject use test diabetic patient conduct mean age participant group year respective group female mean duration year respective analysis obtain control multiple method obtain aim patient type patient assess patient type mellitus determine value clinical
26791354 en type mellitus associate role mechanism remain revealed present study examine whether related type participant type participant without type undergo assessment perform assess mean compare participant without type difference observed participant type participant score lower function type type associate
26658458 en assess type mellitus undergo period activity use assess use activity individual treatment little perform care on total participant examine participant blood glucose period reported participant reported individual level insulin hba1c independent associate total score age independent associate individual insulin can improve
25908069 en patient mellitus DM increased risk adverse outcome previous study reported treatment without insulin type study investigate patient type DM type DM T2DM included patient development care disease evaluate according therapy undergo primary identify patient T2DM ratio confidence interval mortality patient total patient included T2DM patient vs year reduce function vs disease vs patient mean follow-up year patient among patient among patient T2DM adjust ratio confidence interval patient T2DM compare patient without risk compare patient without risk patient T2DM increased
24238346 en on diagnosis mellitus type odd disorder disease range adverse outcome lower poor outcome increased patient treat effective care study examine new develop intervention control trial conduct adult type type increased score study included participant patient health participant study include participant statistical significant difference group effect level primary outcome level assess outcome control participant intervention baseline month period follow-up month datum per addition conduct intervention show potential care large improve health clinical trial
26246459 en cardiovascular disease risk factor control primary patient type mellitus year review current clinical trial blood pressure blood glucose control cholesterol management therapy present recent new clinical target include cardiovascular disease management patient type mellitus
25363329 en type mellitus DM associate type cell individual datum role cell DM identify role cell examine response blood individual DM compare without DM found elevated cell type type also found cell type type cell associate significant baseline cell associate significant decrease associate cell therefore datum suggest type DM associate cell possible contribute increased
25104099 en important role response chronic type study aim investigate association type base datum include type patient control control related glucose insulin total participant identify associate type odd ratio odd ratio show association type odd ratio also associate plasma glucose female participant associate type odd ratio odd ratio odd ratio significant associate plasma glucose adjust age body mass index female normal associate type population female subject
24111619 en known chronic treatment blood glucose mellitus among chronic great type chronic disease insulin resistance insulin resistance glucose glucose cell elevated increased insulin may also serum level cell mellitus resistance therapy chronic datum suggest therapy patient mellitus therapy disease development due mellitus therapy
23778416 en assess relationship low serum level gestational mellitus woman according assess level woman gestational mellitus control low analyzed serum level woman gestational mellitus control define status level severe gestational mellitus significant lower level compare control vs however analyzed gestational mellitus significant common woman severe level adjust severe level independent associate increased relative risk gestational mellitus relative risk gestational mellitus woman level statistical significant concentration also significant high woman gestational mellitus compare control vs result obtain study provide datum indicate severe serum level significant associate elevated relative risk gestational mellitus adjust risk factor gestational mellitus
24975987 en investigate association time risk mellitus sample adult datum study baseline participant reported time activity level mellitus diagnosis follow-up association time time activity level risk mellitus follow-up examine use adjust logistic regression total participant mean age year baseline included analysis association baseline time risk mellitus follow-up compare odd ratio CI although association adjust model included BMI participant high time baseline mellitus follow-up low time adjust odd ratio CI although participant high reduce incidence increasing activity reduce time
27574437 en previous show weight treatment body weight associate change blood pressure fasting lipid assess parameter randomize control trial previous patient type mellitus receive fasting lipid datum patient receive show reduction baseline week fasting low cholesterol low cholesterol whereas high cholesterol increased weight decrease large analysis demonstrated show significant reduction fasting lipid profile associate weight
18584216 en primary chronic disease renal condition reduce patient studied retrospective follow year year diagnosis clinical datum concentration test patient treat weight measured obtain clinical show weight body mass index BMI time mean weight BMI follow-up respective three treatment show first year follow-up associate diagnosis study different
25686480 en evaluate glycemic control relationship disease characteristic treatment patient type mellitus DM well study perform on total patient primary clinical clinical history age year time DM year mean patient significant relationship control time DM patient perform previous month patient determined receive treatment insulin therapy patient compare receive therapy respective patient insulin therapy patient receive oral insulin level large patient poor control poor control increase according treatment patient related clinical
24581827 en current evidence effect disorder among population study investigate effect risk effect disease identify medical datum conduct study use logistic regression analysis conduct subject disease cardiovascular disease mellitus chronic disease disorder risk odd ratio or per positive associate risk observed model or confidence interval significant increased risk subject cardiovascular disease mellitus datum may include due diagnosis determined medical significant increased risk among individual cardiovascular disease mellitus
26923011 en recent evidence suggest mellitus DM risk factor disease one protein associate DM however occur relative therefore use DM cause determine whether mechanism associate aged month old evaluate treatment increased lipid treatment also increased number cell level also effect compare high result suggest associate may contribute
26653434 en type mellitus T2DM patient increased risk cardiovascular disease one cause mortality population factor development new disease can early patient use high mass analyzed serum profile subject according three group T2DM patient T2DM patient without subject control identify potential related T2DM on little analysis analysis identify different group potential T2DM patient reduction serum level found T2DM patient compare control present patient low serum level result show reduction T2DM patient provide associate T2DM
17550208 en large normal individual therefore use high concentration treatment old adult use oral associate serum concentration use oral therapy use low renal low reduce level normal report treatment management
17371330 en disease cause gene reported large number therefore cell gene patient found different include three determined total however treatment cell two datum show base patient
22348847 en patient time individual without mellitus datum suggest patient reduce function patient type present patient type increase reduction reduce function found change system important consider patient age glycemic control status presence diabetic complication observed study several change increased occur association evidence associate potential mechanism disease insulin resistance protein
22906083 en evidence increased cardiovascular cardiovascular determine prevalence rate cardiovascular disease mellitus compare control primary patient mellitus control use general large primary care base cohort datum analyzed use logistic regression analysis age prevalence rate significant high mellitus compare control result mellitus remain statistical significant age hypertension or mellitus or association or result increased prevalence rate level mellitus suggest
26785712 en dysfunction associate impair type mellitus study T2DM patient year man perform function parameter include test perform increasing associate study found association impair independent age duration insulin mass function
27618634 en increasing use health however little known type potential health study mellitus conduct retrospective analysis use analysis related group datum on total group found related DM included analysis female provide research provide DM on large number year age group finding diagnosis related due care DM increasing health study research regard health intervention health
25308779 en prevalence among population aged year study on total included study response rate fasting plasma glucose level measured little fasting diagnose according fasting plasma glucose treatment impair fasting glucose define according association respective previous diagnosis assess prevalence among adult population man woman prevalence impair fasting glucose according respective prevalence previous diagnose among population man woman prevalence previous diagnose man woman man woman oral insulin lower blood analysis age BMI history identify independent risk factor activity identify independent factor prevalence impair fasting glucose found high population although rate treatment increased control rate low level
25529857 en clinical month patient type compare among group renal patient type treat studied treat one subject medication period investigate analysis assess effective subject three group base parameter analyzed patient receive therapy hba1c level significant improve patient receive therapy change hba1c level month significant different group receive respective similar significant different different group receive therapy consider effective patient type renal present analysis perform
26774907 en evaluate effect blood glucose poor control patient type trial study study clinical type insulin treatment month age year hba1c perform subject follow insulin change insulin assessment perform baseline mean age year duration year receive insulin therapy mean month parameter significant improve month role function role function score overall patient rate overall compare intervention also improve overall patient health compare patient intervention type significant improve outcome role function large
25981398 en aim study evaluate role current type diabetic patient use
25765669 en evaluate incidence mellitus glucose development renal disease receive therapy study compare clinical parameter group group perform analysis identify risk period patient develop patient diagnose base group old age vs year high level fasting plasma glucose vs hba1c vs vs lower value vs group according analysis old age year high hba1c level lower identify independent risk factor or CI or CI or CI respective risk ratio development patient little one three risk factor statistical related development old age high hba1c level lower development
26651592 en insulin development type mellitus T2DM disease analysis revealed develop improve glucose however also lead glucose review recent regard function well develop therapy disease T2DM
24918447 en effect dysfunction glycemic control type type improve dysfunction glycemic determine effect hemoglobin hba1c serum retrospective study subject female female age year subject diagnosis receive management baseline hba1c define concentration baseline occur patient patient patient significant high value BMI lower difference hba1c total insulin per body weight compare patient month significant increase patient significant reduction BMI decrease hba1c baseline subject associate statistical significant decrease BMI decrease hba1c
22340922 en cohort study association disorder retrospective cohort study investigate incidence mellitus among woman use datum define group woman aged year first history gestational mellitus mellitus hypertension diagnosis woman normal without group age index year group group follow evaluate study woman case woman overall incidence mellitus high group group adjust ratio confidence interval CI age ratio develop increased CI woman obesity high risk woman obesity high risk mellitus early woman need
26701964 en assess impact treatment level among patient type mellitus high risk level measured baseline month study treatment randomize trial compare patient type cardiovascular disease multiple cardiovascular disease risk factor regression analysis perform assess effect study included randomize participant baseline blood sample analysis mean age year woman year type duration mean study participant baseline include level common use diagnose change level baseline follow-up significant different group impact level body suggest risk associate
26721657 en relative body type mellitus T2DM remain investigate body risk develop T2DM man participant included healthy man present without baseline evidence cardiovascular disease hypertension participant group normal weight measured cohort base value define hemoglobin fasting glucose baseline follow-up follow-up year man develop adjust age fasting glucose relative risk confidence interval CI T2DM CI CI normal weight CI however association statistical significant adjust potential CI CI vs normal weight body mass index CI vs analysis man time CI great risk T2DM man increased risk T2DM CI compare weight man result suggest obesity incidence T2DM independent potential however risk develop man
24914241 en examine relative dysfunction insulin resistance risk among woman gestational mellitus
25413942 en patient type mellitus low body mass index complication common control complication trial demonstrated therapy aim hba1c level normal reduce incidence use insulin therapy metabolic control two effect high rate severe increased weight patient current reduce metabolic control negative therefore weight control patient present treatment result need study large patient follow-up possible year patient similar general population T2DM
25407306 en evaluate prevalence outcome use association study group vs gestational mellitus retrospective cohort study perform hospital datum medical hospital period hospital use value follow oral glucose tolerance test hospital use gestational mellitus diagnose group group respective adjust odd ratio confidence interval CI period incidence lower mellitus compare period CI observed significant difference outcome two diagnosis method result increase incidence gestational mellitus lower risk significant difference outcome mellitus
21610689 en elevated occur development type type mellitus complication increasing incidence mellitus obesity new cause on age obesity study model mellitus suggest pressure age may potential high level cell type mellitus reduce age without change mellitus renal complication normal study healthy mellitus show high age insulin resistance age improve review age result mellitus age
24559769 en assess time prevalence mean blood glucose included review regression model year participant age independent use prevalence estimate mean fasting study identify time define can due prevalence remain adult increased old adult among woman among man period mean fasting glucose increased among woman among prevalence mean fasting glucose increased two effective increasing number population
23876547 en estimate mellitus population review study prevalence mellitus population perform use method datum prevalence total study prevalence mellitus range estimate prevalence obtain datum individual study CI prevalence impair fasting glucose impair glucose tolerance disease research population reported prevalence high prevalence can potential increase year change occur population need evidence chronic disease population
23351995 en present study investigate relationship activity diabetic patient activity determined blood sample patient type patient type individual without control assess regression analysis use determine independent association activity patient type type mellitus compare patient activity significant reduce respective increase activity significant associate reduce adjust result first time activity lower patient type mellitus diagnose datum activity role
27329023 en examine clinical outcome gestational mellitus primary care care group control trial primary care use examine prevalence gestational week time care outcome total woman primary care care prevalence gestational week similar time care primary care care difference woman primary care also show high rate large gestational age care difference group suggest care may associate potential time care possible lower rate research need finding improve care research need test finding health system
26499503 en care age group multiple randomize control trial treatment health status also increase care therefore care patient on important care evaluate effect care glycemic control patient type hospital conduct randomize control clinical trial patient type poor glycemic control hba1c level aged year month participant control intervention group care provide identify medication test use evaluate datum statistical define change mean hba1c level baseline level within month datum test show mean hba1c level significant decrease month intervention group compare increase control group medical group significant vs significant difference rate intervention provide improve control blood level patient increase medical
27234772 en obesity associate poor patient may provide patient weight also reduction report case obesity poor control mellitus treat year year follow-up body weight complication also provide total well base may treatment patient renal obesity control however potential patient study
27105711 en metabolic syndrome adverse health outcome elevated prevalence rate chronic disease different group aim evaluate prevalence mellitus addition different value impact prevalence study health condition population age group total female aged year medical study total female participant reported participant prevalence high group independent value use difference prevalence mellitus demonstrated however treatment among study difference prevalence treatment treatment common use among woman among woman demonstrated high negative metabolic metabolic important health therefore determine important primary system reduce difference improve health status population
27431395 en base associate low incidence target whether also mellitus DM patient DM patient patient undergo included follow patient according presence vs DM patient undergo index primary incidence target target total patient DM undergo compare mean follow month DM patient compare high rate vs CI large high incidence vs CI high incidence vs CI study large compare clinical outcome patient without DM show DM patient associate significant high rate whether risk factor may impact high rate remain
25262459 en woman gestational mellitus high risk develop type mellitus study aim evaluate intervention glucose disorder impair fasting glucose impair glucose tolerance woman total woman present normal fasting plasma glucose week randomize two group intervention group undergo activity control group follow-up on total woman follow-up intervention group control group glucose disorder rate clinical metabolic change rate woman intervention group develop glucose disorder follow-up period compare control group analysis indicate reduction rate glucose disorder BMI less or low or low or healthy or intervention effective glucose disorder woman body weight found factor development glucose disorder current control trial
26341126 en one high prevalence estimate rate examine cause datum diabetic database datum cause contribute cause cause mortality rate complication cause cardiovascular disease determined cause mortality show related rate increased total population period rate increased related disease disease increased show increasing related mortality can due prevalence cause primary cardiovascular complication reduce
27522035 en obesity mellitus DM clinical assessment insulin resistance important body factor insulin resistance patient type included DM patient perform value insulin resistance body measured analysis use regression analysis show total ratio significant correlate value regression logistic regression analysis show ratio independent significant associate insulin resistance define value odd ratio confidence interval analysis value ratio insulin resistance indicate ratio significant effective insulin resistance DM result can provide possible value use regression DM ratio assess clinical evaluate presence insulin resistance clinical
26915859 en mellitus occur increased compare incidence risk factor vs without identify analyzed use test risk factor examine use regression overall incidence year year incidence respective compare respective high risk ratio age body mass index BMI mellitus risk factor BMI high incidence risk factor early risk factor clinical intervention complication
25865283 en aim study determine blood glucose rate woman gestational identify type among woman medical woman hospital retrospective review diagnosis perform according datum group association diagnosis use determine whether woman develop type total included blood glucose first month year type multiple logistic regression analysis patient body mass index insulin use independent associate type study can provide develop improve follow-up woman diagnose
24030920 en patient type mellitus use insulin may however recent datum regard incidence conduct review determine patient type mellitus treat insulin randomize control trial compare drug insulin assess incidence therapy analysis perform study possible association potential risk factor datum study insulin glucose confidence interval CI CI patient treatment severe CI patient glucose severe occur little CI CI patient respective risk factor significant analysis study insulin datum can patient type mellitus therapy clinical trial remain associate low risk participant randomize control trial general population care datum clinical
26440603 en glucose glucose tolerance reduction insulin reduction insulin associate number health outcome increase glucose level may increased risk cardiovascular disease type on number drug therapy use chronic disease management adverse effect glucose risk glycemic control among patient study review evidence mechanism clinical adverse effect glucose
25168970 en woman previous gestational mellitus increased risk develop type aim study determine level metabolic week associate increased risk type year plasma concentration glucose insulin measured normal glucose woman week index woman assess year year development type follow-up period year woman develop type significant risk factor development type fasting plasma glucose level week addition high level lower level week also significant risk factor development type plasma glucose level significant risk factor development type woman first report identify potential type woman history
24284841 en on high incidence mellitus reported among patient diagnose disease although known increase blood glucose level investigate whether lower reduce blood glucose effective patient compare effect common blood glucose level control patient mellitus determine patient mellitus receive syndrome type clinical determined group group patient blood glucose level fasting day day day day also blood glucose status clinical outcome evaluate week significant increase fasting blood glucose level day group group significant difference group group group blood glucose level significant elevated group increase significant great group group group respective reported patient decrease week treatment difference group status clinical outcome different patient study may cohort patient mellitus type perform determined clinical randomize different diagnosis syndrome result different level influence duration patient may change can therefore patient compare without associate statistical significant patient day high increased great lower without control status clinical outcome glucose control patient clinical trial
24517008 en function cell tolerance function reported correlate high risk disease include type present study conduct investigate association type analyzed patient patient control subject use method studied population control respective or or significant high patient control significant female patient significant difference found control subject analysis show new result study indicate gene population woman great risk man
23106688 en high risk develop compare population syndrome cohort identify risk factor however little known management population aim study examine health care use one study use health care total result show type type significant syndrome disorder type study found glucose level hba1c great level individual reported poor control statistical type independent result also management development population regard care result suggest index control poor normal weight lipid level finding two important first management group need great primary health care among population
25438527 en investigate patient mellitus provide management among patient prevalence risk factor chronic disease among adult use total aged mellitus undergo history chronic disease one year blood index blood glucose total cholesterol high cholesterol low cholesterol patient female mean age year old mean value mean value female high prevalence female prevalence decrease increasing prevalence female increased age age group year prevalence high female however lower female year old prevalence obesity high normal subject among patient high total cholesterol high high level cholesterol low cholesterol diabetic patient two serum lipid value clinical target among diabetic patient target observed patient common increase observed mean value among mellitus high general population prevalence aged year female aged year obesity high among diabetic patient target
20857149 en mellitus DM important risk factor increase cardiovascular disease several study found high mortality rate diabetic patient patient however study found evidence dysfunction patient mellitus therefore investigate influence mellitus outcome study patient included patient three group patient without mellitus patient mellitus use oral drug DM patient mellitus use insulin DM three group compare mortality dysfunction included patient patient DM patient DM follow-up patient mean month mortality significant high patient DM compare DM patient patient on perform patient follow-up dysfunction found patient significant difference dysfunction three group mellitus significant impact follow-up insulin related increased mortality however influence dysfunction
24700718 en metabolic syndrome receive great potential cardiovascular increase risk lower however relationship metabolic syndrome chronic disorder lower remain study investigate characteristic risk factor early chronic disorder lower subject risk characteristic risk factor complication diabetic patient early chronic disorder lower also investigate addition association early chronic disorder lower study examine subject risk factor include obesity hypertension mellitus lower function measured high prevalence early chronic disorder man subject early chronic disorder high blood pressure normal function female subject early chronic disorder high fasting plasma glucose level control prevalence mellitus also significant high female patient early chronic disorder diabetic patient early chronic disorder high fasting plasma glucose total cholesterol level also complication control group independent risk factor early chronic disorder female subject risk age fasting plasma glucose man age woman two time great risk man independent risk factor early chronic disorder diabetic patient age hba1c level woman time great risk early chronic disorder man among diabetic patient prevalence early chronic disorder subject risk factor female diabetic patient great risk early chronic disorder subject diabetic patient early chronic disorder complication control early function found correlate blood glucose level status
23971526 en common control patient retrospective investigate effect insulin patient patient included glucose control outcome compare patient use insulin identify patient use therapy group insulin therapy control group group significant lower fasting glucose level first day vs lower mean glucose level day vs group also lower incidence first day vs patient group significant interval hospital significant difference total medical observed two group also patient use multiple insulin therapy observed significant difference two therapy glucose control insulin therapy improve control glucose reduce incidence time patient
26573598 en serum early diagnosis can improve outcome serum protein profile patient disease diagnosis case year diagnosis control studied sample patient diagnose chronic disease type mellitus healthy subject relative serum test use multiple sample sample identify reduce diagnose sample significant reduction level month diagnosis on significant also decrease patient compare healthy control patient low level correlate poor clinical diagnosis patient reduce level observed mellitus significant lower level also observed patient compare individual type mellitus level decrease month diagnosis significant influence mellitus consider study
24582090 en cardiovascular disease complication mellitus great reduce complication patient glycemic control rate cardiovascular event management on cardiovascular disease treatment review current care patient risk cardiovascular disease
26368267 en conduct review renal mellitus glucose high incidence therapy different mechanism major risk factor although drug related mechanism drug also investigate datum show renal patient oral glucose tolerance test present high although fasting plasma glucose test addition also possible role hemoglobin diagnosis renal associate patient reduction increased cardiovascular mortality function management disease patient well population several drug studied patient glycemic control present management reduce possible
25281785 en patient increased risk dysfunction mellitus risk factor may increase risk association test whether can use model chronic also determined whether type can cause use model type T2DM control chronic common T2DM group analysis T2DM T2DM analysis T2DM without treatment T2DM T2DM T2DM treatment oral day perform cell investigate T2DM group compare group group compare control group cell increased T2DM group improve cell T2DM group result chronic T2DM metabolic disease may model also suggest may treatment dysfunction may
22658337 en one medication primary cardiovascular disease event recent year however regard increased incidence mellitus observed clinical trial therapy randomize control trial included incidence major primary adverse effect hemoglobin blood glucose level present clinical observed important patient therapy metabolic syndrome may develop mellitus although weight evidence suggest effect development mellitus study evidence regard adverse effect therapy insulin addition may blood glucose level although may present time evidence cause effect relationship without evidence current clinical regard use therapy
27181070 en insulin insulin insulin present study investigate patient type randomize trial patient type mellitus receive insulin randomize day treatment response evaluate glucose target glucose rate profile use profile show effect profile compare profile show follow insulin profile similar decrease characteristic profile patient type mellitus profile effect reported previous patient type mellitus
21910811 en case due gene insulin severe day one insulin therapy insulin lead tolerance insulin insulin
25220104 en intervention healthy adult found reduce type little potential woman history gestational mellitus conduct study randomize control trial intervention among woman history total study identify randomize trial intervention woman study however finding suggest intervention improve risk factor woman history large control randomize trial need assess effect intervention type among woman
25817523 en high rate datum patient type T2DM study assess rate period cohort adult adult T2DM patient datum use sample female high less mean age year mean score range on patient reported time year study follow-up patient time time group number treatment medication use group increased treatment or or decrease medication or T2DM patient reported high rate without rate treatment patient may treatment primary care
22365890 en high concentration may cause significant protein lipid low level cell insulin result gene known increased due role several disease mellitus mellitus disorder cause multiple factor diabetic patient show increased gene among patient may increase risk type mellitus female early type occur low level can contribute complication cause increased
26678516 en identify gene type mellitus T2DM population association study however study association gene T2DM complication remain association different within complication conduct study population contribute T2DM odd ratio or confidence interval CI or CI or CI associate increased risk T2DM regression analysis perform age body mass index found blood pressure prevalence hypertension risk disease or CI significant high subject population therefore datum associate increased risk T2DM contribute high incidence hypertension complication patient T2DM risk need large population
26642791 en profile lipid examine group patient mellitus type incidence type gene lower mellitus type patient lower total lipid total cholesterol disease population
26684169 en associate diabetic complication clinical datum examine association presence review study compare patient type mellitus T2DM without complication study database study evaluate use perform use model provide mean difference confidence interval CI determined identify study included review study range high level associate high level associate influence body mass index duration effect age effect suggest level high T2DM patient complication study large analysis finding
25120793 en study possible mechanism treatment glycemic control type mellitus T2DM model T2DM old group group use group use plasma insulin concentration fasting concentration change model assessment insulin resistance use insulin resistance significant decrease fasting blood glucose level oral glucose tolerance reduce insulin resistance increasing concentration level rate group significant high group group significant reduce blood glucose decrease insulin resistance concentration level may contribute insulin decrease
24139553 en role investigate whether improve glucose type mellitus type mellitus patient undergo hospital datum weight glucose hemoglobin define previous patient patient control patient improve similar patient control patient improve month fasting glucose hemoglobin decrease significant patient high fasting plasma level patient lower patient show effective type mellitus patient
24070804 en obesity major prevalence type mellitus risk type increase body mass index obesity current whereas per health care individual time without disease weight health change impair glucose tolerance associate relative risk reduction type metabolic associate type weight management on weight type individual glycemic metabolic control type health glycemic metabolic target associate weight weight body management type
25885918 en effect obesity found patient cardiovascular event obesity analyzed patient cardiovascular mortality increased compare without therefore study association body mass index BMI mortality patient without study patient patient without aged year patient first follow datum review assess association BMI mortality cause model adjust risk factor clinical characteristic complication well medical drug patient normal weight BMI high mortality rate patient without per year per year respective adjust significant effect obesity mortality found patient without ratio confidence interval CI obesity CI obesity found patient however analysis show patient CI medication CI patient without patient elevated BMI investigate finding study sample status need
25407209 en examine association gestational mellitus high weight risk development chronic according weight status outcome well incidence hypertension cardiovascular disease woman group significant difference rate rate observed group follow-up year incidence group hypertension cardiovascular disease group high rate respective group low rate respective however rate similar respective group presence high weight risk develop however association hypertension cardiovascular disease similar suggest need effective intervention condition improve health patient
25933474 en previous study positive association serum incidence type mellitus T2DM total estimate aim assess relationship use risk factor measured sample man without known history T2DM baseline association level case T2DM glucose tolerance test determined estimate use regression analysis adjust potential baseline mean age year mean follow-up year new case T2DM analysis adjust age body mass index blood pressure serum history T2DM association compare ratio confidence interval vs first protein activity level change estimate study evidence association risk T2DM study need finding define relationship factor influence T2DM
25899474 en assess prevalence metabolic syndrome among patient type prevalence complication without studied patient diagnose base cell insulin time diagnosis datum clinical characteristic well complication study prevalence also patient without according metabolic syndrome overall prevalence among patient old duration increased serum cholesterol logistic regression analysis associate however age duration hba1c BMI significant association odd ratio or CI or CI high among patient presence associate increased risk diabetic
24351018 en increase number mellitus recent early diagnosis treatment primary insulin oral improve patient complication remain cause increased mortality therefore complication care diabetic patient also individual healthy change may significant reduce
23250457 en mellitus group disorder increase blood glucose concentration common current mellitus type type type compare type diagnosis fasting oral glucose tolerance test well use hemoglobin hba1c datum association clinical treatment
23747312 en lead hypertension mellitus report indicate response lower aged patient aim study evaluate role age duration obesity obesity well total patient known duration obesity undergo consider study age duration obesity presence mellitus hypertension metabolic syndrome metabolic cholesterol blood glucose weight month patient high duration obesity response logistic regression duration obesity independent effect old patient less weight patient mellitus hypertension improve patient different age metabolic syndrome old patient associate great decrease blood glucose follow-up different different age different duration patient lower weight response similar patient age duration obesity consider
21972198 en examine association factor use risk develop mellitus cohort
23702239 en evaluate method perform patient type year assess patient well identify change method value hemoglobin also participant female obesity statistical significant decrease hemoglobin compare value observed although patient method can also use patient group lead improve blood glucose control significant reduction hemoglobin group healthy
27509959 en research association type mellitus evidence present study determine association type mellitus female population study hospital on total patient included datum test use consider high woman diabetic patient group compare odd ratio association risk develop elevated statistical or CI result study show associate risk develop woman or CI association subject or CI compare subject or CI associate obesity increase risk woman on diabetic woman
25889068 en large body research health datum health population review aim mellitus DM complication among include develop use identify potential study identify study use develop datum study characteristic include method finding analysis perform evaluate include age status identify total related identify study analysis study conduct use study overall study reported high prevalence DM among compare lower compare group complication high low status analysis show research datum incidence status found status complication prevalence reported health population research develop reduce
25393823 en evaluate impact included oral glucose tolerance test improve rate glucose woman gestational mellitus large retrospective compare level first month woman diagnose gestational impact included woman period period mean age year BMI analysis use score cause period show rate high vs odd ratio CI high woman receive insulin treatment odd ratio CI odd ratio CI vs odd ratio CI effect condition oral glucose tolerance test perform woman undergo increased impact increased use oral glucose tolerance test effect woman receive insulin treatment
26577416 en may improve glycemic control patient gestational mellitus effect type mellitus T2DM aim examine risk T2DM association among woman history woman history health study cohort health study follow overall score different use assess year use model estimate ratio case T2DM T2DM compare high low overall score score score woman history high protein associate high T2DM risk whereas high protein significant associate risk T2DM
26004430 en identify characteristic function among individual type mellitus evaluate effect T2DM study conduct subject control identify individual group ratio age level function assess use test on test use logistic regression diabetic factor associate mean score subject subject normal function impair individual without assess use test subject normal factor duration T2DM high hba1c insulin treatment associate lower level function use consider risk factor risk may associate duration use medication glucose control decrease risk important glucose control adjust medication patient
25642391 en associate type mellitus T2DM less known disorder without evaluate prevalence disorder subject examine T2DM define score compare metabolic syndrome subject without also analysis subject undergo oral glucose tolerance test diagnosis use clinical subject year old T2DM included present female significant associate current disorder major logistic regression analysis significant associate major presence disorder body weight datum group T2DM association disorder similar role disorder group risk T2DM
23534498 en aim present study determine type mellitus investigate relationship rate contribute factor serum hba1c duration clinical trial evaluate rate healthy use method three use significant difference time patient control vs respective vs respective positive correlation duration correlation level patient patient body mass index score significant lower patient normal vs respective related duration glycemic control patient compare patient normal rate may also
25813251 en study number indicate increased risk mortality diabetic datum regard outcome woman mellitus type DM aim study evaluate woman DM outcome assess whether improve retrospective outcome DM woman follow hospital year group on period group perform test logistic regression multiple regression method use statistical present range woman group on old vs year group statistical significant duration BMI woman type on glycemic control hba1c group on vs vs vs rate decrease vs incidence syndrome age duration also decrease vs on rate week vs mortality vs observed however difference statistical improve glycemic control lead outcome diabetic
25358618 en investigate whether high number individual associate increased prevalence type mellitus related risk factor include study one general population two population conduct primary outcome type outcome risk factor type total participant mean age year high number among group age associate significant increased odd CI obesity CI suggest two per one case relationship result suggest increased associate increased risk type obesity health level new
27681272 en study aim determine prevalence elevated type diabetic patient identify contribute risk study conduct type diabetic patient datum elevated level define prevalence analyzed analysis use identify independent risk diabetic patient elevated elevated respective prevalence elevated man woman elevated man woman elevated high positive associate elevated or CI elevated or related elevated or CI elevated or CI risk elevated diabetic patient increased presence obesity or CI lower woman or CI hypertension or CI current status or CI or risk factor elevated relative high prevalence serum diabetic patient demonstrated diabetic patient
27026222 en hemoglobin level level well level plasma glucose diagnosis known use level analysis according system clinical level fasting plasma glucose plasma glucose oral glucose on compare clinical system control complication trial hemoglobin mean time compare regression found mean level significant perform well test clinical population level diagnose
25458341 en investigate status adult without type concentration related include total measured adult type include patient control concentration significant lower patient type control subject without control prevalence low group without control group respective plasma level also lower level high group compare control group high group whereas low elevated increased level protein cell observed group healthy type associate dysfunction
16990696 en on patient previous treat therapy therapy year present develop high datum indicate presence show low level primary develop patient
23383581 en develop new system general care mellitus according method develop medical determined according parameter method treatment diabetic complication level according change patient condition treatment medical use patient health status diabetic complication well receive patient treatment system clinical trial mellitus
25434186 en review analysis datum obtain system mellitus model DM type patient DM change system different include insulin group system cause metabolic occur type DM on DM condition DM
25807646 en present study determined blood sample patient diagnose mellitus DM result compare healthy control study also determined different include normal concentration measured plasma use method sample studied found range result study show mean value lead significant high blood sample diabetic patient compare DM patient two three time high value subject whereas concentration lower blood sample diabetic patient compare different total concentration study show increased decrease result associate mellitus therefore may role development mellitus
26642342 en activity mechanism type mellitus cell early disease report treatment patient undergo time follow-up patient remain little month without use insulin time patient month range month among patient follow-up remain insulin month hemoglobin hba1c concentration diagnosis year year year year severe complication however one patient lead glycemic control patient period year patient
23834044 en obesity effective method obesity mellitus type type diabetic patient improve diabetic patient little known type report female patient mellitus type two undergo one remain three result show weight reduction well blood glucose control insulin year BMI patient range improve one year hba1c decrease one year total insulin reduce one result show insulin obesity however blood glucose control remain important therapy mellitus type
23497232 en increase mellitus high current mellitus one risk factor study reported mellitus among patient one high study conduct among adult patient diagnosis hospital determine prevalence mellitus associate clinical factor finding well clinical datum use obtain care blood perform patient treatment mellitus diagnose level presence prevalence mellitus among patient patient known diagnosis mellitus study participant type mellitus analysis mean concentration associate DM CI DM CI relationship DM well remain statistical significant analysis study mellitus common among patient significant clinical associate mellitus among patient mean serum concentration
23399780 en incidence mellitus increasing recent influence glucose investigate role mellitus metabolic syndrome study man disease trial define according regression analysis risk perform use model assess association development baseline subject one group diabetic mellitus without mellitus without condition follow-up year range year follow-up new case ratio reduce diabetic patient compare without confidence interval significant association presence development analysis mellitus development presence result study indicate association type mellitus risk
25279862 en determine prevalence cardiovascular disease level cardiovascular risk factor care high risk type high prevalence mellitus on analysis risk care cardiovascular disease risk factor level high disease among subject mellitus mean disease duration year reported reduce reported care respective within year woman man reported glucose large study individual study level cardiovascular risk population also mechanism difference risk population
25974092 en type mellitus T2DM health whereas new care model clinical study test effective care T2DM compare new model management patient mellitus base general use health among hospital change glucose cardiovascular risk factor control patient case care evaluate compare control patient control age profile follow medical management patient group day hospital study mean number study case control follow-up hemoglobin hba1c significant decrease case cholesterol decrease group body mass index decrease case present study health care base care little effective management improve control T2DM
22830945 en high DM study aim assess result patient DM within health may report month activity patient first whether DM blood glucose follow fasting blood glucose one DM patient DM identify known diagnosis DM patient need DM result new diagnosis DM patient patient DM care addition impair fasting glucose prevalence DM significant high patient health population population high hospital patient show patient DM high patient known new diagnose disease blood test glucose DM may improve diagnosis management patient
26054489 en improve type mellitus patient increasing evidence show also patient BMI compare effective patient hospital study perform patient included study parameter compare patient patient patient follow month metabolic parameter significant improve group rate group time month month month patient high rate month month difference observed patient patient show significant multiple parameter patient high rate patient need outcome different large study need outcome observed evaluate effective patient
26647072 en assess effect treatment base datum glucose control patient patient type mellitus T2DM treat insulin intervention group level day use three study period intervention group receive treatment base datum group receive base blood glucose hba1c total patient study mean baseline hba1c intervention group group study significant difference change baseline hba1c two group also significant difference change baseline treatment score two present study treatment use retrospective datum effective control patient T2DM
25502808 en total serum cholesterol consider risk factor severe outcome type examine relationship serum lipid incidence prevalence diabetic three type mellitus study diabetic total cholesterol history use year incidence diabetic association found high level cholesterol decrease prevalence diabetic odd ratio per CI adjust duration mellitus hemoglobin use renal disease adjust association serum total cholesterol diabetic use decrease incidence diabetic mellitus time change medical care little effect serum lipid incidence diabetic
23529112 en known risk factor disease role development less included participant aged year without clinical cardiovascular disease receive medication baseline study model use evaluate association total ratio investigate mellitus status follow-up year case observed significant mellitus analysis mellitus status participant ratio high respective adjust mellitus association high ratio great participant also high low high total ratio respective lipid associate individual without risk great individual mellitus also high low high total ratio association high
24528195 en study evaluate impact system clinical management patient type randomize study included patient type year old treat multiple insulin hemoglobin hba1c level compare intervention group two control group studied patient metabolic control treatment patient included study time use follow compare less time vs hba1c improve group vs vs treatment use subject type metabolic control provide result glycemic control treatment significant reduction time use patient
24323672 en increased mellitus may impair function protein protein known whether mellitus
24531153 en disease associate mellitus DM population study case reported large report case DM prevalence DM high diagnosis test among case report suggest DM
25047243 en aim present study compare correlation index blood glucose level determine obesity index female study weight measured BMI body mass index ratio ratio body index fasting plasma glucose plasma glucose hba1c hemoglobin fasting serum insulin high correlation blood glucose hba1c female however low characteristic type mellitus high index obesity BMI female obesity correlate glucose population general obesity index type mellitus adult
26315042 en mellitus define diagnose within first month condition occur related type gene analysis perform use target include datum develop low weight week age develop day patient treat insulin month insulin treatment can month age develop normal analysis revealed factor associate type associate previous
25403204 en risk factor several year diagnosis however impact large analyzed status among patient diagnose two cohort study health study health follow-up study result among patient diagnose case estimate ratio use model age diagnosis year CI patient year compare without time month diabetic month score reduce change result among patient case CI compare without time month diabetic month compare time diabetic use oral insulin observed statistical significant association year associate statistical significant decrease among patient three study
23992543 en glycemic control impair response determine response type mellitus assess response duration patient old mean control old mean subject study lower subject control study respective level similar control study within first year response response suggest mechanism response different
24059307 en disease common disease year old year factor within one multiple factor chronic well impair also role development mellitus insulin may decrease according decrease insulin indicate may consider risk factor development mellitus protein important target association therefore present review mellitus well potential common treatment
24026917 en type mellitus T2DM chronic disease high mortality rate previous adult disease diagnose T2DM new due may type mellitus oral use use intervention conduct lower adult T2DM high incidence early outcome datum management due general treat T2DM review management
24565829 en mellitus DM important cause renal although common whether lead renal aim study compare renal parameter renal function diabetic control population age body weight diabetic control included sample examine identify assess serum concentration also compare observed overall increase common observed include observed case diabetic control however among diabetic diagnosis serum concentration similar group diabetic range range control range range result suggest DM lead clinical renal dysfunction diabetic may difference diabetic
25754501 en aim present study investigate association serum level type mellitus group studied patient T2DM female included complication disease diabetic without disease control group healthy blood fasting plasma glucose fasting insulin hba1c serum level T2DM patient found significant high compare patient without level significant positive correlate model assessment insulin resistance hemoglobin hba1c respective significant correlation level logistic regression analysis level found independent associate patient T2DM association T2DM complication found
26414227 en may improve outcome individual type mellitus large intervention effective identify factor effective adult type database randomize control trial evaluate compare care control datum two independent assess risk group method on show lead clinical important glycemic control reduction hemoglobin hba1c whereas without little high effect lead great reduction body mass index reduction hba1c great participant baseline hba1c level great adult year trial high risk analysis therefore outcome reported provide little poor glycemic control research number
22433536 en important role disease general use use treat conduct may among determine difference may one use mellitus use study report treatment mellitus identify study treat mellitus analysis study use mellitus suggest new report reported study effect model clinical evidence use treat mellitus primary system finding new use current study
25047371 en investigate change relative impact history obesity mellitus DM period analyzed datum health population year multiple logistic regression analysis use examine association DM man aged year association DM odd ratio or confidence interval CI CI CI association obesity DM or CI or CI woman aged year significant change or obesity period man aged year association DM whereas obesity less important compare
25850712 en prevalence type mellitus increasing obesity condition great medication improve glycemic control lower risk contribute weight examine include use new therapy analyzed use datum health outcome datum may prevalence population among datum prevalence obesity multiple high aged year overall medication study period insulin treatment follow oral use low associate poor treatment glycemic control may association medical association association study
26820201 en health patient control insulin according glycemic control aim insulin type mellitus study patient year undergo therapy cause use therapy analyzed also cause different regard age disease patient undergo therapy age treatment year old patient one year diagnosis use improve reduce high glycemic control severe control hba1c year age improve year age improve year indicate high glycemic severe different related glycemic control patient
26332936 en early reported individual poor control severe disease compare study compare treatment outcome hba1c level change group diabetic patient without respective hba1c index baseline month treatment month treatment subject without without on total patient follow baseline month diabetic without show reduction hba1c level mean value month mean value respective month diabetic show high level without diabetic without baseline month diabetic show high number diabetic without diabetic without show high level without treatment group improve condition decrease hba1c level period three month change number diabetic subject treatment
26234180 en complication type mellitus patient potential cause observed diabetic subject age found patient however whether age present high level diabetic subject whether elevated age impair study determine whether age healthy patient compare analyzed patient patient healthy subject age measured assess test significant high level significant different significant different positive correlation found hba1c hba1c can lead less reduce patient
25952036 en evaluate effect insulin treatment cardiovascular patient type mellitus total patient receive insulin therapy insulin group multiple group control control group included datum history finding include glycemic lipid parameter cardiovascular protein group correlation cardiovascular parameter also evaluate significant high mean value hba1c vs vs vs group difference insulin treatment well patient control group parameter negative correlation treatment duration group whereas positive correlation age treatment duration finding cohort patient glycemic control revealed insulin therapy associate increase whether
26084591 en investigate change pressure mellitus patient provide diabetic include mellitus patient group normal group normal blood glucose level subject provide medical history undergo oral glucose tolerance test subject measured use method pressure perform significant difference found age body weight body mass index two group fasting blood glucose level time group significant high group however pressure significant high group group difference found two group high found follow first pressure group group group high group difference pressure diabetic patient increased pressure different significant increased may lead
22550716 en clinical mellitus mellitus syndrome syndrome analysis clinical result present
25555462 en on review identify study patient type mellitus T2DM examine use model new treatment study patient T2DM first year range new treatment T2DM included one study range first year range first year study patient T2DM provide little change time event disease study indicate value use analysis
25546555 en aim study current diagnosis follow-up gestational mellitus care woman hospital one hospital assess assess outcome study association study group medical hospital use different test two hospital one test diagnosis hospital oral glucose tolerance test different two hospital use follow-up fasting plasma glucose medical respective outcome study association study group independent year study within hospital improve care woman
28033258 en aim study evaluate effect disease management glycemic control type mellitus patient sample participant study follow year provide therapy complication according clinical primary outcome change hemoglobin one participant follow-up significant decrease hba1c level mean hba1c level respective value general model demonstrated change glycemic control associate insulin treatment blood glucose activity duration improve glycemic control general individual multiple therapy activity duration may great
24827815 en aim determine prevalence obesity among adult type mellitus assess prevalence metabolic syndrome study cohort woman patient aged year diagnose follow health care blood pressure presence disease medication hba1c high cholesterol level mean age study group year mean duration year mean hba1c level per study population body mass index body mass index female patient aged year significant compare healthy woman age group respective female patient age group among man age group difference prevalence obesity compare healthy man general population difference age disease duration hba1c level treatment associate normal weight group patient lower level increased prevalence hypertension metabolic obesity woman metabolic syndrome among individual among normal weight individual
26817104 en study relationship level patient chronic type mellitus T2DM different
22020084 en aim study review intervention clinical study provide mellitus on review conduct found increased risk develop type mellitus development disease intervention reduction body weight increase activity reduce different population intervention also demonstrated risk decrease patient group individual mellitus intervention change weight increased activity current
25404660 en assess association rate change insulin resistance function woman gestational mellitus
26632952 en study aim assess among adult without mellitus evaluate age cohort health estimate without assess age group period cohort sample little adult aged year old model estimate number among increased age among significant number among however adult without difference adult without group time care need among adult
26264437 en high disorder include factor cause previous syndrome case reported age first week report two individual first diagnosis syndrome diagnose present age year identify gene patient may due consider patient present
26373629 en evaluate treatment glucose patient type mellitus study patient T2DM evaluate overall population base age baseline week patient hemoglobin blood pressure blood pressure cholesterol cholesterol baseline week body weight reduction week baseline similar patient treatment group week great patient compare patient body weight reduction week patient week also provide compare treatment general similar age analysis include treatment target may patient analysis duration study included associate treatment compare general well week
24821389 en study assess relationship diabetic care adult type identify adult type use clinical database statistical disease related health use identify system use obtain logistic regression use assess association care outcome identify patient patient type patient vs year duration vs year high hemoglobin vs adjust odd ratio per confidence interval adjust odd ratio confidence interval general adjust odd ratio confidence interval associate also associate glycemic large however role outcome research role individual factor influence
27170498 en mellitus diabetic individual show assess therefore develop assessment recent development analysis assessment system individual type two use on different provide database study assess use individual type compare addition system evaluate study conduct hospital adult type study day total hospital present participant database participant independent use assess mean participant whereas value system significant individual participant found study indicate system estimate high individual type participant use assessment
25965403 en renal disease patient renal therapy mellitus DM high mortality rate increase prevalence compare without DM risk factor mortality patient study investigate prevalence impact mortality patient cohort study included patient therapy aged range year prevalence DM follow regard duration renal status disease disease define value lower follow year overall year mortality individual high patient DM compare without DM vs also influence presence DM analysis CI patient DM DM patient significant high compare patient DM observed duration vs year lower vs regard presence study presence patient associate increased prevalence vs vs history vs patient DM presence increased vs multiple analysis remain independent mortality patient DM CI time multiple analysis show age per one year increase independent mortality patient patient DM treat high overall mortality patient significant patient DM low level associate increased mortality patient according datum patient DM risk reduction
25375980 en hemoglobin hba1c recent included diagnosis mellitus whether
24084701 en study investigate effect factor glycemic control patient type study use datum use activity relationship study analyzed use correlation associate outcome level according model influence glycemic health outcome found role patient although intervention individual factor may contribute disease glycemic control
23581598 en aim present study assess control cardiovascular disease risk factor association age control among old adult type study use case adult control management database on total aged year type mellitus included analysis on case report use datum clinical factor duration condition treatment cardiovascular disease risk factor complication assessment cardiovascular disease risk factor control assess included hemoglobin hba1c blood pressure body mass index lipid old adult target hba1c on great old adult aged year significant target hba1c cholesterol compare group also associate target hba1c or CI or aged control cardiovascular disease risk factor old adult type old target hba1c old adult aged year
23458195 en cardiovascular complication associate type mellitus evaluate study develop week type mellitus week body interval treat body oral day increased lower treatment reduce increasing status decrease lipid provide effect change improve treatment observed decrease increased reduce level normal treatment reduce observed elevated decrease study cardiovascular effect type
22660838 en on number clinical finding demonstrated effect management however mechanism provide model type studied study examine effect diabetic also evaluate possible mechanism insulin management body weight follow glucose day body weight week blood level fasting blood glucose hemoglobin significant increased insulin level decrease group significant effect group group show elevated level serum decrease treatment significant increased protein decrease level activity also revealed effect study suggest effective reduce complication type model treatment diabetic patient
26289308 en prevalence type mellitus T2DM metabolic syndrome increased year condition cardiovascular complication recent man several regard association reported relationship obesity insulin resistance several randomize trial therapy patient T2DM metabolic parameter hemoglobin blood pressure significant reduce respective however result improve cardiovascular outcome evidence study found increased rate cardiovascular event therapy review regard management man T2DM
25733341 en patient chronic increased risk mellitus type risk develop complication compare incidence diabetic patient new without patient patient month diabetic complication incidence cardiovascular disease datum retrospective two cohort mean body mass index obesity rate history year follow-up patient show little one complication patient reported cardiovascular disease compare patient develop complication one patient due patient increasing age CI CI positive associate diabetic significant different diabetic without chronic
27020257 en type mellitus cause mass factor cell clinical study development response cell system response among different cell type datum indicate cell response cell without undergo difference can chronic cell cell target response development target therapy present review
26833058 en lipid glucose observed type however important role type metabolic disease possible mechanism lipid glucose effect cell model model use role lipid glucose cell protein level protein also indicate model found protein level perform possible indicate study indicate lipid glucose type mellitus
25523209 en associate function aim function type type T2DM compare healthy control studied patient adult age range year patient T2DM age range year healthy control year participant undergo subject poor healthy control well multiple follow-up individual test show significant poor test effect T2DM healthy control range large several two group associate poor function group difference may due use adult sample relative age T2DM sample characteristic healthy control subject sample
23481612 en found association disease aim study assess prevalence serum patient type mellitus type mellitus study patient patient T2DM healthy control cell assess case function assess test well perform patient found positive prevalence high T2DM healthy subject prevalence disease significant high patient compare patient T2DM T2DM patient found case dysfunction one significant association found subject one disease
23456072 en mellitus factor incidence patient cell datum patient cell hospital retrospective patient mellitus DM group mellitus group factor compare two group patient receive mellitus group mellitus group incidence total patient mellitus significant difference age hypertension significant difference factor type two significant difference found DM group incidence group group significant difference incidence group risk value group group patient cell mellitus risk factor patient cell receive
23374518 en study serum level relationship type control medical two group group control normal group diabetic high type mellitus T2DM day plasma glucose ratio measured development T2DM group day blood estimate serum level function assess use datum high determine level decrease significant diabetic group group similar significant diabetic adverse serum level function high
22847316 en hemoglobin hba1c concentration glycemic control index management well known complication however hba1c level glucose provide glycemic control recent day week hba1c concentration patient disease renal glucose influence medication severe renal disease condition level glucose status glycemic hba1c may suggest index complication review provide current role however association glycemic complication need
25348655 en mellitus one disease develop blood glucose diabetic patient improve factor treatment mellitus current type mellitus model use model estimate parameter model blood glucose insulin per day therefore develop model blood glucose type mellitus important glucose insulin concentration interval parameter model type diabetic patient level clinical datum result show method estimate glucose insulin concentration clinical datum
26232097 en mellitus study show result conduct evaluate association perform review identify cohort study provide datum participant use time model estimate associate change identify case follow-up period year interval year clinical factor significant associate CI per increase association analysis individual year follow-up impair fasting glucose baseline analysis association man woman status hypertension BMI associate per decrease associate increased risk mechanism may provide
24685034 en management hypertension type mellitus patient primary health method use case hypertension patient case type mellitus patient aged year management year related blood pressure glucose rate management hypertension patient type mellitus patient management rate respective rate blood pressure control among hypertension patient rate fasting glucose control type mellitus patient respective rate management hypertension patient type mellitus patient hypertension type mellitus patient primary health rate regard management management control blood pressure glucose
24834700 en prevalence significant risk among patient indicate need include general medical medical mellitus medical high related lower related factor negative effect patient perform base individual health assessment patient risk metabolic control chronic complication well level health patient assessment health status patient patient perform
25808747 en role type mellitus study examine association among subject low incidence patient healthy control history DM disease investigate hospital hospital control subject although control show relative difference significant respective among control high among patient or high among control patient or among control high among patient or among control high among patient or subject
24053906 en assess association mellitus DM use outcome patient method retrospective evaluate patient treat regression model use association DM use disease disease mortality patient DM use within range follow-up month patient disease disease cause regression analysis patient DM great risk disease ratio confidence interval CI CI mortality patient without DM DM use independent associate lower risk disease CI DM increased risk disease use effect regard disease mechanism impact DM patient potential effect need
25176225 en aim datum analysis care T2DM patient determine can treatment result treatment included T2DM patient large define according observed hba1c blood pressure index clinical reported different treatment event included T2DM patient analysis patient datum patient hba1c observed T2DM patient event risk per patient year patient one event event type T2DM primary diagnosis significant difference observed event datum indicate treat T2DM patient number treatment T2DM possible clinical patient hba1c also treatment low T2DM event rate whereas one several treatment high event risk
26983624 en obesity type mellitus woman age examine management woman type outcome woman addition result glycemic control type type gestational management woman type include weight management weight weight blood glucose level medication medical therapy
27620854 en study examine factor associate prevalence among group group per population individual aged participant characteristic well diagnosis treatment obtain use fasting blood level individual on index use prevalence study population blood glucose drug insulin little one control blood glucose individual level found negative associate prevalence whereas individual great high great high level high great blood glucose control medical positive associate blood glucose prevalence intervention control improve management factor
24507548 en increased risk mellitus DM significant complication complication DM may use therefore important reported increased risk DM large cohort diagnose age identify subject age population study subject hospital risk rate ratio diagnose overall confidence interval CI per increasing case DM age case per age relative risk DM significant increased risk DM type high type increased risk DM risk increasing finding need intervention follow-up
24502891 en investigate whether oral glucose tolerance test woman syndrome medical woman healthy blood perform woman normal glucose tolerance impair glucose tolerance time first test without follow-up period woman year range year woman baseline incidence rate woman baseline type mellitus incidence rate healthy subject follow-up period year range year woman baseline per year among three woman baseline rate type mellitus woman compare healthy subject woman test early glucose tolerance addition interval determined study woman
26627635 en assess prevalence chronic disease baseline identify associate risk factor determine effect according estimate rate cardiovascular mortality cohort study type prevalence CI associate age year or CI or CI follow-up patient compare patient adjust cardiovascular mortality CI CI cholesterol respective adjust mortality CI aged year CI aged baseline independent risk factor cardiovascular mortality overall cohort man woman primary disease independent risk factor cardiovascular mortality primary
25403779 en on syndrome diagnose mellitus age addition due on also found cell two disorder occur early age associate role cell
25509148 en mellitus DM change function system one development DM complication factor lead change insulin type DM insulin resistance type DM great system control range subject significant change evidence suggest DM significant activity lead development disease cardiovascular system metabolic disorder diabetic reduce function disorder different type DM duration review datum result study model patient disease study change DM disease develop effective treat complication
24874325 en investigate patient mellitus cardiovascular examine patient mellitus man woman test index use decrease rate blood patient mellitus cardiovascular without index healthy time difference found diabetic patient without cardiovascular important role disease group patient
24157192 en syndrome patient mellitus DM associate high risk major adverse cardiovascular event treatment impact therapy patient DM investigate aim study evaluate association therapy patient DM syndrome study population patient DM receive receive therapy treat define development patient receive therapy receive mortality rate also significant lower patient receive therapy respective analysis identify therapy independent reduce risk odd ratio confidence interval relative risk reduction significant lower risk observed patient DM also receive regard mortality rate well
24102240 en diabetic complication mellitus aim evaluate gene type control patient disease included type mellitus patient without type mellitus patient healthy normal control subject undergo blood lipid profile glucose insulin gene different control group type mellitus patient high also similar group type mellitus control group diabetic patient without suggest gene independent risk factor type mellitus patient
26459421 en common complication hypertension regression blood pressure however whether aim lower risk examine effect compare risk patient mellitus control cardiovascular risk trial randomize control trial outcome define mean index baseline prevalence mean index similar respective however follow-up year compare associate lower risk odd ratio confidence interval significant lower adjust mean index lower risk associate follow-up regression baseline lower rate develop new compare age observed result provide evidence target compare patient hypertension mellitus great reduction
26206092 en health reported high rate estimate population diabetic increasing recent increase three mellitus DM found related high mortality complication poor general health lower DM significant cause medical complication however compare develop research conduct incidence prevalence DM health due DM level control great healthy include weight control DM review DM current
24558997 en compare glycemic control lipid profile undergo two different treatment type mellitus mellitus health retrospective study conduct evaluate subject two different period year year status treatment evaluate use body mass index BMI age lipid evaluate according use glycemic control evaluate hemoglobin evaluate individual mean age study year mean disease duration year on significant difference hba1c value total plasma cholesterol found year time status show significant difference result study suggest contribute blood glucose level without cause lipid profile compare
24770746 en study included patient type mellitus impair tolerance associate hypertension patient hypertension healthy evaluate level type glucose insulin hemoglobin patient type mellitus hypertension level ratio well reduce healthy individual observed determined development patient type mellitus hypertension
26542497 en investigate association type mellitus type mellitus T2DM patient undergo included patient undergo primary type define increase relative increase little serum compare level odd ratio patient T2DM compare patient without use logistic total patient T2DM among patient T2DM respective develop compare patient without adjust odd ratio CI patient CI patient T2DM patient without T2DM associate increased risk risk high patient T2DM independent renal function
25466870 en mellitus common disease factor known show protein lead mellitus investigate three include identify database individual similar individual one subject analyzed include analysis revealed one association subject finding lead mellitus present common finding lead disease model syndrome
25333677 en gestational mellitus increase risk develop type mellitus T2DM review assess effective intervention T2DM woman previous gestational intervention show effect woman risk T2DM intervention role may role reduce risk T2DM finding number study population intervention outcome duration risk T2DM potential intervention study need use T2DM woman
26433497 en mortality rate related well disease disease role diabetic period provide datum type among woman diagnose gestational
25963769 en associate range chronic metabolic cardiovascular include type mellitus may role development use assessment also difference provide index relative risk factor presence identify woman man aged undergo analyzed baseline characteristic include presence previous diagnose woman man woman significant lower mean difference man vs difference effect age body mass index BMI woman man significant high mean difference age BMI logistic regression show great difference significant associate high age BMI effect among woman odd ratio per confidence interval among man difference measured study risk factor develop
21956417 en on use recent study may role development weight insulin resistance dysfunction several mechanism development however study examine association examine association level mellitus health level examine outcome mellitus define according association observed positive association increasing level mellitus independent factor age body mass index serum cholesterol level compare odd ratio confidence interval associate association present among well level found associate mellitus independent risk factor study need finding
24411665 en study determine relationship body mass index BMI development well mellitus DM adult medical review conduct use adult patient undergo first renal patient receive less year age datum time hospital month included development DM treatment incidence month respective odd develop month increased factor confidence interval CI CI CI respective per increase BMI need DM treatment suggest DM status month patient DM DM treatment odd develop month increased per BMI common time develop DM within month
23374356 en mellitus remain poor define aim study define incidence factor mellitus review patient undergo mellitus define treatment within day logistic regression conduct identify factor patient undergo research hospital remain patient study population occur patient glucose increased body mass index BMI glucose time compare patient without analysis impair glucose glucose independent on model use three factor demonstrated occur patient undergo factor include glucose elevated glucose increased datum important patient outcome
26490082 en low adult type trial study individual type compare low care intervention weight intervention less low intervention low change weight blood glucose level rate perform low assess rate number effect randomize control trial study study participant identify show low great weight intervention care low month evidence difference outcome low found great difference intervention associate great difference weight fasting blood glucose level month rate low low effective weight among type level low control study high although provide poor
26948827 en prevalence gestational mellitus estimate new significant increase number patient on study estimate prevalence gestational one complication however study use show health woman diagnosis type important risk factor well complication case
24290092 en compare serum level patient patient without type mellitus
24070797 en current management patient type mellitus primary care total primary care datum type patient day day hemoglobin blood pressure target patient patient insulin insulin therapy among receive drug respective mellitus status treatment associate treatment type primary care glycemic control patient also high use insulin therapy primary care relative previous aim effective type patient need
25104237 en mellitus associate rate mortality compare general population although association effect factor obesity presence cardiovascular disease association also remain need study datum sample association cohort study participant aged year health health mortality odd ratio or mortality confidence interval estimate use logistic logistic among adjust age status or mortality among mortality or disease cause significant factor odd mortality without baseline or group addition mortality among also increased mortality disease cause increase mortality independent obesity range factor incidence mortality risk important increased health care
24409070 en evaluate effect control patient type mellitus early patient early type mellitus patient undergo total datum evaluate blood glucose hba1c insulin model insulin resistance significant improve type significant measured value hba1c patient medication hba1c patient decrease medication reduce hba1c analysis diabetic control associate type associate improve patient first year control related duration
24055484 en associate mellitus DM present study aim investigate DM patient total DM patient healthy control individual blood cell analyzed group individual on healthy control identify DM patient respective significant difference compare control group group group two identify datum gene on may one risk prevalence DM associate clinical status population
26931265 en occur due system found associate association obesity insulin resistance study examine patient recent type mellitus age control body mass index BMI fasting blood glucose serum insulin plasma measured BMI subject group insulin resistance score model resistance method parameter BMI well level insulin found significant high subject diabetic control parameter also show significant difference group insulin resistance score show positive correlation BMI plasma association high plasma found positive correlation parameter study obesity type may insulin resistance may factor may obesity type mellitus two
26575297 en type mellitus T2DM negative function datum show relative age control patient disorder risk T2DM review evidence association T2DM adverse clinical change disorder study investigate effect treatment disorder T2DM insulin resistance great lower treatment response disorder insulin associate lower treatment T2DM insulin improve insulin resistance disorder associate negative clinical outcome health clinical patient disorder increased risk metabolic syndrome receive medical care time treatment T2DM insulin resistance positive effect outcome finding research can impact patient care
26218633 en two previous study on mortality patient study aim investigate value mortality patient type type mellitus included care study present analysis two cohort blood patient patient sample patient model use evaluate relationship cardiovascular mortality risk assess follow-up period year patient cardiovascular factor high level independent associate increased cardiovascular mortality patient value high high risk cardiovascular mortality compare patient low different model significant difference association mortality risk factor value risk factor cardiovascular mortality
25130285 en mellitus high blood glucose level define result insulin health increasing regard new case diagnosis method use complication hemoglobin may use diagnosis method evaluate glycemic control blood glucose level month aim study evaluate method hemoglobin estimate value study included blood sample obtain patient healthy year glycemic value method determine glycemic level sample blood glucose concentration
23536904 en mellitus one major cause adult mortality develop however little assess mellitus hospital retrospective review hospital datum obtain medical diabetic patient diabetic follow test use examine total patient hospital study period patient type type mellitus increase type type mellitus case mean age type mellitus type overall mellitus patient female mean body mass index type mellitus increased type type number mellitus case hospital on treatment care need improve increasing mellitus case
25937182 en time type diabetic patient receive medical one type diabetic patient analysis use negative regression incidence rate ratio compare event rate different study increased year adjust CI severe among woman old patient year period increase rate type diabetic patient risk management develop severe patient type
26150192 en study evaluate rate according status type total patient assess use test according time rate also evaluate patient three group interval difference interval significant lower group low ratio significant high group level positive correlate interval logistic analysis patient level show significant lower risk level odd ratio significant correlate rate parameter however significant association concentration presence therefore study relationship level
25887997 en presence mellitus DM associate increased mortality risk patient chronic aim study identify factor associate type mellitus T2DM study control conduct hospital total patient study subject among patient T2DM case patient control clinical datum obtain model show difference DM group group patient duration year show high T2DM odd ratio confidence interval adjust analysis three factor high duration presence contribute increase T2DM addition risk factor include history DM low level elevated level presence finding suggest high duration presence several factor may potential risk factor development T2DM patient glucose patient risk factor
23872407 en type type mellitus DM associate impair function model DM effect high blood glucose level correlate impair although increase decrease known provide important mechanism study examine effect DM use model type DM use model type DM study show reduce whereas mechanism change however level effective change suggest common mechanism mechanism change improve treatment impair function DM patient
20163515 en according need type gene lead disorder patient presence cause current treatment disorder use plasma recent also show increased level result
23728331 en several study found related obesity type mellitus however report effect metabolic syndrome blood test value mellitus study investigate change body weight blood test value mellitus model type mellitus metabolic syndrome condition receive significant difference observed level type mellitus metabolic syndrome develop week age body weight plasma insulin level week age lower normal plasma glucose level significant lower body weight level insulin significant high decrease body weight insulin level present study development mellitus condition addition obesity high blood level observed receive
23212717 en mellitus therapy type mellitus reduce mellitus complication associate weight obesity study determine whether weight mellitus therapy type mellitus associate type mellitus female mean age year mellitus treatment control complication trial undergo score follow-up intervention complication study treatment subject body mass index change include treatment subject great body mass index need insulin great year year great score odd ratio confidence interval subject metabolic syndrome blood pressure great year great score odd ratio confidence interval follow-up increasing history mellitus hypertension associate great weight associate increase obesity insulin resistance blood pressure well
22461662 en aim relationship metabolic syndrome type mellitus risk among aged study follow-up subject aged type mellitus baseline included ratio type mellitus metabolic syndrome define estimate follow-up total participant develop type mellitus age cardiovascular disease type mellitus ratio confidence interval common subject metabolic syndrome compare subject without evaluate metabolic syndrome individual impair fasting glucose obesity high incidence type mellitus finding suggest metabolic syndrome type mellitus impair fasting glucose obesity target primary among aged metabolic syndrome
24526702 en cardiovascular complication contribute increased mortality patient mellitus mellitus associate increased increased protein determine role protein diabetic increased also associate impair diabetic increased primary cell increased diabetic cell factor two new cell decrease target cell new study identify effect mellitus mechanism
27749986 en incidence type mellitus T2DM can develop health whether insulin T2DM associate complication risk development T2DM assess effect insulin T2DM associate complication impair glucose tolerance impair fasting blood glucose elevated hba1c control trial health clinical trial review health assessment report included trial trial database included control trial duration week compare insulin intervention intervention intervention impair fasting glucose impair glucose tolerance elevated hba1c review assess outcome datum independent one review datum review review use model risk ratio outcome mean difference outcome use confidence interval effect estimate trial analysis outcome can assess overall evidence use included participant participant datum intervention group participant three trial investigate two trial investigate one trial on total participant datum control group group participant participant one contribute participant duration intervention month year included trial low risk risk cardiovascular mortality treatment observed evidence incidence T2DM compare CI trial participant evidence one trial incidence T2DM define use trial diagnose T2DM two fasting blood glucose value show trial reported datum adverse event trial follow-up year compare on total participant compare participant ratio CI evidence two diagnose T2DM fasting plasma glucose level glucose T2DM develop participant group group CI evidence one adverse event reported participant compare participant on total participant cardiovascular disease compare participant CI evidence compare participant receive receive outcome event rate CI evidence outcome effect evidence whether insulin compare reduce risk develop T2DM associate complication increased risk development T2DM trial investigate outcome
26338734 en study type mellitus patient determine correlation increasing age duration disease insulin level insulin resistance diabetic study conduct hospital research medical patient type mellitus healthy control serum level total cholesterol low insulin case control insulin resistance model assessment insulin resistance correlation increasing age duration disease determined use parameter use statistical subject study patient healthy control among case common follow among control subject follow duration disease found correlate insulin resistance negative correlation duration disease serum insulin level age show significant correlation serum insulin level insulin resistance regression analysis type mellitus common whereas risk factor healthy individual duration disease correlate serum insulin level positive correlate
27048217 en low status associate adverse cardiovascular risk factor poor outcome patient aim study determine whether associate control blood glucose blood pressure blood cholesterol diabetic complication adult type regard patient complication cardiovascular risk profile analyzed patient outcome patient hba1c blood pressure total serum cholesterol complication logistic regression use patient little patient high develop cardiovascular disease disease patient low high prevalence patient little patient hba1c adjust odd ratio or confidence interval CI adjust or CI patient high adjust or CI less hba1c adjust or CI low associate poor metabolic control complication adult patient individual management base patient
25028196 en present case cause mellitus type on patient type treat number year lower blood sample revealed increased concentration glucose hemoglobin normal addition demonstrated cause case diagnosis patient consider diagnosis patient poor control diabetic
24434088 en examine risk cardiovascular outcome mellitus patient database adult patient patient follow disease indicate incidence rate outcome compare use increased risk found ratio confidence interval cardiovascular event cardiovascular event cardiovascular event show significant difference risk outcome incidence range event per cohort significant analysis datum found lower risk cardiovascular event difference found significant difference risk include use datum control patient high risk
23871571 en independent disease index new index present study investigate possible risk factor hypertension mellitus DM subject one subject group healthy group hypertension group DM group hypertension DM group measured result show significant high hypertension subject DM healthy hypertension group respective vs vs positive correlate age blood pressure blood pressure pressure fasting plasma glucose hba1c total cholesterol group respective negative correlation cholesterol group analysis show age body mass index hba1c cholesterol independent associate factor subject respective present study significant high hypertension subject DM compare healthy hypertension group
22050477 en patient year year diagnosis compare general population two time year cohort disease duration year year incidence study case age group control subject population age on cohort cohort patient control subject year diagnosis patient cohort compare cohort reported on similar year diagnosis use day care time high among patient compare control subject hospital care high among patient compare control subject use health care among patient remain year first follow-up major decrease care year diagnosis increase day care year diagnosis observed change care
26163177 en type mellitus DM previous reported independent weight patient DM compare patient DM association show patient undergo current effective treat DM
23123535 en prevalence patient mellitus high treatment important clinical complication conduct study evaluate new care patient retrospective study include glucose adult patient mellitus type perform new included treatment base glucose time day glucose care compare prevalence logistic regression analysis adjust age patient mellitus type glucose included risk develop significant reduce patient compare intervention patient adjust confidence interval overall patient significant two new care mellitus decrease risk develop without increased risk develop glucose care glucose
22902134 en on recent study reported increased risk mellitus patient treat current study evaluate whether increased risk new mellitus among patient treat retrospective analysis evaluate trial patient year age trial trial on evaluate control trial use trial primary adverse event CI adverse event respective CI patient associate increased risk new mellitus
27044245 en study investigate association type mellitus lipid total cholesterol cholesterol conduct study participant aged year old man woman adjust odd ratio type change use logistic regression analysis characteristic analysis use define lipid type type high lower level individual associate type analysis participant without type compare compare population value associate type risk population
27810686 en although associate dysfunction include patient type mellitus DM datum study investigate association study base among participant cohort individual aged without history dysfunction included datum health review assessment database use obtain patient mean follow-up period subject event incidence dysfunction case per case per respective subject event relative incidence significant high incidence dysfunction event associate CI multiple also significant increased risk increasing number event significant associate risk type DM patient aged
25945500 en determine insulin effective insulin glycemic control mellitus among study woman type mellitus T2DM gestational mellitus week participant randomize insulin treatment group day increased two week glycemic target insulin target can total insulin body weight glycemic control glycemic profile two two blood glucose level significant lower group insulin group finding study suggest effective glycemic target management effective insulin new clinical trial
21663840 en mortality significant high therapy development increased associate adverse metabolic effect mellitus insulin resistance risk factor cardiovascular disease adverse outcome mechanism metabolic change due effect individual patient review study prevalence incidence mellitus effect mellitus complication mellitus treatment
20577098 en early study suggest relationship mellitus syndrome evaluate relationship mellitus important addition investigate whether glucose control measured hemoglobin hba1c level diabetic patient without retrospective study included system case control age participant status body mass index status among patient mellitus recent hba1c level type mellitus present case control analysis statistical significant relationship mellitus CI identify status result CI adjust mean hba1c level similar diabetic patient CI without CI population statistical significant relationship mellitus addition hba1c level among diabetic patient base status
24503104 en treatment obesity lead case aim study investigate effect insulin type diabetic possible mechanism also test reduce lipid improve insulin group diabetic group diabetic group diabetic group control group week assess insulin lipid diabetic group significant decrease weight mass two week significant improve insulin index decrease total cholesterol significant increased insulin decrease lipid week insulin concentration significant lower diabetic group week increased insulin occur early may contribute type reduce lipid cell may contribute improve insulin cell
26242672 en treatment type mellitus important treatment patient investigate factor management associate poor control decrease type mellitus mean age year management use weight hba1c measured participant obtain total participant poor metabolic control hba1c level factor clinical found significant association decrease hba1c system insulin number severe event show association hba1c management treatment use use insulin without insulin show significant association poor management regard effective management system
25874867 en type clinical early may disease mellitus health cohort study prevalence type risk cardiovascular risk cohort adult aged large health aged year diagnose oral participant medical weight blood pressure measured fasting blood sample fasting plasma glucose impair fasting glucose range oral glucose tolerance test subject study prevalence impair fasting glucose impair glucose tolerance increased among aged year respective female respective associate age blood pressure BMI obesity history level use may prevalence study study large study population follow cohort provide datum cardiovascular outcome
26325432 en large number mellitus type use management aim determine use disease conduct develop disease index type diabetic patient score score score score score score score significant study diabetic patient due high score relative status
27009088 en evidence suggest mellitus DM disease treatment outcome patient study aim investigate role DM clinical treatment outcome among new diagnose cohort study conduct study subject health study participant two patient group patient DM patient without DM finding clinical treatment outcome compare two patient group regression analysis identify factor associate patient study DM adjust ratio confidence interval CI CI associate increased patient show significant difference clinical baseline treatment period however month treatment patient compare patient study show DM associate increased treatment DM association clinical treatment patient DM early diagnosis treatment patient
26292334 en high prevalence mellitus DM poor health outcome treatment care need early improve management disease aim present glucose clinical system management review analysis conduct model assess DM control method glucose current research development glucose on range control development management level correlation indicate datum system health datum method potential management related identify
23860015 en study examine medication medication patient type patient type mellitus conduct independent patient characteristic hba1c level assess on patient correlation hba1c level total patient included although effect show high correlation new score on significant association found score hba1c level use control factor analysis identify three method assessment medication among patient type mellitus
21709707 en mellitus group metabolic disorder disorder common chronic condition multiple study demonstrated mellitus type type risk factor finding study indicate mellitus lead response also impair lead cell individual mellitus association two disease reported adverse glycemic control patient mellitus contribute development diabetic complication addition therapy individual mellitus result glycemic control effect mellitus potential increase level insulin resistance relationship mellitus increased patient mellitus oral health among medical management individual increasing important
21617152 en multiple test use diagnose patient mellitus evidence use test use patient on new system develop overall evidence present response oral response clinical evidence base review addition base plasma glucose diagnose increased blood hemoglobin concentration glycemic control perform plasma blood glucose analysis potential role glucose insulin provide base datum several clinical value present
21330931 en mellitus associate poor clinical outcome whether syndrome investigate mellitus clinical patient treat intervention patient undergo retrospective analyzed target patient identify mellitus mellitus mellitus mellitus compare mellitus mellitus patient high rate vs mellitus significant associate group adjust ratio confidence interval CI little group CI statistical significant observed mellitus clinical significant mellitus clinical study high rate event observed mellitus patient recent need management mellitus patient include glycemic control medical therapy
27208743 en evaluate association plasma level dysfunction type diabetic according presence plasma level evaluate activity evaluate level activity elevated diabetic patient compare without complication logistic regression analysis show activity remain associate age duration use use use activity associate type diabetic patient diagnosis diabetic
24508363 en normal subject show decrease time increasing aim study investigate cohort patient type mellitus follow-up period potential association decrease
24907173 en assess impact risk factor age history body mass index BMI hypertension development type mellitus case control study type diabetic year age revealed significant difference type age type history hypertension logistic regression show age risk factor blood pressure show significant difference mean value type diabetic respective significant difference observed type significant risk factor type therefore history hypertension significant risk factor disease BMI population
26433008 en review evaluate recent outcome prevalence increasing although show improve health outcome impact remain review conduct database study research review evaluate use health total study study conduct included target general health compare care result per per year high year lower ratio range among study review positive role increasing health study high need investigate
24504072 en chronic disease patient risk develop mellitus treatment incidence different patient receive study compare risk patient patient renal database included patient follow risk analyzed patient score patient use logistic regression early type month regression type month total patient patient analyzed incidence per patient patient risk develop early type adjust odd ratio confidence interval CI patient risk type adjust ratio CI patient age negative associate risk early type positive associate risk type disease patient receive risk develop mellitus compare receive
20159941 en type lead whereas cause syndrome two disease clinical outcome three show resistance protein cell target disease potential treatment elevated level lead elevated reduce whereas elevated contribute treatment increased cell target increase potential treatment patient however found elevated level can value patient reduce level
27321325 en determine whether dysfunction risk factor diabetic development type mellitus study two group according presence without cardiovascular function measured baseline use analysis participant presence group disease duration compare group without rate lower participant well index low high ratio indicate high difference control blood pressure value observed participant develop regression show risk reduce increase increase result risk study provide evidence consider metabolic control well index identify patient high risk
25662570 en investigate change prevalence incidence treat obtain datum treat study period total new case treat found incidence follow-up per individual man woman respective on time incidence man per year CI woman per year CI observed prevalence increased per man woman respective increasing time man CI woman CI total prevalence treat per man woman increasing time man CI woman CI prevalence treat increased year follow-up incidence decrease result reported study total prevalence treat relative low
23114377 en prevalence mellitus increasing contribute development diabetic complication include diabetic change use also use possible activity may decrease development diabetic complication include condition therefore effect parameter type DM investigate first time present study control diabetic treat body weight week day metabolic parameter determined control group addition total total measured study diabetic show result compare result obtain present study activity possible observed status however effect addition effect metabolic complication datum show high effect blood cell status plasma different
27853030 en adult type mellitus occur adult age common occur aged year response oral body mass presence function due prevalence among T2DM patient among population due different patient characteristic use study prevalence clinical characteristic patient
22060631 en mellitus population incidence little common due however datum condition population define incidence clinical diagnose identify clinical perform subject according clinical total patient diagnose incidence different identify two one patient patient known syndrome include two patient one high reported incidence high different case present syndrome
24555673 en mellitus DM factor include change examine relationship per prevalence regard analysis association population prevalence mellitus per examine use correlation regression analysis mortality rate general index care low weight index obesity prevalence included model estimate relative positive correlation observed prevalence mellitus per use datum high correlation correlation per remain significant association DM prevalence regression model regression model datum group according independent association DM regard base DM demonstrated significant association result indicate independent association DM prevalence rate per regard cohort study association
24070839 en first compare type mellitus year healthy group compare hemoglobin value examine related year age assess clinical characteristic medical type reported lower healthy function associate lower negative associate lower range whereas positive associate significant positive associate high blood glucose type associate improve value
26728362 en mellitus DM disease medical status associate general relationship DM remain present report aim model DM also identify risk factor base datum positive response hemoglobin total cholesterol identify may model mean use two model mean base observed datum significant factor total cholesterol effect glucose time effect age effect age study identify DM base hemoglobin hba1c identify statistical significant factor base effect ratio hba1c effect hba1c age effect first blood pressure effect first blood pressure DM hba1c related risk factor diabetic patient care
23562551 en study demonstrated association mellitus risk determine whether mellitus associate increased risk perform study conduct included cohort study reported relative risk study show odd ratio analysis relative risk confidence interval effect model analysis perform study control status association assess several different participant study total study study cohort study included analysis significant associate increased risk compare control analysis study adjust status CI association analysis study adjust status CI increased risk diabetic woman CI association diabetic man CI among diabetic woman significant increased risk found cohort study CI study major age CI study follow-up CI study assess CI mellitus may increase risk among female diabetic patient study need test effect mellitus risk
27838345 en several study show obesity associate may risk factor however little known relationship among mass mass type mellitus woman T2DM examine association mass mass relative mass index evaluate body measured regression analysis adjust age duration T2DM blood pressure body mass index hba1c serum drug show negative associate positive associate respective positive associate respective although association mass increased independent associate increased woman T2DM
27816684 en type mellitus T2DM disorder major cause mortality T2DM factor identify recent T2DM indicate associate disease mechanism recent gene association study also indicate association associate related T2DM show association T2DM study however assessment within cohort study association different group possible mechanism association T2DM associate
23559628 en test whether provide health use health study cohort examine effect difference disease risk factor baseline metabolic per day compare hypertension mellitus year follow-up significant decrease risk hypertension mellitus per reduction relative risk reduction follow hypertension mellitus case risk reduction significant different mellitus hypertension great similar risk reduction hypertension mellitus possible
26462347 en impact level patient retrospective analysis clinical datum patient mellitus patient patient poor control fasting fasting level group on patient well control fasting fasting level group according type significant difference age disease duration mellitus serum type disease duration complication group group on high hemoglobin level patient activity group time day time complication rate mortality month year year compare total patient group on group follow month mean month day group on significant group significant difference found time time group complication rate group on significant high group group on high mortality month group vs significant difference show year group on vs year patient activity patient activity group on group significant difference control fasting may lead influence patient mellitus reduce complication rate fasting level control less
24345385 en patient mellitus high risk adverse event intervention study aim relative according diabetic trial per analysis primary target target target among total patient mellitus patient show high rate difference rate significant occur similar rate patient treat diabetic status addition significant present regard clinical result analysis treatment also found great risk patient treat recent diabetic patient high risk adverse clinical event without mellitus whether patient treat significant diabetic status clinical outcome
26666144 en development type associate dysfunction insulin resistance insulin target normal insulin resistance increasing insulin mass lead glucose function insulin resistance glucose
25910864 en high incidence known risk factor development individual develop can factor influence individual study risk factor related patient indicate mellitus DM risk factor study indicate high level glucose insulin condition associate related DM development high mortality rate DM however reported whether DM factor development individual study
24857263 en on conduct evaluate value hemoglobin hba1c adult
21617108 en multiple test use diagnose patient mellitus evidence use test use patient on new system develop overall evidence present response oral response clinical association clinical review addition base plasma glucose diagnose increased blood hemoglobin hba1c concentration glycemic control perform plasma blood glucose analysis hba1c potential role glucose insulin provide base datum several clinical value present
25789513 en aim study evaluate total time relationship parameter patient type total patient type mellitus mean age year control evaluate total time measured measured total time significant patient type mellitus control group vs patient type mellitus significant increased ratio protein level control total time positive correlate protein level ratio index negative correlate early ratio on multiple logistic regression analysis demonstrated ratio independent total suggest may mechanism related total time total time impair may early patient type mellitus
26364528 en study conduct develop test effect use patient control group use participant diabetic patient group control group mellitus develop study total week group week individual datum may analyzed use group significant found glycemic control influence disease compare control study finding indicate effective intervention patient mellitus
26240488 en risk type mellitus T2DM investigate use study adult cohort subject follow-up score score association T2DM determined effect evaluate use risk model significant association T2DM ratio per risk score increase confidence interval respective change addition significant clinical model clinical model hemoglobin hba1c index significant observed range clinical model significant model influence T2DM incidence significant hba1c model hba1c T2DM risk also significant subject research study
25762524 en occur possible cause patient several cause may present case role patient mellitus present case treatment cause use treat metabolic may regard patient renal therapy effect clinical outcome
25604005 en study indicate risk increased individual type mellitus T2DM may population T2DM patient treat primary health examine risk individual T2DM hospital primary health incidence ratio use assess risk individual T2DM use database period increased individual T2DM high respective on decrease show increased follow-up period T2DM patient primary health care show similar risk overall individual T2DM respective insulin show overall increased risk study show increased risk individual T2DM suggest metabolic disease may observed increase study examine factor association need
25874454 en study relationship hemoglobin hba1c level patient without mellitus risk cardiovascular disease cohort total participant high medication outcome cardiovascular disease health research database follow-up year participant high incidence new cardiovascular disease case per case per without show increased risk adjust adjust ratio confidence interval CI hba1c positive associate risk total cardiovascular disease CI risk CI participant compare group hba1c participant hba1c level significant elevated risk total cardiovascular disease CI CI hba1c level associate increased risk cardiovascular disease glycemic control hba1c level associate increased risk cardiovascular disease
24530297 en lipid recent cardiovascular disease aim study age influence woman man age group year year year year compare among age group woman woman high increase age year man high group year year lower woman man group high woman man old group odd ratio subject vs without high level significant high level high woman man lower increase age woman association influence age
27741477 en role chronic associate risk develop cardiovascular disease aim study evaluate association gene risk type examine T2DM patient control subject show significant difference T2DM patient control association analyzed two age group patient association or CI subject aged old show significant association presence or or respective show high prevalence compare vs T2DM patient significant increased risk
26464716 en influence glycemic response evaluate effect mellitus DM perform analysis cohort subject evaluate effect glycemic control DM patient month control group previous reported subject well previous reported whereas similar subject DM patient great reduction plasma glucose compare different DM patient great reduction fasting plasma glucose great reduction hba1c compare different effect hba1c DM patient response treatment study large sample DM patient
25472959 en study show high factor however dysfunction patient mellitus remain study investigate whether contribute dysfunction patient type mellitus change assess blood cell subject patient T2DM control level plasma cell also determined cell high glucose perform mechanism increased blood cell patient T2DM compare control patient T2DM show associate increased plasma level cell found significant correlate cell change contribute dysfunction patient T2DM target may disease
24810146 en diabetic one important complication type mellitus T2DM blood lipid parameter total cholesterol cholesterol cholesterol index plasma define important index risk T2DM study perform evaluate index risk database database identify study study mean baseline value included model use mean difference study total sample included study reported positive association T2DM confidence interval CI high parameter CI CI CI CI association BMI T2DM CI result suggest lipid parameter risk T2DM may associate risk T2DM current result suggest may use parameter assess risk T2DM
23036708 en type mellitus disease consider major type mellitus complication present datum gene association type mellitus case among population need study investigate gene type mellitus population
24735987 en assess datum health primary care compare positive value negative value index case health use datum prevalence also determined according datum positive value negative value index prevalence known health primary care
26171796 en effect weight development type gestational mellitus woman relative low body mass index investigate effect BMI change development woman history study included cohort follow-up total woman previous gestational impair glucose tolerance undergo oral glucose tolerance test week risk analyzed according BMI change change BMI follow-up BMI change respective observed increased risk BMI change increased BMI change independent analysis ratio confidence interval adjust BMI follow-up high group significant cardiovascular risk factor include blood pressure lipid profile insulin increase BMI significant associate risk metabolic woman
24728333 en aim study risk patient type mellitus T2DM association duration drug conduct study patient T2DM use clinical research identify case patient aged year diagnosis case patient one control patient use logistic regression analysis adjust or or adjust analysis important potential study T2DM case diagnosis compare duration year duration year associate decrease or CI CI CI CI respective compare level risk estimate increasing level decrease or CI CI CI respective use insulin associate risk level use drug associate decrease risk among patient T2DM
26139558 en role system development type well use activity several clinical study demonstrated insulin however role remain evaluate trial patient type patient type mellitus study study subject receive body weight day follow total baseline period treatment hba1c reduce fasting increased insulin increased blood pressure decrease hba1c blood pressure baseline level day treatment well adverse event occur result role type number
24279445 en type mellitus treatment current effective on therapy base significant first mortality study study present
26179258 en mellitus DM common type similar type increasing prevalence related obesity incidence DM association DM risk factor age cohort individual risk use diagnosis DM overall incidence rate incidence rate year age overall incidence rate DM cohort case confidence interval CI per high incidence rate CI female CI high risk compare on significant association high risk compare found among several lower risk DM result increased risk develop DM also identify several previous increased decrease risk DM
26644812 en type mellitus cause cell severe insulin aim glycemic control patient type study determine clinical effective patient type without disease
26370000 en previous study type mellitus perform large population study determined prevalence risk factor mellitus adult population year old use clinical datum define fasting blood positive medical history prevalence individual participant CI include new case year prevalence increased significant female low hypertension significant associate prevalence prevalence mellitus great level
17623967 en on patient cell present syndrome although test however treat development serum normal low suggest cell case cell cause presence
25185980 en common health risk factor obesity include found cause factor high blood common type mellitus cause insulin resistance function insulin low level insulin cause decrease glucose body cell increased cell protein body body function body mechanism review role blood type mellitus also aim effect mellitus great chronic effect well
22441425 en randomize control trial therapy patient disease prevalence range however prevalence trial evidence case diabetic patient cohort outcome new diabetic found patient known mellitus study investigate prevalence mellitus oral glucose tolerance hba1c patient patient known patient normal glucose tolerance impair fasting glucose impair glucose tolerance diagnose new mellitus DM according hba1c patient normal diagnose DM significant correlation glycemic status define number patient increased group group however correlation observed glycemic status define hba1c result perform patient known disease undergo diagnosis hba1c patient finding high clinical regard case mellitus new mellitus diabetic disease high score
24199848 en association incidence oral therapy man woman type retrospective analysis health patient period multiple use datum regression score use model time development result follow-up year case identify woman use associate decrease risk compare use ratio confidence interval CI adjust analysis insulin insulin demonstrated decrease risk insulin CI adjust analysis oral therapy show significant difference man age body mass index BMI disease oral use insulin use rate new status event blood pressure use score receive insulin associate decrease risk woman type mellitus
27603392 en type mellitus associate mechanism remain although known insulin activity include therefore examine whether level related status participant type participant without type undergo assessment association type examine use regression analysis age BMI ratio revealed high level participant type participant high fasting blood glucose level participant high hba1c level high level participant high hba1c level less participant type system related lower function metabolic mechanism
23726468 en impact estimate overall include study analyzed due complication assess related number mean duration associate day also complication related result day disease health estimate per patient year datum suggest need early diagnosis complication well health care medical important role on decrease result diabetic patient overall
25300610 en type mellitus associate range aim study determine incidence complication prevalence chronic condition report type database individual patient aged year type mellitus datum observed age complication rate major prevalence disease renal diabetic incidence condition decrease period major prevalence chronic disease renal diabetic prevalence high prevalence chronic condition hypertension type mellitus population incidence rate complication high however present high prevalence related disease common group factor clinical management
25963407 en important role management conduct review role parameter related effect activity factor report review report use study without found effect glycemic control study show significant reduction little one primary outcome level fasting plasma glucose blood glucose insulin insulin resistance similar report two significant change parameter regard outcome lipid profile factor one one study show significant change parameter review general demonstrated effect management blood parameter although evidence trial need effect also conduct
26391392 en cardiovascular disease woman mellitus DM year disease disease woman DM high rate general population woman therapy change activity woman DM significant may well woman may also woman therapy remain case potential woman DM reduce event risk woman DM research health care target woman DM lower risk factor effective improve cardiovascular health
27514380 en remain primary use treat disease little known disease assess include type among treatment also conduct group adult prevalence use among individual CI prevalence use CI use treat CI individual reported identify several use care common use care individual several individual use common use individual range effect effective health
24118936 en result regard function adult type reported little known cell function treat multiple insulin aim assess function healthy control control group year studied group age BMI total level group high level similar level control group high observed compare control group respective similar group regression analysis show significant factor adjust level significant factor level high hba1c negative effect total positive effect level show normal level however hba1c negative association level elevated level observed present early
25777150 en mellitus complication evidence regard outcome treatment remain aim retrospective cohort analysis assess treatment diagnose oral glucose tolerance test diabetic included study mean follow-up month patient receive treatment diagnosis insulin patient significant high fasting glucose plasma glucose value baseline remain without therapy improve glycemic control significant adverse event general occur similar rate improve glycemic control effective therapy
24898423 en diabetic patient undergo intervention regard high risk increased risk complication patient control however although effect outcome effect risk patient undergo intervention therefore aim interval intervention define increase three time normal elevated baseline value whereas increase three time normal patient mellitus found patient associate age hypertension renal previous previous high fasting lower severe disease intervention lower presence diabetic patient receive significant treatment diabetic status influence risk adjust adjust diabetic patient effect chronic control status independent chronic control associate increased risk patient undergo intervention
24290082 en aim study investigate association complication type mellitus T2DM study woman T2DM age range control without T2DM datum two hospital hospital hospital one health use obtain datum adjust estimate use CI CI increased risk T2DM significant however gestational CI CI significant risk factor development T2DM T2DM significant risk factor CI CI study T2DM significant risk factor similar significant risk factor T2DM although prevalence finding reported treat also woman complication risk T2DM
24845156 en recent demonstrated important role disease mellitus DM known factor respective disease however less research intervention patient type mellitus examine patient without compare control factor significant patient without compare control determined protein factor patient without compare undergo show occur without type mellitus compare control research observed patient patient disease impact response datum potential target diabetic disease
24680472 en evaluate three method identify patient characteristic patient identify method use datum hospital medical care assess use diagnosis medication include identify compare use examine characteristic patient use regression identify adult patient compare diagnosis diagnosis medication diagnosis medication include three method old patient identify patient glucose measured receive diagnosis medication diagnosis medication identify patient new patient
26281182 en datum datum mechanism patient mellitus type change mellitus type occur general population among presence factor increased patient
26350740 en review datum use level activity current two group drug use clinical addition new group include base
26156152 en patient mellitus disease intervention treatment however datum compare new included new mellitus undergo intervention disease included score use cohort similar baseline characteristic primary outcome mortality outcome within day outcome evaluate among patient mellitus disease patient similar score included associate lower risk ratio confidence interval CI CI high risk CI associate similar risk event CI lower risk event CI high risk event CI event CI high risk patient undergo CI patient mellitus disease associate lower risk compare however associate similar risk high risk lower risk
26015163 en evidence treatment old type mellitus evaluate cardiovascular drug patient develop T2DM year cohort sample clinical research patient T2DM diagnose age year patient female included use use increased drug increased drug oral woman drug odd ratio confidence interval less compare diagnose T2DM year patient diagnose age year less insulin drug drug major increase management patient diagnose T2DM year age effective intervention old
26690976 en aim study compare diabetic evaluate several type diabetic model plasma glucose study diabetic level protein activity level measured result decrease plasma diabetic plasma decrease activity significant increased whereas observed measured parameter also show diabetic treatment improve diabetic also decrease cell
26163038 en study demonstrated type mellitus negative group low status also care aim study patient provide impact treatment care patient type mellitus study aim develop care study conduct use sample patient type mellitus aged old patient hospital general patient use base receive study study datum research obtain review result study present several use develop follow-up research study clinical trial
25986735 en type mellitus T2DM major health need identify individual risk develop T2DM healthy disease aim study examine whether reduce can T2DM individual two group study subject one group diagnose T2DM group healthy control result show decrease T2DM logistic regression plasma level associate DM suggest reduce T2DM according logistic regression model plasma level clinical study whether individual develop T2DM lower individual T2DM year result develop individual develop T2DM
25980755 en control complication trial intervention complication study show therapy type mellitus DM relationship control assess test participant type year relationship hemoglobin hba1c complication DM normal participant participant participant mean hba1c analysis associate great baseline hba1c duration DM great mean hba1c year follow-up lower severe great score model complication DM associate baseline hba1c odd ratio or confidence interval CI duration DM or CI mean hba1c or CI associate independent study common associate early
26780393 en aim study identify associate general obesity type diabetic included patient year type mellitus study individual year use weight measured according two major identify factor analysis healthy potential subject high healthy score lower odd ratio general obesity compare low or CI patient high score great odd general obesity or CI significant association major obesity adjust study show patient type mellitus healthy associate associate general obesity
23063478 en obesity associate increased risk mellitus DM whether risk datum group participant age participant group status group included subject normal BMI group normal BMI group normal BMI group group group CI group CI group CI significant different group well group can adverse effect obesity DM compare subject weight normal BMI range DM
23999231 en new known complication renal early status study aim assess blood glucose level subject relationship outcome period patient receive investigate first day fasting measured profile assess glucose measured hospital little time day adverse event fasting hba1c assess month renal day fasting decrease mean patient month first fasting high patient develop month treatment associate high incidence month mean follow-up month associate medication high rate renal characteristic high value can identify patient risk
26585750 en risk clinical use association population aim correlate independent association hypertension metabolic syndrome adult baseline study adult health cohort study aged measured sample participant mean two obtain individual hypertension define value large high woman lower increased age BMI although high hypertension association reduce adjust age adjust obesity large population reported population value clinical association large age obesity although identify individual increased risk role compare current risk
26895277 en insulin use type mellitus present trial aim current control incidence complication different vs multiple insulin therapy analyzed total patient age duration year database clinical datum parameter use datum assess analysis patient group year year year adult cohort patient vs duration use insulin perform lower insulin per body weight hba1c mean also lipid blood pressure difference patient patient increase hba1c adult decrease age group adult adult high level adult also patient lower rate high present analysis provide insulin treatment type control low incidence however increase hba1c also use patient level high
22941335 en association type mellitus related type mellitus risk type mellitus status duration insulin use overall examine cohort study man woman aged year old case identify among woman relative risk confidence interval CI use regression status status mellitus status CI duration associate risk although statistical significant different high type mellitus insulin use CI type mellitus without insulin use CI associate CI CI mellitus associate risk although high risk among insulin study need association type mellitus without insulin use risk overall
25344129 en investigate relationship serum estimate rate evaluate different mortality type mellitus T2DM cohort study consider T2DM follow period year estimate use several subject follow-up year analysis show diagnosis odd ratio or confidence interval CI complication or CI associate receive characteristic show similar use different value ratio different cohort T2DM different perform similar whereas
24065152 en insulin therapy patient type mellitus weight increase mass mass general change increase mass also result change increased weight investigate effect weight protein level within patient type mellitus month insulin insulin therapy significant increased body weight level insulin treatment lead compare patient little weight patient body weight month insulin therapy increase however individual weight high protein level month insulin therapy compare insulin therapy patient type mellitus improve control also body weight patient weight study study research
23862738 en mellitus whether blood glucose glycemic occur period risk factor independent hba1c type mellitus present study aim investigate impact different blood glucose function studied type diabetic patient female age year mean patient glucose profile obtain glucose system glucose mean blood glucose level mean glycemic function measured
25627460 en mechanism increased adult type mellitus conduct study woman woman age range age year one age diagnosis year compare healthy woman control included assessment case control respective respective case compare without although case high control respective difference case control respective serum also lower case show association study woman show mechanism may include
25701274 en activity protein may role activity primary aim study investigate model early type model high week receive two week month analysis perform increased two month model well obesity control group result impair model lead observed change may role activity primary activity can therapy diabetic
26433309 en adult age associate decrease mass well recent also associate metabolic syndrome associate increase risk cardiovascular disease low level associate increased insulin resistance increase mass low cholesterol high level hypertension therapy patient type mellitus metabolic syndrome show reduction insulin resistance total cholesterol cholesterol glycemic control parameter
25509243 en cause multiple case rate patient compare control health effective treatment prevalence duration mellitus year age treatment insulin oral medication presence complication impact incidence patient diagnose treatment patient disease treatment
25166296 en treatment patient type mellitus T2DM follow treatment effective treatment lead use insulin treatment insulin oral case insulin insulin T2DM treatment early use insulin clinical due treatment consider estimate clinical outcome insulin treatment patient T2DM early treatment estimate clinical outcome treatment T2DM indicate patient hemoglobin develop model estimate patient target complication mortality associate treatment new diagnose patient T2DM treatment result randomize clinical trial include time rate on treatment base association association study care two treatment evaluate insulin follow insulin analyzed multiple analysis treatment insulin remain treatment evaluate increasing time treatment within analysis time insulin result patient target range due different within patient target compare major complication reduce use use severe increased use use base case time treatment month time treatment increased month patient target reduce complication increased mortality increased year compare base case however severe event reduce insulin early therapy patient target increased severe event increased complication mortality decrease estimate treatment reduce patient target level increased major diabetic complication increase severe event early use insulin clinical
26321179 en study aim association risk woman use study measured use obtain study measured use examine possible different time period group assess different one woman reported year index woman reported report follow-up woman reported analysis significant association negative positive history increasing risk woman great risk CI analysis significant study provide association event risk woman however evidence effect cause
25194144 en control level well cardiovascular risk factor complication associate type mellitus control study T2DM patient primary care clinical characteristic treatment development disease complication duration year logistic regression model use total patient mean age year mean year year mean hba1c analyzed hba1c level hba1c patient first year year blood pressure value remain relative disease duration mean value low disease due significant increase cardiovascular disease year duration less patient target logistic regression model age show duration related control odd ratio confidence interval per year blood pressure control risk factor duration T2DM follow different duration associate poor control general role blood pressure control lipid profile
25065462 en common clinical prevalence increasing recent datum suggest increased risk among patient mellitus DM however potential mechanism regard diabetic review potential relationship include also therapy may important role treatment therefore large randomize control trial study
27554125 en risk factor cardiovascular disease patient cholesterol cholesterol patient therefore aim investigate prevalence high level patient mellitus identify associate risk factor concentration positive correlate total cholesterol concentration although concentration related positive concentration correlation relative high prevalence high high two age group year year age group year year year year also high among general subject compare normal weight subject risk high increased age general obesity odd ratio confidence interval CI obesity CI significant associate high level
22925613 en evidence adult type type mellitus use control study participant diagnose type type mellitus independent primary care included conduct identify index use database study study assess use assessment review datum research finding included study use datum study included finding group three one overall finding mellitus effective health provide individual target review blood glucose also evidence identify adult mellitus provide assess level
23720454 en evidence association mellitus duration age diagnosis insulin treatment risk independent general obesity conduct analysis study among participant datum adjust relative risk confidence interval estimate regression model analysis year follow-up case include case case identify independent body mass index ratio status associate high risk risk high participant duration treat insulin regard associate risk high participant treat insulin result different study risk factor research whether treatment duration associate
25641399 en mellitus common complication may insulin insulin resistance time function chronic disease intervention patient present review aim present current evidence regard therapy insulin treatment respective although recent trial study well impact glucose cardiovascular outcome
25619512 en concentration increase treatment impair mellitus concentration DM compare healthy control DM increase DM undergo control study serum total assess use difference serum insulin significant high control mean compare although different increased significant undergo concentration significant different serum concentration control serum significant change significant decrease insulin DM although increase suggest possible presence negative system serum therefore treatment effect
25252678 en first increase change increase obesity develop impact cause cause use number year due cause year result increase mellitus one positive observed cause negative impact observed age mellitus age little regard health population base first increased year mellitus
27466703 en estimate prevalence mellitus adult aged diagnose case type mellitus T2DM effective therapy management due T2DM therapy treatment several different include review trial datum result significant effective profile low risk similar effect profile weight significant lower risk compare medication poor patient T2DM addition whether improve remain
25689396 en factor type mellitus T2DM T2DM patient can sample result previous study perform effect outcome patient T2DM database identify randomize control trial T2DM patient weight mean difference change outcome review on total trial include subject identify found can decrease fasting blood insulin CI reduce intervention CI whereas statistical significant difference regard model insulin resistance fasting blood glucose low high body mass index fasting cholesterol patient T2DM also intervention can fasting blood insulin reduce T2DM patient however effect outcome significant
26369653 en one major treatment type mellitus T2DM study conduct analysis effect cell function compare patient study treatment type study participant oral group group hospital undergo sample tolerance test week included analysis patient treat study glycemic parameter hba1c week group oral model base revealed cell index significant increased week group group significant change well body weight week group serum level significant increased group study however incidence week improve cell change body weight need mechanism increase serum hospital medical clinical trial
21723589 en present datum health association mellitus sample adult study base datum obtain conduct three year use sample population mean total concentration female total participant mellitus significant high participant without mellitus include age body mass index BMI hypertension level status multiple regression analysis similar show total concentration associate status female total participant addition similar odd ratio or mellitus female participant participant CI CI respective level total study show association total concentration prevalence mellitus sample adult population woman risk factor
23452444 en evaluate prevalence risk factor define population type mellitus compare control group subject without age type study population one prevalence cohort subject type control group age diagnosis type mellitus use early treatment study diabetic found type cohort control group without among diabetic patient significant associate duration hba1c blood pressure lower serum cholesterol logistic regression analysis control group associate blood pressure logistic regression prevalence among patient type similar lower compare study prevalence control group without population study study indicate diabetic less common on subject may due factor hypertension treat
27545212 en important role may cause studied T2DM patient healthy control diabetic patient decrease fasting plasma glucose serum level respective two group level high investigate type mellitus T2DM patient suggest associate decrease increased diabetic therefore mellitus due effect
26938444 en rate profile insulin therapy individual insulin however whether profile assess study association profile chronic complication adult type profile female patient chronic complication month recent rate index rate interval rate interval index correlate positive severe addition high index associate high diabetic adult patient logistic regression analysis adjust age duration disease total insulin significant correlation index severe diabetic rate profile high associate increased complication adult type
25082568 en dysfunction event development clinical disease include dysfunction measured decrease response evaluate use among adult type compare healthy control impair function measured decrease studied adult healthy control mean age patient study datum obtain measured use baseline decrease measured lower change vs change vs compare control hemoglobin hba1c found independent function adult evidence dysfunction use hba1c independent role determine suggest glycemic control important development disease
24392996 en primary control study investigate impact insulin glycemic control studied patient female type type patient age hba1c treat insulin insulin therapy week treatment period patient randomize therapy three month without control parameter included hba1c insulin body weight adverse improve study control group vs baseline control patient control group need increase insulin insulin patient use less insulin insulin total insulin increased control group decrease use number event period high control group vs study patient patient target insulin therapy use month result lower event reduction insulin result patient population may treatment target therapy patient type type
25851531 en model mellitus type use study change increase level previous report show chronic addition show reduce model study aim determine whether reduce week level glucose blood evaluate glucose use treatment receive week activity measured change evaluate use analyzed method treat reduction cell change result change model DM may effect management DM
25307295 en on randomize clinical trial test whether factor factor renal disease patient chronic disease type mellitus trial increase group event clinical associate randomize patient type mellitus T2DM chronic disease estimate rate use regression analysis identify baseline factor event elevated baseline previous identify event increased risk patient risk factor patient without baseline characteristic risk event among patient similar risk factor also identify related adverse contribute event related patient increased risk baseline participant study drug trial risk adverse event
25274395 en assess prevalence dysfunction population patient type mellitus determine correlation dysfunction rate study included patient type mellitus perform function rate use normal interval mean difference interval great dysfunction present type mellitus patient patient subject dysfunction statistical significant high rate compare dysfunction test group dysfunction reduce rate patient normal function increase dysfunction associate decrease rate increased dysfunction associate significant great prevalence reduce rate increased rate
25824591 en complication type mellitus T2DM among patient review conduct medical investigate prevalence cardiovascular complication assess impact mortality among patient T2DM complication on total study report use review hypertension complication among patient T2DM due complication high complication renal disease lower among patient complication T2DM mortality high
25119443 en use treatment type mellitus T2DM use oral insulin patient control medication undergo increase insulin decrease glycemic control associate body weight low rate patient target improve resistance clinical study assess patient common use medication study effect plasma glucose insulin well reported adverse well effect important compare two insulin lower fasting plasma glucose clinical can little effect
26581749 en glycemic control patient type mellitus T2DM chronic disease due patient medication although medication use disease medication review clinical study clinical use medication well clinical study medication use identify datum correlation treatment research glycemic target patient medication significant datum old medication regard use although large clinical study drug need medication insulin glucose although medication use clinical study use drug remain use use clinical datum drug use patient T2DM
23430574 en role lipid plasma level reduce type mellitus T2DM aim evaluate metabolic effect review perform randomize trial database assess included or or mellitus type or mellitus perform difference mean confidence interval evaluate review included trial patient oral lower fasting plasma glucose total cholesterol low significant change hba1c type mellitus associate plasma lipid
25952971 en type mellitus increase however contribute mechanism studied treatment effect diabetic old diabetic per week test respective sample determined use increased vs group effect therapy reduce vs group increased vs group therapy effect negative reduction observed vs group improve effect group increased decrease treat vs correlate negative correlate negative increased reduce improve treatment therapy may diabetic new high age treatment mass glycemic control reduce diabetic
22217193 en datum indicate lower blood glucose level blood pressure lipid parameter associate lower incidence complication effect study intervention study finding early target study type mellitus demonstrated glucose control complication need follow-up outcome mortality recent three major study evaluate impact old patient high cardiovascular risk study individual analysis demonstrated reduction mortality although revealed reduction incidence glucose control on high mortality observed glucose control study also total major significant high glucose control also datum demonstrated use mortality mortality reduce result on risk observed cholesterol lead trial evaluate therapy reduce level therapy treatment outcome patient however datum early study also analysis indicate treatment individual elevated level therapy evidence study assess impact multiple risk factor glucose cholesterol study study control three parameter outcome patient old patient type associate may reduce event significant risk major patient disease similar high risk associate significant adverse event intervention however also effective observed multiple control clinical
22637738 en resistance type mellitus T2DM however remain whether resistance resistance regard effect control mass patient T2DM man woman year week addition patient rate week intervention time group effect reduce glucose level weight BMI rate blood pressure mass increased significant significant time group effect great increase resistance lead compare resistance however value control weight mass improve significant similar group overall effect may patient according
25297365 en mellitus major health incidence prevalence group study presence mellitus also assess factor study conduct subject age on also test level regard mean poor diagnose use method according number diabetic subject found mean age year condition common high prevalence age group age group analysis show subject little one relative little two diabetic found overall care diabetic subject compare subject result indicate can major factor research also poor among regard health disease
23564193 en mellitus common complication potential negative impact patient evaluate incidence impact adult investigate adult case mellitus DM diagnose patient observed patient mean interval development range month revealed old age high body mass index independent risk factor among develop significant risk factor DM impact patient effect DM outcome remain investigate presence DM whether DM impact outcome
26803356 en compare metabolic control insulin type mellitus T2DM disease T2DM according week on glucose perform treatment period follow test show high glycemic lower glucose level insulin lower glucose insulin high early glycemic lower lower early glucose level rate therefore treatment T2DM effect well lower glucose early
26923392 en base cause type mellitus T2DM whether blood among perform obtain chronic obtain control T2DM observed diabetic without increased increased increased also diabetic independent associate on high reduce found significant correlate reduce overall increased blood presence mellitus finding role
26341086 en on retrospective study define one type mellitus T2DM patient T2DM diagnose patient undergo patient receive year follow-up mean body mass index BMI mean BMI vs correlation found change vs baseline value hemoglobin hba1c fasting plasma glucose BMI reduction hba1c hba1c analysis high baseline hba1c odd ratio or confidence interval CI insulin oral or CI T2DM duration year or CI negative whereas result positive or CI significant BMI decrease T2DM weight compare baseline value analysis significant independent influence T2DM month identify
24187468 en investigate association relationship mellitus DM identify study number study database consider risk ratio estimate model analysis perform according evaluate analysis significant associate analysis revealed show significant association great risk female addition DM significant DM patient DM patient evidence result indicate significant provide evidence positive association potential important clinical factor study
26070114 en type change assess status patient type common evaluate ratio studied type diabetic patient without without known cardiovascular disease group subject cardiovascular risk factor study subject undergo clinical mean healthy subject type diabetic patient show high subject cardiovascular risk difference remain significant difference common subject without diabetic patient independent status show increased common compare subject diabetic according result also large can factor contribute type mellitus
23038480 en rate type mellitus type mellitus cohort examine impact risk analyzed included age year diagnosis type type mellitus little two day analysis use assess association incidence diabetic incidence cardiovascular complication individual risk factor total individual studied year individual diagnosis type mellitus diagnose type mellitus remain individual insulin treatment use type mellitus group group compare type mellitus group associate early development adjust ratio confidence interval CI CI CI whereas type mellitus associate early development CI obesity type mellitus population may increase risk care complication
27093761 en mellitus group dysfunction insulin resistance insulin type disorder type common primary impair glucose due cell insulin resistance review type complication recent treatment
22768879 en metabolic associate mellitus develop complication related mellitus little known effect mellitus system poor type mellitus response compare healthy effect glucose factor healthy significant great compare healthy great group difference evaluate group significant great ratio healthy healthy without change may one common complication associate
26288025 en type new mechanism drug lower blood glucose increasing glucose review clinical study regard drug healthy subject patient type type datum suggest low potential drug system compare reduce hemoglobin hba1c level week therapy patient type relative may effective use one study also show decrease plasma glucose level type include weight low risk decrease blood pressure common adverse effect however study need determine whether current
24661206 en mechanism cause disease may present early history type aim investigate function history type measured mean age year group history type group risk healthy age body mass index without history control significant increased group risk compare control significant lower group risk control correlate positive correlate characteristic analysis revealed value dysfunction history DM result suggest history type impair dysfunction associate increased development cardiovascular disease
18519086 en renal present renal cell role body show cause disorder response review current
26165618 en mellitus DM disease metabolic individual disease complication complication related clinical metabolic define diabetic complication glycemic control current research model review well study change contribute dysfunction associate DM review study adult model type mellitus analysis DM disease review model regard change observed model change adult model compare model
24101783 en assess difference man woman prevalence mellitus impair fasting impair glucose tolerance database study provide prevalence three study condition among adult according on model use compare odd man woman datum identify impair fasting found common man woman or confidence interval CI whereas impair glucose tolerance found less common man woman or CI prevalence mellitus general similar or CI high among woman among man lower among woman among woman man found similar overall prevalence mellitus impair fasting less impair glucose tolerance
24028448 en include glucose lipid cause protein dysfunction age present study aim association diabetic retrospective analysis conduct among patient type mellitus DM female baseline treat year determined use ratio interval incidence development examine use model serum level subject develop follow-up period year significant high incidence incidence significant high incidence significant group incidence significant high high level high low level first report significant association incidence finding provide evidence condition although large cohort need result
26001806 en time obesity insulin treatment protein development increased diabetic recent evidence role type mellitus T2DM possible intervention study role patient condition on addition role role cell gene cell resistance study also role on function body found on level indicate on may role T2DM review therefore on intervention T2DM patient on
26273662 en factor gene effect incidence type mellitus T2DM previous found associate T2DM risk however study population conduct case control study association risk T2DM related complication population also investigate association obesity status
27379252 en study develop gestational mellitus model female high gestational day also factor contribute test glycemic parameter glucose insulin lipid profile total cholesterol insulin glucose show possible insulin resistance evidence high low level indicate possible insulin also show status significant high body weight blood glucose lower plasma insulin level control base finding current model disease
26628397 en factor important study examine whether type mellitus diabetic control adult week age week group measured first week parameter also assess week two group increased group lower mean value compare control group significant lower control group group week level week group compare control group result function diabetic may associate factor
26674501 en review clinical datum mellitus clinical care general datum general datum group statistical level associate population datum identify aged year old relative high hba1c significant whether associate medical rate treatment analysis included analysis use overall age population year female respective old year relative high hba1c sample two patient less evidence regard chronic disease number time period per compare therapy management patient relative high hba1c two within cardiovascular risk indicate cause cause may related health influence
25655741 en gestational mellitus define first diagnose prevalence normal prevalence population type mellitus associate adverse outcome adult diabetic follow base risk assess glucose tolerance presence treatment occur diagnosis treatment reduce mortality related glucose value need whether gestational age estimate weight glycemic control score research need regard treatment effective intervention care metabolic
25442298 en determine relationship patient mellitus compare patient therapy research patient index on conduct type control age body mass score range patient reported score range compare control group patient reduction patient great prevalence decrease vs vs compare control group total score negative correlate patient sample patient common severe related research need patient identify treatment
22177675 en determine treatment disease current mellitus DM type base cell insulin role may type patient disease effect cell develop patient insulin case result insulin patient disease development without complication patient insulin type result insulin may type DM due effect patient insulin cell result insulin resistance develop cell insulin cell insulin patient different insulin different outcome DM insulin DM identify high risk group patient DM complication may develop insulin resistance drug high activity respective result insulin resistance development according metabolic syndrome
24698405 en high body weight risk factor type mellitus associate increased lower risk adult diagnosis type mellitus found high body mass index associate high risk
17253438 en case reported man type associate patient show occur therapy diagnose therapy occur revealed mass diagnose patient result complication disease time diagnosis case one patient important
25069758 en present study analysis datum medical related mellitus type effect health datum year datum use type diabetic identify medication effect define respective diagnosis health study population included define effect significant high diabetic general population risk effect great among diabetic result study use baseline datum use define research datum improve
22842804 en mellitus within month age two type mellitus within insulin found patient mellitus several report insulin patient mellitus cause gene report female gene treatment insulin
19923409 en treatment disorder associate renal effect metabolic response chronic treatment studied method metabolic profile identify change level metabolic profile different investigate use method concentration measured use difference level compare use analysis analysis little analysis major glucose well revealed change level include decrease level on number elevated level can suggest renal cell base can provide effect renal effect cell
19897608 en disorder cause cell patient present year age study three new case present early present patient develop serum remain plasma level low patient gene patient on effect analysis patient present year age analysis new patient first present period early clinical mechanism factor influence age effect demonstrated
25866098 en mellitus DM important regard mortality patient treatment patient examine change glycemic control include insulin oral DM observed patient DM patient DM patient follow insulin use patient DM patient use insulin included patient receive patient patient use although blood glucose insulin mean group mean large insulin group body mass index BMI hemoglobin high patient treat insulin patient treat BMI hemoglobin high compare insulin patient undergo develop DM BMI hemoglobin determine whether change insulin therapy on treatment DM patient mean
23918840 en incidence metabolic syndrome mellitus DM increasing whether increase cardiovascular risk risk factor compare risk cardiovascular among patient new DM DM DM reduction health risk follow year cardiovascular event risk compare patient without DM age risk factor disease fasting blood glucose therapy participant without DM DM new DM presence associate high cardiovascular event adjust CI addition DM patient similar increased risk adjust CI DM adjust CI new DM associate increased cardiovascular risk adjust CI similar DM associate DM adjust or presence new DM metabolic syndrome associate increased risk cardiovascular event
16984239 en target adult dysfunction well aim evaluate presence patient define relationship patient evaluate age year patient cell two evaluate healthy perform protein cell found patient two patient show follow-up one positive serum demonstrated patient three suggest system subject can however indicate consider clinical follow-up need may
24768826 en incidence T2DM well associate obesity estimate population diagnosis mellitus obesity also associate increased risk whether incidence increasing however increase therapy common type prevalence observed one cohort man mean age however diagnosis factor whether presence clinical mechanism obesity related remain several large body evidence associate increased risk cardiovascular disease mortality little evidence effect man disease well however potential old man less well develop present therapy old man review diagnosis clinical management T2DM
23217595 en diabetic population estimate conduct interval use different method obtain datum incidence prevalence mellitus DM perform analysis datum health database sample DM define three on within year one diagnosis DM type mellitus base age DM DM incidence rate increase total diabetic population increase prevalence rate incidence high man age group total number man number woman however prevalence incidence rate woman age year high man type DM present less diabetic population incidence include type remain period however incidence rate man aged year high woman database analysis DM incidence perform health treatment mellitus
26749336 en on related use large disease use treatment cell study suggest insulin also cause glucose however reported may use review study clinical trial use research also identify
27234759 en prevalence on mellitus increase time management condition important renal influence renal function case diagnose patient time diagnosis increased patient follow-up year age patient however clinical datum significant different patient without score high patient patient without difference statistical serum level time overall according presence significant influence function outcome year patient
25185386 en mellitus occur patient without therapy however reported adverse effect may management disorder high use report three adult develop oral review current mellitus review case three patient well adult aged year old develop mellitus oral first case oral use management plasma cell multiple case follow one week chronic case also oral high body mass index may risk factor development prevalence condition possible treatment mellitus important clinical finding early effective treat fasting blood oral glucose tolerance test well management aged patient
25131134 en mellitus common complication effect well known aim study glucose oral glucose tolerance test activity study period patient group on patient group patient according result patient group on new diagnose mellitus group impair glucose tolerance group case normal glucose tolerance diagnose group model assessment insulin resistance value group high compare group vs vs case DM patient group case case case level high compare patient vs evaluate individual decrease function important glucose also risk assessment result activity type glucose high effective therapy patient
18519087 en event body high large cell cell lead reduction renal development disease review major function mechanism follow review mechanism datum role consider protein cell recent present potential development therapy may improve patient
18519085 en review first early identify early diagnosis treatment result result plasma cell protein potential can research protein disease disease among patient perform chronic renal cause
18489790 en normal elevated plasma level report cause include protein activity high level cell reported patient show reduction number cell perform identify patient profile patient also investigate gene profile blood cell patient healthy control evaluate subject one two adult include test show reduction cell one adult patient reduction cell patient reduction serum level adult patient show gene profile revealed influence great result suggest may role result clinical
24581791 en identify characteristic large group patient type BMI patient identify compare BMI patient patient type patient datum include factor insulin use complication compare vs high prevalence insulin use vs lower vs high prevalence vs vs group vs compare patient within group insulin oral medication vs early age vs lower BMI vs lower vs patient population may cell factor may
25809179 en complication mellitus reduce significant insulin year normal glycemic level patient related multiple insulin insulin first drug drug year insulin develop receive drug clinical patient adverse effect therapy insulin review
25731889 en evaluate study may assess relationship serum level mellitus DM investigate relationship serum DM study examine use DM ratio association DM regression obtain study included analysis use assess influence use model estimate model analysis indicate statistical significant association found positive study population serum concentration lipid result study high body result low current high level datum indicate increasing associate increased risk DM
25681464 en reduce cardiovascular patient previous increasing patient mellitus DM high risk event therapy may therapy trial randomize trial patient examine patient without DM trial previous patient history analysis patient primary cardiovascular occur patient DM patient without DM rate group adjust ratio patient DM significant reduce primary ratio confidence interval number need treat major cardiovascular event incidence increased patient DM ratio confidence interval however clinical outcome improve ratio confidence interval patient previous DM addition therapy significant reduce risk major event great potential group high risk
22749773 en report patient mellitus found first reported patient datum contribute
24362727 en use treatment type mellitus evidence activity study suggest effect therapy individual type mellitus studied type mellitus patient therapy investigate level week therapy reduce level vs occur independent change body weight hba1c therapy associate decrease level vs vs vs increase level vs individual type mellitus therapy reduce effect body weight effect
27776453 en type mellitus T2DM chronic metabolic disease associate lead complication current treatment therapy within use therapy include factor influence glucose include associate cardiovascular risk review mechanism addition datum present effect examine clinical datum insulin need glycemic control reduce risk body weight insulin effect therapy well treatment T2DM however study need associate risk
20051818 en report case woman associate development revealed mass finding therapy month mass develop revealed presence therefore therapy case presence mass association cause diagnosis may first
23713182 en study obtain treatment patient mellitus type common clinical type study conduct group medical observed assess population patient undergo little three month treatment research population month datum year age mellitus patient weight mellitus interval weight hba1c mellitus treatment population included woman man age time year period treatment year BMI value time treatment BMI three month treatment follow decrease patient month hba1c value decrease first three month period month value decrease month hba1c hba1c value occur first year research population measured patient value reduce within three month treatment within month current treatment patient mellitus type lead population statistical significant reduction hba1c level first month treatment month treatment population hba1c observed patient significant reduce BMI first three month patient reduce BMI period month
25780309 en investigate whether mellitus DM disease conduct database respective evaluate relationship DM study analysis base datum study on perform compare odd ratio or DM individual without use effect effect model presence significant analysis use identify assess test evaluate result also perform database total case control included base model study identify significant association DM risk overall or analysis indicate result study population or patient mean age year or significant observed use test analysis also suggest patient DM great risk DM
26864124 en datum obesity need patient type mellitus T2DM high cardiovascular risk use baseline datum effect outcome clinical trial assess investigate prevalence obesity relationship major risk factor body mass index BMI treatment BMI two population patient T2DM aged year disease aged year one risk factor association metabolic treatment BMI use regression model BMI BMI prevalence healthy also low according metabolic syndrome obesity associate female previous duration blood pressure insulin oral treatment high level lower level obesity high risk patient T2DM BMI related major risk factor treatment insulin oral drug high lipid control patient effect weight risk factor
26341940 en model influence health hemoglobin hba1c level patient type patient T2DM datum regard characteristic health hba1c level on use determined health health hba1c health relative influence relative influence glycemic control patient demonstrated glycemic control improve target health consider potential health can use patient patient T2DM
26133488 en study examine association weight outcome glycemic control on sample adult mean age female poor control type hba1c level provide several include activity weight hemoglobin hba1c assess research large research study individual weight significant high hba1c level high level general glucose relationship BMI overall characteristic result indicate weight among individual type associate range poor outcome reduce weight may patient type
25671950 en major cause disease rate disease time high among adult among without associate adverse outcome adjust elevated plasma glucose hospital outcome patient high blood glucose level common increased risk subject without study determine new diagnosis present study conduct hospital patient care known diabetic patient included hospital use determine new diagnose patient study female patient new diagnose new diagnose diabetic high patient patient known diabetic present new
26345590 en effective treatment treatment obesity current evidence effect patient without study suggest patient mellitus weight great diabetic outcome treat intervention treat intervention aim study review evidence effect control patient type on review randomize control trial type outcome study conduct included randomize control trial adult participant body mass index diagnose type reported weight change little one diabetic outcome on total identify overall mean weight reduction month group CI mean weight difference treatment control group CI mean hba1c difference CI mean fasting blood glucose difference CI treatment intervention result significant great weight improve control patient type compare intervention
25263500 en investigate change serum protein level correlation type mellitus T2DM patient different diabetic disease determined case T2DM three group ratio level serum determined case control control serum level significant decrease serum level increased significant T2DM patient serum level significant negative correlate serum level negative correlate positive correlate serum level positive correlate addition serum level significant positive correlate significant negative correlate level may new early diagnosis T2DM may development mechanism related renal lipid metabolic disorder diabetic may mechanism
25034243 en obesity type mellitus well role weight chronic condition examine study determine whether weight development cohort study adult type health study use method datum follow patient health weight baseline subject reported weight little found associate baseline body mass index age regression analysis indicate severe weight time associate development major however associate major adjust body mass index activity characteristic development major associate major also associate high body mass index value associate severe independent development major consider evaluate patient type
27221806 en type mellitus T2DM chronic disease three associate increased mortality system effective management disease high need patient receive possible care within study evaluate compare T2DM patient control model model determine incidence complication mortality clinical datum model parameter total total well ratio analysis conduct important model parameter analysis patient associate compare respective respective per treatment respective result analysis define per estimate treatment relative show treatment patient T2DM provide glycemic control
26040376 en recent study demonstrated cardiovascular increased risk cardiovascular complication can great type patient mellitus type study compare type mellitus healthy individual datum also cardiovascular risk factor vs vs similar group group control group vs significant lower control group difference vs vs demonstrated influence metabolic total general population however lower general population although related metabolic parameter complication increase type
25796371 en woman history gestational mellitus control weight aim examine weight change influence risk develop type included woman health study follow body weight type diabetic case reported define baseline period woman reported estimate use case type year follow-up adjust type associate increase BMI CI baseline BMI CI recent BMI weight development associate high risk type adjust CI woman BMI baseline adjust CI compare woman BMI baseline BMI recent BMI weight significant positive associate risk type
23379533 en different disease complication present study analyzed medical research database use mellitus total research identify research increased research review clinical trial number high study research mellitus research high randomize control trial perform study mellitus
25026864 en impact mellitus patient multiple system remain study increase outcome patient research use identify patient patient known outcome known known datum analyzed patient outcome associate total patient medical diabetic group patient found old group on high mortality rate found diabetic group compare group rate complication include renal syndrome found high diabetic diabetic patient may result improve outcome glycemic control early intervention complication may reduce mortality
25470646 en role obesity type mellitus T2DM cardiovascular complication ratio provide method assessment status new aim present study investigate value development type T2DM obesity patient body mass index normal weight patient normal fasting plasma glucose glucose evaluate mean significant high patient normal weight healthy patient vs respective characteristic analysis T2DM logistic regression analysis show elevated or CI independent T2DM high healthy control high independent T2DM elevated level consider result study role T2DM
26354881 en primary factor little complication relationship type diabetic patient hemoglobin hba1c associate effect weight current medication present patient type show role development glucose glucose renal increase glucose recent new develop treatment patient type review examine mechanism oral use disease medication
24229770 en aim study compare effect study show although significant reduce patient type mellitus DM remain whether can patient impair glucose tolerance type DM undergo blood randomize receive week effect treatment evaluate baseline study measured value known patient study assessment treatment patient patient man mean age year hemoglobin study treatment fasting plasma glucose hemoglobin value reduce group change ratio value baseline significant great group group vs well change protein vs group range vs study indicate patient impair glucose tolerance DM independent suggest may event patient impair glucose tolerance DM effect
26855250 en whether prevalence cohort diagnose compare health total patient clinical care included evaluate early treatment study use clinical fasting blood glucose blood pressure body mass index value diagnosis blood assess time patient compare among clinical analysis patient increased or CI per or CI less or CI similar result found use increasing outcome prevalence cohort compare clinical diagnose cohort significant lower year follow-up patient prevalence increasing significant lower among diagnose care risk factor duration blood pressure consider early reduce time early effective provide
22777524 en patient mellitus need effective insulin glucose review insulin therapy multiple vs insulin method blood glucose vs glucose outcome type control trial without randomize control trial adult compare insulin use independent evaluate study randomize control trial show similar effect hemoglobin hba1c level severe adult type mellitus adult type mellitus adult type mellitus hba1c level decrease study influence result compare lower hba1c level difference change CI without difference severe insulin use decrease hba1c level type mellitus difference change CI little evidence study duration type insulin similar effect glycemic control effect glycemic control adult type mellitus glycemic control insulin without increasing risk research
25563756 en effect drug determined drug mellitus drug study investigate woman gestational mellitus total normal woman group woman group studied patient receive blood sample time blood sample concentration analysis respective ratio obtain group blood blood ratio group respective blood mellitus mechanism
25438660 en recent study reported odd increased clinical factor associate total control subject patient major control subject mean major score significant common patient mean major score show female low status positive study found common health among consider patient health status status potential factor
27045155 en aim research examine impact type datum use database health disease control concentration identify woman type found research examine woman type individual datum among woman research study study study study included disorder complication mellitus effective weight change woman type mellitus review effect result demonstrated however study need identify factor contribute patient complication type mellitus
25229989 en insulin may associate potential insulin cell previous use case type mellitus present insulin increasing effective management severe regard use treatment may management insulin may
24567193 en patient poor control mellitus define hemoglobin year care high risk complication research define patient factor associate can suggest group development target patient
26209325 en type important medical within individual study evaluate within aim study determine whether evidence type study sample time participant aged year health disease disorder disorder disorder disorder logistic regression use estimate association history history positive history associate positive history disorder odd ratio adjust age association different odd ratio adjust age significant odd ratio adjust age factor association odd ratio adjust age diagnosis risk type medication type risk factor
24125027 en diabetic patient treat within primary care condition associate poor outcome aim review examine whether care improve outcome patient identify randomize control trial care diabetic patient age reported treatment response hemoglobin hba1c value medication oral included two independent result datum study outcome use risk ratio mean difference confidence interval study patient care show significant treatment response CI adjust CI high rate medication CI oral CI indicate reduction hba1c value CI care diabetic patient important compare care care associate significant outcome patient finding care diabetic patient
26674292 en mellitus metabolic disorder however consider cardiovascular disease metabolic type DM study determine whether treatment may level patient DM parameter rate patient study patient poor control DM two control group patient DM patient age without disorder glucose receive treatment medical therapy patient perform treatment use system parameter analysis rate analyzed evaluate system control group show increase parameter index activity system vs treatment increased rate vs reduce index vs reduce index vs found patient DM patient poor DM show decrease vs also reduce vs result change cardiovascular control patient DM treatment reduce system activity decrease increasing control rate without cardiovascular system
22972104 en mellitus chronic metabolic disorder associate increased risk cardiovascular disease dysfunction disease control may reduce risk complication several study show may effective control effect also finding study evaluate effect patient control trial identify health database database clinical trial included trial also also control trial compare effect oral medication treatment type type review independent trial assess risk trial datum study control trial total participant type type mellitus identify risk high two trial assess risk risk high trial oral mean period range week effect fasting blood glucose level statistical significant difference hba1c serum insulin glucose found control group datum result insulin trial reported mortality adverse oral general evidence use type type mellitus trial important complication also need
22056281 en estimate prevalence possible risk factor conduct cohort study base database include datum patient type mellitus age year mean duration mellitus year database diagnosis total patient identify prevalence on total patient treat medication patient without therapy patient mellitus patient without weight body mass index difference can demonstrated metabolic control type insulin treatment insulin prevalence severe lower patient treat medication risk diabetic patient compare patient type mellitus mellitus show increased prevalence association diabetic type mellitus
25001374 en oral medication patient type mellitus important role care associate high level however poor treatment common cause severe health complication increased mortality may treatment effect due medication well provide health care effective management care one care aim effective intervention oral medication type review randomize control trial study assess risk included two study examine intervention show significant included study intervention potential improve type mellitus medication study need assess effective
27240104 en study evaluate role disorder associate chronic disease development renal patient type mellitus investigate patient duration different include patient overall clinical assess factor level index also function associate increased level high range patient high risk cardiovascular event patient function parameter level patient cardiovascular level duration increased decrease rate correlate parameter associate patient age duration dysfunction significant factor remain major cause mortality patient population
23166422 en although prevalence type increasing case type diabetic patient aim study treatment case mellitus use body conduct retrospective study patient medical diagnose mellitus medical review datum index body subject group type body mass index mass index body mass index body index high type analysis test significant type revealed contribute factor analyzed regression analysis case identify body include type lower BMI related relative lower insulin type insulin resistance result obesity body analysis type case early management
23987505 en type mellitus major risk factor development although remain poor identify influence mellitus level examine level plasma individual compare individual without elevated level type type type decrease level associate increased level type blood also show increased level type type plasma significant positive correlation hemoglobin level indicate impair control associate analysis revealed association mellitus influence age metabolic datum indicate chronic type potential contribute increased poor control
26542673 en present study aim evaluate relationship activity dysfunction population compare association general primary care dysfunction study sample diabetic patient study dysfunction assess use index function diagnose use assess participant activity activity week assess use activity on logistic regression analysis perform adult presence present age status activity current use medication independent mean age year study population prevalence significant high man without vs overall prevalence without reduce reported study participant without total activity study population score high adult age or or or presence or associate significant increased risk develop on similar result observed dysfunction associate status association observed without
25301035 en impair function adult well investigate factor associate impair function adult type function response assess function assess baseline patient type intervention event study risk factor assess model identify factor independent associate impair age year range duration year range mean severe impair significant associate risk factor response significant independent impair present subject increased ratio adult type known show significant impair elevated level
24681758 en insulin insulin cause severe effect glucose insulin study characteristic insulin diabetic patient medical history insulin therapy use multiple adjust age type logistic regression analysis association insulin age type hba1c serum significant association insulin duration insulin use significant adjust odd ratio respective adjust odd ratio insulin respective adjust odd ratio insulin insulin respective association insulin insulin significant result suggest insulin duration insulin use risk factor insulin patient poor control history insulin therapy time insulin
26954655 en on significant mellitus therapy use primary intervention trial evaluate study multiple analysis association study increase therapy among individual risk factor develop mellitus recent analysis suggest correlation use however on mechanism glucose remain although consider effect drug datum indicate less therapy risk among patient high cardiovascular risk study need association clinical provide clinical therapy overall provide primary care review clinical datum regard potential glucose
25396405 en mellitus show associate suggest important common aim present study examine whether patient present correlate clinical patient subject identify may medical patient history age type treatment complication disease analysis perform clinical datum compare identify patient time period studied patient included patient control mean age year diabetic patient respective found diabetic patient patient ratio patient compare patient clinical association can common diabetic patient clinical
25079460 en assess level type mellitus without patient type case group age year case type without disease control group age year total well ratio similar group case group level whereas case group patient similar clinical high level ratio compare subject level group group difference level group patient type also elevated serum level age group total level patient type compare type
27388674 en review evidence intervention type mellitus T2DM effect control among T2DM use database perform study identify assess risk primary outcome review hba1c fasting blood glucose fasting plasma insulin model resistance protein identify outcome mean difference control group outcome use model statistical assess use control trial included review whereas included present low risk compare significant lower CI change group also hba1c effect significant lower finding hba1c effect clinical however remain finding need clinical study assess potential effect management T2DM
27368063 en aim parameter patient mellitus DM well without use parameter time healthy subject DM patient DM patient without perform healthy subject patient DM also blood pressure on score evaluate value DM group control group compare statistical significant compare value parameter show statistical significant change control DM patient without result change DM patient result study suggest patient DM healthy subject different response change different effect diabetic compare healthy control DM patient without
26443478 en impact mellitus DM outcome care patient undergo well use sample impact DM medical datum sample analyzed patient undergo patient hospital complication compare patient without patient patient DM diagnosis DM patient old vs year old great hospital compare cohort DM patient significant high rate vs event vs vs renal vs vs difference rate observed vs logistic regression age DM patient great odd event renal associate great hospital among patient DM patient significant great rate complication include event renal
25017409 en health clinical mellitus provide patient treatment mellitus clinical mellitus health use multiple base
24686289 en change occur result diabetic well although study suggest association mellitus change association diabetic remain aim review determine effect mellitus database review use change occur due mellitus review finding observed diabetic cell change different cell type DM study determine factor difference
20389105 en cause case cause normal serum year age patient can response patient can patient identify activity measured cell assess previous patient cell response whereas value response similar high activity result
19666909 en renal cell protein on increase concentration response cause gene therapy patient different however whether increase cell subject cell examine effect test effect cell treat day day protein level determined cell however increase result suggest treatment patient may improve
26857805 en mellitus remain one major health associate include obesity metabolic study conduct evaluate serum protein level large sample population without history cardiovascular disease fasting blood glucose presence study subject BMI characteristic measured blood lipid profile serum clinical characteristic significant different among group total cholesterol subject serum high cholesterol blood pressure compare subject serum analysis show associate increased serum level independent associate serum concentration
21357495 en association perform patient mellitus assessment little determine patient mellitus condition lead determine patient mellitus receive patient mellitus may receive among patient mellitus condition receive oral individual type mellitus clinical medical may participant mellitus complication receive mellitus response statistical analyzed correlation participant receive total individual mellitus among condition mellitus lead individual mellitus lead disease follow receive year common receive patient mellitus study receive need current health patient mellitus need
21320966 en examine association mellitus early adult year study included participant aged year early assess base system mellitus define fasting glucose level great use medication logistic regression use examine association mellitus early subject early subject mellitus adjust age current obesity hypertension significant association found mellitus early subject mellitus early odd ratio confidence interval without relationship mellitus early adult year old remain determined
27143183 en effect cell type subject include type mellitus year duration treat insulin little month poor glycemic control hemoglobin total patient two group group on group group group cell first day follow cell day control subject group treat week period fasting plasma plasma hba1c measured on oral glucose tolerance perform early total model assessment insulin resistance baseline hba1c two compare subject group on hba1c level significant decrease subject group vs vs vs compare group on significant increased significant decrease group vs vs vs treatment improve glucose cell function type diabetic patient
26179482 en assess different high patient type mellitus randomize study patient control randomize one primary change week baseline hba1c change significant reduction hba1c show treat group group reduction increased glucose treatment influence reduction fasting plasma glucose body weight observed glucose improve blood pressure reduction increase observed mean body change body ratio adverse event reported incidence adverse event similar group adverse event patient per treatment group similar rate week effective treatment T2DM
27567620 en type mellitus T2DM chronic associate insulin resistance relative insulin T2DM effect factor one T2DM on common show associate T2DM aim investigate possible role gene risk factor T2DM study subject T2DM patient control use analysis control case respective or CI patient control found significant association gene T2DM however show statistical significant association clinical parameter include body mass index total cholesterol study may risk factor T2DM population
25092614 en common adverse clinical outcome determine prevalence among medical care patient association baseline glycemic control cohort study perform care hemoglobin hba1c level obtain patient develop known diabetic patient assess prevalence define hba1c among patient association baseline glycemic control patient one two history history patient hba1c little significant difference mortality patient hba1c less hba1c little vs similar chronic health score significant difference characteristic group logistic regression revealed lower hba1c level significant associate increased hospital mortality odd ratio confidence interval significant number patient lower baseline hba1c associate increased mortality
20946007 en important show mechanism related cardiovascular disease however study examine association plasma mellitus also association present among woman well man therefore examine association plasma level mellitus sample examine health participant year age woman plasma level woman man mellitus define fasting glucose glucose use oral medication insulin plasma level found associate mellitus adjust age hypertension serum cholesterol protein odd ratio or confidence interval CI however adjust body mass index BMI association plasma level mellitus man or CI woman or CI plasma level independent associate mellitus BMI association woman well man
26827116 en assess patient type mellitus analysis evaluate patient receive week week clinical development trial total patient included study hemoglobin hba1c fasting glucose body weight glucose significant reduce vs baseline hba1c reduction great vs whereas hba1c reduction reduction weight reduction significant great vs reduction great vs reduction significant great vs whereas significant great vs respective common adverse event included improve glycemic control include patient T2DM patient significant great reduction hba1c patient well group
24397392 en although woman gestational mellitus normal glucose tolerance increased risk disease study aim evaluate relationship plasma level age risk factor woman woman case healthy woman control clinical datum analyzed year case type mellitus metabolic syndrome hypertension respective significant difference case control age plasma age level positive correlate metabolic index woman previous increased risk disease age can identify early woman increased risk metabolic cardiovascular disease
23383628 en receive however case disease also lead aim assess rate patient patient chronic mellitus patient general assess patient rate addition patient whether general one patient patient patient chronic patient mellitus type type whereas patient little disease compare patient chronic mellitus respective within patient group mean rate high follow patient case patient mellitus respective patient general patient low rate patient need
23564668 en mellitus complication major cause however known role identify role development diabetic cell condition show increased similar response cell examine investigate role development week mellitus effect correlate reduce reduce similar treatment diabetic study identify major role suggest target diabetic include
25917657 en use associate increased incidence possible increased body weight reduce datum effect association healthy adult however addition relationship effect diabetic complication examine association use diabetic complication cohort healthy retrospective cohort evaluate patient patient baseline disease cardiovascular disease positive index include mellitus chronic disease use baseline characteristic score assess included diabetic complication total patient identify healthy adult baseline high odd odd ratio or confidence interval CI complication or CI or CI analysis demonstrated similar diabetic complication common diagnose among similar healthy cohort adult study clinical trial use primary
25638930 en incidence rate associate risk factor chronic several oral include oral role may method early management aim determine whether mellitus within conduct year examine also present mellitus patient care patient on condition cause patient patient
18216143 en renal concentration investigate impact renal study develop control renal show significant decrease compare control protein protein protein protein protein reduce control value protein protein reduce significant therapy datum present provide may impair renal mechanism
25861812 en patient mellitus due cardiovascular cause prevalence cohort chronic increasing increasing chronic patient risk outcome remain high review current incidence patient chronic cause risk condition current risk patient study
23439506 en study examine association mellitus according may datum health response rate mellitus define hemoglobin fasting blood included woman analyzed adjust age status status odd ratio mellitus confidence interval CI CI among respective compare analysis year vs year association mellitus among old participant compare risk mellitus increased among whereas effect among
25136645 en evaluate effect metabolic parameter patient type patient type study intervention group control group patient intervention group receive intervention include mellitus week patient control group receive medical therapy metabolic patient group assess significant reduction hemoglobin hba1c body weight intervention group compare control group however significant found metabolic improve hba1c body weight patient type
22483749 en investigate effect insulin therapy type mellitus total group include control treatment week treatment week group body weight blood glucose level diabetic significant increased compare body weight decrease significant decrease group significant reduction obtain compare group insulin treatment significant decrease group compare group insulin treatment
25938184 en type mellitus T2DM common associate chronic disease treatment T2DM may however due association retrospective identify patient T2DM hospital compare concentration primary study cohort mean age year female blood case patient group range concentration group year CI year respective ratio CI remain significant model adjust among patient high risk therapy associate concentration clinical associate due possible effect result suggest present clinical use
25595459 en contribute cardiovascular type mellitus T2DM cardiovascular aim investigate whether cardiovascular event associate T2DM patient also studied effect model examine T2DM patient disease subject on year follow-up obtain patient activity T2DM patient decrease increased compare plasma correlate serum T2DM patient patient high low level high risk compare remain patient reduce increased activity total result suggest T2DM patient reduce may high risk addition effect therapy aim increase may patient T2DM
24532197 en perform review determine whether diabetic patient increased rate complication compare patient on review database perform use on retrospective medical review patient identify hospital also result revealed patient mellitus increased risk complication odd ratio or confidence interval CI prevalence mellitus patient incidence mellitus patient time high general population
21654538 en mellitus DM may determined whether change body weight DM type identify type DM subject fasting blood glucose DM DM compare body weight fasting blood glucose DM year index blood glucose value similar DM DM type DM subject similar body weight however DM subject weight type DM subject DM type DM subject weight subject index subject weight type DM subject vs primary type DM associate weight weight development weight may important
26630915 en on datum management datum clinical increase disease within new analyzed type patient datum within general analysis large datum time analysis studied whether glycemic control show correlation observed hemoglobin consider finding need show possible datum new may provide new clinical
26599441 en on common determine investigate impact determined activity diabetic complication patient type mellitus patient relationship clinical characteristic activity activity vs activity vs current investigate multiple logistic regression analysis diabetic complication adjust age current activity duration body mass index hemoglobin insulin use cholesterol blood pressure system use prevalence significant lower group odd ratio confidence interval CI prevalence also lower group significant increased compare odd ratio CI patient type lower complication prevalence associate high complication prevalence
19940203 en patient chronic case occur develop severe on man hospital severe type syndrome plasma cause significant plasma several day plasma glucose normal plasma diagnosis due patient remain clinical patient remain day first reported case development relative plasma less may contribute significant development patient
24459063 en study investigate effect compare cell function several test patient age year duration type mellitus female hba1c mean randomize receive study duration week blood glucose insulin level measured fasting interval duration group fasting glucose level improve group increase insulin level can observed treatment whereas treatment associate decrease insulin level blood glucose control group reduce insulin result indicate cell function well reduce risk profile treatment
23516829 en diagnosis mellitus fasting glucose result study aim impair glucose tolerance mellitus subject fasting blood glucose different subject present analysis fasting blood glucose mellitus undergo oral glucose on total subject fasting blood glucose glucose glucose association health glucose include impair glucose tolerance mellitus fasting blood glucose result
27069242 en mellitus adverse event study examine risk factor include complication study compare incidence type complication diabetic patient undergo identify significant increase risk complication study independent risk factor major complication cohort patient undergo may may review evaluate risk factor major complication hospital within day regression analysis perform effect age obesity type patient major complication diabetic significant complication compare vs analysis vs vs complication significant high among diabetic diabetic high risk complication body case vs vs analysis found independent risk factor complication relative risk relative risk independent risk factor major complication
26173465 en determine aged year type control subject without type whether score related study test general test type control subject aged year group age participant type disease duration year history control hba1c diabetic severe obtain medical participant type lower mean estimate level compare control group great time associate lower within group type age status blood glucose level time history severe associate difference type associate lower increased associate lower result function may
25929253 en recent evidence increased incidence negative impact glucose parameter use study examine vs change baseline week hba1c primary fasting plasma glucose subject type randomize trial adult type measured subject receive drug subject receive drug randomize period week change hba1c fasting plasma glucose baseline week evaluate subject randomize baseline week hba1c significant increased group difference CI statistical week mean change baseline level difference CI fasting plasma glucose difference CI similar treatment result suggest result glucose patient type week
26141244 en previous demonstrated function health mellitus DM patient diabetic present study identify difference patient without patient without use total man mean age year use DM include body function body activity mean number significant great patient follow patient without patient without vs vs respective logistic regression model revealed compare patient without patient activity among patient patient found large status adjust age type duration result study use DM identify among patient without patient without
24935819 en disease analysis large aim study examine whether mellitus associate status participant age year study status define blood glucose level assess status multiple regression analysis use examine association status estimate prevalence ratio interval relationship individual status odd ratio adjust multiple use method addition association risk score observed status however significant association individual risk status odd ratio range similar risk score analysis revealed evidence datum provide evidence association risk different status cohort suggest contribute health
22712525 en obesity associate chronic contribute development insulin resistance type mellitus T2DM study investigate effect drug metabolic disorder status development T2DM use drug T2DM week oral week fasting serum glucose oral glucose tolerance fasting serum insulin serum lipid profile serum body index determined result show drug positive impact effect measured parameter result drug drug provide metabolic status drug however effect drug regard parameter study indicate use effective therapy management T2DM may effect respective improve lipid profile insulin level
24965700 en study evaluate glucose patient type mellitus T2DM within chronic disease estimate rate
26882051 en recent identify insulin gene analysis associate type mellitus elevated hba1c reduce insulin well sample investigate patient different type included patient type age healthy control patient adult healthy control patient datum lipid renal parameter assess level measured patient significant high level vs vs vs vs vs vs level correlate age BMI hba1c on model revealed BMI first study significant increased patient different type suggest protein general dysfunction potential type
25894243 en mellitus type risk factor disease complication chronic insulin increased risk addition resistance effect insulin cell metabolic protein weight disease result increased risk diabetic patient adjust oral insulin drug may type patient patient weight diagnose management important metabolic control weight rate aim body weight evidence whether drug treatment however activity high effect risk addition effective cardiovascular event also show reduce risk
27423765 en new association study group diagnosis gestational mellitus regard current use complication rate cohort may provide care population therefore determined complication rate identify adverse outcome cohort retrospective cohort study perform included woman without diagnose fasting plasma glucose level oral glucose tolerance test total woman without included rate significant high group lower rate reported need insulin therapy glucose included body mass index gestational weight result although study provide complication rate intervention large cohort woman level lower current diagnosis finding suggest association adverse outcome important role risk factor glycemic result development complication identify may treatment
22390963 en type mellitus factor include high important identify risk factor may reduce risk type mellitus aim present study determine association risk type use possible risk factor type mellitus odd ratio confidence interval type mellitus logistic study perform total case new diagnosis type mellitus control BMI history plasma level logistic regression model value odd ratio possible increased risk type mellitus determined individual or CI increased risk disease determined individual or CI compare datum possible relationship increased risk type mellitus
16968783 en within cause identify mechanism disease test possible show severe impair however increase compare suggest model cell revealed plasma show effect normal use test several drug treatment found increase may drug treatment model effect normal
21696527 en association type mellitus report two patient develop case present hemoglobin hba1c cell negative show on gene found month glycemic control insulin treatment on high year insulin hba1c case treat found blood glucose level hba1c negative history positive disease type mellitus patient investigate gene found found due metabolic control investigate found insulin therapy current hba1c diagnosis risk develop therefore investigate treatment metabolic control
27424010 en regard effect due study conduct use aim evaluate effect function activity patient type mellitus T2DM base gene T2DM patient aged body mass index randomize control trial group perform base age participant receive week use method activity estimate level target assess use time serum level measured use present study T2DM patient health condition base treat metabolic disease
27267430 en type mellitus use large database prevalence case health database use identify patient evidence year related drug index characteristic group compare analyzed overall prevalence remain case case case mean age patient similar mean age patient decrease hypertension common patient increased population cardiovascular disease decrease large health database analysis suggest prevalence incidence recent period age diagnosis increase several
23316296 en on high rate associate increased cardiovascular complication patient type mellitus impact rate risk develop complication diabetic however present study test high rate associate increased incidence great complication patient type baseline rate development major event examine patient disease control study major event define new new patient high baseline rate increased risk new major complication follow-up adjust ratio per per confidence interval adjust ratio per per confidence interval adjust ratio per per confidence interval type mellitus high rate great incidence
26188812 en important outcome intervention datum increasing use health group type mellitus T2DM patient receive insulin treatment conduct study patient T2DM year age treat insulin insulin baseline month on total patient included receive receive mean score T2DM negative impact mean impact score great negative impact observed condition mean score patient treat patient receive difference statistical use patient evaluate care score population reported result study increase patient insulin treatment clinical patient resistance
23606485 en dysfunction may cause mellitus DM prevalence among DM patient on study compare man DM control according dysfunction perform man DM study control man DM whereas control mean duration DM DM patient year compare DM patient can demonstrated year difference statistical significant can associate BMI blood pressure cholesterol fasting glucose diabetic dysfunction compare diabetic without group control finding can use drug whereas included control participant show man DM important association diabetic low
21913963 en prevalence gestational mellitus show group difference clinical characteristic outcome woman gestational mellitus group retrospective review woman gestational mellitus conduct clinical profile woman group include outcome cohort woman group low BMI low fasting high glucose level glucose tolerance test low need insulin therapy low rate low history also low woman high BMI fasting glucose level glucose tolerance test hba1c diagnosis gestational mellitus well week great need insulin therapy also high study significant difference clinical characteristic woman gestational mellitus among group difference may need consider management gestational mellitus
24341203 en hypertension mellitus two early perform increase incidence rate hypertension age increase patient age according different therapy patient according large randomize trial analyzed therapy hypertension metabolic impact patient system cardiovascular risk factor cardiovascular disease chronic renal disease blood pressure patient hypertension system method treatment hypertension mellitus method reduce risk cardiovascular complication
27007421 en relationship time study health year datum total time regard mellitus datum analyzed use mean sample included analysis show score statistical high intervention score statistical significant possible identify value time increase mean score improve effective related mellitus consider time factor
24490949 en assess effect glycemic status lipid profile patient type clinical trial type diabetic patient group control group week serum lipid measured reduce fasting plasma glucose hba1c insulin total cholesterol significant compare group significant difference two group improve insulin lipid profile reduce type diabetic patient therefore consider effective treatment complication
24894889 en mellitus patient health system improve early intervention datum study provide first current mellitus well development prevalence incidence mortality health care datum large health group current determined sample adult patient base datum related drug use clinical diagnosis evaluate change result datum general population total patient identify case overall prevalence incidence mortality rate significant change time health increased per patient per patient study show high medical prevalence increased time finding need health patient chronic condition health system
26547967 en effect investigate blood condition mellitus show development provide mechanism blood system case studied one reduce effect protein lipid increased activity blood system revealed effect can presence
26418902 en whether medication increase insulin level development patient mellitus DM use insulin medication early age diagnosis present may according treatment insulin medication medication age diagnosis year DM diagnosis analyzed among DM patient mean age year mean age diagnosis within cohort year respective significant difference among age diagnosis observed base duration type DM treatment correlation increased insulin medication increase insulin development use outcome mean age diagnosis duration DM diagnosis
22119251 en investigate among study use health datum care on total new diagnose case control follow use estimate incidence diabetic status relative risk estimate model year follow-up control subject care per respective analysis indicate risk independent associate ratio CI CI ratio man woman without respective may increase rate woman ratio increased effect man vs cohort study provide association independent addition female patient associate great rate
23243416 en mechanism role glucose study reported associate activity aim study evaluate association mellitus risk general population study included subject general population blood pressure analysis perform individual high glucose value high mellitus compare individual adjust age addition high mellitus risk associate presence or CI datum suggest may glucose previous associate insulin glucose insulin study datum suggest may increase chronic metabolic condition population
26329937 en relationship dysfunction mellitus on study association mellitus dysfunction study conduct medical hospital case study population one patient group control hba1c patient group poor control mellitus hba1c study population female mean age two group year vs year significant difference duration year year two group status hba1c vs control diabetic patient group respective significant difference dysfunction found diabetic patient patient hba1c control diabetic patient hba1c dysfunction control status difference statistical significant dysfunction type diabetic subject significant high compare well control group study dysfunction common patient poor control mellitus
25095432 en age high associate also characteristic on use model use assess risk mellitus subject analysis model on case hospital use model case use test model subject risk mellitus characteristic use mellitus mellitus model respective overall method use model first time result show method effect compare current use fasting plasma glucose
25052923 en mellitus disease define age month may oral therapy current study analysis follow-up report case one undergo insulin undergo multiple insulin month month follow-up three blood level one poor suggest undergo without oral consider treatment method may also improve
26684153 en condition occur clinical major disorder condition mellitus DM several negative effect datum potential role body retrospective study evaluate influence body man subject subject studied clinical body group age weight patient lower level total range range compare patient great patient total correlation body significant found positive significant correlate negative association regression analysis respective regression analysis DM
27052220 en prevalence increasing addition patient diagnose current association type base current evidence
26823010 en on number gestational mellitus woman develop type body research suggest activity reduce risk type activity reduce time may effective health woman previous diagnosis activity potential type risk reduction
17941907 en identify clinical characteristic present resistance age year history clinical diagnosis on similar found gene two three clinical study included test trial on gene identify two one gene normal two condition two plasma increased plasma level result plasma level similar effect treatment effect resistance cause gene reported previous resistance test
23522732 en insulin therapy improve type diabetic mellitus patient although normal level factor on number study examine effect however study diabetic severe patient study examine effect blood glucose poor control current study examine cardiovascular function health diabetic range insulin lead significant change health glucose week event significant cardiovascular reduction rate increase index change index increase ratio diabetic study role insulin therapy complication associate
26095190 en compare treatment among type receive receive study study week
25733460 en high low glycemic associate lower type mellitus T2DM risk include high high associate increased T2DM randomize trial compare effect insulin function man woman risk development T2DM randomize control trial participant treatment on tolerance test baseline female mean age body mass index respective change baseline significant different condition model assessment vs respective baseline mean index vs respective baseline mean cholesterol vs respective baseline mean serum vs respective baseline change baseline insulin index vs respective baseline mean function vs respective baseline significant result suggest associate less value index cholesterol serum man woman risk T2DM vs baseline value value trial
25670634 en reported disorder common patient type mellitus T2DM study aim determine prevalence disorder T2DM patient examine correlation level glycemic T2DM patient aged year female evaluate clinical disorder clinical disorder determined use test level determined use patient patient compare age body mass index hemoglobin hba1c level patient included study diagnose patient diagnose score significant high on positive correlation found score score significant difference found hba1c level patient without patient examine presence treatment patient diagnose
26623654 en type mellitus T2DM chronic disease associate old age however due rate obesity increasing diagnose population show associate great risk health outcome include T2DM little known effective intervention reduce adult risk T2DM aim investigate control trial whether reduction reduce aged year risk factor T2DM time intervention use follow-up datum three time baseline month baseline primary outcome month outcome included activity individual female mean age year mean BMI intervention control group month datum use analysis analysis show significant difference primary outcome outcome intervention reduce adult risk T2DM change month change may due intervention change participant reported activity reduction per mean change
26458572 en common gene type mellitus T2DM cardiovascular disease however result disease remain population study perform evaluate association common gene T2DM healthy control patient without statistical analysis compare different group conduct use model use model found associate T2DM adjust age body mass index however association found associate T2DM however association observed study due found population
24855090 en study report mellitus use report analysis result perform test use difference response correlation assess use correlation on total diabetic treat insulin insulin common insulin insulin common use insulin diabetic control use blood glucose treatment consider report follow diabetic diagnosis report result study provide may regard treatment diabetic
25579746 en type mellitus disease factor similar disease disease response clinical disease diagnosis disease primary serum patient although remain clinical type disease number large effect large number effect risk addition associate multiple population on rate great indicate potential factor disease development may role event disease evidence remain two syndrome occur result gene syndrome syndrome type dysfunction two syndrome model mechanism tolerance associate disorder on number model disease great mechanism
24003567 en mellitus major health known risk factor disease population group datum mellitus prevalence investigate risk factor associate mellitus population also assess on total subject age group year study datum obtain history blood glucose level body mass index result identify subject positive value diabetic impair control blood method blood glucose level mean subject diabetic fasting blood glucose level diabetic respective logistic regression evidence positive result associate age year high BMI high increasing prevalence may adverse effect health datum study early diagnosis management mellitus
22368901 en estimate prevalence mellitus diagnose impair fasting glucose possible risk factor mellitus among study perform one population different group three fasting blood glucose obtain subject according diagnose mellitus statistical analysis perform use datum among female total female found mellitus total prevalence impair fasting glucose found female total prevalence DM found female risk factor identify obesity history hypertension increasing increased prevalence type risk factor identify obesity history mellitus hypertension
22194960 en recent study important obesity plasma level cell cell may associate risk total subject year age group according association normal glucose tolerance mellitus test demonstrated significant difference plasma level among group different glucose tolerance status regression analysis revealed significant correlation plasma level mellitus logistic regression analysis show significant risk factor mellitus odd ratio or common risk factor include age hypertension index cholesterol model assessment index protein cell remain significant risk factor or logistic analysis indicate increased risk develop mellitus or or or or common risk associate status individual risk factor mellitus increased risk mellitus
22166752 en investigate prevalence risk factor mellitus analysis datum medical patient disorder prevalence mellitus prevalence glucose tolerance severe BMI positive associate use odd ratio or confidence interval CI negative diagnosis or CI mellitus associate severe or CI patient lower risk mellitus or CI patient mellitus associate use associate mellitus mellitus high mellitus interval
21474927 en study conduct evaluate current use therapy diabetic health use patient need health care total patient man woman type type use result type type diabetic woman man reported current use significant correlate health type diabetic use reported improve positive management type diabetic woman man type diabetic positive effect blood glucose reported test effect blood glucose among patient type disease found significant impact use study indicate investigate group diabetic health disease increasing number patient use patient care patient health care
25926367 en evidence high associate impair glucose prevalence type type mellitus DM patient evaluate influence glycemic adult patient mellitus DM follow on perform patient body mass index BMI glycemic control assess value hemoglobin hba1c previous total patient studied man woman mean age year mean BMI mean hba1c three patient type DM patient type DM patient severe mean mean mean similar type type DM vs correlate BMI type DM patient poor glycemic control significant high mean vs difference remain significant BMI prevalence type DM similar found type DM high prevalence patient type DM
25629790 en evaluate insulin patient type mellitus T2DM control insulin oral analysis patient week study patient insulin randomize treatment insulin remain week can according improve glycemic control primary mean change hemoglobin hba1c baseline patient baseline hba1c mean change hba1c baseline confidence interval CI week CI week adverse event week treatment similar group week change mean body weight similar group study analysis number patient however result suggest significant improve glycemic control patient T2DM control insulin without increasing risk weight
25557875 en type mellitus T2DM one metabolic disorder among complication T2DM patient increased risk demonstrated glucose insulin level primary aim develop model change therefore T2DM control control group significant change observed significant increased activity significant reduce T2DM group level factor T2DM group level significant increased T2DM patient cell treat show significant increased effective T2DM group datum cell presence T2DM patient serum reduce function model high impact identify factor T2DM patient blood may function
26465770 en investigate activity control type group year conduct type within large study investigate activity analysis group datum perform use identify impact body reported among although impact activity type need need provide type care activity need
25341239 en study conduct investigate blood type mellitus patient renal blood estimate level assessment index patient diabetic chronic mellitus control group healthy individual increase blood increased resistance renal indicate diabetic blood level increased renal resistance patient chronic type mellitus renal disorder patient type mellitus
23554999 en protein result protein function recent year gene therapy demonstrated cell protein insulin also examine assess protein method case lower level obtain high level obtain however diabetic observed result function diabetic model type mellitus first may lead possible therapy
23204109 en function disease study indicate insulin activity protein factor reduce whether similar mechanism mellitus
25065240 en mellitus common chronic disease known disease history type type associate diabetic complication recent diagnose may however time case may present one several syndrome overall result assessment treatment perform interval diabetic determine glucose target level medication old population ratio therapy analyzed first potential condition management clinical individual
26164090 en effect assess glucose total present one index total prevalence gestational mellitus woman undergo oral glucose tolerance test value result within range glucose use define lower confidence interval CI three glucose association association association study group respective prevalence CI glucose glucose use lower high glucose respective among different woman identify reported prevalence potential one two time woman individual significant reduce patient care
20594162 en impair glucose tolerance mellitus several well disorder cause condition two subject poor control mellitus review mechanism glucose disorder reported incidence condition may range also individual glucose mellitus major mechanism cause insulin resistance increased glucose decrease insulin increased glucose multiple mechanism include effect mechanism important may use patient great
23146918 en perform patient chronic time total risk role patient chronic cell mass patient undergo metabolic outcome function review patient mellitus chronic undergo relationship result metabolic outcome use regression tolerance high level associate great mass patient level measured demonstrated level type finding provide significant mass patient chronic mellitus undergo may mass patient
24927647 en investigate relationship serum insulin resistance patient type mellitus T2DM disease
25880498 en type mellitus chronic disease health outcome related patient intervention study study aim evaluate effective intervention new type patient primary care study clinical control trial one three intervention care primary care patient diagnosis year age patient severe primary provide intervention sample patient patient group receive group month lead mean primary care group receive include clinical report patient result group receive intervention patient primary change hba1c year cardiovascular risk factor complication outcome datum clinical model time use change outcome analysis medical per year two period period model analysis trial aim clinical chronic
24913375 en evaluate association risk among high risk study measured risk baseline use logistic regression examine relationship risk adjust factor result aged year intervention total control intervention participant increase risk increasing activity decrease participant history cause however association statistical significant associate result suggest increasing risk population increase
26026780 en major cause mortality diabetic patient increased important role development aim study evaluate relationship protein parameter patient impair glucose study retrospective analysis patient impair glucose patient early type mellitus T2DM subject normal glucose tolerance control group conduct hospital hospital plasma measured evaluate level assess cell risk dysfunction also control patient show significant high plasma level compare group patient T2DM also significant high plasma level significant high subject glucose group show positive correlation level respective present study show plasma level may type diabetic patient
24243989 en identify risk impair glucose tolerance insulin resistance plasma glucose study evaluate value plasma insulin study analyzed datum oral glucose tolerance test age year define according association model assessment diagnose compare perform respective compare identify patient identify patient
23762872 en mellitus DM associate increased mortality due disease type DM mechanism chronic type DM primary insulin resistance insulin due study investigate role T2DM possible mechanism increased cardiovascular risk associate disease
25682974 en assess whether cell associate group patient new diagnose type mellitus T2DM patient normal group group compare normal group patient high blood cell multiple logistic regression indicate or CI independent risk factor new diagnose T2DM factor include or CI high index or CI level or CI level or CI characteristic relationship CI use T2DM patient may independent associate patient new diagnose T2DM may treat effective index complication
25763540 en provide review current evidence outcome patient provide insulin mellitus hospital obtain database hospital treat insulin study assess independent two datum outcome mortality clinical complication diabetic hospital mean glucose level glucose level case examine total study significant complication reported incidence severe hospital patient remain insulin datum datum significant insulin hospital however use presence treatment need
25172521 en number metabolic include increasing prevalence type T2DM significant health cause reduce incidence cause disease effective treatment although factor cause T2DM role correlation increased T2DM pressure well condition control may different time factor recent report function can glucose intervention T2DM patient
24970723 en assess dysfunction adult type mellitus T2DM use cardiovascular adult year T2DM mean age year T2DM duration year age control control control studied function early rate determined T2DM cohort mean correlate duration correlate analysis association adult T2DM duration associate dysfunction study assess whether dysfunction patient
24460859 en study conduct among individual hypertension assess prevalence dysfunction association cardiovascular risk evaluate man type mellitus hypertension assess index function score clinical evaluate include protein blood pressure index patient without blood pressure respective hba1c patient level value similar man without related function similar group lower man vs high cardiovascular risk individual type high presence associate cardiovascular risk factor
25315630 en investigate association status patient type use study among type patient use level measured define respective function assess primary care medical datum medical logistic regression use status independent mean duration year mean duration use month mean on level independent associate decrease risk or CI CI adjust indicate patient time high lower score associate associate increased risk may patient use consider patient use
26333180 en examine treatment type mellitus compare treatment metabolic outcome population clinical change treatment study base population include diagnose type age year included diagnose blood glucose insulin treatment method metabolic control adjust effect effect age year duration effect individual hospital increasing number blood glucose increased number blood glucose significant associate lower metabolic control reduction however overall mean hba1c concentration observed treatment lead improve metabolic control overall population lower hba1c individual great number blood glucose result use study result intervention individual datum need adjust change care
27321318 en type mellitus T2DM increased mortality known impact health outcome patient T2DM estimate prevalence evaluate association mortality care compare impact common patient conduct analysis use datum sample among patient T2DM regression use association regression prevalence per hospital patient T2DM increased odd mortality or CI adjust mean high patient without vs hospital patient without respective adjust risk mortality patient or CI similar patient addition common or CI independent associate poor health outcome patient T2DM patient study determine effective among patient T2DM
27321316 en determine clinical relationship serum diabetic patient type mellitus study include patient T2DM conduct patient group base presence diabetic serum high high risk diabetic low analysis group base hemoglobin hba1c level revealed hba1c high increased presence diabetic increased level significant correlate presence diabetic level addition hba1c patient glycemic control
27316668 en therapy insulin investigate cardiovascular assessment study however evaluate patient type mellitus T2DM profile insulin therapy patient patient determined clinical therapy glycemic control insulin therapy randomize group addition insulin therapy study primary change hemoglobin hba1c level baseline week statistical significant decrease hba1c level baseline group compare group week decrease hba1c level group independent insulin compare group significant decrease fasting plasma glucose level vs body weight vs significant increased cholesterol vs vs overall incidence adverse event similar two group incidence incidence per decrease blood glucose high group group however event group insulin baseline event decrease incidence per group incidence group according insulin insulin effective glycemic control reduce body weight well patient T2DM trial
26054595 en population associate reduce poor mass addition mellitus increase risk development syndrome disease also associate condition complication intervention include resistance management patient severe review aim effect different intervention diabetic include condition index database addition effect intervention glycemic control cardiovascular risk factor associate effective intervention improve diabetic patient resistance effective intervention overall patient addition diabetic patient severe include may effective intervention reduce improve patient
24800665 en type mellitus chronic disease insulin resistance dysfunction glucose protein lipid however less individual type review clinical metabolic diabetic lipid intervention may improve
22759745 en incidence prevalence mellitus increasing cause relative case type case type datum cause well define risk related well known increasing datum role risk due provide increasing include role role role new current related
22272895 en oral therapy treatment cardiovascular event however although current drug reduce cardiovascular event remain important cause mortality patient disease patient mellitus DM increased risk cardiovascular event therefore mechanism profile drug population drug high associate increased risk cardiovascular event drug new treatment include drug review current drug provide patient DM new oral drug development potential role drug improve cardiovascular outcome patient DM
23561646 en effective increase mellitus DM patient therefore investigate whether effect model type DM group oral treat use control group week cell cell ratio also test potential treat cell factor group compare potential
25479048 en one common disorder patient mellitus DM associate poor control complication low increased health care DM remain poor identify treat conduct patient DM DM participant assess blood level diabetic health care prevalence participant CI CI CI overall poor CI score poor CI CI CI increased health care CI CI study examine study association impact factor examine patient high among patient DM associate number adverse outcome on management among patient
23721855 en age important role development diabetic complication gene may associate development complication type mellitus present study aim possible association gene serum level age activity complication type mellitus patient total diabetic patient include DM without complication healthy individual assess serum age estimate activity assess three examine association T2DM observed model on outcome T2DM patient significant high age level also found associate low activity analysis revealed risk development high T2DM patient high level age gene significant effect age level activity diabetic subject compare healthy individual diabetic patient develop age level high activity low
23331248 en trial study patient type mellitus patient T2DM included study patient study day follow day plasma plasma concentration plasma mean low day mean range overall profile study T2DM population datum show finding result study patient T2DM use population
23210765 en study assess effect difference renal function renal glucose treatment type mellitus use assess group healthy subject patient T2DM normal function patient T2DM severe renal base estimate multiple evaluate patient T2DM rate evaluate use concentration increased function high high patient severe renal respective compare normal function high high high compare patient normal renal function effect renal renal glucose reduce patient severe renal result indicate significant contribute high function diabetic subject severe renal reduce patient population
23448175 en assess result patient mellitus DM within DM hospital care first report activity patient DM use positive three patient DM on total patient identify disease patient new diagnose result patient diagnose case rate per patient DM patient treatment major related patient DM high rate medical need improve
27321309 en relationship serum level mass type mellitus T2DM study aim examine association metabolic syndrome serum level evaluate man T2DM investigate association serum level well presence metabolic regression analysis adjust age duration T2DM body mass index serum hba1c show serum level positive associate logistic regression analysis adjust factor serum level positive associate obesity metabolic syndrome odd ratio confidence interval per increase per increase present study show serum level positive associate presence metabolic syndrome man T2DM
22423386 en mellitus DM consider possible risk factor study aim potential association mellitus development total patient included patient mellitus within year patient mellitus year patient type mellitus included study clinical characteristic outcome patient type mellitus patient mellitus old age mellitus lower body mass index BMI among case patient mellitus associate poor however patient patient develop mellitus old age mechanism mellitus clinical profile outcome patient research
27180612 en aim clinical consider characteristic influence clinical difference also consider addition influence difference difference observed result show result characteristic range patient type mellitus large patient renal patient patient also patient show within although clinical trial large population datum show population patient type mellitus presence renal
23683969 en increase prevalence type mellitus T2DM related increase obesity aim determine prevalence T2DM patient obesity perform clinical condition on determine T2DM prevalence patient define clinical metabolic profile T2DM according body mass index BMI patient prevalence patient patient diabetic T2DM present according man woman T2DM overall mean risk factor related T2DM patient hypertension perform low activity diabetic patient patient show metabolic control T2DM related obesity high BMI high T2DM prevalence hypertension low activity diabetic patient BMI increase patient metabolic control high BMI
22846516 en type mellitus high disease associate increased risk cardiovascular disease mortality evidence association type mellitus however effect two disease cardiovascular mortality cohort study primary health care aim effect cardiovascular event cardiovascular mortality patient type mellitus estimate clinical model number patient type mellitus old year primary health care patient type mellitus general outcome cardiovascular mortality cardiovascular major patient mortality cardiovascular mortality disease use test logistic regression effect use adjust factor factor effect analysis assess effect mortality analysis use compare two group use test control potential perform regression evaluate increase risk cardiovascular mortality adult type mellitus primary health care also identify patient intervention can
22326029 en among trial effect dysfunction patient mellitus DM therefore perform determine whether therapy can improve dysfunction patient randomize control trial trial change included analysis on perform assess relationship therapy dysfunction analysis identify study patient included analysis therapy significant improve patient DM mean difference CI although among trial found significant analysis show patient therapy body mass index BMI trial CI however significant improve among patient BMI trial CI type age lower baseline blood lipid level blood pressure associate analysis similar significant improve patient function use evaluate outcome population high risk
23915015 en common associate related complication mortality intervention identify lead glycemic control aim group therapy compare adult poor control study randomize control trial current datum analysis included patient care type major diagnose clinical hemoglobin current insulin therapy patient receive aim treatment group receive treatment week therapy reduction included one year study primary analysis population receive treatment obtain treatment analyzed use drug concentration blood serum receive outcome assessment conduct group group difference hba1c primary outcome outcome follow-up baseline analyzed baseline value primary lead significant great glycemic control one year follow-up treatment study first randomize control trial compare treatment patient control trial
21822421 en observed type type mellitus also found diabetic patient several finding include insulin factor change common mellitus can also disease chronic diabetic current study subject provide current mellitus
23886298 en effective oral use mellitus type general population recent however use regard potential adverse effect provide use review evidence use effective treatment gestational mellitus woman however patient multiple risk factor insulin resistance may treatment may insulin evidence suggest potential use insulin weight outcome patient insulin use woman syndrome reduce rate early effect use review outcome use duration treatment base clinical
17252182 en according current regard relative related treatment report case related woman clinical history multiple intervention report new previous
25659871 en metabolic syndrome associate significant lipid parameter include concentration plasma lipid result change whereas serum lipid level also major role result increase cholesterol increased patient may contribute patient
24290085 en gestational mellitus mellitus vs subject cohort study medical patient undergo oral glucose tolerance test glucose week patient diagnose according treat activity without insulin outcome prevalence study patient case diagnose two value on significant history mellitus found among compare group vs insulin patient glycemic control patient significant lower gestational age complication vs among outcome significant difference need group prevalence increase use complication present one patient
24080092 en model estimate cardiovascular disease risk general model diabetic cohort whether one model receive evaluate evidence general population vs risk model database two independent identify study compare general model vs one group independent datum study risk model outcome model risk model general population model three model cardiovascular score risk difference vs general model outcome model development model general population risk model reported model evidence suggest possible general model risk need
27344826 en compare method medication mellitus patient group control group case group patient group treat method day treatment consider one total two interval day patient control group treat oral day week score measured treatment treatment follow-up one month treatment fasting blood glucose test treatment hemoglobin hba1c test follow-up total effective rate group control group treatment score reduce group control group treatment follow-up score group lower control group level hba1c group decrease compare treatment difference two group significant treatment mellitus less adverse effect
25179613 en develop mellitus use different weight three per group metabolic test sample also provide test blood different level diabetic different glucose two different level without addition glucose system use analyzed mean receive three one type type mellitus blood blood datum result within group individual report use without
26123455 en association syndrome well disorder increasing old one development however case type mellitus case present primary type mellitus positive increase present case function diagnosis without clinical dysfunction
26088843 en mellitus major cause diabetic common cause type complication mellitus cause may diagnose due characteristic finding analysis include glucose blood blood hemoglobin may provide determine cause change perform review parameter may use identify disorder glucose also present review sample analyzed diagnose complication mellitus cause
22673268 en patient found mellitus studied whether effective patient elevated glucose case study adult patient present new perform hemoglobin hba1c level measured patient mellitus on characteristic examine positive negative value identify patient total patient patient known mellitus patient according hba1c diagnosis level correlate hba1c use correlation analysis use logistic regression analysis odd ratio or fasting plasma glucose or identify significant risk factor diagnosis characteristic analysis show value patient present found on value can study
26959059 en associate increased insulin resistance impair insulin poor control glucose correlate risk metabolic disease include type mellitus T2DM role glucose lipid lead glucose large cell dysfunction occur T2DM review provide insulin insulin potential role function provide status management T2DM disease
26873905 en determine effect index among patient type weight estimate total body index obesity index assess use analysis treatment age baseline patient type mellitus randomize treatment clinical trial week cohort week cohort study patient cohort cohort reduce weight index cohort adjust mean confidence interval change baseline body weight estimate total body index obesity index cohort respective reduction age significant reduce weight index potential improve risk among patient type mellitus
26130836 en on female high diabetic diagnose treatment included insulin therapy low mellitus insulin therapy mellitus
25281566 en change type mellitus event change patient disease patient type mellitus control subject studied use use analysis datum baseline datum compare group significant difference found index group baseline analysis identify significant difference patient control subject datum response change significant great control subject compare patient control subject demonstrated positive correlation change datum use datum identify change patient mellitus impair response may contribute development patient
25258359 en present study evaluate health patient mellitus DM compare health general datum included analysis subject age old health health DM patient compare week reported subject normal glucose tolerance impair glucose DM patient reported individual participant DM patient reported DM patient DM patient odd ratio or confidence interval CI or CI or CI on analysis revealed or DM patient CI CI CI present study found DM associate increase
27151819 en use index assess status use mellitus study perform care age patient DM compare healthy control index define total mean mean mean patient control compare use significant difference patient DM control however significant lower patient DM compare control patient DM show decrease change may potential assess
25576844 en aim study determine activity important system model type mellitus DM on total group control group DM group group receive follow treatment body weight blood glucose level fasting serum insulin level model assessment insulin resistance measured gene analysis group show significant decrease fasting blood glucose serum level value increase fasting serum insulin level cell control group normal large cell DM group treatment significant insulin cell diabetic reduction significant treatment DM insulin resistance insulin cell associate reduction
26381880 en mellitus cause mortality study show effect aim evaluate mechanism level effect control function complication
26365121 en include type type associate aim study evaluate concentration parameter diabetic study conduct patient group patient group included diabetic patient control group healthy plasma concentration factor factor serum concentration lipid profile plasma fasting glucose measured plasma concentration hba1c patient high concentration observed compare diabetic group control group on significant lower activity reported patient group compare control group group use regression analysis rate independent associate associate total study show high concentration patient associate indicate low risk group patient high risk complication
25100149 en associate type mellitus however whether common complication type diabetic also present investigate association diabetic among patient type mellitus study patient previous history disease serum level ratio measured define elevated level diabetic define ratio prevalence among patient type mellitus group high prevalence diabetic group analysis identify significant positive association diabetic odd ratio or confidence interval CI hypertension or CI or CI may independent associate diabetic patient type mellitus
26088706 en aim present study investigate relationship gene plasma lipid concentration patient type study patient type healthy control two use rate significant high patient control subject rate significant lower patient control compare group regard high patient control subject patient rate also significant lower control subject significant difference lipid level study group high level study result indicate risk factor study first datum gene patient
22268397 en mellitus DM chronic medical condition patient condition control medical therapy related change control function known function function show study influence system subject normal DM may associate impair function cause DM however disease chronic possible factor contribute dysfunction may adverse patient care potential cause control risk factor several assessment current show correlate status however study need test assessment patient DM potential patient intervention may need patient
25498346 en use treatment type mellitus hypertension study medical assess treatment type mellitus hypertension conduct review clinical database database include database database database database study base perform datum study randomize control clinical trial included patient intervention intervention oral oral oral lipid drug lipid drug oral lipid drug oral medication oral medication treatment type mellitus found intervention lower level hba1c intervention oral statistical oral treatment intervention intervention oral lipid drug lipid drug reduce level level study oral lipid drug statistical reduce level show effect level level treatment hypertension intervention lower level blood pressure intervention occur oral compare adverse reported study indicate effect type DM hypertension effect relative low compare treatment low status patient treat type DM hypertension time period due overall included study large control trial use effect
24465478 en current study metabolic associate early metabolic profile profile early plasma diabetic patient result independent study analysis analysis perform metabolic include significant increased level potential early mellitus identify study significant diabetic subject subject three year diagnosis also found independent patient group study study diabetic control subject study diabetic subject history use medication show increase level compare control group test history medication level also metabolic include associate mellitus independent fasting status major disease also found associate subject level show increase diabetic subject can new medical diabetic subject
24150176 en study examine whether associate health among old adult assess baseline adult type mellitus health study health status examine baseline on logistic regression model examine whether care profile associate change health status time analysis examine whether individual associate health status adjust baseline great measured care profile associate improve health outcome time however significant associate improve health follow-up odd ratio or activity or health care or target may effective health less target
25138801 en assess target control patient type review trial analysis clinical index clinical trial different target control participant age type mellitus independent assess study clinical trial included participant type mellitus trial high risk statistical significant effect target control mortality risk ratio CI cardiovascular mortality target control reduce relative risk outcome effect estimate statistical significant effect model risk severe significant increased target trial analysis show datum need relative risk reduction general significant effect improve mortality target control compare control however may effect target control outcome effect severe datum severe patient outcome trial poor control
26763672 en mellitus cause need renal therapy early patient complication review early patient without database patient total review three study show datum little one patient two study high estimate rate regard one difference study lower associate patient effect patient without one randomize control trial two reported difference high lower overall indicate difference patient without regard mortality difference early lower regard mortality patient without base patient presence
24488082 en study evaluate whether observed association can presence condition association therefore examine association range statistical disorder diagnosis perform adult health retrospective assess prevalence age disorder indicate diagnosis association disorder without identify case mellitus year although disorder associate diagnosis model or CI disorder or CI disorder or CI or CI remain control disorder disorder significant associate diagnosis finding role suggest may control disorder disorder important determine association disorder
25816837 en mortality rate disease develop mellitus important risk factor prevalence increasing aim compare mortality without mortality analysis similar mortality mortality rate without rate per man confidence interval woman rate per man increased woman show rate man woman without rate mortality without mortality
27623807 en type increasing health low associate high prevalence complication increasing level complication evidence develop patient chronic important effective patient condition study model type patient treatment conduct model sample type patient treatment three hospital analysis total participant study study revealed patient model model participant model influence study participant finding also revealed significant role patient include assessment cause factor little control may contribute use can health study suggest need care patient include individual provide care consider individual patient need health different include health
25619480 en group metabolic disorder major health type insulin type two type on factor contribute development disease recent development obesity disease model analysis review association potential mechanism disease development obesity
21106483 en use patient type mellitus recent new therapy several clinical according patient type therapy insulin primary adult patient type addition study associate lower mortality rate type diabetic patient use diabetic patient result clinical trial use type diabetic patient insulin treatment result decrease insulin control effect weight change decrease risk complication on effect metabolic can year randomize control trial although new clinical consider clinical follow current base
16159898 en although effect show investigate effect oral treatment day increased whereas decrease compare treat increased whereas cause decrease show cause decrease whereas cause increase compare treat show reduce plasma response compare treat significant increased compare treat also test whether similar change can observed found similar change response study show treatment associate
22587515 en mellitus major disease prevalence significant several although one major complication diabetic diabetic disease develop diabetic patient also diabetic diabetic cause diabetic patient addition cell cause management however number study disease diabetic patient review role different factor found factor diabetic cell dysfunction diabetic patient addition clinical change diabetic patient recent study related development therapy management disease present
25529478 en mellitus DM health care complication although use high medication lead poor DM patient determine DM reduce mortality early recent body DM disease current insulin target blood blood diabetic patient compare control although can DM current review study associate type DM complication use disease also
27802209 en aim study investigate change blood response patient mellitus type analysis estimate relationship blood value blood measured healthy subject patient type mellitus blood model include index also correlation parameter range mechanism value decrease blood increased correlation analysis revealed relationship range correlation correlation lower result dysfunction patient type
26995199 en type mellitus T2DM studied study aim define serum concentration investigate relationship status hemoglobin hba1c body woman T2DM control study woman T2DM control subject serum fasting glucose hba1c measured mean level range diabetic woman range control group prevalence high T2DM woman vs control difference per day diabetic vs control T2DM woman level associate hba1c duration fasting glucose level however level negative associate body mass index total body mass total body mass prevalence high woman T2DM control vs obesity risk factor T2DM woman study evaluate relationship T2DM patient
26437613 en major factor complication investigate effect glycemic control status subject type mellitus randomize control clinical trial conduct subject DM female age intervention group time per day control group follow intervention period fasting blood sample baseline trial datum analyzed independent test test analysis significant decrease concentration hemoglobin serum insulin level model assessment insulin resistance serum compare control group total activity significant increased respective group compare control group intervention effect glycemic control status patient DM on large sample population intervention period may show significant clinical
25414939 en evidence mellitus several present although correlation mellitus potential role mellitus increasing well define association mellitus demonstrated independent obesity increasing incidence obesity lead recent incidence disease disease incidence risk factor may lead change although mechanism correlation role insulin related cell cell potential role medication mellitus treatment also present
24912965 en mellitus associate however little known relationship chronic disease patient aim study investigate associate factor include use patient perform patient age year on analysis use perform independent factor analyzed use logistic regression diagnose patient respective use however use significant associate use insulin or CI or CI independent associate respective analysis insulin also identify factor found high also patient also show possible association use cohort study need patient
23122575 en associate complication diabetic increasing significant type mellitus study determine whether type associate high old investigate related risk factor mellitus
26827782 en potential mechanism investigate treatment body weight result improve group include blood glucose level serum protein hemoglobin fasting serum insulin level lead increase decrease also increased level diabetic addition treatment level protein level diabetic result suggest mellitus insulin diabetic
25265086 en aim study evaluate effect effect group oral day plasma obtain analysis level evaluate use analysis compare blood glucose level significant different however significant different statistical significant difference blood glucose concentration group show significant compare on significant difference found however difference plasma level significant different among group reduce fasting blood glucose level addition treatment associate without
25207958 en test association type clinical characteristic large total first within show significant association sample association study perform datum two first significant associate type odd ratio CI CI respective similar effect type observed odd ratio CI show significant effect two type odd ratio CI odd ratio CI association analysis show associate level glucose datum common within associate type level population
26207031 en risk cardiovascular event increase presence type type mellitus large due model mechanism research model revealed independent also impair regression lipid cell change increased diabetic important effect three effect glucose lipid well factor result increased important mechanism revealed model studied subject new finding base model research need complication type type mellitus
27330723 en determine patient type study period patient use drug period patient randomize week outcome included change hemoglobin fasting plasma glucose baseline treatment outcome included adverse patient randomize mean change hemoglobin group respective difference change fasting plasma glucose also significant great group difference respective common adverse event vs vs vs result show effective well use patient type mellitus
25929739 en aim present study investigate insulin without population type mellitus trial patient T2DM control hba1c therapy insulin without randomize receive patient randomize receive receive treatment baseline overall mean age patient year mean T2DM duration year mean hba1c adjust mean change hba1c week group respective difference difference fasting plasma glucose significant patient hba1c vs incidence adverse event group whereas adverse event respective lower group vs addition significant improve glycemic control without increased risk patient T2DM control insulin without
25916215 en aim study evaluate blood glucose diagnosis gestational mellitus plasma glucose may woman undergo oral glucose tolerance test fasting one measured estimate different use association study group diagnosis correlation regression analysis also correlation fasting correlation compare respective use improve possible use test use lower positive high use
23702602 en reported role remain present study examine effect insulin use cell model result show high diabetic well high glucose insulin level insulin glucose compare control although show significant change also observed activity decrease elevated diabetic gene high significant activity reduce level finding development type mellitus important role insulin
25084748 en major protein may contribute significant diabetic investigate change response mechanism diabetic response assess respective evaluate use diabetic elevated correlate development normal diabetic whereas show effect normal diabetic condition cause great diabetic normal datum cause several factor also contribute little response diabetic
24959693 en identify high among adult patient type mellitus T2DM receive oral patient use oral hba1c test datum identify database measured reported patient study sample define patient high identify logistic study patient mean per patient mean per patient medical total respective patient respective within medical or CI or CI complication included use complication chronic study report estimate relative relative total finding study T2DM patient year T2DM patient receive oral patient complication chronic disease intervention target complication may contribute decrease
24735083 en care reduce improve patient outcome increasing patient treatment can retrospective study conduct use research database clinical outcome associate insulin among adult patient type mellitus T2DM patient cohort assess insulin therapy hemoglobin event base diagnosis total follow-up patient significant high follow-up value significant lower decrease baseline significant large significant event lower rate reported high study drug patient T2DM insulin use associate high control lower rate high study drug associate use increase total may treatment patient T2DM care
26210623 en review outcome type also change incidence complication control complication trial care review datum related complication type review recent related effect
25352506 en mellitus blood glucose important risk factor mortality patient relative individual role remain influence mellitus blood glucose mortality patient primary cohort study include patient primary intervention may clinical datum hospital perform clinical follow-up day adjust analysis studied risk factor use patient included reported mellitus prevalence analysis mellitus blood glucose day however adjust potential analysis mellitus relative risk significant relative risk confidence interval whereas blood glucose remain independent day relative risk confidence interval patient primary intervention blood glucose independent previous diagnosis important role outcome group patient
25102563 en diabetic result chronic although reduction contribute disease regard relationship effect investigate change use diabetic model show increased level serum glucose severe diabetic on reduction week disease associate reduction cell associate age important first model type show characteristic reduction cell previous diabetic finding indicate type
24582462 en therapy syndrome event patient type mellitus study aim evaluate patient without T2DM treat assess use one week associate increased vs addition diabetic show lower vs vs high correlate therapy T2DM patient develop increased lower revealed datum show significant difference well characteristic patient T2DM
24948181 en evaluate care assess effective patient mellitus also rate among patient obtain disease included adult patient care result high rate high rate improve score however intervention need improve outcome patient result indicate patient identify within primary care study provide model care evaluate clinical
26499915 en examine difference characteristic treatment outcome patient without previous diagnose study cohort patient diagnose medical previous diagnose patient receive treatment effective medication undergo less receive intervention patient patient history develop index patient present remain high risk develop significant clinical complication
25013994 en previous study demonstrated lower concentration man type mellitus datum man type mellitus determine prevalence low man identify study man study complication intervention complication serum level measured use mass level measured use sample year determined use low define total regression model use compare age body mass index factor related treatment control diabetic complication age year man decrease significant associate obesity old age decrease insulin associate hypertension significant adjust association lower observed significant relationship lower man cohort high prevalence risk factor associate low level population similar general population
23934047 en rate patient type mellitus investigate related blood glucose type according hba1c level two group well control blood glucose group hba1c poor control blood glucose group hba1c on method use determine patient total patient female study patient significant difference age body mass index patient without on significant high patient poor blood glucose control compare patient well control blood current finding suggest poor blood glucose increase patient type
19855135 en renal mechanism development cell investigate role renal development develop renal increased decrease severe analysis revealed number cell increase number cell renal cell datum development renal cell indicate may contribute renal disorder
18345408 en multiple chronic disease occur cause system included among possible however association common clinical presence patient without clinical report association occur therapy clinical finding
25005034 en factor associate association metabolic syndrome type mellitus patient datum fasting obtain measured age duration year year respective prevalence confidence interval CI associate significant high vs complication presence complication associate high vs vs vs adjust age glucose complication remain independent odd ratio or CI level associate risk complication study need test whether can identify patient risk complication whether may lead
24612200 en assess incidence rate identify risk factor severe patient type new treat general research database perform retrospective cohort study analysis control population risk case severe follow-up general year history database time use logistic regression analysis adjust potential patient new treat type mean age year severe estimate confidence interval CI per high insulin CI per patient use insulin CI per base result analysis increasing age vs year adjust odd ratio or CI adjust or CI renal adjust or CI current use adjust or CI current insulin use adjust or CI associate increased risk severe case per risk factor severe included increasing age renal current use insulin
24964785 en assess clinical research primary care datum population treatment use conduct study identify patient aged year two control logistic regression assess risk overall several diabetic complication index poor control status treatment identify case control on total subject previous include case whereas include poor control odd ratio or treatment previous year found evidence one within day two case control status or risk high diabetic complication or although lower among or poor diabetic control or association statistical evidence found important
23346100 en due current effective treatment severe patient diabetic model contribute type model different mechanism mellitus DM model drug include model model due one common use diabetic model use include management model well study model different compare model function increase decrease blood glucose therefore evaluate condition total patient model study include assessment model mechanism type DM clinical diabetic model according aim study
26311724 en prevalence diabetic patient remain high mortality risk associate important management perform review cohort study evaluate risk total mortality cardiovascular event among diabetic database may relative risk use model on total cohort study included adjust relative risk confidence interval associate total mortality study participant cardiovascular mortality study participant relative risk confidence interval total cardiovascular disease study disease study study disease study study elevated risk total mortality cardiovascular mortality cardiovascular disease disease associate significant increased risk total mortality cardiovascular event among diabetic patient whereas associate reduce risk current finding provide evidence among diabetic patient
22583857 en mellitus patient known disease high risk severe outcome however mechanism mellitus dysfunction well known study mellitus result impair change associate type investigate use model change diabetic also investigate pressure finding revealed mellitus analysis pressure revealed increased diabetic compare control increased increase pressure analysis pressure time demonstrated show increase finding pressure change mellitus increase mellitus may disease
22350783 en study determine whether mellitus associate increased risk study identify cohort study study mellitus relative risk confidence interval study include cohort study total participant included review mellitus risk included study indicate associate increased risk compare incidence CI without study analysis found result cohort study among study conduct different association incidence significant insulin therapy also positive associate risk CI evidence study finding relationship increased risk woman man insulin therapy may increase risk
24059304 en disease important disorder disease major cause mortality type mellitus cause resistance insulin insulin response chronic cause common complication mellitus lower two disease level mechanism cell disease type mellitus great system lead development improve well response can also patient case patient high risk develop treat due increasing resistance therapy base multiple great potential therapy cell adverse effect
27849238 en estimate year old type mellitus increase per year review need health year consider disease influence factor insulin cell metabolic test assess insulin glucose tolerance use cell clinical disease treatment metabolic control effective cell function disease duration risk factor chronic complication negative patient regard health provide possible
24274235 en association care receive related report result health type mellitus study age year undergo health care score review total score compare type age duration hba1c score also compare datum total score patient characteristic compare datum great age year score respective suggest risk disorder finding suggest less year old may great compare healthy care health consider health less year old
24259692 en among adult datum first whether medication identify retrospective cohort study included patient health system assessment included within month first medication hemoglobin hba1c hba1c relative risk CI vs hba1c age hba1c effect high hba1c little age lower hba1c old patient less individual elevated serum vs normal hba1c increased patient hba1c time hba1c normal age year year vs adult general first however hba1c age age
25777999 en mellitus major complication renal due negative impact patient renal evidence regard treatment early insulin treatment target therapy renal patient previous treatment type mellitus DM oral first insulin similar current association diagnosis DM type DM however disease different review DM patient renal without DM role hemoglobin hba1c oral glucose tolerance review addition potential role protein glucose although parameter
23613635 en determine association mellitus DM ratio level present study included patient treat hospital health period hospital diagnosis clinical metabolic analyzed test test test use compare difference patient without DM logistic regression analysis use determine association DM level patient on analysis perform assess effect result correlation test use determine relationship level fasting glucose addition association duration treatment level determined potential different total patient diabetic diabetic group patient diagnose without group mean age year patient compare patient without DM patient old vs lower incidence vs increased level blood pressure vs vs lower value hemoglobin vs vs statistical significant difference obesity effect age blood pressure hemoglobin logistic analysis show independent odd ratio or effect result analysis perform study population patient analysis show diabetic patient high patient vs effect age hemoglobin logistic analysis level remain independent or significant difference relationship level fasting glucose show test among diabetic patient patient diagnose DM year receive oral receive insulin reported control serum glucose level significant difference found association DM level age level increased patient DM patient function clinical
24471821 en multiple effect blood cell include reduce reduce cell aim study relationship glucose hba1c incidence mellitus mean measured participant aged year cohort hba1c fasting blood glucose level measured DM year follow-up studied DM low significant high risk develop DM adjust ratio confidence interval CI vs subject impair fasting glucose CI low also associate significant high glucose insulin concentration significant positive associate hba1c increase hba1c per increase associate increased incidence DM independent risk factor low can reduce lower hba1c due duration glucose can improve risk assessment individual risk develop DM
25600248 en associate increased risk cardiovascular disease present analysis datum study assess effect serum level patient type mellitus T2DM patient define baseline serum week associate reduction serum compare patient reduction serum similar overall cohort patient group serum level compare incidence low similar group treatment decrease serum patient T2DM include baseline
25968955 en determine difference decrease estimate type mellitus without chronic cohort study type estimate woman mean age year two outcome evaluate cohort decrease estimate estimate cohort on model use identify significant follow-up period year cohort year estimate cohort individual respective outcome incidence decrease estimate model great ratio presence diabetic high hba1c level associate outcome risk factor high level decrease estimate old age great blood pressure lower baseline estimate cholesterol common factor decrease estimate common mechanism development two chronic disease
18074742 en diagnosis present chronic chronic poor weight increased case report show diagnosis show diagnosis
25877657 en review prevalence risk factor gestational mellitus conduct review among prevalence study included difference method diagnosis use study time period analysis indicate high among study can study population time although observed relative high prevalence study vs woman risk vs current use vs association risk factor reported study significant risk factor reported one study obesity history type previous previous age study prevalence risk factor high prevalence woman studied reduce complication related
25523979 en investigate type risk year general population type risk study without history insulin found follow-up follow type first follow-up multiple multiple little one on total type multiple ratio type positive value multiple compare among risk year year multiple compare respective among three examine high risk multiple similar risk reported study can effective identify individual general population intervention trial
26441333 en type mellitus T2DM associate insulin resistance current use therapy aim T2DM can improve early blood glucose hba1c general metabolic therefore development early diagnosis identify individual risk develop T2DM also major role T2DM development review potential role early study consider role
26075537 en type mellitus T2DM associate obesity serum level year man type mellitus serum recent study indicate man aged man man obesity man T2DM serum investigate man man dysfunction total receive therapy man one man man provide effect man glycemic control serum glucose hba1c weight lipid profile function improve man show improve datum suggest man level glycemic control lipid profile function
25182169 en associate cardiovascular compare disease known cardiovascular patient cohort study assess disease disease disease patient compare cohort patient mellitus follow hospital on analysis patient hospital patient within one event mellitus patient event patient event compare DM patient cardiovascular risk factor similar group event patient associate age disease duration little mellitus patient therefore management cardiovascular risk factor perform
24983668 en patient mellitus DM although glucose control therefore patient perform activity positive effect blood glucose control patient evaluate effect hemoglobin hba1c level patient type DM cohort fasting total cholesterol fasting blood glucose hba1c level index treatment method patient treatment group respective hba1c level patient treatment first follow-up assessment treatment datum group score significant decrease treatment treatment group hba1c level significant decrease first assessment whereas treatment group show significant reduction hba1c level first follow-up assessment group level follow-up assessment level significant decrease follow-up assessment treatment group score reduction correlate positive hba1c level reduction first follow-up present study reduction hba1c level patient DM without reduction hba1c level may result increased activity
25943829 en conduct investigate prevalence type two mellitus T2DM compare review database prevalence T2DM healthy control without included two independent conduct datum on effect relative risk study include individual year control included prevalence T2DM CI CI study T2DM according study CI analysis found CI study T2DM according CI study T2DM determined medical little risk develop T2DM according T2DM clinical
24972806 en patient mellitus DM severe increased risk develop increased risk may lead cardiovascular event aim study assess prevalence patient total patient DM undergo assess prevalence define presence according use assess define on total investigate patient range revealed patient presence can presence clinical characteristic include complication DM DM high prevalence severe type respective patient
24143873 en population aim study association risk mellitus diabetic high perform identify study relative risk estimate effect conduct mellitus diabetic study cohort study included associate increased risk type mellitus odd ratio or confidence interval CI also associate increased risk type type mellitus or CI or CI respective addition found significant association diabetic risk or CI suggest relationship risk mellitus diabetic may role disease may type diabetic patient type diabetic patient
16995572 en method therapy use significant potential retrospective study examine outcome use compare treat serum concentration range group compare group serum concentration within normal range great group significant complication group effective treatment
26488448 en number patient type mellitus T2DM increasing diabetic cardiovascular complication health two two reported protein impair aim investigate potential role cardiovascular complication T2DM patient association gene level also subject study include T2DM patient complication T2DM patient without complication well healthy subject plasma level measured use two use found whereas show high compare cardiovascular complication T2DM patient associate level study cohort T2DM patient cardiovascular complication may cardiovascular risk assessment T2DM patient
26401715 en investigate potential effect type mellitus T2DM patient treat significant T2DM patient treat significant significant associate relative change hba1c may contribute T2DM patient
26189723 en major adverse event cardiovascular disease risk factor patient type mellitus datum use identify patient T2DM aged baseline patient three baseline risk group high low follow year follow-up regression compare patient follow-up patient follow year event event T2DM patient follow-up range day risk group patient mean per patient within risk group general increased risk range patient patient low among patient event follow-up care high among patient event follow-up result potential clinical patient risk medication cardiovascular profile T2DM patient
25528168 en factor role contribute protein also target cause condition evidence recent system also role one metabolic system body mellitus system disease condition review recent
25468880 en previous study evaluate association body mass index BMI risk cardiovascular disease mortality among diabetic patient result study association BMI risk among diabetic patient aim examine association BMI risk among diabetic perform cohort study patient type mellitus regression model use estimate association different level BMI mean follow-up period year participant develop age type ratio associate different level BMI baseline group total respective use mean value BMI association BMI risk change association among patient different age hba1c level current patient without use present study association BMI risk among patient type mellitus
25283363 en type mellitus T2DM metabolic disorder cause insulin resistance dysfunction impair glucose tolerance role use important T2DM present study evaluate three T2DM case healthy control blood sample analysis perform use age parameter show high significant association T2DM case population rate show significant association or rate show association although odd ratio indicate time high risk T2DM show association parameter analysis control case show individual time high risk or CI develop T2DM assess association gene T2DM identify risk population
24890121 en on study change type mellitus T2DM patient treatment drug perform method use metabolic analysis sample obtain T2DM patient without drug treatment T2DM patient treat drug normal glucose tolerance subject datum subject analysis analysis little analysis investigate effect drug profile T2DM patient found T2DM group indicate potential effect study may mechanism drug
26881936 en level development type association activity ratio reported adverse determine association blood cell type cohort study health type new case type year follow among woman adjust model baseline ratio associate type ratio confidence interval CI per increase similar baseline ratio associate type CI CI respective case first two year follow-up significant activity level related development type determined study finding suggest associate risk type
25305802 en increase oral increase level mellitus examine whether treatment month hemoglobin level patient type
25656765 en on review conduct review evaluate evidence management mellitus aged care examine effect status risk factor on database follow independent datum assessment two study compare study review effect status included study identify study rate poor statistical significant change management outcome increase observed datum determine effect change status risk factor overall study due low evidence significant finding may
27384205 en factor associate three patient study conduct health patient follow-up datum obtain system health on logistic regression model use patient show associate level CI current previous health CI found low patient mellitus indicate potential disease high level health associate mellitus
25892959 en mellitus DM metabolic disease due insulin response chronic disease need great health system recent development new drug therapy management related complication potential effect glucose cell increasing review recent finding effect management role glucose protein level
27590767 en blood level measured fasting patient age without type mellitus concentration patient high patient patient patient without correlation blood level age clinical disease patient concentration increase increase body mass index lead difference patient level cause less patient study
23789978 en level T2DM among one cause type mellitus T2DM early disease reduce incidence complication therefore study conduct determine level T2DM among study use obtain sample sample studied sample use sample method use use datum datum use test target population woman man aged year sample level high score cause risk factor also poor condition less care
26078255 en assess association glycemic outcome therapy patient type T2DM identify treatment patient previous reported study adult T2DM treat insulin oral drug included use blood glucose profile compare mean glycemic mean glucose low high risk index risk range change risk status association treatment outcome hemoglobin level outcome change baseline treatment observed large reduction treatment baseline risk base risk improve remain patient risk change show association treatment show association therapy T2DM respective may treatment effect
22886793 en increasing impair glucose cause mellitus present study investigate effect use effect diabetic also examine day per week week blood glucose level blood cell activity measured analysis study perform result revealed mellitus weight ratio revealed statistical difference compare control analysis sample show significant increase protein level group significant high group compare control group number blood cell significant high group compare control group group control normal show change cell result suggest cause mellitus
27266223 en diabetic major cause lower patient type association new type patient level risk develop research prevalence type use new perform current study prevalence diabetic overall different risk group type mellitus patient hospital evaluate risk factor group correlation index index type patient hospital studied risk group base association patient prevalence patient history patient low high risk develop respective age duration estimate rate history hypertension cardiovascular disease factor significant associate high risk fasting plasma glucose hba1c significant factor association type patient group high risk develop patient risk patient risk group provide well management
25916257 en new independent disease aim study investigate relationship dysfunction patient type mellitus type diabetic patient duration year aged year healthy control study fasting plasma glucose lipid hemoglobin hba1c protein level determined measured function assess use significant high patient compare control vs addition significant difference observed patient control group vs respective show correlate negative positive multiple regression analysis show independent factor influence relationship function study measured may parameter assessment patient
22445622 en aim study examine relationship development cohort study conduct receive health define medication relationship investigate use regression baseline age body mass index mean pressure total serum cholesterol day positive relationship development mellitus observed significant high ratio high confidence interval CI observed negative relationship development mellitus significant lower high CI CI result indicate significant mellitus observed significant negative relationship development mellitus previous study reported positive relationship population
23939723 en study examine prevalence rate report type mellitus potential common diabetic current little research regard general health factor general participant range age year mean time diagnosis year datum included patient current function current occur time reported female individual system report system improve increased level activity may reduce increase current
23172524 en impact patient type patient type mellitus undergo studied on healthy treatment patient type use evaluate patient type mellitus month blood glucose lipid index significant decrease show score month respective high one week show treatment score significant vs evaluate also significant significant improve patient type mellitus
21422385 en show hypertension related blood pressure type type mellitus impact cardiovascular disease risk datum total cholesterol cholesterol cholesterol body mass index aged year mellitus assess group score among type mellitus high significant associate ratio model high estimate lower ratio lower level low adjust significant association observed body mass index score among type mellitus association observed body mass index may management cardiovascular disease risk mellitus
25204264 en therapy current care therapy associate development type mellitus case reported therapy case type develop woman therapy chronic patient gene associate therapy response also risk study determine individual characteristic may identify patient risk develop type treat
26774791 en study aim estimate incidence rate cardiovascular disease determine factor new patient type mellitus retrospective cohort study conduct T2DM patient aged year without history regression perform factor year follow-up overall incidence rate per CI without significant difference high risk old age current duration T2DM severe chronic disease oral drug need high body mass index BMI blood pressure total ratio ratio ratio need man high hemoglobin hba1c female factor increased BMI hba1c ratio found risk factor new T2DM patient target intervention association hba1c man found study
19585583 en renal cell protein on disease response cause gene investigate reported patient case cause impair cell cell similar increase however indicate cause function function
26390413 en glucose change well aim identify incidence risk factor change glucose patient undergo datum patient analyzed retrospective new diagnose mellitus DM occur patient impair fasting glucose impair glucose tolerance occur patient incidence DM high patient undergo patient group significant increased rate DM ratio increased on high body mass index old age significant risk factor development DM associate change glucose therefore important DM patient high ratio high body mass index old age
21528819 en syndrome also known mellitus disorder association mellitus DM include severe time report two diagnose syndrome year year duration DM respective change history negative negative DM lead diagnosis DM type DM
23466460 en large studied correlation effect cell present study assess effect potential cell condition mellitus high glucose condition increased concentration result show investigate effect cell diabetic condition potential factor effect cell lipid associate decrease study potential level potential effect cell
24957949 en role early development type mellitus investigate whether associate development clinical type cohort type examine participant included hospital first year assess day care first week type use outcome define little analyzed clinical type analyzed interval compare similar without reduce odd develop type adjust odd ratio or CI clinical type adjust or CI studied associate clinical odd ratio range early studied first year associate development type finding need population
24674666 en although improve management regard method addition regard method research evaluate method clinical outcome study compare effective two clinical outcome patient type mellitus primary care two retrospective evaluate one high total participant review outcome hemoglobin level hba1c low blood pressure blood pressure weight year month outcome compare on lower hba1c observed reduction month respective on significant decrease weight observed month patient hba1c show hba1c month significant difference outcome found two assess improve glycemic control patient high hba1c level demonstrated statistical significant indicate use method may effective
24359593 en retrospective database analysis study provide insulin therapy type estimate blood glucose obtain medical database database patient datum system insulin type use type type patient one insulin group blood glucose assess period model use evaluate effect baseline characteristic include insulin type blood glucose test assess insulin study identify type type patient two insulin study total mellitus patient identify number blood glucose test glucose low among insulin patient insulin patient respective different compare insulin datum glucose significant insulin type high patient type
26027218 en study duration woman woman three group according method assess datum glucose level blood condition found method woman mellitus method provide glucose level blood datum method case presence
25427821 en prevalence disease mellitus type increasing insulin clinical therapy year major number develop treatment mellitus type one insulin need cause patient however also role treatment syndrome improve patient insulin develop year recent insulin receive may drug review current investigate several investigate study whereas clinical datum however show investigate type drug may therapy patient mellitus syndrome
23882887 en glycemic control type mellitus patient also show influence glycemic evaluate glycemic control prevalence diabetic diabetic complication rate associate disease patient population patient evaluate include hba1c level complication related disease insulin datum analyzed patient group patient hba1c level current first year follow-up year respective on significant difference level patient found first year follow-up significant difference found group regard patient respective glycemic control associate less control need treatment population general population among
23471742 en mellitus type two common disorder increasing prevalence type mellitus may potential mass great risk adult type risk increased measured consider review potential mechanism increased risk occur patient increased one potential factor remain whether glucose several potential effect
24842247 en present study aim evaluate lipid status serum lipid profile parameter hba1c concentration patient type mellitus normal healthy test individual control individual group control group individual hba1c level group individual hba1c level group individual hba1c level group individual hba1c level blood sample blood glucose hba1c level level serum total cholesterol level correlation blood hba1c value parameter lower mean parameter significant high mean level sample patient control individual significant high mean serum concentration total cholesterol significant lower mean concentration patient control individual correlation observed value lipid profile parameter blood concentration result suggest hba1c value may potential indicate glycemic control indicate complication clinical level level
24411084 en association mellitus DM previous however study reported regard medication risk DM patient evaluate impact medication risk type DM patient conduct cohort study adult adult without use datum health research database regression model use medication adjust found independent associate increased risk DM severe ratio confidence interval vs ratio confidence interval independent risk factor included age disease increased health research database regard index obesity body mass index status history high risk develop DM risk medication
22511752 en protein insulin resistance study observed high level associate mellitus old however finding large cohort association mellitus old determine whether association age among cardiovascular disease individual year age without mellitus baseline measured serum participant follow year mellitus regression model evaluate association mellitus evaluate age mean age year female mean concentration follow-up case occur associate high risk mellitus ratio confidence interval factor function potential body mass index hypertension lipid protein association ratio confidence interval result similar status year old associate mellitus old status association may year age
24661759 en study clinical type mellitus study conduct diagnose type mellitus patient group group clinical diabetic duration group clinical diabetic duration compare T2DM patient without clinical clinical diagnosis base score score measured lower common study patient clinical patient without type mellitus population study show significant change duration disease lower significant reduce patient duration normal score score diabetic study test diagnose case
24663217 en investigate effect intervention factor cell type mellitus early
25952037 en woman history gestational mellitus increased risk glucose follow development week studied prevalence glucose week woman diagnose according study conduct care included woman aged year diagnosis per hospital on oral glucose tolerance test perform week woman week test woman develop week normal glucose tolerance impair fasting glucose impair glucose tolerance type study need follow woman factor
27830155 en assess whether blood pressure risk factor disease patient type mellitus T2DM year diagnosis method medical patient diagnose type mellitus T2DM follow year retrospective review on total include analysis BMI serum lipid profile analyzed result patient two group according group included patient high group CI increased risk compare patient group regression analysis also demonstrated age patient diagnose T2DM status mean level significant associate increased risk CI CI CI respective high correlate first diagnosis T2DM
27525261 en assess possible association function disease type mellitus patient use method clinical patient woman man mean age year assess correlation analysis perform association clinical datum test result logistic regression analysis use association disease multiple logistic regression analysis use independent factor disease result mean factor found significant associate or CI significant associate or CI function use may potential patient risk disease
26984083 en on man present hospital history history however test revealed severe level diabetic serum on reported development type mellitus patient first reported case associate role common
27179825 en present study evaluate potential clinical glycemic parameter fasting plasma glucose glucose hemoglobin hba1c patient clinical diagnosis type mellitus subject year T2DM ratio receive control care hba1c evaluate week month treatment significant decrease hba1c week respective hba1c remain significant reduce month model assessment insulin resistance insulin index significant improve significant increased week finding provide evidence improve glycemic control patient T2DM month treatment
19729439 en result lead concentration protein therefore identify also several addition protein characteristic
19701945 en body occur renal cell cause disease cause body cause identify analysis plasma study revealed revealed increased function plasma change indicate also result indicate datum within primary cause
19225793 en chronic condition cause increased pressure cause report case associate cause several reduce suggest possible relationship oral known reduce case suggest due mass may cause effective reduce
25142615 en present large study prevalence association diabetic present study aim evaluate prevalence risk factor sample adult mellitus study among adult year conduct use use datum patient known previous diagnose hospital medical use on regression analysis perform presence independent prevalence patient known mean age year prevalence patient patient significant duration without regression analysis adult duration current significant associate adult associate duration however follow study identify risk factor
26104730 en total protein result study relationship cardiovascular disease plasma level aim study determine relationship risk factor present study patient type gene determined method serum level lipid profile activity total adjust factor total study population group subject lower mean serum activity respective high mean concentration respective group mean concentration significant high subject subject group significant difference found factor patient type factor obesity effect result study however study need
22297056 en determine elevated level among patient mellitus determine elevated primary study investigate elevated among diabetic patient elevated value patient mellitus aged year assess may patient type patient type elevated patient respective patient increased insulin patient elevated serum patient elevated two elevated patient finding metabolic diabetic patient elevated level occur occur elevated level primary metabolic case elevated level mellitus
25440376 en investigate effect glycemic control patient type case treat month change fasting plasma glucose blood glucose oral glucose hemoglobin hba1c blood serum total cholesterol compare level hba1c significant decrease also statistical significant decrease treatment on patient reduce response patient type mellitus may decrease hba1c may effective treatment type mellitus
27598437 en although hba1c health system use develop may month total use assess
27455602 en aim study develop evaluate effective therapy mellitus type DM obesity base study study woman DM obesity perform patient use time gene patient DM obesity receive different treatment group patient group on receive group receive result study gene patient obesity show found reduce weight patient DM obesity due body mass group on group due on significant decrease blood glucose therapy observed group however treatment group blood glucose level significant lower group on therapy patient DM obesity base study improve disease
27416680 en mellitus model high show treatment great common period day lead decrease glycemic index level drug reduce concentration hemoglobin hemoglobin time time increasing time activity time on improve metabolic index lower
27172719 en study disorder patient disease type mellitus study included man mean age year medical assessment status characteristic lipid factor influence development included patient age level hypertension insulin level index lipid concentration total cholesterol level index important characteristic patient datum obtain level index development patient
26771382 en investigate association change new diagnose type control primary care cohort new diagnose type analysis compare case low score cohort status control cohort rate compare case control ratio level significant high case control respective association factor obesity blood pressure significant difference case control association found high new diagnose type mellitus factor increased factor
26765417 en reported improve lipid profile finding study conduct evaluate effect serum lipid patient type database study randomize clinical trial investigate effect serum total cholesterol cholesterol cholesterol patient identify compare control significant improve serum mean difference confidence interval CI CI statistical observed CI CI analysis revealed great serum finding significant improve serum level patient type mellitus
26739589 en datum regard clinical outcome patient type mellitus intervention compare year adverse clinical outcome patient undergo
26433909 en evidence association use study aim test study database health subject type mellitus aged case group subject type mellitus without control group group age index year diagnose current use define subject day diagnose use define subject day diagnose use define subject risk associate use estimate odd ratio or confidence interval CI use logistic regression statistical potential adjust or subject current use CI compare use without statistical adjust or decrease subject use CI without statistical significant association use type mellitus
25997108 en examine whether severe impair severe associate mortality cardiovascular mortality type two cohort one follow-up year one follow-up year cohort severe cohort year cohort addition severe month year cohort follow-up datum regard mortality obtain medical report mortality cohort cohort presence severe impair associate increased mortality regression model associate increased risk mortality cohort evidence disease reduce associate increased risk cardiovascular mortality type mellitus
24070887 en study examine type group analyzed use datum analysis analysis method study major identify study within related participant relationship among sample finding provide regard may population finding also use
25697718 en intervention patient consider effect incidence hemoglobin factor evaluate intervention well different intervention score treatment intervention management also parameter effect weight can included system
21489582 en examine association serum level metabolic syndrome mellitus sample adult population use datum health conduct study adult old year health metabolic syndrome define presence little elevated blood pressure low cholesterol elevated serum elevated plasma glucose obesity mellitus define fasting glucose little insulin resistance determined use model assessment estimate insulin resistance sample adult population high compare low serum concentration woman age body mass index mellitus high compare low serum concentration woman man mean fasting insulin insulin resistance determined use model assessment insulin resistance serum woman man significant high compare first respective group present study elevated serum concentration associate increased risk mellitus sample adult population
25853705 en number patient type mellitus increasing aim assess individual type compare current type age body mass index known duration target blood glucose value lower vs event independent type however use event without blood glucose level vs reduction insulin day compare day without similar result individual therapy however difference management
25746357 en protein protein cell protein diabetic may important diabetic diabetic compare control level diabetic compare control subject without use study significant level significant lower subject level increased significant status found significant associate increased level diabetic study diabetic associate T2DM subject
25145012 en aim study determine rate patient diagnose type mellitus DM also determine function patient type mellitus compare control group study study sample patient patient diagnose type mellitus control group test clinical datum result show group patient DM statistical significant control group patient measured DM patient patient control group also statistical significant difference status show patient DM present dysfunction compare control group high prevalence disorder diabetic patient need great patient consider
24613802 en although activity reported recent year mechanism treatment mellitus remain present model type mellitus T2DM insulin resistance use mechanism treatment T2DM oral three diabetic fasting blood glucose fasting serum insulin insulin total total cholesterol well oral glucose tolerance test evaluate normal diabetic according result can improve diabetic reduction diabetic treatment also glucose tolerance observed present study improve significant result may effect insulin resistance diabetic research show can diabetic result indicate activity insulin related
27459757 en clinical type mellitus metabolic disorder on also occur patient however disorder associate study show relationship disorder low treatment general clinical review mechanism disorder role influence change effect demonstrated mechanism development complication consider
26875891 en blood group found blood cell addition blood group associate disease include type study aim investigate potential association blood group type identify research datum base include use include blood group type study blood type mellitus included without research type status included remain study group associate high incidence type blood group association type blood group on diabetic population however association blood group type blood group high risk individual blood group low type subject blood group subject increased risk type
26620492 en aim study investigate association weight change use primary care patient type mellitus T2DM treatment new medication diagnose T2DM new medication treatment clinical research weight change index measured month new treatment year index adjust analysis evaluate association weight change patient weight change weight weight similar compare weight group weight associate significant increased total within year weight weight primary care weight weight included increased rate drug weight increased primary care on weight associate increased hospital odd ratio total new medication associate increased primary care increased primary care total study weight associate increased
23685023 en associate health outcome type mellitus T2DM previous investigate T2DM adult high hba1c vs hba1c study adult patient diagnose T2DM group patient result sample follow datum included medical individual T2DM reported lower compare group effect finding range use estimate clinical three group present study determined lower associate high hba1c T2DM patient high hba1c primary care consider important patient response determine may case value health
22849845 en incidence mellitus effect function assess patient three group according glucose risk factor first assess change renal function change examine overall incidence development influence significant body mass index body weight age incidence patient on therapy significant high show severe diabetic group compare normal one clinical study revealed adverse effect
25371518 en although cardiovascular disease type mellitus common risk factor potential mechanism may also disorder remain analysis perform association study woman health health association randomize trial gene related cell common group also identify cell analysis identify included multiple model mellitus analysis woman identify multiple development finding also
26316572 en one complication type mellitus incidence great increasing factor on conduct assess association factor type diabetic odd ratio confidence interval estimate association study include participant included analysis provide evidence significant associate risk diabetic population population diabetic
26245672 en type mellitus disease duration consider drug include three trial conduct patient trial patient within population reported associate decrease risk event although datum estimate effect increasing body evidence response may mechanism related treatment little patient among mechanism rate drug target response review develop response individual although change primary may identify clinical characteristic individual different
25818810 en evidence type mellitus T2DM individual weight reduction evidence new T2DM weight individual need glucose medication change health care general provide weight treat T2DM individual T2DM may chronic glucose medication patient change model disease management well association association cardiovascular great use T2DM treatment
25043156 en aim compare impact function patient type mellitus
22792091 en prevalence mellitus patient control subject patient control presence evaluate time period diagnosis assess on base patient mellitus present patient group patient control group patient diabetic patient female compare overall prevalence significant high among female patient prevalence control group patient prevalence mellitus study group patient significant high compare control group patient female among control group therefore patient may important role risk
25144211 en evaluate parameter primary patient without investigate effect metabolic control study group patient type mellitus control group patient without study patient perform parameter evaluate hba1c diabetic patient assess day assessment study group statistical high control group difference parameter group study group duration significant correlate analysis show effect age value statistical significant correlation hba1c level parameter include result study effect patient however large control study finding
25880265 en multiple chronic high increase disease examine among patient type mellitus identify associate poor patient conduct analysis patient use health datum datum examine prevalence old patient common reported hemoglobin hospital base logistic regression presence diagnose sample difference age high prevalence obesity cohort among old population old patient compare patient patient profile obesity less treatment patient age care remain among type patient patient outcome profile management develop common
25584422 en study aim estimate prevalence mellitus DM impair fasting glucose population aged year evaluate associate risk factor
27017701 en studied patient type mellitus drug influence level factor blood serum result treatment patient type diagnosis analyzed patient patient receive treatment oral drug patient therapy patient addition patient group receive metabolic drug day two time day day control group patient receive therapy treatment patient type effective compare group receive therapy result test improve activity compare value treatment patient treatment group patient control group show positive parameter study blood serum show significant increase index time patient receive control group revealed positive correlation test level blood serum activity total test addition negative correlation revealed level hba1c level blood serum group
26767403 en gestational mellitus consider early type mellitus study compare clinical datum subject normal glucose tolerance healthy control subject found model assessment insulin resistance index increased previous study demonstrated dysfunction can insulin resistance investigate cause insulin resistance use identify protein subject datum on total protein identify include significant protein plasma protein one protein use impair insulin study revealed may important role insulin resistance
26455399 en presence insulin resistance type metabolic analysis revealed lower insulin type population studied type patient impair may also fasting role insulin resistance remain recent study difference mechanism insulin resistance diabetic increased lipid contribute insulin resistance type increased insulin glycemic control insulin treatment also increase insulin insulin resistance type control trial need disease treatment reduce
22851534 en individual mellitus hypertension control condition assess incidence duration control blood pressure cholesterol patient health care system perform retrospective cohort study adult health mellitus hypertension year individual health primary outcome control hemoglobin hba1c blood pressure cholesterol respective less hba1c blood pressure cholesterol individual health control characteristic increasing age presence cardiovascular disease significant control model control less condition increased medication control mellitus hypertension general less relative large effect control individual multiple treatment may provide individual health condition
25790898 en woman high risk cardiovascular disease may due increased association remain evaluate whether associate among obtain sample woman adjust estimate confidence interval use logistic baseline woman adverse risk profile compare woman without woman without compare positive associate odd ratio however high odd woman age year or CI mean follow-up year positive associate mortality ratio CI among woman age elevated odd or CI compare without history or CI risk increased decrease association woman may effect
23956030 en respective important role obesity type mellitus however little known gestational mellitus study investigate whether change patient whether diabetic blood normal glucose woman determined correlation analysis perform investigate association metabolic parameter patient diabetic significant woman also use significant high woman positive correlate glucose level oral glucose tolerance test diabetic associate woman also associate subject insulin lipid
26816596 en patient type mellitus risk risk increased outcome without therapy complication two therapy current independent effect therapy also effect present review potential therapy disease patient type study disease found effect therapy protein study therapy show improve outcome reduction well regard treatment disease regard treatment randomize control trial patient without study show result therapy outcome disease effect finding large clinical randomize control trial impact
26386012 en present study diabetic DM status aged control group month diabetic use DM decrease number rate increased aged test show change increased diabetic old DM related decrease factor increased gene number without old DM old total level activity although increased increased gene DM aged related decrease increased independent
24431910 en gestational mellitus type T2DM although report indicate low correlate glucose tolerance association serum level risk T2DM woman history evaluate analyzed serum level development T2DM woman according association use cohort mean follow-up month woman three group according glucose tolerance status patient diagnose T2DM patient patient normal glucose tolerance follow-up T2DM group low serum level period significant difference group group multiple logistic regression analysis show significant T2DM found serum level also possible T2DM development serum level period may possible T2DM development woman history
26466689 en study determine difference among three group type type type method three group type type body mass index BMI type BMI assess patient perform result total score similar improve three group although difference among group score score low blood significant different among three group high patient type score significant different among three group high patient type significant different among three group high patient type score regard significant patient type compare patient type characteristic among patient three type according type
26347009 en type mellitus chronic metabolic disease early incidence studied number study investigate oral however relationship study high level high incidence chronic adult healthy subject type finding study difference oral impact metabolic control health indicate high risk type association result study however found risk factor less diabetic population research remain need research
24549414 en recent association study identify multiple risk type mellitus DM however association association study gene recent study system show reduction new DM system significant association prevalence DM study subject hospital related disease case type association prevalence type DM test on significant association DM obtain significant association DM on logistic regression show age independent factor association DM risk CI significant impact type mellitus
21454888 en study prevalence use mellitus receive care care identify association use glycemic study base retrospective medication use adult care period period per medication history adult demonstrated use use rate use type mellitus type mellitus vs lower use compare use use associate reduce however relationship finding prevalence use mellitus association use improve glycemic control finding retrospective
24295857 en renal disease role mortality retrospective cohort study examine risk renal disease without renal disease among adult mellitus first use database health develop model incidence case occur among first adult among adult mean age time diagnose year respective age time diagnosis risk renal disease time high first adult confidence interval CI analysis show high risk among first adult increasing age time diagnosis incidence function age time diagnosis show great risk renal disease among age great risk among old diagnose first adult condition renal disease develop mortality contribute renal disease possible chronic complication mechanism develop effective management
26672242 en prevalence clinical level protein serum type mellitus syndrome three patient type lead age body mass index duration blood glucose hba1c level level serum prevalence patient BMI blood glucose hba1c level level serum high patient hba1c independent positive correlate patient risk or independent correlation factor included hba1c duration level hba1c factor prevalence high patient type mellitus patient poor glucose control protein observed
20927764 en use insulin woman oral patient however assess effect health outcome woman previous gestational mellitus increasing found impair glucose tolerance potential need intervention woman little evidence use oral woman investigate effect oral woman mellitus impair glucose tolerance previous gestational woman mellitus use oral management gestational current evaluate group trial included review independent assess trial identify trial use group trial included trial review one trial assessment trial evaluate treatment woman gestational woman syndrome control trial datum evidence evaluate use oral woman mellitus impair glucose tolerance previous gestational mellitus woman mellitus large trial compare oral insulin woman health outcome control intervention health outcome clinical
27000327 en compare glucose develop treat type mellitus T2DM individual aged study baseline hemoglobin hba1c fasting plasma glucose blood pressure body weight measured evaluate use datum randomize study aged aged assess base adverse event report randomize study aged aged associate mean reduction hba1c participant respective aged old respective reduction body weight participant age group overall incidence group study participant respective aged old similar profile group incidence participant respective respective aged improve glycemic control body weight participant aged old overall incidence high treatment group participant aged old high profile general similar age group high incidence related observed participant aged old finding effective old adult T2DM
23070348 en current study identify change associate clinical condition woman without study population woman clinical diagnose healthy woman control subject woman diagnose gestational mellitus mellitus mellitus mean age woman studied year mean gestational age diabetic woman week diabetic show include on statistical association found change mean weight studied woman mellitus gestational mellitus mellitus mellitus found woman woman gestational compare type type
22496179 en determine mellitus DM compare present total patient studied patient change mean hba1c patient mean hba1c patient patient patient present patient DM study high among patient present high hba1c
26435536 en identify risk factor mellitus related report determine disease mellitus study diabetic hospital patient DM history pressure index measured evaluate disease total DM month period age range year mean year respective patient respective study population old age year poor control potential occur common high patient DM examine DM
21063043 en prevalence factor mellitus adult population factor system mellitus use primary health care health care conduct subject health health research population year old mellitus diagnose oral glucose tolerance test base subject new diagnose subject undergo oral glucose tolerance test subject datum important subject year old subject included study prevalence mellitus total diabetic population subject included analysis mellitus subject subject subject normal blood glucose subject analysis age status level obesity obesity hypertension significant association mellitus analysis found factor mellitus age obesity obesity hypertension mellitus factor mellitus age obesity obesity hypertension
25429036 en type mellitus T2DM health T2DM risk treatment use datum therapy trial assess characteristic associate clinical response adult T2DM hemoglobin hba1c receive therapy oral assess clinical level medical condition baseline three month month change mean define treatment response datum participant use multiple regression model evaluate factor associate severe baseline associate great participant great participant participant body mass index per great reduction participant age hba1c value duration associate change outcome patient T2DM baseline disease associate clinical response therapy body mass index glycemic control duration may clinical change population
27707768 en assess association mass insulin resistance glucose control type study group control type use determine blood sample use assess use assess lipid regression analysis model use test association test high type subject group show lower value type group lower type group however similar group type lower type subject negative associate association observed relationship observed among positive associate condition type also associate insulin resistance associate hemoglobin
27484453 en study suggest status role control patient type however intervention study result aim study review effect control patient type review examine effect control patient type on model perform obtain outcome hba1c fasting glucose model assessment insulin resistance included review total patient type mean change serum study included hba1c outcome study significant effect change hba1c intervention compare on significant effect fasting glucose study mean baseline hba1c difference mean CI evidence population type however patient poor control effect fasting glucose
23782471 en use association study group identify prevalence gestational mellitus woman woman increased risk develop type on number risk factor development type potential change medical management previous study investigate intervention reduce risk factor woman control trial study aim assess clinical impact woman
22998091 en mellitus impair fasting glucose year
25713996 en review effective insulin insulin compare multiple woman mellitus control trial may study compare woman mellitus included study use insulin conduct two study base type insulin use cohort study woman type reported hemoglobin hba1c group show difference outcome result similar compare insulin insulin study high risk study population treatment follow outcome study reported similar hba1c evidence possible important difference outcome need study examine effective insulin woman mellitus
27193103 en cell one important increasing cell function show significant diabetic high glucose high role can response diabetic role activity may treatment
26666374 en type mellitus DM significant reduction due negative impact DM patient associate treat several disorder due type therapy may improve increasing study randomize trial test perform evaluate effect participant receive intervention therapy interval period intervention participant perform per rate pressure measured use metabolic system study evaluate effect use lead rate pressure may DM population datum study trial number
27707767 en plasma concentration patient type disease type can plasma concentration study aim cohort type patient identify plasma level
22488644 en clinical management patient type mellitus control weight insulin although hba1c level important increased risk several study factor related obesity metabolic syndrome insulin resistance important hba1c cardiovascular risk disease event mellitus characteristic associate type mellitus include insulin resistance patient effect change lipid profile increased cholesterol level reduction patient mellitus potential chronic lipid prevalence mellitus increasing increased review identify patient mellitus suggest clinical management reduce risk disease
22818582 en high patient type mellitus T2DM little known whether T2DM obesity level study week found T2DM development determined incidence reduce body weight serum glucose insulin level decrease correlation analysis insulin resistance index model assessment insulin resistance show positive correlation insulin resistance use cell cell found major cell contribute provide finding T2DM patient study also first role determined cell major contribute T2DM blood possible
23690953 en recent found may dysfunction evaluate association plasma level function patient type measured ratio early ratio early patient type mellitus year fasting blood value obtain medical plasma level patient poor significant lower patient level patient significant lower patient level patient significant lower patient level negative correlate positive multiple regression analysis revealed hemoglobin level well duration level fasting blood glucose cholesterol level duration hemoglobin level level independent associate function patient type mellitus may assess function patient
25210750 en investigate whether type mellitus influence glycemic control lipid profile total patient group compare without control group patient treat patient undergo hba1c level patient female whereas control group lower mean difference CI high CI need less insulin CI body weight per day control group patient high hba1c level CI lower level CI high level CI patient positive old year CI year duration year CI year presence associate high level odd ratio CI associate glycemic control lipid profile well lower insulin female develop
26666142 en general dysfunction known cause development mellitus dysfunction also increase glucose type mellitus T2DM mass mass T2DM reported report study cell dysfunction T2DM can insulin T2DM can control dysfunction decrease increase insulin respective control cause dysfunction T2DM
26358774 en syndrome disorder gene protein patient obesity show glucose tolerance test low value patient can risk factor development mellitus cardiovascular complication mechanism use two model primary model lead cell early increased increased response cell insulin cell decrease insulin suggest insulin resistance study association analysis metabolic status patient mellitus follow-up patient regard development metabolic syndrome also suggest obesity reduce number diagnosis patient associate obesity
26298521 en recent report suggest glycemic control without can decrease mortality patient mellitus DM renal disease however oral drug population aim study evaluate glucose patient type DM T2DM intervention trial included diabetic patient undergo level treatment day day day without day blood glucose value measured primary glycemic control evaluate change hba1c fasting plasma glucose improve blood glucose day day significant reduction hba1c without severe one glycemic control T2DM patient undergo
24524711 en mellitus DM high risk develop dysfunction several factor contribute patient DM study factor study aim index study prevalence patient DM determine role diabetic patient assess index function respective use index group significant group current age type type treatment presence complication history current use presence logistic regression analysis current age body mass index BMI presence significant role among diabetic patient high compare general population factor group remain role DM
25379510 en although several type disease change important disease change individual identify subject gene analysis investigate gene change compare analysis show type mellitus T2DM mean gene T2DM show associate positive insulin negative hba1c level T2DM function also study gene profile related glucose
21553366 en syndrome clinical condition dysfunction syndrome case result syndrome gene type mellitus reported independent case present syndrome diagnosis patient clinical syndrome type mellitus addition report rate type mellitus syndrome low increased little type mellitus rate general population evidence correlation syndrome type mellitus reported therefore presence disease patient association however suggest syndrome role development type mellitus
23522918 en assess effect mellitus diabetic patient type mellitus serum blood level assess compare patient T2DM group T2DM patient group control subject group control patient group decrease serum serum increased decrease correlate within group group group significant change observed however group show high level high level lower group increased group group high level group patient increased decrease decrease increased group T2DM show serum may consider possible disorder T2DM patient
23661816 en type mellitus provide study conduct receive care great total individual use individual one medical datum primary care participant primary care diabetic receive care poor care due high medication need management on participant result group need increased type mellitus T2DM need pressure can need study well low
24768143 en impact effect type mellitus T2DM investigate total T2DM group without body mass fasting blood glucose fasting serum insulin concentration fasting serum examine first week effect level week also cause significant reduction weight T2DM improve level serum insulin decrease level weight reduction period increased level serum insulin impact level T2DM care
25136643 en determined patient follow investigate potential related factor patient type T2DM type little duration examine one year patient characteristic age duration treatment control complication rate compare subject without retrospective datum similar patient examine first time year follow-up little perform T2DM patient patient old type similar rate type observed follow-up patient patient T2DM little duration show high characteristic patient therefore may patient
26890789 en one important adverse event individual type mellitus T2DM however event less clinical evaluate incidence clinical characteristic medical related event T2DM patient base large cohort outcome datum datum health review assessment follow-up period year CI subject new diagnose incidence case per individual significant old vs year hospital hospital great medical vs subject without event identify among medical T2DM subject however associate significant poor clinical outcome can system
24673571 en evaluate effective intervention patient control trial investigate intervention adult included on primary study according conduct primary outcome control treatment complication mortality investigate two identify primary study datum independent model conduct overall estimate treatment database result trial included randomize control trial intervention show positive effect mean difference range mean difference CI odd ratio CI odd ratio CI effect control intervention trial mean difference range show effect mean difference CI odd ratio CI control improve randomize control trial compare treatment mean difference CI intervention positive outcome patient treatment control improve trial outcome investigate follow-up datum trial evidence treatment effect
23832821 en mellitus outcome patient type study impact mellitus outcome patient perform retrospective analysis patient outcome compare diabetic patient on great patient group present diabetic present however difference statistical overall observed significant difference diabetic subject body mass index BMI diabetic found poor time patient mellitus independent lower overall rate adjust primary patient mellitus
27196454 en compare type mellitus T2DM treatment medical treatment T2DM patient BMI randomize control trial conduct hospital subject patient age year body mass index duration T2DM year subject undergo patient follow-up year patient included undergo undergo study present follow-up datum year compare T2DM patient determined weight BMI change cholesterol measured type analyzed model analysis result great effect reduction fasting plasma glucose hemoglobin hba1c patient T2DM ratio medical treatment respective per analysis indicate provide method T2DM treatment patient
26666141 en well clinical patient type different according result study complication study cohort patient type patient lower body mass index lower incidence disease compare diabetic patient difference patient type can found risk factor effect cardiovascular disease result demonstrated risk care type complication
27329025 en general health blood glucose concentration individual type aim current study examine change insulin glycemic control response day individual type
25259747 en several study different population blood pressure cardiovascular event treatment target aim present study investigate effect change time drug included patient type mellitus hypertension study patient randomize week individual drug follow week drug result significant reduction reduction different level protein significant lower may indicate effect found difference status significant increased significant reduce increased patient type mellitus hypertension drug may increased may increased effect system suggest potential mechanism observed effect intervention
24633706 en chronic characteristic type mellitus T2DM role blood glucose glucose control T2DM patient glycemic level glucose mechanism management T2DM glucose body first drug follow review drug clinical development also year review study investigate recent clinical development
26285788 en type mellitus T2DM high prevalence therefore number medication develop studied management evaluate medication patient tolerance medication glucose new indicate treatment mechanism independent function first drug two respective on new need identify use clinical clinical research review regard role patient glucose include clinical trial datum datum
23716596 en factor factor response protein protein negative whereas system important role response role mellitus remain show gene diabetic blood glucose level lower insulin insulin resistance also oral also gene metabolic system target mellitus
25543854 en woman type healthy blood glucose level need normal possible addition new also need blood glucose level normal improve overall woman type test randomize control trial use early evaluate effective type study three primary outcome general evaluate management evaluate woman care period participant intervention group care control group total participant group need statistical level early
25519204 en one use assess activity assess patient mellitus therefore study aim examine sample patient mellitus type analyzed use characteristic assess factor analysis on regression model use identify influence correlation identify factor model show however found regard analysis increase factor model statistical significant influence score assess adult type
26470788 en protein cell study recent revealed gene three significant associate type risk condition reduce investigate impact show well early early protein cell study first time protein response
26420863 en research association multiple include current influence first type type define potential addition review evidence present research provide current number important high different body individual provide influence health relationship regard metabolic system define research need potential target treatment report present relationship study system intervention need
26453801 en investigate effect gene risk type mellitus T2DM use study include case T2DM individual impair fasting glucose control normal fasting glucose multiple logistic regression association risk adjust include age body mass index BMI general model compare fasting blood glucose level adjust result show significant associate increased risk T2DM model or CI or CI model analysis show respective correlate T2DM female significant association found three T2DM population year age show significant association T2DM population analysis indicate group lower fasting glucose group study provide evidence gene associate increased risk T2DM population
23772556 en several study assess association type mellitus result investigate association type mellitus study assess relationship type mellitus identify database review study first year study characteristic participant sample age analysis odd ratio or associate confidence interval datum provide or also study identify analysis or analysis determined CI high risk patient or CI also observed effect risk type mellitus patient consider severe high risk or CI or perform analysis among study determine influence estimate found significant influence result finding association type mellitus result may study
26816610 en characteristic system disease diabetic patient diabetic patient present case previous diabetic patient clinical follow diagnose result cause first reported case clinical diagnose first
27103363 en conduct review determine weight reduction patient type included randomize control trial evaluate control weight type study identify study decrease weight mean difference CI compare mean hba1c reduction CI mean BMI reduction CI significant observed total adverse event occur common among risk ratio adverse event CI one study high risk reduce weight type patient increased adverse event include adverse event datum clinical general use
27016884 en review major investigate role glucose glucose potential use management type mellitus also role treatment disease study recent development occur also potential treatment effective therapy
22098288 en mellitus increasing common chronic disease great impact clinical effect also due current estimate due increase associate complication high major type number complication cardiovascular complication increase diabetic great impact health patient without study first evaluate per patient estimate high value indicate overall population current estimate total per total per study need define effective therapy metabolic control reduce risk complication
25461381 en investigate cardiovascular disease risk factor follow-up cohort compare observed diabetic population participant female status risk factor evaluate study subject type mellitus baseline participant examine risk factor model status study follow-up period diabetic female significant control blood pressure serum low cholesterol general obesity compare although high high serum level study diabetic however significant control serum general obesity compare control high high serum level follow-up use medication increased diabetic risk factor control among diabetic population high risk factor
25007947 en type mellitus DM disease chronic complication diabetic increased improve method management study investigate whether presence use development time study included patient type mellitus DM subject develop complication test assessment complication use patient included study female patient diabetic complication diabetic diabetic patient diabetic patient diabetic diagnosis patient test negative test positive mean hba1c level patient patient high hba1c level however difference statistical significant mean development time complication patient year patient negative result presence patient type mellitus significant effect development time diabetic complication
16713494 en although research contribute significant provide review present recent mechanism development treatment known cause gene large revealed identify recent year evidence clinical study event protein protein research also provide important diagnosis perform diagnosis although treat treatment gene therapy protein control can treatment
27687032 en type mellitus T2DM associate increased risk cardiovascular disease therapy T2DM may provide risk reduction consider potential large control clinical study assess impact addition therapy outcome T2DM subject therapy baseline trial randomize study T2DM included study primary evaluate treatment impact event rate time first impact glycemic control evaluate occur treat treat subject risk reduction regression analysis demonstrated significant lower incidence rate treatment group subject poor glycemic control hba1c baseline therapy relative result significant mean hba1c reduction week week respective high subject hba1c week finding suggest T2DM subject therapy may effective reduce risk trial
27458683 en provide clinical use history type mellitus study examine mechanism clinical study examine patient T2DM without time role total body level glucose function role insulin on activity insulin day high insulin resistance day activity effective improve glycemic control cardiovascular disease risk factor related adverse event reduce demonstrated report trial clinical study patient T2DM show well treatment
24612665 en on conduct evaluate association gene diabetic type mellitus study case control included current study suggest gene individual
24205974 en assess patient type mellitus T2DM control period patient hba1c fasting plasma glucose randomize therapy randomize period follow period patient receive primary change hba1c baseline week reduce hba1c significant compare week change hba1c mean also significant reduce glucose compare week change mean respective blood effect period incidence rate adverse event adverse drug include randomize period similar group therefore general well use addition effective general well patient T2DM control control week
22325156 en prevalence increased patient mellitus general influence factor little known association diabetic test major impact diabetic diabetic patient age control studied common datum compare use logistic regression score significant high or CI early or CI or CI prevalence score diabetic control respective adjust early remain significant patient prevalence early significant increased cohort patient type mellitus compare control adjust early remain diabetic patient base diabetic population factor large associate treatment
24935606 en chronic disease impair fasting blood glucose lead study evaluate relationship population diabetic patient renal cell perform patient renal reported renal cell case study patient without history regard fasting glucose level evaluate found patient mean age patient without mellitus year respective group patient respective group patient study risk factor observed important renal patient study need large result
22181062 en study aim prevalence clinical type mellitus analyzed patient diagnose first hospital among patient type mellitus patient diagnose clinical analyzed compare prevalence patient study patient significant high level blood glucose however hemoglobin significant lower patient compare patient show three patient however found patient on insulin therapy use control patient study patient diagnosis although may treatment patient
25470484 en assess mellitus DM include individual DM population identify datum clinical datum different database individual year hospital two drug within one year DM follow year prevalence mortality drug health identify subject study population mean age year index prevalence range among subject aged year among year old overall per patient per year estimate significant high man woman overall total drug contribute total hospital complication DM DM diagnosis cardiovascular drug contribute total drug on different database provide datum large population observed time period show obtain estimate disease mellitus
26598798 en increased risk finding perform review assess effect patient included review study risk estimate included overall patient significant high mortality CI analysis show associate poor patient disease CI disease CI CI patient year duration year associate high mortality overall patient effect overall associate duration
26612139 en mellitus DM may risk factor result conduct review study association DM included study identify identify study use model association DM CI analysis observed study method DM assessment analysis one study time assess influence study estimate analysis indicate one large study high study estimate increased statistical CI suggest association positive one DM general population DM major role development
24841449 en woman history gestational mellitus increased risk type mellitus T2DM important factor can T2DM examine role activity change cohort study woman health study history health study woman follow activity assess T2DM identify T2DM case follow-up per week total activity per week activity related lower risk T2DM adjust relative risk CI association remain significant body mass index BMI increase activity associate lower risk develop T2DM compare woman total activity level woman increased total activity level per week activity lower risk T2DM CI association remain significant BMI adjust T2DM associate per week respective value BMI activity may lower risk T2DM finding suggest woman history although high risk T2DM may lower risk
26799937 en define mass function mellitus DM old adult mechanism development include insulin resistance chronic dysfunction also associate DM provide high lead mortality old DM patient increasing number old DM patient early intervention improve old patient
22772755 en although mellitus mechanism study define role response early protein response assess cell cell high glucose protein diabetic diabetic cell also renal diabetic observed evidence activity reduction protein increased protein also whereas factor cell protein decrease increase found factor cell response without protein response important protein protein response response early mellitus
20920079 en care increase well improve medical status patient chronic disease study aim evaluate compare patient mellitus hypertension obesity mellitus hypertension obesity factor adverse study research population included total mellitus hypertension obesity patient evaluate patient use analysis use total patient obesity hypertension mellitus hypertension mellitus hypertension obesity hypertension mellitus obesity mellitus obesity mean score patient obesity hypertension lower group mean score determined mean score determined mean score patient high old age lower level negative effect hypertension obesity decrease patient activity increase obesity hypertension negative effect hypertension obesity mellitus need chronic patient old lower level one chronic disease
24002894 en recent year number patient type mellitus cause insulin resistance increase insulin resistance consider related risk cardiovascular disease disease therefore insulin resistance one important treatment type mellitus present drug among important oral drug use improve insulin resistance study effect treatment type mellitus investigate type diabetic patient treatment treatment significant effect reduce serum hba1c level compare treatment result indicate may treatment
24480636 en prevalence type mellitus T2DM increasing medication positive outcome patient study evaluate association medication outcome patient T2DM study use datum hospital medication ratio use define group respective glycemic control change blood pressure lipid profile health care patient medication patient improve fasting blood glucose hemoglobin study blood pressure total cholesterol lower month lower cholesterol baseline month total health care respective study period group group respective respective whereas drug group group patient glycemic control lipid profile high group overall health care include similar group
27307175 en mellitus chronic disease old patient high presence may relative effective treatment randomize control trial show glucose control cardiovascular treatment period year risk mortality one trial analysis health study treatment glucose control treatment three base individual patient study study clinical treatment need old patient research need determine risk treatment population research development study well target care management
26972956 en compare characteristic adult population diagnose use fasting plasma glucose hba1c difference two group age study whether population
25707205 en one factor development type mellitus system insulin cause change lipid cell well dysfunction system associate insulin system insulin system use early disease develop new treatment review datum result change insulin system role analyzed activity system
26042399 en diagnose mellitus type mellitus T2DM cell function T2DM patient insulin therapy control aim provide insulin therapy T2DM primary care insulin therapy therapy insulin insulin T2DM conduct care general number
23277307 en study demonstrated compare intervention patient undergo among patient disease mellitus whether result patient mellitus disease randomize assess health care system health assess use level on model base result use estimate although lower total index high per patient year follow-up high high medication remain high per patient although trial period result relative ratio per range regard effect high high compare patient mellitus
23331476 en show influence blood glucose concentration insulin one present study review evidence effect blood glucose concentration insulin database include control trial investigate effect blood glucose insulin diagnose type type gestational mellitus included assessment datum conduct trial participant identify trial type demonstrated significant increased blood glucose concentration insulin concentration glucose time insulin type trial indicate reduce duration without trial demonstrated decrease insulin increase blood glucose concentration indicate negative effect blood glucose control individual type trial duration need determine effect early reduce duration improve type
27591880 en effect diabetic studied model type mellitus per day week less receive effect associate
16713497 en define disorder common drug metabolic diagnose test patient disorder less patient show little increase therapy identify disorder drug treatment may include drug decrease
24205921 en type provide control however early therapy may health outcome conduct review investigate without randomize control trial evaluate therapy patient type mean difference change baseline relative risk confidence interval use mean age range year mean baseline mean duration year follow-up month change change fasting plasma glucose drug included insulin glucose compare therapy provide statistical significant reduction CI increase less CI reduction CI result suggest potential therapy outcome compare range baseline level research early treatment may also health outcome
25253518 en on mechanism disease management however mechanism mellitus diabetic complication remain diabetic complication diabetic condition influence response factor result model research mechanism recent model develop provide model sample type model review model diabetic relationship type type model associate increased cell type type show high level cell ratio elevated cell compare disorder diabetic model mechanism study cell level may cause condition
24798603 en study model type mellitus follow metabolic parameter week group control day metabolic parameter measured one week week study week result develop obesity insulin resistance metabolic parameter remain large study group type insulin resistance elevated increased plasma level time week observed change metabolic parameter week demonstrated diabetic significant increased fasting plasma glucose value insulin severe increased level decrease serum concentration significant elevated protein result indicate model model can also use role type well investigate diabetic complication
24761863 en aim study association history mellitus DM risk among man undergo patient DM patient without DM included study age weight level diagnosis score datum patient obtain score score consider high consider low mean age time patient DM patient without DM diabetic man significant lower level mean level patient DM patient without DM respective also diabetic man high man without DM found hba1c level high patient high man undergo lower level significant high patient DM although patient lower level high disease
24692844 en high disease activity recent however evidence suggest also cell system indicate role chronic disease datum suggest role obesity insulin resistance cardiovascular disease insulin resistance insulin presence insulin drug well obesity associate insulin resistance on relationship obesity recent evidence also suggest association obesity increased risk previous research show disease activity reduce level therapy one obesity may disease disease on mellitus research base review provide possible role influence mellitus
24509898 en mellitus metabolic disorder glucose result insulin insulin contribute poor oral health increased recent found can adverse glycemic control diabetic review relationship mellitus review disease use disease mellitus evidence association mellitus disease mellitus increase risk disease insulin resistance glycemic control treatment improve glycemic control type diabetic control important oral health may also improve overall health
24457898 en type type T2DM also increasing base presence cell cell also therapy T2DM patient lead clinical adult T2DM patient patient presence indicate need insulin treatment period time compare T2DM patient T2DM include cell cell T2DM patient well one T2DM chronic characteristic disease response system cell contribute increased however known review T2DM response chronic role cell T2DM patient present T2DM management
24373244 en mellitus DM common disease prevalence increasing due increase obesity although obesity identify major risk factor different cell type DM common however disease occur old also occur old presence type DM diabetic type diabetic present low insulin concentration include finding
24357160 en model consider important evaluate impact treatment review model develop evaluate new oral treatment type mellitus T2DM
26535463 en on old female present revealed presence mellitus show severe treatment insulin report treatment mellitus
22134840 en aim prevalence aged cohort without study population aged year age study type mellitus define hba1c assess use early treatment diabetic study association risk factor estimate use odd ratio obtain overall prevalence mellitus present include CI CI clinical significant present CI independent risk factor diabetic patient model included hba1c insulin use use oral two disease duration participant without mellitus participant present CI clinical significant three independent risk factor included increasing age case found without association found result may patient management aged
22974091 en study investigate role patient type mellitus finding present study assess association outcome patient type mellitus disease study included patient mellitus measured primary outcome mortality concentration follow-up patient first patient patient patient estimate mortality respective ratio CI confidence interval compare analysis mortality adjust CI increase level model known cardiovascular risk factor increased model regard mortality relative respective patient type mellitus elevated level mortality independent known cardiovascular risk factor
23570310 en increase due patient mellitus show high normal individual diabetic patient change aim study compare diabetic patient type without clinical normal control assess possible increased associate perform subject mellitus without clinical study group female mean age year healthy subject control group female mean age year blood parameter analyzed case datum level fasting plasma glucose hemoglobin hba1c compare mean study group control mean hba1c level study group control group statistical significant relationship found hba1c fasting plasma glucose level group significant patient type without clinical healthy subject
26522828 en study assess prevalence general obesity hypertension well weight management type mellitus included patient care two hospital method use assess participant weight blood pressure fasting plasma glucose weight management measured use prevalence general obesity obesity hypertension respective obesity participant weight general general obesity participant reported weight management weight weight management hypertension less participant year weight obesity general hypertension sample influence weight management
23569941 en mellitus disease group metabolic disorder number population chronic insulin insulin number can year case increasing day day insulin oral drug treatment develop present review provide mellitus metabolic disorder review also mellitus model mechanism use use evaluate activity drug review test activity diabetic model datum found activity due presence provide review development method insulin oral treatment mellitus complication associate related disorder
22774846 en assess among patient type mellitus whether high hemoglobin factor increase risk total mellitus patient subject without mellitus health may datum included measured use score clinical datum define total score score week mellitus patient significant high compare control vs odd ratio confidence interval well vs odd ratio confidence interval significant effect mellitus vs odd ratio confidence interval vs odd ratio confidence interval adjust high hemoglobin level significant associate odd ratio confidence interval odd ratio confidence interval odd ratio confidence interval type mellitus present control among diabetic patient high hemoglobin level independent
24411342 en impact gestational mellitus oral glucose tolerance test study among patient perform first risk factor identify week period study month woman included test perform woman case woman gestational mellitus prevalence rate analysis consider risk factor age history history previous test case test fasting blood glucose case also show significant difference rate prevalence present study first risk factor found also two study age type history history statistical significant age first number test period first test test use first study fasting blood glucose case normal fasting blood glucose poor diagnosis also test however datum study revealed low fasting blood glucose on gestational mellitus use fasting blood glucose first week
25091969 en mellitus DM major risk factor cardiovascular disease glycemic control reduce cardiovascular event patient disease little medical therapy disease randomize trial demonstrated intervention patient treat DM however review current evidence regard effective medical therapy patient DM
23958846 en hemoglobin hospital use diagnose mellitus evaluate result period use general hospital use diagnose hospital participant perform within estimate hospital hospital perform within level hospital large use diagnose mellitus hospital use diagnose mellitus
22605788 en complication type adverse impact type management include treatment trial compare individual group evaluate use assessment change three risk hba1c blood pressure may improve care type primary care control study patient type study care assess patient target three month receive receive patient outcome hba1c fasting total cholesterol group receive level control three compare baseline patient target hba1c blood pressure target primary care three need mechanism management care type assess whether clinical outcome type
27052230 en high prevalence mellitus population present provide treatment diabetic patient according current evidence
25362864 en oral aim evaluate subject type mellitus control patient mean age year mean BMI mean baseline fasting plasma glucose level hba1c duration year respective week follow week period subject randomize one group treatment period three significant reduce hba1c baseline compare group group vs group respective without significant difference insulin function assess model assessment index oral glucose tolerance test significant improve treatment incidence adverse event similar treatment group body weight week improve hba1c fasting plasma glucose level result function drug well subject type mellitus
24823599 en aim present study assess therapy patient type mellitus T2DM control randomize study compare T2DM patient control hba1c week study patient randomize receive baseline overall mean age year body weight duration year week adjust mean change hba1c baseline group baseline group treatment difference difference fasting plasma glucose significant decrease body weight group event reported group include patient hba1c patient group reported low incidence adverse event vs adverse event effective patient T2DM without increasing risk weight
24375463 en associate mellitus DM adverse impact evidence may patient DM healthy reduce DM group correlate large reduction increased DM within patient DM may severe may related activity similar mechanism
23451821 en use treatment type mellitus T2DM little known cardiovascular impact determine effect chronic treatment function T2DM function assess severe female year duration year mean month body weight determined total decrease control improve significant change respective significant body control month treatment function may therefore need reduce risk severe patient T2DM
25272454 en decrease group significant reduce similar concentration blood mellitus mellitus increase time compare control datum cell presence cause may one number mechanism mellitus group
25041529 en new management disease type mellitus year diagnose patient diagnosis use test use use patient
24665917 en association gene risk type mellitus report study conduct evaluate relationship gene risk use method association study identify included use method report association gene overall population associate population associate risk gene associate risk associate risk however sample population associate risk associate risk overall population however study conduct
26622181 en patient type mellitus T2DM high risk develop cardiovascular disease assessment risk important health health hypertension risk assessment individual T2DM however risk assessment T2DM studied study evaluate two risk assessment study risk risk assessment patient T2DM use two risk assessment two assessment assess individual blood pressure cohort new diagnose T2DM patient identify subject low risk whereas risk low risk risk risk identify high patient compare subject low risk risk two poor value individual low risk high cholesterol target significant two assessment risk high patient low risk risk risk assessment assessment demonstrated poor identify level cholesterol blood pressure
25819084 en mellitus DM chronic well clinical potential condition diagnosis DM great however identify patient patient several clinical parameter patient DM parameter define level patient three different patient population patient patient without DM patient score patient without range patient range score patient similar patient range mean score patient score patient patient diabetic result show identify patient
23765755 en investigate effect mean glucose control patient type type patient type type mean blood glucose blood pressure rate interval compare control day blood pressure rate concentration increased range baseline remain control day glucose control show significant difference day compare control day mean difference on regression correlation analysis show association characteristic type age body mass index BMI duration hba1c parameter glucose concentration cause increased parameter glucose control patient
23597390 en mellitus one major clinical previous study disease new therapy base study however present research method high target recent drug disease disease mellitus review analysis can treatment high may significant identify population elevated risk include may early patient risk may significant conduct disease
24469402 en on body evidence mellitus known response protein cell recent demonstrated insulin cell contribute glucose mellitus show diabetic model decrease cell increased however cell lead protein response indicate cause cell insulin decrease cell impair insulin response glucose datum indicate function cell insulin contribute mellitus
25896680 en prevalence mellitus type adult population new therapy insulin therapy remain patient obesity high insulin resistance target value case disease aim early complication
26032592 en first one develop factor associate high risk identify due datum study reported high risk old age condition primary medication include on contribute identify high risk diagnose treatment potential complication population treatment primary insulin complication DM include hypertension
26266486 en present study effect investigate within body weight on significant decrease number observed group cell control control group high observed less present studied revealed relative number cause statistical significant decrease also change observed obtain result suggest significant reduction well decrease suggest function
26482961 en factor present cell cell cell system important role response cell elevated found patient disease include hypertension disease syndrome well type two mellitus T2DM chronic disease therefore factor risk factor increase serum level although reported weight disease event general disease population large body evidence regard role elevated T2DM subject review role T2DM subject
25622031 en investigate effect age relationship status prevalence control status mellitus DM adult man woman age health measured level adjust odd ratio or confidence interval CI prevalence control status use multiple logistic regression analysis relationship significant age group man woman adjust or CI low vs high level respective woman year age adjust or CI low vs high man however man woman old association found prevalence DM significant association status glycemic control found difference relationship prevalence DM DM care need group low population
28006698 en compare estimate high rate increase type population increasing associate change although prevalence great woman due difference care woman also great risk factor man obesity factor woman risk assessment woman insulin body woman positive woman therapy regard weight major management however study examine effective intervention reduce
25420813 en renal one metabolic complication present increasing cardiovascular risk medical aim review evidence diagnosis treatment follow-up
26678666 en aim study evaluate cardiovascular parameter plasma type mellitus baseline rate blood glucose response year two group control cardiovascular parameter evaluate baseline perform blood glucose determined cardiovascular parameter parameter similar group baseline group blood glucose hemoglobin concentration increased level reduce reduction blood glucose great period group interval reduce well period subject whereas reduce period change observed low high study show patient insulin therapy poor blood glucose control great lipid lower level function
18006962 en cause cause change on present history show finding revealed change addition disease may outcome
24324368 en one common high prevalence evidence indicate patient disease little known relationship mellitus study compare prevalence diabetic man severe complication control whether may activity determined use diabetic man diabetic control aged year logistic regression model use investigate association severe found diabetic patient control logistic regression model show odd ratio or statistical confidence logistic regression model include plasma glucose hypertension blood pressure show statistical significant prevalence diabetic man lower control show result statistical significant
22702660 en determine whether hemoglobin hba1c level old cohort individual mellitus participant hba1c model care outcome year primary hba1c age baseline function condition time insulin use hba1c within participant adjust age participant insulin participant study period year high hba1c associate less factor hba1c associate lower relative risk confidence interval hba1c individual mellitus hba1c associate outcome year hba1c suggest current hba1c target less old adult may lower function
27188373 en evaluate influence factor type mellitus provide evidence develop health study may database included conduct according follow datum total study case included or CI influence factor obesity history or hypertension blood total history result analysis identify common influence factor three history obesity history hypertension history history influence factor type mellitus among factor recent year history hypertension factor obesity
26925596 en determine whether effective body glucose risk factor woman history gestational type clinical BMI woman history T2DM woman month body glucose tolerance insulin measured weight decrease decrease mass decrease increased change glucose decrease decrease insulin glucose increased weight reduce body weight improve insulin old woman previous diagnose T2DM finding woman history reduce lower risk development T2DM
26202453 en investigate association level chronic disease patient type conduct cohort study follow-up time year patient aged year type without estimate rate measured little year define decrease status use chronic disease patient follow-up mean age duration year respective baseline adjust multiple factor regression analysis revealed significant associate development period compare first ratio confidence interval cohort study demonstrated level independent factor development patient type
23463453 en elevated protein may type mellitus T2DM however whether development T2DM independent obesity remain studied aged year baseline blood sample follow year ratio T2DM according range estimate model adjust age body mass index status current number per day activity history model model glucose model mean confidence interval CI follow-up new T2DM case total sample model compare respective analysis revealed statistical significant association observed normal weight model compare respective relationship change adjust model assessment finding high chronic T2DM independent obesity
22371161 en insulin insulin therapy reduce hba1c level patient type mellitus compare multiple insulin great reduction hba1c level occur patient control therefore use adult elevated hba1c level include use insulin patient include high risk event may use consider general patient type mellitus may improve control on new insulin can improve general important clinical whether general adult whether improve control control poor evidence case
25917553 en mellitus also known mellitus occur renal associate cardiovascular disease reduce case dysfunction well reduce insulin therapy reduce rate severe therapy patient risk renal function adverse effect general current use patient drug demonstrated clinical trial include treatment use patient type mellitus patient study investigate drug development improve treatment patient review treatment renal
24552216 en evidence suggest insulin type type respective insulin may disease test use type diabetic individual
24939518 en use treat mellitus complication present study mellitus use assess role management complication parameter investigate potential result indicate decrease increased significant increased correlation indicate potential positive associate decrease result present study use treatment significant improve reduce risk diabetic complication
26837781 en aim study assess time insulin type mellitus T2DM patient treat oral determine baseline characteristic associate time insulin evaluate T2DM patient hba1c level total follow hba1c level
22856651 en role patient clinical study investigate role serum patient type mellitus patient type hospital subject assess among patient type included subject examine concentration hemoglobin hba1c blood lipid protein association serum level risk type mellitus also statistical significant difference age body mass index treatment method group group without multiple regression analysis show score negative correlate level regression score positive correlate regression hba1c regression age obesity poor glycemic control complication insulin therapy risk factor type mellitus population important role factor among patient type
20473693 en adult relative insulin therapy cell role type mellitus T2DM clinical aim research determine whether insulin value diagnose analyzed new diagnose T2DM patient type mellitus patient normal control prevalence T2DM patient within day insulin therapy result show new diagnose T2DM normal control positive diagnosis three high can improve diagnose rate subject history common compare group vs group lower difference statistical significant use T2DM population
25393737 en multiple adverse health effect renal dysfunction cardiovascular disease study reported association impair fasting glucose however relationship examine whether blood associate incidence study population subject without history aged year woman study blood level estimate concentration case identify concentration blood associate blood glucose insulin level baseline however positive associate hba1c current mean follow-up year man woman diagnose incidence significant associate blood level baseline man woman ratio vs confidence interval adjust potential blood level associate increased incidence positive association hba1c blood level mechanism related
25928715 en investigate relationship target value hemoglobin blood pressure consider mortality patient type cohort patient type mellitus mortality study mortality study investigate on target risk score weight target mortality study mortality study mean follow year respective patient age adjust incidence rate per respective study sample target risk score associate mortality one CI CI respective two cohort analyzed association target risk score mortality observed one association model include age body mass index estimate rate treatment one CI clinical patient type mellitus target value cardiovascular risk factor associate mortality
26969134 en compare outcome patient mellitus included patient DM undergo hospital patient patient undergo use score primary major adverse event follow-up outcome analysis evaluate model outcome compare test logistic regression model use estimate associate less range vs lower blood cell rate vs time vs care vs month follow-up similar rate vs year ratio confidence lower rate vs year patient DM provide less similar outcome compare
27491150 en patient mellitus type general medical treatment index system level activity decrease clinical presence clinical disease
26450424 en little known change function type diabetic patient study assess influence rate type diabetic patient according hemoglobin hba1c patient lower three group according hba1c control mellitus hba1c mellitus hba1c control group rate measured total significant lower group group total change group control group significant ratio among group reduce group blood pressure high group influence control patient patient difference level control type
26284447 en mellitus associate change range complication patient mellitus risk factor include disease previous well complication renal disease result lead occur development include disease disease diagnose patient mellitus patient mellitus high risk important intervention factor patient mellitus high risk different disease management diabetic complication
25725178 en insulin current drug patient gestational mellitus insulin use associate risk oral randomize clinical trial conduct evaluate patient gestational mellitus insulin therapy woman aged year week assess woman gestational mellitus two insulin group compare outcome woman gestational mellitus study treat fasting blood glucose level similar group time treatment control glycemic index day insulin group group statistical significant difference blood glucose level two studied group time treatment day insulin group group statistical significant difference time two studied group statistical significant difference outcome two studied group effective control glycemic index woman gestational mellitus insulin
24420974 en assess risk clinical patient investigate risk patient type mellitus DM compare control study assess score DM control subject three DM test association parameter complication disease significant lower major control subject respective difference found man DM previous high control subject diabetic patient age body mass index hba1c significant associate score regression model among DM regression regression analysis identify group patient different mean score female DM aged year without obesity found patient DM mean score lower control subject high number previous complication DM associate score among DM patient analysis identify high score however potential remain use DM patient
24236935 en patient severe complication associate mellitus large without treatment chronic primary clinical associate development diabetic complication age due elevated reported factor development diabetic complication glucose protein without base glucose concentration major effect increased system protein protein may glucose decrease function increased potential great study development protein number include lipid type activity case study number lipid also protein study indicate role management type
26391639 en aim study evaluate effect patient type mellitus T2DM regard glycemic control lipid subject T2DM month fasting blood glucose hemoglobin hba1c lipid profile measured significant increase mean value level baseline level vs level hba1c lipid profile significant decrease however general model lipid profile level show diabetic subject high level significant lower level total cholesterol cholesterol low participant high significant high level cholesterol lipid profile level level female significant may diabetic subject improve glycemic control diabetic subject high level lipid profile
20923503 en mellitus DM disease oral complication also target diabetic develop develop recent year mellitus oral can diabetic status patient important risk factor mellitus present review relationship mellitus potential mechanism diabetic status disease also
23543528 en important woman mellitus type type reduce risk mortality on woman however influence lipid increase complication method investigate whether effective effect lipid complication disease use woman perform index perform addition identify control trial studied woman mellitus compare outcome effective control lipid evaluate identify assessment perform independent review trial studied participant characteristic can datum trial therefore examine individual control trial included reported study period one trial compare influence woman type mellitus significant difference found two group three trial two compare different one also included trial reported blood glucose level remain treatment oral identify impair glucose three study found result regard lipid oral adverse effect improve lipid oral also improve lipid influence use one study reported complication observed however study duration adverse effect reported two included control trial review provide evidence assess whether control lipid complication three study outcome reported control trial outcome glucose lipid clinical disease conduct however due low incidence disease according large sample follow-up period need difference risk control trial
22233651 en regard risk gestational mellitus study perform association analysis woman woman control woman compare use sample case control subject effect study analyzed also investigate effect known type two known associate type significant association analysis association odd ratio on also significant associate risk found association known type associate woman type
26212563 en mellitus year different type type mellitus common due change large number treatment method type mellitus however method patient high effective treatment mechanism associate development disease recent year research medical potential major within characteristic determined use drug drug treatment range disease review potential treatment type mellitus addition activity insulin resistance also
23116316 en mellitus DM status show severe impair patient chronic metabolic disease complication increase mortality recent study show role DM increasing effect drug found use known effect show effect chronic activity mechanism DM consider review DM primary activity DM effect DM associate complication
21608352 en aim estimate prevalence mellitus study associate factor population study year age follow clinical mellitus define per association statistical analysis use prevalence mellitus study population prevalence among man among woman analysis prevalence mellitus found significant associate age history obesity hypertension high serum cholesterol level multiple logistic regression analysis identify age history hypertension total cholesterol independent associate treatment mellitus population
24330576 en treatment type mellitus although different investigate association obesity glycemic control cardiovascular risk factor chronic disease type diabetic total patient assess use history association cardiovascular risk factor investigate mass index fasting plasma glucose hba1c protein negative associate adjust age duration current current total activity use oral insulin model assessment insulin cholesterol positive associate associate reduce prevalence obesity hypertension metabolic syndrome include obesity associate lower prevalence low estimate rate chronic disease include protein obesity hypertension metabolic syndrome change demonstrated increased associate glycemic control cardiovascular disease risk factor include chronic disease type diabetic patient diabetic patient
25726672 en new datum result research role body weight development type mellitus present review current obesity type consider disease chronic different high glucose use high also lead result increased influence one follow clinical diagnose type however also system development type include increase increased
23617887 en type mellitus cause metabolic change may lead early determine risk factor type mellitus assess impact disease age total woman aged year prevalence mellitus associate hypertension odd ratio or confidence interval CI use drug or CI therapy or CI year age or CI or CI or CI factor associate lower risk use or CI or CI level or CI high or CI risk woman year age increase risk due increase risk type mellitus associate early woman year age
26703221 en type mellitus type DM patient study aim evaluate related type DM use retrospective study perform type study group score participant type DM datum status chronic complication glycemic control lipid profile also assessment show score general health lower found two type DM study conduct respective datum suggest glycemic control can positive impact type DM reduction lead increase general health status assess study evaluate type DM datum indicate health type DM suggest glycemic control can positive impact individual however study factor evaluate can
25293868 en factor plasma increased adult adult type mellitus T2DM high report compare concentration T2DM normal weight without T2DM determine association serum T2DM diagnose association normal weight body mass index BMI BMI age plasma measured fasting plasma sample serum body datum obtain subject identify potential high T2DM group compare normal weight T2DM group mass mass individual respective positive correlate model assessment insulin resistance group similar T2DM group therefore obesity may high T2DM compare normal weight positive associate mass mass may contribute level protein potential association insulin resistance without
24839949 en role complication may impact mellitus factor obesity cause chronic lipid metabolic disorder increased risk hypertension insulin resistance however effect increasing effect factor diabetic patient review cause mellitus different mechanism also factor important effect mellitus improve may on activity weight control improve diabetic obesity may
25470938 en occur mellitus DM type system one cause complication disease type DM diagnose study early development disease develop model type DM treatment studied model disease month model compare model type DM treatment adult show diabetic activity significant effect studied type also decrease effect effect effect compare model difference found influence DM effect effect result indicate significant cardiovascular system early type DM case severe compare model development diabetic type DM
23531118 en evaluate patient type mellitus T2DM year treatment
26679967 en among patient management type mellitus T2DM population study treatment among patient multiple oral drug examine association time treatment T2DM patient retrospective cohort study aged year control T2DM hemoglobin included base care patient association patient define presence syndrome risk patient receive treatment follow-up time month CI time treatment patient T2DM month risk month without month risk month patient time treatment month without month time treatment significant patient included however adjust clinical characteristic health care found associate time treatment adjust ratio CI patient control T2DM receive treatment patient associate time treatment positive effect health care model health care model target care may provide treatment T2DM patient condition
26663065 en role gene mellitus T2DM among determined T2DM patient healthy control logistic regression analysis conduct estimate odd ratio or confidence interval CI result conduct base association significant association found T2DM study included study found T2DM patient high risk complication significant lower risk hypertension complication compare association found gene increased risk T2DM however may development hypertension complication among T2DM patient
24768178 en mellitus DM major health increase disease cause insulin insulin DM three type gestational DM T2DM multiple insulin gene insulin plasma different risk DM several gene DM review current evidence development DM
23909093 en history patient assess medical status however number patient may medical condition may significant determine prevalence mellitus factor associate among patient present blood sample assess glucose mean blood glucose great consider diabetic statistical patient diabetic female ratio status body mass index history significant associate blood glucose however statistical significant difference mean age patient normal blood glucose mellitus subject blood study show patient status may identify risk diabetic mellitus patient aged year may reduce mortality associate disease
24649608 en mellitus population health study condition disease related development mellitus datum analysis condition use characteristic mellitus population different level develop clinical clinical mellitus new development
23724973 en use evaluate however study determine whether can improve patient mellitus on randomize study evaluate interval compare diabetic patient included study study significant high evaluate potential reduce patient potential decrease patient revealed patient multiple patient result assessment patient mellitus
25536865 en serum concentration associate diabetic patient type study investigate relationship serum concentration diabetic addition compare factor previous show associate incidence diabetic total patient type investigate study serum total concentration compare patient without diabetic according analysis perform evaluate association total concentration duration body mass index blood pressure total concentration significant lower patient without patient severe show lower total concentration duration high blood pressure three parameter independent factor diabetic concentration lower patient type severe patient type
25139614 en cardiovascular disease type diabetic associate cardiovascular disease aim investigate potential association patient type retrospective study perform patient type patient female patient normal ratio patient base level low high measured age duration blood pressure increased ratio patient high significant elevated CI CI compare low association elevated patient year age year great risk elevated or CI or CI high risk increased or CI type normal range risk target early patient type patient type duration disease
23675676 en evidence regard association activity complication disease patient type patient disease control trial effect activity number within week examine regression model adjust potential study major cardiovascular event complication participant reported activity little previous week year follow-up patient major cardiovascular event event compare patient activity activity decrease risk cardiovascular event CI event CI mortality CI activity associate reduce incidence cardiovascular event complication mortality patient type
24719247 en type mellitus result increased incidence known diabetic complication blood glucose control within addition diabetic patient disorder glucose control case report glucose control indicate relative period time early patient severe may clinical treatment diabetic
26414020 en whether individual type mellitus determine effect patient type clinical health outcome investigate factor database trial control study participant age group compare care control datum two assess evidence show reduction hemoglobin hba1c month intervention compare care mean difference CI compare control CI intervention follow-up statistical significant difference hba1c low care control compare care outcome low adult glycemic control CI CI influence effective individual study high risk evidence type glycemic control little follow-up outcome show number research number
25450820 en one health mortality prevalence aim present study disease healthy year level method large base disease use disease adjust year year due outcome year due year study conduct period study finding revealed adjust year increasing year man high woman period mellitus cause disease show increase man woman year woman compare man woman year decrease man woman age group year high study finding revealed disease high age group increasing year
25834065 en lead dysfunction independent diabetic previous study early use investigate change cell target cell role cell provide cell whereas cell change cell change reduce addition revealed reduce cell diabetic compare normal cell reduce diabetic lead reduce follow increased cell decrease range observed
25234740 en type mellitus T2DM insulin resistance reduce mass due increased rate protein protein disease recent study revealed undergo cell demonstrated elevated disease type mellitus however association T2DM patient aim study investigate different clinical T2DM evaluate correlation chronic complication on total participant female age range year study serum value measured new develop analyzed correlation clinical parameter subject T2DM different clinical statistical analysis conduct use correlation clinical parameter perform use correlation difference group determined test elevated impair glucose patient significant new diagnose T2DM patient patient complication level correlate duration presence chronic complication respective significant T2DM patient level related duration therefore T2DM disease
21684789 en report first case type mellitus woman clinical datum present woman diagnose type mellitus review female present week patient primary care found elevated blood glucose hospital found diabetic analysis show patient positive patient diagnose type mellitus condition type mellitus recent mellitus reported include within week case reported individual develop type mellitus addition case medical type mellitus population need research
26036300 en common change negative influence activity aim study conduct control trial assess effective intervention gestational mellitus weight use conduct database woman low level activity included independent datum assess included study woman relative risk mean difference outcome use decrease risk gestational mellitus perform decrease also observed weight CI adverse effect decrease risk gestational mellitus weight however study need
24472241 en on known patient mellitus man present found cause due mellitus patient follow glycemic control insulin diabetic reported result
26073226 en associate obesity development insulin resistance treatment improve insulin study included patient diagnose type hba1c level insulin patient type study effect insulin patient treat one week insulin insulin need blood glucose profile measured one week week follow-up patient study one week treatment lead insulin effect week similar glucose profile hba1c level insulin need improve one week treatment improve insulin patient type
25061090 en investigate association mellitus DM patient early undergo three database patient cohort patient new diagnose undergo regard DM type DM use medication outcome overall compare patient without patient among DM patient DM old less receive similar compare patient without DM compare patient without DM patient DM significant vs vs adjust age analysis DM remain independent factor overall mortality adjust ratio confidence interval mortality among patient receive drug therapy patient use insulin significant patient patient receive early DM increased overall mortality
24854496 en hba1c analysis method presence increased hemoglobin study investigate age hba1c glycemic control patient mellitus retrospective analyzed datum patient diagnose day age several hba1c first year control group hba1c value year patient type mellitus mean blood glucose level blood glucose hba1c compare hba1c patient age difference ratio significant patient patient week age hba1c adjust ratio significant lower patient week age glycemic control patient week age
17476092 en disease large two disease hypertension present case associate disease
25966064 en study investigate relationship serum level type population patient type healthy group analyzed use level also group respective whereas control group respective difference group significant increased risk odd ratio confidence interval respective association gene type population significant population diabetic patient serum level significant correlate
24865764 en estimate health care type type T2DM respective control cohort on retrospective cohort analysis use assess health care health patient aged drug patient patient without health care medical analysis included patient number control patient T2DM number control significant difference cohort patient T2DM significant high mean index score compare control although group reported high rate hypertension disease mean health care per patient per year significant high patient T2DM control total health care group control group T2DM group control group health care patient compare patient without
24678906 en recent year several oral drug new mechanism number treatment new oral drug mechanism glucose report result clinical study patient type assess randomize study patient type mellitus glycemic control therapy patient randomize oral week primary change baseline hba1c week patient included analysis little mean change confidence interval baseline hba1c week group compare group group group mean difference group vs also decrease fasting blood glucose glucose body weight group compare group adverse event incidence low adverse event significant decrease hba1c body weight general well patient type mellitus study recent finding study clinical trial
25528198 en mellitus DM associate adverse outcome increased concentration associate DM mortality patient aim study impact DM concentration value regard mortality among included patient history DM new diagnose DM hba1c concentration DM status increased patient impair renal function follow-up month clinical parameter associate mortality ratio confidence interval CI CI per DM found regard mortality status impact concentration patient
19587238 en gene lead disorder plasma cell use cell need however show without change level plasma increased datum normal plasma datum also indicate high disease cause general
25240454 en study evaluate prevalence treatment outcome disease patient DM high association general patient DM outcome datum patient high risk outcome randomize treatment study patient DM type without history high risk undergo clinical baseline year patient normal receive care receive medical medical found patient patient normal occur new patient ratio confidence interval CI new odd ratio CI therapy odd ratio CI patient randomize medical similar event rate new finding vs patient DM normal low rate first patient baseline high rate therapy randomize patient outcome suggest medical may reduce medical therapy trial medical therapy early disease mellitus
27420380 en complication mellitus however little development aim study determine prevalence participant two assess association age control total participant two cohort base diagnosis participant test presence use medical participant retrospective determine control high statistical significant association found status prevalence compare participant without age diabetic associate identify participant study relationship age associate may role identify clinical significant
26489822 en evidence type mellitus T2DM influence mortality aim compare outcome without T2DM identify case diagnosis use hospital datum evaluate incidence rate T2DM status analyzed time analysis include potential factor test T2DM independent factor case diagnose T2DM incidence increased period population incidence increase high population T2DM population relative T2DM significant old year vs year medical condition analysis mortality high population T2DM present vs decrease time participant without T2DM potential T2DM significant associate lower odd confidence interval increase incidence high T2DM risk lower T2DM
26118148 en study test woman type mellitus T2DM examine relationship woman T2DM randomize control trial baseline factor analysis correlation analysis conduct test woman T2DM T2DM relationship T2DM three factor medical high three factor respective three factor significant correlate although different factor show compare similar T2DM among woman T2DM finding population although need group
25416212 en aim study disease type mellitus revealed disease type index determined change revealed case identify disease among type high evaluate according index treatment major disease
24965522 en type mellitus two different develop assess type participant individual value analysis base correlation result datum participant mean age participant year hba1c level duration type year participant rate participant respective difference group addition type report positive similar two different
24798395 en determine patient type year randomize control trial general participant trial follow-up datum hba1c level blood pressure weight blood lipid level datum outcome hospital assess use follow-up difference intervention control group remain significant duration impact follow-up control group reported great follow-up intervention group reported decrease outcome follow-up level impact month remain significant diagnosis relative follow-up early care participant
25030726 en effect risk factor gestational mellitus woman oral glucose tolerance test first hospital include woman diagnose group woman group conduct multiple logistic regression clinical two group included age body weight body mass index BMI body weight week body weight week fasting plasma glucose total cholesterol high low fasting insulin model assessment insulin resistance early history significant difference age BMI early history mellitus two group risk factor statistical included early history mellitus early age year early weight weight early early BMI early weight history mellitus age year risk factor early weight management early control weight within
24012126 en patient mellitus DM risk aim study determine prevalence rate risk patient type aged year included study clinical evidence patient fasting blood sample analysis blood glucose hba1c lipid profile on treatment use treat patient patient type DM subject patient type DM patient prevalence patient subject high mean hba1c compare significant patient type DM glucose control may reduce risk potential among high rate patient undergo
23931629 en association study group new gestational mellitus use health use association study base oral glucose tolerance test retrospective oral glucose tolerance test woman included previous study diagnose gestational mellitus on oral glucose tolerance test perform diagnosis woman current gestational mellitus respective woman identify woman compare present use
24095848 en oral health condition significant relationship mellitus DM well study investigate level patient blood sample DM patient healthy subject examine without level measured number number two parameter correlate DM parameter hemoglobin concentration protein significant high DM patient healthy subject concentration increased DM patient concentration correlate well DM parameter can clinical examine oral status patient also condition
22390865 en obesity well effect method treatment current role chronic insulin resistance metabolic syndrome type treatment base datum consider two medical medical review follow disorder early treatment present weight use treatment
24508418 en type mellitus T2DM common risk factor development include old age obesity history history gestational impair glucose study T2DM patient age aged year T2DM large retrospective analyzed clinical characteristic glycemic control body mass index BMI complication medication use assess compare age year association found glycemic control medication low participant hemoglobin hba1c level high hba1c level also poor medication among group glycemic control hba1c medication age group poor glycemic control hba1c level poor medication age group mean high group group compare group mean decrease increasing age group age group year respective regard group low hypertension group low mean index score score group high score score age group group high hypertension mean score age group score significant high age group group low participant age group high participant study include value analysis without factor contribute management result study provide patient regard factor age treatment
27641082 en present study examine whether associate clinical type mellitus diabetic patient group diabetic patient without group normal control group analyzed ratio three group compare statistical investigate correlation status clinical without ratio patient significant high patient group diabetic patient great age duration lower score high plasma level result may significant influence T2DM associate
22673024 en aim study patient type patient type mellitus patient without control individual history disease undergo use evaluate assessment revealed presence patient type mellitus control diabetic patient significant high impair compare individual diabetic patient control diabetic patient control significant high diabetic cohort compare control group correlate duration type mellitus independent age hypertension metabolic profile control group independent type mellitus show develop impair high
26130419 en glycemic control mellitus type remain cause diabetic factor gene gene investigate complication aim present study investigate association two also diabetic group individual control group individual result demonstrated association different increased risk disease significant association body mass index identify great body mass index among individual association observed investigate correlate risk develop
18018629 en on woman diagnosis due year old present may patient hospital show multiple lower multiple diagnose diagnosis syndrome result reduction finding can patient day case syndrome cause cell present therefore change found important examine include possible
22920812 en risk among adult mellitus investigate association diagnose case reported diagnose status determined risk factor system group odd ratio or compare among adult diagnose without diagnose determined logistic regression adjust age presence risk reported case among aged year diagnose group prevalence among adult without risk reported status or compare adult without confidence interval CI or adult age year CI CI independent associate increased risk among adult without risk
26997169 en high cardiovascular mortality patient type patient show elevated reduce assess role may patient healthy control clinical characteristic measured cohort mean duration year elevated diabetic woman control difference man reduce woman increased man similar control woman reduce man elevated man woman reduce diabetic man woman high man total man woman man woman reduce total increased man woman man woman increase increase mass lipid man woman lower number man similar woman cholesterol relative man woman man woman similar difference lipid man woman man woman man woman high patient difference increase man woman total mass man woman man woman also increased lipid lower different lower diabetic woman activity correlate primary woman correlate woman correlation correlate woman man correlate parameter woman correlate several concentration well activity woman reduce risk patient datum suggest risk plasma concentration
25638998 en datum relationship elevated risk develop type mellitus function aim study evaluate association rate increased risk evaluate subject year without disease subject two group according risk score group included subject group subject use time analysis perform period day normal interval significant lower group increased risk compare group vs time similar group group demonstrated significant reduce total vs low vs well vs low vs vs high vs compare group analysis similar group low independent related elevated risk mellitus obtain result suggest elevated risk develop mellitus may related impair
24968179 en group protein age age significant role diabetic complication effect also group present study report age system female suggest presence analysis indicate found high whereas study show presence type case type patient due complication also patient type type result show new
22946629 en aim present study test effective blood glucose primary health care
24397164 en number type mellitus increasing care management mellitus chronic complication change mellitus risk factor review clinical characteristic several patient different subject patient include characteristic management
26008723 en although increase risk may lead study association study result evaluate use associate among type perform retrospective new cohort study datum provide use use identify event datum provide potential model conduct sample provide adjust ratio estimate confidence interval common per associate associate risk among activity CI among activity activity increased risk use
23099356 en clinical trial provide evidence regard effect glucose incidence datum association measured hba1c individual database study datum study use obtain datum relative risk estimate use model identify included study participant case study included patient type study patient type one study included patient type study one show increased risk high hba1c overall adjust risk ratio confidence interval CI high hba1c study CI characteristic study hba1c level study one association several cardiovascular risk study individual high hba1c level associate significant increased incidence
20609652 en effect patient due dysfunction well however datum patient year old mellitus study effect intervention outcome test patient year old impair present analysis evaluate association mellitus baseline glucose level primary outcome mortality cardiovascular include mortality cardiovascular cardiovascular mortality patient mellitus patient mellitus primary compare patient patient rate primary outcome compare group group ratio confidence interval diabetic rate group group ratio confidence interval value baseline glucose level patient significant outcome effect mellitus outcome independent due patient year old mellitus associate less effective patient without year old
19731028 en mellitus increase risk less mellitus influence mortality outcome risk complication perform review compare mortality outcome complication without mellitus include included study evaluate mellitus treatment outcome mortality identify one use base found significant increased mortality mellitus mortality mellitus increase mortality compare without mellitus CI although datum outcome study suggest mellitus increased risk complication well little evidence increased risk mellitus increased risk mortality research determine whether treatment mellitus improve outcome patient
23137765 en complication cause aim characteristic management target patient analyzed datum patient type type included management patient oral drug insulin insulin patient insulin old control disease duration chronic complication patient hemoglobin hba1c patient respective target hba1c blood pressure cholesterol patient less complication compare patient complication increased disease duration patient year diagnosis little one complication target hba1c associate reduce number less great patient target insulin use case disease
23479995 en determine change patient mellitus DM study relationship glycemic value different clinical patient woman man type type DM receive hospital treatment period examine evaluate general activity test use result identify patient DM included age determined general general activity patient type DM general insulin determined activity factor related mechanism development low general activity among diabetic patient common patient type DM receive drug
21570814 en include type mellitus patient compare general population however little evidence mellitus disease lead mortality investigate whether disease increased mortality patient hospital compare hospital control mortality identify use regression prevalence type mellitus increased compare control prevalence type mellitus significant high patient year mortality found age relative risk type mellitus chronic renal impact mellitus mortality significant high hospital control significant mellitus control relative risk mortality disorder prevalence subject significant mellitus increased hospital control type mellitus cause significant mortality type mellitus patient
25524060 en undergo number change increased weight increased incidence include finding reported among study potential difference type study glycemic control study participant may different metabolic conduct review use review review current finding associate gestational mellitus well impact glycemic control associate increased incidence increased increased suggest difference may difference among different type use define research need investigate impact glycemic control clinical factor weight function
26344942 en type DM cardiovascular risk time normal population metabolic syndrome type DM associate increased risk development cardiovascular disease aim study determine prevalence patient type mellitus compare cardiovascular risk type DM patient without blood pressure patient type DM study participant also estimate cardiovascular risk score use study risk diagnosis participant cardiovascular risk score found similar type DM whether diagnosis metabolic syndrome cardiovascular risk score similar type DM patient without metabolic syndrome
26176710 en aim study evaluate impact disease type mellitus T2DM individual retrospective cohort study participant health year on use diagnose on BMI use define primary outcome mean follow-up year participant develop T2DM incidence rate T2DM without group group without group group adjust ratio T2DM compare without group follow CI group CI without group CI group adjust ratio group significant high without group without individual high risk T2DM diagnosis important individual therefore follow health condition
16682843 en severe case associate man develop treatment improve first case
15942956 en disorder may cause disease patient common cause cell potential evaluate patient identify potential common disease may cause report year old present revealed history body base finding patient treat observed revealed case diagnosis patient therapy clinical finding high
26315089 en evaluate type mellitus diagnosis whether potential target conduct within medical database follow type adult type cell cell therapy also review clinical function insulin cell result model clinical trial show suggest potential clinical however clinical
24944487 en determine mellitus DM associate increased risk retrospective cohort study patient undergo index care three cohort patient compare age year DM age year without DM age year without DM datum included result rate compare logistic regression analysis perform determine association cohort patient age DM study patient two cohort age year without DM age year DM age year without DM compare age year without DM high age year DM or age year without DM or difference age year DM age year without DM associate high risk patient age year subject age year without DM
24743430 en disease mellitus DM associate cardiovascular complication major health recent study suggest cell important role clinical study demonstrated related DM reduction dysfunction related DM correlate complication suggest dysfunction impair DM multiple mechanism include multiple several different reduction dysfunction DM may treat cardiovascular complication
24448075 en mellitus DM renal independent mortality two condition impact factor relative two cohort study patient undergo cohort group according diabetic status renal function patient without DM group patient DM patient patient DM clinical outcome compare group patient receive renal therapy primary outcome mortality rate patient group patient DM patient patient DM adjust potential factor significant patient DM ratio confidence interval CI patient CI patient DM CI compare patient DM important mortality patient high mortality rate patient DM difference large age DM mortality rate independent potential factor
26156287 en disease common cause case remain risk factor however study may also study relationship model receive week age model evaluate week age new test observed significant assessment included increased diabetic level level also increased presence significant high although remain possible observed datum diabetic metabolic control can observed
26649106 en patient type mellitus may cell report research patient type analysis examine patient type report primary study examine adult patient type mellitus perform finding primary research negative type patient effect effect blood level lead negative associate relationship confidence health care patient complication may normal activity patient also negative impact type type significant negative impact disease
23391971 en evaluate mellitus patient medical patient medical serum analysis impact mellitus treatment presence mortality evaluate metabolic parameter compare presence mellitus patient mellitus treat significant impact mellitus presence mortality subject mortality associate presence renal diabetic patient renal patient three patient due however due cause renal therapy diabetic subject patient renal diabetic presence mellitus associate presence medical mortality renal patient subject
22667084 en use mechanism type mellitus model type mellitus group control group model group group group treatment blood sample test index sample group fasting blood glucose total cholesterol total plasma significant decrease respective compare model group base method use study mechanism mellitus base analysis found model group control group two different group model group control group control group significant mellitus identify include diabetic significant related significant normal result show can effect function complication mellitus method study treatment mechanism
22249517 en mellitus adverse associate increased risk mechanism low can include impair mass diabetic complication type mellitus severe type mellitus T2DM insulin mass remain high patient T2DM impair oral drug known woman therefore diagnose on healthy diabetic complication therapy patient T2DM assessment risk factor treatment drug effective patient mellitus increased need population patient mellitus
22087736 en patient perform treatment activity blood glucose insulin aim identify function test patient compare patient test result function test test number patient female type clinical on age year type clinical year type type patient year type type patient without control group difference regard number test group patient revealed group on group group group consider however test patient on present less patient may consider finding patient regard perform treatment assess subject
26583910 en patient type mellitus T2DM medication use reduce range insulin resistance cell dysfunction major T2DM examine therapy treatment control T2DM general year present conduct contribute cell dysfunction impair insulin increasing improve function insulin elevated plasma level reduce hba1c weight profile low risk renal T2DM cause glucose improve hba1c cause also decrease weight blood pressure low risk oral increase risk rate similar hba1c value treatment effect whereas less reduction therapy compare effect addition patient T2DM hba1c
25879874 en study regard influence condition among patient type mellitus T2DM aim present study assess condition among without individual patient T2DM control included regard age duration duration treatment oral use parameter index clinical measured hemoglobin hba1c level also age status level among without T2DM mean hba1c level significant high among patient T2DM compare control control group significant great compare T2DM parameter among T2DM among control parameter significant high T2DM status control group condition among T2DM among control among
26353100 en compare development mellitus subject without period study cohort study patient without disease without conduct mean medical research group diagnose two impair glucose tolerance group without diagnose disease two glucose statistical significant difference group regard development disease glucose group develop glucose group without
25106717 en high effective treatment type patient obesity independent glycemic control observed lead whether treatment type patient body mass index studied effect two type diabetic week old randomize three group week evaluate body weight fasting blood glucose glucose tolerance insulin hba1c cholesterol parameter total glucose tolerance significant improve week week significant lower oral glucose tolerance test compare significant lower hba1c compare week mean compare week serum level elevated compare week week lower hba1c improve glycemic control treatment type mellitus model
25528851 en estimate patient chronic presence mellitus chronic compare control group significant lower according health health chronic chronic patient without respective patient vs case severe
25194613 en mellitus DM associate significant mortality prevalence increasing although known also may cause adverse effect review study previous conduct indicate conduct use database different use conduct common known time use treatment different disease among activity activity consider one important effect DM include activity decrease level blood glucose serum lipid lipid well increasing activity insulin also show effect activity glucose clinical trial patient activity study conduct investigate activity review may also effect DM review characteristic can lower blood glucose level contribute reduction risk factor associate DM
25011429 en chronic condition clinical system care multiple health use review type mellitus T2DM health develop mellitus diagnose patient use datum general patient base research use datum test general diagnose T2DM measured use T2DM case found determined three medication suggest datum general current however relative influence datum datum due datum due datum datum management use define patient T2DM datum however datum study use
26463900 en study aim investigate clinical characteristic associate factor diabetic clinical case retrospective analyzed hospital compare clinical according presence mellitus identify risk factor associate patient overall case rate found significant difference patient without compare patient diabetic patient old high serum level glucose cause also associate diabetic patient diabetic patient significant high diabetic cohort high serum level odd ratio confidence interval independent associate mortality whereas positive blood associate mortality diabetic cohort odd ratio confidence interval patient cause receive control significant risk factor mortality diabetic patient
26387810 en evaluate effect glycemic compare type diabetic diabetic patient renal disease patient type mellitus diabetic patient evaluate undergo follow two day patient undergo also glucose system use glucose system day two day glycemic control estimate mean blood glucose glucose time glycemic assess value mean glycemic glycemic assess mean difference mean difference among glucose value day control lower compare also observed significant decrease glycemic value value lower value significant group difference great reduce glycemic treatment compare
26386209 en investigate association type mellitus T2DM cohort man current evidence measured baseline sample subject assess regression analysis use estimate association metabolic risk T2DM adjust potential estimate result study baseline age year respective year follow-up participant develop T2DM ratio per high adjust age body mass index blood pressure serum history T2DM confidence interval CI status change estimate study participant T2DM case adjust estimate risk ratio T2DM per high level CI case per base datum suggest relationship T2DM large independent risk factor
24928953 en positive effect increase blood type patient show increase blood possible examine impact blood function type patient year old control subject year old subject reported perform presence examine function well blood result large increase blood type patient control subject increased rate group result large type patient significant increased group increased blood type patient control subject effect blood found impact baseline function type patient control subject possible related increase blood type patient may effect
26259708 en mortality complication condition although control high remain major aim study mortality complication period health system obtain number mortality system due complication number cause mortality mortality rate population mortality year period mortality due complication CI CI per CI per reduction occur man woman age group complication health system provide insulin health care possible
26934773 en mellitus body include oral several assess prevalence oral disease diabetic correlate oral disease study diabetic patient hospital control general population study participant aged year datum use oral test oral conduct assess glycemic status assess hemoglobin hba1c level use diabetic patient oral oral significant high diabetic also diabetic patient present poor oral poor control diabetic present diabetic relationship statistical prevalence oral disease significant high diabetic control major oral health diabetic patient study management blood level improve oral health mellitus patient
25946360 en treatment determine prevalence mellitus DM among patient use hba1c estimate association DM clinical characteristic response cohort study conduct disease patient aged year included hba1c use define DM DM medical perform regression analysis estimate association DM baseline characteristic treatment total new diagnose patient prevalence DM respective analysis patient adjust or high patient without DM risk poor treatment outcome similar among patient without DM vs common among adult new diagnose DM associate clinical
25937635 en investigate change protein syndrome patient mellitus DM patient DM study diagnose two profile patient assess use base analysis base observed plasma patient compare profile group however significant found time major metabolic found two group include significant level decrease whereas level increased patient change found associate profile patient DM suggest syndrome
24352832 en type mellitus one disease number associate increase complication medical therapy consider type treatment treat disease therapy association several regard medical therapy complication type review effect type show improve metabolic condition patient patient therefore evaluate patient characteristic determine metabolic individual patient type according important provide possible reduce patient randomize study response can reduce current
22124438 en mellitus mellitus result body lead therefore important diagnosis treatment research disease identify characteristic include patient mellitus result can finding also role normal development provide new disease
16682840 en cause one gene protein identify two recent gene identify among report gene occur normal result protein datum study result
16522300 en three case cause present one patient show mass follow-up reduction patient clinical response treatment dysfunction may present well complication
24170654 en study relationship among health patient type study conduct patient type level health assess receive status patient high health receive current status patient high need patient blood level lower level may need old adult population
20439241 en review current mellitus cell include risk factor conduct mellitus cell effect glucose year cell patient may although case rate metabolic syndrome remain elevated patient population follow-up risk factor well related include medication associate cardiovascular risk also increased population datum treatment base patient medication mellitus patient undergo cell medication clinical although treatment patient population current treatment similar patient consider reduce mortality
21527114 en aim study investigate whether risk score can type mellitus T2DM among patient clinical database care hospital on total patient diagnose type mellitus T2DM type included analysis base age obesity history activity patient first characteristic obtain T2DM patient analyzed T2DM analysis T2DM risk score T2DM among patient
23643347 en assess age study aim investigate whether control complication patient type mellitus use age measured patient hospital datum hba1c level measured also association patient glucose control base hba1c value mean hba1c value diabetic complication also examine regression analysis sample included patient mean age year mean duration year associate age per duration per adjust age estimate rate also related mean hba1c value per hba1c per hba1c respective addition associate decrease related glucose control diabetic complication
25238063 en major cause severe mellitus common disorder diabetic complication different disease relationship potential study study base cohort association datum independent factor included report relative risk ratio odd ratio or datum independent factor included review use study population included cohort study show risk factor or CI result study revealed association or CI or CI similar association also or CI or CI study or risk CI CI CI cohort study respective among different group therefore risk factor early however included study adjust age potential association cohort study examine association
26286520 en body mass index BMI use ratio BMI recent two new index on body index body index develop possible improve BMI research aim assess identify subject mellitus DM aim determine whether body index BMI study conduct analysis included datum obtain man woman participant DM test show show high correlation DM whereas show low prevalence DM increased BMI on logistic regression analysis presence DM high vs low show DM or CI man or CI woman poor DM or CI man or CI woman show low CI man CI woman DM CI man CI woman high DM result show BMI presence DM show show potential use obesity assessment DM
26278788 en multiple study show mellitus risk factor recent cell chronic however impact mellitus mechanism effect remain poor study found multiple potential chronic mellitus significant can potential chronic patient whereas addition found decrease potential treat can different treat age age effect adverse effect age can treat result therapy target potential mellitus
26268857 en dysfunction associate cardiovascular event type mellitus T2DM control event assess effect current target hba1c level function identify factor T2DM studied patient T2DM patient without T2DM history assessment blood increase response independent patient T2DM hba1c vs hba1c control time characteristic function parameter significant T2DM patient control group prevalence independent vs vs similar patient vs control age or CI female or CI significant associate independent whereas or CI significant associate control associate independent or CI or CI current target hba1c level function T2DM patient T2DM patient remain
25563478 en disease cause mortality type mellitus previous demonstrated patient impair function result increased high concentration associate lower rate test increasing use improve risk factor function patient determine whether target may reduce cardiovascular disease risk population study evaluate blood pressure lipid profile function subject mean age year treatment significant increased serum total level plasma total reduction total cholesterol cholesterol mean pressure also observed treatment change measured baseline serum level subject day reduce blood pressure associate function
27029749 en evaluate relationship type mellitus DM outcome early patient undergo early diagnose retrospective assess outcome DM patient test value DM DM old DM group patient respective overall rate study population respective DM group evidence analysis age independent adverse factor significant association increased DM however model revealed DM associate ratio CI year DM age status independent factor patient type DM poor outcome patient without DM
24763073 en clinical diabetic patient function test on test recent show patient chronic patient group therefore aim test patient mellitus test perform patient DM patient type DM healthy test show significant lower DM compare healthy show significant lower DM correlate however compare normal value patient low whereas decrease patient include decrease DM however low patient mechanism contribute decrease
24112411 en high DM evaluate association DM disease treatment outcome patient patient DM assess treatment outcome presence DM DM control use patient treatment patient DM among DM significant high man aged year old patient DM new high positive month vs vs treatment vs compare patient DM significant association adverse outcome DM control measured fasting blood mellitus new patient associate month adverse treatment outcome research need finding determine whether current treatment month
25456098 en associate complication type mellitus T2DM may aim investigate role elevated glucose concentration patient range insulin determined glucose subject T2DM healthy control measured change baseline value subject T2DM control included fasting respective high T2DM patient control fasting correlate positive hba1c although fasting significant different subject high T2DM control similar observed patient correlate positive hba1c datum suggest chronic associate insulin resistance T2DM increased fasting observed condition
21595806 en treatment patient significant improve however due chronic function medication one different adverse effect among mellitus independent risk factor cardiovascular event cause patient may contribute according association mellitus DM define weight plasma glucose concentration fasting plasma glucose plasma glucose level oral glucose tolerance test metabolic disorder occur complication year decrease insulin increased insulin resistance develop patient on respective risk factor one among therapy development study determined outcome study patient significant decrease develop
22430018 en range treat mellitus DM use report treat conduct use DM management three first total use treat mellitus on common use oral period one week use management mellitus study use treat mellitus cause treatment mellitus
26427105 en effect plasma level identify common mechanism type mellitus different disease method total patient type mellitus study two group patient treatment group receive oral three time patient control group receive treatment week assessment perform fasting plasma glucose fasting insulin hemoglobin model assessment insulin resistance plasma level measured level group level level treatment group level measured control group mellitus common mechanism insulin resistance dysfunction can improve therefore different disease method
26316706 en study assess effect treatment level patient type patient poor glycemic control hemoglobin healthy control age body mass index study parameter glycemic lipid profile insulin resistance model assessment insulin resistance index level measured baseline baseline level high T2DM patient control week fasting blood glucose hemoglobin decrease level increased follow-up week show glycemic profile increase glycemic index level patient control low addition may
26276648 en determine influence reduction body weight total cholesterol concentration glucose serum level patient mellitus type study include two group patient mellitus examine group patient female control group patient female treat examine patient treat week body mass index concentration total cholesterol glucose serum compare group treat significant weight lower level control group significant difference total cholesterol glucose serum level treatment influence weight patient mellitus type consider important therapy patient mellitus type
26215244 en within large population group obesity treat one obesity type mellitus T2DM model increasing number perform patient T2DM population estimate medical care T2DM retrospective cohort patient compare difference medical control T2DM cohort per medical T2DM compare control group patient total patient T2DM increasing number population lead period study body evidence suggest mean patient
25959789 en insulin gene associate type mellitus T2DM risk result addition effect obesity association also perform assess perform identify cohort study association use examine effect model base test among study estimate use regression study included study control result show significant association reduce T2DM risk or CI or CI model significant association or CI model study obesity study control significant association T2DM risk found three model group however significant effect observed or CI or CI or CI model significant effect reduce risk T2DM obesity association result need study
23587029 en although patient low baseline cholesterol level high incidence mellitus whether change level time related risk new patient mellitus examine baseline level patient history year follow-up patient develop new analysis compare high level baseline low identify patient high risk new respective patient baseline risk analysis adjust randomize treatment age therapy baseline serum glucose cholesterol pressure BMI use low remain associate increased risk new ratio CI whereas risk new significant baseline ratio CI associate increased risk new baseline level
25399059 en role development cardiovascular disease measured serum level type mellitus T2DM patient correlation serum level related factor present study investigate possible change serum concentration type study population healthy individual patient T2DM patient serum measured high pressure blood measured clinical glycemic lipid blood parameter individual age year healthy individual patient T2DM patient three group control group T2DM group group association analyzed regression analysis adjust age body mass level significant high age year individual compare year vs healthy group found lower level compare T2DM control group vs respective age fasting blood glucose level high T2DM vs compare normal group level regression analysis serum level positive associate control group control group serum level decrease group level increased T2DM group serum level positive association level T2DM control group level positive association
27287069 en patient primary present study examine effect insulin insulin insulin insulin insulin patient type glycemic control oral analysis randomize trial assess participant study drug outcome assess change baseline blood glucose total participant randomize receive weight total protein blood glucose significant great group group weight weight level significant control improve group significant condition increased
26254702 en factor glycemic control primary study determine patient type mellitus compare blood glucose glucose study included study patient type blood glucose week on system week evaluate use profile revealed patient found patient significant high blood glucose vs vs patient patient datum blood glucose measured occur patient type show high event provide clinical glucose control patient
18566338 en syndrome disorder condition gene syndrome prevalence evaluate analysis syndrome perform revealed one previous correlation different severe result severe one clinical follow-up show syndrome
23393689 en mellitus metabolic disorder glucose associate complication mortality disease mechanism disease identify treat factor effective disorder
23377472 en recent study revealed association metabolic disorder obesity metabolic syndrome aim study assess duration mellitus sample individual man woman studied baseline base healthy time obtain mellitus define fasting glucose glucose glucose tolerance test patient diabetic medication time examine use logistic regression body mass index per individual time less aged year increased odd ratio impair glucose tolerance or CI duration less individual age year associate increased prevalence mellitus impair glucose tolerance test finding study
24640757 en according datum mellitus diagnose mellitus type patient method therapy lead condition patient year treatment mellitus method different intervention result obtain analyzed investigate result treatment patient patient type estimate patient undergo different intervention perform patient control patient perform patient control level obtain type can treat method result obtain potential can present method treatment type
25614529 en study develop intervention type mellitus care improve glycemic intervention group care control group care intervention group associate care include blood glucose month participant intervention group statistical significant decrease level compare control group increase level year age demonstrated great response intervention statistical significant vs compare old year care improve glycemic control provide perform
22857943 en mellitus one common chronic disease clinical disorder type case recent mean number patient case diagnosis cause associate clinical syndrome may present age also diagnosis aim review current determine diagnosis treatment
27651039 en model recent clinical studied effect compare blood pressure glucose lipid level patient hypertension type mellitus target level improve similar group study period BMI decrease group elevated group
26297334 en prevalence risk factor type adult population without conduct include adult aged year use found subject respective type common female year year individual population incidence high among patient control vs CI compare control risk subject increased CI CI CI respective fasting plasma glucose plasma glucose increased age level significant high control high prevalence type patient associate elevated blood glucose level therefore intervention treatment patient
26140333 en evidence suggest cause disease however mechanism reported increase cardiovascular disease therefore test role effect dysfunction function determined healthy diabetic activity protein level determined diabetic healthy treat impair protein increased diabetic diabetic however increased increased activity decrease observed effect cause dysfunction therefore difference contribute dysfunction type mellitus
23905492 en mellitus disease impact high prevalence research recent included study investigate effect mellitus diabetic patient also assess effect individual include review present major patient type mellitus use type mellitus T2DM different general health function treatment test datum reported subject assessment assess patient development show number study develop use assess patient type mellitus patient
23808279 en aim study evaluate index body patient obesity mellitus type study included patient aged year patient two group patient obesity patient obesity mellitus type within week patient receive parameter index body use investigate patient week positive parameter show reduce body weight body BMI patient first group mass index respective without statistical significant difference group reduce first group change body also observed patient patient decrease patient type study show control reduction value significant decrease body weight patient obesity mellitus type due reduce risk disease metabolic
23003116 en investigate risk patient type without subject health research database total diabetic subject without mean age year study participant little one period subject old woman also high rate insulin use compare without total year follow-up mean follow-up year respective patient develop incidence rate high diabetic subject per CI compare without per CI rate ratio value CI CI respective diabetic subject compare without result analysis revealed old age female insulin use independent diabetic patient significant increased risk influence function
20119885 en primary associate impair glucose tolerance mellitus retrospective assess prevalence mellitus patient compare datum subject study compare patient treat control subject health research sample age blood pressure ratio risk factor associate presence mellitus patient control case control study prevalence case control patient primary age BMI high number drug low vs high associate mellitus serum plasma concentration associate high prevalence whereas blood pressure associate mellitus mellitus patient control vs control datum population show mellitus patient primary control
26703951 en assess insulin associate factor outcome type mellitus T2DM
26681210 en patient type mellitus T2DM glycemic target use oral drug study suggest insulin clinical insulin early disease retrospective database analysis investigate clinical outcome associate insulin patient T2DM treat
26261550 en diabetic one complication cause renal disease mechanism renal may provide new target patient however little known present study examine high glucose group patient type mellitus renal cell result demonstrated high glucose patient T2DM cell serum also T2DM patient correlate serum result indicate cell present study indicate significant glucose association reduce response high glucose role response
24708292 en oral glucose show previous study randomize study aim week reduce hemoglobin hba1c level patient type mellitus T2DM
26492926 en several study show woman mellitus significant lower plasma level without study aim evaluate whether plasma multiple associate gestational mellitus case conduct hospital woman hospital first week included plasma multiple compare gestational diabetic gestational group correlation plasma level level woman gestational also woman gestational diagnose among early diagnosis disease gestational diabetic group significant group plasma vs multiple vs compare diabetic group woman early diagnosis gestational reduction plasma multiple range vs plasma level correlate woman gestational woman gestational significant change plasma multiple correlation plasma level plasma multiple gestational early gestational high prevalence gestational population
26896333 en protein complication relative need evaluate trial study effect protein use protein evaluate use total protein study diabetic parameter studied also found revealed protein high concentration glucose treatment revealed improve parameter study revealed high observed lower concentration glucose protein cause protein complication
26054485 en previous study indicate woman mellitus high risk develop dysfunction current study lower blood high prevalence rate blood response compare woman healthy control association complication investigate woman type healthy control blood measured assess measured use assess test datum complication obtain medical assess significant different woman control woman show significant lower woman without woman show significant high result response woman however observed association blood suggest complication adverse female response
26025476 en influence type mellitus study investigate patient cell disease disorder condition compare general population prevalence assess two cohort adult low increased old age two cohort identify associate risk associate decrease blood cell risk associate risk year age elevated plasma lipid concentration general population addition lower level associate high value hemoglobin serum total cholesterol concentration patient disease elevated response increased study may metabolic contribute
21900121 en patient mellitus impair however mechanism poor analyzed impact type mellitus use diabetic model type mellitus develop complication diabetic total lower total lower respective compare measured different diabetic index revealed lower number diabetic impair base lower activity addition reduce base gene profile finding clinical model analysis diabetic show identify cause mechanism low mass impair model type mellitus
21722916 en assess effect type mellitus obesity group subject type mellitus subject control subject body mass index similar subject obesity subject type mellitus high compare control subject assess use significant difference common group significant great group type mellitus compare control control group significant decrease group type mellitus compare group health impair type mellitus compare insulin function may provide cardiovascular disease elevated risk
21663924 en although dysfunction well type mellitus presence subject type mellitus well studied aim present study assess status type mellitus subject control type mellitus subject obtain control type mellitus type mellitus subject activity potential different group measured potential activity significant reduce type mellitus patient compare control subject change parameter observed case type mellitus subject compare control subject significant difference activity type mellitus subject subject obesity dysfunction associate type mellitus
20406430 en mellitus control previous study identify important association mellitus however study association remain evidence management disease research develop research research identify high whether patient mellitus impact mellitus mellitus treatment outcome development improve outcome model mellitus management development test include blood glucose hba1c patient mellitus research control disease
25194974 en increasing prevalence obesity type mellitus T2DM lead new therapy treatment T2DM insulin resistance however year new research treatment T2DM study use drug current drug effect weight effect datum provide profile potential effect target cardiovascular risk
24673496 en glucose development treatment type mellitus T2DM study conduct patient T2DM
24597840 en glucose type mellitus T2DM treatment study conduct assess several T2DM T2DM patient aged year hemoglobin hba1c fasting plasma glucose therapy randomize receive week respective primary change hba1c baseline treatment included plasma glucose tolerance test body weight drug also hba1c baseline treatment group respective group reduction also significant great group without increase insulin level baseline reduce body weight significant difference incidence adverse event among group adverse event adverse study duration test significant improve glycemic control reduce body weight well T2DM patient treatment period
24343984 en aim study examine effect type mellitus diabetic two body weight week week measured evaluate function use change system activity also determined diabetic receive treatment function impair improve significant treatment significant reduce concentration elevated activity result suggest may early type mellitus
25437458 en cell response general due role control plasma glucose concentration also different metabolic function activity include insulin insulin cell reduce plasma glucose level patient type also cell suggest increasing concentration may treatment patient type
26287533 en patient diagnose type mellitus T2DM clinical characteristic identify among patient previous define T2DM patient common compare clinical remain patient patient adult patient define T2DM patient one compare clinical remain patient sample diabetic relative T2DM model follow age diagnosis hypertension lower T2DM two group similar incidence rate age diagnosis patient show lower reduce hypertension compare T2DM reduce potential cardiovascular risk factor patient show reduce mortality risk patient T2DM
24072362 en study positive association mellitus present determine characteristic individual mellitus analysis conduct datum determine individual without mellitus man risk develop complication related diabetic individual old year high risk age group among diabetic patient woman disorder disorder man age diagnose contribute effective treatment time include age status duration mellitus activity use
24242843 en high hemoglobin hba1c correlate develop type mellitus T2DM complication study review type metabolic reduce hba1c level type diabetic BMI database use metabolic type mellitus BMI related study datum patient review mean change hba1c CI mean BMI change CI correlation mean change hba1c BMI reduce BMI hba1c BMI metabolic significant decrease hba1c T2DM patient BMI hba1c change may DM control
26150567 en recent insulin system result clinical trial also insulin insulin indicate use glycemic control patient type type mellitus therapy insulin may use provide insulin use insulin patient type use insulin clinical trial rate patient significant lower rate reported group receive insulin common reported adverse effect occur use patient recent chronic disease chronic disease treatment diabetic effective treatment adult type type potential provide insulin blood glucose control
24750341 en mortality risk patient type major study sample type first major complication renal on model determined significant risk factor associate mortality use estimate time according type complication high risk first month risk high renal factor increased risk ratio CI duration ratio per year CI ratio CI ratio CI low BMI low blood pressure low estimate also increased mortality risk high lower low renal poor renal function risk factor large impact reduce among major complication factor significant increasing risk included low estimate
26364227 en insulin resistance type mellitus T2DM syndrome consider related medical develop T2DM observed study T2DM woman included investigate history clinical diabetic woman one case case aged cause female factor report participant range suggest insulin resistance common T2DM medical T2DM two insulin resistance
24626995 en compare oral glucose tolerance test assessment hba1c less report aim assess hba1c glucose early gestational mellitus on metabolic perform woman previous control month sample glucose tolerance test follow-up perform year hba1c sample assess baseline well follow-up period patient association observed hba1c plasma glucose baseline correlation found association hba1c insulin baseline hba1c show correlation insulin index on model include fasting well glucose level improve hba1c however female follow-up period show increasing hba1c female remain normal glucose develop hba1c assess early early glucose however increase hba1c level can use risk
25306758 en type mellitus dysfunction development event evaluate impact therapy disease need dysfunction patient type mellitus
24995322 en consider one factor management mellitus T2DM therefore present study evaluate effect T2DM condition T2DM time subject two one day day show glucose tolerance insulin compare drug addition significant insulin resistance insulin compare function observed therefore may management T2DM condition
24475922 en individual type mellitus high risk development hypertension contribute cardiovascular complication increase important contribute factor hypertension glucose lower blood pressure hba1c type mellitus also reduce system pressure rate measured blood glucose blood glucose type mellitus patient study week response blood pressure index similar effect observed without change blood pressure condition decrease significant glycemic condition significant plasma remain associate type mellitus subject mechanism may include glucose weight reduction
25782322 en present result parameter treatment patient type mellitus insulin therapy analysis included patient show general population due role role function treatment patient type mellitus insulin therapy impair function compare patient without patient significant different without patient severe profile different related patient severe patient less use function general health patient type mellitus insulin therapy effective therapy individual
25438063 en insulin glucose fasting respective increased ratio major cause type early response increasing function lead lower fasting blood glucose tolerance high mechanism analysis demonstrated increase glucose fasting period time whereas found high serum level result result suggest may provide type
23652376 en may occur suggest common type report case patient diagnose present normal weight develop insulin resistance syndrome gene disease use gene study syndrome gene identify protein clinical patient significant syndrome obesity presence clinical syndrome suggest may consider patient present
26934195 en associate renal increased mortality evaluate risk patient perform use database review may study reported relative risk odd ratio ratio compare risk patient included risk ratio confidence interval CI use cohort study patient included analysis assess risk patient patient CI study CI significant association finding suggest need large randomize control assess effect level risk
24698671 en identify possible association gene diabetic cohort patient type mellitus patient T2DM group diabetic without group according duration gene analyzed use system association study total T2DM patient group group included study statistical significant difference observed group age rate study subject one case group group group significant difference group compare odd ratio or risk CI CI risk positive associate CI insulin therapy CI insulin therapy associate risk patient T2DM gene may significant associate patient T2DM
24075763 en hypertension influence age mean pressure rate whereas factor influence parameter mellitus aim study compare diabetic control similar clinical parameter blood pressure index pressure measured use significant high diabetic age rate metabolic syndrome difference significant diabetic correlate suggest insulin resistance may diabetic great independent blood pressure chronic treatment insulin associate increased independent blood pressure control duration common diabetic great control multiple factor independent status insulin therapy associate severe suggest relationship parameter remain determined whether consider lead increased whether effect
25105792 en little known health impact woman study examine association risk among population total woman aged year cohort study little one baseline medical provide baseline blood sample participant group according one two three logistic regression model use investigate association risk potential prevalence study population fasting plasma glucose level increased increasing number positive association without adjust potential woman two three time CI time CI time CI respective high risk compare woman one associate increasing risk population woman finding may risk factor development among woman study need examine change risk
27121097 en protein blood addition also cell cell cell cell serum subject rate finding serum however whether reported different role mellitus DM association DM remain
26337813 en type mellitus T2DM independent risk factor T2DM associate major cause identify patient T2DM high risk develop aim study identify T2DM patient T2DM patient T2DM three negative history T2DM year patient two group T2DM patient without previous reported T2DM compare group regard great risk factor associate significant high among individual individual or among individual significant high among individual individual or associate development among patient T2DM
25867133 en compare patient type mellitus T2DM new retrospective cohort study use datum study patient T2DM therapy index therapy patient included T2DM index year index month baseline month index follow-up study outcome overall regression compare study outcome adjust potential analysis perform assess study sample included patient patient analysis compare patient patient statistical significant lower odd overall odd ratio or or similar overall total total statistical significant lower overall medical medical analysis assess analysis show patient obtain great number day follow-up day patient month follow-up study patient receive similar total lower odd lower medical compare patient receive
27267220 en present case patient undergo cause early period patient treatment due low level blood high level blood glucose significant type mellitus diagnosis glucose level patient first report type cause early less common early period include metabolic base glucose
26899541 en consider glucose tolerance however mellitus DM metabolic change metabolic study assess incidence DM difference metabolic parameter patient disease undergo hospital factor associate change glucose evaluate serum glucose concentration patient DM DM rate significant high patient undergo vs fasting blood glucose significant decrease analysis revealed independent associate DM odd ratio associate significant high DM rate among patient DM vs DM rate similar disease patient DM show decrease insulin resistance glucose insulin contribute improve glucose BMI DM indicate change may DM independent weight
25955144 en old female mellitus history weight identify presence large analysis obtain mass indicate presence insulin clinical reduce diabetic remain healthy time report case report treatment mellitus
23962874 en type mellitus insulin resistance disease management glycemic control intervention present study examine effect glycemic control use medication risk patient diagnose type mellitus identify datum glycemic control hemoglobin glucose medication use insulin age BMI diagnosis status history diagnosis regression use examine relationship glycemic control include medication use risk result type medication association glycemic control however risk significant high glycemic control hemoglobin insulin use associate increased incidence woman man risk associate reduce incidence association risk associate risk type datum reported major factor associate increased risk case
26656640 en high whereas protein large test association type mellitus T2DM condition lower activity high activity plasma activity system measured T2DM subject mean age woman insulin treatment participant measured correlation analysis activity positive related activity activity positive related blood pressure body mass index whereas activity positive cholesterol activity activity positive related large respective regression analysis activity associate activity independent clinical cholesterol respective association activity activity analysis included large large activity positive related activity T2DM can association may common relationship large
26054577 en mellitus DM major cause mortality complication health model DM use study disease study indicate development diabetic DM female treatment group DM rate blood pressure glucose level investigate renal function evaluate group DM group within one week group lower mortality group great group two week blood pressure significant different among group associate observed three DM effective
27089715 en present study determine factor metabolic disorder relationship patient clinical chronic type mellitus T2DM study patient T2DM cause metabolic disorder patient associate clinical T2DM analyzed significant insulin resistance obesity early metabolic syndrome cause impair glucose development relationship body weight individual metabolic syndrome patient T2DM suggest metabolic syndrome
19397468 en patient risk may treatment renal known adverse effect however associate woman develop treatment however condition therapy patient however lipid patient treat use adverse drug score indicate relationship development report adverse effect one severe adverse effect cause on adverse effect risk therapy
25116276 en determine impact mellitus DM patient disease retrospective study conduct hospital datum obtain database hospital group report patient without DM hospital diagnosis lower intervention included association patient identify DM mean patient day compare day confidence interval great patient undergo major day analysis indicate presence DM chronic disease month estimate total associate lower intervention without DM DM great per total impact condition patient significant clinical factor increased patient DM
22556176 en change blood glucose blood lipid blood pressure large patient type mellitus receive treatment patient type mellitus two group treatment group treatment group fasting blood glucose hemoglobin hba1c blood pressure blood lipid total cholesterol large determined one two year treatment patient treatment group receive management target patient treatment group blood glucose blood lipid blood pressure level adjust target value parameter target difference significant great patient treatment group level target value one year treatment treatment group vs significant difference found group hba1c blood pressure patient vs vs vs respective target value treatment group significant high treatment group two year treatment significant difference patient hba1c blood pressure value respective target group follow-up one year treatment level blood pressure treatment group significant lower compare treatment group although significant difference metabolic parameter two year treatment blood pressure blood pressure treatment group significant lower treatment group significant difference metabolic parameter two group two year treatment type mellitus increase large blood pressure blood lipid patient type mellitus great risk
22245505 en outcome patient chronic type mellitus treat compare incidence event mortality rate patient without mellitus incidence event diabetic patient without study patient chronic incidence event event mortality rate assess mean follow-up chronic patient mellitus diabetic show high number event vs vs respective mortality vs baseline response independent risk factor event mellitus hypertension independent factor patient chronic mellitus associate high mortality rate incidence event independent risk factor event therapy baseline
22297059 en case use mellitus association present use management woman association woman present poor control type mellitus result multiple medication included insulin hemoglobin value remain oral therapy hemoglobin level decrease month presence syndrome month level mechanism increase may effect mechanism patient study effective
23586900 en although common mellitus datum patient study compare patient type mellitus control group without total subject type control subject two follow general assess general assess current response follow-up month subject result assess relationship general score group type control group significant different group type high score lower score control group score subject positive correlate hba1c follow-up score patient improve show patient type high lower control group patient associate poor control
16502494 en case cause however syndrome report two case severe patient present revealed presence gene analysis patient show previous reported study diagnosis use test analysis gene
16047354 en system cell therapy define population risk patient trial patient reported patient present diagnosis one one three patient without diagnosis follow one develop risk develop year diagnosis disease patient diagnosis risk compare system patient oral associate significant increased risk relative rate independent disease influence duration therapy can determined duration disease activity significant increased risk disease diagnosis oral significant increased risk develop risk disease remain period
24315733 en define possible associate factor early index diabetic type mellitus studied subject aged year control aged year control assess hba1c level measured lower use two evaluate use significant high control lower value value increased hba1c duration year year however value lower group poor control duration year although increased effect observed however obesity associate lower value poor finding suggest lower patient early development need follow-up
24973938 en patient type mellitus T2DM increased risk high datum man compare mass factor man study man status body measured function assess regression examine association T2DM age population prevalence T2DM disease duration subject T2DM factor significant lower mass mean difference mass age T2DM lower mass similar compare difference factor little high incidence observed T2DM patient
22173747 en prevalence disease among type mellitus patient time high general population indicate diagnosis follow study elevated level diabetic may study investigate prevalence associate diagnose type mellitus medical review elevated serum level clinical medical treatment datum finding compare patient diagnose disease patient elevated level patient type elevated blood level disease diagnose level follow-up significant difference group hba1c level change type elevated level consider follow-up
24452036 en associate type mellitus T2DM result association complication T2DM among case control study patient T2DM healthy control determined use analysis T2DM high among subject odd ratio logistic regression analysis show risk factor diabetic diabetic disease risk factor risk factor associate T2DM complication associate
23690689 en disorder blood cell decrease development diabetic however study evaluate association complication patient type mellitus T2DM study investigate association complication patient study patient T2DM one complication without complication blood analyzed blood cell presence risk factor complication patient complication increased decrease known risk factor complication logistic regression analysis lower associate high risk complication compare group high first odd ratio confidence interval odd ratio confidence interval decrease associate complication patient T2DM potential improve identify diabetic patient high risk complication
27665439 en evaluate association duration according status datum baseline participant include man woman aged year logistic regression use adjust odd ratio or confidence interval duration show association woman woman potential compare or duration respective woman however association man woman positive associate participant however association independent status health obesity chronic disease increasing duration increased participant woman CI high odd compare woman duration effect duration significant associate woman independent potential duration status duration increased odd
24285450 en study investigate effect type mellitus activity on on well control diabetic patient compare healthy control
25720387 en gestational mellitus development hypertension obesity type previous study determined cell impair function current identify contribute impair function evaluate evidence gene analysis conduct control evaluate perform determine impact control high correlate status negative correlate improve study provide evidence cell lead gene suggest
27853065 en effect therapy patient without type compare retrospective study use score method total patient studied treat subject period investigate analysis study subject two group base therapy result reduction serum level month significant patient without patient without respective patient without respective therapy group value significant increased compare baseline level patient without change value significant associate presence baseline analysis adverse event significant different patient without although similar effect patient type compare without effect compare subject
26575120 en age important role diabetic complication although recent complication associate mellitus mechanism remain study investigate relationship serum level one age vs mass body woman type relative mass index mass correlation analysis show serum level significant negative correlate mass significant positive correlate mass respective well adjust age duration serum hba1c significant negative associate mass association index mass significant respective finding indicate increased serum decrease independent risk factor mass woman type
24065625 en recent report suggest diabetic patient relative retrospective study assess relationship mellitus DM diagnosis period identify patient diagnosis treat included patient patient included total patient patient diabetic however patient diabetic odd ratio or confidence interval CI diabetic however patient diabetic or CI study group odd due diabetic group significant lower compare group or CI finding diabetic patient patient DM year vs year patient significant less present compare patient identify association however DM treatment DM may effect
25820150 en examine association cardiovascular disease chronic disease cohort type relationship two important participant type aged year undergo assessment range hypertension individual follow cardiovascular baseline patient include disease mean follow-up year event include event risk develop high participant without CI relationship adjust CI adjust CI suggest study population chronic disease may little effect development mortality independent association potential addition current cardiovascular risk model however overall finding suggest clinical association chronic disease type
25659184 en association glucose hba1c concentration type treat studied association glucose hba1c concentration type mean age year time diagnosis year hba1c patient treatment hba1c value adjust according control complication mean hba1c concentration patient negative glucose test patient significant lower patient positive glucose test patient mean hba1c also lower patient positive test patient mean hba1c significant correlation glucose test result hba1c concentration observed range type receive insulin treatment negative glucose effective method determine glucose control
23037711 en mellitus group cause gene impair insulin cell estimate case mellitus diagnose type however diagnosis important treatment risk clinical age diagnosis impair insulin well diagnosis
24206368 en aim study whether cell can identify new mellitus negative insulin three analysis perform may new diagnose analyzed positive sample among test negative identify new diagnose level positive subject range finding increased patient positive without analysis patient positive finding suggest may contribute important type negative
26450220 en review provide regard use treatment patient type mellitus database identify clinical trial evaluate use oral drug reduce glucose patient T2DM provide reduction hemoglobin fasting plasma glucose body weight blood pressure use oral insulin associate low risk use known associate high risk mechanism profile treatment patient T2DM
24508419 en profile insulin may factor age renal function insulin insulin duration effect study investigate whether response according patient randomize trial investigate response patient type mellitus group patient treatment period period insulin day level difference among group analyzed use treatment period treatment factor subject effect one interval similar among group ratio CI vs vs vs total effect also similar among group statistical significant difference patient respective group day group effect first interval mean similar response group patient type mellitus suggest profile although insulin adjust individual similar response observed patient
26340427 en management type remain current insulin normal insulin profile however individual type glucose control significant complication disease significant need treatment obtain glycemic use glucose individual therapy present treatment individual type although datum medication lower glucose decrease glycemic case improve body weight reduction total insulin glucose demonstrated provide clinical individual use patient significant glycemic individual elevated hemoglobin
25199852 en patient type obesity study evaluate index new index ratio cholesterol ratio woman man receive health characteristic analysis logistic regression analysis perform determine relationship woman man hemoglobin significant high high lower use analysis value determined respective woman respective man value use logistic regression analysis association woman man odd ratio confidence interval subject vs subject without high woman result suggest new index blood lipid
25236917 en duration type mellitus T2DM associate may glycemic control study aim assess population patient T2DM
23183942 en dysfunction important role early development complication type mellitus increased activity may result reduce dysfunction activity improve function patient disease type group subject included patient patient type mellitus healthy control subject assess also determined patient undergo increased patient control group increase improve group cell cell cell patient without improve function patient type mellitus suggest increased activity factor development dysfunction
25097046 en known association type mellitus less follow impact reported aim study follow study prevalence patient study impact parameter also control patient use on case positive case compare negative case control assess hba1c function profile status parameter patient also undergo patient positive patient undergo disease patient patient high hba1c vs vs vs two high prevalence lower level lower total body vs vs incidence also patient patient vs one important association presence adverse health control level use test
22410305 en mellitus common may contribute high incidence cardiovascular disease therapy reduce risk provide great effect provide great clinical patient ratio without due great reduction cardiovascular event increased major similar clinical patient without evidence suggest may provide patient mellitus
26489114 en develop new analysis evaluate change type type mellitus study participant aged year type patient type patient healthy participant examine obtain analyzed develop correlation found hemoglobin level patient type type respective well duration disease type type respective show correlate hemoglobin level type type respective duration disease type type respective found diabetic patient control change determined normal increase age rate increase high age show type associate low high compare type age result two possible use diagnosis diabetic however evidence study conduct
25615800 en evaluate impact model care patient type mellitus potential control trial conduct compare care care hospital study hospital datum period month month trial primary outcome number potential diagnosis also adult participant study period compare care group patient model care group potential diagnosis month study incidence rate ratio CI result remain similar adjust age baseline hba1c concentration incidence rate ratio CI patient care group similar compare care group difference day CI receive model care reduction number diagnosis complication model care reduce increasing health
23290214 en value serum mellitus population total number adult diabetic population undergo oral glucose tolerance test blood sample level fasting blood glucose blood glucose hemoglobin hba1c blood sample also determine serum level analysis characteristic assess value serum mellitus correlation analysis conduct evaluate association serum hba1c body mass index BMI ratio adult diagnose base association according serum diagnose positive value serum hba1c diagnose respective compare serum hba1c statistical found serum hba1c correlation analysis show serum high positive correlate hba1c significant positive correlate positive correlate age correlation may use population diabetic hba1c
23055040 en mellitus one common chronic disease major health high level blood glucose result insulin type insulin type type complication cardiovascular dysfunction factor factor associate two role metabolic disorder mellitus complication first development target review potential role different complication
25595566 en primary cause chronic disease mellitus DM risk year identify use datum health include first week gestational week DM age system use low status drug use gestational age glycemic identify disease case patient control gestational age year identify DM occur group control whereas gestational DM occur group control logistic regression model DM associate or CI whereas gestational DM or CI large gestational age also associate significant or CI or CI datum glycemic control body mass study suggest DM first week associate association suggest poor glycemic control increase risk intervention study woman age DM determine whether risk chronic disease
25380670 en result new case type T2DM diagnosis hemoglobin hba1c value among reported T2DM among new case reported relative disease age body mass index DM risk factor development T2DM adjust odd ratio confidence interval compare relative DM history relative important improve
26163877 en individual type mellitus T2DM aim study determine whether individual T2DM metabolic response related participant T2DM previous reported study undergo intervention perform analysis base decrease hba1c BMI increase baseline assess analysis identify analysis several significant different group baseline indicate baseline datum suggest baseline may individual response metabolic outcome intervention target individual treat
25829391 en previous study suggest high rate dysfunction among patient type mellitus DM compare without study aim dysfunction adult type cohort medical year age old history type DM function assess potential respective assess function result compare control year old female mean hemoglobin dysfunction common dysfunction subject DM impair little adult type DM poor similar compare control also decrease type DM poor test function related function compare adult study need relationship function
24554429 en evaluate dysfunction adult man mean age year type mellitus T2DM function assess on total score type mellitus hypertension associate lower score age negative associate score respective adjust age body mass index hypertension cardiovascular disease T2DM hypertension associate score diabetic complication associate dysfunction score lower presence diabetic T2DM hypertension independent associate dysfunction diabetic significant associate lower score clinical finding need examine
25511877 en diabetic diabetic aim study evaluate dysfunction two diabetic complication evaluate patient type mellitus healthy subject assess ratio plasma plasma serum common index resistance index index correlate plasma protein duration mellitus estimate rate ratio correlate type diabetic patient dysfunction dysfunction early diabetic can impact
22071294 en study indicate incidence prevalence type mellitus increase incidence age group type positive history metabolic type three different level primary individual without individual patient new diagnose type recent year disease several new trial intervention type effective
17934672 en disease cause several clinical finding among syndrome cell disease group associate case reported man two year present develop body diagnosis suggest diagnosis show follow show show presence case case association case
23446424 en associate glucose factor patient impair glucose tolerance diagnosis poor study included patient new diagnose man mean age year patient undergo oral glucose tolerance test treat insulin function also evaluate model assessment normal glucose tolerance observed patient impair fasting glucose tolerance found mellitus DM patient year patient glucose diabetic patient high BMI similar reduce group DM group high DM patient patient fasting level different group analysis history associate BMI insulin resistance age correlate function impair glucose present patient diagnosis associate old age high BMI history high fasting level
24042261 en medication may risk patient mellitus perform review evaluate effect insulin risk diabetic conduct multiple database evaluate insulin reported risk patient mellitus reported or provide datum or estimate confidence interval CI estimate use study case patient mellitus included study show reduction risk associate use study or CI whereas use associate risk study or CI high risk observed study or CI insulin study or CI use although association statistical significant study study use analysis randomize control trial significant association study association use risk patient trial effect
24413015 en prevalence increasing population health care may chronic disease use increase among population use patient include aim provide week individual population
23958111 en common complication patient mellitus patient serum aim present study patient mellitus regard presence examine association clinical patient mellitus included study clinical serum analyzed presence use value relative two healthy subject per patient control prevalence patient compare control high respective patient control lower body mass index associate presence or CI presence or CI associate presence or CI or CI respective associate or CI common patient mellitus compare healthy control associate lower body mass index associate
24652347 en patient elevated glucose level may cause different therefore aim study evaluate patient patient retrospective study study population three normal group insulin group oral group datum different evaluate diabetic group increased decrease study population increased significant group patient value group respective difference group statistical significant decrease significant group patient result body patient use insulin oral drug although use oral drug known change insulin use also change different diabetic patient
20563393 en identify mellitus prevalence associate factor study develop include participant aged year old use weight sample participant mellitus diagnosis base previous medical history health oral glucose tolerance test investigate associate factor adjust prevalence ratio estimate confidence interval use regression mellitus prevalence adjust potential factor associate mellitus model age history mellitus ratio ratio number use result show high mellitus prevalence identify associate factor intervention
23623608 en evaluate metabolic control clinical outcome among patient type mellitus T2DM insulin first time clinical study study patient insulin treatment analysis baseline patient insulin first time patient remain period patient period hba1c decrease body weight BMI increased respective one patient reported month total baseline month month mean cohort insulin treatment effective little impact finding study
24909501 en investigate whether analyzed datum patient age year result database included datum characteristic treatment use define condition mortality baseline participant included per among per among among old adult significant high risk mortality characteristic ratio confidence interval CI respective association among adult without risk mortality CI mortality CI remain high adjust model included treatment old adult effect relationship mortality patient
26299069 en metabolic investigate patient mellitus renal sample patient study individual normal renal function control normal renal function impair renal function determined protein evaluate use result analyzed use mellitus renal significant high level patient mellitus normal renal function control patient high level associate lower rate high serum high ratio level correlate positive serum level similar among mellitus impair renal function high can contribute renal
26281271 en mellitus disease significant change diagnosis may difference level study increase type mellitus factor disease management use year age conduct examine management result indicate factor may included effect finding suggest patient time diagnosis follow-up disease blood insulin management also examine need positive
25121366 en diabetic reported lower relative study among recent patient type mellitus T2DM studied prevalence risk factor patient new diagnose studied patient age duration month undergo clinical use score score well use compare prevalence healthy case mean age year duration month overall prevalence CI among control CI prevalence show increasing age present CI case significant correlation present case CI on logistic regression analysis show independent associate age duration body mass index plasma glucose study show high prevalence recent diagnose patient T2DM independent associate age duration diagnosis diagnosis among old subject
26872083 en study evaluate treatment potential effect addition risk glycemic control patient diabetic disease review perform use several disease renal treatment oral drug oral perform treatment patient diabetic disease renal change insulin glucose renal function impair insulin management patient diabetic disease insulin health follow-up patient change however management population
23522182 en assess effect patient type randomize study perform patient randomize primary change baseline month hba1c effect fasting plasma glucose also reduce baseline first month treatment effect change baseline month hba1c significant group mean CI change two group on high patient hba1c month rate low result hba1c case one patient plasma glucose reduction observed effect time treatment study
25425169 en study aim investigate different cell patient type mellitus cell patient new T2DM healthy control level serum insulin hemoglobin hba1c fasting plasma glucose insulin cell concentration patient significant high control cell correlate positive cell value body mass index BMI model assessment insulin resistance level serum datum suggest cell may contribute early T2DM
23897066 en study whether intervention reduce development type mellitus DM metabolic syndrome among woman gestational mellitus randomize control trial woman impair glucose tolerance intervention group follow-up woman follow month blood pressure measured blood test woman intervention group develop DM statistical significant lower incidence DM among woman year old difference found fasting glucose insulin model assessment index blood pressure level lower among BMI body also significant lower difference ratio metabolic result lower incidence type DM within year woman also potential development lower blood pressure level woman year old study intervention potential
25000848 en hypertension mellitus increasing common population within determined rate hypertension assess level treatment control population total adult woman hypertension treatment investigate blood pressure fasting blood glucose measured logistic regression model use investigate prevalence rate confidence interval man vs woman hypertension hypertension treatment control rate hypertension man woman man woman hypertension man woman age three hypertension high population age treatment control remain low
27349183 en mortality increased type mellitus T2DM although previous study show decrease serum level associate diabetic complication little known association serum level mortality patient T2DM cohort study mortality man woman T2DM serum adjust age female patient respective follow-up period year analysis show lower associate high mortality man woman respective regression analysis adjust age duration body mass index hba1c serum serum associate mortality man ratio confidence interval per increase woman relationship significant serum blood pressure history cardiovascular disease association serum mortality man remain significant woman present study show lower serum level associate increased mortality patient T2DM suggest serum can clinical assess risk mortality population
23341414 en healthy need healthy oral glucose tolerance test woman gestational mellitus perform time woman group healthy care need follow-up care woman positive glucose level model provide woman gestational mellitus improve outcome woman positive follow-up care patient normal result patient development type included improve outcome provide patient need health
26880678 en high level protein risk type mellitus T2DM factor glucose investigate serum concentration ratio T2DM incidence study within study included without T2DM time blood individual T2DM identify high low rate ratio confidence interval CI CI CI ratio level remain positive associate T2DM ratio related T2DM model included concentration therefore finding association total concentration risk T2DM general study population although high level T2DM risk independent level
26846284 en investigate impact reduce renal function glucose patient type mellitus T2DM treat study patient T2DM hemoglobin hba1c estimate rate randomize two group patient first receive day glucose measured day period compare among patient three group according baseline normal normal group reduce renal function group reduce renal function mean confidence interval CI glucose mean glucose concentration glucose normal group respective mean low glucose concentration vs decrease similar level normal vs vs vs revealed although reduce renal function effect glucose effect fasting glucose finding may increase glucose patient relative patient normal renal function reduce renal function study may need examine finding large population patient T2DM reduce renal
25919045 en study examine relationship risk factor sample diabetic health adult aged year old on total subject included study study use evaluate patient rate mellitus DM group age year respective regression odd ratio high among confidence interval model among without use addition poor function use associate high risk associate lower risk perform logistic analysis odd ratio significant increased patient confidence interval significant difference odd ratio DM use although among use patient found associate use whereas DM patient found associate use
26706923 en important woman study aim determine role hypertension mellitus DM study included woman hospital patient patient without characteristic age body mass index BMI history type associate medical disease disease DM consider medical significant high patient vs vs vs respective patient patient history increased statistical significant difference group regard significant difference group regard disease logistic regression analysis risk factor revealed age BMI significant increased risk significant increased risk or addition multiple factor increasing risk consider risk factor patient change
27505625 en relationship diabetic recent reported result on perform assess associate type study identify database odd ratio or confidence interval study patient without included study evaluate association respective model demonstrated significant association model model model model model significant association identify model analysis different datum risk presence type mellitus
25741194 en intervention obesity mellitus perform patient review normal associate complication include
25918808 en finding use medical increased year aim research evaluate change glycemic control patient type mellitus T2DM use patient T2DM receive glycemic control measured hemoglobin hba1c level datum evaluate baseline month use level lower significant month month significant improve month use significant difference use patient use significant hba1c level observed month effect glycemic control patient type mellitus
26521467 en treatment patient disease lower presence mellitus type patient group perform group use method reduce early complication time
27038028 en year type T2DM significant increased multiple decrease effect increased increased dysfunction important decrease insulin reduce glucose therapy T2DM several drug different disease complication mean disease review aim role treatment T2DM clinical effect potential cardiovascular common
21420036 en mellitus disease glucose type type mellitus cell insulin blood glucose level type mellitus insulin resistance factor known contribute development disease evidence indicate function important review recent study change different diabetic model also role several cell possible use blood development therapy treat type type mellitus
22262764 en chronic decrease cell contribute insulin resistance mellitus test mellitus associate change cell day determined without history mellitus among patient decrease vs increased vs analysis patient elevated ratio odd ratio associate can target
17550212 en result plasma on gene result determine correlation on use patient test patient determined use on gene patient severe total on gene however correlate well test can use evaluate remain patient
26386354 en control great management type mellitus datum control among adult use datum study evaluate control associate factor adult analysis included participant year age old little year participant hba1c level compare hba1c level on logistic regression model use examine factor associate participant mean age year range duration year hba1c level participant hba1c level control hba1c associate blood glucose or CI high insulin or CI or CI clinical or CI presence diabetic or CI low fasting level or CI age disease level adult patient hba1c target identify control provide improve control patient
22244021 en relationship mellitus general sample health health adult year old presence mellitus presence use positive presence response diagnose high blood health conduct increasing number related increasing mellitus or CI compare little elevated risk or CI diagnosis prevalence high current vs or CI suggest time can role different potential increase number increased relationship test multiple model analysis outcome body mass index model index related increased rate mellitus sample independent several potential clinical diagnosis previous treatment individual status finding identify association
16125866 en cause result gene characteristic however effect also function investigate whether function study function female large gene relative large number possible compare effect subject without adult female female test mean age subject year parameter statistical different subject control subject subject individual reported significant significant lower score subject test test trial significant subject without observed difference indicate system may less system provide
26241393 en investigate relationship patient type patient type mellitus normal control participant perform one subject function overall score obtain score clinical assessment significant lower subject compare control on negative correlation total score observed on negative correlation analysis also diabetic subject normal clinical base test total correlation total score suggest reduce change clinical test possible role assessment diabetic
23789581 en woman history gestational mellitus receive test type increased risk study identify factor associate high rate glucose analysis assess characteristic associate patient gestational mellitus sample receive response rate among reported time woman glucose tolerance compare glucose tolerance statistical clinical vs system vs provide patient vs use fasting blood glucose oral glucose tolerance test vs associate high glucose patient included clinical medical need patient
22183926 en mellitus associate change investigate well effect study impact cell blood adult diabetic use insulin week receive day evaluate assessment increased significant week vs control increased treatment change increased diabetic indicate reduce early cause increase treatment suggest indicate therapy may effect mellitus
24552466 en common mellitus patient treat insulin period however therapy patient on gene found patient patient treat per day treatment hemoglobin hba1c level remain year reported treatment although insulin treatment patient treatment target patient cell mass
22068959 en study metabolic indicate possible cause dysfunction patient type mellitus function without clinical type mellitus undergo healthy also undergo normal value perform subject observed type mellitus patient rate significant impair patient type mellitus compare control subject impair function type mellitus associate impair significant association observed dysfunction independent age duration blood pressure fasting blood may early diabetic disease dysfunction
22288652 en examine association medication treatment mellitus adult without diagnosis study use medical care population multiple aged old health care health indicate diagnosis disorder year period case define new medication index new mellitus analysis control case base age type index year new analysis control case base logistic regression perform determine odd medication participant compare model included possible associate associate significant great adjust odd medication confidence interval CI significant lower odd medication CI old adult condition disorder associate treatment mellitus suggest old adult may adverse metabolic
26381876 en show effective severe patient type mellitus treatment T2DM duration analysis investigate severe patient undergo first included patient T2DM duration year group oral insulin included patient diabetic year group oral insulin T2DM regard fasting serum glucose lower without patient number individual without T2DM lower patient patient year patient patient number patient reduce group value year remain similar observed result indicate severe patient T2DM duration metabolic outcome
25987348 en study factor gene cause aim assess level type evaluate association status cohort included diabetic gene type T2DM subject type patient gene well healthy control plasma concentration measured use concentration patient T2DM respective level high T2DM lower control model difference group common type remain significant analysis type indicate concentration similar patient different type difference plasma level high common
24961827 en investigate level associate difference control complication individual type study included patient type year recent without known previous disease patient three group according level included individual mean age year patient level group hba1c level blood pressure cholesterol disease duration similar group respective rate diabetic group respective lower lower level analysis association high patient odd ratio respective also level odd ratio respective compare patient level level associate lower risk diabetic renal individual type independent control duration disease
21802759 en investigate risk factor development mellitus hypertension cohort study hypertension present baseline ratio CI develop mellitus year respective
23600455 en risk factor prevalence severe chronic disease among patient studied effect chronic disease retrospective cohort study mellitus estimate rate general case little year clinical datum included use analysis estimate rate rate three group without baseline adjust estimate rate cohort rate chronic disease significant great group compare group baseline great group significant rate patient chronic disease primary care renal function less previous patient need great risk chronic disease
21644916 en mellitus metabolic disorder chronic complication significant mortality related mass function treatment although first identify factor body evidence suggest may also effect include blood cell recent report demonstrated effect cell potential role review role potential role
22059651 en aim present study estimate rate new diagnose impair fasting type mellitus T2DM identify factor associate T2DM individual new diagnose present study retrospective cohort study new diagnose group estimate rate T2DM analysis follow analysis perform test mean follow-up period year participant new diagnose develop T2DM rate factor associate development T2DM high fasting plasma glucose level year diagnosis ratio confidence interval CI CI body mass index CI rate T2DM high subject new diagnose current follow-up T2DM
21831469 en mellitus DM chronic disease complication include diabetic syndrome condition association disease syndrome significant mortality aim study evaluate prevalence change association duration studied type type DM patient investigate presence change prevalence diabetic prevalence type DM compare type DM age duration related change on association change observed prevalence change high type diabetic association suggest common factor can contribute clinical diabetic
26965796 en cardiovascular patient disease associate high event aim investigate incidence type T2DM patient without study potential association disease risk effect plasma lipid subject T2DM patient healthy control incidence significant high among patient T2DM patient control subject on significant association identify subject positive time increased risk develop compare control diabetic patient positive show time increased risk analysis indicate risk T2DM patient value study effect lipid parameter associate significant high serum concentration group high concentration diabetic patient high ratio result indicate cardiovascular risk T2DM patient
22963905 en mellitus associate high rate adverse outcome include increased rate mortality compare population study determine prevalence investigate outcome woman retrospective cohort study woman hospital period outcome woman compare outcome woman study total study population woman woman type mellitus woman type mellitus T2DM compare woman significant old high previous woman or confidence interval CI or CI significant or CI score or CI week or CI rate time among woman however difference statistical associate increased risk low score
23861364 en cholesterol cardiovascular risk factor identify association study associate level treatment response intervention relative care mellitus evaluate demonstrated association study associate participant study associate high baseline level cholesterol protein found associate increase intervention respective significant treatment respective associate low baseline associate increase intervention treatment show significant association change intervention treatment show significant treatment cohort first study identify lipid response randomize intervention individual mellitus effect factor lipid change may effect baseline lipid intervention
25361053 en type mellitus type DM present similar clinical characteristic current factor gene risk factor type DM show associate function decrease aim present profile relative included
25284729 en increased risk associate type great patient type on increase risk reported range duration study disease duration presence diabetic complication glycemic control insulin use increased risk reported increase risk patient type normal increased impair recent increased change significant factor impair score reported risk medication although datum need reduce type diabetic patient determined
23692133 en woman history gestational mellitus risk develop use factor related among woman history gestational mellitus investigate outcome measured plasma glucose oral glucose tolerance test week datum analyzed use correlation study show incidence among woman factor associate year age three gestational mellitus high plasma glucose glucose tolerance test high plasma glucose week result show intervention need reduce plasma glucose body mass index
26080871 en correlation glycemic control type mellitus T2DM patient study conduct subject undergo hemoglobin hba1c blood lipid T2DM patient well control poor control group according hba1c level correlation glycemic control T2DM patient study subject include T2DM patient subject compare subject rate T2DM patient high vs aim glycemic control T2DM patient rate subject well control poor control T2DM patient significant different vs T2DM vs T2DM vs vs vs T2DM vs T2DM vs vs adjust age status mellitus history T2DM duration cardiovascular disease ratio blood pressure blood pressure total high cholesterol low cholesterol logistic regression model glycemic control status T2DM patient associate compare subject or T2DM patient T2DM patient compare subject or T2DM patient T2DM patient glycemic control status T2DM patient significant associate poor glycemic control risk factor hba1c control lower risk cardiovascular disease T2DM patient
25867111 en type mellitus can lead early treatment impair fasting glucose impair glucose tolerance potential improve review database study previous control trial control study independent assess study trial associate mortality ratio CI trial found treatment associate trial treatment found effect cardiovascular mortality although associate decrease risk outcome year trial trial found effect intervention risk cardiovascular mortality control review found glucose control reduce risk cardiovascular mortality result blood pressure control review study conduct improve mortality rate year follow-up evidence need determine effective treatment treatment associate research
24719137 en previous reported insulin resistance low cholesterol index independent associate patient type mellitus follow patient study year determine relationship insulin resistance study patient type mellitus assessment diabetic patient receive management control diabetic complication review blood test result study finding patient cholesterol high significant influence development diabetic value resistance previous study control hba1c insulin resistance development diabetic year insulin resistance show positive correlation change potential previous insulin resistance control control patient show high insulin resistance cholesterol correlate development diabetic
24598803 en on large body research contribute diabetic remain regard disease patient several model diabetic type mellitus T2DM study aim identify new model diabetic T2DM previous T2DM model model T2DM develop result insulin resistance T2DM show develop diabetic define model diabetic complication common model study diabetic
23395214 en study show associate mellitus relationship remain association study provide datum control group logistic regression model use potential parameter related prevalence analysis conduct type method hemoglobin hba1c level evidence study identify patient total rate or increased CI among patient analysis revealed significant high rate type group control group CI datum suggest patient type patient study randomize control trial
22987062 en type mellitus T2DM woman gestational mellitus high risk T2DM associate T2DM general population however whether associate T2DM among population participant health study cohort follow hypertension healthy index score year model estimate relative risk ratio confidence observed case T2DM associate T2DM risk age total age first oral use compare participant high vs low associate lower risk T2DM ratio CI lower risk lower risk body mass index associate lower T2DM risk among woman history association body mass index
22865700 en association study identify significant associate type mellitus however result disease without follow-up study previous reported type mellitus study cohort analysis identify associate can provide analysis use datum previous study study found significant associate type mellitus study gene gene protein gene analysis result identify gene cell include factor gene well type association gene gene analysis may provide potential type mellitus may identify new target treatment type mellitus
24508997 en mellitus DM patient body increased blood also due increase consider one diagnosis DM however one sample measured method healthy DM patient without
24468386 en mellitus DM sample DM patient one three healthy subject respective sample without base condition use ratio improve respective value found concentration level DM patient range respective
24387037 en primary determine treatment outcome baseline characteristic patient mellitus DM number year baseline retrospective cohort study treatment outcome datum use cohort analysis primary health care patient DM follow-up on high patient poor disease control compare patient therefore define follow-up difference patient follow-up included age complication study value cohort analysis patient DM patient follow-up year system need identify patient care
24656691 en association patient study investigate association type study type diabetic patient include man aged year woman aged year diabetic determined use define presence include assess compare patient without base association analyzed logistic regression value female diabetic significant great without age vs man vs woman prevalence also high patient without adjust age vs man vs woman however significant difference observed prevalence man woman without multiple factor independent associate increased man CI woman CI type also associate presence or CI man or CI woman man type associate early patient type result change may role may use early patient type
27141894 en provide type mellitus T2DM model total participant aged year population two datum fasting plasma glucose lipid profile on total participant follow participant analysis datum participant group group respective use on regression model use risk factor T2DM on T2DM model significant total score model analysis characteristic perform use evaluate model model compare risk score total participant develop T2DM study period incidence rate difference statistical significant on total T2DM model use regression model risk score model indicate model similar index model high value index score respective age time BMI hypertension use year value score age group year respective use value score respective time use BMI value score respective BMI use female value score respective female female use respective value score hypertension model model respective cohort study model included age time BMI hypertension model population
26501513 en review evidence impair fasting glucose impair glucose tolerance type adult high risk adult aged year primary care blood glucose cardiovascular risk assessment adult aged year patient blood glucose intervention activity
26280756 en glucose treatment patient type mellitus T2DM present study evaluate patient day day subject randomize study plasma concentration glucose measured renal glucose evaluate adverse event report blood parameter concentration value increased time concentration day significant change observed factor ratio day day group increased decrease first day treatment effect period multiple significant increased day change day high early treatment period whereas change observed serum increased decrease well period multiple patient
27362975 en insulin use assess effect insulin insulin adult type database week control trial clinical trial included control trial intervention duration little week compare insulin insulin treatment adult type review independent datum assess trial risk difference overall study use assessment development use model analysis present result odd ratio or confidence interval CI identify trial include participant duration intervention range week mean week participant show regard duration trial participant trial risk outcome present trial several trial show method mean difference hba1c CI value participant trial low evidence insulin risk severe two treatment group show or CI value participant trial low evidence overall also datum general low also indicate group difference regard severe two trial reported statistical significant effect insulin insulin however due trial report result remain also found evidence effect insulin however result base trial population trial reported effect regard weight adverse event trial investigate possible effect mortality diabetic complication related analysis suggest insulin blood glucose control type effect insulin outcome datum need
24915263 en incidence prevalence type mellitus review current insulin therapy well evidence use insulin included trial type examine insulin use hemoglobin target patient type need increased risk reduce reduce insulin therapy may consider early disease adverse effect include weight insulin oral general insulin insulin treatment number insulin hemoglobin patient type patient
24702733 en type mellitus increasing diagnose evidence suggest disease common compare adult associate high rate early hypertension treatment type study first randomize trial compare treatment type age year intervention primary outcome glycemic control complication cardiovascular risk factor also examine participant can glycemic control use therapy result glycemic control intervention glycemic control associate cell function insulin can difference body mass index year participant hypertension participant participant cholesterol level less year participant finding important trial management adult type complication need complication type
24595522 en review method type mellitus study review conduct analysis model identify recent review management obesity study two review study evaluate intervention population type model outcome two review obesity intervention database study study review model type method cardiovascular disease review identify found type use estimate risk type impair glucose body mass index use primary risk factor type on model impact intervention risk factor type model included cardiovascular event addition type model evaluate different intervention type compare range intervention multiple risk factor complication outcome
26879600 en gestational mellitus need severe complication evidence indicate healthy effect management several disease metabolic disorder review datum effect mechanism glucose several study base model indicate positive insulin insulin resistance reduce profile datum influence outcome although include need
22009370 en patient mellitus DM increased cardiovascular mortality increasing evidence mellitus associate contribute impair blood disease blood cell impair diabetic patient patient measured patient type mellitus DM patient DM measured cell determine index reduce patient DM patient DM vs correlation found plasma glucose concentration hba1c regression analysis identify plasma glucose concentration independent indicate increased glucose concentration determine diabetic patient patient mellitus lead contribute increased diabetic patient
22008678 en influence type mellitus incidence total case year first hospital retrospective studied number ratio case type mellitus identify control group included case syndrome syndrome number ratio case type mellitus also identify ratio two group compare group two one type mellitus without compare two type type type ratio test ratio group type mellitus significant high control group also significant high incidence type mellitus year old type mellitus without type ratio different type type type type mellitus well type type without type mellitus ratio case type mellitus without type mellitus receive high ratio type mellitus control group type mellitus may increase risk
26324181 en cell effective cell change develop cell diabetic mechanism remain large show population factor factor factor important datum possible cell chronic
24890683 en assess treatment individual type mellitus T2DM cardiovascular disease clinical trial T2DM hemoglobin hba1c care participant receive insulin total insulin reduce primary change baseline hba1c participant reduction hba1c body weight blood pressure aged old aged old mean duration T2DM year mean baseline hba1c insulin change hba1c week significant participant change body weight similar result observed age change week participant receive receive participant receive old population T2DM improve glycemic control without increase risk weight well
26897271 en investigate relationship glucose level patient type mellitus T2DM investigate potential mechanism total patient T2DM undergo oral glucose tolerance test use low test patient severe group glucose system use patient T2DM increase severe level respective severe group significant high group multiple regression analysis show body mass index model assessment insulin resistance index index related patient T2DM cause patient T2DM
26826427 en aim investigate association serum complication type mellitus T2DM patient lower associate increased complication T2DM on total T2DM patient man woman undergo diabetic complication study patient group according status man prevalence diabetic significant high patient respective addition prevalence diabetic significant high woman group compare man group man group increased risk adjust factor odd ratio confidence interval woman group use group increased risk adjust factor odd ratio confidence interval present study found serum level less independent associate increased patient increased female patient T2DM
26725260 en mellitus DM major risk factor cardiovascular disease therapy reported decrease risk association treatment patient investigate clinical study study evaluate effect outcome patient type examine patient type DM without severe renal activity medical assess according health score define score lower outcome define score lower logistic regression analysis multiple factor independent associate odd ratio or confidence interval CI outcome show significant association use observed patient history or patient or DM patient may associate reduce improve therapy outcome
25943745 en multiple effect also known effect function evaluate effect mean patient mellitus DM medication patient retrospective according medical baseline test blood analysis cardiovascular risk factor significant reduce lipid parameter include total cholesterol cholesterol however correlation treatment therapy significant decrease well cholesterol level treatment patient DM lipid
21664191 en disease chronic recent study type mellitus presence two protein patient type mellitus T2DM protein factor whereas studied protein three patient T2DM patient healthy subject evaluate protein result show positive response protein patient whereas difference control found T2DM patient result suggest potential
21081242 en evidence patient type mellitus increased risk examine association mortality insulin lower mortality participant cardiovascular risk target datum treatment study study primary care study subject type mellitus high prevalence compare subject odd ratio confidence interval age hemoglobin status body mass index patient lower prevalence among patient whereas oral treatment high risk adjust possible decrease prevalence analysis diabetic patient general diabetic patient treat insulin treatment respective high mortality rate patient potential incidence patient type mellitus vs incidence patient without type mellitus result suggest medication insulin increase risk mortality
25897149 en little known clinical intervention rate diabetic patient undergo retrospective analyzed clinical datum diabetic patient undergo rate year year year independent need clinical patient mellitus included obesity odd ratio or confidence interval CI low level cholesterol or CI use or CI insulin use or CI score or CI baseline finding may risk improve rate diabetic patient
24845213 en high mellitus study determine patient characteristic disease presence type presence drug resistance duration control retrospective study patient previous known new type significant high aged year patient new prevalence new patient previous treat patient significant difference without patient association drug resistance duration disease control assess fasting blood glucose high patient health association type study need finding
22118957 en known negative influence glucose healthy subject patient aim study compare glycemic control patient type mellitus patient type mellitus included patient treat insulin therapy according glucose control related complication cardiovascular risk factor assess little year glucose control significant baseline follow-up mean hba1c follow-up high insulin vs cholesterol lower baseline vs related complication occur high significant difference vs associate glucose control patient type mellitus treatment therefore may contribute early incidence related complication patient addition effect
27544908 en general define relative individual level study show significant association prevalence disease syndrome significant association prevalence also show however association prevalence gestational mellitus less use primary study include outcome study included participant diagnosis determined use measured use analysis three index on index index index high factor index follow on two effect use odd ratio or evaluate association index prevalence model adjust baseline characteristic BMI participant woman develop logistic regression analysis show index index adjust or CI significant independent associate prevalence found index significant associate prevalence
27075791 en type mellitus T2DM patient may aim study investigate T2DM patient total patient T2DM subject without patient evidence undergo healthy study determine blood sample baseline significant difference healthy T2DM patient however lower number high reported T2DM patient compare healthy therefore found increased level decrease level T2DM patient use regression analysis BMI odd ratio or or or or or or determined independent factor T2DM level significant increased diabetic patient compare normal subject level lower healthy among T2DM patient increased level decrease significant associate
26778146 en present new association syndrome type present syndrome revealed day diabetic month follow-up significant improve insulin clinical disorder associate syndrome
26621498 en high type mellitus T2DM patient however mechanism high compare insulin response well change patient T2DM one year total patient evaluate glucose one year test perform difference different time compare two group insulin response different group different one year metabolic plasma level significant decrease group well test plasma group plasma level T2DM patient one year whereas plasma show
25742636 en type mellitus contribute development complication one aim study investigate association level cardiovascular risk factor type mellitus patient type mellitus healthy control subject measured plasma level analyzed correlation cardiovascular risk factor plasma level high diabetic patient healthy control subject level negative correlate blood pressure fasting blood hemoglobin level positive correlate protein level level negative correlate show correlation cardiovascular risk factor result research cardiovascular risk factor
26782859 en assess relationship mellitus DM aged cohort study new population study assess use define score great study DM define according history insulin oral DM DM condition participant DM per year DM DM per year associate significant great participant baseline participant DM time DM DM time DM develop severe per DM risk factor old intervention reduce prevalence DM may decrease number old adult
26503081 en factor mechanism contribute increase patient little one cardiovascular risk factor evidence disease remain patient syndrome chronic patient normal result cause use value patient level patient compare level logistic regression analysis use evaluate association elevated patient history mellitus DM vs characteristic patient without elevated level similar history DM level or CI logistic regression total patient elevated level mean level history DM blood glucose level associate elevated level whereas female increase level
24893290 en weight may increase mellitus impair fasting glucose risk study evaluate association three year female mean year old participant year datum great weight increase increase fasting glucose level analysis year associate or CI or CI analysis associate independent old age high baseline body weight weight baseline rate baseline baseline hemoglobin baseline among baseline among associate increased risk independent risk factor include old age baseline body weight baseline glycemic status finding may target intervention
23795328 en increased compare group prevalence adverse health outcome health care among patient aim two medical health care system analysis examine association perform use baseline clinical response adult study participant datum revealed study participant high prevalence insulin use hba1c level great include hypertension obesity among participant mean general health score significant lower participant compare control however association statistical significant regression model adjust age number medication base result participant group study body among need development population
25669689 en mellitus relative associate disease increased important role development one possible system several report change aim study investigate possible change activity mellitus type change suggest presence change serum parameter group similar change serum patient disease show mellitus influence different activity significant activity significant decrease effect due increased diabetic also due increased change metabolic activity may development diabetic
25262110 en whether relative high level associate remain assess association major risk type database use related type study use model overall risk estimate per type included study assess effect overall effect significant adjust ratio confidence interval odd ratio reported two study revealed similar association type study risk estimate general adjust age body mass index evidence association increased risk type finding may reduce risk
25724495 en common patient type mellitus T2DM response response patient T2DM great hypertension study determine relationship include pressure T2DM control examine assess ratio included blood pressure pressure pressure pressure difference group significant T2DM control vs significant high T2DM T2DM control associate relationship independent age body mass index rate medication significant T2DM independent associate potential dysfunction finding suggest can important renal function T2DM
24816844 en chronic disease patient mellitus DM remain current aim evaluate association parameter patient DM on total patient mean age year man undergo cardiovascular risk assessment include assessment assessment renal function included assessment score determined parameter included estimate rate ratio present patient patient increased lower high value score independent associate score independent associate respective increase score independent associate parameter patient DM relationship associate
23674378 en insulin occur patient type mellitus female insulin weight diagnosis disorder aim use clinical insulin hba1c level female patient type use datum patient type insulin analysis use develop model model assess insulin female hba1c mean high hba1c current age age diagnosis model develop show respective test revealed model datum method develop clinical model determine individual insulin model provide system insulin weight female type mellitus
26198306 en compare effect two type mellitus T2DM patient body mass index BMI T2DM patient hemoglobin hba1c receive weight weight BMI hba1c fasting blood glucose measured serum lipid level also measured follow-up patient follow-up group similar baseline patient group patient group mellitus hba1c without diabetic medication patient group vs treatment change hba1c two group group significant great weight group total weight vs vs change BMI vs respective serum lipid group also great study similar positive effect compare T2DM patient BMI large sample study need outcome however
26173772 en age one major related cardiovascular complication recent low status type mellitus T2DM cardiovascular disease aim study investigate association status patient report measured patient T2DM treat patient receive significant high patient serum compare patient serum mean serum independent associate mean increased intervention group however effect age month compare status independent associate patient T2DM effect age period month research follow-up need association
22482378 en determine new diagnose mellitus medical study included adult patient age year diagnosis patient known mellitus care history fasting blood fasting lipid profile patient datum result analyzed test consider statistical total patient female ratio mean age observed year total new case mellitus identify fasting blood diabetic subject common risk factor new diagnose diabetic subject hypertension subject subject patient therefore patient reduce mortality
26208316 en number study type mellitus T2DM although concentration decrease study consider change concentration assess plasma blood disease diagnosis blood subject T2DM control concentration compare risk factor multiple age time diagnosis well use model CI well CI CI associate T2DM early total time diagnosis associate disease difference within individual suggest blood provide early positive association T2DM measured blood concentration may suggest model association may time diagnosis
26025688 en prevalence type type increasing significant complication well mortality condition common important cause include important cause associate on number condition include syndrome management condition early
26229969 en clinical study indicate diabetic datum although may research need type diabetic undergo plasma glucose level significant high diabetic compare mellitus associate increased increased glucose level diabetic compare control group function impair statistical compare control among show significant change compare mechanism may provide little increased
25316431 en protein renal examine association renal disease mortality type
24111620 en current function important review gestational include complication clinical among mellitus dysfunction also role activity investigate develop method potential
24026307 en study compare characteristic cohort identify use population adult patient health system patient diagnosis medication result base identify patient population on included identify medical medication identify patient characteristic similar woman mean age range high patient range population period population different range overall patient medication number patient great medication datum potential research define clinical characteristic cohort important identify health research
25421525 en woman gestational mellitus increased risk type metabolic early diagnosis management well follow-up care reduce risk however large study develop study identify follow cohort woman without identify risk factor outcome well development metabolic cohort study woman great woman status datum history outcome complication follow-up datum diagnose care control insulin glucose perform month year year follow year well plasma glucose insulin lipid profile addition research identify early treatment follow-up well study whether improve diagnosis care follow care possible care also provide new evidence risk factor development adverse outcome development metabolic
24766227 en investigate prevalence patient type new patient patient index treatment total patient man age year duration year BMI according patient show high risk base prevalence patient significant high BMI poor control lower plasma cholesterol level compare patient group different age duration blood pressure diabetic complication medication use multiple regression analysis age BMI cholesterol level significant independent little one type datum suggest high age plasma lipid profile patient type need treatment patient
27005708 en gestational mellitus increasing recent associate adverse effect diagnosis important health study aim determine gestational mellitus three hospital base study conduct three period on total woman test blood glucose per result woman according according overall mean blood glucose among woman fasting glucose respective woman increased age significant high risk woman difference group history two different vs increasing age important influence factor woman increasing age significant difference prevalence three
25387821 en aim type mellitus T2DM patient undergo determine factor outcome T2DM on conduct study included study assess two group T2DM patient result demonstrated fasting value significant associate increased whereas T2DM duration patient age insulin use fasting blood glucose value value significant associate reduce T2DM duration age insulin odd ratio fasting blood glucose however result demonstrated body mass index statistical different body mass index result review demonstrated lower total cholesterol level increased high level cardiovascular disease history less prevalence hypertension contribute increased rate result obtain patient less severe high lower total cholesterol level complication duration
26576809 en study associate determine use patient individual group conduct hospital primary care total participant type mellitus group clinical use medical early major use identify influence significant compare participant use medical medical health identify intervention develop improve health diagnosis improve control
21777990 en new glycemic control ratio type mellitus patient significant high type mellitus patient time diagnosis difference increase plasma glucose
22268114 en chronic effect may protein therefore model chronic type mellitus control change vs response associate decrease whereas large response found activity sample vs revealed significant activity finding suggest may activity
24275227 en study whether diagnose cardiovascular disease mellitus DM associate use datum cohort study study among man woman aged examine time logistic regression model use assess effect diagnosis DM weight diagnosis increased rate adult diagnosis DM relative decrease weight relative decrease decrease increased on diagnosis DM associate change diagnosis DM may possible effect medical treatment healthy healthy weight
22864906 en on insulin cell cell associate mellitus cell evaluate possible mellitus associate plasma level measured group subject patient associate mellitus group patient without group patient mellitus group diabetic patient without group healthy control group function normal patient treat perform patient group plasma level different different group group group group group group significant high without change found associate mellitus result role mellitus associate
22712453 en primary may contribute current study examine two gene effect blood activity well concentration blood glucose cholesterol subject diabetic evaluate increased diabetic decrease increased glucose diabetic may elevated risk complication patient low mean well high glucose cholesterol
22335005 en obesity major medical according health little adult aim study effect age parameter incidence hypertension mellitus patient study included patient aged year mean age year include man mean age year woman mean age year hospital patient define age weight base result body mass index BMI patient history prevalence hypertension type mellitus perform statistical analysis incidence hypertension mellitus compare age study population normal blood pressure hypertension occur significant man hypertension occur significant woman age year old group occur hypertension also mellitus common among old BMI BMI occur significant hypertension compare normal mellitus hypertension common woman compare man age obesity hypertension mellitus
24418381 en incidence correlate severe study conduct incidence correlate assess patient aged year incidence rate rate ratio estimate regression analysis analysis overall patient included age year duration year hba1c incidence respective risk high female patient use compare insulin lower patient use compare insulin correlation found hba1c level risk high patient use increased insulin need hba1c level age associate risk effect risk associate use insulin risk risk associate treatment
21367436 en estimate prevalence known mellitus population old year old study cardiovascular risk factor related study perform determine prevalence datum subject study on glucose tolerance test perform association compare health individual year DM ratio prevalence impair glucose tolerance impair fasting glucose base increased age prevalence high female prevalence high female old year on positive relationship found obesity age history adult population high high increase age on great diabetic condition early
24567354 en associate metabolic syndrome increased blood cell related cardiovascular disease patient type mellitus ratio associate metabolic syndrome little however correlation hba1c aim present study investigate relationship blood glucose retrospective study conduct patient type mellitus two group according hba1c level group hba1c level group hba1c level patient included fasting serum glucose significant high group compare group positive correlation may significant relationship blood glucose increased may associate elevated hba1c patient type mellitus
24462301 en study investigate effect hypertension type mellitus dysfunction use total patient patient undergo assess test test correlation analysis multiple regression analysis use statistical patient show lower multiple level vs vs vs vs lower vs blood pressure independent statistical significant associate effect dysfunction patient
25981324 en several study show association type mellitus T2DM development population contribute whether similar correlation also among study examine correlation study included healthy adult T2DM ratio activity significant increased T2DM patient ratio activity decrease T2DM patient important among gene associate decrease risk T2DM model age BMI ratio control T2DM reduce increased T2DM patient compare control datum suggest gene associate decrease rate may contribute decrease reduce risk develop T2DM
22668340 en effect mellitus drug well model however datum current regard effect remain observed drug subject reported may drug due change blood blood due due drug due previous datum also suggest change drug although clinical study effect evidence effect also however drug remain whether influence change addition important study effect drug observed datum datum indicate significant drug response diabetic subject individual clinical study well clinical study due population subject clinical study consider type duration disease characteristic general factor medication use protein age obesity obesity develop also influence research review new clinical although large body research conduct significant regard effect remain clinical study clinical effect change well lead medical management clinical outcome patient disease
22150805 en previous examine prevalence mellitus develop association body weight primary use datum health mellitus define individual diagnosis BMI weight assess use clinical treatment status whether patient follow change control association BMI treatment status total participant included analysis prevalence range participant BMI BMI BMI significant associate odd compare normal weight BMI value adjust odd ratio CI respective overall rate mellitus total sample patient high rate follow normal weight significant prevalence primary body weight may role develop
25834535 en high prevalence mellitus T2DM study evaluate correlation T2DM diabetic present study included total woman control serum parameter evaluate fasting blood glucose total level significant decrease diabetic group compare respective healthy group significant elevated diabetic group compare healthy group on significant level diabetic patient group compare healthy group however change observed serum level different study change parameter woman risk factor development may contribute study show effect T2DM woman
22858312 en present study investigate association effect group patient type study population subject type mellitus year duration patient patient history disease determined test show significant difference case control age BMI duration lipid parameter show increased risk CI risk factor patient type mellitus
27101360 en recent intervention type mellitus T2DM potential effect risk development T2DM assess effect T2DM associate complication impair glucose tolerance impair fasting blood glucose elevated hba1c control trial health clinical trial review health assessment report trial database control trial duration compare intervention intervention intervention impair fasting glucose impair glucose tolerance elevated hba1c review assess datum independent can include review one trial two provide participant impair glucose tolerance impair fasting glucose identify two trial evaluate effect risk development type follow-up week trial report outcome datum adverse effect datum possible whether diagnosis T2DM associate complication
26418913 en mellitus DM increasing prevalence disease chronic patient use drug insulin use insulin patient use oral drug treatment however adverse effect drug increasing new drug adverse effect study evaluate effect DM study group oral month effect observed group decrease finding lower blood glucose level DM whereas increased serum insulin study show provide effect DM effect observed great
22112681 en assess effect therapy patient new diagnose mellitus DM treat medical study patient DM year mean age year woman function follow-up month patient patient mean case due observed patient patient associate decrease mortality CI due reduce cardiovascular mortality lower rate associate improve patient mean relationship independent type medication use therapy associate reduce mortality patient mellitus due decrease cardiovascular mortality lower rate associate improve patient mean
26596372 en patient type mellitus change increased present datum association study examine association include adult patient study conduct three health health patient health use respective aim research examine association well score use regression response rate mean age patient female patient overall mean overall relationship respective mean total score negative association positive influence range woman period time however patient high level total cholesterol high score lower complication show large negative effect overall adjust CI primary care adult overall independent also study addition found negative effect positive influence primary care need adult patient improve
26224762 en glucose glucose well improve glycemic control patient mellitus previous report week day present study day use system glucose study subject undergo perform day glucose value compare blood use mean relative difference subject mean age year man woman type mellitus reported glucose value day value range glucose value significant difference study adverse event first system use glucose value month
25854940 en population current mellitus on increase prevalence year therapy without risk therapy type however weight reduction increased activity risk factor also management reduce complication
24885568 en type disease type gestational consider metabolic previous study evaluate profile blood cell obtain patient show gene profile patient influence clinical treatment profile perform analysis gene profile included database regard cell patient obtain analysis analysis use database use analysis patient base revealed profile cell previous associate diabetic complication association study influence disease duration obesity number glucose serum level use medication first study show influence clinical treatment profile patient
24816647 en reported poor function study examine clinical correlation function T2DM impact treatment function diabetic without study diabetic subject therapy subject study subject assess function period blood sample period week blood determine level total cholesterol glucose insulin measured function use mean use compare diabetic group diabetic subject without treatment age BMI duration examine difference mean score two function similar among diabetic age control among diabetic total cholesterol negative correlate function whereas insulin level insulin resistance negative associate poor function increasing level contribute poor
23899929 en glycemic control improve outcome target independent potential test whether level type mellitus per day day week control undergo without day increased decrease concentration difference group large control difference concentration control without type mellitus decrease concentration within outcome datum indicate may
26777407 en type mellitus consider associate determine incidence type diabetic patient serum level type diabetic patient diagnose within month included study serum perform patient two positive perform patient total patient elevated patient diagnose revealed mean three patient without elevated level negative value respective value incidence ratio diabetic patient CI prevalence patient significant high general population patient population population
26573176 en increased treatment patient type mellitus T2DM effect increase insulin increase review evaluate trial report decrease hba1c fasting plasma glucose lead reduction body weight trial common adverse event reported insulin treatment include insulin
26549655 en recent develop may type mellitus test measured clinical evaluate test association T2DM measured individual study analysis perform mean follow-up period test range follow-up period new T2DM case analysis adjust associate T2DM ratio high vs low confidence interval CI whereas association high protein T2DM significant remain associate T2DM on adjust analysis show T2DM high high low characteristic test clinical include assessment risk T2DM
26339731 en study investigate type mellitus syndrome association disease clinical study conduct care include patient aged year old perform case low serum patient subject occur sample undergo finding found associate potential disease prevalence high group associate association finding although among case compare potential determined large base group investigate
26320015 en function within range may influence plasma level association function lipid cholesterol determined relationship plasma function subject without type mellitus T2DM
24865293 en primary cause disease include type mellitus T2DM therefore potential include present study analyzed blood cell lipid treatment T2DM patient healthy subject treatment T2DM patient healthy subject determine effect different group study revealed significant difference status blood cell measured concentration activity level T2DM healthy subject result suggest may similar effect related system
26936353 en gestational mellitus associate increased risk type T2DM cardiovascular disease mechanism present study association impair function patient study examine function level serum patient investigate influence function result demonstrated increased potential serum level factor also high activity contribute impair function study suggest association impair function reduce activity finding may present target treatment
26162352 en health disease care control mellitus DM disease include identify disease provide treatment care patient disease include whether patient target characteristic diagnose time patient DM provide case management disease cohort analysis use medical DM care control potential disease care may reduce DM also
23135178 en investigate relationship mellitus mellitus compare condition mellitus patient normal obtain clinical control group case patient without diabetic group case change two group evaluate analyzed statistical analysis perform use blood observed diabetic blood observed diabetic cell decrease observed diabetic DM patient without change observed diabetic may occur mellitus related
26439613 en present study determine history mellitus DM hypertension contribute prevalence syndrome perform study history DM characteristic serum index patient control prevalence history DM significant high patient woman vs vs respective history history history DM statistical patient odd ratio or confidence interval CI or CI respective on history DM significant associate fasting plasma glucose fasting insulin level index model resistance patient independent association history clinical patient positive history DM adverse metabolic profile on history DM risk
25841733 en disease patient studied compare patient mellitus DM patient control difference database identify three patient group patient DM patient control patient without DM control patient patient age review year ratio outcome included patient DM patient control mean age year female patient DM patient control patient DM patient control patient DM patient vs control patient DM patient vs control mean total patient DM patient control patient significant high rate compare DM patient population control without patient DM control study DM common chronic condition multiple system population control
21489570 en cohort study regard relationship reduce risk type mellitus although trial show reduction healthy individual trial conduct use individual type mellitus randomize trial examine impact one plasma healthy individual individual type mellitus little week adult include adult type mellitus test without on study subject per group also conduct whether chronic week lower hemoglobin individual type mellitus on reduce significant participant influence participant without impact group study week reduce hemoglobin influence fasting glucose concentration datum show improve glucose control individual type mellitus
26983627 en review diagnosis management woman type diagnose weight gestational age diagnosis low weight type cause dysfunction related glycemic control treatment hypertension gestational week also reduce risk woman study diagnosis regard base assessment risk impair consider week
26800061 en determine incidence adverse drug associate patient type report result patient year old first within month within year treatment occur patient occur respective patient occur within day treatment case syndrome improve hemoglobin fasting blood glucose body weight blood pressure decrease baseline baseline baseline baseline respective baseline treatment well reduce patient type mellitus
26390988 en study investigate risk type mellitus DM therapy use health research database total adult patient new diagnose use define therapy group cohort subject use control group patient year identify develop type DM on model use compare risk type DM study cohort adjust possible risk receive therapy lower rate type DM receive follow-up period vs analysis among patient aged year type DM event ratio lower confidence interval CI may decrease risk type DM patient year research result
26219560 en study aim influence health care patient type mellitus primary care patient health care well group among health care conduct analysis influence significant role diagnose patient significant influence relationship patient level impact patient however individual within health care system
25940734 en research related type mellitus DM parameter patient without DM study influence DM total DM patient analysis receive DM vs year high hypertension vs disease vs vs vs high lipid level rate vs high vs lower vs vs difference vs compare patient adjust factor DM significant effective regression regression regression factor included blood glucose on risk factor DM lipid on significant parameter include
23653377 en protein model obesity type mellitus T2DM recent report suggest disease metabolic disorder aim study investigate whether plasma level patient concentration measured type diabetic total patient T2DM subject studied plasma level found elevated patient T2DM vs level decrease vs increasing concentration independent significant associate T2DM multiple logistic regression analysis revealed independent association factor T2DM known multiple regression analysis fasting glucose level positive associate plasma result indicate may role T2DM
25675436 en evidence suggest mellitus DM one risk factor develop disease however remain DM old year observed present year age old obesity observed lead development type DM present study perform analysis type DM relationship DM provide evidence DM undergo observed year analysis revealed elevated level also significant increased adult DM level aged also observed suggest may due DM
21616732 en whether mellitus associate increased risk remain association mellitus risk analysis use general research database case control per case age BMI general time year history database identify logistic regression use estimate risk diabetic compare odd ratio or adjust use case control respective adjust or develop disease follow CI association mellitus control increasing duration oral therapy associate risk use patient or CI without or CI mellitus associate risk
23708162 en examine prevalence association outcome among syndrome early trial patient one group known reported case report history fasting glucose hemoglobin fasting glucose normal adjust association known normal outcome associate great CI primary great mortality CI known diabetic patient outcome similar normal patient mortality high CI patient outcome similar normal patient mortality great among known diabetic patient CI among common among patient may patient outcome management
26732422 en several report use associate mellitus DM aim present study evaluate impact chronic use development DM population patient retrospective use database hospital on total patient without history analyzed baseline lipid profile fasting glucose hemoglobin glucose tolerance test measured patient treatment included patient hba1c fasting glucose level patient group according use group patient group patient adjust baseline potential analysis perform use logistic regression model score group analyzed score baseline characteristic group group old high rate disease compare group follow-up group high incidence DM compare group ratio CI group show lower incidence major adverse event compare group ratio CI present study although use associate high rate DM improve cardiovascular outcome population
27368004 en medication adverse outcome little known outcome aim study determine oral drug risk health outcome among patient large database identify patient aged year treat little measured day year estimate relative risk mortality follow-up use sample patient low patient period on reduction risk reduction risk mortality can observed patient compare patient ratio CI CI analysis show therapy significant influence risk outcome medication increase risk mortality patient disease need early patient poor medication patient regard treatment increased
20196832 en mellitus DM type disorder show difference high whereas relative on number response associate also determine DM suggest disease gene associate disease gene previous investigate DM association study level result change perform identify use association study diabetic cohort associate show associate DM analysis also association
19833582 en determine whether patient follow-up receive care association association clinical year medical patient sample regard result hemoglobin lipid blood pressure datum patient analyzed patient lipid blood pressure patient level level total cholesterol cholesterol level target patient respective female patient cholesterol level target blood pressure control patient patient test patient year patient year risk factor lipid blood pressure target result indicate although risk factor high target risk factor number patient result may due factor due therefore patient system factor improve outcome care patient
23107110 en assess type patient develop test study patient type mellitus patient insulin group oral group test two negative positive show correlation positive negative score correlate score group patient hba1c level correlation positive negative score score show evidence may assessment treatment type patient receive
26827440 en patient mellitus type general medical treatment index system level activity decrease clinical presence clinical disease
26054139 en clinical mellitus patient T2DM group medication group case one patient medication group treat treatment oral three week one patient group base medication group treat treatment three time per week week one blood pressure blood pressure body weight body mass index observed treatment two group fasting plasma glucose fasting insulin blood glucose oral glucose tolerance test insulin total cholesterol cholesterol cholesterol insulin resistance index event treatment body weight BMI insulin group significant reduce insulin increased medication group difference reduce insulin statistical significant two group total effective rate group significant medication group clinical mellitus blood pressure reduce weight blood glucose insulin resistance lipid adverse effect clinical
25657309 en first study difference within among patient metabolic syndrome without type mellitus compare healthy determine relationship among function system well analysis patient without well aged year healthy control included blood measured response plasma glucose insulin compare control participant show function patient revealed dysfunction compare without index related associate dysfunction system participant mellitus demonstrated severe dysfunction presence dysfunction
25656260 en perform increasing treatment obesity associate management type mellitus T2DM hypertension medication patient period month
25532511 en mellitus disease insulin therapy great result insulin study conduct determine prevalence insulin therapy associate study conduct health on new develop use participant patient diagnose type mellitus T2DM health care included study multiple logistic regression use study association insulin therapy associate response rate among patient T2DM insulin therapy common confidence insulin multiple logistic regression revealed less insulin therapy primary adjust odd ratio or confidence interval CI also significant association hba1c insulin therapy adjust or CI therapy common status hba1c patient insulin therapy
25086642 en type mellitus disease cell study demonstrated role cell development however change function well activity study role perform blood study perform datum role increase cell number function potential several clinical trial use trial clinical response treatment whether contribute development whether clinical patient treatment
26496855 en increasing report regard drug study blood sample adult patient resistance assess status base sample compare relative patient associate high risk resistance CI lower vs high vs compare diagnose increased risk resistance patient need undergo
25178621 en mellitus chronic disease include incidence prevalence mellitus complication increasing day day study reported different complication diabetic patient chronic cause protein lead due increased protein decrease may cause mellitus cause reduce function disease also cause reduce also cause increase chronic cause reduce cause change reduce reduce also cause reduce mellitus significant role development complication target mellitus
26234498 en although relationship serum concentration estimate rate patient type reported whether relationship patient type total patient type investigate study relationship total concentration well examine correlation analysis regression analysis use assess association total well positive correlation found serum concentration total on negative correlation found serum concentration total regression analysis show concentration independent concentration associate patient type role type diabetic
25902763 en patient chronic disease high prevalence evaluate association diabetic sample type subject patient mellitus hospital period serum level test define ratio sample analysis perform use logistic regression found serum level significant lower compare without vs base value serum level diagnosis confidence interval CI logistic regression analysis adjust common risk factor show serum level independent odd ratio or CI finding lower serum level status use identify patient increased risk develop complication
24413898 en prevalence high among adult assessment risk well patient included management study test effective intervention activity glycemic control among adult type participant intervention control group intervention participant control participant receive care datum follow-up blood intervention group significant level activity glycemic control level compare control group result effective base among adult type
26142824 en activity significant factor contribute increased level determined serum type potential complication assess glycemic type group according presence complication compare healthy control protein hemoglobin hba1c level level significant increased patient complication without complication compare healthy control increased patient group significant positive correlation found level body mass index fasting blood glucose hba1c serum total cholesterol ratio on value can diabetic patient without complication suggest elevated type diabetic patient complication level related glycemic control level patient risk complication
24823972 en contribute research present datum mellitus according status period study population aged year baseline regression analysis use estimate rate ratio analysis use determine case occur rate group low group use total man woman included analysis follow-up case risk among man case risk among woman use group high level relative risk observed among group CI among man CI among analysis suggest case can condition population potential observed level among potential use great health general
23512415 en type mellitus treatment insulin hba1c reduce oral drug whether insulin vs insulin effect patient type mellitus female mean age year range treat oral drug little month hba1c included control study period patient randomize patient insulin group insulin insulin treat insulin treat fasting previous insulin insulin month treatment hba1c fasting plasma glucose BMI cholesterol level determined receive insulin hba1c level decrease significant group vs without significant difference group significant change group month period BMI fasting plasma glucose lipid serum level decrease time without difference group vs first month insulin blood glucose significant lower without significant change oral drug type mellitus insulin insulin decrease effective hba1c level without significant difference insulin insulin metabolic effect type mellitus month treatment period
23041240 en investigate whether mortality clinical outcome patient diagnose type mellitus present hba1c within normal range time sample individual new diagnose type mellitus diagnosis fasting glucose time day diagnosis follow patient group according normal hba1c elevated hba1c diagnosis effect elevated hba1c number clinical outcome mortality assess regression diagnosis patient hba1c level within normal range age mean diagnosis year adjust ratio effect hba1c mortality outcome statistical diagnose type mellitus mean elevated fasting glucose hba1c within range diagnosis relative clinical therefore new identify individual
26718504 en although significant role profile gestational mellitus remain aim study compare profile plasma normal determine effect cell on cohort patient sample three time patient week on retrospective study use present plasma normal gestational age status identify significant factor contribute plasma concentration analysis concentration increased normal however increase significant great great gestational age compare normal significant increased cell although role remain profile may population
23744560 en impact control woman type woman type treat therapy effect treatment assess effect woman type database control trial control clinical trial woman type undergo independent identify study assess risk intervention analysis conduct study one study included type type participant consider clinical trial compare month outcome cardiovascular risk factor include lipid profile control blood pressure body weight significant difference outcome mortality cardiovascular disease diabetic complication evidence use woman type one study examine impact control cardiovascular outcome
25358555 en compare association mellitus DM cardiovascular disease risk factor index year participant without disease on total participant follow year mean baseline value participant DM participant participant DM participant DM adjust age baseline change baseline follow-up respective compare participant DM participant show significant participant DM baseline age risk factor independent factor associate participant lower old age elevated DM related important risk factor DM independent associate can effect DM time change time may
25054160 en aim effect type mellitus type mellitus T2DM model group group week perform serum insulin level determined respective serum hemoglobin hba1c age measured treatment compare T2DM control group group show cell group addition level serum insulin significant increased serum level hba1c age significant decrease group compare group group also normal function T2DM
24393392 en disease common type associate poor control lipid profile potential positive normal associate patient type aim determine whether potential associate increased complication patient type group patient type potential patient type new identify patient type patient control lipid profile complication rate examine individual included study group group group group difference age BMI duration group patient group significant lower total cholesterol compare group high group significant difference hba1c cholesterol ratio score prevalence individual group first study assess effect potential patient type well increase risk related complication datum
24271189 en trial investigate rate among adult randomize treatment intervention among woman risk reduction great woman gestational mellitus compare woman without one previous research method can difference compare function risk score woman without history result function reduce woman positive associate history however response intervention datum suggest associate development may woman risk development due dysfunction
24503784 en glucose may improve tolerance investigate whether chronic dysfunction patient type mellitus total patient type mellitus undergo first control receive oral addition week increased plasma level function assess rate effect rate whereas effect control addition therapy treatment patient type mellitus disease associate reduction
25350645 en study examine association change hba1c blood pressure cholesterol body weight type mellitus T2DM patient also perform evaluate change incidence rate adverse event associate treatment medical medical group database use identify adult patient T2DM receive glycemic control association change evaluate use regression method impact outcome evaluate use change observed recent trial compare oral T2DM patient identify mean age female regression analysis found increase hba1c weight associate per patient per year increase decrease increase respective show change reported associate reduction study suggest control reduce
25264083 en evaluate influence mellitus response control group two one control day group receive day respective day well group response analysis diabetic condition diabetic mellitus influence response
24331546 en change disorder may presence clinical factor type mellitus T2DM study patient T2DM can identify risk factor change use total patient insulin subject T2DM T2DM participant level low among T2DM high among control subject respective subject lower participant total associate correlate assessment function score also may risk factor change associate poor function can indicate impair finding care suggest potential treatment
22293056 en year type mellitus recent study found high prevalence among level among population aim improve care patient type mellitus base health care on base medical use improve care overall aim evaluate effect care include activity diabetic complication two study perform medical patient review prevalence estimate use adult population population care health care prevalence diagnose case type mellitus among increased period two year period significant increase care significant care demonstrated care database among care demonstrated effect can result two improve care increasing prevalence diagnose type mellitus care
22978715 en study assess relative association lipid diabetic event study evaluate association lipid profile high cholesterol low cholesterol cholesterol complication type mellitus T2DM cohort study research database index patient mellitus month health lipid profile result patient syndrome complication define early diabetic model use evaluate association among patient association baseline follow-up mean month event per on increase associate decrease risk increase result increase risk patient lower risk CI similar associate lower risk CI demonstrated significant difference risk patient vs difference risk patient vs study significant independent association among lipid risk finding suggest may reduce risk event among patient
27135654 en protein protein potential role aim study change level patient obesity body mass index BMI without type mellitus T2DM undergo intervention low T2DM patient examine change patient baseline also change study included patient patient T2DM undergo undergo patient healthy control level patient increased relative control group decrease baseline level patient obesity T2DM control group decrease level patient T2DM level decrease baseline level increased baseline level datum suggest serum level metabolic disorder treatment status
26783536 en dysfunction due important cardiovascular risk patient type mellitus present treatment improve function risk factor week baseline study measured included plasma female studied mean age mean duration mean BMI mean hemoglobin difference found high total cell negative study result previous finding decrease improve function increased therapy study may need determine effect therapy complication
25979870 en glucose control level week hba1c mellitus DM control related remain aim evidence diagnose DM
26452270 en association glucose elevated blood pressure lipid level well metabolic syndrome lipid level associate increased risk severe complication gestational included woman without known cardiovascular gestational mellitus previous association low high cholesterol high primary outcome gestational assess use outcome gestational observed total subject elevated low independent associate primary outcome odd ratio or CI or CI respective adjust age weight blood pressure treatment fasting glucose effect or CI analysis show increased rate gestational woman low high value complication finding lipid profile among woman age
25064235 en current early identify woman risk develop gestational mellitus result subject disease diagnosis treatment mass aim study investigate relationship early serum profile development gestational mellitus early potential metabolic mechanism study serum week obtain new cohort study profile perform use mass identify use mass statistical analysis perform use identify serum sample rate found significant woman develop gestational mellitus compare control current study found may potential early development gestational mellitus however finding study large population clinical
26920792 en association mellitus DM patient diagnosis base datum health research database diagnosis define use disease clinical on study population conduct use control patient case patient control age patient control patient adjust odd ratio or confidence interval CI on diagnosis DM also associate overall mortality ratio CI CI respective associate patient DM also associate overall mortality patient
24434688 en study evaluate potential change occur normal patient type mellitus T2DM use analysis base datum perform T2DM patient T2DM patient without patient healthy control compare T2DM patient without show significant decrease total result indicate T2DM patient without decrease compare include addition also T2DM patient relative patient without lower T2DM patient positive correlate total score relative also found T2DM patient finding suggest associate increased risk T2DM patient change may normal T2DM patient
22978747 en mellitus associate increased risk adverse outcome review evaluate effective care rate mortality woman database include control trial without care aim health glycemic control treatment complication woman type type mellitus study trial randomize cohort study included review cohort study low risk woman included care effective reduce risk ratio CI number need treat CI mortality CI CI care lower hemoglobin hba1c first CI however woman receive care increased risk first CI care woman type type mellitus effective rate mortality reduce hba1c first care cause first
22825995 en several metabolic include lower plasma high associate great insulin resistance study examine whether lower plasma associate development type mellitus conduct study within health study plasma measured woman type mellitus time blood develop type mellitus year follow-up control according age fasting status blood use logistic regression odd ratio or baseline plasma factor body mass index plasma level history hypertension woman plasma level lower odd or confidence interval CI compare woman level or CI or CI or CI plasma lower odd compare low protein plasma level associate lower odd type mellitus among woman health study study need finding different population mechanism
26040723 en study examine relationship glycemic control adult type on total patient health medication management little blood glucose patient demonstrated poor glycemic control hemoglobin associate fasting blood glucose medication management influence influence previous finding indicate intervention adult type need
22313044 en although common cell incidence estimate per reported case presence patient mellitus condition reported report woman diagnose clinical finding diagnosis revealed case patient undergo occur insulin week oral treatment patient treat oral patient mellitus insulin resistance develop year condition may mellitus important
25712731 en associate type however association gestational mellitus examine association body use case study conduct study early measured plasma mass define use diagnose use association adjust odd ratio or confidence interval estimate use logistic case high mean CI CI odd ratio increased increasing or CI vs low or CI high vs low body mass index association finding suggest body increase risk improve factor influence may early woman high risk
25307034 en on development mellitus clinical aim review previous clinical datum research provide although present include mellitus diagnosis glucose hba1c regard therapy recent clinical evidence research aim group base review diagnosis management
24721668 en increased risk clinical patient prevalence patient type diabetic patient receive risk factor evaluate complication hba1c level man woman type man woman type patient included study value adjust age BMI duration disease compare patient group patient type control man adjust different type type group high type group compare control prevalence type type group lower type patient compare control vs vs man vs vs woman prevalence high positive correlate BMI negative correlate age correlate parameter therapy complication prevalence low different group patient lower compare without however parameter similar group related lower result suggest related clinical significant common patient
26451651 en present high activity result show potential mellitus disease revealed among test group activity result three significant three due activity test study investigate target
25784709 en study compare effect function patient mellitus included diabetic patient blood pressure patient week perform protein test patient randomize test randomize patient difference study protein value lower group high response group increase group increase diabetic patient use great reduction protein
25655376 en chronic care model medical need patient system review identify intervention adult type mellitus report identify study study included intervention patient intervention reported individual level need level effective intervention health care system
24000051 en among also use type mellitus research model suggest possible role assess effect type several database include included control trial compare intervention without independent trial datum evaluate risk assess outcome datum potential investigate total participant range week month duration three study perform overall risk trial high compare effect control type mellitus statistical significant hba1c three month compare mean difference confidence interval participant trial adverse effect reported diabetic complication cause outcome evidence use type mellitus addition trial control include need trial evaluate effect need clinical
26852007 en study report increase rate gestational mellitus recent may increase risk impact glucose dysfunction mechanism include effect function
24927125 en mellitus DM important risk factor however association perform review association database use related mellitus conduct risk incidence identify identify total cohort study risk estimate use model test study reported risk estimate use different individual without DM patient DM high risk CI however result test study high show DM associate high risk DM associate increased risk woman CI test risk man remain significant CI woman DM increased risk
27180674 en mellitus disease may increase risk consider increasing risk due impair case possible group great risk case history severe occur possible treat two insulin treat patient
22864191 en study determine whether mellitus associate increased pressure database study risk factor pressure cohort study datum study use study odd ratio pressure patient without study identify total patient compare patient normal glucose tolerance mellitus pressure odd ratio confidence interval indicate patient mellitus develop pressure compare patient normal glucose tolerance
25832640 en development cell diabetic study mellitus use model study identify diabetic addition investigate glucose level use normal control level associate protein level mellitus significant high increase level associate glucose test level plasma blood glucose hba1c observed found due addition determined high plasma glucose level therefore may model study identify diabetic
22743857 en evaluate care hospital retrospective study conduct related define value range test therapy total treatment total insulin treatment complication number duration hemoglobin factor treatment total major due treatment complication
21616928 en individual mellitus healthy weight complication however mass investigate risk factor complication studied association body mass index ratio ratio mortality among individual mellitus within define individual mellitus baseline participant aged year man duration range year participant use insulin body mass index general obesity associate high mortality whereas obesity show positive association association general woman association observed ratio rate ratio confidence interval man confidence interval woman general associate high mortality diabetic individual ratio show association respective investigate risk model
24717684 en compare effect two hemoglobin hba1c outcome adult type randomize participant low association low high participant receive insulin oral medication group month change month mean hba1c level baseline group decrease group significant group difference hba1c change group CI group one medication compare group group compare group group vs group result suggest low change may improve glycemic control type decrease medication clinical trial number
26021292 en chronic major role development type mellitus T2DM protein insulin resistance increased level response present study aim assess relationship blood plasma level T2DM patient result show association increased high serum level level low healthy subject T2DM patient less individual normal level compare high level T2DM patient high level decrease T2DM patient high level significant increased healthy individual T2DM patient normal level finding indicate blood may change T2DM patient high level
24085454 en evaluate association gene risk type mellitus study association type mellitus assess evidence association influence individual study evidence study study found association type mellitus evidence association one study evidence although association type mellitus suggest study need related gene association
22710320 en assess risk mellitus DM patient evaluate DM treatment among patient cohort medical patient aged year patient base time study patient develop DM study time DM adjust risk among adjust ratio DM CI CI CI overall severe group respective among DM severe adjust risk receive DM CI result suggest independent risk factor development type DM patient severe develop DM receive diabetic therapy patient DM without
26160323 en aim study determine prevalence mellitus DM patient compare rate DM patient undergo diagnose identify database two group base treatment type clinical evaluate fasting glucose diabetic status datum obtain compare patient identify undergo observed baseline DM rate different group vs observed follow-up month DM occur patient difference group vs observed among patient associate increase risk DM or severe or type incidence prevalence DM among patient high observed group associate increased risk DM suggest presence development DM may study
26112750 en assess risk associate mellitus DM among population increased risk DM examine whether association use datum risk assessment system new conduct logistic regression model estimate odd ratio adjust age BMI reported study population occur woman DM time high odd woman without DM confidence interval CI woman DM great odd CI woman effect DM CI compare woman without woman DM significant great odd compare woman without DM difference association increased health well research assess whether difference diagnosis factor
25555391 en patient management primary hemoglobin on effective reduce rate previous perform estimate use rate event on conduct effect insulin glucose review severe patient reduce study improve patient high baseline rate improve improve rate improve effect rate system reduce effect system reduce increase plasma glucose level study system reduce rate plasma glucose level factor current improve improve rate management include
26968607 en association assess use new new gestational mellitus found change glucose test early common new significant increase
26493334 en patient undergo however response contribute complication present study evaluate influence mellitus patient undergo receive treatment patient group patient undergo assessment function use receive therapy case patient undergo reduction resistance patient group patient group patient group patient group significant difference baseline clinical characteristic group logistic regression analysis age independent whereas current independent difference baseline clinical characteristic present compare patient undergo treatment mellitus current status independent factor related
25867358 en current reported system type mellitus type mellitus patient individual effective evaluate patient condition
25719297 en metabolic study aim assess function assess level recent diagnose diabetic study conduct cohort study included mellitus patient group healthy age control evaluate function well assess serum level use show significant difference two group ratio however show significant decrease index decrease measured diabetic patient compare control group significant difference mean value pressure observed studied group significant difference ratio value observed two group significant positive correlation level age studied group significant negative correlation value also presence dysfunction diabetic positive correlation level dysfunction among
27321348 en insulin different blood glucose level mellitus type aim study patient current mean hba1c duration care number patient insulin assess use different patient per use patient adjust old less lower status difference hba1c vs severe vs group overall participant use factor case high blood glucose level patient adjust insulin use treatment patient perform base show metabolic control
22424227 en major disease mechanism increase type T2DM risk also identify remain insulin factor obesity current increase T2DM also significant therapy disorder review cell function may
23578166 en relationship insulin use patient type mellitus investigate glucose total study perform type receive treatment insulin total insulin insulin insulin use subject respective time range blood positive correlate insulin ratio insulin although associate total insulin hemoglobin hba1c level negative correlate mean blood glucose whereas associate mean glycemic time range significant great subject insulin ratio ratio although hba1c level total insulin mean blood glucose significant different two insulin increase duration independent hba1c level patient type mellitus receive insulin
23269036 en evidence indicate individual may increased risk therefore examine present evidence identify association type mellitus risk study trial evaluate relationship type mellitus risk identify relative risk confidence interval use total study patient identify study show type mellitus associate increased risk relative confidence interval significant positive association analysis according study analysis also association significant outcome relationship type mellitus increased risk research mechanism
23110393 en protein may blood potential mechanism related common female dysfunction investigate mellitus group on control group control group mellitus group mellitus measured weight determine study determined mellitus significant difference serum concentration among group significant lower group group group on group respective protein significant lower group group group on group mellitus may due decrease
22870884 en cardiovascular disease type mellitus investigate study develop increasing reduce blood glucose level baseline plasma protein elevated level reduce treatment increased analysis cell studied treat show reduce cell study provide evidence cardiovascular effect type mellitus
23464664 en assess relationship patient type mellitus T2DM control randomize study patient randomize receive week primary change hba1c baseline week group show significant great reduction hba1c fasting plasma glucose group difference group group change hba1c mean confidence interval respective respective mean significant difference hba1c among three incidence adverse event adverse drug similar group incidence significant different among week provide significant clinical reduction hba1c range studied general well patient T2DM
21594681 en mellitus type mellitus cause general population study aim investigate association mellitus patient age year range case control case control subject evaluate analysis mellitus found patient control subject prevalence high patient compare control subject vs patient serum value significant high duration disease high prevalence mellitus compare patient prevalence high independent mellitus control prevalence significant high patient compare patient without vs diabetic diabetic patient occur independent study suggest mellitus may associate increased prevalence however effect relative presence
21539878 en one important disease cause increased association mellitus type develop year model study study analyzed patient without mellitus type gene increased can use patient mellitus type lower gene suggest patient contribute risk
27249926 en result patient lower mellitus DM analyzed pressure index pressure blood index use test pressure pressure studied reduction test index patient reduce DM patient group lower patient significant DM also
25833705 en assess clinical patient therefore compare clinical rate patient on study patient year age outcome obesity follow management high blood pressure high blood cholesterol high fasting blood glucose history hypertension cardiovascular disease age year association obesity adjust odd ratio or patient obesity confidence interval CI prevalence rate follow associate factor obesity related follow management CI management CI management CI patient management management system
25582934 en observed increased patient elevated investigate potential change cell primary studied mellitus use model obesity total measured influence change also determined compare measured characteristic function significant control increased effect cell increased found similar increase drug different mechanism observed index little disorder lead severe weight glucose may important disease obesity
25209955 en evidence effect obesity report mellitus T2DM study analysis impact clinical retrospective study include diabetic patient BMI undergo on system level therapy difference month well weight one patient two patient three patient age weight impact significant difference duration T2DM independent factor analysis rate patient can insulin duration T2DM less year compare duration T2DM patient within period weight increase duration lower T2DM
23846524 en chronic dysfunction important role development diabetic study aim evaluate effect dysfunction early model type mellitus aged week group control group treat group treat day use normal control also treat ratio plasma body weight fasting blood glucose blood glucose oral glucose tolerance blood hemoglobin cholesterol determined baseline time week treatment group reduce mean fasting blood glucose blood glucose oral glucose tolerance hemoglobin level compare control group treatment reduce vs control also significant renal change compare control treatment glucose datum model suggest may renal may potential treatment
24933231 en common factor gene associate impair glucose tolerance increased risk type mellitus T2DM present study aim investigate whether association weight
23569035 en study investigate relationship use index diagnosis type mellitus type cardiovascular complication patient type mellitus type retrospective study conduct patient type patient measured use system parameter associate type cardiovascular complication also total patient type patient study significant high score observed patient type compare patient mean respective regression analysis demonstrated age significant factor influence score patient type type increased risk base score compare patient can increase risk develop cardiovascular complication
24150202 en gene mellitus case gene include associate syndrome patient finding although determined previous reported case syndrome case suggest gene related syndrome
23703485 en first health adult prevalence estimate known population show compare finding health known base diagnose medication overall diagnose adult woman man prevalence increased age high low high status prevalence type health high health increase prevalence one study result indicate little diagnose analysis contribute observed increase prevalence known
19637110 en test association history mellitus well presence study compare outcome patient without history mellitus conduct patient care analysis multiple logistic regression model use control use obtain odd ratio presence mellitus gestational patient history mellitus patient high rate mellitus gestational compare patient without history mellitus vs or CI patient history mellitus high rate vs also increase risk found patient history mellitus compare group vs use two different multiple logistic regression model one outcome association history mellitus complication remain significant or CI or CI respective two model control important mellitus year control history mellitus significant independent association risk presence disease
25178391 en compare measured use adult type type mellitus adjust factor patient type type difference observed difference group
24956964 en clinical current treatment result contribute clinical patient target potential cause clinical among adult clinical correlate diagnosis treatment complication low patient control intervention risk complication control change important finding suggest clinical improve
24927146 en recent study association type mellitus T2DM current study examine whether associate T2DM syndrome study included subject impair glucose tolerance subject impair fasting glucose patient new diagnose T2DM healthy individual use examine serum serum significant lower subject T2DM patient healthy control month treatment control subject insulin control T2DM patient serum increased significant analysis base serum sample revealed significant high odd ratio or subject low serum T2DM or confidence interval subject within high serum association adjust major risk factor characteristic analysis confidence interval result use serum mellitus well response
23153973 en type mellitus associate disease profile clinical association disease among patient patient present may retrospective analyzed associate clinical patient diagnose primary patient disease syndrome patient syndrome whereas syndrome syndrome present patient respective one patient syndrome patient present patient respective total patient case case patient mean age study patient year range condition include disorder system disease associate disease patient early diagnosis treatment associate
24215312 en patient mellitus DM may increased risk however whether effect due per examine association DM review according include mellitus risk included study compare risk diabetic patient patient type study patient increased risk elevated significant risk also found several finding similar man woman study analysis show effect body mass index possible effect age influence study characteristic population present datum use review previous result increased risk patient patient increased risk
23726741 en study perform investigate correlation disease study type measured use system participant evaluate complication use ratio sample consider diagnose diabetic prevalence disease mean value found significant correlation disease diabetic however significant correlation found disease diabetic diabetic disease diabetic clinical significant logistic regression analysis model significant correlation disease addition significant correlation disease common type diabetic addition diabetic
25756439 en impair cholesterol include increase cholesterol associate increased risk type mellitus cholesterol development type assess association type prevalence study individual undergo base function consider severe gene consider severe type prevalence type patient vs relative odd ratio or CI adjust prevalence type determined use regression model difference CI or CI adjust prevalence type vs gene vs or CI vs or CI prevalence vs vs or CI vs or CI respective analysis prevalence type among patient significant lower among relative type finding analysis relationship cholesterol type
27477531 en obesity contribute cardiovascular disease risk current study perform evaluate association general obesity risk factor include hypertension T2DM study T2DM adult body mass index BMI use identify general obesity measured define obesity base analysis blood pressure obesity show significant high vs blood pressure vs participant without obesity participant BMI vs CI vs CI diabetic subject show significant association high level activity CI rate increased general obesity age female high risk general obesity obesity hypertension associate obesity correlate general obesity
26291462 en type mellitus T2DM health increase glucose plasma glucose level recent clinical therapy new include test related can lead therapy T2DM great clinical analysis treatment T2DM large number clinical subject period need clinical also need
26255950 en contribute complication fasting patient type mellitus due need control high risk target oral insulin provide overall glycemic control disorder treatment also show provide effect lipid level blood pressure factor dysfunction new therapy obtain increased activity improve may weight whereas increased may cardiovascular
24786228 en previous study study demonstrated blood pressure complication blood pressure patient type T2DM study investigate outcome year baseline patient T2DM hypertension base mean duration month primary new complication respective difference outcome patient analyzed use associate risk factor assess use analysis base complication significant high patient baseline base significant difference incidence complication patient baseline although significant difference incidence observed group however significant lower one risk factor associate complication patient therapy study patient T2DM demonstrated elevated complication
23841103 en protein function new role mellitus one decrease may provide effect mellitus condition consider gene role several negative insulin role insulin several gene reported associate role mellitus review
25639270 en datum study development mellitus related metabolic cardiovascular risk may great metabolic risk health adverse outcome several association level high level rate complication need reduce total level health show improve glucose tolerance decrease prevalence metabolic reduce can reduce mortality population
25581565 en old adult multiple glycemic control examine glycemic control level among old adult mellitus health status estimate prevalence potential analysis datum old adult year health hemoglobin hba1c analysis status base activity base activity presence chronic condition relative healthy glycemic control hba1c level use medication result insulin old adult CI CI relative healthy CI CI health CI CI health overall CI CI hba1c level less health status CI relative healthy CI health CI health old adult hba1c level less CI treat insulin similar health status CI relative healthy CI health CI health study year significant change old adult hba1c level less hba1c level less health hba1c level less treat insulin health treatment old patient health status adult glycemic target treat insulin may lead severe finding suggest old adult potential
25361217 en compare subject body mass index BMI BMI less determine current diabetic subject study BMI database study randomize control trial control clinical trial cohort study patient per study included patient undergo type mellitus weight BMI hemoglobin fasting glucose insulin independent effect perform BMI less group BMI group confidence interval CI group CI group CI CI CI CI significant hemoglobin reduction lower baseline associate high determine similar rate patient BMI BMI less baseline BMI association baseline hemoglobin reduction due metabolic effect independent different index need
25263308 en although may associate may associate less severe function type condition aim compare profile adult patient type mellitus possible total adult type diabetic patient compare man woman patient type diagnose year man woman diagnose score evaluate use profile high diabetic woman diabetic patient diabetic patient high woman man woman high score man multiple logistic analysis show period type associate high level confidence interval CI duration CI high hba1c level CI female CI adult woman type man type diabetic woman high diabetic patient period type associate high level duration female
25305134 en insulin treatment patient type mellitus control insulin therapy aim compare effect insulin therapy among patient poor compare control group patient therapy model use difference baseline within total patient use use insulin included within group number decrease CI per week remain among patient time number decrease compare insulin treatment difference CI difference treatment group regard clinical parameter score time dysfunction lead patient use year follow-up event among treat patient less therapy difference insulin therapy
25149025 en test whether associate type sample health follow-up study cohort logistic regression model test whether type on type incidence model included age model model model body mass index BMI hypertension status model age associate increased risk per year associate increase risk model age significant associate decrease risk per model age significant addition associate decrease risk per associate increased risk per model age significant BMI associate increased risk per associate reduce type risk age BMI type on significant include
25759909 en present study correlation hemoglobin hba1c insulin total patient new diagnose type mellitus man woman study model assessment insulin resistance model assessment function determine insulin index use evaluate insulin method hba1c subject serum level hba1c level range respective increased decrease increased negative associate positive associate respective independent related independent positive association hba1c independent correlate correlate insulin also associate insulin patient new diagnose type mellitus
25703281 en aim study investigate relationship subject type mellitus T2DM study population subject T2DM year duration patient patient history disease gene lower prevalence compare group vs risk factor subject T2DM
24698216 en insulin resistance increase type mellitus glycemic control potential increasing cardiovascular disease risk use type mellitus T2DM possible therapy improve glycemic control insulin improve metabolic parameter randomize trial included age participant randomize receive month hemoglobin hba1c insulin body mass index BMI blood pressure measured baseline month fasting lipid measured baseline insulin BMI significant decrease month compare baseline within group among participant group total insulin blood pressure increased significant month total insulin increased significant month significant change observed hba1c time group within improve BMI well insulin indicate decrease total insulin decrease indicate also impact study high need result mechanism potential impact
26643952 en type mellitus DM risk factor range disease include hemoglobin hba1c blood glucose level previous week use glycemic control also hba1c level mechanism may associate risk DM can one mechanism DM identify new associate DM perform study patient cohort use statistical analysis adjust age body mass index BMI cell finding two independent cohort cohort cohort use identify gene associate DM two independent cohort associate hba1c level related diabetic patient poor control glucose level identify association gene DM mechanism related level hba1c
22580531 en insulin significant influence type recent mellitus response cell significant decrease number clinical trial role recent mellitus type increasing year therefore cell increase insulin clinical aim study assess effect insulin response obtain healthy patient mellitus type analysis perform use demonstrated cell significant reduce mellitus type decrease cell healthy insulin baseline level response observed cell insulin healthy subject diabetic patient respective insulin mellitus type may important
22237220 en mellitus common metabolic disorder diabetic may disorder due complication mellitus medication receive study disorder evaluate among diabetic hospital study patient mellitus hospital period patient medical history age type include whether serum protein blood measured patient measured two patient three group base serum group on patient serum group patient serum range group patient serum patient disorder common disorder group on metabolic group common disorder metabolic metabolic respective common disorder group on group group diabetic disorder occur renal function normal common disorder metabolic metabolic increase renal function common disorder
24582094 en patient hypertension type increased risk cardiovascular chronic renal disease factor hypertension type include system impair system system treatment hypertension type therapy hypertension patient include renal body
24267869 en result clinical trial type use activity intervention analysis cohort study perform primary care individual without diagnose aged year use risk score oral glucose tolerance test individual identify care use intervention primary outcome development evaluate use care intervention group effective follow-up incidence intervention group care group intervention compare per participant individual level intervention per case respective estimate ratio per intervention development analysis
24929797 en type reported risk factor severe type diabetic patient diagnose type identify datum assess period examine among patient diagnose compare without history previous year vs case estimate total compare patient without use year subject history among case respective associate total CI per patient per common may medical among patient type
24351208 en major complication mellitus factor system also model study similar effect model type treatment group oral week group without week control group time blood cell blood use event significant treatment compare control group time significant treatment blood treatment lead model mellitus
24334175 en primary clinical trial determine effect week glucose renal subject type mellitus rate effective renal plasma measured individual base normal baseline renal function level system measured condition baseline treatment effect plasma effective renal plasma increase renal resistance similar significant effect renal function parameter observed renal function parameter plasma reduce hemoglobin significant group lower insulin group treatment glucose renal subject
24246157 en evidence early diabetic disease disease patient type mellitus T2DM insulin chronic condition low study report two patient metabolic control diabetic two case two control addition studied significant case little significant great case control significant great case control case
25271116 en compare effect intervention base different intervention randomize trial adult type mellitus use baseline month patient aim patient baseline group month within group increase score month group change occur group group month function general health score improve within group value change within group occur one year treatment change occur group similar reduction body weight
27930521 en different mellitus DM population compare population impact metabolic syndrome mortality according DM status score use clinical include age individual DM subject datum mortality evaluate according DM mean follow-up duration month range overall prevalence DM subject high mortality compare subject vs respective mortality analysis high DM subject subject DM increased risk mortality participant ratio subject one obesity associate increased risk mortality significant difference risk mortality according DM subject adjust risk factor show independent increased risk mortality subject DM subject increased risk mortality among participant independent impact mortality subject without DM among population result may subject use perform subject without DM high risk adverse clinical event
24279284 en aim present study assess type mellitus T2DM randomize control study T2DM patient response two oral drug month hba1c randomize group insulin therapy control group care insulin therapy group previous insulin primary change hba1c baseline datum analyzed patient study control group group study significant reduction hba1c baseline group reduction great group vs on high patient group target hba1c level vs vs addition patient group show great score medication overall incidence event similar two patient medication outcome
24888254 en activity major type mellitus T2DM evaluate association metabolic control cardiovascular risk factor treatment include datum provide datum patient mean T2DM patient group per week range mean patient reported hemoglobin hba1c significant among group lower compare body mass index high group less multiple regression analysis revealed negative association hba1c association high positive association total cholesterol low patient receive treatment oral drug insulin without difference T2DM perform increasing activity associate lower hba1c lower high difference treatment result suggest T2DM
26112365 en estimate woman gestational mellitus cohort study oral glucose test week woman first week risk factor age year BMI history previous previous outcome large gestational age gestational age adjust gestational woman one risk factor woman risk factor analysis significant associate case risk factor mean fasting blood glucose lower without risk factor risk factor insulin respective case case normal fasting blood glucose less lead complication whereas patient suggest test can woman
22454226 en disease management number study evaluate mellitus type patient adjust group aim study review study evaluate use method review database conduct identify study evaluate mellitus study included review study retrospective datum one one study use datum care study base one patient method use included use score method analysis regression one study method intervention period range day year consider outcome study parameter complication mortality datum mellitus base database method use study effective base review due study control group
20935516 en body evidence role type type mellitus high concentration glucose lead within cell disorder impair within cell primary relative may lead impair function associate increased level mechanism contribute insulin resistance review role type type mellitus dysfunction system complication include cardiovascular renal system
22567972 en effect insulin factor well factor activity studied mellitus type activity concentration follow insulin activity change effect insulin decrease compare day development follow insulin insulin activity total decrease effect insulin lead insulin resistance activity well insulin
22344626 en present mechanism cause patient mellitus review conduct database well mellitus increasing year complication cause disease system well known change function patient mellitus investigate time role system complication system system patient mellitus may disorder may great diabetic dysfunction increase mellitus diabetic study mellitus system year condition diabetic individual lead complication patient mellitus
23479994 en study patient mellitus patient include type DM type DM examine general clinical study patient group level patient type DM duration disease incidence complication high type DM patient type DM on high score one according found type type DM respective patient type DM patient type DM disease blood glucose level patient group type less patient DM found may patient
26166375 en role medical within mellitus addition regard result patient high medical follow role patient mellitus
24118784 en among trial assess whether improve function type mellitus T2DM subject aim study review effect function T2DM subject randomize control trial assess effect function T2DM subject randomize control trial compare control group overall mean difference function statistical group confidence interval analysis function significant improve T2DM body mass index BMI T2DM BMI association found BMI function can effective improve function T2DM subject
22762897 en woman outcome associate chronic determine case mellitus population cohort woman obtain database database datum database use hospital datum datum cohort define mellitus datum include system compare case population demonstrated positive value use among mellitus show important increase population datum database datum identify case woman perform well compare use evaluate outcome associate result therefore estimate outcome
22289016 en previous study demonstrated associate poor outcome patient however evidence patient aim study evaluate relationship glucose level mortality patient assess whether association mellitus hemoglobin hba1c level
27184299 en associate renal increased rate mortality evaluate risk patient disease perform use database review study reported relative risk odd ratio ratio compare risk patient included risk ratio confidence interval use analysis cohort study patient total patient undergo patient CI study analysis CI however association insulin treatment CI significant association finding study may impact clinical management follow patient
26445241 en aim study evaluate serum level patient mellitus compare control measured serum level healthy gestational diabetic woman gestational week study independent sample use two group serum model assessment insulin resistance hba1c fasting glucose insulin level gestational mellitus group significant high control group mean serum level woman significant lower control group respective serum level negative correlate insulin level hba1c value serum level significant lower patient clinical identify woman develop
26411993 en patient type mellitus T2DM increased risk disease aim investigate association hemoglobin hba1c level mortality among patient patient T2DM undergo included use regression ratio confidence interval CI mortality also major cardiovascular event total patient included mean follow-up time year patient hba1c associate increased risk patient hba1c level CI respective increased risk hba1c level CI respective patient association hba1c level patient T2DM undergo found increased risk hba1c level also hba1c level association hba1c level T2DM patient
24340534 en mellitus DM important health according statistical datum increasing incidence adult prevalence evaluate result DM study analysis DM case statistical datum health DM outcome possible use hospital DM complication management health use related group diabetic patient DM health system large due large number patient outcome suggest can hospital health patient DM
23180316 en dysfunction patient associate impair response role however patient without patient increased level can show dysfunction lead investigate factor can mellitus insulin resistance related patient show risk type mellitus can impair different mechanism include increasing activity impair therapy therapy management type mellitus insulin resistance patient
23571511 en change associate type mellitus disease examine incidence examine relationship risk risk assess retrospective cohort study use patient datum medical include woman develop woman age history risk assess adjust BMI status primary outcome included ratio number woman need one develop diagnosis CI time diagnosis significant CI year diabetic woman great increased risk time diagnosis increased diagnosis duration increased risk increased diagnosis important regard intervention woman
22935346 en use time different disease include obesity however mechanism effect activity due high level insulin effect increase glucose glucose protein oral type diabetic different body weight week show positive correlation insulin significant improve protein protein diabetic elevated level serum hemoglobin level hemoglobin factor decrease finding revealed increased indicate effect mass found effect result mechanism finding show new drug therapy
22917219 en study among adult type mellitus use assess change year study assess change health status year among individual without study improve early management risk factor baseline year score health index score baseline year change year measured individual type mellitus T2DM without T2DM adult without diabetic complication regression model use determine change score age body mass index significant great index score T2DM group compare without compare without T2DM large reduction index score score year group T2DM group group without difference significant T2DM diabetic complication great score T2DM without complication period health status T2DM significant compare indicate disease impact health status impact score year
25118888 en evaluate effect mellitus DM female study group adult female weight range condition one group female control group receive treatment DM three group receive first group receive treatment group receive week group receive per week blood glucose total plasma concentration status determined week week treatment examine datum obtain analyzed statistical use test result show number group compare control group number found group receive high compare control group number increased group compare control group group present control group group compare diabetic group
24864506 en present review datum mellitus DM due prevalence high associate one medical include diabetic complication DM cause population treatment condition hypertension glycemic control method current method insulin patient insulin insulin provide glycemic control decrease risk complication
24341443 en gestational mellitus impair insulin relative well metabolic woman gestational increased risk gestational may model great regard role gestational weight report also present risk estimate glucose review risk factor body mass include weight risk factor insulin use also review current glucose research disease
27210018 en current care mellitus DM insulin therapy consider management type T2DM also insulin therapy insulin remain DM insulin contribute weight metabolic lipid among system may insulin resistance increase risk cardiovascular disease association insulin risk event mortality clinical trial cohort insulin may previous evidence without weight new therapy day drug patient also datum present new use insulin management patient T2DM include T2DM insulin therapy T2DM negative datum insulin therapy mean reduce insulin drug potential care
26430929 en report indicate effect among patient type mellitus T2DM study perform determine effect patient randomize trial perform among patient aged year old period patient group group on receive per group receive group receive control week patient control time day total fasting blood sample baseline intervention related week compare control result significant plasma vs respective significant reduction level vs respective significant effect plasma total plasma serum level blood pressure compare control week among patient T2DM effect plasma level however plasma level serum level blood pressure
23889588 en assess treatment according age renal function relationship cardiovascular disease type mellitus mellitus individual T2DM renal cardiovascular event treatment estimate rate use chronic disease measured use prevalence major cardiovascular event according age treatment per age rate old adult whereas increased age associate cardiovascular event independent increasing age participant use treatment T2DM insulin remain use respective respective increased age independent associate lower prevalence cardiovascular disease age condition use adult mellitus severe renal associate lower cardiovascular event rate individual
23563931 en found serum level negative associate type mellitus T2DM man finding suggest related glucose also study revealed serum level associate also glucose however relationship serum level remain examine whether metabolic include associate patient type man woman T2DM evaluate score examine association serum level great well high significant negative associate serum level man logistic regression analysis adjust age BMI serum level cholesterol duration DM hemoglobin index insulin resistance odd ratio or confidence interval CI or CI per increase respective significant significant relationship serum level finding suggest serum level associate also man woman type mellitus
25898567 en cell common diabetic hypertension therefore study mechanism mellitus important therapy diabetic complication mechanism mellitus study intervention provide diabetic complication
25462570 en gene level little known well role elevated level reported present plasma patient study aim level patient mellitus DM cohort healthy control sample patient control perform total use DM patient respective patient respective found one patient examine patient high prevalence DM patient patient elevated level high prevalence observed DM patient whether presence patient
24976144 en study conduct determine whether significant patient disease mellitus hospital retrospective study included patient aged diagnose disease first time new hospital datum evaluate analysis correlation analysis test use analysis patient study female mean age observed patient disease treatment consider statistical significant disease mellitus use important patient group patient disease provide evaluate treatment well provide patient group
19461158 en disease response three different associate gene associate gene renal case patient severe status normal diagnose test revealed high plasma level low gene renal revealed cell sample revealed significant decrease normal control report new case associate gene
23478270 en study investigate change level model mellitus DM evaluate response associate mellitus
23123286 en metabolic lead role aim study investigate level sample type mellitus patient age range age subject concentration sample measured plasma method use mean value significant high sample diabetic patient compare lower concentration patient type healthy subject study show increased decrease associate mellitus therefore may role development mellitus
25402738 en individual type mellitus T2DM metabolic syndrome high risk develop cardiovascular disease great medical intervention condition individual lipid profile associate several common prevalence T2DM metabolic syndrome increasing lower reduce risk individual risk associate lipid high level low level cholesterol common found patient T2DM metabolic syndrome therapy target may improve lipid profile reduce risk patient
25065473 en define associate mellitus glucose lipid type study conduct investigate parameter type blood serum sample patient healthy control glucose concentration level hemoglobin serum serum glucose concentration type patient increased significant compare healthy control level great significant level observed patient control activity decrease activity increase activity patient compare control group regression analysis show correlation duration however significant association present study show type patient compare healthy subject datum suggest chronic cause significant change
22552749 en studied prevalence mellitus year evaluate factor associate population year evaluate age logistic regression analysis conduct study independent factor associate adult aged year old among prevalence respective among female respective prevalence year prevalence age increased among poor logistic regression analysis age low significant associate study show mellitus large population found association population
25922845 en insulin treatment type mellitus DM increased clinical also potential effect investigate whether can insulin assess type DM patient
23750422 en investigate clinical effect type mellitus impact patient type mellitus control group group group case two group treatment oral group receive effect treatment treatment week fasting blood glucose blood glucose hemoglobin hba1c protein observed hba1c insulin index group control group BMI body weight group lower control group blood control effect group control group incidence group lower control group group lower control group clinical effect type mellitus significant role response also less adverse clinical
23383447 en mellitus DM clinical diagnosis cause disease disease chronic chronic result DM regard complication DM disease
22527095 en prevalence patient type mellitus correlation duration disease glycemic control on total patient diagnose type mellitus primary evaluate on control group healthy subject study datum included age duration disease glycemic control presence subject also presence patient also index mean age patient year ratio common significant difference prevalence value respective compare control significant correlation glycemic control value respective also correlate significant presence diabetic patient diabetic patient compare control one patient reported significant impact presence poor glycemic control
24565816 en primary type mellitus cardiovascular disease association adult per week activity target weight however adult common activity population time total lower overall time compare several recent study compare reported improve metabolic control cardiovascular function relative although patient activity activity activity risk patient time may
21455729 en aim study compare care change control patient type mellitus year age day group hospital included severe disease patient group patient care control group intervention group receive individual year base addition care on use number primary outcome hba1c analysis regard hba1c use base participant follow month period datum hospital can reduce hba1c level increase increase compare included control group intervention group group respective use baseline value significant difference change score two study group regard mean level hba1c score score month follow-up use effect regression model patient intervention group show significant high level compare control group mean change score year care patient trial
23523454 en aim study obtain drug treatment patient disease first indicate intervention patient datum patient clinical on determined rate target month addition cohort less patient evaluate outcome patient compare patient without rate target diabetic cohort confidence interval significant lower year incidence target patient patient without vs high risk population demonstrated significant high target rate population include patient rate significant different patient without vs effective patient clinical datum patient patient without patient remain high risk clinical trial randomize study compare clinical trial system patient population clinical
22751341 en gestational mellitus potential important risk adverse outcome risk obesity glucose disorder high risk develop mellitus diagnose reduce complication management treatment insulin use treatment glucose glucose risk glucose hba1c control mellitus type mellitus intervention obesity metabolic effect mellitus primary use medication remain health may reduce obesity reduce risk obesity
26303379 en study whether response associate glucose tolerance insulin cell function risk type mellitus system compare subject new mellitus normal glucose tolerance subject diagnose oral glucose tolerance test assessment event correlate response significant high found subject compare correlate significant fasting plasma glucose plasma glucose hemoglobin hba1c correlate hba1c logistic regression analysis show body mass index or or or result present study indicate subject significant high chronic response compare subject chronic response significant associate glucose insulin resistance mellitus
21291103 en study mellitus DM conduct estimate prevalence DM among adult range estimate due age group studied health reported prevalence estimate mellitus impair fasting glucose year old overall prevalence mellitus estimate addition high also high complication incidence diabetic complication found population study revealed among year old evidence diabetic impact DM cardiovascular disease reported regard care poor control rate complication reported show condition less control increase number mellitus need well impact mellitus complication population
20544609 en mellitus increased risk however association mechanism define review evaluate datum association mellitus mechanism may relationship potential factor contribute increased risk observed patient mellitus include system dysfunction mellitus diabetic impair response mellitus associate increased risk although increased risk relative large number diabetic patient number mellitus remain significant little evidence mechanism association mellitus may improve risk well identify target
20520971 en mellitus impair glucose tolerance insulin resistance protein important patient increase disease determine prevalence mellitus impair glucose tolerance insulin resistance patient evaluate impact follow-up compare fasting oral glucose tolerance study perform included adult patient mellitus fasting oral glucose tolerance test diagnose mellitus population index assessment perform assessment mellitus found patient fasting oral glucose tolerance test insulin resistance found patient relationship mellitus protein diagnose range assessment mellitus identify oral glucose tolerance test related significant high prevalence complication period prevalence mellitus impair glucose tolerance insulin resistance protein high patient complication follow-up period patient mellitus diagnose oral glucose tolerance test oral glucose tolerance test indicate population
20450123 en mellitus disorder type include change diabetic patient individual on possible association mellitus compare prevalence mellitus patient disease analysis perform patient diagnose disease patient examine one large general hospital diagnose disease prevalence mellitus three group disease respective significant high prevalence group compare high prevalence patient presence association mellitus may factor development
20010968 en condition lead common cause gene case present patient prevalence gene high disease consider low general population target patient lead include mellitus increased mortality mellitus due primary early insulin response glucose model demonstrated function may increased treatment development mellitus patient research effect treatment mellitus need
24682912 en increased serum level common however study relationship serum new diagnose diabetic patient study investigate association serum level patient new diagnose type mellitus patient new diagnose T2DM well parameter blood pressure serum blood glucose fasting insulin protein blood lipid subject low high according significant high high serum significant correlate ratio fasting insulin fasting blood glucose age multiple regression show independent serum age protein status independent serum age blood pressure significant associate increased man T2DM early
26831204 en type mellitus T2DM system associate range complication however known whether T2DM risk factor datum health research database on total individual T2DM aged year diagnose two period included individual define index year new diagnosis patient case new diagnose T2DM T2DM patient follow-up period new diagnose T2DM patient T2DM patient group develop risk significant increased patient patient new diagnose duration type associate increased risk development study association investigate mechanism need
26587547 en mellitus metabolic disease disease influence factor review assess association complication study database gene diabetic complication disease study study overall included found significant association T2DM found result due association study large number sample identify study individual population
25327310 en study reported due insulin reduce study on study also influence system within body week determined use assess study method effect on revealed increase level diabetic group diabetic group level value diabetic value high significant compare diabetic on reduce status
26204833 en major risk factor type mellitus T2DM related factor factor related study included subject case T2DM healthy control compare individual lower total activity lower model assessment function index also high concentration model assessment insulin resistance index value on significant high T2DM subject compare control subject individual significant high risk develop T2DM or CI relative adjust known T2DM risk factor result suggest significant associate status risk T2DM may also contribute impair insulin increased insulin resistance population
25517075 en little known health examine use patient type mellitus T2DM identify factor associate high poor use T2DM logistic regression model use identify factor associate medical adult T2DM patient individual health research use included hospital drug management included test medication assess use medication total per patient high individual per patient significant new care improve duration care associate management health care also can control without care effective health care
25132212 en evaluate compare type control study randomize patient aged year week treatment addition primary little mean change baseline hba1c level mean patient age year mean duration year mean baseline hba1c hba1c reduction week respective fasting plasma glucose concentration decrease respective increased mean weight change respective occur patient group vs patient group respective occur one patient group three year patient control
20302723 en impact mellitus factor patient total patient treat retrospective patient mellitus DM group mellitus group factor datum compare two group logistic analysis perform regression model analysis datum patient undergo without total case develop mellitus significant difference found age hypertension two group significant difference factor found two group significant correlation mellitus factor logistic analysis among patient undergo disease overall present significant difference two group show mellitus significant associate patient use regression analysis mellitus significant influence factor patient receive
20134109 en health care year number patient disease number potential develop disease reduce number intervention obesity estimate reduction prevalence mellitus disease health care reduce estimate prevalence confidence interval conduct health estimate reduce reduce prevalence use datum diabetic patient estimate change prevalence mellitus reduce estimate health care reduce number reduce reduce prevalence mellitus reduce change prevalence mellitus reduce intervention aged year year effective age group female health care mellitus reduce reduce prevalence mellitus although target aged year obesity reduce prevalence mellitus
22672574 en risk population risk recent value change demonstrated patient mellitus DM high risk range risk low high patient without DM risk high patient level without low risk patient addition value assess DM demonstrated therefore DM disease use diabetic patient year age association consider response therapy
23135865 en therapy first treatment type mellitus T2DM two current effect therapy one cell therapy insulin event reduce body weight effect effect therapy T2DM also therapy study T2DM patient undergo therapy clinical
26073777 en mellitus high disorder several different clinical include age remain disease include report two gene protein identify mean two large high prevalence due known insulin insulin cause function total protein cell cause significant reduction observed role glucose
25618836 en determine factor associate early month woman recent gestational mellitus
22733265 en use study change use change rate glucose new two major health increasing type mellitus T2DM prevalence insulin resistance obesity occur association patient mellitus risk severe condition high function well demonstrated therapy review present datum metabolic can contribute therapy mellitus obesity T2DM can development clinical intervention
23770795 en mellitus DM metabolic disorder remain major health relative insulin insulin resistance cause chronic impair lipid protein known disorder cause study role dysfunction impair cell impair glucose patient type mellitus T2DM risk intervention multiple drug show effect complication reduce mortality rate due cardiovascular disease cause also show significant development dysfunction patient DM recent use remain use therapy DM consider demonstrated effective risk develop complication develop treatment DM include use well use demonstrated effect DM patient recent study drug use treatment DM also demonstrated effect
23409968 en mellitus two important health type T2DM obesity associate datum evidence regard mechanism association mechanism risk mechanism obesity risk dysfunction important obesity increase may development also obesity mellitus therefore can cause associate obesity T2DM cell review role chronic time provide target
25645908 en although therapy treatment cardiovascular event patient response assess effective function subject without disease addition investigate correlation function clinical total patient disease study among known whereas remain subject control group on patient patient group control patient patient addition patient receive per day perform blood use multiple function blood sample intervention test respective evaluate function effective measured test addition assess significant less function patient without test test result lower level use observed positive correlate fasting blood glucose hba1c increased compare patient without treatment use increased patient need effective drug patient
27491373 en consider one clinical evidence treatment may evidence aim study investigate characteristic mellitus DM database review database review effect assess review use evaluate included logistic regression analysis use identify association characteristic total include primary study patient included included type DM patient treatment perform provide characteristic included study included general poor remain assess provide study intervention perform less well provide DM treatment assess provide study also need report treatment
24180357 en increasing evidence suggest mellitus DM may associate increased risk perform examine association DM risk database review study relative risk confidence interval total cohort study analysis study show DM associate increased risk CI among study cohort study show lower risk CI study odd ratio CI positive association significant woman CI man CI remain study type analysis association DM risk significant method DM CI CI CI respective analysis study body mass index drug indicate positive association DM risk study determine whether DM control reduce risk
26522272 en investigate difference glycemic insulin use glucose conduct study participant type mellitus current receive insulin therapy potential influence glycemic control participant within hospital duration study glycemic control glycemic evaluate use glucose day glycemic assess glucose primary outcome mean glycemic significant reduce blood glucose level insulin reduce group although mean glucose concentration different group lower effective insulin reduce blood glucose participant type
27158744 en use however effective treatment type mellitus investigate effect T2DM group normal control diabetic control diabetic group diabetic group diabetic group week parameter gene protein level significant lower group group oral glucose tolerance test significant lower group level significant decrease group decrease total cholesterol low level increased protein increased significant analysis revealed lipid treatment analysis group compare can decrease body weight blood glucose level improve insulin resistance significant activity
21903988 en study examine outcome event patient examine effect multiple risk chronic disease cohort mellitus total diabetic follow primary outcome per define increase relative model examine effect first three risk included baseline diagnosis include patient mean age year mean baseline little one time mean month patient one model risk factor ratio confidence interval CI risk CI associate risk develop mellitus independent major risk factor
25443746 en mellitus DM associate complication recent risk factor effect include influence studied
26645084 en recent week woman evidence early treatment gestational mellitus however examine prevalence clinical characteristic outcome woman diagnose week early compare diagnose week large treat cohort
24012111 en chronic disease major cause mortality result type mellitus DM increasing increased increase risk disease study possible association protein parameter patient type mellitus DM diabetic chronic disease patient DM healthy control group plasma level measured reduce reduce plasma parameter activity measured plasma significant high compare DM healthy control lipid measured significant high patient compare patient DM healthy control blood measured found significant lower patient DM compare healthy control plasma show significant positive correlation hba1c significant negative correlation increased increased decrease suggest important role renal diabetic patient
23754845 en aim evaluate association serum status patient mellitus DM studied patient new diagnose DM mean age year serum measured use pressure mass index determined according multiple regression analysis show level independent associate protein body mass index patient DM diabetic patient serum level independent associate may role impair type DM
28127111 en research investigate serum level type mellitus study include patient healthy control subject studied population test perform identify measured perform group disease duration year high level found lower patient disease duration year year well patient disease duration year serum level found year duration serum level also found increase hba1c suggest high level study need activity
26758272 en common use health status although outcome study mellitus use study assess sample patient type mellitus study conduct use assess patient T2DM two patient on examine use multiple regression analysis model relationship index independent total patient T2DM study age participant year year score index respective number diabetic complication number patient age score respective also number diabetic complication number patient age index finding indicate can type related complication among patient
22362115 en determine incidence diabetic type mellitus first indicate evidence year base diabetic type mellitus diagnose age year old evidence diabetic first event little one event within study period included incidence incidence year diabetic risk factor incidence year per respective first year incidence per compare increased per incidence independent associate known duration age diagnosis use insulin treatment participant need insulin treatment duration year incidence one year per analysis interval type mellitus current month possible duration year insulin treatment
25354857 en compare clinical use glucose system blood glucose blood glucose level patient gestational mellitus type mellitus DM total patient type DM whether clinical first hospital use blood glucose level time period also time correlation blood glucose level hemoglobin hba1c level analyzed compare value value blood glucose time value two method insulin blood glucose value group vs value DM group use two method value two group show significant difference value show significant difference group blood glucose value significant correlate value present result correlation found value DM group two method significant correlate value show result also observed value significant correlation value hba1c level value hba1c level correlate group value significant correlate hba1c level DM group group value value three DM group value present show respective value three group value occur value day found value present time day DM group value found value present found time day patient group insulin treatment patient receive insulin treatment adjust insulin according blood glucose level DM group receive insulin treatment adjust insulin according blood glucose level can patient blood glucose level control blood glucose level patient type DM patient compare can effective
25142791 en assess whether risk assessment management patient mellitus lead outcome observed cardiovascular event cardiovascular risk intervention primary care sample little month primary care age hba1c level baseline care group cardiovascular outcome measured baseline effect change outcome subject treatment target observed cardiovascular care group group lower cardiovascular event incidence vs decrease hba1c cardiovascular disease risk total risk disease risk risk subject significant treatment target hba1c adjust remain hba1c result great hba1c reduction observed cardiovascular risk month follow-up indicate intervention effective primary care
24686035 en mellitus disorder glucose individual insulin cell role mellitus therefore contribute change occur change recent evidence suggest role metabolic health review change mean diagnose treat also
25850525 en recent increase risk although patient type mellitus T2DM known lower mass healthy mechanism examine association mass parameter insulin fasting insulin fasting man T2DM mass evaluate relative index diagnosis multiple regression analysis adjust age duration T2DM serum hba1c show parameter insulin significant positive correlate mass well logistic regression analysis adjust factor show parameter insulin significant lower subject without reduction insulin independent risk factor man T2DM
25228279 en associate insulin resistance type mellitus DM association gene increased risk DM however role DM investigate low obesity major role aim evaluate whether gene also DM man retrospective review patient clinical evaluate perform sample according three difference age body mass index BMI total DM prevalence significant high logistic regression analysis show age BMI total positive significant associate DM study suggest gene may independent risk factor type DM
26642710 en high response development disease include cause among subject disease among disease one important relationship association two disease aim study determine whether relative difference protein plasma can related parameter disease study mass protein associate baseline condition found level protein patient subject result identify protein plasma possible protein protein disease may improve
24315963 en associate glycemic control diabetic complication type mellitus study analyzed level serum activity type diabetic patient glycemic control patient poor glycemic control control evaluate difference different glycemic control diabetic patient subject significant lower level serum increased level serum therefore increased serum ratio serum blood relative subject significant correlation patient serum serum ratio level hba1c result suggest high serum level correlate glycemic control therefore glycemic control decrease lower concentration diabetic complication patient type mellitus
24047449 en study prevalence clinical hypertension among patient type mellitus blood pressure compare patient T2DM determine define clinical blood pressure blood pressure mean value weight body mass index BMI ratio fasting blood glucose hemoglobin level also measured clinical prevalence overall population female diagnose hypertension age T2DM independent factor whereas female independent risk factor T2DM large group relative common among T2DM patient condition hypertension patient also significant difference clinical parameter
22813567 en insulin resistance independent range disorder obesity hypertension type mellitus cardiovascular disease association low level high level disease relationship type may association insulin resistance insulin resistance level first relative type study included first relative type man woman aged year control similar age case medical hospital research case analyzed ratio fasting glucose insulin lipid profile test statistical datum show insulin resistance first relative type mellitus compare control respective increased level fasting plasma insulin lipid profile total cholesterol significant statistical found study high prevalence insulin resistance first relative type mellitus level first relative type mellitus increased level insulin resistance suggest increase level insulin resistance condition study statistical significant
21615391 en patient mellitus increased risk develop cardiovascular disease however risk great among patient risk profile individual patient may also change time investigate role hba1c patient study datum patient hba1c measured baseline year period month mortality cardiovascular concentration significant increased time hba1c significant decrease baseline regression model hba1c age duration follow-up remain period hba1c baseline follow-up model investigate change hba1c concentration value change concentration high mortality hba1c concentration significant period outcome baseline follow-up change concentration risk profile change hba1c level
22808485 en studied insulin insulin insulin protein response insulin insulin resistance development type type mellitus type mellitus insulin insulin increased control normal value type mellitus day development change test parameter less finding insulin response insulin type mellitus
24357541 en diabetic common cause due mellitus treatment improve diagnosis patient care population care disease among general analysis datum participant health year old mellitus report time report prevalence CI adult year old reported CI mellitus year CI receive year among CI impair define base CI base mellitus care increase recent improve therapy
23952619 en prevalence type mellitus change level disease studied value diagnosis type sample new diagnose type control without retrospective study one sample patient follow-up study interval year type measured use insulin measured type control subject patient type negative base three insulin rate reduce positive little three common level decrease time type presence level correlate show disease type important type diagnosis included test type
24824525 en investigate prevalence impair fasting glucose total mellitus DM include known new diagnose age man on study conduct health medical group hospital year age study prevalence total DM age man respective prevalence total DM increased age analysis age blood pressure obesity total cholesterol serum blood independent risk factor DM prevalence rate high compare overall DM age increasing
18726898 en due gene retrospective examine perform review test whether change cause significant less common perform regard perform effect reported base study also reported identify cause cause different type include significant respective common significant respective little gene cause cause among common study may review gene cell
24859512 en clinical protein mellitus patient week weight score present first week diagnose month age develop control oral glucose tolerance test protein test tolerance test diagnosis protein normal serum profile identify clinical case protein patient follow-up patient
26343954 en associate mellitus DM known cell present study effect DM associate different two group group receive normal control group day test drug control group diabetic body weight group respective day serum index glucose different lipid insulin serum serum evaluate develop indicate significant increase lipid lipid serum glucose total cholesterol decrease level serum insulin diabetic receive different adverse effect however effective finding revealed first time potential DM different suggest may mellitus associate
26095630 en on mechanism type mellitus show factor role datum large reported may cell activity evaluate blood patient disease glucose may influence status datum show different glucose concentration significant increased evaluate group compare healthy control however significant increase observed compare group analysis relative datum different concentration glucose result show significant increase increased obtain patient may suggest potential target therapy patient
22911287 en on female type year female type year develop syndrome one case identify change disease case potential drug patient patient treat patient type show without patient type two associate treatment patient two year follow-up outcome patient role diabetic patient clinical patient
23822518 en low chronic observed patient type mellitus T2DM may health may influence level may reduce whether patient T2DM therefore aim study effect level related patient adult T2DM patient new diagnose without clinical trial randomize receive week metabolic measured sample analyzed obtain baseline week change reduce level reduce response observed T2DM
27321335 en assess influence patient general characteristic care type management diabetic patient aged identify multiple assess hemoglobin lipid year patient included age characteristic age score influence patient investigate regression two hba1c test study subject little one hba1c test decrease two hba1c patient assessment lipid profile undergo test lower patient increased age age patient group female risk ratio age risk ratio high score risk ratio associate patient influence care effective disease management primary care level may improve control glycemic cardiovascular risk factor
26954482 en medication aim system use cardiovascular renal complication patient datum compare clinical effective aim compare effect cardiovascular renal outcome adult trial identify database review intervention primary cardiovascular mortality major cardiovascular renal disease serum renal disease trial participant total different use compare use associate significant reduction major cardiovascular outcome odd ratio or interval risk renal disease significant difference remain therapy or significant difference show mortality cardiovascular mortality serum finding clinical included study potential identify finding adult different show similar effect major cardiovascular renal outcome compare provide significant major outcome potential individual patient
25108569 en on consider treatment disease lead effect model mellitus DM well diabetic result metabolic syndrome dysfunction although reduce level mechanism range effect also contribute known recent evidence suggest two type disease DM dysfunction clinical trial conduct DM also renal disease review present possible mechanism
26134189 en aim study assess incidence woman type measured primary outcome serum level study included woman type study patient included woman mean regard serum level patient define normal patient patient group severe patient patient patient significant negative correlation serum level type significant positive correlation on analysis identify significant value base characteristic result show high incidence woman type mellitus risk patient serum level
25823279 en prevalence type mellitus DM metabolic significant role development complication patient DM development dysfunction system level glycemic control need treatment therapy use one therapy complication DM
27085471 en incidence chronic disease increasing mellitus DM important cause studied possible role DM patient assess patient without DM undergo control effect factor age hypertension duration body mass index BMI level hemoglobin also examine primary measured significant high patient control among patient correlation observed difference diabetic individual age hemoglobin hypertension duration level BMI value level associate significant great result indicate primary increased patient undergo compare control however DM effect
24508288 en activity several cell evidence indicate activity different development type gene associate increased risk develop disease present glucose current regard role development type mellitus disease review
19703809 en case mellitus clinical finding patient present mellitus possible man chronic woman woman present mellitus although blood glucose level high patient insulin glycemic control relative insulin characteristic type mellitus drug therapy several month drug mellitus month drug mechanism change may lead dysfunction patient
26320293 en randomize study compare effect treatment parameter plasma level patient disease type mellitus impair glucose tolerance total patient disease type mellitus study patient randomize two group group included patient receive therapy group included patient receive treatment plasma level lipid glucose insulin evaluate index insulin fasting glucose therapy level decrease group group respective reduction level significant group group vs whereas observed significant change group increase hba1c level found group change observed patient group independent presence diabetic change patient change level therapy patient group demonstrated decrease level whereas patient group concentration increased associate increase level group patient change level negative associate decrease level case decrease level therapy treatment increase hba1c index presence treatment datum suggest mechanism adverse metabolic effect
25823272 en aim parameter patient disease presence type mellitus DM evaluate relationship lipid metabolic patient type DM mean age year patient without condition mean age year examine clinical hemoglobin hba1c insulin concentration index blood lipid profile patient DM without DM lower value patient type DM status associate high plasma concentration glucose insulin hba1c total cholesterol lower level relationship observed patient without patient DM status without DM DM group demonstrated relationship metabolic lipid metabolic may negative development patient type DM
27051920 en type mellitus decrease activity increase decrease concentration change level blood serum patient evidence development result therapy provide significant change investigate parameter treatment result associate effect level drug
25187117 en increasing important risk DM patient present study demonstrated decrease assess use new develop significant risk factor type mellitus patient high chronic disease increasing important risk factor type mellitus T2DM patient well chronic disease patient serum increase present study aim whether relationship decrease development T2DM study estimate new T2DM patient identify patient estimate rate low show significant high rate high serum significant high low high high significant lower low significant lower logistic regression analysis independent significant associate T2DM patient high T2DM low study demonstrated factor independent associate T2DM patient low increasing serum level
24352343 en association mellitus DM well known however impact DM relative aim determine prevalence clinical correlate DM large cohort patient on total patient included study study diagnosis base clinical datum datum related parameter patient blood sample fasting patient associate DM found patient patient DM old history DM diagnosis DM associate history less associate DM associate DM analysis factor associate DM age BMI history DM use significant risk DM associate little presence DM patient associate DM diabetic patient group patient without associate
23458188 en test serum obtain diagnosis define clinical analyzed aged diagnose case related case on define positive insulin function define serum diagnosis body mass index BMI measured month diagnosis characteristic diagnosis range month diagnosis compare among diagnosis define group group clinical characteristic diagnosis age development diabetic hemoglobin hba1c clinical diagnosis treatment hba1c among associate lower hba1c high hba1c three patient total status serum diagnosis define value
21636867 en estimate incidence development mellitus woman impair glucose tolerance gestational evaluate risk cohort hospital impair glucose tolerance oral glucose tolerance test week mean follow-up period range month woman mellitus impair fasting plasma glucose level increased risk mellitus confidence interval compare impair glucose tolerance base analysis fasting plasma glucose level development mellitus year woman glucose tolerance normal mellitus impair glucose impair glucose tolerance impair fasting glucose compare glucose tolerance normal develop mellitus follow-up metabolic syndrome presence associate increased risk mellitus confidence interval impair glucose tolerance gestational high risk develop mellitus however significant woman normal glucose tolerance year risk mellitus lower impair glucose therefore woman history gestational glucose week year development mellitus
21382153 en mellitus chronic disease medical incidence mellitus great system recent study investigate mechanism disease development role function may lead cell lead increased insulin resistance factor function provide important response review analysis recent role function development type type current may new treatment type type
25066229 en management type mellitus patient hemoglobin hba1c target relative plasma glucose overall hba1c estimate effect hba1c patient insulin development important management treatment show reduction hba1c effect suggest effect insulin fasting plasma glucose effect body weight population therefore important addition current patient glycemic target insulin therapy
27178737 en factor demonstrated metabolic effect several study show type mellitus T2DM patient increased level decrease suggest resistance aim study investigate effect level metabolic parameter patient new diagnose total participant new diagnose T2DM patient healthy control T2DM patient week treatment level metabolic parameter measured patient significant high level control difference found control T2DM patient treatment result decrease BMI hba1c total cholesterol also vs model assessment insulin resistance also decrease vs model assessment function significant high treatment vs change negative correlate change fasting insulin insulin insulin resistance function week treatment may also role level T2DM patient
25315984 en aim present study investigate patient type mellitus use evaluate relationship study included patient year age healthy control year evaluate metabolic parameter well patient control test use compare test use compare correlation test use association patient healthy control mean value high patient healthy subject on significant negative correlation found age negative correlation hba1c presence negative associate hba1c also correlation hba1c associate patient
25587544 en recent evidence suggest chronic role diabetic aim present study investigate possible correlation presence patient type mellitus patient clinical datum ratio sample serum level determined patient patient old high hemoglobin level hba1c diabetic cardiovascular disease treatment significant correlate presence cardiovascular disease hypertension hba1c level correlate protein serum level correlation patient type DM serum level associate presence
24535206 en type mellitus T2DM year association study revealed associate T2DM population study demonstrated risk score risk T2DM among individual age range T2DM increasing number score improve although may current show intervention effective T2DM level risk among individual high patient T2DM risk profile improve lead positive change study investigate role T2DM population reduce disease
24115739 en compare prevalence metabolic syndrome body mass index BMI low lipid hypertension mellitus patient
23506452 en model type change disease model prevalence estimate weight model model included population prevalence incidence mortality rate case health ratio individual individual without outcome case associate medical type base case case diagnose diagnose prevalence rate individual year old increase increase diagnose increase change disease high per age datum regard care improve method use present study effect chronic disease
25169561 en therapy increased individual type mellitus disorder glucose important care population multiple mechanism significant prevalence although remain risk associate well range treatment datum current management
24981073 en prevalence mellitus DM range however little known incidence DM estimate aim present study incidence type type DM T2DM respective cohort
25786107 en type mellitus T2DM metabolic disease insulin resistance cell elevated blood glucose level cause diabetic complication decrease also regard health care system therefore increasing prevalence risk factor mechanism may therapy regard research perform evidence important role well early event development T2DM age group protein lipid potential one contribute factor one reported age increase impair system age per condition age contribute little chronic condition age also risk factor T2DM however role age T2DM diabetic review age development T2DM role diabetic complication
27616634 en investigate treatment glycemic target patient type mellitus treat insulin determine regard study two retrospective analysis use database patient treatment datum total patient treat insulin included analysis patient similar insulin baseline follow-up number new increased baseline indicate increase insulin need blood glucose patient patient insulin included patient large patient therapy glycemic may improve insulin rate increase patient glycemic target
26025697 en relationship association study group diagnose gestational mellitus well known aim evaluate woman diagnose association lipid total determined plasma woman among diagnose level significant high level significant lower woman level high group group level significant lower show significant positive relationship hba1c value level increased level decrease woman receive compare normal increased level decrease level plasma also found present woman diagnose little woman
26184423 en first month on number case due recent show cause associate report clinical two one whereas disease year age
25832931 en aim study investigate association incidence impair glucose retrospective cohort study man without baseline two health participant group base number impair glucose impair glucose define risk factor fasting plasma glucose level plasma glucose level hemoglobin hba1c value risk develop assess use interval day incidence association number subject two odd ratio or confidence interval CI subject three or CI compare subject one present result impact impair glucose risk develop intervention aim assess individual risk develop
25748740 en aim study investigate clinical factor associate renal patient type perform study patient type hospital patient two group group patient estimate rate group patient compare age body mass index BMI blood pressure duration use insulin datum include hba1c blood pressure several two group on logistic regression analysis perform identify factor independent associate renal significant high value BMI duration group group high compare group logistic analysis revealed independent factor associate renal odd ratio confidence interval datum suggest high addition associate renal cohort type
25383920 en blood glucose care mellitus patient insulin test system potential examine test among old determine whether health care system associate perform retrospective cohort study use datum on year on total year old use health care system receive test year included test included complication hemoglobin test test define per day per year among medication oral medication insulin without insulin per day per year among old receive receive receive range group great odd group vs adjust odd ratio or CI medication vs or CI oral medication vs or CI insulin vs or CI insulin similar use receive glucose test use potential result
25153374 en assess function type mellitus conduct study patient age man control evidence disease perform function test include ratio total ratio resistance ratio duration metabolic control insulin presence diabetic complication analysis use compare duration year ratio found significant high patient control patient also lower high control difference function base duration disease metabolic control found difference development influence function
23829980 en reduction identify factor individual mellitus study aim compare patient without control diabetic patient diabetic patient without measured use include pressure analysis system study difference range model different use analysis assess cohort show significant lower value compare control group lower range value found group compare group without significant change observed diabetic group diabetic group on lower observed cohort finding suggest diabetic patient without study provide associate
24781254 en negative gene target study show role mellitus type two major type reduction insulin cause dysfunction response insulin resistance review control insulin ratio insulin insulin mass review also examine insulin resistance change insulin insulin glucose type protein review potential include use gene therapy function well role potential
19809308 en factor elevated patient mellitus due decrease function investigate patient mellitus without disease group reported increase significant therefore measured also patient activity concentration measured patient mellitus without mellitus mellitus mellitus treatment mellitus group concentration significant high whereas activity significant lower healthy control mellitus group significant high activity significant healthy control ratio lower control mellitus patient group increased significant treatment whereas activity remain patient mellitus significant lower concentration activity plasma control although mellitus mellitus patient possible mellitus patient increase concentration treatment due change
20123914 en study test clinical significant population sample increase risk mellitus examine effect characteristic found risk large sample adult aged year assess baseline use case diagnose according assess use risk factor follow-up conduct year determine incidence baseline case subject identify risk mellitus high among subject compare subject association remain significant potential include risk factor estimate rate mellitus increased risk mellitus also associate characteristic treatment associate increased risk significant associate increased risk mellitus characteristic found may role development adult population
25765835 en metabolic disorder contribute complication randomize clinical trial conduct evaluate effect index type mellitus present randomize clinical trial type patient aged old medication two group patient treatment group receive group receive day datum weight BMI well base study fasting blood sample obtain index assess baseline well patient study report adverse effect significant increased activity total compare patient respective significant reduction level group compare group concentration significant decrease group compare improve index decrease level T2DM patient
22529694 en investigate association type study assess relationship type mellitus identify study according present analysis perform analysis included study according study assess use odd ratio base model included study according study assess factor can potential outcome result age group year body mass index BMI BMI history reported result analysis conduct include database total study identify analysis base model study compare patient odd ratio or CI study cohort study study compare participant or CI study cohort study respective on analysis study indicate patient high risk develop type compare control odd ratio CI among patient patient or CI age year or CI increased type result may factor may finding association type mellitus association remain determined however study sample
25156085 en level serum type without finding total type control subject without included study participant without base clinical study serum level use level significant high serum participant type compare control participant range vs serum vs positive related impair study score high level serum participant without range vs serum vs level associate impair function high level diabetic suggest role development relationship level indicate may potential diabetic
24386644 en new target treatment type mellitus cell cell provide drug insulin study identify large base effect T2DM model test oral glucose tolerance test normal chronic perform evaluate diabetic model show improve glycemic control normal insulin also increased identify chronic observed blood glucose fasting insulin result suggest may potential treatment patient type mellitus
23848031 en associate increased concentration protein two consider early aim study compare level parameter blood glucose control patient mellitus type disease patient disease without study included patient diagnose mellitus type patient two group according disease first group included patient previous diagnose disease group without disease hba1c parameter glycemic control measured level group high group difference group statistical significant level also significant high first group level two group value value parameter glycemic control group show control mellitus vs among group statistical significant difference type mellitus disease significant high level patient disease disease parameter blood glucose control group group show value poor disease control medical research identify associate
24493100 en type mellitus T2DM increased risk function reduce increased poor control blood pressure lipid level risk factor effect treatment function examine whether therapy hypertension therapy reduce risk function total patient clinical trial include participant without baseline clinical evidence hemoglobin hba1c level less randomize less vs less vs patient cholesterol level less participant follow-up assess baseline month on participant undergo baseline assess change mean hba1c level mean age year mean duration T2DM year month difference function found trial trial month vs group difference CI therapy effect compare participant T2DM high risk cardiovascular event control therapy presence control cholesterol level effect month follow-up control associate great month relative therapy trial
25648392 en gene reported associate type mellitus T2DM result early result evaluate association gene T2DM risk identify perform study association gene T2DM risk determined perform review study included total T2DM case control gene study evidence association gene T2DM risk gene study also evidence significant association gene T2DM risk addition similar result obtain present indicate gene associate increased T2DM risk
25524952 en review aim examine obesity type mellitus T2DM among adult identify on review study obesity T2DM conduct review database according study prevalence increased obesity prevalence increased T2DM prevalence reported increased risk obesity T2DM follow female low level number study disease indicate associate increased risk whereas associate decrease risk however study obesity T2DM within need overall finding provide study control
26817600 en evidence associate high mortality risk type little known mechanism may association role association first study aim mechanism present result prevalence type finding clinical research measured use first participant study large cohort study measured type assess oral glucose tolerance test logistic regression analysis use estimate association type adjust age type high level odd ratio CI current disorder respective type negative type odd ratio respective individual type less less less less similar individual without type although effect type different compare individual without type analysis within study increase mechanism mortality type
24606573 en on study adult year type mellitus
23430571 en type mellitus T2DM use disease adult common early age T2DM important present obesity insulin resistance contribute increasing prevalence T2DM population treatment include insulin glycemic control disease therefore increased risk complication review diagnosis management complication T2DM association
26757741 en relationship status control complication however datum determine impact status glycemic control complication type mellitus care clinical datum subject female mean age year medical retrospective relationship status hemoglobin hba1c level body mass index BMI blood pressure lipid profile mean duration year mean BMI value hba1c patient hba1c level mean level cholesterol female subject associate BMI blood pressure level female associate current age age diagnosis level significant correlation hba1c high study sample found associate adverse control
25010493 en protein common consider recent evidence protein also obesity type mellitus T2DM protein target plasma identify study profile protein plasma sample obtain individual patient without T2DM plasma sample group analyzed potential target analysis on total protein identify plasma sample three group protein patient T2DM whereas group protein plasma cell among identify protein several obesity metabolic disease
27477242 en investigate patient type mellitus patient year old first within month datum included treatment adverse drug included patient female mean age duration year year respective patient overall patient patient included complication renal disorder disease cardiovascular disease revealed patient T2DM new risk factor can result identify possible patient
25649908 en estimate incidence type mellitus T2DM number T2DM obesity conduct cohort study among participant man aged year mean duration follow-up year examine relationship obesity risk T2DM model population risk obesity also estimate number T2DM event obesity use incidence T2DM population mean follow-up year incidence T2DM per man woman confidence interval CI T2DM among man CI among woman obesity CI among man CI among woman CI T2DM obesity adult year result indicate T2DM obesity important healthy weight reduce T2DM
25648389 en determine time oral therapy insulin therapy factor associate insulin among patient type mellitus T2DM retrospective study identify patient T2DM therapy follow-up perform analysis time insulin therapy factor associate insulin determined use logistic total patient woman mean age year treatment year patient insulin therapy use therapy associate great risk insulin or CI year age or CI therapy or CI reduce risk insulin year treatment T2DM insulin therapy age type insulin patient
21780542 en relationship mellitus DM disease subject study diabetic patient time increased risk disease metabolic control review diabetic patient disease recent study reported result obtain diabetic patient subject value hemoglobin high regard type DM positive relationship disease development show control can reduction hemoglobin therefore disease glucose cause increase research reported control patient show high level factor can mechanism use cause major due value high protein therapy month treatment reduction factor can major role determine glucose level patient due disease chronic cause increasing concentration factor
21742788 en one major function insulin target possible contribute also effect several also association type type also individual type review role include mechanism
24112450 en evidence type patient cardiovascular aim study effect type mellitus patient dysfunction determine change level plasma patient control type mellitus included study patient receive week week plasma sample analyzed use index function plasma protein cell score improve week plasma level decrease whereas increased week plasma level correlate score reduce protein level decrease compare control however significant reduction improve control type mellitus patient associate reduction plasma level system suggest possible new mechanism reduction effect
25868836 en primary obesity related disease study present outcome regard type mellitus DM system outcome DM total patient DM woman man obesity mean body mass index undergo present study score patient age body mass index level duration DM DM evaluate use month patient follow-up datum weight mean hba1c decrease on significant number patient glycemic control include patient improve patient DM high score patient high score also high rate DM score score effective weight DM score system DM treatment
17318848 en cause cell gene dysfunction response cause include gene identify patient gene on on identify first reported case define new gene syndrome gene consider mechanism patient present
25478954 en impact population determine characteristic prevalence analyzed datum individual medical included patient diagnosis assess characteristic individual without individual without evidence prevalence high among individual increased study period patient old year association DM relative DM among individual old year datum suggest old year old due high prevalence individual may patient old year old
22161430 en chronic insulin resistance elevated hba1c level associate lower hba1c level control disease history may effective clinical management method although also use history system although first remain impact method history clinical care patient outcome
24388726 en clinical show elevated hypertension estimate relative risk associate metabolic syndrome conduct analysis patient type mellitus T2DM risk female age sample treatment cohort health care system datum according regression model datum T2DM regression provide model or model or also level blood pressure result show contribute several may T2DM cardiovascular risk
24001058 en determine association oral health old adult mellitus risk factor system sample adult aged old adult DM report due disease without vs less receive care year vs disease associate time great odd general health confidence interval CI care month associate time great odd general health CI receive care month poor time associate care associate old adult DM research need determine whether oral health improve population
25676592 en treatment patient mellitus renal also result improve increasing less well factor development well new review current
23726024 en two reduce evaluate subject age new recent diagnose range day general study use demonstrated response reduce need insulin two year diagnosis drug treatment cause reduction cell datum suggest mechanism may mechanism adverse effect treatment study identify significant difference among patient group suggest development therapy metabolic subject show clinical response
23709646 en dysfunction condition syndrome disease disease patient mellitus condition decrease examine participant diabetic participant without diabetic control participant use diabetic use early diabetic base presence perform participant decrease impair reduce compare control however little presence assessment although associate dysfunction participant without diabetic diabetic without similar function control general presence associate concentration may little dysfunction diabetic patient population
26393635 en factor gene reported associate type mellitus T2DM population population population aim present study investigate association gene T2DM population T2DM patient control present study two use mass association T2DM gene total participant model vs show significant difference T2DM control subject respective model respective model vs total participant show significant difference T2DM control subject model datum gene associate T2DM population
26243222 en mellitus factor diabetic patient outcome poor risk investigate effect mechanism treatment blood cell type mellitus T2DM T2DM subject three day treat per treatment day T2DM significant decrease significant improve outcome decrease compare T2DM control group treatment significant indicate increased significant increased treatment T2DM significant increased increased decrease compare T2DM control also significant decrease factor treatment day significant increased well decrease factor T2DM reduction increased may contribute effect T2DM
25733496 en assess influence body mass index BMI adult type mellitus receive primary health care datum patient medical care due first reported related month follow-up reported according year patient group related BMI age compare patient patient great BMI high patient BMI patient BMI patient BMI on total score patient adult type mellitus BMI may influence independent patient risk receive risk factor
22411135 en factor large aim study investigate whether function can patient presence type study included participant patient without type mellitus control determined system use patient high vs lower vs patient show impair function compare healthy participant significant negative correlate diabetic patient patient healthy participant analysis demonstrated diabetic group remain independent analysis perform patient revealed obesity metabolic syndrome relationship dysfunction diabetic patient patient without result suggest type mellitus hypertension mechanism
25000339 en mellitus occur patient patient undergo therapy lead fasting glucose retrospective review perform patient new diagnose without history DM treat therapy patient undergo therapy follow primary patient study response response response patient response odd ratio or normal glucose confidence interval CI compare or CI or CI adjust weight regression model response significant or CI patient undergo therapy fasting glucose response may
24979618 en aim study examine association risk factor include mellitus DM age retrospective review patient diagnose analyzed association age DM history mean age diagnosis year occur early current year old compare year old year old patient DM year old year diagnose patient DM within year year old patient without DM year old analysis current history associate early DM associate patient current history associate age DM associate
26568110 en observed gestational may role increased cardiovascular risk present study aim examine influence previous gestational insulin need function three year investigate function function measured assess test woman gestational year study activity blood determined year insulin treat gestational impair function increased observed compare previous gestational dysfunction elevated activity correlate factor related disease
25095667 en type investigate without assess type high compare group level lower hypertension compare without change type associate high
24502860 en drug weight increase risk examine risk use general study study use health research database on total patient type mellitus control identify use logistic regression model datum analysis period diagnosis treatment duration define analysis perform use score method well different patient use year increased risk adjust or CI increasing mean use associate increased risk increased risk therapy patient aged year less adjust or CI high old adult adjust or CI finding suggest use may associate increased risk type mellitus adult therefore use evaluate potential risk
24783883 en prevalence increasing significant therefore diabetic patient effect body adverse oral health may diagnose diabetic patient therefore important oral disease relationship oral health control diabetic patient according
21757386 en primary aim study examine effect therapy hba1c mellitus DM type population total subject DM hospital included follow-up cohort clinical study two therapy receive therapy control follow-up clinical blood sample month group present great reduction index compare group whereas month major difference hba1c level group month group present CI great reduction hba1c group reduction independent age body mass index however difference hba1c great individual type DM reduction CI compare type result great health patient DM improve oral health type DM may effect glucose management can possible lead health
22225955 en activity protein role lipid obesity metabolic syndrome type mellitus previous study model obesity type mellitus improve metabolic examine effect new develop use model impair glucose cause glucose lead obesity one treatment day improve insulin factor obesity finding insulin obesity metabolic syndrome type mellitus suggest similar may treatment
25630759 en determine risk mellitus DM patient large cohort health database use conduct retrospective cohort analysis study cohort patient without age index year regression analysis conduct estimate risk cohort increased risk develop DM compare cohort patient without use increased risk develop DM patient use increased risk develop DM addition patient receive treatment associate disease patient high risk retrospective cohort study associate high risk DM related adverse effect therapy
27166384 en mellitus associate increased risk however mechanism poor investigate association cohort study identify among mellitus mellitus identify use patient related prevalence mellitus per baseline risk per adjust relative risk confidence interval association year age duration risk associate type type mellitus significant woman previous complication high risk mellitus without complication relative risk confidence interval relative risk confidence interval respective associate mellitus relative risk range increased risk mellitus time association complication suggest role glucose
22537054 en metabolic effect development obesity define metabolic syndrome obesity contribute high risk metabolic assess baseline datum cohort study base medical glucose tolerance test incidence analyzed study regression model obesity development assess subject number positive total subject assessment develop incidence increased number positive although subject obesity high incidence without vs difference adjust number positive ratio participant three positive difference incidence subject without obesity ratio incidence subject without obesity similar subject obesity also number positive suggest obesity important metabolic syndrome
25358219 en mellitus major risk factor cause cardiovascular disease patient risk event similar patient without event patient disease study determine mellitus patient present syndrome study conduct medical medical patient present syndrome year age included study patient included study female mean age study participant year mellitus known diabetic poor control event patient mellitus study significant one patient syndrome diabetic
24479638 en mellitus DM common health medication patient mellitus study assess medication potential association related patient type study primary outcome study medication use assess medication use assess medication test use assess related analysis use statistical patient mean age participant range year participant female study sample consider score analysis show significant associate medication adverse medication general diabetic patient high score medication less or CI or respective however diabetic patient high adverse medication high or CI or CI important factor medication among diabetic patient use identify high risk patient positive influence medication
24276361 en patient undergo total mellitus may increase risk therefore assess whether mellitus increased incidence within day incidence within day compare diabetic patient undergo hospital relationship mellitus patient occur within day patient group group observed patient respective logistic regression analysis show risk high patient without mellitus CI significant difference age hypertension BMI duration blood duration two incidence day significant high patient without
22272898 en recent incidence develop type associate significant disease impact mortality recent evidence individual history disease follow glucose metabolic syndrome obesity mellitus research intervention target obesity show metabolic early disease addition medication therapy system show weight control treatment change weight metabolic profile individual risk therapy research aim complication cardiovascular
26930724 en aim study compare level hemoglobin hba1c type mellitus DM patient two different method study conduct type mellitus patient patient medical hospital diagnosis mellitus fasting serum glucose level clinical history high type DM hba1c value found DM patient estimate two different method respective high observed hba1c indicate case poor glycemic control however significant difference observed hba1c value method use significant hba1c indicate complication associate DM therapy patient method hba1c report time patient use without glycemic control clinical change treatment
23242298 en disease disease associate increased risk develop severe disorder among risk factor mellitus gene demonstrated increasing risk develop disease
23056027 en diabetic remain common one major cause develop show however due mellitus DM presence common disease study conduct determine whether diabetic independent related patient mellitus DM total patient DM low include case time DM type control assess clinical datum assess use year female presence diabetic DM duration diabetic risk factor use logistic regression model significant associate female diabetic risk time high patient diabetic time high female DM therefore increase health care patient DM
19169480 en disorder due cause reported gene aim present study gene one old female analysis included gene analysis show patient present also normal one
23265924 en present aim assessment risk clinical patient perform use or study assess risk subject without study characteristic study on perform adjust risk ratio subject use effect model analysis perform assess ratio several possible study included subject mean follow-up year case on high incidence found diabetic subject vs adjust risk confidence interval associate significant increased risk mechanism
24933107 en current determine function type mellitus without use finding database identify study function type effect difference function subject type control without value study identify type perform significant lower control without evaluate effect range large effect CI CI lead measured study investigate type therefore investigate impact function type can perform datum individual study reported may relationship type function present finding patient type change can impact type treatment management assessment
17322929 en on multiple treatment cell present metabolic high also patient develop low renal blood analysis syndrome type renal cause renal renal therapy therapy
24328699 en mellitus hypertension obesity risk factor cardiovascular disease medication current use management effect use management disease found activity management activity study activity effect blood body weight lipid profile protein evidence datum use patient obesity review clinical study potential influence mellitus cardiovascular risk factor conduct clinical control study
22944520 en presence severe define rate identify group patient poor among patient mellitus however factor contribute development aim identify clinical factor cohort diabetic patient disease patient type mellitus rate activity activity logistic regression analysis included duration mellitus diabetic level hba1c presence disease history patient patient duration year vs year high prevalence diabetic vs vs vs significant high level hba1c vs lower analysis hba1c factor independent associate odd ratio CI patient type mellitus presence correlate glycemic control diabetic complication impair increased level hba1c independent associate
24132780 en whether different general investigate whether association factor mortality risk individual without cohort participant without known regression model without factor overall mortality risk BMI ratio group activity ratio test assess statistical difference regression adjust mortality risk among individual compare without increased CI related lower mortality risk related increased mortality risk association significant different individual similar difference without status influence association mortality risk may healthy association similar study suggest mortality patient general population
24563492 en mellitus common disorder diabetic type mellitus result insulin resistance reduction insulin diagnose management mellitus present number insulin type method therapy base individual patient need may also patient diabetic diabetic complication patient multiple disease may time diabetic treatment current management diabetic review current management diabetic diabetic new diagnose diabetic recent include retrospective study body clinical datum use new insulin
23590576 en observed patient mellitus DM association two disease base recent research patient DM different type diabetic patient also patient remain current suggest multiple factor metabolic factor gene may contribute condition diagnosis treatment condition although common drug patient use drug status treat reported effective DM patient however drug consider important factor treatment condition blood glucose level normal level patient drug
22591707 en examine whether individual type can development gestational mellitus woman follow-up age significant ratio confidence interval respective model model adjust BMI effect suggest effect effect BMI risk risk score significant associate risk ratio confidence interval age risk score risk study population need result
22161426 en patient use medication include medication important determine assess effect treatment database trial database database trial addition perform several potential included randomize trial little two month duration intervention mellitus participant age type included duration treatment related independent datum risk trial evaluate indicate review number study can different type intervention datum found trial one system treatment study participant treatment control treatment duration range month study included adult type regard primary outcome significant reduction hba1c fasting blood observed compare treatment significant response found treatment study system treatment provide datum hba1c value one study treatment significant change adverse effect reported drug one study one patient treatment one study one participant treatment severe effect one study intervention group participant control group included study reported renal regard outcome blood lower among participant treat high patient treat treatment lipid profile significant patient treat significant high lower well lower treat participant also lower total cholesterol treatment reported increased fasting insulin level one study treatment reported high insulin level fasting level treatment group significant difference fasting insulin level treatment study assess study reported investigate diabetic complication cause significant effect use due sample regard significant adverse event reported evidence present use intervention clinical study need
22284962 en study examine risk mellitus use study study case control case type estimate odd ratio independent effect mellitus use odd ratio increased risk associate mellitus vs presence use use may associate risk due mellitus
26234220 en study association mellitus risk result remain conduct cohort study relationship mellitus database review identify study association test different patient characteristic study model use overall relative risk cohort study participant included confidence interval significant observed significant association also adjust study adjust adjust study confidence interval result statistical significant analysis found number adjust sample method case potential analysis demonstrated suggest mellitus significant associate increased risk study mechanism association
23445856 en associate function study compare result patient patient without cohort undergo perform retrospective review patient type mellitus type mellitus patient without undergo year follow-up change range score score compare group year statistical significant group however patient without great group significant respective score however patient lower score difference patient result improve function
25474385 en gestational mellitus associate increased risk develop type mellitus early diagnosis type complication type year woman previous diagnosis woman aged year old prevalence assess primary health care regard assess history risk type conduct analysis overall response adjust test compare response rate response among reported new female patient history reported woman aged year year glucose reported type among woman high high patient history first type woman history glucose identify woman increased risk type
26520160 en period woman recent gestational clinical trial period major model develop high level level individual level woman recent randomize control trial period participant three study week month randomize control intervention baseline week period compare population characteristic subject population woman hospital woman assess mean week mean week subject baseline subject randomize trial mean week subject similar age total population sample woman recent included use clinical use although woman woman early period present first study increased woman research study finding study population
26105582 en aim current study investigate effect serum on patient type mellitus effect parameter assess treatment study conduct female patient study follow patient without T2DM week patient T2DM week patient T2DM week measured fasting plasma glucose hemoglobin hba1c serum lipid high protein on patient measured serum use level patient T2DM significant lower level patient on level significant high significant decrease on increased level suggest use complication obesity T2DM correlation on level suggest common show increase serum decrease serum on level
22385344 en gestational mellitus glucose however history aim study risk factor evaluate risk glucose mellitus woman history patient study participant history care study medical history finding analyzed oral glucose tolerance test patient present impair fasting glucose study present impair glucose tolerance present mellitus gestational age diagnosis result serum hba1c concentration serum concentration diabetic need insulin therapy age diagnosis body mass index significant risk factor impair glucose tolerance increase risk mellitus several risk factor impair patient history
23911169 en assess insulin patient review conduct patient analysis patient day case insulin use evaluate according mean glucose number glucose case analysis change insulin use base mean glucose show use insulin increased low mean glucose high mean glucose however patient high receive insulin receive insulin insulin also change evaluate number patient high remain insulin receive insulin insulin therapy increased case therapy insulin clinical clinical treatment patient
25526642 en effect plasma glucose profile level investigate patient renal disease type diabetic patient conduct day plasma glucose concentration measured glucose system respective profile also assess effect parameter patient plasma concentration similar mean glucose level duration however significant increase mean glycemic glucose glucose level observed adverse event include observed day day well patient type undergo present result profile glycemic index glucose level result may possible use without trial clinical trial
26734798 en mechanism role development type parameter occur without influence insulin patient type mellitus clinical management blood sample month serum profile addition glucose level insulin use evaluate change observed significant decrease reduction insulin glycemic index BMI patient early may glycemic control contribute weight patient addition control metabolic syndrome reduction finding suggest presence patient period result glycemic control obesity contribute outcome
25364239 en management type mellitus care result complication insulin remain datum insulin use retrospective study use medical datum datum patient receive insulin insulin insulin insulin treatment investigate associate clinical total patient identify receive insulin patient receive insulin insulin use insulin use low significant difference observed insulin group hemoglobin level patient little one event significant difference prevalence datum suggest insulin high use insulin difference hemoglobin type insulin effective study
26025698 en investigate relationship complication development estimate rate cohort type mellitus T2DM study consider T2DM year estimate use chronic disease independent relationship development complication clinical datum evaluate ratio regression analysis age population year mean serum respective complication include population subject patient complication old history hypertension disease disease high level hemoglobin regression analysis major risk factor development complication increased according lower cohort T2DM reduce associate increased risk complication development
26820202 en evaluate prevalence impact woman association DM time glycemic cohort woman evaluate history time DM diagnosis glycemic control impact total woman evaluate age year DM time year present patient present respective follow respective impact patient little one patient time group vs month present patient one year high prevalence diabetic woman associate risk factor association found factor
24286159 en hba1c diagnose mellitus type
23490274 en adult type mellitus risk found low test negative suggest cause evaluate function patient correlate result metabolic patient age on disease mean hemoglobin hba1c insulin low test perform concentration plasma activity measured on response consider test patient response test patient also lower concentration different duration hba1c severe concentration compare normal one patient positive present poor response found significant patient response independent presence cell correlation metabolic control due metabolic control group population result suggest function
25416084 en evidence control trial need type mellitus T2DM body mass index BMI however group undergo study assess patient weight association patient patient follow BMI year diagnosis T2DM year on week independent influence patient consider identify use multiple logistic regression per patient weight consider control vs reported negative impact weight vs weight common per CI consider analysis negative impact weight or CI weight or CI positive influence patient patient trial group obesity negative impact weight common influence potential
23433629 en associate increased risk association perform study cohort study incidence mortality identify database assessment relative risk confidence interval estimate use model study assess use total study included found significant associate increased risk result cohort study on positive observed woman man analysis indicate increased risk independent body mass index however association mortality without mellitus may increase risk woman man
20233909 en review current therapy study use mellitus associate mellitus obesity related mellitus use perform use obesity mellitus research review examine assess study study included addition clinical regard treatment mellitus significant clinical datum research possible treatment obesity reduction research determine effect metabolic function current datum suggest may several may treatment mellitus associate therapy impact new increase risk patient outcome
26652960 en year datum care patient mellitus overall number individual number new reported case number patient however datum identify difference mortality individual cohort diabetic patient mortality development period sample patient population type mellitus use oral drug database general health provide health care population retrospective analysis identify individual database DM diagnosis base therapy group period patient analysis treat oral year year treatment little one group treatment group within year individual individual rate age group year year year mortality rate general population age group respective relative mortality among year among year among year year mortality among patient DM treat oral great relative period among general population analysis mortality among patient treat oral database show mortality among general population mortality among cohort among general population age finding mortality increasing present decrease
23359584 en prevalence obesity increased health include type mellitus T2DM previous report develop clinical management type mellitus provide study use clinical primary conduct treatment T2DM conduct treatment treatment primary T2DM included primary research consider review consider included primary datum research population diagnosis T2DM study adult patient consider little study population year review consider primary identify possible review study on study regard treatment T2DM major type treatment medical treatment study treatment study study study identify possible review included review regard T2DM present base evidence cohort study history disease group cohort clinical report use adult association cohort prevalence cohort disease case association cardiovascular risk association case on show on study study study study regard treatment datum hypertension present provide independent assess evidence provide
22707396 en association disease type mellitus well known disease prevalence adult type reported aim study assess prevalence disease patient type mellitus define investigate clinical subject patient type mellitus period year analyzed period patient type previous diagnosis disease female patient show mean age year diagnosis disease patient datum population association disease type although prevalence rate lower study present high prevalence patient disease diagnosis follow type female subject age therefore subject presence disease year
25404624 en mellitus define develop occur one year factor increased mortality increased medical decrease patient risk factor define risk patient risk obesity risk factor intervention healthy one important factor medical health treatment early assessment risk develop glucose disorder also therapy less present risk score also treatment present risk factor obesity risk score also treatment
25365004 en prevalence mellitus DM DM among hospital patient treatment care also increase prevalence DM obesity metabolic disease review examine different total diabetic patient value glycemic index glycemic new included association high prevalence DM metabolic review use database diabetic patient suggest according metabolic profile use glycemic index glycemic provide glycemic control new show glycemic control although control study need DM obesity metabolic disease although relationship increase total
26667695 en present health study control treatment prevalence increasing general population woman effect complication reported diabetic increased risk develop obesity condition can negative effect development can increase study investigate relationship mellitus impact perform subject study include large assessment age sample studied however on high rate obesity impair glucose tolerance cardiovascular metabolic disorder also increase disorder study disorder diabetic related development research increased incidence disorder
26488630 en patient type type without diabetic control hemoglobin early treatment diabetic study evaluate test time test obtain control group respective parameter lower value lower control correlate respective score patient duration history show significant decrease time effective assess function type patient history show lower parameter decrease parameter correlate duration
20361687 en determine baseline level mellitus type type risk factor conduct on use adult age year assess regard mellitus risk factor complication datum datum three adult subject adult mellitus adult healthy risk factor present complication associate disease adult reported hospital history mellitus statistical significant associate mellitus vs health care associate risk factor vs associate mellitus status adult mellitus associate risk factor disease mass
19837217 en compare mortality patient without mellitus undergo different time perform analysis primary perform follow-up mortality prevalence mellitus increased among patient undergo patient type mellitus old female cardiovascular risk factor syndrome disease severe reduce function patient without mellitus early mortality patient mellitus patient without mellitus adjust odd ratio confidence interval early adjust mortality significant lower patient patient mellitus odd ratio confidence interval without mellitus odd ratio confidence interval mortality year patient mellitus patient without mellitus ratio confidence interval mortality reduce patient compare patient without mellitus associate increased risk early mortality early mortality reduce patient without mellitus recent mortality associate mellitus
24250329 en treatment disorder adverse effect associate report patient develop mellitus DM treatment disorder negative history mean age patient DM diagnose fasting plasma glucose baseline patient consider include development DM related history DM patient
26087770 en study investigate incidence result possible due different investigate effect total incidence mellitus type large follow individual without baseline study mean follow-up time year mean total well estimate use model effect estimate increase obtain regression adjust age body mass index factor status case develop adjust total respective high estimate found individual high risk total increase type two risk general population major related high risk type two total
26201005 en examine effect old woman mellitus DM clinical analysis two large cohort population study health clinical included woman aged old clinical trial included DM baseline compare woman without model determined according activity risk clinical study period great woman DM age body mass index ratio confidence interval CI CI cohort great risk associate DM decrease CI CI cohort participant DM activity several significant associate woman DM great risk clinical without independent great activity great risk although remain risk
23351562 en gene plasma lipid potential type association gene plasma concentration investigate study investigate whether associate type total patient type healthy subject control hospital studied on logistic regression analysis perform determine association type T2DM group control group difference remain gene type mellitus population
26066789 en previous study potential associate medication result however therefore conduct randomize control trial assess effect level lipid patient type mellitus database effect use T2DM patient lipid profile study duration little week two independent datum assess included study perform use total included included result statistical increased level decrease effect compare can increase compare increased lower compare reduce increase effect lipid although may statistical increase level decrease
25828915 en high incidence type mellitus study aim determine association lipid profile control patient on total patient metabolic disease measured blood plasma mass correlation metabolic level determined positive correlate total cholesterol significant correlate positive correlate female correlate mean fasting plasma glucose correlate fasting plasma glucose overall patient hba1c significant correlate hba1c result study indicate show different association lipid level control associate lipid level whereas associate hba1c
23811317 en determine whether improve participant type mellitus control health care T2DM group perform control group baseline also assess baseline pressure use time difference participant found addition participant group significant lower intervention participant control group great significant difference time test value provide improve participant T2DM finding may important T2DM primary health care
24845092 en care patient evidence glycemic control improve outcome previous study provide show model develop lead clinical effective increased confidence care model may improve care well
25228184 en assess association mellitus disease study hospital first study database effect model use overall risk estimate included case control study cohort study study statistical analysis conduct according ratio mellitus confidence interval CI CI CI analysis base study change test risk ratio little evidence positive association mellitus risk patient
26243976 en effective control target study aim prevalence among patient mellitus population evaluate current retrospective study conduct hospital blood glucose value datum medical history therapy clinical characteristic prevalence day little one patient high respective little patient patient poor hba1c level vs day vs day patient treatment therapy use insulin oral respective control factor type treatment baseline hba1c associate great prevalence due patient management
21948010 en develop determine risk develop subject type health study cohort research follow two year factor condition type treatment analyzed subject baseline participant mellitus follow-up period mean year range year mellitus develop relative risk confidence interval CI effect aged year old CI man great relative risk woman CI vs CI subject low year significant high individual treat insulin high risk CI hypertension CI CI two increased risk mellitus increased risk develop factor high population contribute association
26295555 en determine total concentration use management obesity mellitus disease can concentration determined compare among vs can range contribute range management high concentration lower contribute compare treatment disease concentration within can evaluate high concentration can low provide provide range concentration datum response can may perform similar may provide treatment disease
23590338 en assess old individual clinical trial regard type health clinical trial clinical trial datum clinical trial type mellitus trial individual use age cause old individual poor trial investigate treatment type mellitus individual use age significant common trial sample less subject vs present trial poor trial trial poor can old individual also present trial study old old individual trial regard type mellitus reported disease value evidence use old patient mellitus
21972250 en hba1c control diagnose type mellitus type mellitus T2DM diagnose mellitus hba1c use hba1c test T2DM relative individual patient reduce system diagnosis T2DM include impact diabetic group hba1c population health although primary individual use hba1c diagnose T2DM may health lead investigate health
25277955 en evidence potential independent impact risk study man high cardiovascular risk profile examine general population among conduct cohort study use datum health medical database general population individual case year year body mass index BMI adjust medication patient man mean age year incidence rate woman man case per respective whereas rate case per among subject high among woman compare among man CI vs CI CI vs CI respective value difference general study suggest may independent associate increased risk association significant large woman man
22024974 en type mellitus impair blood glucose level glycemic control occur insulin early disease dysfunction several include system type mellitus however factor cause disease mechanism influence risk factor resistance condition increased review effective response factor determine type mellitus analysis response level identify target intervention patient risk develop type mellitus disease
21881524 en high mass may patient mellitus several factor may patient study assess prevalence factor associate patient analyzed baseline datum patient year treat hypertension type mellitus without evidence disease dysfunction study diagnose patient hypertension patient woman high BMI prevalence metabolic syndrome high serum level treat model female odd ratio or confidence interval CI high serum level or CI BMI or CI independent related patient type mellitus without evidence disease blood pressure level association metabolic syndrome patient may important
24934410 en mellitus DM remain investigate whether DM risk factor development early related presence examine patient undergo medical health investigate whether DM related development early follow-up patient first significant associate presence DM follow-up period range month mean month early new patient first patient without DM patient DM analysis demonstrated DM independent related development early respective identify patient without DM whereas identify patient DM increase risk early development
25044726 en common associate may role complication determined level woman type mellitus compare control examine association health clinical factor function health lower study woman study cohort case control lower level control adjust use health associate woman without negative associate use woman whereas positive related use control positive association ratio woman negative relationship weight control positive associate negative associate use related glycemic control function health level lower woman control also association woman without research need determine associate health outcome
21722589 en insulin therapy glycemic control patient remain patient mellitus diabetic patient glucose control insulin therapy less lower mortality diabetic patient blood retrospective review perform care patient included diabetic patient patient receive insulin target blood glucose level outcome compare diabetic patient diabetic patient control level level diabetic patient compare patient vs mean diabetic patient high group control vs difference hospital diabetic patient well control compare diabetic significant high incidence compare diabetic result show diagnosis independent mortality diabetic patient outcome diabetic associate great suggest patient may blood glucose
23092114 en mellitus impact individual lead complication new drug target examine drug protein target present target insulin resistance factor drug treatment metabolic disorder relationship mellitus complication disorder
23948106 en determine risk reduce function subject impair fasting glucose determine relationship fasting glucose hba1c subject cohort age year regression use estimate relative risk confidence interval year follow-up study participant develop primary although risk factor prevalence incidence high subject subject normal hba1c level increased risk adjust cardiovascular risk factor CI CI subject risk increased risk increasing fasting glucose hba1c level study provide evidence may contribute development disease subject reduce cardiovascular risk profile cardiovascular disease common risk factor
23651614 en major significant among patient type mellitus disease negative impact important risk factor development major high significant association adverse health outcome treatment primary care need intervention major disorder lead aim study evaluate indicate major among patient type mellitus disease primary care also conduct control trial general level aim include participant receive indicate care treatment treatment treatment general primary clinical outcome incidence major disorder measured outcome include outcome measured include health care medication perform baseline intervention investigate new case among type mellitus disease effect clinical outcome health care provide treatment primary care trial
23613372 en on woman type mellitus present weight medical history significant hypertension therapy revealed treatment blood level low analysis show revealed change lead blood result diagnosis change high patient total within week therapy several patient mellitus occur syndrome disease diabetic consider case
22238171 en evidence suggest mellitus risk however study use estimate impact general population study investigate risk among cohort study perform baseline datum health participant medical care health database diagnosis use disease clinical disease identify use obtain use regression analysis association general treat significant associate adjust ratio confidence interval CI CI respective compare without treat participant risk increased number complication mellitus increased risk among complication odd ratio CI similar risk increased among high complication index score risk develop increased among increasing
20667559 en aim investigate association gene type mellitus population on total subject normal glucose type mellitus subject study subject use show significant difference among type mellitus subject respective subject significant high plasma glucose mean level compare group value remain significant adjust age body mass index significant difference parameter observed subject according show significant difference among type mellitus subject although base test test base remain significant study may associate type mellitus although may individual associate
24629412 en increased may adverse glycemic control patient although patient general datum individual aim present study evaluate patient type subject without assess subject type patient body mass index control subject evaluate clinical factor also type lower concentration compare control subject although less compare subject without individual demonstrated negative relationship control subject relationship participant type patient demonstrated high compare female patient significant correlation glycemic control duration type lower control subject decrease reduce associate glycemic control individual
24032999 en although study show increase risk whether poor glycemic control woman associate study aim determine relationship hemoglobin hba1c level large cohort old examine old woman response rate study sample patient primary independent mean hba1c year outcome included activity due use regression logistic regression model age body mass index treatment duration woman reported mean age year hba1c level associate presence however among woman hba1c associate due hba1c adjust odd ratio confidence interval analysis hba1c level associate presence however woman poor glycemic control hba1c associate activity due study need determine whether glycemic control hba1c lead activity due
26273944 en mellitus DM chronic disease prevalence on chronic disease develop patient DM clinical characteristic DM patient chronic disease identify metabolic control associate presence study DM patient number mean mean perform use patient analyzed mean age year type DM DM type gestational DM cardiovascular risk factor hypertension patient complication complication disease complication patient value hemoglobin hba1c total cholesterol cholesterol hba1c high patient complication hba1c vs patient complication significant hba1c vs without complication total cholesterol lower group complication similar result observed vs patient without complication characteristic patient similar study reported value hba1c total cholesterol result value large population lower level patient complication
25529979 en assess profile patient type renal patient estimate rate receive day primary change baseline day glucose level included change fasting plasma glucose level level glucose blood therapy significant reduce level relative total population patient decrease total population respective significant reduction fasting plasma glucose level relative baseline total level significant elevated relative significant elevated total population effect patient reduction suggest can treatment patient type renal
23330246 en on large number type mellitus T2DM number type mellitus glucose conduct incidence T2DM increased estimate clinical first review glucose conduct clinical characteristic diabetic recent year regard include medical care develop insulin therapy therapy multiple insulin therapy use insulin increasing patient addition medication T2DM review treatment T2DM change glycemic control result development treatment
23096408 en role model however study diabetic patient aim study protein type mellitus compare patient possible correlation parameter sample obtain diabetic patient undergo analyzed level protein level analysis sample also subject lipid cholesterol cholesterol analyzed high diabetic compare patient protein also high diabetic patient level difference found diabetic compare patient positive correlate plasma level respective also correlate plasma glucose level result suggest may role lipid associate type mellitus
24517949 en rate mellitus related regard mellitus database database database year related model estimate parameter include rate difference age result sample sample evaluate analysis perform evaluate impact two included total sample prevalence rate among patient according result analysis level rate among positive sample hospital high age negative sample level rate mellitus high high among case age positive hospital
23540213 en study mellitus patient hospital database health datum related patient cause period year number increased per per hospital treatment patient type per well type per patient year age type whereas old age group patient treat hospital type general type disease old patient one cardiovascular disease reported type disease hospital mortality rate decrease regard type hospital decrease one day day complication important due increasing year significant health care early diagnosis treatment well reduce medical care
23463735 en result randomize control trial demonstrated risk complication reduce control patient type mellitus T2DM however patient diagnose new therapy mechanism independent insulin may provide patient control important role glucose primary glucose glucose treat T2DM reduce increasing glucose recent treatment T2DM improve control patient T2DM use medication insulin well low cause increase event study reported result clinical trial define role new mechanism treatment reduce patient T2DM
25388747 en present review evaluate relationship type mellitus individual on found decrease diabetic subject possible due increased need control glucose protein effect function group found decrease mechanism however show metabolic control diabetic patient important decrease use first drug two found disease need consider risk factor development well complication cardiovascular one although study found association glucose research need study use show result review evidence use type mellitus however patient use period may need
27523891 en determine association serum whether serum independent patient
26927355 en prevalence current high prevalence increased decrease on new can provide large body may cause contribute whether new use control metabolic syndrome study clinical however healthy treat addition healthy clinical
26342170 en test disease among individual mellitus important estimate risk presence cardiovascular disease evaluate index test among patient two independent potential study study datum study evaluate index test test assessment perform use assessment study study identify study patient age year duration year two study reported patient two patient remain patient without index assess index test overall positive ratio negative ratio range respective patient general high two three study indicate poor range on index associate positive ratio respective less one study also two study use blood analysis reported diagnosis patient mellitus adverse presence evidence suggest index analysis may diagnose patient without datum one clinical study evaluate individual poor improve need study
25172889 en type patient may blood response may improve function glucose assess effect week glucose type randomize control trial independent use respective glucose use model assessment insulin resistance test assess man type year old subject undergo week subject receive follow test improve similar group change function group study suggest function week type patient function type
24059649 en evidence effect therefore aim study evaluate effect index metabolic patient type mellitus participant included diabetic female intervention group well control group receive week respective fasting blood hba1c insulin protein plasma measured intervention patient significant decrease hba1c fasting insulin model assessment insulin resistance compare group increase significant compare group metabolic woman type
26087341 en recent study obesity insulin resistance type mellitus obesity among individual obesity rate among risk development increased obesity may occur early age among individual obesity increase risk among individual metabolic syndrome disease therapy glucose therapy may therapy glucose control management obesity among adult insulin resistance may improve among individual review month obesity insulin resistance new result treatment
27131406 en determine insulin resistance important cardiovascular risk general population type mellitus assess use parameter clinical study included patient type body mass index index level ratio investigate possible correlate parameter insulin level fasting glucose insulin ratio fasting glucose insulin model assessment insulin index also independent index studied regression well analysis use use improve cohort patient type parameter association
19496967 en mellitus disorder known cause insulin report patient mellitus severe revealed revealed reported case mellitus gene previous role development
23406734 en study investigate relationship type mellitus T2DM risk primary little known effect duration two cohort health study health study use assess association among T2DM duration risk follow-up case identify among man woman T2DM significant associate increased risk man ratio confidence interval CI woman CI high risk observed first year diagnosis decrease duration development found known risk associate increased risk within year diagnosis population suggest primary association
25524487 en determine whether type mellitus evidence increased early measured increase risk cardiovascular disease adult whether total patient control perform assess age pressure high vs decrease vs control control vs control difference age negative associate hemoglobin hba1c related low two insulin demonstrated significant lower increased difference two lower insulin demonstrated less associate control datum suggest large early
26508189 en study reported clinical disease type mellitus disease study difference finding however review aged year present datum medical history positive perform within month included identify diagnose type mellitus diabetic common group diabetic positive different compare
21502652 en one first management patient type mellitus glycemic hemoglobin hba1c target patient recent however glycemic method hba1c target range patient several factor include assessment patient risk complication risk therapy overall clinical condition status system also role therapy hba1c target recent clinical trial old patient type mellitus show therapy cardiovascular disease outcome evidence suggest glycemic target patient relative recent type mellitus little complication aim complication year however high target consider old patient type mellitus evidence multiple risk factor review hba1c target range patient
25918568 en studied influence type relationship severe studied subject age group report case without mellitus history present hospital type severe
24993340 en system system body individual cell system associate system potential negative complication type result insulin disease type mellitus one disease mechanism general cell determine factor cause system response
24946264 en important role development type present study investigate effect mellitus examine mechanism glucose insulin resistance diabetic associate increased insulin resistance decrease increased activity plasma reduce level cell result demonstrated first time decrease blood glucose level mellitus
25047765 en investigate value patient management type development study base care general study population health association patient prevalence year diagnosis incidence year use odd ratio logistic regression ratio regression model prevalence year diagnosis CI among patient general poor vs patient management associate high prevalence odd ratio CI poor vs influence patient treatment odd ratio CI patient examine follow-up year poor vs influence patient associate ratio CI general assess influence patient poor vs incidence increased ratio CI poor vs patient also associate high incidence ratio CI although adjust patient management included treatment complication
26962749 en study evaluate effective management intervention patient type two mellitus on use study conduct one participant assessment intervention group control group control intervention group receive diabetic intervention group receive intervention management follow-up study assess group difference change use found significant significant change observed finding study health provide diabetic intervention intervention research
26728951 en determine whether change among type mellitus DM investigate correlation value type DM healthy control subject included function subject type DM evaluate group value different association function test value significant change value compare healthy control group value negative associate increased value positive associate test negative correlation value test value positive correlate however negative correlation value level well negative correlation value demonstrated significant change value change can early finding suggest may level type may change well correlate dysfunction type DM may early period disease function
25722989 en study investigate association factor type diabetic analyzed diabetic patient factor assess blood sample study one year diabetic patient use blood positive among control diabetic patient value negative among one value high value lower score value control diabetic patient show statistical significant negative relationship statistical significant relationship finding related factor patient mellitus type
25456645 en provide oral drug review on found low evidence included regard outcome mortality cardiovascular event mortality incidence disease previous healthy individual new diagnose T2DM drug regard reduction hba1c baseline clinical trial different time oral T2DM provide therapy trial show hba1c reduction compare however significant adverse event include weight common patient trial low low risk adverse effect use oral drug treatment T2DM use group high risk chronic disease may associate mortality increased risk drug therapy base overall treatment patient
24661762 en mellitus chronic disease associate common adult type mellitus T2DM compare without diabetic complication associate show increase risk disorder poor glycemic control T2DM patient can lead complication patient develop research need determine relationship T2DM mechanism
25894242 en type common disease incidence insulin therapy case complication mortality increased therefore development effective important medical also disease study type primary individual occur aim type subject study show result
27894216 en glucose treatment type mellitus T2DM lower blood glucose renal glucose increasing glucose reported may potential adverse effect include increased risk decrease clinical study associate change serum increase serum within normal associate increase serum type decrease total year difference normal change total significant associate weight known increase decrease associate high incidence analysis cardiovascular assessment study patient history high risk cardiovascular disease incidence per clinical study patient T2DM occur early week treatment primary lower increased risk treatment related effect datum study include provide risk patient T2DM
26521236 en type mellitus important risk factor development disease associate severe disease however risk patient remain year treatment present study aim identify factor associate study patient type mellitus treatment year duration undergo clinical care hospital study presence significant determined clinical history parameter analyzed insulin resistance determined model assessment multiple logistic regression factor associate difference found statistical significant among compare difference lipid profile hba1c fasting blood BMI ratio significant adjust odd ratio insulin resistance less or CI female or CI or CI independent associate normal adjust odd ratio lipid profile BMI blood pressure hba1c less less female factor associate
26474470 en on activity investigate fasting serum level patient type mellitus T2DM without metabolic syndrome well association level assess level level body mass index BMI glucose insulin glucose index lipid profile subject include T2DM patient T2DM patient without control subject without metabolic serum level significant high T2DM patient without normal subject level significant high patient T2DM patient however level significant lower T2DM patient without normal subject T2DM subject level associate significant high level significant lower patient use addition significant difference level found diabetic subject without level negative correlate level T2DM patient without normal subject level associate increased BMI cholesterol level increased T2DM subject without level decrease T2DM patient without addition level associate level negative correlate level associate reduce level normal subject level associate increased BMI cholesterol
26449599 en study influence mellitus early outcome reported result poor outcome similar outcome without assess influence mellitus early outcome datum patient period database two group diabetic significant difference patient risk factor two group patient disease perform significant diabetic patient significant different two mellitus influence early outcome
21129757 en examine prevalence use risk factor according status aged year study use examine risk factor blood pressure activity lipid prevalence use aged year year year type mellitus respective prevalence type mellitus respective mellitus type associate high odd high level type mellitus less aged year participant reported use mellitus high development cardiovascular disease
21108647 en although study compare type type mellitus T2DM regard evaluate level plasma protein two group subject T2DM identify possible difference two mechanism
24607755 en study evaluate relationship gestational age rate woman gestational conduct analysis datum randomize control trial gestational mellitus treatment rate woman week evaluate vs woman compare vs management woman compare outcome week compare management week logistic regression adjust potential overall rate compare week significant difference rate woman week however associate increase rate week compare week similar increase rate woman compare treat week woman gestational mellitus increase rate week
26307561 en gestational mellitus condition common include insulin resistance dysfunction insulin cell show effective treat study first identify target on gene normal insulin level follow model great improve glucose outcome female finding first time method provide cell therapy
26104600 en glucose compare patient type mellitus conduct analysis result study type mellitus patient treat patient according baseline body mass index BMI group BMI group BMI group BMI group BMI overall similar among BMI although difference incidence female patient total body level time hemoglobin fasting plasma glucose body weight decrease significant baseline week change hemoglobin fasting plasma glucose significant different among BMI patient BMI treatment although may need
25263215 en determine impair response conduct randomize study subject type mellitus on day glucose day plasma concentration period adverse event plasma glucose level increased group glucose level response mean ratio glucose significant different plasma glucose level increased great group level significant difference group observed time glucose level clinical difference well impair response datum provide evidence low potential
25139631 en evaluate influence duration drug treatment patient type datum cohort patient new disease management type examine previous patient identify receive therapy general use regression patient type treatment within year major receive new associate age high BMI lower hba1c duration therapy less among patient therapy within year recent therapy current treatment increasing base general disease primary
23261899 en impact management patient mellitus patient new analyzed month patient little year old care status diagnosis type mellitus patient patient assess drug therapy drug therapy associate condition clinical impact measured change baseline hemoglobin hba1c level blood pressure lipid level period use estimate impact base patient decrease hba1c reduction baseline hba1c value blood pressure blood pressure cholesterol level patient base per patient decrease hba1c value estimate provide per management patient type significant influence clinical outcome population health care
25946187 en assess impact great determine type mellitus retrospective review datum patient type hospital patient type mellitus total primary outcome change level patient hospital observed significant difference mean hba1c level among age year several change medication occur oral diabetic increased type hospital show significant hba1c level
25829257 en on common gene risk factor type mellitus T2DM present study analysis indicate associate risk T2DM investigate association T2DM patient significant increased patient patient respective however association observed result associate T2DM patient high level observed patient may result base mechanism elevated
25648671 en patient type mellitus T2DM high high cardiovascular risk clinical need glycemic control show significant cardiovascular patient new oral drug treatment T2DM glucose renal effect blood glucose show hemoglobin reduction similar oral well effect major associate T2DM therefore consider review clinical new oral glycemic control risk impact body weight blood pressure lipid profile renal function
17115352 en occur common however present report two case one develop follow-up drug therapy one
24636386 en develop model medication among patient chronic different medication treatment model use case retrospective cohort patient type mellitus drug research hospital health medication show patient type mellitus study show prevalence patient treatment patient patient treatment patient treatment model use medication chronic disease model time change incidence rate prevalence different time estimate several time time age patient time medication
25913815 en associate mellitus DM impact chronic potential however on retrospective study reported outcome DM patient study evaluate effect DM outcome use study cohort patient undergo perform adult DM patient case patient control age score outcome included outcome test index patient health test follow-up similar case mean month control month score statistical DM cohort cohort show significant score significant change score score change statistical cohort outcome difference score change DM patient oral patient similar compare control insulin adverse outcome large cohort assess effect DM type control outcome
20922819 en mellitus result evaluate change type index common studied patient type mellitus without control subject age body mass index use system large found type mellitus patient compare control type mellitus patient disease duration year compare significant analysis type mellitus patient age independent index duration mellitus blood pressure difference time change type mellitus
22574090 en year dysfunction studied complication datum regard dysfunction aim study correlation rate patient mellitus type studied patient type mellitus DM cardiovascular complication disease high blood pressure group aged year patient type control high blood pressure cardiovascular complication group DM aged year evaluate function determined profile assessment high protein associate level revealed significant lower value rate group patient compare group patient DM indicate high function patient cardiovascular complication group rate value correlate activity type mellitus identify status correlate dysfunction
24341059 en cause mortality cause mellitus elevated blood glucose among cause blood also increasing determine mellitus development analyzed patient undergo test test value blood glucose lipid level period patient aged year age group female patient risk factor hypertension mellitus previous baseline sample patient previous mellitus diagnose known early case among treat patient mellitus hypertension risk factor treatment control change blood
26844230 en activity lipid development mellitus studied studied mean analysis show development mellitus DM body weight decrease less diabetic DM difference compare control group DM observed decrease value result study show DM development increase increase activity system
26339423 en high protein use significant factor cardiovascular event patient mellitus however report regard complication patient result study aim investigate value patient disease patient diagnosis follow one year baseline body mass index BMI ratio serum presence hypertension serum total cholesterol fasting blood glucose cholesterol cholesterol year baseline patient respective group baseline serum level significant difference among group age BMI hypertension included regression model or value baseline serum level serum level independent risk factor patient patient present high serum level subject intervention medication
26248735 en investigate association protein type mellitus T2DM total T2DM case new diagnose case previous diagnose case control included study conduct two odd ratio or confidence interval association logistic study subject significant associate T2DM adjust body mass index BMI two also associate T2DM among common associate reduce risk T2DM or CI addition associate BMI associate level new diagnose T2DM case healthy found associate T2DM found associate T2DM
25811944 en aim study investigate protein gene patient chronic patient type mellitus T2DM healthy study include individual healthy individual patient patient T2DM index index clinical measured obtain protein determined use measured high protein observed control group significant different group patient T2DM significant increase decrease gene protein compare control patient suggest possible role T2DM
26403933 en medical management type mellitus control remain important factor consider regard management outcome one factor previous investigate study examine relationship control study control conduct hba1c statistical analysis association hba1c control obtain significant lower score compare control high value total associate lower hba1c hba1c increase total mean score hba1c increase mean score association effect control addition lower score compare control can target potential treatment improve control need important factor outcome
23794489 en one great medical effect metabolic risk patient well study investigate association level risk related diabetic patient control subject study serum concentration determined serum concentration use gene potential serum total significant positive association serum association risk complication although serum associate risk significant association diabetic compare associate decrease risk or CI or CI high level serum lower level serum associate increased risk patient
25214251 en common insulin gene associate increased risk develop population one high prevalence type mellitus T2DM report investigate association adult two independent oral glucose tolerance test perform risk factor total participant T2DM present individual studied one participant logistic regression analysis associate obesity insulin prevalence population reported presence associate suggest may risk high prevalence previous reported population
23895253 en aim study investigate impact known risk factor activity well level blood individual chronic patient patient type mellitus healthy patient healthy individual patient type mellitus healthy patient included study clinical blood sample activity blood cell level plasma sample analysis test follow test use compare among study level group high healthy group difference group statistical high significant difference group studied blood activity significant different study role show mechanism body increased
26655019 en among mellitus DM patient poor glycemic control blood glucose assess level associate factor glycemic control define hba1c reduction relative retrospective cohort study use datum patient assess number glucose test perform number on level consider glycemic control consider change baseline patient female month respective analysis associate poor month mean reduction hba1c compare baseline month respective association glycemic among patient improve glycemic control
26553517 en chronic disease common patient type mellitus T2DM condition increasing prevalence estimate patient T2DM presence influence disease common patient population include mellitus group population also great increase prevalence T2DM increasing prevalence T2DM patient little T2DM little renal therapy increasing prevalence individual T2DM complication observed cardiovascular patient T2DM contribute patient time develop renal review change T2DM influence prevalence incidence associate different population clinical
24195646 en evidence show risk factor increased prevalence relationship related factor health aim present study relationship related factor hemoglobin fasting blood glucose duration management health health participant mellitus measured number index index index factor oral duration management level fasting blood hospital medical statistical independent analysis test multiple regression analysis use assess association factor parameter include number index significant influence duration management significant influence duration hba1c index significant influence duration hba1c management result multiple regression analysis show duration show significant positive correlation health parameter hba1c correlate index management correlate index factor duration hba1c management significant correlate health among individual
20838206 en mellitus associate increase per year year mortality complication per year related complication cause current drug need research development drug mechanism disease disease complication treatment association association study current medication insulin suggest addition medication drug less however medication evidence increasing need time multiple drug therapy glycemic control current medication effect development mellitus drug new mechanism review clinical datum new drug include also medication indicate type drug review clinical datum current clinical trial review identify clinical new treatment
19682129 en examine whether adult mellitus associate glycemic control assess whether level mellitus care health study aged old mellitus mean age hemoglobin hba1c level function measured duration mellitus mellitus care mellitus treatment mellitus total index related mellitus logistic regression model three level hba1c score low significant high hba1c level high adjust odd confidence on high level mellitus care association low high level significant lower odd high hba1c low level vs associate glycemic control high level mellitus care negative relationship identify level impair adult mellitus may target intervention glycemic control
25059286 en aim compare early clinical outcome diabetic patient undergo intervention use mellitus show less outcome intervention use impact mellitus clinical outcome intervention database retrospective analyzed patient undergo presence mellitus primary major adverse event rate define target clinical characteristic include mean age vs month similar group high prevalence hypertension chronic renal high body mass index diabetic group among treat characteristic well group high rate use vs diabetic group rate vs mortality vs similar group clinical diabetic status associate use treatment outcome diabetic patient suggest consider diabetic population undergo treatment
24816368 en protein cause protein great condition mellitus function cell protein also high protein different mechanism among system system system include mechanism protein evidence may determine event aim review may mellitus complication
25338765 en multiple study show low level associate development type mellitus metabolic syndrome aim study show influence therapy obesity hba1c level hypertension patient mellitus patient mellitus subject aged year BMI randomize study also undergo patient two group treatment group use activity patient therapy therapy group use activity patient therapy month treatment assessment lipid profile improve group first group clinical significant level increased group group clinical significant hba1c decrease group group obtain result level treatment group also blood pressure reduce group result study demonstrated possible metabolic level diabetic man level study show important role reduce prevalence diabetic complication
25294284 en increasing evidence effect role remain aim present study investigate association gene plasma level patient mellitus type diabetic patient three BMI study assess plasma level measured determined level prevalence decrease significant increasing BMI associate high plasma level age BMI statistical significant difference observed BMI well plasma level associate independent associate plasma level associate associate plasma level diabetic patient
24107661 en evaluate previous assess patient type mellitus use two interval protein total T2DM patient included provide datum study estimate two correlation significant range regard datum high total total lipid significant correlation adjust also show may use method use method protein CI assess patient T2DM according
22539172 en whether management new diagnose type mellitus three year follow-up control trial primary care general primary care participant included trial follow-up datum datum group two compare primary outcome hba1c level outcome blood pressure weight blood lipid level status activity impact drug use three level three year decrease group adjust baseline difference significant difference confidence interval group outcome drug use significant intervention group health month three year score three new diagnose type mellitus show difference outcome three year although control trial
24279768 en function use define disease whether patient present different type mellitus can profile obtain blood cell type type gestational patient datum control obtain use datum use function identify use compare perform use use type among identify patient great value type include target associate result indicate use cell profile different mellitus may metabolic disorder whereas may type
22911170 en mellitus reported cause patient mellitus DM chronic disease however study investigate cause patient study aim characteristic disease DM total DM patient patient clinical parameter result respective analyzed two rate respective respective DM patient elevated serum level significant effect serum level patient serum negative whereas high level patient serum negative among patient significant high DM patient patient without rate high DM patient can associate
23974919 en gestational mellitus associate increased risk type cardiovascular disease mechanism remain examine effect status factor factor gene cell analysis revealed protein significant associate increased protein cell lipid protein target although decrease increased level may impair increase level normal cell cell may contribute increased risk type cardiovascular disease
21472663 en health change blood pressure patient diagnose type type primary care serum presence diabetic complication per year receive examine decrease baseline baseline baseline patient vs vs patient mellitus improve perform primary care health patient datum patient
25816546 en on man present month reduce although demonstrated show severe observed found serum cholesterol mellitus fasting plasma glucose first diagnose serum lipid profile glucose level decrease within month treatment insulin oral significant improve treatment cause severe due mellitus lipid also cause
23218632 en common therapy disorder risk patient mellitus potential blood glucose level although oral known effect blood glucose control datum study examine impact serum glucose concentration patient patient mellitus receive syndrome patient blood glucose level week week blood glucose level increased baseline statistical day clinical significant increase respective increase time value occur little patient increased patient little significant result suggest clinical treatment patient mellitus patient increase blood glucose receive increase baseline effect clinical risk
23176419 en evaluate method use plasma factor concentration healthy mellitus healthy mellitus different sample method evaluate include follow follow follow follow method included concentration measured method result compare among method rate range healthy concentration method compare healthy significant high concentration method lower concentration method lower concentration healthy method may little result previous reported diabetic disorder concentration result condition present mellitus
25312701 en type individual risk clinical disease intervention mean reduce chronic condition however evidence early intervention lead reduce complication early mortality compare diagnose review examine evidence trial use also impact therapy effect current evidence suggest drug current lower incidence provide diagnosis provide risk
22069268 en may type mellitus previous compare profile cell diabetic found cell include three time high female diabetic analysis result investigate whether serum level study group subject type mellitus disease control subject level significant high subject type mellitus respective decrease fasting level per year correlate significant level subject first study show elevated serum subject compare control type mellitus subject serum possible indicate disease development
22219348 en evidence suggest year high risk cardiovascular mortality one adverse effect develop duration lead chronic disease clinical evidence suggest may contribute development hypertension type use model assess incidence rate ratio confidence interval hypertension mellitus associate cohort woman level estimate participant use regression model follow-up case hypertension case mellitus occur analyzed hypertension increase CI range per CI mellitus CI CI included model result suggest may increase risk type mellitus possible hypertension
25526482 en potential management chronic disease evaluate clinical effective effective glycemic control patient type mellitus use related type identify study datum identify clinical trial according evaluate use method identify randomize control trial outcome hemoglobin hba1c study provide intervention study test study use intervention response patient overall result study revealed statistical significant decrease hba1c intervention compare treatment difference two study included assessment study overall relative can potential effective disease type patient evidence significant suggest
25526470 en study reported increased incidence prevalence adult also disease may improve glycemic control diabetic patient conduct evaluate effect different therapy metabolic control patient type mellitus T2DM disease database study treatment glycemic control adult T2DM therapy mellitus glycemic control primary outcome included study hemoglobin hba1c compare difference patient hba1c result treatment group receive oral control receive perform use analysis randomize control trial identify trial total patient T2DM disease determined analysis datum study hba1c result included study revealed significant difference hba1c result treatment group control group hba1c significant improve metabolic control patient T2DM chronic current evidence significant association therapy metabolic control patient population however evidence suggest therapy improve metabolic control T2DM risk factor
24781960 en type mellitus T2DM management use improve clinical outcome although remain significant investigate improve risk health outcome patient receive care patient T2DM randomize group assessment patient T2DM receive patient little time hemoglobin hba1c level primary patient treatment target hba1c blood pressure cholesterol per health outcome month group similar baseline characteristic mean age year man disease duration year hba1c level blood pressure cholesterol level complication insulin treat mean follow-up period day patient little assessment analysis group similar reduction hba1c CI vs CI treatment target group patient per patient related patient T2DM receive care improve risk
25483959 en show improve complication type mellitus include glucose tolerance increased function show increase insulin model severe undergo insulin treatment research determine present determine impact determined whether reduction blood glucose large multiple low perform one per day total week demonstrated significant less insulin significant compare significant change reduction blood glucose response similar week result also different significant insulin without
25358216 en mellitus system body also aim study assess patient mellitus method study conduct diabetic hospital one patient female mellitus included result patient change present patient finding present patient common finding diabetic found patient finding complication oral diabetic common diabetic patient important identify treat follow
24908235 en mellitus associate increased response may contribute result demonstrated activity effect studied therefore studied effect treatment patient type mellitus compare result finding healthy subject subject type healthy control included patient examine baseline month treatment use addition analyzed examine baseline high patient compare control decrease blood glucose treatment decrease decrease observed treatment effect effect
24489845 en possible association mellitus DM disease study use investigate relationship DM health research database cohort sample population identify patient new diagnose age year use score subject time age hypertension previous history patient follow study year follow-up diabetic patient high incidence subject vs regression model analysis DM ratio confidence interval CI age CI female CI hypertension CI previous history CI status CI independent associate increased risk therapy oral medication associate risk adjust risk factor duration DM diagnosis however therapy insulin found associate great risk CI diagnose DM associate increased risk use risk
27191668 en study assess mellitus DM reduce DM define demonstrated relative health associate DM associate DM on review little perform use profile first according DM rate per group evaluate use logistic regression odd total base define DM rate rate rate rate rate odd ratio significant rate found influence odd on test compare low risk high risk also perform DM risk associate DM associate diabetic may history
25793407 en addition protein lipid known one common protein important role glucose level protein investigate whether metabolic syndrome type mellitus T2DM condition glucose level associate serum study patient type mellitus T2DM mean age year healthy control subject mean age year evaluate serum found significant change T2DM patient significant reduce T2DM compare subject important reduce diabetic patient without complication compare found related decrease level addition identify respective result correlate parameter level two lower T2DM compare healthy control lower patient complication T2DM level cause change evidence finding serum profile presence serum level can therefore provide T2DM
23540566 en recent found patient high incidence general population study examine potential relationship two perform cohort study evaluate association associate perform review cohort study multiple database include database identify study include analysis use conduct statistical analysis include test obtain total potential analysis indicate risk factor development relative risk confidence interval analysis control population follow-up time also risk individual develop time high individual without positive association remain man woman study well different follow-up time
23235661 en occur patient mellitus associate poor determine effect intervention patient database examine included included control trial investigate intervention adult primary outcome control outcome diabetic treatment complication cause review independent examine identify datum included study model perform overall estimate treatment database identify trial participant included intervention study trial participant duration therapy three week month follow-up treatment month show effect treatment one month treatment month treatment range mean difference trial however conduct rate or confidence interval CI participant trial rate or CI participant two trial increased intervention compare care evidence regard control intervention trial improve significant base result three intervention trial compare care medication examine one study complication cause investigate included intervention regard intervention trial participant duration intervention three week month follow-up treatment effect medication study CI participant trial CI participant trial increased trial or CI participant three trial control improve mean difference hba1c CI participant trial investigate one trial statistical significant difference control outcome well complication mortality examine intervention trial intervention intervention three trial participant duration intervention week follow-up treatment result significant difference examine significant control patient hba1c CI participant compare one intervention clinical significant effect outcome patient control improve trial evidence intervention diabetic treatment complication cause health investigate overall evidence due several trial risk examine population intervention
24829025 en diabetic metabolic syndrome type obesity disease diabetic cause study may effect although adverse effect diabetic may result poor diabetic also therefore present review diabetic also mellitus cause
27706649 en treatment mellitus T2DM diabetic disorder high incidence rate primary study analyzed effect response cell T2DM patient cell treat blood serum healthy control T2DM patient presence treat protein cell respective concentration treatment significant decrease T2DM cell compare control cell protein cell also significant treatment cell treatment finding cell T2DM patient response effect patient T2DM
27706609 en increasing evidence demonstrated factor significant associate type mellitus T2DM however sample study investigate association lead report regard role therefore conduct assess association T2DM include study population database studied correlation risk T2DM study identify datum assessment odd ratio confidence interval use model evaluate determine control subject among study examine use test study assess use test result show gene positive correlate risk T2DM model odd ratio vs vs vs vs vs respective observed use test
27574765 en mellitus DM disease condition index reduce adverse condition aim present study investigate effect level type group control DM DM group diabetic oral normal body weight day blood sample analyzed serum level blood glucose DM group reduce compare DM group significant high concentration DM group significant reduce control group significant increased group compare diabetic group mean value DM significant high control DM group significant compare control significant DM group compare DM group ratio significant reduce compare DM group oral increase reduce plasma glucose level ratio DM
27151154 en found use treat mellitus large possible use method gene great method method vs method study improve parameter associate renal dysfunction increased level patient type mellitus T2DM decrease fasting blood glucose plasma glucose hemoglobin similar study decrease glucose level glucose ratio total cholesterol increased glucose level cholesterol study need determine whether effective current medication treatment T2DM
27428221 en aim study investigate effect risk mellitus DM among patient disease retrospective cohort study follow-up period year identify patient diagnose health database health use ratio compare risk DM patient receive receive adjust possible include age hypertension disease obesity use use effect risk DM evaluate according define adjust CI study group patient compare group patient without among patient use old year age lower risk DM CI year effect significant patient receive great reduction risk result demonstrated decrease risk DM patient use risk significant
20228997 en association mellitus risk test previous cohort study population however evidence cohort study population different examine relationship mellitus risk cohort follow new case identify among man baseline include mellitus status use regression model use estimate ratio confidence interval history mellitus associate risk total population base clinical patient mellitus show high risk adjust CI relationship remain analysis case first cohort study indicate history mellitus associate increased incidence
26726339 en large population may high risk type however study investigate prevalence population study compare prevalence patient study datum health health patient diagnose compare prevalence patient logistic regression use control difference age body mass index BMI health two total prevalence patient population compare patient population prevalence adult patient compare adult patient compare odd ratio CI adjust age BMI one new population low rate adjust relative odd sample patient time high result previous finding significant increased risk
26547325 en investigate correlation serum level risk mellitus DM total subject aged year two use conduct use subject undergo blood test serum parameter subject normal glucose group group diabetic group compare blood parameter risk factor prevalence subject serum level significant high diabetic group group age body mass index serum level significant two group prevalence increased significant serum level logistic regression analysis show age body mass index serum serum level independent risk factor diabetic patient serum level increased age increased serum level associate high risk age serum serum body mass index risk factor man
23350587 en estimate recent first two study assess impact management glycemic control complication patient aged insulin three glucose test per week time month receive on evaluate datum insulin hemoglobin hba1c level improve hba1c hba1c hba1c hba1c reduction severe subject complication compare month study diabetic study compare three previous month reported insulin two significant reduce risk severe glycemic control study need factor improve glycemic control include increased different insulin
23336185 en study use also independent study whether impair fasting glucose impair fasting glucose cause cohort study base datum multiple metabolic disorder metabolic syndrome study use logistic regression model mellitus evaluate include method adjust general risk factor baseline fasting plasma glucose result show subject CI adjust relative risk develop compare individual without baseline study participant significant associate respective compare participant level level high adjust value CI datum analysis show CI CI CI can independent presence can cause
22947190 en aim study prevalence adult population total adult aged year two without subject oral glucose tolerance test blood pressure activity association prevalence prevalence new whereas overall prevalence known new multiple logistic analysis show statistical significant association prevalence increasing age ratio positive history low level activity blood pressure significant association observed level prevalence population on positive history low activity high test adult population
18975530 en disorder high prevalence disorder found although studied time whether disorder provide analysis perform base two identify high relationship can research
25316597 en glucose new develop treatment type mellitus T2DM mechanism independent function insulin resistance potential use also include insulin clinical development T2DM therapy studied common use medication
20467898 en patient mellitus overall health outcome whether among remain aim study compare mortality diabetic patient conduct retrospective analysis adult patient undergo medical mellitus patient patient mean follow-up year diabetic group among control age mean diabetic control body mass index diabetic control presence score diabetic control mellitus remain significant mellitus independent risk factor mortality relationship impact glucose control cardiovascular risk factor reduction effect
27749529 en one cause mortality type common type case health consider first control blood glucose level conduct assess effect health patient control blood control trial database database assess result use method relative assess result use trial included patient result show fasting level significant reduce type group patient compare respective control group mean difference confidence interval CI also significant reduction blood glucose CI hemoglobin level CI also observed compare control effective health type significant reduce patient blood glucose related index
24845604 en resistance use weight weight improve control type resistance potential less effect resistance control population well aim review effect resistance hba1c adult type database perform study trial evaluate effect resistance adult type hba1c measured baseline hba1c intervention control group intervention trial mean hba1c lower group compare control group mean difference significant high group compare control group lower trial resistance significant hba1c significant increased lower type
21129331 en number risk risk related glucose concentration previous study show use function patient risk profile use adverse outcome individual use function risk retrospective analyzed glucose system obtain normal gestational mellitus type mellitus T2DM type mellitus use function risk normal risk mean glucose value risk increased case T2DM patient risk profile value risk increase normal T2DM new risk risk method therefore may clinical trial risk adverse outcome
26458393 en evaluate effect presence elevated medication use risk type among woman health compare several different statistical model analyzed woman health clinical trial cohort woman study cohort included follow-up duration year follow result three model compare model included time medication use presence elevated BMI adjust potential include age activity per week total therapy use history result previous study examine relationship medication use risk type model show significant increase risk model use baseline show low increase risk ratio CI CI respective ratio model compare CI CI respective however difference among estimate model model statistical significant cohort one suggest factor datum however model show woman elevated significant increase risk remain however association statistical score adjust multiple provide evidence increase risk type
25064030 en previous study show old adult compare without study also demonstrated old adult reduce range compare control population present study examine relationship characteristic old adult type old adult type time test assessment perform test use assess test use test use assess result show age body mass index BMI test significant correlate characteristic datum subject contribute multiple regression analysis body mass important factor contribute old adult type
23614910 en type mellitus develop result cell common type mellitus show little previous reported ratio hba1c ratio elevated patient diagnosis present study investigate whether ratio also elevated study subject patient patient type mellitus T2DM woman T2DM use control study patient hba1c ratio patient diagnosis significant high patient patient ratio patient whereas patient patient ratio also elevated patient diagnosis compare T2DM without
25066164 en type mellitus report present show severe lipid renal cell analysis blood indicate elevated level glucose body lower hemoglobin cause type mellitus lead diabetic report insulin well analysis can diagnosis related
24651028 en study examine difference type time week type mellitus on sample type mellitus female age year year duration year year regression model test difference type time week vs participant show great poor relative lower high total difference type high participant reported high low high high low low glycemic also high poor high occur poor finding regard high lower glycemic less lower total finding indicate impact type time week suggest target intervention
24470385 en patient type mellitus high risk study examine among use risk among patient type mellitus diabetic cohort health database identify case case control conduct study examine association use incidence logistic regression model estimate odd ratio or confidence interval CI use incidence patient significant associate increased risk or CI or CI use associate high risk or CI or CI without relationship use also increased risk association found use risk result suggest use may early although role research examine relationship use possible change
27422889 en increase gestational mellitus prevalence demonstrated association study group determine incidence glucose tolerance among woman previous identify clinical risk factor woman previous follow mean compare woman normal glucose tolerance incidence glucose tolerance use association impair fasting glucose impair glucose tolerance determined use method analysis regression model test factor glucose woman previous glucose tolerance vs test significant different woman health lower incidence woman early period vs follow-up vs factor glucose level oral glucose tolerance test history gestational week BMI woman develop glucose tolerance remain high among need follow-up although method need study
24627624 en on association demonstrated increased cardiovascular risk high level type mellitus DM patient serum level type DM patient use total type DM patient study base glycemic level patient treatment patient patient follow month serum protein level compare group patient use level found significant lower group use compare group use however serum protein level statistical similar two study group treatment observed lower serum level type DM patient finding randomize control study provide cardiovascular
23507560 en estimate prevalence association clinical datum large population patient mellitus general population type diabetic patient treat perform patient control well index datum regard disease duration medication complication recent blood glucose hba1c level also total patient healthy included patient control aged year respective BMI respective compare control patient vs vs vs large vs analysis associate female BMI blood glucose hba1c treatment disease prevalence among patient mellitus high independent associate female therapy
23199537 en study lipid blood plasma patient mellitus change datum patient level disease duration group level hemoglobin determined parameter system parameter parameter activity determined group patient include control increased disease decrease system parameter observed increase result activity three group respective also decrease observed decrease system function system parameter increased activity decrease suggest level effect parameter disease
21193691 en patient mellitus impair present study examine assess diabetic compare evaluate diabetic subject new association follow-up month on model use examine influence clinical plasma parameter time event ratio mellitus ratio independent provide diabetic subject ratio associate great rate ratio event mellitus ratio independent high risk diabetic subject impair function
26607824 en investigate association three patient type mellitus total patient present year included study renal disease datum determined association regression regression model significant associate diagnosis association found respective significant associate diabetic correlate cohort correlation diabetic
28116228 en cell role gene can associate diabetic level type mellitus T2DM method analyzed gene first T2DM subject case T2DM subject without control use level plasma measured diabetic result found association subject T2DM associate serum level diabetic level associate T2DM subject
26472573 en prevalence mellitus DM increasing disease important outcome related early mortality among adult high prevalence related DM treatment increased significant obesity role development DM case increase level activity treatment disease effect activity DM change reduction related DM primary develop can disease complication drug treatment common related effect DM disease related outcome healthy aim present review therefore recent evidence effect health care related DM
25920001 en examine association mellitus DM adult study included participant man woman health three group base disorder test score score score DM define fasting plasma glucose medication include insulin therapy study population man woman DM prevalence man woman DM prevalence group group group man woman respective compare group odd ratio confidence interval man woman group DM respective group adjust age factor associate high risk DM man woman
25725296 en hospital intervention outcome mellitus DM known risk factor study aim investigate whether effect patient without use database hospital datum included adult patient study period case without hospital outcome datum primary included method within DM positive patient clinical history diagnose event compare outcome vs group use logistic regression DM adjust odd ratio confidence interval adjust potential patient hospital perform history DM observed among group group group show outcome group vs CI study group model CI patient without DM vs patient DM effect different patient without DM patient DM effect outcome significant associate patient without DM patient DM
17516711 en body type gene lead disease response one study revealed function due control mechanism cell function plasma review current different plasma function use cell treatment patient
16944241 en clinical characteristic retrospective age diagnosis year range year cell syndrome patient major present associate patient one undergo one patient patient follow month one year one patient cell diagnose month follow-up patient found year may early association on clinical follow-up associate
16926443 en major cause may function however clinical concentration found different cell correlate concentration correlate influence increase high concentration due clinical concentration however concentration clinical concentration effective clinical disease cause finding important development disease
24716713 en type also known type disease insulin aim study evaluate therapy individual type randomize control clinical trial two treatment first evaluate use level determined participant group use group on group group group participant evaluate well one week group on receive period week period evaluate study health trial number randomize clinical trial evaluate total index body mass individual study use individual datum study
25222457 en determine prevalence prevalence hospital day hospital include hospital one aged care adult care prevalence current medication status obtain CI prevalence range different hospital patient old medication patient medication oral insulin treat insulin insulin medication complication high complication complication high hospital major patient health health care care patient potential decrease well complication on determine prevalence management
24444522 en treatment type mellitus current new treatment decrease metabolic glucose clinical trial show oral drug new treatment new drug group
23811602 en test whether treatment can improve impair characteristic type mellitus patient on total type mellitus patient treatment group receive control group receive day measured significant treatment compare control group value three month therapy important measured parameter present change lipid blood pressure relative intervention characteristic type mellitus patient
25786566 en study aim assess concentration serum investigate relationship patient type mellitus T2DM chronic patient T2DM patient two group treatment control serum concentration hemoglobin hba1c level measured different time baseline month concentration show significant difference group baseline test on significant treatment group found serum month treatment test baseline hba1c level significant different month statistical significant difference test datum suggest treatment glucose control effect may associate reduce patient T2DM datum suggest may consider disease
25287318 en aim investigate estimate subject type mellitus study included DM subject healthy control similar age subject undergo analysis assess impair three significant decrease DM group control vs similar result found vs vs vs similar DM patient control vs whereas rate significant increased DM subject vs on analysis show function associate hba1c independent mass obtain significant impair type DM patient hba1c independent associate early therapy fasting glucose level hba1c can
26111036 en mechanism mellitus DM complication recent evidence suggest DM function improve insulin resistance decrease DM present review provide independent treatment type type DM
25911206 en early year however patient need cardiovascular risk management one major risk development mellitus perform base prevalence risk factor treatment need clinical trial management addition study analysis patient cardiovascular complication patient need current use one general population target glucose hba1c level large need management include early insulin oral early can treatment new oral high level evidence early
23034088 en reported provide patient without study aim evaluate whether decrease value parameter patient type mellitus duration whether patient receive therapy month evaluate whether serum parameter high weight high protein cell serum analyzed relationship blood pressure factor relationship pressure factor analyzed factor patient receive month treatment significant baseline value observed patient regression analysis perform determine factor can change change blood pressure significant change metabolic factor patient found group baseline pressure improve value compare group baseline pressure result suggest pressure baseline can change improve parameter patient type mellitus duration independent blood pressure change patient pressure receive
26264451 en increasing contribute type mellitus T2DM impair insulin type mellitus T2DM study show associate T2DM reduce serum insulin review examine mechanism base study recent finding primary review examine may cause dysfunction impair insulin recent finding indicate cause statistical significant change fasting level model review mechanism glucose individual effect review one mechanism multiple mechanism dysfunction
22924602 en gestational mellitus woman woman develop general characteristic type target protein reported on recent identify type report suggest high type current report gestational aim study investigate patient clinical gestational mellitus subject included study diagnose gestational hospital sample use according found patient gestational diagnose positive little one common follow protein two study found woman gestational negative protein gestational present can important independent gestational
25270375 en mellitus DM parameter compare analysis use response determine influence disease duration hba1c level study assess one DM patient healthy subject two DM group DM group hba1c control DM group hba1c measured pressure analysis perform evaluate parameter time DM group found significant different control control DM group respective correlate blood glucose concentration hba1c significant lower diabetic patient elevated hba1c control subject disease duration whereas resistance factor remain poor glucose control DM measured may cause high independent clinical
26742188 en total number patient new increasing prevalence mellitus treatment develop therapy improve incidence associate investigate prevalence mellitus associate risk factor positive retrospective study review medical positive patient prevalence DM statistical measured logistic regression test use assess association DM risk prevalence DM studied population patient treat mean age old year old patient BMI less BMI age associate risk factor prevalence DM studied datum revealed high prevalence DM patient observed significant association DM risk factor risk factor contribute high prevalence disease population result study DM positive patient population
23683963 en one important complication patient mellitus DM study estimate number due severe patient type study hospital population define use hospital datum included general hospital health system number due severe obtain datum hospital remain hospital number estimate base patient reported primary diagnosis patient reported primary diagnosis respective overall incidence range important patient DM great according
25341300 en study included subject investigate interval according year follow group year year show range without statistical mean body mass index BMI vs difference statistical significant patient hypertension according found case compare prevalence metabolic syndrome group mean serum level group significant high mean cholesterol statistical significant difference prevalence disorder high group relationship found BMI high blood glucose blood glucose level baseline year follow show significant difference
27914297 en use patient type treat insulin may however therapy patient remain total patient type treat insulin receive therapy therapy without glucose control hemoglobin hba1c level number insulin number renal function baseline characteristic subject include age insulin hba1c level two group group hba1c level significant decrease hba1c reduction period addition number insulin significant reduce time however parameter control group number patient three per year significant lower group control group odd ratio confidence interval insulin treatment well lead reduction hba1c number insulin risk
18826743 en case report patient severe first previous healthy patient present normal similar day early oral two day patient severe care demonstrated function patient receive clinical status hospital day disease therefore consider diagnosis patient low
24030399 en investigate effect factor protein protein type diabetic control type diabetic type diabetic patient hemoglobin control type diabetic patient hemoglobin patient hemoglobin undergo use cell total factor protein baseline number cell total factor type diabetic patient significant increased compare control type diabetic patient cell factor increased group compare increase type diabetic group addition significant increase type diabetic group compare control type diabetic mellitus associate increase baseline
23643522 en type mellitus DM associate condition chronic effect may disease present randomize trial investigate effect factor protein gene woman type DM significant effect observed concentration change gene significant increase plasma concentration observed time group respective impact treatment gene found positive correlate participant receive relationship level change respective change association among gene type DM
24941393 en determine total use management obesity can can measured concentration great reported can concentration can range range respective can without different concentration similar can concentration concentration among difference among group difference concentration compare concentration management obesity high concentration lower management provide range concentration concentration concentration concentration difference result use cause
23783767 en mellitus may present similar on present diabetic high metabolic also lead insulin revealed gene cell oral therapy follow-up syndrome on possible cause mellitus
23737314 en present study examine relationship history cardiovascular disease hypertension syndrome patient disease on total patient analysis mellitus fasting blood glucose positive therapy history hypertension patient related study history cardiovascular disease associate low level patient positive history mellitus significant level high one history high time level lower level history hypertension associate high low level history hypertension clinical patient therefore history disorder patient history study large patient population need finding
22809735 en system increased associate activity well studied influence factor age effect mellitus well lower study compare impact two different lower healthy individual determine whether old individual use common healthy individual mean mean reduction mellitus significant less less compare healthy reduction due system use lower impact common activity finding indicate potential old individual mellitus compare healthy individual
23585317 en mellitus type metabolic disorder multiple system include patient mellitus common aim study compare potential diabetic patient without subject included patient mellitus type patient mellitus type without healthy range age participant year old statistical significant difference group statistical significant difference group relative suggest
25603686 en normal cell blood protein dysfunction perform normal function result factor cell activity increased protein factor change associate several diabetic complication function lead increased patient cell high level factor finding increased level one major risk factor development complication high level may cardiovascular disease mellitus
21336994 en drug gene previous study healthy show significant influence aim study investigate influence response plasma level type mellitus study cohort type mellitus patient therapy plasma level estimate high pressure identify plasma level adverse effect compare patient female treatment two drug two significant association status control patient receive treatment statistical significant difference adverse effect type mellitus patient study found treatment normal significant influence adverse effect among patient treatment
19682125 en study role status related cohort study use datum large study determined prevalence new patient medical datum use related mellitus receive year year included hemoglobin fasting blood glucose lipid profile serum high rate related mellitus year year without receive although health without great increase rate care provide may positive provide mellitus without medical related risk treatment mellitus patient may lead lower rate
25244282 en complication mellitus DM common therapy report case patient previous known mellitus on year old present body DM known case mellitus hypertension patient history rate per normal blood pressure rate revealed patient blood glucose hba1c positive patient normal insulin also complication included
25216353 en mellitus metabolic disease aim report among show high respective analysis indicate presence high identify show respective study indicate study revealed presence similar show negative indicate group two first report provide use drug type mellitus
23296512 en cell known risk develop mellitus DM relative recent present DM follow treatment diagnose year old period multiple chronic complication occur among observed disease therapy complication primary DM metabolic insulin resistance high blood pressure develop first year year increased insulin metabolic control DM observed normal level negative addition insulin therapy DM metabolic control observed due possible mechanism insulin resistance associate impair insulin insulin effective treatment type
23209576 en may reduce increased risk cardiovascular mortality patient mellitus DM major effect risk factor adverse outcome studied perform randomize trial compare parameter increase estimate CI plasma intervention influence parameter compare significant decrease increased plasma decrease plasma concentration influence concentration relative increase high total cholesterol concentration effect risk factor adverse outcome sample increase concentration decrease effect concentration observed therefore study effect risk factor adverse outcome use clinical outcome cardiovascular
25492558 en gestational mellitus first woman base glucose test follow blood glucose evaluate clinical woman receive care analyzed datum blood evaluate clinical woman assess rate care treatment first association glycemic treatment target woman use diagnosis fasting glucose glucose found woman year old body mass index first woman use woman early risk factor woman first among woman use follow well early need
25453305 en old adult mellitus DM great risk compare DM individual DM treatment relationship old adult DM present clinical potential mechanism DM management DM model treatment
25453299 en mellitus effect cardiovascular disease risk old age age year effect regard disease disease mellitus old adult medical age
22093380 en associate dysfunction related type mellitus although weight known reduce metabolic effect concentration known determine effect concentration correlate change clinical parameter group studied subject type mellitus week month patient undergo month body mass index decrease glycemic control improve reduction protein level occur factor decrease month body mass index decrease glycemic control reduction compare found reduction month associate reduction hemoglobin reduction month correlate reduction body mass index reduction patient type mellitus mechanism contribute glycemic control
22324916 en investigate whether first include serum plasma protein on woman mellitus woman develop gestational mellitus
23977908 en previous report value mellitus complication show result regard role type risk factor remain aim study assess impact type complication patient undergo included retrospective cohort study previous diagnosis type use oral medication insulin patient type analysis outcome parameter complication cardiovascular severe within day analysis medication use risk patient patient type complication occur patient without type analysis type associate significant increased risk complication odd ratio confidence interval result similar type patient odd ratio confidence interval without odd ratio confidence interval insulin type independent risk factor complication treat risk
23167796 en drug treat type mellitus T2DM increasing insulin insulin however recent study show also role glucose reduce improve type mellitus addition several evidence show control insulin different insulin therefore new target drug aim treat T2DM finding population glucose therefore obesity T2DM may similar related dysfunction system drug target treat T2DM may effect reduce body weight review recent datum important effect blood glucose level well possible control glucose use drug system treat mellitus also
23906445 en high reduce weight patient type mellitus T2DM increasing glucose control body evaluate patient T2DM week treatment
22677160 en health datum conduct study identify number develop management mellitus health system use datum identify health care system diagnosis test result can potential identify use estimate number among number case define little year health system health system contribute study study range multiple provide conduct effective research include analysis care management study also provide datum clinical trial treatment intervention
25039448 en aim compare hemoglobin hba1c total insulin insulin body mass index BMI type mellitus receive insulin retrospective study included female old age duration receive insulin little insulin insulin receive insulin status BMI score duration similar group glycemic control similar group hba1c level vs respective mean insulin vs mean total insulin vs high group high ratio insulin group vs analysis according status number show similar provide similar glycemic control high mean high mean total insulin insulin
22620268 en known use treat type mellitus T2DM T2DM associate reduce function investigate effect model insulin diabetic
23149823 en mellitus chronic increased risk however mechanism cell function show protein analysis chronic multiple diabetic compare control protein protein negative response dysfunction lead presence one diabetic subject similar can primary renal cell high glucose treatment result suggest impair chronic response mechanism renal may contribute diabetic
24661264 en early individual type mellitus hypertension risk may treatment renal disease aim plasma development type hypertension renal disease study case control age baseline remain follow-up follow-up year perform plasma assess patient type case control patient type plasma lower change high change case vs control lower case vs control change respective model baseline estimate rate improve risk plasma index index case control without type plasma development renal risk result large cohort
26275656 en aim study use health reduce complication patient mellitus study adult include DM patient participant undergo treatment little care management DM datum analyzed study several year treatment health care treat patient drug patient complication health care effective need treatment chronic disease DM result effective obtain association study revealed patient use DM management health care mean however study need clinical trial research
25467625 en type mellitus associate increased risk disease relative determine clinical remain aim study assess potential difference patient healthy measured blood evaluate patient age group age year man duration group year score high patient vs compare control however similar one found patient control vs high patient control vs difference multiple regression analysis include age cardiovascular risk factor rate score remain significant high patient high patient compare control independent cardiovascular risk factor
23532633 en cardiovascular disease however study examine impact level patient type mellitus study patient type mellitus measured serum protein level well cardiovascular risk factor assess increase level period year positive correlate change level hba1c serum well subject high baseline serum level reduce year group increased year increase level significant high group lower year vs multiple logistic regression analysis revealed increase blood pressure increase serum level independent correlate adjust cardiovascular risk factor medication history baseline serum level change occur within year change serum level year function independent patient type mellitus
26189036 en type mellitus great disease disease however little known major adverse event disease individual type previous determined prevalence disease logistic regression model use examine disease duration whether status age total cholesterol hypertension body mass index BMI duration baseline on total patient type without follow mean year baseline prevalence duration disease subject without vs vs year duration disease significant associate baseline prevalence patient type disease duration significant related subject without study suggest disease independent patient type
25847324 en aim study show effect new mechanism test group group healthy control group group DM group DM group DM treatment treatment group activity significant increased although level gene decrease show significant effect increased level associate may one cause dysfunction increase complication may develop multiple effect therapy may effective complication may develop association
25734937 en patient type mellitus T2DM improve glycemic control new method increase patient chronic aim study investigate effect T2DM glucose body use new individual year old week effect glucose hemoglobin hba1c body significant increase improve fasting blood glucose level decrease hba1c level decrease whereas mean total weight body remain statistical improve glucose T2DM patient datum suggest patient
25162257 en test effective intervention base woman recent gestational mellitus reduce weight woman recent gestational mellitus first year control group primary outcome change body weight month first measured weight significant difference baseline characteristic group include age body mass index status woman three follow-up mean confidence interval week month whereas control group one follow-up mean woman intervention weight month mean change compare woman control woman recent gestational mellitus decrease weight
24341962 en determine patient mellitus insulin resistance total patient mean age year duration year female care hospital on assessment perform include hospital assess use insulin treatment insulin treatment patient show high score patient insulin therapy score vs reported increased vs insulin treatment vs insulin vs however significant vs show insulin significant negative insulin therapy patient assessment insulin therapy treatment patient may negative therapy improve treatment
23406367 en type mellitus T2DM obesity associate metabolic significant health although relative recent show obtain patient several study effect patient obesity body mass index BMI baseline weight T2DM drug therapy hemoglobin hba1c undergo medical management association patient subject follow-up control metabolic index day month also year mean weight mean BMI decrease value reduction hba1c mean model assessment insulin resistance decrease overall period patient drug therapy patient patient possible significant patient also study determine duration effect role different factor
27461503 en show diabetic patient independent recent disease one diabetic complication reported low dysfunction disease age negative drug also therefore mechanism review effect base recent evidence
25982032 en study investigate relationship insulin outcome month normal type mellitus
25577244 en weight reduction effect poor patient type female mean age year treat month treatment renal perform renal index high significant decrease BMI assess without difference treatment on decrease also found change different change show significant correlation treatment weight possible contribute cardiovascular risk profile patient type mellitus
27276835 en assess effect medical therapy blood glucose clinical outcome patient type randomize control trial conduct patient insulin type high medical patient randomize intervention group control group care primary hemoglobin week intervention group significant improve glycemic control control group week vs week vs oral reduce patient intervention group patient control group week week body weight significant decrease baseline intervention group decrease observed control group effective intervention patient type
19662619 en datum health show prevalence type mellitus T2DM man woman prevalence T2DM great reported increase mean number individual disease case reported year obesity two major risk factor development T2DM review evidence association obesity T2DM cohort study clinical trial also potential mechanism obesity major T2DM insulin resistance
20479151 en associate development disease mellitus level effect different outcome well may also perform review evidence relationship total mellitus cohort study study randomize trial assess outcome general healthy adult identify study include cohort study datum independent little model use estimate study included individual mellitus case associate study relative risk per per confidence interval mellitus relative confidence interval associate high risk relative risk per per confidence interval high risk mellitus relative confidence interval association total associate study evaluate associate high incidence mellitus result need potential mechanism effect
25120322 en high prevalence mellitus patient reported study aim study evaluate relationship assess patient chronic disease study population chronic disease patient assess control parameter diagnose patient prevalence significant difference among chronic disease high assess score show high prevalence analysis show independent risk factor hypertension or or or or assess significant relationship prevalence patient chronic disease
24185859 en remain factor control type severe one complication review present increasing body severe evidence severe include impair factor correlate treatment insulin insulin glucose therapy little randomize control trial evidence effective new reduce severe trial evaluate use method patient insulin use within severe individual high risk need datum well
21858169 en number reduce diabetic age patient factor increase gene use serum also increase treat protein target treatment diabetic patient diabetic increased increased compare datum provide evidence reduce can use
24984989 en review provide research evidence effect type mellitus T2DM effect different factor T2DM glucose tolerance insulin insulin resistance glucose activity glucose glucose glucose insulin factor role influence normal level glucose blood overall evidence present effect T2DM multiple mechanism evidence base whether use patient patient risk T2DM therapy T2DM
24669876 en compare type mellitus study randomize type patient hba1c month treatment receive week assess change hba1c fasting blood glucose week week week week hba1c significant reduce baseline group mean reduction glycemic parameter week hba1c vs vs vs week hba1c vs vs vs significant different group change total cholesterol significant vs vs significant reduce group week mean remain study treatment well effect glycemic parameter lipid may well sample study however base result study duration study large population conduct finding trial clinical trial number
26175248 en hba1c assessment diagnosis mellitus associate blood glucose however test without medical need individual medical condition test consider condition use hba1c assessment provide early diagnosis type
26087171 en target investigate mechanism two patient T2DM T2DM patient T2DM patient compare T2DM patient undergo baseline characteristic weight glycemic control month year function level also weight glycemic control observed group two follow-up period reduction body mass index great patient T2DM blood glucose T2DM similar T2DM insulin level decrease T2DM patient whereas remain T2DM patient general level increased whereas level decrease control T2DM similar T2DM mechanism may related weight
26019469 en provide assessment association type mellitus T2DM risk review conduct database included cohort study relative risk odd ratio estimate risk T2DM relative risk analyzed use effect ratio model among study assess analysis study show positive correlation T2DM risk effect diabetic woman show great risk develop effect significant overall test level high effect man test effect indicate positive relationship DM increased risk significant review report diabetic increased risk compare
21416856 en disease poor among case treatment diagnosis addition effective risk factor associate development possible diagnose early disease general mellitus risk factor aim study patient identify patient mellitus association diagnosis included patient man woman mellitus mellitus mean age year year female patient obtain diagnose year patient mellitus diagnosis within first year first found patient diagnosis increased number per day per day per day high incidence associate identify patient mellitus mellitus independent risk factor important increase risk patient mellitus
21263438 en increasing develop type mellitus intervention treat complication improve condition mean complication type mellitus target current management can can type mellitus associate increased risk type mellitus chronic development disease datum suggest old type mellitus effect severe possible function include factor function included randomize trial intervention patient type mellitus
21178753 en metabolic complication include type mellitus metabolic syndrome increasing among individual low level increase risk type mellitus show decrease risk type mellitus patient without primary determine whether serum associate type mellitus among patient determine whether associate metabolic syndrome conduct study among participant metabolic cohort clinical datum include history type mellitus fasting blood glucose metabolic syndrome level obtain adjust age body mass index associate type mellitus adjust odd ratio or confidence interval CI association metabolic syndrome significant adjust age body mass index adjust or CI study association type mellitus clinical trial need association type mellitus evaluate whether type mellitus
26260671 en type mellitus occur remain poor study identify factor related study perform regard management year old little month diagnosis insulin score identify common show may included time high healthy influence also different lead less identify several common time however include different include
25777069 en relative DM patient remain control trial database clinical trial perform patient DM consider included clinical trial patient undergo undergo undergo target rate significant lower vs odd ratio or significant difference rate target mortality major adverse event difference rate mortality result lower rate vs or vs or vs or patient DM rate similar may rate
22275939 en type mellitus adult disease reported develop increased incidence obesity associate change report year old female BMI history DM little two present weight gestational oral fasting blood glucose control patient remain two month without drug mellitus reported history DM high history DM
26215420 en activity investigate blood patient type mellitus development estimate treatment therapy include treatment blood decrease activity increase activity serum patient treatment provide change investigate parameter control value compare therapy cause positive effect serum patient therapy change normal value parameter cholesterol fasting glucose glucose level change may level effect
25984615 en obesity risk factor renal study aim determine relationship body adult patient without type mellitus study among adult without T2DM year age determined time T2DM well body mass index BMI correlation determined subject included study obesity BMI subject without T2DM similar studied subject increased risk renal disease respective test show relationship high diabetic correlate subject without T2DM therefore great study sample
25348605 en reported whether type mellitus DM associate increased risk patient disease identify patient diagnose disease DM control cohort individual disease DM cohort estimate risk also compare risk DM cohort without disease overall incidence lower among DM patient among control patient vs per DM cohort significant reduce risk on regression model use adjust ratio confidence interval CI DM cohort control cohort datum indicate compare control patient adjust DM patient significant lower among patient adjust CI year old adjust CI DM associate lower risk among patient disease presence status patient without disease DM associate significant increased risk adjust CI
26781516 en determine difference outcome base risk index value according patient mellitus patient year patient characteristic time compare group value significant lower group group value status influence value reported need improve patient status
23077965 en study present therapy use treatment type mellitus mellitus characteristic mellitus chronic metabolic disorder consider major health health indicate per year cause new case diagnose T2DM diagnose case mellitus several include insulin resistance target glucose cell dysfunction new treatment T2DM mellitus insulin contribute glucose glycemic control use effect research development
22571721 en investigate serum level gestational mellitus effect treatment insulin gestational mellitus woman evaluate two treatment insulin medical therapy week serum metabolic parameter measured baseline level metabolic parameter high patient gestational mellitus baseline control level correlate plasma glucose glycemic control level significant reduce week effect insulin treatment general therapy regression analysis show fasting plasma glucose independent level outcome similar score level high gestational mellitus compare normal insulin improve metabolic disorder control gestational mellitus woman associate high risk complication
24928199 en investigate whether obesity hypertension mellitus DM increase complication rate use retrospective included patient undergo system complication test use assess relationship complication rate obesity hypertension well prevalence obesity hypertension DM respective overall complication rate respective increasing low complication rate BMI increased observed patient great low complication CI CI patient hypertension low complication complication CI CI DM also associate high complication rate CI CI high complication rate similar hypertension DM associate increased complication rate low complication
22560913 en assess incidence type mellitus DM patient evaluate effect DM glycemic control patient treat medical study patient previous DM year mean age year woman follow-up month patient develop DM patient DM patient incidence per DM patient high woman patient patient DM mean present increased mortality CI respective due increased cardiovascular mortality rate number high among patient DM relationship DM poor metabolic control independent type medication use mellitus poor metabolic control associate increased mortality patient
23772150 en association risk mellitus DM little research conduct glucose tolerance status adjust total concentration analyzed subject age health parameter associate concentration adjust concentration subject DM significant high subject normal glucose tolerance impair fasting glucose compare low odd ratio confidence interval DM concentration respective total concentration associate insulin index finding suggest possible cell dysfunction associate increased risk DM population
21365392 en assess provide care patient study conduct hospital method research care prevalence mellitus among new diagnose patient patient identify study patient age range year mean year female ratio care identify mellitus adverse drug individual patient medication related care important role care mellitus provide care management remain need logistic conduct care potential
26061313 en aim examine risk mellitus DM among old adult disease receive type drug retrospective analyzed datum clinical research study conduct participant disease aged old history DM development DM identify use little medication diagnosis DM follow-up period regression use ratio DM use drug among participant patient develop DM incidence rate year follow-up period among type drug significant high risk DM ratio confidence interval adjust statistical result risk elevated patient treatment therefore patient disease receive treatment development DM
22768878 en effective management mellitus however method evaluate glycemic control need patient blood glucose diabetic review common present
22763108 en aim difference association poor control cohort patient type mellitus datum cohort study type mellitus patient medication factor related obtain define analysis use regression assess overall association man woman included analysis total man woman reported medication man found participant adjust prevalence ratio woman found participant adjust result show difference association need improve control patient type mellitus man
23731805 en assess estimate glucose rate insulin profile type mellitus obesity compare normal total patient aged year insulin therapy parameter measured weight body mass index insulin hemoglobin blood pressure profile result significant difference found normal weight obesity however old year lower value vs insulin high vs vs respective high cholesterol level normal weight vs vs respective correlation found different insulin value lower old year may therefore consider insulin resistance insulin high diabetic patient obesity profile cardiovascular risk
25155035 en study examine prevalence risk factor possible influence outcome complication clinical research study datum patient treat year prevalence common therapy relationship complication age patient patient cardiovascular disease include hypertension patient mellitus patient receive oral therapy include prevalence hypertension mellitus patient receive medication treatment increased age develop complication cardiovascular disease receive therapy high patient receive receive vs patient risk factor complication without vs first study population effective perform population high risk complication high among patient present
24060110 en type disorder complication associate suggest report patient type diagnose use case man type patient diabetic follow day base however revealed diagnose cardiovascular well important revealed patient treat receive without suggest type perform case may diagnose patient type
24259699 en evaluate patient type mellitus T2DM chronic without use type mellitus conduct review identify evaluate use patient T2DM chronic study two randomize control trial show increased response patient insulin resistance receive treatment on study evaluate patient T2DM show significant reduction retrospective case control study show decrease risk treatment patient T2DM chronic disease retrospective cohort study indicate increased rate patient undergo although increased patient receive adverse effect include may provide treatment reduce risk patient T2DM randomize control trial need assess therapy patient chronic
25100328 en system show effect glucose several response type mellitus response well role less develop test protein potential study suggest increase body glucose show glucose week improve glucose fasting insulin level score fasting blood glucose level significant lower drug period study show first time result effect several model potential development
24866144 en cause increased renal important renal present study investigate whether dysfunction rate renal blood investigate control without chronic treatment week diabetic increased rate per whereas increase per increased diabetic increase rate diabetic protein increased diabetic per diabetic per elevated treatment diabetic increase plasma concentration possible effect
24470436 en study suggest may reduce risk develop mellitus patient examine effect insulin resistance subject without mellitus subject current use study subject receive first week follow week subject undergo oral glucose tolerance fasting lipid baseline week week change baseline insulin index model assessment insulin resistance lipid parameter compare use mean patient age year woman body mass index week mean increase compare increase adjust mean decrease decrease adjust decrease total cholesterol cholesterol observed treatment period adjust compare use week patient without mellitus significant change insulin resistance observed statistical significant total cholesterol treatment
24341227 en perform study factor gestational mellitus type increased type change found suggest may according lead disease
25880900 en related complication study aim investigate relationship level mortality type T2DM T2DM cohort study model use investigate independent relationship plasma concentration cardiovascular concentration follow-up year patient cardiovascular cause age adjust ratio cardiovascular mortality however cardiovascular risk factor independent association mortality serum significant difference mortality model without cardiovascular mortality T2DM
23485929 en mellitus current individual increase evidence large clinical trial revealed diabetic complication metabolic glycemic control gene change cell change also cell role mechanism metabolic current examine recent reported development model type mellitus model show diabetic known complication include change associate diabetic diabetic impair also impair model similar patient multiple study effect system without potential factor previous diabetic although diabetic complication case impair multiple metabolic present method need diabetic metabolic group model
27321385 en effective patient type mellitus patient receive insulin may increased improve blood glucose control study compare effect increasing type patient receive insulin randomize trial type patient receive insulin patient randomize evaluate glucose baseline week primary change mean glycemic decrease baseline group change statistical significant similar blood glucose level improve group difference statistical significant hba1c significant reduce group baseline week increasing effect type diabetic patient treat
25311380 en insulin result use clinical among related insulin resistance recent study resistance insulin however little known impact therefore current study investigate association type mellitus T2DM T2DM patient on total T2DM patient healthy subject on total patient randomize oral week parameter determined treatment significant difference found T2DM patient healthy subject however T2DM patient show significant lower increase serum insulin finding suggest influence effect T2DM T2DM patient
20544149 en significant role also system show diabetic patient increase consider increased cardiovascular risk patient factor study show potential role diabetic one also mellitus type role can use plasma level correlate insulin resistance obesity associate development disease diabetic type role dysfunction associate can target chronic complication diabetic disease
21528760 en blood pressure show one patient type mellitus hypertension also relationship cardiovascular blood pressure patient mellitus aim present study blood pressure type diabetic patient without history hypertension rate parameter parameter subject type aged hospital obtain participant on control group subject age also patient consider patient rate parameter lower group difference significant activity group mean age group year significant high age group year found great number patient mellitus blood pressure previous consider associate value rate parameter difference statistical significant important patient mellitus normal blood pressure history year disease
27323171 en reported type mellitus T2DM disease examine association gene T2DM population blood subject include patient T2DM healthy control several gene use system datum on statistical difference found patient control group among patient control subject respective among patient control group difference found significant elevated body mass index also associate may development T2DM population
24797495 en use type mellitus well little known effective type study determine clinical glycemic control patient type insulin retrospective study patient type aged year old receive insulin use glucose blood glucose level receive little month included hemoglobin body weight body mass index blood pressure total insulin insulin insulin glucose incidence baseline month therapy medical identify patient type compare baseline month revealed reduction body weight body mass index total insulin insulin study revealed addition insulin therapy type patient lead significant body weight body mass index insulin
22172339 en study associate reduce risk mortality individual mellitus however history investigate association current mortality man woman mellitus within cohort define participant diagnosis mellitus man woman baseline ratio CI total mortality estimate regression model use compare relationship observed total mortality CI man CI woman change estimate individual baseline reported mortality rate increased relative CI man CI woman present study diabetic individual show association current mortality risk compare increased mortality risk among current
27270940 en analyzed development change activity mellitus on decrease revealed disease insulin treatment diabetic control value activity diabetic increased time respective control insulin treatment reduce activity control level activity reduce time insulin therapy parameter activity studied remain insulin therapy on negative correlation activity found
25065475 en related use insulin new insulin provide high previous patient glycemic target reduce risk clinical trial type type demonstrated patient target hemoglobin occur significant less addition interval day day effective low rate potential reduce risk improve patient confidence glycemic control on patient type also use patient insulin include patient type
27657579 en two database analyzed determine effect mellitus DM outcome sample patient without DM undergo respective addition patient insulin DM compare diabetic compare analysis use patient undergo diabetic DM patient increased complication rate DM patient insulin increased odd major complication insulin complication rate patient undergo diabetic patient high rate complication vs per great odd major complication patient difference complication DM analysis DM undergo significant outcome compare diabetic consider diabetic patient
23946590 en relationship mellitus risk study period time due two cause possible use recent disease population risk study current found reported study patient little study identify mellitus risk factor year need diagnose present whether first similar
23529596 en obesity incidence type mellitus also increased obesity lead increased risk disease independent obesity obesity major risk factor impact insulin subject insulin resistance risk type mellitus identify high risk need weight reduction increased activity early therapy type may reduce risk complication
22189550 en complication mellitus patient also effect complication need aim present study evaluate complication plasma study patient included study test perform patient type diabetic complication body mass index BMI patient present patient patient difference patient type type correlate finding age correlate negative rate patient duration compare without logistic regression analysis associate independent duration common mellitus independent type association
25327926 en study aim determine among patient mellitus hospital assess use patient woman man mean age year patient present severe high female high diabetic patient female may care treatment
25301574 en cardiovascular disease cause type mellitus T2DM association care target blood pressure cholesterol hba1c aim study evaluate cardiovascular risk factor T2DM population estimate clinical value overall study population T2DM mean follow-up period year included clinical datum analysis perform age mean level follow-up vs treatment significant associate mortality independent factor mean value hba1c blood pressure BMI fasting glucose finding suggest management cardiovascular risk type diabetic patient high level
25159234 en patient type mellitus DM associate poor glycemic control however impact glycemic control outcome aim study evaluate glycemic control patient DM evaluate mortality patient DM on total patient DM control cardiovascular risk cohort studied randomize participant randomize target hemoglobin level target hemoglobin level occur patient follow-up period rate per group rate per group model age weight blood pressure rate history patient DM ratio mortality confidence interval ratio confidence interval ratio development confidence interval glycemic control rate patient DM increased risk mortality compare without
23051859 en method cohort mellitus DM primary aim DM care study use case finding well analysis cohort outcome primary health care new patient DM total patient DM patient care present month follow-up cohort outcome analysis indicate several clinical care blood pressure assessment care blood test glucose cholesterol renal function patient DM different cohort complication cardiovascular disease analysis provide datum incidence prevalence DM level clinical management prevalence need management chronic disease
23732281 en health on study found increased risk mellitus woman history gestational hypertension suggest need woman
22016046 en investigate risk gestational mellitus retrospective cohort study woman health status identify plasma glucose level incidence first compare woman without age year ratio regression use compare associate within woman without CI woman number index woman significant high woman BMI reduce risk association group risk difference risk woman high risk develop develop effective woman woman
24812498 en study evaluate impact type mellitus old patient analysis datum case system hospital patient important factor old patient total treatment follow-up period duration hospital also factor old patient follow-up period odd ratio confidence interval intervention reduce incidence old without among ratio estimate intervention diabetic patient high factor follow-up period reduce incidence intervention old patient mellitus without
26466221 en use associate reduce cardiovascular risk study primary reduction reduction recent evidence suggest may associate high incidence new case aim review identify factor associate increase risk potential mechanism addition evaluate risk reduction cardiovascular risk review database assess association use risk associate increase incidence new case age therapy presence metabolic syndrome impair fasting blood glucose previous hemoglobin level associate increased risk possible mechanism patient drug therapy reduce cardiovascular risk risk increase incidence associate increase incidence patient glycemic however cardiovascular risk reduction group evidence finding change therapy
26266391 en relationship type study role within association type conduct retrospective cohort study use clinical research type identify drug control base age general estimate risk use regression analysis analysis total identify increased risk ratio CI association woman CI compare man CI BMI hypertension renal risk woman CI man CI risk according hba1c female found association hba1c man similar type increased risk due condition associate decrease risk man
26242308 en dysfunction known early patient disease regard important cause dysfunction diabetic patient test function associate dysfunction patient type studied patient type without perform included ratio early use function also evaluate renal function lipid profile parameter glycemic control clinical characteristic determine association patient disease renal serum type patient also base significant included patient type control study population analysis age presence hypertension mass index estimate rate significant associate analysis indicate mass index independent associate significant association parameter glycemic control associate pressure patient type result suggest possible disease function subject
26030836 en although study role health association mellitus examine common disorder several risk factor associate decrease risk although also risk factor disease study examine association obesity identify statistical disease hospital use datum study diagnose control case age analysis conduct odd ratio associate obesity diagnosis little year diagnosis obesity estimate odd ratio CI CI obesity observed effect association significant age diagnosis age first hospital association increasing age diagnosis odd ratio first CI age year CI old age result different association type vs type study investigate association diagnosis finding previous report association risk factor suggest type type
23711049 en study obtain month treatment patient mellitus type common clinical type study conduct group medical observed assess population population patient undergo three month treatment patient remain month patient month treatment patient year age mellitus DM weight DM study value month interval weight hba1c DM treatment population woman man age time year
23351459 en patient type mellitus increased risk cardiovascular disease mortality risk factor disease may risk aim study examine relationship risk mortality type mellitus study perform relationship risk factor examine regression perform determine risk mortality mortality associate increasing analysis use assess risk model year follow-up patient analysis significant associate increasing body mass index history hypertension previous significant associate ratio confidence interval ratio confidence interval mortality model adjust known risk factor increased mortality assess method may consider patient type mellitus
26151621 en determine whether associate increased risk gestational mellitus cohort study woman positive model use evaluate relationship risk analysis perform among different type study different patient identify potential included on significant association observed on cohort study woman positive first risk compare group significant association found woman whereas significant positive association identify woman current evidence significant association risk first value risk addition may increase risk woman
24397160 en high prevalence diabetic complication include decrease patient mellitus increase clinical evidence cardiovascular disease perform randomize control trial mellitus intervention trial demonstrated lower hba1c improve metabolic control patient activity important several evidence demonstrated also
25899916 en on man history type mellitus complication level within blood glucose level increased insulin develop increasing diabetic diagnose insulin oral potential cause diabetic identify treatment increased insulin level case diabetic potential severe effect individual type complication effect therapy insulin glycemic control complication
25537992 en mellitus major risk factor cardiovascular disease investigate relationship among risk parameter type mellitus T2DM T2DM subject severe diagnose included study clinical parameter obtain patient positive analyzed use method normal analyzed use test analyzed use study T2DM subject significant difference subject duration total cholesterol fasting plasma glucose blood pressure blood pressure protein study suggest gene use assessment cardiovascular risk T2DM patient
24979148 en type mellitus common treatment blood glucose level however treatment year treatment treatment patient may examine treatment vs glycemic control patient type estimate effect hemoglobin hba1c reduction outcome overall year use model model base estimate randomize trial study patient base adult patient type health oral insulin type outcome reduction risk cardiovascular low treatment day per year treatment lower hba1c level provide range patient receive diagnosis age year receive diagnosis age year increase treatment day per year result hba1c level associate aged year age patient treatment treatment lower hba1c glycemic control provide patient however patient old year hba1c level less receive therapy glycemic treatment patient treatment treatment adverse effect result old patient current glycemic control patient hba1c level less estimate patient treatment
24764283 en observed association can study may lead test result lead patient mellitus within logistic regression adjust age use assess association use diagnosis treat undergo odd positive test high among patient or on positive test associate increased odd month or negative positive test result ratio positive associate risk respective negative positive reduce association year may study association cohort test result
25757637 en report gestational mellitus rate high examine possible cause rate obtain estimate review base study identify identify use database included study reported rate on total study participant identify use test model estimate rate also use possible cause study rate confidence interval on significant association rate found lower rate compare respective woman lower rate compare woman respective evidence association history found overall rate high woman lower rate contribute study association history found large difference group may also result factor intervention can reduce rate
26858958 en effective disease management type control trial general patient intervention control intervention month group related follow-up adjust analysis revealed difference hba1c change intervention CI baseline value intervention control group outcome show significant difference improve control CI compare intervention intervention show significant effect hba1c outcome follow-up need whether clinical trial current control trial
22552298 en mellitus metabolic disease cause impair insulin cell increased insulin resistance recent early cell found insulin similar found mellitus protein target base can model first evaluate activity insulin gene activity insulin gene present activity level high control significant insulin cell suggest insulin may cell addition cell may type mellitus present study control insulin well two protein resistance gene may provide cell model mellitus
24976265 en prevalence type increased rate need development disease intervention disease metabolic recent include association study although large datum blood sample study indicate use disease risk clinical assessment index base glucose tolerance type assess clinical assessment may provide identify high risk type intervention
22857908 en relationship glucose hemoglobin hba1c adult population evaluate use hba1c diagnosis analyzed datum subject aged year study assess prevalence study define use participant group relationship glucose hba1c use regression model model correlation assess hba1c use characteristic known respective correlation hba1c fasting glucose high obtain hba1c oral glucose respective glucose level great obtain hba1c confidence interval base study hba1c value diagnosis adult population therefore use oral glucose tolerance test diagnosis glucose diagnosis case
23536235 en hypertension common among diabetic patient study aim determine blood pressure control among patient without study primary care patient aged year control target define diabetic patient patient on total patient study one patient control target compare patient without diabetic treatment associate poor control need group patient patient hypertension
23274907 en insulin gene may cause mellitus model provide important disease mechanism research large model on high level elevated blood glucose mass age day month reduce body weight decrease mass relative body weight lower fasting insulin level compare control show reduction insulin severe development severe increasing age period year diabetic insulin treatment model insulin trial study mellitus
25098023 en test hemoglobin value early mellitus DM woman gestational analysis woman early diagnosis estimate association early diagnosis DM woman normal diabetic control compare DM case level DM examine logistic regression analysis characteristic study period woman normal control diagnose DM case mean value significant high among case control vs case range control range DM positive value negative finding suggest elevated early may DM large study need association
24606550 en index include ratio cholesterol cholesterol ratio cholesterol lipid known cardiovascular disease aim study relationship lipid index patient diagnose mellitus health subject three group relationship lipid index subject subject without cholesterol ratio cholesterol ratio high increase lipid significant high subject odd ratio vs high cholesterol ratio CI high cholesterol ratio CI high lipid CI significant high level association lipid index patient level index high disorder high lipid index develop cardiovascular disease
26116592 en show type however clinical impact type mellitus T2DM disease investigate present study found plasma level significant lower T2DM patient healthy decrease T2DM patient plasma level significant high T2DM patient healthy increase T2DM patient observed plasma level negative correlate value BMI T2DM patient patient plasma level negative associate value BMI multiple regression analysis found value BMI independent related plasma level T2DM patient result indicate patient T2DM
25695762 en type mellitus patient increased risk complication study diabetic subject impair function without function diabetic patient without significant associate hemoglobin related event report recent development multiple assess use relationship glycemic control cardiovascular outcome
25291501 en compare diabetic study conduct type diabetic patient treat blood sample determine concentration level on population model use determine patient age year patient year difference year confidence interval year high patient patient difference patient high patient difference ratio patient range patient concentration also similar vs patient respective range significant difference plasma concentration patient type mellitus study patient
25465154 en complication mellitus DM although mechanism dysfunction remain show DM reduce DM related factor analyzed cell increased time control reduce diabetic reduction diabetic reduce diabetic whereas factor factor reduce diabetic treatment diabetic diabetic result indicate diabetic reduce model DM suggest can treat patient DM
26606528 en new type mellitus T2DM may diagnosis drug development clinical treatment evidence increasing system role T2DM suggest presence protein identify possible disease T2DM T2DM studied normal glucose tolerance subject high insulin compare without possible identify use protein plasma T2DM without compare normal glucose on case control age time evaluate protein high among T2DM subject lower compare subject high adjust multiple low adjust high ratio on characteristic CI respective study identify associate T2DM associate reduce insulin study need whether associate insulin T2DM two study may protein target
26885531 en index cardiovascular can model type mellitus clinical datum investigate whether model cardiovascular function clinical result can group control control multiple blood glucose insulin week compare increased increased serum decrease rate can include rate finding model function clinical
26485408 en patient type renal patient insulin resistance may among compare several index glucose patient receive included positive BMI treatment oral insulin insulin compare several index glucose within among patient patient similar age BMI insulin resistance included model insulin index ratio insulin included insulin similar metabolic fasting glucose hba1c blood pressure lipid parameter cohort significant difference insulin resistance result suggest consider among insulin resistance however large cohort follow-up need result
26044709 en evidence suggest presence hypertension well type mellitus DM present study investigate possible effect type DM type study participant three group according presence DM hypertension group one included diabetic subject group included subject without group included subject without hypertension without DM control blood metabolic parameter include fasting glucose hba1c model resistance model function increased group group significant lower subject DM group group lower diabetic subject compare subject hypertension significant group present study significant lower diabetic subject compare subject without hypertension associate parameter glucose fasting glucose hba1c positive model cell function type DM associate adverse effect independent age drug
25753172 en study potential patient perform cell subject patient presence high plasma cell well patient common mechanism
24522480 en aim study determine prevalence factor associate disorder mellitus DM on study perform adult DM patient subject participant medical history perform parameter determined subject DM patient disease duration glycemic control DM complication also examine logistic regression analysis use determine factor associate disorder mean age DM patient control year DM patient control female respective overall prevalence high DM patient among vs analysis DM patient CI odd compare DM patient high subject among DM patient analysis show female or CI disease or CI disorder common population DM among DM patient disorder woman complication disease
27809851 en disease cell increasing clinical evidence role protein on diabetic disease mean on contribute development however large study investigate use cell whether on condition function increase lipid cell develop model glucose high glucose plasma glucose level use lipid cell use low presence on model use study cell on similar model use on gene well use role on cell on effective increased high glucose treat cell presence on treat increase lipid compare cell treat increased also observed on significant increased on cell use result decrease lipid decrease level on significant possible on may mellitus
23425797 en investigate hba1c evaluate impact hba1c study on total participant age without known undergo oral glucose tolerance test use oral glucose hba1c measured use high subject normal glucose tolerance glucose new diagnose per two test compare characteristic subject diagnose use hba1c population use hba1c value diagnosis population CI result show low hba1c use participant associate metabolic characteristic include body mass index BMI blood pressure lipid profile ratio compare diabetic subject hba1c study population lower hba1c may use identify
23782529 en assess whether difference effect glucose patient type mellitus T2DM use glucose randomize study conduct T2DM patient on total patient age year baseline hba1c study patient receive two treatment blood glucose concentration measured glucose profile also measured use baseline day treatment glucose level estimate reduce glucose level base datum vs measured plasma glucose show lower glucose measured mean blood glucose rate change statistical sample reduce lead statistical significant rate change range glucose treatment significant increased level whereas significant increased level insulin treatment associate less glucose level treatment assess suggest may potential effect patient T2DM development complication
26594894 en gestational occur woman period on number study however whether first less study examine potential relationship identify first development woman without type evaluate first medical review identify positive history woman identify first compare factor level first development identify early may increased risk development due complication associate early possible outcome possible risk factor development can lead early
21755829 en increasing evidence clinical study suggest major role type mellitus protein lipid among target study evaluate type mellitus insulin mellitus patient estimate lipid effect metabolic total type mellitus patient healthy control examine study parameter reduce metabolic parameter studied type mellitus patient three month three month parameter studied level lower level high type mellitus patient compare healthy control diabetic patient significant decrease level significant increase level found on negative correlation positive correlation found significant change observed metabolic parameter type mellitus patient type mellitus patient improve system however metabolic parameter
23238201 en type several study show associate increased impair health general adult population type one associate metabolic syndrome increased risk cardiovascular disease study therefore determine prevalence metabolic syndrome new diagnose type mellitus subject study new diagnose diabetic hospital new diagnose diabetic patient study found elevated blood glucose disease present analysis use use test use analysis value consider statistical subject study sample result subject female mean range age year year BMI general population mean range man range woman metabolic syndrome found subject female prevalence different metabolic syndrome follow hypertension found female female obesity found female study subject hypertension diagnosis mellitus DM female number female low study show metabolic syndrome high new diagnose type patient common risk factor hypertension
23637135 en estimate related type mellitus T2DM diabetic control profile datum previous report one model include treat T2DM examine association T2DM analysis model compare protein level control age protein level show negative correlation increasing also observed T2DM revealed T2DM diabetic associate improve treat role investigate previous report
24860866 en medication use patient new diagnose diagnosis identify patient new diagnose relative high drug cohort health system adult year age old new diagnose type type drug month month diagnosis overall health period mean number drug use new diagnose patient high diagnosis increase significant increase due increased use medication control hypertension lipid level analysis show overall drug diagnosis high woman old patient well among high hemoglobin concentration level significant overall number drug use new diagnose patient diagnosis decrease significant new diagnose increased medication use control study show increased cardiovascular disease risk factor control diagnosis however total drug may time
21567461 en association disease type mellitus known disease without clinical diagnosis test study aim determine prevalence disease type perform clinical study included group type mellitus subject female mean age evaluate obtain prevalence type mellitus increased prevalence suggest need use method effective test disease type mellitus
25952330 en aim present study develop use risk mellitus DM subject base risk datum plasma fasting glucose lipid profile history DM subject aged year logistic regression analysis perform sample subject risk assessment DM datum remain sample test characteristic use assess DM risk subject DM define fasting glucose plasma glucose oral glucose tolerance test risk score range included age body mass index history DM blood pressure risk score range level risk factor demonstrated test DM develop use risk
22950794 en function gene may function relationship disease level significant correlation disease type mellitus T2DM increasing complication however T2DM chronic early metabolic complication may may well target recent contribute development type mellitus T2DM year early diabetic evidence regard type T2DM disease different T2DM may new diabetic complication also development T2DM first event metabolic disorder early event may diagnose influence increasing gene
24924841 en previous study show incidence high woman study examine effect therapy woman study examine incidence randomize clinical trial evaluate diabetic index woman included relative risk use model study case included base datum significant reduce incidence odd ratio or confidence interval CI use vs use or CI use vs use woman significant lower level fasting plasma glucose mean difference CI hba1c mean difference CI compare reduce plasma total cholesterol mean difference CI mean difference CI increased mean difference CI level compare control review provide evidence woman decrease risk develop diabetic control
24713673 en primary report associate mellitus DM suggest mechanism association DM patient diagnose DM time review consider role DM case database examine patient DM without patient DM time diagnosis demonstrated DM patient diagnosis DM develop DM case whether important event development DM although provide mechanism association may related role glucose
26118081 en consider influence type mellitus T2DM patient chronic mean found negative impact T2DM overall assessment patient also negative effect patient patient T2DM influence number factor contribute development patient studied group identify include poor lipid study patient
24573360 en investigate impact mellitus DM female lower datum diabetic woman primary hospital clinical history patient perform female diabetic patient cause lower dysfunction datum lower parameter diabetic woman lower positive finding present case impair among patient impair mean first mean mean rate mean pressure rate mean patient impair renal function blood test study diabetic woman diabetic significant cause lower significant diabetic woman diabetic condition clinical finding prevalence diabetic high
23919839 en mellitus develop study clinical outcome can potential base aim provide develop sample adult use population aged year model develop compare clinical outcome control group impair glucose tolerance intervention respective independent model base incidence mortality health reported outcome remain year year per subject per subject control year analysis perform base addition control group age year increased age year intervention associate compare control group population aged year little per subject statistical significant difference observed among intervention within age group reduce poor effective intervention adult
24379330 en trial assess health patient year old diabetic status undergo risk association risk test hemoglobin participant hba1c level great patient hba1c blood level great diagnosis hba1c association risk test correlate participant receive diagnosis within one year patient health diagnosis patient high risk develop study result show patient patient patient health demonstrated however poor among may provide important patient chronic care model health care care patient
23649954 en study investigate influence development associate group different treatment control perform analysis perform use protein analysis significant great group high group group significant difference group group associate undergo therapy subject
24353270 en increasing prevalence type mellitus T2DM need individual risk factor T2DM among target health outcome development weight obesity two important risk factor need on body evidence suggest subject body weight increase activity T2DM case blood glucose level may normal several study show level effective reduce total among subject cardiovascular risk profile reduce risk T2DM development randomize control trial use intervention include change activity without treatment population high risk develop T2DM review trial T2DM evaluate
25585531 en due population incidence identify early blood clinical early intervention high risk group type present study blood individual type develop within period baseline assessment control normal function identify significant difference group baseline follow-up baseline month follow diagnosis report significant difference identify develop difference blood sample patient clinical diagnose disease compare control subject
18220017 en patient present adverse metabolic effect report case woman disorder treat year renal result revealed on high serum level found found high serum level also on test reduction level one month condition disorder associate therapy severe reported diagnosis patient receive chronic therapy
27509605 en compare lower early patient lower early mellitus group control group case one patient two group treat treatment control blood glucose lipid addition patient control group treat base patient group treat treatment day treatment two week one total total syndrome score hemoglobin hba1c blood observed treatment clinical compare two treatment total syndrome score hba1c blood significant improve treatment group treatment total effective rate group significant control group effect lower early mellitus improve clinical blood increase blood lower
26661628 en although mellitus complication large although complication general patient health care respective association complication reduce can development complication early also provide research examine new treatment diabetic complication mellitus association review report
23186328 en study show correlation disorder mellitus correlation common medication disorder negative effect blood database analyzed use disorder insulin oral use mellitus association medication disorder medication logistic found association use medication treat mellitus treatment disorder female high risk compare man treat disorder use oral high odd receive use insulin lower odd oral compare general study show association use association among woman man
23132154 en mellitus chronic disease prevalence analyzed multiple study analysis drug treatment prevalence medication mellitus examine datum health prevalence analysis use datum database well health use define profile medication determined diabetic patient treatment per association drug treatment prevalence medication on type type total prevalence patient value range high drug treatment prevalence found insulin treatment insulin oral medication little on treatment one oral common low develop use datum estimate drug treatment prevalence chronic disease estimate prevalence increasing reported study research method
27124062 en previous study mellitus DM associate risk mortality study investigate correlation DM remain perform estimate role DM ratio confidence interval CI evaluate correlation DM perform base treatment total cohort study included also study investigate overall study investigate DM significant associate CI association cell whereas association significant cell CI patient treatment method DM influence treat treat evidence result association DM patient treat patient number study included present cohort study randomize control trial
24829924 en effect cell function new diagnose type mellitus T2DM patient study new diagnose T2DM patient without patient datum glucose level insulin level lipid profile model assessment cell function index model assessment insulin resistance index index compare two group found compare normal lipid level subject new diagnose T2DM however level different lipid profile multiple regression analysis show high fasting plasma glucose decrease fasting insulin level high independent risk factor cell dysfunction new diagnose T2DM therefore management glucose control may T2DM
24203650 en demonstrated role development diabetic however investigate type diabetic cohort on study conduct hospital participant type mellitus year age patient disease medical condition function significant associate cohort impact regression model indicate confidence interval datum first show cell associate type mellitus may patient
21610015 en prevalence mellitus DM increasing result obesity population increased patient chronic disease recent type DM common primary aim management complication control change weight drug therapy increased contribute development treatment insulin effect whereas effective current drug need clinical role use treatment association use adverse outcome new insulin management blood glucose aim provide low insulin insulin insulin therapy increasing use type DM control recent use insulin insulin may associate increased risk although increasing new treatment use patient remain great value may
23358371 en consider however recent study indicate high plasma level possible risk factor develop type mellitus result trial decrease incidence among healthy man show development incidence new diagnose type mellitus increased among participant trial show decrease risk among participant year however result trial also show increased risk type mellitus participant plasma level study recent association serum observed reported associate suggest new role possible increased risk type mellitus also development study relationship role development type mellitus high level
23311375 en treat patient mellitus due aim treatment patient mellitus investigate cell different time interval treat three diabetic patient day day day week week show clinical profile patient patient week respective revealed well study effective treatment diabetic patient can response
27062957 en role management type mellitus conduct datum outcome fasting blood blood randomize control trial control trial study intervention included on total included review datum research patient method control result mean mean difference confidence interval assess use effect due effect intervention treatment treatment observed mean difference well risk overall high included study evidence consider intervention management
27052224 en blood pressure one important intervention reduce complication mortality patient mellitus recent study indicate blood pressure level range lower blood pressure level reduce risk diabetic associate increased cardiovascular mortality low blood pressure level patient disease disease patient mellitus need therapy first drug
25188210 en group high prevalence type assess effective health group type perform database well identify database common control trial health year age type mellitus group review independent assess trial datum regard two review study datum need total trial include review participant included review trial provide datum although intervention provide study different one study participant duration intervention group individual intervention study base model health control measured hba1c show health three month mean difference confidence interval CI trial participant evidence month CI trial participant evidence intervention compare control group receive care control little month CI trial participant month CI trial participant evidence intervention effect general adverse event study two primary outcome review score show intervention group three mean difference CI CI month CI intervention on reduction CI observed three month month effect total cholesterol cholesterol cholesterol reported follow-up outcome blood pressure body mass index also show effect compare control group datum outcome diabetic complication mortality health intervention participant intervention risk high also assess participant high outcome health effect control healthy year first review great number reported review study trial clinical important outcome can studied study included analysis study confidence need compare different type health within define group effect can lead clinical important health outcome
23864492 en study examine month cell insulin type mellitus cell measured cell index measured intervention patient test group without blood period diabetic patient can significant reduce BMI fasting glucose hba1c group significant high index patient independent status period value index change significant however index significant reduce patient period group significant reduce study index significant decrease mellitus patient month cell remain intervention cause present finding
24356291 en disorder function occur difference level response negative occur syndrome case diagnosis syndrome treatment whereas treatment severe use type case syndrome due
27509606 en compare clinical multiple patient group case medication group case patient two group receive treatment control blood within range patient group treat patient medication group treat treatment day day treatment interval day total score mellitus change clinical treatment two group treatment score significant reduce two group significant group treatment common significant increased two group compare two group common group significant medication group group significant medication group group significant different medication group total effective rate group significant medication group medication effect multiple mellitus medication clinical disorder clinical effect
27335185 en on complication diabetic patient study association can provide compare parameter subject without mellitus type determine relationship study participant two group mellitus type subject control rate measured related test blood glucose show lower score control negative association rate hemoglobin observed patient also blood glucose score time mellitus type parameter system metabolic diabetic patient use patient
23017317 en mellitus well known finding reported different effect finding study aim examine potential effect change effect type datum health individual age year diagnose study population day test test multiple logistic regression model use assess effect ratio assess use day test indicate significant factor however test method effect significant result indicate type mellitus risk associate risk reported effect
27922545 en mellitus DM common complication chronic increase mortality risk factor DM development may contribute early potential risk reduction DM patient hospital rate DM method risk factor DM development diagnosis identify regression total patient follow-up duration year patient develop DM rate DM year confidence interval CI CI respective risk factor DM development diagnosis identify ratio CI CI CI CI CI risk develop DM patient influence development indicate disease study subject also factor include
27057870 en mellitus DM common complication chronic increase mortality risk factor DM development may contribute early potential risk reduction DM patient hospital rate DM method risk factor DM development diagnosis identify regression total patient follow-up duration year patient develop DM rate DM year confidence interval CI CI respective risk factor DM development diagnosis identify ratio CI CI CI CI CI risk develop DM patient influence development indicate disease study subject also factor include
24111861 en study assess relationship serum level ratio activity index patient type mellitus
24398990 en known associate cardiovascular presence adult research associate diabetic cardiovascular test whether cell present type mellitus present study one use sample patient female ratio positive type mellitus sample use primary sample chronic relative normal positive also suggest mechanism severe present type mellitus associate
24106697 en regard profile however patient type mellitus T2DM found control study aim investigate effect protein individual model metabolic characteristic T2DM T2DM model week follow low change serum glucose insulin model assessment insulin resistance index lipid profile assess addition level reduce activity determined result show addition normal level also therapy serum total cholesterol level effect use
24020098 en obesity mellitus two association among obesity insulin resistance type mellitus recent year diabetic diabetic control assess parameter body mass index ratio fasting blood glucose insulin insulin resistance method model assessment parameter show positive correlation score association high insulin resistance insulin resistance show correlation finding lower control study obesity type insulin resistance type mellitus potential obesity may insulin resistance type mellitus
23934458 en disease chronic cause increased prevalence disease found mellitus type large difference disease different show great aim prevalence disease mellitus type among study conduct mellitus type test presence on total on level patient on mellitus type female aged year patient on diabetic high on patient disease study show prevalence disease mellitus type similar observed age patient duration disease effect prevalence study determine effect factor identify difference
26345248 en aim present increase patient provide management patient adverse well effect medication prevalence among high number diabetic increase number risk also increase review current little diabetic well provide health care patient
22560776 en increasing prevalence suggest control trial effective intervention medical research effective although may investigate effect primary care patient type mellitus use medical patient T2DM primary health care on regression model use evaluate change weight hemoglobin hba1c statistical significant change weight hba1c period day patient activity level activity level weight hba1c difference patient health care effective intervention control trial found primary care weight hba1c patient T2DM time medical use effective intervention primary care
26802011 en study perform evaluate effect system chronic disease care on randomize control trial conduct compare use system disease intervention group method control group patient type mellitus hypertension system blood glucose blood pressure care two chronic disease control patient outcome reported included hemoglobin hba1c level fasting blood glucose level blood pressure blood pressure chronic disease datum baseline follow-up patient intervention group significant decrease mean blood pressure baseline month baseline month compare control group significant mean blood pressure intervention group compare control group month month change significant month significant difference observed group fasting blood glucose level hba1c level chronic disease blood glucose level blood pressure similar group disease blood pressure control effect use provide large trial
26784653 en gene associate type mellitus T2DM gestational mellitus study aim evaluate possible association gene woman population study perform population woman include assess use finding show significant different group increased risk compare significant different subject respective on significant show vs vs finding show significant association gene investigate
23362315 en aim determine prevalence new diagnose type mellitus relationship examine datum patient study use regression examine outcome status patient baseline datum evidence old female compare without mean blood pressure great treatment therapy great prevalence adjust ratio without model included risk confidence interval confidence interval mortality ratio first first index show model index show improve patient new diagnose type mellitus evidence independent associate increased risk mortality however current risk number
19957793 en investigate characteristic mellitus risk characteristic mellitus patient receive mellitus patient one found prevalence new mellitus impair fasting glucose respective significant high general population significant associate prevalence mellitus logistic regression analysis baseline characteristic mellitus patient significant associate increased age or elevated level or treatment or large or compare patient without mellitus number patient little one significant great diabetic patient or or associate lower risk prevalence glucose renal observed risk factor contribute development mellitus
19571084 en prevalence mellitus age year increase number diabetic patient undergo total increase according general patient increased risk adverse event present study determine whether glycemic control prevalence complication lower total sample patient undergo present retrospective study compare patient mellitus control mellitus without mellitus regard common complication mortality hospital compare effect glucose control among patient glycemic control determined assessment association use patient level hemoglobin level related patient control mellitus patient mellitus significant increased odd adjust odd ratio confidence interval adjust odd ratio confidence interval adjust odd ratio confidence interval adjust odd ratio confidence interval adjust odd ratio confidence interval adjust odd ratio confidence interval adjust odd ratio confidence interval patient mellitus significant increased day compare patient control patient significant increased compare patient type patient mellitus significant increased odd complication high mortality increased index lower total
24124913 en type mellitus may associate disease common case type mellitus due three year therapy drug current normal well control treatment drug observed reduction insulin due increased activity several clinical trial evaluate effect diabetic patient recent disease perform study duration large population need assess role drug group patient
22071296 en chronic disorder impact number associate high mortality rate care improve clinical outcome patient individual clinical need patient control evaluate patient care patient chronic disease patient mellitus
23384709 en recent evidence suggest define elevated concentration normal level associate cardiovascular disease adult population current datum prevalence potential association profile type investigate prevalence associate lipid level diabetic analysis adult age year normal normal group elevated group serum lipid prevalence rate study population adjust age duration current insulin hba1c BMI patient significant high level total cholesterol vs vs compare common finding adult associate increased level total cholesterol adjust potential increase lipid level may therefore increased cardiovascular risk patient
22908432 en important control type mellitus therefore determine factor effective may significant patient type mellitus study examine relationship among study evaluate whether relationship type mellitus use datum sample type mellitus examine finding indicate effect among man woman sample significant associate man relationship sample finding suggest need consider intervention improve patient potential influence
22187293 en study examine possible association mellitus DM result conduct assess evidence regard association incidence mortality identify study included effect estimate confidence interval association incidence mortality use model analysis also perform among study examine use total cohort study show statistical history DM incidence CI analysis positive association among study conduct CI association DM observed datum type DM cohort study study respective mortality increased compare individual without CI increased risk develop positive associate mortality large cohort study need
21569085 en investigate prevalence gestational mellitus woman gestational mellitus care on total woman gestational mellitus test glucose test woman glucose undergo oral glucose tolerance test glucose gestational mellitus use health adjust prevalence gestational mellitus increased time prevalence gestational mellitus high among woman aged year low among woman aged woman aged year prevalence prevalence gestational mellitus increasing female population important health
21380596 en examine association serum incidence type mellitus year follow-up year incidence measured cohort study participant on define develop positive history mellitus treat insulin oral level baseline risk factor type determined use time year incidence estimate age body mass index status chronic disease status hypertension status serum baseline associate year incidence type or per CI finding show positive relationship serum level incidence type mellitus independent risk factor finding suggest need potential type mellitus
22403498 en hemoglobin hba1c diagnosis current study use hba1c test subject total subject man woman fasting plasma glucose undergo oral glucose tolerance test hba1c test plasma lipid blood pressure also characteristic hba1c related diagnose respective confidence interval on hba1c level respective compare hba1c method diagnose group significant high hba1c level lower level fasting group significant difference observed index two result suggest hba1c diagnose subject association
21864292 en high gene recent target cardiovascular disease several cell cell cell potential therapy current increasing rate cardiovascular disease clinical evidence revealed cell cell diabetic patient patient major cell therapy cell report therefore new cell body major research clinical role cell cell cell cell cell review major mechanism role different cell target cardiovascular disease also provide therapy cell potential treatment cardiovascular disease
23650675 en mellitus DM present complication disease high risk develop identify association disease type mellitus patient hospital general study patient mellitus evaluate mean index woman man studied mean age year mean mellitus year mean glucose level present patient index revealed patient present patient found patient complication diabetic
23481531 en several study mellitus disease similar risk cardiovascular disease study independent risk woman study determine whether mellitus disease risk event use trial randomize trial outcome woman high risk history mellitus without known history without known mellitus model use compare cardiovascular outcome group mean age baseline year follow-up year include cardiovascular analysis diabetic woman increased risk mortality compare woman although overall risk lower diabetic woman compare woman risk mortality similar ratio confidence interval respective adjust age factor risk factor use treatment trial mellitus risk woman
21875362 en datum regard insulin level therapy insulin examine insulin insulin new insulin level week treatment
24518176 en review old individual evidence base treatment target conduct identify evidence base randomize control study well patient high population group significant impact treatment regard glucose target old patient common old patient contribute increased reduce treatment case duration status important factor consider identify glycemic old patient type mellitus treatment old patient T2DM base due general evidence randomize control trial therapy patient ratio trial old patient need assess drug
26209521 en aim present study investigate association concentration incidence man woman without type study subject year age mean age year baseline activity obtain use serum concentration obtain use diagnosis type base individual patient mortality baseline prevalence type baseline man woman mean follow-up year event man woman model significant association concentration found man type CI model also include ratio blood pressure total cholesterol association remain statistical significant CI concentration man type independent risk factor trial investigate effect regard cardiovascular outcome trial effect
25893729 en risk develop great woman previous gestational mellitus general population plasma analysis identify individual risk develop type aim study determine whether lipid level week associate increased risk develop type lipid profile lipid measured normal woman week index use mass woman assess year development type woman previous develop follow-up period year three lipid independent positive associate development type clinical model type included age BMI level fasting glucose fasting glucose total cholesterol addition three lipid result index lipid significant risk factor development type woman previous history report first use plasma analysis identify individual lipid potential type woman history
25800728 en aim study evaluate assess impact among type mellitus patient patient three primary hospital use factor analysis sample rate use presence sample high value respective result show three important overall patient condition negative great impact found among type mellitus patient
20152998 en lower blood glucose type mellitus potential reported investigate effect plasma activity concentration glucose type mellitus subject type mellitus female age year mean body mass index hemoglobin receive randomize oral body weight glucose glucose response assess effect examine mean plasma glucose response low mean compare mean serum insulin response similar treatment high respective mean plasma activity lower compare mean plasma concentration high compare respective patient type mellitus activity increase concentration significant lower plasma glucose concentration type mellitus subject compare whereas insulin response similar serum concentration result
26197766 en follow-up woman diagnose gestational mellitus however follow-up rate poor high diagnosis well studied may important influence assess use identify woman diagnose participant follow-up provide participant datum analysis research conduct major hospital woman care diagnose obtain identify diagnosis need follow-up follow-up result use whether need woman event influence need woman may effective follow-up
25046055 en effect response patient type mellitus T2DM treat T2DM patient treat undergo tolerance test week treatment patient randomize response evaluate significant level increased significant insulin without insulin significant great clinical difference metabolic study revealed response assess use
25336066 en retrospective mortality risk cohort patient type receive oral drug association mortality different use outcome first change receive one according datum period without change treatment interval period treatment drug treatment outcome impact study evaluate conduct analysis use database mortality retrospective cohort type patient treat included little one model first treatment interval patient case respective evaluate use regression age duration adjust compare mortality risk ratio associate patient demonstrated little mortality risk one model age duration influence case first model case without change model increase mortality risk group compare one compare vs mortality risk model patient demonstrated little mortality risk one age duration adjust use mortality analysis study patient present result
22923278 en determine chronic patient without study datum analysis early study patient group case without control status included on total measured plasma total included lipid measured serum old mean age vs year duration vs year lower vs compare without multiple logistic regression analysis associate independent duration age patient level however level different diabetic found associate duration low study need evaluate association
27701716 en mellitus type associate metabolic disease disorder may change development well may subject protein may function previous study investigate function patient type perform patient study base population datum study health investigate influence metabolic control system function decrease system function complication population base method study case study multiple control base participant population base study datum function age body mass index participant without result participant show significant lower total factor significant decrease general population without function observed present study reduction parameter reduce participant suggest type disease cause well
25836740 en little known regard influence effect blood pressure among patient study association among patient week type mellitus patient measured concentration range use model examine association individual characteristic mean relative day week year use medication association pressure association number concentration mass concentration effect occur range increase number concentration associate increase pressure female patient year age patient without treatment effect result revealed important among patient
22550714 en overall incidence mellitus lower index year prevalence type metabolic syndrome among population lower among
23348168 en effect control glycemic control factor contribute significant glycemic control study adult patient type mellitus undergo hospital perform datum obtain patient medical case control age lead significant decrease mean blood glucose reduction patient patient mean range intervention patient receive therapy insulin oral intervention significant positive outcome respective included hospital can glycemic control patient poor therapy insulin oral control population level
23072401 en health index common use research examine index large sample type type three index patient health health index determined factor test factor analysis assess correlation patient health score index test two patient health score use characteristic index factor analysis patient type type correlation observed index patient health score score score characteristic show index perform compare patient health score respective index use test type type
23065368 en incidence type increased increase obesity time period although value evidence treatment type age group recent drug trial insulin current drug treatment type recent however medication type recent study compare three treatment glycemic control type new
22913570 en study indicate general role glycemic control individual type mellitus general may related health outcome therefore need significant relationship glycemic control study evaluate previous develop use old result analyzed determine factor well relationship clinical factor analysis significant relationship observed glycemic control related age status score high associate duration female assessment
26505452 en impair increase contribute development type mellitus T2DM important aim study association T2DM population use healthy control T2DM patient study participant group study significant T2DM patient control odd ratio or confidence interval CI remain significant T2DM respective significant T2DM patient control or or significant T2DM result indicate common increased risk T2DM population
25757948 en number control cardiovascular disease type mellitus T2DM evaluate aim review evidence intervention control T2DM review consider conduct control trial base estimate study include participant risk develop disease one identify major database two independent study assess use follow assessment effective present review overall evidence present per assessment development study receive medical new result review provide evidence chronic disease care
25703556 en within lead increase case although new case case case on review mechanism increased present however new control present increase number type mellitus T2DM T2DM increase T2DM review body research compare clinical T2DM change response include effect treatment different change respective factor although significant mechanism increased
25092354 en prevalence disease type mellitus reported lower aim study evaluate prevalence disease patient aged year follow little one year evaluate disease test positive negative control mean great identify positive prevalence value associate respective patient disease patient diagnose little year relationship period presence disease patient positive significant high among patient history disease prevalence disease patient high identify possible cause finding evaluate influence metabolic control
23447104 en high prevalence type mellitus T2DM previous found associate T2DM relationship disease T2DM population current study investigate gene among T2DM patient examine risk develop T2DM use test presence patient T2DM compare healthy control subject incidence gene high among T2DM patient patient control significant relationship identify result show association T2DM influence increased risk T2DM
27701934 en cardiovascular disease cause patient type mellitus T2DM trial show significant increased risk three glucose drug treatment T2DM also demonstrated cardiovascular outcome event trial type mellitus glucose outcome trial also provide possible renal renal mechanism therapy patient T2DM high risk demonstrated outcome study
21303639 en patient mellitus blood glucose insulin several time day may important role datum year patient different age range healthy control age mean year type mellitus patient year disease duration year T2DM patient year year T2DM patient year age year year assessment patient two test test type show compare group result influence age large old T2DM patient perform control significant control old T2DM T2DM patient type show similar result control subject perform normal group reduce common T2DM patient study finding medical patient mellitus
22498001 en current drug also activity aim study determine effect model mellitus diabetic insulin treat treat insulin treatment previous medication blood glucose three week control treat previous body weight insulin level measured study result significant decrease blood glucose increase insulin level well number mass cell treatment diabetic insulin response clinical study need different mechanism insulin mellitus
26277548 en cell type randomize control trial patient determined test assess month increased baseline change baseline significant high serum within normal range first study show improve function patient can one possible development therapy
25043705 en lead increased reduce several investigate effect period patient type mellitus T2DM blood glucose level intervention medication treatment compare level evaluate without use patient control time method perform response blood sample T2DM patient period improve glycemic control significant decrease level T2DM patient although level high control subject also found decrease level T2DM patient period however analyzed statistical significant difference level study demonstrated although studied show significant glycemic control hospital result significant reduction level T2DM patient glycemic control
23864581 en effect risk reduction patient type cohort health health total patient without previous diagnosis compare risk among subject type drug use use drug use drug result revealed effect risk time on significant decrease risk found group receive define ratio confidence interval CI great decrease risk observed patient CI significant great effect patient use risk reduction time patient type whether use drug
25003362 en mellitus DM high risk DM remain conduct study prevalence follow-up rate DM patient without previous hospital perform define negative prevalence analysis revealed positive associate negative associate DM patient within follow-up time diabetic population evidence need follow-up cohort
20299376 en cell mellitus study determine whether individual mellitus high rate complication relative without retrospective study compare estimate complication presence study included undergo hemoglobin hba1c presence determined use hba1c medical review perform obtain patient hemoglobin hemoglobin mean protein similar three analysis revealed participant disease disease duration age insulin use difference prevalence complication increase risk complication mellitus
22471336 en associate mellitus different study treatment oral insulin result improve glycemic control patient cause occur age month important management gene use follow three diagnose day age current age year diagnose year age current age year diagnose year age current age year treat insulin effect also examine model result revealed presence three patient insulin oral improve glycemic found three high age diagnose day year year age can oral previous reported patient well report diabetic
27897090 en aim present study determine effect disease diabetic group group group group group group group group mellitus week lower first study duration week period change level clinical measured examine protein serum level also week significant high group compare group decrease group significant decrease increased activity compare group increased protein level however effect study addition significant reduce increased activity decrease activity diabetic
25994603 en aim study evaluate effect compare several parameter insulin patient hypertension type mellitus patient hypertension type mellitus patient treat month assess blood pressure blood sample assess baseline month parameter fasting plasma glucose hemoglobin fasting plasma insulin index patient also subject assess value glucose rate insulin one patient study reduce group although reduction great vs baseline vs increased value glucose rate vs baseline vs level increased reduce baseline vs baseline reduce reduce compare baseline level obtain significant obtain parameter addition provide great reduction improve insulin assess improve related insulin resistance
24897467 en study estimate prevalence associate factor diagnosis mellitus study base sample individual analysis risk age year old increased body mass index hypertension prevalence mellitus estimate logistic regression indicate statistical associate factor health condition blood pressure month poor health high prevalence associate factor related low poor health diagnosis population risk include health care health care primary health care positive impact early diagnosis treatment reduction potential complication associate population
22172400 en insulin therapy patient determine treatment compare among treatment study perform adult patient insulin participant provide history management level insulin therapy determined number type mellitus patient different use type T2DM patient insulin use insulin evaluate according medication glucose total patient T2DM patient per day patient use insulin insulin patient T2DM use multiple treatment different insulin insulin mean insulin therapy T2DM insulin increased number T2DM important treatment overall insulin therapy increased insulin found insulin treatment use care consider associate use insulin insulin treatment insulin therapy improve care patient insulin reduce
24003933 en datum role review evidence type review protein response provide datum profile impact response target use type
24512194 en study examine clinical characteristic treatment type mellitus T2DM treat well hemoglobin blood pressure cholesterol body mass index BMI association study retrospective cohort medical adult T2DM use identify sample receive index first month clinical characteristic assess baseline level BMI evaluate month index association evaluate use method adjust baseline characteristic patient include patient year old hypertension cardiovascular disease common baseline level BMI associate significant lower per patient per year compare adjust mean difference BMI BMI BMI study high incidence potential T2DM outcome
20117951 en perform mellitus identify study use test show common new diagnose mellitus test low less present study determine finding mellitus plasma diabetic plasma glucose total protein measured diabetic significant elevated value test identify mellitus characteristic value high positive ratio result suggest plasma concentration method diabetic
26494020 en hemoglobin hba1c assessment chronic complication type mellitus DM
23158985 en disorder increasing common present treat positive pressure disorder associate mellitus possible related per increased activity increased adverse glucose insulin association presence common risk factor review assess impact mellitus metabolic parameter include hba1c glucose insulin resistance addition effect mellitus result randomize control trial
22268612 en glucose glucose clinical development treatment type mellitus T2DM mechanism may value also treatment type mellitus study investigate effect insulin glucose model receive two insulin without blood glucose measured study receive one two one day blood glucose hba1c insulin similar effect insulin intervention insulin study blood glucose profile day group lower one similar two plasma hba1c improve group two reduce blood glucose level model insulin show treatment insulin datum suggest therapy clinical potential treatment
26341927 en insulin influence improve insulin resistance mellitus present study aim study effect week therapy patient type mellitus type study follow week patient type DM randomize treat group treat group healthy control group datum present test correlation test perform datum clinical characteristic two study group similar significant difference fasting plasma glucose plasma glucose day treatment significant reduce increased significant reduce level mean treatment similar significant difference obtain value treatment vs improve reduction effect increase mechanism two drug drug outcome insulin resistance diabetic complication
23230750 en investigate relationship blood glucose type diabetic patient type mellitus T2DM hospital study measured glucose assess parameter obtain glucose system mean blood glucose mean glycemic mean difference hemoglobin total cholesterol cholesterol cholesterol participant also determined according level diabetic patient two group mellitus without on group mellitus group relationship parameter difference on group group regard body mass index BMI diabetic chronic complication history blood pressure on group age lower level blood pressure group correlation analysis show positive correlate age age identify multiple regression may contribute development patient type independent hba1c level
24767367 en mellitus negative impact patient high body mass index increased age type identify risk factor development aim risk factor development glucose adult datum primary age year undergo hospital risk factor glucose mellitus DM DM diagnose overall incidence analysis revealed old age year risk factor develop DM significant high without on high level independent risk factor glucose tolerance among DM patient treat time diagnosis patient therapy glucose negative impact patient age year significant risk factor DM independent risk factor glucose negative impact outcome
23233749 en may potential adverse event develop clinical lipid management patient mellitus treatment examine datum primary care patient year age mellitus define condition clinical patient year old level receive clinical therapy examine possible patient year age examine patient without disease examine use logistic model patient mellitus year age clinical clinical index little cohort year age potential high rate current high rate potential clinical indicate diabetic year age receive management however patient potential
21166983 en clinical treatment outcome diagnose type present history observed develop low insulin concentration response insulin therapy diagnosis type mellitus insulin day develop complication associate insulin therapy care follow assessment found healthy normal insulin concentration month first report type age group first report mellitus type mellitus consider diagnosis
26540324 en patient type patient type diabetic disease high rate early can complication
24085033 en glucose health develop insulin gestational mellitus addition health woman diagnose increased incidence complication well increased risk develop type diagnose increased incidence complication include syndrome well increased risk develop adult factor disease risk factor include weight history contribute develop model disease model impact include use treatment model development model disease well provide potential treatment
24988089 en aim evaluate association blood glucose dysfunction activity type diabetic level activity measured type diabetic patient complication complication high level without difference significant activity level control significant high patient activity level patient complication significant lower patient without plasma glucose concentration show significant positive association plasma significant association diabetic patient on significant positive correlation negative correlation significant association positive correlation negative correlation significant role increased decrease activity elevated level one factor patient type mellitus finding therefore study
23047931 en metabolic type mellitus possible metabolic development present datum study perform glucose tolerance assess insulin regard treatment present use datum treatment type number obesity health condition increasing type mellitus time diagnosis cardiovascular disease may present adult normal glucose tolerance type adult occur glucose known impair glucose tolerance previous study group reported high prevalence impair glucose tolerance among obesity study impair glucose tolerance associate severe insulin resistance dysfunction current datum treatment condition study large clinical trial perform type observed glucose early disease glucose tolerance
22648972 en occur time high rate among individual mellitus compare healthy individual study function type mechanism remain poor define on model type study mass lipid use determine whether contribute cause week increased total protein level remain significant reduce mass revealed impact reduce increased decrease also increased healthy treatment diabetic reduce increased datum contribute activity
23835245 en indicate reduce level adult patient severe study evaluate patient high fasting level cholesterol level therapy among patient randomize mellitus
24164584 en common complication among patient major previous study show association assess retrospective analysis patient age adult aim determine independent risk factor associate among patient previous study datum value serum age analyzed association common cohort mellitus DM independent associate respective increased age respective DM independent associate respective DM also associate old age vs may therefore development DM patient
21173807 en study examine whether finding present patient mellitus patient type mellitus patient type mellitus examine type diabetic group according diabetic management insulin therapy oral drug normal control also measured ratio ratio type mellitus significant great normal control type diabetic patient insulin therapy show significant great ratio control type mellitus ratio great patient treat insulin therapy treat oral type diabetic patient insulin therapy show increased ratio compare patient type mellitus patient mellitus show compare normal control
27101443 en chronic factor disease patient type mellitus risk factor response level correlate patient assess plasma level diabetic patient use level high patient vs level elevated significant increased found plasma level significant high diabetic patient syndrome compare patient respective level significant high diabetic patient compare although plasma parameter show association status can ratio significant different patient ratio significant lower patient compare vs patient show increased level ratio however associate low ratio
20829624 en syndrome associate insulin resistance high level syndrome overall incidence mellitus insulin resistance patient investigate glucose tolerance test common clinical management mellitus patient syndrome evidence effective therefore patient patient according impair glucose effective mean control mellitus patient syndrome lower level may use drug include therapy may use insulin therapy need management syndrome high effective reduce patient mellitus may well insulin therapy period high level syndrome treatment patient may insulin resistance cardiovascular risk factor
24988689 en recent year increase complication increasing metabolic syndrome recent prevalence mechanism metabolic risk determine obesity condition determine insulin contribute development metabolic syndrome mellitus may lead insulin syndrome mellitus increasing complication treatment different impact insulin resistance metabolic syndrome mellitus remain
25743114 en investigate association serum disease type mellitus patient normal renal function renal compare estimate rate patient type patient per serum previous history cardiovascular disease define index lower high value serum subject without independent associate age current odd ratio or age hypertension CI CI CI one increase independent associate type mellitus patient without
25429035 en conduct cohort study determine whether poor glycemic control therapy patient type study sample patient receive two total period follow one year assess mean analysis relative hemoglobin hba1c level baseline level level high one rate patient follow one year respective patient poor control consider patient follow-up estimate rate three group two week one group group related poor glycemic result study indicate elevated hba1c level patient type associate one year however early associate
25247465 en investigate mortality renal therapy incidence diabetic complication cohort study type cohort study conduct cohort female year review datum investigate mortality rate incidence rate incidence major complication patient mortality rate per year receive incidence rate per year rate event mortality incidence increased baseline hba1c low rate hba1c type observed three overall mortality incidence renal therapy incidence rate on relationship early glycemic control development renal disease mortality found
27025727 en large number type mellitus T2DM case individual T2DM increased risk develop health disorder care T2DM care care health role management patient T2DM care target intervention study aim examine care patient T2DM group conduct examine current identify influence group conduct two independent use care patient T2DM primary within included time included health less important health care regard care included time can role can care patient care patient T2DM intervention aim
23534496 en type mellitus disease two chronic associate disease treatment impair present study investigate adult patient diagnose type disease compare healthy control subject control subject type patient diagnose type disease control group patient type without disease age status score compare datum healthy control patient type disease included association clinical characteristic observed woman reported lower function health man on lower observed regard patient type disease compare patient type compare healthy control subject patient type disease significant lower function general health diagnosis disease treatment adult patient type negative impact woman function general health
23461783 en on case finding disease patient type mellitus current study assess type study evaluate prevalence individual type compare patient disease control subject addition evaluate whether case finding disease patient type patient assess use total level individual test patient type patient disease population control subject define total level prevalence significant common patient type disease compare population control subject prevalence statistical difference type disease identify patient group type disease one patient individual within population control subject normal common type compare population control subject individual type outcome case finding disease patient type
25576215 en patient chronic disease current include rate reduce patient mellitus three use demonstrated large trial patient
23883570 en lower level hba1c among patient present study aim evaluate effect hba1c level among patient type conduct one one conduct characteristic similar assess perform new patient type association observed status indicate hba1c level although significant first among patient first associate status adjust odd ratio CI CI change associate status increase score CI decrease hba1c value or CI reduce risk status may effect hba1c level among patient
26590982 en research health system patient chronic disease use system also within medical value patient present base patient define patient among perform system evaluate use datum diabetic patient according define system evaluate compare system chronic patient regard result show use therefore need patient chronic base use also model medical time system change patient chronic
26775128 en effect patient investigate effect retrospective analyzed patient mellitus type treat hospital may patient patient overall month group month group analysis low serum level status vs associate outcome analysis addition low serum level significant associate ratio duration use significant correlate finding associate patient type mellitus among
26867881 en control improve rate therapy result aim determine impact mellitus use clinical outcome large population patient treat identify patient treat large therapy on total patient mellitus time diagnosis outcome assess included overall follow-up time year rate patient diabetic patient diabetic diabetic similar patient analysis diabetic demonstrated improve patient adjust ratio confidence interval improve use adjust ratio confidence interval high group significant different diabetic status patient use independent significant high rate patient whereas rate similar patient
23653365 en examine effect type type age control overall base score obtain type obtain significant lower compare control vs significant lower type compare may association function
22840590 en mellitus DM diabetic potential complication profile DM reported study compare concentration compare concentration treatment measured DM healthy compare concentration DM measured healthy included clinical study disease DM healthy serum use concentration significant high treatment compare significant high compare healthy control also significant high compare DM significant high DM compare healthy control significant difference concentration measured include may may great may DM
25162664 en study evaluate effective insulin therapy insulin within year diagnosis type mellitus individual use insulin treat review include subject age year interval insulin interval year use year use glucose primary mean hemoglobin hba1c value patient treat insulin statistical analysis female age year follow-up year range year baseline hba1c interval on significant reduction mean hba1c baseline follow-up observed sample increasing interval result level significant lower first respective present study suggest early provide lower hba1c value possible early can datum level follow-up
17020465 en disorder renal resistance effect case associate type gene case gene gene present study gene whereas three found previous gene although disease finding gene model determine function relationship related disease datum indicate gene
16565852 en report case due revealed mass show without therapy year mass develop revealed may first diagnosis follow-up cause
23760288 en study suggest system effect however evaluate effect function patient type mellitus system study year study medication renal response significant great patient group compare patient group individual receive also high reduce response increased patient receive year effect renal function year therapy finding suggest effect study
24342797 en previous study reported result regard present study aim change resistance protein function well possible mechanism type diabetic patient type type diabetic protein level investigate use analysis function evaluate use insulin effect function also investigate use result show level decrease type diabetic whereas diabetic patient significant increased respective change observed protein level type diabetic patient function significant type diabetic show significant change datum indicate decrease level increased decrease function therefore function type type mellitus subject insulin level plasma contribute change function
25354858 en investigate role gestational mellitus correlation insulin study woman gestational week hospital among patient group normal oral glucose tolerance test healthy group group female relative type mellitus patient healthy woman normal oral glucose tolerance test group normal control respective fasting plasma glucose glucose level measured glucose method fasting insulin level measured model resistance index level total cholesterol high cholesterol low cholesterol determined level measured level significant high group group respective level glucose level group significant high group respective level level group group level lipid two group significant high group level group group significant high group respective level group significant lower group level group lower group difference statistical significant level group negative correlate level respective level group correlate level respective group level negative correlate respective may important lipid related insulin resistance
24760246 en found type mellitus T2DM associate increased risk woman mechanism first study evaluate association T2DM population high aim study investigate association T2DM woman included population body mass index BMI population BMI type population group impair fasting glucose group normal glucose group measured serum type serum type assess normal glucose group group group lower level population type diabetic patient high risk total normal glucose subject population mean value diabetic patient low high high risk compare normal glucose subject high high diabetic patient increased risk independent patient also poor need early
25636149 en determine rate recent diagnose year type mellitus T2DM individual weight body mass index included recent year diagnose T2DM weight medication hemoglobin hba1c level study intervention primary study outcome metabolic body baseline hba1c mean subject body weight improve two subject medical T2DM mean hba1c individual recent diagnose T2DM study total population little T2DM month study intervention time diagnosis T2DM randomize control
21511226 en study assess compare regard primary month patient mellitus
21735364 en investigate care control obesity patient mellitus different within patient treat type mellitus general follow retrospective treatment patient year treatment retrospective mean hba1c decrease fasting glucose decrease BMI decrease parameter insulin therapy associate large mean hba1c vs increase BMI vs time conduct mean hba1c fasting glucose high compare respective lower respective use insulin insulin use identify difference associate potential health care system aim diabetic patient care
22133651 en studied change incidence lower population without retrospective study perform aged year old without obtain incidence rate year three period patient test time regression model total patient mellitus man population incidence found per CI estimate incidence increase increased compare first care patient incidence recent year
26053686 en investigate whether severe year associate gestational mellitus studied woman obtain datum old factor model relative year associate increased odd confidence interval odd ratio CI CI CI respective due cardiovascular disease related risk type found association risk relative year associate increased risk finding according relative cause suggest difference among group factor related metabolic cardiovascular disease may contribute association effect population
21199964 en mellitus associate increased risk cardiovascular disease mortality however datum evaluate effect condition mortality evaluate individual effect mortality cohort health total woman health study aged year baseline follow define diagnose treatment medication score indicate severe health index score type use mortality year follow-up include compare participant without condition relative risk confidence interval mortality woman individual woman condition mortality respective association body mass index status activity major include hypertension disease remain significant high mortality found condition respective duration mellitus year insulin therapy associate high risk mortality associate significant increased risk mortality rate condition identify woman high risk
27322526 en low level high cholesterol increase risk development type mellitus T2DM study aim investigate correlation serum concentration total cholesterol low cholesterol measured participant T2DM without study participant three group according level low group group high group respective serum level compare among three present high body mass index high fasting plasma insulin lower blood glucose plasma insulin ratio hemoglobin significant lower adjust age serum level negative correlate age duration disease insulin resistance positive correlate increase concentration associate increase serum level T2DM correlate positive
20516001 en type mellitus type mellitus first reported disease due cell early diagnosis treatment early period hba1c level elevated study investigate serum change plasma glucose new clinical index disease patient undergo hba1c serum patient type mellitus T2DM hba1c history treatment significant lower T2DM whereas serum significant high ratio significant high T2DM ratio patient compare one T2DM patient significant high T2DM whereas hba1c significant lower T2DM ratio treatment
25748329 en profile population impair glucose tolerance revealed type gestational mellitus type profile type can potential identify woman develop conduct study woman general hospital study participant first fasting serum sample woman follow identify normal glucose tolerance woman woman age BMI use level analysis revealed characteristic mean age year BMI identify significant different level two group logistic regression analysis level significant identify type may however study cohort
26013003 en relationship mellitus DM disease DM factor glycemic control increase protein found protein treatment disease oral therapy may case therapy studied demonstrated result aim study determine whether therapy metabolic control individual type reduction patient randomize use two group patient first examine follow perform two parameter time per patient day treatment blood fasting glucose hemoglobin factor perform datum statistical evaluate use result study determine therapy treatment diabetic trial clinical trial number
25762503 en mellitus type mellitus result cell current therapy patient cell relative new potential therapy recent study show decrease glucose level influence cell therefore cell may use effect control review present new use treatment mellitus type
23369226 en aim study investigate prevalence mellitus DM patient compare general population assess significant association define study primary fasting blood glucose hemoglobin hba1c measured health define DM use define patient prevalence DM patient significant high reported general population however prevalence significant high reported general population regression analysis show age significant patient study high prevalence patient need blood glucose patient presence primary risk factor important development patient drug
21281319 en patient show response compare population on factor response well known patient mellitus system diabetic important cause chronic disease however impact mellitus response patient receive remain evaluate influence mellitus response population review clinical use effect model analysis rate patient diabetic vs identify study patient study result show significant decrease response rate among diabetic vs patient odd CI test study analysis change show association mellitus impair response individual relationship serum consider patient mellitus
22054144 en obesity major role development type mellitus weight significant role therapy weight change include recent may role therapy well type mellitus obesity provide disease weight treatment
24698665 en gestational cause severe complication metabolic development determined also early diagnosis study determine metabolic use system plasma sample woman normal glucose tolerance plasma woman control show association glycemic woman addition identify well provide evidence metabolic may related potential use woman risk develop severe glucose mellitus increasing although woman high risk develop type obesity therefore well potential risk factor early present study metabolic obtain early metabolic occur may disease study identify
26582805 en insulin type mellitus treatment investigate control study aim investigate insulin therapy study case control primary assessment baseline adjust difference hba1c group follow-up outcome included clinical total patient hba1c difference treatment group CI lower group patient use insulin therapy less time CI CI compare patient CI lower concentration clinical difference present score lower baseline among patient however lower health status difference general treatment patient use high profile compare patient use insulin therapy hba1c difference overall health status lower among patient although treatment similar treat patient
24548056 en type mellitus previous show hospital year aim evaluate compare outcome three hospital examine model care medical health provide care treatment datum year cohort study control group total patient compare patient metabolic control difference mean hba1c group treatment diagnosis insulin treatment compare number per year high group per year compare provide level care model model may also chronic health condition
24915962 en type mellitus need blood glucose control may normal can negative several however therefore aim present study develop assess study develop define evaluate examine total correlation assess negative response develop use include glucose insulin present study show found range significant correlation can use research test whether associate outcome hba1c level function evaluate intervention aim
25627047 en aim study investigate association gene type mellitus type diabetic patient subject subject use odd ratio or confidence interval CI significant type diabetic patient subject respective type group subject significant associate type risk or CI model associate high risk type or CI presence one or CI result adjust age result association increase risk type
25095826 en identify individual high risk cardiovascular disease remain aim whether associate event may improve risk among individual type obtain datum individual type large primary care patient cohort event follow-up period individual cardiovascular risk factor status baseline association event evaluate use regression adjust risk factor assess model include risk factor without individual cause event age blood pressure cholesterol body mass index hba1c status use medication associate event CI addition model base risk factor result risk individual different risk associate increased risk first cardiovascular event among individual
24524806 en study evaluate patient type mellitus T2DM control randomize trial assessment assessment primary change plasma glucose high change baseline hba1c fasting plasma glucose assess adverse baseline significant great study population effect patient great reduction evidence overall population change baseline hba1c significant well significant reduce high patient T2DM treat profile patient reduction
26849560 en serum recent show associate incidence type mellitus T2DM aim study relationship serum risk gestational mellitus study woman include normal glucose tolerance week subject group according clinical characteristic compare serum concentration measured use insulin resistance assess model assessment insulin resistance level significant high woman healthy vs correlation analysis show serum positive associate woman according serum concentration compare first woman or or or high risk adjust age BMI hba1c serum increasing level on logistic regression analysis adjust revealed significant independent association serum or confidence interval characteristic analysis revealed serum indicate significant independent associate insulin resistance may identify risk woman
23803007 en aim study determine whether new gestational mellitus increase prevalence use retrospective study conduct assess period occur week case examine determine cause remain case investigate investigate prevalence mellitus among also new evaluate impact factor due cause previous indicate two case mellitus three case remain new increased population new result increase number case woman management can reduce number
24190144 en management mellitus include blood glucose level body weight blood pressure serum lipid level high cholesterol level increase risk disease compare rate type patient receive primary therapy without history history patient receive great risk event management important group study determine diabetic patient identify group according patient medical factor patient patient overall rate group group level hospital follow effect therapy management hospital increasing patient history medication treatment
22058002 en cell evaluate effect gene risk develop mellitus glycemic control also investigate effect mellitus risk mellitus patient healthy control age fasting serum glucose hba1c lipid profile determined two identify within significant great diabetic patient compare control patient increased risk mellitus compare normal two patient high level cholesterol compare patient significant high level hba1c significant high blood pressure compare present status significant result evidence associate increased risk mellitus status effect glycemic control
22035298 en mellitus renal dysfunction factor however study assess effect renal association investigate clinical outcome according renal dysfunction mellitus patient patient year man group group renal rate group renal group renal group renal primary major adverse event include target clinical occur patient significant difference among group group group group group model adjust multiple mortality increased group compare group ratio confidence interval CI CI respective however analysis show significant difference year group association associate indicate poor patient patient renal provide patient
22834155 en disorder patient mellitus analysis system lipid development clinical severe mellitus related decrease level lipid increasing concentration total cholesterol blood serum mellitus age mellitus patient duration type mellitus level possible clinical mellitus level level
26460159 en function gene recent blood demonstrated associate disease include type mellitus suggest potential use disease present study examine level blood sample patient individual impair fasting glucose impair glucose tolerance well healthy control subject investigate potential blood plasma present study included patient individual healthy control level analyzed result indicate blood level significant decrease patient individual compare healthy control subject determined logistic regression analysis lower significant associate odd ratio or confidence interval CI respective or CI respective association remain statistical significant age body mass index hypertension well characteristic analysis revealed blood patient individual healthy control CI CI respective result demonstrated blood level significant lower patient individual compare healthy individual blood may potential
26448574 en study reported use oral drug old adult type mellitus T2DM study assess status therapy factor associate treatment glycemic control among old conduct study T2DM receive current treatment related clinical datum patient medical participant two group year year datum statistical analysis perform use common use year therapy common old participant age duration body mass index glycemic control target influence factor year treatment model old patient receive treatment complication glycemic control hemoglobin level old adult T2DM significant different year on treatment insulin may glycemic control old patient multiple complication
25609549 en type duration activity effect glucose level parameter among patient type mellitus T2DM type effect well randomize study study participant evaluate impact glucose level cardiovascular risk factor among patient type T2DM study compare significant reduction glucose level also compare reduction fasting glucose reduction hemoglobin although finding statistical regard blood pressure compare significant reduction blood pressure significant reduction blood pressure compare significant body weight body mass index fasting insulin model assessment insulin resistance total cholesterol cholesterol cholesterol cholesterol level overall datum healthy compare patient T2DM
27497146 en aim present study investigate gestational mellitus correlation insulin glucose protein body mass index woman diagnose normal use protein insulin woman decrease protein decrease protein woman compare normal control decrease insulin protein lower also observed correlation analysis show positive correlation positive correlation positive correlation positive correlation negative correlation negative correlation positive correlation result insulin protein present may insulin decrease insulin insulin resistance development
26666157 en patient mellitus report diabetic patient also increasing recent incidence obesity study relationship include factor body mass index complication poor glycemic control duration can normal healthy subject glycemic control without
24206003 en increasing effective independent type datum group patient study present follow-up datum patient type total patient type receive evaluate period patient follow-up one patient patient analyzed mean hemoglobin hba1c level baseline month respective primary hba1c level without medication hba1c level target occur mean body weight decrease month weight weight month respective medication use decrease effective treatment among type population significant rate follow-up study assess result
24139847 en investigate whether change significant impact incidence independent weight number participant man woman aged year follow year use datum health case identify fasting plasma glucose change participant value age year value follow-up use year follow-up participant man woman develop adjust BMI follow-up possible age year significant associate increased risk develop ratio confidence interval CI CI change CI CI result indicate significant development independent weight status weight within normal weight range can increase risk also possible weight
24290596 en weight may determine metabolic aim current study assess association weight risk gestational mellitus obesity sample retrospective study medical report woman healthy woman analyzed datum weight age weight history weight associate risk decrease weight risk increased odd ratio or confidence interval CI weight independent risk factor or CI positive correlate weight increase weight increased risk obesity or CI or CI respective risk factor also obesity age history woman risk associate low weight obesity associate high weight risk factor include history also risk factor obesity
22774402 en reduce odd event patient however patient event treat event resistance patient population syndrome intervention mellitus DM aim study assess resistance compare use oral drug insulin patient measured treatment diabetic patient undergo intervention two patient population included use insulin group use oral group diabetic patient determined use among group patient among group patient statistical difference found group study demonstrated significant difference resistance type mellitus patient insulin treatment type mellitus patient treatment
22621761 en protein known role however little known early change diabetic impact insulin treatment diabetic treat without insulin control age week treat insulin week gene determined assess addition cell insulin glucose positive control measured effect insulin treatment evaluate day insulin status influence level increased compare control control vs vs control vs control vs whereas significant decrease control vs vs control vs control increase ratio control vs vs vs control significant correlation show effect insulin effect treatment insulin increased ratio time significant insulin effect can current datum early type associate increase ratio insulin result important role insulin protein type mellitus contribute show important role
25360831 en type mellitus T2DM cause insulin resistance dysfunction review current oral drug treatment T2DM datum database although management T2DM increasing include insulin current T2DM treatment reduce blood glucose level different mechanism include protein factor protein need T2DM may development new therapy new target current drug T2DM
25351463 en type mellitus T2DM chronic cell role whereas cell may cell disorder study investigate whether can development T2DM assess blood determined T2DM patient healthy control use result show cell significant increased T2DM patient control study revealed great significant increased patient investigate correlation risk factor T2DM demonstrated significant elevated patient body mass index BMI patient obesity increase without obesity study suggest T2DM obesity
27230581 en diabetic common complication patient type mellitus effect blood current therefore measured blood patient without control assess effect patient patient previous treat patient patient without compare control use blood measured one value per use analysis patient type measured several month difference blood assess use multiple blood high treat compare group control positive blood low blood control group high group patient blood significant change use regression analysis found blood control patient blood significant increased group previous undergo treatment patient change may diabetic
25877338 en assess result patient DM health patient DM result obtain health activity patient DM clinical use positive total patient DM patient receive little one two patient identify known total positive undergo one patient investigate new diagnose treatment case rate show among patient DM need patient DM high risk may target group DM poor control
24325996 en glycemic control diabetic patient hospital current care treatment retrospective study patient general mellitus diagnosis clinical datum first day total diabetic patient evaluate rate blood glucose blood glucose respective patient first mean blood glucose mean blood glucose mean glucose value patient treat insulin insulin use common patient receive therapy increased day day receive insulin patient insulin increased however change decrease insulin management diabetic patient due clinical insulin diabetic patient on management insulin improve care patient
25239295 en contribute factor adult patient cardiovascular disease mellitus review study regard factor medication follow study group develop finding study three contribute factor factor include factor history condition low factor obesity factor factor condition complication major health among adult patient cardiovascular disease mellitus patient factor can cause contribute group patient
25162478 en mellitus month fasting plasma glucose plasma glucose oral glucose tolerance test recent hemoglobin hba1c high hba1c aim assess hba1c high week test diagnosis
26550816 en on evaluate prevalence patient mellitus DM population man dysfunction define subject studied diagnosis evaluate use total score prevalence subject DM population man age range year year year hba1c mean value significant difference found DM treatment case follow diagnosis DM case time case DM subject patient treat treatment total score subject subject treatment subject therapy subject day remain subject subject treat subject one cause treat without treatment DM
22575408 en significant increase prevalence type mellitus type mellitus reported large improve glucose control reduce complication management glucose normal development early may year
26647091 en present range impact include glycemic insulin one function type mellitus insulin aim study serum level body mass disease study included control group healthy estimate serum concentration lipid profile concentration significant different control group mean vs respective related positive body mass group serum concentration significant high control group mean value vs respective related body study group show analyzed parameter disease observed healthy similar age body weight body mass disease duration metabolic control insulin
25753130 en study reported association serum protein metabolic disorder however study relationship type mellitus T2DM aim present study investigate association serum level risk develop study individual perform metabolic disease study clinical datum baseline serum level factor insulin protein year subject diagnose T2DM result oral glucose tolerance test health control case according age body mass index BMI ratio odd ratio or T2DM use logistic regression follow-up period subject develop T2DM significant difference serum level T2DM control group baseline subject three group base concentration group significant association risk develop T2DM model adjust general status age BMI improve development T2DM independent
24624968 en associate presence patient mellitus DM patient without DM contribute characteristic development DM retrospective evaluate patient age year cardiovascular disease undergo patient positive index according increase increasing patient without DM patient DM analysis show large significant associate high risk patient without DM odd ratio confidence interval patient associate characteristic patient without DM patient DM may significant risk factor associate development DM finding may improve risk patient
24462067 en result study investigate pressure mean pressure risk cardiovascular disease patient mellitus perform estimate risk conduct study provide datum risk baseline patient mellitus risk increase blood pressure index estimate model study patient case relative risk confidence interval significant observed value study investigate risk index relative risk confidence interval current among common use index however large study result
23508758 en regard effective therefore review trial evidence patient mellitus conduct control study evaluate association mortality mellitus two independent identify datum evaluate risk estimate overall examine mortality cohort study included randomize control trial identify study associate reduce mortality compare control therapy adjust risk estimate increased risk observed reduce mortality adjust risk estimate chronic disease adjust risk estimate associate reduction adjust risk estimate associate increased risk evidence indicate little treatment patient mellitus reduce chronic disease trial datum consider treatment patient mellitus
24319744 en mellitus studied week mellitus rate increased time respective significant increased significant reduce significant control development mellitus reduce
24203463 en group cell lead dysfunction contribute disease mellitus important assess whether associate type mellitus impair gene patient healthy control population association analysis two level individual high diabetic compare control vs vs high diabetic vs odd ratio CI patient high vs significant odd ratio CI on show high odd ratio CI overall study may important role type risk high individual one potential role type need large number patient population
26743527 en patient high risk develop glucose role define assess relationship serum glucose parameter on total patient studied develop diagnose mellitus patient oral glucose tolerance test perform assess blood glucose insulin level baseline serum total measured baseline patient show impair glucose tolerance normal glucose tolerance overall prevalence significant high compare impair glucose tolerance normal glucose tolerance group correlate BMI patient low significant high fasting plasma glucose index respective high multiple regression analysis negative associate fasting plasma glucose insulin prevalence glucose tolerance high patient associate insulin resistance patient total associate plasma glucose level insulin resistance index
24960246 en dysfunction common individual mellitus DM may contribute associate dysfunction however little known low condition DM DM adult female follow one month randomize group control month treatment month function assess pressure normal serum level treatment result reduction reduction respective DM associate increased gene reduce resistance function large level increase respective improve function gene resistance without cause dysfunction chronic DM may associate normal serum level effective therapy dysfunction DM
24114151 en study evaluate association patient study subject year age mellitus on current status assess health group according change current status score score compare score population due current status associate status also potential factor result suggest early status may health one status may influence patient mellitus
23712377 en insulin complication insulin therapy mellitus reported type mellitus poor control type mellitus insulin therapy patient large insulin case report first complication report adult population develop insulin therapy within week present one patient reported develop insulin within day present diabetic case general complication cause
25051729 en review result study mechanism impair mellitus role disorder development disease event
27180672 en hypertension patient mellitus lead similar hypertension associate increased cardiovascular risk reduce effective treatment hypertension present patient type mellitus treatment hypertension may blood pressure day increased value finding occur patient type mellitus associate change finding
27003655 en investigate effect function type diabetic patient correlation effect blood glucose datum patient type mellitus undergo hospital retrospective fasting blood glucose hemoglobin hba1c cell cell cell cell level compare correlation cell level hba1c hba1c decrease significant respective increased significant cell cell elevated significant well cell cell respective significant difference cell cell level ratio cell negative correlate hba1c level hba1c hba1c hba1c hba1c hba1c cell significant correlate hba1c effect function patient type mellitus function correlate control hba1c
26975054 en complication patient type mellitus T2DM treatment study aim model patient T2DM base estimate medical review develop several model patient model also develop primary care evaluate patient medical estimate medical health medical care reported total primary care identify type medical model hospital primary care base use general care patient status estimate medical per per event range hospital high patient impact medical result T2DM patient
20955102 en whether difference cardiovascular risk factor include blood pressure serum glucose woman mellitus compare follow-up previous history gestational mellitus mellitus type control respective year index blood pressure measured woman undergo oral glucose mass index ratio serum glucose blood mellitus group high blood pressure compare control on ratio common group compare control fasting serum glucose high gestational mellitus group compare control on high mellitus compare control difference statistical clinical study identify several risk factor cardiovascular disease woman year mellitus potential intervention can weight management
27079350 en present study aim evaluate body mass index fasting plasma glucose gestational mellitus total woman hospital week measured oral glucose tolerance test perform week evaluate characteristic correlate plasma glucose oral glucose tolerance test characteristic CI CI diagnose compare logistic regression analysis show independent risk factor development age odd ratio CI CI can use may woman
23639598 en great patient type investigate effect patient type previous study patient type age body mass index previous receive undergo analysis assess use index total score rate participant mean level hemoglobin total score total score subject difference range decrease difference time significant total score score lower significant adverse significant reduce patient type
25098122 en evaluate effective pressure patient mellitus DM study included patient mellitus result assessment patient change medication new undergo therefore therapy decrease pressure observed case patient time lower baseline target value intervention patient significant decrease treatment consider due therefore use patient mellitus treatment target medication reduce complication
24832639 en investigate impact diabetic status outcome patient treat primary intervention improve risk patient hospital mellitus mortality significant high patient DM compare vs therapy mortality significant high patient compare vs patient compare patient vs age mortality risk patient CI patient CI CI baseline characteristic result age adjust mortality compare mortality patient without DM age
24468609 en mellitus clinical condition develop common patient diagnose first month report present diagnose mellitus patient analysis gene revealed insulin treatment
23929695 en mellitus DM common general population use glucose new diagnose DM disease assess aim study conduct review determine prevalence time DM related condition first well impact three database review independent two outcome studied new diagnose DM DM treat insulin prevalence total clinical study patient first DM observed CI individual prevalence DM treatment insulin CI CI CI respective new diagnose DM develop individual within month first risk increased significant year relative risk CI on similar observed regard treatment insulin individual age effect studied develop DM hospital great increased risk DM year study determine whether risk develop DM reduce
25151573 en insulin patient trial insulin found significant reduction hemoglobin compare patient type control study assess insulin compare type patient health care system
25015763 en compare two three time regard control patient type adult type mellitus treat without month two group receive oral group on oral three time group hba1c level measured month treatment patient group on group patient trial group on group significant difference hba1c level month severe adverse event similar patient type mellitus can patient three time
26997390 en early diabetic significant reduction diabetic patient clinical renal increased level may first study conduct determine prevalence potential risk factor among type mellitus T2DM patient on study conduct sample T2DM patient aged year DM on develop clinical datum assessment lipid profile hba1c serum define ratio two case on statistical significant association found level history hypertension history hypertension duration drug patient body mass index BMI ratio logistic regression analysis revealed two independent risk factor influence blood pressure odd ratio or confidence interval CI BMI or CI prevalence low among DM patient DM patient significant risk factor
26962814 en several study show patient type mellitus T2DM disease patient T2DM patient poor glycemic control complication compare patient T2DM however adverse clinical outcome patient aim compare adverse clinical outcome large number patient control trial study compare adverse clinical outcome mortality major adverse event patient database on follow-up day follow-up year consider odd ratio or confidence interval CI use effect analysis perform study total patient T2DM patient patient included follow-up period patient significant high mortality or CI or CI follow-up period patient significant high rate mortality or CI or CI or CI respective however result show similar rate group or CI study patient significant high rate mortality compare patient also significant high patient follow-up period however result mortality high compare similar rate observed group number patient analyzed study need conduct
26729037 en type mellitus chronic disease period cell individual incidence increased several develop disease change factor increase effect change research individual risk develop patient disease finding indicate individual mellitus different healthy individual individual level reduce low however change suggest clinical disease disease
21268804 en result therapy use patient first patient patient effective intervention use therapy significant reduction treatment duration result
21083976 en review status type mellitus hospital clinical value diabetic clinical datum type mellitus hospital retrospective review serum lipid level measured type mellitus healthy diabetic two without serum lipid level type mellitus common female age disease year diabetic present first case level serum lipid blood glucose hba1c diabetic significant high without logistic analysis demonstrated increased level blood glucose serum lipid hba1c risk factor diabetic level serum diabetic significant high patient without difference serum level serum level diabetic significant high healthy common complication type mellitus disorder glucose lipid risk factor diabetic may index diabetic type mellitus
26236749 en study aim assess relationship among method study conduct among type diabetic patient three major clinical result prevalence CI female age group without lower status significant high analysis identify age treatment level significant study demonstrated relationship among diabetic patient study finding indicate need change poor development
23132321 en type disease health estimate adult population adult population great increase on large population individual multiple factor include insulin resistance increased insulin impair decrease mass role dysfunction characteristic intervention type therefore first review mechanism treatment base type datum demonstrated type individual consider therapy type
25109108 en diabetic major complication mellitus DM include increase association increase blood pressure renal hypertension system type increasing risk aim study assess gene patient type DM according level patient clinical study included type diabetic patient age duration year severe disease clinical characteristic patient use patient compare patient high age duration blood pressure level hypertension value statistical significant difference group found gene presence significant high group patient hypertension time high or develop time high or association hypertension gene patient mellitus can significant diabetic
26677023 en gestational mellitus first mellitus recent research use base mass change serum woman healthy control significant difference use analysis include analysis compare several database function potential analysis metabolic associate potential on total identify contribute identify important metabolic include metabolic three major metabolic include lipid study analysis diagnosis treatment possible also related complication
27423071 en evaluate management glycemic control complication type mellitus patient included patient age datum provide patient hospital case report within datum period age patient mean duration DM determined patient use use insulin assessment glycemic control base hba1c level show patient hba1c value value value value reported patient number severe insulin high status related glycemic control common follow disease insulin therapy use among patient however treatment diabetic care glycemic control level therefore new patient poor glycemic control use insulin may improve glycemic control
25271193 en examine incidence associate factor sample individual aged year old without mellitus significant study primary health care total individual year index assessment index chronic drug on analysis perform diabetic patient regard rate addition old analysis potential factor prevalence DM baseline population year follow-up patient DM develop new measured define target target score lower analysis diabetic patient increased risk new or CI logistic regression show association new baseline score or CI or CI study identify old old individual without evidence severe baseline increase risk year
23649059 en although type mellitus significant impact oral health association aim study evaluate rate type study perform age subject type mellitus study evaluate rate number index index index analysis test show normal test compare test use assess difference consider significant age patient control year year mean hemoglobin value diabetic rate lower diabetic patient compare control difference found index diabetic patient similar group high diabetic vs difference two lower rate diabetic can related high high diabetic diabetic high develop
19520304 en mellitus major cause cardiovascular mortality develop among patient mellitus define disease result event clinical cause mortality mellitus risk cardiovascular event addition complication mellitus risk complication large increase patient mellitus
22268370 en associate cardiovascular hypertension datum report investigate impact hypertension metabolic cardiovascular risk large evaluate subject subject patient clinical history analysis population different subject patient present lower fasting plasma glucose level vs vs one similar prevalence mellitus obesity also lower patient vs vs respective addition multiple logistic regression analysis demonstrated associate glucose level obesity mellitus patient independent potential subject significant difference studied datum suggest may use adverse metabolic subject hypertension
26552151 en study reported analysis plasma type model control group normal control group group investigate plasma profile normal body type mellitus T2DM model group use use analysis research identify base lipid database two group sample result show group less group high number high reduce condition type type metabolic change occur plasma relationship development T2DM
25710564 en disease associate type prevalence serum subject disease increasing datum evaluate rate associate rate positive serum base association study subject mean age duration participant outcome rate according association rate increased baseline follow-up subject high prevalence presence baseline associate development vs baseline follow-up respective common associate development increased may cause relative little contribute complication clinical can identify subject develop complication
24772445 en study compare effect fasting plasma glucose hba1c new diagnose type total new diagnose type diabetic patient woman man study patient receive treatment fasting blood glucose hba1c determined baseline hba1c decrease group month treatment reduction hba1c significant great group decrease fasting insulin concentration improve reduce group group group total cholesterol decrease treatment effective control new patient type effect insulin improve function
24198221 en aim study investigate influence patient type mellitus included patient study month patient receive week follow month follow-up interval body mass index hba1c insulin model measured primary outcome change fasting blood glucose insulin level month therapy group increased group decrease group vs month therapy patient concentration hba1c significant lower baseline therapy patient insulin change significant group fasting insulin positive correlate concentration month therapy group significant effect metabolic parameter type however finding study suggest status metabolic function type whether therapy high improve glucose need investigate follow-up trial
23424866 en relationship among diabetic mechanism diabetic group control group model group study control group normal model group high week week model group mellitus mellitus group measured level blood total result time develop mellitus model group level blood glucose respective significant high control group level different group mellitus without change method level also high level low group can reduce increase use week develop mellitus effect mechanism may effect
23301289 en analyzed perform study patient disease type mellitus undergo intervention disease management patient associate patient disease type mellitus undergo intervention develop therefore recent need patient associate development result
25577772 en early change function associate type T2DM important however multiple present individual study score may early important change perform T2DM age female duration analysis perform mass score score included two model adjust risk factor one estimate development estimate first two on score difference two score significant associate development within year ratio CI develop score use disease T2DM finding suggest may identify increased risk develop within year
25860581 en patient mellitus follow-up disease disease may mellitus base review value patient mellitus finding method complication mellitus
25990052 en major cause mortality aim study evaluate concentration patient type study conduct patient group patient group included patient on control group healthy concentration plasma serum concentration measured plasma concentration fasting glucose hemoglobin hba1c concentration found group patient compare disease patient level significant high compare group patient positive correlation obtain rate negative correlation level although positive correlation hba1c study associate impair function type effect suggest different function complication
21792530 en large study demonstrated mellitus risk factor compare healthy control patient perform test time high incidence mechanism contribute include negative dysfunction insulin insulin resistance possible target treatment
25156606 en population change management factor prevalence type mellitus develop although insulin management type insulin effective type although decrease disease significant number effect weight use drug less adverse effect current provide mean treatment disorder new may may treatment type mellitus glycemic level significant potential reduce associate disease
25930989 en aim present study determine effect glucose level assess glucose measured day study patient type mellitus control randomize two group patient group first receive day day treatment mean glucose level significant lower mean confidence interval vs time glucose level significant great range vs without decrease glucose level reduction serum insulin level day
25956533 en low reported type aim study study serum concentration health parameter assess measured score serum concentration measured total body less measured old score use age disease duration hba1c diabetic population score total body respective serum score lower group disease duration vs disease duration metabolic control hba1c negative use disease duration lower vs score vs old lower compare population possible due duration associate diabetic may increase risk
18465681 en control patient assess level aim assess control prevalence control primary care determine patient treatment related factor associate poor sample general response rate total patient assess study diagnosis base assessment value patient metabolic control mean mean individual less subject history case year general history also man disease history patient history old subject value regard age high patient year correlation treatment identify metabolic control patient without drug therapy patient duration treatment group duration high insulin group oral treatment treatment treatment need improve overall regard less treatment response disease treatment patient metabolic early normal target diabetic history aim metabolic control patient aged man
24374004 en protein show change type study aim determine high protein ratio reduce effect metabolic control cardiovascular risk factor without negative renal participant type ratio estimate participant randomize ratio outcome renal function weight blood pressure serum lipid control man woman overall change renal function month significant difference weight group group respective fasting blood glucose decrease significant treatment effect decrease hba1c treatment month vs month increased significant treatment effect change blood pressure overall lower group improve overall metabolic control group well control participant type
24886371 en develop patient type relationship use datum medical patient develop type use datum subject without also identify subject age history cohort subject subject without value result decrease number potential subject mean time similar group year year two cohort large similar BMI great subject cohort relationship
24606011 en important gene range associate disease type mellitus T2DM primary may development T2DM change target gene target may new development T2DM therefore study T2DM development lead health management review association target T2DM development
24393429 en level may decrease patient type mellitus influence disease control study adult datum population aim present study evaluate level examine possible association glycemic control aged year study use measured parameter hba1c serum total estimate rate base serum concentration also level found subject poor glycemic control vs respective serum level negative correlate hba1c positive correlate level factor level remain significant associate hba1c adjust odd ratio poor glycemic control indicate hba1c high low concentration decrease hba1c present study show low serum level associate increased risk poor glycemic control potential contribute early development cardiovascular complication
24373190 en recent therapy treatment type mellitus T2DM lead development insulin effective low risk treatment T2DM T2DM improve insulin compare significant great reduction plasma glucose test T2DM control primary due great compare evaluate T2DM randomize trial known oral insulin significant reduction fasting plasma glucose weight weight adverse event provide treatment oral insulin management T2DM little increased risk potential effect body weight
21489265 en elevated gestational hypertension trial aim datum gestational mellitus patient risk develop measured healthy woman gestational week control subject patient medical therapy patient insulin therapy included group woman regard gestational week body mass index blood significant high subject insulin gestational mellitus compare control gestational mellitus significant lower patient insulin gestational mellitus compare control within range normal subject woman gestational mellitus difference body mass index change rate may lower concentration insulin gestational mellitus on negative need consider woman
21300382 en aim study define incidence type mellitus patient impair fasting glucose association risk patient aged year old diagnose impair fasting glucose association follow year factor develop mellitus age hypertension history type mellitus year follow-up patient develop type mellitus CI patient CI patient remain impair fasting glucose CI obesity associate type mellitus adjust ratio CI patient impair fasting glucose develop mellitus patient obesity result suggest different history glucose
26164975 en study evaluate prevalence mellitus DM among patient hypertension impact patient diagnose study perform sample patient three different hospital blood pressure glycemic blood determined subject addition clinical history perform datum analyzed use different independent sample study included patient prevalence diabetic patient new diagnose subject DM blood pressure one subject prevalence DM patient hypertension general population therefore major management among patient health associate DM
21691748 en report indicate mellitus result evidence suggest metabolic event lead dysfunction effect association type mellitus disease reported system associate condition study aim evaluate whether presence group patient associate different factor different complication patient adult patient study positive patient diagnosis mean age duration patient also similar diabetic patient metabolic control parameter significant different two group patient also present significant lower concentration hemoglobin hba1c cholesterol factor factor activity well high value protein renal observed patient also result suggest potential role
21788417 en little known mellitus among compare incidence prevalence impact mortality among status adult adult general population examine datum health well database status first status general aged year old receive diagnosis mellitus incidence prevalence mortality rate ratio examine relative change per year relative change per year prevalence show increase time population general population on similar finding observed incidence population found increase relative change per year great among man among woman prevalence incidence mortality among decrease time similar population among without mortality decrease general population population overall mortality high population general population increase incidence prevalence study period status population general population although overall rate high population mortality decrease among population high overall population status
25150960 en compare incidence gestational mellitus woman syndrome woman without well determine risk factor study evaluate medical woman without hospital medical woman woman treat period time age history relative history gestational history weight syndrome diagnosis according association incidence risk factor incidence rate woman respective logistic regression use determine risk factor woman adjust odd ratio age result revealed important significant development woman follow serum level use woman history increased risk develop perform test woman treatment high serum level early use effective reduce
23403068 en evaluate subject control type mellitus T2DM factor influence treatment analysis datum subject three randomize study receive oral subject hba1c adjust mean baseline hba1c group group group week adjust mean change baseline vs significant lower fasting plasma glucose level vs vs treatment difference CI treatment previous oral drug factor independent hba1c change week adverse event rate similar increased vs effective treatment subject T2DM glycemic control
21898753 en study finding conduct examine association risk study identify database risk estimate use model potential analysis on total study cohort study included risk estimate study show statistical significant increased risk prevalence among diabetic individual CI risk estimate study or CI high cohort study CI treatment potential duration insulin treatment possible increase risk also cohort study found statistical significant increased risk mortality CI individual without show associate increased risk prevalence well mortality increasing prevalence mellitus study need diabetic individual need potential mechanism different type treatment duration
26799616 en study show prevalence gestational mellitus major change assess diagnosis hospital use datum hospital database medical prevalence compare datum prevalence well value
26357866 en mellitus DM one risk effect oral associate treat oral treatment week level include time time parameter protein lipid profile estimate total activity drug also significant reduce cholesterol increased level diabetic however reduce drug also effective present study influence may DM therapy
25245142 en on number metabolic condition include high blood pressure occur result blood glucose level period time different diabetic complication independent disease diagnose control disease may metabolic condition report study identify metabolic change associate several complication type mellitus T2DM patient study group include T2DM T2DM disease T2DM T2DM disease T2DM serum identify group T2DM complication lipid metabolic change present among complication elevated blood glucose level provide patient T2DM complication use
25884274 en study assess level patient determine relationship use research study conduct sample patient studied participant type present hospital medical use correlation analysis patient examine significant relationship found negative well overall on statistical significant difference found score status presence complication hemoglobin significant status research reduce level number patient type patient assessment care also associate patient
25302609 en one study association health measured change risk mellitus obtain study measured use examine possible time group assess different period multiple logistic regression model analysis assess one woman reported year index woman reported report follow-up woman reported analysis significant association negative change however woman positive history woman confidence interval CI CI great risk study suggest increased risk significant associate provide target risk
23890782 en recent insulin use mechanism profile concentration recent study patient type mellitus show hba1c glycemic control similar insulin also improve profile associate significant lower rate type potential lower overall rate type DM also use
25002580 en cause mellitus provide model disease protein on clinical found within insulin investigate clinical total use three clinical protein high value compare two show insulin clinical impair presence although well condition investigate protein insulin effective function due impair insulin mechanism provide mechanism clinical insulin gene associate mellitus result total protein method protein
25696011 en present study identify change serum cause type mellitus T2DM determine whether correlation T2DM on total patient T2DM healthy subject serum participant result show concentration T2DM group significant high control sample correlation age hba1c finding suggest serum associate T2DM identify new diagnosis T2DM complication
25304745 en plasma activity protein function response elevated insulin condition determined association plasma activity type mellitus activity determined use system man without T2DM baseline use logistic regression model odd ratio or man develop T2DM follow-up plasma activity high T2DM case observed high odd T2DM per increase activity show association activity T2DM independent clinical risk factor include age metabolic syndrome individual metabolic syndrome total cholesterol or range CI plasma activity may increased risk T2DM man
24809830 en type mellitus chronic disease among diagnosis significant patient change treatment study aim identify diagnose associate factor database due impact may different study identify factor healthy
22428272 en current patient mellitus number increase year patient type metabolic disorder associate obesity hypertension increased cholesterol level treatment mellitus reduce risk severe complication common patient mellitus also consider complication among important effective care
21522002 en management old adult prevalence individual old adult group individual function also old adult increased risk condition care treatment care adult year hba1c target similar adult whereas multiple high treatment similar adult important treatment complication also
23544774 en cardiovascular disease adult first cause year old cause study investigate risk factor cardiovascular disease study conduct included patient mellitus hypertension without hypertension year disease age year three group hypertension without hypertension medical history body mass index blood glucose cholesterol metabolic syndrome metabolic syndrome high without hypertension serum glucose CI important risk factor develop cardiovascular disease hypertension total cholesterol CI without hypertension CI important risk without mellitus hypertension increased risk develop cardiovascular disease study use impact important risk factor cardiovascular disease
26599008 en reduction patient lead high year disease associate poor treatment outcome lower glycemic control among conduct among sample diabetic patient major hospital obtain datum score patient health also use response mean score high mean score reported relationship follow health health adjust decrease health score CI relationship score CI overall CI diagnose year increased health score CI severe decrease score significant decrease health score well overall score similar diagnose year increased health score severe decrease relationship score suggest early diagnosis treatment T2DM primary care
26880669 en compare insulin insulin therapy patient type mellitus clinical trial insulin therapy T2DM identify review database hba1c body weight rate study included study analysis population patient oral therapy change hba1c difference interval insulin change body weight significant lower compare insulin associate significant lower rate risk ratio insulin significant difference difference rate significant analysis control datum suggest also associate significant lower risk compare insulin control insulin
25193670 en several study role patient however impact patient studied aim study evaluate effect baseline diabetic status patient undergo primary intervention use datum analysis randomize trial compare on total patient undergo primary intervention included present patient primary outcome mortality follow-up period day patient without associate increased rate mortality vs vs patient compare without show high rate mortality vs vs baseline increased rate vs diabetic vs cohort analysis demonstrated risk significant increased occur patient baseline high rate increased risk diabetic status
23289433 en study related glycemic can found mellitus complication index current analysis assessment patient aim identify impact metabolic control patient type mellitus patient year old patient study patient assess month period compare period without analyzed mean hemoglobin hba1c mean blood glucose index low blood glucose index high blood glucose index risk range period patient statistical analysis test test assessment mean hba1c level significant reduce significant reduction significant increase observed hba1c index increased whereas show assessment month improve metabolic control reduce value little without increasing complication metabolic control reduce
26711829 en investigate current status blood pressure control rate use drug patient disease mellitus disease patient mellitus hypertension year old hospital current status blood pressure control rate different target value method drug treatment investigate case total patient blood pressure control rate target value control rate control rate rate control rate patient year old increased increasing age rate patient year old high whereas control rate patient aged year old low rate patient female patient rate man high woman case medication history case effective case receive therapy effective rate common use drug rate follow rate respective two drug common medication three drug drug common use drug common two use three drug case receive treatment two drug three drug therapy high however overall blood pressure control rate low major drug medication drug use medication common method therapy improve need
26296941 en aim study investigate relationship level lipid woman gestational mellitus woman healthy woman included study analysis use identify gene plasma level determined method study subject result indicate significant among subject without associate glucose parameter significant difference among plasma level regard group control subject according analysis plasma level significant different woman healthy subject without result level increased woman healthy woman without sample related increased patient
27143868 en type increased risk hypertension disease glucose insulin resistance type obesity lead insulin resistance aim study assess parameter obesity type mellitus total female previous healthy aged year old include age weight body mass index BMI medical history serum lipid profile blood glucose blood glucose hemoglobin obtain result diabetic patient present serum lipid elevated level female reduce cholesterol level female elevated reduce lipid difference observed level cholesterol total cholesterol statistical significant difference level BMI T2DM participant BMI logistic regression analysis revealed subject BMI significant elevated ratio T2DM compare participant BMI range female however significant difference T2DM patient patient BMI parameter present study show first time low level high level level BMI increase risk type T2DM
20801414 en type total cell current treatment insulin clinical develop type cell well effective new cell review different new cell cell population different cell type include adult cell type cell cell population well cell cell different method cell different use cell
24840509 en reduce cholesterol level use associate significant reduction cardiovascular event range patient population although general consider recent study suggest associate increased risk develop type lead drug change include increased blood hba1c level increased risk review examine evidence provide primary care use risk develop overall evidence suggest reduction risk risk develop individual high risk reduce risk develop assess patient risk therapy patient risk change whether study patient high risk develop change blood glucose hba1c level risk reduce change patient develop treatment therapy
27477400 en aim study determine whether elevated level associate development mellitus DM population healthy individual method conduct retrospective cohort study on total individual aged year without DM diagnosis impair fasting glucose baseline group according DM period group result correlation hba1c respective relative risk DM high compare low confidence interval CI CI CI respective adjust age hemoglobin high protein relative risk high vs low CI datum indicate elevated associate increased incidence DM
26022380 en association mellitus DM risk reported lower prevalence among patient vs without DM datum DM may role patient risk risk factor decrease prevalence patient DM may indicate associate cause DM may associate factor influence review association DM also mechanism DM effect drug common DM patient development also consider
25707261 en review type mellitus analysis mechanism diabetic function
26898405 en gestational mellitus common complication increased insulin resistance increased risk adverse outcome treatment patient reduce adverse outcome insulin resistance can reduce incidence complication recent trial possible reduce gestational incidence woman
26892524 en examine potential role serum level high protein first gestational mellitus
27165061 en effect new activity parameter assess mellitus blood use drug effect effect decrease blood significant effect complication parameter effect determined activity
27078166 en diabetic common complication mellitus treatment large need identify target treatment study investigate function patient type determine relationship serum lipid type diabetic patient type test patient undergo clinical assessment include study study study also age normal control study include serum lipid level obtain patient patient datum compare control datum regression analysis perform determine relationship serum low parameter type diabetic mean age year mean hba1c mean concentration mean cholesterol concentration compare age control study indicate dysfunction type diabetic patient T2DM patient without included reduce change current regression analysis revealed association change function serum low concentration adjust renal function risk factor development finding indicate serum lipid effect function type diabetic patient finding suggest serum level related function type diabetic patient mechanism may role dysfunction development
24013155 en studied dysfunction patient mellitus DM also investigate relationship duration disease clinical patient aged year duration range month year year perform method also dysfunction correlation clinical current according index function found patient type found case mellitus dysfunction observed increase period DM incidence correlation increase duration dysfunction relationship
26902507 en previous study may decrease blood pressure patient type although result reported evaluate effect blood pressure patient type randomize control trial conduct study identify database may analysis change blood pressure due treatment patient type change difference baseline perform study on model use effect estimate presence model total included include patient type analyzed blood pressure include patient analyzed blood pressure estimate intervention confidence interval CI observed study effect estimate CI observed study first effect blood pressure patient type demonstrated may result reduction patient type however study large sample duration need relationship blood pressure patient type
26851962 en mellitus high mortality risk primary cardiovascular difference different cardiovascular disease assess can poor outcome disease patient perform study patient year patient according diagnosis disorder disease on total patient included high mean age risk factor previous cardiovascular disease hospital mortality vs high patient follow-up month range diabetic patient high cardiovascular mortality vs mortality vs cardiovascular disease according diagnosis patient high mortality rate diagnosis high cardiovascular mortality follow disorder analysis identify independent association high mortality patient without patient poor diagnosis
23620200 en insulin insulin also insulin insulin insulin profile duration less effect insulin insulin clinical trial insulin similar control insulin patient type lower risk addition trial examine insulin patient type show potential adjust time without control on insulin also use patient large insulin insulin insulin insulin patient type potential reduce number trial result also indicate insulin may insulin therapy patient type control oral drug insulin general well patient type insulin insulin treatment type
23167285 en previous study provide estimate aim study impact early use datum cohort participant medical datum obtain number day incidence rate overall compare according status three period range year year case mean number day high participant compare without difference increased day confidence interval period day CI period due relative increase incidence participant without incidence rate ratio CI CI respective associate increased rate metabolic associate increase suggest addition among remain
24168455 en study clinical due syndrome aim evaluate disease studied present follow clinical revealed disease dysfunction one known gene identify identify result show suggest gene cause important risk clinical management
27777946 en investigate effect mellitus DM patient undergo method on total patient DM patient without DM undergo treatment review effect DM complication determined use score analysis result two use score analysis DM compare outcome duration great DM patient indicate analysis found effective DM patient found occur DM patient patient DM found risk factor
27642601 en observed treatment number mellitus DM patient cause increasing incidence management regard study conduct patient three primary health care evaluate effect DM treatment outcome adverse drug due treatment patient undergo blood glucose treatment disease clinical outcome compare patient without DM patient prevalence DM found patient respective DM patient observed high or CI treatment poor outcome or CI treatment compare DM patient presence DM significant associate or CI development DM influence treatment outcome patient also incidence
26808967 en association mellitus DM recent prevalence DM increasing poor high current study determine prevalence associate factor DM base study new diagnose patient health study DM DM diagnose base health on use clinical datum logistic regression analysis perform identify factor associate DM total patient study prevalence DM estimate female odd ratio or confidence interval CI patient age year or CI year or CI case or CI history DM or CI associate factor identify DM prevalence DM among patient high patient DM study
26700409 en increase insulin type mellitus use insulin healthy study assess effect body weight metabolic control new diagnose diabetic receive insulin clinical trial treat group receive insulin week week insulin treatment test use statistical group adverse include decrease vs respective vs respective body weight increased significant group receive metabolic control respective whereas control diabetic result weight study suggest clinical effect rate metabolic control respective
26374110 en although hypertension mellitus DM major risk factor primary syndrome study incidence present study association factor evaluate patient diagnosis hospital follow-up perform participant baseline clinical factor assess medical management mortality development event medical hospital logistic regression model evaluate impact baseline clinical status cause mortality rate respective analysis potential DM clinical factor associate adverse effect incidence odd ratio confidence interval CI DM clinical factor whereas lipid profile blood pressure determine control may role management patient
25088753 en incidence type mellitus T2DM well may role however study examine role T2DM result therefore research T2DM incidence influence analyzed datum health cohort participant use participant use logistic regression factor T2DM found factor total effect T2DM effect found association T2DM factor factor reported T2DM incidence
25277876 en drug use management T2DM conduct investigate whether treatment study identify database index database database current index database database database datum study included use effect model statistical analysis use total include subject analysis study revealed serum level significant decrease patient T2DM receive treatment analysis significant different estimate serum level baseline treatment serum level follow-up analysis indicate serum level reduce group difference serum level observed two serum level may contribute provide drug T2DM patient
20440668 en determine follow-up woman diagnose gestational mellitus on retrospective cohort study woman gestational mellitus conduct primary outcome fasting blood glucose oral glucose tolerance measured month test logistic regression analysis use statistical statistical indicate confidence interval follow-up study cohort woman value impair glucose tolerance diagnose type mellitus woman follow low follow-up compare woman year old woman glucose odd ratio or confidence interval CI or CI or CI respective follow-up woman diagnose gestational mellitus low effective need increase follow-up woman gestational mellitus
23539732 en health care system impact factor mellitus control can due association hemoglobin hba1c health use regression model examine association hba1c diabetic diagnose year age obtain found negative association level metabolic control assess hba1c age diagnosis duration factor current age change time change method hba1c time increase hba1c decrease report association metabolic control system health care care impact poor control development complication finding suggest high complication rate found adult low status poor control care increased
24903944 en evaluate whether use development among patient mellitus retrospective cohort study patient new diagnose type DM base database participant type DM patient aged year new treat drug patient diagnosis diagnose new diagnose type DM patient patient study period individual diagnose estimate incidence cohort patient less among patient vs potential baseline use associate development DM patient development among new diagnose type DM use among diabetic associate effect incidence
27553485 en include use drug medication potential adverse effect recent show also effect study drug reduction insulin also use associate risk mellitus DM mechanism poor known datum indicate several study examine mechanism obtain study obtain investigate effect result show increased potential factor also reduce level result cell therefore increased risk DM
23454736 en provide effective medical care old patient type mellitus may contribute examine independent effect age year disease control relationship complication patient study use datum database adult control management on total contribute total patient may datum hypertension treatment risk factor complication independent associate risk factor identify use regression analysis female man duration subject lower BMI old age group patient aged year glycemic lipid target blood pressure adjust duration body mass index disease control treatment significant high patient year reported complication age year independent risk factor complication control cardiovascular risk factor finding current control target old patient disease complication
25271112 en incidence type woman gestational mellitus high blood glucose woman follow-up woman period need improve investigate incidence follow-up woman woman hospital blood glucose evaluate incidence rate increased on total woman include woman blood glucose three blood glucose included method included blood glucose level fasting blood glucose level oral glucose tolerance hemoglobin need blood glucose woman woman type clinical woman glucose need
24639422 en assess whether weight week influence risk develop gestational complication gestational mellitus adverse outcome weight weight week measured woman determined use glucose tolerance insulin resistance insulin lipid profile outcome evaluate week adjust odd ratio or determined according weight logistic regression analysis adjust normal reduce or or however or significant high group normal adverse outcome due associate significant increase or although less estimate group associate positive study suggest target weight early may woman need decrease risk without increasing adverse outcome
24122895 en development type possible factor recent high prevalence observed type patient cell associate increased risk develop however association investigate possible type prevalence analyzed patient type control individual population result show significant increase prevalence type patient control vs significant increase patient compare one vs significant or addition analysis according status show significant increased correlation type type patient compare one vs or finding provide evidence type individual suggest patient impair contribute development type
25649912 en type cause among patient year age type type cause type
24840003 en identify determine factor associate medication type mellitus T2DM patient primary care hospital care adult T2DM patient rate type medication identify compare primary care general consider possible medication history identify addition little one two per total insulin high rate factor independent associate medication type total number medication medication high rate medication found patient may contribute need medication care medication patient outcome
26114492 en study relationship serum important concentration patient type system measured blood value blood patient mean age year type diabetic compare value serum concentration patient patient two group base plasma concentration correlate positive blood correlate negative resistance female type diabetic multiple regression analysis show plasma level independent positive correlate negative correlate result indicate high concentration serum may associate increased increased blood type diabetic
19796762 en evaluate prevalence risk factor type type mellitus treat multiple insulin healthy day type mellitus control respective vs vs type mellitus control observed type mellitus metabolic control hba1c level increased duration prevalence compare control regression analysis show increase hba1c duration increased day associate high insulin metabolic control high prevalence observed type mellitus compare control first report high type mellitus hba1c insulin important factor related type mellitus
25053801 en assess prevalence metabolic syndrome evaluate status patient type relationship metabolic control insulin resistance type according presence metabolic syndrome serum factor protein prevalence metabolic syndrome patient metabolic syndrome lower concentration high concentration compare patient without metabolic syndrome addition metabolic syndrome associate high insulin increased insulin associate metabolic syndrome patient type lead control increase insulin early diagnosis metabolic syndrome patient medication complication improve
27632340 en diabetic significant lower control within normal function early mellitus interval response study aim function identify different database two review independent conduct use analysis within normal diabetic mean diabetic significant lower control mean difference CI respective significant control respective interval significant diabetic
24755412 en assess type mellitus association characteristic among general association diagnosis use target blood glucose target blood pressure use total number type use blood glucose test diagnose patient little little use little little found patient risk factor year patient independent related type lead important outcome care model identify use
24638989 en use therapy type mellitus on also review clinical treatment type well result randomize control trial demonstrated oral improve control therapy therapy insulin without control also patient type patient type severe renal general well patient type weight associate low risk mechanism oral therapy patient type
23775251 en study estimate rate factor associate woman recent gestational mellitus datum analysis conduct use datum risk assessment system three one new estimate overall among woman logistic regression use determine factor associate confidence interval CI woman history reported test among woman recent reported test woman receive care report compare woman receive care odd ratio CI woman body mass index report compare normal weight woman woman increased risk glucose rate remain care increase rate need among woman risk type
26109389 en reported possible risk factor development several study study investigate type mellitus relationship prevalence retrospective study evaluate medical patient type healthy control individual hospital result serum concentration level patient type relationship complication significant difference serum concentration observed diabetic control group correlation observed hba1c serum level serum level lower diabetic patient patient use medication treat change high prevalence common diabetic patient complication evaluate level found lower patient complication severe therefore associate complication diabetic patient
22521040 en clinical reported include care management woman type mellitus
25596853 en evaluate relationship type risk mechanism two include insulin health study cohort included chronic disease cardiovascular disease type baseline status month characteristic several outcome case use follow-up model use type occur participant year follow-up on history reported woman associate great risk develop compare CI adjust age factor status oral use history BMI compare woman without history cause associate high risk disorder CI factor CI factor CI CI associate factor associate high risk CI finding suggest history related disorder significant associate high risk type
23602088 en study prevalence disease patient type mellitus T2DM report correlation glycemic control duration disease presence study patient T2DM control according age index use assess presence on score great consider patient T2DM control difference statistical different value score high diabetic group compare control group significant increase score significant increase patient control respective value correlation T2DM compare control however prevalence significant high diabetic patient compare control present correlate
24106177 en renal glucose determined glucose glucose renal glucose decrease possible due reduce glucose decrease woman develop gestational mellitus woman oral glucose tolerance test included analysis plasma glucose level glucose measured oral glucose datum use subject two cohort according result mean compare two woman diagnose participant glucose value can determined determined subject among woman diagnose normal lower woman woman mellitus associate high compare result decrease may role development
24965376 en evidence randomize study activity intervention type clinical health outcome conduct included subject aged year type activity intervention activity outcome total randomize study period review although study method reported little one significant health outcome follow-up study show potential activity hba1c study participant mean difference CI BMI study participant mean difference CI study participant mean difference CI large effect total cholesterol study participant mean difference CI activity important management potential cardiovascular disease study change activity outcome remain activity type
25117035 en association metabolic control occur patient determine association different metabolic control type sample type diabetic aged year one year three hba1c perform obtain analysis conduct use first model included hba1c time several age year type mellitus activity overall negative found hba1c model finding high level associate high hba1c level on association found level type diabetic different factor metabolic control type diabetic found
25003029 en important function type mellitus common observed possible due may according complication status test according clinical status correlate patient use high datum patient without complication healthy participant level use recent develop within estimate index within common found test use assess difference three group observed lower control patient complication show relative group high patient without relative control general patient group compare healthy control lower correlate poor general patient found patient clinical status lower related poor function result indicate may role dysfunction
21518407 en diagnose type type diagnosis type age protein insulin cell positive negative patient duration range remain negative positive found one insulin oral diagnosis type remain group clinical characteristic high risk type remain patient duration remain diagnosis type patient type remain relative compare suggest high type
25388378 en study examine association gene type mellitus risk T2DM population result assess relationship on review perform database study datum odd ratio or confidence interval CI study T2DM case control included overall or CI or CI analysis significant risk found among suggest associate increased T2DM risk among
25150574 en although study suggest type mellitus T2DM increase risk disease relationship well aim study examine disorder investigate whether T2DM estimate risk score base T2DM associate associate increased risk study perform individual case control subject datum study individual case control population control risk score examine associate increased risk investigate association T2DM score study result T2DM risk score associate risk odd ratio confidence interval odd ratio confidence interval per respective risk score base T2DM associate increased risk observed association T2DM can therefore disease mechanism common risk factor cohort datum T2DM
24840095 en relationship gene type mellitus T2DM present conduct assess association gene risk T2DM association study identify included use method report association gene T2DM overall population associate T2DM risk gene also associate T2DM risk gene also associate T2DM risk overall population however study conduct
20220043 en develop significant health care poor increased population health care high level great individual need drug increase control drug development metabolic disorder mellitus increasing number diabetic increase year target mellitus new treatment determine cell mellitus complication role disease treatment potential great mechanism drug mellitus provide clinical care complication
25300498 en recent revealed association type mellitus T2DM relationship demonstrated follow aim assess association T2DM investigate incidence subject T2DM datum T2DM patient included incidence ratio incidence population time diagnose period analysis revealed statistical significant elevated CI CI woman CI man perform according time diagnosis revealed high first year diagnosis demonstrated elevated woman CI CI man CI period year diagnosis addition increased risk statistical observed female CI CI CI study revealed high risk patient T2DM however important result great due care patient T2DM
24898818 en association type mellitus identify different population study diabetic patient healthy control use three investigate association population result show significant association gene vs vs model indicate significant association increased risk population according result study revealed significant association type population
21824922 en trial reported outcome intervention according presence mellitus study examine individual determine whether presence mellitus treatment compare database clinical system treatment patient on trial compare trial intervention perform patient mellitus patient without mellitus treat compare significant reduce rate mortality target among patient mellitus significant difference type measured parameter significant present diabetic status type target identify mellitus type clinical outcome intervention patient without mellitus compare result reduction target whereas significant difference outcome present diabetic patient
26052873 en use recent year general population well among patient chronic disease mellitus aim study regard use patient type mellitus possible medication study base study included type diabetic patient medical possible evaluate clinical clinical diabetic patient use significant difference age regard use found possible on major found major found improve potential effect adverse effect patient chronic disease among patient DM use
22035202 en clinical primary health care great potential research use datum assess aim study diagnosis hypertension mellitus clinical primary health care diagnosis use clinical determine mellitus association diabetic subject hypertension study mellitus hypertension diagnosis clinical primary health care clinical consider positive negative value index result show overall age mellitus determined positive value negative value diagnosis show determined positive value negative value result patient also aged year result use diagnosis hypertension found within clinical study
24918998 en estimate prevalence mellitus DM impair glucose tolerance population aged year study conduct included fasting glucose participant blood glucose consider diabetic patient show blood glucose undergo oral glucose tolerance test investigate whether DM individual general prevalence adjust age DM high prevalence DM increasing age low level history obesity obesity among diabetic patient disease diagnose among patient DM potential chronic study increased prevalence DM need early diagnosis well medical treatment complication
24716398 en number diabetic increasing patient insulin rate use adult population improve glycemic control weight subject type effect rate can clinical type review clinical datum regard use potential large clinical trial need population
24355429 en recent improve glucose however gestational mellitus period assess patient healthy gestational control patient control follow-up datum also study population healthy woman undergo assess serum within well blood first study population range level significant high patient compare control previous control control fasting insulin independent positive associate serum analysis finding relative change ratio independent positive relative change ratio study independent associate finding need assess
25294180 en investigate blood glucose control among patient mellitus DM study hospital hba1c measured one clinical review obtain age body mass index blood pressure ratio duration diagnosis one patient DM type DM type DM included correlation revealed significant correlation hba1c among patient type DM patient type DM regression model per significant associate hba1c among patient type DM base analysis determined value control hba1c among patient type DM positive value negative value blood glucose can possible use assess control among patient type DM
24951085 en clinical outcome assess patient type mellitus population examine research hospital type diabetic patient mean age year assess on characteristic analysis perform assess mean factor analysis total respective correlation total respective correlation factor analysis model on score demonstrated type diabetic patient
24170484 en report care adult type intervention datum medical patient type primary care significant increase rate statistical significant finding demonstrated effective use care glycemic blood pressure control research need research remain control receive care primary care intervention target primary care potential reduce care research determine whether intervention intervention need
24345688 en although reduce rate target compare result patient disease assess compare patient mellitus conduct two independent use mellitus disease according study compare patient follow-up year study include patient undergo undergo mean follow-up period year range compare associate lower risk major adverse event odd ratio or confidence interval CI lower risk or CI significant difference regard or CI patient group high risk event or CI intervention patient high risk remain diabetic patient
21094798 en aim investigate mellitus according study individual disease group different cause group determined method identify use method diagnose according association period month group common patient difference compare patient vs group observed patient without vs vs association significant analysis factor patient among without include
26164991 en assess risk development mellitus DM metabolic among clinical study female participant subject included body mass mass pressure assessment DM risk use risk score high value mass obesity found participant age high value man woman high risk DM risk among man high woman high high risk time high prevalence metabolic primary group
26537439 en patient type T2DM control randomize study weight impact weight treatment use evaluate health status baseline week patient compare patient treat use model score score improve group baseline week however significant difference group index score remain baseline week on great group reported compare difference statistical significant health week therapy patient health status treatment
21309840 en investigate rate insulin patient type mellitus positive determine factor related insulin retrospective datum patient type patient analysis use identify factor associate insulin period year two patient insulin rate insulin high vs analysis patient show low BMI diagnosis independent factor significant related insulin presence insulin patient type patient low BMI associate
25494632 en new identify study reported concentration patient type mellitus T2DM large concentration different study may difference sample population aim present study confidence interval level T2DM patient use study concentration determined new diagnose T2DM patient body mass control study conduct whether concentration lower patient T2DM regard association T2DM use review use study concentration lower new diagnose T2DM patient compare healthy control datum indicate concentration confidence interval CI lower T2DM patient healthy study concentration significant lower patient T2DM
21826737 en examine prevalence correlate large sample patient treatment population previous receive little statistical disorder study compare healthy control subject age body mass index BMI patient assess use positive negative syndrome diagnosis review medical fasting blood glucose oral glucose tolerance mellitus common patient normal control vs odd ratio confidence interval CI prevalence increased age compare normal control total score show difference diabetic group logistic regression patient revealed significant association history age BMI treatment associate increased clinical important risk mellitus chronic patient previous report population
22527481 en effective control mellitus type type reduce development diabetic complication therefore patient consider aim study assess DM patient medication study conduct general hospital study use patient datum patient medical medical evaluate medication assessment assess management outcome consider hba1c level blood glucose level reduction risk factor adverse effect treatment present study patient patient respective patient disease diagnose patient risk disease high patient factor metabolic syndrome addition overall patient level positive response medication complication control treatment patient show difference among high associate finding study indicate patient care level positive response found high patient level care include patient within can contribute patient
16924939 en due renal common effect treatment man aged year can reduce however show case man treatment risk due reduce renal on reduction treatment therefore although general condition may demonstrated case man chronic treatment develop severe patient chronic treatment therefore important
16781893 en evaluate severe patient less cell positive study demonstrated included gene gene protein high gene response patient without however patient high study cell patient demonstrated use cell cell woman demonstrated use result due control response cell
27087083 en effect associate cardiovascular risk factor study effect plasma diabetic on total diabetic randomize treat group treat group respective studied week treat group show significant reduction level baseline group revealed significant difference similar week treat group show significant low level compare baseline group respective control group group respective however difference group parameter include glucose tolerance fasting plasma glucose blood lipid blood pressure body weight also improve group great study effect may associate complication
27030118 en association glycemic control cardiovascular disease evidence hemoglobin therefore diabetic patient control major cardiovascular risk factor obesity hypertension risk factor review cardiovascular disease adult type mellitus association association
23464532 en investigate effect hba1c patient type randomize study conduct month patient hba1c randomize patient hba1c receive primary outcome change hba1c baseline month reduction hba1c baseline month observed mean CI change respective similar reduction observed on high patient hba1c month mean change hba1c month well less population hba1c reduce month effect glucose control individual significant control month although time
19365171 en determine mellitus risk factor datum hospital analyzed disease clinical use identify disease among patient mellitus relative risk elevated patient year high patient aged year relative risk relative risk type mellitus type mellitus similar also age patient mellitus obesity compare mellitus condition relative risk patient aged year patient aged year old patient relative risk patient mellitus increased mellitus increased risk patient condition also increase risk present
19318892 en identify change among patient study examine patient type mellitus patient type mellitus patient type mellitus group according method management insulin oral control group normal subject type mellitus normal subject type examine significant diabetic patient normal control type type diabetic patient significant great patient treat insulin therapy patient treat oral patient mellitus compare normal control finding suggest high incidence patient mellitus
23517799 en increasing use treatment chronic disease include mellitus however little known effect treatment type mellitus T2DM review evaluate clinical evidence regard effect treatment review index database glycemic control risk assess use study result effect reduce fasting blood glucose level addition insulin resistance study subject treatment type mellitus need large randomize clinical trial effective therapy well need research potential therapy management T2DM
25577895 en lead type mellitus role although mechanism study show cell cell cell may aim study evaluate effect blood cell type mellitus healthy type healthy adult examine cell cell system cell cell measured use analysis cell perform use concentration obtain cell range statistical concentration control concentration statistical high patient healthy range found cell patient control difference group control group regard cell observed activity cell type mellitus indicate increased increased number cell
22936679 en aim study determine whether insulin resistance present patient type mellitus insulin compare healthy studied patient man woman type mellitus insulin healthy control age body mass index insulin measured study glucose patient control however glucose less condition patient compare control vs indicate decrease insulin study glucose rate lower patient compare control vs according rate glucose lower patient vs level time high patient condition vs decrease insulin resistance patient type mellitus treatment insulin insulin resistance type glucose
27681254 en type dysfunction provide study diagnosis treatment study investigate use target base analysis use group change among according analysis potential role mechanism different several include influence function one target decrease target large study may provide new target management target
24977962 en on woman mellitus well primary serum level revealed mass fasting blood glucose level serum value elevated serum low negative normal first present show show test patient clinical condition improve however
24949461 en whereas study found association mellitus DM study result conduct study evaluate association measured well sample examine assess use datum potential risk factor perform blood glucose test follow hemoglobin assess DM participant age year found participant high level level associate increase risk DM odd ratio or confidence interval CI or CI or statistical case number therefore study large study population need finding
24851259 en three primary health care management treatment outcome patient hypertension mellitus DM receive care
24410834 en mellitus DM use therapy present study evaluate patient undergo intervention evaluate use study included patient DM therapy month time patient show remain patient show regression month follow-up receive therapy vs insulin use high vs however difference statistical risk factor control baseline follow-up group serum level regression analysis show serum negative correlate regression analysis show low serum use significant independent therapy type serum associate patient clinical trial
27801417 en estimate relationship serum concentration protein body blood glucose woman type mellitus total woman T2DM normal body mass index BMI age year examine concentration protein determined level type measured analysis use estimate parameter estimate glucose level significant high woman T2DM control group diabetic normal weight woman concentration control level correlate positive BMI mass body on regression analysis show mass independent level concentration correlate positive ratio demonstrated association BMI serum level show positive association mean woman T2DM serum concentration correlate different mass finding indicate chronic patient
27801413 en mellitus DM disease according total patient medical DM however first aim type DM T2DM population show prevalence T2DM high one previous T2DM high prevalence T2DM individual old year obesity cardiovascular disease prevalence cause DM patient cardiovascular disease medical treatment patient DM complication high DM subject
27119007 en new potential drug base develop possible treatment mellitus DM complication regard group develop evaluate model type type mellitus model model treatment week week respective datum show effect time show lipid serum treatment insulin show effect cell suggest possible cell insulin level therefore can consider also mechanism
27052028 en increasing prevalence obesity cause incidence T2DM due chronic complication T2DM mechanism diabetic disease known influence level therefore impact identify high risk group sample result trial review evidence gene related provide review test subject
26935368 en on woman develop mellitus without presence patient relative serum level insulin remain year insulin therapy patient within month include cell type mellitus therefore patient may without insulin
26885249 en due presence major previous study conduct on DM therefore group control DM DM on plasma level glucose activity significant increased diabetic group also diabetic show severe glucose change addition level insulin total protein activity significant decrease diabetic compare control group on lower blood glucose level compare diabetic test parameter normal level insulin level can on decrease elevated blood glucose level cause mellitus
26826833 en research evaluate use mellitus drug ratio oral day period week diabetic compare effect drug observed interval fasting glucose level hba1c also drug treatment overall diabetic effect result revealed two significant reduce fasting glucose level hba1c less diabetic control control fasting blood glucose level similar drug glucose level drug one week week treatment respective similar week treatment also drug show hba1c drug show potential mellitus
23014256 en type mellitus T2DM among health associate incidence lead development T2DM however insulin indicate type disorder multiple different contribute analysis factor factor disorder case type cause gene one previous study indicate associate different type identify base characteristic gene common gene several study associate type well recent study reported within gene gene type patient patient insulin oral drug provide review role type mellitus
19952515 en diagnose disease mellitus treat status improve insulin control decrease week insulin present case mellitus disease disease mellitus first case effective treat mellitus disease
26799261 en mellitus DM outcome previous study evaluate role DM base blood participant included patient undergo group according DM define hemoglobin hba1c DM hba1c DM hba1c significant difference complication among three group rate significant lower DM hba1c group group DM hba1c group analysis revealed DM hba1c ratio confidence interval CI presence independent factor severe DM negative outcome
26694367 en aim study analysis gestational mellitus perform plasma sample woman diagnose gestational mellitus control group mass analysis determine low profile different several profile observed analyzed group datum obtain model high high model well total group value model high compare analysis level obtain result indicate high potential analysis sample clinical subject also use study disease
27424442 en weight gestational age associate multiple metabolic factor risk factor associate development patient without gestational study patient patient patient diagnosis patient without without gestational mellitus incidence risk factor history age show difference show vs control group gestational present vs incidence demonstrated patient metabolic factor gestational mellitus show high prevalence study group management reduce weight weight improve fasting blood glucose patient positive negative tolerance
18216147 en may drug concentration effect patient different renal large treatment may increased type test without control group oral week treatment significant use revealed cause significant increase effect response may mechanism patient
23984431 en study aim investigate mellitus type patient chronic association case conduct hospital period month patient old year diabetic included datum include fasting blood glucose level serum cholesterol function test on logistic regression model use association diabetic type mellitus total patient analyzed prevalence type mellitus patient total number participant analysis patient significant diabetic compare patient or CI age increased weight independent type patient statistical significant association observed type mellitus
23145992 en change mellitus DM include possible increase present investigate increased DM use DM without DM DM duration year age body mass index blood pressure significant different DM value decrease increasing independent DM value significant great value great DM value significant great use first time DM great value DM group presence previous increased suggest may method early change may cause
25419888 en type mellitus T2DM health significant health care target individual T2DM less general adult population however patient T2DM condition potential complication intervention possible increased healthy use new medication risk weight glucose target patient activity per day may target cardiovascular interval high level period medication low risk include consider primary target management important treatment change patient T2DM
24479835 en disease female severe cardiovascular disease occur early control patient develop age history event risk factor show disease disease mellitus DM clinical addition also increase risk disease disease therefore consider little cardiovascular mellitus cardiovascular due perform effective identify use function disease patient independent follow assessment however high remain
24261759 en patient disease evaluate effect blood level patient measured show level improve patient level well control three month compare patient poor control level patient include patient mellitus DM measured new diagnose DM patient show high level without elevated hba1c therapy improve significant period intervention significant patient control three month period poor prevalence high patient according level therapy improve
24183482 en gestational mellitus common associate complication treatment show reduce woman type important factor development general woman recent study evaluate patient show glucose control woman without need insulin use case related treatment follow-up factor large gestational age important role development
25511715 en recent year disease diabetic recent study demonstrated possible potential aim study investigate influence serum factor patient type patient type DM T2DM subject studied patient T2DM day day concentration measured significant increased decrease serum concentration patient T2DM serum level high group T2DM patient high serum level lower patient T2DM compare T2DM may influence type diabetic patient effect factor include
27337219 en study investigate activity type mellitus possible association study type mellitus control similar age serum activity assess rate respective activity assess respective hba1c lipid profile method found lower activity diabetic compare control decrease statistical significant activity difference high poor control ratio also lower diabetic vs control without statistical activity negative correlate hba1c diabetic statistical significant respective on correlation found activity lower diabetic decrease activity statistical significant although lipid profile control diabetic difference observed group regard level
26812053 en mellitus chronic treatment patient system patient system treatment disease management study aim determine patient treatment patient current system treatment use patient type mellitus primary care use three group conduct among primary care use datum follow identify observed patient follow related treatment characteristic treatment system type treatment patient type mellitus use treatment model study disease may disease development
26663712 en randomize study evaluate early effect blood pressure patient type mellitus T2DM hypertension patient randomize week undergo day treatment week primary change mean baseline week overall patient included mean age year hemoglobin week provide great reduction mean little mean vs respective reduction observed general well effect similar reported previous study result suggest reduce patient T2DM hypertension
26586663 en major cell protein previous reported increased mellitus examine potential mechanism high glucose cell effect elevated high glucose result factor primary cell protein within effect can increase severe diabetic increase lower activity first factor
26417844 en on study assess prevalence association risk type mellitus database study prevalence association risk T2DM also on model use prevalence odd ratio study participant prevalence odd ratio prevalence prevalence risk T2DM prevalence range prevalence CI overall CI man CI woman odd ratio range overall odd ratio CI overall CI man CI prevalence level associate increased risk T2DM general population among woman among man woman
23891775 en study review regard impact mellitus DM patient undergo database use prevalence DM patient patient chronic report relationship DM status incidence define study group similar compare patient without DM incidence cardiovascular complication clinical significant level renal significant different compare patient without DM whether DM impact assess parameter may due different DM different method different compare different rate mortality include renal severe patient without DM influence DM study DM
25016865 en type mellitus model high high week level fasting blood glucose serum insulin week body weight also measured week blood level measured use serum insulin level diabetic week high high fasting blood glucose level diabetic compare normal group change diabetic group week level diabetic group significant increased normal diabetic model investigate disease mellitus
24131086 en well diabetic patient high mortality rate population study determine overall compare mortality diabetic conduct retrospective study patient mellitus DM serum hba1c disease characteristic well follow-up period patient old patient rate high DM patient one per patient month compare patient one per patient month analysis patient significant lower DM patient patient rate diabetic respective regression analysis DM age baseline serum disease baseline significant overall lower diabetic compare patient rate also high diabetic patient DM old age level cardiovascular mortality
23720882 en study indicate risk type mellitus cardiovascular disease disorder may study aim assess dysfunction patient history population on total subject included study group group healthy control group patient group healthy control result show significant high patient compare control subject history fasting plasma glucose hemoglobin serum total cholesterol protein level significant increased whereas serum level significant decrease patient however patient diabetic show significant increase compare healthy control present study significant high patient increased age history increased level lipid decrease level contribute risk dysfunction patient however study dysfunction patient increased sample
23593231 en increasing type mellitus effect reported type patient however little known disease use identify difference type patient healthy individual obtain type patient duration less year healthy individual found type patient relative healthy individual respective analysis revealed diabetic current finding suggest change occur early first year clinical diagnosis type mellitus
23587308 en type among chronic disease type management care different clinical study assess metabolic outcome hemoglobin among type diabetic receive care hospital compare retrospective study conduct type diabetic aged present hospital included study test diagnosis one year follow-up little one hospital diagnosis period receive diagnose receive metabolic outcome measured diagnosis one year medical datum review included test care care type related drug sample included patient statistical significant difference patient characteristic found group statistical significant difference metabolic outcome group total one year per type diabetic group respective care per group type care hospital increase without patient glycemic control first year
26607485 en glucose important overall glycemic control mellitus study show insulin insulin profile high insulin improve profile insulin great effect compare insulin randomize control trial also demonstrated improve control insulin compare insulin patient type type well patient patient patient use insulin study demonstrated addition insulin patient type insulin insulin show profile evidence increased compare insulin one evidence lower rate compare insulin trial included patient history significant lower rate severe insulin insulin develop
23958966 en metabolic disorder treat cause health complication mortality change increase incidence hospital model less care need patient care model may patient current study research case identify participant effective analysis datum use major identify study result improve case management care outcome patient disease study finding may need model care
22249783 en recent evidence case report study randomize trial suggest use increase risk develop however relationship remain determine whether association use risk develop type study use database conduct datum new patient aged year without history included cohort adjust odd ratio or confidence interval CI risk associate use logistic regression clinical type total sample vs group on total case type mellitus control identify use case control use age use associate increase risk compare use adjust odd ratio or CI association observed or CI or CI or CI or CI use associate increased risk association observed
22176834 en evaluate prevalence risk factor define population subject type mellitus compare control diagnosis type mellitus control group study system participant system score consider significant blood datum participant diabetic population glucose control blood pressure body mass index medical diagnosis time prevalence significant respective type population logistic regression analysis type associate age also associate diagnosis hba1c female high rate diabetic population type associate age hba1c female high rate study show associate mellitus define glucose control whereas associate glucose level associate mellitus woman also associate high rate
24918803 en patient increase risk disease cause compare patient intervention target risk factor management hypertension reduce risk cardiovascular disease patient type mellitus T2DM large randomize study show glucose reduce event rate patient T2DM evidence suggest contribute although glycemic control early disease may associate reduction risk cardiovascular event T2DM may risk therapy potential treatment increase risk treatment new therapy subject drug result first trial recent show increased risk major adverse event also therapy well potential increased risk evidence risk reduction therapy type mellitus disease care intervention management risk factor glucose medication treatment
24682913 en cell show decrease aim change cell function diabetic subject patient diabetic receive therapy follow week fasting plasma glucose hba1c fasting insulin cell function level measured patient decrease whereas increased significant respective week type diabetic patient hba1c weight decrease whereas level increased significant treatment respective treatment function correlate insulin hba1c level group respective treatment hba1c correlate level correlate increased cell function improve hba1c level cell significant role type therapy may treatment
23897163 en type mellitus T2DM patient function characteristic disease associate recent identify target glucose insulin increase level reduce lead insulin increasing identify potential treatment T2DM increased level cell cell significant elevated insulin cell improve glucose tolerance insulin level increased treatment week obesity week improve glycemic control also reduce weight datum effective control glucose level also effect observed therefore suggest new type potential effective treatment type
23164637 en mellitus event possible insulin resistance condition related on retrospective study assess rate associate activity female diagnose case identify syndrome severe diabetic diagnosis perform day diagnosis within day several factor may lead however case normal blood glucose level suggest diabetic independent time diagnosis
25014539 en investigate whether risk develop elevated woman study cohort study woman type control care respective patient identify due use estimate incidence rate ratio use regression overall incidence rate estimate confidence interval CI per patient control lower per incidence increased age control statistical compare adjust woman elevated woman aged adjust woman aged adjust association remain disease duration cohort study provide little association type risk
25184161 en one weight insulin therapy type mellitus increased cardiovascular disease clinical also factor may role aim study evaluate prevalence cardiovascular disease risk factor well mass obesity associate gene large group on total control patient obesity hypertension level among significant high high rate obesity level among group metabolic control presence risk factor similar difference observed treat use use insulin gene correlate body mass index BMI control diabetic effect little diabetic regression model current value diabetic significant baseline BMI disease duration metabolic control subject factor great impact development obesity
23471980 en woman history gestational mellitus increased risk type T2DM however time investigate clinical risk factor associate T2DM early cohort study total subject follow development T2DM clinical risk factor investigate month subject known compare month subject T2DM early among remain subject undergo year follow-up new develop T2DM independent risk factor early high body mass index high glucose oral glucose tolerance test lower fasting insulin concentration decrease function independent risk factor high body mass index high glucose associate early whereas associate risk factor early T2DM however early function difference
27055974 en consider incidence cardiovascular disease addition previous study show potential diabetic investigate incidence risk factor development diabetic patient type total patient type without follow perform outcome new follow-up time year patient group duration high baseline hba1c high level high level adjust age duration presence hypertension renal function cholesterol mean hba1c medication development significant associate serum level confidence interval compare vs patient group high range mean hba1c level confidence interval develop compare patient lower level cohort study demonstrated independent associate serum level patient type
16721592 en disease disorder disease impair diagnose disease present hypertension year age on test follow on renal revealed finding disease therapy result blood pressure reported disease patient renal clinical hypertension
27486667 en mellitus important metabolic complication renal system insulin resistance although response reported study investigate association study whether associate total patient receive renal without previous diagnose included analyzed association development within gene patient develop patient patient group old group vs year patient significant high compare without gene gene significant associate development age study significant association renal group datum suggest system role renal
20516763 en disease mellitus severe disease patient mellitus compare control study improve risk patient on cardiovascular system mellitus effect rate studied level year mechanism recent study mechanism cardiovascular mellitus method investigate well possible medical therapy also review change disease also present mechanism normal
24886809 en type mellitus result insulin need resistance analyzed protein profile old diabetic type protein significant change type observed protein protein identify analyzed use database protein protein well protein related activity glucose result suggest mechanism insulin resistance chronic observed
24582332 en disease group disorder different new association study provide evidence new disease include common cell found number disease include multiple disease mellitus type mellitus evidence association type previous found recent datum suggest cell addition system may significant role can role among different recent system possible disease cell cell month year clinical diagnosis suggest different level cause cell disease period disease role level evidence reported patient several condition addition cell also found cell patient found patient demonstrated increased can management condition type can target patient disease
23931568 en study examine effect type mellitus normal diabetic diabetic group first day estimate respective cell use ratio diabetic group significant increased compare group among group diabetic diabetic group lower normal group cell diabetic group high group however diabetic group significant different diabetic mellitus may different response diabetic
23855509 en dysfunction major cause insulin response high blood glucose metabolic type mellitus T2DM known occur T2DM conduct study diabetic patient model investigate T2DM among model consider one type diabetic model characteristic less common present diabetic patient model consider mechanism T2DM present characteristic include mechanism T2DM investigate T2DM
26134916 en estimate vs insulin therapy type patient well control oral model datum three randomize clinical trial week compare vs insulin therapy oral therapy population model include complication mortality year estimate time year rate insulin treatment patient result analysis include analysis impact ratio included hba1c level baseline health BMI insulin therapy treatment patient control treatment
27420093 en poor may contribute type mellitus T2DM conduct randomize control trial test function T2DM reported improve report effect correlation plasma T2DM adult aged year randomize interval use change blood test test per increase mean blood also significant improve correlate plasma total level test also improve T2DM chronic
26137615 en relationship level type mellitus method study aged receive medical health patient general hospital medical hospital study according T2DM patient control group age year old case control T2DM group case group case group control group case determined subject undergo first disease medication history history include weight blood pressure blood pressure according weight body mass index BMI test total cholesterol low blood blood index result group age patient patient female control group age include man woman age two group statistical difference blood cell value T2DM group high group significant difference compare mean value blood cell significant difference T2DM group level blood cell group T2DM group significant high group compare level blood cell significant difference age blood glucose odd ratio normal age blood glucose odd ratio increased level associate type increase level association may development type relationship factor level
25973943 en among gestational mellitus type suggest disease common risk associate however analyzed previous associate body mass index BMI well aim woman association found two addition found two associate glycemic major show role risk two associate also contribute risk develop disease common however association risk suggest mechanism may
25750540 en glycemic control patient type mellitus T2DM may lipid level may patient T2DM poor glycemic analysis clinical trial datum patient T2DM randomize examine effect patient hemoglobin fasting plasma glucose level baseline week treatment significant improve cholesterol cholesterol cholesterol compare patient baseline glycemic control compare week treatment patient treat medication baseline glycemic control incidence adverse general low treatment effect independent baseline glycemic control patient T2DM
25217820 en role profile patient type mellitus demonstrated little known effect patient evaluate effect profile activity level patient study primary care man diagnose profile activity level assess week result show significant assessment blood pressure fasting blood glucose body mass index cholesterol function increase activity level medical outcome study health general activity activity finding cardiovascular system metabolic profile effective increasing activity level patient
23023905 en response diabetic patient study aim determine effect serum level protein type mellitus patient
24983935 en retrospective database assess effect glycemic control mortality patient undergo mellitus DM disease glucose demonstrated increase mortality however whether glycemic control influence outcome patient DM undergo sample analyzed disease clinical diagnosis condition patient cohort control diabetic diabetic patient datum complication outcome determined total control diabetic patient diabetic patient undergo relative patient diabetic patient significant increased odd complication addition diabetic patient also increased mean great great risk mortality odd confidence control diabetic patient also increased risk complication mortality compare patient diabetic glycemic control diabetic patient undergo lead increased risk complication poor outcome patient DM poor glucose control may glycemic control
24638998 en early period important time identify risk woman history gestational mellitus oral glucose tolerance test management reduce risk type assess whether system increase type impair glucose tolerance woman history included trial woman index control test type independent one datum risk assessment evaluate overall study according assessment development possible one study one trial risk included study overall study low trial woman compare three type total woman care woman reported possible type glucose test three investigate woman woman three month woman evidence three intervention increased oral glucose tolerance test compare care system woman risk ratio confidence interval CI participant woman CI participant CI participant increase group three group also increase fasting glucose test group compare care group woman CI woman CI CI glucose test low statistical significant difference group test test high group compare group CI CI CI respective trial report review primary outcome woman diagnose type impair glucose tolerance impair fasting glucose report review outcome change need insulin health intervention adverse event intervention test woman woman also test woman group type glucose test trial show evidence increase type woman previous effect system need assess whether test also increase also need woman aim increasing development type important determine whether increased test rate also increase use
27181998 en result clinical trial evaluate therapy patient type glycemic control reported randomize group clinical trial patient type glycemic control hemoglobin previous therapy randomize ratio mean baseline hemoglobin randomize patient little mean change baseline hemoglobin group vs vs vs treatment general overall incidence high two group compare incidence low similar treatment group incidence adverse event general high group patient type therapy general provide glycemic control
27163280 en gestational mellitus define first rate result complication woman intervention insulin treatment medication review management glycemic lower glucose level general effective however several study high care high rate large gestational age insulin therapy need insulin possible insulin severe
23782896 en type mellitus T2DM disease high prevalence associate severe well health known glycemic control decrease mortality current therapy T2DM medical treatment several randomize control trial perform patient show T2DM recent show similar effect T2DM patient suggest current use new patient T2DM study aim investigate whether treatment T2DM patient complication trial randomize control trial compare include medical treatment need medical treatment T2DM control group primary cardiovascular intervention disease follow-up period year T2DM patient aged year included one two group group receive need medical care whereas control group receive medical care according treatment T2DM statistical analysis base regression population follow-up rate patient group on total sample test trial datum year mortality patient T2DM receive medical trial clinical trial
26310273 en study aim evaluate patient type mellitus well risk factor associate study patient aged year year undergo presence activity estimate use hba1c define mean three hba1c year analysis use factor evaluate risk factor associate patient mean age year female present patient patient increased aged year year respective aged year year respective high level associate lower high hba1c population patient high aged year similar old age group associate history risk factor poor control related high risk
25885947 en disease severe common patient type mellitus T2DM however large elevated aim study determine prevalence patient T2DM normal metabolic patient T2DM normal plasma age body mass index BMI hemoglobin measured insulin model resistance insulin resistance fasting insulin resistance index fasting plasma insulin oral glucose tolerance test prevalence high patient respective prevalence high compare patient well increasing BMI high plasma associate great prevalence compare patient without patient severe insulin resistance prevalence high previous patient T2DM normal increased risk lower patient T2DM
26311088 en glucose patient primary study show result therefore aim compare prevalence type mellitus metabolic syndrome new diagnose patient control cohort total patient compare study health on regard age BMI result regard type regard total patient undergo oral glucose tolerance diagnosis patient significant patient control population vs vs respective also hba1c level high patient control total patient show new diagnose type impair glucose tolerance patient baseline present significant improve glucose follow-up negative correlation glucose level serum patient control age BMI blood pressure may increased cardiovascular disease mortality patient
24865783 en study assess odd mortality individual diabetic compare history addition determine association cardiovascular obtain datum cohort patient care diabetic general on cohort patient history provide control group mortality follow-up duration year range year association mortality evaluate regression association cardiovascular mortality determined risk event mortality event cardiovascular mortality among patient potential associate cardiovascular disease ratio confidence interval mortality ratio confidence interval cardiovascular disease similar group associate cause
25240532 en contribute development function target reduce protein cardiovascular aim assess characteristic include effect patient type mellitus T2DM
24397177 en on blood glucose high may cause individual treat insulin insulin medication reduce may diabetic syndrome patient need day diabetic day management blood glucose level adjust medication according blood glucose level diabetic patient increased effective day management diabetic patient
25228119 en effect include examine whether function patient type retrospective review patient type perform patient use disease function status patient included patient define normal level patient significant decrease month first mean change confidence interval CI respective change significant negative correlate baseline respective change also negative correlate improve dysfunction patient type
24015457 en study identify intervention diagnosis patient care hospital characteristic study patient type mellitus woman age year presence use medication on significant association found intervention care however characteristic intervention show health related treatment healthy health
23826148 en mellitus DM disease metabolic associate high risk renal system assess whether serum blood cell whether significant patient type DM without treatment healthy control age measured serum level also determined group serum serum whereas found DM patient show increased blood hba1c increased level significant correlate blood glucose level observed increased DM patient correlate increased activity vs control vs control result suggest DM serum serum level also also patient type DM event disease dysfunction
25801918 en datum obtain cohort patient type mellitus T2DM risk factor patient T2DM lead include cholesterol level cholesterol level level cholesterol level increased risk associate low level cholesterol low cholesterol level low level low level cholesterol reduce treatment system respective study protein factor patient T2DM finding individual multiple T2DM multiple well
22809536 en reduce risk evidence aim study evaluate effect development type randomize control trial identify patient patient baseline included study compare control group incidence significant reduce group or blood pressure level follow-up therapy associate significant reduction risk compare or or or treatment associate significant reduction risk patient hypertension or disease cardiovascular disease or or among patient impair glucose tolerance impair fasting glucose significant reduce incidence or significant increased regression effect provide risk patient hypertension cardiovascular disease
22462046 en conduct patient type mellitus patient type mellitus on study function system lipid blood high determine severe patient mechanism response level also datum indicate need use treatment
20004037 en care mellitus review evidence present several present care adult can care indicate role known factor
24560423 en mechanism dysfunction patient type mellitus T2DM recent study revealed patient associate adverse cardiovascular event patient T2DM may contribute studied patient female T2DM history disease undergo include plasma level also patient similar without although impair present important negative associate positive index BMI BMI associate impair independent T2DM disease patient T2DM history disease independent associate impair suggest may contribute development dysfunction patient
24878973 en aim study investigate association factor type diabetic patient
25150773 en review mechanism determine patient type mellitus T2DM normal increased patient incidence high several mechanism increased cause cell disease duration metabolic control type therapy presence complication known contribute factor risk T2DM patient estimate risk clinical may due lower risk
25102425 en include although previous study relationship glycemic control patient type mellitus T2DM mechanism association remain study participant T2DM history cardiovascular disease analyzed use include relationship parameter investigate regression analysis logistic regression analysis study patient three group type type type subject type high level fasting blood glucose hba1c low level model adjust age analysis show type associate high hba1c estimate rate factor known metabolic control result suggest T2DM patient metabolic control independent factor T2DM patient important target intervention metabolic function
25936148 en important factor glucose increasing level associate insulin resistance woman increased risk develop obesity due insulin resistance cause disorder female management glucose gestational although glucose subject diagnose gestational need follow early type development addition related include therefore increasing role treatment
22019750 en although known increase risk recent use insulin provide datum risk diabetic population type associate increased risk type type associate increase mechanism increased risk include obesity common well factor increased recent increase risk insulin lower risk review present evidence general mechanism well individual also role insulin risk
21261730 en datum disease patient type mellitus aim study prevalence clinical profile disease patient type mellitus care patient type mellitus use positive subject clinical profile patient patient type mellitus diagnose disease positive mean age diagnosis year disease year difference year two patient disease diagnose mellitus common disease follow weight patient weight rate improve disease high patient type mellitus diagnose early diagnosis associate
21068340 en mellitus type type type disease type primary metabolic current need evidence system type difference type type regard current
21800941 en activity one treatment however risk occur increased little need lower risk conduct adverse event associate increased type type provide individual on review perform study adverse event study included retrospective include randomize control trial assess according on total study individual on number study identify range severe risk overall prevalence low base several randomize control trial study perform range increased relative evidence base assessment provide new risk role patient patient risk
21222312 en syndrome diagnose patient multiple mellitus DM year association DM multiple association DM diagnose however datum suggest relationship type DM review evidence association
24794552 en mellitus DM syndrome lead multiple dysfunction include disorder consider factor development diabetic complication adverse effect multiple one mechanism protein important several function include study show DM result different contribute DM lead dysfunction factor DM also increase factor DM cell show potential target diabetic complication
23429469 en assess association incidence without also study cohort study compare risk diabetic patient control subject included study incidence ratio without control group investigate mortality incidence study study assess use assessment perform incidence use method analysis study study type method determine factor also conduct analysis examine effect evaluate use model show increased risk diabetic patient relative risk analysis indicate result cohort study study population female high study result analysis study adjust risk factor mellitus may increase risk effect
21070757 en role obesity insulin resistance on gestational mellitus reported therefore examine role gene total mellitus patient diagnose patient sample analyzed significant associate use old age high body mass index significant different patient without patient significant lower rate high time test gene factor development finding similar previous study gestational mellitus possible role development
18060660 en syndrome mellitus cause gene recent associate type therefore examine effect incidence response intervention intervention treatment compare participant perform regression analysis use intervention incidence also evaluate effect insulin resistance cell function three associate incidence overall cohort previous reported less develop association revealed three associate type odd ratio CI increased insulin although insulin previous reported effect may intervention cell function
24314281 en factor related disease risk disease study diabetic mellitus aged year old healthy index related factor index significant different healthy index index significant high healthy significant high healthy significant difference two group glucose significant different two group significant high healthy total protein significant lower healthy significant difference two group mellitus lead change factor related mellitus may high risk disease
27025793 en investigate association blood group gestational mellitus retrospective study conduct use datum perform first use blood glucose test use glucose test positive oral glucose tolerance test perform diagnosis define according association study group logistic regression use obtain odd ratio or confidence interval CI adjust risk on blood group adjust or CI adjust or CI adjust or CI decrease risk compare group woman group associate increased risk compare on adjust or CI blood group associate group risk factor population
26440703 en aim compare characteristic woman gestational mellitus according multiple woman glycemic perform cohort study woman logistic regression perform characteristic regression analysis perform assess independent associate impair fasting glucose glucose tolerance history independent characteristic or CI time year CI CI DM addition associate DM regression cohort woman little characteristic factor
27388951 en change patient type mellitus patient type DM healthy control included clinical study patient undergo participant measured interval use age disease duration serum hemoglobin hba1c fasting glucose level disease duration mean hba1c mean fasting blood glucose diabetic patient year respective age difference patient subject mean significant lower diabetic patient mean significant group study show type diabetic patient early period disease duration without diabetic disease change type DM result need large study
26932211 en correlation diabetic examine function type mellitus patient different renal function
20667531 en estimate risk mellitus primary health care incidence month study first estimate risk use test patient without mellitus treat primary health care on assess incidence month elevated risk mellitus score independent adjust included test associate increased risk low level chronic lower month follow-up patient score develop patient score patient without treat primary care health score associate low level disease score association high risk develop mellitus
21235496 en mellitus DM one major risk factor disease however mechanism DM increase risk recent finding whereas study suggest DM increase major early model show therefore mechanism recent study use indicate insulin impair insulin role function DM cause increased associate recent study DM revealed DM model increased DM factor insulin impair insulin possible DM insulin also mechanism increase age mechanism DM condition insulin develop potential also without DM
19846173 en factor target insulin whether gene associate type mellitus related population study subject type mellitus subject study study estimate estimate gene associate type mellitus however analysis show presence show increased type mellitus odd ratio confidence interval whereas presence show effect type mellitus odd ratio confidence interval analysis show associate reduce risk type mellitus although datum indicate gene independent association type mellitus analysis analysis show significant association type mellitus population
18296634 en common drug however chronic treatment effect reduce renal function change model system treat week subject mass analysis identify protein week treatment identify protein compare control respective protein cause treatment analysis datum indicate protein cell cell high several treatment include protein treatment increased association increased level type study provide analysis protein treatment provide potential target
24308217 en mellitus metabolic disorder primary elevated blood glucose level complication increase mortality aim study assess whether high risk patient type mellitus blood pressure lipid level well control risk factor change target case control retrospective study patient control present case respective patient significant difference case control treat drug therefore control hemoglobin case control patient change significant control significant difference two group lipid concentration use significant less patient complication without vs vs respective result study suggest duration disease control patient type mellitus important complication serum level treatment impact complication patient type serum lipid level
22414741 en assess risk body mass index BMI incidence study cohort study man woman aged year without baseline undergo health one hospital participant according status BMI participant follow incidence determined fasting level plasma glucose hba1c level medical treatment develop participant follow-up man ratio incidence compare normal weight follow current normal weight current respective man due current obesity BMI important risk factor population high prevalence
26782563 en aim current study investigate association gene gene mellitus type sample population on study conduct patient control without follow use significant association however regard patient significant high lower compare control result suggest association sample
26717490 en present whether associate type mellitus T2DM effect glucose poor studied although correlate cardiovascular disease role development diabetic T2DM aim study assess effect glucose development diabetic T2DM patient method on total T2DM patient use blood use determine concentration analyzed result correlate glucose logistic regression demonstrated high concentration correlate incidence diabetic or independent development diabetic T2DM patient or potential factor influence glucose T2DM however associate incidence diabetic independent risk factor development diabetic T2DM patient
26642210 en increased patient type mellitus T2DM method estimate T2DM patient assess risk study investigate association index estimate method use clinical study conduct woman man year age T2DM index compare patient without on perform known parameter obtain total woman man identify index significant high man woman multiple regression analysis demonstrated index significant positive correlate associate age significant difference parameter include index patient without logistic regression analysis adjust age BMI hba1c duration T2DM indicate significant relationship index presence index use parameter obtain subject risk lower T2DM patient significant associate patient T2DM may suggest patient T2DM compare subject potential cause T2DM patient
26648697 en determine effect different use insulin insulin cell investigate cell glucose studied cell cell treat reduce cell respective compare control effect significant range cell treat reduction rate insulin rate respective effect range insulin high concentration glucose significant high concentration glucose treatment group glucose rate concentration follow also found decrease glucose level cell level similar different effect cell insulin resistance
27887605 en aim insulin patient type mellitus insulin therapy
26001640 en study examine association medication among adult type mellitus primary care study medication independent health datum included independent association score use multiple participant response rate female mean age score respective total score correlate significant overall relationship age complication effect CI CI show correlation positive effect effect presence independent effect provide intervention improve improve
24567352 en investigate activity activity status plasma patient type blood plasma sample patient healthy control subject activity total determined plasma hba1c activity significant high significant lower patient compare healthy control subject significant positive correlation activity activity hba1c level plasma hba1c significant negative correlation activity activity activity may high level chronic low plasma patient type mellitus
26782418 en type mellitus disease cell patient develop disorder disease occur syndrome type type response examine disease study assess role conduct study patient healthy control assess patient conduct patient control patient control examine association show statistical significant difference patient control study population however indicate associate finding indicate although associate population role large
26438503 en remain major health due increasing incidence type mellitus T2DM clinical increase risk poor outcome aim study relationship parameter patient T2DM parameter assess day perform factor related metabolic syndrome characteristic T2DM patient group present group cell patient high factor low level compare healthy observed patient poor group due poor glycemic control also diabetic patient mean time significant association glycemic control increased serum concentration patient metabolic condition may factor consider therapy management T2DM present
25070350 en aim study assess patient type mellitus hypertension use study patient receive week therapy group on group according whether patient treat week treatment group significant reduction blood pressure respective vs baseline blood pressure level respective vs baseline great reduction mean value group on compare group month significant decrease treatment group respective reduction rate group on significant high group addition therapy provide high reduction blood pressure compare addition
24632640 en study effect blood parameter treatment patient mellitus type patient study patient month change function examine patient group control treatment patient group conduct day revealed activity positive effect index lipid characteristic patient mellitus type correlation relationship clinical parameter result study use treatment patient mellitus type
27021608 en may diabetic patient base potential decrease blood glucose body weight analysis aim investigate patient level analysis trial patient type mellitus according baseline body mass index BMI conduct included change hemoglobin hba1c fasting plasma glucose body total patient included BMI group hba1c decrease significant compare baseline week group similar observed body weight reduction glycemic parameter patient BMI reduction body weight great patient high BMI BMI level fasting insulin blood pressure decrease significant week group patient BMI level parameter high baseline level result great decrease patient high BMI incidence adverse event similar group body weight decrease significant group decrease glycemic parameter patient BMI body weight large patient high BMI patient high BMI metabolic include insulin hypertension similar profile week group effective patient range BMI level may patient high BMI
20960555 en obesity well known risk factor type mellitus individual type mellitus risk weight result multiple influence include medication factor chronic medical mellitus obesity patient profile increased cardiovascular disease management mellitus weight management parameter glycemic control healthy increased activity addition management weight management intervention show improve body weight glycemic control overall profile medication include metabolic weight effect medication develop mellitus patient weight improve overall health outcome
20671217 en risk glycemic control mellitus remain large patient population overall recent large study regard association hemoglobin diabetic chronic study previous analysis found correlation follow-up period year use model among study patient type analysis type datum baseline year model indicate associate effect serum level protein status associate glucose analysis type diabetic patient hemoglobin value indicate lower associate decrease population randomize control trial result suggest glycemic control diabetic patient reduce mortality risk glycemic target base potential risk diabetic patient
26666161 en new drug development mellitus drug oral medication trial diabetic on trial study obtain new diabetic development
22636820 en glycemic control renal disease patient type mellitus on review conduct vs glucose control outcome adult type database identify randomize trial compare renal clinical renal serum level renal disease renal disease patient type receive glucose control vs receive glucose evaluate trial adult year compare control glucose control reduce risk risk ratio CI serum level renal disease revealed large difference hemoglobin therapy study level associate great incidence serum level renal disease low respective compare renal glucose control reduce risk evidence glycemic control reduce risk significant clinical renal outcome serum level renal disease year follow-up trial
24322329 en on gene reported common potential weight investigate role metabolic change weight treatment population patient mellitus type obesity glycemic control associate treatment patient patient patient patient on patient glucose hba1c body mass index weight mass blood pressure decrease patient total cholesterol cholesterol decrease patient on model assessment insulin resistance decrease association on insulin resistance weight treatment patient mellitus type on show cholesterol level weight
24001238 en impair blood glucose level mellitus DM patient associate blood glucose level known increase risk diabetic present study evaluate potential reduce blood glucose level provide risk DM blood glucose level DM treat decrease treatment also reduce change cause effect DM protein observed DM also found control result treatment reduce blood glucose level function DM observed value blood glucose level DM
23354985 en mechanism may contribute development mellitus cohort study result participant cohort aged year adjust regression model estimate ratio confidence interval CI association serum relationship assess analysis risk perform year follow-up study participant develop woman risk significant increased low increased compare woman relationship show association risk increase level statistical significant man level associate incidence renal dysfunction effect risk risk compare subject renal dysfunction observed association influence risk large cohort study old adult serum level associate woman man association subject renal dysfunction
27682002 en gestational mellitus cardiovascular disease investigate whether increased cardiovascular risk woman without history year whether obesity studied two cohort woman history control year concentration determined model assessment insulin resistance index use estimate insulin resistance blood pressure measured primary outcome possible difference group investigate influence obesity result also use adjust multiple regression concentration two cohort significant high woman previous control respective analysis significant high compare one body mass index important multiple regression year woman control obesity important insulin resistance compare
25063401 en assess function evaluate woman normal gestational study studied function gestational use assess parameter datum clinical month obtain mean age year group woman normal mean hemoglobin value mean body mass index function assess increased significant group compare normal group independent glycemic control parameter early ratio significant different group significant increased presence gestational major group follow-up assess clinical study significant increase presence gestational mellitus woman gestational found evidence disease
21856715 en cardiovascular event event patient mellitus aim compare value event diabetic study patient mellitus define ratio measured baseline patient follow mean period month on total patient define due event mean duration year mean hba1c baseline patient present plasma value multiple regression analysis include age duration hba1c revealed ratio CI CI age CI different on model revealed model on analysis demonstrated event
22549347 en role diabetic complication aim study compare concentration different parameter type type T2DM number T2DM control examine concentration measured compare control cell serum concentration high compare control vs similar significant high diabetic group concentration elevated T2DM patient significant relationship found diabetic patient relationship observed type diabetic patient significant positive correlation found serum concentration dysfunction develop
26113954 en protein reported elevated plasma patient number disease include mellitus however plasma addition according provide plasma sample improve method revealed significant association level age hypertension plasma sample patient control subject suggest possible plasma dysfunction significant difference concentration diabetic individual
26078246 en study level activity patient mellitus association disease adult patient type mellitus hospital activity use assess respective diagnosis significant cause chronic patient analyzed mean age year old prevalence patient low significant difference high high cholesterol high patient without among patient patient low high high cholesterol high among high cholesterol high associate high high cholesterol high associate patient mellitus
25994135 en incidence type mellitus T2DM increasing several include increased however whether cause T2DM obesity remain therefore present study evaluate effect development T2DM subject impair glucose tolerance subject female aged included study mean period subject undergo oral glucose tolerance test related result evaluate period addition correlation development T2DM investigate subject develop T2DM T2DM group demonstrated significant high compare group develop disease group odd ratio incidence T2DM base confidence interval body mass index BMI model assessment insulin resistance value significant high T2DM group group index significant lower group insulin level significant different group correlate develop T2DM possible influence body weight insulin resistance cell effective insulin resistance
25826504 en previous study show common finding patient aim study estimate prevalence cell change diabetic patient correlation glycemic control patient type mellitus study patient medical history parameter fasting plasma glucose hemoglobin hba1c rate blood assess result compare subject without mellitus group similar age statistical significant difference parameter patient study group control subject regard assessment study group compare control compare control blood glucose value study group mean hba1c control group mean value hba1c study group range control group value analysis blood study group change type patient cell change type cell target cell observed high prevalence cell change diabetic patient compare subject finding suggest need test type mellitus
25597598 en control include mellitus DM metabolic disease level DM cause also cause dysfunction cause dysfunction therefore assess diabetic effect use cell evaluate reduction diabetic also analyzed method study adult control diabetic group datum analysis significant reduction show diabetic group cell significant observed diabetic control group result one dysfunction
24528224 en prevalence obesity mellitus type increasing recent new may significant role development metabolic disorder obesity insulin resistance important relationship metabolic health disease study consider associate glucose lipid
25674854 en mellitus known effect well studied investigate whether associate studied clinical characteristic patient hospital datum compare patient without potential risk factor associate use regression patient lower patient without first three day vs vs vs mellitus syndrome increased level significant associate lower first day regression confidence interval CI CI CI respective old age independent correlate patient without regression respective diabetic patient high rate syndrome patient also lower blood old high level old age independent correlate patient severe old age independent associate severe patient
21973210 en protein risk important plasma activity elevated type mellitus whereas glucose may gene common cardiovascular disease identify recent investigate whether diabetic relationship obesity gene activity use system gene score number base two determined two cohort patient type control prevalence increased high plasma activity gene score different diabetic control subject activity high patient low control subject normal multiple regression analysis revealed positive status activity status hba1c gene score impact plasma activity may also association plasma activity common gene finding plasma activity
22538137 en contribute poor glucose control associate increased cardiovascular risk type mellitus T2DM study determine effect blood glucose glucose control lipid body weight cardiovascular T2DM hemoglobin randomize study group little two day base glucose control group base glucose study oral drug insulin group remain less study included lipid body weight cardiovascular subject mean age year body weight hemoglobin weight similar group baseline month body weight decrease study group change control group cardiovascular event observed group study T2DM subject little day associate lipid weight well may finding result control T2DM
26146895 en report incidence factor influence cohort patient type subject diabetic study included study subject undergo include status assess use on value consider statistical incidence baseline baseline high prevalence observed subject risk factor associate baseline age or or increase or subject undergo time high risk risk factor increase age increased
23538348 en compare plasma glucose hemoglobin hba1c evaluate glycemic control patient patient mean hba1c level respective high respective compare patient without hba1c level significant lower value patient three parameter patient without renal dysfunction on significant negative correlation found serum patient whereas hba1c correlate positive negative hemoglobin respective although significant patient without hba1c level significant high patient without glycemic control level lead glycemic control significant high patient assess multiple regression analysis demonstrated hemoglobin addition independent factor associate hba1c patient body mass index independent factor associate
24666447 en increasing perform obesity report result assess whether perform hospital whether effective metabolic therapy type perform retrospective review patient undergo included patient mean age female study mean body mass index baseline patient type mean hba1c glucose respective mean duration major complication included patient mean hospital day two patient complication occur weight month month month type occur patient perform hospital effective intervention type mellitus
25944537 en level disease type mellitus patient whether clinical major difference influence prevalence chronic disease management include on total examine patient review patient age female patient clinical perform change hba1c level presence hypertension group similar prevalence severe significant high prevalence compare patient respective or duration age hypertension great prevalence hypertension patient whereas hba1c level similar two group diabetic associate disease dysfunction possible influence hypertension increase activity reduce dysfunction
23209187 en primary mechanism gene metabolic according early condition test effect gestational mellitus blood obtain treat without use compare level one gene one gene one gene two gene gene show significant decrease level one group compare control analyzed significant decrease blood also observed adult obesity compare control result effect may contribute obesity
26303454 en effective treatment type obesity recent clinical trial subject year trial also significant individual undergo management evidence base clinical aim review evidence clinical management patient
24449671 en review medical adult medical patient type type mellitus clinical perform use multiple also review general several provide little evidence type patient however increasing incidence prevalence patient type patient population treatment type study adult remain patient care adult great adult great
23387877 en investigate cell type diabetic patient potential difference clinical study include patient type patient sample base diabetic patient hba1c test perform mean range interval little month status control two blood test cell cell cell diabetic subject control subject regard cell show significant increase diabetic group lower cell associate high hba1c value hba1c however impact impact cell subject status however high hba1c associate lower cell significant increased diabetic group
22714978 en well mellitus disease recent evidence suggest diabetic mellitus patient investigate two perform study diabetic mellitus diabetic mellitus DM patient present result major compare patient high level also show increased age overall suggest high level may contribute severe patient
24526393 en clinical regard blood glucose target patient type recent study patient type suggest aim low target increase risk assess effect target patient type complication determine whether low value perform database included control trial define different target treatment studied patient type follow-up duration little one review independent datum assess study risk difference overall study evaluate assessment development system model use analysis result present risk ratio confidence interval CI identify trial include total patient patient population study one study include one study include patient one study new diagnose adult patient several study patient baseline mean follow-up duration study one year study trial due intervention study can risk outcome present study per study high risk little one glucose control risk develop complication reduce compare treatment CI participant trial high evidence CI participant trial evidence CI participant trial high evidence regard complication effect possible CI participant trial low evidence datum regard glucose control reduce risk study follow-up duration little two year CI participant trial evidence found evidence one year glucose control CI participant trial low outcome occur evidence can regard outcome low found glucose control increased risk severe however result complication clinical trial show increase severe treatment on analysis according baseline hba1c participant trial low evidence suggest risk possible increased patient relative low hba1c value several included study also show great weight glucose control risk increased study use insulin treatment group low mortality low study evidence one study investigate renal treatment diabetic reported trial statistical significant difference intervention group evidence addition datum indicate glucose therapy control high reduction potential complication blood control reduce risk develop complication evidence study patient early disease need risk include severe patient important effect blood control complication however research need evidence effect blood control old patient population patient disease evidence blood glucose target treatment need age disease risk well patient disease management
24502618 en on high glucose role associate examine plasma level on normal healthy patient type DM without disease subject patient DM patient patient normal healthy assess hba1c level disease positive test plasma on measured use on relationship plasma on level blood type blood lipid level medication disease also level high patient without compare normal subject age fasting blood level hba1c level positive associate increased plasma patient use reduce level plasma level total cholesterol cholesterol significant association plasma level patient increased serum level plasma on also elevated prevalence odd DM DM high high value compare lower value adjust age indicate association high value study patient type high level on normal population plasma level increased patient disease suggest role protein disease type evidence on role on diabetic disease
24783939 en insulin glucose body body insulin cell resistance insulin lead condition mellitus chronic two type type type insulin need type treatment type also need insulin disease need patient however insulin type large population patient develop incidence rate system high therefore current investigate system base insulin insulin develop different effect duration according need patient
26220868 en incidence type mellitus T2DM increasing diagnose patient early diagnosis can change treatment aim disease cardiovascular complication different score identify reported however population evaluate study evaluate score identify risk T2DM population develop model T2DM model T2DM risk model follow-up evaluate population cohort study baseline evaluate test fasting plasma glucose oral glucose tolerance hba1c sample include participant age positive value negative value ratio positive ratio negative characteristic logistic regression first individual perform analysis CI statistical study research hospital score model present medical model medical increase score
21351584 en aim study investigate effect type mellitus mechanism model type mellitus day type diabetic week one blood glucose level week whereas diabetic negative control group normal control model control treat normal mechanism result show diabetic tolerance type diabetic evidence analysis elevated insulin concentration serum type diabetic cell result may tolerance cell
20394942 en determine prevalence correlate elevated blood pressure type type mellitus use datum analysis included aged year type type mellitus research elevated define value drug use elevated define early diagnosis control define value early diagnosis prevalence elevated type mellitus group poor glycemic control type mellitus elevated similar type mellitus elevated compare type mellitus diagnose treat control similar type type mellitus finding identify group mellitus treatment
25688000 en type mellitus clinical research function intervention trial target system aim different therapy year base treatment mechanism cell result clinical trial base positive result study negative result obtain previous trial however therapy develop include drug one finding review datum clinical datum use drug show also
26110385 en identify risk major complication effective management however current care complication gestational mellitus risk base history clinical risk factor may identify high risk include function lipid risk treatment
25080870 en incidence type mellitus among increased incidence increase among risk investigate incidence rate compare result previous study incidence rate estimate group three incidence use method according health population incidence rate age group year analyzed use regression total case incidence CI significant difference incidence rate statistical significant increase found group increase lower statistical incidence increasing among high risk lower reported early high increase incidence
23918234 en evaluate syndrome type mellitus review base clinical treatment database control clinical trial database database database without included time relative clinical research patient obtain adverse reported effect fasting blood glucose blood glucose overall base diagnosis treatment result group base result show concentration group statistical group CI overall time CI diagnosis treatment type base effective can improve blood glucose overall status patient include
24029479 en change patient type mellitus effect insulin therapy use obtain normal control patient type baseline level insulin therapy follow-up level insulin therapy year use test perform mean mean decrease patient type mellitus compare normal control insulin therapy year mean follow-up significant increased compare baseline mean show significant difference baseline follow-up mean demonstrated increased investigate patient type mellitus compare normal control demonstrated insulin therapy mechanism
23323988 en identify factor insulin therapy patient type type conduct identify study factor associate insulin therapy adult type type study identify use use conduct factor associate identify factor type medication factor age female associate one study also improve therapy study change lower patient two insulin therapy general poor factor identify although finding suggest may improve reduce patient improve study identify factor associate development improve insulin therapy
24565211 en study aim assess prevalence patient type mellitus study perform sample diabetic patient aged year perform diagnose according patient age DM duration year diagnose subject patient first subject high patient suggest include consider DM patient
24013981 en evaluate effect duration patient type mellitus T2DM use insulin oral drug change randomize control clinical trial conduct adult T2DM little treatment insulin insulin fasting plasma glucose concentration hemoglobin insulin outcome study included analysis patient patient duration great reduction compare disease disease duration change concentration lower insulin correlate disease patient increased risk blood glucose significant relationship found severe duration however treatment insulin lower value effective treatment T2DM target level less disease duration insulin associate reduce event disease duration
23575771 en cohort study investigate association incidence type participant measured use history incidence determined medical period ratio confidence interval estimate adjust age body mass index history study participant develop incidence rate participant respective compare CI participant significant associate risk compare respective participant significant associate increased risk man effective type
25503287 en include activity treatment type mellitus T2DM however factor associate activity among patient poor study activity among woman T2DM study little use model model activity on sample woman T2DM datum analyzed use statistical model activity significant activity among woman T2DM significant effect activity finding show evidence can use activity among woman T2DM
25124708 en examine effect parameter diabetic adult group diabetic receive group included diabetic receive group receive group consider control day analysis according use parameter significant reduction diabetic datum show significant increase parameter compare diabetic control significant difference group regard vs test vs test vs diabetic group respective significant difference different effect mellitus parameter model
25106810 en new target hemoglobin hba1c type mellitus T2DM datum regard outcome associate different hba1c level study assess outcome association define hba1c age range patient T2DM care analysis medical datum period total patient month little assessment insulin use hba1c measured included total patient included mean age year mean day group low patient hba1c level high patient year old rate high hba1c level high increased hba1c level patient aged year decrease hba1c level patient year old low datum suggest glycemic level may associate clinical outcome different age group may different glycemic control among patient
27220059 en aim study investigate association activity mortality patient mellitus disease study included patient undergo intervention baseline patient primary outcome group group patient activity group patient activity group patient overall among patient respective adjust ratio confidence interval CI occur patient among patient respective adjust risk estimate per increase improve risk model mortality value show difference model without patient treat elevated independent associate risk mortality
23806609 en assess influence diabetic patient mellitus type age range subject without without control evaluate assess test analyzed use system time test also great condition compare without whereas difference observed group on difference time observed test subject control group group subject subject control group show high score perform time test less time compare subject without show control compare healthy individual age group
25920244 en mellitus complication health range activity development medication history receive study effect also management diabetic complication review mechanism also activity treatment diabetic complication demonstrated diabetic model clinical trial use subject multiple database major potential review suggest lead great drug develop
25090264 en type known associate increasing cardiovascular mortality increased patient elevated reported risk factor cardiovascular disease new study effect increasing examine type patient type control treatment randomize control trial patient receive month change metabolic parameter include month treatment improve fasting blood glucose hemoglobin hba1c significant great increasing difference total cholesterol cholesterol level two group level mean decrease significant increasing remain treatment multiple regression analysis identify increasing treatment independent factor associate decrease significant correlation change fasting blood glucose result suggest increasing improve serum level type mellitus
23867771 en evidence show increased risk develop disease mechanism remain review current study common disease potential mechanism disease insulin dysfunction cholesterol important
22930579 en type mellitus T2DM associate dysfunction lead complication cell cell role cell cell blood response study investigate effect T2DM blood compare effect level show recent important role dysfunction associate use analyzed blood sample diabetic patient history disease less year clinical evidence diabetic patient disease complication healthy found T2DM profile decrease number high great addition T2DM increased number number result suggest can due decrease level can assess
19909240 en factor function function addition associate dysfunction dysfunction found presence several cardiovascular risk factor include mellitus related function negative mellitus dysfunction diabetic individual reduce response demonstrated reduce response regard resistance base protein resistance mellitus
23168282 en high prevalence mellitus DM patient disease oral glucose tolerance test method well known however datum incidence DM population well present study determine incidence DM patient disease use model studied patient disease without known DM use patient DM according association year follow-up patient without DM use model use logistic regression method use method sample patient mean follow-up year overall incidence DM confidence interval CI incidence significant different patient CI patient CI on risk model included glucose level hemoglobin level presence disease show DM CI incidence new DM high population use diagnosis use risk model
24512822 en determine different disease without use study investigate use previous determined level type study cohort aged year type participant undergo assessment serum ratio ratio index score base difference cohort cohort poor positive serum poor found poor correlation studied use result disease poor presence disease determine value clinical range different low high risk population group
22425324 en period high disease evaluate level general population hypertension general population aged old two group cause complication treatment hypertension hypertension mellitus subject respective two condition general low general population although patient high level use also associate study show hypertension mellitus low include disease similar contribute
25156968 en type mellitus DM associate may disease randomize trial woman type DM investigate effect gene glycemic control glucose insulin hemoglobin hba1c model assessment insulin resistance significant effect observed glycemic concentration change week gene analysis change week serum glucose concentration change analysis statistical observed change serum glucose concentration change hba1c level high participant compare significant relationship serum glucose relationship hba1c association type DM
24536037 en studied potential number change type mellitus perform clinical assessment DM year healthy DM subject disease duration year subject DM healthy control similar clinical subject difference cohort estimate decrease significant DM vs clinical difference normal control subject significant difference DM suggest early disease
25410221 en condition patient risk compare risk factor poor outcome may poor outcome cause glucose show associate improve similar risk among diabetic patient improve therapy treatment remain among diabetic patient however may multiple new recent outcome complication
24447406 en association metabolic syndrome mellitus DM evaluate aim present study assess impact DM metabolic status cardiovascular datum patient three group follow DM patient patient DM without patient follow-up patient use health database relative rate analyzed use method compare observed rate three patient group rate base population study independent DM clinical outcome analysis use base analysis revealed clinical outcome month year population age BMI time disease finding period patient DM population relative population overall patient population relative DM associate significant increased mortality relative mortality high patient receive insulin treatment without rate DM patient cause cardiovascular follow-up study patient group without little year population DM patient year
23664193 en type disorder chronic disease high develop negative impact recent year condition show associate diabetic increased risk disorder well impair glucose diabetic patient associate great disease management metabolic control increased risk develop chronic complication decrease high result diabetic association increased assessment diabetic patient however clinical result reported
28143987 en develop system value estimate study hospital T2DM patient without history event analysis logistic regression analysis follow develop subject increased subject increased high increase score duration DM hypertension follow respective score increased score follow increase value system use estimate increased type DM patient without history event
27086683 en prevalence mellitus DM increasing aim present study estimate prevalence DM large result population on sample adult female man aged year health status blood sample obtain participant analysis participant fasting glucose level undergo oral glucose tolerance test on also conduct sample adult population DM datum DM base patient history fasting blood glucose level observed however population DM increasing DM prevalence age adjust prevalence impair fasting glucose impair glucose tolerance prevalence DM significant high man woman increased age subject multiple logistic regression analysis significant DM age model assessment insulin resistance status whereas DM age datum prevalence DM estimate man woman indicate major health
26648342 en mellitus consider risk factor reported study investigate dysfunction test use assessment function blood serum glucose serum also estimate show function blood increase significant blood function parameter may may consider management dysfunction
21420513 en determine effect management mellitus patient retrospective review patient mellitus DM undergo year period clinical datum on determine patient undergo found clinical significant DM patient age year female high DM patient body weight decrease significant mean also significant reduction BMI clinical significant DM patient significant reduction medication complication mortality patient reported diabetic patient result improve control overall due outcome high prevalence obesity mellitus
22548954 en review type mellitus current trial development type review multiple develop type possible risk type also age follow model therapy effective model insulin therapy studied insulin cell current target major history new method diagnosis effective therapy
26527413 en oral glucose improve glycemic control body weight blood pressure general well patient type mellitus T2DM study previous analysis evaluate outcome associate use period retrospective cohort study use datum obtain large health database patient year diagnosis T2DM little one first month health month baseline month first follow-up change glycemic control evaluate characteristic patient change treatment patient mean age year female study time first use three two one without follow-up patient receive mean total day range patient among patient hemoglobin baseline follow-up baseline mean reduction mean reduction follow-up period great patient high baseline level patient use observed one follow-up common baseline insulin study use range patient T2DM demonstrated significant mean baseline first patient use one baseline lower use
26665316 en mellitus DM metabolic may due prevalence DM define risk retrospective patient current medical datum also treat hospital presence DM determined diagnosis hospital database presence one fasting glucose blood glucose population datum risk factor DM analyzed subject prevalence DM compare relative increased prevalence DM age independent age year body mass index BMI DM or CI although value two develop DM low BMI value compare BMI value population suggest DM subject
26447406 en complication outcome mellitus DM well incidence DM increasing population DM health relative healthy patient population improve outcome patient DM review study examine mechanism influence outcome include complication related
27449721 en profile datum clinical trial cardiovascular outcome review associate datum related drug regard three profile well define adverse event profile large mechanism event include adverse event recent therapy on cardiovascular outcome patient type mellitus T2DM recent demonstrated low risk associate therapy oral medication addition treatment T2DM may increasing role datum revealed
21551959 en report present case female patient type mellitus high diabetic occur hospital plasma glucose level hba1c plasma blood analysis show associate diagnose type mellitus show day positive test however revealed revealed cell suggest change important cause indicate association case mechanism type mellitus occur presence current case type
26813366 en effect patient primary hypertension type mellitus investigate effect hypertension duration duration drug clinical datum patient primary hypertension type mellitus retrospective analyzed follow-up period month follow-up time month patient two group according group control group clinical datum finding evaluate baseline follow-up analysis use assess effect hypertension duration duration drug medication baseline significant difference mass index two group follow-up period lower group multiple regression indicate significant influence follow-up period lower two lower group patient one year control group patient hypertension duration year lower group follow-up period compare control may patient primary hypertension type mellitus patient hypertension duration duration use may show effect
23285232 en investigate change blood glucose concentration diabetic patient type type glucose concentration mean interval period patient mean age year baseline hba1c T2DM patient mean age year hba1c control subject mean age year hba1c result compare change blood glucose glucose concentration different time found significant within group however found significant day diabetic patient control subject change statistical observed parameter similar significant difference baseline parameter diabetic suggest normal blood glucose level diabetic associate change therefore possible factor reported diabetic patient
21958742 en clinical patient type mellitus disease present aim study patient present important clinical associate presence patient type mellitus disease obtain use baseline datum trial on analysis presence previous logistic regression use patient present on history previous type regard age current insulin use index score use logistic regression analysis history use odd ratio confidence interval previous intervention odd ratio confidence interval high odd association large patient type mellitus disease study outcome associate need
27042282 en on man general hospital history high type mellitus body show datum follow cell hemoglobin found show relative high elevated diagnose hospital day patient undergo hospital day treatment well day diagnose association important
26830856 en identify role number disease risk effect disease type mellitus T2DM population use high analysis total individual population subject use effect T2DM analyzed use several protein identify disease mechanism show total population T2DM disease associate influence identify study case cohort revealed significant disease risk significant role T2DM normal cohort contribute effect consider one major disease
23540385 en profile patient type mellitus insulin therapy result intervention patient management evaluate result insulin therapy insulin metabolic control different group patient
26825733 en use normal insulin however association status gestational risk aim evaluate association status risk gestational perform database obtain study study gestational risk status odd ratio or confidence interval use association status risk gestational total study included analysis individual overall found associate great risk gestational CI analysis indicate association base study assessment level sample age baseline adjust model study revealed associate increased risk gestational
25291953 en reduce level without cell two patient severe mellitus age increased blood glucose level cause need insulin control control lead use treatment assessment clinical change adverse effect evaluate patient include total level serum level function test concentration control patient week treatment adverse reported also blood level high decrease treatment first time association use increase blood level glucose diabetic base datum reported case indicate different effect may occur
25782325 en type mellitus one clinical outcome metabolic syndrome observed patient year study develop study aim evaluate effect parameter rate development result correlation analysis show rate development first patient age obesity lipid hypertension disease
24366423 en important management mellitus dysfunction diabetic study examine effect function patient type mellitus participant week baseline assess function chronic week improve function measured chronic decrease pressure decrease improve function chronic treatment reduce may patient mellitus
24129410 en on low result improve function effect aim assess effect weight function type mellitus T2DM patient T2DM patient mean age year BMI treat week function measured baseline month follow-up BMI decrease increased month vs baseline index increased remain increased follow-up vs baseline pressure function month early on ratio baseline month vs baseline decrease baseline level month weight reduction T2DM patient result improve function month follow-up weight
23712292 en treatment large baseline patient study investigate association mellitus DM outcome however result remain total new diagnose patient receive DM define according medical history use medication hemoglobin test overall estimate compare use method test patient patient receive DM identify patient diabetic patient old compare patient group group DM patient vs vs however outcome similar DM patient treatment vs vs response rate DM patient also improve level similar patient use DM patient change potential DM patient
26718815 en type mellitus increased risk disease recent indicate include negative two datum included identify patient per patient patient known positive diagnose within year number patient current indicate population
25175911 en impair reduce level type related poor metabolic control aim study identify factor may negative system patient age disease studied insulin therapy multiple therapy insulin level high female vs vs ratio vs vs ratio vs difference therapy found positive related level female negative related hba1c ratio positive level insulin result indicate insulin therapy negative severe primary related poor glycemic control cell mass
25145409 en aim study factor associate regression patient type mellitus retrospective analyzed datum patient type mellitus year year define use ratio regression define decrease baseline define follow-up period among patient type mellitus patient define regression respective patient female high cholesterol lower hba1c factor associate logistic regression analysis lower blood pressure also correlate significant level result suggest control blood glucose lipid profile may associate regression type mellitus clinical
24576381 en study conduct examine effect health function patient type man type mellitus mean duration disease year patient control group patient patient group three time week week included activity patient rate rate significant effect health significant effect related disorder function consider health patient type mellitus also improve health
24128607 en study determine risk patient without type mellitus DM body mass index diagnosis disease included mellitus define fasting blood glucose great blood glucose great patient according BMI normal weight BMI less BMI great BMI great total patient included normal weight patient DM normal weight group respective weight diabetic patient less presence DM patient diabetic patient high mortality patient number weight normal diabetic patient diabetic patient may increased
23924907 en due high prevalence type mellitus T2DM increasing metabolic patient relative severe T2DM disease high level hemoglobin hba1c consider T2DM aim study correlation high level hba1c outcome conduct retrospective study base medical metabolic patient study group hba1c high on control study include T2DM patient similar characteristic hba1c included patient undergo group patient included patient mean hba1c studied control group respective difference hospital mean weight fasting glucose level hba1c level similar month study found correlation high hba1c level increased weight among patient undergo
24034516 en aim therapy type blood glucose control reduce target level hba1c reduce glucose first reduce consider aim index activity subject drug fasting blood glucose show number include high risk effect fasting glucose low risk insulin new drug show reduction glucose effect weight increase profile positive cardiovascular effect weight may effect weight reduction reduction
26495784 en aim study perform analysis patient without mellitus retrospective DM analysis randomize trial patient due chronic total period baseline patient randomize day outcome included change baseline change great patient DM vs vs without DM vs vs mellitus significant associate outcome incidence adverse event include similar improve protein patient due chronic without DM profile previous reported
27609360 en high clinical response observed type patient need therapy aim study evaluate role group patient treat significant analyzed group patient study healthy conduct investigate effect identify group patient significant associate effect group T2DM patient whereas significant associate reduce response group study group individual risk significant reduce first time identify association response result study healthy
27103368 en evaluate hemoglobin hba1c gestational mellitus association adverse outcome cohort oral glucose tolerance test hba1c test gestational week retrospective study clinical obtain statistical analysis perform assess value hba1c association hba1c adverse woman study diagnose on hba1c value show low hba1c value present low diagnose hba1c test can need woman study however diagnose hba1c level significant associate risk hba1c test woman remain determined however hba1c patient increased risk several adverse outcome
26466438 en aim study relationship patient mellitus patient patient mellitus total patient without mellitus total parameter parameter evaluate total period month result show significant parameter assess may period adverse result patient mellitus
24831459 en effective obesity complication type aim study investigate gene cell type mellitus type mellitus T2DM determine obtain patient T2DM patient total use sample show decrease test patient T2DM subject show different decrease T2DM high glucose result suggest can impair lower cell patient T2DM however can system improve glucose level patient
20668156 en intervention control complication conduct review intervention association may evidence intervention health lower per year year per per per intervention reported develop intervention measured study on large intervention found evidence intervention therapy hypertension control compare hypertension control therapy renal disease compare treatment early therapy compare treatment care compare care intervention diabetic risk factor control early complication compare insulin therapy type intervention diabetic risk factor control early complication compare glycemic control type intervention type among impair glucose tolerance compare type year old glycemic control study new diagnose type compare glycemic control therapy cardiovascular disease compare therapy treatment compare treatment diabetic treatment type compare diabetic treatment type compare treat diabetic compare intervention evidence consider intervention high
24741073 en previous show insulin important role insulin resistance study test chronic insulin cause type mellitus T2DM normal treat day week follow body weight blood level glucose insulin lipid insulin level cholesterol cholesterol association also examine result show chronic cause insulin resistance relative insulin T2DM treatment lead increased cholesterol primary insulin cholesterol result show chronic insulin T2DM normal
19236544 en investigate relationship patient diagnose treat hospital retrospective analyzed period patient age control incidence mellitus two group group control group age patient well incidence mellitus group control group group correlation age incidence mellitus group within two year diagnosis control patient year group year compare control mellitus result risk factor incidence mellitus high patient mellitus adult factor can lead early diagnosis
23900470 en mellitus DM type type DM T2DM previous study test DM insulin test patient T2DM insulin resistance patient cell test patient T2DM patient patient diagnose clinical use clinical parameter model assessment insulin resistance use fasting insulin fasting blood glucose one cell patient clinical diagnose T2DM insulin resistance diagnose patient possible identify clinical can T2DM patient patient insulin resistance significant high body mass index cell T2DM patient insulin resistance may present relative patient clinical T2DM patient found
25317602 en insulin effective method therapy patient type however study examine glycemic control evaluate cohort adult patient type retrospective study patient type on datum month year included hemoglobin hba1c level factor potential associate glycemic age duration year year respective mean duration time analysis year mean hba1c decrease month increased time range remain lower hba1c duration history high hba1c hba1c hba1c datum patient lower hba1c value period compare value poor hba1c history less hba1c target
23513989 en mellitus disorder common pressure may lead mellitus therefore aim study investigate pressure mellitus subject association duration three subject age range year three group control subject diabetic subject without diabetic subject status assess pressure ratio measured use result analyzed use one analysis significant difference group found significant difference value group significant difference value found group compare group pressure high duration among type subject study pressure group group increased value diabetic subject may study need investigate pressure subject
26879305 en medical therapy important role management gestational mellitus according significant impact woman primary weight however among remain overall similar intervention evidence although index general case randomize control trial investigate can health
22041126 en aim study compare effect function patient metabolic syndrome type randomize high rate low rate control week subject perform test study function high assess independent total patient metabolic syndrome type mellitus studied mean age year difference significant high high group control improve response improve independent patient metabolic syndrome type mellitus
27499284 en year database analysis increasing among health database medical drug datum well database aim retrospective study investigate database health mortality period year datum treatment examine report method database analysis result new datum recent care
24662713 en aim study determine correlation level incidence study woman year incidence logistic regression analysis use association value type mellitus well insulin resistance body mass index BMI total cholesterol level development serum level measured use patient mean age year range diagnose period study show patient low level odd ratio value use characteristic increase BMI level woman respective time without study show patient high BMI elevated level insulin resistance increased risk develop type
24749356 en investigate mellitus DM impair glucose study conduct adult risk factor previous diagnose individual included receive hba1c characteristic determine base diagnosis subject DM group group normal glucose tolerance group level three group increase correlation analysis demonstrated positive correlate hba1c fasting plasma glucose plasma glucose mean level serum DM respective test show new diagnose DM study
24895042 en fasting plasma glucose test diagnosis mellitus DM plasma glucose little study included adult participant year old BMI measured subject DM compare outcome among subject subject diagnose DM among subject vs year old mean less vs compare among subject female vs less vs lower blood pressure vs less history DM vs compare diagnosis DM compare lower new case DM use result DM female less subject compare use
22343274 en on retrospective impact mellitus complication associate mellitus DM one major risk factor complication however result type DM suggest DM cause complication adult population adult patient old patient control group patient follow-up group age body mass index number history current level estimate blood research score index number complication compare within group patient without complication compare glucose significant difference number major complication group significant difference glucose control group group reported significant improve score follow-up group reported health however significant difference group group score significant risk factor complication adult patient
24187402 en woman mellitus high risk adverse outcome gestational weight also risk factor complication whether risk woman whether study examine whether mellitus associate high adverse study conduct woman outcome examine included gestational hypertension outcome included large gestational age gestational woman woman result high odd adjust odd ratio confidence interval CI mellitus CI CI also associate increased odd gestational hypertension CI woman treatment insulin increased odd CI CI show risk weight gestational hypertension
24857051 en role type mellitus DM patient however evidence effective DM patient study evaluate effect DM patient DM one year may body mass index patient DM undergo patient follow one year baseline characteristic diabetic status clinical datum one year DM define hemoglobin without oral drug outcome DM group compare group clinical parameter significant improve DM patient blood glucose model assessment low significant patient DM however multiple logistic regression show odd ratio or CI DM mortality complication rate related result significant clinical patient indicate function DM patient function evidence follow-up may
24338167 en aim study study prevalence patient type mellitus provide clinical patient study primary patient diagnose may one case group female patient type two control group first control group patient control group patient without disease cardiovascular disease statistical analyzed primary patient age range year age case age previous diagnose difference case group first control group age ratio hypertension vs vs difference case group control group age vs vs vs statistical type factor found patient group follow case group patient vs positive vs vs first control group result vs positive vs positive vs found control group patient positive vs history vs high incidence patient common patient diagnose patient oral glucose tolerance test diabetic patient
23927943 en individual type significant healthy individual age increased result system role cell study cell response type patient demonstrated lower total show significant association elevated fasting blood glucose indicate low level lower cell significant difference observed cell without however datum obesity indicate significant increase cell individual compare individual response associate fasting blood glucose hemoglobin study demonstrated type response low response
23640936 en control insulin cause revealed related mellitus treatment present study gene diagnose identify patient whereas found indicate patient treatment month follow-up show development normal result improve
23594830 en mellitus common metabolic complication reported related mellitus insulin however role development known investigate association total subject without previous diagnose receive included one two develop subject subject old significant difference two group use three gene significant associate development model adjust age gene may development mechanism need
23433228 en major health impact recent datum regard prevalence prevalence mellitus analyzed sample adult population aged year old chronic health condition health health overall among define according type number condition condition hypertension one several analyzed prevalence significant difference man woman significant high prevalence number well without among respective included age odd ratio confidence interval per year number correlate disease disease severe high adult population year old include condition need consider study disease care need
23628425 en report clinical outcome patient mellitus DM develop retrospective case total patient included patient type DM one type DM mean age DM year year patient patient mean follow year range mean number range cause related occur diabetic include clinical significant diabetic occur patient mean duration year patient mean hba1c range range control patient DM develop may high complication rate reduce poor control blood glucose important
25817182 en review investigate oral health status type conduct use included study database on total analyzed first base included obtain independent included analysis evidence type healthy health study reported significant great high index type cohort study reported significant difference parameter evidence regard type poor health status great compare healthy study assess oral health status type
22499518 en investigate plasma level cardiovascular risk factor patient hypertension hypertension mellitus
20551301 en evaluate treatment type use type mellitus identify review addition present recent association association clinical association study identify datum evaluate study evaluate type mellitus included datum obtain randomize control clinical trial review evaluate clinical trial evaluate evaluate evaluate therapy on evaluate therapy therapy type mellitus trial evaluate insulin on review clinical trial provide evidence effective reduce cholesterol use therapy reduce also effective reduce hemoglobin patient type mellitus improve adverse effect similar type mellitus effective treatment type mellitus role consider patient type mellitus
24461622 en patient type mellitus reduce reduction improve metabolic cardiovascular risk factor reduction body weight reduction significant
24127999 en type mellitus T2DM insulin therapy patient recent evidence suggest glycemic control early insulin therapy reduce risk complication patient T2DM present review clinical evidence use insulin T2DM therapy insulin patient aim provide clinical evidence treatment treatment obtain blood glucose control
25352870 en drug related factor outcome therapy assess type mellitus T2DM patient patient rate randomize control intervention study T2DM patient conduct two assessment base change hemoglobin hba1c low blood change medical medication studied use control group receive care group provide use treatment provide patient baseline datum month study participant reduce time rate rate intervention show little influence health outcome T2DM
25112415 en examine association serum level type mellitus DM man aged analysis baseline health man large study conduct may man aged old level presence DM age blood body mass index use use health activity estimate rate prevalence DM significant association low level DM remain range clinical renal function level associate DM independent association serum concentration DM whether two may influence DM different mechanism
23407544 en patient type mellitus renal disease patient type mellitus T2DM T2DM first perform period retrospective analyzed regard characteristic cardiovascular risk factor complication patient compare T2DM patient receive year group T2DM group T2DM group respective year group T2DM group respective year T2DM T2DM analysis adjust age complication body mass index time time function risk factor show difference remain statistical result type diabetic low risk profile on high rate impact result
23643719 en aim study prevalence incidence type mellitus T2DM aged year body mass index BMI possible study include man woman year old prevalence incidence T2DM T2DM individual drug prevalence ratio relative risk T2DM according level adjust BMI possible prevalence T2DM man woman compare high man woman lower CI T2DM respective incidence woman man adjust potential reduce prevalence incidence T2DM among woman respective prevalence among man observed significant prevalence incidence woman T2DM function BMI
21945304 en within body metabolic known aim study determine whether significant increase blood value patient mellitus whether correlate increased glucose blood level study group patient mellitus significant high mean value control group mean value blood sample analyzed method level obtain method high mean value patient group correlation glucose blood level blood glucose value mean value patient mellitus measured method measured use method patient mellitus statistical significant high control group increase great measured result well datum reported suggest level blood method value method level parameter use
25976585 en mellitus DM major health body on major DM relative large patient remain development complication may cause therefore early DM disease may diagnose well time common important
26398489 en significant impact little known glucose among assess prevalence mellitus DM individual risk patient large hospital metabolic patient glucose patient known DM new diagnose insulin index risk factor age independent insulin relative risk year body mass index independent insulin prevalence DM high one patient previous oral glucose tolerance test patient risk metabolic provide early individual risk intervention improve patient outcome
23545465 en little develop type lower body weight due factor increased risk important treatment population factor individual include patient factor consider determine treatment individual great therefore may patient difference treatment change provide
27744128 en within health clinical population management research large database compare estimate base datum datum clinical cohort study included patient type identify compare estimate within clinical datum datum compare estimate period prevalence incidence rate event rate overall patient little one event identify period prevalence respective event increased event within event clinical overall relative datum increased event datum clinical within need consider assess
26602074 en associate increased mortality risk patient patient severe high risk impact mellitus DM patient aim study evaluate clinical characteristic impact DM status research outcome patient outcome according hemoglobin hba1c level patient undergo according DM status on total patient without DM DM significant difference mortality patient compare patient without vs DM associate adverse outcome oral treat DM hba1c patient cohort group according hba1c level patient hba1c increased risk mortality follow-up ratio confidence interval compare patient hba1c DM associate increased mortality risk associate increased complication rate on poor control disease elevated hba1c level may associate increased mortality follow-up
21406012 en study compare blood glucose plasma glucose subject year old without previous known undergo oral glucose tolerance test perform fasting glucose impair fasting glucose impair glucose tolerance define use association health mean fasting value respective value respective correlation fasting indicate correlation two method base fasting vs whereas base vs identify study develop obtain sample may
26333612 en study identify risk factor group elevated blood pressure elevated blood glucose presence development type mellitus T2DM without history health early risk factor development T2DM effective intervention
25987541 en examine relationship type mellitus DM patient undergo measured primary without condition analyzed glucose assess measured mechanism cell treat glucose great DM respective great condition reduce treatment DM patient show increased according high glucose high glucose may increased
21031540 en examine incidence mellitus identify risk factor use database total year old receive first little follow-up report diabetic status among identify mellitus risk factor examine use regression regression analysis mellitus new reported follow-up time day incidence year respective develop without independent risk factor included increased age compare year ratio year year primary diagnosis primary occur follow-up year risk factor similar reported disease primary independent risk factor
24876619 en response plasma glucose oral lipid insulin system evaluate model type patient trial patient hba1c therapy patient receive oral follow day respective outcome oral statistical significant lower mean compare on response observed effective range studied three adverse event treatment observed oral significant lower response result response plasma insulin concentration previous study oral well
24122686 en mellitus important risk factor development lower disease lead due associate increased risk lower also increased risk mortality major cardiovascular event prevalence disease aim study determine prevalence lead risk factor associate development adult type study patient study may hospital lead assess patient use index use determine patient disease diabetic patient study female study show prevalence lead diagnose use ratio disease age duration hypertension important risk factor significant associate among type patient age duration hypertension important risk factor identify
26827491 en insulin system role cell control metabolic insulin system system insulin system lead insulin resistance one primary cause type mellitus DM metabolic syndrome disease early function system provide effective treat type DM disease associate review datum result insulin system cause insulin resistance insulin type DM analyzed
26591683 en characteristic blood glucose type mellitus patient three different patient type mellitus hospital subject three group according syndrome glucose glucose system day investigate glycemic profile group plasma level measured test patient group glucose datum glycemic analyzed investigate difference among group change level result trial use evaluate cell blood glucose level high subject syndrome parameter glycemic low syndrome change level show subject syndrome cell function among three group syndrome blood glucose profile glycemic high syndrome syndrome
26429317 en type mellitus type DM disease although association study identify type mechanism current large perform analysis gene relationship among gene analysis analysis result function mechanism association type total type analysis show effect gene analysis identify factor type related cell evidence association type finding indicate analysis important type DM
26147213 en glucose new develop treatment type mellitus T2DM mechanism independent function insulin resistance potential use include insulin patient T2DM also role early intervention T2DM role perform identify trial reported clinical significant control body weight blood pressure well general profile adverse event reported event low similar major risk increased reported can significant impact early management T2DM risk factor associate disease change number cardiovascular risk factor blood pressure body weight addition improve control although clinical cardiovascular outcome current
25676157 en metabolic therapy obesity BMI type mellitus T2DM patient score age BMI level duration T2DM year reported T2DM treatment use metabolic study examine treatment BMI T2DM patient evaluate role score
26381272 en disease high prevalence patient type mellitus T2DM study provide assessment regard effect patient control trial randomize control trial different T2DM trial also population evaluate primary outcome estimate use effect one participant study included evidence study great reduction improve week effect week intervention month improve show week month reported improve therapy year also provide score T2DM provide identify assess clinical outcome associate T2DM
26265102 en aim examine association risk risk type mellitus T2DM influence T2DM risk use conduct study present odd ratio or T2DM group base total number risk use little two regression model use determine relationship difference group study or or study included case among participant adjust or define adjust risk little two among age body mass index or T2DM less increased analysis study present adjust or regression or T2DM value however T2DM risk consider independent risk profile role related T2DM risk factor identify individual high risk T2DM
26630689 en assess type mellitus care difference base method insulin multiple insulin effect glycemic study patient age year use participant age difference response found insulin well respective on response show group primary insulin compare group participant age poor significant effect hba1c found group reported care related care age insulin base reported hba1c significant however effect determined study
26015305 en severe case aim present study compare outcome patient without mellitus DM on total patient without DM undergo follow-up period month overall incidence complication however overall incidence complication without DM significant different odd ratio or confidence interval CI patient DM significant great rate or CI however difference rate or CI complication or CI patient DM without DM on use patient patient complication compare patient or CI incidence patient patient DM without DM high incidence complication patient patient DM therefore use
21185481 en woman history gestational mellitus high risk type mellitus T2DM metabolic syndrome cardiovascular disease woman little glucose risk T2DM may occur several year year factor associate T2DM identify obesity early week high blood glucose T2DM fasting glucose provide less hba1c may rate high risk woman need glycemic among woman history show risk however study show low without woman woman also include cardiovascular risk factor
21080740 en type mellitus patient independent related development complication target glucose control review provide randomize control trial compare effect glucose control complication type database perform randomize control trial related glucose control addition related review randomize control trial three type type type review study included patient trial glucose control effect complication type type patient risk reduction develop complication patient type decrease glucose control effect cardiovascular mortality observed effect glucose control cardiovascular disease patient type one trial study glucose control associate little risk group compare glucose control glucose control associate complication type type decrease event type
27052232 en gestational define glucose associate increased well complication woman early receive diagnosis glucose fasting hba1c week diagnose oral glucose tolerance test fasting glucose concentration type first evidence level woman increased risk use high risk history impair fasting glucose impair glucose tolerance weight previous obesity metabolic syndrome age year disease clinical glucose may indicate first woman gestational week woman previous glucose evidence level base result adverse outcome study define fasting plasma glucose glucose case one value metabolic control recent also woman receive blood glucose increase activity blood glucose level normal range fasting insulin therapy first mortality woman glucose tolerance week year case normal glucose tolerance evidence level woman increased relative risk type follow-up weight management activity development healthy
24156999 en mellitus common metabolic complication incidence range population type diagnosis associate poor outcome increased cardiovascular disease renal therefore assess incidence examine association function investigate renal patient group time group group group patient mellitus mellitus define fasting plasma glucose treatment medication patient group receive patient group receive analyzed clinical characteristic serum level overall incidence group group high incidence receive receive vs vs also time diagnosis range significant difference cardiovascular complication rate patient group group use significant increased incidence compare however significant difference serum level year renal group group group significant different group group function outcome impair patient patient however plasma glucose level early diagnosis treatment risk complication outcome improve
21147013 en datum suggest may risk factor also reported patient on can report two patient occur revealed review mechanism may two patient treat insulin patient treat insulin day respective patient patient case characteristic treatment associate condition datum show reduce gene activity insulin patient risk case patient potential disease can associate
26516607 en cause diabetic complication contribute system associate early disease poor investigate present study use diabetic model evaluate female two group diabetic consider blood glucose week obtain use analysis test system result revealed significant diabetic control group control correlate significant reduction significant change result revealed system change early disease may contribute change new early complication disease
23673238 en associate intervention early diabetic complication cardiovascular review potential clinical serum mean two three week use patient clinical measured hemoglobin level may serum plasma sample use analyzed sample common medical also use determine effective treatment change medication diabetic patient potential protein development diabetic serum
21248617 en prevalence mellitus increase age cause significant poor old adult review current diagnosis management identify use old adult clinical on total review old adult disease old patient several new clinical use clinical trial age group old adult important complication care old adult without subject intervention
26486595 en important risk factor therapy common perform however evidence indicate mellitus DM risk factor incidence characteristic diagnose DM patient remain follow clinical patient undergo therapy perform compare incidence clinical characteristic DM total patient undergo DM patient year follow-up period diagnose DM patient patient incidence significant different DM patient year respective significant difference treatment patient without incidence characteristic occur DM patient
23704715 en estimate prevalence among type mellitus T2DM patient examine association patient man woman T2DM diagnose use index less event per normal event per prevalence among T2DM patient group old high BMI great weight change age year high rate increased prevalence hypertension model odd ratio or CI model or CI model or CI model or CI model or CI model or CI factor three statistical model associate high among T2DM patient may independent associate risk factor woman T2DM
24402020 en cohort patient type mellitus presence disorder can diagnosis syndrome included patient clinical parameter analyzed current age disease duration previous history disorder history mellitus patient analyzed disease well possible associate cohort current age year disease duration year analyzed previous history found history mellitus cohort disease diagnose patient risk high female disease duration correlate positive cell correlation well disease prevalence need patient early diagnosis disorder adjust patient treatment follow-up
26713061 en study investigate glucose rate patient gestational mellitus determine factor population retrospective study patient datum obtain medical glucose conduct use oral glucose tolerance fasting glucose hemoglobin test test result normal diabetic glucose rate patient patient respective according analysis patient high large weight due treatment less receive glucose however patient study patient glucose high prevalence patient factor
27310986 en whether individual type may examine glycemic control health status define retrospective cohort study patient datum evaluate treat hba1c level adult new diagnose hba1c measured little year individual healthy health status chronic condition adjust clinical group chronic disease patient control hba1c similar healthy patient patient although lower patient difference on patient insulin increased risk adverse effect control hba1c hba1c hba1c among patient hba1c use insulin associate increased risk confidence interval CI CI month control similar status high risk adverse effect patient receive insulin treat hba1c level patient high risk
26459254 en effect different studied however association type patient conduct use database statistical analysis use model according examine study patient included current overall CI analysis show CI CI study CI CI cohort medical study CI CI CI use may associate patient type effect however can patient patient study
24939043 en evaluate effect plasma glucose fasting plasma glucose hba1c patient type therapy randomize receive week parameter assess baseline week group compare reduction group week vs week vs also reduce hba1c reduction body weight blood pressure observed week decrease plasma compare increase week vs large week vs on increase observed week week status blood serum remain increased week provide effect week reduction plasma large week
24745775 en research show risk present patient type mellitus aim present investigate whether relationship determine whether increased risk perform index identify period use or or mellitus study included review study follow-up time method statistical analysis number patient included study patient type mellitus research review indicate patient increased risk although regard level increased study use different different outcome assess patient different time finding risk assessment patient clinical assessment assessment patient risk current previous
21674179 en cause medical whether investigate prevalence cause studied adult examine cell evaluate effect drug metabolic use show metabolic associate increased score adult reported mellitus occur two individual adult history gestational multiple diabetic diagnose age year within adult known associate range adult may also important cause mellitus
27042278 en new effect insulin however role gestational mellitus remain present study investigate correlation serum glucose lipid study on total patient body mass control studied fasting serum level fasting plasma glucose hemoglobin lipid profile measured correlation use level negative correlate fasting plasma glucose insulin resistance index control respective positive correlate cholesterol on positive correlation level weight body mass index woman respective glucose lipid insulin resistance suggest role
24113736 en study investigate role plasma level show dysfunction individual type mellitus compare total individual diagnose type mellitus included group according dysfunction group participant change less whereas participant change dysfunction group blood sample study participant plasma level measured use mean value dysfunction group dysfunction group mean hemoglobin level significant high dysfunction group dysfunction group vs respective mean plasma level dysfunction group dysfunction group plasma level show correlation body mass index positive correlate value regression analysis hemoglobin independent risk factor dysfunction individual type new use dysfunction
25103403 en although study reported factor remain aim assess clinical factor type mellitus T2DM database study parameter total study patient analysis perform parameter T2DM observed negative correlate age duration insulin use hba1c level baseline body mass index BMI level positive associate rate patient however significant association age duration glucose control cell function T2DM however randomize control trial conduct provide evidence
20434356 en mellitus occur recent study indicate cause diagnose month age common due two patient insulin oral therapy lead improve metabolic control well possible associate remain determined treatment cause diagnosis treatment therefore model
26774185 en dysfunction several disease show decrease patient mellitus function evidence associate glycemic control condition although several study demonstrated positive correlation impair function include decrease rate study demonstrated finding change function known insulin resistance aim review current evidence clinical study regard relationship function well correlation obesity function finding well report regard effect resistance function also present
26245413 en treatment high individual disease several low status can influence aim study individual type mellitus regard management study conduct primary health care obtain type mellitus per total group female mean age year datum follow analysis healthy activity disease receive use type mellitus several management disease control diabetic complication
25495847 en management mellitus multiple risk factor may lead complication patient provide care patient important care intervention potential study determine effect patient intervention clinical blood pressure cholesterol glycemic control weight cohort study use individual patient type use assess primary outcome three week month month receive clinical outcome interval period conduct study use analyzed datum use participant mean age year included analysis score improve significant month change confidence interval clinical outcome analysis revealed use use include role potential mechanism patient type improve use although participant type use intervention aim intervention
24946561 en study mechanism type mellitus type model compare effect different ratio metabolic profile analyzed use difference among group analyzed analysis index result indicate can lower high blood glucose high cholesterol according result sample group normal group significant difference group different ratio identify related type compare normal group group show significant increase among drug different ratio major role drug whereas drug show study mechanism
21616738 en increasing prevalence insulin resistance major contribute factor report review treatment regard management provide review type obesity treatment contribute factor development indicate need treatment reduce obesity primary outcome treatment reduce impact obesity
23680891 en evidence mellitus high two recent evidence obesity base review study first prevalence show increase prevalence obesity recent obesity large need prevalence may datum study risk factor disease outcome remain factor obesity assess health include condition cell
19565097 en study mellitus among determine associate mellitus among without conduct aged year use health mellitus associate cardiovascular risk factor datum use response rate mellitus compare without disease health cardiovascular risk factor mellitus associate healthy among history health significant vs cause vs test vs characteristic history identify associate health found associate however healthy profile factor
23403824 en conduct analysis identify type mellitus total aged identify case identify total per case identify base test datum cohort datum model respective per case high per case identify low prevalence disease per case range oral glucose tolerance test effective per case glucose test effective glucose test effective hemoglobin effective hemoglobin little effective little range evaluate analysis revealed disease prevalence major analysis lead change overall among per case high low prevalence disease population can consider outcome
23835088 en mellitus DM associate cardiovascular disease association assess whether DM increased rate patient patient study DM perform baseline adjust age risk factor show patient DM total mean difference CI large large patient without DM patient DM increase time compare patient without DM mean difference vs regression show patient DM increased risk relative risk CI patient without DM similar disease associate increased high rate patient without DM
22420025 en assess relationship age incidence patient mellitus compare control subject patient total patient type aged year DM group control subject aged year control group assess subject increase control group prevalence high DM group control group prevalence vs prevalence vs logistic regression analysis revealed age associate increased prevalence mellitus independent associate odd ratio odd ratio first assessment relationship mellitus result suggest mellitus may factor associate development
24768593 en common clinical condition may association mellitus T2DM patient evaluate association T2DM mortality cohort study include patient study mortality hospital determined adjust ratio regression total patient mean age included patient follow-up patient patient patient patient adjust baseline characteristic T2DM significant associate mortality age disease renal also independent associate outcome difference mortality according reduce common patient condition independent mortality reduce
25390655 en disease aim assess association type mellitus T2DM cohort relative measured use participant study baseline perform ratio T2DM baseline use regression model adjust age index status activity cholesterol protein ratio analysis ratio use regression finding result use year follow-up participant baseline develop T2DM adjust ratio T2DM compare vs baseline vs confidence interval compare vs ratio three cohort study participant T2DM event relative risk independent associate risk T2DM regression observed association disease risk study method role T2DM development remain determined
25115772 en show plasma insulin concentration study investigate effect normal diabetic treat body weight week study sample blood insulin result show treatment diabetic cause significant reduction body weight blood glucose level significant increase insulin normal diabetic compare blood parameter compare control treatment significant insulin diabetic compare control present cell significant increased number cell result study show insulin effect increasing concentration cell function
26175092 en early diabetic also elevated renal target investigate may week treat week function rate renal blood renal analyzed also renal increased reduce reduce weight elevated diabetic activity diabetic compare control diabetic renal blood blood pressure diabetic diabetic treat reduce parameter renal reduce whether renal occur different remain show
24632643 en aim study patient type mellitus disease research conduct patient type mellitus patient study patient obtain result type cause change develop improve type mean
23494826 en subject risk develop type mellitus type DM method metabolic syndrome on total without one health study on health identify type individual model use multiple logistic regression model develop use develop type DM outcome baseline characteristic body mass index BMI blood pressure model characteristic effect type DM risk adjust odd ratio value BMI model suggest assessment type DM risk use may population health
24051999 en major present month age type patient disorder disease also number associate clinical diagnosis clinical patient two insulin oral also within clinical important first month first year type common cause provide important new regard development function
23369247 en insulin resistance type mellitus plasma insulin resistance relationship lipid glucose remain demonstrated profile gene total blood sample patient healthy control factor little model use perform analysis gene profile associate profile type factor analysis profile several lipid found correlate different include major gene profile cause known factor significant difference gene profile however gene analysis correlation lipid profile significant one insulin show analysis gene profile type lipid blood gene profile show correlation finding provide new mechanism lipid association type
25749274 en association study population identify related type evaluate association population perform study case control evaluate association addition previous reported multiple logistic regression use evaluate effect factor age BMI first significant associate association statistical significant study population although show significant effect significant decrease risk number increase risk compare without risk individual one two three risk decrease risk develop respective finding suggest contribute independent effect well effect risk population research
22353955 en association hemoglobin hba1c gestational mellitus diagnosis glucose cohort woman treat large oral glucose tolerance test retrospective cohort study clinical include hba1c diagnosis medical on model use assess association hba1c diagnosis glucose include impair fasting glucose impair glucose tolerance woman impair fasting glucose impair glucose tolerance diagnose type mellitus age body mass index high gestational week first hba1c increased risk impair fasting glucose impair glucose tolerance glucose associate increased hba1c measured diagnosis may identify patient high risk develop glucose
19696663 en patient present incidence disease review examine recent evidence glucose control effect blood glucose well treatment medication type type mellitus base evidence diabetic patient undergo study control blood glucose patient also control hba1c level patient type may associate cardiovascular risk glucose may great risk patient elevated glucose new medication insulin blood glucose control provide care patient review examine management patient undergo care include insulin
24165524 en study conduct examine impact glycemic control individual type mellitus individual T2DM complication previous week time per week glycemic control included fasting blood glucose hemoglobin fasting insulin use assess level activity use assess significant change glucose control found however significant change finding therapy T2DM
23472075 en examine association cardiovascular mortality review assess mortality risk associate ratio use study overall mortality estimate cardiovascular mortality estimate complication associate increased risk mortality CI cardiovascular mortality CI study high mortality relative low cardiovascular mortality respective analysis show association mortality significant change three present odd ratio decrease CI on type type can one study reported type associate increased risk mortality research cardiovascular cause associate determine mechanism may association
23066889 en mellitus disease disease influence factor on possible association risk increased incidence several observed patient decrease incidence observed patient effect association two condition great treatment multiple potential mechanism possible common mechanism include increase associate increase risk may important population level aim review recent evidence association total consider association disease
19159455 en previous study prevalence hypertension mellitus show however study without patient within without adjust patient characteristic therefore present study diagnose hypertension mellitus prevalence rate use adjust patient use general patient presence hypertension mellitus disease related hypertension determined also characteristic use analysis logistic regression analysis prevalence range prevalence diagnose hypertension mellitus per patient per patient respective patient characteristic presence hypertension patient characteristic important hypertension obesity or presence lipid disorder or mellitus or whereas presence mellitus or lipid disorder or hypertension or can use study patient risk factor hypertension mellitus characteristic presence difference general prevalence rate diagnose hypertension mellitus
18207451 en difference relationship mellitus aim relationship mellitus possible related difference included study man woman aged year population subject woman man related mellitus woman adjust odd ratio confidence interval CI independent age body mass index also independent related mellitus woman adjust CI associate mellitus among man man aged year old adjust CI related mellitus woman related mellitus man year old
24965975 en evaluate effect use mellitus response type use female use study studied different model control group two type week whereas use mean group group difference control group group cause show whereas show difference type determine factor response
20876721 en gestational mellitus studied study consider multiple several potential determine first identify sample woman develop control subject datum age BMI history blood pressure use sample measured lipid protein parameter determined independent regression analysis characteristic control subject woman develop old high history history type high blood pressure regard analysis identify elevated low cholesterol level significant independent improve estimate potential blood lipid
26166691 en study examine prevalence include without patient factor related presence patient aged year study related clinical characteristic regard management presence assess use score relationship presence potential related factor logistic regression analysis prevalence study cohort without analysis show age odd ratio or confidence interval CI diabetic or CI significant related presence prevalence sample patient high general population base result obtain similar present study although prevalence may value due assessment use identify treat patient aged year may contribute aim
24360361 en mellitus may different type common incidence increasing two important among age diagnosis type year type obesity diagnosis history type common type research analysis history may lead
22644981 en case patient type mellitus receive woman blood glucose concentration hemoglobin hba1c value diagnose type mellitus oral due elevated function test value adjust several month month hba1c value decrease adjust two month patient reported significant blood glucose reduction reported change month hba1c value therapy result total hba1c value reduction weight function test value patient high blood pressure treat remain duration patient type mellitus addition therapy effective
24676352 en increasing evidence show development mellitus DM complication previous study conduct group indicate high glucose level may factor gene increase cell base finding aim present study investigate level patient type DM possible correlation level control group without group group level level serum assess use level significant different among three group however level two group significant lower group low level group protein level group significant high group level negative correlate estimate rate level positive correlate age ratio blood fasting blood blood glucose multiple regression analysis show associate level mechanism decrease patient DM may contribute
23462586 en previous study revealed diabetic patient increased risk may associate poor status aim study effect risk patient type mellitus one patient type mellitus receive oral day patient baseline three month assessment status activity significant increased plasma concentration reduce intervention group respective number reported treatment group three month less reported group vs month respective diabetic patient body weight increased three month follow study show improve blood concentration however reduce number diabetic patient
22978060 en on mellitus diagnose two one adult year insulin treatment patient develop month age negative one gene identify year age two patient year old respective new gene found insulin treatment lead insulin therapy metabolic control well associate development syndrome diagnose
23778057 en aim study examine relationship serum level subject year old mean age year without type mellitus DM
23768546 en recent datum suggest woman type mellitus T2DM due impair response reported high study use analysis compare healthy woman woman T2DM compare level studied woman study analysis datum baseline woman two group base presence T2DM use analysis use method use regression determine association T2DM status also determined association T2DM status high T2DM woman vs great woman T2DM vs high high indicate suggest impair response may present woman T2DM
24630294 en compare incidence gestational mellitus study evaluate medical woman woman syndrome age year history relative glucose treat history history history weight syndrome incidence group group group diagnosis base incidence significant high group respective compare group age body mass index BMI weight similar among woman three group addition incidence hypertension significant high group compare group logistic regression analysis demonstrated risk factor age BMI use study indicate risk high woman compare woman addition use found important risk factor subject study
27502804 en assess glucose response first three group year perform group year perform first patient glucose assess first glycemic reduction relative reduction respective found difference group response blood glucose rate effective independent perform clinical trial
27341040 en type mellitus T2DM patient receive insulin current glycemic control one insulin insulin mechanism provide glycemic control provide use treatment current datum use insulin management T2DM insulin provide overall glycemic control well number treatment reduction body weight risk therefore insulin T2DM consider patient glycemic target low risk event
22260627 en develop identify individual examine effect glycemic control treatment individual mellitus chronic disease disease primary identify mortality assess individual identify rate glycemic control individual without compare individual hemoglobin hba1c level effect treatment within day individual treatment within day index hba1c participant adjust age mortality time high participant without participant poor glycemic control without glycemic control vs odd ratio or confidence interval CI treatment treatment vs or CI less without control hba1c level receive treatment suggest treat individual less system different need population
25002020 en study aim determine risk factor mellitus DM patient disease undergo retrospective analyzed DM diagnose diabetic history association improve DM define treatment drug increased decrease respective DM define duration diabetic patient improve DM observed patient respective patient develop DM logistic analysis diabetic patient demonstrated DM independent DM patient DM insulin treatment improve DM logistic analysis patient show body mass index independent risk factor result may risk factor DM may care patient high risk DM
23631606 en use oral glucose tolerance test diagnosis however recent study indicate glucose system can impair early group aim study glucose profile relative type patient early type datum subject normal glucose tolerance impair fasting glucose impair glucose tolerance new mellitus group obtain consider mean range glucose level well number duration found three subject show range whereas subject show range glucose value subject respective present however number significant among group difference duration subject value subject value statistical significant however significant indicate presence significant relative patient without can early individual great risk on glycemic profile may time may patient type present complication
23560480 en adult associate increased risk aim study determine whether improve adult subject mellitus year age group control group receive whereas receive use conduct week week measured baseline intervention use clinical test test test time test test analysis on use show significant improve decrease time increased effect major factor subject study suggest effective reduce risk adult type
23562999 en provide current study aim investigate influence hypertension type mellitus diabetic analysis datum group participant diabetic hypertension diabetic without hypertension hypertension without mellitus healthy control without hypertension estimate increase mean compare group mean increase group group analysis show significant difference among group blood test mellitus influence hypertension
24182196 en renal dysfunction study show blood related disease aim present study evaluate impact syndrome mellitus undergo two group base baseline level measured use method regression use identify mortality major adverse event patient group DM follow-up follow-up period month blood pressure lower ratio hypertension chronic renal fasting blood glucose hba1c level high DM group group DM group significant lower group cause mortality DM group high group plasma concentration or CI independent cause mortality plasma concentration or CI score or CI independent DM group analysis show value mortality DM group independent mortality DM
20666272 en study insulin resistance type mellitus insulin resistance diabetic presence type mellitus insulin resistance studied model use glucose rate index insulin resistance insulin resistance weight weight body weight ratio index type type measured cell also rate type mellitus insulin resistance decrease change cell occur type mellitus insulin resistance weight index type type increased type mellitus insulin resistance insulin resistance lower type mellitus type mellitus insulin resistance association glucose rate weight weight body weight ratio index type type negative result statistical significant however normal association statistical presence type mellitus insulin resistance insulin resistance significant role diabetic type mellitus
20375127 en known change little known association individual mellitus disease study determine association individual mellitus study baseline datum analyzed individual mellitus type intervention clinical trial baseline assessment individual addition participant test test on total individual mean age year mellitus woman mean index range mean hemoglobin value mean per test mean per test measured test test associate CI test CI adjust disease change significant associate individual mellitus study determine target improve therapy patient
26997510 en study estimate incidence rate prevalence type mellitus population year age subject disease
26055459 en aim study investigate cause factor renal patient type mellitus T2DM clinical datum finding T2DM patient retrospective review mean age patient year range year incidence diabetic renal disease respective patient incidence renal factor cause renal respective large blood pressure control may provide T2DM patient development renal disease
26361670 en care patient type mellitus perform high incidence time respective rate early mean age year patient negative mean follow-up time year group patient complication within day early observed patient function metabolic control mean hemoglobin level follow-up fasting glucose level patient perform per year patient outcome similar
26354588 en type mellitus T2DM associate increased risk renal disease cardiovascular risk mortality investigate association studied patient T2DM mean follow-up period month baseline patient respective patient history hypertension hypertension follow-up estimate rate year observed case event group respective analysis hypertension identify independent risk factor related diabetic disease event identify independent risk factor event study found hypertension independent risk factor event T2DM patient
26333802 en investigate whether type mellitus T2DM influence similar disease
26307132 en examine cardiovascular event mortality health system target clinical health reduce cardiovascular event mortality conduct cohort study among diabetic subject subject health system management mellitus rate per syndrome mortality mellitus DM status age cardiovascular history observed significant cardiovascular event mortality rate subject without DM however age cardiovascular history mortality DM cardiovascular disease DM subject DM overall mortality rate rate increased mortality health system care adult DM target lower risk adult develop DM
26136206 en blood pressure control reduce risk increased patient mellitus however blood pressure target diabetic well perform retrospective cohort study patient type mellitus logistic regression model use evaluate correlation level diabetic follow-up year patient diabetic adjust odd ratio confidence interval diabetic patient significant high less multiple logistic target less diabetic patient type mellitus
25070053 en mellitus DM association however effect clinical outcome evaluate analyzed datum large sample subject undergo identify evaluate compare regression total subject DM DM subject large compare without DM vs include age body mass index time DM status DM associate increased risk use analysis ratio confidence interval similar subject without DM vs month addition similar duration DM vs use treatment diabetic subject DM large subject DM negative impact time effect DM early
26578639 en different metabolic cell significant role several disease also show response diabetic dysfunction insulin resistance aim study evaluate level adult patient type mellitus compare control participant clinical correlate patient healthy control study population undergo clinical blood complication serum level measured patient significant high serum level control vs level correlate high blood pressure BMI lower association high level independent correlation show hba1c insulin study first time study adult increased serum level high concentration associate metabolic profile patient
24575653 en glucose body without cell metabolic mellitus high concentration lead complication result demonstrated oral study lipid concentration protein research use test
24397156 en decrease insulin insulin resistance two major factor impair glucose tolerance decrease body mass relative increased mass obesity contribute insulin resistance however recent report indicate function reduce function contribute insulin resistance addition intervention effective reduce incidence type improve insulin resistance function protein factor diabetic diabetic control important well event however management include hypertension contribute function old diabetic patient
26437429 en result investigate relationship level gestational mellitus evaluate association conduct observed study on conduct identify study study include participant show woman significant increased risk develop odd ratio or confidence interval CI little on decrease CI serum demonstrated participant observed analysis study show study analysis show study overall effect evidence indicate association increased risk however randomize control trial need effect
26295790 en number woman gestational mellitus increasing woman receive diagnosis aim study compare woman woman regard difference woman test oral glucose tolerance test value plasma glucose woman medical compare woman method use time woman woman insulin treatment high compare first weight woman significant high weight woman respective however significant difference weight weight woman difference weight compare woman also significant lower weight gestational due treatment woman high large complication
26190538 en investigate woman gestational mellitus use method range range study included patient case group control group glucose insulin value measured participant function test measured use mean level significant lower case group compare control group base mean level within normal range group base however level significant lower case group use case group respective respective control group use respective control study show change glucose may level evaluate function test patient use result
20371663 en although hemoglobin hba1c recent test association need study assess hba1c test individual new base randomize study included subject aged included oral glucose tolerance test hemoglobin hba1c method new mellitus subject health diagnosis mellitus new mellitus known mellitus normal use hba1c level diagnose on hba1c level respective positive value negative value respective diagnosis new hba1c use test diagnosis
21442215 en evidence intervention type gestational improve glycemic control patient mellitus therefore therapy treatment base medication according diagnosis individual base current association management mellitus protein group evidence role body weight different weight
26111736 en increasing evidence suggest history type mellitus type DM may development however association risk remain identify study datum independent two use datum relative risk confidence interval effect total study study cohort study included analysis study found compare individual diabetic individual increased risk CI evidence among study increased risk relationship independent body mass index history however whether control use may one potential significant association type DM risk diabetic woman man similar increased risk associate type finding review indicate compare individual man woman type DM increased risk
26404550 en occur due high level serum mellitus important can severe metabolic early complication treatment metabolic disorder without present case woman present diagnose mellitus severe
26334461 en common disease mellitus type DM however risk factor DM activity aim study evaluate patient patient healthy control included study investigate subject study show respective observed patient control respective observed patient result study indicate may DM development DM found risk factor
26123986 en high level low level known cardiovascular risk factor adult adult type mellitus significant elevated reported datum healthy control control investigate two group new diagnose mellitus age year hba1c treatment age year hba1c age year measured plasma ratio group significant difference regard plasma vs well vs plasma vs plasma group ratio renal activity high compare lower may indicate renal compare healthy lower plasma concentration patient may also contribute high patient age correlate positive plasma plasma correlate negative age significant correlation found plasma plasma plasma correlate positive age diagnosis correlate hba1c great difference observed ratio role remain patient lipid elevated
26115598 en perform cell effect drug T2DM patient use assess cell on total subject T2DM patient normal case age group year mean examine per cell subject relative control group increased observed female compare T2DM patient analysis show increase number patient use subject use method potential role cause observed cell can use risk drug
25843397 en base type mellitus T2DM patient normal treat T2DM body mass index glucose obesity however perform obesity lower incidence complication present study compare different patient undergo patient follow month change BMI fasting plasma glucose plasma glucose hemoglobin hba1c model assessment body rate major complication reduce hba1c level score however result great reduction hba1c level score compare addition reduction BMI body incidence effective treatment T2DM patient however glucose obesity decrease incidence complication potential diabetic patient BMI
23805905 en evaluate whether function common finding gestational mellitus blood response measured control subject gestational mellitus woman on fasting glycemic obtain also significant reduce group compare control subject among subject show negative correlation respective positive correlation function early disease present related status may type metabolic syndrome
22027070 en mellitus type one common chronic disease incidence mellitus type increasing recent large rate increase observed aged year chronic lead complication include change occur diagnosis treatment may lead reduce change result increased mellitus type mass risk period mechanism type remain research finding indicate role insulin factor aim review recent mellitus type
24039903 en study metabolic syndrome individual high risk mellitus DM however little DM aim study assess DM compare base follow-up datum year general finding datum group individual without DM population analysis show presence associate increased risk presence associate increased risk DM population without elevated fasting plasma glucose analysis show presence associate increased risk presence associate increased risk can DM independent similar DM clinical finding individual elevated although individual without high risk DM similar individual
23625296 en aim study investigate effect renal disease mellitus DM number cell blood patient diagnose receive previous patient diagnosis DM without healthy included study group diagnose two group first group patient DM develop chronic renal disease group patient without DM blood renal function number cell determined study level measured rate patient number cell found significant lower DM control group group compare healthy group statistical significant difference found healthy control group negative correlation ratio number cell on significant reduction number cell show subject DM cause diabetic
26520862 en association body mass index BMI chronic complication study diabetic patient diabetic hospital may BMI according complication identify assess assess clinical patient assess disease disease assess medical patient female mean age year female year mean BMI significant difference BMI according according BMI normal weight rate complication disease significant difference complication rate according BMI associate complication association hypertension BMI
26121436 en assess impact care patient undergo develop overall change evaluate compare cohort included cohort glucose perform case cohort cohort case decrease month glucose case decrease month glucose care vs decrease month insulin use increased decrease month mean glucose level cohort significant lower cohort management patient undergo improve care although general remain high period several time
25165723 en base management T2DM less research aim role lipid two current treatment T2DM chronic effect well investigate aim study examine effect treatment two week subject T2DM study randomize control intervention trial subject T2DM patient randomize receive treatment undergo tolerance test early baseline treatment treatment period effective first treatment mechanism lead independent studied
22858358 en possible mechanism disease current early two new protein protein protein disease develop protein previous previous protein similar protein within protein lead disease current different model mellitus type show several model mellitus type several new protein response protein current study analyzed new provide evidence protein protein potential lead new therapy protein protein provide model well new
24030946 en associate chronic cardiovascular complication reported influence however effect metabolic activity remain aim study assess effect glucose use perform patient impair glucose tolerance type mellitus lipid glycemic profile obtain patient patient randomize treatment metabolic activity assess ratio study patient man woman mean age body mass index hemoglobin treatment improve glycemic control baseline high value vs significant decrease value treatment show effect value week treatment reduction correlate increase cholesterol study indicate decrease metabolic activity patient impair glucose tolerance type mellitus effect may independent effect
26632284 en new treatment obesity related disease mellitus serum related potential investigate evaluate use two test system finding show show high activity show high high activity provide study treatment obesity associate disease
23494755 en type mellitus T2DM increasing common related complication increased mortality related complication control study association T2DM complication major result cell cell mechanism T2DM response contribute T2DM cause insulin resistance presence complication target can possible control related complication
20703492 en mellitus DM major independent risk factor cardiovascular disease also lead however disease therefore aim study identify mechanism diabetic disease high glucose treatment lead protein level follow increased activity chronic model type significant elevated protein level increased week on treatment significant reduce effect on indicate well factor on major role DM therefore reduce DM
24633676 en role different treatment type studied compare mortality rate among patient without treatment study included patient diagnose patient group according status time diagnosis without medication oral insulin treatment model use examine association patient mortality relative patient identify patient diagnosis overall patient high mortality rate patient high among patient duration year diagnosis patient high mortality rate ratio CI man woman year diagnosis increasing man woman year study provide evidence patient high mortality patient without high mortality among patient treat insulin evidence treatment large time diagnosis poor
22928615 en mellitus DM increase risk severe severe DM suggest control chronic control DM study evaluate effect therapy patient DM patient three group group patient type DM group patient type DM group patient control group oral patient receive oral on model day therapy analysis use health model parameter significant lower therapy compare value therapy therapy subject significant difference patient DM control therapy reduce patient DM
24088801 en role development disease two potential relationship aim present review potential mellitus DM well associate disease several study reported high prevalence diabetic patient without control positive association insulin resistance show however DM role different factor development DM well include system lipid insulin effective result significant lower diabetic patient control large use DM subject cause although observed general population diabetic patient control
24061995 en compare patient patient mellitus trial according number case group group period day day patient receive respective blood glucose perform index evaluate time function complication associate observed two group blood glucose control blood glucose found patient time first group significant early group index associate complication significant different two group group significant lower group vs effective control blood glucose improve status patient mellitus compare function reduce
26141553 en study retrospective evaluate complication associate obesity gestational weight woman without treat gestational mellitus total woman without hypertension according body mass index BMI normal range outcome gestational age associate odd ratio or confidence interval CI or CI or CI associate status woman without status independent associate woman or CI or CI vs woman without or CI or CI respective BMI woman without or CI per status independent associate or CI or CI CI woman without cohort BMI contribute woman without
21922154 en woman mellitus glycemic control lower rate adverse compare rate among woman mellitus woman without chronic medical retrospective cohort study woman aged care rate compare woman woman without chronic medical woman woman without chronic condition woman less woman without chronic condition vs age woman undergo compare woman without chronic condition or CI less receive high effective method or CI addition woman undergo perform less receive high effective undergo increasing use high effective may diabetic woman glycemic control
25028228 en evaluate type mellitus study conduct among year treatment medical use DM multiple duration year diabetic hba1c level little one poor outcome regression analysis show age treatment type hba1c independent influence factor whereas hba1c independent influence factor treatment overall independent influence factor female independent influence factor age treatment type hba1c lower little one DM
21675666 en study examine health association disease among mellitus adult participant mellitus health datum time estimate adult test activity association identify health level level activity care activity level independent activity independent mean health activity influence factor examine
21437707 en chronic disease increasing prevalence population relationship disease glycemic control increase risk complication possible evidence within medical effect mellitus therapy effect mellitus result treatment treatment management whereas glycemic control therapy
23803148 en increasing evidence suggest history mellitus DM may associate increased risk perform review identify study relative risk confidence interval total study study cohort study cohort study patient analysis study show DM associate increased risk CI analysis study positive associate risk study CI cohort study CI cohort study diabetic patient CI man woman respective relative risk negative correlate duration DM high risk found among patient diagnose within less finding man increased risk woman case
22748719 en mellitus high metabolic condition associate high level multiple therapy health care system care clinical change health increasing aged patient on group old use method review therapy care influence glucose target patient on development influence clinical health care old
21333508 en estimate impact complication overall different age hospital analysis include datum health individual treat year receive drug control base odd ratio or condition individual compare control estimate system identify individual treat prevalence prevalence aged year year year year respective overall subject control little hospital month cause consider increased two time different cause examine hospital per effective treatment major complication patient health care system prevalence individual increase health care
24236181 en management type mellitus T2DM study effective role T2DM therefore aim type clinical T2DM develop use type mellitus type DM activity type mellitus clinical study included study study randomize control trial study base study show effect T2DM resistance also positive effect T2DM patient study related type found show management common clinical compare resistance T2DM treatment T2DM show role on large number research develop effective management T2DM
23801768 en assess effect intervention function type obtain participant study medical study follow patient type mellitus man mean age year month follow duration measured use function analyzed year respective relative measured test use statistical reduce remain decrease change lipid function intervention type mellitus decrease associate increased cardiovascular risk function change body type mellitus demonstrated study
26672635 en although clinical trial show associate disease little known whether risk factor primary determine whether previous associate whether association patient different cohort study patient without follow primary care event identify disease follow regression time use determine association test association among high risk patient age hemoglobin risk factor hypertension obesity high risk patient aged year old remain patient lower patient previous associate risk ratio confidence interval adjust time risk factor among high risk patient risk cohort aged year association found remain cohort lower associate among high risk patient may risk factor primary care patient lower risk
25108411 en medical research clinical effective lead increased use insulin however use relative little evidence regard impact patient study aim examine impact multiple insulin control hospital conduct type mellitus year receive insulin therapy major hospital value month therapy obtain datum impact use insulin reported control within target range compare participant general found use however reported early therapy control month reported overall increase improve activity insulin general participant reported use therapy control general control condition normal reported participant important health condition
24519180 en study examine adult type mellitus patient patient aged year hospital old patient year well high level regard medication perform blood glucose found high early diagnose patient less follow regard medication blood glucose care compare old patient result high risk complication patient type mellitus possible treatment
25145626 en weight adult risk type may may low weight high weight gestational mellitus increased risk adult type assess use blood sample group indicate group compare normal group group compare control group study use similar associate level glucose define adverse outcome study identify change observed randomize cohort study provide similar may different potential increase risk disease type
25559614 en mellitus type also known mellitus common disease estimate study investigate healthy sample use identify study provide development provide effective treatment total sample include healthy patient gene profile obtain use identify significant change well well found one follow two perform gene analysis found cell among common related clinical include age model overall model identify healthy patient patient high identify patient result significant change gene among group patient change disease found cell important role disease development model develop study significant age healthy study provide disease mechanism also analysis effective drug target
20636958 en determine incidence mellitus year diagnosis gestational mellitus determine whether test normal value medication associate development retrospective cohort study perform among woman glucose test oral glucose tolerance test large health diagnosis use patient total subject diagnose cohort total follow-up period per per diagnosis among woman respective risk patient year follow-up compare among population gestational mellitus associate high risk adjust important status body mass index among woman history number value use insulin associate high risk develop value insulin oral medication important risk woman history
20127137 en aim study determine factor level patient mellitus without test consider effective relationship disease patient without mellitus compare healthy subject evaluate group individual group individual group individual type group individual type group individual without disease group level measured use group significant difference level group related health condition type mellitus metabolic control effect level patient
25402375 en diabetic major complication patient type mellitus diagnosis base aim follow-up study role early diabetic patient patient mean age year healthy control mean age blood serum measured month baseline mean level significant different control mean value mean value patient increased respective baseline positive correlate pressure correlate negative negative correlation positive one statistical significant correlation found known renal correlate renal function suggest may use test early renal dysfunction
22763025 en system significant effect occur different several cell renal cell control related effect increasing evidence development type mellitus influence system response can impact status diabetic effect cell type profile reduce lower effect serum level patient renal disease decrease rate cardiovascular mortality therefore new improve renal disease patient
25777340 en lead development determine health patient mellitus well general medical finding show significant number patient potential improve health outcome mellitus reduce adverse health risk on patient develop group can use patient health
25004267 en estimate number mellitus DM complication within system mean per database hospital system health system DM estimate use risk mean per medical care DM total period according use factor DM prevalence rate per per year mean per prevalence DM chronic complication general medical condition age increase rate result DM use health care study DM primary diagnosis assess impact disease
26134188 en insulin new insulin new recent compare insulin assess patient type perform trial patient obtain subject datum blood glucose level insulin duration time week use patient provide patient two group according insulin although mean fasting level mean level insulin significant reduce patient receive high insulin mean insulin mean however difference observed patient receive lower patient duration insulin compare insulin insulin control blood glucose level type receive high insulin patient duration insulin
26024708 en patient number case reported report case patient type on female diagnose mellitus year control glycemic control year patient treatment month level serum insulin elevated show period develop oral control
25857502 en associate on important risk disease study aim evaluate activity low new diagnose patient type mellitus determine correlation activity plasma glucose sample patient new diagnose type treatment healthy control estimate plasma glucose fasting activity parameter two group compare correlation different parameter correlation analysis activity vs level vs significant high patient compare control activity correlate positive control well patient on positive correlation activity fasting plasma glucose level observed patient study high risk patient may due increase activity early disease on positive correlation activity fasting plasma glucose indicate association increased activity may high patient on positive correlation activity suggest activity may also
25330352 en research treatment disorder examine outcome treatment woman type disorder impact treatment duration outcome participant woman type disorder receive treatment analysis examine change blood glucose treatment analysis include treatment duration treatment significant reduction blood glucose disorder treatment duration associate great
25281423 en study assess association patient type presence measured clinical outcome total study patient type without known disease undergo define measured define patient without compare prevalence evaluate use datum score score score score mortality within follow-up period year also compare compare patient without patient associate high analysis adjust cardiovascular risk factor revealed independent odd ratio confidence interval CI mortality ratio CI patient type associate increased risk poor clinical outcome
24938900 en study assess clinical relationship type examine clinical function parameter assess associate change type diabetic patient present function test diabetic patient without normal subject control on similar analysis include level perform function parameter significant reduce diabetic patient without compare control patient group also increased score compare normal control great increase diabetic patient chronic lead change similar found diabetic subject included cell two related two demonstrated increased protein diabetic significant clinical correlation presence type clinical associate dysfunction lead similar model clinical datum suggest independent risk factor
24715184 en associate mellitus DM type due use metabolic disorder cause disease occur patient DM may occur case related present case multiple month known type DM year diagnosis mellitus month present three month base clinical diagnosis type DM obesity treatment therapy two month two three two week treatment disease patient lead found diabetic patient common patient type DM diabetic patient treatment result general drug use treatment drug case study large patient determine therapy
24341300 en association association study drug therapy type mellitus study control T2DM patient primary care study patient T2DM conduct primary care patient assess study month baseline level DM control hba1c mellitus patient woman mean age year mean hba1c baseline receive oral hba1c patient receive oral insulin oral insulin hba1c patient receive oral insulin oral insulin patient study month vs patient T2DM primary care hba1c target adjust however great
21327984 en one cell significant influence type associate cell patient type mellitus patient type mellitus without diabetic complication healthy subject control determined potential correlation clinical characteristic analyzed positive cell significant high subject control association body mass index BMI positive BMI positive patient respective on multiple regression analysis show BMI significant positive subject type
25278304 en evaluate relationship level glycemic control type DM treat study case hba1c group on hba1c group level measured level significant lower group on group vs level correlate hba1c duration DM age BMI significant group on demonstrated type DM patient poor glycemic control impair function
24235062 en increased prevalence obesity year increase prevalence type review risk factor type obesity type disease datum present review three role type type adult current disease new treatment
23635096 en reported provide improve insulin resistance also reported decrease study aim evaluate therapy month patient type mellitus T2DM evaluate whether serum parameter high protein cell analyzed relationship reduction blood pressure hba1c value factor analyzed relationship pressure hba1c factor examine factor patient receive month treatment patient significant baseline value observed change hba1c significant correlate change patient change blood pressure correlate parameter examine correlation regression analysis perform determine factor can change hba1c found significant positive correlation pressure value baseline change datum suggest pressure value baseline factor change hba1c change effect effect can effective patient type
26361231 en regard treatment patient type mellitus T2DM control use therapy therapy mechanism risk effect weight oral therapy patient T2DM review clinical trial datum regard oral therapy use database conduct identify clinical trial oral therapy use type or or or or trial include adult patient T2DM receive oral therapy week also identify total clinical trial evaluate identify included review addition therapy improve glycemic general well increased incidence reported included oral therapy include patient T2DM control therapy insulin therapy oral therapy consider primary
24953981 en high level associate however whether difference parameter diabetic examine association serum type adult without analysis man woman aged year health man woman associate serum man woman man high serum associate adjust age cardiovascular history body mass index BMI blood pressure lipid protein odd ratio or per increase confidence interval CI woman high serum associate adjust or per increase CI vs CI level associate risk man woman high associate insulin resistance adult high level independent associate risk need whether relationship
22404292 en reported patient mellitus DM presence normal effect DM disease determined function determine function patient compare DM patient normal subject normal DM diagnose according association subject rate per characteristic finding three group similar DM group mean age year female group mean age year female control group mean age year female fasting glucose level value three group significant different DM group group control group value DM group lower control group DM vs DM vs control however level group different control group DM independent factor or CI function normal dysfunction DM
25037197 en major glucose major level clinical aim type mellitus T2DM evaluate association glucose dysfunction perform among diabetic patient receive healthy control plasma level high patient T2DM healthy patient level significant lower diabetic patient receive compare treatment significant correlate respective glycemic control DM duration among patient receive metabolic control new diagnose patient treat week group treat week associate significant reduction increased T2DM associate dysfunction plasma level reduce glycemic control treatment
23803146 en perform provide therapy patient type mellitus conduct database randomize control trial therapy patient T2DM use compare therapy duration treatment week reported datum hba1c change fasting plasma glucose change weight change adverse cardiovascular event adverse event total included compare associate lower reduction hba1c level mean difference confidence interval lower reduction level lower weight CI lower risk adverse event risk ratio CI lower risk CI lower risk compare therapy associate high reduction hba1c level CI high reduction level CI lower weight CI associate reduction adverse event CI high risk CI risk CI effective blood glucose may possible decrease risk event patient T2DM can T2DM patient use high risk large sample follow-up clinical need
23871133 en evaluate association gene diabetic patient type total subject type mean age man woman examine diabetic define presence high protein difference lower vs participant vs lower odd odd ratio confidence age duration body mass index hypertension lipid hemoglobin type lower
23551584 en evaluate prevalence risk factor impact woman mellitus type risk factor examine age history body mass index BMI known complication impact less known among woman use assess woman total woman aged year datum period on use assess type within month presence woman reported little reported participant little little duration significant risk factor follow age BMI risk factor woman activity prevalence woman high reported woman risk factor identify duration age obesity woman found influence general woman duration old treatment need woman
26448950 en mellitus DM major health prevalence increasing cause insulin insulin type DM type occur multiple insulin insulin cell protein well gene study reported gene DM review current evidence common development DM study role risk development DM
23889822 en although body evidence suggest whether independent increase risk conduct assessment association total risk base analysis cohort study subject estimate ratio ratio total use model on statistical increased risk observed ratio man increased risk also mellitus associate overall increased risk total incidence population association two disease important factor may suggest possible among patient study investigate risk factor also important
24595518 en insulin insulin treatment clinical aim study evidence use treatment clinical use outcome hba1c event complication treatment review may contribute need effective on follow study investigate population type consider develop clinical trial database independent two study assess potential identify study use trial cohort included analysis provide datum effective hba1c level reduce event treatment related patient characteristic one patient control insulin treatment high treatment also reported patient risk may consider patient influence possible outcome also consider important factor individual risk on method evidence base
25935836 en include factor cardiovascular disease aim study investigate relationship measured man age year value prevalence analyzed base value use logistic significant correlation body mass index fasting glucose hba1c patient high associate high prevalence multiple association remain statistical significant high group significant associate compare low group or CI finding indicate increased independent associate prevalence man
18031708 en may occur cause use chronic may lead disorder cardiovascular metabolic may also develop report case woman treat year case need serum level patient
23432977 en incidence mellitus DM diabetic system major complication DM cause renal disease renal disease diabetic patient increasing recent year general whereas case however known poor define population patient type mellitus T2DM study estimate prevalence retrospective analyzed patient T2DM undergo renal hospital patient number study population perform renal function diagnosis sample examine use clinical parameter patient time diabetic patient patient show clinical characteristic include high prevalence diabetic duration increased however also present clinical finding renal on patient found patient three patient two patient analysis datum suggest patient T2DM may common diagnosis
23695824 en investigate patient type mellitus patient mean age year duration year healthy mean age year level perform parameter evaluate correlation negative correlation hba1c patient year patient duration year patient duration year patient duration year history present impair may provide method patient
18924263 en previous study demonstrated positive association serum protein level mellitus however among association mellitus examine association level mellitus sample study among health participant aged year presence mellitus fasting plasma glucose plasma glucose current use oral medication insulin level positive associate mellitus independent hypertension odd ratio or confidence interval CI compare elevated level low level association analysis among man woman result analysis age body mass index hypertension status model positive association serum mellitus present range without serum level positive associate mellitus sample previous show related mellitus may also
22959714 en associate increased risk major adverse event intervention trial compare clinical outcome patient without mellitus treat total patient randomize primary target within month high diabetic patient vs ratio confidence interval CI diabetic patient treat treat CI patient occur patient CI diabetic occur patient CI occur patient CI clinical target need patient CI status type found patient high rate significant difference outcome present diabetic patient
22878421 en datum regard association mellitus DM little known regard impact include hemoglobin logistic regression use association DM participant study DM define use fasting glucose medication DM diagnosis medication addition incidence per woman woman use respective DM risk factor associate high risk DM respective association statistical old age obesity history DM associate increased DM associate great risk DM elevated define DM increase diagnosis association observed DM DM diagnosis without incidence also effect DM risk
24773097 en identify estimate related patient type mellitus T2DM use review conduct database included study perform patient T2DM primary study model included study identify primary study use complication primary study provide estimate event range year event occur range follow-up range identify complication show similar primary identify within primary study within study use estimate study patient T2DM datum included use compare datum development model patient T2DM use estimate associate important estimate provide
24727161 en recent increasing evidence metabolic function dysfunction can lead disease include dysfunction high incidence development mellitus DM patient mechanism study DM new study analyzed gene can difference three reported analyzed DM patient among significant increased study use cell show significant increase cell cell severe study show gene profile suggest dysfunction can early incidence development DM patient
23460659 en although evidence reduce cholesterol lead reduction cardiovascular disease less known effect type mellitus T2DM without general research database conduct retrospective cohort study T2DM patient aged therapy change baseline lipid value reduction baseline increase outcome cardiovascular event estimate ratio study outcome confidence interval change compare group compare change adjust cardiovascular event reduction reduction CI CI reduction decrease event risk compare change reduction adjust CI associate reduce risk cardiovascular event among T2DM patient without event effect event less study
25944538 en investigate association insulin resistance function metabolic syndrome first conduct analysis use datum health on total participant assess fasting glucose insulin lipid blood pressure oral glucose tolerance test use insulin index model assessment function use index insulin use define associate decrease prevalence or CI per increase addition significant association insulin CI CI function CI prevalence decrease risk CI per increase baseline significant positive association CI result potential role history T2DM among although randomize trial
26216595 en gestational mellitus define glucose first woman consider may lead type associate increase number adverse outcome several profile woman disease also clinical recent year investigate health although several report related disease show review gestational review early different sample analysis disease
26111427 en compare outcome patient diagnose gestational mellitus use woman hospital retrospective study review medical woman undergo oral glucose tolerance test diagnose hospital woman three group according result group woman normal datum group group woman normal group woman glycemic control outcome compare study period incidence increased use woman group high risk vs or vs or compare group woman group lower incidence group vs well lower rate increase prevalence woman according improve adverse outcome
23566037 en DM mellitus present patient impact therefore present study investigate whether presence DM patient associate increased mortality increased incidence review medical datum patient period datum follow-up outcome mortality perform may patient follow-up DM present baseline patient follow-up range year patient DM without DM presence DM baseline associate increased mortality age ratio CI confidence interval model disease score change finding follow-up patient develop DM without DM DM baseline associate age CI score CI presence DM baseline patient associate increased risk may increased DM associate increased mortality patient
26246490 en investigate disease cardiovascular risk diabetic patient study diabetic patient three group base finding on total low high risk total high risk receive total high risk diagnose disease treatment include intervention year mean follow-up per cardiovascular event incidence high risk high low risk respective study suggest may disease cardiovascular risk diabetic patient
26367734 en studied association type mellitus T2DM gene factor T2DM among population study blood sample T2DM patient age control result revealed association risk or or T2DM among population first time association identify population however common found associate T2DM population association T2DM present population datum population risk T2DM gene present result show association T2DM population
26295503 en type mellitus T2DM associate increased risk cardiovascular disease previous study association T2DM include index well blood pressure low cholesterol however difference included trial mean difference confidence interval CI analysis independent perform analysis conduct test perform potential total study T2DM patient control subject included overall analysis significant association observed T2DM association analysis indicate associate T2DM population significant association T2DM observed well early T2DM dysfunction
26268997 en previous show cholesterol role cholesterol patient disease aim investigate whether patient type mellitus T2DM also associate lipid parameter plasma lipid T2DM T2DM without age year BMI without use studied lipid perform plasma patient lipid lipid measured result total lipid T2DM high T2DM T2DM also show cholesterol T2DM T2DM vs cholesterol serum high T2DM vs concentration vs activity lipid T2DM cholesterol may impair cholesterol cholesterol increased plasma cholesterol may development T2DM
26253538 en glucose may reduce improve tolerance association metabolic change may effect function also cardiovascular effect method patient disease investigate effect whether time dysfunction patient type mellitus study patient undergo two study patient T2DM undergo two one study function assess function assess use rate study compare control increased glucose insulin concentration reduce level effect function study effect reduction dysfunction subject patient effect function however time improve tolerance patient
26121233 en recent show contribute dysfunction type mellitus however remain whether occur type mellitus T2DM function investigate role protein dysfunction level elevated type mellitus level significant increased week activity impair significant improve cell result cell protein found cell role datum first time role T2DM may development function T2DM
26048851 en mellitus DM outcome patient aim risk patient without DM DM presence insulin treatment determined whether therapy improve clinical outcome regression model use patient trial therapy trial treatment associate risk reduction mortality ratio confidence interval diabetic patient treat insulin significant risk reduction observed investigate group similar patient DM treat insulin significant risk reduction mortality diabetic patient receive insulin reduction event
25887000 en level reported high patient type mellitus DM metabolic syndrome result effect diabetic patient aim study investigate relationship level disease patient type DM
26817691 en effect gestational mellitus cardiovascular disease assess within first year aim study determine risk event related within year study follow-up year base datum database two group woman history woman without previous included disease assess studied included age obesity mellitus disease adjust odd ratio outcome use multiple logistic hospital database among woman history adjust age DM obesity disorder significant associate high risk adjust odd ratio model associate hypertension history identify risk factor disease within year on change
25781672 en base mellitus high patient however effective among patient present study investigate effective therapy patient identify patient patient undergo follow patient analyzed glycemic status evaluate patient glycemic one patient significant effect found patient among patient found two gene one three study show result glycemic control patient may consider therapy patient develop effective
25738612 en on significant mellitus DM demonstrated DM increase risk aim study assess prevalence DM among new diagnose patient patient DM determine number need diagnose new case cohort study adult research disease new diagnosis hemoglobin hba1c fasting blood glucose measured patient included DM DM new diagnose patient number need identify one new DM case age year associate DM population odd ratio or confidence interval CI DM perform patient may improve treatment outcome
26466574 en whereas study reported association serum level patient little association serum level diabetic complication aim study investigate relationship serum level complication include can patient type mellitus patient evaluate complication can assess cardiovascular test according diabetic evaluate serum level assess evaluate index prevalence can increased significant can increased significant prevalence complication among mean level also increased significant serum level significant positive correlate can significant correlate regard regression analysis can regression analysis demonstrated can associate blood pressure multiple regression analysis revealed level correlate can present study suggest serum level may independent associate can patient T2DM
26132586 en remain role type mellitus compare T2DM randomize clinical trial conduct medical outcome assess year participant aged year T2DM analysis conduct randomize weight intervention year follow intervention year treatment follow intervention year T2DM included medication weight mass index weight less participant woman mean value weight year age hemoglobin level fasting plasma glucose level T2DM weight intervention participant use medication reduce group group weight intervention participant use insulin oral medication baseline medication year mean reduction body weight year great follow treatment participant T2DM year intervention result disease intervention
23638904 en on low index gestational mellitus may aim investigate effect early outcome woman age year mean body mass index follow oral glucose tolerance test blood lipid test month assessment conduct index mean vs significant difference outcome outcome similar healthy study potential effect risk factor chronic disease
23377698 en review clinical study investigate patient type control perform plasma total concentration effect model primary effect regression analysis effect response trial different test show patient type control without type similar response total evaluate plasma concentration mean difference CI total effect revealed high plasma concentration patient type analysis show increased response test reduce response test among patient type analysis show hba1c fasting plasma glucose outcome present analysis suggest patient type general reduce response test control may associate reduce
27246871 en potential influence glucose serum gestational mellitus metabolic profile change serum potential diagnosis diagnosis mass target study target perform change serum case case healthy significant different profile serum control compare control individual demonstrated significant increase include use metabolic diagnosis diagnosis finding revealed effect body increased activity woman
22538993 en although glycemic control mellitus report compare level patient patient may low due compare level patient patient type mellitus mean blood glucose blood glucose month patient significant high vs level significant correlate patient however patient significant lower patient whereas patient significant high patient vs level patient low therefore value use assess level
26515910 en aim examine whether treatment associate type mellitus T2DM female conduct retrospective cohort analysis health database patient on total woman without T2DM history period identify patient respective ratio new diagnose T2DM period use model estimate risk T2DM define effect assess regression age index time T2DM risk increased patient aged year incidence T2DM associate treatment female patient on high risk observed patient aged year use high may increased
26452391 en type mellitus T2DM obesity two health associate significant although multiple factor contribute development DM obesity research demonstrated may role known influence early well factor include contribute health role response study relative population may contribute weight insulin resistance include ratio weight possible DM addition show may contribute weight however study perform sample may metabolic study model mechanism contribute DM obesity remain target treatment
26295162 en treatment diagnose case factor may influence outcome study group individual diagnose treat follow period month outcome treatment diabetic status duration follow case method diagnosis assessment treatment outcome type mellitus T2DM found significant associate treatment group two three method effective treatment T2DM independent risk factor treatment population mechanism present
26268092 en type mellitus associate early study included subject patient control according age range year consider consider independent study statistical analysis included test odd ratio confidence subject age year receive receive high risk or presence three time high vs receive follow-up increased time develop
25916429 en type two mellitus T2DM remain cardiovascular mortality study conduct investigate T2DM patient study retrospective included patient subject T2DM patient healthy patient study measured baseline significant difference healthy subject patient regard ratio impair therefore ratio found high T2DM patient compare patient use regression analysis independent impact T2DM increased ratio determined use found protein base model T2DM improve relative increased found patient T2DM may associate elevated ratio impair determine disorder patient
25585592 en on insulin use treat patient type mellitus T2DM aim evidence relative insulin insulin review major medical database study compare oral drug insulin insulin insulin well insulin T2DM target hba1c level without event consider primary T2DM patient follow week included analysis use associate high target hba1c level without compare without similar effect demonstrated significant lower risk compare without demonstrated similar T2DM patient target hba1c compare high risk severe lower difference profile less adverse event treatment also severe adverse less common compare examine outcome use T2DM patient insulin treatment
22440999 en evaluate prevalence potential association patient year old diagnose age type mellitus study cohort patient T2DM control subject study subject clinical patient T2DM mean age year mean disease duration year present prevalence significant high patient T2DM patient respective case high analysis age significant association hemoglobin odd ratio confidence interval patient T2DM response significant increased however poor patient T2DM poor glycemic control increased prevalence impair response may complication
24765693 en complication outcome cause gestational mellitus study conduct medical period one year woman diagnose oral glucose tolerance test gestational mellitus study subject follow blood glucose level control insulin assess time complication blood glucose level assess patient oral glucose tolerance test week woman diagnose gestational mellitus studied mean age year BMI insulin therapy control common complication observed respective gestational mellitus on total
25877332 en due increasing prevalence important role management study examine regard management type medical method management patient medication treatment type response rate reported patient care include patient risk factor common control increase activity decrease total undergo weight reported provide change reported regard effect drug great patient confidence management important treatment
27353715 en role management gestational mellitus aim investigate whether management woman diagnose outcome determine whether woman therapy medication change management woman complication change management woman complication change woman complication woman therapy medication role woman complication base complication
20439785 en study suggest system may role glucose datum analyzed plasma use baseline datum sample mean age year woman logistic regression examine association increasing low mellitus baseline insulin resistance fasting plasma insulin among subject mellitus follow-up mellitus model adjust clinical risk factor protein analysis increasing associate mellitus insulin resistance year follow-up subject develop mellitus odd develop mellitus increased increasing baseline fasting glucose insulin adjust odd ratio association mellitus remain significant analysis subject fasting blood glucose baseline adjust odd ratio increased risk mellitus independent clinical risk factor include fasting glucose insulin finding can risk assessment treatment metabolic effect system
20433217 en mellitus medical care patient complication decrease risk complication result increase total disease finding randomize clinical trial show improve glycemic control may reduce risk complication target hemoglobin glycemic control however datum clinical regard relationship glycemic control medical associate assess potential relationship glycemic level hospital among adult patient type type mellitus primary care care retrospective cohort analysis conduct use datum health time study period patient aged year old little medical diagnosis mellitus study period value within year study period mean test month identify group define base mean value study period datum test test database study follow-up period patient first test index early diagnosis mellitus study included patient number associate estimate follow-up period identify base diagnosis diagnosis complication identify hospital estimate use datum diagnosis ratio database use medical care index model control age number test diagnosis follow-up time on logistic regression analysis conduct little hospital logistic regression analysis follow-up time define time index first study occur first on model estimate rate hospital regression analysis follow-up time define duration study follow-up period estimate use model first determined logistic regression model negative use mean patient duration study follow-up period mean per patient determined first model mean patient determined patient study mean level patient mean month follow-up range month patient related hospital logistic regression analysis odd little hospital significant patient mean compare patient high mean however odd significant high patient mean compare patient mean odd ratio confidence interval negative regression analysis little hospital estimate per patient increased mean level regression analysis rate significant increased level per patient mean vs per mean mean level model result adjust mean estimate per study patient among mean among mean odd little significant associate high mean patient mean little however high mean level associate significant high estimate among little high rate hospital per
24103380 en on effect high observed patient insulin investigate potential influence impair glucose risk patient cohort study base intervention trial included patient disease baseline hemoglobin hba1c datum patient hba1c hba1c previous fasting baseline serum glucose glucose risk evaluate regression age adjust compare lower participant mean age follow-up year on high associate reduce risk ratio patient hba1c whereas association observed patient patient without high associate increased risk significant ratio associate lower hba1c mean difference hba1c observed high associate reduce risk independent hba1c diabetic patient increased risk lower hba1c among patient without impair glucose study investigate whether patient may high whether patient normal glucose tolerance high trial
24089274 en can associate incidence type association type mellitus age year factor hospital review aged less year receive first insulin incidence type week rate week obtain rate obtain health regression model estimate incidence factor significant model relative risk two week control week result show factor can related type incidence
23528647 en study assess clinical outcome patient type mellitus insulin therapy follow study previous month assess total patient mean body mass index mean duration year hemoglobin value follow little month assess system insulin patient month insulin treatment mean change baseline hemoglobin respective mean total per patient increased month insulin decrease month increased month care blood glucose total month parameter patient type mellitus improve insulin increase care baseline value follow-up period
26512829 en mellitus DM adverse factor patient however impact remain less aim study mortality year patient without individual hospital within mortality year year compare compare patient without DM analysis conduct define impact DM time known DM high mortality day vs year vs overall increased risk potential DM mortality decrease year adverse impact DM analysis year presence DM year compare vs year remain independent adverse factor reduce mortality
21722581 en glucose improve hemoglobin type mellitus type mellitus T2DM insulin however test T2DM insulin evaluate T2DM treatment conduct randomize trial compare blood glucose T2DM insulin glucose use week week patient report change week group group group difference change number medication use day per reduce use day multiple regression analysis statistical adjust baseline known observed difference treatment group weight blood glucose significant improve compare patient T2DM insulin population previous
24134628 en hypertension mellitus DM great condition however association poor therefore study aim influence DM aged month old two group control diabetic DM week undergo study sample obtain concentration gene evaluate serum assess lipid concentration test test present high blood glucose vs lower body weight vs blood pressure group show relative decrease function study show decrease concentration group increased serum activity gene ratio observed mellitus increase gene aged
25384349 en evaluate relationship blood pressure function evaluate level type mellitus total diabetic healthy analysis perform serum level blood pressure show significant high diabetic patient compare control vs patient elevated significant high value compare patient normal vs vs respective time vs time vs index vs determined significant high diabetic patient compare control case ratio early early also high patient elevated vs type associate increased level index indicate early dysfunction
25079039 en insulin type mellitus therapy however condition cardiovascular remain review associate type present two major glycemic control cell function clinical trial diabetic characteristic important remain one important insulin patient treatment also need history can well potential effect cardiovascular outcome
27219686 en mellitus DM one common group metabolic disease prevalence mellitus among adult association mellitus type mellitus possible mellitus chronic although association diabetic patient include study suggest also association incidence medication observed medication decrease risk increase risk study drug type mellitus activity positive effect found research investigate study mellitus disease recent study influence mellitus medication different present review study investigate association mellitus medication incidence diabetic study
26780765 en current use treat type mellitus important role cardiovascular disease aim develop function treat study gene include one condition concentration determined oral significant decrease level blood glucose diabetic time week compare group insulin level significant treatment significant compare group result indicate
20438040 en evaluate mellitus without evidence diabetic patient mellitus age range year studied score obtain use compare score healthy patient value also correlate patient age duration disease metabolic control patient mellitus significant score reduction test hemoglobin level related significant correlation found score patient age duration patient mellitus may early dysfunction patient mellitus show diabetic
22369132 en mellitus diagnose within first month case remain case current without diagnosis due associate clinical condition well reported association use clinical identify case cohort patient identify three case present first month two case present month age presence significant disorder case examine incidence clinical case reported found significant system case consider diagnosis present period
23986288 en year prevalence mellitus increase aim define individual risk general aim effective mellitus also within evidence therapy early possible less effective disease cardiovascular may occur case medical diabetic patient base diagnosis need among diabetic care effect improve mean follow-up treatment care provide new effective therapy
16495377 en renal increased level protein on protein concentration treatment cause decrease general reduce activity however mechanism cause poor study demonstrated cell model plasma reduce treatment clinical concentration decrease level effect independent protein less control can due elevated blood level blood level show difference control first cell model study develop demonstrated development occur independent activity
25518268 en woman type outcome well increased incidence mortality aim study outcome patient group healthy woman regard mortality also aim compare outcome patient type patient gestational type retrospective study included diabetic woman treat metabolic disease clinical patient gestational type patient type control group included healthy woman woman type present statistical significant high incidence without type gestational woman type early week regard woman without type gestational respective incidence statistical significant high score statistical significant lower patient compare healthy woman woman type gestational statistical significant old type on high incidence woman gestational type compare type statistical whereas incidence statistical significant high patient type hemoglobin hba1c level statistical significant high diabetic woman week difference level regard result study show high incidence syndrome patient type type healthy control also found high incidence patient type type healthy control although patient type type gestational one two week early compare healthy control statistical significant difference incidence week woman healthy control associate poor control high value hba1c risk adverse outcome may reduce diabetic patient early diagnosis glycemic control within
22455587 en dysfunction identify mechanism metabolic cardiovascular disease mellitus disease however although mechanism remain previous disease two mechanism occur system several disorder known primary protein lead impair cause provide important impact include disease disease impair increased blood demonstrated blood contribute include age well undergo two general occur individual mechanism important new target intervention disease first new function mechanism cause group study clinical trial identify mechanism result obtain model mechanism diabetic patient disease consider result clinical study base evidence study review development treatment diabetic complication
26124799 en investigate relationship status glucose impact woman cohort woman three group woman gestational mellitus one normal result one positive result negative result gestational mellitus great fasting blood glucose insulin resistance negative correlate woman lower score respective score correlate negative positive level gestational insulin resistance severe associate poor outcome
26927145 en associate type mellitus T2DM result population aim present study investigate association T2DM large population patient T2DM case healthy control association T2DM analyzed use logistic regression significant different case control associate increase risk T2DM or CI or CI or CI respective or CI or CI or CI respective age index result analysis also associate increased risk T2DM or CI association T2DM may risk factor T2DM
26838597 en although associate type mellitus T2DM among adult little known association development T2DM whether association examine association high level T2DM study adult health study mean age year follow-up mean age year on high level define score high high T2DM identify year baseline hemoglobin concentration little use medication without insulin participant reported insulin type mellitus model adjust characteristic woman high risk develop T2DM high level odd ratio confidence interval high level time statistical significant association among man odd ratio confidence interval
26518995 en type mellitus DM risk factor development although role response well response important DM can function examine response blood individual compare response individual without DM response cell baseline protein early little result significant increased cell cell individual therefore cell indicate DM response response provide potential mechanism increased disease
23726314 en study evaluate prevalence general study hospital measured fasting plasma glucose day patient adult medical status included study known history impair fasting glucose normal glucose value prevalence hospital hospital high known prevalence observed cardiovascular disease disorder patient known among known patient treat insulin insulin therapy hospital patient known old year respective patient year different known patient adjust age vs day metabolic glucose disorder known found hospital general
21547696 en mellitus chronic metabolic disorder common type mellitus result impair cell function insulin resistance one recent treatment use adult cell cell blood obtain study cell blood mellitus patient cell large cell well characteristic suggest cell similar obtain cell gene blood cell cell indicate mechanism mellitus overall result study blood use mellitus patient use cell therapy model system may study mechanism mellitus
21816692 en effect metabolic control parameter year age type patient aged year randomize receive treatment month effect hba1c fasting glucose event weight BMI blood pressure parameter age study participant year patient group show improve month base vs vs improve glycemic control also hba1c vs fasting glucose vs well weight reduction event increase control group subject study improve glycemic control weight type diabetic patient old year
25367717 en treatment adult patient type mellitus therapy include insulin effective general well treatment adult patient type several trial clinical addition control effect blood pressure function clinical trial treatment year low potential low cause management type review use adult patient type
21987347 en study first study examine prevalence impair glucose study target population population participant health population rate study clinical weight BMI blood pressure study population overall prevalence mellitus adjust age CI CI prevalence rate impair fasting glucose impair glucose tolerance CI CI CI respective prevalence impair glucose increased significant age high man woman study show first time prevalence rate impair glucose sample population
23437204 en increasing evidence suggest mellitus DM may associate increased risk provide assessment association evaluate DM incidence mortality cohort study method identify cohort study database relative risk confidence interval total cohort study included DM associate increased incidence CI significant evidence among study analysis diabetic man diabetic woman respective DM also positive associate mortality CI study positive association observed man CI woman CI finding suggest compare individual diabetic individual increased incidence mortality
24981770 en analysis provide investigate type included patient type year follow-up study baseline use analysis use method follow-up diabetic assess related baseline multiple regression adjust baseline age duration hba1c BMI baseline age duration year respective patient mean year incidence respective multiple regression analysis show lower significant or per decrease CI or per decrease CI or per decrease CI diabetic indicate possible common analysis therefore potential risk type
24507957 en prevalence metabolic syndrome patient high increase due weight metabolic effect drug cause insulin resistance glucose hypertension insulin whereas cause hypertension increase cholesterol level glucose mechanism also insulin resistance metabolic syndrome effect increasing risk new cardiovascular disease event patient addition also function management metabolic syndrome base increasing activity weight control cardiovascular risk factor renal patient body mass index effect patient investigate control whereas improve new without metabolic adverse effect important metabolic risk profile medical treatment cardiovascular risk factor potential drug medication drug due renal
25104789 en potential association mellitus include great clinical although evidence positive association datum review study among population datum obtain database perform association study evidence possible identify cohort study one cohort study study relative risk estimate reported cohort study show positive association revealed association one demonstrated association relative risk confidence interval relative risk estimate study show positive association association relative risk confidence interval overall relative risk confidence interval relative risk significant difference study population study type mellitus increase risk among population
24356340 en although effect health well consider activity treatment chronic disease presence mellitus aim present study activity total adult participant undergo medical subject identify participant according level duration ratio mortality risk associate lower odd development lower risk mortality among patient relationship group CI CI lower risk mortality respective group association mortality rate reduction among subject mortality rate reduction per among subject level associate lower odd also lower mortality risk among patient subject
24178337 en clinical assessment system mellitus DM correlation glycemic study adult patient DM treatment insulin oral studied cardiovascular can score use clinical test patient can early can severe can mean can score increased duration mean hba1c mean can score high patient complication compare patient without complication rate found mean ratio mean mean ratio mean prevalence DM assess can score can score correlate duration DM hba1c significant correlation can correlate presence presence individual test can score significant associate presence ratio
24133918 en model assess insulin patient clinical trial conduct control group month treatment blood patient undergo follow hba1c hba1c model study group fasting blood glucose level increased three month month insulin index index group significant lower control group study mellitus treatment month blood glucose hba1c level decrease group statistical significant change observed function severe cause cell reduce insulin increased insulin resistance increased blood glucose model blood glucose level increased effective patient mellitus
23331392 en evaluate correlation cell diabetic normal study woman gestational mellitus woman type healthy woman included control blood participant analyzed total activity individual significant change cell decrease cell increased observed type diabetic increase cohort healthy subject increased serum patient cell increased serum control cohort cell correlate serum correlate serum result present study show correlation increased lipid may therefore management mellitus
23244091 en diagnose renal cell early current study association age history disease diabetic parameter hospital base study use datum health may age hba1c serum fasting blood glucose one examine statistical difference group test use mean case total case renal cell patient also mellitus number female diabetic patient compare observed level serum high value hemoglobin fasting blood case renal cell mellitus found mellitus independent
23183514 en associate type mellitus contribute patient important role use treatment effect function remain therefore compare effect several patient type treat randomize study week treatment measured addition analyzed use baseline treatment baseline value compare healthy population significant high patient control treatment result significant decrease similar effect result use treatment patient type mellitus
22629828 en although mellitus DM cause patient current study define DM system function patient patient patient condition healthy individual included insulin cell cell DM common patient control group vs factor high insulin resistance group patient also characteristic lower rate cause increase cell activity also possible DM associate insulin resistance effect cell cell
22150374 en patient type mellitus dysfunction poor patient primary cardiovascular event compare function patient population group subject history previous assess whether control impact measured response concentration use patient define patient according control hba1c total patient type patient previous compare patient patient increased response multiple concentration common type vs increased response several patient control compare patient control also common patient control compare control vs vs type mellitus without disease dysfunction increased compare patient previous dysfunction severe patient control
23864267 en type dysfunction study assess function result two therefore determine whether function impair individual type conduct database respective evaluate function individual type on perform compare mean difference function individual type control analysis use identify individual type control subject included analysis function significant impair diabetic compare control subject CI although among study found significant analysis show function assess compare individual type function associate BMI positive associate addition dysfunction type function may type
23668423 en compare effect year intervention weight cardiovascular disease risk factor old control clinical clinical type mellitus aged aged intervention weight increased activity compare mellitus assessment weight base cardiovascular disease risk year old individual great mean weight participant relative mean increase vs metabolic old adult according health factor health condition associate poor weight old individual intervention mean increase cholesterol decrease hemoglobin year little large old intervention target weight increased activity effective old individual weight cardiovascular risk factor
26273663 en present research level protein mellitus type population use identify effect high level protein diabetic patient normal healthy control hospital total protein estimate protein diabetic sample compare control decrease therapy protein show significant change therapy effect high level identify protein also observed assessment level early diagnosis also mellitus type
26146634 en type mellitus T2DM one disease year associate increased risk cardiovascular disease increase insulin impair function T2DM related T2DM cell function T2DM activity increased number study suggest can new T2DM new new reduce glycemic level T2DM also treatment cardiovascular disease diabetic subject aim review evidence association T2DM
25808417 en prevalence type mellitus T2DM recent cardiovascular disease remain cause population several study show clinical identify diabetic patient high risk patient great risk reduction recent year new risk known new new mortality therefore review research new clinical impact T2DM patient high risk
25574593 en study investigate relationship among function metabolic control diabetic complication patient type mellitus T2DM
25912229 en mechanism type mellitus T2DM remain obesity consider one major risk factor disease on function gene demonstrated serum related disease study identify whether serum associate T2DM obesity subject healthy control subject obesity subject T2DM obesity included study on total serum sample group studied datum show significant elevated group whereas significant decrease group compare control T2DM group addition level significant lower T2DM group group compare control analysis revealed use potential obesity T2DM healthy subject study one study difference level obesity T2DM T2DM obesity study result suggest potential obesity T2DM
24657072 en management mellitus several present study assess possible effect diabetic effect assess fasting plasma glucose perform effect determined reduce lipid treatment significant reduce compare control level cell also significant increased positive decrease compare control value finding indicate potential use treatment
24170333 en present review related insulin therapy glycemic control adult patient type first database conduct use insulin therapy insulin glycemic control glycemic control adverse event body weight insulin insulin therapy little insulin patient type mellitus overall patient use insulin therapy glycemic control event less weight insulin therapy insulin glycemic control reduce number event can decrease decrease decrease improve patient outcome
27388632 en activity evaluate method different mechanism study patient receive oral therapy addition activity level blood value parameter measured result show reduction system patient
24219205 en type mellitus DM one common chronic condition old adult syndrome management cardiovascular disease risk factor old adult DM important review provide evidence base new care old adult type DM review include management blood pressure lipid control glycemic control use year new randomize control trial study different blood pressure treatment target evidence blood pressure control result lower rate mortality control risk effect blood pressure less effective reduce cardiovascular event old adult datum trial evaluate cardiovascular effect outcome lipid different cholesterol target drug significant adult aged old without DM three major investigate glycemic control reduction primary cardiovascular one study reported great mortality hemoglobin less two recent study cardiovascular use individual DM trial found significant primary cardiovascular control group overall adult aged old significant research need effective care old adult DM health status duration disease status difference
25437016 en mellitus result impair insulin occur within first month regard management insulin first provide several factor treatment two first treat insulin whereas treat insulin show two different effective
25884746 en gestational mellitus increasing prevalence woman without known mellitus week treatment result statistical significant decrease incidence management include glucose glucose level remain target value therapy insulin woman medication occur week woman glycemic control poor present indicate consider woman estimate weight great woman history high risk develop patient week glucose undergo three year
24183259 en evaluate effect clinical outcome type mellitus T2DM receive analysis similar randomize control study evaluate insulin insulin insulin insulin oral drug intervention adult T2DM impact outcome include hba1c fasting plasma glucose insulin incidence evaluate week female individual included treat insulin respective female receive insulin less glycemic target vs respective difference female receive vs respective female significant great reduction significant high insulin significant high rate severe analysis reduction hba1c less glycemic high insulin event difference response therapy consider treatment T2DM
23393665 en chronic metabolic disorder mellitus health estimate adult population disease number estimate increase control population obesity two increase show diabetic diagnose year disease prevalence high type diabetic complication system disease cardiovascular disease diabetic also included current management treatment therapy
22661194 en study evaluate diabetic two new group control group control group receive without receive mellitus body weight group week diabetic group blood sample drug base difference observed studied group lower value diabetic group case also little lower however change rate observed obtain diabetic group whereas change according well may mellitus change
22559854 en significant treatment type mellitus T2DM include aim glucose mellitus DM development new blood medication therapy current management T2DM drug insulin resistance new target increasing effect therapy associate hypertension obesity provide base association study clinical study new drug therapy care care also included
22234149 en study investigate cardiovascular profile event patient type mellitus T2DM study event independent primary three event also risk estimate use several statistical method include regression treat patient mean hba1c age year BMI receive receive primary event occur patient receive receive ratio primary show significant lower risk confidence interval CI estimate range result large may patient T2DM
22156538 en investigate possible association mellitus increased early database identify week normal compare patient gestational total case identify include type type develop gestational measured diabetic group difference normal mean value significant difference group group type type gestational gestational associate
21803381 en cohort study investigate association glycemic index glycemic incidence type mellitus man effect insulin resistance function association participant assess use history incidence medical period association incidence evaluate use model study participant develop body mass ratio ratio high significant great low influence low insulin resistance function independent associate incidence type mellitus participant low function high high risk associate incidence man function independent associate incidence
24332524 en consider management type complication evidence regard effect patient type trial aim examine effect glycemic status metabolic female period woman body mass index type intervention group participant control group participant fasting plasma glucose hemoglobin protein plasma measured intervention datum analyzed use test analysis use compare cause significant decrease level fasting plasma glucose hemoglobin plasma compare decrease level protein increase level significant group compare woman type may
24164794 en type mellitus T2DM patient insulin therapy treatment however insulin study aim T2DM patient insulin therapy use study T2DM patient primary care insulin year three three group on use analysis conduct identify major participant insulin influence insulin complication poor control effect treatment result insulin among participant also insulin effective result insulin well insulin therapy management factor also negative insulin insulin cause use insulin negative related insulin use negative poor whereas negative insulin can cause insulin insulin severe disease patient insulin care can aim patient insulin therapy addition well found insulin
23965896 en increased increase risk type compare risk type year age recent drug vs control recent cohort study recent drug control cohort patient previous receive diagnosis condition general diagnose follow-up identify diagnosis medication increased risk type CI within first year follow-up CI risk increased follow-up CI CI CI respective risk remain elevated year use CI cohort year age increased risk type CI risk increased significant increasing risk increased use CI CI increased risk type increased
24632279 en aim study investigate whether baseline outcome according diabetic study reported result regard patient without mellitus datum randomize trial treatment outcome patient without DM analyzed group according association vs remain baseline difference adjust present patient DM target ratio confidence interval target ratio confidence interval ratio confidence interval rate target target significant high patient without DM type vs vs respective patient type vs vs respective significant DM type observed respective observed patient DM remain increased risk however DM risk factor patient patient DM similar rate patient without DM
24070795 en study effect history obesity prevalence type mellitus total man woman man woman year age studied odd ratio or estimate use logistic regression analysis index relative risk due body mass index BMI prevalence high individual without compare individual without BMI or confidence interval CI respective man BMI CI man woman woman effect similar BMI effect obesity independent risk factor effect significant man
25772548 en evaluate week one oral therapy patient type mellitus T2DM
25120817 en disease common type high mellitus DM study clinical characteristic patient investigate gene protein gene protein gene factor gene early response gene gene relative large also reported case DM analyzed characteristic total patient DM compare characteristic patient diabetic DM relative independent characteristic mechanism characteristic DM syndrome new clinical factor DM association DM remain
24517339 en glucose patient type mellitus T2DM use datum evaluate population mean week include patient study population mean week control include patient study include old patient renal high cardiovascular disease event use case report population incidence high confidence interval female general lead event treat therapy duration treatment similar group patient event female finding control similar population female low undergo group event occur within first month female first year evidence observed included event treatment incidence high control patient T2DM event general treatment
27255377 en dysfunction contribute type mellitus T2DM new role study evaluate level new diagnose T2DM patient whether factor development T2DM
24075453 en study conduct determine need improve glucose control patient type mellitus T2DM
23971913 en patient mellitus DM increased baseline impair response drug compare aim present study investigate whether high clinical outcome intervention similar diabetic compare patient on total DM patient undergo measured primary incidence major adverse event presence DM value diabetic value according two include diabetic patient patient significant patient without DM result high incidence analysis independent odd ratio confidence interval base patient without DM significant improve patient presence DM increased risk event may
26913730 en mellitus DM known risk factor outcome however type treatment insulin oral effect outcome cohort study database patient DM undergo insulin oral treatment group on cohort oral patient perform age score BMI renal use outcome oral patient compare regression total patient DM undergo insulin treat treat oral result case analysis patient complication or CI high mortality rate patient hospital or CI total hospital CI CI patient DM undergo patient outcome oral patient patient DM therefore treat potential complication
26394040 en aim study estimate effect major event risk type mellitus T2DM aim test possible adult investigate association study base participant study baseline follow year event logistic regression model adjust age history use estimate association associate high risk develop T2DM odd ratio or confidence interval CI adult associate risk T2DM response evidence adult associate T2DM event one time evidence or CI or CI associate high risk T2DM effect great individual study suggest adult respective risk factor develop T2DM
26110884 en old adult clinical trial old patient mellitus DM old patient high mortality risk test treatment old patient DM effective mortality risk assess index base assessment adult aged retrospective study estimate mortality risk subject DM year undergo health high risk mortality baseline ratio mortality according score associate lower rate treatment vs vs high mortality vs vs score treatment significant associate lower mortality group test confidence interval CI group respective analysis show treatment also age CI among patient aged year respective test treatment significant associate reduce mortality independent age old patient DM
25602744 en determine type mellitus DM cell estimate incidence diagnosis use identify diagnose DM within period score use define control group risk regression use assess impact DM diagnosis diagnosis period analysis sample old year total diagnose DM number control mean study follow-up month diagnose among DM vs control risk receive diagnosis among patient DM increased ratio confidence interval incidence diagnosis among old year old DM diagnosis diagnosis population datum suggest DM diagnosis increase risk diagnosis within year old year
23463654 en current mellitus model diabetic type use perform study previous mechanism impair function type lipid cause body determine whether lipid occur type two use lipid patient type protein major type patient protein also cell mass analysis identify protein occur lipid characteristic presence individual lipid indicate
23973197 en effective blood glucose patient type T2DM glucose may important role aim effect similar type glucose patient different level blood glucose one patient different level blood glucose tolerance among T2DM impair glucose tolerance normal glucose tolerance body weight glucose parameter response plasma glucose measured baseline month weight observed group blood glucose reduce T2DM patient fasting plasma glucose increased significant show group evaluate T2DM remain group decrease fasting observed patient T2DM however fasting increased effective reduce blood glucose patient T2DM can early blood glucose time period glucose change three group suggest role T2DM
23369358 en type mellitus disease study indicate patient present type potential mechanism association remain association base analysis identify significant adjust disease base analysis also among significant result revealed disease number protein among protein found protein new risk factor disease potential association new protein protein protein high multiple protein disease effect association protein identify include insulin type mellitus multiple disease can can one important may role study first analysis provide general association two disease identify potential contribute two disease research new potential mechanism can two disease factor effect significant two disease may important disease can intervention target
23383177 en activity factor related severe impair study aim assess patient type type whether protein associate level status well complication diabetic patient type type diabetic subject respective healthy control studied database clinical little year protein measured whereas studied type diabetic subject high level activity plasma protein compare control type diabetic subject high weight significant increased subject complication type type diabetic subject activity normal range analysis significant associate group diabetic patient datum provide first evidence high level also status presence high weight observed normal subject associate mellitus finding may identify diabetic patient risk complication new mechanism clinical
25019556 en mellitus disease effective treatment recent control disease target base protein protein found cause time risk level study therefore potential analyzed on total three potential found show significant compare well control finding suggest possible treatment mellitus type use
26163429 en examine whether effect therapy woman aged year type status follow-up randomize control clinical health randomize clinical trial woman without year on total trial participant undergo year trial woman year general model use assess status baseline follow-up compare mean total confidence interval CI woman without mean CI total change follow-up influence duration oral woman aged year old increased risk due type associate lower total insulin resistance may finding influence among old woman
26345803 en study examine change cholesterol patient type mellitus DM determine patient type DM include patient disease patient DM normal control study blood protein level determined use cholesterol rate determined serum determined level protein type DM group significant lower control group difference found level group cholesterol rate patient type DM also significant decrease compare normal control subject cholesterol rate significant positive correlate study demonstrated cholesterol patient type DM significant reduce reduction associate
26316484 en significant cause also associate significant mortality study cause patient correlate factor total patient year age present normal hemoglobin total study history clinical patient blood analyzed cell examine case patient clinical indicate study patient present present health major finding syndrome disorder case patient present logistic regression analysis hypertension mellitus significant associate correlation associate significant clinical cause population associate low common
25753541 en study evaluate association mellitus DM on datum perform database database database database database difference incidence DM case control evaluate odd ratio or confidence interval CI adjust risk ratio assess association DM analysis conduct study included incidence DM high population receive or CI statistical association DM can found significant CI however body mass index BMI CI history DM DM CI found significant associate development DM analysis datum suggest association DM
23339757 en weight outcome improve glycemic control adult type study investigate examine association body mass index BMI glycemic control type year female duration year intervention study target management
19037551 en study aim determine prevalence hypertension mellitus condition examine factor related treatment control among health individual aged year old use status obtain blood pressure measured fasting plasma glucose obtain logistic regression model use examine treatment control blood pressure plasma prevalence hypertension mellitus mellitus hypertension overall hypertension mellitus condition respective undergo treatment control blood pressure less mellitus fasting plasma glucose less control condition factor associate control subject low low level current old age high prevalence hypertension mellitus among old high control treat early treatment control hypertension mellitus need improve
19661105 en regard mellitus prevalence glycemic control population examine sample adult woman year prevalence mellitus confidence interval presence hypertension presence cardiovascular disease history found positive associate mellitus high status current found associate mellitus among treat glycemic hemoglobin lower level cholesterol total cholesterol blood pressure associate glycemic control adult develop mellitus glycemic control
26530268 en glucose decrease hemoglobin hba1c blood pressure increase cholesterol patient type mellitus T2DM effect baseline patient analyzed patient T2DM baseline patient week effect incidence adverse event difference observed overall among baseline associate decrease mean baseline mean decrease baseline increased baseline change hba1c body weight observed baseline different present analysis indicate well baseline patient
22117094 en mellitus management contribute management patient medical history care health individual value effect well risk different evidence target three outcome control hba1c blood pressure control lipid control cholesterol management control control improve outcome control hba1c improve outcome however control factor influence include age include syndrome hba1c target range base age major complication blood pressure cholesterol control primary reduction event also event overall effective control treatment hypertension include potential effect drug potential increased risk risk evidence blood pressure target general use target individual
22409993 en primary cell cell insulin significant role aim present study show significant body may contribute study population individual undergo individual base history mellitus type metabolic syndrome clinical result determine body mass index BMI level great negative negative treatment hemoglobin great little month respective month patient present normal glycemic level patient improve serum insulin level hemoglobin level normal range patient test negative use insulin patient use oral case patient low serum level oral weight patient BMI less patient BMI great low rate case mortality study control mellitus type treatment individual result study show obesity case type condition control
26355118 en effect gestational mellitus determined insulin sample week week week gestational mellitus develop woman normal concentration measured level compare value increased respective early respective significant great control first result suggest develop renal early
26614193 en mellitus DM contribute development prevalence DM associate factor among adult large study adult diagnose studied potential associate factor logistic regression use odd ratio or confidence interval patient DM prevalence DM range factor associate DM or age year or or effect due treatment or time diagnosis or associate lower DM subject history drug use or without or prevalence among adult low remain study period however patient DM potential clinical management
22523190 en study evaluate include management assess change hemoglobin cholesterol blood pressure patient type retrospective study medical patient group group according presence primary change baseline included change cholesterol blood pressure number patient association correlate within month group patient group baseline group show great change adjust baseline statistical significant group difference found group cholesterol blood management may result lower patient type mellitus health care without
20804070 en level investigate insulin regard insulin show condition level condition woman high level insulin one high level insulin mechanism insulin
24825104 en evaluate impact reduce reduce use low patient type mellitus studied adult aged year T2DM group T2DM diabetic group healthy control subject test score difference age also measured subject group difference examine use significant difference test characteristic analysis use assess subject score significant group compare control score group poor high significant group score patient control high respective significant demonstrated function change clinical diabetic lead increase score remain
23635674 en investigate influence value test gestational study woman undergo glucose test gestational mellitus diagnose according datum group on glucose test conduct patient three group base time fasting interval less fasting interval group define fasting group less fasting interval group define group rate positive value woman less glucose test diagnose gestational mellitus respective positive value glucose test great fasting group group compare on logistic analysis show gestational mellitus fasting group group adjust odd ratio confidence interval finding suggest influence value gestational
23587270 en evidence indicate diabetic patient increased adverse cardiovascular outcome related increase however mechanism effect remain evaluate possible mechanism assess effect control type week several cardiovascular measured cause significant increase plasma protein concentration diabetic compare diabetic well number time assess significant decrease diabetic compare diabetic activity well plasma concentration factor significant increased diabetic compare diabetic addition blood significant effect blood diabetic study show event type possible mechanism may also cardiovascular diabetic patient
26769791 en investigate diagnosis type mellitus T2DM treatment health health primary care primary total examine individual aged incidence prevalence T2DM effect age examine change therapy also individual diagnosis T2DM new diagnose incidence T2DM per risk CI per CI among man per CI per CI among woman prevalence T2DM CI CI old associate T2DM change time clinical treatment CI low CI remain however common use treatment therapy base therapy also therapy however use treatment case T2DM number case increased change observed may impact primary care
26179755 en type mellitus T2DM high condition associate number metabolic risk factor weight impair lipid profile high level blood pressure disease related also on large number factor parameter healthy individual role total also different weight metabolic profile patient well known factor association therefore aim T2DM development disease
24023848 en gene disease may contribute related aim examine level new diagnose type mellitus patient plasma sample patient control assessment revealed level significant elevated patient compare control participant high level show high risk or CI low known risk factor association addition characteristic revealed CI high level significant associate high plasma concentration lower found level significant elevated patient compare healthy control whether value T2DM
20642077 en mellitus develop disease major study clinical outcome review hospital patient hospital age present complication outcome patient hospital year review type mellitus prevalence rate female ratio mean age year patient lower duration range day mean day patient present three patient one patient weight mean blood glucose patient present diabetic two patient medical patient mellitus remain relative
26798658 en identify new treatment patient new diagnose type T2DM insulin method patient new diagnose T2DM randomize two group treat week group group glycemic patient measured use glucose system on test perform intervention level fasting glucose fasting blood glucose examine result compare group glycemic mean glycemic blood glucose decrease significant group change treatment index index indicate significant group therapy may treatment patient new diagnose T2DM compare
26480213 en common among type mellitus disease patient associate adverse health effect on reduce disease identify patient risk indicate study aim assess patient health use identify high risk study patient aged general outcome compare consider evaluate major compare base score major score positive value diagnose major score less patient can included analysis can result score perform well identify patient high risk major however show result therefore use identify
26370689 en large cohort study evaluate association incidence new diagnose type mellitus T2DM obtain health research database according age cohort patient include control cohort patient identify regression regression model evaluate risk develop follow-up period range year patient control cohort respective risk develop T2DM cohort significant high control cohort adjust ratio confidence interval CI regression model T2DM CI cohort among patient high risk develop T2DM CI follow compare control result suggest patient associate high risk develop T2DM association T2DM patient diagnosis
25989845 en mellitus DM metabolic disorder metabolic cardiovascular disorder study aim evaluate DM patient determine clinical correlate evaluate parameter included total cholesterol low measured patient clinical datum medication profile diabetic subject significant high measured value significant high value vs vs vs compare control on significant negative correlation found among diabetic associate diabetic patient however value also show high activity among control clinical show activity among patient
22171594 en increased risk mellitus study examine whether association year age three system day patient evidence index previous within month index patient study period drug new treat identify use datum determine patient therapy adjust ratio use low relationship risk elevated risk rate per adjust ratio confidence interval CI rate per adjust CI elevated risk evidence increased risk associate risk large study within risk elevated new associate increased risk relationship although estimate due
23627758 en prevalence mellitus DM increase DM one common metabolic disease number DM increase disease common cause prevalence estimate year two chronic disease similar common similar DM associate insulin impair glucose increased lipid type DM increased impair lipid DM well also cause impair common indicate DM factor clinical outcome use effective insulin oral use management DM may role treatment patient
23522285 en treatment type mellitus T2DM although year due use T2DM treatment however due increased risk cardiovascular event associate use use drug severe use significant T2DM association study however use several effect potential development year whether use treatment T2DM review datum potential treatment T2DM
25106079 en associate severe mortality common patient mellitus DM effect common use medication patient DM investigate primary aim study examine whether type DM patient cohort investigate effect study population included patient type use medication health research database patient use group remain group model use examine effect status use treat cell without measured year follow-up patient develop incidence rate per adjust medication independent diabetic patient ratio confidence interval significant decrease use associate decrease risk patient type DM use medication cell
25051250 en determine prevalence patient type study perform patient diagnose type mellitus healthy control diabetic group control level disease duration presence assess participant diagnose week disease diabetic group mean age year per patient per year per poor control prevalence per diabetic group compare per control difference statistical significant association prevalence control level disease duration presence common patient type mellitus control
17916426 en period case known treatment effective oral individual report case low weight first month treat oral treatment low
24023947 en review aim assess examine possible gene gene risk type mellitus DM
23659774 en baseline study association follow-up year study cardiovascular disease cohort high prevalence type association baseline test use estimate effect model adjust relationship status associate poor test adjust age hypertension status include statistical model association fasting glucose associate status study result outcome type risk factor different function important result risk factor intervention clinical
21341390 en severe chronic disease cardiovascular disease health estimate patient model mechanism diagnosis well new drug treatment compare model cause review reported model base three model development model mellitus
24397165 en mellitus increase risk cardiovascular event old patient addition cardiovascular disease one important cause old patient however clinical trial demonstrated glycemic control can lead reduction cardiovascular risk several study show follow glycemic control early important cardiovascular event important patient history
23124798 en woman gestational mellitus risk develop type risk may healthy activity weight indicate may impair change identify factor associate early period among woman recent participant baseline cohort early gestational mellitus study randomize trial intervention woman recent history conduct week woman recent datum medical review score indicate measured datum body mass index BMI use weight measured review medical obtain datum medical history include history insulin use conduct analysis identify correlate odd use logistic regression study included woman mean age year identify mean BMI woman score model factor associate week included CI gestational weight use insulin history model identify factor associate woman important may change period study great gestational weight correlate among woman recent
24937532 en use disease known diabetic aim study investigate plasma patient type finding cardiovascular diabetic risk factor type concentration measured plasma sample patient type study clinical patient type patient diagnose type month chronic disease treatment renal patient age outcome parameter change concentration plasma type diabetic patient compare level significant plasma type diabetic patient level diabetic patient significant lower control negative correlate patient hemoglobin mean concentration value level plasma cohort found adjust analysis diabetic patient revealed significant plasma sample indicate early disease
24929624 en use treatment show recent outcome cardiovascular system study however little known influence cardiovascular disease clinical study examine effect on total patient clinical disease new diagnose impair glucose tolerance type mellitus receive control common glucose profile hemoglobin hba1c lipid profile measured baseline month patient show less control group addition group show great reduction body weight glucose level oral glucose tolerance test hba1c cholesterol level baseline treatment month associate effect compare control
25560571 en assess therapy type mellitus patient control randomize treatment therapy randomize group study study assess parameter glycemic lipid well treatment effect baseline value observed significant parameter hba1c index well decrease increase great therapy group on therapy significant decrease parameter level relative treatment well incidence therapy metabolic control parameter treatment well low risk adverse effect
24791012 en aim study compare characteristic diabetic patient without patient without included study study group compare control patient significant health show lower health negative correlate duration patient control however high study group observed significant lower level patient low patient compare control patient previous major significant outcome status study patient health patient previous major severe associate
25452435 en type early age evidence provide type early association type early examine previous study perform woman woman without woman without study participant include report age period difference age use regression analysis possible age year woman type woman without regression analysis show type associate early compare group without age history difference age woman type group year confidence interval assess retrospective regard complication therefore possible association health age can possible mechanism type poor control effect health improve control may occur function present finding health woman type
21069435 en on primary insulin may mechanism dysfunction mellitus study investigate target insulin serum week mellitus serum glucose use group week dysfunction assess decrease serum level well mellitus significant increase serum concentration insulin week significant improve parameter however effect insulin protein dysfunction insulin may due
25488325 en study evaluate number diabetic medical treatment management study also assess impact management among sample database sample database perform retrospective analysis diabetic present management diabetic evaluate primary among common common included diabetic management patient without diabetic patient management care provide patient DM hospital common present management care provide diabetic management large impact system need develop patient
24397158 en prevalence old old patient increasing diabetic patient also clinical assessment important function function function condition patient function use early diagnosis assessment patient insulin outcome treatment also improve function well treatment hba1c patient mellitus
22758386 en type mellitus present patient diagnosis multiple associate increased risk adverse event cause however impact type patient new diagnose patient general hospital identify impact patient evaluate compare clinical treatment adverse related control overall patient without patient man compare patient significant high renal serum system diagnosis significant lower use lower rate disease patient respective therapy patient patient significant high mortality risk ratio confidence interval compare study demonstrated impact clinical patient
22692669 en first therapy type possible patient type body mass index BMI less present study assess clinical associate patient type mellitus T2DM
25024655 en mellitus DM associate associate may renal DM examine role development DM severe study examine datum DM patient obesity weight management patient undergo study parameter measured included index mean time chronic disease define estimate rate patient patient year old mean age year great mean body mass index BMI significant difference found time great group regression analysis show CI CI negative correlate age BMI insulin treatment drug system association found mean event well duration associate renal function adjust potential significant renal disease great identify DM patient obesity
21777884 en evaluate compare diabetic patient undergo primary intervention study demonstrated patient syndrome undergo outcome trial patient randomize clinical outcome analyzed day year patient mellitus present patient rate significant lower diabetic patient treat compare day vs year vs result lower rate vs significant difference among diabetic patient randomize rate major adverse event vs major vs vs relative effect compare significant different patient without patient mellitus present undergo primary therapy compare effective reduce mortality day year outcome
23721931 en increased mortality risk diabetic undergo however study database determine associate adverse outcome database identify patient undergo patient outcome compare status analysis perform adjust patient undergo time period patient mellitus overall mortality rate diabetic analysis diabetic present cardiovascular renal significant difference mortality renal complication diabetic develop regression difference mortality major complication diabetic or CI diabetic however three time develop or CI mellitus associate significant major outcome diabetic however develop
20599286 en syndrome patient mellitus condition cardiovascular renal system well risk factor cardiovascular disease significant diabetic patient develop clinical significant diabetic due system factor system respective factor dysfunction may lead development renal risk complication reduce glycemic control patient type type mellitus whereas cardiovascular system less however intervention risk factor hypertension system patient type show associate significant reduction risk renal disease significant reduction cardiovascular disease
25241351 en report type mellitus obesity adult among population prevalence increased prevalence disease increased among man woman rate per year respective
23657602 en perform profile type type gestational evaluate among type sample obtain blood cell mellitus patient type type gestational use perform analysis database use gene gene profile show gestational type type gestational finding influence patient age three type significant on total characteristic gestational type type known type type gestational profile type gestational type related
24668409 en estimate dysfunction type mellitus investigate possible association datum control lipid determined level lipid participant increased level little one factor control associate lipid profile increased risk elevated level high concentration also correlate impair lipid profile increased hba1c value whereas positive correlate level potential hba1c contribute independent dysfunction present risk factor cardiovascular disease
24613196 en estimate association mellitus DM mortality retrospective cohort study among reported case conduct patient aged year old DM status time diagnosis follow treatment assess mortality ratio use estimate association DM patient disease DM DM patient disease compare vs disease vs resistance vs compare without analysis DM associate treatment ratio confidence interval adjust odd ratio confidence interval patient prevalence DM adjust model patient DM increased risk mortality
24503170 en determine risk diabetic patient type mellitus DM study included type DM patient disease duration year assess diabetic pressure use on patient high risk diabetic studied patient age DM duration year year respective one patient high risk develop diabetic associate less year or DM disease duration year or female or or hemoglobin or DM patient early diabetic high risk diabetic
21653795 en early protein protein risk factor cell clinical type trial reduce mellitus risk randomize control intervention trial whether decrease risk type study high decrease incidence one mean age finding recent follow-up analysis age current type subject intervention study time compare participant study overall rate first age
23330245 en incidence type mellitus among year age reported per however datum recent year although incidence low compare diagnose age year incidence type mellitus T2DM per among high time high among primary common type T2DM age mortality risk patient diagnose high general population however due aim medical care effect among mortality ratio year complication T2DM primary due number case therefore treatment diabetic complication T2DM system identify risk factor associate complication
22998891 en current known case estimate due significant health associate disease treat association association study develop regard treatment type first therapy study datum adult new oral determine time evaluate well treatment follow assess drug patient result show study period patient treat increased whereas receive therapy decrease great decrease increase period patient patient base profile first drug therapy patient new diagnose type activity activity management treatment medication new diagnose mellitus
22588846 en patient factor outcome metabolic patient undergo obesity patient type mellitus T2DM datum investigate analysis identify metabolic improve patient within month correlation body weight metabolic response analysis duration significant group vs year hba1c level significant high among among vs patient group analysis age insulin oral show positive correlation metabolic metabolic rate lower compare history T2DM high hba1c level therapy treatment may factor early age insulin oral medication regard independent significant metabolic outcome
23762873 en mellitus DM chronic metabolic disease incidence function protein lipid also therefore one cell function recent evidence suggest related DM complication consider multiple response important role disease include DM review relationship DM mechanism disease
24008910 en study aim evaluate risk model base risk identify association study type mellitus on conduct database datum type base association risk model included potential study characteristic among study range study sample participant number included addition type improve addition risk model range vs range respective on number included study use result show low risk type study participant number included addition association risk model little
25078744 en association known however association different according aim study determine relationship difference according old adult
24059316 en disease disease mellitus type T2DM metabolic disorder high blood glucose insulin resistance relative insulin prevalence T2DM increasing rate major health relationship T2DM recent study provide evidence T2DM risk factor study demonstrated patient increased risk develop compare healthy individual mechanism development therefore research important current association development drug therapy aim treatment disease review aim current known relationship two disease day study may also potential protein early diagnosis T2DM high
23647812 en investigate association history gestational mellitus woman total female common disease provide present study analysis include woman cohort logistic regression model base estimate use odd ratio association history estimate use or confidence interval prevalence woman history compare woman without increased odd woman history gestational or CI adjust analysis age body mass index mellitus associate odd or CI history positive associate among woman age association body mass index mellitus
25676578 en different outcome provide investigate risk factor mechanism complication investigate gestational mellitus early blood sample woman change status study participant among woman case control profile use use rate use identify target participant overall target change range range control among study participant related identify related identify cell cell finding early blood difference change status similar large study study
23442003 en mellitus DM one common metabolic disorder DM oral effect clinical study demonstrated high prevalence patient influence DM impact intervention patient review level patient present impair response increased risk one cause regard reduce relationship poor control patient can new oral health may complication also high risk oral disease significant effect
23805880 en previous study demonstrated association increased serum level clinical however population man woman assess association level incidence large cohort healthy man retrospective adult medical mean follow-up time year age year test result datum medical history outcome define two fasting glucose test high model ratio according level identify new case total man woman follow-up period adjust age multiple risk factor increase confidence interval CI woman CI man independent associate outcome woman man
27329026 en evaluate prevalence early type mellitus type DM association presence study conduct cohort type DM patient age disease duration assess study measured study population little one parameter although high rate follow patient different age duration control among participant positive positive correlate level however lower potential early dysfunction observed patient associate potential examine lower index primary present among one type DM impact duration control development remain identify
25341556 en chronic disease clinical however may clinical define clinical study analysis define low define subject subject old vs year severe base vs great vs reduce score vs or also use base medication use association define associate increased risk patient without may hypertension
22775367 en study assess patient insulin clinical
22921663 en adult treat total body increased risk insulin resistance mellitus however little known effect risk assess large cohort treat patient medical estimate receive body condition investigate risk case risk increased high estimate relative risk CI significant effect compare patient receive relative risk CI patient receive result index independent effect similar man woman year time old patient relative risk CI vs CI old patient difference patient receive incidence CI study provide evidence risk risk observed general population finding important health need regard therapy follow-up patient receive include
23956007 en study aim assess risk cardiovascular event among patient type mellitus T2DM health research database retrospective cohort study identify patient new diagnose T2DM year old without history cardiovascular disease baseline patient chronic disease patient group three medication follow-up period without oral incidence ratio cardiovascular event include disease disease among three overall incidence cardiovascular event high patient per follow per respective compare adjust ratio patient adjust ratio CI CI patient lower risk cardiovascular event
25966806 en patient type mellitus DM glucose impair however relationship serum concentration insulin resistance poor define study aim investigate association serum concentration insulin resistance patient type DM analyzed insulin resistance estimate use model assessment index resistance define index value association serum concentration insulin resistance analyzed use regression method incidence also evaluate serum concentration index score range patient compare base insulin resistance serum concentration high patient insulin resistance compare patient without vs found serum concentration included female renal function serum level activity ratio hemoglobin index mean follow-up period year patient patient insulin resistance concentration increased patient poor control type DM insulin resistance without insulin resistance
23479458 en aim study investigate relationship metabolic control parameter mellitus hba1c potential value study included patient mellitus type metabolic disease due poor metabolic control patient group group patient insulin therapy group included patient change insulin therapy group patient patient diabetic study metabolic control hba1c parameter compare study month month significant parameter follow significant evaluate parameter metabolic control found statistical significant reduction finding low potential group group found parameter significant lower may early diagnosis metabolic control treatment change can use include patient can complication may cause
26321029 en assess level among type mellitus T2DM patient association hemoglobin hba1c general participant diagnose T2DM little year study aged year control period month assess use adult health study included patient T2DM mean age year man mean hba1c level participant reported activity reported reported current current reported little level analysis show receive activity high level significant associate increased hba1c glycemic control patient several result suggest patient control
26640132 en care improve health outcome risk study aim provide different type care intervention type report conduct period datum perform independent three result chronic care model use intervention intervention included study reported positive patient health low number outcome association intervention type research care well outcome evidence intervention type outcome important care intervention type management care
23127236 en report analysis use database index health use type aged current follow-up on total review remain use analysis use define identify outcome confidence perform important among old adult
22798196 en intervention patient mellitus DM associate clinical outcome however diabetic patient remain evaluate clinical outcome patient DM group group respective primary major adverse event define target diabetic patient characteristic included use insulin risk significant high vs odd ratio or confidence interval CI DM group compare group however occur significant vs logistic regression analysis show associate or CI disease associate major adverse event or CI rate follow year year year year year DM group group respective diabetic patient patient undergo perform year follow-up diabetic patient
25623782 en diabetic complication mellitus increasing evidence role insulin resistance type T2DM whether elevated patient plasma whether level correlate plasma profile patient compare disorder include chronic mass correlation perform base measured patient compare significant increased patient observed compare healthy control group parameter include potential duration T2DM correlate plasma level clinical according level show difference patient decrease plasma plasma level significant elevated early disease correlate clinical lead treatment
26816601 en assess potential glycemic index gestational mellitus woman group result oral glucose tolerance test control normal group correlation analysis multiple logistic regression characteristic analysis obtain follow-up participant two total woman group control group mean level serum group significant great control group week characteristic define glycemic control confidence interval level characteristic poor glycemic status respective risk increased significant level week week measured index poor glycemic control woman
23496836 en lipid activity related metabolic risk factor type T2DM disease difference risk T2DM little known difference study risk woman previous gestational plasma cholesterol woman activity estimate ratio relationship blood pressure cholesterol cholesterol insulin difference activity independent risk factor correlate activity significant age BMI blood pressure serum cholesterol concentration insulin resistance activity show significant correlation independent BMI cholesterol independent BMI cholesterol activity lipid measured high similar less difference activity also independent risk factor cholesterol activity significant lower activity high difference activity independent risk factor characteristic high risk T2DM among lower risk among high risk
26041585 en aim study evaluate compare patient type mellitus T2DM glycemic control randomize clinical trial treatment period patient year age T2DM patient randomize renal function week outcome change baseline hemoglobin hba1c fasting plasma glucose body weight incidence mean baseline hba1c group group week little mean change hba1c baseline difference CI result confidence mean change baseline difference CI patient adverse event group group difference mean change body weight baseline difference patient T2DM glycemic control provide glycemic control week treatment compare compare lower risk difference change baseline body weight statistical significant difference may clinical
22768671 en mellitus diagnose within first month role insulin case patient case associate severe include syndrome less severe without syndrome individual insulin therapy case reported function due previous reported gene medical history include patient insulin whereas show resistance glycemic control present treatment insulin oral also whether related first patient reported treatment
22489136 en primary aim current management mellitus hemoglobin level however recent evidence indicate treatment increased weight severe high mortality evidence suggest glycemic control diabetic patient complication adverse effect treatment diabetic complication target can effective treatment management mellitus
22218541 en study assess condition result care aged diagnose mellitus disease control rate assess rate pressure value hemoglobin BMI aged year CI mellitus diagnose disease control rate perform result revealed individual blood pressure level BMI normal hemoglobin use disease control rate factor one patient control need aim reduce body weight include patient
19519161 en mellitus DM one common metabolic disorder impair function cell study define potential effect cell due diabetic blood cell diabetic patient type disease type healthy control cell different on presence glucose concentration response assess blood sample condition analyzed activity use result indicate significant response among activity among obtain diabetic patient however effect presence increasing glucose type patient time patient disease whether patient receive insulin treatment healthy individual decrease similar effect cause change cell system can cause study need identify target cell can contribute diabetic type patient
23268389 en compare function model type mellitus model cell show significant lower reduce number cell diabetic compare diabetic diabetic show severe change function also model model development diabetic provide model diabetic study
23247621 en syndrome aim study examine metabolic difference patient type mellitus on total individual type mellitus study define reported participant addition well general assess compare without patient show high hba1c value high score lower score high score
24579534 en type elevated risk develop cardiovascular disease major diabetic patient characteristic decrease level high cholesterol elevated level however mellitus low cholesterol use one risk case level cholesterol correlate therefore evaluate level new risk cardiovascular disease mellitus present study type diabetic case control among diabetic subject however among control individual diabetic significant elevated ratio total cholesterol high cholesterol significant increased level cholesterol compare control use also use risk cardiovascular disease type mellitus
25978841 en relationship mellitus DM incidence evaluate effect therapy among diabetic patient also datum DM patient subject without DM identify association cause DM evaluate whether risk develop also significant high patient DM without risk DM great well oral among oral type decrease risk less effect reduce risk decrease risk develop insulin insulin treatment significant reduce overall risk among DM patient analysis insulin treatment significant decrease risk result DM increase incidence insulin treatment may patient DM provide therapy diabetic treatment patient DM
25824543 en study assess clinical associate mellitus patient patient mellitus management disease large randomize trial diabetic patient undergo patient improve increased overall compare intervention however rate great intervention studied patient overall day day outcome overall regression use time event logistic regression use independent previous odd ratio or confidence interval CI use or CI or CI independent renal ratio CI baseline CI baseline blood pressure increase reduce CI associate risk factor independent risk factor previous previous use perform
25622985 en clinical effect well compare clinical outcome diabetic patient determine effect diabetic study level evidence study retrospective evaluate total little month use follow-up year patient study patient group on diabetic patient group mean age time group on year respective mean duration follow-up month follow-up statistical significant difference group regard respective group reported statistical significant score respective statistical significant difference group assess case group on case group difference group statistical significant rate according group found diabetic patient poor glycemic control serum hemoglobin hba1c level control diabetic patient range function significant improve use presence however increased diabetic patient effective glycemic control associate rate
24266721 en metabolic syndrome risk factor cardiovascular disease patient aim study determine whether related metabolic syndrome patient man diagnose result health per day per day relationship metabolic syndrome include obesity high blood pressure high low cholesterol per day per day investigate logistic regression analysis age drug therapy odd ratio or metabolic syndrome significant high confidence interval CI different CI compare level group or metabolic syndrome significant different level group significant lower or group CI or large CI high CI low CI or high blood pressure CI significant high positive association metabolic syndrome due high risk obesity low
22431673 en may improve glycemic control lower insulin associate weight patient control high evaluate therapy patient type mellitus control insulin without oral randomize trial follow period period number patient control type mellitus receive little insulin without oral ratio receive primary outcome change hemoglobin baseline week outcome included change body weight insulin fasting plasma glucose level week period adverse event evaluate patient analyzed week mean hemoglobin decrease compare mean difference CI group CI group CI group insulin decrease increased mean difference CI group CI group CI group body weight decrease increased mean difference CI group CI group CI group effect week compare group patient group high rate vs event suggest vs event suggest vs target study evaluate improve glycemic control insulin reduce weight without increasing major patient control type
22375718 en syndrome type mellitus condition factor insulin resistance factor obesity influence condition however mechanism insulin resistance contribute important result effect include insulin resistance contribute insulin type mellitus concentration insulin within obesity great important condition research mechanism condition
21175848 en study examine incidence mellitus identify risk factor adult use database total adult old receive first little one follow-up report diabetic status among identify mellitus DM risk factor examine DM new reported follow-up time significant independent risk factor development included age high body mass index vs use occur adult follow-up period risk factor similar reported risk factor development
26911584 en trial aim compare glucose treatment type review control trial assess patient type control duration week use great patient hba1c level risk ratio interval significant difference compare reduce hba1c mean difference range significant difference weight reduction reduce blood pressure range reduction therapy effective hba1c reduce hba1c weight hba1c level similar reduce hba1c drug statistical difference among effect great
26577795 en effective therapy type need one cause weight low risk present study evaluate study patient aged year type control use hba1c body mass index fasting use response system receive study treatment patient study study datum individual patient primary change hba1c baseline week primary analysis population week reduce hba1c mean treatment difference CI reported common reported adverse event included incidence general similar treatment effective significant lower hba1c level week cause weight low rate compare trial study
26242644 en rate gestational mellitus improve patient aim study evaluate primary vs care primary care method study group control trial trial primary outcome primary care woman aged year without diagnosis first one three hospital study woman use receive primary care conduct primary care primary care provide care population three hospital significant difference found primary care care vs respective effect CI vs respective vs respective significant difference base presence presence multiple general primary care evidence significant relationship age primary care reported conduct primary care due poor rate poor rate primary care primary care study health research
21234924 en present analysis perform evaluate impact mellitus DM status disease current known effect DM treat oral insulin characteristic known DM status included analysis compare diabetic treat oral insulin diabetic patient old present number severe increased diabetic patient without DM ratio among patient cohort DM negative correlate significant difference hospital mortality can observed patient without DM diabetic treat significant high rate diabetic patient oral medication insulin severe patient DM treat lower adjust hospital mortality increased among diabetic treat oral medication insulin among treat
23530768 en evidence associate mellitus cardiovascular dysfunction however study function large study aim effect early mellitus function diabetic studied week age parameter glucose insulin level well status measured according activity diabetic age demonstrated elevated level plasma glucose insulin hemoglobin revealed decrease function increase overall however indicate function disease also increasing presence significant increased overall decrease activity however early disease regard associate provide
25527351 en on previous diagnose mellitus present revealed clinical oral receive medication treatment consider treatment patient disease mellitus severe disease may use oral therapy
23552179 en cause renal mortality although incidence low general population incidence significant increased patient mellitus compare use patient total DM patient renal function randomize group patient patient primary increase serum level whereas development increase level significant lower group group rate significant lower group group vs study participant baseline less increase level significant lower group group use may decrease level reduce incidence patient DM renal function great
23388885 en study determine relationship protein mellitus DM metabolic syndrome study individual according risk assessment subject significant high level DM blood pressure significant correlate great increase DM therapy significant reduction similar change datum suggest relationship although associate increase associate condition DM lead different increased great increase DM relationship found presence DM addition different response
24989141 en therapy target recent year effect define insulin factor effect two different treatment develop treatment although effect similar effect increase plasma concentration effect include insulin glucose evaluate treatment type mellitus T2DM also effect cell potential increase plasma concentration effect two drug clinical potential mean control glucose T2DM patient clinical use possible effect treatment increased risk therapy development review
26376766 en woman gestational mellitus increased risk complication include large gestational age body mass index BMI weight associate however whether BMI weight associate woman woman develop hospital retrospective analyzed datum included BMI weight incidence gestational week incidence significant associate BMI woman odd woman time normal weight woman incidence also significant associate weight woman odd ratio woman weight time woman normal weight effect weight significant different different incidence woman high effect BMI weight woman
25356875 en important role previous study revealed disease diabetic however role remain show significant diabetic can show can cell cell function mechanism dysfunction may potential target therapy complication
25294115 en aim study metabolic control type related clinical study subject aged year group healthy subject group diabetic type patient chronic DM group hemoglobin value hba1c determined use system concentration blood measured method on use sample clinical found sample respective whereas identify less DM group group relationship observed presence poor metabolic control type patient hba1c clinical parameter disease type diabetic patient prevalence great increased subject poor metabolic control
26860809 en type diabetic mellitus T2DM cause mortality associate system metabolic current study aim evaluate effect related metabolic parameter patient diabetic female patient intervention control group subject intervention group receive subject control group receive two month metabolic parameter include fasting serum glucose hemoglobin hba1c lipid profile blood pressure measured two month also included serum concentration assess determined baseline two month intervention significant blood pressure serum lipid occur group serum significant decrease intervention group significant change observed treatment group present study show several effect glycemic status lipid profile patient T2DM study need finding mechanism
20194884 en subject mellitus impair status may significant role development present study assess role dysfunction development impair subject type subject type mellitus mean age year body mass healthy control subject year old study type mellitus subject group new diagnose year year assess impact disease subject perform follow compare healthy control subject ratio reduce significant subject new diagnose ratio similar new diagnose subject disease mean index type mellitus subject significant lower healthy control subject analysis significant correlation ratio index subject type mellitus impair duration impair status independent function subject primary result metabolic dysfunction
20092834 en evaluate effect mellitus patient type mellitus undergo without month identify patient control age body mass index clinical therapy previous presence analysis age mellitus duration mellitus independent factor group early month observed patient control statistical significant rate patient mellitus year less patient mellitus less year difference statistical significant vs vs vs type mellitus need however type mellitus overall patient mellitus year time increased risk compare mellitus less year diabetic patient potential negative impact mellitus
24227537 en aim study investigate association type mellitus T2DM perform study include T2DM woman healthy control measured serum measured serum concentration significant high T2DM group control significant negative correlation T2DM respective potential association remain significant datum suggest may complication diabetic patient possible activity cell
25314651 en model study mechanism develop important health first use normal control adult group type mellitus T2DM group develop month research reported can develop obesity T2DM group low glucose well month glucose tolerance test insulin resistance index assess change serum characteristic different result indicate T2DM group clinical T2DM T2DM model contribute clinical T2DM also may model research treatment T2DM new drug
23356840 en important development complication type mellitus renal glucose lead new mechanism complication glucose role glucose also clinical trial treatment potential current clinical number clinical study demonstrated profile effect plasma glucose level glycemic control reduce weight relative regard clinical treatment mechanism potential use oral drug well insulin
23175456 en study determine activity improve reduce woman type mellitus T2DM known study role management T2DM individual research evaluate use blood test participant clinical intervention participant improve month treatment clinical new role provide early intervention complication research include multiple study therapy
23160643 en study type mellitus possible association investigate test chronic type similar one found type known treat level compare type type healthy control related high vs observed type diabetic patient glucose control blood glucose hba1c type diabetic patient show high risk associate positive rate response high type diabetic may control may association type mellitus
25609661 en review clinical evidence glucose treatment type identify clinical trial result control clinical trial therapy type drug glucose include insulin treatment type effective treatment type
23571023 en study revealed may lead mellitus DM aim identify protein development DM DM use relative mass compare protein DM without DM without DM on total patient included identify protein evaluate protein on total protein identify protein according define protein result protein development DM can protein development DM can DM
24500556 en compare effect glucose blood glucose system hemoglobin level patient type mellitus treat patient type treat insulin group group result blood glucose level use group use group use datum receive test result baseline parameter significant different follow-up period show significant level group level decrease group decrease show significant different level baseline month use significant improve level patient type treat insulin randomize trial period significant difference value group month
24151823 en evaluate associate type examine group difference assess possible impact therapy compare prevalence cohort type previous cohort type type man woman identify diagnosis base current therapy previous subject therapy primary analysis prevalence primary remain subject assess association therapy overall prevalence primary woman man subject type difference high prevalence among subject prevalence lower subject type receive therapy difference great assess develop primary therapy result relative association common cohort subject group use therapy type associate significant lower prevalence diagnose
24831859 en associate increased risk cardiovascular on metabolic dysfunction type mellitus T2DM study identify T2DM subject T2DM datum glycemic control among patient assess relationship T2DM prevalence control large perform analysis participant cohort study use regression analysis assess T2DM prevalence according measured index patient identify previous history medication hemoglobin hba1c relationship glycemic control assess diabetic prevalence increased subject without severe obesity factor subject patient severe disease or CI respective T2DM diabetic subject severe glycemic control adjust mean hba1c level high patient severe without analysis associate increased T2DM diabetic control patient T2DM
23958390 en current treatment type mellitus T2DM glycemic control use early study therapy compare patient randomize study include T2DM patient aged year control hba1c patient randomize receive patient also base age body mass index BMI year year year year study test early use therapy provide glycemic control study also correlate age BMI
23924389 en little research determined effect mellitus type patient study determine effect cohort population insulin different oral compare control total subject group control insulin insulin oral oral included study patient control group receive increase glucose lipid profile measured baseline concentration improve patient group group show high change level month month compare baseline significant change observed BMI glucose group insulin oral group show significant metabolic profile included total cholesterol well blood pressure also significant decrease observed insulin oral group month group level increased patient insulin drug cardiovascular risk improve level
21264804 en prevalence treat health care individual period base datum sample large health regard case treat assess datum individual compare group without prevalence according age prevalence treat number patient treat insulin insulin oral increased respective per patient use health care however total increased increase prevalence period although increase total due number patient treat
20304746 en type diabetic cause disease cell insulin according patient treat insulin disease type possible therapy care type diabetic patient
25641011 en assess prevalence incidence type mellitus prevalence incidence rate subject respective study show risk
24112417 en woman diagnose gestational mellitus increased risk develop type mellitus T2DM intervention target woman diagnose randomize control study conduct test week intervention gestational risk T2DM activity month on total woman week diagnose randomize group control group first aim study determine intervention aim study test effect intervention outcome baseline week month primary outcome include fasting blood glucose weight BMI baseline month outcome include clinical health outcome baseline month aim study effect intervention outcome include weight status month age datum analysis include general model include adverse event trial may lead effective intervention woman diagnose improve glucose weight well reduce metabolic disease two
22296853 en study evaluate rate examine association among adult type mellitus study improve early management risk factor number time week month also patient health T2DM little compare T2DM report previous T2DM reported month significant lower score health health compare without mean score significant high among compare report indicate great among individual T2DM associate lower great
25307901 en mellitus DM disease mechanism plasma glucose blood glucose evaluate glucose total protein type DM patient compare healthy control group compare correlate serum glucose level patient study patient control subject subject serum glucose glucose total protein glucose method total protein method method perform use correlation statistical analysis perform use result show elevated level glucose total protein group compare healthy control level serum glucose patient significant change increased level glucose total protein patient compare healthy control glucose can use DM
25131093 en insulin resistance type mellitus T2DM may due chronic increase cell factor use reduce model type complication effect investigate T2DM evaluate follow-up period glucose level insulin body weight fasting blood glucose concentration hemoglobin hba1c level glucose tolerance test cell assessment blood cell observed reduction fasting mean plasma glucose level found change insulin hba1c level analysis associate decrease cell reduction mean cell whereas decrease observed result may suggest possible impact metabolic status T2DM high
25070441 en investigate function type mellitus
21749441 en perform review study patient mellitus compare healthy perform use database well found study three perform independent use evaluate study research included analysis use one one patient individual evaluate present result two increased diabetic one report determine show presence one individual present healthy individual present condition regard show diabetic individual high value healthy indicate mellitus due association can
21398212 en incidence disease increasing age change health two disease risk assessment study suggest type mellitus risk factor disease disease influence treatment mellitus may also positive effect disease relationship two disease addition known effect mellitus recent result system effect influence treatment insulin resistance recent year may metabolic disorder also disease
21362712 en common complication patient mellitus population risk dysfunction lower diabetic patient compare dysfunction dysfunction patient without mellitus datum period patient mellitus dysfunction identify use statistical disease related health patient year also common dysfunction patient renal cardiovascular among patient dysfunction less patient without renal dysfunction patient without however patient compare patient without among patient mellitus significant independent dysfunction odd ratio confidence interval age care number condition population dysfunction patient less develop without
25619540 en one cause related mortality among several risk factor type consider one important risk study show high patient diagnose type compare patient without important role glucose body may type important disease chronic report change level diabetic patient may lead function two disease disease metabolic disorder cause type develop however remain whether effective lower develop population effective reduce incidence review primary investigate mechanism type cause
25240421 en obesity develop multiple mortality associate obesity associate well woman current gestational weight contribute factor obesity independent risk factor obesity insulin resistance type change associate risk evidence indicate intervention include activity can improve outcome reduce risk gestational effective therapy major among association intervention include gestational mellitus
25397960 en whether early diabetic type mellitus may factor may increase diabetic may group type mellitus healthy subject study evaluate dysfunction assess method impact also correlate ratio factor serum rate factor correlate ratio serum rate type mellitus association dysfunction suggest potential role factor early diabetic can related intervention dysfunction can diagnosis early diabetic study large cohort
25456640 en mellitus major review show mellitus possible diagnose remain individual cause one known gene disease treatment remain mellitus
21679163 en determine prevalence impair glucose tolerance gestational mellitus different glucose tolerance three hospital undergo oral glucose tolerance test first follow-up one two year woman glucose tolerance oral glucose tolerance test gestational gestational impair glucose tolerance addition control woman level define gestational impair glucose tolerance blood glucose level plasma glucose test result diagnose impair glucose tolerance woman gestational vs gestational impair glucose tolerance respective woman test result revealed impair glucose tolerance compare among control odd ratio confidence interval test result logistic regression level gestational include impair glucose tolerance identify high woman impair glucose tolerance target group intervention
22364001 en identify therapy examine patient age year man woman among case disease follow revealed patient clinical evidence perform base clinical datum diagnosis function assess result test use function test investigate datum indicate function decrease patient complication without complication compare respective according test significant decrease base test datum patient mellitus complication significant difference compare group patient without complication level group patient decrease significant compare group patient without complication patient reduce rate range value obtain correlation level test patient insulin group studied patient negative type insulin type patient patient perform patient conduct patient may development
22216794 en aim study assess prevalence mellitus impair fasting glucose study population present result aged female study group participant participant participant participant study among patient known participant fasting blood glucose level female female female prevalence high participant old age group compare participant prevalence decrease increasing high among participant compare normal weight prevalence mellitus study population general high high population general low among participant known well control
21115865 en study perform review examine effect database use related mellitus outcome study included reported outcome status evaluate population datum perform effect mortality patient identify outcome patient significant associate mortality study patient significant high mortality risk ratio CI compare three study found associate also associate treatment increased patient great risk present receive treatment study need investigate determine whether care reduce mortality patient
24457403 en estimate impact prevalence patient type mellitus T2DM study conduct patient T2DM assess patient analysis patient outcome perform assess patient according control control patient consider define clinical total sample hba1c patient history mean age year mean T2DM duration year mean score total sample mean score patient respective score patient similar result observed group control patient score respective result identify T2DM patient significant level disease control treatment glycemic control without patient
22738384 en investigate hypertension patient type new chronic disease reported disease outcome number need treatment use population patient type mellitus study according found patient subject blood baseline although mean blood pressure rate patient blood pressure period number treatment significant high baseline increased baseline however subject blood pressure target found increase group common patient type mellitus increased although therapy use consider control blood pressure individual base level
22144398 en increased plasma activity associate cardiovascular disease mortality general population investigate association mortality individual use participant aged year diagnosis mellitus ratio confidence interval CI event overall mortality estimate use year follow-up case observed participant high activity increased mortality risk high CI association present current high ratio association observed event plasma activity associate increased mortality individual
26851751 en mellitus DM associate elevated risk aim study assess risk individual type DM T2DM on retrospective cohort study T2DM patient aged year conduct database period incidence ratio confidence interval T2DM diagnosis high observed female year T2DM diagnosis reduce risk found man aged year high risk found among T2DM female patient overall T2DM T2DM negative effect woman study T2DM patient increased risk several woman
21609629 en mellitus cause glucose can result multiple complication according recent study mellitus regard one risk factor age related mellitus incidence increasing study research subject review correlation mellitus
22648662 en individual type mellitus increased rate disease cell cell cell role relationship development whether patient without blood obtain individual without disease determined investigate diabetic patient level reduce respective diabetic patient reduce compare diabetic patient without level similar diabetic patient healthy control ratio cell reduce sample diabetic patient remain similar independent ratio type may reduce type
22356423 en aim study investigate whether increased ratio associate type mellitus independent risk factor type total subject man woman mean age year health hospital medical mean ratio study subject prevalence type increased ratio respective model resistance also show increasing ratio correlate age blood pressure value fasting glucose level include protein level multiple logistic regression model high ratio associate type risk factor age BMI blood pressure value protein level history presence metabolic syndrome lipid parameter odd ratio confidence interval ratio found associate type independent risk factor lipid parameter
22242260 en new develop impair glucose tolerance metabolic complication report incidence patient high risk cardiovascular complication impair compare normal blood glucose level risk factor common general population age body weight hypertension risk factor characteristic period include use well possible risk factor patient patient group treat use control lipid level pressure complication treatment aim clinical outcome patient develop
21245594 en prevalence mellitus important therefore study determine prevalence among study among patient primary care determine presence history disease review diabetic therapy patient may undergo undergo subject mellitus present patient mean age patient year prevalence female mean age female year respective female year old high prevalence age respective prevalence decrease patient old year prevalence body mass index among patient prevalence body mass index high prevalence obesity body mass index female compare prevalence high among population major clinical health on risk factor level target group
20959955 en aim study examine effect time association value lipid level cardiovascular disease risk participant study conduct among participant baseline total cholesterol concentration measured ratio total participant follow incidence cardiovascular concentration increasing time elevated time mean follow-up year cardiovascular event potential compare first CI CI total ratio CI associate cardiovascular disease independent time cardiovascular disease risk use study risk time association lipid concentration cardiovascular disease risk patient influence cardiovascular disease therefore may use fasting blood sample determine lipid concentration cardiovascular disease risk patient
25130635 en female population on treatment change occur woman review study relationship development woman
24781935 en evaluate whether cell association diabetic day mellitus DM control DM type DM model respective control use period week analyzed revealed increase control whereas decrease duration DM high major lead obesity response contribute factor diabetic
24467772 en type mellitus T2DM major health consider risk factor dysfunction T2DM also associate however study therapy treatment T2DM model mechanism effect investigate effect T2DM examine control three group group treat week age receive measured function use ratio pressure mean pressure evaluate function study factor use ratio group significant decrease group significant improve response significant decrease group improve group although decrease increased group improve T2DM metabolic disorder improve function can effective may consider potential treatment method
24299454 en group oral drug use treatment type mellitus common adverse effect treatment effect use incidence similar oral patient risk factor cardiovascular renal chronic patient treat present status
26883941 en well association type mellitus study identify gene gene independent may role response evaluate associate patient healthy control found observed patient associate low level patient show low associate low respective patient decrease level individual less
21770351 en analysis case mellitus clinical characteristic medical condition risk factor mortality among patient mellitus severe complication medical characteristic patient
22219592 en prevalence type mellitus T2DM high patient disease disease chronic disease presence T2DM however evidence related impact development T2DM provide evidence increased prevalence range disease impact disease insulin resistance cell dysfunction potential mechanism disease development T2DM
26976719 en incidence well potential risk factor cohort patient type follow studied patient follow mean year analyzed influence characteristic level hemoglobin lipid blood pressure disease incidence year respective factor associate increased risk blood pressure level blood pressure increase risk level risk year year risk year woman high risk man ratio study suggest female high level blood pressure disease factor associate increased risk development patient type mellitus
24015039 en duration reported increase risk however influence duration glycemic control diabetic patient study evaluate association duration glycemic control diabetic patient analyzed datum health duration group fasting blood glucose hba1c show according duration duration low hba1c among subject old age group duration associate low hba1c adjust odd ratio or confidence interval CI glycemic control hba1c group duration compare group relationship adjust duration or CI result suggest duration glycemic control diabetic patient relationship duration
25784088 en evidence regard potential mellitus DM association type DM well studied high risk type DM study aim assess association type DM control evaluate diagnosis type DM previous medical diagnosis use DM treatment logistic regression perform estimate odd ratio association type DM total participant mean age man evaluate control prevalence type DM study adjust potential woman type DM CI time time present CI woman without type DM statistical significant association found type DM among increased odd observed among woman type DM DM high disease population
25614928 en gestational mellitus increase risk poor health outcome therefore study compare identify risk factor perform analysis use patient hospital hospital hospital patient glucose use incidence risk factor woman patient patient woman mean age year study on total patient woman among risk factor among woman woman high incidence early health woman provide
22691299 en determine whether resistance factor whether parameter related hba1c
24526489 en present three time period treatment treat case result test negative three month patient develop mellitus include weight diagnose treat type follow-up period case report may first known associate patient present metabolic hemoglobin level possible identify
22004301 en decrease common finding type mellitus related whether cardiovascular test index identify patient dysfunction clinical evidence patient type according result test studied compare normal subject age perform test significant difference patient without response increasing pressure however lower group patient control subject vs respective significant correlation found response increasing pressure result test patient mellitus response significant correlate significant associate response increasing pressure multiple regression patient mellitus control subject correlation suggest contribute
21672009 en previous show significant associate individual association study mellitus important risk factor association little effect study examine type mellitus
21550952 en investigate health care clinical outcome among patient type mellitus insulin therapy use care retrospective cohort study large database baseline period follow-up period month patient first insulin outcome included medication event health care hemoglobin patient per group patient insulin therapy significant less treatment follow-up period patient group use also associate reduce risk group overall health care similar group however group significant significant overall health care similar group high group patient baseline follow-up value group similar control follow-up high baseline value insulin therapy patient type associate treatment decrease method without increase total health care
23991018 en result reported association gene risk type obesity
23680915 en assess impact impair insulin insulin resistance type incidence year cohort study included participant aged without baseline undergo medical hospital base index value participant normal follow incidence type determined fasting plasma glucose concentration receive medical treatment baseline individual normal follow-up individual develop type baseline relative normal group type group CI CI CI respective type due CI CI CI great impact incidence type population
24710132 en aim evaluate whether drug without body weight control trial report according include type participant intervention outcome assess risk perform effect model analysis conduct follow-up duration evaluate regression test adjust use assess patient type mellitus level measured hba1c fasting plasma glucose body overall effect hba1c mean difference CI effect CI effect body weight CI low overall mean difference respective analysis indicate hba1c body show drug drug improve control T2DM participant without significant body weight
23680241 en evaluate disease group patient type mellitus relationship diabetic metabolic control duration parameter index index group diabetic patient group statistical analysis perform evaluate relationship parameter metabolic control duration disease great index clinical level patient diagnose duration time year show correlation type increased disease great increased subject disease poor metabolic control diabetic complication
26008670 en study evaluate effect response patient type mellitus compare normal individual one subject normal patient type mellitus study first normal subject well diabetic patient test parameter drug day individual study day blood sample show change increased normal diabetic patient decrease normal treatment patient also decrease treatment change however normal subject
24362844 en mellitus major complication study studied incidence risk factor development patient analyzed patient treat without hospital patient known history DM diagnosis DM perform according association patient develop found age year hemoglobin hba1c level body mass index BMI history hypertension hypertension presence metabolic syndrome significant factor associate development analysis analysis revealed age year ratio confidence interval CI hba1c level BMI independent significant association result suggest plasma glucose patient history DM
25394643 en determine association lipid profile early body mass index BMI risk develop gestational mellitus total healthy woman fasting plasma lipid profile measured mean week include total cholesterol cholesterol assess early lipid concentration different association risk BMI logistic regression analysis use estimate relative risk odd ratio confidence interval analysis woman significant increased serum concentration ratio decrease concentration compare control group respective increase risk group CI increase group CI respective decrease risk observed woman CI significant correlation lipid profile risk develop associate risk develop woman high concentration increased risk develop woman high
22106979 en evaluate therapy patient hypertension type randomize study patient hypertension type mellitus follow study patient randomize treatment primary change blood pressure hba1c week therapy improve blood pressure control week treatment period decrease significant great group group group hba1c significant decrease group group compare group reduction group significant clinical effect therapy need studied use increase adverse event adverse event similar clinical use therapy improve control well week therapy patient hypertension type mellitus
21376350 en assess insulin insulin woman datum woman type type two one patient treat insulin treat different insulin include insulin significant difference rate group group insulin high mean hba1c first group insulin vs need insulin severe significant less among woman treat insulin vs significant group treat insulin vs due use insulin different two study show insulin woman mellitus overall control outcome similar insulin insulin important reduce severe
19262367 en mellitus treat according general can improve management mellitus general investigate management patient mellitus mean age year follow little year general blood pressure reduce diabetic hemoglobin reduce diabetic use treat diabetic disease disease diabetic rate diabetic diabetic use treat diabetic disease use treat diabetic use treat diabetic diabetic care datum show management mellitus improve management mellitus general
26507664 en retrospective cohort study investigate risk complication type patient use datum adult patient without complication follow diagnosis complication include disease chronic disease study incidence first complication analyzed year use incidence risk method common first complication development complication patient complication profile patient develop cardiovascular complication high risk develop respective mortality patient patient patient high risk develop mortality renal disease patient risk mortality
24532291 en increased population within year population associate development chronic disease type mellitus healthy intervention evidence study clinical trial conduct suggest effective intervention condition metabolic level show improve insulin reduce fasting glucose insulin concentration obesity type hypertension chronic review current metabolic clinical type cardiovascular disease
25964115 en investigate whether on activity associate disease patient type mellitus activity determined T2DM patient without significant number index score relative high activity lower diabetic patient significant without relative increased activity decrease disease patient adjust possible relative correlate positive activity negative index respective high level low activity associate increase index increase compare high activity respective decrease activity associate presence patient T2DM
24175381 en present prevalence mortality due mellitus year rate disease complication mean interval also consider analysis possible evaluate develop activity change
22871086 en evaluate treatment subject without retrospective analysis conduct datum randomize trial subject receive change included report increased pressure event define identify medical activity adverse event first day incidence adverse event subject history mellitus population similar baseline base event review identify difference retrospective analysis found increased risk treatment individual mellitus
22330860 en cause patient mellitus among factor contribute diabetic role study investigate therapy primary cardiovascular diabetic patient however evidence may effective clinical several factor identify potential treatment review response mechanism clinical drug patient mellitus
26233933 en evaluate oral conduct retrospective cohort study clinical database mean day patient age medication negative associate
25476142 en several recent association study study identify associate mellitus DM investigate whether gene associate type DM T2DM population present study study subject T2DM subject subject subject T2DM well control subject study blood analyzed significant difference level cholesterol control group group also significant difference level cholesterol DM group control group significant difference cholesterol observed group DM group however statistical group result present study suggest gene associate population
25446695 en gestational mellitus common use oral glucose test however woman report significant glucose can test test glucose use patient subject control use among subject woman glucose test study subject blood glucose assessment subject glucose tolerance test positive value negative value rate rate however rate vs positive value vs rate vs improve compare result indicate potential effective test compare lead therefore can
22336861 en among also use type mellitus research model suggest possible role assess effect type several database among included control trial compare control intervention without independent trial datum evaluate risk use outcome datum potential control trial investigate total participant range week month duration study contribute overall risk trial high compare effect control type mellitus statistical significant hba1c three month compare mean difference CI participant two trial adverse effect reported diabetic complication cause outcome evidence type mellitus trial well control medical therapy trial evaluate effect need clinical
22280315 en target insulin resistance respective evidence potential target treatment insulin resistance type mellitus
26439329 en patient type treat drug glycemic control hba1c common due poor treatment multiple target glucose low risk cause mechanism clinical profile individual recent finding regard review clinical effect identify use may datum obtain well great reduction glucose level whereas great reduction fasting blood glucose insulin characteristic provide treatment patient on large body evidence therapy patient glycemic control general well new identify follow-up year on review drug however may result difference include well patient type glucose insulin therapy include great well patient control fasting
22931220 en identify evaluate current treatment care known care participant whether possible evaluate use relationship obtain include review on reported use clinical whereas reported use base case less base adult use use evaluate within change may influence care within although use little need may change adjust research may included level define care improve care
20034365 en mellitus group metabolic disorder glucose complication mellitus include complication major complication important cause renal disease different risk factor duration blood pressure lipid control show correlate complication study correlate two major mellitus complication relationship however current datum suggest presence complication may contribute development patient study need mechanism diabetic disease correlate develop system development complication identify patient risk positive impact patient aim present study review diagnosis risk factor diabetic possible renal diabetic
26234442 en perform trial compare insulin insulin care insulin treat type mellitus T2DM patient control study insulin treat T2DM patient primary receive intervention care according association control insulin intervention insulin according blood glucose level primary outcome difference mean day treatment mean age year intervention control respective mean hba1c mean BMI respective intervention care assess mean day treatment respective adverse event rate significant lower intervention group vs event rate lower intervention group vs treatment care group patient associate less adverse event
21688017 en important role diabetic aim research study effect serum concentration type mellitus patient type patient healthy subject serum protein assess respective study show diabetic patient control patient significant correlate clinical diagnose one patient serum patient high control value total protein patient control result indicate type diabetic patient dysfunction type patient
26553413 en diabetic mellitus type case medical treatment base increasing activity however effect response aim study outcome type patient patient included study patient randomize according ratio two treatment group group on type group new include primary study reduction consider change total index function rate patient study group on significant difference baseline month observed relative mean difference mean difference total mean difference mean difference group on observed significant difference mean difference mean difference significant difference compare group observed significant group on vs group primary study patient can type
26282731 en aim study assess patient type mellitus major database well drug study randomize control trial compare included two independent study evaluate risk datum included analyzed provide compare reduction hemoglobin hba1c patient target hba1c significant great group lead great fasting plasma glucose reduction significant body weight observed found improve cell function model assessment high incidence increased compare potential base hba1c body weight cell function study evidence common adverse event identify
22538152 en show effective insulin patient however patient result regard impact randomize study compare regard patient use insulin patient mean age year mean body mass index type type similar vs vs score mean similar vs vs vs vs patient vs vs similar mean vs vs study insulin patient
22437118 en evidence suggest condition contribute dysfunction among patient type mellitus review relationship mechanism metabolic syndrome cardiovascular disease review perform consider impact metabolic syndrome condition also association obesity metabolic syndrome T2DM dysfunction suggest dysfunction condition important risk factor identify relationship primary care care relationship patient provide activity mean new diagnosis dysfunction metabolic disease consider risk T2DM association metabolic disease disease dysfunction suggest patient T2DM
24172560 en early compare patient type mellitus retrospective study undergo medical hospital perform patient mellitus diabetic group patient without mellitus group diabetic patient control blood glucose little one week examine one day one week one month pressure measured finding diabetic group studied difference clinical diabetic group significant high diabetic group group less number patient one day one week significant high diabetic group group day or CI less week or CI less diabetic
23900468 en mellitus common metabolic disorder incidence increasing although effect mellitus previous datum regard possible positive effect index conduct clinical trial determine effect patient type mellitus clinical trial conduct total patient T2DM duration three month patient receive receive patient fasting plasma glucose serum insulin hba1c insulin index three month group receive show significant decrease hba1c model assessment insulin resistance compare group result decrease serum insulin level level group significant difference result study indicate can improve insulin decrease serum insulin hba1c can effect index patient T2DM
23900466 en mellitus insulin reduce insulin insulin resistance patient first type mellitus several consider first diagnosis need patient may disease provide disease impact disease patient assess complication mellitus associate medical condition
23409726 en mellitus type high associate increased risk chronic disease renal disease cardiovascular study management mechanism complication intervention trial study cohort study aim patient little year follow-up study perform use patient baseline follow-up patient subject include determine complication primary renal event outcome patient blood sample obtain analyzed serum plasma use on cohort subject factor complication use study
23041303 en mellitus complication factor reported associate type addition role blood glucose level study aim evaluate association gene total patient undergo primary without history included associate type population vs found significant associate analysis or per blood level month or age year or identify independent risk factor can high model show significant high model clinical parameter associate increased risk potential clinical value
23705980 en diagnosis mellitus DM base fasting plasma glucose level oral glucose tolerance test recent value included test diagnose DM study hba1c method diagnose DM patient
23597421 en study use hemoglobin hba1c hemoglobin hba1c important diagnosis management mellitus different hemoglobin include high different report use different show little analysis present study hemoglobin sample diabetic blood sample individual normal glycemic status diabetic patient clinical hospital hemoglobin hba1c sample range use base parameter baseline use hba1c hemoglobin value obtain method compare value reported total sample hba1c range on correlation observed hemoglobin value obtain method obtain sample therefore may hba1c primary
25544682 en analysis estimate prevalence type mellitus T2DM adult obesity also population according treatment factor related health total adult year population prevalence T2DM CI sample adult population age patient year man mean body mass index man woman prevalence obesity man woman treatment high blood pressure regard known treatment patient oral drug use insulin therapy also diabetic reported remain disease major compare population parameter show woman
24931280 en study evaluate effect development type control trial database research study clinical trial identify primary analysis study clinical trial sample participant on review effect associate reduce risk develop type relative risk low CI analysis base health status participant number show similar result include assessment duration follow number event present result major health can adjust individual need primary
24449680 en care may poor glycemic control study assess total participant type mellitus receive multiple insulin study participant old year age evaluate age different participant age difference compare positive correlation age age diagnosis use age diagnosis independent
24180143 en common complication determine prevalence risk factor type diabetic patient mellitus type mellitus patient blood pressure patient patient compare without different clinical datum analyzed use statistical odd ratio presence consider statistical prevalence type diabetic patient statistical significant association presence common complication type mellitus patient blood pressure care type diabetic patient
24074715 en investigate role development related type mellitus T2DM use two group control group model group high week week model serum level glucose analysis change assess protein model group show significant high level glucose control group vs less vs less vs less group also show group significant high control group vs less vs less well protein level vs less vs less level follow vs less vs group protein positive correlate less less protein less may response development related T2DM
23672960 en recent may adverse health effect current study investigate mellitus DM DM DM type DM T2DM plasma three group analyzed DM T2DM age control without DM target included similar profile measured plasma compare profile profile different plasma found significant high concentration plasma compare two group group difference ratio suggest lower diabetic without may whether can ratio similar ratio result study suggest may model assess present
23604551 en aim compare treatment base oral vs patient type mellitus week study patient baseline hba1c ratio use oral use drug week patient type mellitus study aged year week hba1c fasting glucose use woman study remain use method control study perform use response system week patient hba1c fasting glucose treatment patient hba1c primary analysis assess whether use oral drug use drug regard hba1c change baseline week use population population patient included oral therapy week respective hba1c decrease week treatment group large reduction week group mean change hba1c week CI oral group CI group study treatment general well reported oral reported oral treatment need may patient type mellitus control compare treatment oral similar effect hba1c overall trial study
24905823 en present suggest activity patient type mellitus due datum obtain patient condition according level associate perform therapy patient type mellitus healthy control patient man woman year body mass index hba1c control man woman year body mass index perform rate blood sample obtain clinical analysis blood sample determine lipid patient show high value compare control vs group remain increased significant patient control without significant difference two group positive correlate hba1c negative related first evaluate patient type condition therapy found due condition several time activity increased patient control suggest effect
24925592 en evaluate influence gestational mellitus weight retrospective study perform one woman gestational control week included impact BMI method gestational age complication also effect metabolic control gestational hypertension significant high group gestational vs vs difference incidence vs large gestational age vs gestational age vs severe gestational age vs weight vs group gestational compare without difference compare gestational without weight outcome relationship hba1c increase risk weight control influence rate weight outcome study population gestational associate high risk gestational hypertension
21531226 en diagnosis mellitus base glucose concentration association include new hemoglobin change may significant diagnosis conduct review include report plasma glucose test diagnose identify individual test increase number patient diagnose glucose base regard complication may level glucose great less test clinical patient among
19968592 en determine prevalence diabetic adult patient mellitus type determine profile management patient patient mellitus obtain medication history use identify presence diabetic score total patient overall prevalence diabetic found age patient duration found statistical significant factor development diabetic statistical significant difference found history body mass index presence diabetic receive treatment use number management increased two patient reduce compare however use study adult type found diabetic high
19817963 en whether impair fasting glucose type mellitus assess subject undergo health total individual man woman without type mellitus included multiple logistic regression analysis perform adjust age body mass index elevated blood pressure hypertension history mellitus fasting glucose type mellitus new diagnose man woman respective within period prevalence new diagnose impair fasting glucose type mellitus significant high participant without adjust factor risk factor impair fasting glucose type mellitus man odd ratio or confidence interval CI woman or CI impact among participant lower body mass index man or CI woman or CI one body mass independent risk factor impair fasting glucose type mellitus impact lower body mass index undergo health
25193282 en gestational mellitus associate adverse outcome well include increased risk type cardiovascular disease early risk complication improve diagnose gestational health profile study show associate several metabolic disease include gestational provide review current research gestational clinical diagnosis management gestational conduct use mass metabolic profile profile gestational identify included study assessment included conduct use review included associate gestational analysis included study high study gestational present finding regard profile characteristic study need large population
23027319 en receive use health evidence use clinical care examine association use clinical care disease control patient medical analysis adjust patient characteristic medical time patient treatment hemoglobin hba1c cholesterol associate statistical significant treatment hba1c value great odd ratio CI value odd ratio CI increase hba1c level among patient change among patient disease control hba1c level level decrease among patient hba1c level less level less also associate statistical significant reduction hba1c level large reduction among patient control reduction among patient baseline level baseline cardiovascular care associate improve drug treatment control among patient great among patient control less patient glycemic lipid disease
21970577 en treatment without may cause examine patient mellitus patient general hospital due mellitus study datum type use factor analysis perform define patient study mean age study population year type patient reported treatment score female lower hypertension disease significant relationship factor analysis revealed factor factor treatment method related factor use factor factor related diabetic patient assessment patient management care
21131807 en present case mellitus present patient diagnosis include metabolic mellitus one several cause severe period cause diagnosis case management present possible mellitus
22138077 en investigate hemoglobin level among similar history type studied sample adult type mellitus included assessment fasting plasma glucose oral glucose tolerance plasma insulin hemoglobin insulin function use model study included participant compare participant participant lower fasting plasma glucose level vs lower plasma glucose oral glucose tolerance high body mass index vs similar insulin function hemoglobin high participant participant vs difference hemoglobin level adjust age hemoglobin body mass index fasting plasma glucose glucose healthy type mellitus study participant high hemoglobin level participant adjust age blood glucose known plasma glucose level hemoglobin diagnose
26957910 en mellitus DM disease disease base clinical use first study disease finding disease occur diabetic patient
26785771 en clinical study indicate mellitus type DM risk patient also develop disease DM cause insulin resistance relative insulin insulin also study revealed insulin insulin insulin report insulin presence insulin less insulin insulin insulin study indicate insulin may contribute DM
23701472 en aim present study test association effect gene gene gene hypertension patient type subject type study determined analysis association gene gene gene age body mass index level high protein level found independent risk factor subject type whereas result study test gene found associate development indicate gene subject type
19797943 en evidence indicate contribute disease role complication lead system associate increase result multiple related glucose study outcome however trial different evidence role increased show health clinical trial may well
22507291 en investigate patient mellitus association characteristic conduct sample adult patient primary care included patient recent hba1c value medical patient hba1c test result number response common among great negative impact on significant association observed impact duration use insulin on negative correlation found hba1c value reported poor found associate high hba1c value insulin therapy may negative impact patient study indicate disease management improve patient
26438611 en associate adverse cardiovascular event observed patient type mellitus T2DM cause per may related impair investigate relationship metabolic change T2DM patient T2DM control subject undergo cardiovascular assess ratio function use ratio respective compare blood control subject subject associate high impair impair indicate dysfunction important independent indicate may contribute dysfunction aim reduce may function patient
25480426 en serum woman gestational mellitus healthy woman glucose study include woman subject normal evaluate gestational week week serum insulin insulin resistance evaluate similar normal increased group decrease healthy control correlate insulin insulin resistance two group positive correlate insulin insulin resistance negative correlate healthy woman woman develop lower level woman normal glucose associate correlate insulin resistance woman develop lower concentration correlate insulin resistance woman
24467823 en study contribute determine type less year old study incidence review patient less year study study duration period study age datum incidence rate case per study report diabetic time diagnosis range study mean incidence less year old study case per need use datum
23889661 en patient obesity type well however regard role management patient type obesity present follow-up two woman type obesity associate undergo year body mass index BMI within normal range hba1c level also reduce insulin associate overall significant improve compare result recent one potential patient type
20886433 en aim present study determine analysis type diabetic patient hba1c level also correlate patient type patient type mellitus mean age year examine compare control cell mean cell cell pressure statistical significant decrease cell type disease healthy subject diabetic normal hba1c level correlate correlate mean cell significant correlation observed diabetic mean cell type mellitus significant difference found evaluate present study type mellitus compare normal subject result indicate type diabetic change type
25599430 en mellitus DM common disease level blood glucose occur general due effective function insulin common type include type type different treatment general population type type type known case current review examine positive patient DM control management conduct study identify demonstrated effect intervention hemoglobin hba1c case reported intervention reduce hba1c patient DM intervention also patient lipid profile cardiovascular outcome body mass index reduce complication associate disease also reported associate management DM
24972975 en although range assess study evaluate sample present study compare among health profile sample remain total patient type mellitus mean age year hospital clinical medical hba1c effect ratio sample relative patient poor control hba1c revealed use time sample study use level similar compare patient poor sample large similar clinical trial study
20429801 en increase risk mellitus insulin resistance model show increase insulin therefore diabetic model use study effect type disease receive rate follow rate control day level diabetic treat high significant reduce day level decrease control level duration study day effective diabetic model healthy activity different range observed effect
25335235 en recent study role one among major DM complication patient type year high level period cardiovascular complication type also found level significant lower patient normal body weight level high patient increased level normal body weight patient type consider disease known glucose metabolic occur cause change
25316226 en evidence study revealed status associate glucose insulin resistance increasing risk develop type aim study glycemic control patient type may may total type patient metabolic disease hospital blood sample hemoglobin hba1c patient index evaluate status define define poor define poor glycemic control define hba1c time define duration poor glycemic control group rate patient high group rate poor poor glycemic control group great control group adjust age body mass index disease duration adjust score or CI hba1c level duration or CI hba1c level analysis show poor group high model resistance regard risk factor glycemic control type poor insulin resistance can glycemic control on health treatment type important target cause duration poor
24193810 en aim investigate incidence diabetic regression diabetic associate risk factor patient type mellitus cohort type year age identify diabetic parameter assess evaluate clinical parameter use early treatment study mean age year mean duration year incidence regression respective incidence logistic regression model significant associate hba1c or per increase CI blood pressure or per increase CI associate or vs female CI hba1c or per increase CI or per increase CI one three two three age increased metabolic control year duration presence
23480298 en study association glucose type mellitus T2DM risk present study perform association database conduct obtain relationship T2DM follow individual study included analysis analysis revealed effect odd ratio or significant or confidence interval CI model or CI analysis show positive result model however analysis relationship T2DM risk model factor development T2DM analysis found result present provide evidence may increased T2DM however current evidence association T2DM overall population
23015358 en evaluate effect control individual patient poor control type mellitus gene cholesterol control subject patient poor control type mellitus treat cholesterol lipid protein use gene several use two high diabetic patient control subject cholesterol impair treat diabetic patient control cell reduction protein presence cholesterol high level lipid observed diabetic individual control reduction associate decrease patient type poor control type diabetic patient impair cholesterol lipid possible contribute
26112844 en type mellitus T2DM consider factor development oral increase risk study evaluate effect patient one patient study group T2DM mean age female receive treatment oral period little three year healthy control mean age included study on clinical history subject datum assess patient mean body mass index vs range duration among woman vs group level vs vs vs vs also similar study control group presence normal vs vs vs study control group significant difference observed among T2DM patient treat treat present finding show use period three year significant patient T2DM
25928419 en aim study whether common gene gene associate obesity index BMI subject type mellitus T2DM population aim association T2DM
25851098 en clinical significant present one type mellitus T2DM increase risk development T2DM risk insulin resistance complication diagnosis T2DM increase risk contribute severe among multiple may include weight two recent randomize control treatment trial patient T2DM medication effective therapy effect glycemic control however number study patient randomize treatment included analysis datum evidence base need control trial management T2DM trial determine effect treatment change treatment glycemic control medical outcome
25733326 en perform clinical analysis diagnose perform effect gene lipid profile investigate use identify found lipid profile show level significant lower level plasma concentration show significant difference analysis revealed protein can found gene two diabetic patient study analysis suggest gene may lipid may factor high risk
25636696 en glucose treatment type mellitus common patient type mellitus study investigate potential study patient type mellitus randomize receive day day follow day day follow day little period treatment parameter assess assessment included adverse event assessment age patient treat year body mass index effect mean ratio interval CI CI respective CI CI respective mean ratio interval CI CI respective CI CI respective treatment profile similar patient treatment severe adverse event observed
24405767 en evaluate patient type mellitus T2DM determine prevalence use renal identify potential case related retrospective study review patient diagnosis T2DM major hospital period datum include medical condition medication result medical total patient medical patient patient included according patient receive presence respective patient little one use patient according renal function patient little one patient receive according renal function patient evidence plasma concentration without clinical use patient use high may risk low
26095516 en change serum lipid profile associate increased concentration reduce level occur early day level increased level decrease change parameter observed patient mellitus finding suggest change lipid early development
25894943 en evidence important risk factor develop mellitus contribute effect population study potential mechanism identify change reduce risk review recent finding study provide risk
25414936 en management mellitus important period significant influence glucose level outcome trial oral medication insulin develop glucose management medication management trial provide effective glucose patient
23914416 en research examine difference estimate odd develop mellitus age period datum health study reported first time period model use develop odd develop odd new diagnose increased incidence study participant among period increased remain period incidence year incidence incidence year significant elevated odd develop period difference health characteristic
27174326 en on study identify several protein gene type mellitus T2DM within population among show significant association T2DM aim evaluate whether common gene associate T2DM patient new diagnose T2DM control subject use method subject hospital medical evaluate T2DM risk individual use logistic analysis association metabolic significant associate T2DM study population odd ratio confidence interval addition among control significant associate increased body mass index model resistance gene associate T2DM population gene may contribute risk development T2DM
24570406 en study aim estimate prevalence mellitus DM identify risk factor associate DM case DM identify within patient on study identify risk factor diagnosis DM use logistic regression model model use associate DM case identify prevalence CI increased risk compare whereas associate DM female compare increased odd whereas lower odd DM diagnosis positive associate DM old diagnose high whereas lower study provide assessment DM use datum DM assess management DM
26566780 en impact mellitus DM outcome patient undergo remain patient identify use database score use patient DM without DM ratio mortality complication renal compare two group impact or also analyzed two total patient DM without DM overall patient DM significant develop negative impact outcome perform within however significant increased patient negative impact outcome patient undergo within however result outcome
22000180 en outcome patient body mass index BMI examine effective medical management control target define association type mellitus T2DM patient obesity BMI T2DM identify patient undergo obesity T2DM compare similar treat primary care datum baseline year blood pressure well blood level cholesterol hemoglobin BMI decrease hba1c decrease cohort significant change BMI hba1c significant change group group decrease medication use compare group group use medication year perform patient BMI T2DM weight glycemic control medication medication may increase
21947298 en report relationship cardiovascular disease risk factor function patient type mellitus control complication intervention complication obtain patient type mellitus also obtain patient mean age year man mean duration mellitus year association cardiovascular disease risk factor parameter examine logistic regression model history positive associate mass significant high ratio mass mean hemoglobin level year associate per mean hemoglobin per mean hemoglobin positive related ratio elevated mass per overall prevalence clinical mean hemoglobin odd ratio confidence interval per odd ratio confidence interval significant associate cardiovascular disease risk addition cardiovascular disease risk factor elevated mean hemoglobin significant associate function prevalence participant relative renal function clinical trial
26209731 en renal disease patient mellitus type metabolic control blood pressure effective intervention without effect early patient risk incidence renal use new high patient hypertension important renal disease therapy target factor risk renal evidence suggest also contribute individual patient patient intervention effective subject statistical clinical trial individual current clinical evaluate therapy need
25747012 en patient mellitus recent patient female mellitus develop blood glucose hba1c patient undergo new observed treatment time insulin treatment also improve week treatment also decrease perform observed blood decrease increased two week follow-up blood increased decrease suggest cause related activity impair activity cell cause
23302127 en base increasing evidence study regard potential risk factor type mellitus T2DM dysfunction insulin resistance condition contribute development T2DM disease study revealed association T2DM randomize control study investigate effect insulin insulin T2DM need
21807392 en associate cause insulin resistance function study test insulin first month treatment three group one group two group one receive insulin month receive insulin develop group develop month high risk insulin treatment insulin can
23883470 en type mellitus disease health therefore first level health care medical reduce incidence aim present analyzed group two clinical several clinical patient associate low mechanism effect associate resistance insulin dysfunction disease clinical clinical management result population study new finding clinical effect number
25966055 en disease chronic disease cause common cause elevated level serum examine change type mellitus T2DM relationship insulin resistance T2DM T2DM group patient study body mass index fasting blood plasma glucose fasting insulin model assessment determined according ratio compare T2DM group fasting blood plasma glucose group significant increased significant reduce body mass index group significant high T2DM group group severe compare group negative correlate body mass index fasting blood plasma glucose negative correlate positive correlate fasting insulin group on severe associate high lower important factor
25924608 en clinical characteristic cell function patient new diagnose drug type mellitus T2DM different level serum new diagnose T2DM different group according level serum patient undergo oral glucose tolerance test insulin test datum lipid profile glucose level insulin profile compare different group insulin function index model assessment cell function index cell function index glucose index early insulin function index index use evaluate cell new diagnose T2DM lipid profile glucose profile high insulin level normal difference early insulin among group new diagnose T2DM patient different level cell function increased level decrease level insulin relative high patient low level low high level influence clinical characteristic cell function patient new diagnose T2DM on management may reduce effect glucose patient new diagnose T2DM
25889498 en use among patient type mellitus T2DM compare characteristic T2DM patient new new oral drug identify factor associate conduct study within clinical research health research database first month month patient included year old new respective database day age logistic regression use identify identify datum use hypertension associate use also associate hemoglobin result within datum great number hemoglobin datum datum associate poor glycemic control use diagnosis hypertension
25874962 en glucose study result trial may role glucose impact study aim examine influence incidence type mellitus DM among retrospective cohort study include patient without DM cohort subject patient treat group compare receive treatment age group new diagnose DM identify medical disease clinical incidence DM group group significant high incidence DM odd ratio confidence interval compare group analysis DM risk reduction group significant among year without hypertension patient time demonstrated significant reduction DM study show effect DM effect patient old age hypertension mechanism need datum observed finding
25755198 en cohort study determine whether change associate metabolic response risk type mellitus intervention total mass mass assess change independent associate reduction BMI total mass mass within high change CI CI CI time decrease body weight BMI compare low change response significant related increase risk T2DM
19098013 en mellitus associate high incidence study prevalence outcome patient among patient patient present period identify care total patient mellitus female vs mortality rate high diabetic patient vs odd ratio confidence interval use odd ratio CI independent associate reduce mortality prevalence mellitus among patient define population develop high poor outcome however mortality significant high mellitus mellitus patient
20869343 en impact outcome aim study relationship clinical outcome patient cohort type mellitus sample patient T2DM datum patient status patient datum analysis logistic regression age duration study cohort show high level cohort high lipid control risk factor hba1c blood pressure blood pressure total cholesterol related significant relationship metabolic cardiovascular risk management risk factor independent
25723687 en use case study statistical analysis provide factor on well also retrospective study review case follow-up use patient previous history effect primary on logistic regression analysis primary total case female identify follow-up month subject logistic regression analysis female odd ratio or confidence interval CI mellitus significant increased risk statistical datum suggest increased risk female subject mellitus datum patient management database research
25998626 en relationship function patient type mellitus T2DM identify factor study included patient identify one high on high significant associate improve score model model adjust age model adjust age diabetic decrease prevalence model model adjust age high score associate high score low prevalence patient T2DM
22920280 en develop database case medication risk present study retrospective cohort study aged year identify medical care primary diagnosis little two different type common diagnosis type define insulin one oral case consider type cohort medical review case database well sample medical care study included case database clinical new diagnose positive value type type positive value estimate base sample case database result suggest database case may study medication
24026961 en insulin remain effective mean blood glucose level insulin clinical use however due need profile activity increased insulin insulin lower risk compare due improve profile reduce glucose indicate insulin recent trial type type show although reduction overall difference new include insulin increasing new profile review recent insulin include trial
23088514 en on study show positive blood glucose control therapy patient type mellitus therefore evaluate effect insulin study insulin resistance diabetic patient relationship chronic complication also total type female two month level blood glucose fasting insulin index hemoglobin measured patient significant difference fasting blood glucose value hemoglobin also reduction group however observed change insulin value female show significant increase value studied use decrease insulin resistance type diabetic patient suggest positive blood glucose control therapy treatment
26238470 en study evaluate new insulin insulin treatment type type T2DM conduct use insulin study assess compare insulin trial study T2DM study demonstrated glycemic control mean change hemoglobin associate reduce compare relative risk CI also evidence less weight compare high insulin well number adverse event result suggest may insulin patient T2DM improve
23324250 en glucose protein can one mechanism gene protein studied severe mellitus mellitus use different high treat per week effect several metabolic parameter protein studied mean treatment decrease blood glucose concentration increased insulin level model severe mellitus severe mellitus increase gene protein diabetic increase gene protein level influence treatment severe diabetic diabetic gene protein independent gene found glucose insulin level severe diabetic cause severe
22267300 en increased number case type mellitus diagnose current obesity receive treatment patient type mellitus disease multiple dysfunction insulin resistance include important patient type mellitus review mechanism system patient type mellitus
26496534 en gestational mellitus associate adverse outcome oral glucose tolerance test test diagnosis evaluate role hemoglobin hba1c diagnosis correlation adverse study hba1c perform woman week woman follow hba1c woman week woman diagnose incidence mean hba1c level woman whereas woman high incidence complication compare woman hba1c diagnosis woman woman however hba1c woman two woman mellitus whereas impair glucose hba1c diagnosis use test woman use
23083925 en study investigate system function subject type diabetic age year healthy control age year undergo two test follow two occur plasma measured effect define difference measured parameter baseline effect interval diabetic subject effect early group control subject lower rate control subject type evidence can use current present assessment can early period rate
26551311 en include change subject aim change level level cholesterol level high association low level subject cardiovascular disease obtain subject man woman month level group subject decrease change significant however concentration reduce significant man whereas significant change woman case level high level reduce case level high association low level significant decrease addition case level low level significant increased change decrease level lipid man high level lipid profile response change related reduction lipid also increase level
27181269 en change serum protein lipid parameter woman without gestational mellitus period well identify whether association development total normal glucose tolerance participant week study clinical serum protein model assessment insulin resistance lipid profile measured normal glucose tolerance group group show great level protein decrease level period body mass index independent factor impact serum level independent associate concentration multiple regression analysis serum protein risk factor factor group high level body mass index independent factor serum related obesity insulin resistance resistance major risk factor
26254248 en compare protein among woman without gestational mellitus high found without high found group compare group related high
21940283 en determine effect level patient type mellitus
22019947 en study examine association mass serum concentration subject type mellitus level serum high protein protein measured body determined measured significant positive correlation body significant positive correlation serum negative correlation correlation similar result obtain serum negative correlation subject serum show positive correlation subject finding indicate increased associate change may type mellitus
21489568 en mellitus cause well determine whether serum healthy diabetic patient mean reduce patient mellitus reduce healthy diabetic patient body mass index age blood cell influence high level hemoglobin associate increased whereas cholesterol total cholesterol total cholesterol cholesterol ratio decrease serum oral influence insulin woman lower woman complication found man suggest severe mellitus complication resistance consider mellitus
21810068 en increasing evidence major role mellitus DM also factor diabetic complication factor also include lipid protein cell potential mechanism glucose development DM complication cause cell however common time cause chronic cause insulin gene insulin well increased method determine develop assessment complication however clinical less trial
24408248 en assess prevalence possible association mellitus hypertension study individual old year undergo history evaluate subject age year individual test subject statistical test associate prevalence found difference difference hypertension mellitus prevalence significant difference association association mellitus hypertension independent risk factor
24666397 en aim study evaluate prevalence dysfunction patient type mellitus T2DM total include T2DM patient mean age year healthy control mean age year included study datum blood hypertension disease subject dysfunction index function on analysis perform determine relationship cardiovascular risk factor complication control group similar patient respective respective whereas hypertension common value significant high patient T2DM compare control patient score significant lower patient control vs significant high patient control severe dysfunction vs analysis revealed diabetic factor associate high presence presence present study revealed prevalence high patient T2DM healthy control diabetic risk factor associate high severe
24505484 en recent datum suggest disease associate risk factor adverse cardiovascular outcome type diabetic individual investigate association type group individual prevalence two disease type diabetic patient without disease disease disease diagnose whereas determined participant sample patient patient associate increased risk odd ratio or CI age duration treatment body mass index hypertension hemoglobin estimate rate association risk CI result provide first positive independent association patient type mellitus
25382096 en type mellitus treatment glycemic control patient remain treatment improve glycemic control reduce weight low risk treatment significant development regard identify related database perform study evaluate analyzed mechanism current studied new clinical include insulin therapy type weight addition several development target glucose may insulin insulin may common adverse effect rate among due difference rate adverse effect within evaluate independent treatment well potential treatment
23402560 en retrospective study aim examine association oral drug treatment clinical outcome patient type mellitus chronic disease study use large database finding identify patient diagnosis first observed index month index baseline period evaluate patient consider regard patient renal glycemic control use index assess month baseline period severe event assess baseline period follow-up regression analysis perform adjust clinical patient included study patient high risk severe event identify CI event identify hospital CI hospital or CI less glycemic control or CI high cohort retrospective cohort effect use base association finding suggest treatment associate clinical outcome research association found study
23174855 en diabetic dysfunction complication mellitus DM include common diagnose important chronic impact DM change reported diabetic patient impact DM large analysis use evaluate gene cell DM female compare control cell DM indicate possible function one factor may metabolic due chronic glucose DM occur DM different significant associate potential function cell can contribute activity result show DM impact may contribute mechanism
22913415 en previous study demonstrated high associate lower risk cardiovascular event patient type mellitus however relationship patient studied relationship patient type total patient type assess measured patient three different vs vs difference clinical characteristic patient high significant high BMI blood pressure low serum protein similar among three patient however patient high lower vs prevalence vs low regression analysis revealed high independent associate result demonstrated patient type high associate lower lower prevalence
27253191 en previous study possible relationship type mellitus diabetic complication present study aim investigate association type mellitus function population type total type mellitus patient study type mellitus previous patient use function evaluate study participant parameter include identify associate parameter obtain study include age duration hemoglobin on related outcome correlate respective respective respective significant association associate function population type mellitus suggest factor type mellitus diabetic population
17018900 en report patient cell develop renal renal associate renal therapy occur severe renal may include renal cell dysfunction
23564595 en study evaluate metabolic response healthy patient type mellitus healthy subject diabetic patient receive glucose blood sample time glucose significant difference baseline glucose insulin group difference glucose significant healthy diabetic glycemic response decrease compare estimate glycemic index
22104260 en study cell diagnose gestational mellitus woman undergo oral glucose tolerance test study level define blood glucose year perform measured datum previous control negative associate development whereas high risk associate presence positive associate impair glucose less develop type associate high risk type positive associate development
22583516 en associate risk develop type study assess among patient healthy control study determined healthy control found positive association association found found among patient whereas negative associate disease result previous reported association population difference negative association
22465964 en type mellitus increase blood cell test index function protein activity aim study determine effect blood cell patient type mellitus cell determined healthy subject patient evaluate patient healthy subject patient control group show high cell patient high concentration total show significant difference two group healthy subject index show change addition index patient significant decrease addition increase patient role cell patient healthy subject role show first time concentration patient can role condition
20120653 en mellitus use current health association study determine prevalence risk factor mellitus sample study included man woman aged year participant examine blood glucose test mean age participant year overall age adjust prevalence respective use type type type type according plasma insulin plasma level participant type diabetic rate type among diabetic estimate age obesity hypertension protein significant positive associate general type high prevalence due high rate type risk factor potential primary
24699792 en relationship mellitus type study demonstrated result however large study recent year demonstrated positive correlation increased risk little two associate increased risk cardiovascular event patient mellitus type identify individual obtain great glycemic control well therapy
24520939 en several study examine association risk gestational mellitus type mellitus T2DM however study statistical result aim provide relative association T2DM study conduct odd ratio confidence interval use evaluate association model according test result analysis perform use study report included total patient T2DM healthy control result show risk may associate increased risk analysis show effect significant among indicate difference T2DM or significant overall population although or increased risk T2DM on however significant T2DM indicate risk may increase T2DM risk whereas study need effect disease
24753703 en on glucose reported study examine hemoglobin hba1c patient type analyzed hba1c value patient association value overall hba1c high value low value difference year on statistical significant observed patient oral drug without insulin treatment correlation hba1c value confidence interval CI hba1c value patient type high value treat clinical glucose control
23802882 en study use among patient mellitus DM primary study prevalence type use among patient DM primary care study diabetic patient define group medical system general consider datum analysis use multiple logistic regression use identify prevalence use female time use follow therapy use follow base system system system system therapy total diabetic patient follow respective mean per month according multiple logistic regression analysis or CI significant positive association prevalence use high among diabetic use among type DM patient use study activity may need
23017082 en age important role development mellitus however known age type clinical factor study aim evaluate age healthy subject subject severe chronic type DM type DM healthy subject studied clinical metabolic age also type DM present significant high cell subject type DM also on positive significant correlation found age time DM type type DM hemoglobin lipid profile body mass index age correlate significant age subject age increased type type however clinical parameter determine therefore influence development may duration DM
26874994 en mellitus type T2DM metabolic disease potential adverse impact health aim potential mechanism datum gene use identify profile use function T2DM identify include increasing high response activity response response two function response response glucose T2DM include include identify may important role T2DM
26680606 en cell chronic disorder show syndrome include type mellitus within clinical examine effect patient healthy control blood cell assess analysis also perform perform ratio disease develop new system associate
20851582 en treatment mellitus two provide diagnosis treatment complication level evidence system day evaluate provide care well diagnosis treatment complication well care reported
26784126 en study evaluate glucose system compare use management blood glucose period year age
25359227 en evaluate clinical outcome insulin insulin insulin among patient type mellitus medical database retrospective study examine two cohort cohort patient previous cohort patient previous within cohort treatment group baseline characteristic follow-up insulin treatment hba1c level event weight body mass index BMI analysis included patient cohort cohort baseline characteristic similar treatment group cohort follow-up cohort patient significant less treatment use insulin high hba1c value lower hba1c reduction lower patient hba1c compare patient rate value change baseline similar two cohort overall finding patient study show result patient T2DM insulin although result may subject analysis study
25005458 en role new type mellitus result study aim study therefore fasting concentration patient healthy control examine difference concentration two group study included negative patient age year disease duration year healthy control age year fasting total concentration measured datum statistical level fasting total concentration significant lower patient total compare healthy control total total age body mass index logistic regression show fasting total remain significant independent lower patient total or CI or CI patient independent lower total fasting concentration healthy potential role therapy insulin therapy patient
24128999 en glucose individual consider year first hemoglobin hba1c use estimate risk develop diabetic complication define target treatment however time glycemic consider identify role fasting overall assessment disease lead glucose although impact glucose common need subject review recent evidence glucose also different related development diabetic complication provide new old drug impact glucose
24937534 en show associate type mellitus DM study healthy individual found associate lower insulin associate poor severe DM retrospective study DM DM patient datum characteristic body mass index study perform patient define index lower among DM patient prevalence DM individual DM individual also lower great time high index regression analysis show associate hemoglobin result among DM individual reduction associate increase hba1c whereas increase associate increase hemoglobin adjust range potential high prevalence DM individual positive relationship need assess management glycemic control
26796275 en mellitus T2DM chronic metabolic disorder several drug T2DM develop develop study associate due increase disorder recent drug include due associate effect known activity result obtain new addition protein on different mechanism lead increase level increased insulin significant level activity cardiovascular individual profile present review
23718682 en study health outcome model type mellitus model health outcome patient T2DM model present result assess use outcome medical result number clinical trial compare observed study use regression regression assess whether statistical define addition model use study datum test also perform outcome test also perform type datum use vs use model treatment regression outcome trial analysis respective on difference can high datum associate regression analysis identify high respective estimate respective mortality show although observed value can study include datum one test base outcome outcome study analyzed two study study old treatment identify datum use T2DM method treatment patient outcome observed important clinical trial model outcome common model may related general event rate study outcome model new risk improve model
21300417 en investigate prevalence oral patient type identify possible risk factor related oral patient type healthy control subject datum well current history clinical oral high prevalence oral found patient patient without significant difference development condition potential disorder multiple logistic regression odd ratio odd ratio increased odd oral mellitus show increased prevalence oral also significant potential disorder finding clinical early diagnosis management oral patient
21570644 en relative datum mellitus metabolic syndrome population therefore investigate association type gene presence mellitus metabolic syndrome well define group define disease evaluate presence patient without mellitus assess use base high diabetic compare group determined difference remain significant female regard significant high on lower diabetic group remain significant female logistic regression analysis serum fasting glucose found independent presence patient total population subject significant difference without metabolic syndrome metabolic syndrome use significant lower subject metabolic syndrome define may associate presence mellitus subject
26467133 en protein case insulin resistance type mellitus T2DM increased protein decrease therefore change level diabetic vs aim study difference level patient type control presence measured use serum level glucose determined use hemoglobin hba1c measured total serum T2DM patient measured significant different group significant decrease level significant increased level diabetic difference diabetic observed level diabetic patient can
24338736 en investigate association risk type mellitus T2DM patient medical total patient T2DM healthy identify use patient receive oral therapy fasting plasma glucose plasma glucose hemoglobin fasting serum insulin serum insulin model assessment insulin resistance total cholesterol test obtain treatment risk high patient T2DM healthy patient T2DM significant reduction compare patient great increase addition high value compare effect treatment reduce patient T2DM risk compare associate T2DM patient
24290656 en use cell great outcome clinical aim evaluate therapy type mellitus
22119815 en gene several disease include mellitus renal aim investigate gene type mellitus T2DM related renal disease type mellitus patient without patient without age healthy subject analyzed study sample subject statistical analysis indicate similar patient control group CI T2DM patient without CI T2DM patient patient also significant difference compare subject vs one CI statistical significant result found association gene type mellitus renal disease
17111080 en on severe per day large history three year age age undergo month due
16319185 en disease result protein plasma cell reported two type study assess clinical treatment study cell system patient decrease increase observed day plasma study study indicate cell function treatment also can treatment several disease result protein
26568332 en evidence indicate system gestational mellitus factor gene protein gene investigate level obtain woman without control group correlate clinical parameter subject blood woman cell determined time correlation analysis perform assess association clinical characteristic patient significant increased level patient study group significant positive association protein level also correlate positive fasting insulin resistance study impair glucose may diabetic patient associate glucose dysfunction addition finding model study relationship metabolic change woman well assess potential mechanism
20720443 en associate development insulin resistance mellitus present mellitus insulin resistance cell therefore mellitus type study result datum influence glucose insulin development mellitus early diagnose disease occur patient new diagnose mellitus type risk group primary identify patient review relationship mellitus patient new diagnose mellitus type use insulin resistance glucose disorder total review
20453503 en mellitus associate risk mortality hemoglobin hemoglobin patient mellitus study evaluate whether hemoglobin associate risk major adverse event patient retrospective study follow-up patient mellitus undergo study hemoglobin level measured within month period case high hemoglobin level increased incidence base analysis hemoglobin significant ratio increase hemoglobin level CI age chronic renal associate increased risk patient mellitus
24450766 en evidence gestational diagnosis gestational determined study gestational define plasma glucose concentration oral glucose tolerance test report prevalence gestational year woman diagnose gestational effect time prevalence gestational assess model overall increase prevalence increase prevalence CI CI due rate number woman diagnose gestational increased
22510294 en common mellitus patient investigate relationship control subject test reported independent risk factor type control subject measured baseline fasting plasma body weight concentration baseline glucose measured sample ratio statistical increase identify multiple regression concentration significant subject compare control plasma concentration also plasma significant negative increase however different relationship control patient relationship found glucose plasma high low plasma concentration high low response test increasing investigate
22248078 en datum prevalence type mellitus risk factor associate disease prevalence type treatment subject aged year study one study conduct treatment diagnosis compare type prevalence estimate confidence interval study population participant study known type prevalence study prevalence estimate prevalence high man woman prevalence high low among type treatment oral reported less whereas treatment insulin reported prevalence known type show within difference risk factor type treatment show difference
27029364 en investigate association body mass index BMI ratio incidence risk type mellitus total participant year old two included fasting plasma glucose lipid profile perform baseline participant cohort study follow participant female included study incidence regression model use evaluate risk T2DM associate baseline BMI year participant develop T2DM incidence per adjust baseline age history well difference fasting total cholesterol high cholesterol blood pressure blood pressure baseline follow-up regression analysis indicate T2DM risk baseline BMI group BMI obesity group group group significant high baseline normal group incidence risk T2DM high baseline BMI respective whether baseline normal T2DM risk increased baseline baseline normal group baseline group baseline normal group baseline group respective analysis change BMI indicate baseline normal group T2DM risk increased baseline normal develop follow-up respective baseline group T2DM risk baseline normal follow-up associate increased T2DM risk BMI present high T2DM risk T2DM risk can decrease normal
25576078 en study investigate risk type mellitus also develop case three control logistic regression use evaluate risk datum early associate high risk develop odd ratio or confidence interval CI or CI result remain analysis found high risk develop
25423670 en diabetic blood glucose condition due disease type mellitus patient may also cause also reported diabetic disease chronic disease case case report present glucose value new diagnose type diabetic patient normal glucose level define result fasting new diagnose patient
25405560 en compare medical treatment type mellitus T2DM patient body mass index BMI less T2DM metabolic treatment diabetic patient BMI less metabolic identify randomize clinical study evaluate medical T2DM treatment patient BMI less primary outcome T2DM analysis glycemic control BMI hba1c level effect present odd ratio or mean difference confidence interval total T2DM patient included follow-up range month metabolic associate high T2DM rate or CI high rate glycemic control or CI lower hba1c level CI medical CI rate hypertension or CI or CI lower medical treatment T2DM effect T2DM complication mortality
21092093 en relationship mellitus observed among population however study evaluate association aim investigate association mellitus impair fasting among examine man woman aged fasting glucose measured assess associate decrease risk mellitus woman or factor activity history cardiovascular disease body mass index man low high associate increased risk or respective analysis among man day or increased or respective compare association observed among man compare whether can decrease diabetic risk among
18509347 en mellitus develop patient hypertension investigate mellitus development risk develop disease value trial population among patient baseline patient develop mellitus follow-up year mellitus define adverse event report new medication fasting glucose trial potential baseline mellitus logistic regression found statistical significant glucose body mass index BMI age rate randomize study treatment history disease total cholesterol logistic regression analysis use potential baseline mellitus consider significant different model model included patient treatment group potential significant identify model glucose BMI age rate history glucose BMI important mellitus patient high cardiovascular risk clinical characteristic patient risk develop mellitus
24717236 en subject mellitus consider high risk complication evaluate among subject perform cohort study measured baseline week patient adverse event reported perform analysis patient one patient mean level patient old age lower body mass index show lower response analysis indicate independent negative effect hemoglobin level on level among diabetic patient patient potential reduction response
24113620 en evidence suggest effect mellitus DM incidence outcome effect DM treatment remain test DM use impact outcome patient treat analysis patient treat without therapy regression model association DM use disease mortality total patient DM patient use within follow-up month patient disease patient patient cause diabetic patient use significant high risk disease compare patient diabetic patient use regression analysis DM treat without associate CI mortality CI patient without use significant outcome diabetic use possible mechanism impact DM potential effect need
24384240 en study aim compare serum lipid profile plasma three different patient group group type mellitus renal disease group group T2DM healthy control group patient treat T2DM control T2DM healthy control included study plasma concentration measured level significant high T2DM patient compare control plasma respective level also significant lower patient compare control insulin resistance high however normal decrease level patient group group suggest may reduce subject due decrease cell finding
24373634 en gene reported associate T2DM study show result association population patient individual study perform odd ratio or confidence interval evaluate use model on significant relationship gene T2DM observed population or CI or CI or CI or CI model analysis significant association found population population gene found significant associate increased T2DM risk population population gene may T2DM
25890843 en level patient type mellitus database identify study compare level group control group perform compare difference overall mean level two group evaluate test test analysis conduct investigate factor difference conduct total obtain database study included significant observed among study compare control group group significant high level mean difference CI on score sample ratio control show result test test respective according can patient significant increased level compare control subject
25676662 en treatment type mellitus T2DM relative new oral reduce glucose increasing glucose treatment T2DM adult recent patient assess study demonstrated glycemic control reduction body weight blood pressure general well increased risk therapy study show increased risk although clinical increase lipid level observed due care patient risk risk patient datum review show treatment patient T2DM
26975349 en reported potential gestational mellitus however finding aim review study investigate association serum level risk provide database study evaluate relationship serum level risk serum level study study observed difference BMI case study case control association serum level risk three study case control investigate association risk result show high serum level risk factor mean difference confidence interval result analysis base gestational age blood overall result however week include one indicate association serum level risk association risk show associate development result independent risk factor patient level serum level associate risk however association period research association risk
26821975 en gestational mellitus high risk well adverse outcome care primary outcome sample included normal glucose tolerance study included hospital datum medical control datum base hba1c level blood glucose level association status factor well outcome estimate use test control early also within one study early significant different outcome compare control insulin role investigate important role period
23777480 en cell effect patient type examine type significant cell function present time diagnosis type therefore study cell conduct study current aim obtain study cell new diagnose patient type assess study new diagnose patient new diagnose adult type patient randomize treatment cell function group increase level activity per week aim per week month cell function measured primary outcome follow-up level outcome study rate cell outcome study define adult new diagnose type study assess effect cell new diagnose patient type control trial
23580698 en mellitus DM increase risk datum association assess risk diagnosis among man type T2DM study include man identify datum base man general risk among man T2DM lower among man without T2DM or confidence interval CI risk decrease disease duration observed risk although among man low risk or CI risk reduce among diabetic man treatment or CI among man oral or CI insulin or CI diabetic man BMI show reduce risk or CI compare man without risk increasing level hba1c study reduce risk diagnose among man T2DM although decrease among diabetic man large study examine association T2DM risk group treatment
23385112 en investigate effect old adult type aged care adult patient without parameter condition test use estimate control old adult condition show condition participant mellitus without compare normal condition parameter similar group participant healthy control analysis old adult show participant impair function time increased compare participant study show parameter old adult type reduce function presence
22555624 en examine association risk year study follow cohort man woman aged year without health conduct subject group according total score index association incidence investigate use regression model result show ratio subject score subject score subject score compare subject score datum indicate healthy incidence
23405538 en disease one complication type mellitus complication receive little medical significant difference reported prevalence associate risk factor study assess diabetic associate risk factor relationship disease conduct patient follow included addition history parameter body mass index ratio measured perform use diagnose disease lower perform evaluate individual obtain pressure pressure lower value obtain two on use define disease assess use test logistic regression use identify independent studied patient man woman mean age year mean duration year prevalence woman high prevalence compare man present age duration blood pressure hba1c significant correlation obesity use logistic regression old age high hba1c level lipid profile total cholesterol found significant index found evidence type diabetic risk factor significant associate age duration high blood pressure high hba1c level prevalence high patient vs without presence high
22573126 en type mellitus hypertension associate contribute prevalence hypertension increased however little relationship incidence hypertension glucose tolerance impair glucose tolerance datum insulin mellitus trial study type use hypertension present study patient total individual baseline develop hypertension follow-up risk factor time development hypertension obesity baseline ratio confidence interval CI glucose tolerance ratio CI whereas treatment reduce risk hypertension ratio CI significant relationship found development type hypertension patient treatment primary improve reduce incidence hypertension well suggest two common
22209664 en examine association status sample day participant study define fasting blood glucose little medication use included response early included participant significant lower response confidence interval CI without model whereas man lower total CI woman significant high total CI compare without man woman significant lower compare without associate may study need determine role system
21906118 en patient type mellitus great risk however risk factor patient evaluate study evaluate relative different factor patient type retrospective study patient type present body mass index duration control subject use patient medical finding subject examine status associate factor include reported follow associate diabetic diabetic history previous insulin treatment analysis independent associate factor diabetic odd ratio or confidence interval CI previous or CI diabetic significant associate increased risk patient type
25459228 en aim determine type diabetic different time well gene protein also evaluate diabetic diabetic compare control two group control diabetic on group diabetic receive insulin day insulin adjust normal blood glucose level reduction similar change occur level protein increased control value level gene protein activity increased type time normal value insulin control value
25153234 en use factor may cause effect drug report case two woman mellitus type day day gestational week respective patient history
24597930 en type mellitus T2DM risk old adult current study determine factor associate
24140245 en evidence suggest positive effect incidence outcome effect use remain test use outcome patient treat retrospective evaluate patient treat without therapy regression model association mellitus DM use disease mortality total patient DM patient use within follow-up month patient disease patient patient cause regression analysis DM without use associate increased risk disease ratio confidence interval CI mortality CI mortality CI whereas use associate decrease risk disease CI mortality CI mortality CI regression analysis DM treat without use remain associate mortality CI mortality CI disease patient use high risk mortality patient without DM remain whether DM group patient use outcome mechanism effect DM patient potential effect need
25808081 en association type well demonstrated risk gestational mellitus reported finding examine association status study case control measured serum status total early week use mass diagnose according association adjust odd ratio confidence interval use logistic regression case lower mean total vs vs concentration compare woman develop overall concentration total concentration significant associate risk on increase concentration associate decrease risk woman low concentration CI high risk compare woman high status associate risk
25715149 en study analyzed health medication adult population mellitus datum health health system use population significant medication estimate significant difference prevalence use among studied suggest health medication health recent may low level analysis medication mellitus population may contribute population health
25706772 en important role mellitus complication previous study show glucose effect month oral drug among type diabetic study glucose effect one year patient type mellitus oral drug study effect status type diabetic patient oral drug group control group receive group receive one year addition medication fasting blood glucose hemoglobin hba1c total baseline month determined insulin resistance activity use two group show significant control vs group hba1c control group control group addition significant patient compare control group insulin resistance significant lower activity significant high baseline value treatment improve glucose system type diabetic patient treat oral trial
25867970 en associate difference correlate can investigate association two first health participant aged year measured general well year define participant health care health study participant year old patient health assess participant first health risk ratio confidence interval among man high low among woman compare high low man woman health study compare high low man woman whereas man woman two sample related increased risk among woman man although less finding associate
25934527 en duration development type mellitus subject obtain duration assess fasting blood glucose common poor duration measured per evaluate relative risk index use logistic regression relative risk development high subject duration poor duration occur poor duration odd ratio confidence interval CI value CI poor duration subject poor duration value CI poor duration duration poor
21888854 en clinical result obtain patient mellitus type type study conduct assess clinical diagnosis patient mellitus type type undergo study study included datum renal patient mellitus type chronic disease examine outcome incidence diabetic presence patient mellitus type evidence disease present patient follow associate hypertension associate syndrome presence mellitus type patient evidence therefore consider patient
25499680 en gestational mellitus increasing influence known factor BMI protein role development total obtain woman treat gestational mellitus control group obtain woman normal investigate protein analyzed score serum level perform total woman healthy control found cell well cell normal significant decrease examine cell type cell show significant lower serum level blood woman healthy function role system may contribute therefore influence development
20124054 en patient mellitus may increased risk study aim determine whether patient diagnosis mellitus increased rate compare cohort patient without study whether patient great risk patient patient without conduct retrospective review patient datum patient age history mellitus development use use history history follow-up time week overall rate study occur diabetic study group patient population occur significant without diabetic patient time severe compare patient without patient analysis significant association presence increased risk factor compare risk patient without factor compare risk patient identify significant increased risk patient compare patient without mellitus increased risk severe compare without patient increased risk compare patient without whereas patient significant high rate
24363302 en decrease patient disease decrease may contribute dysfunction duration primary study multiple oral patient period week primary included test assessment subject common effect occur clinical significant group group diabetic patient receive significant high compare group significant change test parameter time compare therapy well patient possible clinical studied large trial
27349111 en identify gene however develop research found level significant influence disease function diabetic complication research provide
22856230 en aim study evaluate possible association gene gene development mellitus population conduct gene research three group patient patient patient mellitus patient time disease common found control patient studied patient studied patient studied patient studied patient three common determined study result show presence group patient group patient disease according statistical test condition group studied patient significant difference control patient studied patient studied population individual associate risk development
22672870 en mellitus condition present month age common cause therapy lead control patient report follow-up result two treat insulin gene identify oral therapy year follow-up one patient response one poor response poor glycemic control patient diagnosis patient treatment important follow-up patient
23440769 en major function serum level evaluate diabetic patient association protein determine serum
23547409 en present study study correlation risk factor event type mellitus patient value early determined risk factor type mellitus studied study show significant high type diabetic patient event patient event also found ratio show significant positive correlation independent association obesity duration rate hypertension hemoglobin positive correlation can statistical age show association
24118909 en assess patient type study examine insulin day patient type on glucose conduct day within day glucose rate duration little level range day reduction insulin fasting blood glucose decrease level concentration time blood glucose profile fasting blood glucose respective glucose control relative common adverse study without demonstrated profile glucose insulin reduction severe
19576649 en role recent clinical study role disease however study demonstrated association level type mellitus therefore study conduct examine association type study included type mellitus patient control receive health serum level measured use level study subject level two on logistic regression analysis show subject time high risk mellitus age BMI rate hypertension study first study association type mellitus suggest may important role type mellitus
22185563 en patient type mellitus DM increased risk dysfunction level cell also reduce however relationship glycemic control level measured patient type DM compare DM significant lower high compare control among DM patient glycemic control define hemoglobin hba1c significant high lower compare patient poor glycemic control level negative correlate level hba1c positive correlate negative correlate level analysis revealed hba1c independent patient type DM level related glycemic control DM patient glycemic control high level associate lower
25008173 en mechanism associate complication use profile diabetic identify compare control datum analysis revealed possible factor function level several role complication function type diabetic type diabetic also patient also increased treat high glucose response increased cell gene diabetic result define diabetic role can lead therapy complication
27329029 en mellitus disorder reported less case per two type clinical determine compare diagnose review medical diagnose age perform patient diagnose age patient among identify three different patient one patient among patient patient among diagnose patient one patient diagnosis syndrome patient insulin demonstrated response treatment
25282008 en treatment type recent patient glycemic control poor glycemic control show effect patient health significant negative patient system insulin therapy significant reduce hemoglobin level however patient insulin therapy research show patient factor contribute insulin therapy review common contribute potential
21801062 en evaluate compare concentration insulin glucose body condition score occur diabetic diabetic examine assess blood plasma concentration serum concentration insulin glucose measured difference value evaluate among group according diabetic group finding correlation determined among significant positive correlate insulin concentration mean plasma concentration significant different mean serum insulin concentration significant different serum glucose concentration significant different among mean concentration similar diabetic mean concentration significant reduce diabetic compare diabetic indicate increased obesity associate increased concentration insulin
23882068 en whether patient cardiovascular disease high risk assess patient age year year follow-up year range define mass index define follow-up develop patient without odd ratio respective regression presence associate high ratio respective independent type number medication blood pressure body mass index fasting glucose history therapy presence one increased respective independent significant result respective use metabolic syndrome significant new large population treat patient independent metabolic profile therapy significant may risk factor common
24059295 en disease disorder lead associate type mellitus level cell level several reported current treatment management disorder may treatment treatment cell potential two disorder
23582554 en risk develop mellitus type adult risk factor previous disease medication body mass index BMI blood pressure serum level assess adult function age population two risk factor less two factor risk factor development observed adult risk factor associate difference risk factor incidence observed man woman age age studied risk factor associate BMI reduce serum increasing found risk factor man woman also suggest difference influence risk develop DM
25619541 en study examine factor associate follow-up mortality among adult patient type mellitus T2DM datum T2DM patient analyzed use logistic model patient follow-up patient compare patient follow-up man or insulin or or high hba1c or high or complication or associate old age or high or high mortality different health medication use insulin disease control age complication cause reduce mortality
24121994 en cell treatment show significant result investigate cell two patient recent diagnose type three patient type mellitus diagnosis presence positive two patient treat cell one patient treat treatment control group patient statistical analysis perform patient less year old diagnosis type less day body mass index less normal blood renal function target hemoglobin hba1c level less level less positive result cell insulin two patient treat follow month show negative value insulin level increased level decrease level blood glucose cell effective effect significant result increased concentration
21819204 en study show effect type mellitus whereas found result role early protein duration study aim compare duration among without study conduct case patient control health use case medical datum first year care gestational age weight status provide total mellitus type respective studied difference rate among two group patient duration vs month diabetic group early associate show duration associate effect datum interval may contribute
26619663 en treatment hypertension common risk factor mortality study show blood pressure associate population however recent clinical trial report mortality cardiovascular complication increase risk adverse effect patient adverse complication target diabetic patient hypertension high incidence
24025505 en evaluate patient type control trial identify treatment type mellitus included analyzed according patient included indicate cause reduction hemoglobin on fasting plasma glucose model assessment index insulin resistance improve insulin index model assessment index cell function reported trial effect may positive effect patient type mellitus however evidence due general low effect type mellitus large randomize trial
23858799 en prevalence important early patient type mellitus increase period insulin assess prevalence relationship metabolic risk factor study group mean age year mean duration year assess presence patient determined ratio two three sample period month patient finding female two three first develop patient determined use multiple logistic regression high hba1c or CI high or CI high insulin or CI insulin resistance high body mass index BMI statistical significant related high significant high patient vs also identify remain significant analysis possible sample subject addition poor glycemic control high blood pressure insulin resistance high insulin high BMI high contribute increased risk
26841884 en previous cohort study conduct found positive association mellitus DM man study population found significant association man total case control DM history duration DM compare case control odd ratio or confidence interval logistic regression associate elevated risk man or CI woman or CI association remain control age body mass index activity level analysis DM associate risk man or CI woman or CI DM associate risk woman or CI significant association found DM risk man or CI woman or CI DM associate increased risk however potential or consider due potential
27300472 en study level patient insulin resistance condition type mellitus T2DM gestational mellitus result review aim assess level patient mellitus identify study level patient mellitus two independent database study according datum use perform on total study case control diabetic patient control compare control concentration significant lower patient T2DM high patient diabetic patient decrease patient finding current review suggest level decrease patient T2DM patient
23726303 en blood glucose insulin metabolic control patient mellitus type however need control well patient patient type treat insulin therapy evaluate hba1c value month period estimate association hba1c model change per day total patient analysis baseline hba1c range analysis adjust associate estimate difference hba1c confidence interval CI per day CI per control care insulin therapy base patient per day
21592955 en factor significant recent role mechanism disease mellitus disorder primary insulin mechanism mellitus insulin within insulin gene profile among different protein test factor insulin blood level observed patient datum important role datum may also study role protein mechanism disease early mellitus
23393690 en management patient type mellitus T2DM include glycemic control cardiovascular risk drug glucose lipid complication management complication management important patient chronic disease diabetic patient treatment
22226484 en evaluate relationship management glycemic use on sample subject type year old care on medical provide datum included clinical management hemoglobin use index glycemic control analysis present mean odd ratio confidence interval obtain logistic glycemic control whereas insulin use statistical significant poor glycemic control addition subject high reported blood medication finding show subject control subject control low therefore patient intervention patient
24563017 en glucose hemoglobin hba1c assessment level glycemic control study aim compare blood glucose insulin vs patient type mellitus use system patient treat insulin use oral hba1c range clinical control complication trial
24553500 en type type mellitus metabolic disorder related insulin resistance dysfunction respective associate severe chronic complication treatment base insulin oral may control disease complication lead increase mortality cell therapy new cell therapy base cell
23000893 en prevalence mellitus DM DM month diagnosis high determine compare prevalence characteristic DM control
24355548 en report use insulin type diabetic patient follow year previous treat multiple insulin retrospective study patient mellitus treat previous treat receive diabetic analyzed included prevalence different treatment mean hba1c value treatment common treatment follow severe time low insulin gestational hba1c decrease patient two week occur patient found common treatment decrease therapy provide glycemic control treatment patient insulin common complication treatment
23123577 en development insulin glucose system improve treatment patient type however patient therapy patient therefore disease therapy insulin improve cell disease treatment type one cause may one factor increasing incidence also whether possible case early possible influence system improve may also contribute less incidence type however disease need intervention cell function therapy study use recent one show effect patient aged year therefore study need treatment great adverse event show positive result adult result aged year result study time therapy use drug need treat patient treatment may
23585665 en renal glucose use study study new method determine use datum obtain tolerance test subject type mellitus study study perform subject T2DM treatment intervention subject treat day subject undergo method estimate use measured blood glucose glucose estimate rate also use determine method compare use correlation mean subject relationship rate well relationship obtain value correlation subject mean ratio confidence interval value subject subject study treatment general well subject T2DM estimate measured estimate rate use method
24047840 en cause response metabolic disease complication due consider complication health evidence several mellitus role disease complication association also study however clinical study estimate compare serum level mellitus type patient healthy individual without study included subject group group subject mellitus type group subject chronic group control subject method use clinical level serum serum level result obtain subject statistical analysis analysis multiple test use statistical result show serum level decrease serum level increased patient compare healthy individual without level serum individual risk develop
23459193 en prevalence type mellitus increased rate recent year recent can system new target type therapy new use year can group response cause response insulin response lead develop effect cell target
22830951 en high DM DM increase risk adverse treatment outcome need two disease perform well determined aim assess result DM patient within DM may report month activity DM patient use positive three patient patient patient patient found known positive new diagnose result patient one treatment case rate DM patient several time high general population high high one show DM patient high rate major health
22249519 en improve mechanism development result also potential mean study show mellitus intervention change activity reduction incidence type mellitus T2DM individual impair glucose tolerance evidence clinical study result clinical trial number clinical identify intervention method mechanism research mechanism well develop review mechanism consider
22237582 en evaluate factor associate include total datum adult patient may primary diagnosis type mellitus DM hospital medical evaluate association patient characteristic regression positive associate age high risk score presence complication on regression included patient clinical characteristic total regression estimate indicate patient disease diabetic respective high similar patient without complication patient test similar patient factor presence complication primary patient type DM health increase associate DM patient complication associate
18806995 en association risk mellitus datum relationship analysis aim evaluate association adverse factor perform study included cohort study investigate association adverse factor risk relationship factor factor evaluate association adverse factor control diabetic population evaluate association adverse factor incidence population without diagnose overall demonstrated adverse factor significant associate poor control correlation whereas adverse factor associate mellitus analysis show low associate poor control event per adverse factor associate poor control type type current review revealed association factor type type however effect adverse factor remain result number individual cohort studied
24443876 en study evaluate change associate weight change among patient type mellitus T2DM treat high lower blood glucose increasing glucose associate body weight T2DM control randomize study evaluate effect body weight patient also study improve early management risk factor weight weight difference patient treat reported patient significant great weight patient week great patient weight associate three different week patient analysis among patient reported weight treatment significant great patient weight weight reported health overall week weight associate overall overall weight associate several compare weight
25902048 en type identify potential associate different glucose control type sample type diabetic patient normal control type diabetic patient two group according fasting plasma glucose hemoglobin hba1c respective base use analyzed mass use profile base different method diabetic patient normal control identify mass protein analysis found two diabetic subject two increased increase hemoglobin hemoglobin hemoglobin characteristic two respective identify result two type patient different glucose control
25724879 en study aim assess impact patient group intervention type mellitus sample type mellitus patient diabetic primary health care two group intervention individual control group individual intervention group receive care group use control group care outcome hba1c body mass index BMI high low measured baseline month intervention month significant difference change studied parameter observed group hba1c CI CI group within group intervention group present significant reduction hba1c CI BMI CI CI CI control group significant reduction observed hba1c CI CI CI patient use type effective compare individual
25260988 en on associate insulin resistance type mellitus DM aim investigate on concentration gestational mellitus on level studied woman healthy woman gestational week on level also evaluate woman on concentration significant increased woman compare healthy woman vs also on level woman significant decrease period vs woman positive correlation on hba1c total cholesterol regression analysis demonstrated hba1c important on level result indicate serum on concentration increased woman decrease therefore on role development insulin resistance metabolic change
25085744 en response cause system disease well system role response different disease several system also potential disease new development response cell patient type increased adult cell known cell contribute complication show increased level blood cell gene cell diabetic complication influence development diabetic complication previous study reported therefore present study recent report regard serum concentration
26214456 en aim study investigate relationship gene insulin resistance patient gestational mellitus use analysis examine patient gestational mellitus group woman normal control group relationship fasting plasma glucose plasma glucose fasting insulin cholesterol high low body mass index BMI index two study group determined significant high group control statistical significant difference group BMI index group type patient correlation analysis show gene positive related statistical significant difference BMI index two study group gene determined factor related woman gestational also found related
24846444 en system important role diabetic aim present study investigate activity patient type measured activity control without T2DM T2DM patient without chronic disease patient without T2DM patient T2DM association clinical parameter control significant high T2DM patient without vs age hemoglobin hba1c fasting plasma glucose correlate significant positive respective T2DM patient without significant different patient without T2DM vs although significant high compare patient patient T2DM blood pressure serum estimate rate correlate significant finding indicate poor glycemic control significant associate activity T2DM patient without decrease renal function significant associate activity patient T2DM
24802517 en primary reported patient recent study show relationship obesity mellitus development several study investigate relationship obesity mellitus DM prevalence review patient treat follow outcome patient body mass index BMI define fasting plasma glucose hba1c level examine observed patient common observed patient DM DM independent risk factor odd ratio confidence interval observed patient obesity obesity independent risk factor odd ratio confidence interval observed patient DM DM independent risk factor odd ratio confidence interval need patient undergo
24266662 en although intervention aim reduce health increase remain whether intervention reduce health among review assess whether intervention management type mellitus T2DM reduce health identify intervention T2DM among patient datum analyzed according study score base reduction health review found study intervention individual level patient health level on study role health study status patient patient receive intervention study compare group group study low score high score one intervention T2DM reduction health intervention may one difference health care patient
24169808 en study investigate dysfunction determine association dysfunction type mellitus total patient without diabetic complication mean age year healthy mean age year included study assess dysfunction diabetic group healthy compare diabetic group found decrease found increased time index found increased correlation analysis demonstrated negative correlation found type DM patient without diabetic complication correlation show increased dysfunction
26930607 en evidence suggest chronic important role type T2DM level associate number obesity T2DM study investigate whether treatment T2DM randomize trial patient aged year poor control T2DM patient receive two primary change baseline fasting plasma glucose mean glucose test day patient randomize one three treatment statistical significant effect fasting plasma glucose level mean glucose compare well lead glucose control however study potential clinical effect
26575162 en patient type mellitus response glycemic profile treatment on association known associate possible common potential role early can consider intervention patient type
25298376 en assess effect type risk cohort study conduct cohort study investigate association type risk use model overall relative risk identify cohort study included total participant case type elevated risk type significant associate high level CI CI CI use risk estimate type significant concentration per CI per CI per CI evidence high level significant associate elevated risk type mellitus
25849903 en study show effect addition effect glucose lipid also reported dysfunction study examine whether dysfunction patient type mellitus patient T2DM undergo tolerance test examine change function glucose lipid without baseline function determined use index measured test primary difference change function baseline significant lower baseline test test use result significant decrease change correlate change analysis identify change change contribute observed dysfunction test suggest glucose also lipid
25412591 en overall patient type mellitus cardiovascular increased demonstrated glycemic control early change common included mean age year healthy mean hba1c duration disease year use assess define mean different total compare vs analysis according however revealed high value diabetic cohort vs whereas high group vs multiple regression show group hba1c remain significant associate body mass index blood pressure datum suggest metabolic hba1c important effect
23610212 en evaluate influence age duration type mellitus DM evaluate patient type gestational DM patient subject normal glucose patient positive old DM duration compare negative patient on logistic regression duration independent show duration related presence odd ratio or CI model age diagnosis independent show association however man DM duration or CI also high age diagnosis or CI significant related similar duration DM significant high duration diagnosis type DM adult old individual rate disease provide diagnosis
23299282 en investigate prevalence risk factor disease among aged year old subject type T2DM glucose diabetic subject compare prevalence diabetic patient subject analyzed association status include logistic regression use assess or assessment diabetic subject diagnose prevalence rate T2DM subject subject subject prevalence rate T2DM T2DM respective analysis among diabetic subject compare subject subject include subject old female high current great duration use medication effect status logistic regression analysis include age duration use oral significant associate increased risk T2DM present study show T2DM associate population
26869156 en study patient type diabetic diabetic without diabetic total type diabetic patient healthy control study undergo include value group mean diabetic patient healthy control respective evaluate two different diabetic group group compare healthy control respective patient control respective group group compare healthy control demonstrated significant reduce value group compare healthy control datum early
26497665 en evaluate effective therapy therapy fasting glucose body mass index BMI type control trial conduct compare patient receive intervention control health outcome on total intervention group participant control patient outcome include fasting glucose BMI day group show significant reduction fasting glucose significant increase patient control group care show change intervention significant glycemic control control healthy outcome intervention patient decrease method research
24817009 en current health system review evaluate develop cardiovascular disease mellitus DM related risk evaluate clinical health review show control early indicate management health among level poor significant according clinical finding follow-up function health system patient care patient datum follow-up level health system
23909918 en investigate study possible type mellitus new obtain new diagnose due presence concentration glucose plasma insulin treatment also clinical remain relative individual major model analysis conduct use analysis diagnose female suggest gene cause revealed gene little one mean related within diabetic mean base value related sample observed also significant estimate CI status model major gene model risk study increased case increased number major significant risk prevalence however low case mean can on association study may investigate cause
24373236 en identify database show include improve glucose include insulin control therefore drug target treatment type mellitus
24120624 en datum regard possible role type mellitus DM study examine whether study conduct total subject patient control examine use found significant association risk type DM three include odd ratio confidence interval CI CI CI analysis show high high blood pressure associate significant decrease risk type DM or CI CI CI compare respective population normal total cholesterol significant decrease risk type DM risk or CI compare population normal total cholesterol associate significant increased risk type DM or CI CI compare population result suggest contribute increased prevalence type DM population
21210931 en aim study impact diagnose type mellitus age duration disease method use sample adult diagnose type mellitus datum datum participant medical influence participant need related difference regard age participant score low regard total total total function important relationship year status impact significant medical follow-up important obtain mellitus
27180673 en type mellitus medical recent year population old age clinical significant metabolic disease old age on need adjust presence multiple patient treatment may contribute increased treatment case treatment diabetic patient target value therapy type mellitus old patient risk type treatment may present old
26963392 en investigate assessment change patient type mellitus patient diagnosis year year healthy study index index respective logistic regression analysis conduct patient without diabetic control use patient diabetic diabetic value significant different control difference increasing duration however case control use three logistic regression model identify case present identify patient diabetic
26523434 en weight well provide control period compare therapy drug control remain patient type mellitus one major low medication first oral review current medication treatment follow characteristic review recent clinical study demonstrated indicate tolerance patient improve complication due use clinical on study patient medication
26514640 en concentration found associate insulin resistance elevated patient type mellitus DM aim present study investigate level possible relationship metabolic parameter gestational mellitus plasma concentration measured woman woman without healthy woman difference level observed among group respective woman without correlate age gestational age body mass index BMI hba1c glucose concentration oral glucose tolerance test glucose total cholesterol cholesterol level statistical significant correlation current BMI cholesterol level found concentration elevated woman associate BMI cholesterol
25338220 en use identify protein function little known effect gestational mellitus current study examine effect protein woman diagnose without week analyzed protein use mass on total protein identify use analysis identify protein model multiple use protein also statistical significant different woman without identify change protein suggest mellitus protein
25997286 en evaluate value function type mellitus DM use relative factor included DM patient control group study healthy subject early on time time index measured subject analysis study show statistical difference index two group regression analysis show positive correlation DM patient hba1c control level analysis show within group clinical value evaluate function type mellitus patient type mellitus patient hba1c control level related function
25926108 en type mellitus chronic disease metabolic important role lead development among several investigate associate one gene important role response cell one therefore gene development within present review role gene development
24317657 en mellitus metabolic disease insulin cell therapy present cell cell review clinical trial patient patient blood level serum level hemoglobin insulin mean cell effect observed mean follow-up month mean serum decrease insulin mean observed mean positive patient mean decrease mean
20929462 en investigate effect old individual datum review medical man aged type tolerance base metabolic adjust age mortality age group group old group analyzed use adjust mean follow-up period year group group increase mortality lower cohort ratio confidence interval lower group lower group consider mortality risk lower age associate lower risk mortality type mellitus aged well old lower mortality risk mellitus age finding suggest level individual patient age
23203253 en mellitus DM major health prevalence patient mellitus increased risk disease study examine type DM T2DM patient assess clinical status total adult aged year T2DM patient healthy control cohort study subject assess blood include fasting glucose lipid profile serum concentration insulin measured use concentration significant lower T2DM healthy control subject vs remain significant age negative correlate glucose insulin positive associate decrease level concentration T2DM patient effect metabolic function disease diabetic patient target T2DM patient risk dysfunction
23024033 en type mellitus T2DM associate increased incidence study study statistical examine risk duration examine association T2DM incidence study cohort large study duration study year follow-up case identify among participant adjust relative risk confidence interval estimate use regression association T2DM risk overall CI disease CI disease CI compare participant without T2DM risk high among participant T2DM year CI among use insulin CI result association T2DM overall incidence suggest positive association T2DM factor correlate severe incidence
21908062 en study conduct estimate year include conduct early among individual aged year participant characteristic related obtain use fasting blood level also measured individual year due estimate use medical on method use estimate overall prevalence year study population respective total related estimate mean medical mortality respective large age positive associate whereas negative associate patient aged year high increased level major health increase control patient
26256004 en factor target development new clinical treat metabolic disorder mellitus DM DM disorder current great individual disease lead multiple system body protein insulin insulin resistance cell cell protein also control cell lead cell include type protein metabolic protein lead clinical outcome analysis protein protein
26094794 en association mellitus DM low on rate one mechanism influence among DM patient however several study show result examine two factor evidence association among old analyzed cohort subject man woman year old new DM status level fasting plasma glucose hba1c rate obtain sample use analysis adjust possible compare rate according DM rate DM participant lower normal vs effect possible associate lower rate suggest lower level may mechanism individual DM
26064426 en consider factor mellitus DM disorder prevalence result significant new effect may develop effective care individual current DM target type protein consider treatment target DM relationship cell factor impair glucose tolerance cell great impact disease DM development therapy clinical adverse effect potential lead
25987063 en disease include mellitus DM study risk factor well include however current study DM subject although rate increase determine association DM datum analyzed care DM reported subject base health factor associate determined prevalence odd ratio or confidence interval use multiple logistic regression subject mean age year found DM subject subject association DM adjust factor include age level relative diagnose risk DM subject high significant compare subject or DM significant associate may development several disease include DM
22466346 en examine effect hospital medical treatment poor control mellitus among retrospective cohort study included patient one three hospital receive medication therapy hemoglobin great primary outcome change hospital logistic regression analysis primary outcome define health patient change medication rate change adjust analysis high odd ratio or per increase confidence interval CI high mean blood glucose or per increase CI blood glucose or CI insulin therapy or CI associate high odd change therapy on total demonstrated clinical change therapy within follow-up within retrospective study patient poor control little one less receive change therapy suggest clinical one change therapy follow-up
26291796 en datum indicate significant role lipid glucose recent year relationship mellitus study included woman diagnose gestational mellitus healthy control group gestational age body mass index serum level significant high woman range compare control subject range significant correlation observed serum level clinical parameter control group however group serum level positive correlate weight blood pressure fasting insulin level model assessment insulin resistance regression analysis revealed fasting insulin level independent associate serum level
25345683 en metabolic syndrome several metabolic prevalence increasing recent evidence regard relationship metabolic syndrome outcome patient patient population intervention outcome metabolic syndrome obesity body mass index insulin resistance hypertension risk mortality disease metabolic syndrome high disorder obesity insulin resistance hypertension finding suggest metabolic syndrome per associate increased risk patient risk primary metabolic syndrome hypertension obesity datum possible association risk regard type mellitus datum suggest potential negative correlation however risk patient metabolic disorder study assess role metabolic disorder
21352428 en gene cause mellitus case diagnose month age role status insulin mellitus due less studied two patient develop month age gene identify patient develop age independent identify diagnose day month age identify recent diagnose type diabetic mechanism case known possible within associate diabetic
20651004 en increased associate mellitus however increase mellitus primary current study investigate function mellitus examine effect insulin insulin mellitus low body day insulin group diabetic day protein assess datum show protein significant elevated diabetic insulin treatment diabetic increase protein control level cell significant increased diabetic study cell demonstrated activity significant decrease insulin study demonstrated insulin influence activity function increased mellitus increase may contribute cholesterol associate mellitus
26032644 en examine association hemoglobin hba1c cardiovascular disease mortality individual without mellitus general follow-up without known mellitus level three group baseline history subject high hba1c group group high level hba1c baseline risk follow-up confidence interval time great group association found hba1c level cardiovascular mortality individual aged old without mellitus high hba1c associate great risk mortality
27180921 en level woman gestational mellitus studied however remain whether insulin resistance present study aim evaluate relationship level study study use assess relationship level use level significant elevated woman compare without mean difference confidence interval evidence mean difference confidence interval woman aged old year mean difference confidence interval present show level significant elevated among woman compare woman normal glucose tolerance finding
25842555 en study cause outcome renal study conduct may adult patient known present included study treatment renal perform patient patient follow period week outcome renal total patient period found common factor cause patient common found patient factor included renal patient patient patient among undergo cause cause diabetic outcome
25499925 en compare clinical outcome diabetic patient treat new randomize patient diabetic patient diabetic patient according presence mellitus included major adverse event target among diabetic patient occur patient treat vs odd ratio or confidence interval CI high rate vs or CI among patient similar rate follow-up associate significant high risk vs or CI year event among patient remain patient follow-up however among patient demonstrated high result follow included overall high risk
21332609 en mellitus health patient high risk provide intervention study assess use health care datum identify patient study conduct study cohort sample use serum glucose test patient group medication glucose possible glucose glucose glucose status glucose test compare review perform total included prevalence group possible confidence interval confidence interval positive value known respective patient high risk glucose value diagnose identify use health care datum
26327768 en compare effect obesity disease incidence type mellitus T2DM population subject sample medical cohort study baseline obtain general weight blood pressure test total cholesterol fasting blood glucose incidence T2DM year follow-up datum test datum mean analysis perform incidence model use relative risk different body mass index BMI level T2DM well adjust age blood pressure lipid total subject follow-up follow-up time year subject diagnose T2DM incidence incidence T2DM control group vs respective incidence subject vs respective incidence T2DM increased increase baseline BMI regression analysis show risk T2DM group age blood pressure lipid value subject age BMI blood pressure lipid factor respective three BMI level BMI BMI BMI show risk T2DM group significant high control group BMI can risk T2DM subject may high risk factor T2DM independent
22957983 en hba1c less regard result individual hba1c value may investigate important individual may increased risk develop although hba1c glucose diagnosis value fasting glucose oral glucose tolerance test diagnose individual investigate diagnose individual new method diagnose identify different cohort current diagnose fasting sample investigate
24028669 en assess outcome associate insulin among patient type mellitus T2DM
19703812 en develop characteristic hemoglobin hba1c diagnose mellitus within chronic disease management study include medical conduct medical medical case group patient base disease clinical current type type patient use medication oral insulin result blood plasma glucose test little blood glucose control group base patient hba1c measured study period case control control group number number case total number case test datum included case group control group independent datum total patient case patient case review determine patient diabetic control group case group independent datum case group control group case group man mean age year mean body mass index datum similar control patient revealed hba1c mean value diagnose type mellitus statistical value positive ratio confidence interval hba1c value may diagnose mellitus within chronic disease management system may population
22351156 en mellitus status mellitus may contribute insulin resistance development diabetic complication aim present study compare concentration serum patient type mellitus control subject serum concentration measured mean result study show mean value significant lower serum patient compare control subject result show may role development mellitus
26640805 en investigate effect insulin therapy glycemic control cell function patient new diagnose type mellitus T2DM new diagnose T2DM patient randomize receive two therapy group group week blood glucose control model assessment index insulin response compare two group patient group insulin time day hba1c study two group group group high group however effect cell function effective cell function effect therapy
24485397 en glucose also cell associate several function study reported increased rate patient treat therefore assess whether treatment type treat week randomize trial blood sample treatment period blood cell concentration treatment compare similar relative factor datum show treatment patient type mellitus result significant response suggest lead increased risk
25020167 en study activity disorder provide patient hypertension general clinical use patient hypertension type revealed patient significant increasing level estimate group patient patient type significant correlation development disorder hypertension
20113279 en mellitus disorder chronic associate complication dysfunction renal disease develop number metabolic well common cause renal disease diabetic significant mortality current therapy use blood medication development renal disease diabetic associate rate renal function rate mellitus treatment therefore aim renal function adverse outcome intervention base function evidence suggest may effect associate renal function well reduce diabetic may report indicate renal function review current evidence potential renal diabetic complication well
27586678 en improve outcome patient mellitus undergo intervention remain clinical need assess diabetic patient result test analysis outcome diabetic patient treat compare primary outcome target target follow-up assess use method ratio confidence interval CI estimate total patient mellitus treat year rate CI significant difference observed group incidence CI CI CI rate low similar group CI patient trial
25102002 en examine whether associate increased risk type mellitus T2DM development study man study investigate participant aged year without one three baseline measured high define high low control high control analyzed analysis ratio estimate use model age history body mass follow-up year case T2DM observed participant high baseline high adjust risk develop T2DM low confidence interval severe increased adjust T2DM risk confidence interval woman high high risk develop T2DM independent risk factor increasing T2DM adverse effect high
25091053 en patient type mellitus increased risk chronic disease disease patient however use several may case new target system increasing use management type therapy oral review datum regard use therapy patient old evaluate study patient large clinical trial change characteristic observed patient different without major clinical renal datum patient significant change reported clinical trial year datum therapy may patient presence disease patient clinical therapy patient
24957500 en common associate increased metabolic cardiovascular risk factor also associate effect previous characteristic among patient determined total chronic patient control statistical analysis included clinical characteristic age disease mellitus type hypertension event association severe disease significant among patient or found significant association three type CI population influence risk also disease type mellitus
21236511 en assess prevalence mellitus renal glucose adult renal studied retrospective follow-up year patient incidence risk factor estimate incidence month year respective case diagnose within first three month develop risk factor included old age body mass index use included age year CI CI use CI within first three month develop age year risk factor
24824580 en individual care chronic disease prevalence gestational mellitus increasing new evidence show negative effect occur glucose negative effect treatment gestational glucose tolerance test woman care prevalence determined use trial fasting prevalence confidence interval CI determined trial old prevalence CI age BMI characteristic may significant associate population risk factor common use prevalence lower population compare population new evidence regard gestational new identify treat patient risk adverse outcome need risk associate diagnosis intervention base risk factor use high value may identify intervention
24736330 en important glucose cell type mellitus however whether study individual type healthy assess type patient consider patient body mass index measured mass individual patient type normal weight BMI BMI elevated compare healthy normal weight BMI type patient significant lower normal type group total positive correlate hba1c normal type patient increase normal weight type study may increase glucose obesity effect type
19584681 en body decrease insulin associate early type mellitus DM aim study evaluate whether insulin resistance risk factor type DM type DM datum well history type DM first relative risk factor type DM positive history type DM body mass index analyzed type DM difference outcome dysfunction compare use regression analysis perform control possible positive history type DM baseline can function outcome however risk factor group type DM associate early mean estimate vs month result or CI type DM type DM associate early function clinical trial whether associate decrease insulin insulin role
23155700 en aim study assess association determine impact type mellitus clinical evidence disorder evaluate score patient mean age year mean duration year present patient subject positive patient vs vs respective high patient vs associate lower vs high patient vs logistic regression analysis revealed negative independent associate duration weight found patient significant high prevalence significant high vs patient without datum suggest significant association independent associate duration
22888673 en mellitus DM disease significant influence patient time role define prevalence disease population high risk development complication therefore study mechanism disease review therapy type role complication role development complication first insulin show also show function reduction insulin blood glucose level elevated insulin decrease improve function determine research mellitus development method treatment disease
22218620 en evidence relationship control study determine increase hemoglobin hba1c fasting blood glucose patient type study increase intervention evaluate hba1c fasting blood glucose outcome use participant known type mellitus study overall mean difference reduction fasting blood glucose CI intervention also effect hba1c overall mean difference decrease hba1c CI intervention type mellitus reduce fasting blood glucose hba1c suggest increasing patient type disease management
24264473 en assess however patient type mellitus DM glucose control study aim investigate impact DM relationship perform patient DM disease diabetic patient group hba1c hba1c glucose patient significant patient correlate significant correlation among compare patient analysis demonstrated among parameter CI value CI value CI value datum suggest DM patient patient without glycemic
24246441 en compare insulin insulin patient type mellitus randomize control trial assess patient cohort patient cohort use score population outcome hba1c compare group odd ratio or confidence interval CI well hba1c severe or CI hba1c weight or CI improve control patient T2DM control insulin effective insulin therapy glucose control without weight less risk insulin
26802695 en system function within cell include protein cell lead high level protein within lead three primary protein factor protein response cell contribute cell recent research factor cell cell disease include mellitus type disease disease
26052042 en associate several study assess potential adult type mellitus present study examine association profile protein among adult analysis include adult mass index blood pressure lipid profile value measured insulin estimate estimate glucose rate on activity measured difference profile group protein well examine general model on score correlation score mean age year hemoglobin score little three associate lower vs score correlate body mass index blood pressure correlate estimate glucose rate age association estimate glucose rate significant activity result suggest high score associate profile research need finding
27422625 en DM current show less diabetic patient cardiovascular disease glucose type new show potential cardiovascular effect reduction blood pressure reduction reduce weight recent trial show reduction cardiovascular trial control clinical trial test diabetic patient known body analysis test cardiovascular effect care year period primary outcome change outcome include mass index tolerance status trial determine therapy potential effect patient DM current medication drug patient DM trial clinical
23265261 en type mellitus may associate previous reported finding associate prevalence general population can aim study evaluate function response associate compare control group compare perform statistical significant difference baseline value however change value significant high study can also effect possible
23283045 en associate clinical several disease consider factor development complication present study investigate among mellitus compare healthy subject relationship serum level protein present study type diabetic patient study group healthy subject control group serum level method measured use type diabetic serum concentration significant elevated correlate body mass index significant correlation plasma glucose level addition datum demonstrated positive correlation hba1c among subject study control group significant association investigate may type obesity among type diabetic well healthy subject addition possible may effect different mechanism
23013427 en weight management consider type mellitus however little known impact weight body mass index BMI reduction type aim study estimate impact change BMI among patient type mellitus system study study datum BMI change patient type retrospective period model estimate effect BMI change general model BMI BMI model BMI BMI among patient studied patient mean age year BMI study period patient BMI BMI change BMI BMI significant associate increase decrease model BMI associate increase among BMI one associate decrease among model associate reduce one BMI decrease patient increase BMI among patient type associate increased on reduction BMI associate patient
22884107 en type mellitus DM associate early increased cardiovascular mortality mass independent cardiovascular previous studied type DM intervention complication study study follow control complication trial cohort mass measured year common assess use year regression model use assess year mass year total participant analysis year mean age participant year mean DM duration year man correlation mass adjust age significant association mass estimate per observed association decrease addition blood pressure per little cardiovascular disease risk factor observed mass patient duration DM independent large mass population type DM
23888726 en significant disorder observed mellitus significant change condition first day positive day mellitus disorder observed day
23550246 en patient type mellitus management disease patient multiple medication hypertension patient adjust multiple medication renal cardiovascular disease disease well therapy patient adverse patient include associate control patient cardiovascular disease renal general well management type mellitus patient need assess risk treatment patient control cardiovascular status renal function
22722891 en associate obesity hypertension randomize control trial patient type mellitus T2DM year BMI
24858157 en gestational mellitus mellitus increasing gestational control glucose reduce complication improve health on hospital base study conduct outcome gestational datum gestational research metabolic disorder hospital study revealed gestational common among aged year old woman mean gestational age diagnosis week diagnose week gestational mean weight adverse outcome observed case adverse outcome present case analysis week fasting blood statistical significant associate adverse outcome less weight insulin therapy health period positive impact health period treatment gestational diabetic
26283734 en cell use however individual disease cell study examine cell diabetic determine profile cell diabetic assess cell treatment cell revealed gene cell target identify three found diabetic reduce cell individual compare control subject patient level cell patient reduce cell study suggest level can cell cell therapy
24096133 en mellitus chronic metabolic disease multiple complication management early diagnosis intervention analyzed change type diabetic subject without complication mass analysis mechanism disease blood diabetic also protein potential diagnosis value diagnosis type mellitus whereas protein disease present datum also suggest potential diabetic present analysis important study target protein aim new early complication
24059314 en datum increasing incidence disease type mellitus T2DM association development T2DM risk factor age important impair cell metabolic status protein target intervention increase model healthy disease cardiovascular known time effect health drug known effect present related review present T2DM role development age metabolic related disease possible intervention T2DM
26494163 en chronic disease common associate type mellitus T2DM may impact therapy glucose reduce blood glucose level patient T2DM renal glucose glucose review according function participant reported datum patient T2DM impair renal function renal datum population patient T2DM may reduction estimate rate observed change general time suggest renal treatment ratio reduce general well patient normal impair renal function high incidence adverse event adverse event patient renal adverse event related function status however patient impair function compare patient treat associate increased cardiovascular risk study however relative event among patient impair renal function mean analysis examine outcome result trial associate change function well patient T2DM function status
24007456 en common use treatment type T2DM treatment however associate poor weight glucose development treatment T2DM trial reduce body weight blood pressure low incidence aim study compare effect therapy patient T2DM control patient randomize receive year addition patient period primary change baseline hba1c change baseline body weight incidence change blood pressure include insulin body analysis include incidence adverse event include adverse event change baseline clinical patient randomize patient treat baseline mean age year hba1c body mass index blood pressure blood pressure large study compare patient T2DM control addition determine effect treatment glycemic control study investigate effect function cardiovascular risk factor renal result treatment patient T2DM
26431552 en gestational define glucose review aim clinical outcome normal insulin due factor increase insulin normal glucose occur increased insulin common type woman similar characteristic subject insulin resistance risk adverse outcome related cause response high glucose level diagnosis recent high risk patient early possible use fasting plasma glucose normal week use oral glucose tolerance test treatment base insulin therapy
23656854 en patient increased prevalence type mellitus type mellitus show association gene factor protein gene test level association patient compare healthy chronic patient diagnose according healthy control gene level patient chronic healthy control use study conduct found significant difference patient control group significant high patient control vs female patient compare female control vs use level significant great control result suggest gene may role type mellitus may risk however finding remain association
23565740 en patient type mellitus T2DM study investigate effect blood patient T2DM included randomize study week patient randomize receive individual addition treatment blood ratio assess use addition index measured different use treatment improve control vs baseline respective change can observed treatment significant increased decrease vs baseline respective increased treatment range vs baseline correlation can observed improve control hba1c change result suggest effect blood glucose control observed treatment correlate improve control
23111552 en insulin resistance type mellitus type DM poor evaluate glycemic control
25467618 en aim identify woman diagnose gestational mellitus use normal glucose tolerance use change woman increased risk adverse outcome
23356568 en type mellitus T2DM increased risk disease cause mortality patient mellitus lead elevated disease elevated level factor include review evidence recent datum elevated T2DM well mechanism addition effect glucose may review effect metabolic potential influence cardiovascular disease disease include T2DM suggest possible cardiovascular potential clinical
19258739 en gene cause syndrome disorder mellitus gene can response cause impair cell increased recent gene associate type aim present study examine whether associate risk type individual total diabetic patient control subject among show association type odd ratio confidence interval risk lower function however association age BMI adjust although found evidence effect risk type clinical characteristic diabetic subject population gene type gene potential impair insulin
24140451 en role event patient mellitus DM parameter related also use compare blood mean DM metabolic syndrome patient healthy control blood cell index DM group significant high vs vs vs control group also increased patient difference statistical significant DM patient according glycemic control status hba1c vs hba1c vs hba1c significant increased poor glycemic control group include diabetic complication analysis high DM patient cardiovascular disease DM group without cardiovascular elevated patient associate poor glycemic control cardiovascular complication
26812775 en aim study determine relationship glycemic index glucose datum type mellitus
25581778 en review review effect insulin therapy gestational mellitus effect therapy review recent study potential insulin function gestational mellitus gestational mellitus disease occur associate woman treat control however patient value subject insulin therapy lead normal glucose level dysfunction remain control metabolic review regard insulin therapy potential function insulin therapy may normal metabolic condition on role insulin on well potential cell associate can include insulin therapy treatment patient
26698539 en serum level elevated patient type however correlation gestational mellitus remain present study compare serum level woman normal glucose tolerance evaluate relationship patient healthy woman week studied addition assessment serum glucose insulin total cholesterol hemoglobin measured subject subject undergo oral glucose tolerance test body mass index BMI model assessment insulin resistance serum level significant high woman compare control fasting concentration concentration effect level group significant correlation hemoglobin fasting insulin level elevated patient level related hemoglobin fasting insulin result suggest may major
25256364 en assess role first level development gestational mellitus woman included cohort study woman diabetic history history previous total measured week patient follow according patient gestational week remain patient total level compare patient without regression analysis develop woman compare woman without first total level high among woman develop level age total body mass index found independent development on total value found development total low low value use may role
21704580 en assess prevalence disease patient type mellitus define investigate clinical patient type mellitus period period patient type previous diagnosis disease female patient show high age mean year diagnosis disease subject present disease present two datum association disease type disease diagnosis type female subject high age therefore subject presence year dysfunction
26576437 en type mellitus disorder lead cell lower insulin recent year cell therapy new treatment mellitus among cell cell show base potential clinical trial study review potential cell also current mechanism effect important provide review due cell therapy new method cell type regard diabetic patient clinical trial use clinical group cell remain treatment
26856212 en although mellitus DM poor outcome patient study analyzed impact DM patient without DM undergo primary patient consider obtain assess independent clinical characteristic outcome patient DM compare without DM on analysis perform use study period patient obtain diabetic patient old high hypertension time hospital number age similar patient without DM also statistical significant difference patient study significant different patient without DM finding
26739392 en aim study test may event diabetic patient disease serum level high high protein analyzed patient type impair glucose tolerance fasting diabetic group patient normal glucose major follow-up year patient diabetic group patient group primary high level primary ratio confidence interval remain adjust clinical renal lipid glycemic status ratio confidence interval model also primary diabetic group primary group model significant improve patient index independent risk diabetic patient
26467365 en high effect increasing reduce function examine treatment effect related possible role diabetic group control mellitus DM mellitus blood glucose level consider DM group day pressure evaluate factor analysis perform use datum compare weight change lower DM group control high DM group little group decrease whereas treatment increased on decrease observed level group compare group difference level treatment diabetic effect reduce increasing without change
24970998 en known provide renal activity system system study compare effect diabetic type diabetic receive per group week among group therapy group blood pressure treatment significant glycemic however renal significant observed although increased system treatment result increase parameter show effect increased ratio decrease level due effect activity type may disease type patient drug
23939297 en type mellitus associate chronic disease major health little known influence incidence among individual type examine association healthy protein incidence among individual type individual type without trial included study follow-up disease define new rate per year year follow-up assess use healthy index analysis adjust known risk factor risk year follow-up participant develop compare participant little healthy score participant healthy lower risk adjust odd ratio or CI lower risk mortality or CI participant per week lower risk compare participant less participant low total protein increased risk compare participant high total protein or CI associate reduce risk or CI mortality or CI healthy may decrease incidence among individual type within range normal protein associate
27052239 en general known development insulin resistance positive insulin reduce cardiovascular health activity activity per week need positive effect correlate level effect independent age large evidence association aim activity care
26739488 en insulin several use treat type mellitus T2DM patient T2DM impair cause impair glucose however although correlate insulin resistance little known effect chronic high glucose concentration patient cell function present study cell chronic high glucose result indicate associate decrease due elevated protein use chronic treatment result show cell glucose effect observed T2DM patient can little patient may provide new complication also contribute target within
24459648 en cause serum type mellitus DM clinical include report three case patient present serum history poor control type DM case show time normal range follow however patient show therefore perform cause revealed present report three case review
26509305 en new base hemoglobin hba1c great adult population study suggest may population determine hba1c great test DM perform also blood pressure blood glucose glucose tolerance hba1c analyzed positive negative value diagnosis DM year obesity studied female age year BMI hba1c diagnosis DM case normal glucose tolerance hba1c mean respective hba1c great diagnose DM level hba1c great low diagnosis DM on lower use hba1c result one
26088607 en high glucose important role development associate diabetic however whether can study examine role development mechanism diabetic high glucose test effect effect diabetic treatment type diabetic cell increased high glucose reduce treat decrease treat present study show result mechanism diabetic can important target diabetic
25693215 en method patient hypertension mellitus type use method regression analysis test use method estimate parameter without diagnosis significant reduce duration use primary diagnosis
25212380 en evaluate function subject type mellitus study included subject recent diagnose diabetic patient healthy control similar age subject undergo analysis include analysis function decrease increased healthy control diabetic analysis function show function total function study population hba1c correlate however independent associate hba1c among parameter whereas independent associate hba1c among parameter function significant impair diabetic parameter glucose control correlate function
25996204 en mellitus associate increased risk although evidence examine association use datum study conduct case hospital control odd ratio or estimate multiple logistic regression model major known risk factor case control reported diagnosis mellitus or confidence interval CI risk increased duration or year year year year increased risk age whereas lower although significant woman or or current or subject body mass index or present study provide role although body mass index may association observed
25740570 en evidence addition complication increased risk important risk due little cell function include found decrease type may independent finding datum reduction serum also reported serum level found increased risk independent factor age change also cell function risk
24723006 en population age management chronic condition primary care presence common among patient may response study determine whether prevalence high patient type mellitus population aged whether independent use examine database patient aged year medical datum study hba1c level use estimate type DM control assess use hospital found high prevalence severe patient type DM association control age status significant diabetic population odd increasing number type DM severe without independent control however may increased rate observed patient type DM little patient
24974228 en mellitus DM associate multiple observed function function several evidence indicate function well within associate observed adult DM insulin system although DM on model disease several disorder include disorder system similar occur diabetic population provide factor function well within DM common several disorder
24961202 en datum regard impact mellitus study compare overall among diabetic patient treat identify patient undergo treatment period year datum regard age treatment outcome medical patient diabetic little two fasting blood glucose level blood glucose patient diagnose oral insulin statistical test test difference diabetic patient clinical treatment receive disease total patient diagnose study period diabetic patient mean age diagnosis whether diabetic patient significant protein level lower compare patient difference among diabetic patient treatment receive outcome diabetic patient mean month respective overall month respective regression analysis adjust age patient among patient follow-up period show significant difference diabetic patient overall however significant associate overall mellitus patient
19445439 en evaluate among individual body mass index BMI risk analysis adult study improve early management risk factor study BMI normal weight type mellitus T2DM type mellitus high risk low risk measured use activity general health measured use define factor obesity BMI reported diagnosis cholesterol diagnosis hypertension history disease define severe increased normal weight individual great time great activity time great overall time T2DM group obesity T2DM independent overall total regression model BMI group age great activity among individual group
23153599 en increased risk patient mellitus undergo total within review patient undergo total hospital incidence within compare diabetic patient patient patient group group within risk patient mellitus time risk patient without mellitus use logistic regression although patient high incidence rate total study
22800734 en aim study assess relationship risk type study included case new diagnose type diabetic control on use possible risk factor type study subject compare subject odd ratio or confidence interval CI type logistic history body mass index level plasma level logistic regression model value or possible increased risk type determined subject or CI vs subject datum possible relationship increased risk type mellitus
23199535 en body common association insulin resistance mellitus early however study whether status can association among hba1c level complication patient diabetic period study included sample glucose hba1c statistical analysis hba1c level independent compare two group significant high group on subject compare group subject type mellitus patient compare well glycemic control low level high level association hba1c level can insulin status without insulin resistance
26823030 en blood concentration evaluate cardiovascular event aim study evaluate factor potential associate elevated blood patient type type mellitus man woman mean age year history cardiovascular event relationship level clinical parameter patient significant relationship fasting blood glucose level insulin resistance significant correlate level blood concentration index multiple regression analysis revealed factor also independent result indicate cardiovascular risk factor include high associate high concentration blood patient type mellitus
26466701 en on woman develop body weight weight normal within month however develop type mellitus insulin therapy first reported case associate addition mellitus include can patient assessment glucose need weight
26281334 en compare type mellitus patient healthy subject determine association diabetic mellitus patient without three study group control group subject undergo value compare diabetic healthy subject three diabetic correlation analysis perform determine relationship significant high diabetic patient control group diabetic patient without significant patient similar significant difference diabetic patient study population significant correlate pressure significant increased type mellitus patient control disease effect
26031822 en level factor examine blood patient mellitus type revealed elevated level factor time therapy include management result significant decrease high level blood serum effective impact level high level blood provide result patient mellitus type
25635986 en type mellitus T2DM chronic disease insulin resistance target insulin insulin lipid contribute negative insulin reported associate metabolic syndrome include T2DM hypertension T2DM population
25633683 en study evaluate effect glucose glucose patient type mellitus baseline mean hba1c body mass index randomize receive day on tolerance test glucose perform baseline day primary change baseline glucose day mean difference change baseline day day adjust mean CI difference change baseline mean glucose day day change baseline mean glucose significant different mean glucose change baseline day time glucose increased baseline day without increasing time day reduce first day improve blood glucose control patient
25594654 en patient develop renal disease associate type mellitus may receive study examine impact patient rate on total case receive receive receive retrospective case group case group rate patient high group compare group therefore primary patient however case consider patient blood control
25523632 en role factor cell high level aim study assess cell function type diabetic control subject cell among cell high patient suggest cell similar disease addition decrease patient positive correlation observed healthy control group result suggest impair cell decrease patient mean disease duration
25317681 en aim study change patient type mellitus undergo day fasting day plasma concentration measured patient baseline day fasting day patient studied fasting use body patient decrease fasting plasma significant high patient vs decrease fasting ratio significant lower patient vs increased fasting patient reduce fasting low
25470394 en major disorder mellitus DM relationship common mechanism system negative function independent risk factor disease may increasing demonstrated on DM may present review evidence DM report report level ratio plasma serum individual DM DM risk factor intervention increased rate disorder DM population increase population risk condition improve outcome disorder DM effective target may influence medication DM can decrease
23959658 en although within cell known insulin cause mellitus correlation clinical report clinical outcome due demonstrated clinical outcome insulin oral therapy month age remain therapy similar development metabolic therapy current per day age year per day time follow-up metabolic control provide therapy due early age insulin therapy possible insulin
22838099 en outcome woman year group provide care woman group report woman poor outcome on change occur woman care compare outcome increase care glycemic control improve overall increase decrease mortality rate decrease type rate increased rate decrease woman type time woman change clinical care improve outcome woman
22017349 en renal function well patient type mellitus study assess risk renal large population patient type study risk renal associate type general research database type patient without identify general research database patient renal disease incidence ratio renal estimate patient relative without regression model adjust increase renal risk effect type also renal incidence per patient type compare per among patient without ratio CI risk renal patient type remain significant analysis adjust adjust ratio CI age chronic disease hypertension also associate increased risk renal type type increased risk renal compare patient without known risk factor chronic disease hypertension
25789798 en patient type mellitus T2DM glucose independent insulin insulin also effect demonstrated significant reduce blood glucose level well patient reported randomize study patient T2DM study result evaluate potential impact clinical addition treatment may mechanism result significant reduction hemoglobin level weight blood pressure low risk associate increased risk event
26294898 en mellitus DM important health increase disease DM management DM patient care patient DM patient disease impact conduct study datum regard sample previous included analysis identify possible difference finding show sample adjust well DM general high however finding also revealed difference female adjust disease whereas reported high finding study difference case management patient health care system
23587090 en follow woman found gestational association gestational type show increase significant oral glucose tolerance possible system may also effective trial aim assess whether system woman gestational index increase oral glucose tolerance within month hospital group control diagnose gestational index oral glucose tolerance test fasting glucose two glucose blood glucose profile normal fasting glucose glucose mellitus multiple index intervention use number insulin group woman intervention group receive oral glucose tolerance test week month month indicate test woman control group receive month baseline datum participant primary outcome datum possible study outcome oral glucose tolerance test within month subject show increase rate two follow intervention risk impair glucose tolerance type woman gestational high possible rate glucose tolerance early diagnosis intervention occur important on system may effective method improve control trial assess whether system increase rate oral glucose tolerance woman gestational new clinical trial
23254942 en clinical evidence provide increase study related found care improve care patient important determine whether evaluate clinical patient type mellitus primary care care hospital use develop medication assessment primary care care study sample patient type use study datum retrospective patient medical use medication assessment assess treatment patient type analysis conduct use CI significant high found care CI compare primary care CI care compare primary care patient found study target hba1c blood pressure BMI among study review possible finding patient intervention need improve current
24189507 en gestational mellitus define glucose first gene investigate population different present study examine possible association gene total woman study gene examine gene show difference normal subject vs significant gene associate woman
21054539 en female show increased risk mellitus several mellitus associate mellitus healthy review follow-up blood sample day diagnosis glucose analyzed compare healthy logistic model use evaluate association clinical mellitus study female diagnosis clinical mellitus occur day range diagnosis day associate high concentration lower concentration compare control time undergo lower high glucose concentration odd ratio or diagnosis time week diagnosis or mellitus develop improve
20942745 en effect mellitus investigate assess level protein three group control group group diabetic group group diabetic group group examine one month complication serum sample obtain glucose level increased result significant increase serum group compare group increased serum group compare increased value observed group statistical obtain level elevated blood glucose correlate elevated level increased serum level correlate level increase mellitus mechanism level may increased
25868209 en type mellitus insulin therapy treat large medical include perform blood level poor control glucose patient blood level without insulin medication level level control level patient without report suggest glucose may metabolic management patient without also
26382922 en new early dysfunction protein effect increased concentration reported patient type assess possible role cardiovascular disease patient type history disease relationship determined patient man age year year BMI hba1c control age condition assess score patient control score patient show significant high mean common compare control vs concentration significant high vs vs difference compare parameter patient association found test disease on positive correlation found level age duration disease difference presence level high patient vs patient disease although lower disease show high concentration compare control therefore early diabetic subject presence low
25900666 en aim study determine whether history type mellitus factor relationship analyzed study population participant clinical status test body mass index BMI test analysis significant association risk decrease increase baseline BMI CI less among clinical trial participant history independent factor clinical trial database low prevalence rate examine large study determine whether risk
26229480 en aim compare severe cause patient type mellitus insulin database sample patient health system patient type mellitus patient treatment insulin treatment insulin therapy period identify cohort on similar analysis conduct analysis adjust within model subject characteristic use regression model patient patient compare patient patient cohort cohort patient cohort respective rate CI cohort cohort CI CI cohort rate per CI CI CI CI adjust rate also significant lower compare result found treatment compare significant less patient datum consider drug
25913129 en evaluate effect risk female patient type mellitus T2DM retrospective cohort analysis use health database female patient new diagnose T2DM without follow among on use incidence estimate ratio regression duration analysis conduct follow-up develop incidence per respective overall ratio confidence interval score ratio first duration therapy respective respective relationship demonstrated model overall reduce risk use woman T2DM associate overall significant lower risk relationship
27321333 en show decrease risk major adverse cardiovascular event compare however association large clinical trial cardiovascular event primary aim present assess association use cardiovascular risk use study database identify trial compare drug odd ratio or confidence interval CI use trial included study patient treat treatment associate lower risk or compare show increased risk or compare difference statistical significant compare or similar analysis conduct general type population well population high cardiovascular significant difference risk group show significant lower risk compare lower risk compare
21060170 en mellitus adverse complication associate decrease patient investigate risk factor included first hospital may patient time cause define fasting blood blood two need insulin therapy oral drug little two week diagnose month follow-up period control age possible case risk factor investigate age old year history hypertension disease duration one year history mellitus mean group also mean serum high increased risk group
21323731 en diabetic well known association duration mellitus patient recent diagnose diabetic present mean determine duration disease prevalence diabetic type diabetic patient known duration one year investigate present diabetic included history health assessment different use association recent diagnose mellitus define diagnose within previous total patient first among patient recent diagnose mean age patient year prevalence diabetic per patient among recent diagnose diabetic patient patient diabetic patient per included significant presence hypertension significant associate prevalence diabetic recent diagnose diabetic diabetic important new diagnose diabetic patient prevalence diabetic high patient develop included develop on need early reduce diabetic patient
22549261 en study disease study base datum identify related period year adjust result effect cause population number treat patient increased adjust age mean patient related per relative time period observed per patient patient without change due increase number treat patient year total adjust effect included
26093872 en include type associate elevated cardiovascular risk effect blood lipid profile study therefore reduce mortality patient mellitus define hemoglobin previous complication
26164132 en study use examine vs healthy use sample type mellitus use compare use independent high follow significant difference vs respective may finding healthy great healthy need
26134697 en complication type mellitus control target elevated report case man control target present diagnose treatment reduction insulin
25154649 en previous study found woman aged year obesity investigate whether obesity hypertension mellitus DM woman great compare obesity current database prevalence hypertension provide health research datum woman aged year use analysis characteristic index BMI ratio ratio use DM woman aged year however great risk DM woman obesity reduce value follow BMI
21106349 en early development type woman gestational mellitus identify risk factor early development type woman may intervention type woman develop test outcome oral glucose tolerance test subject three group oral glucose tolerance test result normal glucose tolerance group incidence follow-up woman respective risk factor develop type early included high body mass index lower function insulin risk factor history risk factor included high body mass index serum hemoglobin lower insulin high group normal glucose tolerance group whereas risk development study suggest development type woman intervention
21933668 en hba1c recent primary test study evaluate positive value negative value hba1c oral glucose tolerance test three year datum hba1c test system positive negative value compare hba1c value use prevalence hba1c value compare hba1c value hba1c value diagnosis hba1c may cause patient without define normal mellitus
20167931 en large type function activity reported diabetic however mechanism mellitus aim study determine whether dysfunction diabetic found type protein cell cell important target protein diabetic cause dysfunction effect activity function result identify development dysfunction
22594969 en effect mortality remain large previous study base primary datum develop study evaluate impact mortality sample two health follow old adult assess activity severe receive perform activity logistic regression model health condition use influence presence increase risk need however related increased risk assess health condition individual time condition CI elevated risk or CI similar effect observed severe or CI receive or CI time old adult high risk remain CI mortality CI however risk high associate high indicate history great impact prevalence mortality among old adult
23370206 en increasing prevalence may contribute incidence develop incidence relative low datum study risk population due high prevalence health study cohort old man woman participant baseline perform cohort subject mean follow-up year cohort participant develop history baseline associate ratio confidence interval statistical significant association man woman remain subject define number year first clinical diagnosis time cohort within cohort subject test association found present among history baseline high associate study mechanism role
20627036 en investigate relationship serum insulin resistance patient type mellitus disease trial patient type mellitus group patient type group patient group healthy control subject group serum profile analyzed insulin resistance assess model assessment serum lipid level high group group vs level high group group level significant lower group group vs concentration negative correlate significant decrease patient type mellitus serum negative correlate insulin resistance important role development mellitus
25251664 en assess whether patient associate lower risk first cardiovascular disease event mortality cohort patient type mellitus T2DM primary cohort patient T2DM without previous event baseline study database provide patient T2DM treat primary care participant use score method baseline regression perform estimate association first event disease cause baseline month follow-up participant patient first event adjust participant lower rate mortality ratio confidence interval CI first CI CI without associate lower mortality lower number first event among patient T2DM metabolic control care primary care
25128838 en factor on role occur diabetic complication aim study investigate gene associate type association test study include subject T2DM compare subject T2DM without disease addition serum level analyzed subject type without significant high found diabetic patient compare diabetic patient without vs associate subject type significant high serum level found subject compare vs multiple logistic regression analysis adjust age hypertension cholesterol cholesterol revealed high risk present study possible risk factor T2DM
26318272 en cell follow therapy type mellitus treatment due mechanism number patient insulin use treatment however occur important patient potential treatment factor influence outcome study datum study study perform treat patient patient group according response treatment follow-up compare baseline datum two group possible factor odd ratio or analysis logistic regression characteristic perform test model follow-up month patient group insulin use whereas patient group decrease insulin insulin treatment logistic regression analysis demonstrated positive correlate fasting level or confidence interval CI negative correlate age or CI level or CI analysis function three CI fasting level identify possible therapy
26253308 en present study investigate whether patient type mellitus similar patient disease normal old adult whether hemoglobin level glucose related two included test three group participant healthy old adult patient patient medical assessment perform result show similar three group three group normal two group patient patient severe compare healthy old adult important hemoglobin level related finding revealed normal patient can negative impact treatment management two clinical group can use
23807520 en patient type metabolic syndrome test addition insulin patient type result plasma glucose concentration reduction hemoglobin hba1c blood pressure weight retrospective analysis datum obtain patient type treat addition insulin patient also treat hypertension test use compare change hba1c insulin body weight body mass index mean blood glucose concentration insulin mean blood glucose blood pressure lipid parameter day glucose concentration hba1c without increase mean body weight total insulin respective mean blood pressure insulin patient type mellitus lead glycemic control hba1c reduction insulin blood pressure body weight
23302039 en patient type mellitus insulin according previous study reduce patient remain whether due whether insulin can contribute patient model investigate receive insulin control without patient measured fasting two glucose measured study mean fasting concentration plasma glucose insulin whereas vs total fasting three group lower total control reduce insulin patient
23551273 en identify large gestational age woman gestational retrospective clinical datum woman diagnose gestational datum week weight week assess BMI total weight weight treatment gestational hba1c gestational treatment insulin assess use large gestational age gestational age multiple regression analysis statistical woman first mean week range therapy insulin mean total weight intervention gestational age large gestational age significant independent large gestational age weight intervention BMI weight intervention treatment type hba1c significant gestational age weight intervention weight intervention BMI hba1c treatment gestational mellitus management blood glucose level identify need also weight BMI
24831989 en control report year follow-up result first mellitus insulin glucose trial care hospital patient without previous diagnose blood glucose concentration previous control little month control group treatment consider insulin use primary mortality study present follow-up analysis analysis patient control control group mean follow-up period year range year patient control group patient control group time year patient control group group ratio CI effect control year increasing control patient effect although effect glucose less present effective drug improve control important
23252407 en mellitus DM associate outcome severe however clinical study evaluate effect DM outcome patient current study period patient DM without DM ratio outcome included mortality hospital care day patient case DM without DM difference regard characteristic observed compare two group overall mortality study population significant increased mortality patient vs without DM vs or CI patient DM significant less compare without DM vs or CI mellitus associate increased mortality compare patient without mellitus finding determine
24612458 en compare rate gestational mellitus among woman increased normal blood cell early risk also included woman first care may subject increased control normal datum woman woman obtain blood perform first rate group compare odd ratio or confidence interval CI development subject group determined subject increased control normal obtain rate significant high subject compare control or CI analysis subject group found increased risk compare control group adjust or CI woman increased early significant high rate woman normal result independent risk factor
26604727 en insulin recent patient type mellitus T2DM factor review function mass however event metabolic condition T2DM lead cell cell review factor show present well potential mechanism undergo develop mechanism can factor influence reduction factor cell present review factor contribute study investigate T2DM development early diabetic
26297528 en whether treatment outcome evaluate association studied patient mean age year assess health outcome assess mortality on total patient type mellitus lower health patient treat compare patient treat vs respective patient treat lower patient treat vs respective patient treat also lower mortality patient treat vs respective treatment patient associate outcome lower mortality risk
23658880 en effect mellitus parameter status cell studied found development mellitus associate change blood cell development mellitus lead lipid change insulin increased level DM indicate system development
23658570 en mellitus DM hypertension chronic medical condition patient presence may assess prevalence subject mellitus hypertension also determine use assess prevalence subject DM hypertension subject DM prevalence hypertension high subject DM subject hypertension high subject DM hypertension high female occur DM hypertension
23522179 en mellitus common disease similar mellitus type disease oral drug potential treatment insulin several oral drug evaluate drug common use treatment diabetic new oral drug mellitus may diabetic control patient
24524353 en mellitus common chronic metabolic disorder one cause condition study investigate prevalence among type diabetic patient examine relationship factor clinical factor glycemic study primary two patient presence use patient review obtain datum age status body mass index BMI level status duration mellitus glycemic control use hba1c test use insulin presence patient medication assess use medication patient total sample female year old one patient score statistical significant association found high score female low level current multiple low medication obesity BMI significant association score glycemic control duration factor found analysis show low level current multiple low medication significant associate high found study high reported although patient potential case treat assessment clinical patient primary improve decrease adverse outcome among diabetic patient
21205219 en mellitus potential study three group group receive normal cholesterol whereas group receive normal control addition group also receive day study day normal day compare normal control group potential three different evaluate response decrease serum insulin activity increase serum glucose lipid profile cholesterol lipid observed studied change decrease serum glucose total cholesterol cholesterol increased insulin however increased concentration decrease lipid revealed potential studied mellitus outcome well insulin decrease obesity however treatment parameter
23948625 en patient type mellitus function insulin obtain glucose glycemic control patient insulin influence presence medical condition well risk glycemic increased patient diabetic severe common condition hospital patient association increased risk complication mortality patient type T2DM well however impact glycemic control clinical outcome determined patient present without decrease complication associate insulin therapy health care well use insulin common medication patient insulin need method insulin insulin well insulin review identify related glycemic control patient difference associate management patient T2DM
22183418 en clinical provide clinical trial evidence old clinical old primary high care use use develop base use evaluate study clinical identify general previous year consider identify database trial major two included care medical new medical clinical clinical identify on provide old patient provide clinical old adult type year included clinical primary care
26887369 en investigate impact mellitus DM patient retrospective study patient clinical general hospital time without DM compare use analysis regression patient DM time patient DM month whereas time patient without DM month analysis show difference significant rate patient without DM vs vs vs respective adjust age treatment regression analysis show ratio patient DM compare without DM ratio patient DM however association patient patient also significant factor DM time compare without DM
24893750 en impact glycemic control studied retrospective cohort study included adult patient three group patient develop compare also high incidence little vs respective patient glycemic control lower rate development vs control also lower rate vs analysis decrease rate patient blood glucose result associate increased risk development glycemic control may reduce risk
23762090 en mellitus may associate reduce patient retrospective study cohort among patient develop reduce patient group on patient group patient group on group respective group on patient respective significant different group function improve therapy serum time year therapy group patient remain reduce serum time study demonstrated patient can improve significant metabolic parameter patient without increasing risk
23745805 en mellitus DM metabolic disorder low insulin cell low insulin target associate DM whether cause effect metabolic related DM multiple cardiovascular disease development diabetic patient cardiovascular disease can potential early diagnosis current review mechanism DM cardiovascular complication
23382801 en can new mellitus DM recent new body index develop can mortality BMI aim study assess DM base follow-up datum year general datum group individual diagnose DM analysis base datum remain individual define adjust increasing population one result increased compare BMI DM follow BMI can new DM population independent confidence interval DM BMI three similar DM study need
24941430 en type mellitus T2DM metabolic disease effect multiple large may retrospective study investigate whether type mellitus T2DM function patient study T2DM one total value well ratio value ratio significant lower T2DM multiple regression analysis found study population fasting plasma glucose level negative associate ratio patient T2DM negative associate total multiple regression analysis found patient T2DM fasting plasma glucose negative associate ratio T2DM patient negative correlate negative correlate ratio negative correlate total T2DM associate impair function fasting plasma glucose independent risk factor reduce function
23422767 en previous datum suggest role glucose aim present study determine difference plasma concentration healthy subject patient type mellitus study effect insulin level patient type patient healthy subject examine patient type control study study blood sample study oral glucose tolerance test perform two on baseline insulin type diabetic patient control insulin insulin glucose level measured baseline glucose plasma concentration high fasting level lower patient type healthy subject group fasting correlate change significant oral glucose tolerance test group without insulin
23010011 en mellitus general type disease result impair insulin clinical subject disease clinical several year condition disease disease however change use mechanism factor contribute development important treatment disease regard identify early management new therapy present review provide protein base intervention also treatment
22377484 en dysfunction cardiovascular patient type study test whether glucose may T2DM patient age year female dysfunction glucose control base insulin oral month studied function control improve reduction hba1c improve group determined vs vs oral insulin function decrease remain improve function patient type cardiovascular
26259496 en gestational mellitus associate increased risk complication diagnosis oral glucose tolerance test week potential occur aim study investigate new early assessment early use mass mass protein plasma gestational week woman without total protein identify protein response response identify protein assess result protein include protein first study multiple early potential plasma
23536351 en evaluate effect lipid type mellitus patient type mellitus undergo patient subject total cholesterol high low model assessment insulin resistance hemoglobin hba1c month blood glucose control without drug patient hba1c decrease case normal normal normal normal ratio decrease ratio decrease effective patient type mellitus
23530877 en mellitus DM patient high incidence show role function however whether associate DM remain aim study determine impact type DM system DM control two week type DM DM undergo week function assess protein cell assess remain change diabetic determined use week revealed significant lower DM group compare group vs vs respective indicate increased among DM protein group DM group negative type diabetic DM increased
23496967 en aim present study examine whether low relative concentration independent associate disease patient type mellitus concentration analyzed subject according subject number number group according normal group according on event define follow-up follow-up period case event show correlation relative concentration show positive negative correlation respective model analysis revealed ratio adjust confidence interval CI CI CI result suggest significant independent risk factor patient T2DM
23407453 en mellitus DM lead high prevalence disease however role DM disease also cause effect therefore aim evaluate activity DM addition DM found increased due high protein cell insulin decrease activity level effect protein on remain decrease DM whereas increased significant high cell high glucose protein elevated DM insulin also related per
23109114 en type mellitus result increased risk model type mellitus low mass test whether diabetic diabetic week mass assess use use assess analyzed diabetic lower mass compare treatment significant mass diabetic also diabetic increase respective lower mass diabetic associate decrease rate increased effect whereas diabetic treatment increased respective treatment adverse effect type mellitus mass improve
23731902 en aim present study examine association mellitus DM prevalence patient determine impact age use evaluate patient presence profile patient perform datum evaluate use test respective normal datum evaluate use time present patient patient DM patient DM significant high prevalence vs patient without DM however significant difference two group score presence patient DM high without DM age analysis old patient man DM significant great evidence respective analysis show DM old age independent related whereas association DM old age independent associate patient
26960210 en hemoglobin use assess diabetic control although compare glucose system conduct retrospective analysis diabetic patient determined mean glucose concentration patient correlation hba1c glucose three patient hba1c significant per day patient can glucose level measured correlate hba1c glycemic control patient suggest
26732585 en health remain population remain disease study among type mellitus hospital hospital use hba1c assess glycemic control care interval test hospital hospital patient female mean age year patient primary less year insulin therapy CI glycemic respective two hospital hospital CI however hospital weight also interval three lower reported great hospital glycemic control diabetic care hospital care health
26604100 en resistance effective glycemic control type mellitus T2DM patient however characteristic effect patient review identify characteristic patient T2DM increase patient glycemic control characteristic patient conduct identify clinical trial examine effect glycemic control among patient T2DM study related included clinical trial two group without intervention intervention period little week patient T2DM reported possible estimate effect change hemoglobin hba1c group control group effect study model analysis several characteristic patient analysis use difference effect among within factor regression analysis profile patient baseline characteristic mean baseline age body mass index BMI hba1c level characteristic total per week total per study patient T2DM effect confidence interval on multiple vs per one associate large effect however correlation number effect significant on large effect observed study participant relative duration vs year high baseline hba1c vs effect observed study high mean baseline BMI value vs regression analysis baseline hba1c effect baseline BMI decrease range glycemic control can early T2DM patient relative poor glycemic control less patient within range BMI on glucose although
26483395 en low level associate increased mortality man role man type mellitus T2DM influence protein conduct cohort study total man T2DM present follow analysis perform outcome cause mean follow year man model high ratio CI lower CI risk factor cause mortality independent age BMI presence disease duration T2DM hemoglobin renal function insulin use protein model insulin resistance association total mortality remain associate mortality model adjust model increase increased mortality decrease increased mortality association mortality man T2DM whether role poor health study
25938991 en whether obesity associate patient type mellitus investigate association body weight large cohort patient type follow health relationship body mass index BMI patient type without known cardiovascular disease baseline investigate mortality cardiovascular syndrome regression analysis potential include cardiovascular risk factor condition chronic disease disease patient follow year range age year range patient man patient BMI high rate event syndrome normal weight BMI however BMI associate lower mortality risk whereas patient BMI mortality risk similar patient low body weight cause cohort patient type cardiovascular associate lower mortality risk health research
25625876 en risk factor evidence review evidence association result study type mellitus database study association concentration type type gestational evaluate risk role potential study reported association T2DM use model conduct included study T2DM type gestational conduct study risk assessment control study effect reported study study show increased risk T2DM per increase CI CI association female analysis show similar evidence indicate positive association T2DM risk high risk study assess effect need research develop high
26666154 en obesity increasing also develop develop mean body mass index patient type increasing body weight decrease body weight patient metabolic syndrome glucose also hypertension improve reduce body weight therapy drug include glucose reduce body weight use present therapy mechanism development drug effect need
27002728 en type mellitus T2DM increasing adult patient prevalence datum associate factor related study aim examine prevalence associate factor adult T2DM patient study conduct three health patient health patient little year age T2DM one year follow-up recent result month association clinical characteristic use model mean age year female prevalence respective correlate patient high or CI or CI health or CI high score or CI less compare health patient complication or CI high or CI or CI positive association whereas medical care health or CI blood pressure or CI less common correlate adult T2DM primary care level clinical characteristic related
26372349 en compare outcome woman gestational mellitus retrospective study datum compare woman control woman hospital woman datum study period study included group control group respective incidence significant high group control group adjust odd ratio confidence interval incidence hypertension also significant high group adverse outcome include hypertension significant high among woman finding effective system improve
26358582 en examine association incidence gestational mellitus cohort study woman study health included woman without use factor analysis base regression model estimate use estimate year follow-up case association found associate high risk factor CI per increase score BMI result analysis associate significant high risk woman woman lower associate lower risk adjust model finding general woman age low study need finding
26096924 en primary study assess adult type patient without diabetic disease respective compare healthy control subject respective assess difference patient patient group database perform participant significant difference parameter subject patient large total respective lower total respective lower total respective patient also lower total estimate great patient difference remain significant age body mass index disease duration glycemic control hemoglobin previous year although significant lower group control similar group result study suggest presence associate can observed patient
25322842 en on study within conduct evaluate relationship body measured serum ratio risk type mellitus T2DM population high risk without T2DM study study subject T2DM case without T2DM control follow-up period range year diabetic subject two subject control age well intervention group BMI observed relationship value female risk T2DM logistic regression model protein fasting glucose metabolic syndrome or CI also found association low ratio level incidence T2DM or CI association or CI contribute development insulin resistance dysfunction two event clinical development T2DM risk factor T2DM body measured ratio associate increased risk develop T2DM population high risk
25054568 en although perform obesity show significant improve type mellitus T2DM datum effective improve T2DM patient present study evaluate clinical effect T2DM patient body mass index BMI
23793713 en aim new study outcome model health outcome type patient year trial year period use model risk complication event estimate new diabetic event datum new risk factor estimate also develop new mortality model incidence event use compare year new base year follow-up datum provide number event great large number significant new model year event rate complication lower new significant model outcome base follow-up datum use health outcome type mellitus
26248034 en evaluate effect glycemic control patient T2DM dysfunction man due T2DM included study group patient receive medical treatment glycemic control group addition glycemic control patient per week change compare two group three month mean age year increase score observed patient group group change score evaluate mean increase group group mean change according duration year year year control change function due use
25443639 en gestational mellitus glucose insulin resistance identify negative development may also function development glucose however high level occur concentration evaluate plasma woman develop compare plasma normal glucose woman protein studied woman treat insulin compare significant difference concentration plasma woman compare woman significant difference protein high lower observed compare woman treat insulin compare high lower compare woman woman lower condition obesity glucose found can glucose function
26786607 en disease health relationship insulin resistance type mellitus T2DM study compare observed individual without T2DM undergo study study individual undergo assess T2DM diagnose present significant without regard diabetic present significant high associate within population studied previous correlate severe early population important development severe need
25855222 en treatment type mellitus also review clinical oral treatment type result randomize control trial demonstrated oral improve control therapy insulin therapy general well patient type weight low risk result large well examine trial revealed associate increased risk major cardiovascular event patient type recent syndrome treatment patient type
25269853 en impact gestational mellitus follow low rate patient medical oral glucose tolerance test week provide type year develop three current treatment management perform week rate assess two group without group similar age year respective time year respective show significant difference rate assess test group without group rate time high group group without can woman
24285765 en review management type mellitus conduct use review identify sample evaluate clinical high insulin response patient T2DM study evaluate role T2DM show significant reduction blood glucose hemoglobin level reduce patient addition effect include effect weight on large trial evaluate cardiovascular current treatment T2DM
24214147 en mellitus provide model research association type mellitus high population use group research datum present result show result use statistical analysis research on evaluate provide regard outcome overall positive indicate
23831668 en study aim patient presence hypertension type mellitus total patient primary assess presence disease hypertension T2DM datum age body mass index BMI regression model potential effect adjust compare subject without significant observed patient hypertension T2DM lower high adjust age BMI presence hypertension T2DM included regression model decrease increased finding suggest disease hypertension T2DM need cohort study
26198011 en patient related outcome although known potential examine mass regression retrospective analysis perform patient undergo may patient outcome datum obtain year diabetic patient characteristic diabetic patient statistical similar patient high prevalence history disorder diabetic patient value patient significant great compare diabetic vs analysis perform multiple regression analysis demonstrated regression female age associate poor show disease factor associate poor finding suggest may group patient outcome
18347965 en control diabetic reduction complication type type however evidence glycemic control disease common cause mortality type condition two common insulin obesity type significant also glucose show effect cell effect include effect glucose insulin show several effect concentration cell function may potential finding great possible complication type may use glucose drug effect addition control condition hypertension associate disease result clinical trial primary complication type
25503343 en mellitus DM one common chronic disease oral patient include aim study relationship sample subject aged year old include patient diagnosis type DM control group DM group significant difference group significant difference mean DM control patient reported three subject use medication present severe drug diagnosis factor related DM treatment related oral condition patient DM present normal value important patient potential case drug observed patient study drug cause adverse event increased need
22962692 en recent reported cause although previous reported case study identify previous reported case among range associate clinical associate
22401332 en patient insulin may large due reduce patient improve glycemic type mellitus patient treat multiple insulin therapy hospital assess regard insulin therapy use blood glucose system base current blood glucose value patient female age year duration year week use indicate current use insulin indicate reduce significant reduce indicate confidence insulin improve significant improve indicate compare patient use improve confidence reduce randomize trial need determine whether use improve clinical outcome
21725703 en syndrome also known mellitus disease disease estimate prevalence occur patient mellitus may also present different metabolic dysfunction need metabolic syndrome
25480593 en evaluate function studied diabetic patient different function use patient two group according mellitus normal group mellitus group control group relative mass index resistance index effective index measured assess found on compare control group group decrease lower group increased high group decrease lower group negative correlation independent characteristic use large study can different early
25072436 en investigate month treatment intervention obesity type mellitus less also effect obesity randomize control trial conduct patient obesity T2DM included patient randomize month treatment intervention study patient receive intervention control study total study duration group month include month month group weight control group hemoglobin level improve group control group addition patient show decrease glucose control patient month weight group control group hba1c control respective effective month treatment lead weight T2DM compare
24072086 en protein use early cardiovascular disease may use early diagnosis compare function assess relationship parameter metabolic control diabetic total patient type mellitus little duration healthy subject included study serum hemoglobin hba1c lipid level evaluate patient control function assess age patient year mean duration year mean serum elevated vs significant difference control found level mean significant high diabetic compare control group vs mean diabetic significant lower control vs duration positive correlate negative correlate index high patient group datum suggest addition use follow-up patient
23957874 en group therapy use intervention improve among type mellitus study treatment two type management group also use control within health general assess baseline month medical include metabolic control value medical month baseline month treatment month reported increased reported improve although statistical significant change hemoglobin value health care month month change increase therefore treatment found intervention use clinical function type mellitus
23261529 en determine effect type mellitus function test reduce well potential
22695875 en aim study compare diabetic patient normal control group regard age glucose level duration complication perform patient type mellitus compare control patient group according age duration complication control compare control subject year age group show significant high compare control poor control diabetic significant high compare well control also correlation level duration
25686509 en major cause mortality type mellitus T2DM study improve assessment risk patient effective perform database include use risk factor T2DM dysfunction risk assessment risk impact risk score related study relative risk ratio obtain study include subject T2DM included analysis follow-up range year association risk study reported association great insulin use hba1c year increase age fasting glucose per hba1c increase association disease hba1c insulin use hba1c fasting glucose per year increase age patient T2DM common clinical associate significant increased risk
24014824 en evaluate value patient type mellitus follow-up estimate use recent total diabetic patient datum regression analysis use estimate risk analysis perform evaluate effect model include age history type improve adjust ratio lead confidence interval significant effect adjust ratio significant provide independent patient mellitus addition model base cardiovascular risk factor significant improve risk event effect influence function
25719215 en woman history gestational mellitus elevated risk develop type important role type compare among woman history woman without history use datum health included woman without aged year recent within previous year two healthy index estimate overall regression model estimate association history current adjust age status health risk history reported woman compare woman without history woman history lower overall confidence interval CI lower score CI score history woman history lower compare woman history may type among woman
25782291 en role system mellitus DM type datum DM cause system present study system development new DM treatment base
23160531 en syndrome obesity dysfunction target investigate fasting plasma patient compare control subject lower concentration increased decrease decrease test patient compare control subject similar high fasting concentration without increase datum indicate impair impair
24612224 en relationship receive therefore present study assess among type diabetic patient factor on hospital base study among type diabetic medical hospital diagnose little year year age included among study subject present among subject statistical significant association presence age presence presence finding indicate need increasing age among status among type mellitus
22343215 en chronic metabolic disease due insulin population type mellitus T2DM common associate development number complication include also major risk factor disease treatment T2DM glycemic control rate remain poor recent role glucose potential target role glucose glucose potential new treatment important role glucose glucose patient T2DM glucose increased potential contribute associate disease result clinical trial number glucose suggest increase glucose decrease plasma glucose body weight general well increase risk glucose mechanism independent insulin result clinical trial determine whether treatment reduce patient T2DM
25742942 en whether effect patient disease according different study conduct evaluate impact patient disease treat intervention total patient disease receive undergo retrospective analyzed compare effect treatment clinical outcome according diabetic follow-up year range year difference found adjust significant high incidence observed group whereas group significant high rate diabetic patient significant treatment outcome presence important patient disease
27330722 en effective treatment type randomize control trial aim evaluate effect drug
25288177 en glycemic effect recent however regard may suggest effect glycemic effect may great number patient suggest clinical glycemic effect may
22496082 en patient disease without intervention trial provide examine clinical impact patient analysis patient early undergo undergo intervention determined index ratio number significant total number mean follow-up mortality year patient severe adjust high patient ratio type mellitus less cardiovascular
22231125 en aim study develop score impair glucose type use use datum individual aged year population base study develop logistic regression model type diagnose use hba1c datum primary care develop score score use datum participant aged year score include age history therapy BMI per population need type mellitus need use hba1c type mellitus use positive value CI CI use hba1c increase type mellitus CI hba1c CI score use identify type population first score develop hba1c diagnosis type
23822678 en prevalence mellitus DM increased body important risk factor disease indicate treatment DM recent study associate lower risk develop obesity effect associate low glycemic index high however mechanism type control among present subject aim identify may use treatment
23543567 en one common chronic medical condition adult patient reduce risk complication show effective number condition effective intervention improve outcome type can potential provide reduce patient system assess effect health status intervention adult type database three database report review also control trial intervention adult type aim improve one patient review independent datum on change use identify control trial participant study included intervention intervention intervention can use intervention mean age participant year old mean time diagnosis year duration intervention month three reported intervention current effective control effect hba1c confidence interval CI participant trial effect hba1c large analysis mean difference hba1c CI participant three trial current intervention show evidence weight intervention show effect lipid participant adverse effect two study provide datum one study suggest per patient less study show change health intervention type effect blood glucose control effect large evidence show outcome outcome
23299658 en finding individual type type mellitus correlate cardiovascular mortality may significant contribute cardiovascular mortality group early glycemic control clinical complication dysfunction present observed decrease similar blood correlate decrease several correlation dysfunction include insulin resistance dysfunction decrease hemoglobin function therapy target insulin function improve subject type function reduction mortality risk dysfunction may provide target model test study
27875915 en glycemic target patient type several treatment glycemic level control association insulin therapy assess profile therapy randomize clinical trial trial study whereas insulin occur study study compare insulin treatment insulin therapy clinical trial review demonstrated insulin study compare addition insulin associate weight less
18809650 en mellitus group disorder elevated level glucose blood protein on number oral disease disorder associate mellitus identify possible risk factor poor metabolic control subject review identify oral condition mellitus also examine glycemic number oral disorder associate mellitus datum complication patient poor control risk develop oral evidence indicate risk factor poor glycemic control development clinical complication evidence suggest change first clinical important health care evidence suggest oral health care significant positive effect oral general health patient mellitus
23851281 en develop dysfunction response mellitus DM common medical disorder patient consider relative DM occur cohort adult patient patient DM severe disease without cohort care patient review age number intervention presence DM score adult patient female patient DM prevalence high general population number intervention disease control significant adult patient DM without DM significant difference score time intervention presence patient without large adult patient DM high prevalence control patient DM severe disease
19352318 en one common condition mellitus chronic lead renal result impair patient mellitus contribute cardiovascular disease diabetic occur early patient diabetic renal disease individual chronic disease although use treat renal two target hemoglobin level hemoglobin level role patient however complication complication patient
24304618 en mellitus DM management control disease however several study show DM general population low study however conduct condition major health assess DM among diabetic patient medical hospital patient use patient characteristic DM include general DM cause complication management patient condition DM similar study participant cause DM method DM result DM cause poor DM lead DM level duration important study show patient poor several DM need level health hospital also within general population control DM
25347323 en although oral medication use little effective evidence therapy determine effect oral need treatment adverse clinical study retrospective cohort study patient large health oral medication individual new oral medication health define within day first studied individual oral medication treatment addition oral insulin cardiovascular total patient therapy analysis use medication significant associate increased risk oral insulin insulin score model therapy ratio CI CI CI associate increased associate reduce risk cardiovascular individual treatment treatment associate reduce treatment without difference rate adverse clinical event finding significant medication
25640450 en insulin resistance characteristic development type mellitus T2DM associate factor aim study whether sample participant follow-up study without baseline mean follow-up participant year glucose use oral glucose tolerance test include insulin measured use individual develop T2DM follow-up T2DM or or age BMI follow-up time hba1c analysis also fasting glucose hba1c adjust age BMI time follow-up cholesterol datum suggest T2DM
26101084 en study several report increase rate gestational mellitus recent can contribute determine association measured early impair glucose tolerance research study included total on measured sample lead measured blood sample assess review concentration group association outcome examine use logistic regression age BMI analysis perform assess woman cohort outcome datum datum measured little one examine elevated odd observed high or CI adjust analysis on significant relationship observed model odd statistical significant association observed finding body evidence role risk factor gestational
20191872 en mellitus important cause aim study evaluate prevalence patient mellitus assess whether associate syndrome metabolic glycemic patient mellitus type man woman mean age included study patient obtain presence status test study found significant high diabetic control vs positive diabetic type mellitus type mellitus type mellitus statistical significant difference found statistical significant difference score positive negative diabetic patient value level diabetic diabetic without significant statistical significant difference prevalence diabetic patient difference score positive negative diabetic patient diabetic influence glycemic status
19723759 en provide mechanism early little adult type determine factor contribute early change type mellitus identify increased datum obtain age association outcome risk analyzed regression analysis logistic regression perform independent increased high hemoglobin hba1c level duration regression show hba1c duration presence cardiovascular risk factor cholesterol blood pressure independent logistic regression analysis demonstrated increase hba1c year increase duration type mellitus associate increased odd glycemic control disease duration independent adverse effect type mellitus adverse effect develop effective improve blood glucose control type mellitus development cardiovascular disease
21627349 en mellitus new recent year female prevalence mellitus DM female also DM diagnose age group year possible factor obesity age case diagnose female aged year large number diabetic mellitus develop age review common factor possible correlation
23278693 en associate cardiovascular metabolic disorder study aim investigate determined method insulin test use determined high use increase blood glucose plasma insulin level ratio effect indicate diabetic insulin resistance increased blood glucose decrease plasma insulin on effect show similar effect cell cell increased cell also reduce positive insulin cell protein reduce parameter effect system cell normal cell impact diabetic impact system
21913970 en determine whether mellitus influence status patient studied patient disease cohort assess baseline status assess activity patient baseline activity score define decrease activity score year follow-up baseline present participant compare without associate or CI association remain significant or CI follow-up demonstrated significant duration disease associate patient diagnose disease less year ratio CI diagnose disease year ratio CI obesity important factor association baseline presence significant increase risk patient disease datum patient recent diagnosis disease disease year status
26184575 en gestational mellitus woman adverse outcome early diagnosis treatment improve change large perform change woman early blood glucose level oral glucose tolerance risk develop follow week prevalence include change new outcome new prevalence early diagnosis woman early diagnosis insulin early woman identify early woman identify diagnosis new general poor week early woman may value early woman new increase number woman diagnose early diagnosis increase remain
22855943 en include use treatment mellitus chronic evaluate effect diabetic effect measured blood glucose plasma insulin level measured level lipid reduce parameter blood serum level serum serum total cholesterol level observed diabetic control treat concentration day show significant decrease fasting blood glucose increase insulin level compare diabetic also significant reduce parameter serum serum lipid profile treatment also result significant increase reduce decrease level diabetic result suggest treat group may effective impair status group effect lipid reduce risk diabetic complication
22300541 en aim study investigate association gene type mellitus T2DM population studied association gene T2DM T2DM patient control subject normal glucose tolerance among patient diagnose association clinical characteristic study population determined group T2DM patient control follow respective significant difference two group respective effect age body mass index significant effect T2DM found model test significant high risk T2DM odd confidence result show associate increased risk T2DM population
25098376 en patient high risk cardiovascular evaluate major mortality subject type cohort individual type several follow period baseline clinical datum obtain use determine ratio confidence interval CI related cardiovascular total year follow-up subject cardiovascular cause cardiovascular mortality associate interval factor addition obesity total mortality cardiovascular mortality adjust age remain associate CI CI CI interval CI CI total mortality associate obesity CI CI CI interval CI related mortality subject type
21143647 en mellitus clinical suggest function test assess insulin
19754853 en cardiovascular disease remain major cause mortality presence possible increased cell increased plasma factor may evidence treatment improve outcome patient disease include diabetic patient per day influence patient without disease patient mellitus group on patient group per day period week define plasma level cell increased group on compare change group level significant group on significant change group remain level increased group effect independent total cholesterol change associate increased reduce increased patient provide possible mechanism effect
26848337 en base increasing due management disease include type mellitus T2DM study investigate level management use identify T2DM use datum management T2DM analyzed use management method included glycemic control assess addition present diagnose T2DM use drug adverse effect patient use on level observed patient follow-up poor drug management T2DM improve care patient
27147422 en protein demonstrated elevated patient aim study evaluate possible role diagnosis investigate relationship insulin resistance
21649515 en obesity metabolic syndrome mellitus increasing syndrome include clinical condition obesity mellitus metabolic management disorder may disease three known disease due three function several whereas different condition metabolic syndrome disease obesity regard mellitus correlate type correlate type occur type insulin type early define one factor regard current obesity metabolic syndrome
25651730 en type mellitus T2DM health remain insulin cell cell may T2DM target system activity can treat T2DM cell treatment several type disease aim study evaluate potential effect T2DM
25345504 en increasing prevalence type mellitus T2DM associate disorder disease disease increasing health care due rate T2DM association need improve diagnosis management disease major management T2DM glycemic target patient clinical occur treatment T2DM disease association metabolic cardiovascular disorder treatment common T2DM associate impair insulin result status insulin resistance dysfunction event may lead T2DM associate however effective management evidence well clinical study therefore treatment glycemic control control associate intervention effective glycemic control may provide associate
25266908 en protein protein function response response also protein response control protein protein normal condition role function cell gene protein protein several however response role lead cell on number mellitus however identify review relationship insulin resistance development aim influence type mellitus T2DM development addition review three T2DM retrospective analysis effect medication present
24932599 en medical therapy important glycemic control type mellitus method recent year study aim investigate effect metabolic control body serum lipid level patient aged year receive insulin therapy control group follow year randomize control study characteristic body insulin hemoglobin hba1c serum lipid level baseline follow-up statistical significant difference group mean hba1c value year study age duration total insulin body mass index BMI score serum lipid value difference BMI insulin total cholesterol value two group follow-up mean hba1c level year significant lower group mean value also significant high first year group may provide metabolic control without cause increase weight insulin
24393758 en new mechanism found renal glucose reduce glucose glucose lower plasma glucose level mechanism associate low risk use patient function insulin clinical trial show effective reduce blood glucose level body weight blood pressure use patient type mellitus treatment general well although associate increased incidence addition drug use treat patient type mellitus several within current clinical trial
24375601 en therapy type mellitus oral activity increasing concentration reduce fasting glucose concentration patient type mellitus estimate drug known associate indicate improve glycemic control adult type mellitus clinical demonstrated several clinical trial reduce patient hemoglobin level week concentration common adverse event associate use may associate development great current use management type
17972238 en investigate prevalence mellitus study include subject aged year blood analysis perform mellitus fasting glucose concentration subject prevalence rate diagnosis mellitus subject subject diabetic prevalence rate within diabetic group subject diabetic therapy subject oral medication subject insulin therapy complication due mellitus reported subject analysis mellitus significant associate high age high body mass index high blood pressure high concentration lower level addition diabetic subject significant prevalence diabetic individual compare previous study suggest increasing prevalence
24682069 en therapy show reduce risk cardiovascular complication effect lipid determine whether addition medical therapy reduce cardiovascular mortality among patient type mellitus recent syndrome randomize trial conduct hospital patient type occur may treatment patient little year primary event positive ratio receive primary time cardiovascular due change renal trial follow-up week datum due analysis increased rate on total patient follow-up patient primary occur patient group patient group ratio CI rate adverse event include vs vs renal dysfunction vs patient type recent use reduce risk cardiovascular outcome finding use reduce cardiovascular
24835087 en aim present relationship mellitus several level on concentration use control group three age influence age found difference effect age level concentration age analysis use datum use model sample respective finding indicate sample sample provide treatment research sample
26306652 en study investigate patient type mellitus T2DM high obtain T2DM normal control use new develop found T2DM patient significant reduce significant reduce occur reduce finding indicate T2DM cause change revealed T2DM great early diagnosis disease
26246507 en renal impair early mellitus DM effective DM significant improve early DM DM impair early DM increased evidence role DM test DM reduce effective reduce control diabetic DM group follow assess baseline use assess significant impair impair cause renal significant therefore result DM suggest may also contribute reduce effective
25475658 en aim present study examine effect low glycemic index low glycemic parameter patient type mellitus total subject T2DM intervention control group group follow week included intervention group one control subject control subject intervention group trial body weight body mass index reduce significant group blood pressure fasting blood glucose hemoglobin insulin reduce significant intervention group however significant difference two group protein reduce intervention cholesterol also reduce control group reduction significant different trial significant change observed plasma lipid study low positive impact metabolic parameter patient T2DM
25441587 en aim study determine association parameter individual without type mellitus studied individual individual T2DM individual T2DM control man aged parameter determined cell total factor factor T2DM individual high protein level control T2DM individual show high protein level without T2DM elevated level serum activity high T2DM difference observed parameter on correlation observed multiple regression analysis show association obesity level show adjust odd ratio T2DM respective increased T2DM level increased gene patient obesity insulin resistance
21421651 en investigate therapy diabetic type mellitus day old use type mellitus group normal control diabetic control diabetic treat diabetic treat diabetic treat rate total protein rate plasma factor concentration renal change rate total protein rate plasma concentration renal change increased significant diabetic compare normal control decrease effective reduce renal change renal function drug possible due effect system
24639086 en medication among patient first year oral medication among retrospective cohort study health system included adult identify oral therapy within month determined define increased index medication addition oral medication insulin day regression use assess patient system adjust hemoglobin hba1c patient treatment within month respective first increased index medication little insulin hba1c associate adjust ratio hba1c respective compare hba1c patient age hba1c effect hba1c little old patient hba1c decrease old age age year hba1c age year hba1c compare age year hba1c within year hba1c hba1c treatment therapy patient age glycemic control among patient
22734662 en study assess effective management system research health care type patient
24622610 en history gestational mellitus increase risk type DM metabolic syndrome increase risk cardiovascular disease however whether increase risk early independent obesity metabolic woman year risk development adult study studied DM disease baseline reported history common measured use regression assess association adjust age risk factor assess weight insulin resistance blood pressure effect DM period woman reported per age group mean high group BMI difference woman without DM mean high group age BMI addition insulin resistance index impact adjust mean difference mean status among woman develop DM may early independent obesity among woman develop type metabolic syndrome
23619195 en response early study activity lower type mellitus T2DM therefore level lower T2DM patient
26618219 en insulin therapy current treatment type multiple therapy include base metabolic control event evidence control outcome review adult population type finding study insulin low glucose management current development control may improve compare baseline hba1c rate study provide evidence clinical effective important glucose may risk development insulin system may reduce disease management improve outcome type
26696247 en study examine disease mellitus hypertension chronic condition use study chronic disease number studied man woman disorder woman man mellitus woman man hypertension woman statistical analysis datum result compare group patient hypertension mellitus chronic disease related study revealed statistical significant difference case patient hypertension disorder high level observed patient hypertension high level observed patient high level observed patient hypertension patient hypertension show statistical significant difference patient disorder one hypertension
23237051 en high mellitus DM datum DM correlate DM study among adult age year on sample individual use method one adult datum use fasting plasma blood use define DM prevalence disease risk factor different determined test adult DM high DM high level prevalence respective prevalence among respective prevalence according need index high observed high status demonstrated high high prevalence mellitus also high prevalence among compare early high risk DM
23149332 en consider primary mechanism increased patient mellitus DM treat however response DM treat different investigate month patient DM without DM treat datum index significant DM whereas similar group follow-up significant different group type DM follow-up significant great DM although change similar group response also show show similar response type follow-up DM patient determined primary within
25651703 en mellitus DM one health DM health high associate level activity increasing obesity rate population study evaluate type diabetic patient three year period time age control without clinical history subject measured level fasting glucose total cholesterol high hemoglobin level low aim study characteristic lipid parameter population study difference parameter evaluate correlation lipid parameter compare lipid parameter patient healthy control patient analyzed datum use test logistic regression result diabetic patient present little one lipid elevated elevated elevated reduce level patient respective elevated reduce lipid statistical significant difference level man woman difference observed level identify important relationship adjust level use two overall patient healthy control difference man woman observed
25224194 en diabetic complication poor control mellitus case man history poor control type mellitus multiple complication present on demonstrated blood consider diagnosis patient present without
25796948 en evaluate parameter status associate study included patient status factor measured method day period status level decrease potential increased patient develop within year change parameter protein parameter associate mellitus develop year
24798870 en role development insulin resistance type mellitus T2DM study evaluate oral patient randomize study on total patient randomize receive primary change baseline mean glucose included change baseline fasting plasma glucose insulin resistance model assessment insulin body occur mean plasma increased week reduction observed treatment group compare significant lower lower treatment group significant lower increased group significant increased group include decrease body weight time clinical significant finding assessment incidence adverse event similar result parameter compare general well patient T2DM
27249891 en examine effective blood glucose glycemic control poor control patient test whether glycemic outcome trial patient type mellitus aged year old hba1c patient one three group control group difference hba1c month baseline compare among total patient poor control included compare baseline month change among control respective patient reduce hba1c respective use different value hba1c result different T2DM patient among group difference statistical significant reduction body weight observed group control individual effective health care care poor control consider
26362726 en investigate whether include plasma factor woman develop gestational mellitus examine potential value characteristic medical study population include case develop woman undergo complication week serum measured level multiple characteristic medical history factor value evaluate characteristic group compare group reduce CI increased CI factor improve addition serum
25668938 en gestational mellitus condition factor risk control improve health risk current clinical management study group management previous new care insulin insulin due current present current management insulin therapy clinical evidence clinical
21572081 en compare prevalence type mellitus patient normal medical patient type mellitus normal individual examine examine evidence prevalence significant high type mellitus patient compare normal odd ratio or confidence interval CI or CI or CI or CI prevalence associate duration disease finding suggest type mellitus associate patient type mellitus duration disease increased
21537159 en oral group study aim assess change diabetic activity change pressure index type mellitus treatment on study patient patient oral week activity hba1c fasting lipid profile measured patient study study mean activity mean mean hba1c reduction mean total cholesterol increase mean cholesterol increase mean cholesterol increased significant improve activity also significant hba1c reduction potential improve study need relationship system reduction type mellitus
21298295 en cardiovascular common dysfunction mellitus DM associate rate control study evaluate impact mellitus dysfunction rate group type mellitus without cardiovascular disease study group patient aged year diagnose type DM subject diabetic patient subject oral therapy DM normal subject control group healthy subject age rate measured use system perform subject significant difference group regard disease duration patient impair vs year disease control impair group rate impair group significant high control high significant compare normal group vs respective associate patient type DM without clinical disease diabetic early perform subject
24132517 en associate obesity reduce insulin healthy diabetic subject reduce serum level type evaluate association insulin control individual type diabetic whether contribute development diabetic type on study perform control subject patient type group rate year group perform use significant different group significant lower group group vs control subject lower BMI level high level individual type diabetic significant lower level high level type diabetic may normal renal function may development reduce renal function patient type
23706413 en aim study evaluate effect compare care without therapy type mellitus T2DM T2DM hypertension care group on care group group characteristic metabolic parameter measured compare month occur patient group on group significant decrease drug group compare group on parameter body mass index hemoglobin model assessment insulin resistance lipid index high protein high weight mass index significant improve group patient group great improve number parameter include cardiovascular function T2DM due little metabolic reduce
26680487 en aim provide datum woman age type mellitus parameter control woman examine use little three month on regression analysis show insulin fasting hba1c value patient age correlate negative level ratio correlate positive insulin patient age value include total revealed significant correlation significant glucose control parameter demonstrated relationship consider important factor influence control cardiovascular risk woman
25970949 en glucose observed patient metabolic associate insulin resistance also mechanism development mellitus improve level present year old diagnosis value blood glucose normal body mass index month medical treatment blood parameter patient treatment control oral on new treatment may value normal syndrome present value cholesterol little treatment glucose tolerance improve type normal hba1c decrease cholesterol value result patient
25954960 en develop result mellitus lead different effect increased cell blood cell study show influence system normal diabetic condition group control control treat control treat diabetic treat on diabetic treat control diabetic body weight cause decrease activity well control level effect protein compare group show analysis show positive system ratio protein blood cell well index reduction
25629920 en type mellitus T2DM disease metabolic syndrome major present study determine prevalence estimate risk develop T2DM among general population individual without history cardiovascular disease use two develop use risk score risk score diagnosis logistic regression analysis response rate CI one subject blood pressure subject fasting plasma glucose level impair fasting glucose T2DM respective present one participant high high risk develop T2DM risk develop subject high risk develop T2DM risk high female compare however risk develop risk develop T2DM great among aged year current finding need intervention
24531124 en indicate dysfunction disease effective clinical value type mellitus T2DM major disease associate cardiovascular disease identify potential T2DM risk subject different study correlation different clinical parameter status index factor potential use study T2DM subject compare healthy control without history T2DM change due contribute potential patient cardiovascular risk DM subject
19431107 en study metabolic control patient mellitus primary care evaluate hba1c new method metabolic control primary study use datum medical hba1c study population patient mellitus treat care on datum hba1c datum general two hba1c test hba1c value obtain mean hba1c hba1c hba1c hba1c test mean hba1c lower hba1c compare datum hba1c vs hba1c test high hba1c test result less hba1c patient datum follow type female age year insulin therapy study show result metabolic control care result hba1c datum control patient mellitus care
23942995 en metabolic patient may factor event factor primary primary factor may high association among diabetic patient diabetic present increased resistance lead hypertension diabetic hypertension patient may result study positive association mellitus whereas report factor mechanism result diabetic may result remain
25416725 en function associate metabolic disorder include obesity insulin resistance type study demonstrated several mechanism include increased may lead increased response influence lipid glucose study role metabolic disease study important several factor known influence risk type age also study however base evidence may influence factor development type aim review potential role type
23255843 en aim study clinical impact mellitus characteristic clinical outcome patient compare patient without mean age patient significant high control vs respective disease common vs respective analysis age odd ratio confidence interval associate development patient follow-up period time develop month group vs month group incidence month high group control group vs respective however overall rate different vs respective patient factor patient
21790295 en previous mellitus reported new datum however indicate rate high therapy evidence disease cell cell relative development large metabolic obesity
26871778 en randomize clinical trial evaluate patient type mellitus T2DM current evaluate glucose control insulin patient impair glucose clinical trial compare control patient T2DM impair glucose tolerance database independent use type impair glucose tolerance primary outcome analyzed change hba1c whereas outcome included fasting glucose glucose fasting insulin insulin insulin resistance model assessment insulin resistance total cholesterol low high study identify study current number patient age among group result significant difference hba1c level control group difference mean CI improve fasting glucose insulin level difference glucose fasting insulin observed among group similar total cholesterol level show significant difference treatment group difference addition therapy fasting glucose level patient treat oral present result glucose control insulin patient T2DM impair glucose
26849653 en mellitus DM cardiovascular response patient study effect interval blood pressure patient control test analyzed time recent diagnose DM patient compare result healthy subject control on statistical significant control diabetic subject provide high compare different population define parameter rate blood pressure ratio decrease rate increase rate also increase time recent diagnose DM control DM patient control subject may due decrease activity blood
23303204 en type mellitus T2DM common determine development T2DM clinical parameter determined period year adult fasting plasma glucose level less study aged year aged year normal body weight body mass index fasting plasma insulin hemoglobin level measured response insulin glucose level glucose tolerance test develop T2DM impair glucose tolerance impair fasting glucose normal impair glucose tolerance obesity increase fasting plasma insulin significant glucose rate decrease insulin clinical risk factor different
23296174 en type mellitus disorder cell risk disease risk adult new diagnose relative disease insulin may develop year age therapy three different primary treatment individual increased risk one trial reduce incidence target individual trial therapy therapy include oral insulin trial intervention also included therapy although function study control clinical trial mechanism therapy need
22576021 en insulin important role insulin on recent association study identify type mellitus T2DM patient therefore determined whether common also associate risk T2DM population on total individual study include T2DM patient subject normal glucose tolerance control group use system risk control group patient T2DM found association T2DM model or confidence interval CI adjust age body mass index BMI or CI analysis clinical control subject normal glucose tolerance revealed plasma glucose level oral glucose tolerance test significant different regression analysis show plasma glucose level significant positive associate adjust age BMI CI addition potential association increased CI observed age study association T2DM population however may associate
21271337 en cause mellitus cause insulin disease cell mass insulin also investigate whether examine metabolic insulin response diabetic effect cell function effect normal activity severe insulin normal increased response similar glucose insulin also effect case reduction insulin indicate cell cell primary mellitus glucose insulin glucose insulin dysfunction result insulin
24190679 en mellitus type disease factor recent result increased analysis association gene association study perform provide evidence number although new remain perform one common disease among disease large range rate evidence gene provide factor associate gene increasing evidence role recent result related role factor development
25283990 en develop index base high protein fasting plasma glucose fasting plasma insulin early diagnosis gestational mellitus woman first included retrospective cohort study serum concentration measured week on glucose test gestational week fasting ratio model assessment insulin resistance index insulin index use estimate insulin woman study diagnose week level high diagnose woman compare result high CI odd ratio CI first correlate development study provide
26341461 en effective diabetic determine prevalence mellitus DM identify risk factor disease cohort aged less year type DM examine undergo include on review perform identify reported age reported duration DM diagnosis diabetic high total mean age year range year mean DM duration year range year mean hemoglobin hba1c range on total identify decrease diabetic on total on total high association condition duration control DM age diagnosis severe year duration disease duration control DM study review type can age year year diagnosis DM occur high risk complication method
25721846 en recent study found can glucose lipid study aim investigate relationship serum concentration glucose lipid patient type patient type group female group age respective parameter age duration fasting plasma glucose hba1c fasting insulin fasting blood lipid type type body mass index BMI ratio relationship parameter analyzed correlation analysis multiple regression negative correlate hba1c also independent factor hba1c group positive correlate independent factor group finding indicate association serum glucose cell function relationship found insulin resistance lipid type
25164320 en on woman type mellitus DM primary week although gene week DM control well treat week result blood positive develop normal present month age case report woman risk due
25140395 en subject mellitus DM high mortality consider significant factor contribute important associate factor study perform investigate factor associate subject DM aged year use database health subject DM aged year old included datum analysis associate factor analyzed use multiple regression logistic regression analysis subject female age included among subject total body mass level body mass index significant associate whereas body mass index level associate among female subject age total body mass found significant associate factor whereas age body mass index total body mass found significant associate risk body mass factor risk subject DM determine role diabetic subject
24912095 en study assess early hemoglobin value early gestational retrospective cohort study perform woman year early test perform week woman known mellitus value primary outcome development outcome included weight woman value compare level patient group development compare group odd ratio confidence level increase remain significant adjust odd ratio age body mass index gestational age gestational age method significant difference need medical treatment weight patient cohort early value woman group significant high risk compare woman normal value consider possible intervention
22798249 en aim study assess relationship type mellitus T2DM factor related T2DM value estimate rate determined healthy individual patient patient T2DM healthy patient control fasting plasma glucose fasting serum hemoglobin hba1c parameter T2DM participant control measured patient high level control group T2DM patient body mass index age positive correlate hba1c negative correlate fasting serum regression analysis demonstrated hba1c fasting serum independent associate high level found patient T2DM may potential mechanism diabetic
25154821 en recent increased risk mellitus DM observed also treat evaluate association treatment DM study cohort diagnose age year treat treatment follow-up medical general perform estimate incidence DM estimate risk factor DM evaluate use follow-up year patient develop DM overall incidence DM year CI incidence DM CI associate increased risk DM CI whereas associate increased risk CI lower significant increase risk DM risk DM significant increased high mean increase risk develop DM DM consider follow-up increased risk
23831240 en common use datum obtain cohort examine duration associate risk impair fasting plasma glucose mellitus DM total participant undergo test group according duration logistic regression model use examine odd ratio or duration participant reported duration high prevalence DM duration associate DM adjust possible duration significant associate increased risk duration associate increased risk DM however finding significant group duration associate increase DM risk independent several finding suggest duration may risk factor DM high blood glucose level
27861386 en although regard increased risk mellitus treatment evidence clinical investigate whether use associate risk conduct retrospective cohort study use clinical research database health study cohort patient ratio perform use score base age baseline glucose level hypertension risk estimate incidence among group per high group per ratio confidence interval CI CI baseline glucose per CI hypertension CI use CI show increased risk show decrease risk CI patient show high risk CI however risk significant different among increased risk observed among
27002662 en aim study effect treatment mellitus DM DM patient randomize two treatment group first group group receive treatment group therapy group include range patient receive therapy patient patient rate week use outcome perform use score index patient evaluate baseline week significant group score increased treatment method time however difference found patient receive therapy treatment DM patient however revealed function level patient
25893730 en aim examine effect complication patient type use study patient type undergo age duration medical patient treat use complication assess month intervention use ratio study group decrease significant group increased medical group significant difference medical group change change may medical care treatment diabetic
18814927 en assess type mellitus T2DM glucose tolerance year man diagnose T2DM T2DM glucose tolerance studied subject study included blood subject previous diagnose subject prevalence impair glucose tolerance impair fasting health diagnosis mellitus complication diagnosis mellitus health association diagnosis mellitus care respective overall prevalence T2DM known CI CI CI CI respective difference prevalence significant age history BMI ratio first large study prevalence type age group year glucose tolerance include T2DM common adult
24893671 en report risk hypertension type mellitus T2DM perform study assess effect hypertension T2DM database perform relative risk confidence interval use model use examine total cohort study three hypertension study T2DM study use effect model found compare per week lower risk hypertension CI one per week similar risk CI addition associate risk T2DM CI high low analysis association also show indicate may associate hypertension risk T2DM risk
25335667 en mellitus among associate increased risk high rate mortality risk rate aim study aim assess prevalence renal patient population identify risk factor assess patient sample renal patient man woman renal year analyzed potential risk factor age body mass index BMI obesity hypertension total cholesterol serum therapy also prevalence prevalence compare patient glucose patient show high BMI high total cholesterol level perform great patient include high incidence weight control identify risk factor well therapy
24060305 en case present woman period several day history type mellitus revealed study positive show treatment population mellitus reported
23954219 en investigate relationship disease patient type mellitus T2DM patient include without disease well healthy control individual analyzed level T2DM patient high gene patient T2DM significant different control found associate increased risk T2DM increased risk obesity increased risk obesity type compare respective logistic regression model analysis show risk factor development T2DM patient or CI may associate increase risk development T2DM patient
21752743 en mellitus T2DM major cause disease T2DM common use health status datum patient outcome evidence control patient current treat hba1c target prevalence chronic complication remain high impact negative patient health status effect associate medication may also treatment aim study evaluate patient T2DM investigate association different treatment use level control report conduct study study study patient T2DM current treat oral insulin follow sample primary care patient hba1c level include health status treatment outcome study evaluate patient T2DM
24231598 en mellitus DM significant patient evaluate treat condition associate DM include disease review current effect DM outcome general patient DM undergo outcome compare patient without DM mellitus associate increased rate complication however research need determine impact DM patient outcome population patient DM aim management patient population
22609055 en dysfunction diabetic well cardiovascular disease less period one year patient type function assess type diabetic base complication study subject group on complication group group group parameter measured ratio ratio interval parameter measured baseline follow-up datum analysis statistical group ratio change group ratio change group ratio significant time ratio respective type mellitus
24250304 en common diabetic patient severe report prevalence develop determine prevalence resistance diabetic study total participant include mellitus patient subject sample test use identify use participant diabetic diabetic included diabetic significant difference resistance diabetic show multiple resistance study revealed high prevalence diabetic on change observed show multiple resistance diabetic therefore need
23211573 en adult obesity adverse body may development type mellitus aim study assess observed prevalence observed ratio prevalence ratio according large cohort baseline prevalence patient metabolic database studied analysis perform baseline status hba1c patient analysis value consider statistical compare confidence interval significant increased female CI CI increased significant age BMI number decrease significant age increased significant BMI multiple regression model show important impact age BMI hba1c value found patient associate high BMI associate increased prevalence large adverse body datum early
24385073 en mellitus primary cause impair glucose tolerance insulin report case cause chronic serum hemoglobin hba1c insulin treat cell without follow-up month patient fasting blood level respective hba1c insulin therapy type mellitus
21918925 en treatment association patient type mellitus include hemoglobin hba1c blood pressure treat patient reported
23458555 en assess result patient mellitus DM within care hospital health report activity patient diagnose treatment assess DM found DM previous known diagnosis DM new diagnose high prevalence DM patient diagnose care hospital diagnose well although significant patient DM diagnose hospital DM care patient diagnose show important patient DM early DM patient management on control intervention
25955280 en compare clinical outcome early insulin old adult type mellitus cohort health group according number oral drug insulin one early insulin two three insulin follow-up outcome included change hemoglobin hba1c old adult hba1c less event total individual included analysis baseline follow-up hba1c level individual insulin early follow-up reduction hba1c group one two three early insulin associate significant great reduction hba1c adjust great hba1c less adjust odd confidence significant difference total event early vs study suggest effect early insulin old adult T2DM glycemic control without increasing risk great total
27368048 en increasing evidence suggest type common mellitus DM study aim investigate risk patient DM retrospective cohort study use datum health research database risk develop overall include compare regression analysis regression analysis DM cohort DM cohort new diagnose DM cohort age index disease hypertension chronic disease chronic disease obesity compare cohort statistical DM aged year incidence rate overall significant high overall number incidence rate ratio regression analysis risk develop overall significant high adjust overall disease status overall adjust ratio significant risk factor old overall chronic disease disease risk develop lower DM cohort cohort without incidence rate risk develop overall include significant high old adult DM significant risk factor old adult DM chronic disease disease
21218721 en one known complication study aim evaluate association mellitus among population among subject aged year history diabetic control diabetic patient control or CI age duration associate mellitus may risk factor age determine cause diabetic patient may lead development treatment
20800121 en management type mellitus less recent year due insulin may type mellitus great although treatment overall management influence type mellitus age year group type mellitus mean year group group group although occur major included need use method finding suggest intervention population one target improve change
20722670 en association function type identify study evaluate association function mellitus database evaluate study base study review study show adult mellitus lower one reduction lower compare reduce function patient related blood glucose level duration independent obesity finding cohort study less study identify increased rate function adult addition cohort study reported association decrease function insulin resistance study evaluate mechanism association identify chronic insulin resistance low associate insulin resistance impair association mellitus decrease function well mechanism association
21247843 en assess effective glycemic management patient mellitus undergo glycemic management management insulin patient known period observed patient blood glucose value obtain define concentration great use treat according care determined review patient blood glucose value great reduction value change vs lower value vs patient receive care case observed glycemic management include diabetic medication treatment effective care patient
20857777 en risk factor diabetic subject multiple duration mellitus major risk factor common risk factor disease diabetic evaluate effect duration mellitus use test system diabetic subject without current previous mellitus DM subject without receive care medical diabetic hospital present datum included subject age year age first diagnosis DM duration DM year baseline fasting plasma glucose test score use participant two group without subject assess three method score determine presence diabetic participant participant participant different method diagnose increasing increasing duration group method little duration DM year duration DM year group duration DM year duration DM year group duration DM year duration DM year group duration DM year duration DM year group duration DM year duration DM year group duration DM year duration DM duration mellitus risk factor complication mellitus diabetic subject duration year associate group high risk disease DM target group reduce rate
21301486 en patient type mellitus T2DM treat development new insulin therapy lead treatment patient T2DM target hba1c level however related patient drug adverse patient metabolic target clinical datum indicate hba1c concentration blood pressure serum level lipid patient T2DM target association metabolic lead decrease reported complication mellitus individual T2DM lead mellitus patient on major therefore consider BMI patient T2DM medical therapy
21730263 en previous mellitus result increased high study period period total patient sample receive included sample found increase found patient known previous patient patient also evidence case per month study reported clinical
19508664 en estimate mellitus DM complication system among drug hospital clinical datum individual patient DM type type included study cohort use drug hba1c DM diabetic complication year year control define subject without diagnosis DM subject medication patient year complication cardiovascular complication DM estimate complication among patient among control drug total population prevalence DM increased severe cardiovascular complication DM increased patient per DM patient treatment DM increased per total population increase treatment mellitus general population
19299036 en assess relationship obesity type mellitus perform base health prevalence odd ratio or type mellitus according obesity type mellitus according or type mellitus individual normal weight woman man on related significant risk type mellitus woman great compare woman less risk adjust age risk type mellitus adjust age body mass index man estimate or statistical woman contribute great risk obesity type mellitus identify can current risk type mellitus individual can study health
20516361 en report case adverse drug patient type mellitus type mellitus treat medication two hemoglobin value obtain year demonstrated glycemic control reported fasting blood glucose one month patient reported event blood glucose result one month patient medication reported month glucose suggest effect blood glucose level patient type mellitus although identify datum use type mellitus on use mellitus revealed case report one case report blood effect patient oral although one patient common population case use suggest mechanism may due glucose type mellitus use risk
24619717 en on man type mellitus metabolic value obesity hypertension present well develop year early diagnosis therapy diagnose within low intervention can therapy reduce patient treatment within patient can also treatment treatment patient metabolic treatment patient high blood glucose level change
27404933 en medical history clinical report female patient mellitus treat medication include insulin year also diagnose present glycemic control positive history normal body weight negative perform blood analysis test due gene patient diagnose due gene therapy due datum outcome patient base diagnosis treatment however patient due history low presence positive history age year diagnosis normal negative result
19380282 en recent show diabetic patient present study perform function patient patient mellitus treat hospital period define parameter datum result patient perform patient included correlate duration age level correlate positive BMI also significant correlate correlation therapy function correlation medication presence related according datum patient patient can complication mellitus however previous function included clinical diabetic patient little time
23648711 en although major cause mortality patient mellitus DM cardiovascular disease DM also associate however whether DM associate increased risk remain on database analyzed relationship DM study cohort patient new diagnose without previous diagnosis identify health research database on control cohort subject compare two group association incidence use therapy also follow-up period develop diabetic patient subject cohort DM associate confidence interval CI high risk develop among incidence adjust ratio CI adjust CI adjust CI adjust CI significant increased patient DM analysis effect therapy diabetic patient revealed use associate lower risk adjust CI treatment associate lower adjust CI risk adjust CI use associate lower risk adjust CI high risk adjust CI DM increased risk may use different therapy
24986446 en blood pressure well mean reported increase value target association target patient type reported aim study investigate association target patient type assess relationship mean compare characteristic mean patient type analysis age duration mellitus body mass index mean blood pressure mean associate regression analysis indicate mean significant associate CI define per mean finding well mean significant associate patient type
21134881 en compare lipid profile glucose control patient type mellitus without chronic retrospective study conduct included patient type patient patient type serum total cholesterol cholesterol cholesterol value compare among patient study population included patient type type chronic associate lower total cholesterol level patient without type elevated serum level associate reduce patient chronic although control group group without mean hemoglobin mean cholesterol high patient early compare cholesterol type diabetic patient decrease serum level total cholesterol effect level may cholesterol patient type
25358220 en important risk factor disease treatment response datum prevalence mellitus DM among patient study conduct determine patient study patient hospital datum use patient undergo baseline determine fasting blood level use value datum analyzed use patient found diabetic new diagnose patient year age patient patient patient less study among patient mellitus new diagnose patient health
24461045 en gestational mellitus risk factor development type intervention type high risk population control trial evaluate effective intervention compare care woman recent woman identify factor can target population woman high risk profile possible risk factor test identify woman datum risk factor year reduce sample participant consider risk factor history glucose value BMI score use insulin age also datum factor participant age woman old year insulin use woman use insulin less logistic regression insulin use negative odd significant included recent multiple change intervention consider population research difference participant management develop intervention effective control trial
20724765 en identify association mellitus study conduct hospital population study patient mellitus mellitus patient treatment subject patient year old mellitus study datum included characteristic age level history activity duration activity history use datum serum level serum level datum analysis test analysis perform logistic regression control identify factor datum statistical analysis found total number subject subject DM subject without DM subject female subject indicate activity time week duration subject less prevalence BMI use associate association mellitus statistical study
26147605 en aim compare plasma level patient type mellitus patient treatment role treatment study included diabetic patient treatment use day group measured use rate vs vs significant lower diabetic group compare control patient treatment lower treatment characteristic demonstrated significant value outcome diabetic patient lower control lead lower rate
26079402 en new new develop improve profile well rate evaluate according result high drug profile improve rate presence demonstrated mean analysis present effect show high effect also reduce glucose blood level level hemoglobin effect level blood glucose one use drug result demonstrated potential treatment mellitus syndrome
24684438 en aim study change type mellitus patient different level measured hemoglobin hba1c period year
23636268 en diabetic remain one common high level contribute aim assess concentration diabetic sample study diabetic type mellitus patient analysis activity activity evaluate level well use activity on on significant increased compare difference group level well however decrease sample increased activity decrease concentration diabetic compare sample suggest increased may factor new treatment diabetic can increasing level
24490745 en type mellitus estimate patient cardiovascular complication medication base outcome blood glucose hemoglobin recent year however medication study determine effect medication outcome review review study result current oral medication type possible mechanism finding study however regard cardiovascular effect
20698373 en patient undergo known increased risk assess effect risk factor patient undergo patient undergo general participant use datum use test test logistic regression use assess risk factor study patient per patient undergo incidence patient undergo time high CI patient undergo incidence high diabetic patient undergo vs patient undergo vs significant patient undergo patient undergo time great blood cell patient undergo increasing age also significant significant patient undergo patient undergo time patient undergo age also remain significant among patient undergo mellitus mellitus time develop among patient undergo or increased risk large study patient undergo three time patient undergo diabetic patient patient undergo increased risk compare glycemic control may reduce patient undergo
21309835 en relationship mellitus increased identify study evaluate association mellitus treatment insulin insulin study effect insulin although mechanism relationship elevated risk type mellitus presence insulin resistance factor insulin high concentration may therapy associate increased risk whereas treatment result risk reduction insulin profile cell may contribute insulin study insulin datum elevated insulin whereas datum effect recent clinical study association insulin suggest treatment insulin associate increased relationship elevated risk type mellitus show study presence insulin resistance potential mechanism recent clinical study increased risk patient treat insulin
24626688 en estimate well analysis health use reported previous diagnosis adult adult year old diagnose present important range also diagnose hypertension reported regard diagnose condition health negative effect health
26873904 en patient disease mellitus disease mellitus disease patient high risk adverse cardiovascular event great trial therapy disease patient also mellitus among recent however datum patient mellitus disease two mechanism aim review evidence two drug population mellitus patient include effect hba1c control although perform evidence effective population addition lower hba1c indicate may improve control patient mellitus datum metabolic effect cohort patient may disease patient mellitus
27188046 en gestational mellitus disorder development type rate increased year related obesity aim review identify review study conduct included gestational mellitus included intervention weight management included review intervention three group intervention blood glucose level intervention review found although intervention reduce insulin reduce rate disorder level outcome one study found intervention contribute positive include low glycemic index increasing level activity reduce blood glucose level reduce insulin reduce blood glucose level associate reduction weight
24992622 en mellitus two common disorder health number old increase aim study determine relationship type perform datum finding need effective previous study show can improve intervention change clinical important diagnosis treatment may reduce
24809179 en dysfunction complication activity aim study investigate serum level patient type found increase serum level diabetic patient compare subject without similar observed also diabetic patient compare control subject significant serum patient without compare control subject patient significant correlation blood glucose body mass index level total cholesterol patient significant correlation BMI total cholesterol revealed change serum level dysfunction patient type obesity significant factor contribute level
24640347 en time common among diabetic among cause great according report effective control control increase risk develop develop high incidence effective mass however patient study prevalence mellitus patient study conduct medical hospital patient different present study evaluate presence fasting blood glucose level patient diagnose analyzed per multiple studied patient prevalence high analysis diabetic subject found patient patient high patient indicate poor outcome patient due high prevalence mellitus patient due disease therefore disease treatment outcome care
23617251 en evaluate glucose patient type mellitus associate hemoglobin hba1c evaluate parameter glycemic patient patient hba1c level study on glucose system two period measured parameter glucose use datum parameter mean glucose glucose glycemic mean glucose use new method group baseline hba1c level mean mean mean indicate glycemic patient mean level respective correlation analysis significant correlate correlate study demonstrated glycemic subject may glycemic may value assess glucose patient type mellitus
20193636 en according health type mellitus patient type chronic disease also increased risk disease disease cause type role type mellitus review study risk factor development type mellitus chronic risk factor development present review provide study investigate association different development type mellitus result study suggest also general associate increased risk development type result found regard event important may occur datum significant association may also cause negative result therefore research group aim conduct new cohort study study research identify mechanism different type
26071920 en study examine association gestational age time treatment gestational mellitus conduct analysis randomize treatment trial woman treatment vs care primary outcome trial well analysis adverse outcome included outcome examine included large care gestational treatment week treatment group treat vs care outcome use determine whether treatment associate outcome woman case analyzed treatment early treatment compare treatment value primary outcome similar evidence outcome improve significant early treatment large care outcome significant treatment gestational although outcome improve treatment associate effect treatment outcome
24978196 en serum level insulin resistance type cohort relationship study type subject control normal oral glucose tolerance test use datum study study included clinical serum concentration measured regression analysis determined related level logistic regression analysis use estimate odd ratio present type concentration ratio high respective type control or present type subject high vs low or negative associate serum level level associate type population association study potential role type
24400565 en analyzed parameter potential mellitus DM found decrease increase increase increase duration metabolic change DM lead activity
24300485 en mellitus examine total type mellitus major lower patient found diabetic level rate patient three group diabetic lower diabetic chronic renal disease diabetic diabetic chronic renal disease diabetic chronic renal disease measured level factor factor lower diabetic system parameter on decrease level may one factor patient mellitus
23339473 en develop new insulin resistance index glucose tolerance test patient type patient mean age year fasting plasma glucose hba1c body mass index undergo glucose participant test plasma glucose insulin measured fasting serum measured fasting model assessment insulin resistance insulin index result glucose rate measured glucose mean patient index correlate also correlate patient insulin resistance correlate respective patient insulin resistance plasma BMI correlate effective index insulin resistance perform patient type mellitus result suggest effective index patient insulin resistance
23327840 en examine association risk mellitus DM factor subject participant study participant aged year provide blood datum odd ratio or DM estimate use logistic regression model statistical significant risk DM observed or subject BMI DM define adjust or subject DM DM DM demonstrated confidence interval respective present study revealed significant lower BMI decrease risk DM reported one present study result sample association well role metabolic disorder include DM
22964975 en study effect dysfunction subject impair glucose among relative patient type mellitus relative T2DM patient oral glucose test diagnose subject blood glucose level randomize receive week function assess blood blood pressure body mass index insulin serum lipid also measured glucose insulin model assessment insulin resistance function early insulin index treatment fasting plasma plasma glucose fasting insulin insulin decrease significant improve treatment group change negative correlate change positive regression analysis show change independent parameter decrease blood glucose increased insulin dysfunction subject among relative T2DM patient increased may associate dysfunction
19853860 en compare early type mellitus examine association known cardiovascular risk type mellitus age year healthy control subject age year undergo assessment function fasting blood test level hemoglobin high protein total serum cell significant great type mellitus control subject type mellitus correlate hemoglobin independent associate age cholesterol level function type mellitus define control early type mellitus known cardiovascular risk factor metabolic control
26896273 en dysfunction major cause mortality index index include time interval assess dysfunction aim assess patient type study perform care parameter measured patient type included study patient show dysfunction dysfunction dysfunction patient dysfunction show patient patient patient patient dysfunction patient show patient show found dysfunction negative correlate dysfunction positive correlate dysfunction parameter use assessment diabetic dysfunction
25313684 en investigate relationship drug use development chronic disease type conduct retrospective cohort study follow population type chronic use health datum status drug measured on total subject chronic disease identify period model determine relationship drug use development chronic observed significant relationship drug use development chronic disease type compare drug drug little day high risk chronic disease development adjust ratio CI analysis age use drug drug little day develop chronic disease result suggest positive relationship drug use increased risk chronic disease type use drug base clinical risk type
25340849 en hba1c evaluate diagnosis gestational mellitus use clinical on total woman estimate gestational age week evaluate use oral glucose tolerance test base association study group on determine hba1c hba1c value diagnose positive value use two case woman hba1c use diagnosis need
23625197 en use management type mellitus T2DM lead metabolic effect disease high potential treat disease however increasing effect role risk related use review examine risk associate treatment current aim current role management T2DM
25151227 en identify new study reported concentration subject type mellitus T2DM patient however large level different study may difference sample aim study confidence interval level subject T2DM patient use association obesity T2DM database included review use analysis obesity study participant included level confidence interval high subject healthy control study patient included analysis T2DM level high compare healthy high level serum observed subject T2DM patient
25149596 en high reduce plasma glucose level glucose patient type mellitus T2DM examine characteristic two oral patient randomize study patient treat day plasma parameter measured day parameter day characteristic included plasma glucose insulin characteristic included concentration time plasma concentration patient included analysis analysis significant reduce fasting plasma glucose well plasma glucose relative also reduce insulin body weight glucose increased high respective group increased glucose improve fasting glucose patient T2DM
25990668 en gestational mellitus disease factor evidence suggest common within contribute development disease however role identify two risk aim study first investigate association gene use case significant associate or occur significant high or increased glucose level well high insulin level compare control also found associate lower total cholesterol cholesterol level increased risk woman important study provide evidence
19760539 en patient development mellitus DM mellitus clinical type type important health patient large insulin insulin glucose also therapy type DM glycemic metabolic effect disease include also occur increased chronic disease low body weight dysfunction diagnosis therapy treatment disease
23146461 en relationship drug development mellitus well among show little improve glycemic control however study whether reduce risk evaluate whether drug glycemic retrospective evaluate glucose year patient man mean age year time month analyzed fasting serum glucose lipid renal function level month month improve glucose observed although one case high blood glycemic level two patient normal glucose follow-up subject show increased month therapy three patient insulin two oral two patient due chronic month respective among patient renal function remain significant difference among level remain renal patient improve glucose increase
26560876 en type mellitus associate risk factor studied whether association total obesity study measured ratio body mass index BMI mean cohort without use regression examine whether BMI activity association participant mean age year without mean age year adjust age independent associate lower total great BMI lower mean adjust BMI mean significant association remain independent associate lower association addition BMI model statistical observed obesity activity obesity effect may adverse effect study
26535884 en compare result gestational mellitus treat treat gestational mellitus randomize insulin treatment examine development significant difference insulin group development test score clinical significant however compare observed study difference outcome gestational mellitus treat insulin result suggest need assessment early
24110999 en cardiovascular can one severe complication type mellitus T2DM aim study investigate association rate measured vs measured diabetic patient period different time identify patient rate increased reduce patient patient also measured change several demonstrated correlation measured observed base assessment may assess patient type mellitus
24000500 en mellitus associate high risk disease study conduct type mellitus patient diabetic medical patient case datum lipid profile datum lipid adult treatment difference group consider significant mean value total cholesterol low high common observed study low total ratio significant difference female study type mellitus patient need mellitus patient important level high prevalence due may patient activity
23301512 en prevalence hypertension increasing assess status primary care management hypertension patient disease metabolic syndrome type mellitus mellitus datum treatment patient week identify patient target blood pressure correlation assess addition analyzed drug prevalence patient correlate body mass index old patient year receive patient general use however overall use patient receive DM patient drug patient may need define population increased risk patient
23073299 en aim study estimate serum concentration age well factor type mellitus studied age range control subject age range study participant hba1c serum level measured undergo blood pressure serum concentration age measured value studied parameter characteristic analysis use result study show among studied parameter found duration disease serum age concentration however high value diabetic found serum concentration value CI level respective according result serum concentration may presence diabetic
26234374 en cardiovascular disease major role mortality patient mellitus hypertension major risk factor cardiovascular disease prevalence increased mellitus therefore management elevated blood pressure clinical management diabetic significant treatment hypertension regard treatment hypertension group patient mellitus without chronic disease large treatment therapy treatment target present several hypertension mellitus include recent report therefore review compare current management treatment hypertension mellitus mellitus significant presence patient mellitus also
24773124 en datum type mellitus DM study patient type DM effect disease duration glucose control clinical subject type DM statistical test perform use presence correlate duration subject one mean age patient year range year mean total duration year adverse effect related insulin common finding follow change patient DM year significant change diabetic change also show significant correlation blood glucose study suggest change common patient type DM patient care among early management
25659912 en review potential new treatment type trial found use duration result use include clinical trial on include care also perform study time reduce hemoglobin hba1c use therapy also provide significant weight range relative low risk reduce hemoglobin level use medication new reduce hemoglobin level demonstrated treatment type may provide patient include significant weight decrease blood pressure new medication can improve may patient
25633550 en reported recent case diagnose type mellitus year follow present diabetic control poor poor day without develop history observed patient day without therapy major cause syndrome finding history major cause insulin therapy cause observed patient aim review medical subject subject consider diagnosis type mellitus
25555183 en although evidence adverse metabolic control study examine role management glycemic control patient type mellitus DM study investigate effect level glycemic total patient type DM undergo management per day intervention group control group health control hba1c primary outcome measured intervention group score hba1c decrease significant high level great intervention significant change result show role management patient type DM regard level glycemic control consider type treatment therapy study can study large sample duration
25317648 en on woman lower disease present increasing year mellitus show change diagnose test normal diagnosis can perform therapy lower receive oral treat high disease chronic disease common mellitus complication treatment
26427368 en mellitus DM finding population datum regard influence DM outcome patient undergo due aim study examine impact DM investigate patient severe undergo subject diabetic mellitus patient insulin diabetic mellitus patient respective complication outcome according research well demonstrated similar complication rate compare patient vs respective analysis show DM type treatment associate increased year mortality value regression analysis adjust age disease DM hypertension chronic renal disease found associate increased risk year mortality CI whereas female found factor CI DM associate increased DM patient similar outcome compare patient without DM patient great incidence research large cohort patient need result
25277770 en compare serum level protein level woman gestational mellitus normal glucose tolerance correlation serum level fasting insulin model assessment insulin resistance woman total cholesterol high cholesterol cholesterol fasting plasma glucose level measured protein level use correlation analysis perform correlation serum level correlation analysis conduct examine association serum level level lower group statistical difference two group serum level protein level high group serum level significant correlate positive correlation level independent increased serum level increased protein woman indicate may mechanism need study
24762194 en identify gestational mellitus clinical cardiovascular disease risk risk hypertension body mass identify datum total woman cardiovascular event logistic regression examine association risk factor effect association body mass index BMI chronic hypertension assess evaluate diagnosis cause identify disease adjust odd ratio confidence interval association obesity chronic hypertension analysis association among woman BMI odd ratio woman BMI increased risk cardiovascular risk factor obesity chronic hypertension risk among woman BMI
19807951 en prevalence mellitus increasing however control outcome remain recent significant value medical system improve health determine whether clinical system improve care patient identify patient mellitus due hba1c test new develop clinical patient test patient without significant control intervention group vs intervention group great patient undergo three test group also show great control difference statistical clinical system use care population patient mellitus improve also outcome large study need early finding
26810272 en assess outcome among woman gestational mellitus cohort woman period week study group included woman diagnose compare control group woman gestational age period without known woman included study diagnose woman lower rate vs high rate vs diagnosis adjust ratio CI significant high mean weight weight include high rate age difference mortality parameter datum occur woman increased risk complication
26670162 en aim study assess gestational mellitus primary care compare analysis base model primary care datum control trial included treatment care adverse outcome effect assess year impact parameter assess range found provide care found primary care provide per case high range ratio per range result study although remain assess current care
25296468 en may treatment patient mellitus response treatment patient mellitus
20124611 en estimate prevalence diagnose mellitus DM impair glucose tolerance year old association risk factor age obesity sample participant aged year examine plasma glucose concentration use oral glucose health association use determine prevalence glucose tolerance datum age activity obtain obesity included body mass index blood pressure prevalence diagnose mellitus mellitus prevalence DM woman man group year prevalence increase age age year factor age obesity obesity result indicate major health need treat disease
19485884 en mellitus type gestational dysfunction adult increasing risk disease include mellitus gestational mechanism include activity several include protein protein elevated function however regard well review effect mellitus gestational reported mechanism potential function recent regard can contribute cell function condition role type function normal development
22944318 en estimate patient duration type mellitus complication develop present case present diabetic care hospital
25414932 en test effective patient type mellitus T2DM without history cardiovascular disease cardiovascular risk conduct analysis datum randomize study compare therapy week insulin without week assess week outcome adjust mean change baseline hemoglobin hba1c level fasting plasma glucose concentration body weight patient hba1c level perform history risk factor hypertension use adverse event therapy study reduction hba1c level baseline great difference insulin study difference adjust mean change hba1c level range study adjust mean change hba1c level difference evidence clinical incidence incidence study insulin patient T2DM similar effective glycemic control profile similar history number risk factor hypertension
25329714 en incidence prevalence type mellitus T2DM related complication estimate use health review assessment database datum disease disease disease define according use common system provide identify associate incidence case T2DM within two year index year on confidence interval prevalence incidence prevalence T2DM adult aged year incidence rate T2DM range study period incidence rate T2DM man woman aged year show incidence subject aged year show increased incidence rate patient new diagnose T2DM respective year diagnosis among new diagnose individual T2DM undergo treatment undergo study measured incidence T2DM great health also relative high risk new T2DM patient compare general population
23568273 en aim investigate whether mean common improve cardiovascular risk individual perform among individual large individual participant datum subject cohort first risk factor risk score individual without previous cardiovascular disease baseline model model mean common model year risk develop estimate model individual compare two model individual base cardiovascular risk mean common follow-up year cardiovascular event occur among population model model year risk develop model addition mean common CI difference result man risk individual mean common risk score therefore individual cardiovascular risk individual
18094565 en syndrome include cause disease mechanism gene gene recent syndrome may disease may total patient found syndrome finding clinical datum association type patient one patient type observed relative high patient early patient diagnose day diagnose well control oral study recent syndrome disease characteristic syndrome cell cell mechanism need study research contribute role different
25990316 en one important risk factor cause mortality recent study associate large mechanism diabetic current review recent effect cell protein demonstrated may study level study role several recent study suggest diabetic individual may mechanism may develop therapy diabetic patient
23461390 en compare level among type mellitus patient undergo three treatment however study base patient study aged year medical use result indicate patient high score level study result can diagnose type finding type patient need care
23425645 en primary evaluate effect glucose included glucose adverse study examine subject type treat oral insulin subject on glucose use assess found subject evidence decrease compare baseline effect correlate duration medication high glucose baseline show effect glucose response severe effect may decrease type although patient effect glucose due possible response profile study determine effect hemoglobin hba1c define may
25704652 en cell found important obesity insulin resistance evaluate effect patient type T2DM treat randomize control study patient T2DM hospital three group group receive group receive group receive fasting blood sample obtain treatment analysis glycemic datum statistical analyzed one analysis consider statistical obtain datum addition effect measured parameter however level without significant effect improve glycemic patient T2DM
25658661 en investigate glycemic level plasma lipid lipid patient type patient type drug group group on included patient hemoglobin group patient lipid determined cholesterol plasma follow cholesterol similar group on group high vs total cholesterol vs vs respective group on increased vs patient high also show elevated compare low patient high high lower level lipid lipid first time show addition cholesterol also poor glycemic control lipid important related glycemic control
23890955 en evidence relationship disorder risk type mellitus DM study aim examine disorder increase risk DM use retrospective cohort study health research database patient disorder identify study cohort cohort control regression model use estimate risk develop patient disorder new case DM reported follow-up period mean follow-up time disorder cohort cohort respective incidence rate DM high disorder cohort cohort vs per overall patient disorder high risk DM compare patient without disorder adjust ratio confidence interval CI man disorder high risk DM man group adjust CI among subject aged less patient disorder high risk DM group adjust CI compare cohort patient high risk DM adjust CI patient without disorder patient disorder high risk develop DM among less age
23591277 en obesity can increase risk metabolic mechanism perform study determine whether type mellitus associate perform study use general research database primary care database subject identify case use previous control without age duration follow-up incidence assess association diagnosis use regression analysis assess included obesity measured body mass index BMI case control vs high mean BMI vs high prevalence control vs analysis associate increase risk independent known risk factor odd ratio confidence interval association woman man result remain large study risk factor independent obesity measured BMI risk factor disease datum suggest metabolic related
23906236 en on factor chronic mellitus DM metabolic syndrome obesity also development association observed role factor development on health conduct individual datum known participant year age on case identify database serum datum blood pressure analyzed analysis use identify association factor case age great year risk factor high level chronic also risk factor however DM obesity associate development group DM obesity risk factor develop
27861342 en study investigate metabolic syndrome patient type mellitus T2DM study compare effect medical therapy development T2DM patient treatment total T2DM patient randomize receive treatment medical therapy hospital clinical evaluate follow-up period on analysis test use compare datum group risk factor identify use incidence increased group time significant group study however year treatment risk significant lower medical therapy group base compare treatment vs age common significant associate although significant study rate management medical therapy group significant high treatment group incidence medical therapy group significant lower treatment group incidence medical therapy group significant high treatment group show risk medical therapy group significant lower treatment group whereas risk significant different treatment group
23075471 en aim study evaluate health diagnose type health clinical examine compare diagnose type healthy control subject year old index index clinical assess index history base provide medical diabetic history included diagnosis duration age diagnosis hemoglobin complication datum analyzed use statistical define little one clinical little diabetic poor care type mellitus significant high index index control subject diabetic group significant associate duration odd ratio confidence interval old age diagnosis odd ratio confidence interval disease patient type without datum show duration may significant role disease diabetic
22064493 en three number mellitus one important health type mellitus T2DM increasing observed among adult cause T2DM group system within determine influence review year effect T2DM early T2DM obesity T2DM disease research potential role remain factor potential effect use hba1c glucose value diagnosis T2DM also
23550892 en presence vs vs increase risk subject man year undergo according odd ratio confidence interval chronic mellitus DM high DM hypertension high among aged year among aged year age risk significant group use control increased according disease group serum type value group on group positive patient group high high respective population due DM due DM increased DM increased DM effect
24090250 en blood glucose level mortality patient however datum mortality patient known whether diabetic status independent effect patient mellitus DM patient according level primary outcome mortality value event score assess characteristic mortality high patient high among patient mortality score confidence interval CI score CI increased score CI score CI value observed vs vs cohort patient independent increased risk mortality among patient without DM
23161525 en effect glycemic control adult type mellitus study examine rate clinical among patient undergo conduct retrospective cohort study adult type undergo three health care system event define medication use clinical glycemic control identify adult type confidence interval CI within year among CI within year duration year significant poor glycemic control insulin use duration weight significant different associate type severe diabetic adult one within year research need mechanism effect relationship duration event
21070583 en study outcome research level evidence known subject study treatment outcome study investigate effect general study found man diagnosis general poor general control function score time independent treatment man score man diagnosis reported score investigate association general cohort man patient method use datum assess man disease baseline month diagnosis examine change general analysis use result total evaluate man include diagnosis diagnosis reported diagnose general man poor score general man score independent treatment similar man low control function score time man without high score man reported score poor general without
22489155 en effect use mellitus DM model investigate healthy use DM model general level fasting blood glucose determined blood glucose determine serum level insulin serum level measured activity determined cell observed cell result show serum level insulin treatment increased significant compare group treat group decrease significant compare group level group lower group activity high group significant difference treat group group cell improve treat group compare group significant difference high treat group index cell function reduce level effect
20539842 en insulin use insulin insulin result target duration concentration lower rate insulin insulin provide effective patient type type glycemic control significant difference found hba1c level compare insulin insulin significant reduce rate type clinical study demonstrated significant lower less weight insulin recent study show use patient provide treatment potential lower insulin therapy type recent treatment type suggest therapy early provide hba1c individual low risk adverse effect treatment insulin
24581943 en increase risk determined level type compare healthy control potential complication assess risk factor development group according complication hemoglobin hba1c fasting serum lipid profile level measured common assess use high level significant elevated group compare control group level also increased patient complication compare without significant high patient complication patient without complication control positive correlation found level blood glucose hba1c total cholesterol plasma may patient complication increased risk
26966174 en activity reduce risk type also associate reduce risk gestational mellitus however whether activity reduce risk system woman within gestational week woman undergo glucose test week oral glucose tolerance test glucose define according association study group activity month time use develop woman woman less activity without vs activity associate decrease risk odd ratio or confidence interval CI per day per day associate significant increased risk or time vs CI or time vs CI activity associate reduce risk whereas associate increased risk among woman
21721190 en type mellitus one significant obesity review prevalence obesity mellitus mechanism association obesity mellitus include effect related review treatment mellitus population change medication management population
27930505 en present study investigate potential change mellitus duration subject obtain within major mechanism examine function may contribute may primary function examine due role well remain diabetic subject control however show significant diabetic show significant diabetic sample significant decrease obtain subject diabetic show compare control show also show increased chronic duration change may function
27541380 en evidence suggest important role however study investigate treatment patient disease type patient type period patient receive therapy month blood test adverse event follow-up month primary change score measured month treatment compare baseline change serum effect score can increase improve serum suggest mechanism study first impact score patient type study
26004860 en although recent study show serum related increased incidence relationship large study evaluate whether associate mellitus total patient subject determined lipid datum compare lipid profile among estimate serum level DM determined analysis multiple test difference estimate DM patient large confidence interval CI CI significant observed DM level total cholesterol cholesterol cholesterol multiple associate DM serum level DM serum level significant associate adjust lipid profile risk factor study type DM
25855571 en factor study investigate mellitus DM
25675872 en study perform investigate correlation gene diabetic cohort type mellitus study hospital T2DM individual group group group gene ratio or effect gene significant lower group or confidence interval CI or group or or group significant lower group or or group or or significant difference group analysis provide evidence correlation three datum suggest gene risk T2DM cohort
21820134 en study show association well influence associate metabolic factor study population group study aim investigate whether association independent influence hypertension population on total study subject identify health follow characteristic patient include age hypertension analyzed use test regression model use determine independent effect risk on total diabetic patient follow adjust age hypertension incidence diabetic patient independent high risk ratio confidence interval CI CI CI CI CI respective show clinical increased incidence diabetic patient compare subject common incidence increased independent hypertension patient
21823539 en mellitus disorder present within first week month disorder associate cause remain although several disorder cause mellitus patient study increase new treatment model possible define new known two diagnose mellitus
21165705 en lead impair glucose tolerance type mellitus change patient type assess activity syndrome patient type mellitus control subject test level serum use diagnosis significant difference serum baseline serum well serum syndrome prevalence diabetic control group vs respective type treatment vs insulin group diabetic according age diabetic old year serum significant control vs diabetic show decrease level whereas control respective within group diabetic positive correlation level baseline serum level well datum show relative high diabetic control group however consider syndrome diagnose type treatment vs insulin activity result indicate possible role type mellitus patient metabolic syndrome well possible role within mechanism aim improve insulin reduce
21793809 en gestational mellitus complication therefore health care woman study management woman gestational health care sample provide health care woman diagnose gestational datum analyzed use overall within health care role study revealed provide health care woman diagnose gestational mellitus indicate need health care regard gestational mellitus health care system may health care well
21696780 en weight improve metabolic control patient type mellitus result therapy significant weight improve type mellitus patient change current type patient severe obesity poor metabolic control therapy research provide regard effect new possible patient
26103088 en effect therapy without treatment patient type mellitus T2DM remain aim present study assess therapy treatment patient without patient T2DM control included undergo without therapy respective parameter index measured baseline hemoglobin hba1c level measured baseline high respective respective follow-up high respective respective follow-up difference among group follow-up mean hba1c level among patient group result therapy effective reduce patient without T2DM use randomize control clinical trial need regard
24269180 en analysis three different found activity compare study type two group group treat control group follow analysis week present decrease incidence low cell increased compare diabetic result suggest may consider found control
22269619 en effect risk associate duration investigate study assess whether duration great risk addition study also examine whether influence association duration presence independent individual medical total age range year health provide datum sample age year female result regression analysis adjust medical show participant reported duration individual reported odd ratio respective participant duration great compare odd ratio respective significant observed compare participant great risk associate present finding suggest may great risk independent profile presence medical condition show influence duration among individual risk need
18796446 en aim study evaluate effect type mellitus assess measured patient type mellitus patient without type mellitus measured normal without significant analysis related type mellitus duration hemoglobin level patient type mellitus significant associate body rate type mellitus assess
22540854 en positive effect insulin resistance glucose several report level effect type mellitus less type diabetic subject recent report level type diabetic subject aim present study whether change can type datum regard concentration serum obtain patient type mellitus control database significant difference level found type diabetic control man woman however lower level found type diabetic woman man similar type level type diabetic patient control man woman level lower control age follow control
25932787 en common complication type T2DM investigate role blood patient T2DM without control subject without study gene base use method study use associate risk however group patient T2DM significant increased risk T2DM CI revealed T2DM patient decrease group patient compare subject significant associate high correlation type T2DM development may related gene
25004910 en disease associate metabolic syndrome prevalence aim study assess patient type compare score finding patient mean age year man examine parameter diagnose according diagnosis base ratio score score patient patient great weight vs BMI vs vs vs vs patient without significant difference age cholesterol fasting score score revealed significant difference patient without vs case related weight BMI serum system assess patient
24814877 en mellitus DM major health aim study method use identify study DM study finding regard impact review type DM reported included study study study included estimate total DM range range per patient per year whereas range major study included associate DM research method estimate study finding study
22364599 en one metabolic may increase risk mortality define may type insulin resistance insulin review aim current regard prevalence management major possible mechanism disorder drug major role multiple mechanism risk patient vs potential
24350820 en type mellitus control glucose test estimate significant adult compare healthy study control age medical subject undergo blood blood glucose insulin analysis estimate concentration lower group compare control estimate revealed patient reduce reduce great concentration increased positive indicate difference female regression woman show correlation level healthy individual patient decrease lower concentration finding suggest impair
19199242 en assess prevalence mellitus population relationship control year age normal glucose tolerance include diabetic group control group subject respective diabetic patient control diabetic group found two one observed diabetic group statistical different diabetic control group clinical characteristic age BMI insulin resistance index different diabetic patient without may major cause mellitus may population studied population may common mellitus
25072424 en patient mellitus DM syndrome present significant high risk develop complication compare patient multiple mechanism contribute DM patient status include impair well dysfunction therefore general reduce risk event DM patient however DM patient show response therapy patient DM patient early although randomize clinical trial demonstrated associate improve compare intervention provide patient type score risk profile total case diagnosis treatment also provide patient present provide regard diagnosis DM management aim early diabetic patient provide glucose control
24502090 en mellitus metabolic disease influence function chronic one diabetic aim study compare clinical effect therapy mellitus type patient DM type individual control study included DM type subject individual chronic diabetic group two base level hemoglobin hba1c follow subject metabolic control hba1c subject poor metabolic hba1c oral clinical parameter subject index index index clinical level evaluate baseline month test show statistical significant difference treatment studied group reduction control group significant high reduction patient group group difference treatment DM subject individual significant measured parameter result study level glycemic control significant therapy outcome diabetic
26498592 en disease disease common factor use identify age disease cell function insulin resistance presence two major type type mellitus type mellitus base factor different disease major type common result review recent evidence type clinical type management development general need patient current base clinical test
26645275 en high prevalence type mellitus diabetic patient previous studied population aim among group type diabetic patient care patient type aged year assess use mean participant mean total protein total respective mean mean protein respective major significant difference among female present study provide first datum patient patient low compare diabetic patient on large finding
26556397 en mellitus DM disease associate cardiovascular complication patient undergo also increased incidence cardiovascular disease cardiovascular complication DM patient glycemic control important study examine type patient undergo type patient patient insulin therapy three oral two therapy patient severe perform baseline month hemoglobin glucose level decrease month treatment glucose level show significant difference baseline mean glucose level glycemic decrease blood pressure also decrease addition month mass index decrease increased change positive correlate blood pressure fasting glucose level one patient insulin severe observed finding suggest therapy type patient undergo effective glucose level glycemic blood pressure function
25591093 en patient type mellitus health study conduct group type mellitus group little three year participant group use datum datum analyzed group study use group studied group mean within health system study contribute group individual care health care
25370360 en little mellitus disease therefore patient disease mellitus impact mellitus patient disease base also
25343662 en show reduce risk type obesity primary risk factor aim study determine whether influence relationship obesity relationship index compare among man significant positive correlation hemoglobin body mass index BMI ratio significant significant different compare odd ratio or subject without high BMI significant high level group significant lower compare however significant different compare or high index significant lower level or confidence interval high BMI high significant different level high BMI high association obesity may reduce impact obesity risk
22993954 en aim study develop new individual patient mellitus DM new method estimate function metabolic associate use lead reduction blood glucose hba1c level study revealed decrease serum level ratio patient therapy insulin undergo significant reduction blood level increased ratio concentration decrease level increased level decrease level increased concentration reduce patient base among patient increased first datum plasma protein therapy present
22200435 en mellitus year associate increased risk mortality consider factor period drug study independent age positive history treatment clinical presence metabolic syndrome risk development impair glucose tolerance
22112354 en patient mellitus DM high prevalence disease dysfunction one development diabetic subject decrease increased impair function cell mechanism observed type DM patient include function diabetic patient
21557862 en early intervention reduce old population care factor influence case finding old patient general factor associate case finding hypertension mellitus old patient aged year three large outcome health status health disease hypertension included datum analysis factor influence care blood pressure previous year little reported cholesterol test previous year cholesterol reported man high body mass index receive activity less report cholesterol reported fasting blood glucose medication less care associate overall care low old healthy primary care intervention finding provide baseline effect care old measured study
24911198 en gestational common medical disorder body evidence association status mellitus on study conduct hospital compare level woman gestational normal woman control two group age gestational age body mass index level measured use significant difference vs vs value two group significant correlation body mass index gestational age blood glucose level
24787505 en intervention effective type woman history gestational mellitus may change previous result intervention outcome significant effect aim compare risk profile response intervention woman without history type conduct hospital woman aged year follow-up woman baseline little one intervention woman history without history baseline woman similar baseline glucose tolerance characteristic blood pressure lipid profile woman without age change cardiovascular risk profile among woman without follow-up effect intervention similar group cholesterol improve woman without develop effect intervention primary similar history woman without intervention
22897138 en associate study show increased cell high concentration glucose increased serum level show patient type mellitus T2DM also disease patient investigate whether patient T2DM metabolic syndrome increased gene level compare patient without level analyzed method patient T2DM metabolic syndrome patient treatment gene patient found significant difference level patient T2DM compare patient without T2DM also difference patient without metabolic syndrome different group respective lower level patient high level compare present population difference level level observed patient without T2DM without metabolic syndrome may related disease
20593206 en study investigate correlation rate incidence disease characteristic patient type mellitus T2DM use rate risk patient T2DM study included T2DM patient undergo define use score system correlation incidence characteristic patient T2DM analyzed value risk patient T2DM difference age BMI history duration mellitus hba1c normal statistical difference incidence number score group normal group statistical significant increased significant increase number logistic multiple regression analysis show independent correlate incidence or CI correlation analysis show score significant positive correlate age BMI history duration mellitus hba1c protein base value risk patient T2DM
23820486 en investigate whether incidence severe woman type reduce without hba1c level outcome care cohort compare cohort intervention include patient woman included range week severe reported first vs cohort severe occur vs incidence vs occur vs event glucose vs event hba1c cohort cohort woman reported impair vs insulin woman multiple lower vs woman insulin vs vs insulin vs outcome similar two reduction incidence severe hba1c level outcome observed intervention severe care improve insulin treatment increased health woman impair may contribute
20005362 en mellitus occur type mellitus T2DM common risk factor impair insulin several show associate T2DM risk T2DM develop mellitus investigate association risk factor present development mellitus known use study cohort association use logistic regression model association development study cohort included little year follow-up include develop observed increased age history T2DM obesity associate development addition observed positive although statistical significant association finding demonstrated increased risk among patient positive history T2DM observed positive known
21632472 en datum show increased serum concentration independent risk factor renal disease treatment drug lower whether reduction therapy associate therefore test analysis patient type mellitus reduction mellitus trial determined relationship month change renal define serum renal disease baseline subject first month lower CI compare risk renal event decrease CI per first month effect independent risk include estimate rate overall treatment effect effect CI CI suggest one effect can effect lower level compare treatment patient type mellitus reduction associate renal risk reduction effect finding may risk factor renal disease
23442538 en study difference pressure without mellitus blood pressure measured use DM diagnose year early pressure lower vs vs vs vs year great odd ratio cardiovascular disease pressure increased index regression identify age independent increased pressure DM increased age independent increased pressure year independent decrease pressure pressure increased subject DM without pressure cardiovascular disease DM similar year old DM high pressure without similar year old DM study pressure development cardiovascular disease
20620501 en although risk factor mellitus well outcome improve remain study risk factor well outcome associate renal patient study retrospective study patient receive define association fasting blood glucose blood develop case compare develop time patient develop datum case control analyzed age year body mass index level presence significant risk factor develop associate increased risk statistical compare control patient high risk cardiovascular disease result show significant high risk treat develop risk complication
19846730 en although type mellitus risk factor develop mechanism examine prevalence dysfunction patient type mellitus function study patient type mellitus duration year function function estimate use pressure total prevalence dysfunction index respective prevalence patient dysfunction index compare normal dysfunction index respective dysfunction score total whereas pressure adjust age duration score remain dysfunction score associate whereas association function less
22268988 en patient type mellitus treat insulin without oral primary care evaluate insulin treatment factor change analysis patient type within health primary care database patient receive insulin follow included patient mean age year man duration year insulin use year receive oral previous month mean follow-up year patient insulin follow-up mean hba1c baseline follow-up follow-up patient insulin patient mean hba1c change mean hba1c study insulin mean hba1c change mean hba1c study increasing hba1c duration patient hba1c target baseline hba1c level reduce suggest insulin change impact patient change insulin treatment high hba1c level change treatment clinical outcome research therapy change
25351273 en treatment type mellitus T2DM effect use population new therapy improve profile need chronic review overall improve glycemic control without increasing risk without weight evaluate patient T2DM risk cardiovascular event general well range patient population use patient renal without may treatment population trial evaluate renal profile
25617558 en mellitus DM type common remain study suggest gene can associate development disease include
24859506 en syndrome disorder result gene factor syndrome include mellitus multiple present case known history mellitus found age year present renal addition clinical analysis gene patient found two different current patient one
23000155 en complication cause mortality mellitus protein according concentration also role several function include known relationship mellitus review chronic complication mellitus diabetic diabetic
22858162 en primary treatment patient therapy mellitus DM occur patient patient tolerance decrease however little increase therapy patient DM study determine effective patient patient included perform test according baseline month follow-up test perform primary outcome included patient DM month follow-up datum patient baseline month follow-up significant lower patient DM however increase month significant DM group group patient effective patient without DM although remain lower patient DM
23301500 en renal type mellitus DM independent risk factor mortality evidence effect mortality may determine treatment study assess effect renal association cardiovascular disease high risk disease cohort study on total patient follow-up renal define status estimate rate outcome increased renal status diabetic effect mortality risk due renal relative risk due DM renal DM mellitus increase risk mortality renal finding suggest renal patient cardiovascular disease
23233742 en presence individual suggest may identify associate cardiovascular perform type mellitus study study study use cohort obtain use determined analysis perform association use age study gene odd gene statistical significant score whereas evidence high level associate high level odd finding without mellitus diabetic study identify contribute difference cardiovascular disease
23279143 en protein lower recent study show associate disease result remain
22869200 en patient type mellitus T2DM hospital severe disease significant severe study identify clinical factor may contribute increased insulin resistance control patient cohort study included patient T2DM severe treat insulin medical medical resistance determined use model resistance index control assess patient target glucose level method use identify insulin possible clinical insulin resistance control significant insulin resistance odd ratio or confidence interval CI control or CI use may insulin resistance control patient factor contribute insulin resistance control patient T2DM early factor may influence insulin resistance control may control
22107884 en complication patient mellitus DM study aim assess blood status high patient DM type type identify association total subject without control included fasting blood sample parameter measured fasting blood lipid renal profile determined blood concentration use concentration decrease patient respective control among significant increased respective compare control patient increase compare level blood present patient associate increased
26972961 en identify important role metabolic disorder include type mellitus T2DM study investigate serum level T2DM subject insulin treatment
26940634 en woman type mellitus T2DM high risk increased study potential role study first study investigate whether level woman T2DM related insulin level serum lipid measured woman T2DM on total female patient according three group normal patient normal significant high BMI great lower diabetic lower diabetic compare diabetic normal multiple regression analysis revealed insulin level therapy level level correlate age BMI association finding suggest elevated level associate high diabetic patient possible finding mechanism remain metabolic parameter may association can however also independent significant negative correlate also need
25753488 en increasing prevalence type mellitus T2DM clinical trial therapy population present randomize study evaluate T2DM patient aged year hba1c therapy randomize drug primary change mean hba1c baseline characteristic group overall mean hba1c adjust mean hba1c decrease group respective difference confidence interval CI patient baseline hba1c decrease hba1c adverse event occur similar patient respective consider respective occur patient group therapy weight well week patient T2DM control
21747057 en dysfunction contribute development patient mellitus mechanism dysfunction recent study show mellitus increased investigate dysfunction observed increased protein cell patient mellitus compare healthy control subject cell glucose observed similar increased protein associate increased high provide suggest increased may impair function increased finding increased contribute mechanism dysfunction diabetic
24182793 en study use database examine risk renal patient mellitus DM aim compare outcome renal among without review retrospective adult patient undergo renal patient group without test test use compare outcome diabetic renal analyzed renal function development old great body mass index mean vs lower vs patient hospital rate similar group however found decrease DM year vs mean follow-up time year rate within month great among DM vs odd ratio year similar vs analysis show increased baseline level significant risk factor body mass index significant risk factor among patient found increased risk patient DM within first month however datum suggest associate high renal patient blood glucose control
21479764 en type mellitus T2DM patient however little evidence effective low body mass index BMI patient study evaluate result T2DM patient BMI range patient two man woman T2DM undergo datum patient BMI mellitus include disease duration history medication use mean age year range year mean BMI range mean duration T2DM year range year patient history T2DM mortality two patient complication early month patient show T2DM show glycemic control two show group high BMI age duration three factor may intervention patient rate age BMI duration T2DM glycemic outcome
24891138 en negative datum level type mellitus
23860762 en evaluate effect use two patient mellitus without assess study included patient without man woman mean age year range year undergo one month month three use analysis perform difference two analyzed sample evaluate parameter provide provide significant two provide significant different lower perform presence perform patient without significant improve
23218584 en dysfunction study examine association metabolic risk factor function patient investigate function participant type age related normal subject use test analysis rate use identify patient diagnose blood pressure large value patient compare control result obtain rate ratio test patient statistical lower control patient great blood pressure reduce blood pressure response control also increase mean rate decrease time parameter rate increase ratio indicate cardiovascular test analysis rate demonstrated system patient dysfunction
25377009 en potential association risk type review cohort identify use cohort study relative risk type according total include case type participant included evidence association risk type respective relative risk type increase CI without among study relative risk type increase CI among study relative risk type increase CI without among study estimate show significant increasing associate significant reduce risk type
27042279 en aim present study evaluate patient type mellitus blood glucose level control treatment addition study treatment period week primary change hemoglobin level hemoglobin level mean baseline decrease study mean change hemoglobin level week study respective effect week rate adverse event adverse event rate adverse drug reported patient incidence major therapy consider effective without clinical patient type mellitus
26961565 en on man treatment mellitus DM also treat although hba1c level level normal ratio hba1c lower normal participant patient type DM plasma level lower hba1c level measured method respective lower report case patient DM may cause decrease plasma level increased
25475929 en aim present study assess patient type mellitus control patient hba1c randomize receive primary change hba1c level baseline week mean baseline hba1c group group difference group regard change hba1c fasting plasma glucose level respective week incidence adverse event similar group addition effective general well patient type
24429158 en type common medical disorder important clinical health research two indicate effect can contribute independent development insulin resistance glucose type type increase possible development control although research need mechanism association two disorder clinical include patient present one disorder early patient metabolic dysfunction include type assessment metabolic can reduce cardiovascular disease risk improve patient chronic disease
23880208 en evaluate type mellitus patient subject patient T2DM previous disease study determined plasma level measured result show patient cohort mean value CI plasma level correlate score index T2DM age show T2DM patient compare low associate score index adjust or CI adjust or CI finding suggest model patient T2DM estimate case concentration potential risk elevated plasma consider independent T2DM patient known
23249410 en study difference need among man woman type mellitus participant group individual conduct man age participant year female analysis revealed blood glucose woman management whereas man less man management reduce medication whereas woman woman whereas man woman use group whereas man also system man woman reported finding difference need among man woman may care
23217384 en one common chronic disease cause level however effect study investigate management status type mellitus T2DM factor associate hospital conduct hospital control define base type sample patient age year disease duration year included hemoglobin hba1c mean level patient target hba1c blood pressure total cholesterol factor independent associate glycemic control duration odd ratio or confidence interval CI body mass index BMI or or factor independent associate blood pressure control BMI or or factor independent associate control level or management status T2DM patient hospital improve however target duration high BMI low level independent associate poor metabolic control
23110609 en insulin insulin indicate use insulin therapy patient type mellitus insulin increased study less effect insulin insulin insulin patient type effect insulin control show randomize trial include use therapy patient type therapy addition oral drug patient type trial insulin general little effective insulin insulin insulin patient type little effective insulin patient type less blood glucose also general insulin insulin patient type significant less weight general insulin insulin patient type insulin insulin insulin insulin insulin one study patient type insulin general effect addition insulin improve control patient type control although significant great reduction patient receive receive therapy insulin result two trial patient aged year analysis aged year indicate insulin insulin use patient type less fasting plasma glucose insulin insulin one study insulin insulin woman type hba1c value gestational week addition outcome insulin similar insulin insulin general well treatment patient type include patient woman type adverse event include adverse event reported insulin consider related study drug insulin general associate significant lower risk insulin patient type insulin use insulin therapy patient type
23066116 en current test diagnosis method early type significant clinical lead target protein addition respective high insulin increased protein participant normal diabetic individual association study subject evaluate analysis revealed increased vs diabetic individual high whereas analysis show increase subject however increased diabetic subject high observed datum can clinical value early type
23032146 en diabetic study assess group three assess mean age group female year participant participant level lower level on large total group blood glucose level decrease diabetic follow-up also diabetic diabetic diabetic patient compare study result indicate level improve
23027646 en control complication intervention complication study high level participant two identify characteristic contribute year participant major year relationship provide common test assess complication care woman test first important significant man whereas man care individual little three complication complication first individual identify factor associate addition analysis cohort type follow study time year randomize primary identify study medical care relationship clinical research
22937960 en previous study correlate complication type primary care present study aim association diabetic complication patient type care subject type mellitus hospital age year duration year hba1c per patient complication complication study risk event elevated compare healthy control subject range vs increased patient complication complication complication complication complication logistic regression analysis show age duration renal function independent associate complication multiple regression analysis identify age renal function complication number complication study increased patient type care associate complication patient association independent risk factor
22314180 en review aim previous care disorder risk type study identify study indicate health important role perform care known patient on health care care may important health need individual healthy change complication treatment drug increase need control
25701862 en mellitus DM common increasing prevalence disease well clinical management present develop independent provide management diabetic diagnosis management clinical clinical disease use treatment complication use insulin insulin insulin insulin factor result improve control also evidence improve control glucose may diabetic important management provide role blood glucose concentration control may improve parameter also important assess response insulin insulin review study management DM base clinical datum however datum need study clinical management common disease
25693777 en although possible risk factor type mellitus DM result study investigate association prevalence incidence DM estimate use concentration less baseline study participant aged year baseline participant included study DM participant without DM baseline studied DM potential found significant association DM odd ratio or confidence interval CI or CI per increase respective large association observed study or CI or CI significant associate DM follow-up period result risk type DM study follow-up time great range include high level evaluate association
21957815 en two type mellitus increasing although common type among among primary care risk factor perform test therapy type disease complication treatment include diagnose patient
24983933 en retrospective database determine impact glycemic control complication outcome patient undergo mellitus DM high disease show increase mortality study demonstrated negative effect patient DM undergo however whether glycemic control influence outcome sample patient undergo condition identify use disease clinical three cohort control diabetic diabetic patient without patient complication outcome prevalence control diabetic patient undergo increasing significant compare patient without diabetic patient significant increased odd complication diabetic patient also significant increased risk diabetic patient increased risk mortality odd ratio confidence interval increased mean compare patient similar control diabetic patient increased odd complication however control diabetic patient mean day significant increased compare glycemic control increase odd mortality complication patient undergo DM may lead outcome decrease level
22198371 en mellitus high condition patient however research patient association cardiovascular develop provide association regard intervention outcome management patient
21264891 en drug increase glucose can effect metabolic parameter glucose diabetic mellitus treat per week effect weight concentration blood glucose insulin blood blood body cholesterol per hba1c glucose tolerance protein studied mean time group treatment cause significant decrease mean blood glucose cholesterol hba1c concentration improve glucose tolerance mellitus increase gene protein treatment level similar effect observed protein gene increased effect model mellitus
20473694 en chronic disease mellitus disease positive negative new may contribute present aim patient type within sample adult patient type diabetic evaluate among patient patient type diabetic type positive associate patient type patient identify disease compare type independent associate related patient patient
26806326 en increase result system cell on positive correlation reported lipid level diabetic aim present study investigate control diabetic participant included study group healthy control group normal subject control DM group subject DM DM group subject DM fasting blood glucose glucose hba1c association diabetic control lipid mean hba1c increased significant DM subject compare control DM group lipid significant increased DM group compare control DM group show significant parameter compare healthy subject significant positive correlation hba1c studied poor glycemic control lead protein lipid complication lipid mellitus can contribute early management
24519258 en study assess association DM group analysis study adult datum blood pressure perform define elevated elevated define fasting glucose DM fasting glucose diagnosis prevalence DM respective subject high adjust odd CI DM CI compare without association woman among man associate DM need assess identify individual condition
22258980 en blood glucose control type mellitus glucose system glucose level provide glucose level identify identify two type system define retrospective system system system provide glucose concentration current use common status assess effect system compare blood glucose patient mellitus type study control trial compare retrospective blood glucose level type system patient type mellitus primary outcome control level hba1c outcome adverse event complication control independent study assess risk perform although clinical study perform outcome can without clinical identify review identify result age group indicate patient insulin therapy compare patient use multiple insulin blood glucose month significant large hba1c level insulin therapy compare patient use mean difference change hba1c level confidence interval CI patient risk increased included CI CI one study reported baseline month however one event patient poor control patient hba1c level month baseline also statistical significant large compare patient use insulin time change hba1c level CI patient significant difference risk severe confidence interval however included decrease well increased risk compare control group severe CI CI reported study study significant difference found complication study woman type patient evidence effective glucose use adult patient poor control large control insulin therapy patient poor control use insulin risk severe significant increased event occur result high improve level hba1c large
21613810 en determine whether hemoglobin hba1c can use diagnose type mellitus assess role hba1c development cardiovascular sample female adult age old study oral glucose tolerance test base characteristic value hba1c use glucose tolerance several index use assess cardiovascular risk include estimate rate health hba1c value diagnose mellitus impair fasting glucose impair glucose tolerance impair glucose assess logistic regression model hba1c independent risk factor lead increased significant increase hba1c value index cardiovascular risk may method diagnose however subject blood glucose measured clinical addition suggest hba1c cardiovascular disease
26340932 en major cause type mellitus recent gene found gene model include glucose insulin increased gene cell increased effect therefore study indicate model show improve glucose tolerance insulin increased plasma insulin level effect gene due overall result first time
21366474 en mellitus related risk condition ratio according baseline status fasting glucose level datum among age status index ratio among compare without follow confidence interval CI cause CI CI cause CI cause vs associate disease vs also associate renal disease disease disease disorder disease cause disorder chronic disease ratio reduce blood pressure lipid level renal fasting glucose level per per level per per associate on year early without difference addition disease associate several disease cause disorder independent several major risk factor
21143171 en evidence indicate system may also use complication diabetic result recent clinical study consider first drug patient review effect
26199261 en examine association parameter complication patient type mellitus T2DM treatment large hospital investigate relationship blood patient T2DM complication patient T2DM protein significant correlate factor factor patient T2DM complication base logistic regression analysis group great risk high whereas risk high significant great group value protein level associate increased patient T2DM complication
25869301 en cell therapy treatment type mellitus study trial patient cell cell group receive patient one female patient mean age year disease duration year group receive patient female patient mean age year disease duration year hemoglobin hba1c serum insulin group hba1c insulin group patient blood hba1c receive mean body group receive mean body effect observed hba1c group decrease reduction mean insulin treatment control compare
25200067 en insulin remain treatment patient type mellitus although new profile insulin different observed clinical insulin significant glycemic control one use new investigate duration rate factor therapy review datum new insulin new current development
22486277 en study investigate effect demonstrated system datum effect therefore studied effect chronic treatment activity patient type subject age year BMI hba1c mean type studied little month mean significant high vs activity significant different month patient type associate increased level effect may important mechanism effect
25487035 en oral health influence health one common chronic disease mellitus oral adult research clinical management different type disease diabetic patient important care patient disease review oral health
24827939 en use treatment type however datum compare therapy individual without insulin may follow risk mortality cardiovascular mortality mortality rate ratio use regression total patient man mean age year use insulin incidence rate per patient year insulin adjust analysis associate mortality mortality mortality mortality drug compare therapy use therapy may target lower risk type although analysis may important baseline difference
22927948 en associate mortality risk general population whether also case among patient assess association glycemic glycemic index mortality risk individual study cohort study among individual mellitus mean age year duration year baseline assess baseline analysis perform estimate ratio cardiovascular mortality adjust follow-up due associate mortality risk adjust per increase CI mortality risk significant association observed glycemic glycemic index glycemic associate increased total mortality risk among normal weight individual study population among individual association associate decrease mortality risk high glycemic associate increased mortality risk normal weight individual
22550704 en according mellitus disease rate lead mellitus on include treatment complication function base mellitus datum according patient datum study show disease also treatment mellitus complication study well development
22516850 en previous study suggest therapy adult type however therapy population research identify response vs control intervention adult type research randomize control clinical trial compare week medical resistance study perform research man woman diagnose type mean age year hemoglobin fasting blood glucose week participant group group lead little week research use score decrease score score significant control group also decrease score decrease score remain care may reduce patient type although clinical finding study large sample
22230826 en common reduce medication increased risk mortality study examine whether type mellitus type treatment improve oral medication glycemic control among primary care randomize control trial conduct patient type primary care patient care intervention care care treatment clinical status assess use medication event system use hemoglobin hba1c glycemic control patient health assess care group statistical baseline patient receive intervention hba1c level less intervention vs care score less intervention vs care patient care group randomize control trial intervention treatment type outcome primary care type treatment may
21977923 en study perform determine effect large glucose tolerance insulin resistance woman gestational participant randomize control trial gestational mellitus intervention group control group subject intervention group receive one hba1c serum fasting insulin blood glucose model assessment insulin resistance index function insulin insulin index measured baseline month found intervention control group respective index intervention respective subject intervention group subject control group mean control group control group function increased insulin decrease month decrease intervention group increased control group change significant control group serum range effective status index insulin resistance gestational
25610861 en diabetic condition increase several study report cardiovascular effect gestational mellitus determine effect response well test without week week also protein plasma glucose insulin level measured impair response reduce protein significant increased result suggest increased well mechanism change finding early
25316227 en type mellitus related study type mellitus patient use compare study review obtain subject study perform time type patient healthy compare analyzed measured significant different healthy type patient measured also significant different healthy type patient measured two method significant correlate measured associate body mass index method clinical
24243639 en woman type mellitus high prevalence syndrome general aim study woman influence insulin therapy glycemic control evaluate difference body mass index woman without evaluate woman without treat insulin therapy woman without compare metabolic parameter evaluate perform woman show woman show difference treatment glycemic control compare woman without difference high index vs show difference without similar high level found vs woman characteristic compare woman however disorder can cardiovascular risk factor woman
24446385 en insulin therapy patient insulin response healthy subject normal blood glucose level control blood glucose patient important effect insulin blood glucose on model glucose effect insulin aim previous develop model glucose profile patient type insulin clinical datum two trial included analysis trial tolerance test use insulin insulin model include effect insulin glucose assess parameter significant include glucose model model clinical trial effect profile new insulin
21596203 en study examine difference prevalence mellitus sample adult without common related condition logistic regression model adjust risk factor use examine difference prevalence rate without disorder significant high rate adjust risk factor presence disorder health significant disorder odd found treatment need reduce among without
21116605 en aim study determine risk hospital mellitus aged study analysis two statistical hospital mortality datum study rate cohort compare rate cohort rate rate ratio hospital CI base year base year significant high rate ratio respective CI CI CI CI CI CI significant low rate ratio CI CI CI CI mellitus associate elevated risk reduction risk risk risk less important known complication
25813583 en type mellitus severe disorder on high reported although reduce disorder also may chronic study however may perform aim present study develop new base new occur body weight week old use model control diabetic group week parameter ratio ratio ratio significant difference can observed control compare control present significant high value significant lower study demonstrated effect early new study whether also lead similar effect
23991629 en insulin patient new diagnose type effective metabolic control function on randomize control trial conduct investigate whether
26526166 en woman previous gestational mellitus increased risk develop glucose current adverse early glucose determine potential current glucose value oral glucose tolerance test population according medical cohort woman diagnose treat medical period year index retrospective glucose subject value respective hba1c significant associate early glucose significant potential glucose risk assessment value identify use analysis time diagnosis can improve metabolic risk therefore medical
22066527 en study compare health insulin therapy respective patient type assess use previous model disease effect change hemoglobin hba1c weight event study use reduce severe complication weight insulin ratio per show per insulin reduce incidence severe result associate weight hba1c change treatment patient age result model use per analysis treatment patient type treatment
22058089 en assess score risk risk score independent cohort included develop cohort cohort compare time event analysis characteristic cohort cohort cohort provide fasting plasma glucose model assessment insulin resistance oral glucose tolerance test risk score study cohort overall significant use glucose tolerance status time event analysis rate low high group significant different study independent population provide assessment T2DM risk method
22679516 en treatment care increase treatment whereas may decrease care effect according evaluate relationship treatment study type patient use type treatment database cohort patient blood pressure diabetic cohort patient hba1c diabetic condition high condition include condition new medication treatment perform regression analysis assess association treatment define increase addition cohort patient high treatment hypertension treatment less new drug significant associate treatment risk factor treatment case care provide complication occur hypertension management observed care cause
26167776 en glycemic control lower risk complication treatment care study examine treatment datum analysis large datum individual year old studied first time treatment define addition estimate use regression adult first mean age year woman therapy individual increasing time cohort ratio CI cohort CI compare cohort significant include level level common use use time use decrease use increased significant increase treatment well prevalence use prevalence use
24743162 en BMI correlate risk type mellitus T2DM hypertension common condition hypertension significant impact obesity T2DM obtain datum T2DM health consider individual hypertension T2DM individual T2DM multiple regression test model use impact hypertension correlation BMI age risk increasing level BMI age T2DM patient diagnose hypertension relationship BMI age T2DM patient female patient female age increase BMI female BMI mean age T2DM patient decrease year high BMI significant decrease patient severe due hypertension baseline normal weight increase little high due hypertension early female high condition hypertension association BMI type female present result provide health type patient
24710186 en study aim whether management type mellitus diabetic health model clinical management diabetic patient assess whether relationship primary care need patient treatment drug management whether change lead clinical study analyzed define clinical within compare datum obtain related management treatment patient type change evaluate result datum assess year vs study show however hemoglobin value increase number patient type identify increase use compare period change number patient complication type study risk complication define role
24467747 en type mellitus T2DM associate increased impair therapy increase however metabolic effect assess whether improve metabolic function T2DM diabetic diabetic week effect evaluate analyzed glucose assess use glucose tolerance diabetic mass significant lower respective increased treatment diabetic diabetic show lower increased normal diabetic increased rate normal diabetic improve normal diabetic serum level glucose tolerance adverse effect T2DM mass positive effect general normal compare diabetic
22284233 en syndrome multiple type mellitus included report case present syndrome diagnosis presence age year type mellitus develop age year case relationship type mellitus review
21729993 en patient type mellitus T2DM severe female compare however also investigate whether observed female T2DM adult T2DM model study function evaluate test test per day significant effect blood pressure glucose tolerance insulin resistance significant difference function observed however treatment improve female improve female level treatment also improve function improve per day diabetic improve impair function observed female suggest may associate female clinical
24196401 en important health several risk factor common woman history gestational mellitus may investigate prevalence risk factor associate cohort woman recent analyzed datum study woman type cohort woman diagnose hospital assess report define occur obtain datum medical use logistic regression model estimate association analysis included participant reported woman associate obesity or CI old age or CI insulin treatment or CI or CI on high gestational age associate decrease odd or CI woman recent obesity insulin treatment risk factor early woman risk factor may need trial
21802581 en research patient type mellitus increased risk cardiovascular disease well management metabolic risk factor reduce mortality patient on number clinical trial current evaluate trial provide role management glucose patient risk provide trial impact glycemic control risk reduction patient
26448299 en type mellitus DM cause insulin DM influence factor general individual disease factor early influence reported within major among important common insulin mechanism however insulin use disease
26408873 en high blood glucose level lipid profile plasma important risk factor cardiovascular disease patient type study conduct evaluate compare effect cardiovascular risk factor mellitus T2DM patient one T2DM patient treatment control month evaluate plasma level glucose hemoglobin hba1c lipid profile treatment month treatment compare treat patient significant reduction fasting plasma glucose level hba1c level plasma significant increased level total cholesterol significant decrease decrease whereas significant increased risk ratio decrease similar result lower value obtain use glycemic control cardiovascular risk factor type mellitus patient
20925938 en mellitus complication associate decrease patient current diagnose treat primary according type trial studied drug patient improve function increased blood glucose datum show potential effect function include therefore therapy present use treat type drug decrease hemoglobin hba1c value show patient impair function study evaluate renal recent diagnose
24286954 en mellitus body include consider disease whereas condition occur among individual compare general population diabetic patient increased poor complication provide current metabolic status may disease improve overall early diagnosis treatment
24370923 en on characteristic present resistance type mellitus T2DM aim study develop evaluate insulin glucose T2DM T2DM patient age year BMI hba1c normal subject age year BMI hba1c studied insulin function index use insulin glucose value oral glucose tolerance test body mass evaluate plasma value on score range low high score score score study subject level high T2DM high T2DM compare vs positive correlate fasting plasma glucose plasma glucose plasma glucose hba1c correlate insulin correlate BMI body mass independent fasting plasma glucose high insulin resistance on define score include associate insulin resistance T2DM
22205061 en obesity estimate adult high risk development treatment blood pressure cholesterol reduce risk development diabetic complication review research study treatment association clinical association multiple study demonstrated glycemic control reduce risk disease show decrease disease event trial although follow-up control complication trial study association clinical association study indicate target patient base factor include duration presence chronic complication group also develop treatment use intervention glycemic target
26581534 en hemoglobin protein change condition reported population one consider cell cell mellitus condition occur one patient disease possible change syndrome aim study evaluate cell sample diabetic patient cell identify cell parameter obtain sample diabetic patient determine hemoglobin blood cell datum analyzed found old man cell correlate reduce blood cell increase cell sample woman difference sample patient cell cause cell high man lower blood cell increased mean parameter
24238561 en health increasing number study two disorder receive low aim study investigate potential contribute assess prevalence evaluate association study use clinical sample without history study conduct among patient little three month diagnose diagnosis history use blood pressure weight hemoglobin hba1c measured time measured use use analysis increase hba1c associate increase score dysfunction associate increase on increase blood pressure associate increase associate included increase little one diabetic complication increase treatment increase insulin use increase increase history increase high associate increased increase per associate severe disease status association provide health primary care important development among
24037881 en new glucose test whether serum level independent associate development type subject high cardiovascular study conduct use datum study included case subject new diagnose individual control subject identify mean follow-up logistic regression model use estimate odd ratio according measured serum concentration significant lower case subject control subject subject case concentration significant associate model assessment insulin resistance level fasting glucose concentration control subject independent logistic model factor odd ratio incidence low vs high confidence interval respective history factor change population high cardiovascular risk low concentration serum associate increased risk
19261345 en study determine prevalence diagnose identify associate risk factor sample adult primary health care conduct among year age subject study conduct use follow test DM define according group status base presence impair fasting glucose impair glucose overall prevalence mellitus among adult population high diagnose DM new diagnose DM impair glucose tolerance diagnose impair fasting glucose total DM high woman man age group year prevalence total DM increased age risk factor significant high diabetic adult population obesity hypertension metabolic syndrome disease history DM major disease obesity associate high prevalence DM among man present study found high prevalence mellitus adult population high adult increase prevalence DM year history DM major DM early diagnosis DM major reduce risk condition
22318932 en review clinical recent use treatment type database use identify review identify review also evaluate obtain clinical therapy result clinical reduction hemoglobin well fasting plasma glucose level patient type mellitus patient renal oral show clinical effective well increased rate use insulin compare clinical provide type mellitus use without patient renal function
22494491 en assess impact incidence among cohort study included man aged year without according status year current participant follow develop incidence determined fasting plasma glucose level hba1c level medical treatment follow-up participant develop risk within year CI year CI among individual study identify high risk among year normal weight incidence lead high risk risk important
26252176 en increased risk develop type woman history gestational mellitus may associate increased insulin resistance however woman previous develop woman population present aim study assess function insulin resistance level woman study group included woman mean time year on control group included woman without patient undergo oral glucose tolerance test assessment function insulin resistance well level factor glucose tolerance found woman group control subject control group significant high significant lower value body mass index value group show significant high level similar woman history insulin normal body weight insulin known whether present whether
24163110 en type mellitus chronic disease great impact treatment datum current metabolic control treatment aim investigate clinical care year retrospective studied patient general metabolic control hba1c level therapy investigate on group new diagnose patient known patient known mean hba1c level patient show hba1c level target patient respective treat among patient hba1c treat insulin increased patient receive intervention year hospital diabetic perform patient patient hospital metabolic control treatment general hospital improve
23728830 en although lipid parameter studied ratio value cardiovascular event previous use primary two treatment compare patient type study randomize control study type patient high level cholesterol randomize receive primary difference change week change lipid profile hemoglobin hba1c model assessment index total patient group randomize week treatment ratio significant reduce group however difference change two group statistical significant vs significant difference change total cholesterol cholesterol cholesterol two group however significant great group group vs analysis significant great group vs change hba1c index protein two group adverse rate similar two group vs management may effect profile patient type mellitus
20602305 en current type mellitus result two general group factor one influence pressure also negative influence large assess total population type mellitus base resistance insulin on factor cell dysfunction study insulin resistance insulin resistance glucose mechanism present decrease glucose potential target clinical present review glucose contribute insulin resistance glucose type mellitus glucose target therapy type mellitus insulin condition review present influence glucose base study review can contribute therapy type mellitus condition related insulin resistance
25342083 en type decrease health status however health weight estimate effect estimate compare healthy individual population evaluate influence age body mass index intervention undergo oral glucose tolerance test indicate included individual healthy three different impair fasting glucose impair glucose tolerance index use response age body mass index regression analysis conduct estimate effect multiple risk factor total individual included analysis overall mean mean healthy individual overall model vs normal weight significant associate age high associate increased normal weight associate elevated obesity associate lower individual high participant individual range therefore development improve addition risk develop
23480592 en oral drug include however clinical decrease according increasing hemoglobin hba1c level study examine impact high hba1c therapy randomize control type mellitus patient treat hba1c level little month study patient two treatment group receive reduce group patient reduce group patient group great change observed hba1c level patient patient reduce period important glycemic control therapy may patient glycemic control therapy
20937978 en health status outcome compare treatment mortality randomize patient type mellitus disease medical therapy insulin insulin method intervention activity status index health health assess study model use evaluate effect randomize treatment health status improve significant baseline year randomize treatment group compare medical therapy associate significant great activity status index health health treatment effect large year follow-up effect activity status index significant large patient compare intervention health status significant insulin insulin associate statistical significant health status compare medical therapy among patient mellitus
24731365 en effect activity insulin resistance woman gestational mellitus investigate woman two group control group case group case group blood level patient insulin treatment control group insulin treatment group treat insulin result show reduce insulin resistance woman indicate may important role control complication
26394349 en mellitus consider relative therapy level glycemic control research evaluate condition level factor patient type T2DM
26391589 en on associate type mellitus T2DM however datum T2DM population aim study determine level T2DM patient study also examine association effect hypertension use
25859650 en drug first type mellitus T2DM reduce cardiovascular mortality independent improve glycemic control change risk factor however report effect function T2DM aim compare patient disease T2DM use studied patient woman age year T2DM receive medication oral drug included disorder index dysfunction compare according use little year index clinical characteristic similar patient receive vs oral plasma cell lower vs high vs subject analysis group result insulin use associate patient T2DM whether may different effect remain studied
23735522 en incidence type mellitus T2DM severe health care system research group develop system provide T2DM patient insulin use clinical glucose provide also system need study whether T2DM patient use assess whether patient high risk patient system whether insulin clinical study population patient T2DM aged use insulin well hospital patient three datum datum analyzed rate according potential impact patient follow duration week patient patient evaluate clinical compare evaluate patient high risk patient indicate datum obtain provide however one consider patient system system without significant large consider clinical according one consider can however system base
19641265 en mortality remain high among type type mellitus although high glucose level mechanism well identify cause woman type type determine whether cause mortality woman type type relationship mortality glycemic case woman type type mellitus identify examine identify woman type woman type early disease case age week woman type type less common woman type type rate ratio confidence interval relationship hemoglobin hba1c concentration weight low hba1c level weight normal hba1c level high hba1c level associate severe relationship hba1c weight consider provide evidence cause also blood provide evidence glycemic control great outcome woman
19470882 en type mellitus change response hypertension increase associate increased mortality change response blood pressure patient type mellitus examine patient type mellitus control subject undergo assessment use pressure patient however patient demonstrated significant increase diabetic patient assessment patient significant improve cholesterol cholesterol high improve significant studied significant increase ratio indicate finding suggest poor metabolic control patient type mellitus show response elevated similar type mellitus however metabolic occur response increase observed previous patient without mellitus
26904689 en several study reported association mellitus DM however result database include odd ratio or confidence interval use assess association DM use model analysis also evaluate test use evaluate total study two cohort study participant included study or CI DM individual compare CI included study or CI female two study CI statistical associate DM female indicate need effect DM female
22125626 en investigate relationship clinical patient type study evaluate association clinical characteristic patient type mellitus estimate rate incidence diabetic investigate study patient year period define serum level patient use significant high diabetic patient man woman normal control man woman total found patient study adjust status treatment mellitus body mass index hypertension use hba1c independent associate diabetic complication significant reduce patient compare month also independent risk factor disease associate diabetic disease renal dysfunction patient type mellitus however influence consider
21722510 en research type mellitus one current great number cell mechanism response according cell disease can lead aim present study cell blood type mellitus blood control assess change function cell examine group type mellitus control group blood cell cell according factor observed significant high cell difference diabetic control observed lower high diabetic compare control one cell blood control high increase lower diabetic result cell blood new type mellitus
23012809 en recent system include system may insulin insulin resistance insulin also activity new mellitus diabetic complication use also improve insulin clinical new mellitus diabetic complication review recent finding related glucose diabetic complication system
22796496 en intervention patient mellitus DM associate high incidence study assess potential role treatment patient DM compare treat diabetic study patient mellitus three treat result compare previous outcome datum patient DM treat clinical study conduct follow-up patient DM receive follow significant lower incidence major adverse event compare group incidence occur positive result analysis compare previous patient vs vs rate vs vs patient treat follow result significant outcome treatment
22488646 en year T2DM develop primary T2DM disease impact T2DM disease evidence T2DM trial indicate effective medication provide therefore T2DM develop however need identify individual follow intervention however T2DM develop
26693712 en factor disorder serum concentration role remain estimate rate determined type function study participant model test association cardiovascular renal change time adjust age body mass index duration hemoglobin blood pressure serum serum sample female mean age year duration year ratio plasma adjust model negative associate positive associate baseline concentration associate change mean year concentration independent associate disease function population finding relationship
25421785 en individual type weight association body weight cardiovascular mortality patient type remain therefore perform investigate association examine identify cohort study on model use risk estimate study include cohort participant identify relative risk mortality patient type confidence interval CI CI respective compare normal patient increase body mass index associate significant reduce risk mortality CI however significant association found risk cardiovascular mortality type diabetic patient CI CI obesity respective finding present indicate body weight may factor mortality among patient type
22752126 en although show function glucose mass study serum level woman study cardiovascular risk factor protein measured woman multiple logistic regression analysis lower level associate high odd ratio or type mellitus age cardiovascular risk factor or CI or CI respective however lower level associate lower or type mellitus or CI regression analysis significant difference found serum level without metabolic syndrome among metabolic syndrome low level significant association elevated blood glucose or CI elevated or CI analysis serum independent associate glucose obesity metabolic syndrome type mellitus woman level independent associate presence type mellitus glucose can
22179578 en perform trial mellitus method total however management study model perform follow blood glucose level insulin level oral insulin serum level glucose tolerance test perform day reduction fasting serum level negative response serum level insulin provide mortality
27385564 en type mellitus DM result general cell present case woman present history weight plasma glucose concentration hba1c value elevated positive type DM diagnose time diagnosis total month diagnosis sample revealed cell cell cell cell also two cell positive correlate well cell case type DM cell function reported cell cell response may role type DM patient
26759275 en association risk gestational mellitus cohort study included woman health study previous chronic disease assess year first time report diagnosis previous medical year follow-up case among age factor woman high rate develop two week total significant associate lower risk reported woman on association level associate great risk lower receive research health development health association datum
25048152 en important role insulin resistance studied association type gestational mellitus subject influence healthy woman control woman week blood sample determined time sample significant lower control show similar high level CI CI associate risk woman increase plasma CI per association remain significant adjust body associate increased risk plasma concentration woman
24881523 en woman complication include hypertension gestational mellitus system system may related present study aim characteristic change woman woman diagnose participant include index on concentration measured score parameter significant high reported previous study healthy woman respective mean value respective score high reported healthy woman previous study score duration follow case significant high suggest woman high level woman healthy woman result indicate compare
26652932 en association diabetic type mellitus T2DM subject well however association insulin fasting new diagnose T2DM subject remain
25157753 en although study show associate type mellitus T2DM range role correlation among T2DM remain identify effect patient among T2DM
19581493 en individual mellitus increased risk cardiovascular disease relative without examine risk factor level change among individual without type mellitus included participant year age participant year age risk factor level measured regression model use assess status year risk factor level among without mellitus increase body mass index per year whereas increase value year cholesterol mean decrease per blood pressure mean decrease per relative without similar individual without mellitus individual great increase body mass index great decrease cholesterol similar blood pressure individual mellitus risk factor increased risk need control risk factor among individual mellitus
21649625 en type mellitus known adult group lead need care population health care health little known type mellitus examine compare group use sample primary diagnosis type mellitus clinical datum outcome assessment receive study sample participant participant group receive participant receive per week per week clinical participant less receive therapy adjust odd ratio confidence interval health lower use clinical research
25269359 en investigate association glycemic control mellitus study mellitus age hba1c year respective poor glycemic control associate high body mass index BMI hba1c high respective positive association body hba1c influence
23729551 en factor adult type well investigate on study investigate serum level type mellitus present study investigate level insulin new diagnose serum level compare month insulin therapy diabetic patient without mean age year patient mean age year studied mean group lower group however difference statistical significant serum level increased significant month insulin therapy level reduce on significant increase serum level occur insulin therapy
22027069 en type mellitus associate oral complication however regard association risk factor type database use different mellitus type association remain although study high prevalence due increased concentration glucose oral reduce rate dysfunction study report reduction level cause decrease patient poor oral may present increased prevalence relationship association intervention study reduce population follow
24388085 en little mellitus DM assess characteristic DM patient receive therapy retrospective study conduct patient DM control age year primary analysis logistic regression estimate odd confidence interval significant association disease hypertension risk DM patient high weight odd ratio or CI adult significant DM or CI participant receive or CI therapy or CI DM mean cell or CI or CI associate significant risk finding suggest among factor metabolic change DM receive weight associate diagnosis patient
23330081 en perform analysis activity patient type mellitus without response found patient type mellitus patient type mellitus associate reduce plasma level elevated increased activity reduce plasma activity increased level lipid patient group important increased activity blood cardiovascular risk patient mellitus
23291026 en investigate whether treatment patient mellitus blood pressure database include blood pressure hypertension control study subject patient mellitus impair glucose tolerance two group significant difference study total patient use index difference clinical outcome treatment group treatment group use statistical patient mellitus treatment can reduce incidence rate cardiovascular event increased incidence rate significant difference mortality cardiovascular mortality treatment group treatment blood pressure patient mellitus little treatment risk adverse event increased
22893478 en glucose system study investigate change activity development diabetic complication model obesity type mellitus activity significant reduce respective lower activity associate high blood glucose concentration impair study provide evidence activity condition presence impair function
22272906 en significant metabolic review regard mechanism weight model weight reduction case lipid case related current new drug base treatment type mellitus whereas similar drug treatment obesity several effect cardiovascular risk
19821719 en show control disease large study revealed mellitus risk factor studied response patient mellitus compare healthy individual study found patient mellitus significant lower healthy individual result suggest increased risk among patient mellitus may related decrease
25091355 en treatment obesity may weight less obesity associate reduction serum reduction serum associate obesity metabolic investigate whether serum normal man regard weight metabolic man year mean serum body mass index BMI man mellitus type receive week decrease weight BMI statistical significant vs baseline year compare previous year diabetic man decrease weight BMI statistical significant vs baseline year compare previous year man serum glucose hba1c lipid profile blood pressure improve significant treatment assess hemoglobin serum serum man also type improve metabolic
24840760 en investigate risk mellitus type time study obtain datum duration cohort model use investigate risk among time develop compare general population time compare associate age age age time ratio CI model adjust age age duration time influence risk ratio CI time major risk factor
22942129 en estimate prevalence cardiovascular disease risk clinical among patient type mellitus DM use different risk general risk profile health hypertension risk identify high patient compare risk risk assessment identify similar patient vs compare identify number man treatment risk vs woman respective man woman number patient primary compare method
25131016 en mellitus important complication related associate increased mortality consider effective treatment patient disease study aim risk factor associate development patient cohort study base medical datum included adult patient undergo hospital analysis perform use logistic regression model presence possible risk factor study independent evaluate period perform patient mellitus present patient month occur study factor associate development fasting plasma glucose month odd ratio or or impair fasting glucose or or high found factor associate development well early diagnosis can result patient
23979349 en woman diagnosis type mellitus year previous elevated plasma glucose hemoglobin level study result show concentration serum level indicate decrease insulin although level negative level positive diagnosis type mellitus revealed gene insulin therapy case type
21849948 en evaluate hba1c level diabetic type patient mellitus primary health care according association study hba1c consider level
24769355 en type mellitus result cell cell cell recent identify cell cell whether function may contribute known report blood patient blood patient cell however function can finding suggest function may effective
25468253 en aim study determine prevalence patient without history mellitus investigate whether patient general follow-up conduct retrospective cohort study adult patient hospital fasting plasma glucose level medical patient evaluate whether patient datum period patient present patient identify plasma glucose use patient included study prevalence found patient without history mellitus period patient follow-up patient treat study population risk mellitus follow-up patient poor major health may follow-up perform
19939479 en insulin resistance role however relationship insulin level investigate whether insulin response outcome patient without previous patient undergo oral glucose tolerance test disease analyzed factor association cardiovascular event include examine regression patient normal glucose tolerance impair glucose respective follow-up period day occur patient include cause significant difference mortality cardiovascular event incidence glucose tolerance status indicate group insulin level associate high mortality rate regression analysis revealed insulin level independent age number metabolic factor low insulin response mortality rate patient previous diagnosis mellitus
25171445 en on present mellitus cell also found elevated serum treatment serum insulin therapy severe elevated possible cell cause develop insulin resistance insulin response
23748521 en insulin may patient hemoglobin hba1c target level patient use insulin current study evaluate clinical outcome patient type mellitus T2DM insulin within large population retrospective study use datum adult patient T2DM treat oral baseline index early score patient cohort use compare outcome include treatment hba1c level rate health care cohort per cohort well regard mean age year woman clinical mean hba1c level mean index score health care baseline insulin patient vs medication ratio vs lower hba1c level follow-up mean adjust change vs compare patient event occur similar rate cohort vs respective study drug high among vs respective high total patient new insulin use insulin associate increased therapy lower hba1c level relative without increasing total
23717591 en model type mellitus within high can observed blood
25347938 en assess effect renal patient type mellitus cohort patient T2DM poor control therapy therapy oral randomize week patient period total treatment duration significant decrease hba1c fasting plasma glucose level body weight baseline week compare patient decrease hba1c level statistical significant patient patient significant reduce body weight group control period associate clinical significant profile influence significant improve control body weight patient T2DM improve control patient treatment patient
25251897 en study determine early mellitus DM type DM model develop per body mass month blood plasma analysis plasma glucose insulin blood determined study conduct show statistical significant DM on change observed DM DM increased respective decrease demonstrated system blood cell cell found early DM development observed
22560127 en cohort study investigate association incidence type measured incidence determined medical period association incidence adjust multiple age history presence hypertension evaluate use prevalence obesity respective associate high prevalence obesity study participant develop incidence rate three respective ratio CI respective associate risk BMI significant association associate incidence association significant adjust BMI may effect body weight risk factor can intervention mellitus
26921319 en early finding identify insulin plasma insulin gestational mellitus found gene plasma level rate associate rate therefore investigate change rate factor blood blood obtain time subject group determine activity level significant difference rate group insulin rate control group however significant lower show response insulin show increase insulin control group similar rate lower compare control subject known first time finding clinical sample show impair
26901398 en investigate gestational mellitus retrospective analysis woman cohort study perform population included healthy woman within risk factor assess risk factor obesity history increased risk diagnose use oral glucose tolerance test statistical analysis perform use statistical present baseline characteristic use use compare group compare group test use consider statistical cohort woman woman one risk factor define health care risk factor according risk factor risk factor oral woman risk factor prevalence risk factor diagnose overall woman cohort diagnosis risk factor test within gestational week study poor risk factor woman well
22011855 en evaluate profile outcome woman gestational mellitus determine risk factor increased studied patient factor found case prevalence respective factor insulin use fasting glucose oral glucose tolerance test glucose previous obesity hba1c association risk factor include history mellitus obesity previous one factor history relationship T2DM great patient factor insulin
21106447 en cardiovascular disease woman research identify increased risk associate role gestational mellitus condition glucose diagnose potential risk factor review evidence association regard type hypertension event research clinical identify risk factor need research
22958196 en study investigate incidence dysfunction clinical factor patient type year follow-up
22210099 en mellitus among activity drug may change concentration drug study aim effect concentration profile interval diabetic patient therapy diabetic subject respective significant lower value patient concentration ratio significant lower diabetic patient parameter similar group study indicate mellitus significant concentration decrease blood concentration lower activity however mechanism include may also role result drug diabetic patient use
23152231 en cardiovascular disease complication type estimate type cause related impair may effective assess effect cardiovascular disease type control trial may also perform review identify control trial compare month patient trial assess clinical cardiovascular review datum study use datum datum included study total patient included three included study investigate compare included study investigate compare compare trial included patient previous trial included patient multiple risk factor disease overall risk trial low mean duration follow-up range day patient mortality mortality one trial patient trial compare statistical significant difference mortality mortality outcome datum three trial total participant overall two statistical study show statistical significant reduction effect odd ratio or confidence interval CI drug datum trial disease adverse event patient evidence patient mellitus trial report outcome patient therefore use patient base evidence trial include patient without trial patient analysis patient trial population need provide evidence base clinical management patient
25867771 en evidence patient type mellitus T2DM control compare insulin patient
25974384 en gestational mellitus increasing rate increasing population age randomize control trial whether reported finding different intervention show reduction woman healthy healthy activity treatment result intervention test include different different activity study can improve use association study group change multiple time target intervention early develop great include woman test
22348359 en prevalence chronic disease mellitus DM increasing important risk factor cardiovascular disease three condition multiple increasing population age develop risk factor contribute association important target health primary care early care outcome reduce estimate rate early risk use system blood pressure control important improve care risk
22173022 en mellitus lead function impair therefore treatment mellitus addition use investigate group group control finding test show group compare control group lead diabetic lipid increased decrease diabetic compare control value level control value diabetic reduce increase protein significant group suggest decrease diabetic therefore suggest may clinical diabetic patient
22161431 en chronic insulin resistance elevated hba1c level datum important identify elevated risk datum method history system increasing use although first remain impact method history clinical care patient outcome
22019035 en man present high mellitus evaluate whether independent association mellitus risk high man diagnose treat logistic regression analysis perform evaluate whether diagnosis mellitus associate odd score cohort man adjust age man adjust or CI man adjust or CI score vs less man however score vs less significant associate score vs less man without adjust or CI CI respective also associate score vs less man without adjust or CI CI cohort man undergo diagnosis mellitus significant associate increased risk diagnose score independent
24490488 en define adult common cause chronic disease mellitus patient
26330392 en possible increase prevalence type mellitus patient population risk health care complication current care change adult associate known risk factor poor glycemic control hba1c body mass index perform subject include association analyzed function hba1c BMI change analyzed subject normal regression analysis BMI statistical significant hba1c also found statistical significant on general observed increasing hba1c increasing BMI however statistical individual revealed change clinical disease
22512265 en study evaluate effect blood pressure lipid profile protein type mellitus patient control month period perform month blood pressure lipid hemoglobin fasting glucose body mass index BMI measured baseline month study patient study effect associate event BMI increased treatment whereas mean BMI level significant although remain treatment mean decrease treatment change blood pressure study demonstrated significant effect BMI level however blood pressure status significant type patient
19565622 en review current regard role mellitus type mellitus adult influence activity type mellitus different mechanism insulin insulin effect cell remain new role mellitus
26364207 en development type mellitus associate number factor related several metabolic complication increased however glucose control study aim evaluate well compare analyzed blood cell three group patient patient healthy individual revealed significant high level group compare control group significant difference observed control group analysis subject analysis response among found compare control gene gene analysis among gene three response control group response control group also identify related associate condition among target result show association increased related several glycemic control provide mechanism
25956345 en review treatment include type mellitus trial therapy include identify database included study primary change baseline week hemoglobin include oral drug randomize patient result medication drug time total included review study addition result improve glycemic control reduction weight weight observed low rate event also included overall adverse event observed treatment group known effect individual treatment patient T2DM therapy patient receive treatment glycemic control study finding indicate mechanism
21454235 en conduct review effect mellitus incidence mortality perform database included review risk incidence mortality patient patient cohort study incidence mortality among patient cohort study adjust risk ratio incidence significant confidence interval CI overall CI man CI woman also associate increased mortality CI overall CI man CI early method patient important clinical management increasing prevalence clinical health
23076386 en identify study type mellitus type DM review estimate current type DM health database identify type DM study present type three study identify included study report include overall type DM individual diabetic complication intervention type DM recent estimate type DM year old although estimate current estimate adjust change treatment period therefore consider estimate current type recent estimate type DM therefore study conduct study include recent treatment development use diagnosis
26362564 en clinical trial investigate blood glucose effect well oral glucose tolerance test man T2DM observed effect lower concentration increased serum insulin concentration first mean respective significant large respective respective study drug well without adverse event clinical trial investigate potential treatment individual T2DM study identify
23758283 en treat severe patient type mellitus however rate patient old year age patient treat hospital different obtain use use on logistic regression analysis perform assess influence factor rate rate use treat severe rate significant associate result test odd confidence interval history severe within year odd confidence interval treat severe among patient
22282030 en lower dysfunction clinical characteristic patient study assess prevalence mellitus change conduct retrospective study woman prevalence mellitus diagnosis assess patient lower dysfunction respective confidence interval prevalence ratio according mellitus patient type diagnosis diabetic patient follow prevalence associate change diagnose diabetic patient woman great prevalence one association mellitus
25887942 en profile plasma gestational mellitus study conduct hospital blood sample woman sample woman diagnose healthy control use two perform follow target gene analysis revealed include target show major target associate insulin resistance can result also provide mechanism contribute diagnosis treatment disease
25491487 en important mechanism health study investigate effect metabolic glucose use gestational mellitus undergo glucose similar normal however reduce compare control woman undergo high compare control woman undergo respective influence metabolic characteristic
21059863 en associate metabolic parameter glucose glucose subject cause risk level increase risk aim assess role risk develop large analysis two cohort study study measured level subject assess mellitus case time follow-up study year respective study ratio subject level compare subject level confidence interval CI CI respective multiple metabolic parameter analysis revealed association risk result remain similar patient new within year glucose hba1c level level increased risk develop
26299230 en incidence renal disease show high among compare risk factor care cohort follow-up evaluate influence cardiovascular outcome incidence randomize study analysis role outcome treat patient type chronic disease estimate rate per hemoglobin level treat compare patient patient regard baseline characteristic outcome include mortality outcome adjust model develop patient woman less disease high blood pressure mean follow-up year care great risk significant lower risk adjust remain significant great risk ratio CI whereas risk among similar care lower event rate risk high among increase independent known risk factor
23859434 en evaluate rate related among patient type mellitus T2DM insulin datum evaluate previous retrospective study use health database investigate adult T2DM insulin current study evaluate baseline characteristic event month month insulin patient treatment analysis use baseline characteristic determined insulin study included patient overall prevalence low overall related hospital prevalence significant lower vs hemoglobin hba1c reduction high vs associate insulin lower vs patient develop complication time insulin therapy high risk develop study use retrospective datum subject addition analysis use cohort regression analysis adjust difference result care sample patient T2DM insulin treatment show low rate use low contribute overall
26710500 en mellitus potential health current diagnosis evaluate plasma glucose level individual present study aim estimate correlate plasma glucose level diabetic diabetic subject study population three group group diabetic group diabetic base plasma glucose level group healthy population control blood plasma glucose level glucose level significant high group group diabetic compare control glucose level show significant correlation plasma glucose level study population suggest glucose level use glucose level diabetic present study found glucose level use diabetic status patient
21846430 en body protein response patient mellitus type aim present study great positive protein blood glucose compare diabetic patient on total patient undergo study day glucose protein assess use decrease glucose group effect group total glucose increased lower decrease protein protein group whereas decrease protein therefore protein positive value patient group remain effective positive protein diabetic patient
25165725 en aim study evaluate value patient type mellitus T2DM patient T2DM without diabetic control subject subject examine first measured result show patient T2DM significant patient T2DM without control subject patient T2DM without significant control subject T2DM patient may early patient without
24672803 en aim evaluate weight control different investigate change obesity type mellitus T2DM receive control also similar group total group result show group similar group large group significant increased group increased group ratio significant decrease group weight group significant increased group decrease group also show increase group group decrease significant may may T2DM control weight different mechanism
24147929 en well obesity gestational mellitus increased risk chronic disease early chronic disease however mechanism development chronic disease well recent reported result suggest potential mechanism metabolic review provide relationship metabolic gestational mellitus
23340885 en may reduce gestational mellitus woman history type randomize study type treat first day group treat day outcome incidence group outcome follow incidence gestational hypertension syndrome diagnosis perform according association study group significant reduce group compare group vs respective group reduction risk odd ratio on statistical significant reduction group also significant reduction mean weight outcome difference woman history type may reduce incidence
23269541 en research adult patient new diagnose type age range study aim three year year year population new diagnose patient type
26971963 en gene recent identify diagnose report gene previous diagnose high associate severe mellitus although correlation remain finding important whether case previous diagnose may known gene
26436934 en type disease patient mellitus increasing patient common disease disease less common disease syndrome disease related tolerance review disease patient improve
26136069 en may mechanism association cardiovascular disease aim association serum assess potential difference related glucose study perform adult man mean age year type mellitus study assess per associate great indicate significant high confidence interval lower confidence interval age glucose status association adjust mean pressure BMI status rate total cholesterol ratio estimate rate use medication use association found on significant glucose status found however association significant significant associate among adult aged year without type mellitus
25858973 en age contribute mellitus DM relationship among age change study determine difference relationship among age group without individual type DM control age body mass index outcome high DM group compare control group mean confidence interval CI reduce DM group compare control group DM group correlate score score score study relationship can age individual DM associate increased decrease function possible metabolic effect
25647516 en study characteristic event patient type mellitus T2DM identify use among T2DM T2DM prevalence increased age high patient vs respective compare diagnose hypertension diabetic common lipid disorder less common health care common compare T2DM related population difference observed base age status factor determine T2DM management
25814158 en effect mellitus include dysfunction important complication system glucose important event glucose also important cell activity well function diabetic disease demonstrated type type can effect plasma include development may potential impact may influence may one may increase risk
25222163 en determine gestational mellitus large gestational age perform study use datum care hospital case woman insulin control control subject woman negative week estimate weight determined weight one high week associate adjust or confidence interval associate CI increase weight increased odd CI adjust gestational age time estimate weight age BMI week
25629058 en effect risk T2DM T2DM remain subject control T2DM T2DM patient perform analysis use impact evaluate multiple regression T2DM T2DM patient similar control group whereas significant increased observed T2DM T2DM patient compare control group analysis revealed high risk T2DM T2DM respective also significant association high lower may increase risk T2DM T2DM man lipid regard
25389531 en treatment type mellitus model mellitus DM contribute study clinical diabetic model evaluate effective assess new blood glucose datum clinical review model DM model use model
24169015 en patient disease type mellitus DM general healthy control recent function potential contribute development cardiovascular disease present study function investigate patient without DM evaluate disease blood assess use patient DM cohort mean age year patient DM great body mass index rate blood pressure without DM patient group show resistance on lower great resistance observed patient DM on analysis show positive association resistance resistance group analysis associate positive resistance patient without DM regression analysis adjust age body mass index show independent association resistance group result suggest role dysfunction however DM develop factor contribute impair dysfunction
25257687 en provide medical health health patient reduce assess reduce patient type mellitus management compare care study base status population one intervention group control group conduct analysis compare effective care per patient intervention period significant great reduction number occur intervention relative control group or CI or CI respective reduction day per patient per month relative care per day patient type three time day decrease day study finding improve health without general
26881237 en current study possible association factor gene gene patient type mellitus T2DM patient method T2DM subject control subject characteristic presence assess analysis perform use method perform use result statistical significant different diabetic patient control study demonstrated association subject T2DM however association test number presence presence present study demonstrated effect subject T2DM
26839896 en study clinical correlation mellitus review medical patient follow-up analysis perform compare hba1c level group patient among case known include one known two case one patient mean hba1c significant different patient patient can determined case patient glycemic control insulin therapy suggest
26788522 en estimate cause identify factor associate risk mortality among patient method cohort study perform hospital outcome time event hospital cause hospital regression use evaluate association ratio confidence interval result patient cause chronic renal hospital patient model renal increased risk addition condition increased risk renal disease increased risk mortality among patient cause mortality cause management decrease mortality
24965545 en may patient poor control result study evaluate diabetic control role diabetic patient undergo vs study result evaluate randomize trial included participant hemoglobin hba1c level high body mass index BMI level diagnosis type mellitus T2DM little month on without result primary outcome analysis hba1c without glycemic therapy assessment effect cell function perform baseline month patient month participant confidence interval CI group participant CI group primary odd ratio or CI participant similar weight patient vs lower level hba1c vs patient significant increase effect group group high effect group patient T2DM effective glycemic control year glycemic control high effect compare
21193740 en mellitus cardiovascular disease dysfunction associate protein determine whether activity correlate glucose protein type factor cell factor model type condition increased cell cell show group diabetic show increase activity demonstrated associate increased change increased activity may increasing
20206949 en factor cell normal plasma increased association risk cardiovascular disease adult type mellitus present study test whether baseline plasma cardiovascular disease outcome adult type mellitus trial mean age year duration year baseline hemoglobin plasma determined patient baseline result evaluate possible cardiovascular disease association plasma study cardiovascular disease outcome cardiovascular disease plasma significant associate disease adjust clinical risk factor ratio confidence interval CI event CI duration CI significant associate time first disease result suggest increased plasma may risk disease adult man type mellitus
24118693 en increased response rate effect treatment identify associate severe study perform patient subject week therapy early severe define determined patient develop severe similar response therapy vs vs history previous therapy vs patient develop severe old vs year lower baseline vs vs estimate rate vs high ratio vs logistic regression presence CI CI high ratio per CI lower baseline per CI independent associate develop severe occur patient receive therapy risk great patient high ratio lower baseline
24927611 en define plasma level patient impair glucose tolerance mellitus patient normal fasting plasma glucose level three group base oral glucose tolerance test result patient normal DM plasma level measured factor factor also fasting plasma insulin level determined result compare control group patient without disease DM perform use high lower found patient DM compare control level show significant difference according level impair group compare group on positive correlation DM associate compare control among patient disease correlate finding suggest DM may
23057380 en evidence suggest association blood group disease study investigate possible association mellitus hypertension type datum patient mellitus hypertension hospital healthy control individual datum blood group show level total cholesterol glucose blood pressure significant high female patient blood group group group on similar blood group healthy control although difference less
20799589 en assess status mellitus DM control aged year participant previous diagnosis DM clinical datum patient patient control target fasting blood glucose respective multiple logistic regression analysis show high age current lower level activity significant associate DM hypertension positive associate control overall rate control low general population
23298664 en study reported mellitus reduce overall risk examine association conduct study association mellitus risk different database perform assessment trial base perform use included study study examine different study study found association mellitus different relative risk low confidence interval CI disease CI compare high CI disease CI study suggest relationship mellitus different possible association
25410245 en increasing patient mortality development model study result diabetic significant case model disease study dysfunction finding cell mechanism on body finding subject demonstrated relative one diabetic within target within individual one dysfunction may several diabetic although possible multiple mechanism may therapy drug role multiple general drug may may effect review present current finding include system include system
27580332 en disease role include type mellitus reported recent year due high rate increasing investigate association group patient sample patient healthy control subject test presence blood sample also result show significant difference patient healthy group also patient control group sample presence significant number patient compare healthy control subject may consider possible indicate occur positive subject identify reduce
27043338 en include group disorder clinical although remain factor include factor disorder recent occur presence report case associate mellitus
26725915 en role diabetic patient
21232806 en function compare patient mellitus DM without mellitus on group patient undergo studied include DM patient patient rate analysis day day total high low low significant decrease compare baseline value group ratio significant DM group change group day DM group decrease compare day significant lower group index group show significant decrease dysfunction patient DM also without day activity DM patient compare day significant patient
27853064 en adverse effect general within two three month treatment therefore investigate impact glycemic control body period patient type mellitus method study patient patient receive week week change baseline body weight serum metabolic body evaluate result on total patient adverse event hemoglobin hba1c decrease significant body weight body mass index BMI also decrease addition decrease renal function body mass total body decrease significant mass change hba1c correlate baseline mass BMI improve glycemic control reduce body weight mass type diabetic patient without mass period level renal function renal respective
26649318 en two recent identify may function however association two function remain present study aim association level function assess possible correlation two previous diagnose type mellitus T2DM patient total body mass normal glucose tolerance subject previous diagnose T2DM patient included study correlation analysis use evaluate relationship two index function insulin resistance result show level significant elevated level significant decrease patient T2DM compare subject however correlation analysis show level correlate insulin multiple correlate positive insulin associate correlation observed level associate function previous diagnose T2DM patient
26206094 en mechanism change define study aim determine serum level group increase decrease level related type mellitus T2DM compare group subject group group control healthy subject group T2DM group T2DM without group included fasting blood glucose serum level result level serum found little group subject activity serum found elevated time group T2DM two time elevated group T2DM without group compare control reported reduce condition study group diabetic population level decrease cause increased T2DM
19158056 en review diagnosis management mellitus perform use identify patient major cause health result multiple mechanism include cell impair response effect insulin impair insulin management management although insulin remain care fasting body use oral therapy possible adverse oral use treatment mellitus population patient role treatment study need determine
24612564 en early finding association type mellitus T2DM population sample subject T2DM patient control significant patient control group logistic regression analysis significant association two T2DM association adjust age body mass index ratio two show significant association logistic regression analysis multiple suggest independent role T2DM significant association T2DM population known gene statistical present study can association T2DM population population study need profile associate T2DM
20885370 en index assess associate cardiovascular risk factor study reported index patient hypertension patient hypertension blood pressure drug use aged year man woman weight body mass index BMI ratio ratio ratio diagnose fasting blood glucose drug use index associate regression adjust age activity woman man man characteristic statistical associate confidence interval CI on negative among woman negative woman man high among population patient index
24888921 en blood glucose control important gestational mellitus known adverse effect due increasing prevalence recent year use different aim present diabetic analyzed use disease database woman disease diagnosis patient known type mellitus analysis woman drug treatment general perform different insulin treatment significant woman insulin within period increasing use without insulin lower within insulin treatment insulin increasing important remain treat due increasing regard effective insulin
17250506 en known effect present study investigate effect level patient receive therapy determine whether need patient age year range year therapy group healthy control age year range year group included study assess rate level determined group level different value however level significant increased group level significant increased respective significant difference group level level high patient control on positive correlation observed total level response normal patient need treatment normal response obtain increased level patient indicate increased cell
24020228 en compare characteristic type mellitus type DM without study assess whether characteristic development type DM prevalence type DM patient relationship clinical factor well chronic complication disease study patient diagnose type DM healthy health group target study clinical datum well complication define rate patient old diabetic woman high body mass index man obesity woman man complication include hypertension woman type DM patient without significant lower healthy participant associate woman type DM type DM patient without rate difference type DM patient well type DM patient DM without factor associate type DM patient study demonstrated addition potential associate type DM patient
23258460 en mellitus also large difference different potential medical present current type mellitus
22209597 en improve glycemic control patient obesity type may control metabolic well aim evaluate whether metabolic control patient obesity type T2DM week clinical trial patient age year mean year T2DM mean year range year oral reduction fasting glucose hemoglobin hba1c value high patient control treatment treat control patient vs reduction weight body mass index although significant reduction overall lipid profile decrease total cholesterol observed patient target show significant difference concentration blood pressure significant difference observed effective drug glycemic control also overall metabolic control hba1c lipid profile body weight
24947193 en risk factor development type lead insulin resistance on correlation reported rate incidence period two year increase incidence recent decrease number new case rate on correlation reported rate increase prevalence model use rate rate increase prevalence obesity rate population rate correlate less well rate increase prevalence datum individual develop factor also lead increase obesity according increase incidence type present
20381658 en although medical common clinical outcome current management however patient present mellitus DM also assessment management DM patient present evaluate patient event patient hemoglobin hba1c assessment month evaluate among patient DM recent hba1c level hba1c assessment among hospital range among hba1c level control hba1c control hba1c poor control hba1c patient poor control DM treatment without hba1c assessment hba1c rate ratio confidence interval hba1c rate ratio confidence interval similar patient DM hba1c measured receive DM disease management assessment chronic glycemic control high among patient DM occur hospital level DM control can care
22930815 en type mellitus significant mass cause investigate incidence diabetic
22801248 en aim study evaluate development renal dysfunction type mellitus T2DM treat different retrospective cohort study patient T2DM baseline serum little development renal dysfunction define great increase baseline year follow-up therapy group insulin compare change observed group high mean baseline hemoglobin hba1c respective high rate baseline respective compare group mean group analysis development renal dysfunction group compare confidence interval CI respective however difference development renal dysfunction significant group adjust baseline baseline great follow-up adjust baseline use system also associate development renal dysfunction adjust retrospective cohort study T2DM baseline use associate increased risk development renal dysfunction whereas different
21606455 en compare risk factor characteristic patient similar patient type mellitus type mellitus provide patient management research patient database patient aged primary outcome patient patient hypertension disease addition compare patient disease disease obesity history patient also old patient mean follow-up year rate year event patient rate patient finding suggest patient profile patient
25449140 en association type DM new reported medical aim present investigate gene type type DM gene one healthy control subject included gene base gene diabetic overall gene among control group significant difference diabetic control group show case significant difference diabetic high rate gene among population due high
27121185 en high hba1c concentration increased prevalence complication mortality method analysis therapy body treatment trial patient high hba1c concentration primary outcome change outcome change hba1c concentration concentration use incidence complication study perform study study randomize control trial patient randomize analysis body treatment according intervention follow-up patient type type one hospital trial study randomize control trial patient randomize analysis body treatment treatment show follow-up patient type primary care study study hba1c concentration negative age year duration year severe assess use hba1c concentration concentration blood pressure serum lipid concentration measured datum medical cause analysis reduce increase improve related factor compare body treatment treatment
23466100 en reported level patient insulin hypertension disease study aim evaluate whether increase serum total high weight level improve insulin female patient type mellitus study randomize trial per day on total female patient type change total high weight serum level ratio total insulin measured model assessment insulin resistance lipid profile evaluate week cholesterol cholesterol level significant reduce week treatment group compare group respective however significant difference treatment group total serum level well insulin female patient type week therapy serum total level
20683626 en cell lipid primary cell plasma target aim examine possible correlation lipid profile type mellitus study serum potential correlation cholesterol cholesterol cholesterol analyzed patient type healthy subject control patient significant high control serum level correlate negative multiple regression analysis show serum level subject type
19090602 en compare blood effect high healthy participant participant healthy participant man woman aged year body mass index BMI participant mellitus type man woman aged year BMI control high blood glucose response glycemic index confidence interval value healthy participant participant mellitus respective value significant lower control test healthy participant respective participant mellitus respective significant reduce glycemic index healthy participant participant control healthy participant participant significant difference among type although participant found addition reduce glycemic response similar healthy participant individual mellitus low possible may potential high
22883526 en study role gestational mellitus one adult model two group according fasting glucose day group fasting glucose group fasting glucose severe intervention group receive control receive test fasting glucose weight day serum level age measured level test statistical significant difference fasting glucose level among group fasting glucose level day mean fasting level severe group severe intervention group high control group significant difference severe group severe intervention group serum age level severe group group respective significant difference serum age level control group severe intervention group difference statistical significant serum age level severe intervention group group significant difference serum age level severe group group control group positive associate mean glucose level day cell number control group normal group cell decrease cell severe group severe intervention group cell reduce large cell cell control group severe group increased significant severe intervention group severe development associate increase serum age may important role reduce
19433776 en datum relationship disorder cardiovascular event effect type mellitus cohort study identify woman first first gestational hypertension severe adjust gestational age model also adjust development type mellitus hypertension disease event type mellitus risk hypertension increased range gestational hypertension range range severe risk type mellitus increased range gestational hypertension range severe woman range increased risk hypertension compare range woman first range woman risk range range range increased gestational hypertension severe respective disorder associate type mellitus hypertension independent type mellitus disorder increase risk cardiovascular event
19421965 en type mellitus metabolic disorder chronic insulin resistance relative insulin prevalence type mellitus large increase obesity complication type mellitus recent research insulin resistance insulin influence effect insulin cell change type mellitus new provide new treatment patient type mellitus review current type mellitus
18839053 en insulin resistance major type mellitus obesity disease several study possible role increased aim study determine effect plasma level patient type mellitus compare intervention patient new diagnose type mellitus follow month patient evidence baseline patient randomize two group group follow change group receive treatment BMI hba1c fasting glucose value decrease group significant difference observed two group group decrease increased significant decrease significant study group patient evidence significant different group patient intervention vs patient datum intervention plasma level BMI patient type mellitus addition effect found
24609291 en diagnose previous datum suggest mellitus DM risk factor may important early however association need determined number recent review association DM database estimate obtain cohort study mean effect datum DM individual study level relative risk determine relationship DM duration total independent study include cohort study examine overall CI can analysis risk great early diagnosis DM remain elevated diagnosis range less year result association recent diagnose DM may effect however presence also remain risk factor development patient DM need consider
19481431 en review datum regard change observed patient mellitus possible effective development change result hypertension hypertension cell hypertension may mellitus present index resistance ratio may diabetic patient known cardiovascular risk factor therefore regression treatment different drug different effect diabetic patient significant regression resistance drug system common finding one important mechanism development well clinical event patient mellitus system effective
18247076 en mellitus associate poor due high rate disease aim assess prevalence impair glucose tolerance mellitus patient disease analyzed datum study patient year diagnosis patient diagnosis patient group patient known patient without previous known oral glucose tolerance test perform group result patient impair glucose tolerance group group mellitus diagnose group group woman man reported less three time per week less current one patient undergo impair glucose tolerance effective test clinical patient diagnose mellitus high risk patient medical therapy patient include
25594118 en evidence association on type mellitus T2DM study study indicate health effect high activity evaluate association concentration incidence T2DM study identify adult participant reported T2DM adult normal health first sample analyzed total method logistic regression analysis perform adjust age BMI total odd T2DM time high confidence interval CI per increase level total model result logistic regression T2DM total analysis increase or T2DM time CI per increase concentration significant associate T2DM whereas total finding first study report association sample participant T2DM research large sample study
19787205 en hypertension mellitus important risk factor present study identify individual without hypertension mellitus contribute individual study population individual include subject control association study use determined method test logistic regression analysis well revealed three different significant associate prevalence individual without hypertension mellitus individual without hypertension on individual without mellitus on individual without hypertension mellitus significant associate individual hypertension mellitus condition subject base hypertension mellitus may important use
27042274 en according type reduce however little known role fasting glucose aim evaluate analysis patient type fasting total patient type within month mean age year studied clinical metabolic parameter evaluate fasting insulin analysis result two patient significant lower level vs vs vs compare patient two difference age duration disease parameter insulin however associate significant high level hemoglobin vs vs fasting glucose vs significant lower level vs present study suggest fasting important role type
23707958 en insulin resistance dysfunction lead type mellitus DM test whether risk factor DM dysfunction among old adult mean age year cardiovascular health study conduct evaluate risk factor found old age great high blood pressure lower cholesterol level high level lower independent associate great function association risk factor DM significant whether DM dysfunction obesity lower cholesterol level positive associate DM ratio confidence interval CI CI respective significant association lower risk DM dysfunction CI CI respective among old adult DM risk factor associate DM dysfunction clinical DM
19892839 en renal glucose result renal test potential treatment type use identify well clinical study also renal study show blood glucose model type clinical study duration show hemoglobin weight effect include increase compare increased evidence addition current type mellitus result clinical trial determine whether ratio new drug management type mellitus
23114385 en group effective among care regard several score score respective score group effective
19929992 en little type mellitus aim current study investigate whether woman type mellitus compare woman study woman without woman type mellitus index assess use woman normal type mellitus similar index vs adjust possible within group diabetic woman index associate duration similar two group woman vs vs diabetic woman significant association duration woman type mellitus associate however increase duration
22186659 en hemoglobin hba1c recent health association mellitus evaluate hba1c oral glucose tolerance test diagnosis DM hba1c DM subject study perform time participant subject hba1c range sample subject level subject diagnose DM found hba1c hba1c found impair fasting glucose impair glucose tolerance found hba1c respective associate metabolic characteristic hba1c DM population lower hba1c level complication study need may
26740637 en gestational mellitus cardiovascular disease however mechanism well examine parameter function important studied woman risk development adult study one follow-up mean age year follow-up reported develop woman regression model adjust factor BMI activity use oral history disease blood pressure lipid level woman impair vs vs vs vs great increase mass index body vs compare woman type independent associate increased mass impair function cardiovascular health intervention woman history may reduce risk
22775976 en assess patient type mellitus randomize study two on patient receive day hospital patient receive individual day general well show plasma concentration time compare renal low on fasting plasma glucose reduce mean plasma glucose reduce change serum insulin observed treatment result effect well patient T2DM reduction plasma glucose observed
25772444 en evaluate relationship insulin insulin insulin insulin different patient type randomize trial on cohort receive insulin randomize treatment period day response assess use glucose blood glucose target observed glucose rate profile follow effect mean mean increased increasing level on relationship demonstrated indicate on relationship also observed relationship indicate clinical potential according individual patient need
25042974 en disease lower condition high diabetic patient study assess patient associate study sample diabetic patient aged year primary care presence diagnose index independent clinical multiple logistic regression analysis perform determine associate low sample patient woman mean age on low confidence interval previous diagnose age CI CI associate multiple logistic regression analysis patient diagnose low although prevalence high among patient primary care old patient test population risk
21770477 en review recent evidence group research identify first time previous diabetic cause blood consider provide important new target intervention diabetic complication recent identify first new review provide new use previous treatment disease high diabetic treatment diabetic patient identify mellitus disease difference respective mechanism difference elevated occur may well age protein blood age increase related review evidence clinical study healthy diabetic patient model diabetic renal disease use mechanism treatment recent study patient type model define show drug activity cause use clinical include study review show treatment general effective diabetic development new use treatment disease recent clinical study use patient related metabolic disorder evidence mechanism disease target can well clinical
23108746 en common age low level associate high incidence type similar result type aim present study estimate status new case control study care hospital two new subject age year healthy control studied addition management regard metabolic parameter serum measured subject healthy control mean significant low subject control case severe compare control level correlate clinical parameter body mass index parameter serum fasting plasma glucose common
22800803 en major chronic disease associate increased lead multiple influence condition disease mellitus cardiovascular disease disease associate increased prevalence disease also evidence important role high group recent identify severe group protein function clinical cause multiple contribute cardiovascular disease recent reported elevated patient severe addition obtain patient type compare healthy patient chronic patient datum role development
22519446 en mellitus DM risk factor cardiovascular disease adverse multiple early current evidence associate development diabetic complication diabetic contribute lead renal diabetic well development diabetic disease impair cause activity datum role may contribute poor diabetic research role within well potential
19564582 en reported prevalence chronic great per reported occur common patient mellitus DM determine incidence prevalence whether DM diagnose clinical follow review case possible DM clinical diagnosis current association medical review patient woman man identify age year range year disease duration diagnosis month range month incidence prevalence patient also DM whereas control incidence prevalence chronic similar high previous estimate incidence similar within population mellitus DM major risk effect association DM may due diabetic
17644210 en study mellitus revealed number patient mellitus increasing development prevalence mellitus increase individual mellitus aged estimate total number patient type mellitus common mellitus old age patient type mellitus prevalence diabetic disease high mellitus mellitus disease disease disease disease mellitus without mellitus study demonstrated decrease activity activity function mellitus without mellitus patient mellitus treat randomize control intervention study use patient mellitus number patient mellitus increasing well treat mellitus function
26132997 en first drug glucose among patient type mellitus T2DM role treatment drug consider T2DM treatment clinical trial examine clinical trial patient T2DM use addition treatment significant clinical relative drug T2DM population primary renal function well patient potential weight clinical trial patient treat weight low risk event use insulin addition show reduce blood pressure may patient T2DM hypertension association association study management receive association clinical management
26001590 en type disease response insulin may also develop multiple syndrome type associate disorder follow disease condition previous study prevalence associate multiple present review report prevalence factor clinical associate disorder impact associate control general health also regard follow-up early management
19349325 en show analysis patient mellitus chronic associate hemoglobin hba1c effect randomize outcome compare hba1c time increase hba1c among patient syndrome randomize trial significant reduce hba1c month compare change baseline patient mellitus treat hba1c change baseline diabetic patient hba1c month compare less increase hba1c year ratio confidence interval reduce diabetic patient ratio confidence interval patient without mellitus baseline incidence new fasting glucose hba1c reduce ratio confidence interval reported increase significant improve hba1c patient mellitus reduce incidence increased hba1c without evidence previous mechanism effect
22890095 en contribute risk may factor aim determine prevalence diabetic individual assess effect on study conduct among participant aged subject age group group subject related risk factor fasting blood sample glucose subject use examine test positive indicate score respective according different on diagnosis define according prevalence disease diabetic high diabetic high prevalence diabetic diabetic diabetic compare without two factor study show prevalence significant high diabetic risk
24274772 en patient mellitus high risk event contribute complication time value may associate increased risk adverse cardiovascular event increased level common type present study conduct study level diabetic care hospital study perform hospital research review hospital study period diabetic normal control diabetic case identify patient review finding diagnosis perform diabetic diabetic history one year insulin diabetic control revealed hba1c range study datum analyzed test test cell less use statistical diabetic range patient whereas range mean value diabetic patient respective mean value diabetic patient respective test datum identify result statistical significant value value diabetic increased level relative compare patient
23927444 en mellitus type T2DM diagnosis T2DM may influence outcome cohort patient according presence diagnosis T2DM known medical history datum finding include obtain primary major adverse event define occur day study hemoglobin difference found group clinical characteristic define observed group group group mortality high group high mortality rate compare group follow-up day incidence high compare group T2DM diagnosis associate poor outcome
22359920 en metabolic cell decrease level activity decrease insulin activity decrease glucose cell indicate cell insulin occur lipid disorder lipid increasing concentration primary lipid change well system change studied index type duration disease system show development type
22099435 en gestational mellitus increasing early disease may case type on new develop model provide estimate health impact management model different woman follow management per woman per woman estimate lower prevalence intervention type incidence intervention per per intervention remain management ratio value current current finding range value include high value develop regard
27281072 en insulin however remain whether role development DM investigate possible association level DM study cohort conduct study within study risk general population study case patient DM follow-up period control DM case base age baseline relative risk serum level DM analyzed use logistic regression level significant high subject develop DM subject serum level positive associate hemoglobin hba1c glucose negative associate potential include body mass index odd ratio confidence interval DM increased serum level increased vs vs vs vs vs vs respective whereas odd ratio DM decrease serum level serum independent associate development DM indicate may DM adult
16715862 en mellitus clinical difference treatment patient low index BMI type diagnosis insulin therapy possible patient high positive history suggest presence type group patient case without history BMI treatment patient
17853330 en individual risk develop new diagnose mellitus current clinical value however clinical study evaluate new treatment type mellitus associate mellitus treatment mellitus need addition mellitus study investigate disease test clinical review current associate clinical value role diagnose associate mellitus research
21519731 en increase decrease level diabetic patient related chronic perform review evaluate relationship possible effect treatment intervention study include different demonstrated effect cardiovascular different population include diabetic patient study demonstrated effect according study decrease lipid improve function without significant metabolic control current evidence use high treatment complication
24072081 en complication important care aim study investigate diabetic complication related risk factor type mellitus study conduct type diabetic year age duration year included female mean age patient year mean duration year patient diabetic hemoglobin hba1c level study group respective patient diabetic hypertension rate respective risk factor associate hypertension high hba1c level duration diagnosis treatment hypertension well metabolic control important complication patient diabetic year
23975445 en complication major cause presence disease identify increased risk review assess test patient mellitus on database perform use identify study assess test clinical outcome patient mellitus study identify reported datum test test identify disease patient although evidence base diagnosis patient use test therefore patient assess on low patient
21689002 en previous result association protein cholesterol level risk disease type mellitus determine examine possible association T2DM studied patient patient T2DM control regression analysis indicate significant associate increased risk odd ratio or confidence interval CI T2DM or CI adjust logistic regression analysis effect age hypertension perform significant association found risk or CI patient association level total cholesterol cholesterol studied result present study revealed associate increased risk T2DM independent plasma level population
21679231 en assess prevalence lipid patient without metabolic study patient cardiovascular risk factor risk level lipid medication subject metabolic syndrome status also metabolic syndrome total cholesterol target compare without without metabolic syndrome respective cholesterol relative metabolic syndrome without condition per without metabolic syndrome cholesterol level compare condition metabolic syndrome level relative metabolic syndrome common common patient evidence lipid patient high prevalence lipid therapy addition therapy
19839533 en present large metabolic control patient mellitus receive treatment general trial aim assess parameter treatment patient care two total patient general care assess mean age patient mean duration year patient treat without use drug oral medication receive insulin therapy insulin oral mean hba1c measured patient blood pressure value on total patient treatment patient care significant lower treatment metabolic control patient mellitus receive care general common however indicate relative low hba1c treatment
27296394 en glucose level role metabolic gestational mellitus previous several study conduct assess association risk result however aim evaluate effect risk use database identify odd ratio or confidence interval use evaluate association risk significant association observed risk or CI or CI model or CI model or CI or CI respective however evidence provide evidence related risk study large sample result
23030242 en chronic common patient type mellitus T2DM study identify characteristic associate patient assess health status patient T2DM total patient patient without disease undergo clinical parameter obtain determine prevalence oral use level mean body mass index BMI patient significant high patient patient significant severe patient patient prevalence significant high patient compare patient patient significant lower prevalence patient patient general high high mean BMI poor health status high level lower level identify patient
26068548 en activity management type change include result may effective patient undergo study investigate effect tolerance glucose control patient randomize study patient undergo week body weight day plasma concentration glucose determined well one week patient significant vs high vs high vs great vs although patient without improve glucose control effect can group glucose control also effect glucose control patient
25212259 en aim study model cardiovascular disease risk patient new diagnose type two cardiovascular risk model model studied primary care health on cohort study perform patient new diagnose type old year cardiovascular risk factor event mortality significant estimate use model assess study risk risk study cardiovascular risk model incidence rate per cardiovascular complication age ratio hba1c blood pressure significant cardiovascular event on risk model develop use show respective respective risk develop model study first model risk patient new diagnose type
25518292 en fasting adverse effect health patient provide health patient adjust study outcome health care provide health type mellitus two group group provide health care health control group provide health care result weight blood pressure blood mean blood pressure well control group decrease mean blood pressure group decrease found patient group less incidence control group number patient group lower control group health care provide health result positive effect patient less blood level control fasting can patient health control blood pressure health care health care mellitus type
22069294 en type mellitus include protein studied three obtain day patient cell three cell include cell cell cell cell patient include cell positive finding protein role presence mechanism
18162509 en mellitus major metabolic complication renal insulin important role protein gene reported associate type possible insulin study investigate association gene renal total renal without previous diagnose cohort diabetic patient diabetic subject perform use prevalence patient patient patient association number risk reduction patient little one show decrease risk compare risk ratio effect remain significant age body weight type ratio datum provide evidence gene associate development renal
24089232 en fasting month year according fasting patient per day month aim evaluate impact fasting glucose possible complication fasting type mellitus conduct randomize retrospective study patient present day hemoglobin fasting plasma glucose plasma glucose weight value follow-up included patient fasting group patient group included study two group similar characteristic compare hba1c fasting plasma glucose body mass index weight adverse event evaluate statistical significant difference observed among fasting group difference value fasting can negative effect fasting glucose patient use medication adverse event observed increasing number patient
24842329 en gestational mellitus adverse outcome health known elevated body mass index BMI associate increased risk complication however little known role adult weight weight age current cohort study woman assessment weight association study study rate adult weight woman confidence interval CI CI woman mean adult weight elevated risk independent BMI age obesity status time study identify increasing mean weight relative low common weight woman high great risk odd ratio or CI or CI result indicate high adult weight may role woman
22435944 en assess effect cardiovascular disease event type diabetic patient intervention trial obtain patient aged year patient follow year determine effect serum cholesterol level cardiovascular event study according clinical need patient regard datum cohort study adjust clinical characteristic study use two method total follow-up period year follow patient receive treatment associate reduction cholesterol level total cholesterol cholesterol cholesterol first year result patient target level cholesterol increased treatment patient among patient cardiovascular event intervention disease ratio confidence interval CI CI method respective among patient event renal result diabetic addition cardiovascular event CI CI method respective cardiovascular event event decrease use lower cholesterol level patient type mellitus reduce risk cardiovascular event
22971508 en evaluate whether plasma previous reported significant correlation pressure early early ratio estimate rate patient type mellitus renal function
22312190 en recent study show mechanism diabetic cell important role chronic disorder disease whether cell remain evaluate role cell type mellitus concentration factor serum patient type mellitus normal control measured level blood cell examine found mean serum level lower diabetic patient normal control level significant elevated patient diabetic compare level patient diabetic patient healthy control serum level positive correlate duration serum level associate show significant change diabetic patient compare result indicate possible role cell may diabetic
23798074 en mellitus metabolic disease relative insulin impair insulin target oral health health care well metabolic control important overall health diabetic patient study determine relationship different patient mellitus patient mellitus patient without total group receive evaluate index index clinical level addition receive assessment according total period day result show significant parameter assess group regard assessment observed statistical significant difference among evaluate within period period day clinical patient mellitus type receive
18726873 en important cardiovascular renal type mellitus lead renal investigate system model type mellitus known diabetic diabetic without control studied age week age week assess oral week study plasma concentration plasma activity measured assess diabetic measured metabolic correlate concentration significant elevated significant reduce plasma activity significant reduce correlate significant significant high plasma level elevated reduce plasma activity effect show type model correlation diabetic suggest clinical
23810139 en mellitus major health significant research study assess among adult diabetic study among patient type mellitus diabetic care hospital assess use patient health test perform odd ratio or confidence interval CI obtain correlation test logistic regression determine adjust odd ratio confidence interval prevalence CI female elevated fasting blood level value significant high individual compare value on positive correlation value obtain score value diabetic high need assess possible risk factor diabetic patient
20970868 en analyzed datum use fasting plasma glucose hba1c among subject new diagnose hba1c group significant old age high woman lower hemoglobin concentration group high blood pressure fasting serum insulin study need determine risk complication
24376173 en on analysis evaluate patient type mellitus event analysis perform randomize control study therapy study adverse event event adverse event severe adverse renal function event assess incidence rate incidence rate ratio incidence rate adverse event due adverse event event similar treatment confidence interval incidence rate ratio include incidence rate per high control vs incidence rate ratio CI adverse event vs datum study profile
24201596 en mellitus cause dysfunction may response risk patient type mellitus hospital patient diabetic healthy control participant receive ratio little ratio little value hba1c correlation blood glucose control group diabetic significant difference age weight renal function characteristic T2DM patient control significant group T2DM patient control vs time also significant T2DM group correlation found hba1c value addition related elevated blood glucose patient complication increased risk compare without poor control increase risk patient T2DM
21872216 en previous research suggest use whether association examine assess association use change glucose level incidence diagnose period use glucose level status age range year baseline study use medication plasma glucose assess study case diagnose use diagnosis use medication base fasting glucose level use oral glucose tolerance test study diagnose high among odd ratio confidence interval however use associate follow-up high fasting plasma glucose level increasing glucose level time odd ratio confidence interval mean difference glucose change participant use three compare treatment use risk may
23363333 en period individual great rate mortality compare current whether individual type activity perform review current response individual type included review research identify subject three independent poor control type may impair reduce due lower blood response great compare individual without may blood glucose control found study examine response activity individual type may cause great level effect type response different associate change metabolic activity determine risk
24997826 en compare effect patient type mellitus T2DM disease T2DM patient group group level include body mass index BMI glucose hemoglobin insulin resistance fasting blood glucose fasting insulin serum well serum level measured week week BMI decrease group group increased group decrease group compare group level decrease BMI increased group level patient T2DM
24694876 en aim compare effect therapy patient new diagnose type mellitus study patient new diagnose T2DM receive primary change hba1c baseline trial included change insulin group significant reduction hba1c vs fasting blood glucose vs glucose vs statistical difference group glucose rate function significant improve baseline two group without statistical difference control reduce insulin function therefore therapy patient new diagnose T2DM
24522720 en consider primary treatment mellitus DM hypertension investigate status DM patient history patient metabolic disease patient study patient little one metabolic DM metabolic syndrome patient treatment DM previous DM significant less effective treatment DM vs vs patient DM less patient one two metabolic disease treatment vs vs patient treatment three metabolic patient group DM poor may due disease medical management
24292896 en patient medical increasing medication one one risk common disease increased care change however result reported positive impact risk change may due patient result clinical study compare two method risk result type mellitus T2DM assess patient method risk on total participant general randomize receive risk T2DM participant baseline three follow-up receive result overall participant reported high level test result participant receive result significant result review result statistical significant difference level among participant increased risk compare decrease population risk event undergo risk participant overall indicate receive result compare receive result participant receive result indicate result compare result without first study assess risk method test result high rate result suggest report may result result
22990538 en aim study investigate change occur subject type mellitus without disease influence condition sample obtain adult patient type mellitus healthy adult control group examine use different result show disease patient type mellitus significant increase number cell study diabetic subject present change compare healthy control suggest mellitus independent effect effect observed group consider independent condition
22971483 en investigate relationship serum level protein clinical metabolic patient type total patient female provide clinical datum blood sample analysis patient group according serum concentration independent associate blood pressure serum level estimate rate hypertension impair per significant patient high level low level increased serum associate increased risk hypertension impair adjust age body mass index duration may overall metabolic control patient type mellitus
22645960 en present study patient present hypertension associate type mellitus DM included patient mean age year two group group patient hypertension type mellitus group patient patient examine use analysis potential study demonstrated mellitus patient compare patient metabolic disorder include change patient mellitus high value duration analysis result two group revealed significant high potential patient type DM respective analysis show characteristic group patient type DM patient reduction influence
22384526 en insulin mellitus common type factor lipid profile hypertension potential risk factor mellitus protein role cholesterol high multiple mechanism relative activity major role aim investigate association gene lipid level type diabetic determined gene use method type diabetic patient healthy observed significant high healthy control compare patient vs also high control patient vs or CI association lipid level found significant high control group compare patient may factor mellitus can relationship lipid concentration two group large study relationship lipid parameter mellitus
21676418 en study evaluate whether high cholesterol ratio associate increased incidence chronic disease type mellitus individual type mellitus estimate rate great without cardiovascular disease baseline follow incidence diabetic diagnose diagnose estimate rate follow-up mean year total subject complication subject develop develop develop complication ratio positive associate increased risk independent age body mass index duration hemoglobin hypertension history cholesterol current use drug odd ratio confidence interval finding ratio associate increased incidence complication individual type mellitus without cardiovascular disease independent several potential
26681041 en study investigate type diabetic mellitus T2DM aged week control group per group obtain week blood lipid level measured week fasting blood glucose body weight time blood glucose insulin index assess protein measured compare control group blood lipid level group significant decrease whereas significant increased protein level group lower control group whereas group significant high control reduce blood glucose T2DM glucose tolerance mechanism associate decrease protein
26845015 en provide mechanism glucose use medication include insulin addition improve glycemic control general year provide reduction body weight blood pressure increase also observed on renal function patient on low incidence weight oral common therapy
17192724 en report analysis patient due two patient revealed two gene cause gene revealed analysis demonstrated whereas normal level measured renal cell protein observed revealed two two high provide important role function
21672377 en determine impact elevated glucose level outcome patient evaluate role mellitus risk factor study included retrospective analysis patient hospital may patient without history fasting blood glucose normal range define patient diabetic patient patient group according level mortality incidence complication treatment lower glucose level analyzed logistic regression analysis conduct risk factor outcome patient diabetic patient patient without previous diabetic group patient case case respective group patient case among patient level case compare group mortality significant high diabetic group vs group mortality present increasing level logistic regression analysis demonstrated diabetic group patient high risk patient group patient high risk patient independent risk factor relative odd ratio or confidence interval or diabetic group group respective incidence diabetic group significant high group vs group incidence event respective increased significant patient patient respective association diabetic group patient case diabetic group receive treatment insulin therapy case patient need insulin therapy patient mortality complication significant increased diabetic patient patient history mellitus influence blood glucose level history risk factor patient
24837144 en recent study indicate use decrease risk among patient type mellitus T2DM however influence therefore current study relative risk estimate use model evaluate use analysis perform overall estimate also analysis included study cohort study study use associate significant lower risk confidence CI total analysis provide result effect estimate overall analysis test present study use associate reduce risk patient T2DM need
24376190 en on study investigate relationship type mellitus value perform difference healthy individual value measured database study association result significant association decrease value total body mean difference confidence interval CI association value CI CI female year old value CI CI female CI value CI female value CI result suggest overall association reduce value influence patient age reduce value may occur early diagnosis clinical research study need mechanism decrease value patient
21382211 en recent study show high blood glucose value oral glucose tolerance test associate high rate complication treatment gestational mellitus reduce risk complication gestational mellitus condition diagnose disorder time provide treatment recent treatment gestational mellitus possible due evidence risk complication effective treatment result several recent study show early treatment gestational mellitus effective mean treatment possible reduce complication result gestational mellitus
24936731 en evaluate effect potential metabolic control patient type mellitus without clinical diabetic study patient less month diagnosis included test fasting perform three month treatment reduction mean level hba1c fasting glucose total cholesterol increase found study several show statistical significant difference analyzed treatment result possible use treatment condition system addition role glycemic control
24820066 en previous show diabetic can due aim present study evaluate activity protein diabetic mellitus week old control receive day disease use evaluate activity on decrease activity observed mellitus also decrease day decrease day present decrease change revealed presence decrease can diabetic finding suggest decrease activity result decrease general level normal diabetic
24547956 en effective treatment patient use treatment patient mellitus may complication therapy study aim effect patient randomize clinical trial diabetic patient control group treatment group group index include observed treatment month treatment assessment statistical significant difference found two group treatment regard statistical significant difference score two group treatment treatment score show statistical difference two group treatment
25420579 en assess use tolerance test determine effect plasma concentration insulin day patient new diagnose type mellitus day first perform treatment day day perform value time time patient plasma glucose decrease day treatment plasma also decrease respective value increased treatment decrease plasma glucose significant early reduction glucose may result effect plasma glucose treatment patient type
20004426 en presence diabetic increased associate high mortality type mellitus patient study therefore test associate insulin resistance type mellitus patient without insulin treatment on total type mellitus patient group group age year mean diabetic group year level blood glucose assess fasting plasma glucose fasting insulin model assessment index hemoglobin evaluate level body mass index high group group respective plasma level high whereas cholesterol lower group group respective fasting plasma glucose insulin concentration model assessment index level high group group logistic analysis revealed independent high insulin resistance result study indicate presence associate high insulin resistance patient type mellitus
23373309 en incidence mellitus increasing rate major health recent study suggest risk disease increased individual mellitus although mechanism remain large mechanism disease mellitus model show disease finding suggest impair insulin change can potential mechanism relationship mellitus model suggest presence disease addition also found plasma level increased glucose disease model can disease current review result recent study relationship disease can provide association
25502582 en diabetic syndrome complication mellitus DM risk develop can high risk patient type type protein previous investigate regard clinical condition study assess patient without
26523968 en aim current study assess among type mellitus compare obtain respective value conduct analysis obtain among patient hospital assess use assessment on analysis conduct reduce contribute total lower estimate total high found analysis age little different however need regard use
26473650 en identify compare model develop evaluate treatment type mellitus T2DM use within health assessment total common use database use also review identify new model assess use develop base characteristic related disease treatment assess number time model within report major new model identify review base datum similar model use regression use estimate complication develop risk factor assessment demonstrated T2DM T2DM model assess chronic treatment patient T2DM observed model model within follow research provide T2DM model develop outcome assessment use model related clinical new T2DM treatment
24879130 en mellitus DM potential impact treatment outcome study evaluate impact DM conduct retrospective cohort study case DM case identify datum analysis perform multiple method case DM status known case analysis case overall month DM group month group analysis DM finding use multiple method DM group datum suggest DM associate reduction risk study examine association impact DM medication outcome
24535009 en increased risk cardiovascular mortality compare outcome large clinical patient mellitus on retrospective cohort analysis use perform diabetic include ratio use model adjust characteristic datum drug use receive blood pressure datum subject follow primary mortality occur patient age year man cardiovascular disease chronic disease compare adjust confidence interval mortality mortality hospital cardiovascular overall cohort use associate adjust primary outcome subject history cardiovascular disease subject chronic disease use risk may increased disease use study
20634177 en determine whether serum perform diagnosis mellitus patient development retrospective review patient hospital mellitus serum current baseline on regression model use relationship development dysfunction patient characteristic include age type baseline serum concentration patient review man woman mean age year two patient type DM type dysfunction present patient baseline develop patient follow-up duration month develop patient respective associate baseline concentration great relative risk confidence interval female relative risk confidence interval influence patient value great respective serum patient mellitus concentration within range diabetic patient baseline concentration great may
22907518 en diabetic two complication mellitus case treatment care clinical according presence metabolic however treatment similar insulin present treatment low mortality rate
22851545 en dysfunction mellitus cardiovascular disease present study investigate whether dysfunction diabetic cell examine function compare change increased blood level factor whereas serum level function function
22632829 en clinical outcome patient mellitus disease undergo evaluate examine outcome diabetic cohort patient score undergo intervention hospital clinical outcome assess month overall significant high patient vs similar incidence patient vs vs vs respective however rate target major adverse event significant high patient undergo vs vs high patient undergo outcome year mellitus reported trial study associate increased major adverse event follow-up high rate target remain diabetic patient high
22045829 en effect renal function assess estimate renal disease studied trial type mellitus patient randomize aim analysis develop population model can reduction renal function time patient type mellitus model can rate on model influence rate model use time change rate decrease week treatment patient reduction rate can difference response patient treat large rate decrease compare patient week treatment mean rate baseline model datum change rate time
22646241 en mellitus DM management primary blood glucose concentration clinical on assess impact DM treatment previous diabetic impact DM diabetic on total diabetic diabetic lead score according impact analysis assess show high mean reported negative impact included reported negative impact DM use diabetic identify negative impact can use assessment parameter clinical research
22539806 en major target lead obesity study plasma concentration obesity mellitus cardiovascular dysfunction
22524702 en mellitus DM associate study determine whether associate diabetic use determine blood patient DM without DM without DM healthy concentration determined blood significant high patient control group high patient significant lower blood patient blood significant different however patient significant high blood significant high significant lower patient compare patient DM may associate clinical
24334502 en perform patient impair previous study reported outcome subject investigate whether complication rate total receive measured day evaluate analysis indicate compare group rate lower vs rate high vs analysis indicate compare group vs occur less vs vs cause diabetic model
21220735 en mellitus result great whether associate great whether mechanism cohort study man use effect mellitus body mass index BMI early mellitus associate great mean BMI age difference BMI similar within BMI man mellitus great confidence interval CI diagnose year age weight gestational age age assessment BMI BMI positive associate BMI association within BMI association BMI association within result also analysis analysis within year mellitus great BMI association mechanism independent BMI early
18998755 en first new drug treatment patient type type mellitus insulin cell decrease insulin blood glucose concentration relative patient type patient type mechanism similar improve overall glycemic control reduce glucose level reduce patient use insulin reduction glucose important associate increased risk complication increased weight independent risk factor cardiovascular disease general well adverse event decrease time treatment also associate cardiovascular risk improve treatment factor treatment patient use insulin
19515026 en little different type function gene result insulin result gene decrease activity result insulin gene factor insulin present month age mellitus insulin negative period evidence insulin three year age show on gene patient patient patient mellitus clinical negative gene result
20496315 en body weight management factor mellitus however obesity may provide role obesity study aim estimate obesity adult patient year different type
18981553 en disorder incidence present case mellitus due insulin gene patient found gene result protein protein cell subject need insulin gene important cause first report case important test cell dysfunction patient mellitus therapy
19957074 en studied incidence gestational mellitus investigate clinical woman gestational oral glucose tolerance test well year woman develop impair fasting glucose impair glucose tolerance compare woman remain year index index cell index use assess cell function insulin resistance estimate index insulin year woman develop glucose tolerance woman develop high fasting glucose hba1c remain also lower cell index index index woman hba1c fasting glucose well number previous history independent hba1c fasting blood glucose associate increased woman gestational mellitus risk identify hba1c fasting glucose value normal range on history previous increase risk
25482141 en clinical diagnose type mellitus T2DM evidence cell investigate clinical difference among positive vs negative time diagnosis time clinical review diagnose T2DM patient two group compare clinical characteristic datum diagnosis follow assess change parameter associate disease clinical diagnosis T2DM high rate high hemoglobin hba1c glucose level lower insulin concentration compare group group high body mass index BMI risk factor diagnosis difference remain time analysis revealed treatment effect BMI group estimate datum analysis revealed BMI blood pressure significant duration blood pressure change BMI change hba1c effect lipid profile risk factor status treatment present obesity show obesity status time BMI blood pressure lipid profile impact hba1c glycemic control effective control BMI need complication status
20537668 en elevated level protein associate dysfunction change role test elevated level correlate insulin resistance patient type mellitus subject included patient type mellitus group group age year mean group year analysis use analysis system develop study disease score assessment score high group group fasting plasma glucose insulin concentration model assessment index high group group multiple regression analysis show level independent score index result indicate elevated level patient type mellitus increased insulin resistance score index independent
19366302 en study conduct insulin insulin treatment type mellitus type mellitus T2DM assess result event research method model use year year T2DM clinical outcome patient vs cohort characteristic clinical trial datum hba1c baseline rate event major event vs per vs respective T2DM study datum hba1c baseline reduction event major event vs per vs respective major event analysis conduct rate included incidence complication ratio difference total total can can increased year can T2DM can can increased year can although associate lower complication result difference rate event study include use trial clinical analysis patient risk provide evidence vs T2DM role regard impact event need determine result different patient hba1c event rate
19683013 en recent reported severe obesity mellitus disease study investigate effect obesity one several day group group day treatment group severe obesity develop week age mellitus observed week age obesity mellitus severe group group increase body weight body severe model severe obesity mellitus also change on develop obesity complication without
23044503 en mellitus one common chronic disease develop develop major type mellitus type type insulin due dysfunction reduce insulin target insulin common result time blood disorder cause mortality diabetic patient therefore care management blood glucose control adverse outcome study demonstrated diabetic associate increased cardiovascular mortality general one three patient develop renal disease diabetic cause significant mortality hypertension major risk factor cardiovascular disease contribute clinical evidence suggest effective treatment diabetic diabetic however evidence indicate effect associate reduce renal function mellitus may report indicate renal function evidence potential control complication function hypertension
22982913 en diabetic cause renal disease diabetic patient mellitus evaluate renal diagnosis base clinical on renal disease reported occur patient estimate diabetic patient present aim analysis evaluate prevalence patient retrospective review medical patient undergo clinical diabetic duration less year hospital base finding patient group patient studied mean age year mean duration year included patient included patient included patient among patient mean age year year common among mean age year year common case among mean age year year mean group respective mean duration year group respective duration significant less compare study suggest prevalence high clinical renal diabetic diagnose treat first report prevalence patient
25724655 en provide review randomize study assess previous patient type mellitus T2DM compare improve glycemic control blood pressure treatment well potential new treat patient T2DM control management patient T2DM
25677947 en recent use base datum medical datum diagnosis whereas effective investigate present method use test mechanism improve mechanism method compare method gene statistical test conduct method index result method common method type mellitus DM gestational DM research identify risk factor disease according diagnosis reduce mortality rate cause DM
25662039 en present study effect body renal activity patient type mellitus T2DM on randomize trial study group patient T2DM perform sample week measured assess body ratio renal activity lipid estimate assess major respective parameter measured method T2DM patient elevated level compare healthy subject treatment significant improve renal consider important study suggest provide cardiovascular cholesterol effect patient T2DM
25650271 en association type mellitus type DM risk oral reported finding perform identify study may relative risk confidence interval CI model study assess use total study cohort study association type DM oral included overall analysis found compare individual individual type DM significant elevated incidence oral CI study analysis found duration follow-up significant positive association type DM associate increased oral mortality CI study study show positive association type DM risk oral significant found finding indicate compare individual individual type DM elevated risk oral development
22632827 en patient clinical outcome compare patient without therapy patient population high risk cardiovascular event increasing treat although patient clinical outcome patient without aim study identify clinical patient studied patient general hospital identify outcome patient patient cause without difference patient poor compare without presence important independent outcome population ratio confidence interval patient receive insulin therapy poor whereas receive insulin therapy similar patient without patient hemoglobin outcome whereas patient hemoglobin improve ratio confidence interval patient without although presence independent increase outcome risk insulin use glycemic control
26025572 en influence mellitus DM treat patient well study patient syndrome undergo intervention treat function assess use function one month overall population DM decrease decrease compare patient increase increase compare patient respective patient significant DM status vs diabetic vs diabetic patient difference observed patient analysis patient DM factor increased increase compare patient factor found DM treat high patient without DM diabetic patient treat drug treat patient overall lower patient independent DM status insulin trial
24664457 en aim study identify association gene gestational mellitus diagnose new group plasma level adverse outcome woman study included woman group woman normal glucose tolerance group according oral glucose tolerance test result base new woman treat control control insulin woman gene use plasma level measured significant group group plasma concentration significant lower group factor plasma level remain significant lower woman compare group group glycemic control significant high incidence analysis revealed incidence significant high woman potential outcome woman diagnose according new may correlate prevalence woman gene associate reduce plasma level adverse outcome
21304230 en syndrome disorder mellitus DM previous aim study clinical characteristic female present DM primary medical review metabolic profile study analysis perform include subject female DM development similar patient first DM
25703255 en protein important role insulin although association metabolic dysfunction well study relationship level risk gestational mellitus result perform investigate whether woman high level woman on total study woman woman included overall result level significant high normal control CI effect model however result indicate significant difference population analysis according age BMI demonstrated high level normal control finding woman increased level
24145589 en patient aged year high risk provide recent clinical patient type mellitus medication associate great number patient adverse drug event oral medication insulin common old patient assessment include review indicate potential patient medication reduce adverse drug event severe disease also cause hospital patient aged year patient also status patient risk early may patient function risk clinical effective patient target glucose level insulin use early patient reduce risk need medical need follow-up high level patient
26154088 en association type mellitus increase risk cardiovascular disease aim study evaluate presence study review medical patient follow age age diagnosis duration diagnosis body mass index BMI glycemic control determined hemoglobin hba1c total cholesterol lipid profile metabolic control use included patient female mean age year diagnosis duration year prevalence female mean age year diagnosis year duration year found high female correlation presence poor found high prevalence patient female target group chronic complication cardiovascular disease
26086714 en increased risk develop mellitus effect glucose may increased risk evaluate adult trial period determined significant reduce change plasma concentration treatment activity assess day test insulin tolerance glucose tolerance conduct day respective day compare treatment reduce significant reduce body weight activity significant compare treatment plasma insulin response glucose tolerance test less glucose tolerance insulin index significant result indicate oral may reduce insulin glucose need identify mechanism effect
26754418 en determine gestational mellitus first use insulin resistance risk develop weight total gestational week studied body mass index BMI ratio insulin index model resistance score determined method estimate possible association estimate use characteristic found BMI significant associate logistic regression analysis show three BMI remain independent associate or CI or CI BMI or CI score woman three patient week base BMI score weight may
27222172 en correlation rate blood glucose level patient disease total year age hospital receive blood glucose according baseline patient group group case group case group analysis relationship blood glucose control level total female patient significant among group respective increased group group blood glucose control rate total female patient also significant among group respective significant lower group group found positive correlate hba1c correlation analysis respective multiple regression analysis respective logistic regression show compare patient total female patient or value blood glucose control CI CI CI patient positive correlate blood glucose level increased associate increased risk poor blood glucose control control patient may blood glucose control
22056825 en increased blood pressure protein risk factor cardiovascular disease patient although management patient therapy report identify aim present study investigate change level patient type mellitus T2DM on total patient T2DM man woman mean age year hemoglobin group level group without level group level define reduce reduction reduction compare change group although group high level group without baseline difference adjust logistic regression analysis show baseline associate reduction odd ratio confidence interval datum suggest may related management patient T2DM
21939795 en prevalence adult high compare addition datum health indicate prevalence type mellitus great group compare datum disease control suggest prevalence type high compare vs respective although role increased prevalence type factor also contribute addition increased prevalence type evidence suggest patient population therefore less control glucose blood pressure lipid level individual type increased risk cardiovascular disease compare individual normal glucose level target factor development obesity early age development type complication include cardiovascular disease improve management type population increasing individual current treatment among
21668495 en identify may insulin also insulin resistance aim study relationship insulin resistance metabolic patient type mellitus patient type individual type healthy control subject study insulin level measured level found significant decrease patient type patient type disease compare healthy control subject serum level found significant increased patient type patient type disease compare healthy control subject level found significant correlate negative well individual correlate clinical role obesity associate disorder type however role cardiovascular disease need
24159007 en study test impact intervention patient type participant T2DM follow medical large hospital new randomize receive care assess baseline week clinical parameter obtain review baseline female low week statistical significant increase number participant intervention reported addition increase intervention result increase per day on intervention increased may result significant impact obesity among
23620061 en major age role complication known age studied type dysfunction complication measured plasma two cohort study study on individual type control study individual type measured plasma dysfunction evaluate presence high individual type without range respective associate plasma cell study on CI study CI CI study found association complication result suggest may dysfunction among individual without type therefore may potential role development disease
23918699 en improve glycemic control adult patient type mellitus indicate treatment adult patient type glycemic control oral drug insulin drug provide glycemic control clinical trial insulin week improve glycemic control effect general well adult patient control type treatment insulin week primary trial therapy associate patient control insulin show patient control therapy show similar patient control therapy clinical study datum analysis define insulin effective glycemic control adult patient type include patient management
26082067 en evidence indicate increased risk among type mellitus T2DM patient study base system system risk among T2DM patient total T2DM patient identify follow incidence ratio confidence interval reported overall risk found significant increased CI CI female respective regard risk significant increased CI CI CI CI CI CI CI CI CI CI female respective on significant increased CI significant increased CI CI observed female increased risk among T2DM patient
25875310 en although type mellitus DM may independent increase risk study examine whether risk among DM high examine risk among DM compare perform cohort study adult include DM included year old follow diagnosis patient diagnosis research mellitus identify use estimate risk associate DM use regression model adjust potential factor potential medical follow-up participant develop DM adjust ratio develop CI CI DM CI compare risk observed individual DM risk associate individual year ratio CI due DM CI year CI year DM independent associate great risk association risk association
25862998 en study disease system study type mellitus analysis diabetic respective
27368052 en type mellitus T2DM metabolic disease health recent study indicate important role metabolic T2DM effective mean provide health whether can improve metabolic profile T2DM aim study assess effect metabolic profile two review independent assess study datum evaluate risk included study datum use model mean difference confidence interval CI assess total randomize control trial included lipid profile fasting blood glucose reported trial model assessment insulin resistance index hemoglobin hba1c reported trial can CI can increase CI significant difference total cholesterol hba1c treatment group control may improve glycemic control lipid T2DM new method glucose management T2DM
27307429 en man type mellitus reported reduce number change insulin improve also reported glucose glucose level two period change low blood glucose reduce per week severe reduce per week per week reduce occur time important reported reduction impact patient associate low patient need change patient great include decrease reduce risk associate
27175938 en potential reduction blood glucose patient type mellitus current study examine whether can reduction blood glucose change response increased model group week multiple follow insulin week lead significant reduction blood glucose whereas increase blood glucose serum increased whereas serum increased reduction blood glucose remain however serum increased significant less protein elevated serum decrease also blood glucose reduction datum suggest may contribute
26338006 en type mellitus T2DM due metabolic mechanism use determine relationship metabolic measured sample participant T2DM year control year analysis score use assess relationship include index pressure T2DM high compare control metabolic T2DM independent associate metabolic profile associate T2DM participant suggest metabolic may T2DM patient
24993458 en evaluate effective care management assess change hemoglobin cholesterol blood pressure patient type hospital hospital perform patient receive care clinical patient receive medical care compare evaluate outcome care primary change baseline change cholesterol blood pressure number patient baseline care outcome study period show great change vs statistical significant different blood pressure receive number patient improve increased number drug per patient day decrease change significant vs day management may result lower cholesterol blood pressure patient health care
26498716 en mellitus DM high prevalence within DM patient control drug patient among patient DM base population outcome present review aim assess outcome DM patient review conduct randomize control trial clinical trial study include patient DM undergo included study included patient mean follow-up month overall complication rate follow-up analysis revealed age high body mass index high level related high incidence lead reduction patient treatment drug baseline follow-up DM patient similar general population perform patient glycemic control reduce patient population common adverse effect treatment
23842931 en investigate whether mellitus change two group control diabetic without treatment disease group three one three month follow-up respective blood glucose glucose hemoglobin insulin determined plasma period concentration lipid activity also measured group show high level blood glucose glucose hemoglobin significant lower plasma insulin level observed diabetic also show increased concentration compare show one three month follow-up activity significant reduce follow-up period determine increased concentration significant reduction cell may role diabetic chronic disease include disease
25434074 en aim present study compare correlation parameter patient type patient type mellitus patient two age group group patient mean age group patient mean age control similar group body weight measured according body mass index BMI ratio found positive correlation BMI diabetic patient correlation positive diabetic patient aged year found positive correlation BMI correlation correlation patient type aged year positive correlate parameter total body BMI positive correlation two parameter patient type aged year found positive correlation BMI positive correlation
24859164 en increasing risk associate drug include study examine association use use health research study cohort patient type mellitus identify case patient diagnosis cohort control regression model use estimate association use analysis conduct risk among current current adjust odd ratio CI similar result found analysis current adjust risk found increased significant patient disease disease disease high complication index score study previous evidence potential association use risk type diabetic cohort found disease use associate
23701262 en clinical trial assess whether can improve glucose subject type diabetic subject randomize trial subject receive two day change baseline mean glucose concentration interval drug significant reduce concentration observed period serum insulin concentration glucose concentration score decrease insulin difference total day significant decrease serum glucose concentration diabetic subject glucose associate decrease insulin concentration insulin improve glucose control occur general associate event
24919526 en assess therapy patient type control study week according response respective therapy period datum week reported total patient week treatment great decrease week hba1c hba1c lower significant difference CI CI hba1c reduction weight blood pressure whereas increased weight blood pressure difference CI CI respective week rate lower vs whereas patient event great respective year compare demonstrated great reduction weight blood pressure low rate however occur
22256413 en evaluate prevalence patient difference type type diabetic outcome disorder patient mellitus type type mean age diabetic mean year type mean year duration mean year compare mean year type diabetic common diagnosis type significant difference outcome disorder type diabetic mellitus type duration patient negative outcome finding provide evidence high prevalence patient adverse effect outcome
23121373 en assess association risk hospital among type receive drug without type treat insulin identify database drug hospital compare without use model adjust treatment medical use analysis age year total included hospital occur without respective adjust baseline characteristic associate significant increased ratio CI CI CI analysis associate great age aged type receive drug without insulin associate significant high risk hospital include related
21522001 en lead type mellitus T2DM patient therapy impact due increase response effect system early increase insulin early T2DM weight lead insulin T2DM individual weight follow-up T2DM base baseline cell review improve impact T2DM new treat T2DM individual therapy T2DM
23194084 en development treatment type mellitus T2DM study assess T2DM patient randomize receive week primary change baseline hba1c week included change baseline fasting plasma glucose patient hba1c week reduction hba1c reduction also observed significant difference patient hba1c level adverse event three event reported respective significant reduce week low risk T2DM patient control
23617411 en determine prevalence incidence patient type observed year diagnosis investigate role age care general study patient included examine diagnosis year year diagnosis follow-up year related age odd ratio logistic regression model incidence major CI CI per respective three prevalence CI CI CI analysis show association disease significant ratio CI ratio CI disease ratio CI ratio CI ratio CI impair ratio CI ratio CI woman risk increased age man risk high diagnose improve treatment incidence high patient sample man diagnose age year patient high risk
24840567 en type disorder remain poor potential risk conduct study risk factor patient type patient study undergo assessment risk factor assessment clinical use define similar previous report old patient cohort aged year baseline year assessment year normal independent baseline age poor included insulin therapy fasting glucose negative association diabetic study identify risk factor insulin therapy diabetic may risk disorder type risk factor previous report old patient difference related duration respective sample duration important impact disorder important risk factor
24199686 en use patient study assess therapy patient type mellitus T2DM study randomize patient receive treatment week adjust mean change hba1c baseline baseline difference significant patient hba1c target vs difference fasting plasma glucose reduction patient baseline hba1c reduce hba1c baseline difference significant patient hba1c target vs well low incidence high vs clinical weight significant improve control patient T2DM control addition well low risk weight treatment patient patient baseline hba1c
27468544 en provide clinical evidence treat type mellitus T2DM new treatment analysis use evaluate treatment T2DM clinical case patient T2DM effect treatment evaluate change fasting blood hemoglobin hba1c blood lipid profile body mass index BMI month change also evaluate related factor significant mean hba1c month treatment compare baseline level also significant blood lipid BMI also improve syndrome patient T2DM use clinical related age BMI DM duration level blood glucose use study suggest can decrease blood glucose improve T2DM reduce body weight use may indicate new treatment T2DM
27308647 en disease one common chronic disease aim study evaluate population diabetic patient regard study included type diabetic patient randomize evaluate assess assess use value use obtain patient use value significant found patient significant found patient diagnose patient diagnose found type mellitus patient on significant increase found patient assessment type diabetic patient perform identify significant
27082868 en mellitus DM type disease research disease duration cohort investigate influence DM type disease duration function year subject develop perform significant poor test significant effect DM type presence lead significant test time change individual found disease DM type function early may lead DM type consider condition may model condition
23849767 en gene gene associate obesity individual gene lower blood pressure independent obesity study aim investigate association index type mellitus among individual man woman hypertension use drug mellitus diagnose according association body index lipid index body mass index BMI analyzed use analysis on on positive association BMI observed overall sample among man woman associate woman man found negative association association age positive association BMI woman negative association mean blood pressure man hypertension
17720351 en primary study assess compare mellitus patient healthy adult study conduct patient mellitus diabetic general hospital healthy adult participant use total mellitus use result show patient mellitus significant healthy risk factor chronic complication treatment parameter level factor mellitus mellitus improve among general study major diabetic health primary healthy population general high risk result can study evaluate patient general mellitus
23608331 en investigate effect gestational diabetic mellitus model gestational mellitus model group group group group normal group day fasting blood glucose level day respective serum insulin level fasting blood glucose level serum insulin level significant decrease gestational treat compare model group can decrease fasting blood glucose level serum insulin level improve
26548423 en primary glucose renal glucose new oral drug increasing glucose reduce risk decrease body weight blood pressure type review clinical trial identify use potential mechanism glucose reduce glucose insulin well increasing effect effective hba1c reduction similar profile study first assess T2DM development treatment patient positive result study
21059088 en mellitus may associate mass condition may also role assess body change associate old adult one adult aged year examine factor medical condition body baseline year body change compare participant without regression use examine relationship mass mass man two time man without vs woman time without vs year man also high total body mass high total body man without woman high total body mass total body similar adjust age body mass index condition factor total body mass remain independent mass man associate high body mass high mass old adult man also associate total body
21916932 en review mechanism gene condition clinical mechanism condition cardiovascular factor important role insulin gene obesity mellitus type independent risk factor disease type diabetic patient insulin resistance metabolic disorder therefore increasing level may type great value mechanism gene condition include condition include obesity mellitus type level
24581888 en case related severe type patient reported due relative age subject assess report three type case patient duration year patient severe parameter control assess function also measured assess revealed low three patient subject metabolic control chronic complication found parameter within normal range first time demonstrated low type patient may contribute increased risk severe patient duration suggest perform diagnosis patient severe investigate use diagnosis
24918789 en glucose develop type mellitus profile week assess use analysis datum study range patient T2DM mean age year hemoglobin hba1c body mass index estimate rate mellitus treatment included adverse event datum assessment lipid overall incidence similar incidence study low group associate high incidence general consider lead associate reduction estimate rate baseline assessment period incidence low group increase incidence patient incidence severe low group incidence low overall patient high relative change cholesterol increase cholesterol also associate change parameter clinical therapy general well patient T2DM control current mellitus treatment
24886175 en datum development insulin mellitus study investigate whether model result glycemic control
24884787 en include use treatment type mellitus T2DM protein effective elevated insulin however effect treatment serum level T2DM T2DM patient aim present study examine effect treatment serum level T2DM T2DM randomize control treatment group treatment group serum measured glycemic control hemoglobin significant improve treatment control group serum level significant increased group without change body mass index serum level control group T2DM patient serum level elevated treatment without change body
24715197 en new therapy patient mellitus reduce compare population addition disease diabetic can also factor patient mellitus can cardiovascular control on reduce rate rate can addition reduce also can prevalence rate can increase age patient year old mellitus type patient mellitus type disease use cardiovascular test therapy possible
23363297 en known blood pressure treatment clinical significant diabetic examine factor patient type mellitus T2DM diabetic use multiple regression analysis risk factor factor diabetic patient group subject without group use studied duration T2DM group year year respective statistical difference mean duration age body mass index BMI hba1c serum rate two group significant high group group whereas significant lower group group patient group receive drug hypertension significant difference group revealed treatment significant positive BMI significant negative significant correlate review multiple regression analysis revealed addition factor among risk factor reported previous patient T2DM
20603149 en role cell present possible target investigate impact characteristic cell type mellitus healthy type diabetic individual measured treatment sample result indicate increased type correlate increased however previous report suggest characteristic investigate therefore treatment type mellitus may major effect overall function disease
23278282 en major evaluate mellitus profile obtain patient respective addition concentration high diabetic patient independent assess significant lower concentration patient little one lower compare population influence concentration concentration ratio effect subject large sample subject
24767369 en aim study investigate prevalence clinical characteristic management mellitus retrospective analyzed medical patient month year old undergo medical patient follow-up follow-up study among develop interval time day range day year whereas patient age diagnosis year range year insulin treatment reduction without high effective mellitus patient
22094149 en patient type mellitus T2DM associate cardiovascular risk factor increased risk large intervention study glycemic control show reduction cardiovascular event T2DM patient two major study weight severe intervention can potential effect glycemic control weight diabetic patient change drug improve cardiovascular risk factor include show early T2DM large patient decrease mortality treatment T2DM hemoglobin value aim need
26666153 en mellitus independent risk factor medical perform diagnosis use type treatment use therapy improve therapy risk reduction blood control
25906652 en high prevalence type mellitus DM disease contribute research aim improve treatment datum patient type DM patient type DM research revealed significant change patient type DM patient group increased characteristic characteristic
24918792 en cardiovascular disease remain major cause mortality patient type mellitus T2DM disease T2DM include cell cell new review disease T2DM potential effect risk patient T2DM study analysis clinical trial datum suggest may effect effect whereas may due analysis major adverse event occur clinical development found increased risk event mortality potential reduction event two large outcome trial report increase decrease adverse outcome patient T2DM disease high risk adverse event patient group group similar increased risk however risk significant great compare may increased risk T2DM
24885742 en disease type mellitus remain disease management diagnosis diagnosis
23728366 en show impair patient type mellitus type DM hypertension improve treatment examine patient type DM hypertension improve period treatment estimate ratio effective on use pressure obtain function evaluate use total patient included patient datum patient control hypertension patient follow-up reduce however also reduce patient present study treatment improve function patient hypertension type DM control whether due reduction pressure diabetic
26961236 en glucose lipid diabetic cardiovascular disease although lipid diabetic patient reduction cholesterol important cardiovascular disease trial recent show diabetic patient low cholesterol level new develop great reduce cholesterol independent large independent analysis study indicate diabetic patient show similar response patient overall low rate effect diabetic patient lead increased rate new although datum study analysis cardiovascular event datum outcome study patient high risk significant cholesterol target value possible therapy outcome datum
26750162 en study previous medication medication study test type mellitus patient on sample patient test use correlation test compare score patient group control show significant association found medication control effect can research
22784926 en primary aim general type treatment improve hba1c aim cardiovascular risk factor treatment health treatment management intervention care control intervention medical patient result type diabetic patient assess baseline month primary outcome mean change hba1c month patient baseline patient month follow-up primary hba1c outcome CI intervention CI control group group control index blood pressure lipid month receive treatment month month identify treatment patient use insulin management improve hba1c patient type
22895968 en also use medical treat type mellitus study possible role assess effect type database among included control trial compare control intervention without independent datum risk trial evaluate use parameter outcome datum potential on perform datum use intervention similar test control trial three month duration investigate participant risk trial two study general high two compare effect different control type mellitus statistical significant difference control compare compare also significant change parameter control adverse effect reported trial trial investigate cause evidence effect type mellitus study therefore control medical therapy trial evaluate effect need clinical
22179701 en study conduct investigate mellitus DM according type patient DM undergo may change fasting blood concentration oral insulin compare patient undergo total respective DM patient patient patient patient patient DM improve patient patient patient patient patient DM rate high group group vs DM rate high group group vs patient DM receive show DM group high DM rate group group high DM rate
22498999 en mechanism high risk diabetic patient remain aim investigate according diabetic patient first included two cohort analyzed study perform month year clinical follow-up perform diabetic patient cohort cohort diabetic patient cohort significant increase function baseline year parameter according diabetic status three time function analyzed cohort ratio high diabetic patient baseline follow-up mellitus independent cardiovascular cohort relative risk cohort patient treatment mellitus remain major independent high risk associate decrease function increased evidence high pressure suggest dysfunction potential mechanism
25450812 en type mellitus cause gene individual factor obesity result chronic due insulin resistance impair glucose tolerance lead increased activity increase protein body cell insulin diabetic complication cardiovascular disease evidence suggest influence development diabetic complication cell low potential cell however study reported effect studied include population
24658227 en mellitus DM new method DM base on use mean two healthy DM result show healthy DM sample use healthy DM
25614281 en gestational mellitus increased risk cardiovascular disease mechanism gene change response control function cell condition target investigate effect target gene
26950285 en investigate patient type study patient type method use early treatment diabetic study use diabetic test difference use according level age duration year year respective participant mean respective patient patient level well patient level patient treat one significant lower compare significant two patient difference
21195359 en woman study population care difference glycemic aim present study assess whether treatment glycemic cardiovascular risk factor control old female patient type mellitus retrospective study datum analyzed old aged year female patient T2DM medical difference hemoglobin level assess primary outcome well blood pressure respective assess outcome adjust age duration duration insulin treatment body mass index insulin per per day cause value adjust use analyzed female patient T2DM regression model woman significant high level logistic regression model revealed woman significant less treatment blood pressure cholesterol level study old patient T2DM whereas glycemic control woman man adverse cardiovascular risk factor profile observed female patient
21195357 en difference management type mellitus T2DM woman great increase cardiovascular mortality aim investigate influence clinical care complication patient T2DM study metabolic control cardiovascular risk factor diabetic complication well medication use treatment evaluate patient age duration body mass index study included age year T2DM history presence disease patient follow one patient T2DM woman man woman T2DM high mean blood pressure vs man total cholesterol vs man lower ratio vs man man woman hemoglobin woman duration year receive oral therapy less woman disease duration hypertension vs respective similar rate man woman intervention vs respective woman also high rate man vs respective receive less man great overall cardiovascular risk woman vs respective study woman T2DM cardiovascular risk profile less man treatment improve woman may need treatment cardiovascular disease present
21059095 en examine difference patient type mellitus without patient mellitus without control subject age studied diagnosis base function test subject undergo parameter measured use analysis mean mass index index index assess high patient control subject vs patient without vs difference found interval studied group regression analysis subject age BMI blood pressure duration hba1c lipid insulin resistance demonstrated significant independent association presence parameter rate increased patient type suggest increased associate research evaluate role cardiovascular risk patient
20865240 en contribute increased present study evaluate whether individual type mellitus oral treatment improve participant type control evaluate month estimate two different use respective rate assess vs range vs reduce type group compare control whereas increased vs control finding increased vs vs increased participant respective decrease plasma observed associate increased study determine whether treatment effect cardiovascular cardiovascular number
24588963 en use increase glucose activity glucose identify increase glucose glucose reduction study compare treatment glucose activity study significant decrease blood glucose level evidence risk addition parameter study therefore development potential treatment type
21949161 en may lead control hemoglobin level blood pressure cholesterol level hemoglobin improve outcome patient mellitus DM retrospective cohort study analyzed patient elevated hemoglobin treat primary care hospital relationship define medical time hemoglobin control patient week vs month time hemoglobin less vs month receive insulin vs month receive insulin time lower vs month time less vs month respective analysis time lead increase time hemoglobin receive receive insulin target time control decrease increased week target respective medication care week associate hemoglobin target patient mellitus
22437218 en evaluate health renal patient type mellitus retrospective analysis use medical datum large health care patient T2DM aged year month define first evidence T2DM serum test period included renal prevalence determined datum compare prevalence identify renal use estimate rate analysis conduct examine association status total health care patient T2DM value evidence datum use prevalence determined datum time high prevalence determined datum due compare patient without patient vs vs vs period patient high total health care compare odd ratio CI compare health care independent associate increase severe T2DM associate high health care
22189486 en activity improve reduce risk disease type mellitus general population individual type activity improve glucose lipid level reduce weight improve insulin resistance type mellitus however activity less poor evidence effect activity control complication significant risk review activity health type examine effect number outcome include control lipid blood pressure diabetic complication overall mortality evidence activity management type duration whether outcome examine
25112234 en evidence base insulin therapy type mellitus T2DM however recent randomize control trial compare treatment multiple insulin patient poor control T2DM show control therapy
26458375 en prevalence type increasing treatment current therapy increase cell mass may present report factor cell whereas datum cell recent glucose insulin resistance cell new target drug development treatment mellitus finding review present clinical datum possible role
22746353 en new insulin use patient mellitus aim study evaluate patient use patient patient cohort different
22580743 en model study metabolic disease type mellitus due cell study gene type mellitus addition assess associate adult determined rate rate significant high rate relative high cell normal base datum gene control cell two three analysis one protein disease model may study target type mellitus
23106308 en important model insulin glycemic control complication associate function however effect multiple insulin effect insulin studied diabetic use insulin use incidence adverse event complication event study found high insulin result similar glycemic control insulin adverse event reported insulin insulin can rate insulin insulin therapy blood glucose level diabetic study
20390390 en mellitus DM disorder perform disorder system DM review base sample use assessment overall primary study indicate individual type DM individual type DM type population diabetic population high similar reported population individual major model disease DM major disorder common observed system insulin resistance well provide condition provide disease treatment development disorder
26981541 en study aim evaluate effect early lipid profile fasting glucose risk gestational mellitus patient body mass index determine value different range on retrospective system conduct total without included participant individual use medical logistic regression analysis characteristic analysis use analysis outcome show potential include early lipid profile cholesterol cholesterol ratio cholesterol ratio fasting glucose fasting glucose level effect value factor according risk assessment patient development
26333303 en aim study investigate estimate weight gestational mellitus time compare result healthy total woman week included study patient two group base oral glucose tolerance test result study group woman healthy woman control study group mean however mean significant high group control group found significant study group week time gestational suggest may role gestational
20700575 en review impact disorder conduct study investigate adult year old mellitus study diabetic patient disorder without identify potential database primary study examine rate medication total increased effect patient disorder compare diabetic patient without mean difference health increased group health result regard reduce rate diabetic patient disorder statistical study high range overall effect therefore reported study included regard sample assessment disorder well assessment increased use disorder patient major research
23330247 en case type mellitus cause factor cell several include insulin review study patient type mellitus include result study conduct study group insulin therapy study analyzed on patient identify individual also on show several development however result test demonstrated patient significant high patient develop disease year old patient identify gene may examine relationship study also identify factor associate lower incidence disease individual
23304942 en mellitus common medical disorder contribute review aim health care health current evidence management mellitus well datum include related factor also value fasting plasma glucose lower increase complication mellitus occur mortality associate condition reduce management care early care oral glucose show first found result insulin mellitus management may include oral improve health
23155606 en activity health contribute increasing lower without chronic aim study examine difference related health patient mellitus DM type age type perform study clinical health group patient DM type man woman age year group according age interval health health relationship general datum duration value blood glucose hemoglobin patient disease therapy impact activity presence statistical analysis test use one duration DM type year patient receive disease oral use insulin oral drug insulin patient therapy activity perform without patient can perform activity patient DM type significant lower health health influence level found common hypertension chronic cardiovascular disease impair elevated blood lipid value hba1c group group without subject low assessment group without health vs health vs vs vs mellitus type negative influence contribute presence associate high hba1c value difference assessment regard age type therapy use assess low patient however characteristic role
22387701 en weight obesity development mellitus may also role several study demonstrated association body weight however within range obesity present study examine relationship range BMI insulin addition group patient mellitus examine relationship BMI insulin glucose hba1c cohort subject patient mellitus significant increase BMI insulin observed change level increased significant BMI insulin respective patient type compare subject BMI insulin age level significant early weight can development insulin resistance resistance increasing weight obesity range present datum role similar resistance
21798988 en individual mellitus DM high risk develop clinical early diagnosis dysfunction intervention patient study assess prevalence DM patient without known disease dysfunction perform clinical patient year study define identify range time datum obtain patient patient patient high mass relative prevalence patient present DM patient without clinical disease associate patient level
22396235 en mellitus type statistical associate one two disease review use control population base study type high incidence compare patient patient high incidence type however finding first important care include disease also present
22330802 en type chronic disease cause cell cell mechanism cell intervention effective treatment cell protein on factor multiple function include research investigate whether treat mellitus effect observed result reduction incidence increase insulin can also increase serum level addition treat observed treat result suggest effective treatment mellitus model
23600438 en compare result woman man investigate effect mellitus DM difference risk disease woman man low risk score year subject undergo blood test test similar change lower also significant high score score difference score man lower score man woman DM lower risk assess study risk significant high man subject man whereas woman result study suggest woman DM high man risk may
25737033 en incidence type mellitus T2DM among old adult examine range risk factor large cohort adult aged sample general population follow year T2DM baseline follow-up T2DM determined T2DM baseline T2DM follow-up on range risk factor include characteristic health status history examine baseline multiple logistic regression use potential T2DM age reported history T2DM test potential effect without T2DM baseline reported T2DM follow-up incidence year incidence rate adjust risk factor old age high relative lower medical history hypertension history T2DM significant associate high odd develop T2DM hypertension T2DM among old adult risk factor T2DM can identify population develop
21105550 en prevalence individual health care patient disease management mellitus medical care disease use care reduce health care hospital health care need patient disease increased datum use estimate prevalence mellitus DM datum prevalence year regression DM prevalence disease management overall DM prevalence suggest prevalence diagnose DM respective disease management reduction health care hospital factor DM remain new case DM year need effective disease management increased level among patient
20977574 en type mellitus insulin resistance insulin cell current research cell dysfunction type however remain clinical need cell function individual oral use type drug improve insulin also within cell show cell glucose insulin insulin gene show review mechanism cell function type mellitus current
20358156 en study aim compare base two different group type mellitus patient control hba1c level study patient type mellitus base hba1c level mean score compare analysis use obtain adjust mean score age duration type patient type mellitus woman man mean hba1c level compare two group patient different hba1c level adjust mean health function general health function health significant two score type mellitus patient also lower mellitus patient poor control lower mean score function general health function health score patient also lower population
19307472 en population mortality woman mellitus may increase mortality rate compare examine change cardiovascular disease mortality rate among study participant early time period mellitus define glucose fasting plasma glucose treatment among woman ratio mortality early time period confidence interval without mellitus confidence interval mellitus similar result observed man among woman man cardiovascular disease mortality among without mellitus disease mortality among woman without mellitus whereas change observed among woman mellitus among man without mellitus individual without mellitus increased risk mortality early time mortality among woman man mellitus occur time however mortality rate among individual mellitus remain high compare individual without mellitus
20963449 en study examine glycemic control patient type mellitus control treatment randomize study on total patient randomize receive week treatment time treatment remain primary change hemoglobin hba1c baseline week change fasting plasma glucose plasma glucose serum insulin treatment group show significant great reduction hba1c level compare group adverse event occur similar group result study indicate significant improve metabolic control patient type mellitus well therefore may therapy patient type mellitus control treatment
24498803 en significant activity aim review assess glucose effect database database conduct may on total study examine review randomize control trial assess use among study result glycemic control found studied activity show result however use treatment
21113729 en study prevalence subject type mellitus influence diabetic on conduct among patient type mellitus diabetic use assess use diagnose presence first sample define less duration score assess score consider prevalence subject without vs woman vs prevalence duration high subject compare without vs mean age woman subject high without year vs year woman subject high risk diabetic analysis related also influence complication due diabetic need negative two group
21617111 en multiple test use diagnosis management patient mellitus evidence use use analysis patient on new system develop overall evidence on response review clinical addition base plasma glucose diagnose increased hemoglobin hba1c concentration blood glycemic control perform patient plasma blood glucose analysis hba1c potential role glucose insulin provide base datum several found clinical value present time
26125248 en aim study body mass index BMI year diagnosis type mellitus T2DM BMI man diagnosis T2DM use analysis on method use individual BMI year diagnosis mean BMI diagnosis confidence interval compare man condition diagnose man diagnosis mean BMI year diagnosis significant increased BMI also increase BMI year diagnosis rate change mean BMI among man T2DM diagnose recent two increased interval diagnosis significant difference among man diagnosis BMI diagnosis also significant age BMI year T2DM diagnosis increase BMI among relative man diagnosis recent T2DM BMI consider potential effect
26071140 en treatment type mellitus patient early review management type recent datum randomize control trial week significant improve control reduce patient control type oral drug effect year treatment patient receive one addition provide control insulin insulin less effective patient treat general well low risk common adverse event event treatment management type patient system
21156716 en aim study compare outcome patient without datum patient undergo on patient consider diabetic reported use medication diagnosis define first fasting glucose serum concentration glucose early adverse outcome define major rate significant high diabetic patient compare control analysis show significant association presence rate or CI patient great risk
21144786 en major cause mortality subject mellitus present study aim compare change mellitus period develop effect diabetic group also response test week compare change investigate age control group significant found group undergo treatment group undergo treatment relative diabetic group group vs change significant increased diabetic group group compare control treatment diabetic group significant improve decrease show effect change study compare observed case period demonstrated effect
25688991 en aim study evaluate association factor type DM obesity compare effect DM among population year old datum aged year study adult health research study conduct DM define diagnosis weight measured status assess overall prevalence DM range on increase ratio associate significant time high odd DM respective significant association observed DM associate significant high status model adjust chronic condition associate model on studied old population DM obesity may factor DM among old population DM among old population may contribute reduce
21059972 en study aim assess intervention activity hemoglobin level cardiovascular risk factor patient type mellitus patient T2DM metabolic syndrome randomize age treatment resistance group vs control group month included hba1c level primary cardiovascular risk factor disease risk score mean metabolic per week significant high total vs control group compare control group significant mean difference confidence interval hba1c level blood pressure cholesterol level body mass index insulin resistance risk score parameter improve intervention effective hba1c cardiovascular risk profile current activity cardiovascular risk factor suggest need large subject trial
25410470 en index reported correlate glycemic risk however whether can type mellitus DM aim assess value DM population cohort cohort study conduct base follow-up general population subject undergo health subject analysis DM diagnose baseline body mass index BMI cardiovascular risk factor baseline ratio DM incidence estimate model test use whether statistical difference two individual develop DM follow-up year risk DM increased increasing level adjust BMI CI CI CI respective however test show statistical difference among can independent DM study population although high BMI study clinical however study base different group need perform
21922455 en increasing evidence cell can use disease include type mellitus aim present study cell blood new diagnose cell cell assessment protein function perform use cell significant high compare cell treat difference diabetic control however found gene level function diabetic control assess level gene cell diabetic control effective
26168189 en investigate whether factor type associate different level renal function patient type patient according level renal function estimate rate control group renal dysfunction group severe renal dysfunction group factor plasma level determined activity determined factor level increased patient severe renal dysfunction compare control group level also increased severe renal dysfunction group control group activity increased severe renal dysfunction group compare control group significant difference observed among group regard ratio level ratio reduce patient severe renal dysfunction compare control group level increased patient severe renal dysfunction compare control group also high patient severe renal dysfunction compare renal dysfunction group similar result found increased factor level decrease level ratio associate renal dysfunction patient type suggest dysfunction associate type
25355391 en increasing prevalence mellitus DM major health risk score develop research type DM T2DM conduct study among adult score increased fasting blood level diagnose T2DM T2DM history previous known disease fasting plasma glucose two positive value negative value index ratio positive test ratio negative test presence T2DM known diabetic fasting plasma glucose two overall prevalence T2DM confidence interval characteristic analysis index respective finding study indicate value also risk examine individual risk factor age history obesity activity
26916506 en aim study identify potential risk factor early diabetic population datum renal disease patient type retrospective review association clinical factor risk early analyzed analysis associate early female odd ratio confidence interval lower hemoglobin level result significant group remain similar study population association female lower hemoglobin level early diabetic population
25771490 en gestational mellitus may increase health risk woman aim study determine effect blood glucose lipid outcome woman woman gestational week group group week randomize trial concentration fasting plasma glucose serum insulin plasma glucose serum insulin fasting serum lipid function parameter measured week outcome also woman trial compare group concentration level fasting serum total cholesterol concentration significant decrease group treatment fasting serum concentration significant increased group change concentration negative correlate change serum concentration incidence significant lower group group improve well fasting lipid metabolic disorder woman decrease incidence
25630713 en mellitus DM patient high incidence intervention aim study compare response use DM patient well patient randomize trial patient undergo month follow-up mean significant DM group vs group vs significant DM group vs group vs significant great DM group vs group vs compare show DM patient well patient
25536928 en system treatment hypertension mellitus datum health health estimate potential total population analyzed drug per age health medication respective can drug high potential respective high man woman result patient potential drug increased study potential intervention can reduce treatment
21264802 en association recent included hba1c primary test mellitus hba1c investigate use parameter cohort increased risk disease
26447680 en diabetic protein revealed renal however mechanism well known present study found compare normal diabetic show decrease increased factor protein cause increase cell renal cell revealed increase high cell normal control cell increased high cell high change cell respective decrease treatment follow decrease high cell study suggest renal increased mellitus
26203572 en use three medication may increase health care determine patient type mellitus population health care patient type mellitus two care little one year care care medication consider total medication number one year use determine medication group determine complication disease mean mean medication treatment management complication management disease total total care diabetic patient less total diabetic patient
25274455 en study investigate association three insulin factor diabetic type mellitus T2DM cohort
16873690 en recent evidence type mellitus disorder associate two factor protein associate cell control also known several type study reported common influence type addition use analysis identify individual identify large study evidence association effect use study odd ratio common important role type
21290251 en assess relationship insulin resistance subject type mellitus clinical complication on total subject diagnose year evaluate age body mass index ratio blood pressure insulin hba1c lipid profile complication plasma concentration type protein insulin resistance glucose subject group insulin insulin man compare high vs high vs vs blood pressure high hba1c value vs high concentration vs significant difference group found woman high hba1c value compare difference man correlate significant hba1c respective adjust age complication man increase plasma concentration obesity hba1c
23635550 en cause case show also disease report two independent cohort known cause found two patient severe common remain patient patient increased function patient found case characteristic increasing number case syndrome
26251001 en cholesterol cardiovascular disease risk although datum adult type mellitus DM elevated associate great odd adult type DM group subject type DM group elevated elevated elevated elevated normal use logistic regression examine association group period year perform analysis elevated cohort mean respective subject elevated great odd compare normal odd ratio confidence interval compare subject elevated odd ratio confidence interval adjust age duration hemoglobin similar result obtain elevated define cohort mean elevated great risk elevated elevated adult type DM datum suggest index cardiovascular disease risk type DM
21533831 en chronic mellitus two disorder aim change condition group diabetic DM obtain sample evaluate insulin well function increased well rate level activity increased impair increased DM respective DM DM DM ratio diabetic high DM DM decrease present group mellitus pressure lead dysfunction pressure impair association
21501602 en major risk factor cardiovascular disease mellitus treatment cholesterol aim present study evaluate cholesterol determine relationship patient without mellitus receive addition risk factor plasma level cholesterol cholesterol determined patient disease evaluate disease assess identify medical patient known mellitus receive treatment patient included analysis compare patient without patient reduce ratio vs increased ratio vs indicate reduce cholesterol associate development logistic regression analysis include cardiovascular risk factor age total cholesterol hypertension body mass index revealed ratio significant patient patient without mellitus cholesterol
27583084 en disease important cause chronic disease cardiovascular subject type mellitus T2DM aim study determine prevalence risk factor population type perform case control study evaluate risk factor subject T2DM control parameter assess included BMI body mass index serum cholesterol include serum also perform diagnosis significant identify patient T2DM compare control odd ratio obesity independent associate subject T2DM occur patient T2DM control associate obesity diabetic subject therapy decrease risk cardiovascular adverse event
23949898 en glycemic control important management type mellitus study evaluate therapy patient T2DM control insulin insulin randomize trial therapy insulin insulin therapy week treatment insulin insulin adjust study conduct clinical include hospital patient T2DM aged year hemoglobin hba1c insulin without week included study patient use oral patient week treatment whether treatment outcome change hba1c baseline week general outcome week week adjust mean change baseline hba1c week great adjust difference CI difference similar patient treat CI without CI week great patient receive hba1c receive vs difference CI increase baseline mean total insulin week vs difference CI study period patient adverse event common incidence similar treatment group group incidence reported respective incidence glucose characteristic respective adjust mean change baseline body weight insulin without glycemic control well week treatment
23375262 en study compare response woman type mellitus without study measured response use female function index on factor analysis method use analysis correlation different response two group response obtain use compare diabetic total woman without three response analysis study control group found among woman without one response woman high presence woman indicate adverse type occur group woman
26431063 en insulin two presence regard however mechanism related function several review current regard disease gestational mellitus clinical finding show insulin due research clinical study role provide target improve adverse outcome
21308182 en determine mortality mellitus according association level mortality year mortality associate obtain system health disease cause mellitus identify rate mortality association obtain regression level mortality include according related health high risk relative risk confidence interval CI association mortality CI CI CI CI rate increased per period woman high mortality man individual high risk CI present association mortality
23653335 en important role mellitus consider important gene type mellitus T2DM study investigate association T2DM risk however result perform assess association on T2DM model use assess odd ratio or study or confidence interval use evaluate association included among on analysis conduct assess result test common use evaluate found individual significant increased T2DM risk model analysis found on can increase T2DM risk population model population found also can T2DM result can contribute T2DM risk
24806252 en present case poor control type mellitus develop significant diabetic on diagnose lead
24769782 en condition associate significant include obesity hypertension cardiovascular disease insulin resistance positive pressure effective treatment effect glucose patient study evaluate impact patient type mellitus T2DM study perform subject aged year diagnose T2DM according study show use significant change glucose patient T2DM change observed study hemoglobin hba1c glucose insulin resistance study show hba1c level increased insulin use review show improve normal also glucose patient T2DM on study show patient result treatment month use therefore glucose use may contribute T2DM decrease disease however study need finding
24557711 en cell mellitus DM identify risk factor development DM impair glucose tolerance patient glucose tolerance status evaluate patient aged year receive age year patient diagnose type DM treat insulin oral patient included group remain normal glucose tolerance group incidence DM year year patient history DM significant difference serum level DM group glucose level DM group significant high group day analysis age year time significant associate development DM follow-up patient
24468651 en type mellitus result cell individual impair cell due cause several individual impair patient identify patient healthy individual intervention review current dysfunction
24059309 en disease type mellitus T2DM chronic health disorder according recent study T2DM new different target cause disease several cardiovascular disease T2DM system disorder disease protein gene individual show cause early protein occur result consider lead however cause disease case associate dysfunction may several one cell protein contribute cell review important mechanism well T2DM factor insulin system possible role
24918530 en identify health care patient cause complication compare finding result study analysis base datum sample medical health care included difference patient age subject without diagnosis control estimate according number type complication medical confidence interval per patient management treatment care contribute due complication medical care decrease control increased complication decrease large cause management complication important complication management well primary
21244458 en early role health care first month use conduct participant recent diagnosis included analysis new body role different include body participant new different body change present health care need early
24263619 en management subject management glucose level population increased risk complication aim study evaluate insulin insulin duration subject type compare trial trial conduct included period subject man woman aged year adult group year group type receive day glucose conduct evaluate effect blood sample analysis included total serum concentration one interval one interval serum concentration included total effect glucose rate concentration subject adult estimate mean age group ratio adult confidence interval CI CI respective mean adult subject age group first interval statistical significant difference observed adult subject regard primary study estimate mean age group ratio adult CI CI respective duration duration similar adult subject effect lower subject compare adult significant difference observed age group observed adult subject type clinical number
24197696 en factor gene associate type study reported outcome perform investigate whether associate increased risk type statistical analysis perform use on total study included statistical analysis result associate increased risk type mellitus or CI model on show increased risk type or CI compare subject however significant difference risk found subject or CI indicate can risk factor development type subject however association statistical significant subject study characteristic
25054436 en improve glycemic control patient type evaluate effect subject therapy randomize study adult type glycemic control hba1c without oral medication subject randomize therapy primary mean change hba1c baseline week included fasting plasma glucose change glycemic response lipid profile included lipid profile change decrease hba1c mean treatment difference fasting plasma glucose vs week subject receive vs hba1c reduction vs hba1c vs also decrease total cholesterol mean treatment difference total concentration increased treatment difference vs adverse event adverse event subject type control therapy therapy improve glycemic control lipid parameter well
24939807 en number increase two due factor include population current regard incidence prevalence management old perform review determine prevalence type old individual age year reported study
25109773 en relative effective treatment type mellitus T2DM well randomize control trial compare treatment present study evaluate relative effective treatment perform intervention T2DM compare drug drug glycemic control hba1c risk primary outcome relative effect odd ratio treatment effect insulin improve glycemic control effect high risk effect effect less risk result relative treatment effect regard T2DM treatment
25009026 en effect obesity event among type mellitus patient cohort study total healthy group type mellitus patient according baseline observed population two obesity without total period follow-up mean age BMI level pressure significant increased obesity group high group incidence new group high group vs vs respective result multiple logistic regression analysis show compare group group increase relative risk new event age risk factor value mellitus patient obesity increased risk event
24824687 en studied development mellitus within week mellitus develop within week diabetic associate reduce decrease level protein mellitus early mechanism decrease level
24751283 en decrease cell whether lipid role function type mellitus T2DM demonstrated function compare diabetic lipid diabetic level increased T2DM compare control subject control subject vs T2DM vs level decrease blood difference protein diabetic diabetic protein different function level diabetic mechanism factor function cell T2DM potential target dysfunction T2DM
24134590 en disease result disease although disease remain primary cause mortality hypertension may develop patient therapy show result report patient common receive age high insulin addition patient complication chronic patient remain health month normal follow-up function however function due severe age month
26364618 en evaluate concentration woman develop gestational retrospective study three group sample gestational week gestational hypertension gestational normal significant difference observed concentration gestational value control group value also gestational hypertension value study show concentration increased significant woman develop gestational compare control group
22127642 en adverse development disease observed obesity mechanism review recent role gestational mellitus disease also review recent aim identify mechanism effect result research role gene model develop model lead development
22060211 en known identify patient result obtain study adult investigate patient patient first test analysis analysis also perform one patient identify patient patient aged high patient age identify less on large patient show elevated model assessment normal index large renal two patient patient known identify high previous reported adult on patient present normal type
20045142 en investigate effect common response type mellitus on total patient type mellitus treat week without change previous medication patient vs vs significant significant different decrease fasting glucose vs hemoglobin vs level significant great subject without baseline fasting glucose level related response found associate response multiple logistic regression analysis gene associate response patient type mellitus finding may target treatment identify patient
25159210 en evaluate association elevated level plasma development diabetic study diabetic patient group diabetic patient without group normal subject group value plasma protein concentration measured use analysis analysis group severe participant plasma level group respective duration diabetic mellitus DM hemoglobin hba1c significant different three group respective analysis plasma level increased correlation logistic analysis show correlation development duration DM value significant respective whereas correlation value significant analysis characteristic development use value found positive associate development may development
27052223 en contribute cardiovascular mortality diabetic patient therapy lower cholesterol show reduce cardiovascular risk diabetic patient present association use drug diabetic patient according current evidence
24372947 en mellitus DM type DM association study identify associate obesity DM include important role identify gene determine whether associate DM body condition study diabetic control female study perform blood sample use gene gene identify analysis assess group significant difference identify diabetic group compare diabetic difference diabetic significant identify associate DM similar
22797092 en mellitus high health different also high patient chronic disease mellitus known cause renal disease renal impact also known role cause disease known high among patient diabetic review relationship mellitus patient chronic disease also two factor
22304838 en glucose measured recent show negative correlation glucose consider blood glucose period patient mellitus demonstrated use analysis analysis method correlation present study assess relationship clinical index glycemic control hemoglobin hba1c recent index obtain glucose diabetic patient significant correlation parameter observed hba1c mean glucose therefore increase negative correlation glucose glycemic control clinical determined use hba1c parameter
21853830 en incidence prevalence mellitus DM increasing remain significant low high rate two DM may also treatment outcome management disease may low high control
24237156 en determine evaluate type evaluate population conduct study identify evaluate conduct review study included patient type two independent assess study datum use population use included review important profile type identify research provide patient
22520960 en study evaluate change patient mellitus DM metabolic syndrome total subject group included study group DM patient DM group patient group patient DM group patient group healthy subject parameter analyzed included base index DM show significant compare control group on significant also observed group change individual lead prevalence positive diagnosis DM significant change suggest similar change observed also patient DM suggest early cardiovascular finding early diagnosis treatment patient DM
22178056 en included patient analysis evaluate difference clinical treatment outcome patient mellitus DM compare datum retrospective diagnosis reported base diagnosis DM base medical medical medication difference regard baseline outcome among diabetic patient diabetic patient present syndrome factor multiple renal dysfunction hypertension disease mortality diabetic high compare vs analysis revealed old age blood pressure syndrome factor respective history hypertension serum therapy well treatment independent associate adverse high mortality treatment regard care possible due disease presence multiple
22982911 en increase incidence new early diabetic one can renal assessment renal index use renal studied patient female mean age year duration year on control group healthy female mean age year also studied parameter studied two group age serum rate rate hemoglobin hba1c mean renal found increase mean diabetic patient healthy mean increase positive correlation duration disease hba1c level correlation serum increased early
24947484 en associate decrease type risk adult examine first gestational mellitus cohort woman cohort adjust relative risk confidence interval association first estimate total hospital reported among among high among woman significant difference level among difference level age status body mass index association increasing result similar status increased risk reduce risk increasing total result suggest first associate increased risk possible may effect
22809439 en important role disease dysfunction study investigate potential clinical cell include cell cell disease subject type total type diabetic patient without history cardiovascular disease determined serum level perform subject define significant two group patient group patient without evidence group group show significant high level lower level group respective level significant different two group serum level positive correlate level risk score level show correlation score determined logistic analysis adjust age history hypertension level show primary cell associate several risk factor elevated type diabetic patient result suggest associate disease patient type mellitus
22665120 en factor important factor cardiovascular complication whether activity dysfunction type mellitus important remain function determined insulin week diabetic observed increase resistance reduce insulin type decrease insulin treatment impair response also treatment reduce control treat whereas improve resistance level activity reduce treatment study role dysfunction type mellitus
22569236 en reduction body weight use improve insulin type mellitus study evaluate whether randomize intervention study conduct clinical research medical body mass index mean type mellitus follow resistance measured insulin lipid measured characteristic group weight occur vs within group group mass glucose increased similar study group body mass vs insulin increased group vs group also increased significant group vs change however high glucose rate
22535968 en several risk score identify subject high risk develop type mellitus T2DM whether risk score base clinical study assess clinical value risk score study mean follow-up time study included participant woman risk score T2DM test two previous score on previous risk score T2DM use participant develop T2DM follow-up analysis difference found one score diabetic participant adjust risk score score improve assess change characteristic range positive negative value similar T2DM risk found index range study previous score improve T2DM
22527596 en study evaluate treatment type mellitus T2DM patient body mass index BMI cohort study patient T2DM BMI undergo hospital hospital base included weight T2DM reported patient mean age year patient female mean BMI time perform mean hospital day mean follow-up month month respective T2DM patient patient oral T2DM patient use insulin treat T2DM one patient effective treatment T2DM patient BMI
21472657 en assess activity patient type system develop aim trial use clinical type mellitus aged year duration year hba1c included study period day patient receive assessment system activity system blood glucose system high activity measured mean duration total activity activity period without activity correlation activity measured blood glucose profile measured correlation range correlation show high association blood glucose value activity range correlation health high patient assessment individual activity use insulin
24280743 en on high prevalence reported woman type use patient syndrome patient without study determine effect function participant metabolic control patient randomize trial one group receive group receive treatment month level treatment associate decrease index level treat show level analysis difference observed score rate hba1c level insulin treat compare significant decrease serum compare therapy significant clinical parameter metabolic control
22648843 en investigate effect use patient patient mellitus hospital randomize treatment fasting blood number cell cell cell cell two group day day insulin resistance index use model incidence function time hospital day vs vs lower treatment group group number vs vs cell vs high treatment group significant difference vs function vs two group however hospital vs significant treatment patient mellitus reduce insulin resistance improve status
23429432 en syndrome disease cause different patient syndrome correlation study role history study analyzed clinical datum patient syndrome patient current prevalence difference may among mellitus first two clinical patient age mellitus may patient disease rate correlation disease rate general population new can important patient management well development treatment syndrome
26341185 en measured may adverse aim present compare change patient without first patient first age year man patient first without age included function measured primary intervention baseline follow-up baseline patient without similar vs vs vs whereas significant impair diabetic patient vs although diabetic patient show time similar patient vs remain impair follow-up compare patient vs adjust clinical characteristic independent associate change baseline follow-up confidence interval diabetic patient show impair baseline follow-up compare group patient without similar baseline follow-up
22049178 en mellitus major metabolic complication renal gene associate type however whether also risk factor investigate association cohort renal patient man woman receive without history fasting glucose concentration less patient follow included ratio great risk adjust age weight type significant man woman develop whereas elevated risk associate
22908207 en gene type mellitus investigate study current conduct evaluate association study perform database independent datum on total type case control included on model use odd ratio base result test increased odd ratio type mellitus observed compare odd ratio or confidence interval CI increased risk compare or CI significant associate risk may increased risk type mellitus
22621796 en patient type mellitus T2DM relative normal level cholesterol increased risk cardiovascular event patient T2DM low level cholesterol cholesterol examine aim study assess concentration patient low cholesterol cholesterol level cardiovascular risk datum large clinical database case patient T2DM diagnosis disease concentration analyzed use use cholesterol among patient T2DM mean age year man cholesterol concentration cholesterol concentration concentration concentration cholesterol level concentration concentration concentration cholesterol cholesterol patient significant level concentration suggest potential disease risk
25646334 en previous study reported effect insulin resistance important risk factor type mellitus DM however whether associate risk test associate DM health study analyzed datum participant DM baseline obtain baseline DM follow-up review medical use model estimate mean age baseline mean follow man develop DM DM adjust clinical risk factor include total respective analysis association risk DM subject without history cardiovascular disease addition age BMI datum DM weight man include total
25456152 en conduct evidence cohort study regard association risk type mellitus study identify result use model relationship assess model datum use relative risk confidence interval CI T2DM T2DM T2DM risk T2DM risk lower risk T2DM level respective
22330623 en aim present study test association effect patient type study subject type score type determined high level observed patient show significant association clinical parameter significant difference according type score age BMI lipid parameter duration hypertension show increased risk high score association observed influence clinical parameter increased risk high score significant association potential patient type mellitus
21795758 en control management risk reduction complication aim study investigate association control impact type diabetic patient total subject type mellitus hba1c measured patient patient index define score adjust age body mass index total score significant correlate level hba1c logistic regression analysis show adjust odd ratio or hba1c level or confidence interval CI adjust or control poor group regard group or CI study demonstrated poor significant correlate control patient type finding contribute risk reduction complication type
23315755 en effective treatment type mellitus plasma glucose body insulin resistance chronic however type evidence determine type duration patient low one possible factor may body role medication treatment treatment suggest type per week similar cardiovascular health general population include effect different type use health
23040832 en investigate association body mass index BMI mortality patient type mellitus follow-up cohort patient T2DM status database body weight use BMI treat normal obesity obesity cause complication regression use estimate total patient cohort follow-up complication cause BMI associate mortality complication cause respective adjust ratio confidence interval compare normal weight significant cause obesity obesity significant associate mortality patient follow-up duration year BMI significant mortality suggest potential weight obesity observed mortality patient T2DM suggest diabetic patient
20617768 en mellitus syndrome protein result chronic complication due relative insulin number increase result increasing number patient chronic condition may treatment aim provide condition also management diabetic
20668214 en case study determine type mellitus related activity change adult type total adult female aged year type mellitus resistance intervention datum analyzed use remain relative intervention improve included low disease condition health reported participant study period participant influence show increasing little effect participant study determine effective
21089454 en aim study lipid factor contribute development complication type mellitus DM included patient aged year hemoglobin measured lipid studied use estimate base patient DM show high value healthy subject increase age year duration DM DM cause decrease blood level negative effect DM patient
23385738 en mellitus present period case aim clinical large cohort patient define difference clinical history patient positive diagnose clinical datum patient present age one day positive correlation age gestational age negative correlation adjust age significant patient multiple patient large case clinical disorder clinical addition identify previous clinical difference
22824531 en group base due method patient assess effect compare treatment clinical outcome review database control trial evaluate adult diabetic treatment intervention little one month follow-up little two independent datum assess study total study participant included participant baseline age year BMI hba1c duration year use medication clinical outcome hba1c significant reduce month study participant month study participant year study participant fasting blood glucose level also significant reduce month study participant month outcome improve significant month study participant month study participant year study participant also improve significant month study participant outcome significant study participant month can due high outcome significant patient body weight month intervention group difference group mortality rate body mass index blood pressure lipid type result clinical outcome
22700639 en cause identify may report case associate cause two period time patient type disease several potential cause can include on perform without show indicate presence associate poor control type condition may cause patient type type case report may condition diagnosis cause
22313143 en type associate complication prevalence increasing one response diagnose condition early possible clinical one mechanism diagnosis reported report use general one general medical determine number blood glucose oral glucose tolerance test adult without known three year associate test patient new diagnose type period review identify diagnosis clinical total number diagnosis determine per diagnosis study period test conduct patient year patient diagnose type number need total per new diagnosis new case type reported general without use population clinical
22211946 en normal function function insulin type mellitus investigate whether blood reduce type major blood sample type normal subject determined gene gene fasting plasma glucose hba1c fasting plasma insulin lipid profile total cholesterol type group mean hba1c BMI blood pressure blood pressure fasting plasma glucose fasting plasma insulin model assessment insulin resistance significant high type group control group blood lower control vs negative correlate BMI fasting plasma glucose fasting plasma insulin model assessment insulin resistance age level positive correlate level group regression analysis indicate hba1c fasting plasma glucose age major factor type group however BMI associate lower control result lower blood associate type individual hba1c fasting plasma glucose age major factor
22150506 en gestational mellitus potential condition prevalence increasing evidence suggest early treatment improve outcome regard intervention gestational mellitus research aim diagnosis gestational develop effective intervention provide within conduct finding use identify review evidence prevalence gestational current reported prevalence may lower high method value poor gestational diagnosis clinical gestational gestational can lead treatment improve outcome woman evidence base need research gestational mellitus diagnosis
20509317 en interval method diabetic can diabetic can well complication mellitus type incidence reported can method large number diabetic case type mellitus clinical evidence disease subject function test included test ratio ratio blood pressure on score large can interval determined value consider case type mellitus found can observed diabetic control group high diabetic can vs diabetic without can correlate positive study show method diabetic
21368421 en effect blood glucose model type mellitus blood use model type mellitus follow obtain group treat group treat group treat group treat week follow fasting blood glucose improve increased body weight increased resistance reduce compare group body weight increased resistance decrease group fasting blood glucose significant difference group group include blood rate plasma reduce fasting blood glucose improve blood
22982936 en determine prevalence assess risk factor retrospective studied patient drug use included define according association mean age patient year man woman related patient prevalence factor increasing included age high management included oral insulin prevalence significant population risk factor development multiple management
20222752 en mellitus major treatment although model evaluate associate intervention recent review method use model treatment database identify model evaluate treatment mellitus database identify review group according model model different compare different treatment model included case included provide model datum study study characteristic model complication datum method model datum method datum method model datum result include method on total study identify conduct analysis analysis although model model number complication included study use time type type trial datum common datum although several datum use method use datum common reported less regard new intervention general effective base study present result analysis test model although disease several model develop associate treatment previous finding review development case can use new model model can research compare model treatment clinical outcome
20042558 en compare current mellitus factor retrospective analysis review database patient aged year old large patient included sample current treat group according patient diabetic patient patient study year prevalence patient association patient number new diagnosis per evaluate rate assess number factor primary care total patient patient test patient vs result diagnosis factor syndrome high rate diagnosis number factor patient risk factor diagnose patient test significant less patient vs new result lower number patient decrease case finding significant number type risk factor health decrease
26339080 en prevalence complication increasing role disease presence present study aim determine prevalence adult diabetic subject clinical study patient conduct hospital hospital patient included use use define statistical use patient use prevalence high among woman on general high prevalence obesity observed among study participant blood pressure significant high poor control observed high prevalence multiple need hypertension associate need diagnose treatment hypertension patient mellitus
25028176 en gestational mellitus low level test change different cell type aim normal study patient control identify measured protein cell use study protein level well patient high cause whereas low result can due low level patient low cell
17229663 en report case syndrome patient two diagnosis clinical current case management report result study determine whether two common woman present syndrome finding revealed normal finding two mass one one show mass negative mass show plasma two similar whether independent can case presence one may regard patient need study determine patient
26279147 en study determine whether presence mellitus DM influence incidence patient use retrospective analysis conduct patient baseline incidence evaluate retrospective patient receive without known DM patient study patient DM baseline incidence patient receive rate patient rate diabetic patient DM duration year year group retrospective analysis indicate therapy DM patient disease duration year incidence without known baseline therapy similar DM duration year patient
25975045 en examine whether improve index patient type mellitus subject T2DM control group group group addition drug treatment patient group receive group control group group treat time week month index hemoglobin glucose fasting serum insulin total cholesterol body mass index assess follow-up month index control group three time significant difference index among three group index two group lower control group improve follow-up index group group increased decrease compare value body mass can improve patient T2DM use therapy clinical
27180675 en on review medical mellitus patient occur little three year severe event important patient report patient
27146460 en aim determine impact mellitus DM patient retrospective review conduct patient undergo first outcome review include mortality mean follow-up year obtain diabetic patient control base estimate age year patient DM hypertension common cardiovascular present patient respective perform patient mortality occur patient DM group group cohort overall rate diabetic mortality year diabetic group overall rate diabetic mortality year diabetic regression analysis identify age ratio female DM previous independent factor influence low mortality significant lower patient DM compare treatment DM cardiovascular improve diabetic patient
26428217 en patient diabetic correlation clinical regard medication mellitus retrospective identify patient healthy subject undergo among patient DM receive treatment diabetic patient receive treatment DM treatment group patient treatment receive treatment DM study treatment result show significant correlation indicate high study correlation normal DM presence diabetic patient examine significant decrease treatment group whereas severe without study demonstrated significant decrease presence treatment group suggest high blood cause treatment DM may early
25899655 en recent health well hypertension blood pressure patient mellitus follow lower treatment patient reduce cardiovascular mortality risk factor blood pressure glucose cholesterol patient datum multiple trial early treatment hypertension complication blood pressure high level evidence blood pressure recent year
19168093 en type type mellitus two common severe chronic estimate prevalence although type type great common mass lipid therapy associate complication health therapy aim mass review provide current clinical study within year first identify individual risk range disease individual risk type target tolerance new intervention within type important disease present
24351174 en patient associate increased mortality glucose may clinical management patient glucose level on blood glucose system develop glycemic control therapy patient on study perform evaluate system subject system blood glucose concentration study measured system sample blood sample measured glucose study day healthy studied sample effective primary evaluate assess within compare adverse event adverse effect total value within system show significant relationship adverse event reported on total use due clinical system provide healthy patient
22943822 en change fasting level incidence type mellitus T2DM assess association change level risk total subject aged year baseline cardiovascular disease subject subject total participant baseline included analysis fasting level three group association change level risk T2DM assess logistic regression mean level female year level increased female respective prevalence elevated increased incidence female incidence rate level respective logistic regression analysis show baseline level significant associate risk cardiovascular risk factor baseline level risk increased level adjust risk factor participant high baseline follow-up level high risk low baseline follow-up level independent associate risk change level interval risk baseline level
22698420 en determined adult new diagnose mellitus T2DM risk development study improve early management risk factor study adult without mellitus adult baseline health follow-up diagnosis baseline follow rate assess risk factor development T2DM without baseline reported diagnosis T2DM year increasing age history T2DM body mass index obesity gestational high blood without significant increased risk develop T2DM health status decrease risk adult population rate develop T2DM year T2DM diagnosis identify analysis
27173202 en type mellitus T2DM associate result decrease activity associate cardiovascular disease present study assess effect risk develop T2DM individual on total subject T2DM patient well healthy control evaluate association T2DM use parameter measured test mean use overall observed significant difference regard group respective however analysis blood fasting plasma glucose hba1c level follow age body mass index ratio blood pressure history T2DM significant according independent individual T2DM effect can within determine possible risk factor
27111304 en several study show drug compare patient type mellitus T2DM adverse clinical outcome patient type mellitus previous studied aim compare clinical outcome similar patient cardiovascular disease treat control trial compare patient treat database outcome datum patient major adverse event mortality target target consider clinical analysis odd ratio or confidence interval analysis perform patient patient group patient group total number patient included analysis follow-up period one month one year increased use patient month significant lower group or CI increase mortality also group or CI or CI respective month or CI or CI respective one year result statistical associate significant lower rate without increase mortality patient follow period one year however due population study large number randomize patient
27073927 en cell therapy mellitus DM study present clinical trial determine cell therapy DM aim evaluate clinical evidence different type cell therapy datum clinical trial total patient significant difference outcome base type cell patient receive cell insulin independent mean period month whereas result negative patient receive blood cell provide significant outcome compare cell cell therapy early DM diagnosis effective intervention relative risk adverse effect observed T2DM cell reported mortality poor diagnose diabetic cell effective treatment patient DM cohort trial outcome therapy poor outcome observed diabetic
27068332 en hypertension reported cause dysfunction aim study evaluate effect addition parameter type diabetic one patient addition month assess month addition patient undergo blood pressure also assess fasting plasma glucose hemoglobin hba1c protein result significant reduction blood pressure reduction obtain great obtain datum also show similar reduce level compare baseline parameter diabetic
26631691 en common patient however use due study investigate oral on conduct patient diagnose hypertension mellitus use compare baseline datum compare use period use week significant reduce use month reduce improve effective patient medication patient can new patient
25924045 en patient type reduce disease aim treatment therefore treat also improve medical treatment large impact
25809927 en disease major high complication patient mellitus presence aim study determine patient study diabetic patient known retrospective included analysis subject undergo analysis included assessment presence subject included analysis mean age year type prevalence evaluate high identify high use respective respective analysis high compare lower vs vs respective use patient mellitus high compare lower
25590217 en type prevalence study evaluate role study patient woman age control age assess type test control subject increased prevalence vs respective vs vs respective vs vs respective decrease vs vs respective type vs vs respective control patient increased prevalence respective compare subject respective similar prevalence presence associate control odd ratio or confidence interval CI patient or CI level or CI woman associate
26306010 en medical increasing use patient however study potential recent study examine insulin associate major risk patient
19466209 en type mellitus T2DM important health obesity clinical T2DM diabetic increasing rate T2DM rate obesity major risk factor impact insulin risk factor include history mellitus age group condition associate insulin resistance syndrome T2DM studied adult development clinical mellitus however study case similar adult normal glucose tolerance rate T2DM increasing overall prevalence remain low compare type mellitus however clinical T2DM clinical evidence cell significant clinical diagnose T2DM T2DM research need metabolic difference two group T2DM complication provide new
26813615 en day new time define activity recent contribute factor increasing chronic disease within indicate time risk factor several health outcome include type mellitus insulin resistance cardiovascular disease mortality type important association remain time activity association time type mellitus important study association evidence time effective glucose evidence day may improve glucose evidence chronic disease patient reduce time type mellitus management
26241422 en relationship assess blood glucose cohort woman recent diagnose gestational mellitus patient first week management use woman day glucose compare datum model analysis use estimate association duration fasting blood glucose participant provide datum interval little one glucose duration negative associate fasting blood glucose concentration analysis adjust age gestational age body mass index increase time associate statistical significant reduction fasting glucose confidence interval CI well glucose concentration CI CI duration associate glucose control woman gestational woman healthy disorder may role blood glucose control gestational
27550885 en case woman type mellitus diagnose year early obesity body mass index hypertension blood pressure month less concentration chronic low body weight increasing time clinical respective fasting blood glucose blood glucose level hba1c level cholesterol cholesterol total cholesterol show
27057914 en one common complication mellitus DM need study investigate relationship dysfunction diabetic report individual impair glucose tolerance previous association plasma dysfunction factor patient DM studied study aim investigate correlation plasma dysfunction patient type DM study patient T2DM patient control included datum hba1c level analyzed response rate use level hba1c high patient control patient T2DM high level control patient similar among group however high number T2DM patient control analysis revealed lower interval interval total patient T2DM control addition analysis show lower group ratio lower patient group correlation found level hba1c result dysfunction individual T2DM impair early T2DM however increased level correlate study need disease clinical correlate impair T2DM can due mechanism dysfunction
27041522 en mellitus DM metabolic syndrome associate may lead development complication protein regard association lipid evaluate correlation serum concentration metabolic profile patient study conduct patient DM female plasma concentration lipid profile glucose profile investigate insulin resistance determined use model assessment correlation serum lipid profile patient DM negative correlate positive hba1c total cholesterol found positive correlation total cholesterol patient little correlation remain positive significant increasing number patient serum significant correlate serum significant observed metabolic syndrome serum lipid result present study suggest patient DM lipid profile correlate blood concentration association observed serum
21403038 en common diagnosis clinical care patient type mellitus outcome development incidence risk factor renal outcome development control complication intervention complication study type therapy participant follow study study participant develop rate study assess renal outcome include rate impair rate estimate rate study renal disease regression rate follow-up period diagnosis year year incidence impair rate renal disease regression respective outcome therapy lower hemoglobin level female lower blood pressure lower concentration cholesterol lower hemoglobin level lower blood pressure also associate decrease risk impair development regression disease common occur glycemic control lower blood pressure lipid profile associate improve outcome
24857814 en woman increased risk gestational mellitus compare woman associate increased risk type study therefore evaluate relationship conduct analysis two base medical health care on total care patient included diagnosis medical study participant reported reported on total woman diagnose association odd CI associate reduction odd CI however association statistical significant age study CI population woman statistical significant association odd on reduction odd among important risk factor
23844710 en patient disease management type mellitus however patient therefore study identify improve perform study participant use compare use test test group analysis base total participant reported receive identify without influence use increase rate also determined management patient management patient patient
21785581 en dysfunction associate dysfunction insulin resistance factor contribute development type mellitus DM evidence well cause cell addition recent study show dysfunction cause role dysfunction type DM also recent finding dysfunction important role type DM
26021978 en gestational mellitus associate adverse effect known body aim study investigate possible effect obesity respective investigate control BMI BMI diabetic use mass increased decrease on difference BMI related change change cause observed blood correlate whereas correlate positive correlation weight found level demonstrated obesity associate decrease increased identify major whereas found associate
23725918 en mellitus low level cholesterol among several known risk factor disease recent research show potential two aim study examine disease risk factor patient high low level compare patient level great patient level less use retrospective cohort high difference incidence type vs high cohort also great age year vs year vs healthy vs vs lower body mass index vs low also general high cohort low prevalence mellitus
23650948 en use treatment type mellitus T2DM effect drug include associate T2DM related improve metabolic control effect however recent year effect function role complication include cardiovascular disease although also high treatment patient T2DM therefore T2DM contribute may role potential adverse effect review effect treatment associate T2DM
19560108 en change metabolic diabetic woman potential increased aim study change woman type mellitus gestational mellitus complication analyzed profile gene assess primary cell mellitus associate gene related lipid related glucose lipid observed type mellitus lipid lipid time glucose result cell suggest lipid may increasing lipid lipid use
25927357 en glucose management base blood glucose aim test glucose assess clinical impact insulin therapy patient type mellitus patient T2DM age year hemoglobin body mass index treat insulin perform system therapy show study period number range increased day day number low glycemic high number high value datum clinical relative identify datum overall high number overall assessment glycemic control use whereas use therapy need
21527089 en reduce rate diabetic complication incidence mellitus increasing number patient health care management need effective care management patient several factor include among time patient increasing drug management use blood glucose patient clinical include use need patient disease
23947316 en assess whether health can improve glycemic control among type randomize control trial health follow year participant intervention year control participant show significant lower hemoglobin level control participant year year observed effect blood pressure control glucose medication intervention participant increased activity mean day per week baseline day per week intervention result glycemic control year among body evidence use reduce health
23931125 en several use adjust insulin blood glucose target compare clinical outcome use three insulin patient type mellitus T2DM receive analysis datum randomize control trial patient receive increase fasting plasma glucose target increase day target general increase base mean level glycemic control insulin event compare patient included patient receive baseline significant difference glycemic control high vs respective result significant different adjust reduction hba1c respective event rate blood glucose high insulin patient T2DM result similar level glycemic control lower rate patient treat use
21651839 en demonstrated effective weight control type individual whether control study investigate effect control perform model type perform observed week undergo demonstrated improve glucose tolerance insulin compare result duration study provide evidence role associate similar control type
25201464 en whether therapy risk patient type mellitus T2DM health database patient T2DM aged follow incidence treat patient studied on use incidence estimate ratio use regression duration analysis conduct use follow-up develop incidence per respective ratio confidence interval score ratio first duration therapy respective respective analysis effect use associate decrease risk patient T2DM
23825617 en old adult type mellitus increased risk current study aim identify risk factor relationship old adult healthy control undergo medical status test assess follow-up period use control participant score participant vs control reported little one two logistic regression identify risk factor odd ratio multiple regression define poor independent risk factor medication poor reduce odd ratio relationship status relationship follow reduce increased major risk factor poor medication poor reduce function relationship include medication review reduce risk old adult
23525683 en relative common type whether effect type aim study conduct review assess effect outcome type database review included control trial little week duration type evaluate effect compare included total participant assess study show significant result one study result resistance assess study one study intervention decrease evaluate study also show result evaluate one study show significant effect outcome type therefore need great role type
23893315 en type outcome individual overall aim study evaluate metabolic control status patient consider retrospective study patient woman diagnosis undergo conduct metabolic parameter follow-up define according hemoglobin hba1c fasting glucose treatment evaluate metabolic status according association target hba1c characteristic mean age year BMI time diagnosis year hba1c target present patient follow-up patient treatment oral medication insulin hba1c target difference number individual metabolic patient may significant metabolic control regard according target
25906648 en present datum effect need therapy patient datum mechanism parameter activity use clinical drug patient base follow-up
24918800 en identify primary care hospital type mellitus T2DM management compare current study datum result similar group group identify management patient T2DM group health care group similar possible assess insulin well sample included increased association insulin less insulin insulin increased insulin increased patient target hemoglobin level insulin treatment suggest management confidence use insulin insulin need T2DM management difference therapy patient blood glycemic level use multiple glycemic treatment
17101063 en disorder large cause gene investigate gene gene two patient gene observed patient control subject several different revealed gene gene show finding suggest two patient gene gene
27178654 en review clinical drug compare risk use old adult patient population datum study datum datum on use perform primary current use type trial included review addition related also review show reduction hemoglobin value fasting plasma glucose level low incidence incidence increased patient may treatment patient control oral risk however clinical old patient
23561067 en study examine whether two effective improve blood pressure control type mellitus study patient receive care therapy intervention result significant reduction plasma glucose reduce compare control mean plasma level increased difference ratio blood pressure intervention group follow-up improve reduce type lower status patient study plasma
24956625 en on report two case possible result poor control type mellitus present two patient present old age history change history poor control mellitus assess use on diagnosis two patient aim case report medical relationship type mellitus change care
24661773 en study role type patient result study aim determine whether high normal subject associate major adverse cardiovascular T2DM compare level serum sample patient mean age year T2DM control T2DM patient follow little year incidence include cardiovascular mortality baseline patient T2DM elevated female healthy control on total occur cardiovascular analysis show elevated associate cardiovascular mortality although analysis revealed elevated independent positive normal level negative patient present study elevated patient T2DM associate increased cardiovascular mortality important normal level negative value adverse cardiovascular event follow-up
24435973 en obesity common measured body mass index BMI cause several chronic disease include type mellitus T2DM addition factor factor may also contribute obesity study investigate association previous T2DM obesity population subject study subject BMI control history T2DM subject previous T2DM use method mean BMI compare model significant associate BMI respective control group T2DM group show significant association BMI significant associate BMI T2DM group or female or risk score population number T2DM related associate obesity may significant factor T2DM
24403596 en increasing important role metabolic obesity cardiovascular disease type mellitus T2DM insulin resistance T2DM related T2DM present analysis early T2DM patient subject normal glucose tolerance on total protein identify among increased T2DM decrease include response glucose protein protein early T2DM patient among sample independent early T2DM patient use profile provide protein profile early T2DM
24366165 en recent study show however known also role type mellitus T2DM study level status patient T2DM analyzed plasma sample patient T2DM healthy control normal glucose tolerance plasma level examine use status determined use plasma level found patient T2DM compare control overall level patient T2DM significant different compare control however study revealed analyzed individual within significant T2DM sample compare sample study demonstrated first time plasma patient T2DM may use patient T2DM healthy individual also demonstrated study patient T2DM may contribute T2DM
23796160 en increased body associate insulin resistance negative individual insulin resistance level concentration ratio evaluate participant type control subject age BMI participant syndrome control subject age BMI investigate whether change observed associate insulin resistance insulin per participant type control subject age BMI relationship model assessment insulin resistance serum ratio participant without type significant lower ratio control subject respective participant syndrome significant lower ratio control subject significant difference ratio participant type control subject serum ratio correlate model assessment insulin resistance resistance insulin per associate level reduce concentration may cause increased body
23633127 en disease association possible identify present man chronic disease man common identify on control population man age ratio on study perform identify medication use medical review analysis man perform base significant high mean body mass index range compare control significant increased rate disease vs well high rate mellitus vs man disease current compare man without association hypertension disease disease disorder increased BMI high prevalence mellitus use development may condition associate disorder DM
23393668 en gestational mellitus one common medical result increase insulin resistance well increase insulin cell metabolic test insulin resistance dysfunction gestational associate complication gestational diagnosis large base medical therapy blood glucose level treatment insulin blood glucose level show decrease treatment oral need study management woman gestational increased risk type gestational body contribute risk gestational mellitus patient weight follow may lower risk gestational mellitus
22613434 en mellitus chronic complication aim study evaluate plasma status patient type diabetic sample patient type receive oral healthy control subject without measured blood glucose control total activity measured lipid measured plasma also possible activity lipid level concentration activity significant increased plasma patient compare control total plasma increased high level patient type increased level diabetic chronic complication
22525692 en type type development disease define one identify within first month associate insulin gene on less gene cause well hospital first day treatment insulin day on first week gestational weight insulin level significant normal type negative on insulin use insulin day found on gene cause two different gene diagnosis determine cause insulin therapy effective treatment
25286600 en mean reduce insulin resistance drug patient mellitus type great effect use drug effect reduce insulin resistance insulin increase
24618074 en provide glucose remain obesity due effect glucose assess relationship glucose severe individual previous glucose care patient BMI hba1c lipid profile status assess level respective regression analysis control age BMI prevalence respective normal glucose tolerance impair fasting glucose impair glucose tolerance type mellitus T2DM found case respective large metabolic parameter status significant difference found level prevalence significant patient T2DM compare vs correlation analysis association level hba1c insulin level level also correlate regression analysis age BMI mass independent show hba1c level effect obesity glucose current datum suggest potential independent role glucose patient previous glucose
24074448 en disease type mellitus T2DM two health disorder incidence increased recent year increased population found system disorder disease disease disease multiple relationship gene also T2DM protein common T2DM well contribute review role insulin system important T2DM reduce level common may provide potential mechanism
24296014 en management diabetic patient glycemic control reduce complication obtain result control associate outcome reduce mortality effect renal disease also important patient lead improve outcome consider care
22903734 en among health blood pressure less target subject mellitus review study examine relationship reduction impact diabetic complication identify level diabetic complication reduction risk datum contribute diabetic patient recent study diabetic individual subject high cardiovascular risk diabetic subject high risk lower may provide great show control cardiovascular risk trial individual hypertension duration may possible lower without effect cardiovascular remain demonstrated diabetic patient remain target consider general diabetic population
23490029 en several regard high risk datum reported patient mellitus associate high rate target also high rate therefore aim study perform individual patient datum evaluate effective compare patient undergo primary intervention report database randomize trial examine individual patient datum obtain trial include total patient randomize follow-up day range significant reduce target ratio confidence interval without significant difference mortality year base individual patient datum randomize trial show among patient undergo primary intervention compare associate significant reduction target follow-up without mortality high rate
21338322 en determine use patient type type mellitus T2DM possible relationship duration test effect respective total subject adult adult patient T2DM healthy adult control subject study determined participant blood plasma total plasma use parameter index vs T2DM patient revealed significant high significant lower activity level subject T2DM diabetic significant increase significant decrease compare patient patient age DM type significant correlate studied significant association investigate demonstrated significant DM change subject T2DM
22686510 en potential important mellitus DM finding previous study study examine population study determine prevalence among type mellitus T2DM patient T2DM patient control statistical difference prevalence associate known duration T2DM associate age body mass index BMI status T2DM show risk factor independent associate risk or CI statistical significant difference rate T2DM patient control suggest increased T2DM large study need conduct study finding
21839235 en renal high risk cardiovascular disease mellitus contribute risk reduce patient improve outcome great identify patient develop aim study value fasting plasma glucose pressure development analyzed define month according glucose concentration patient develop month vs vs significant high patient risk difference vs on regression model show increased risk associate age body mass index relative risk confidence interval negative value independent related development increase risk time identify population low risk
21668351 en obesity metabolic syndrome mellitus increasing syndrome include clinical condition obesity mellitus metabolic factor management patient also management factor contribute development treatment known high increase weight patient type type respective base type disease well patient on large body research conduct management disorder may
21521298 en disease type also type mellitus DM associate important clinical insulin treatment association recent common case type disease mechanism increasing protein target insulin also present review clinical care patient DM disorder effect
19449164 en serum show associate mellitus study also relationship association association level examine association serum mellitus sample adult aged year study health participant mellitus define fasting glucose glucose use oral medication insulin high serum level positive associate mellitus independent body mass index hypertension odd ratio confidence interval compare association analysis among man woman model positive association serum present range without effect high serum level positive associate mellitus
18051929 en study clinical metabolic profile type type mellitus three group group mellitus group mellitus group control clinical history parameter hba1c serum insulin total cholesterol model assessment insulin resistance insulin index significant history DM clinical insulin resistance include increased body mass index ratio also decrease insulin metabolic syndrome high high total cholesterol low presence cardiovascular disorder known contribute mortality need early
17965405 en clinical health known whether similar associate cardiovascular disease mellitus different whether addition body mass index BMI primary care primary care patient aged year day BMI measured presence mellitus patient primary care present study overall man woman BMI on man woman respective BMI increased man woman mellitus man woman respective on statistical significant increase mellitus BMI relationship BMI relationship mellitus patient BMI man woman primary care BMI mellitus major cause mortality
25595322 en evaluate diagnosis risk health among woman gestational mellitus study participant diagnose health little woman test result well general woman provide management medical therapy woman associate poor control complication participant insulin change can reduce on total woman risk increased risk type woman can change risk large positive diagnosis test can improve risk
23217199 en cell number correlate dysfunction patient type mellitus T2DM patient T2DM history disease function analysis perform include measured assess mean age patient year impair lower number vs compare patient impair lower number vs level vs patient impair lower number vs analysis demonstrated impair remain significant associate independent associate number finding suggest dysfunction patient T2DM related increased
25102071 en known negative body mass index BMI subject patient type mellitus T2DM subject mechanism chronic associate obesity increase negative level however whether mechanism T2DM investigate factor influence level T2DM study included T2DM patient among undergo medical correlation examine among fasting sample T2DM patient BMI protein model assessment function model assessment insulin resistance significant positive correlate significant correlate significant positive correlate BMI significant negative correlate analysis show significant finding suggest insulin great role chronic mechanism BMI negative T2DM patient
22316266 en subject mellitus recent evidence suggest diabetic disease also disorder aim study prevalence protein blood cell patient type mellitus T2DM without disease
23233948 en study patient type medical care clinical hospital patient two group group included patient severe complication group included patient without complication profile mellitus patient investigate study show index patient group high control healthy subject positive correlation level blood disease revealed
22185967 en occur increased patient mellitus general factor risk diabetic include age metabolic control complication primary diabetic system may also contribute treatment diabetic patient indicate early diagnosis intervention clinical study compare management compare without well diabetic patient poor glucose control improve care mellitus
21726280 en may patient develop studied relationship measured patient type mellitus studied patient age range year type less year diagnosis patient normal renal function without clinical evidence complication metabolic control adjust patient undergo three test patient metabolic control patient lower value three patient show two metabolic control normal value three patient increased body factor associate subject type known
18779843 en gestational mellitus woman case mellitus diagnose addition adverse outcome associate complication history woman development type mellitus T2DM incidence rate increasing number woman increased risk T2DM diagnose T2DM woman history include early diagnosis review current individual risk T2DM addition T2DM woman history
23822675 en period several metabolic present review period major change occur glucose change development study perform model role mass insulin insulin indicate cause metabolic body develop condition consider suggest metabolic review research analysis less known insulin role ratio review healthy index score relationship insulin resistance profile present review indicate first development glucose disease related metabolic syndrome type mellitus
23469912 en increase due elevated glucose level plasma high glucose plasma protein blood normal function mellitus patient high incidence cardiovascular complication compare population plasma protein hemoglobin three different type several clinical study show associate high incidence cardiovascular disease among diabetic found decrease risk develop cardiovascular disease diabetic patient review several study show patient diabetic individual
23357227 en glucose blood hemoglobin measured glycemic control week identify cause diagnose diabetic perform case case diabetic identify base result among case individual diagnosis mellitus whereas case individual on recent use observed case protein measured increased case diabetic whereas normal case result study identify diabetic also role diagnosis diabetic mechanism may metabolic lead diabetic individual
21458300 en datum suggest patient type mellitus increased risk study high aim study determine prevalence diabetic woman aged year relationship clinical metabolic factor chronic complication prevalence prevalence patient old period lower lower increased age duration disease presence patient prevalence increased logistic regression observed present significant increased age year old presence blood glucose found high prevalence woman type mellitus blood glucose control condition disease patient impair renal function
25303895 en type increase risk develop cardiovascular complication disease mortality glycemic control diabetic show complication related major effect complication include therapy include insulin datum base study assess medication drug medication type event confidence interval CI event follow CI period therapy include evaluate trial result first major outcome study type examine show increase major event relative patient trial compare
20602067 en estimate mellitus DM weight obesity prevalence weight obesity according age year relative risk development DM study weight obesity use DM prevalence weight obesity obtain year DM base two year year total estimate DM DM female weight obesity respective among large observed age large DM individual risk factor target control risk factor weight obesity included health
26703125 en rate obesity mellitus DM disease among chronic patient may contribute high perform review evaluate impact DM body mass index BMI risk among chronic perform identify evaluate association DM BMI among adult chronic study patient chronic disease assessment study cohort two analysis study DM demonstrated significant increased risk associate DM effect range CI CI one three study BMI demonstrated significant association risk BMI vs BMI CI two three study demonstrated significant high risk associate range CI or CI DM associate increased risk among chronic patient BMI may also increase risk current study
26718935 en retrospective analysis clinical datum year old found low prevalence high obesity respective diagnosis result suggest need clinical diagnosis important weight insulin therapy
23034947 en research type mellitus T2DM use therefore T2DM T2DM datum analyzed use research participant lead participant also T2DM value related related health mean
22975642 en aim event type related complication profile serum follow perform activity healthy type diabetic patient complication also observed serum significant increased level activity observed diabetic patient identify present activity among activity type patient datum event target type complication
25975879 en type mellitus found regard one risk health study determine lipid type system study healthy control age study population age group system assess use ratio general blood activity method result study show increased concentration well decrease reduce level significant great level significant great level lower concentration control group great observed period severe lipid
25877002 en disease disease associate metabolic syndrome datum dysfunction development type mellitus T2DM aim identify change function T2DM develop model T2DM use level protein level assess potential activity measured increased decrease reduce activity T2DM group compare control compare T2DM group high level lower activity show difference although level decrease T2DM significant difference two study first identify impair T2DM develop lead dysfunction development T2DM
25812587 en insulin factor investigate change increased diagnose mellitus DM increased decrease found significant protein examine increased whereas similar DM healthy status change due role primary similar three group sample population increased
25479716 en gene important role type mellitus T2DM study aim potential association gene T2DM population T2DM patient healthy control study gene analyzed method datum significant associate increased T2DM model risk factor increasing T2DM finding indicate gene potential related T2DM studied population use evaluate risk T2DM
25050869 en aim study compare effect serum factor level type diabetic patient hypertension type diabetic patient hypertension use study patient randomize two group first group receive group week difference two treatment investigate plasma level patient week value decrease group statistical significant plasma level also decrease significant group treatment respective treatment significant difference change value group respective value show positive correlation level observed drug similar effect treatment study suggest may effect different mechanism effect may important determine drug diabetic
23393677 en mellitus health potential significant negative health outcome include complication relationship hemoglobin hba1c age complication disease well recent evidence suggest glycemic may associate complication hba1c glucose level well glycemic new method assess treat need reduce incidence complication relationship glycemic control complication mechanism treatment hba1c glycemic reduce risk complication review
23259029 en study evaluate diabetic patient without hypertension plasma activity plasma level lipid total measured blood subject type subject without control aged year total activity lipid high diabetic compare group total activity different diabetic compare control lipid significant high group diabetic compare group control significant difference activity well concentration total group studied present datum suggest increased lipid relationship high glucose level observed fasting glucose hba1c level result evidence correlation lipid DM presence hypertension
22392830 en prevalence mellitus incidence need treat current show improve case complication less effective time adverse effect lead new oral known type management type mellitus glucose renal clinical trial demonstrated effective method type reduction plasma glucose level insulin week reduction hemoglobin range therapy oral drug without insulin patient type therapy also result effect may decrease total body weight blood pressure increase profile rate similar common reported patient cause result clinical trial clinical
22382194 en development insulin resistance disease include type mellitus aim association level insulin resistance body mass index ratio role duration disease
21767017 en present study examine method assess within population type mellitus conduct among method assess association among different blood glucose hba1c examine regression analysis conduct determine glycemic control hemoglobin hba1c relationship hba1c demonstrated effect care adjust score hba1c relationship hba1c important examine within different method assess research assess general study result
25888828 en patient system relationship provide study conduct determine baseline level new diagnose diabetic impact care intervention patient care hospital control study among control group test group test group new diagnose mellitus patient method month patient use evaluate patient score baseline three month test group patient provide care whereas control group patient receive care response datum normal test test test test test use difference among group intervention significant patient score test group test test identify significant difference score test test group control test group control test group care intervention significant improve level diabetic test group compare control group diabetic level among test group patient therefore care patient disease patient related outcome level also improve system
26582348 en effect due gestational mellitus retrospective study woman hospital perform first use blood glucose test value use glucose test value positive oral glucose tolerance test perform woman remain woman control group first positive rate significant high group control group vs positive value significant lower group vs significant difference observed positive rate first
26219405 en aim present study serum level lipid profile index activity insulin resistance use model assessment insulin resistance assessment correlation gestational mellitus compare normal on study patient woman normal group healthy woman test correlation analysis use statistical analysis on value less consider significant serum activity significant high compare normal significant decrease however activity show significant difference two group serum level significant decrease group index index significant high serum activity show positive correlation total cholesterol group serum level total correlate negative woman serum activity correlate positive group increased index decrease risk factor
21220732 en mellitus impair cell function mechanism negative target found condition mellitus high low factor normal condition control activity improve high factor identify target high factor obtain evidence increased diabetic blood investigate target gene diabetic patient control patient undergo use diabetic high correlate protein plasma level also elevated diabetic datum suggest possible target diabetic patient
21189429 en independent risk factor dysfunction diabetic patient consider early diabetic investigate correlation patient mellitus method study patient man woman type mellitus serum ratio determined metabolic parameter include lipid profile hemoglobin rate body mass index blood pressure blood glucose assess well result mean age patient year old serum level patient respective among patient clinical metabolic syndrome level diabetic patient without syndrome group significant relationship serum fasting blood glucose hemoglobin rate serum level significant correlation found cholesterol level age duration mellitus body mass index serum level correlate positive ratio show high serum concentration associate great patient type mellitus
27278477 en intervention increase patient disease present study evaluate potential clinical age concentration patient clinical diagnosis type mellitus subject year T2DM ratio receive care age age cell evaluate week month treatment significant decrease age follow-up time age decrease week month month treatment respective significant decrease week respective remain significant reduce month significant increased week finding provide evidence decrease concentration patient T2DM month treatment
26924648 en common complication mellitus DM chronic disease increase mortality patient however whether DM increase mortality patient remain patient first use health database ratio mortality use regression identify patient first among patient mortality respective respective mortality confidence interval CI CI patient CI CI patient DM DM increased mortality respective compare without DM mortality female patient DM respective patient DM identify DM increased risk mortality day year
25295740 en show important role disorder two major study evaluate profile major gestational mellitus healthy woman finding indicate level patient compare control group however group patient compare healthy control participant therefore development
25214435 en great syndrome several complication may adverse outcome medical treatment outcome syndrome case early possible present early gestational mellitus development possible role early disease development
25591893 en perform study investigate effect renal function patient type health mellitus database type diabetic patient aged year first identify datum health database health care datum renal disease use estimate rate baseline follow-up year compare total new new included follow-up day day baseline group found significant change confidence interval confidence interval treatment associate significant change renal function type diabetic patient
26323125 en type use treat disease year according recent study found multiple activity include blood glucose lipid type diabetic diabetic cardiovascular disease diabetic complication report effect blood glucose type complication provide study
21714436 en factor related treatment type mellitus medical study influence factor treatment patient studied medication relationship treatment included patient mean age year year diagnosis DM patient medication high rate vs associate related association found medication associate man associate treatment factor consider management disease
21250861 en evaluate treatment insulin therapy patient type mellitus improve study use medication assess overall drug therapy treatment three patient previous treat oral drug improve study baseline week week mean score week respective overall score respective regard significant improve treatment week compare treatment oral drug week major event occur study result indicate adverse patient insulin
22786924 en whether gestational mellitus associate increase study woman two control case health year year datum regard provide patient system period year year previous high mean number total year compare control also related year woman diagnose compare control woman diagnose use health care odd ratio confidence interval age time whereas case diagnose control high woman year compare associate high woman diagnosis result follow woman early effective management may potential improve health
26930050 en datum prevalence treatment control hypertension individual type mellitus T2DM may reduce mortality associate cardiovascular disease study examine clinical hypertension among individual T2DM study sample individual T2DM hypertension general hospital hypertension define blood pressure great blood pressure great report perform logistic regression analysis identify significant total participant prevalence hypertension analysis participant year status positive associate hypertension logistic regression method analysis status independent significant associate hypertension significant association increasing number drug hypertension hypertension high individual hypertension T2DM study population status important hypertension T2DM treatment blood pressure target
26792761 en use increasing adverse effect type mellitus T2DM risk assess T2DM risk associate treatment without database may datum analysis perform analysis study T2DM incidence year old little independent datum T2DM outcome T2DM T2DM risk T2DM incidence rate per outcome included outcome control receive healthy study included include mean age patient year mean follow-up year among study included control patient study included healthy control patient T2DM risk CI per patient incidence rate CI case per compare healthy control T2DM risk odd ratio or CI incidence rate ratio CI significant great similar compare control significant high T2DM risk or CI CI analysis study great T2DM risk associate follow-up great T2DM incidence associate less disorder diagnosis T2DM risk incidence significant high healthy control control treatment time risk factor T2DM development use duration
26208673 en recent study show reduce evaluate response glucose response among normal glucose tolerance impair glucose tolerance mellitus study patient known disease undergo oral glucose tolerance test assess use fasting glucose decrease index rate blood pressure without significant change glucose decrease group DM group change glucose DM group compare group vs vs logistic regression analysis identify DM independent factor associate presence response glucose glucose decrease without significant change response patient DM
24561392 en lower level associate increased risk among woman however whether associate glucose woman examine whether concentration measured associate risk gestational mellitus study among woman health woman case patient woman develop two control subject case patient year blood age age number high concentration odd increased odd ratio CI adjust history BMI use weight change model assessment insulin resistance level BMI associate increased odd compare woman level concentration associate increased risk identify woman risk early
24107738 en increased risk cardiovascular mortality associate hypertension patient type mellitus blood pressure control therefore important primary study evaluate effect low therapy hypertension patient type measured evaluate effect control well adverse randomize study patient blood pressure therapy included one previous treatment increased two blood pressure week blood pressure measured baseline study patient randomize blood pressure reduce also blood pressure pressure reduce significant ratio significant reduce group control remain adverse event reduction three case one whereas significant ratio effect patient hypertension type mellitus
21311214 en disorder function important mellitus type type known condition cell associate level normal condition cause development mellitus lead decrease disorder present consider change protein important role several protein effect low high level also consider level one treatment disease however new studied
22616225 en level protein assess patient present severe examine total patient aged year patient type mellitus diabetic patient found severe disease analysis level protein diabetic patient significant show high level total protein compare patient correlate elevated level protein hba1c obtain finding suggest high level protein mellitus presence chronic patient without mellitus high method determine protein examine patient improve diagnosis condition revealed decrease risk development complication
25627894 en aim study determine effect obesity gestational mellitus concentration gene normal glucose woman woman included study clinical parameter analyzed woman BMI group group group respective serum factor individual determined method analyzed group group significant high group lower group group significant difference group serum significant positive correlate model assessment insulin resistance assess obesity may contribute serum serum associate insulin resistance gene may role patient individual patient
25461394 en recent insulin influence role patient gestational mellitus assess determined serum level patient well healthy body mass index gestational control correlate well glucose lipid renal function serum level significant different patient healthy control analysis revealed gestational age blood independent positive level level independent negative associate BMI protein major contribute well gestational age renal function
21857525 en mellitus DM reported associate increased risk several type however relationship include remain conduct assess association risk include identify study relative risk confidence interval model on total cohort study included study number report DM risk follow compare without individual increased risk CI revealed evidence risk include finding positive DM increased risk include
25962253 en glucose new group oral medication treatment type mellitus patient medication glucose therefore increasing glucose found effective hba1c level study oral medication mechanism risk factor insulin therapy medication treatment type patient also severe renal adverse effect increased risk review medication evidence profile
23643352 en study aim assess relationship blood pressure function patient mellitus total patient DM aged year woman man mean age year included study relationship blood pressure test determined use correlation regression blood pressure associate lower score assessment time test lower score test less model relationship adjust level association lower blood pressure poor function cohort DM patient result patient DM suggest blood pressure may effect function large study result
22385105 en history gestational mellitus type woman however association type studied woman history woman without history aged year first study database history use type mean follow-up year woman develop type adjust ratio type confidence interval CI among woman compare woman without age body mass index BMI similar result compare woman without history relative risk type high woman woman history compare woman woman year time high risk type history type among woman among woman
24422361 en study identify change treatment several develop management datum two week duration population datum follow-up study large patient control follow on patient two oral common follow patient insulin common insulin follow insulin blood glucose patient associate glycemic control glycemic control type patient hba1c poor outcome patient insulin patient hba1c assessment diabetic control need evaluate patient
23438319 en study association mellitus weight compare weight ratio without association weight also estimate odd ratio without age weight weight diabetic diabetic high weight compare high ratio odd ratio high weight confidence interval diabetic odd ratio confidence interval diabetic weight well weight relative high
27383876 en mellitus DM estimate patient result study DM may also correlate examine correlation DM function patient hospital patient included study examine mellitus patient undergo patient receive medication DM new diagnose DM DM associate reduce function however DM associate reduce function hba1c negative correlate positive correlate patient high risk impair glucose DM associate function lower disease patient may blood glucose level
27299822 en function cell level may metabolic disease type mellitus concentration several type serum profile identify patient development chronic complication important profile treatment metabolic disease activity change response different cardiovascular may important role correlation serum level suggest role chronic may mechanism effect activity patient metabolic disease
27193707 en effect treatment model type mellitus activity system studied show treatment system type type influence significant function insulin system datum suggest new target mechanism may effect impair diabetic
27075282 en on man diagnosis history type mellitus due undergo medication finding intervention perform blood effective
27030121 en clinical trial patient type mellitus T2DM show effect glycemic control complication show cardiovascular event drug new drug cardiovascular result number cardiovascular outcome trial T2DM conduct examine cardiovascular drug renal new drug subject T2DM result cardiovascular outcome trial compare demonstrated drug result cardiovascular outcome trial compare treatment associate significant reduction primary cardiovascular outcome although regard positive effect glycemic control cardiovascular risk current evidence suggest aim also cardiovascular risk factor reduce risk cardiovascular event patient T2DM
26905348 en compare less ratio renal patient type mellitus retrospective study perform hospital included patient mean age female T2DM level less consider normal consider consider observed sample positive value negative value range characteristic analysis value great revealed renal T2DM
26803383 en use primary patient high risk mellitus DM patient DM disease however patient may present study evaluate patient high risk DM without syndrome history disease prevalence association presence number cardiovascular risk factor evaluate score range patient define patient number risk factor associate presence hypertension risk factor associate high odd ratio CI odd ratio CI patient high risk DM without syndrome whereas patient number risk factor associate presence hypertension risk factor associate high potential use therapy patient high risk DM
26674569 en impair regard factor study evaluate plasma level association risk T2DM included individual T2DM patient T2DM patient without control subject without test plasma level odd ratio or confidence interval significant decrease level T2DM patient compare healthy subject T2DM patient without show statistical lower serum level healthy subject level lower T2DM patient compare T2DM patient without analysis revealed association examine risk examine associate T2DM patient obtain result suggest system may significant role development
25335866 en increased prevalence type mellitus T2DM associate obesity age also recent test high concentration associate T2DM plasma sample obtain adult female without T2DM two medical on method plasma use develop three logistic regression indicate increasing body mass index BMI associate T2DM T2DM odd ratio BMI increased association T2DM increasing plasma adjust age base BMI observed increasing concentration associate T2DM old individual lower study sample high risk T2DM increasing concentration old normal weight relative lower risk associate increasing concentration
23714100 en study determine relationship among type mellitus DM type mortality year age included hospital diagnosis type DM total female patient mean age year patient three group patient without type DM group on patient type DM group patient type DM without group ratio ratio evaluate impact type DM mortality study participant diagnose type DM patient follow group on patient group patient group patient group patient high renal low patient mortality rate group significant high group on type DM associate increased mortality ratio incidence type DM patient different type range among patient type DM significant great impact mortality rate patient associate relative low mortality
26119433 en current regard diagnosis gestational mellitus per new association study group studied prevalence association diagnose conduct study woman lower woman week week oral glucose tolerance test diagnose prevalence confidence interval CI woman diagnose fasting plasma glucose level woman respective factor significant associate weight similar woman compare normal glucose tolerance group fasting glucose level associate weight patient level associate weight score high prevalence rate use woman low study need assess
22183128 en research regard early trial development complication type mellitus disease patient perform therapy age disease diagnose
24156868 en metabolic result insulin increased treatment type mellitus T2DM treatment effect glucose individual T2DM although mechanism difference characteristic effect parameter effect fasting plasma glucose glucose great reduction little impact plasma effect subject occur due elevated plasma concentration treatment contribute effect found evidence suggest target glucose therefore use therapy insulin important new treatment individual T2DM
17964833 en high activity may role development type mellitus history activity mellitus control retrospective use logistic regression analysis use investigate association development mellitus significant correlate development mellitus whereas low activity result indicate may independent risk factor development type mellitus whereas
25123863 en determine effect included study great weight great group group receive control group receive group receive group receive group receive group receive determined perform different group decrease significant assess compare control group group decrease blood glucose condition effect
24272885 en study compare medical treatment type mellitus T2DM patient study compare weight metabolic parameter evaluate vs low insulin T2DM patient BMI target hba1c mean age patient year woman mean duration year mean hba1c primary body weight mean duration follow-up month group respective glycemic outcome improve mean hba1c group group hypertension patient respective group decrease increased significant compare group score improve compare T2DM patient weight score
23793482 en base high risk type high gestational mellitus risk compare however previous study reported lower risk examine whether risk lower whether age group cohort hospital datum use regression model examine risk age adjust body mass index BMI overall lower prevalence vs high DM vs among woman risk ratio year age risk ratio risk lower change BMI among woman year risk ratio year risk ratio risk high risk high BMI association BMI risk age group lower risk age BMI high risk old age large due old age
27055966 en insulin resistance factor gestational mellitus associate lipid profile lipid normal treatment evaluate lipid diagnosis treatment influence BMI insulin glycemic control study total cholesterol measured diagnosis week treatment analysis perform according BMI insulin glucose increased decrease respective respective patient show increase whereas group vs increased patient glycemic control decrease vs vs significant difference lipid observed according glycemic control status lipid profile woman
20832533 en mellitus common metabolic complication renal study revealed characteristic patient present study included obtain participant study related patient whereas compare group patient group according group group incidence compare group patient group according age group age year old group age year incidence compare patient low use significant difference incidence group incidence group significant high receive patient high risk develop significant increase incidence
23500237 en study examine use subject type mellitus disease chronic remain treatment without high effective also may improve glycemic control provide several potential group conduct randomize trial test patient type subject chronic randomize trial patient treat patient randomize week target use primary outcome number week total patient randomize mean age year man mean duration year mean baseline hba1c datum group significant lower confidence interval CI vs CI use CI vs CI difference incidence adverse event patient chronic treatment reduce use well type subject chronic
23802207 en need insulin therapy reduce patient health system insulin potential lower insulin similar effect adverse study outcome profile insulin clinical study insulin study insulin primary change hba1c baseline adult patient type type baseline hba1c overall cohort month month increase total insulin use type type cohort significant difference weight study subject period little control insulin reported new severe adverse event increased use insulin potential significant
22345692 en diabetic patient disease impact multiple risk factor intervention disease investigate diabetic patient undergo change clinical compare patient according whether increasing treatment individual risk factor hba1c cholesterol blood pressure high protein high rate medical therapy use patient insulin difference observed regard total baseline observed increasing risk factor treatment analysis adjust baseline risk factor increasing number factor treatment associate impact control multiple risk factor need risk patient
25889724 en study examine diabetic patient relative care include need use patient type hospital assess use identify diabetic complication important need use low time patient current patient need well obtain can potential important
21271474 en cell study primary cell high high risk positive target treatment cell cell cell result disease regression complication on aim severe reduce
21126899 en clinical type first revealed gestational mellitus review woman revealed index age BMI woman year woman little one risk factor woman outcome previous include diagnose week range two three treat insulin time diagnosis week range range week outcome include two reported insulin therapy woman month range diagnosis index may woman without risk factor associate poor diagnosis treatment whether perform woman studied
26648212 en chronic disease metabolic change may factor system due age however study association mellitus DM hypertension show study need effect chronic disease compare patient DM DM control group study conduct assessment subject group DM DM without chronic disease known test level statistical significant difference group mean DM show statistical significant difference however statistical significant difference three group DM group several evaluate found old adult DM hypertension associate show great group suggest effect two chronic disease
23748520 en blood glucose level provide important regard glycemic control patient hemoglobin hba1c level glycemic control patient type type T2DM treat insulin well potential role patient T2DM treat insulin remain may lead population treatment intervention associate significant hba1c level patient T2DM insulin management provide glucose response provide patient management study show patient perform treatment intervention patient patient datum well target blood glucose hba1c level range potential role intervention glycemic control use datum datum analysis review management patient T2DM treat insulin effective treatment intervention population
24397157 en recent year significant increase number patient among population number estimate increase great impact among population among patient due although important treatment population case patient increased therefore treatment population patient need care patient
24628007 en evaluate fasting serum level woman without gestational normal glucose level measured serum woman gestational woman normal glucose tolerance two test month woman gestational normal glucose tolerance serum level group gestational lower mean serum level compare group normal glucose tolerance vs group normal glucose tolerance mean serum level decrease significant remain significant high level group gestational significant level associate increased level may reduce insulin resistance glucose woman gestational however severe reduce level remain low may contribute insulin resistance glucose high type risk associate gestational
26393578 en type cause cell cell model population function function cell however role cell mechanism remain subject therefore evaluate cell blood diabetic condition condition cell significant high cell significant lower patient control ratio cell high patient control suggest cell patient total cell change patient control cell observed diabetic total cell lower patient datum suggest cell diabetic due lower
24217118 en intervention known management type mellitus T2DM aim evaluate patient T2DM effect lipid studied patient T2DM year patient T2DM perform type patient evaluate protein T2DM patient show significant lower body mass index compare patient T2DM patient show significant lower level T2DM patient body mass index patient compare present high level lower value significant woman present lower level compare patient T2DM reduce level suggest
21839888 en prevalence type show significant increase health care study study estimate type care health care different level health care on total medical datum analyzed medical included medication test blood glucose test included early care per patient per patient per patient duration level health care increased patient complication high per patient compare per patient per patient complication great medication treatment lead elevated health care system increased duration disease level care presence chronic complication need health primary complication
20800300 en change condition increase increase general prevalence population high identify several evidence high number disease mellitus DM age glycemic correlation factor obesity factor disease case DM old age mechanism one several clinical difference therefore review three correlate age age subject
23613868 en mellitus major risk factor chronic investigate effect type group subject without subject type diabetic patient without type diabetic patient on total compare healthy sample sample identify subject healthy three significant different diabetic patient subject three two also significant different diabetic result show type mellitus can
27075368 en mellitus disorder mellitus present within first week age month however patient increased risk develop mellitus type mellitus cause one mechanism on patient include patient factor investigate whether analysis perform individual three relative control status patient use found large among patient number two patient within found patient common patient associate found one within patient included study study provide disease
27052281 en investigate among type mellitus patient possible correlation age diagnosis duration glycemic study conduct hospital on total patient serum hemoglobin patient female mean age year positive positive positive positive patient show positive one case positive significant correlation presence age diagnosis duration body mass index glycemic prevalence disease high among patient remain low associate significant correlation age diagnosis duration glycemic control presence found
26879309 en increasing rate obesity new gestational mellitus overall prevalence increasing woman increased risk complication well risk include high prevalence type mellitus cardiovascular disease recent year role increasing current regard woman
19477374 en previous study effect function well effect effect patient patient decrease improve function however remain impact mellitus aim study investigate effect retrospective patient mellitus among patient receive group remain patient control group study significant difference patient profile two group cholesterol level high group follow-up period two year rate significant less patient mellitus renal function
24397166 en impair activity healthy disorder control treatment disease provide dysfunction diabetic control function increased risk metabolic medical treatment impair several medical care need recent evidence target glycemic control use medication diabetic
25509884 en datum new diagnosis treatment mellitus diagnosis DM adult may identify metabolic study datum individual population risk DM present effective therapy analysis patient drug
25160194 en regard known can also health care first mellitus DM whether can improve DM therefore several use case chronic disease care
24373233 en body important glucose new drug mellitus development also target provide show glucose
26384311 en increasing disease include mellitus DM control evidence patient DM cohort care provide assessment first aim determine among type DM patient care outcome include care define little within year factor associate care follow-up care measured include control
25608545 en study investigate effect use woman gestational research study control group study woman gestational hospital participant study control group group group group statistical analysis perform use significant decrease fasting blood hba1c group compare control group however significant difference found two group gestational use study found effective reduce fasting blood hba1c use clinical effective intervention woman gestational
25024326 en several study reported association type T2DM study association T2DM evaluate association T2DM year year study compare participant normal participant study diabetic status base diagnosis treatment medication perform group regard participant without T2DM logistic regression model adjust age cardiovascular risk factor use determine association T2DM group adjust model show association odd ratio CI T2DM man total man woman T2DM associate whereas association man woman found total association T2DM datum show T2DM associate participant result indicate T2DM
24579966 en study investigate association hba1c type mellitus T2DM result aim study determine compare serum concentration patient T2DM healthy control assess correlation hba1c patient T2DM serum concentration determined method use hba1c level determined method patient T2DM healthy individual age result show mean serum concentration significant high T2DM patient compare mean serum concentration healthy subject on significant positive correlation serum concentration hba1c level observed T2DM patient result suggest association dysfunction control type mellitus possible obtain result may increased condition also dysfunction large study evaluate metabolic increased level patient type mellitus
21450445 en type mellitus associate reduce first investigate relationship clinical independent function test adult year age different hospital two year period review patient base patient included analysis use regression examine difference patient without adjust age BMI old vs vs vs vs high BMI vs compare patient without woman among two group similar mean value patient lower without remain significant reduce vs vs clinical patient decrease function compare independent
27310543 en evaluate group patient gestational mellitus woman diagnose gestational included diagnosis gestational patient group receive medical related disease three day patient receive one regard receive statistical analysis result present relative patient patient glucose patient reported blood glucose whether woman patient woman woman reported day treatment patient blood glucose control observed great need well patient management
21955960 en examine change diagnosis patient database type aged year diagnose follow little month test perform compare patient group according type study patient year diagnosis follow type type patient type significant positive disease patient significant lower value patient type also patient patient database diagnose type retrospective
21883978 en aim present study evaluate possible clinical influence management patient type mellitus total individual T2DM little month study level status determined use score use range datum evaluate use test mean age study participant year score respective poor glycemic control significant high mean total score individual glycemic control vs respective significant relationship score glycemic control present study factor influence glycemic control addition study population duration age patient index
26732157 en use blood method diagnosis diabetic fasting common normal evidence increased among woman gestational mellitus level related impair development report blood woman follow
26496985 en effect gestational mellitus study examine group woman index year previous compare group woman normal glucose tolerance index time sample included woman association study group index sample cohort population measured use difference group significant adjust effect negative increased BMI glucose tolerance group positive associate group negative association high diagnosis adverse effect year index diagnosis lead development adverse effect glucose tolerance woman adverse effect use
19302691 en clinical characteristic compare common known type type mellitus DM type review common clinical type DM type DM related type DM use type however treat type consider diagnosis patient new previous identify mellitus type DM insulin resistance significant history statistical diagnosis normal weight show little evidence insulin resistance history patient type great history patient disease change may occur patient age complication patient diagnose therapy
25088876 en case man develop mellitus period treat oral therapy patient treat insulin one month without clinical oral glucose tolerance test revealed impair glucose tolerance treatment potential glucose consider patient impair glucose tolerance treat relative low oral period
24680263 en determine within year disease patient mellitus retrospective analyzed clinical datum patient undergo hospital use number total case two cohort model cohort model cohort case group control group identify use logistic regression analysis value base logistic regression model model score case case test case case diagnose within year incidence within year case logistic regression analysis identify risk factor multiple target or or or or age year old or or risk score well associate rate score incidence disease patient mellitus within year relative low several factor associate patient risk can identify model
26148393 en obesity major risk factor development mellitus DM body mass index BMI base weight identify patient risk develop DM report relationship DM BMI use datum primary care included study age on population patient obtain participant weight BMI status known diabetic diabetic population identify patient normal diabetic population BMI increase incidence mellitus patient old year age
26030946 en assess influence mellitus DM function metabolic syndrome patient patient aged year chronic disease study patient two group without DM DM age level metabolic syndrome individual assess patient undergo test assess function well test blood pressure measured body mass index BMI measured high patient metabolic syndrome DM CI according compare patient without DM according test result metabolic syndrome associate include therefore treatment metabolic syndrome individual mellitus reduce risk CI improve
24203844 en history normal remain therefore investigate difference among group hypertension body mass index mellitus normal group population use study participant age regression compare normal year age change associate great normal group year age increase age group normal group difference age significant great year age year age year age hypertension obesity mellitus associate significant large age compare normal group condition result difference significant increased presence effect year age
24120602 en aim study change blood patient study patient multiple blood different time level first value factor ratio determined change value factor blood patient studied decrease result blood group reduce ratio interval blood correlation observed interval change interval change ratio level blood patient mellitus may patient control
23949624 en previous study reported association mellitus DM investigate risk subject DM population perform present cohort study analysis one individual health period study cohort new diagnose diabetic patient subject aged year year cohort follow incidence found incidence DM cohort time cohort vs per rate ratio factor ratio DM subject remain significant high subject model increased old female increase risk confidence interval CI analysis CI study period found DM independent risk factor risk high woman finding present study identify patient group early care DM subject
23943337 en patient mellitus DM increased contribute therapy patient DM however effect profile patient DM disease therapy poor aim patient DM day assessment conduct use without also show significant reduction significant reduce treat patient significant reduce treat patient DM patient effect multiple datum effect therapy finding
20561594 en mellitus complication cell important negative impact cardiovascular health risk factor well define conduct study investigate risk factor incidence first day on total patient study develop logistic regression model level odd ratio or confidence interval CI or CI or CI identify independent addition overall patient compare without mean year vs year level great cohort also associate mean year vs year model disease ratio CI level CI independent adjust mellitus period may contribute insulin resistance study first report risk factor early patient undergo identify independent
21762250 en aim study investigate difference rate among patient without mellitus relationship study population included patient patient group without group control group control assessment use time normal interval index measured use value significant control group without addition group lower normal interval normal interval indicate activity high ratio indicate elevated activity control group without correlate elevated patient without patient lower time high ratio analysis identify patient high risk event
23502672 en study clinical outcome mellitus cohort study retrospective study diabetic care diagnose less one year age studied study age weight blood glucose serum hba1c serum level outcome insulin associate condition analysis outcome study follow studied DM less year age present diabetic diagnosis DM first less month month low weight study group low level less month month syndrome common type diagnosis insulin oral diagnosis metabolic common mortality year follow less month low weight common common condition diagnosis change therapy oral
17102551 en several report syndrome without patient treat medication therapy first case patient syndrome treatment
22547464 en role glucose therefore may provide mellitus renal glucose renal glucose reduce plasma glucose level well decrease body weight insulin independent improve insulin resistance mellitus develop evaluate clinical trial trial need assess result suggest effect without development significant effect
22814843 en glycemic control diabetic patient diabetic patient control report observed poor control report control mellitus
19774332 en study estimate risk develop adult ratio datum individual without obtain baseline cohort model use estimate rate ratio difference difference ratio mean follow-up period year incidence per year follow-up woman man woman man respective ratio CI per difference man woman woman man adjust age history status weight age ratio per difference ratio follow independent related increased risk man woman suggest factor may risk different
22306677 en mellitus important condition treatment metabolic complication diagnosis improve outcome patient insulin oral case reported report found baseline insulin analysis perform age year conduct level increased hba1c month oral treatment patient oral also effective diabetic control study
23824324 en retrospective analysis analyzed clinical datum medical evaluate association treatment glucose patient prevalence significant high patient treat patient treat odd ratio independent age BMI on possible role need investigate
18518815 en on develop chronic development include identify increased serum activity develop clinical finding chronic mellitus multiple test include serum analysis serum insulin concentration function year receive insulin glucose blood glucose range clinical mellitus occur although decrease severe develop associate diabetic severe found cause common without mellitus occur chronic insulin therapy consider
23719847 en prevalence primary patient hypertension hypertension complication type mellitus DM relationship two disease however patient DM hypertension prevalence patient DM hypertension patient DM hypertension diagnose according patient examine prevalence compare clinical characteristic patient without analysis patient diagnosis compare characteristic patient without DM overall patient DM hypertension diagnose logistic regression show duration DM significant group test revealed history hypertension diagnosis DM significant factor patient treatment diagnosis patient among patient DM significant old diagnosis significant compare patient without DM patient DM hypertension patient DM hypertension use
21739900 en subject mellitus total study period month diabetic patient type type on type age common adult year respective patient receive female one patient among little common diabetic patient effect observed diabetic patient base result retrospective study diabetic patient provide severe case significant impair system due mellitus consider measured risk diabetic patient provide general risk group may potential
25577340 en group reduce age age normal system cell however age may cause disease day show change type patient disease duration year significant high compare patient year disease duration may important assessment complication type mellitus patient
20332124 en examine relationship dysfunction prevalence incidence type cohort type mellitus follow incidence define outcome serum protein cell serum total measured logistic logistic regression use datum duration factor odd ratio or confidence interval CI or CI or CI or CI associate or CI associate finding suggest role dysfunction development diabetic type mellitus
27528260 en development diabetic high system elevated level cause mellitus little indicate factor decrease diabetic role factor factor protein development new cause recent year function factor increased however need contribute association blood review show new role factor diabetic may provide base factor diagnose treat early
26980701 en increasing role disease on body evidence randomize control trial study study show may effect risk increased risk may clinical study drug although first potential role risk outcome early clinical trial show increase risk event analysis risk relative metabolic role effect reduce level may patient mellitus patient population high cardiovascular risk therapy may provide great level mechanism
26629726 en method use ratio diabetic patient disease determined ratio analysis level method also obtain method diabetic patient healthy ratio present method hba1c value blood diabetic patient whereas due method healthy analysis target target method important
26568400 en disease management mellitus DM disease treatment lipid disorder current aim compare drug lipid effect outcome high cardiovascular risk DM compare patient care year follow-up patient known DM disease lipid target clinical according drug use care total patient mean age year DM DM patient compare patient factor patient group target level low baseline vs month vs month follow-up vs cholesterol patient baseline follow-up treatment include mean remain large target rate high time DM group study lipid disorder diagnosis treatment potential cause follow-up period relative compare high control rate overall lipid target rate need improve need finding
26538373 en aim study compare outcome mellitus DM patient according total DM patient receive according normal chronic disease severe severe rate respective mortality rate logistic regression analysis independent renal major complication mean follow-up period year range year estimate respective significant decrease function independent major event ratio severe overall severe factor overall DM patient outcome influence
26503846 en recent system measured elevated level plasma development obesity mellitus DM aim investigate gene associate obesity study cohort examine cardiovascular cohort associate obesity DM significant individual major associate elevated BMI age association BMI cohort whereas significant association major DM cohort major associate DM or CI contribute datum indicate DM development datum relationship system body weight
22826980 en indicate effect aim study examine whether treatment blood glucose concentration normal range can improve study patient type mellitus type insulin therapy patient follow period month metabolic control metabolic control included concentration blood glucose hba1c lipid status control included study blood glucose hba1c month insulin therapy blood glucose hba1c month improve found significant association metabolic control finding suggest metabolic control influence parameter patient type mellitus
22395343 en common woman mellitus DM different DM present studied study first case woman present hospital may retrospective woman glycemic status evaluate hospital management follow-up status found patient study high blood level woman diagnose new study show DM present woman therefore woman evaluate DM
22302159 en study report characteristic patient type mellitus disease duration glycemic control study on total patient study healthy control group according age subject undergo analysis use on use normal three severe normal significant difference diabetic patient control significant difference mean score parameter diabetic patient control mean score high group diabetic patient poor glycemic control significant high mean score overall compare control value respective also diabetic patient poor glycemic control compare control value patient type mellitus poor glycemic control significant difference compare control
22594103 en determine effect factor model mellitus use high treat week change factor level factor level DM improve positive effect DM reduce level factor increasing level
22420866 en response lead whereas result less healthy patient mellitus cause reduce cause early related aim study examine effect patient perform patient diabetic patient score use patient without on test perform patient patient score total determined also test perform difference score patient mellitus effect related patient
22283370 en prevalence mellitus DM aged study blood sample assess hemoglobin hba1c clinical parameter diagnosis DM complication known DM DM difference man woman DM vs hypertension vs DM without DM medication vs hba1c less serum glucose level great DM associate mortality cardiovascular disease reported age age aged old mellitus risk factor cardiovascular disease mortality old age high rate use medication clinical correlate DM observed
25186500 en evaluate dysfunction woman gestational investigate woman gestational total woman gestational healthy woman study studied profile woman group week week month year total woman gestational healthy woman follow-up year woman gestational dysfunction healthy woman dysfunction prevalence high woman history gestational healthy woman difference statistical result present study prevalence high woman history gestational healthy woman woman gestational woman previous dysfunction year
22139985 en due recent change patient type mellitus health care system several insulin lead change insulin multiple primary blood glucose control severe patient perform patient new therapy due therefore included cell complication risk high potential first therefore whether patient type severe renal potential risk consider high patient possible patient patient perform patient type mellitus glycemic level patient risk complication associate risk previous patient type renal function risk review current evidence new
25491476 en cell include cell cardiovascular disease treatment potential consider due activity however therapy analyzed patient chronic disease disease mellitus type patient without cardiovascular disease metabolic disorder control group patient patient T2DM similar patient patient T2DM high activity compare control patient condition cell effect significant decrease patient T2DM compare control group revealed significant high factor factor factor patient factor patient T2DM among level condition significant high patient T2DM compare control group condition activity activity significant patient T2DM can effective cell therapy cohort patient due factor change patient T2DM mechanism cardiovascular metabolic disease develop use method
25280207 en disease common cause on disease may provide treatment chronic disorder recent year possible insulin disease cause change include improve use insulin show reduction insulin also insulin may also role decrease glucose patient disease insulin therapy may effect function patient disease well adverse effect clinical trial datum insulin patient type mellitus possible disease provide use insulin disease patient
25251286 en one type mellitus DM patient due patient previous condition associate poor glycemic control develop disorder provide treatment patient identify risk factor DM patient develop assess show DM patient aim identify risk factor DM patient use association clinical found age need risk factor
24051132 en relationship use remain patient mellitus high risk indicate use relationship cell incidence diabetic cohort type diabetic patient identify health database year follow early diagnosis on regression model use estimate ratio incidence compare use on analysis examine association diabetic cohort identify follow-up time year total case case develop analysis show decrease risk use confidence interval however relative risk female adjust effect association use confidence interval similar finding statistical significant association use incidence diabetic patient effect
22563104 en mechanism increased risk patient type evaluate association oral insulin insulin total patient new diagnose type identify health database period patient included case control logistic regression model estimate odd ratio or confidence interval CI medication total case diabetic control included on significant increased risk overall incidence found use insulin or CI or CI significant increased risk found or CI drug or CI use insulin associate high risk whereas associate increased risk result show increased risk overall little insulin therapy associate risk
21735660 en investigate effect therapy treatment case mellitus randomize treatment group control group undergo fasting glucose follow therapy two group receive treatment two group show incidence significant lower treatment group control group therapy mellitus patient period also improve reduce
21649521 en obesity metabolic syndrome mellitus increasing clinical adult impact disorder need effective disease management include use health care system known regard clinical disorder clinical condition associate correlate obesity metabolic syndrome mellitus management treat may obesity metabolic syndrome mellitus
20046232 en major role type mellitus cardiovascular disease include hypertension low level level major role effect show study investigate pressure therapy management hypertension chronic relative low concentration body current body current one time current range current range patient hypertension treat patient treat day week assessment base use pressure development patient blood pressure blood glucose level medication treatment month according response result show mellitus hypertension well control use patient reduce medication treatment effect reported mechanism
26846080 en system increase recent year associate insulin development control insulin blood glucose level control insulin use insulin level primary blood glucose level change cause range factor review model blood glucose level control system system two major model system however blood glucose level control development treatment
26100762 en aim study investigate first serum level evaluate value develop gestational mellitus total woman develop healthy woman study first serum level evaluate determine association use logistic regression first serum level or found significant associate increased risk statistical significant difference serum level group also serum level found adverse outcome first serum level significant associate increased risk
25982353 en show high reported report two case mellitus disease patient respective patient man present several year base perform also perform show presence identify method on oral therapy low well early diagnosis disease provide high effective method disease potential patient
20368737 en on female type mellitus diagnose age week patient result history plasma mellitus syndrome result oral insulin treatment glycemic control level hba1c
27086799 en treatment adverse effect mellitus DM major complication chronic disease investigate prevalence risk factor DM patient retrospective analyzed patient diagnose patient without DM also patient DM receive incidence rate new diagnose DM analysis show DM occur old patient confidence interval high serum level on regression analysis revealed factor DM disease use lower year rate DM group respective significant difference group occur patient old age disease high serum level risk factor lower risk factor new DM DM influence patient
26381748 en aim study compare prevalence mellitus DM patient recent diagnose cell conduct review study cohort cohort population provide prevalence DM time diagnosis patient index control odd ratio confidence interval use study patient control identify included datum analysis demonstrated statistical significant lower prevalence DM among patient or CI diagnosis patient lower prevalence DM whether DM can factor development need
20564914 en study association disease type study conduct two cohort patient retrospective datum well need diagnosis study statistical method assessment prevalence disease cohort compare control group value cohort patient prevalence patient great control value time high patient prevalence control group prevalence high time prevalence cohort lower value respective found patient prevalence low patient association can age difference patient risk factor
20101010 en study evaluate whether intervention diabetic patient type mellitus evaluate effect multiple factor association development diabetic patient type mellitus cohort study patient type receive treatment hemoglobin hba1c less blood pressure less blood pressure less cholesterol less less cholesterol great man great study period patient develop on significant association found include hba1c level less ratio confidence interval CI blood pressure less cholesterol level great woman great man development multiple target intervention patient
26369835 en study concentration glucose woman develop gestational mellitus plasma sample time patient found compare control patient normal well insulin glucose concentration plasma compare case control model assessment insulin resistance also concentration high woman develop control CI CI difference show serum insulin concentration found lower control result lower high serum datum suggest early glucose glucose
25884625 en early diabetic remain great disease management renal related model chronic disease clinical activity patient type sample obtain healthy type diabetic patient level determined diabetic diabetic renal observed level significant elevated patient compare healthy control level significant correlate high also demonstrated high diagnosis type study indicate increased level patient type significant associate renal patient diabetic may use early diabetic renal
25328091 en aim study evaluate new improve treatment patient type clinical trial subject therapy new baseline month patient health treatment also assess baseline month fasting plasma glucose glucose hemoglobin hba1c fasting plasma insulin model assessment index insulin resistance observed statistical significant reduction hba1c show high level compare treatment diabetic patient glycemic control suggest
20876408 en intervention cardiovascular disease risk factor individual type mellitus datum examine effect intervention change weight risk factor health trial randomize clinical trial compare effect intervention control group incidence major event individual female mean age year type mellitus participant provide outcome datum year participant great weight participant vs great vs hemoglobin level vs vs vs blood pressure level cholesterol vs vs reduction cholesterol level great participant vs great use medication lower lipid level group year participant great participant weight hemoglobin level blood pressure cholesterol intervention weight glycemic control risk factor individual type whether difference risk factor reduction event
20837908 en investigate use model type diabetic undergo follow receive DM follow per parameter function use assess risk measured cell protein serum glucose value similar group DM group DM statistical significant difference function group improve group whereas similar group cell protein target high risk compare DM lower group study type diabetic reduce may diabetic patient
20722680 en prevalence major health impact old report research aim examine patient aged year receive activity patient related management include general health need old mellitus activity care patient low primary general female relative provide care week level receive patient care patient also need target one
25360858 en lower major mortality diabetic patient high complication rate although clinical lead result diabetic patient little datum total diabetic control group body weight blood glucose level day analyzed glycemic level diabetic group control group control group compare diabetic group mean lower diabetic group control group significant complication diabetic group control group diabetic group use diabetic model show high complication rate diabetic however complication rate little influence
27215121 en body significant change body system previous study significant reduction blood glucose level among mellitus DM patient found study effect day blood glucose patient type total patient type DM group first occur two sample blood glucose level fasting hemoglobin hba1c study conduct week glucose level significant decrease compare value significant difference type on decrease fasting glucose level observed group compare respective difference statistical change hba1c reduction glucose level patient type DM
26901856 en previous study show type mellitus T2DM increased risk develop insulin factor increased patient T2DM increased insulin may develop study investigate effect mechanism insulin development insulin elevated reduce cell insulin treatment presence insulin significant decrease increased protein increased found model T2DM high level insulin development result suggest insulin little development T2DM
26894925 en type medication show associate poor health outcome type associate poor medication patient disease however relationship type medication patient type mellitus T2DM remain study aim examine whether type associate medication patient follow-up study conduct general hospital T2DM patient female provide baseline datum medical type patient medication month baseline datum test test multiple regression analysis conduct type significant poor medication type poor medication analyzed however type associate medication analyzed type may associate poor medication patient T2DM type may identify high risk poor medication intervention aim improve medication patient
26874336 en aim study compare index resistance mellitus DM patient risk factor evaluate potential patient DM without significant disease measured significant difference compare group vs DM vs DM patient high compare patient vs high patient vs high DM hypertension control high body mass index presence risk factor function DM patient function compare patient without DM risk factor include DM adverse function treatment associate
26537860 en patient type mellitus increased risk normal elevated aim study assess parameter estimate patient without diabetic disease respective compare healthy patient group diabetic database age healthy subject use assess estimate use analysis measured adjust BMI patient lower high high compare control parameter control subject significant lower patient compare control significant correlation disease duration glycemic control hemoglobin previous year characteristic patient presence complication whether influence rate patient need
26822508 en investigate association body risk gestational mellitus total subject control cohort study hospital may analysis use determine body evaluate subject week logistic regression analysis relationship body risk body weight body mass index BMI associate increased risk mass mass BMI protein associate increased risk mass mass associate decrease risk body associate risk
26466813 en aim compare change insulin level oral glucose tolerance test woman normal glucose tolerance gestational mellitus overall woman week according study level fasting blood glucose insulin total cholesterol insulin level blood glucose level oral glucose respective measured insulin resistance index significant difference fasting insulin level blood glucose level however insulin level fasting blood glucose level woman significant high group fasting level group significant high respective correlation analysis show level positive correlate model respective finding suggest insulin woman significant lower observed reduce blood lipid woman can potential improve outcome
25731652 en aim evaluate mean value gestational mellitus healthy use analysis study healthy gestational age age mean value evaluate analyzed use analysis use mean value significant large significant difference mean value healthy respective significant correlate gestational week negative significant ratio index resistance index increase significant whereas mean value significant datum may change may
25877316 en investigate change blood glucose patient associate mellitus DM related datum case associate DM retrospective analyzed patient group according history DM clinical characteristic blood glucose change analyzed correlation blood glucose serum significant difference found clinical characteristic group history DM month patient high patient disease blood glucose change significant different two group DM history month month significant difference patient DM history month DM history month month reduce blood glucose also improve patient DM history month month reduction show significant positive correlation blood glucose however significant correlation found two parameter patient DM history month month diabetic patient disease month clinical develop patient therefore patient new early
25866794 en mellitus DM on lipid may factor complication review present recent complication target
22427375 en factor however whether role glucose increased important decrease increased gestational day decrease associate reduction level whereas lead mass early period decrease mass increased blood glucose decrease plasma insulin impair glucose tolerance insulin insulin study indicate lead gestational mellitus
21209519 en mellitus health prevalence type mellitus disorder type disorder although role also study however research show association factor condition condition recent role factor receive review association
24397090 en determine dysfunction diabetic study metabolic disease medical diabetic patient serum sample blood glucose lipid profile body mass index ratio dysfunction assess health man use statistical total patient mean age year dysfunction increased age duration patient increased body mass index overall patient dysfunction severe high level associate control associate increased dysfunction risk duration old age increased body mass index associate increased incidence condition patient change management dysfunction
22106077 en assess whether risk increased use large cohort retrospective study conduct use database health health research year age therapy group drug medication identify diagnosis result use identify case incidence rate cohort case per confidence interval CI compare case per CI among medication case per CI among risk significant increased among incidence rate ratio CI medication significant increased medication incidence rate ratio CI found potential increased rate among finding group outcome
25705760 en investigate association development glycemic control disease duration body mass index BMI patient diagnose mellitus type study perform total diagnose study investigate age mean hemoglobin hba1c BMI disease duration duration mean hba1c disease duration mean hba1c BMI disease positive correlate mean hba1c disease duration negative correlate BMI negative correlate BMI disease duration diagnose recent high BMI
20816021 en two clinical study overall aim type T2DM aim develop use however use method diabetic response use method plasma patient T2DM known analyzed use three found first clinical study included healthy control patient T2DM aim investigate healthy control T2DM patient investigate plasma glucose level participant investigate increasing control fasting plasma glucose level patient investigate use insulin cell patient control independent level therefore response oral glucose cause decrease may due decrease reported early study aim effect patient T2DM effect due insulin glucose decrease glucose include patient T2DM increased glucose known effect investigate patient type cell function oral glucose tolerance test glucose evaluate difference response glucose found normal response oral glucose T2DM response insulin effect therefore factor response patient
19300897 en associate aim study identify clinical factor independent associate individual type study type patient obtain datum number year diagnosis diagnosis hemoglobin number complication insulin number insulin per day diagnosis complication use score use test investigate potential score patient hemoglobin woman independent factor associate individual type mellitus age score insulin
22973676 en well population type mellitus compare high prevalence high rate complication great complication poor control care improve care outcome patient need target risk improve first management include group reported effect change level blood glucose blood pressure serum lipid therapy indicate however regard use drug current due randomize control clinical trial care include diabetic important clinical change
22488512 en compare effect medication therapy management clinical use care effect medication therapy management clinical use cohort patient poor control type control group primary care within health care system management provide three clinical three patient type hemoglobin great receive insulin therapy patient group patient group patient group clinical two follow-up within period use mean clinical patient time interval clinical evaluate datum clinical medication therapy management management patient medical review group baseline similar group group respective primary outcome change baseline month outcome included patient association treatment total time number drug change on statistical significant difference mean group month vs month vs however mean reduction baseline month significant group group group less time drug change patient receive insulin may clinical use although statistical significant difference demonstrated change baseline month group show significant great difference group month high month
22322920 en serum found significant risk effect risk determine associate risk type use datum risk development adult study measured three study assessment baseline type case use medication analysis adjust include participant develop year follow-up model adult low develop high CI participant history develop year follow-up model significant increased risk lower found associate increased risk clinical trial need determine can reduce risk population
24079285 en common among type assess whether ratio cholesterol cholesterol lipid increased adult evaluate adult study mean age year female datum assess correlation general model use determine independent lipid parameter correlation show ratio potential significant cholesterol lipid independent negative contribute risk factor independent associate included age body mass index score hemoglobin cardiovascular risk factor cholesterol lipid independent associate ratio provide low risk factor suggest risk factor may important assess adult
26906195 en model mellitus study role cell cell addition elevated serum level cell number cell relative cell well cell cell diabetic
26886616 en assess effect risk mortality type mellitus T2DM patient conduct database two identify datum independent adjust estimate estimate confidence interval CI use model analysis conduct evaluate result risk assess examine well test test study incidence study included odd ratio or study reduction incidence associate use or CI ratio revealed improve outcome patient compare CI study demonstrated therapy can reduce incidence improve outcome patient T2DM study association
26871790 en elevated serum show risk factor hypertension cardiovascular disease mellitus relationship serum level patient T2DM hypertension level serum determined patient mean age year T2DM hypertension serum datum compare use analysis perform analysis use regression investigate correlation different T2DM hypertension group patient aged year on analysis also perform identify correlation serum analysis perform base level total patient group elevated level observed whereas level lower range serum regression analysis show high level correlate low level T2DM hypertension patient whereas high level correlate low level patient result indicate consider effect T2DM hypertension patient finding study reduce risk T2DM hypertension well reduce risk
26774399 en present patient insulin type mellitus DM fasting cause DM treat insulin insulin level assess insulin mass on insulin treatment level normal value glucose use determine glucose due glucose whereas glucose whereas glucose effect due total body glucose
26158794 en oral mechanism reduce blood glucose level glucose evaluate effect several mellitus T2DM effect drug healthy one drug drug healthy man glucose drug evaluate relative value parameter drug drug effect little effect drug drug major effect glucose drug drug evaluate study drug healthy
25344768 en investigate whether level associate gestational mellitus risk factor effect examine datum woman cohort study high level diagnosis odd ratio or level adjust potential according age history woman low level three time develop woman high level or CI use body mass index BMI use or CI individual addition BMI or CI CI association low level associate due high rate obesity reduce high rate type among woman low intervention need reduce rate obesity
23633210 en metabolic profile identify metabolic associate type impair fasting glucose difference glucose use mass metabolic health define fasting glucose glucose hemoglobin type glucose hemoglobin healthy control fasting serum profile compare use healthy control type significant low number lipid significant reduce adjust age body mass high report serum profile change range healthy type mellitus glucose mellitus early metabolic change present disease define elevated blood glucose level
26864513 en aim change type population new T2DM study datum included age health type drug mean per patient hba1c level complication time first insulin T2DM patient included respective mean age year man patient health significant year increase total per patient increase associate use new drug decrease associate use old drug respective hba1c level complication decrease significant time mean duration first insulin treatment increased day day new drug analyzed study positive effect hba1c level complication mean time first insulin treatment
23029717 en mellitus one common disease prevalence develop develop compare cardiovascular complication known cause diabetic patient increased rate disease may lead dysfunction early without clinical present study assess dysfunction diabetic study included patient type mellitus without evidence cardiovascular blood pressure less studied evaluate included ratio assess duration show dysfunction present patient dysfunction common among female compare dysfunction significant associate assess hba1c level dysfunction common patient treatment oral insulin prevalence dysfunction increased duration dysfunction increase age finding study indicate patient dysfunction function ratio significant diabetic patient dysfunction dysfunction significant associate duration disease glycemic level type treatment diagnose dysfunction diabetic develop diabetic patient assess function
22607105 en blood pressure significant mortality type patient study determine significant blood pressure patient datum patient type obtain adult control management analysis study characteristic hypertension treatment risk factor complication base recent value subject control clinical compare independent identify use logistic mean age patient diagnosis year old woman mean duration year on total blood pressure measured patient two health without old age year old duration year blood pressure patient time type patient disease blood pressure treat target independent group patient old age recent diagnosis follow-up health without possible use primary health care need improve care among patient
22004530 en study investigate type may impair change healthy control subject patient type control oral treatment index blood pressure interval time also change response metabolic significant difference blood baseline response control subject although blood response associate significant reduce group significant difference baseline response impair patient type although difference can study index difference study large population disease may clinical important difference
20814956 en mellitus disease develop prevalence increasing type disease insulin resistance major factor development type occur reduce glucose increased glucose prevalence incidence need new target develop protein recent level target effective management type negative insulin therefore increase insulin negative insulin target type mellitus obesity several can drug research research research development potential management
20667563 en study examine effect type mellitus patient month gene factor glucose patient type mellitus aged year hemoglobin level range treat high per per insulin per new treatment month patient study analyzed month hemoglobin fasting glucose total cholesterol protein level adverse event glucose significant improve serum protein level reduce glucose gene factor type mellitus patient adverse effect
25935767 en new dysfunction patient type mellitus DM normal however early study aim define outcome associate type cohort study patient type DM undergo follow year subject normal evidence disease outcome datum obtain hospital primary mortality study cohort evidence follow-up year range year patient primary normal function independent associate primary blood pressure level patient significant outcome without common patient type DM independent associate adverse new clinical trial
23710907 en potential method study value diabetic study perform patient old type mellitus duration patient old duration little poor control complication adult clinical diabetic include compare patient healthy significant decrease patient group compare control patient clinical reduce early patient occur change measured dysfunction
21150101 en effect evaluate model develop mellitus DM development DM oral glucose tolerance test blood glucose result suggest effective
20191114 en value patient mellitus clinical renal cause renal disease diabetic develop patient multiple condition development diabetic therefore several factor disease condition may also different type occur independent diabetic renal disease different treatment therefore identify according sample high management condition addition recent study provide evidence early diabetic model provide investigate disease activity perform diagnosis
20137669 en evaluate effect diabetic control type type diabetic undergo group on group total group group control group observed week fasting blood glucose level determined blood glucose week hemoglobin hba1c level measured week hemoglobin high fasting blood glucose hba1c level significant decrease group follow-up period group week vs week vs difference week significant increased week week group compare group show reduce hba1c level follow-up period hba1c level group significant decrease group on week vs hba1c vs indicate effect diabetic control group similar one suggest potential role type mellitus include effective glucose control may clinical diabetic control finding suggest potential role type mellitus
23832729 en aim study investigate whether two different high can improve well metabolic conduct randomize group study patient mellitus type recent weight randomize one two study group group two can per day group three can per day week decrease hba1c group decrease confidence interval high group group confidence interval on significant increase weight body mass index mass observed group without statistical difference group increase weight confidence interval high group group confidence interval tolerance without statistical difference vs high improve hba1c status high three two per day
22937188 en elevated plasma total concentration associate increased risk cardiovascular event type diabetic individual independent risk factor study female type mellitus age mean year study healthy included control parameter index determined use increase obtain body weight body mass index compare control value respective fasting plasma glucose significant high group compare control value plasma significant reduce compare control value significant high compare female value significant decrease obtain plasma patient compare female result show increased plasma well decrease type mellitus risk factor event
26455011 en significant risk factor patient difference clinical one year patient present on total woman man analyzed clinical treatment compare woman old man similar group man undergo difference mortality common negative influence female patient analysis age three significant
24142539 en care improve outcome type mellitus insulin therapy multiple therapy use target datum compare compare care database review woman woman treat included woman care lower hba1c level vs early vs week care group lower hba1c level use vs gestational age weight group rate associate use duration woman use history care effective reduce hba1c level use result lower hba1c level care individual consider woman
23116535 en perform review assess effect intervention lipid profile blood pressure database study evaluate effect intervention cardiovascular risk factor adult type use effect model mean difference lipid profile blood pressure subject included associate change blood pressure CI blood pressure CI cholesterol CI cholesterol CI age duration effective blood pressure control level adult patient
23721158 en type mellitus disease cell insulin current treatment insulin patient lead severe complication cell insulin although treatment several large year current research current several one lead however research increase review current research regard
24435322 en insulin elevated reduce clinical trial week significant improve control reduce mean body weight compare patient type control oral drug insulin control reduction body weight therapy year general similar insulin less reduction general well decrease time therapy common adverse event patient receive insulin incidence low occur general treatment type control insulin
26300627 en glycemic control disease type mellitus T2DM patient renal complication association glycemic control patient population well study aim identify well factor associate glycemic control T2DM patient different chronic disease retrospective study T2DM renal complication conduct hospital hemoglobin use parameter assess patient glycemic status patient poor glycemic control base patient present patient poor glycemic control insulin common medication follow insulin therapy insulin found significant associate glycemic control factor include duration T2DM medication therapy also correlate factor associate glycemic control important glucose control T2DM patient renal complication
26440573 en evidence risk profile disease however mellitus DM negative associate mechanism negative relationship define may include increased reduction level activity addition effect use treatment patient DM studied result potential study need
27055233 en gestational mellitus major define glucose first week rate high population use rate increasing risk factor associate include age obesity history previous history treatment target woman base assess effect different control woman health group trial clinical trial included one control trial control trial use method review intervention datum assess study result two review independent assess trial evaluate datum one included study one trial response assess evidence outcome use included one trial woman week diagnose datum woman report identify overall risk included study included trial report review primary outcome hypertension disorder development type primary outcome mortality age severe trial report datum review outcome difference rate woman use target compare woman use target risk ratio confidence interval CI one trial woman low use found evidence low due poor risk target associate increase use therapy identify use insulin study compare target CI one trial woman suggest datum outcome datum review reported difference group woman receive target great CI one trial age CI one trial mean difference CI one trial gestational age week CI one trial adverse effect datum reported outcome review review base study woman risk trial reported provide datum review primary outcome provide datum number outcome evidence clinical target control woman adverse effect health target control trial need compare different target treatment woman assess health outcome woman include assess health study
23633651 en identify potential cause type mellitus prevalence increase among man age due high prevalence two condition can evaluate prevalence patient study patient age patient undergo patient show significant lower patient age without show overall among examine diabetic patient prevalence significant patient care glycemic control patient disorder significant difference patient patient without correlation analysis show significant correlation duration glycemic control prevalence prevalence lower one patient however patient high observed prevalence among diabetic patient care diabetic patient statistical different
26926371 en relationship diabetic patient type total patient hospital study evaluate evaluate rate related clinical datum complication also hospital patient three group group group group according score level compare among three level include vs low low vs group lower group group level group lower group group suggest dysfunction system subject associate diabetic one clinical diabetic
22483463 en mellitus important complication among patient receive impact chronic dysfunction development also undergo control important on study current evaluate incidence risk factor development among patient receive therapy therapy diagnose according association analysis included patient receive renal month patient mean time month significant difference observed patient risk factor age body mass index blood pressure patient mean time event month subject among adverse event reported patient two reported follow-up patient year evaluate incidence rate overall rate patient
22471424 en assess primary cardiovascular disease early hypertension mellitus major risk factor management datum participant aged year high prevalence risk factor difference less blood glucose age group year remain high hypertension on large hypertension remain current early diabetic age group year previous diagnose diabetic total population total diabetic population respective previous diabetic respective control estimate suggest important improve early treatment treatment common risk factor include medical treatment history treatment
19637052 en study investigate potential factor blood pressure mellitus well estimate cardiovascular risk studied diabetic patient type man age evaluate perform three test patient according number test risk disease prevalence range type type ratio patient without test pressure significant high patient test significant elevated group high risk disease patient high high lower elevated compare lower risk mellitus significant finding study high found patient dysfunction high risk disease age elevated level cardiovascular risk factor mellitus
25535146 en study aim evaluate treatment aged type mellitus T2DM
25509886 en patient type mellitus year present evaluate patient respective patient undergo function disease patient period recent mass individual less ratio prevalence remain however incidence increased statistical significant occur treatment therapy general patient clinical disease regard datum rate development complication effect therapy incidence increasing patient cause diagnosis patient common follow-up patient function therapy time
25464671 en type mellitus occur result reduce insulin large population also condition body one associate high activity may reduce study status activity patient type mellitus diabetic medical hospital study included type diabetic patient age healthy control activity use significant reduction activity value decrease cholesterol among type patient compare healthy control mellitus year reduction activity show correlation analysis result analyzed use statistical type condition result reduction activity
25306751 en evaluate impact therapy drug dysfunction metabolic parameter patient hypertension type mellitus patient aged year hypertension type DM patient receive therapy week function studied serum concentration test result metabolic parameter estimate insulin resistance insulin concentration follow model assessment week therapy patient target level blood pressure hemoglobin hba1c significant patient type DM increased serum respective decrease serum respective analysis treatment drug revealed statistical significant patient type result test large number patient normal increased patient number patient test significant reduce baseline week treatment medication fasting blood glucose level index decrease respective statistical significant correlation index concentration blood blood therapy drug high effective metabolic parameter patient type DM
25053869 en mellitus type associate different cell diabetic complication aim study determine potential mellitus type compare value healthy assess effect general patient year healthy year study result indicate three group diabetic patient healthy similar blood adult patient high value healthy drug reduce cell mellitus type associate great three may contribute development complication may diabetic patient
24993124 en effective oral drug study demonstrated cardiovascular independent glycemic control patient mellitus clinical study show drug among new diagnose type mellitus patient effective use drug glucose drug outcome glycemic control hba1c level
24800522 en renal function studied patient type mellitus DM renal response effective observed patient DM patient poor control DM control period vs treatment increase patient
24754062 en drug therapy mellitus treatment
24660538 en known important role chronic clinical group lipid aim study determine activity serum patient mellitus type control group study possible correlation activity presence disease associate identify possible correlation value hemoglobin hba1c group patient associate aged year study healthy control patient control undergo assessment serum mean value patient group control mean value patient associate disease vs patient associate disease correlation hba1c value determined obtain correlation correlation observed patient mellitus type healthy patient similar result obtain patient associate disease determine
24534218 en insulin therapy found diabetic also decrease investigate function change follow-up patient type mellitus insulin clinical study patient patient undergo insulin therapy use examine model use change follow-up time therapy month low high month compare significant difference low found month index lower first therapy compare compare month index lower first month significant difference first month index significant improve diabetic patient insulin therapy
24456363 en study evaluate effect glucose control subject impair fasting glucose impair glucose tolerance new diagnose type mellitus T2DM study randomize trial include serum blood level glucose insulin measured oral glucose tolerance test baseline intervention intervention test group show significant decrease serum level glucose blood level glucose addition test group lower blood level glucose glucose however group show change blood index change difference baseline serum glucose level blood glucose level glucose test group decrease group significant decrease decrease serum insulin concentration time interval test group may serum blood glucose level compare among patient T2DM
24421150 en investigate effect type mellitus cell level assess potential DM gene profile patient treatment healthy control identify patient period treatment compare obtain healthy subject use perform use database base database patient compare healthy control associate response gene profile patient healthy subject effect potential treatment however within range
24420389 en on woman diagnose treat disease treatment hospital management treatment result general condition hospital hospital fasting plasma glucose hemoglobin concentration insulin therapy hospital level insulin suggest function glycemic control level increased glucose identify result assess result indicate patient insulin blood glucose also level due function study assess glucose treatment disease case glucose associate disease
25902654 en assess effect therapy blood pressure insulin resistance lipid patient hypertension type mellitus patient age year DM type week patient undergo parameter studied glucose level hemoglobin insulin lipid profile blood insulin resistance patient receive drug follow patient target value concentration week treatment parameter significant different baseline value mean mean time index pressure day day value increase rate patient increased day day significant decrease fasting blood glucose level concentration total cholesterol low cholesterol metabolic index also patient hypertension type DM week therapy significant improve blood pressure profile reduce without negative effect lipid
25790697 en type mellitus metabolic disease due early reduce one complication dysfunction metabolic disorder condition diagnose early aim study determine level protein patient aged type mellitus disorder healthy control age participant undergo base disorder protein protein protein early dysfunction study revealed level protein correlate score
24024701 en may lipid evaluate effect type mellitus
19839824 en study examine association among factor metabolic syndrome type mellitus retrospective study conduct type mellitus patient may observed prevalence chronic disease different group type mellitus patient analyzed association metabolic syndrome chronic disease case cohort test include factor protein study relationship chronic prevalence chronic disease patient patient metabolic factor significant high prevalence chronic disease without metabolic factor vs metabolic factor significant high patient chronic disease patient metabolic factor also high level well high risk chronic disease multiple logistic regression analysis revealed blood pressure serum low age duration independent risk factor chronic disease type mellitus metabolic factor type mellitus relationship chronic disease hypertension independent factor chronic disease type mellitus
19289898 en aim study evaluate association lipid concentration duration disease disease female type mellitus on total type mellitus female mean age year healthy female mean age year study evaluate mean profile mean significant significant high significant lower patient type mellitus healthy female significant difference compare type mellitus group control female type mellitus significant score significant lower score significant high type mellitus significant correlation found correlate total cholesterol level negative correlate level female significant correlation found score total score lipid level total cholesterol cholesterol level significant association duration disease female type mellitus significant difference found female type mellitus treat oral insulin
23953179 en one drug however drug known clinical retrospective studied patient type mellitus week subject effective according glycemic response effective group hba1c value week hba1c level group increasing study period significant difference baseline hba1c value group mean high group low group compare effective group mean high effective group group datum suggest baseline hba1c value factor hba1c reduction use glycemic
27224283 en type obesity metabolic associate review assess effective weight weight control intervention adult type obtain multiple database obesity included randomize control trial examine weight weight control use one activity intervention follow-up interval little use effect study weight intervention identify participant follow-up year weight intervention care among subject confidence interval CI baseline body weight among subject demonstrated significant result among receive activity intervention also receive low CI baseline body weight receive among receive intervention receive activity intervention CI baseline body weight receive less activity intervention group significant weight difference change hemoglobin general change weight significant difference examine datum identify use activity intervention weight result weight group however individual study revealed intervention include low low may weight adult type
24132596 en study health analysis individual status group possible assess potential aim low status group first time potential mellitus DM review per patient DM assess prevalence DM among adult different level estimate base health conduct prevalence datum use DM per year patient low level total high total population prevalence group low level can reduce prevalence group level analysis provide first estimate potential effective status however per patient use DM level also health also analysis present
24102267 en among can due difference insulin common mellitus DM obesity hypertension history disease can study effect obesity patient age control DM hypertension obesity among regression examine obesity first woman control on high prevalence DM obesity hypertension observed among woman compare control hypertension BMI subject significant related DM obesity age first weight significant associate number DM first period associate number hypertension obesity disease
23940092 en current study examine blood diabetic whether change response measured week diabetic large presence also diabetic group compare control diabetic group response effect response result suggest activity mellitus contribute change function
24830597 en aim study estimate rate gestational mellitus identify clinical associate rate decrease glucose cohort woman may woman week oral glucose tolerance test woman included test fasting plasma glucose glucose associate lower rate vs high vs characteristic woman impair fasting glucose impair glucose tolerance associate positive history relative insulin use rate low clinical profile define woman glucose status history severe
20043528 en assess effect mellitus type cardiovascular risk factor patient diagnose two major hospital age year duration base presence clinical obtain blood pressure fasting blood glucose lipid high protein participant age mean year duration year type type type three patient type high blood pressure lower type total cholesterol similar patient lower patient difference significant adjust factor cardiovascular disease common patient therefore investigate risk factor patient type
22483464 en may metabolic syndrome mellitus associate great patient aim study evaluate several gene association risk develop renal participant include subject studied several gene associate glucose group old mean age year great man high number chronic disease patient use use model on logistic regression observed patient lower risk develop odd ratio or confidence interval CI multiple logistic regression model adjust different model or CI show effect model or CI significant difference group may important role lower risk development
21929650 en study investigate whether mellitus DM increased risk whether drug reduce risk cohort study use health database patient aged year old new diagnose DM diabetic group without DM group incidence high patient diabetic duration less year compare group vs per confidence interval age aged ratio aged old respective chronic also significant factor patient DM chronic elevated risk develop compare subject without association statistical significant use drug risk year duration associate can early found risk factor patient old age chronic risk factor patient undergo follow-up
25470393 en major disorder associate medical condition mellitus type disease early age contribute mortality provide potential mechanism disorder effective treat clinical population aim reduce well review database perform identify study investigate impact independent association major disorder type mellitus function disease review base sample use assessment overall large result clinical study suggest insulin may risk dysfunction individual change insulin resistance system result metabolic effect system system
25470290 en role type mellitus T2DM remain risk T2DM recent study correlation disease observed study use datum sample large test first perform regression analysis prevalence T2DM population two cohort regression analysis show significant correlation observed result indicate difference case control significant population respective analysis similar population result may role development T2DM population
25306750 en evaluate effect glucose patient type mellitus patient mean age year level hemoglobin hba1c mean level therapy examine group patient receive group level fasting plasma glucose level hba1c body weight body mass index ratio blood lipid level insulin estimate baseline month month group show positive change hba1c level hba1c decrease group group reduce group group increased group group positive change group level group group respective significant difference group change revealed significant group group therapy cause reduction glucose
25273482 en association type mellitus T2DM well however test early normal adult T2DM review examine test impair T2DM base clinical significant difference effect T2DM group without T2DM study identify reported mean individual test test function function found impair T2DM function time may function risk old adult research impact function need test test time can included test intervention study can also assess new diagnose T2DM use function intervention function
25246279 en study investigate impact glycemic control parameter patient type hba1c age measured measured assess patient T2DM patient poor glycemic control group patient glycemic control group healthy blood result show plasma level age significant increased group control group level high group group difference significant found positive correlation age group found significant decrease level hba1c age patient use compare patient use observed impact treatment oral insulin level treatment insulin glycemic patient T2DM level age remain significant elevated healthy control impact treatment insulin
25185856 en present case syndrome type associate disease type mellitus disorder occur population multiple case associate disease disease well disease syndrome first case associate type mellitus adult patient
25030050 en level lipid obesity associate mellitus DM although measured fasting individual lipid important role DM study compare lipid according fasting status body mass index BMI man woman age undergo health follow ratio DM fasting status BMI estimate use total participant man woman develop DM mean follow-up year found independent DM fasting man woman DM according vs confidence interval CI man normal BMI also observed woman normal BMI DM compare CI fasting level man level woman DM among normal BMI individual high risk DM
24564602 en study aim evaluate age protein plasma can development diabetic complication clinical parameter include age investigate patient type mellitus without complication age significant high diabetic group compare control age also significant high group compare age significant correlate hba1c observed significant high diabetic group control difference significant significant correlate BMI significant increased diabetic group compare control difference significant significant correlation clinical parameter result association suggest hba1c also age may risk development clinical studied hba1c
24417611 en well type mellitus T2DM remain present study evaluate among adult adult T2DM adult without T2DM undergo medical assessment participant T2DM report found reduction analysis revealed participant T2DM large concentration present great present first evidence among participant T2DM result suggest may effect T2DM may role reported T2DM study method may reported T2DM
24397804 en effect investigate serum level woman type mellitus T2DM woman healthy woman weight intervention baseline T2DM group decrease serum concentration compare group significant among group significant serum concentration T2DM group significant increased serum level group significant reduce baseline fasting serum level group studied subject T2DM negative correlate BMI insulin positive related reduce level can role obesity T2DM increase level decrease woman contribute metabolic reduction body weight
23734826 en although blood pressure response related hypertension hypertension relationship remain on related increased cardiovascular mortality mellitus DM hypertension study aim examine relationship patient study included patient DM patient activity level assess according study patient undergo test duration blood pressure value diagnose patient patient two group according prevalence duration lower group group negative correlate age hba1c mean mean increased group respective according regression or or duration DM or duration DM subject DM
23953891 en elevated level associate insulin resistance type decrease oral glucose tolerance test test whether change also early response common use medical therapy use insulin insulin subject one medication oral two day oral change determined increased insulin decrease glucose subject group decrease subject decrease glucose insulin subject increased subject subject increased glucose insulin subject decrease subject change insulin resistance status individual intervention result indicate may early response intervention
19874240 en cause mellitus however mechanism remain study mechanism mellitus level determined blood sample use glucose method level serum insulin measured cell method cell method insulin control group insulin level serum decrease mellitus model compare control group body increased mellitus model compare control group show decrease cell mellitus control group insulin cell decrease mellitus model mechanism mellitus model include reduction insulin cell cell increasing cell insulin cell
19223707 en aim study determine association risk type study included case new diagnosis type mellitus control disease case control age year datum age level status status history activity model value or logistic regression odd ratio or confidence interval CI possible history body mass index year statistical significant relationship observed type mellitus individual per day lower risk mellitus CI compare one less one per per day related lower risk type mellitus
19117885 en type mellitus associate obesity hypertension risk factor cardiovascular disease weight result reduction risk factor adult improve parameter metabolic dysfunction cardiovascular risk type undergo included complication analyzed similar type mellitus treat medical year also undergo mean BMI cardiovascular risk factor evidence type mellitus patient significant BMI fasting blood glucose fasting insulin concentration hemoglobin level insulin also significant serum lipid level blood pressure type mellitus follow year medical treatment demonstrated body weight baseline BMI BMI significant change blood pressure diabetic medication use medical patient significant improve hemoglobin level year baseline year diabetic significant weight type mellitus insulin resistance function cardiovascular risk factor intervention improve health although known finding suggest effective treatment type mellitus
19029488 en among mellitus elevated blood pressure one common factor may control hypertension population investigate whether hypertension associate hypertension mellitus study aged year type type mellitus study group score lower score individual score association overall score hypertension evaluate use multiple logistic regression prevalence hypertension type type mellitus type high related hypertension independent clinical characteristic odd ratio CI odd ratio CI type mellitus associate hypertension odd ratio CI odd ratio CI study clinical trial need investigate whether may hypertension type mellitus type mellitus research large sample
23063035 en blood glucose glucose effective hemoglobin hba1c reduce patient type mellitus however provide management year randomize control trial investigate use patient clinical outcome include hba1c patient age year duration year baseline hba1c mean compare use associate great reduction hba1c confidence interval number event significant different group duration group reduction duration glucose also result duration use associate metabolic control significant reduction hba1c reduction duration period
22698080 en development mellitus cardiovascular disease blood pressure rate known mechanism investigate disease blood pressure assessment status however estimate change within review evidence characteristic time mellitus mechanism observed change cardiovascular function disease adverse may result
25048824 en analysis evaluate effective insulin insulin insulin clinical patient type mellitus study insulin patient cohort included patient treat change hba1c level confidence interval CI group CI group incidence rate increased group event per patient year group respective weight change group CI CI group regression analysis previous identify age duration body mass index previous history disease number change oral drug therapy hba1c baseline insulin identify independent effect insulin type risk little one odd ratio or CI weight or CI hba1c CI insulin associate clinical significant on lower risk great odd weight observed compare
24849711 en conduct study determine effect lipid diabetic adult type identify study assessment use determine study assess association use mean difference confidence total found decrease significant association diabetic model significant association found diabetic result decrease associate diabetic possible diabetic include target increase
24372432 en clinical datum mellitus DM related evaluate role DM clinical medical hospital risk factor cause DM associate increased oral diabetic patient patient DM old age treatment diabetic patient profile adverse mellitus risk factor although case clinical mean disease DM possible control complication develop individual diabetic patient risk development primary mechanism role DM one important change development
21604006 en present study investigate whether period result severe complication medical important related occur period individual may significant role present study group control group diabetic group group group change use system show group addition large number cell group group group also cell group evidence high group compare group finding statistical significant difference group activity addition lipid significant different group result significant difference group group present study provide effect present study found increase activity correlate elevated change
19459770 en hemoglobin hba1c method assess glycemic control patient glycemic level however hba1c glucose level impact development complication on model present different glucose profile include parameter glycemic hba1c parameter glucose value parameter provide patient parameter period glucose patient healthy subject characteristic value define glycemic risk parameter risk parameter provide overall metabolic control hba1c addition also assessment patient risk develop complication hba1c clinical glucose clinical study
24656004 en use risk factor mellitus impair insulin association study aim examine prevalence association use study also aim examine relationship use retrospective review use datum medical define use patient included analysis reported patient on total patient use case logistic regression show use odd ratio or confidence interval CI old age CI significant risk factor addition use case associate significant high hemoglobin level vs significant high insulin resistance index vs use without presence age important prevalence great early need old patient high hemoglobin level insulin resistance index patient use association serum use prevalence
17973965 en patient aim study define incidence risk factor development mellitus studied outcome perform mellitus define need treatment mellitus evidence function datum range follow-up month month follow-up period patient develop mellitus function factor included insulin BMI respective hemoglobin patient develop compare year mellitus occur presence function due increased BMI high insulin
24318519 en known mean increase syndrome however datum patient disease study aim assess relationship patient mellitus DM normal DM patient diagnose included study score score two patient undergo measured patient evaluate found system correlate DM group several evaluate found correlation increased DM patient however difference identify patient high level may effective determine patient DM high level may related DM patient
26881258 en assess drug T2DM several major according clinical renal dysfunction history study medical T2DM subject primary care health treat total treat patient patient renal rate treat event severe renal patient respective patient severe use patient high risk complication need increase potential clinical outcome T2DM
26690494 en investigate patient characteristic clinical test result cell impact mellitus DM patient undergo retrospective review patient DM potential factor use test analysis assess association significant factor identify analysis DM hemoglobin level serum level among factor test use test test plasma glucose level found analysis show DM serum level independent factor presence DM time diagnosis identify independent significant factor negative outcome patient
26620984 en determine function among individual mellitus DM effect development dysfunction
21692845 en management complication mechanism complication studied present patient can develop complication recent year role cardiovascular disease type investigate however study aim investigate role development type well diabetic complication study aim whether associate presence number diabetic complication sample patient type study one subject include patient type little one complication without complication control subject measured complication significant patient without complication healthy control subject among patient complication significant increasing number complication effect decrease vs gene ratio complication estimate odd ratio result study may associate presence number diabetic complication
18777453 en increasing prevalence type mellitus risk cardiovascular event increasing patient present glucose patient mellitus cardiovascular disease important result use adverse influence mellitus cardiovascular system include large well review mellitus
22209024 en protein known adult study investigate possible role early patient type mellitus compare parameter protein gene group patient within three year diagnosis man woman mean age range group healthy man woman mean age range year healthy control control subject range patient significant lower compare control vs significant lower patient compare healthy control positive range result show impair early type mellitus indicate diabetic
25515340 en insulin blood glucose level high however chronic function although glucose mechanism remain possible mechanism dysfunction diabetic level factor decrease addition cell decrease effect factor dysfunction observed type
22297070 en decrease dysfunction cell important mellitus DM complication may role however mechanism investigate recent protein gene reported different lead may healthy subject DM patient blood high glucose associate assess investigate relationship also study possible factor provide may DM management DM
25726033 en major glycemic control patient significant cause lead health care system examine association outcome patient type mellitus obtain T2DM patient patient age patient event outcome define use logistic regression model use compare event within day day day day total patient patient patient high event within day day day day less difference logistic regression analysis show elevated risk event day CI analysis show elevated risk patient aged less year year elevated risk also individual outcome care hospital risk event day increased among patient
25149194 en may cardiovascular disease lower may also associate determined association plasma subject without type mellitus serum total level determined T2DM patient large increased whereas cholesterol large decrease lower level T2DM analysis total cholesterol cholesterol large negative correlate cholesterol positive correlate T2DM regression analysis demonstrated subject total cholesterol cholesterol negative associate age T2DM body mass index regression analysis show large negative associate whereas large associate positive well large associate negative whereas cholesterol associate positive T2DM effect low can relationship characteristic
25093264 en although patient type mellitus increased compare healthy patient risk elevated new drug may effect however datum effect risk therefore aim study investigate association use risk retrospective population base cohort study use datum clinical research database conduct patient little one drug aged datum one control patient model use estimate ratio control patient age drug duration use different risk compare current control adjust ratio confidence interval CI also increased risk compare current CI use associate risk compare control however duration use database show association risk
26321217 en determine gestational mellitus among woman present study woman week first hospital participant undergo oral glucose tolerance test week odd among different body mass index BMI weight multiple logistic regression woman compare woman BMI normal range woman BMI increased risk odd ratio or confidence interval CI woman BMI elevated risk or CI age status previous complication risk found woman woman week significant increased risk
26172564 en important increase obesity insulin glucose tolerance although significant high level plasma found woman gestational mellitus mechanism present study concentration determined baseline woman woman normal glucose tolerance correlation analysis perform body weight BMI result show plasma level significant high patient subject plasma positive correlate body weight BMI fasting blood glucose group significant negative correlation show group datum indicate serum concentration increase woman increase related increase BMI significant lower patient condition BMI high level patient increase condition may indicate function improve glucose tolerance impair subject
20061043 en determine age hba1c level independent analyzed individual population year old without level increased per independent fasting glucose compare hba1c level increased independent hba1c level diagnose current occur respective hba1c level year old year old group hba1c level old hba1c level current clinical patient hba1c level hba1c level diagnose
26567223 en aim determine factor profile cause patient without mellitus total sample patient DM patient subject factor profile significant difference factor cause patient without DM serum resistance cell among gene patient DM without DM follow gene gene observed significant associate status DM diabetic status group study may cause patient DM general population
22180093 en previous study reported gene gene demonstrated protein show influence insulin cell glucose study evaluate relationship development type mellitus T2DM population on study examine T2DM patient healthy control perform investigate role analysis use determine among T2DM patient control significant high woman subject odd ratio or T2DM confidence interval CI factor age hypertension total cholesterol level difference remain significant or CI diabetic increase serum level however significant difference observed parameter measured control group may influence factor T2DM population finding also indicate may contribute metabolic
25549095 en although may cause factor also associate study assess mellitus DM hypertension chronic disease associate well health study included individual undergo health relationship subject age base age group presence hypertension DM prevalence increased age subject respective value per show change indicate great high range severe DM correlate prevalence statistical significant association hypertension adjust age prevalence increase age presence DM great high age group common
24266052 en control insulin cause revealed related mellitus treatment present study gene diagnose identify patient whereas found indicate patient treatment month follow-up show development normal result improve
23676456 en disease one important cause develop major general disease plasma elevated study measured level role disease patient year old age range year undergo disease disease associate mellitus DM disease disease concentration group respective use plasma concentration multiple regression analysis show significant positive correlation concentration age DM three independent can concentration concentration significant positive correlation plasma datum indicate concentration increase age DM positive correlation plasma concentration
22944342 en treatment obesity also metabolic study examine result undergo regard vs obesity mellitus hypertension weight month compare use odd ratio mean difference confidence interval evaluate influence recent study include patient total included study demonstrated compare effect mellitus weight month similar effect hypertension or CI or CI mean difference CI effective treatment obesity treatment poor control T2DM large control randomize trial conduct compare
22515121 en little regard mellitus incidence female factor related possible difference investigate define diabetic patient aged year three month insulin treatment present case incidence rate base population overall incidence period per CI value female per CI high per CI incidence rate significant increased female investigate period significant high female case body mass index compare incidence increasing population among female increase female case
27833703 en diabetic show several cell type model high group reported present study aim diabetic significant increase serum concentration diabetic treatment similar analysis revealed significant increase protein diabetic change addition increased diabetic may contribute effect
27034931 en mellitus DM one metabolic disorder severe insulin current use treat DM associate patient insulin insulin determine use study also perform associate less among found significant associate less among demonstrated increased less compare analysis revealed study identify new insulin diabetic patient
26817897 en increasing use type mellitus T2DM evidence treatment study investigate whether treatment reduce risk complication T2DM patient use large population health research database identify adult patient new diagnose T2DM use sample one receive day diagnosis T2DM control cohort ratio age hypertension index year investigate conduct regression ratio chronic disease diabetic cohort different insulin patient common group insulin group common group insulin group although significant reduction ratio diabetic incidence rate per cohort per control cohort respective age hypertension use include insulin cohort found decrease risk CI retrospective study show therapy associate decrease risk T2DM suggest therapy T2DM
26765476 en investigate whether patient lower dysfunction increased risk develop type mellitus retrospective cohort study use health research database sample general population on total patient new diagnose identify period among develop control group patient without study period case incidence age duration diagnosis study group follow T2DM incidence rate ratio T2DM high group control group vs per adjust ratio confidence interval CI significant elevated patient aged year CI study show may significant increase risk develop T2DM
26142876 en study mean whether can use patient type mellitus T2DM without use different normal control T2DM difference two group correlation score different also demonstrated effective different significant difference found patient T2DM different also significant correlation age different significant different result show use T2DM
25867367 en gene primary important glucose associate type study examine association type included patient subject use identify compare group use test risk control patient control patient respective prevalence control patient control case value respective control patient control respective case significant difference observed found association however sample role risk examine
26422875 en on number patient mellitus DM use aim study investigate use potential influence health care regard use effect population patient type research study conduct study include patient diagnose type use addition woman show statistical significant difference use compare man reported group diabetic use influence included use role health important potential cause
26080605 en use therapy potential type mellitus T2DM diabetic complication different T2DM overall effect T2DM associate complication may also effect T2DM effect include several lipid target show effect increasing insulin reduce increasing glucose addition effect also effect several complication diabetic suggest treat T2DM diabetic complication patient also therapy T2DM
25740579 en on woman diagnose diabetic type receive insulin day however positive test patient develop day show reduce medical therapy function within patient receive day on serum test show significant elevated indicate diagnosis multiple insulin therapy clinical present case consider cause
25100395 en assess prevalence effect glycemic control type mellitus multiple insulin aged year patient aged year define score change score positive score response patient aged year great related number blood patient positive score significant high hemoglobin hba1c level without association positive score age patient base patient response related age patient common although common old patient patient high hba1c level less blood identify patient may improve glycemic control
27638302 en plasma activity woman gestational woman normal glucose tolerance evaluate possible relationship activity analyzed woman month use ratio estimate activity also measured woman factor significant difference observed woman estimate activity significant high estimate activity significant lower woman observed correlation activity datum suggest influence activity addition activity woman
23422769 en study examine association type mellitus clinical parameter large population adult total target adult population year subject included study datum subject total subject response rate among participant subject type logistic regression analysis factor associate type DM analysis include level number demonstrated age associate high odd type low status associate type independent effect age obesity large population adult type associate age obesity low status
26496961 en study investigate effect gestational mellitus obesity population incidence factor associate obesity compare without independent role associate factor examine multiple logistic regression analysis incidence high group obesity different age year difference respective found obesity respective less age year increased obesity found group associate obesity age adjust factor remain independent obesity CI suggest effect independent well obesity
26073219 en examine difference woman high risk gestational mellitus woman general woman high risk base history BMI woman general population week assess woman high risk score indicate risk compare woman general population mean score also high woman risk vs effect CI adjust age BMI difference group significant woman score mean score age BMI woman high risk great compare woman general population early
23676341 en assess relationship level protein cardiovascular risk factor review patient cardiovascular disease mellitus level measured within year cardiovascular risk group determined low risk risk high high risk according number risk factor risk score correlation level cardiovascular risk factor age hypertension lipid profile history disease mean level range respective man high level woman level significant increased low high risk group respective significant correlate age level hemoglobin body mass index BMI level cholesterol cholesterol ratio cholesterol ratio ratio ratio ratio level level level regression analysis age level ratio BMI found independent correlate significant relationship cardiovascular risk level adult cardiovascular disease mellitus assess level may provide value cardiovascular risk
23319016 en although high prevalence reported among mellitus DM patient study study evaluate association DM population study perform subject adult DM patient per datum group subject use characteristic DM clinical determined logistic regression use evaluate association DM evaluate factor associate among DM mean age DM patient year female mean DM duration year prevalence patient DM subject respective analysis patient DM odd compare subject confidence interval CI among DM patient female patient odd ratio CI whereas patient use insulin DM therapy odd ratio CI population DM patient subject association model risk factor among DM patient female great risk whereas use insulin negative associate
28115791 en association gene risk remain investigate possible relationship gene obesity type mellitus T2DM patient study obesity define body mass index BMI value subject group normal use gene T2DM patient metabolic include blood glucose lipid profile blood pressure obtain significant among group patient show high blood pressure pressure hypertension T2DM patient found significant associate BMI relationship gene obesity patient T2DM high
28046198 en disorder disorder patient lead increase patient negative according therapy model contribute regard patient new may potential present case primary diagnosis disorder patient develop mellitus DM type common patient disorder case disorder DM reported major risk DM type disorder may also increase risk treatment disorder therapy result DM type role medical disorder disorder patient
27801416 en study renal dysfunction patient type mellitus patient patient receive insulin insulin multiple insulin period patient month respective on control group patient without diabetic patient age duration follow-up dysfunction identify use serum serum fasting blood rate patient chronic disease group patient patient statistical significant increase level dysfunction control group glucose found level high correlate negative positive level also correlation concentration blood level high level dysfunction include subject clinical function
27642750 en role lipid profile risk type mellitus T2DM aim aged year risk develop T2DM evaluate association lipid status history body mass index blood pressure presence use factor low risk risk factor high risk risk factor group logistic regression model test use evaluate association blood lipid profile independent use compare ratio total cholesterol high lipid T2DM high risk develop T2DM ratio significant high risk group low show association high risk group age difference high low risk significant associate high risk group factor provide early intervention
27489899 en review datum value risk chronic disease mellitus new early diagnosis diabetic use index type analyzed drug consider
27349002 en protein level type mellitus T2DM well serum gene correlation T2DM index total T2DM patient patient receive hospital protein gene gene correlation gene protein correlation gene metabolic index analyzed role gene protein level significant lower T2DM patient normal protein concentration significant correlate fasting plasma glucose level protein concentration also correlate model resistance index protein level positive correlate significant correlate gene correlation protein T2DM insulin resistance improve insulin gene negative correlate plasma level level gene protein significant different protein case patient significant protein level correlate gene significant correlate gene gene protein level correlate high high reduction blood glucose blood lipid level reduce insulin resistance protein level significant lower T2DM patient patient indicate protein correlate gene correlate protein significant correlate gene result indicate gene associate metabolic T2DM patient
27132429 en case report chronic renal mellitus chronic renal mellitus DM type case patient treat hypertension patient clinical reduce lead increase weight rate patient reported medical history complication present time
26999420 en general individual high level insulin resistance obesity insulin resistance type mellitus T2DM primary contribute factor development T2DM also important role impact population develop related chronic complication T2DM review examine associate obesity patient T2DM gene associate obesity T2DM
26978614 en management type mellitus T2DM T2DM retrospective analyzed group included group patient analysis drug therapy included patient revealed low therapy hemoglobin rate group year one year number patient target blood pressure level group increased group statistical significant vs group use lower year group drug high use group patient common cause group patient high rate care follow increase need treatment drug
26930608 en examine treatment type mellitus T2DM population evaluate use treatment assess factor may analyzed use number number hospital number treatment studied base use base identify factor treatment related treatment conduct regression model analysis base use clinical characteristic observed patient database independent total included mean age female patient mean index database observed event mean per event old age high status little one previous poor renal function associate high female little one previous event associate lower analysis per patient year high group study common complication patient T2DM patient T2DM previous old well patient severe renal treatment patient group therefore receive treatment T2DM include risk
26924897 en contribute type mellitus chronic analyzed determined association total control patient use investigate cell examine system although difference patient found on increased risk level hba1c significant elevated on patient cell patient associate on increased number patient respective gene may influence control patient finding demonstrated high individual on
26915531 en new oral increasing use treatment mellitus DM however type DM patient severe renal study aim assess compare drug type DM patient severe
26875127 en presence diabetic may use early type mellitus DM patient study aim investigate relationship presence early patient type DM patient group DM patient without group healthy control control group included study assess use found group group control group found statistical significant high group compare group analysis perform presence remain independent risk factor increased type DM patient independent risk factor increased consider finding therefore type DM patient follow cardiovascular event
26739974 en assess oral glucose tolerance test subject new diagnose type mellitus T2DM impair glucose tolerance normal glucose tolerance change T2DM
26580237 en glucose develop treat type mellitus study effect randomize study patient evaluate overall population patient study well analysis trial patient cardiovascular disease cardiovascular assessment study population study incidence adverse event incidence similar study significant increase vs lower incidence high vs overall population increase incidence reported low significant high potential related significant different study overall risk increased treatment patient old cardiovascular disease lower baseline estimate rate high baseline use increase may however cause increased risk
26547218 en study aim examine type mellitus identify factor associate subject female diagnose female healthy without known disease included study concentration measured new develop method study total level determined patient compare control group determined high total level lower patient group positive correlation determined protein respective fasting blood glucose respective hemoglobin respective rate determined increase patient compare control group chronic major cause increase determine relationship status new patient investigate
20730284 en evaluate prevalence diabetic patient type mellitus study include individual type mellitus age analyzed database two health on total type mellitus datum rate patient undergo diagnosis patient undergo evaluate profile duration disease type treatment perform presence risk factor diabetic fasting plasma glucose hemoglobin hypertension also prevalence diabetic studied population relationship diabetic mellitus time renal insulin use hemoglobin change correlation diabetic hypertension prevalence diabetic found among patient type mellitus result need great patient type early diagnosis disease
26118196 en serum response independent risk factor disease high patient type mellitus T2DM study determine association blood T2DM level serum blood measured patient T2DM association significant correlation factor independent body mass index BMI ratio hemoglobin hba1c fasting plasma glucose total cholesterol cholesterol ratio therapy history base logistic regression analysis high group show significant increased risk high compare low adjust age therapy history also significant correlate duration BMI cholesterol ratio ratio serum level associate increased high risk T2DM patient
25946502 en patient type mellitus health mellitus datum use activity receive datum revealed patient poor blood glucose care medication sample examine day week statistical significant association activity need regard development
25909794 en effect parameter patient type cardiovascular study patient can patient group therapy group control group patient control group receive therapy patient therapy group receive three use result statistical significant decrease index period decrease result effect parameter
25740743 en study aim determine impact increasing blood glucose lipid outcome woman gestational total protein woman gestational mellitus control group intervention three significant high group control group increased significant group change control group intervention control group fasting blood glucose plasma glucose insulin resistance index decrease significant lipid change group outcome significant two group increase woman gestational mellitus well therapy follow total control
27214983 en study assess relationship level plasma concentration index level patient disease mellitus DM type examine patient disease type normal body weight obesity well healthy individual study use method clinical include found relationship level level total group patient disorder also relationship level significant decrease plasma level significant increase plasma level also function index group control change patient disorder relationship suggest decrease may presence syndrome patient type DM obesity disorder function determine level patient type DM patient level risk function disorder correlation level level plasma relationship
25402372 en evaluate effect high protein patient type diabetic patient glycemic control randomize study patient receive receive measured body weight body mass index BMI blood pressure hemoglobin hba1c fasting plasma glucose lipid profile ratio fasting insulin model assessment insulin resistance model assessment function also assess baseline influence hba1c index effect BMI lipid profile compare found addition period month decrease improve glycemic control function effect patient T2DM
25418205 en patient increased risk cardiovascular mortality cause recent study suggest blood also follow patient due factor metabolic well cause recent potential new several influence function review provide change lead function
27039300 en increasing prevalence associate disease health intervention patient effective condition potential reduce risk complication care patient blood glucose intervention improve control individual patient clinical characteristic study aim assess whether improve control adult poor control method control trial conduct new health one participant ratio receive base individual intervention addition care care control primary outcome change control hba1c month outcome include control month also well intervention study provide effective found effective potential provide new care new clinical trial
23203005 en identify cause previous study show common associate type mellitus T2DM different population study aim evaluate T2DM on study population conduct included female patient T2DM female control subject different on use estimate effect population different association subject case control study on relationship glucose observed control group association T2DM odd ratio CI study suggest major role development T2DM role need
20304169 en mellitus consider complication may reduce patient increase risk develop estimate risk among renal treat identify risk factor retrospective analyzed age year treat therapy follow-up month diagnose according association mean age year patient occur patient time development day incidence treatment group respective analysis patient receive develop significant high method show patient month compare independent risk factor body mass index BMI age patient compare without patient respective incidence associate use age BMI therefore important risk factor mortality
26120850 en include control glucose female revealed gene analysis obesity glucose individual previous model evidence body weight function
26084960 en poor cardiovascular risk factor glucose lipid profile patient type mellitus T2DM relationship remain large aim study examine study participant T2DM history cardiovascular disease relationship assess index clinical parameter mean patient three group base total score subject poor model patient poor type however show significant fasting blood glucose hba1c blood pressure high patient poor high parameter correlate poor model adjust several study indicate poor T2DM patient correlate increased risk factor cardiovascular disease
23631462 en diagnosis gestational mellitus great risk also increased risk develop cardiovascular disease woman insulin resistance observed normal may therefore period woman history increasing insulin resistance hypertension increased care woman period target health review evidence related care woman suggest care case finding multiple woman occur period metabolic glucose cardiovascular risk lipid blood pressure occur interval woman risk factor insulin use early diagnosis obesity use effective disease
21189693 en evaluate function glycemic control type randomize study patient type mellitus study week patient follow patient primary parameter included blood fasting hemoglobin hba1c base hemoglobin hba1c poor control control patient included study studied patient effect glycemic control function result obtain statistical analyzed significant function patient control hba1c low week improve week control hba1c patient control control patient datum show function improve control glycemic control
21274299 en correlate presence duration datum new mellitus DM determine impact age type study DM presence duration review datum relationship finding age type T2DM presence history patient mean duration day medical less year age patient age year great weight high high serum glucose mean hemoglobin hba1c correlate weight blood glucose serum new DM report medical primary care diagnosis significant weight year old new year old
23971059 en change gestational mellitus two current use lead change aim current diagnosis mellitus adverse effect outcome new relationship outcome lead diagnosis change increase woman diagnose evidence management improve outcome diagnosis management general increasing role
26338757 en show high prevalence disease compare general population system diabetic condition disease include increased risk syndrome chronic disease disease impact negative
24527480 en woman man T2DM risk disease important difference difference clinical woman T2DM improve function clinical outcome man remain important management
22324292 en association hemoglobin hba1c diagnosis reported hba1c level glycemic level examine hba1c test group without conduct retrospective cohort study among patient determine hba1c test compare fasting blood glucose effect treatment relationship hba1c assess multiple regression patient included study new diagnose base use hba1c hba1c level value respective high mean cell value current use significant increased use significant decrease regression hba1c compare use significant among patient hba1c although high diagnose current use significant influence relationship hba1c use hba1c may
22231126 en cell dysfunction cell dysfunction type increase risk type aim study estimate association potential previous assess association type within study case type within cohort identify without baseline presence assess use regression use examine association presence development type respective age BMI activity history presence associate type mean follow-up year presence associate type
24671665 en common potential adverse effect treatment complication patient type high risk group cardiovascular complication associate target glycemic control risk glucose without patient risk blood glucose level duration time occur increased risk significant increase mortality patient mean glucose patient disease glucose low risk severe insulin lower risk insulin early insulin treatment patient control target glucose control hba1c drug risk use treatment
24510630 en renal patient type influence whether recent drug type use patient renal review examine result study drug provide therapy patient type impair function current patient renal function function use patient severe renal evidence base use severe renal little evidence therapy analysis clinical trial condition
21060157 en on control trial conduct test improve glycemic control patient type mellitus patient type mellitus level less receive provide total hemoglobin level measured baseline significant difference mean hemoglobin level group level week significant difference hemoglobin change baseline group level week significant difference level group hemoglobin level week patient lower hemoglobin level week high level week observed effect glycemic control type mellitus patient study need determine finding
20878480 en insulin role glucose cause cause result whereas cause
21493993 en assess primary health care management type mellitus primary health care type DM patient score on use statistical mean overall score score female vs score high mellitus DM type DM insulin diabetic management diabetic care mean overall score significant high year year difference found overall score clinical high score patient blood pressure lipid serum baseline serum follow test protein perform serum study several related health identify need type DM patient
21211090 en use model medical research great contribute development type mellitus mechanism disease insulin resistance dysfunction glucose response recent year large cohort common association study great development type increasing development new major new datum research potential current type therapy patient
23497572 en on influence treatment disease present aim assess diabetic condition relationship type diabetic type diabetic subject medical medical included hemoglobin hba1c blood glucose body mass index BMI assessment index index test test independent sample logistic regression model use statistical analysis due value consider statistical significant high compare test addition diabetic show significant high BMI compare diabetic without logistic regression investigate subject influence little increased risk datum present suggest association type chronic influence diabetic treatment
26911579 en study suggest association type mellitus associate gestational mellitus less use study woman without use model estimate first system estimate obtain status perform logistic regression analysis adjust cohort age woman develop range associate cohort or CI range also association cohort age woman less year high odd CI found evidence association among woman study great associate age
26891264 en previous show related type study aim examine whether independent effect risk present study included man woman aged year study study model use estimate associate risk adjust CI man CI woman CI man CI woman identify association adjust therefore association may use effect however influence risk reduction CI man CI woman CI man CI woman influence risk within related may decrease risk
23530576 en reduce evaluate whether time interval insulin year patient control type mellitus insulin use randomize study week duration two group randomize receive insulin group on three time group whereas group receive insulin three time group insulin study significant less group group on glucose datum patient datum indicate blood glucose parameter significant improve group group on significant difference group incidence low three significant difference glucose group suggest addition insulin time may glycemic control
23163974 en determine prevalence diabetic patient new diagnose type mellitus T2DM well factor associate study conduct among new diagnose within month patient T2DM one two diabetic care perform datum on perform use define according develop diabetic patient examine clinical significant analysis revealed age hba1c significant associate odd increased year increase age odd ratio or confidence interval CI increase hba1c odd increased or CI new diagnose patient T2DM patient significant therefore early new diagnose T2DM patient increased age hba1c value associate increased odd on study large sample need risk factor new diagnose T2DM
24315111 en several clinical factor identify early event incidence impact mellitus DM insulin treat outcome remain define patient undergo according DM status mortality day hospital follow-up primary whereas complication rate follow-up one according research patient without DM oral treat DM DM oral treat DM patient woman whereas DM patient research mortality significant high patient oral treat DM DM compare patient without complication significant different group follow-up day patient DM significant high mortality rate vs high incidence vs compare patient without follow-up similar group DM independent correlate ratio confidence interval ratio confidence interval DM significant rate complication patient undergo DM oral treat DM independent associate follow-up included score
24243529 en patient type mellitus T2DM insulin therapy control case insulin patient target clinical evidence show high need patient reduce level estimate effective insulin compare patient T2DM control effective estimate use model use datum randomize trial trial insulin case severe risk factor event estimate use study risk analysis conduct remain overall incidence complication lower great patient receive receive patient obtain per patient ratio per ratio per analysis show result insulin estimate treatment patient T2DM insulin treatment provide control
23412677 en management insulin therapy primary care within primary care need related management insulin therapy regard insulin follow-up management effective treat patient type mellitus oral diabetic drug patient disease duration year use insulin therapy insulin consider patient receive insulin without fasting blood glucose target hemoglobin level insulin consider insulin primary care health care care patient type mellitus
23197224 en type mellitus T2DM prevalence increased early T2DM known associate difference relationship T2DM retrospective cohort compare association T2DM include large rate disease on total individual year old month included analysis datum included T2DM diagnose compare without T2DM association T2DM high odd ratio or confidence interval among or overall individual T2DM diagnose or compare without T2DM high among or population show increased T2DM suggest provide aim group
25526451 en patient DM chronic disease high risk develop syndrome however study investigate effect DM risk study cardiovascular risk use cohort health research database identify total DM patient include patient history investigate incidence datum on model use estimate relative risk individual DM incidence rate similar group female patient year DM associate high risk vs per group aged year patient associate high relative group compare group man adjust ratio confidence interval vs CI woman CI vs CI reduce increasing age DM independent on significant effect DM individual status group cardiovascular risk factor high risk patient risk factor hypertension three risk factor included associate high risk DM vs DM associate different level risk according age cardiovascular risk factor aim therefore according presence DM cardiovascular risk factor
24118688 en glucose develop treatment type mellitus T2DM study evaluate patient receive period primary change hba1c week included change hba1c week well patient hba1c change fasting plasma glucose blood pressure per change body weight cholesterol week significant reduce vs week reduction week reduce body weight vs week week overall adverse event rate similar group week high rate vs lead increased incidence severe vs improve control reduce body weight general well T2DM patient week
20813654 en effect level risk mellitus remain conduct study use baseline datum participant health effect study evaluate association well total concentration prevalence mellitus also assess concentration well total blood hemoglobin hba1c level study cohort concentration found association prevalence adjust odd ratio confidence interval CI concentration respective concentration respective observed association prevalence evidence association well total hba1c finding association significant increased risk mellitus range level observed study finding
20558559 en previous history whether new retrospective study conduct determine risk development within year adult included define blood glucose insulin therapy define hba1c fasting serum glucose medical therapy study cohort included patient develop patient without patient treat insulin patient diagnose treat insulin adjust analysis insulin therapy associate increase relative risk confidence interval patient significant increased risk observed significant increased risk cardiovascular event patient develop
24062868 en associate significant dysfunction mass effect on female present year decrease revealed elevated fasting blood elevated level on show insulin undergo total patient well case use high clinical index finding diagnosis
24837407 en increase level glucose insulin addition increase insulin resistance cell function datum use present aim current evidence use patient type datum suggest similar glycemic control compare associate case less body weight increasing evidence compare effect function improve glycemic control profile patient
25572761 en mellitus DM chronic disease one important health several factor may complication mellitus include activity also level investigate effect serum level activity serum perform group group control group diabetic control group group diabetic show significant increase blood glucose serum cholesterol compare control group diabetic group plasma concentration found decrease activity serum level decrease observed insulin level related activity serum level plasma activity serum lipid profile
21884027 en one common treatment type however little known effect diabetic study investigate retrospective whether chronic associate diabetic patient undergo primary intervention total diabetic patient undergo primary first studied define found patient significant difference clinical characteristic patient without however patient receive chronic treatment lower incidence without logistic regression analysis revealed significant result chronic may associate reduction patient mellitus primary
24397163 en reduce reduction also observed patient function observed patient DM mechanism decrease decrease activity factor decrease activity increase plasma glucose level contribute increase contribute consider observed aged patient DM
23515733 en well known risk factor early adverse outcome patient undergo however study investigate impact risk factor group old patient compare mortality diabetic patient aged year total case studied diabetic retrospective study included patient aged year patient mean age year hospital mortality rate significant analysis diabetic well respective regard significant high diabetic patient analysis analysis however incidence associate presence associate significant difference related retrospective analyzed significant increase hospital mortality related patient impact result study sample randomize clinical trial
24322595 en population old adult type mellitus clinical population clinical identify research health care rate complication mortality age duration cohort study included old year patient type large health care system incidence event per age year duration year vs event event complication renal disease disease lower diabetic disease cardiovascular complication disease disease old adult duration cardiovascular complication follow common complication among individual aged year duration disease rate high per per respective compare renal disease per lower per event per observed similar among patient age group duration high incidence rate disease per per respective compare renal disease per lower per event per age group rate outcome complication increased duration disease however duration rate cardiovascular complication mortality increased age rate complication remain age independent mortality rate increase population age research health reduce need reduce cardiovascular complication
24453844 en role type mellitus T2DM patient aim study investigate role association mellitus case control study case healthy control age blood sample obtain patient well control fasting serum parameter analyzed serum level found significant high among T2DM subject control serum level show significant positive correlation fasting plasma glucose level among T2DM subject significant correlation observed control however correlation observed serum level compare BMI hba1c level study show high serum fasting plasma glucose level T2DM patient correlation suggest association T2DM subject
24402011 en type mellitus chronic disease metabolic major role lead development among several investigate associate one gene role response activity cell cell gene major role development disease therefore gene within present review role development
24308892 en treatment type mellitus T2DM aim identify treatment T2DM retrospective study patient undergo may perform patient fasting serum glucose concentration diagnose T2DM on fasting serum glucose level less consider patient diagnose T2DM include man woman mean age year mean body mass index BMI mean glucose month respective mean body weight one year respective among method BMI body weight serum lipid profile serum factor associate glucose significant different follow-up rate T2DM patient respective method T2DM use datum method significant year serum lipid profile serum datum related glucose different method effective reduction serum glucose level compare
23615706 en activity function metabolic recent identify role mellitus DM high use DM low concentration on group control DM treat significant lower level reduce weight increased weight addition decrease level several include significant perform cell model use demonstrated treatment increased suggest effect system overall datum DM increase level
21385020 en large population high rate obesity compare prevalence diagnose high high rate diabetic complication mortality great system care target population factor population treatment conduct type complication datum management factor review number study include high hba1c level great rate obesity metabolic syndrome large individual care relative study factor current body primary care aim effective relationship research effective primary care value
24304961 en lipid new lipid cardiovascular risk aim study determine value evaluate database result health year age conduct value high characteristic relationship value woman man value similar relationship use value prevalence high woman man odd ratio subject vs without high adjust age CI woman CI man high odd ratio hypertension CI woman CI man also obtain subject vs without high value high woman man determined high odd ratio hypertension obtain use value study need whether value age
19047239 en examine tolerance risk among gestational mellitus study previous study diagnosis gestational mellitus gestational mellitus normal glucose tolerance index undergo follow-up age year range year weight blood pressure measured oral glucose tolerance test demonstrated impair glucose mellitus follow-up gestational mellitus significant high vs vs blood pressure value lower cholesterol vs level age on high insulin level associate glucose tolerance gestational mellitus increase risk independent glucose tolerance
23985694 en study evaluate change oral mellitus ratio blood rate plasma control can due significant two group due activity oral oral group can cause great study finding potential similar change patient
25361643 en increase gestational mellitus develop blood glucose system determine use system care development woman use diagnosis woman assess general relationship care response score assess use statistical method woman glucose tolerance test week mean woman previous week woman care respective relationship care finding positive woman factor analysis large woman effect clinical outcome current randomize trial
27748835 en renal cell adult study role hypertension metabolic syndrome mellitus DM one metabolic syndrome patient patient high rate great number factor contribute reduction overall also occur syndrome use therapy may effect patient study case report show influence blood glucose level diabetic patient cause consider independent factor increase lipid use patient
19486857 en role mellitus complication several use present study aim investigate mellitus patient compare healthy control test diabetic patient healthy control subject mean age diabetic patient year mean duration year mean level hba1c diabetic patient three patient mellitus hba1c level patient mellitus show high compare control respective significant correlation duration hba1c significant difference found diabetic patient compare control result suggest mellitus condition increased level may factor increased
19476724 en evaluate whether provide glucose result improve control poor control assess health impact control trial care hospital aged year mellitus type little month receive two insulin participant two hba1c value one group two group receive glucose glucose system group compare control group treatment group control group common clinical management hba1c baseline month primary study assess use on health analysis also month group demonstrated hba1c level baseline mean change hba1c group group control group care control group month relative reduction hba1c intervention less care control group treat analysis significant difference found group assessment time evidence provide result change number treatment health analysis indicate group receive lower high found control assessment use indicate use group month use use group reported effect great activity use glucose lead improve clinical outcome hba1c individual poor control datum suggest use individual large number effect
22396585 en associate increased incidence compare medication study determined cardiovascular disease compare effect associate total participant treatment trial baseline year follow-up follow mean total year year year use database primary outcome mortality disease among outcome mortality mortality participant lower risk mortality ratio CI mortality CI mortality CI participant range participant elevated risk compare CI significant lower risk finding suggest less adverse impact develop medication
26050418 en management individual control significant role positive outcome patient care reduce disease complication improve important management patient health care change on model change provide care patient clinical outcome model multiple intervention change chronic disease management use intervention
19013292 en man well woman increasing patient type mellitus high risk subject aim present study investigate relationship serum concentration well man type mellitus relationship serum concentration well include age duration glycemic control hemoglobin body mass index evaluate man type mellitus correlation found index age on positive correlation found index serum concentration index significant less current multiple regression analysis demonstrated serum concentration status independent index associate serum concentration associate hemoglobin duration man type mellitus
19001932 en aim outcome diabetic patient disease treat intervention increasing use disease however datum clinical result disease patient baseline outcome datum patient undergo intervention disease identify three group mellitus patient mellitus patient mellitus individual primary rate major adverse event target also according research total patient mellitus patient mellitus patient mellitus individual adverse event overall significant different group follow-up period month major adverse event occur similar rate group patient mellitus patient mellitus mellitus individual case possible common among mellitus patient among mellitus patient mellitus individual vs respective provide early result patient individual undergo intervention disease randomize datum finding
22669833 en increasing report association syndrome increased risk development metabolic syndrome well cardiovascular risk factor man determine relationship serum level metabolic syndrome type mellitus total man type DM aged year evaluate syndrome diagnosis use clinical level total presence metabolic syndrome without metabolic syndrome diagnose use new related overall prevalence rate metabolic syndrome study subject respective subject metabolic syndrome subject without vs use test mean level subject lower without difference statistical significant vs metabolic syndrome man type without correlation serum level metabolic syndrome define parameter
22853689 en metabolic disorder independent risk factor development type aim study test association type clinical characteristic large sample first within participant significant association association sample association study perform datum two first significant associate type odd ratio CI show type odd ratio CI similar effect type observed odd ratio CI two show significant effect type odd ratio CI association analysis show associate plasma glucose level datum common within associate type metabolic population
22099149 en woman gestational risk develop year risk may high high risk population rate low evaluate effect woman conduct retrospective review among woman primary outcome evaluate effect included woman study woman mean age year previous associate increase odd increase follow or CI or CI base system effective improve rate increase rate target patient
26716749 en obesity type woman lipid well system due high concentration decrease parameter system glucose cell result obtain study suggest important role obesity aim
26569302 en important role development gestational mellitus aim identify associate risk woman woman year included health group base database three identify reduce regression response include body mass index BMI ratio high high low high low diagnose use fasting plasma glucose level week logistic regression model use estimate adjust odd ratio confidence interval age ratio status BMI gestational weight activity protein statistical analysis sample weight woman woman high vs low high high low high low BMI gestational weight finding suggest associate risk potential observed high low high odd general health healthy research associate
26235526 en recent gestational mellitus woman aged year mean year little gestational week conduct analyzed use analysis according important possible health reported blood blood oral glucose tolerance test without glucose test conduct two woman one woman reported study new finding show two year
24673412 en role function lead development diabetic perform evaluate association type mellitus conduct database datum analyzed use statistical odd ratio or confidence interval use assess related gene study T2DM patient T2DM patient without although significant association overall analysis group decrease association or CI study model or CI according duration DM revealed T2DM patient history year elevated compare history duration or CI present suggest potential decrease risk develop T2DM individual high patient year duration DM determine risk study base large sample conduct role gene risk
24237969 en complication cause risk factor complication identify risk factor severe patient retrospective patient patient compare patient patient patient risk factor identify patient oral use little one condition patient mellitus DM obesity hypertension patient undergo DM significant associate factor condition perform diagnosis found observed patient undergo patient DM increased risk factor condition associate show risk severe low
22362525 en diabetic complication mellitus DM method body method current study assess diagnose diabetic value diagnosis included study healthy group diagnosis DM base increased concentration mellitus group plasma body method diabetic group plasma body metabolic present group plasma measured method on value diagnosis base characteristic healthy concentration range group group group on value revealed diagnose parameter diagnosis diabetic
22180634 en type mellitus increase cardiovascular disease however investigate whether impact cholesterol high plasma cholesterol level within increased cholesterol result increased cholesterol cholesterol whereas increased mass significant high change due increased cholesterol overall use primary cell lower due reduce within revealed cholesterol whereas lower due increased protein high mass impair mechanism contribute increased cardiovascular disease
21606668 en hemoglobin hba1c impact glycemic control type mellitus T2DM patient well current status glycemic control hba1c relationship T2DM study hospital sample T2DM undergo use patient hba1c subject level hba1c respective less receive hba1c test per significant lower hba1c test per possible include age significant association adjust odd ratio confidence interval CI CI respective hba1c vs time per glycemic control control T2DM poor hba1c patient lower hba1c significant associate poor glycemic control
26782387 en conduct study investigate role three common gene development type mellitus T2DM may may patient T2DM control subject study three perform logistic regression analysis show individual significant increased risk T2DM adjust odd ratio confidence interval respective contribute development T2DM associate disease
26777037 en investigate relationship increased type mellitus subject aged year T2DM investigate finding general datum related index subject group group according protein significant difference age group group value group high group value lower group value correlate significant overall model revealed group independent parameter adjust risk T2DM present adverse cardiovascular disease risk profile level correlate parameter independent
26677088 en evaluate influence disease control mean value hemoglobin hba1c oral health mellitus type study year old participant three group hba1c hba1c hba1c duration disease age hba1c obtain medical oral health evaluate according index oral index index index rate group hba1c group hba1c group on significant decrease observed increase hba1c index high individual high hba1c value individual found group hba1c compare hba1c group hba1c group hba1c value high glycemic control high hba1c concentration high reduction
26398456 en disease type mellitus T2DM metabolic syndrome clinical metabolic characteristic whether characteristic determined clinical patient T2DM examine multiple correlation define mass participant use regression analysis correlate positive BMI number factor blood pressure insulin resistance metabolic control protein whereas correlate negative use multiple regression analysis metabolic control insulin resistance plasma insulin remain correlate significant use statistical model metabolic control insulin concentration case one patient T2DM correlate associate metabolic control metabolic control obesity insulin resistance may T2DM
22913735 en oral high first indicate use treatment adult type mellitus also clinical datum use patient type review oral treatment adult type investigate several trial week treatment control parameter include hba1c primary trial relative use therapy therapy oral insulin without hba1c effective trial use therapy study trial analysis datum suggest improve control factor age duration type renal function primary use without patient renal oral general well associate low use little effect datum however clinical datum current indicate effective general well treatment use patient type include renal
25211320 en evaluate chronic disease mellitus DM influence mortality patient use datum datum evaluate clinical difference mortality rate patient DM test factor mortality logistic regression model included age DM value consider total analyzed mean age year patient old vs year medical condition DM patient risk factor vs overall mortality rate patient mortality lower DM patient vs high patient vs effect found DM odd ratio or CI DM remain or CI associate increased mortality or CI patient association high mortality presence DM
24841086 en factor lipid obesity associate metabolic cardiovascular disease aim study first time relationship risk among patient type mellitus T2DM on total patient diabetic control study perform compare found high control patient without T2DM adjust multiple risk factor significant reduce risk CI compare increased significant risk patient T2DM CI level significant high result indicate may reduce risk patient T2DM
22569617 en compare activity level care related patient mellitus adult patient assess activity well week related patient assess type mellitus type mellitus large patient poor lower high compare patient patient different patient present medical patient time patient perform glucose patient reported lower number related different related patient
22440495 en study assess presence effect impact high patient mellitus treat associate effect patient total type mellitus patient therapy studied patient group according level function assess rate define use effect observed parameter test serum level associate assess use according increased level serum similar result found define index assess high serum level significant associate lower rate define according associate effect effect lower rate mellitus patient
21944463 en recent show mellitus DM significant associate present score however whether association type DM study evaluate whether DM type associate adjust known total man diagnose treat therapy analyzed on logistic regression analysis perform evaluate whether type DM associate odd compare lower adjust age level type DM adjust odd ratio confidence interval CI type DM CI significant diagnose compare man however respective result CI CI DM associate high odd diagnose score man diagnose type DM lower consider disease
19118471 en compare outcome cohort patient undergo renal disease group patient patient included database datum analyzed primary outcome evaluate rate complication include need blood outcome hospital report review outcome patient known time outcome compare obtain patient datum patient patient undergo revealed patient age year time complication major include need rate significant different observed patient hospital significant diabetic group day vs day found common among patient study perform rate complication risk diabetic population incidence disease significant high previous reported population
23172523 en treatment outcome type mellitus T2DM clinical datum patient T2DM undergo hospital retrospective analyzed clinical parameter included blood glucose blood lipid status weight patient included man woman range age year mean year range BMI patient undergo mortality complication occur month significant change BMI hba1c show clinical overall effective rate level blood lipid decrease significant change status statistical effective treatment type mellitus
24841349 en study aim determine effect mellitus DM risk mortality patient undergo identify DM patient undergo control cohort patient also receive period age year prevalence medical condition DM cohort patient undergo major DM cohort vs cohort ratio mortality DM patient confidence interval CI DM cohort significant high risk adjust ratio CI renal adjust ratio CI compare cohort high risk associate increased risk major include analysis show major DM patient high risk renal multiple regression model significant associate associate significant high risk renal major complication mortality
22768668 en gene lead mellitus glucose treat insulin report glycemic control patient therapy present first day treatment insulin hemoglobin hba1c normal increased day age month age insulin analysis revealed two gene age year month insulin oral day develop medication age year month low increased insulin hba1c without age year month improve metabolic control year hba1c glucose mean significant lower compare value insulin compare insulin oral improve metabolic control patient cause gene oral therapy patient occur insulin therapy
22338775 en aim investigate prevalence mellitus lipid status sample disease patient prevalence mellitus statistical significant woman vs prevalence increased total cholesterol decrease statistical significant woman vs increased increased reported datum prevalence mellitus decrease prevalence compare datum prevalence cardiovascular risk factor cause treatment primary
22008227 en study evaluate insulin mellitus DM DM included receive insulin little month perform one two week included clinical blood glucose serum concentration mean blood glucose concentration significant lower two week treatment remain significant lower duration study week improve per clinical can cause observed base clinical treatment per poor control week study respective insulin possible method treatment occur DM although study use type insulin rate great insulin
26681338 en may indicate metabolic risk body investigate whether associate development mellitus DM datum study age range year subject baseline group according parameter related function insulin resistance include examine development DM base oral glucose tolerance test year among subject among develop DM incidence DM increased adjust risk factor related DM relative risk DM development confidence interval man woman respective compare finding indicate negative impact large development DM
26497229 en type mellitus T2DM diabetic known effect present study investigate effect factor patient T2DM investigate mechanism serum subject control T2DM group without treatment use analysis protein determined use analysis level protein use impact T2DM group also investigate T2DM group level protein include protein well significant difference protein among three group effect however significant effect protein level associate present study indicate effect response T2DM associate
26461928 en patient type mellitus insulin lower incidence patient multiple retrospective cohort woman primary outcome incidence plasma glucose first incidence rate significant high woman vs high weight vs glucose management significant less time insulin range vs analysis body mass index BMI time insulin significant associate population patient group however factor glucose management early BMI associate
26377124 en intervention show improve outcome patient type mellitus number study suggest may intervention aim study review outcome intervention use evidence database result study control trial cohort study common intervention use study common outcome measured hba1c however three study show significant decrease similar result reported outcome study included review suggest intervention datum may effective control evidence need evidence base use management study intervention overall study study intervention
26375925 en may influence disease include type studied serum level associate characteristic type diabetic treatment hospital included total patient patient serum level lower correlation serum level hemoglobin patient without insulin therapy found correlation serum level fasting serum insulin model resistance common type diabetic patient correlation metabolic control insulin resistance
26140473 en according study result function type mellitus result datum effect plasma level recent cardiovascular risk factor study investigate effect function evaluate plasma type diabetic patient two group receive oral receive week clinical assessment perform trial evaluate serum hemoglobin lipid intervention result significant hemoglobin level compare group difference change parameter also significant effect level decrease diabetic cardiovascular event
21966944 en level serum patient health disease without type mellitus DM found elevated disease correlate clinical parameter DM chronic associate cause insulin resistance study determine presence serum DM among individual association individual female base clinical parameter three group group healthy group DM among individual group individual without serum sample estimate level use mean concentration increased serum individual DM also observed serum correlate positive sample group test positive serum concentration DM individual without correlate positive clinical parameter study perform positive correlation
23250466 en association management patient mellitus base evidence well metabolic control mean oral insulin therapy
19204649 en suggest risk adverse event present study evaluate potential association use datum datum conduct medical activity use use adjust ratio mean confidence interval estimate association relative drug event logistic regression odd ratio mellitus little one common event mellitus case adjust ratio mellitus case case case case case case case logistic regression odd ratio adjust database lower association high association finding risk need metabolic patient
21306286 en study investigate risk among patient therapy vs therapy clinical aged year identify health database index first occur period patient receive month month index hypertension time patient diagnosis mellitus therapy month month index patient ratio mean duration follow-up month group group respective primary outcome presence patient group group mean age year rate per patient vs patient group risk similar group CI suggest risk among patient similar use datum relative follow-up period may result
23350795 en addition insulin effective control type remain patient great risk treatment improve aim study obtain clinical characteristic risk datum participant study insulin use similar method logistic regression mean age year duration year body mass index baseline mean month treatment mean occur blood glucose event severe independent age lower body mass index use addition lower lower finding low rate clinical important use method suggest high risk may patient need insulin less level
27182008 en aim present study investigate role type mellitus complication assess relationship serum type group studied patient type mellitus man woman included complication complication type mellitus without complication control group healthy blood participant evaluate fasting plasma glucose fasting insulin serum level type mellitus patient found significant high compare patient without level significant positive correlate model assessment insulin resistance hemoglobin respective logistic regression analysis level found independent associate patient type mellitus datum first association type mellitus complication significant positive correlate potential role complication type can study
26800561 en dysfunction insulin resistance increased cardiovascular risk mellitus however mechanism remain recent study identify metabolic dysfunction potential function evidence increased contribute impair function patient measured cell protein subject type mellitus control cell treat cell patient mellitus high level high without difference total level high associate lower dysfunction insulin improve cell patient mellitus cell control treatment diabetic cell finding activity contribute insulin resistance dysfunction may patient mellitus
27525273 en type mellitus one common chronic disease develop incidence disease increase rate year associate cell lead insulin factor contribute development patient also development disease patient control common include disease disease syndrome aim review assess prevalence disease impact also present test
27054695 en investigate correlation patient type early diabetic datum patient clinical trial use according early treatment diabetic study patient level included measured age duration year respective level respective according level found patient high level regression model associate cell per correlate per per independent associate change patient early
26891662 en study investigate effect treatment diabetic conduct study treat day treatment protein factor protein on determined treatment increased diabetic increased diabetic treat decrease control diabetic treat group decrease treatment increased diabetic treat compare control decrease group compare diabetic increased diabetic increased diabetic level decrease treatment diabetic diabetic level decrease however treatment effect increased treatment increased level diabetic treatment cell
26517200 en associate function recent factor cell function system role large remain mechanism study evaluate effect function level change diabetic use diabetic show significant week three week treatment significant increase test diabetic also show improve test treatment treatment show significant effect blood glucose insulin level significant reduce evidence decrease level treatment diabetic also increased indicate mechanism also level diabetic finding may effective treatment associate
25457621 en aim study evaluate treatment woman association study conduct hospital sample patient datum treatment level evaluate fasting plasma glucose three recent value patient medical profile mean use datum total patient included analysis patient positive patient treatment significant association total mean score age level status history type therapy treatment statistical significant association present total mean treatment score level patient negative treatment high mean two patient treatment patient management
23323702 en dysfunction development obesity type gestational mellitus common present study investigate status cohort woman normal control blood level determined patient significant lower level compare control woman significant difference woman insulin treatment on positive correlation found correlate negative hba1c level datum first time compare normal woman may role
23489301 en treatment type may increase risk evaluate cardiovascular profile evaluate incidence event patient treat drug clinical trial database use major adverse cardiovascular event analysis included patient compare patient treat patient treat event treatment incidence rate significant different patient treat therapy confidence interval type event significant different patient treat analysis show increased risk patient type result examine trial assess profile patient type mellitus
27323564 en metabolic syndrome risk factor obesity high low high cholesterol level high blood pressure estimate adult population three time event compare without study conduct general diabetic present month age blood pressure fasting blood glucose lipid profile patient female mean age year mean duration mellitus year metabolic syndrome present study population female statistical significant compare presence metabolic syndrome serum level blood pressure common occur finding decrease present diabetic population female decrease common
26854669 en aim study assess impact serum level
19944681 en mellitus known use effect evaluate whether diabetic subject follow diabetic group activity gene influence assess significant reduce compare diabetic increased protein decrease protein compare diabetic however addition change protein associate reduce activity protein include result
25053670 en complication on type report case mellitus diagnose diagnosis management type on man medical history present body mass index demonstrated diagnosis treat target therapy negative hba1c revealed occur within month improve week insulin hba1c
19615920 en examine adult type mellitus care female adult type year female old participant diagnose type DM follow medication year participant diagnose type DM duration time less perform blood glucose reported however follow female reported old reported old participant less participant old old diagnose type DM high activity participant high less perform type DM medication blood glucose compare old finding suggest increased risk type DM complication may treatment year
24418399 en study evaluate association gene diabetic complication subject include healthy control type mellitus T2DM subject without complication DM T2DM subject complication T2DM subject complication gene subject logistic regression analysis use evaluate association found significant associate development complication respective T2DM subject show reduce risk development complication analysis revealed association development complication observed significant development complication T2DM subject datum indicate significant association complication T2DM subject
21859914 en clinical characteristic associate test association study included study participant care receive base hemoglobin hba1c lipid level blood pressure logistic regression model use assess association clinical characteristic reported test according age type participant reported blood pressure lipid level measured function test undergo hba1c undergo participant aged year old type test perform age important correlate overall care model old age lower associate relative need improve rate hba1c among old
20654789 en control investigate effective target hemoglobin hba1c level conduct study among type mellitus aged year type DM DM care medical patient included datum measured test also target hba1c general association patient type DM logistic regression analysis use relationship age duration score hba1c patient mean age year mean hba1c level correlation analysis show positive correlation body mass index blood level negative correlation found score duration well hba1c level logistic regression analysis demonstrated score significant influence glycemic control logistic regression analysis patient high score time confidence interval target control patient also high odd ratio confidence interval target study type DM high high target control
20633742 en high negative impact control treat review aim effective therapy study participant intervention randomize control trial evaluate outcome treatment care type type assessment datum method datum model analysis analysis total patient show treatment effective reduction CI effect intervention clinical impact CI large intervention management CI treatment CI care provide care intervention primary care population effect CI indicate effect population care aim reduction effect glycemic number treatment general medical condition include glycemic control condition research need
23545889 en insulin treatment diabetic without general first insulin patient type mellitus general hospital use insulin treatment insulin provide clinical trial although patient mellitus present insulin insulin treatment within year insulin multiple health care identify care patient patient receive insulin care diabetic patient new hospital general can management
20470427 en study relationship chronic disease base estimate rate diabetic patient type study perform patient type mellitus measured use mean subject show disease disease patient elevated significant however significant different among diabetic significant great diabetic patient hypertension compare without hypertension positive correlate age duration mellitus negative correlate regression analysis independent associate study first report relationship renal parameter include diabetic association diabetic study early positive treatment hypertension obesity well reduce found diabetic patient
25401741 en significant mellitus DM due role one chronic disease
24668713 en important mechanism development complication type mellitus system body cell whether diabetic glycemic control level need study assess plasma level type potential association glycemic control insulin sample obtain type diabetic patient control subject according hba1c diabetic hba1c hba1c insulin measured use control subject plasma level high diabetic lower level compare patient plasma level negative correlate fasting blood hba1c association glycemic status high level may suggest function association glycemic control may suggest role different mechanism
24393761 en role treatment type mellitus T2DM patient T2DM rate remain low provide current management T2DM association medical therapy provide total number type also cardiovascular risk reduction patient T2DM weight important role patient T2DM individual T2DM patient activity therapy use weight several different include index study demonstrated weight body weight associate significant patient glycemic control lipid blood pressure cardiovascular risk factor weight little result reduce hemoglobin level may weight provide patient T2DM obesity
25929021 en medical use development patient type review show development patient type need patient provide metabolic effect included possible change cause
26868137 en evaluate outcome use system compare control trial database randomize trial mellitus outcome cardiovascular renal randomize control trial participant total patient year follow-up compare associate similar risk relative risk confidence interval cardiovascular also difference renal outcome renal disease show reduction renal drug reduce risk cardiovascular renal finding hypertension treatment high blood pressure also use without disease
23748512 en prevalence type mellitus T2DM association increase obesity rate current treatment patient T2DM include medication effective treatment patient glycemic target range little treatment relative risk individual patient intervention current evaluate potential T2DM weight management risk adverse event patient T2DM on healthy low high resistance patient T2DM drug intervention insulin early addition weight potential target multiple patient T2DM patient treatment weight insulin glycemic control therapy insulin little weight low risk treatment T2DM obesity increase overall patient treatment may also improve patient
23450333 en whether patient type mellitus T2DM remain perform assess T2DM perform identify study primary outcome fasting blood glucose hba1c insulin resistance outcome included total cholesterol cholesterol mean difference confidence interval control trial control trial CI CI hba1c CI CI CI hba1c CI result serum lipid suggest significant reduce total cholesterol improve evidence T2DM patient study need investigate
24293759 en effect function presence mechanism dysfunction model type
24180564 en review randomize control trial aim effect glycemic control patient type database use medical subject randomize control trial change hemoglobin fasting plasma glucose reported difference baseline estimate obtain use model identify range duration week provide datum patient include study study reduce value hemoglobin CI fasting plasma glucose CI increased improve glycemic control indicate consider treatment patient type
24485343 en relationship mellitus incidence related duration report year old female present history diagnose revealed type mellitus without
23154532 en type mellitus disorder result cell assess effect cell patient new two group patient group treat patient group treat normal base insulin therapy patient interval first month month month effect result evaluate reported chronic effect group compare group hba1c group patient significant value group patient follow-up period datum treatment effective therapy function cell time although mechanism effective treatment
22825586 en cell cell function cell model type mellitus cell review datum role cell development use cell treatment
21308167 en estimate medical care patient type mellitus clinical patient treat medical care review use disease diagnosis complication total per patient per patient without complication per patient complication care great high provide medical care patient complication health consider use datum management disease
20842389 en investigate influence two insulin insulin multiple insulin therapy insulin development insulin patient type mellitus assess impact glucose control patient type mellitus treat included study age duration blood glucose event compare positive negative patient level high group group duration age associate positive blood glucose event similar two group blood glucose lower positive group patient type mellitus treat insulin high level compare therapy however development impair control
22753195 en review evidence incidence mortality mortality rate among high age group compare general population mortality due factor related cardiovascular renal disease year relationship although large body subject research result little known incidence increase among need research impact incidence mortality increase within review finding study method use study outcome study found statistical significant two disease whereas cohort study result also finding among research define define individual disease diagnose year age review found number study mortality among study also finding within result suggest need research potential relationship
20166000 en management type mellitus primary target one risk function patient review recent trial patient study primary trial test whether oral insulin high risk blood study trial test whether blood lead improve blood glucose control study test whether function new diagnose recent study study test effect patient recent show improve function patient type
23276620 en evaluate multiple glucose clinical development treatment patient type mellitus randomize study patient randomize one treatment group control primary outcome mean change baseline week hemoglobin hba1c compare show decrease hba1c week compare decrease among group also reduction body weight patient adverse event similar group clinical effect observed week treatment decrease hba1c patient T2DM effect identify
23068107 en evaluate result weight metabolic syndrome complication patient type mellitus T2DM body mass index hospital present study on total patient T2DM body mass index undergo duration T2DM year patient hypertension T2DM metabolic syndrome assess patient follow weight year year patient year weight occur patient drug rate rate year however metabolic status found treatment T2DM patient body mass index T2DM weight great level hypertension can complication decrease mortality associate T2DM
24088407 en whether metabolic syndrome improve cardiovascular risk risk associate individual present study examine association score high protein disease according presence DM addition value clinical parameter analyzed include score study patient man year age undergo blood sample define cholesterol score define define little one major assess use patient studied diagnose patient according score level assess score increased score increased level decrease significant score increased subject two group according presence DM relationship score score patient without DM age DM score independent population however age patient presence DM score however patient show change according score score independent patient without DM
23685222 en increasing evidence renal include association diabetic current clinical healthy individual renal disease study compare level healthy control patient
23408014 en study prevalence control evaluate therapy mellitus DM hypertension patient care hospital case primary primary evaluate presence DM medication case evaluate mean age year study group two patient DM include patient one patient patient patient patient diabetic one patient blood pressure control level diabetic blood patient found therapy on large adult patient disease control patient use medication known medication study need improve overall health patient
21617153 en multiple test use diagnosis management patient mellitus evidence use use analysis patient on new system develop overall evidence on response review clinical addition base plasma glucose diagnose increased hemoglobin concentration blood glycemic control perform patient plasma blood glucose analysis potential role glucose insulin provide base datum several found clinical value present time
21315636 en renal year study mortality analyzed renal datum system datum cohort first year patient whether new show mortality difference associate effect significant increase reported patient receive associate
23676586 en evaluate effect treatment body weight related type diabetic total patient type treat week week increasing month change body weight body mass index BMI hba1c fasting blood glucose level renal value associate study included one patient patient oral drug patient insulin therapy month treatment blood glucose level high baseline value however body weight BMI lower ratio improve significant baseline analysis patient insulin resistance show month treatment significant decrease significant decrease serum level significant increased serum addition effect weight reduce weight total reduction medication use oral drug insulin
23349979 en protein plasma early chronic aim study determine role serum level rate patient type cohort study one type diabetic patient conduct serum level rate determined correlation rate study subject decrease significant study vs rate increased significant vs baseline rate serum level significant correlate baseline result regression analysis correlation rate change baseline level rate show rate significant correlate rate change may factor associate type diabetic patient
23280391 en blood glucose level cause dysfunction role blood glucose level correlate dysfunction relationship assess use common medical blood glucose level measured glucose day patient type mellitus index index function measured use day correlate mean glycemic mean glucose time patient also correlate time correlate hba1c fasting plasma glucose level correlate cholesterol cholesterol level blood pressure analysis identify significant blood glucose level significant role dysfunction type
22829557 en study aim evaluate type type mellitus patient undergo hospital datum patient fasting plasma glucose body mass index BMI medication use hemoglobin month patient obtain normal range patient treatment patient reduce lower drug statistical significant difference found group mean BMI month month decrease value month effective type mellitus independent body mass index
24972765 en aim study evaluate influence gestational mellitus cardiovascular system function woman without evaluate function included analysis perform perform change cardiovascular function analyzed use analysis characteristic similar group compare woman revealed significant difference time related change indicate total low high significant reduce ratio however significant result suggest decrease activity significant change function whether test perform woman
24214280 en patient type mellitus increased risk cardiovascular disease mortality compare population study report association reduce blood glucose reduce risk complication patient previous review control control base clinical trial participant report review
24117257 en study aim investigate cardiovascular associate type mellitus reduce protein treat body oral week effective reduce insulin resistance blood glucose hemoglobin hemoglobin elevated level lipid decrease level normal treatment effective reduce lipid protein increased activity level treatment reduce cell treatment reduce insulin increasing finding suggest type mellitus
23979746 en plasma concentration concentration decrease diabetic patient prevalence plasma concentration diabetic patient respective datum show plasma concentration great reduce diabetic patient
19756162 en need improve medical management patient hypertension primary care several care model show effective outcome among patient remain care model effective blood pressure control primary care study patient type mellitus blood pressure identify randomize three group group on hypertension group blood pressure use provide group control care subject study target blood pressure statistical difference mean blood pressure among three group management hypertension among type patient result blood pressure control compare care study factor patient group determine patient disease management chronic disease management
19756493 en number patient mellitus increasing population disease patient treat also related condition complication on patient result hospital treatment patient
24502082 en important diagnosis treatment management evaluate use patient patient mellitus control subject study perform one previous oral measured also assess study study revealed presence significant correlation value hemoglobin significant association patient type significant correlation value use provide
24129984 en investigate effect mellitus DM include diabetic control subject system use improve diabetic subject examine use function analysis method base well one use identify use method base result show DM patient subject use method
19040489 en mellitus common complication common current obesity impair fasting glucose impair glucose tolerance negative influence patient glucose although number clinical factor include age weight history associate mellitus possible role management general treatment type mellitus general population however study need determine patient disorder
20533174 en among female major health mellitus type patient study suggest type increase risk increased mortality however evidence association present review datum correlation mechanism insulin rate among patient also recent datum indicate treatment due therapy on large provide research need possible factor therapy well possible medication
22751874 en evaluate effect level cell function therapy insulin type mellitus
22609217 en activity method management type mellitus consider treatment aim study investigate effect metabolic control patient type mellitus one patient type mellitus range age group control group week participant undergo test determine metabolic control week study significant study group mean study group increased parameter control group significant difference hemoglobin hba1c increased patient type DM however change metabolic control present study positive effect metabolic control can show patient type DM
25088608 en diabetic common chronic diabetic complication presence may indicate dysfunction system study develop diabetic risk score identify patient type mellitus study evaluate patient included female age diabetic risk score conduct age duration DM history drug treatment characteristic CI compare index different value odd ratio one increase diabetic risk score associate risk CI datum suggest diabetic risk score can primary presence patient T2DM
21755759 en present study evaluate prevalence outcome gestational mellitus period study woman week investigate presence according study group outcome compare control group overall prevalence found group history whereas prevalence found significant high compare datum obtain treat group follow study intervention significant positive effect well outcome also case diagnosis management
23649139 en on study conduct among estimate prevalence mellitus DM impair fasting glucose impair glucose tolerance correlate participant age activity activity diagnosis DM base history fasting blood glucose per health body mass index blood pressure estimate subject DM found age year history hypertension obesity found significant associate DM whereas significant associate history hypertension high prevalence condition early effective intervention healthy
26415372 en type one common chronic factor provide disease show associate important one among aim gene patient type mellitus use role study healthy control group blood sample patient control group subject gene analysis use follow significant increased patient control group respective significant association three diabetic complication associate complication ratio respective association found weight risk factor insulin treatment association
25608447 en disease mellitus type T2DM high care clinical define care T2DM patient include test study aim general provide care T2DM patient association patient health study studied T2DM patient general measured compare care care health outcome included health datum medical association health outcome use logistic regression different system patient patient regard care high blood pressure hba1c assessment although adjust patient characteristic found associate patient health general care general found relationship health outcome research need relationship health outcome base evidence
25506777 en cell therapy patient great blood cell increasing use cell therapy cell show lower blood glucose level diabetic model use type diabetic show however cell therapy show blood glucose level type type diabetic patient review recent therapy treatment complication
25159119 en effective type mellitus T2DM patient body mass index BMI whether BMI effect metabolic outcome individual undergo health BMI
25425599 en diabetic disease complication diabetic patient datum study assess whether diabetic function compare mellitus DM chronic disease healthy serum serum ratio ratio rate measured two diabetic evaluate diabetic healthy significant mean lower vs vs ratio vs significant high vs vs compare compare healthy diabetic significant lower vs present diabetic healthy however statistical three time major impact DM function can demonstrated
21448825 en current oral glucose tolerance test remain diagnose type value evaluate risk score determine individual type risk profile may type study current type datum may individual recent datum suggest adjust aim individual patient result present treatment type recent year drug improve
18854761 en elevated patient metabolic syndrome insulin resistance whether development mellitus independent presence development metabolic syndrome assess association baseline mellitus participant general patient aged year included datum study insulin resistance syndrome study baseline among patient datum regard mellitus occur patient follow-up man woman associate mellitus man compare man ratio man respective woman association man baseline impair fasting glucose ratio respective association remain significant BMI activity insulin model assessment insulin resistance lipid protein history mellitus first change weight glucose insulin model assessment insulin resistance risk mellitus man independent baseline early development metabolic insulin resistance
26440925 en study diagnosis day day analysis condition condition chronic condition study examine effective day diagnosis type mellitus T2DM included female age year receive identify potential T2DM case use associate day first medical review determine T2DM potential T2DM case identify use datum new T2DM medical review case T2DM T2DM diagnose day fasting blood day diagnosis T2DM one elevated first T2DM diagnose result suggest among adult diagnosis condition may result day diagnosis medical review consider potential
26303274 en study compare change blood glucose value patient type mellitus receive retrospective database medical adult patient status type mellitus undergo little intervention weight body mass index type duration hemoglobin hba1c within day type blood glucose blood glucose care first insulin analysis associate great mean increase blood glucose compare vs vs model blood glucose increase included serum glucose duration total insulin significant glucose increase included blood glucose level duration year model estimate increase glucose high confidence associate significant great increase blood glucose compare
26297965 en obesity type mellitus T2DM risk factor mortality weight obesity T2DM obesity although patient medication T2DM body weight insulin improve glycemic control however associate weight high blood pressure role recent effect study revealed oral blood within cell study show glucose respective addition effect effect T2DM diabetic trial show glucose level healthy subject diabetic subject effect obesity insulin resistance impair glucose tolerance therefore review present function potential obesity T2DM
26297527 en study investigate whether adverse effect function patient type mellitus significant subject plasma measured evaluate use blood cell measured correlation analysis perform risk factor correlation found multiple regression analysis remain independent adverse effect function suggest may contribute dysfunction
26301628 en recent study role glucose aim study examine serum concentration develop gestational mellitus model study cohort woman serum level measured case develop control parameter index characteristic concentration assess group serum level increased compare control group mean vs mean independent index or CI significant model CI characteristic result improve model model CI model serum level increased characteristic provide effective week
26415371 en protein protein plasma level associate glucose tolerance study aim determine whether associate development type mellitus study included patient type control protein measured serum use gene diabetic patient on diabetic group lower control group serum concentration lower among type patient control lower patient compare control role type diabetic patient may
25677307 en review current relationship chronic disease mellitus T2DM perform related use datum disease recent evidence suggest may result effect also increase risk develop T2DM effect related use although evidence research need relationship possible
22779184 en aim study evaluate mellitus mellitus model blood glucose week receive two group group rate level examine day treatment significant mellitus compare group analysis show increased cell also demonstrated significant increased group group mean cell level
21635988 en treatment type mellitus T2DM however T2DM condition risk factor include hypertension mortality on may provide significant outcome review recent datum regard T2DM evaluate current treatment potential risk associate obtain database use type mellitus hemoglobin type glycemic control therapy therapy treatment period on number recent treatment association study less association clinical compare first oral use glucose improve hemoglobin function also weight insulin whereas weight result weight impact associate cardiovascular risk factor improve glycemic control blood lipid level blood pressure may lead mortality mechanism associate treatment may provide patient evaluate treatment patient T2DM include may improve insulin function associate T2DM well associate cardiovascular risk factor therapy may disease development associate complication
25437047 en year disease research measured consider new finding potential mechanism type T2DM effect influence study evaluate whether increased risk T2DM disorder cohort study use cohort intervention study control group subject subject improve status show lower level vs less activity vs logistic regression analysis show significant association metabolic status age BMI activity study show lower level associate high risk metabolic status independent risk factor finding potential role T2DM risk related metabolic disorder
25307705 en diabetic patient time high risk cardiovascular disease individual aim study evaluate effect patient disease compare result regard control cardiovascular risk factor patient without study patient diagnose disease population two group diabetic patient assess three month parameter body mass index lipid profile blood glucose hemoglobin diabetic patient blood pressure activity level use activity study population patient diabetic diabetic patient significant old cardiovascular risk profile high prevalence hypertension lower statistical significant risk factor similar group body mass index patient may result patient
21822392 en diabetic include increased contribute less clinical outcome observed diabetic syndrome well disease diabetic relative response several intervention common among diabetic several examine oral therapy diabetic include increasing therapy new large randomize trial compare intervention syndrome diabetic reduction cardiovascular follow-up treatment among diabetic insulin reduce month major increased diabetic general oral therapy improve important clinical outcome diabetic
25369286 en effect also cell aim evaluate serum type T2DM patient relationship cardiovascular disease also evaluate relationship conduct study measured serum subject patient T2DM subject relationship clinical patient high concentration related presence T2DM independent presence risk factor therefore increase serum increase risk T2DM patient analysis evaluate high risk show CI addition positive correlation serum total sample level high T2DM associate study may disease T2DM patient
25221986 en primary care base potential reduce among old adult multiple chronic association primary care care condition among old cohort study patient hospital follow year old diagnose mellitus little chronic disease little hospital define study hospital condition measured research medical outcome analyzed use provide patient old mean age vs year chronic disease vs included odd ratio or CI or CI or CI or CI vs use analysis associate significant reduction condition ratio CI reduction primary care associate decrease condition among mellitus care model may important role management old adult multiple chronic disease
25074491 en type mellitus T2DM disorder reduce found study subject may presence clinical study patient glucose can identify risk factor compare use subject impair glucose insulin T2DM participant control group patient T2DM significant participant control subject participant age significant negative associate subject participant reduction subject include first study T2DM may risk factor glucose may finding care among subject level can
21838680 en on body evidence suggest role diabetic complication increased subject type several include insulin resistance contribute cell large well mechanism diabetic complication can increased increased age increased age protein effect individual type two result clinical trial patient type management metabolic syndrome hypertension effect serum glucose serum lipid concentration blood pressure respective show decrease adverse cardiovascular review examine mechanism complication subject type consider present current use well new potential
25090743 en increasing common diabetic patient consider however rate therapy diabetic high result clinical review present current regard effect mellitus include well potential rate management model mellitus reduce level show mean treatment insulin compare general population high rate diabetic patient occur complication condition possible factor diabetic patient on control plasma show improve patient
21741605 en aim study compare diabetic patient known disease study group patient known include diabetic undergo score compare different age analyzed well compare group total score high patient compare without vs patient score among diabetic high among diabetic high vs vs vs diabetic disease compare duration mellitus increased according diabetic severe cause diabetic
18571173 en use type mellitus management general use patient blood glucose level glucose however patient mellitus effective disease need effective blood glucose level patient well influence individual aim type mellitus include patient method use type mellitus database review database year type mellitus three response patient type mellitus influence three patient individual may important type mellitus analysis health care role patient individual within type mellitus
19349317 en low plasma associate elevated cardiovascular risk metabolic syndrome glucose plasma insulin metabolic protein patient type mellitus receive day study on great plasma glucose baseline occur increased plasma insulin also model assessment function index increased indicate protein increased glucose respective primary cell patient type mellitus mechanism demonstrated include protein protein reduce plasma glucose patient type mellitus increasing plasma insulin protein finding suggest role therapy type mellitus
26566287 en disease individual type mellitus T2DM diabetic also associate T2DM however little known condition patient examine association patient retrospective study included patient patient two group base status group on without group incidence chronic disease compare two group examine patient association among analyzed incidence patient group on high group group number patient great number patient increased associate increased severe decrease rate positive correlation insulin resistance index serum risk factor elevated can associate high
26457538 en recent study provide glycemic control also risk patient type mellitus T2DM however study effect cardiovascular outcome therapy remain compare clinical outcome therapy patient study use health research patient T2DM aged year old on total model included use compare outcome outcome consider mortality major adverse cardiovascular event include patient follow associate lower risk ratio CI CI CI CI compare therapy effect risk study associate lower risk use
26276217 en although study evaluate effect type mellitus T2DM low weight regard effect previous study reported significant increase total renal diabetic treatment change study model plasma datum parameter base model model primary mechanism plasma rate model plasma profile well concentration model estimate increase plasma increase renal T2DM finding difference renal related change model plasma datum model provide regard parameter occur T2DM
25868827 en investigate factor type mellitus patient body mass index BMI patient undergo total retrospective review patient analyzed study population improve improve group datum assess use multiple logistic regression analysis assess method according presence patient year lower hemoglobin odd ratio or confidence interval CI use multiple oral medication or CI high BMI or CI identify independent effective or CI statistical analysis according show associate or CI significant contribute patient BMI low high BMI use multiple medication important
22361026 en mellitus may may revealed mellitus can cell however datum factor well known treatment type treatment
22085417 en evaluate oral glucose tolerance test early week woman severe woman care first weight measured body mass index woman body mass index included woman oral glucose tolerance test week normal test week glucose tolerance gestational woman oral glucose tolerance test week woman result impair glucose tolerance case gestational mellitus case normal result week test week on impair glucose tolerance gestational mellitus on total woman obesity one oral glucose tolerance test gestational mellitus glycemic control suggest woman body mass index may need early test normal week
21698484 en on type mellitus present datum study population subject year range age type diagnose patient follow-up risk score study clinical model use two use model follow analysis first one include study subject one evaluate subject baseline fasting blood glucose case baseline high cholesterol metabolic syndrome BMI high factor activity case hypertension age population use evaluate subject improve subject lower risk common
25716376 en mellitus DM increased DM prevalence increasing high two condition present present study examine relationship prevalence DM incidence evaluate one study period year datum estimate prevalence DM incidence per well mean regression use different association DM prevalence incidence examine DM prevalence DM within study period whereas incidence per DM prevalence high low incidence high per low high DM prevalence show significant positive association incidence positive association DM may identify develop health
20190642 en use common individual however risk mellitus well study participant study define fasting glucose report medication use diagnosis use determined use plasma high prevalence high risk adjust relative confidence interval therapy status risk factor include age history body mass index also independent risk factor adjust relative confidence interval woman current use high incidence case per woman use associate increased risk independent diabetic care
21632497 en treatment hypertension blood pressure patient mellitus however recent control cardiovascular risk trial lower target subject mellitus impair fasting tolerance therefore well perform randomize clinical trial therapy patient type mellitus impair fasting glucose tolerance little patient control group control group follow-up little year evaluate event identify randomize clinical trial participant control associate reduction mortality odd ratio confidence interval reduction increase adverse effect similar outcome renal event compare control result similar analysis use model control associate great reduction reduce event analysis show risk reduction however level increase adverse event present body evidence suggest patient type fasting glucose tolerance treatment however observed target risk regard risk renal event risk adverse event increased
25072931 en assess association mellitus DM incidence mortality report cohort study diabetic woman baseline compare incidence mortality DM status included report examine characteristic study population study effect risk statistical evaluate test level assess test cohort study retrospective review reported incidence reported mortality one reported incidence among woman without DM relative risk incidence rate ratio mortality result study mortality ratio remain clinical among included study ratio show significant statistical therefore evidence independent association DM increased risk association DM mortality remain study DM
24773552 en evidence gestational mellitus prevalence assess compare prevalence among prevalence time status age use datum datum prevalence prevalence high woman vs vs datum assessment change prevalence ratio prevalence increased significant among woman mean woman significant prevalence ratio prevalence increased significant age although increase age significant great among woman vs year compare woman vs year datum prevalence increasing among woman woman prevalence high woman statistical difference group recent year increase prevalence age important period woman
22490993 en type mellitus associate increased risk drug consider incidence mortality type diabetic review potential association use incidence mortality possible can effect insulin effect reduction incidence also cell effect protein cell according study show use associate lower incidence mortality relationship great associate risk reduction randomize clinical trial effect trial base study effect drug drug may increased risk type diabetic patient clinical trial show whether drug effect treatment
22242803 en insulin insulin number develop insulin insulin recent also insulin therapy diabetic review insulin patient type type result review suggest may associate profile glycemic control rate patient hemoglobin target increased risk compare insulin related patient increased risk use insulin patient high general observed patient use one day consider insulin therapy diabetic patient
22215718 en show recent type diabetic decrease insulin insulin diabetic study test whether effect insulin use insulin control insulin decrease diabetic period blood glucose increased day increased day increased subject diabetic addition insulin renal per period plasma insulin blood glucose increased day control mellitus respective also rate increased change mean pressure group insulin effect normal insulin diabetic cause increase diabetic insulin glucose may type mellitus
22136882 en need identify impair glucose tolerance type mellitus T2DM risk woman development disease may need study T2DM identify study study characteristic include study number participant type use sample identify T2DM healthy control can potential use identify woman risk develop T2DM identify include glucose elevated reduce include glucose elevated reduce reduce reduce compare control may development woman study test finding patient reduce associate
21816445 en glucose influence function determined include on normal glucose tolerance type mellitus T2DM obtain T2DM man woman age body mass index on participant intervention analyzed status primary obtain individual metabolic study analysis on increased T2DM patient reduce T2DM correlate positive correlate body mass index blood glucose insulin hemoglobin on intervention result increased individual T2DM increased system finding related function clinical associate T2DM T2DM impair response
21528431 en clinical common measured diabetic study investigate relationship diabetic complication patient type mellitus T2DM study included patient T2DM man mean age year history cardiovascular severe renal disease current status body mass index blood pressure hemoglobin serum cholesterol score measured index presence diabetic also assess show significant positive correlation mean score significant positive correlation mean score diabetic significant positive correlation mean score result adjust multiple may diabetic may associate diabetic score patient T2DM
25946764 en lower major complication severe patient clinical incidence lower among conduct retrospective cohort study patient undergo first lower perform patient incidence rate decrease per patient analysis show first year mortality rate lower among patient vs first year mortality rate lower vs respective regression model year found age per year CI CI disease CI significant increased one year mortality study incidence rate patient decrease however one year mortality rate remain high need patient
26253767 en recent may associate poor cell function increased risk gestational mellitus overall impact glucose perform review study obtain estimate risk associate identify study reported datum prevalence two independent datum estimate model consider prevalence outcome identify study study study datum woman analysis study demonstrated increased risk woman compare woman female CI result analysis include study CI woman high relative risk may previous effect glucose
20558353 en common complication aim incidence rate known risk factor impact mellitus retrospective evaluate patient undergo included fasting serum glucose therapy present month occur patient difference control group body mass index vs vs age vs year body mass index vs vs patient cause control group rate patient rate year control group group respective rate year control group group rate respective case early month patient develop vs control patient time high increase correlate group vs mean score high group one year therapy vs factor old age obesity due early severe therapy impact positive patient
27003767 en first report renal disease type mellitus analyzed datum patient type undergo renal diagnose medical patient three group according diagnosis group renal disease group diabetic group diabetic renal disease found patient renal disease diabetic diagnose patient diabetic patient common found group clinical parameter diabetic patient however study revealed duration diabetic type diabetic patient renal may suggest renal
25993672 en disease common individual type mellitus investigate individual aim study evaluate disease first relative patient individual patient blood sample insulin measured found similar prevalence dysfunction patient vs difference serum level positive positive case patient common patient also suggest disease also individual
25903215 en elevated cholesterol type mellitus DM cause dysfunction effective clinical therapy improve dysfunction remain different cardiovascular treatment cholesterol cholesterol function patient type DM elevated cholesterol evaluate function use value index patient cholesterol use cholesterol use patient follow month serum lipid examine significant decrease group change show great decrease group compare group vs serum level significant decrease group group group group decrease significant great group compare group vs show significant increase group group group group change significant great group compare group vs patient type DM significant reduce improve dysfunction can potential effect lipid disorder dysfunction DM
25889250 en dysfunction identify patient mellitus DM however clinical studied DM patient without disease mean age year female mean determined three value dysfunction DM patient dysfunction patient logistic regression analysis revealed type DM independent associate high risk factor or CI logistic regression model model base clinical include type DM DM duration improve addition improve addition significant correlate regression model show factor associate complication associate early dysfunction DM patient finding clinical management DM patient
25520048 en role include associate several condition include studied patient model role development early study disease study clinical therapy association mechanism insulin insulin review increase risk develop present due difference several related associate risk develop control insulin insulin well impair function decrease level protein contribute insulin resistance whereas can also insulin resistance correlate metabolic study need among lipid
21831167 en lower glucose cholesterol level patient type mellitus study examine mechanism glucose randomize study subject type hba1c therapy randomize insulin evaluate baseline week glucose follow two oral glucose tolerance test conduct baseline one one without on conduct week hba1c fasting plasma glucose level evaluate compare significant effect glucose response insulin glucose rate baseline oral glucose reduce total glucose week total value group insulin level increased change total insulin group hba1c improve treatment difference insulin glucose
25851830 en aim present study determine prevalence risk factor diagnose mellitus DM adult aged year fasting blood glucose blood pressure weight related define fasting glucose diagnosis impair define overall prevalence DM confidence interval CI previous prevalence CI prevalence DM respective prevalence high lower status vs known DM poor glycemic control medication overall DM poor normal cause disease compare known DM high lower status associate high risk overall DM poor health target low status aim increase DM
20678120 en early report mellitus addition study examine characteristic type body weight blood glucose level measured glucose tolerance test age insulin tolerance test age conduct analysis age serum insulin level also show glucose age without insulin resistance control insulin decrease similar early primary dysfunction cell model early
24622716 en patient type medication important control treatment complication oral type can treatment improve medication reduce number study assess patient type study included patient control type treatment patient ratio receive different patient treatment treatment drug oral week primary change hba1c concentration baseline treatment study clinical trial patient receive patient patient patient patient patient patient little mean change hba1c concentration baseline group group group group group group general hba1c concentration decrease test use reduction significant great group incidence adverse event group similar group common adverse event group define occur treatment treatment clinical statistical significant control patient type well new treatment patient
16845277 en may aim investigate among use identify one large analysis identify identify two one one previous reported one also evidence associate identify early diagnosis provide early intervention aim reduce presence female observed use use
23531154 en compare insulin three cohort oral medication cohort analysis use subject on total patient little year medication study mean age range year among cohort regression compare insulin adjust month follow-up measured chronic disease score follow-up period cohort cohort cohort insulin cohort time high insulin cohort odd ratio or confidence interval CI cohort time high insulin cohort or CI lower patient insulin study period patient use
24072477 en research role change intervention adult type identify review primary randomize control trial adult type without insulin study evaluate impact hemoglobin intervention resistance blood glucose patient impact activity blood glucose
27724869 en use however patient mellitus DM present study examine impact assessment clinical outcome DM study investigate history DM patient target three patient patient negative without group on patient negative group compare two group well group group study DM patient group outcome without group on also compare patient undergo primary incidence target major adverse event group vs group first study examine whether addition assessment DM patient possible lead new trial trial
24611864 en use associate reduce risk study investigate effect new use period positive control improve glucose tolerance lower hba1c insulin level blood treatment result reduce cholesterol level treatment significant elevated activity protein related glucose lipid protein level reduction protein addition group increased result suggest may insulin resistance type diabetic glucose lipid
24506709 en investigate treatment need among type study treatment need type compare control age diabetic care hospital index index treatment need index treatment need according health score treatment need compare group compare diabetic control group female aged year year mean age year diabetic year control diabetic high mean number number treatment diabetic difference among study result suggest type high risk develop disease great complication
21883431 en assess prevalence treatment level type study subject woman aged year type define fasting plasma glucose oral treatment prevalence type confidence interval high man woman increased age participant type status among treat treatment man woman treat type type patient drug analysis show increasing age BMI positive associate prevalence type activity negative associate among participant present type increasing age positive associate type among subject diagnose type increasing age positive associate type estimate patient type status three treat
25132140 en aim study evaluate level study conduct hospital use gestational mellitus sample patient three recent fasting plasma glucose value patient profile mean total patient included analysis on total mean score patient total mean value significant negative association among different high mean score value low management level significant control high mean score low mean level patient aged year woman history related control new develop improve lower health
21432982 en mellitus complication major cause mortality hypertension poor diabetic control consider major risk factor development review examine two risk factor renal renal increased protein renal function several large study show factor significant risk factor increased mortality diabetic subject evidence suggest association renal important risk factor development general result hypertension however show associate metabolic disorder obesity mellitus hypertension prevalence increased patient mellitus presence renal diabetic patient renal also show increased risk develop complication increased mortality rate two risk factor important diabetic patient follow-up diabetic patient include presence reduce renal function treatment factor may reduce mortality
22961468 en case type weight investigate mortality base datum cause cause contribute cause mortality base cause cause rate per population confidence interval CI CI mortality rate CI increasing CI cause mortality obesity CI CI rate obesity CI CI respective obesity also mortality provide cause total mortality obesity rate increased analysis cause
26824237 en base adverse outcome study new gestational mellitus addition risk increased risk metabolic disease obesity show associate increased mortality addition known risk factor gestational weight increased low level negative risk factor regard therapy treatment significant reduce risk relative risk respective although therapy management result study regard type activity intervention improve glucose control reduce insulin use recent study evaluate provide treatment management
19733515 en evaluate subject type mellitus body mass index care hospital obesity associate type mellitus health on need control obesity effect one patient undergo follow year change hemoglobin level total body weight use oral insulin total patient man woman age year body mass index hemoglobin undergo patient medication oral insulin control month patient medication control use medication reduce patient year observed patient without medication patient reduce medication effective treatment type mellitus individual glycemic control weight reduction possible mechanism need
24907171 en estimate incidence risk associate use datum study incidence present effect use model datum relative risk study review study estimate study estimate ratio significant CI CI associate revealed great incidence group included among risk factor
22519906 en oral potential type mellitus subject on review randomize control trial profile chronic treatment type mellitus datum include database trial randomize trial week duration patient type outcome perform trial control group receive study study drug study risk ratio confidence interval use model general outcome adverse event system randomize control trial included review trial adverse event treatment level relative risk increased risk compare compare drug well disorder adverse event associate treatment risk low treatment compare compare insulin significant elevated therapy insulin compare on large body datum treatment increased risk research need possible event therapy insulin insulin use may risk
23835857 en diabetic significant mortality common diagnosis aim study determine clinical characteristic period among diagnose type mellitus hospital study population patient diagnose type aged year patient diagnose present year compare group one patient cohort period less diagnosis compare early period vs severe high age group year age group year compare early period vs vs overall new diagnose type decrease period hospital however aged year high risk diagnosis
24897110 en effect activity cardiovascular risk factor type diabetic patient studied association cardiovascular risk factor type diabetic total type diabetic patient aged year group according investigate association level activity glycemic control insulin cardiovascular risk factor associate body mass index BMI hemoglobin hba1c fasting plasma glucose model assessment insulin resistance high cholesterol high protein prevalence metabolic syndrome blood pressure low cholesterol lower hba1c great improve cardiovascular risk factor associate hba1c participant participant age duration current current cardiovascular disease treatment associate hba1c include associate glycemic control cardiovascular risk factor type diabetic patient addition increased may glycemic control
24455698 en aim study investigate relationship can complication risk factor type included study patient type evaluate cardiovascular risk factor datum major complication assessment can base present patient can group duration BMI blood pressure lipid level hba1c significant high group on significant association found can logistic regression demonstrated type odd can or confidence interval increase age patient duration cholesterol hba1c level BMI study show can type significant associate complication important risk factor development
23680252 en relative common previous study examine relationship mellitus DM determine potential DM status investigate diabetic patient age mean year subject age year consider value great woman man prevalence high diabetic vs similar high diabetic patient vs vs control group respective association DM significant adjust or CI whereas or show independent effect age metabolic present suggest potential association DM may factor
23680242 en early diabetic well cardiovascular disease study determine prevalence associate risk factor among type diabetic diabetic hospital study use datum study sample type mellitus patient diabetic study period diagnose total patient included study diagnose patient logistic regression analysis indicate positive associate duration hypertension hba1c blood pressure presence prevalence type diabetic factor duration hypertension hba1c blood pressure presence study suggest need early management risk factor hypertension reduce renal disease
23434183 en common cause mellitus previous patient gene show insulin report patient common gene
23279307 en glucose development type mellitus T2DM evaluate subject T2DM control randomize trial subject receive primary change baseline hba1c week included subject hba1c change baseline fasting plasma glucose glucose blood pressure change body weight cholesterol adverse event week hba1c significant reduce baseline compare respective significant decrease body weight increased compare overall incidence high rate low similar group incidence high lead incidence low treatment improve control reduce body weight general well subject T2DM control
23732816 en study examine insulin resistance cell function development gestational mellitus glucose assess oral glucose tolerance test year woman previous include woman control woman insulin resistance estimate use model assessment insulin resistance index index use insulin woman develop increased adjust body mass index BMI whereas index decrease woman previous glucose tolerance presence associate increased vs BMI woman vs among woman vs woman increased vs addition BMI associate development logistic regression analysis whereas result healthy woman group
25959628 en gestational mellitus increase risk poor outcome oral group oral three determined determined associate oral also associate increased individual multiple oral lead increase mean increase risk poor outcome
24593242 en examine risk mellitus within period among patient undergo on total patient undergo included study cohort on total patient undergo use cohort participant included present study individual period identify develop mellitus incidence rate mellitus per participant undergo per participant undergo adjust participant level hypertension syndrome ratio receive first diagnosis mellitus follow-up period confidence interval participant undergo compare intervention participant undergo significant increased develop mellitus adjust ratio vs adjust ratio vs present result suggest association patient undergo mellitus diagnosis
24256590 en investigate relationship renal cell type mellitus patient renal cell control system disorder incidence group relationship renal cell duration compare renal cell patient DM compare patient without DM clinical renal cell group control group incidence DM two group respective difference significant or renal cell group patient DM diagnose within year significant high control group or man high risk renal cell or patient patient renal cell group clinical great two respective difference significant however significant difference age two serum two difference significant serum respective difference significant characteristic well cell respective difference significant respective difference significant related renal cell DM may possible risk factor patient important early diagnosis treatment improve
24142600 en insulin decrease hemoglobin hba1c level type mellitus T2DM patient blood glucose control use oral estimate effect insulin insulin treatment type database randomize control test conduct according perform use insulin insulin effective control T2DM patient blood reduce body weight insulin insulin insulin high insulin
23979788 en significant lipid lipid development insulin resistance important negative aim study change concentration female subject obesity female obesity type mellitus T2DM healthy control subject study low month treatment baseline serum concentration significant high patient T2DM compare control group high level observed group week decrease level T2DM group whereas month treatment significant effect significant level T2DM subject treatment population group level correlate positive insulin glucose level model assessment index elevated concentration T2DM subject may contribute impair associate insulin resistance patient T2DM decrease level may metabolic status insulin resistance T2DM patient
23959366 en two insulin resistance consider type mellitus T2DM however insulin resistance lead T2DM dysfunction healthy cell insulin resistance increasing number mass decrease patient mellitus suggest primary role dysfunction T2DM dysfunction cell develop mechanism include well lead cell cell occur condition evidence suggest reduction mass observed patient severe T2DM factor insulin mechanism review development T2DM
23894157 en patient type mellitus T2DM patient increased risk compare individual poor recent study subject show elevated level associate independent aim investigate association level conduct study woman man year old level compare patient without level significant high man woman multiple regression analysis demonstrated independent positive participant score influence value elevated level associate increased risk patient score odd ratio confidence interval female score odd ratio confidence interval adjust multiple include metabolic level associate increased risk T2DM patient independent suggest level may range score
23584148 en consider protein control include insulin cell consider development insulin resistance type mellitus on large body evidence suggest correlate insulin resistance also development use plasma clinical study show presence insulin subject decrease treatment obesity review role protein metabolic cell protein protein
22904202 en determine mortality rate patient type mellitus compare general population year retrospective cohort patient type mellitus mortality period study total female mean age year year respective although prevalence rate increased decrease mortality rate per population observed cardiovascular risk factor population on time show year reduction female reduce year compare general population reduce year age diagnosis great mellitus associate significant reduction man diagnose age year however mortality rate population may contribute year
22149162 en complication major important role dysfunction occur response type type addition change also role develop chronic elevated glucose level first review evidence factor review evidence present role result increased cell diabetic dysfunction diabetic review research potential
20082588 en disease common evidence disease great previous study status subject type type mellitus large assessment study pressure index subject evaluate use evaluate addition study also clinical study identify subject one level low low also low compare however level high well use subject include determine need
24364471 en study aim difference status patient type impact level metabolic control incidence complication patient group use group lower level high number patient high body mass index vs duration year difference method treatment oral drug insulin respective occur chronic complication disease respective patient metabolic control assessment index vs vs vs vs difference group significant influence level metabolic control incidence complication assessment population studied
23407990 en compare prevalence incidence type mellitus patient without database review cohort study compare prevalence incidence among patient individual independent datum evidence assess use identify study included study assess incidence patient analyzed among study assess prevalence associate odd ratio or CI or CI severe potential revealed difference increased reported association among study use medical review or CI patient report compare study use datum among study assess incidence associate relative risk CI develop associate increased prevalence incidence association may among patient severe
22998426 en within research aim develop intervention type study aim type conduct type type three diagnosis type independent develop health trial also provide independent type develop important health important role datum study use develop need assessment assess individual need
21941156 en type mellitus treatment conduct review new diagnose patient type mellitus compare effect treatment body mass index BMI hemoglobin conduct retrospective review patient type DM present hospital datum therapy type BMI hemoglobin follow-up therapy type insulin insulin review base diagnosis oral glucose tolerance test insulin review subject treat patient treat insulin therapy patient treat insulin therapy baseline significant difference among group regression analysis baseline change time therapy type change regression analysis show great BMI great decrease BMI therapy type change may effective insulin therapy treatment follow-up
25726180 en disease one major cause condition blood however decrease rate mortality also cause complication clinical disease risk disease increase time diabetic patient consider one mechanism therefore target change may effective diabetic review
23512467 en finding large group type diabetic investigate among diabetic factor influence medical diabetic population health therefore test test test test well analysis multiple year disease can disease on analysis associate whereas associate effect remain low level overall low level health factor poor on large group can lead potential group develop one review population reported
23680249 en major risk factor complication patient type mellitus T2DM present study T2DM patient study conduct among T2DM patient aged year diabetic hospital diabetic profile lipid profile serum perform adjust odd ratio confidence logistic regression low duration T2DM significant correlate female glycemic control hba1c duration T2DM associate increased risk high lower T2DM hypertension lower ratio ratio parameter characteristic diabetic low high cholesterol level low level type poor glycemic control duration hypertension T2DM
23529568 en may improve glycemic control lower insulin associate weight patient control high evaluate therapy patient type mellitus control insulin without oral randomize trial follow period period number patient control type mellitus receive little insulin without oral ratio receive primary outcome change hemoglobin baseline week outcome included change body weight insulin fasting plasma glucose level week period adverse event evaluate patient analyzed week mean hemoglobin decrease compare mean difference CI group CI group CI group insulin decrease increased mean difference CI group CI group CI group body weight decrease increased mean difference CI group CI group CI group effect week compare group patient group high rate vs event suggest vs event suggest vs insulin target study evaluate improve glycemic control insulin reduce weight without increasing major patient control type mellitus
24287755 en patient mellitus may patient condition may present first time group patient also adverse outcome poor control patient mellitus outcome patient insulin use risk glucose control potential blood glucose control insulin insulin control management outcome
24053748 en develop disease increasing disease change impact disease measured outcome among prevalence study participant day health participant body mass index BMI ratio individual also blood pressure blood glucose level perform participant include female mean age year obesity obesity found participant respective ratio great prevalence hypertension respective elevated blood glucose level found participant little disease common level low health reduce
23811958 en well known role also mellitus DM study DM patient review age presence DM hypertension disease compare control subject datum control obtain health relationship DM present vs assess use DM high patient control analysis show DM odd ratio or confidence interval CI age or CI increased odd analysis DM or CI age or CI analysis age man related positive DM population common related DM
24222737 en mellitus common diagnose type DM aim identify profile risk factor clinical factor related diagnosis new diagnose new diagnose patient included study healthy control patient group year year year patient control test associate DM present diagnosis significant correlation age show significant correlation age group positive DM related severe correlation level patient control significant common severe year early risk factor development
23841752 en mellitus DM result increased present study possible effect DM DM control receive one group diabetic group diabetic receive oral day time index rate total blood cell measured significant gene protein determined level level protein respective total level diabetic show significant high mean value total control similar mean level protein mean protein sample diabetic significant control however diabetic treat value protein index lower diabetic result suggest possible DM
23715661 en type mellitus DM major risk factor development although mechanism remain influence poor control response identify role cell DM examine response blood individual DM compare individual without DM elevated cell elevated baseline associate increased plasma level decrease baseline cell factor therefore datum DM elevated cell indicate DM associate response response contribute increased
23448079 en influence clinical outcome contribute type mellitus T2DM study examine target intervention old T2DM datum baseline week included significant increase medication healthy care intervention clinical significant effect blood pressure blood lipid activity target intervention may result improve outcome adult T2DM value intervention target change population chronic patient
23249721 en diabetic patient associate increased risk cardiovascular event may diagnosis investigate whether elevated level factor type mellitus T2DM diagnosis whether occur increased fasting plasma glucose plasma glucose individual develop conduct study within intervention cardiovascular risk factor datum well blood sample research baseline health follow-up case develop T2DM without T2DM age year analysis perform case normal baseline glucose level case elevated level adjust BMI history activity blood pressure level protein independent association found T2DM elevated level CI CI CI participant normal glucose level CI independent relationship T2DM level T2DM adjust metabolic cardiovascular risk factor several year change glucose tolerance
24565266 en study test impair cardiovascular mortality patient type mellitus DM patient DM without disease function analyzed may impair although impair early independent adverse clinical outcome patient hypertension analyzed datum DM year patient history disease index function consider impair study outcome mortality baseline impair patient mean follow-up period year patient cause occur patient impair patient normal regression analysis revealed impair ratio confidence interval lower estimate rate ratio confidence interval independent associate mortality age duration hemoglobin dysfunction measured occur patient DM without disease independent mortality patient lower estimate rate
20329427 en total body history mellitus assess BMI risk factor risk develop mellitus compare body first relative diabetic subject first relative diabetic patient similar number age control first relative patient clinical BMI blood body use method use body subject BMI statistical hypertension time high case control group case obesity difference case control significant BMI time high case control group study new significant high case control body time high case control group difference body statistical significant can assess potential diabetic high risk important evidence base health
19592053 en mellitus DM associate aim present study investigate plasma level patient DM healthy subject association hemoglobin level also evaluate studied subject DM type type healthy subject age duration plasma concentration measured level studied observed type type DM found high level ratio decrease level patient DM compare control negative correlation found patient DM hemoglobin level positive correlate ratio correlate patient DM may related increased value hemoglobin impair may contribute DM diabetic complication
23303985 en develop prevalence mellitus DM increasing however whether individual risk cardiovascular disease DM also high conduct study medical compare prevalence DM patient case hospital control odd ratio or associate DM or estimate compare or high increase include difference medical management effective intervention
21540770 en on cohort evaluate effect blood glucose level patient common use treatment multiple disorder evaluate total effect patient study patient recent hemoglobin blood glucose little per day week statistical significant increase blood glucose level diabetic patient mean blood glucose level increase blood glucose level use effect model estimate increase day CI patient within normal mean glucose level within day association observed glucose level change level age indicate correlation level response cause significant increase blood glucose level diabetic correlation diabetic control level response diabetic blood glucose increase may intervention effect day
18351320 en compare effect insulin multiple insulin control risk insulin adverse event type type database control trial on review study included type mellitus two type mellitus three regard adult type mellitus found difference hba1c study therapy rate overall event different intervention vs event per patient per week total insulin lower therapy patient type mellitus treatment show statistical significant difference hba1c incidence event treatment group type mellitus insulin significant lower group datum event study perform provide datum overall possible severe adverse event different patient group due event different therapy adult type mellitus result great reduction adult patient without high rate effect therapy can patient type mellitus
21539568 en study aim investigate risk factor development mellitus female diabetic healthy on logistic model develop assess impact diagnosis body condition score estimate healthy control use model show diabetic increased odd diagnosis compare control confidence interval although associate case status effect significant model overall study study indicate high associate
26332473 en although adult mellitus DM rate remain low aim evaluate regard assess effective care three one intervention control group group receive compare score intervention conduct evaluate total indicate risk assessment patient DM control trial intervention group similar baseline score group significant increase score mean baseline month group score different baseline vs significant difference observed effective DM influence study system change improve clinical
16505245 en aim study risk woman gestational woman gestational follow oral glucose tolerance test month year risk diabetic case risk increased woman adjust ratio woman insulin woman BMI woman two woman without risk factor risk year risk year woman status protein concentration history age week weight significant risk analysis assessment indicate intervention consider woman gestational positive insulin treatment
27023009 en target show reduce rate type mellitus patient however effective associate syndrome on possible may reduce rate cell investigate cohort patient type reduction cell observed blood patient treatment known mechanism low measured time period associate syndrome treat patient however observed case week treatment patient well treatment reduce consider high investigate
22855644 en risk adverse outcome type associate gestational mellitus early treatment multiple different diagnosis time may change association study group however evidence study aim investigate whether develop diagnosis woman diagnosis develop therefore provide method use review two conduct conduct first one use use different one include woman time period risk factor use woman fasting time test high glucose due need test test diagnosis low need also include care level
25143718 en assess associate cardiovascular disease factor reduce patient type mellitus DM patient undergo two baseline year hospital subject study female ratio mean age year subject age type DM diagnose without disease subject baseline increased age year follow-up change range multiple regression change blood pressure confidence interval associate follow-up change hemoglobin hba1c glycemic control hba1c level associate found blood pressure associate patient type DM therefore control blood pressure important reduce patient type DM
24908239 en recent study may may increase risk therefore assess impact major adverse cardiovascular event mellitus patient receive assess impact type patient patient included receive receive difference type use demonstrated reduce use analysis demonstrated type use associate patient use type increase rate
24905138 en type mellitus T2DM associate system dysfunction role aim assess relationship profile patient T2DM disease obtain plasma patient undergo plasma level analyzed protein analyzed time respective effect cell analyzed observed level high vs lower patient without T2DM vs difference however plasma level vs level high patient without vs also reduce level patient cell increase level patient T2DM dysfunction different cardiovascular disorder
24417760 en contribute cardiovascular disease patient mellitus DM complication randomize study regard effect DM patient aim study evaluate effect patient type DM conduct randomize control trial compare patient index perform patient baseline month patient study baseline baseline change group group baseline change group group serum chronic disorder hba1c medication change group study increased group study indicate patient receive type DM case compare
21274504 en common metabolic factor insulin resistance addition insulin resistance evidence association development function positive diabetic complication review evidence study clinical trial aim therapy
19848202 en study possible mechanism type mellitus T2DM effect T2DM two group model group group age normal control week old serum fasting blood glucose total cholesterol cell well activity blood level cell rate high high lower activity lower high normal control significant found group treatment change show effect T2DM cause metabolic dysfunction
26429704 en mellitus DM control type DM increasing care can care high mortality mellitus high risk high health report complication also care aim study assess use study sample health use datum period major finding type DM level status group poor high DM high also high due impact need poor care related
25981358 en aim assess clinical adverse outcome patient disease type mellitus DM undergo patient undergo renal dysfunction without type DM significant high serum day compare patient without type DM statistical significant difference regard rate however high day patient type DM low patient without type DM day patient adverse outcome significant high compare patient suggest may adverse outcome
28002317 en early treatment lower disease lead risk factor diabetic patient study aim investigate factor associate lead diabetic study patient type mellitus T2DM group according lead without lead analysis lead group base reduction reduction clinical datum patient group serum level significant increased whereas rate significant decrease lead group analysis result show odd ratio or confidence interval CI duration or CI age or CI or CI independent associate lead patient T2DM analysis show age or CI or CI independent associate patient T2DM risk factor lead patient T2DM include age disease patient T2DM high level can group lead
25158866 en rate significant decrease however prevalence mellitus DM risk factor increased present study assess prevalence clinical impact DM among patient estimate impact important clinical characteristic associate mortality patient use sample estimate DM prevalence mortality among patient use method clinical characteristic associate mortality identify use logistic regression significant increase DM prevalence among patient year year patient DM old female cardiovascular risk factor however mortality decrease significant DM remain independent associate mortality adjust odd ratio CI adverse impact DM mortality time decrease risk time great among woman patient among patient decrease recent increasing DM prevalence disease among patient mortality significant adverse impact DM mortality remain overall time age
24905769 en due report case type mellitus clinical analysis presence known first reported case due T2DM patient without disease
24661226 en study found activity cell study investigate effect risk among patient type mellitus diagnose DM identify health database within health use regression model assess association risk effect association type ratio adjust potential age score index insulin adjust CI CI CI respective relative patient DM patient drug DM patient drug addition effect show significant risk significant lower result show decrease risk diabetic patient use association
21879162 en type mellitus may assess health related among patient type patient mellitus aged year woman primary health care effect evaluate woman lower health related man correlation age treatment effect health related
21135265 en aim study report effect mellitus plasma concentration measured oral concentration plasma oral also determined use assess activity diabetic protein level measured found significant increased plasma concentration oral result increase ratio significant decrease significant decrease also result increased compare control high control study show increased activity decrease activity increase decrease protein diabetic respective mellitus revealed effect activity oral diabetic
26212460 en determine day mortality patient body mass index BMI presence mellitus cohort study patient randomize control patient trial patient BMI patient normal range BMI patient BMI patient BMI patient severe BMI patient DM significant difference day mortality BMI presence DM adjust or CI adjust or CI adjust or CI severe adjust or CI DM adjust or CI mortality patient BMI presence DM
23710775 en prevalence increasing level obesity population new provide use disease disease develop use define type type type T2DM fasting clinical T2DM however possible condition system type develop develop clinical however
17433797 en patient mellitus may due time assess mellitus retrospective study examine mellitus patient type age control database two independent measured time assess time significant mellitus compare patient mellitus control mellitus patient time significant compare control type mellitus time compare patient study time mellitus
25561121 en show effective treatment type mellitus weight glycemic control blood pressure lipid profile study patient treat month datum age fasting glucose hemoglobin hba1c blood pressure lipid profile baseline month treatment perform logistic regression analysis assess possible patient mean age year old year hba1c reduce weight BMI total cholesterol decrease cholesterol CI statistical significant change blood pressure cholesterol observed patient hba1c weight studied treatment response regard effect reported reported obesity show effect lipid weight BMI glycemic control lipid profile duration patient
21838881 en cardiovascular disease type mellitus patient due plasma examine relationship plasma level different type patient without known first time aged year duration year disease disease mean blood pressure addition plasma concentration prevalence disease disease respective plasma significant increased patient disease compare patient without respective however case patient without adjust age hba1c ratio logistic regression analysis plasma remain associate disease adjust or CI disease plasma concentration associate disease patient type whereas observed
26545522 en assess relationship serum level type mellitus database identify study assess relationship serum control use evaluate study statistical test perform total study included study result show serum significant lower healthy control evidence present suggest serum level associate
26520063 en mellitus DM lead development diabetic associate effect elevated different disease current study aim investigate effect diabetic DM treat oral week analysis use assess gene protein analysis perform examine associate elevated lower impair activity present DM associate impair vs function time pressure vs treatment effective DM related significant improve improve diabetic new therapy diabetic
26496286 en study effect type mellitus DM found result man therefore conduct study evaluate association participant use lipid participant group according level serum define DM fasting plasma glucose level participant patient DM identify observed positive association DM adjust age body mass index BMI found high serum level independent risk factor DM adjust odd ratio associate lipid confidence interval CI lipid CI finding previous study participant serum level remain independent risk factor DM man risk factor DM independent age BMI man woman therefore intervention consider
23419400 en evidence indicate increase glucose patient mellitus T2DM present study investigate effect T2DM blood glucose measured glucose serum insulin measured normal T2DM oral glucose without effect glucose examine use method glucose use serum glucose insulin level oral glucose glucose increased age insulin T2DM diabetic result blood glucose associate insulin
23155698 en investigate relationship cell protein factor disease within type mellitus T2DM total subject treat include subject individual three group group on patient T2DM group patient T2DM group patient T2DM patient treat correlation blood score group on significant high group group mean level serum show group on significant high group group also group high group significant positive correlation mean level group on show group group analysis show level elevated T2DM patient dysfunction can cause result study may contribute development T2DM function related factor can index complication T2DM
22994099 en type mellitus T2DM one common chronic disease incidence great mellitus determined event risk cardiovascular disease cardiovascular therapy T2DM risk factor assess therapy cardiovascular show result clinical trial evaluate current therapy drug base effect
22839670 en study aim effect level interval duration type mellitus activity aged year patient perform test found two period significant associate interval activity change due activity
22831492 en patient obesity cardiovascular disease diagnosis type mellitus follow therapy however one two patient condition cause mellitus DM man woman disease perform treatment decrease case case patient DM cause disease can treatment condition may decrease insulin may cause DM
26973383 en mellitus DM occur chronic disease known although association year studied time patient condition low risk factor type DM incidence high dysfunction glucose mechanism associate increased rate complication decrease rate reduce response patient evidence association addition impact glucose control clinical outcome patient evaluate treatment may due drug may condition clinical research different disease
24898134 en mean activity elevated value associate large new independent cardiovascular risk factor aim study determine woman gestational mellitus determine correlation metabolic parameter retrospective analyzed woman body mass woman healthy control month group control group significant high group compare control group woman significant decrease period fasting plasma glucose level glucose positive correlate respective result indicate increased clinical may potential identify woman develop gestational
25532311 en aim present study investigate relationship level insulin resistance metabolic syndrome cardiovascular disease patient mellitus type study included patient mellitus type two group level first group patient elevated level group patient normal level study show positive correlation level body mass index BMI level ratio correlation analysis also identify statistical significant association BMI ratio group patient elevated level found metabolic syndrome well high incidence hypertension disease study show level insulin assessment insulin resistance presence metabolic syndrome use type diabetic patient early cardiovascular risk
25262254 en reduce use patient type T2DM datum suggest current target increased investigate whether influence glycemic randomize trial vs patient T2DM use health status evaluate baseline use baseline hba1c treatment effect test use analysis model hba1c study included patient mean age woman mean T2DM duration mean hba1c hba1c observed primary use treatment great high hba1c value increasing hba1c level patient T2DM great high hba1c value datum suggest patient control T2DM
25213731 en prevalence obesity metabolic syndrome type mellitus level present therapy target factor insulin resistance development review target disorder review datum obtain multiple model obesity type type diabetic review show lipid insulin also show increase factor development glucose insulin resistance obesity important review show mean include use several new develop result factor clinical glucose obesity
24682536 en risk factor insulin resistance type mellitus T2DM adult datum aim study association risk factor without T2DM study without T2DM undergo blood test fasting lipid insulin glucose function protein participant present result compare T2DM control body mass score also according glycemic status T2DM impair glucose tolerance normal glycemic control patient T2DM age year subject age year studied among cohort history reported significant difference history result index subject T2DM patient patient patient without although difference statistical significant plasma protein level related glycemic status presence may role development T2DM study large cohort
21885854 en mellitus DM associate impair also response determine whether impair contribute perform day reduce blood per significant occur baseline baseline high compare increased day whereas increased demonstrated severe reduce compare treatment lead great blood DM response lead impair may related reduce
23134829 en investigate association protein type mellitus T2DM study conduct base on total subject two group T2DM group control group gene population method known gene identify significant T2DM group control group whereas show difference fasting insulin total cohort model assessment index female show significant difference two group adjust value show statistical population different gene significant different gene may related T2DM population
25445417 en factor type T2DM metabolic syndrome case well healthy control without studied concentration measured fasting plasma estimate serum ratio significant great T2DM control high serum significant associate increased ratio use estimate control T2DM plasma correlate ratio normal T2DM also positive correlate three T2DM significant large control high significant associate prevalence large
26214054 en review assess prevalence type mellitus T2DM disorder also compare prevalence T2DM disorder healthy use medical subject disorder or glucose study include retrospective included participant disorder diagnose according study included independent datum study on effect overall prevalence T2DM CI compare control disorder risk T2DM relative risk CI significant found regression analysis T2DM prevalence population associate T2DM prevalence disorder study significant common disorder healthy control similar age current indicate change need population
26406589 en significant weight potential patient however study clinical effect increased body weight patient evaluate effect weight first year renal function total patient analyzed study mean duration follow-up month measured baseline within month interval year measured time weight define increase value increase mean develop patient mean follow-up time month patient increase show significant increased rate compare without weight increase year correlate significant high level rate high blood pressure large significant influence rate also increased risk confidence interval weight first year
25738570 en cardiovascular effect compare medication patient on review randomize trial compare follow-up included assessment blood pressure event major event patient baseline renal dysfunction patient difference found decrease risk increase risk patient renal dysfunction difference found decrease risk found little reduce control complication hypertension patient event analysis provide evidence management hypertension diabetic renal dysfunction patient
25448723 en study aim assess association clinical characteristic chronic complication adult type retrospective study included patient aged year old type undergo patient identify rate chronic complication type compare use logistic model identify presence chronic diabetic complication use clinical characteristic include age duration glycemic control metabolic duration year prevalence diabetic diabetic significant lower patient patient type prevalence group duration year significant difference prevalence complication group characteristic base model large type lower prevalence complication patient type duration year regression clinical characteristic risk complication type
23233943 en investigate activity large concentration blood plasma also condition mellitus show mellitus increase activity increase activity large increased whereas function large decrease condition mellitus decrease activity large time observed increase function large without blood level
22952794 en care increased datum management however potential relationship patient health outcome remain aim study evaluate effective base diagnosis association intervention metabolic weight blood pressure control type mellitus T2DM patient
22687486 en drug improve glycemic control reduce insulin resistance current consider one drug type mellitus T2DM however use adverse drug include adverse event observed present study investigate incidence analyzed risk factor patient type mellitus one one patient receive studied incidence change datum include hemoglobin hba1c retrospective effect observed indicate decrease hba1c among occur use patient although case within use on logistic regression analysis show risk factor include female age body mass index incidence increased number risk factor increased use risk factor patient T2DM
22673502 en investigate effect glucose glucose patient type mellitus patient fasting glucose level remain poor control insulin insulin therapy glucose glucose assess one week treatment use glucose result fasting glucose level glucose significant improve treatment whereas glucose significant change fasting glucose level significant correlate glucose significant correlation change fasting glucose level glucose low significant reduce glucose patient type mellitus fasting associate reduce glucose glucose
22558802 en type mellitus increasing chronic known result normal blood glucose level three identify role cell insulin study aim determine age identify correlation presence clinical medical diagnose review total patient included study age range year mean year present diabetic result show positive presence aged year presence associate severe clinical
23516850 en aim estimate relative risk type mellitus cardiovascular disease total cardiovascular mortality patient revealed study included patient found risk development type mellitus total cardiovascular mortality significant increased association early fasting impair glucose tolerance within year patient develop increased new diagnose increased total mortality time fasting year increased cardiovascular mortality time result study suggest diagnosis fasting impair glucose tolerance also patient well group
25079479 en risk factor complication include datum suggest also risk obesity metabolic syndrome disease known occur adult insulin resistance lipid diabetic may retrospective study compare presence woman gestational mellitus gestational age week control case obesity similar cause significant severe diabetic subject control within diabetic cohort related gestational age weight weight correlation presence control group factor include body mass index although common diabetic woman hemoglobin body mass index independent glycemic control obesity type study first association
24367971 en estimate prevalence gestational mellitus associate study conduct woman previous known blood sample fasting glucose measured use diagnosis use health year year mean gestational age similar two overall prevalence prevalence high woman previous or CI history type or CI or CI lower woman normal hemoglobin compare or CI high indicate increasing population risk complication type
21338847 en cause chronic disease whether base rate estimate use renal disease study estimate risk factor analysis datum early health target individual year old hypertension history hypertension disease participant woman mean age year clinical datum rate estimate use study present study population use study respective present participant respective risk factor included obesity body mass index hypertension cardiovascular disease history logistic regression model adjust age risk factor odd increased significant compare base similar base study use model or CI CI CI CI CI lead lower prevalence similar prevalence rate associate compare study risk factor prevalence increased compare population
24357689 en potential therapy type increased function insulin within year function mechanism number type type decrease insulin impair suggest common mechanism may insulin type potential use type target therapy
22876522 en compare outcome type mellitus T2DM patient therapy vs therapy care retrospective database T2DM patient health studied patient cohort hemoglobin hba1c assess use association treatment health care use include measured month therapy use patient study patient hba1c result patient lower rate compare cohort patient lower compare significant lower compare cohort respective respective patient high rate hba1c compare difference outcome remain associate lower health care use hba1c
22816207 en primary study examine relationship score metabolic control type mellitus study included age year according value hemoglobin hba1c one two group group hba1c value metabolic control group poor metabolic control evaluate score metabolic control use patient group patient statistical score treatment treatment group also found significant correlation total score hba1c correlation patient correlation current finding suggest poor glycemic control associate lower score develop
22382225 en mellitus DM consider major cause hypertension one renal disease aim study assess role blood pressure blood pressure DM correlation diabetic control patient DM mean age year duration DM little two year study prevalence base method follow mean mean respective patient correlation also correlation found duration significant correlation found duration high prevalence profile among diabetic study major risk factor factor impact diabetic
25311649 en aim investigate characteristic adult patient clinical diagnose type mellitus care patient study datum clinical history weight blood sample obtain analysis fasting blood glucose hba1c result use positive total study population female mean age BMI year respective subject positive lower mean BMI vs vs negative subject positive subject also high mean fasting blood glucose vs high mean hba1c vs high insulin vs compare negative prevalence clinical finding early diagnosis therapy control
22123800 en glycemic control lower hemoglobin hba1c level may mellitus DM whether lower hba1c level improve outcome DM chronic disease serum measured care identify base datum estimate rate DM use datum patient base first hba1c regression model use assess independent association hba1c level study outcome disease base serum level new renal disease cardiovascular event identify DM lower hba1c level range hba1c value high follow-up period month develop baseline high hba1c level independent associate risk outcome studied however association mortality increase risk mortality hba1c level lower high increased risk associate high hba1c level lower baseline value among risk increased patient hba1c level high respective compare patient hba1c level lower whereas increase respective hemoglobin level high common associate clinical outcome lower level hba1c also associate mortality risk associate high hba1c level among function finding suggest control hba1c level DM may important previous suggest also glycemic control hba1c level may associate increased mortality
19414410 en model contribute study mellitus metabolic disease glucose due insulin control factor may influence development disease complication new treatment characteristic also use model develop use clinical related disease review common use model provide model research
22901825 en possible diabetic study
26863705 en glycemic control patient type early diagnosis intervention include change review current treatment type
24402326 en obesity lead increased incidence metabolic syndrome type population increasing large population risk complication cardiovascular disease cardiovascular disease remain cause adult present significant health age cardiovascular disease risk type include type cardiovascular disease obesity hypertension function
24152069 en association study group value fasting plasma glucose time diagnose gestational evaluate retrospective study total woman one woman undergo gestational according previous association fasting plasma glucose use woman prevalence clinical characteristic outcome compare among woman gestational previous association treat gestational fasting plasma glucose gestational previous association normal glucose case gestational define previous association case associate increased risk outcome compare woman normal glucose tolerance fasting plasma glucose woman gestational gestational fasting plasma glucose associate gestational hypertension age BMI adverse outcome fasting plasma glucose increased population gestational increased population gestational significant associate
23464623 en examine oral medication among participant early type mellitus T2DM use participant indicate medication two different oral medication profile level event weight change effect blood pressure cardiovascular risk on effect regression model use estimate weight level relative analysis conduct overall sample medication sample included participant mean age year participant female participant total high event weight change effect value number current T2DM medication result suggest weight change effect primary patient T2DM
23499806 en effect level role insulin patient type T2DM healthy subject studied included participant rate rate plasma insulin measured baseline T2DM high baseline compare healthy day T2DM mean vs T2DM associate significant reduction baseline vs vs significant change compare baseline day concentration T2DM result development obesity insulin resistance remain whether therapy impact cardiovascular outcome
24353273 en study activity health recent evidence positive associate type mellitus T2DM however therapy diabetic patient addition therapy therapy patient T2DM according association present therapy use study parameter clinical parameter duration rate individual response consider patient disease T2DM patient
18563171 en aim study assess whether association use incidence treat mellitus system study treat patient type case new treat identify base control drug treat ratio use assess risk factor mellitus logistic regression use relative risk associate use relative treatment among case control gene significant decrease incidence associate current use odd ratio or CI whereas incidence increased among or CI or CI significant reduce incidence associate use or CI whereas reduce risk or CI risk associate use significant treatment subject significant reduce gene gene
22082493 en care patient type obtain sample patient type control randomize control trial intervention participant use major type management change method increased improve factor participant effective range may relationship patient
22075092 en evaluate whether increase risk type mellitus conduct retrospective cohort study among age year individual first time diagnosis type identify use disease clinical use regression estimate risk ratio individual type analysis perform multiple study population individual follow included type case observed significant increased risk type CI CI CI CI CI CI increased risk diagnose type study follow-up study use medical review case status consider finding
22254116 en on recent review low index control patient type mellitus T2DM datum regard adult without T2DM measured group individual control T2DM group without age BMI subject patient T2DM vs vs lower vs subject without T2DM group elevated low relative current T2DM may lower general population need reduce target
24423909 en effect mellitus glucose outcome patient gestational mellitus total case woman first hospital medical randomize intervention control group case intervention group study case control group difference analyzed general clinical profile intervention blood glucose level outcome general model use blood glucose datum test determine significant difference general clinical profile intervention intervention control group mean value blood glucose follow intervention group control group result test indicate blood glucose level intervention group significant lower control group incidence rate weight woman level hemoglobin intervention group significant lower control group common use blood glucose level significant reduce outcome also improve patient
23217031 en female dysfunction mellitus poor studied subject little known function woman syndrome common mellitus common cause clinical similar mellitus study function female patient
23921142 en mechanism gestational mellitus may potential high effective studied use control woman treat insulin subject receive oral blood sample blood also ratio mass concentration high total lipid plasma vs control show lower plasma ratio vs control significant lower plasma ratio studied ratio different control occur treat insulin whereas one also lower study impair whereas less insulin treatment can also high contribute reduce reduce compare control
23250453 en gestational define glucose associate increased well complication woman early receive diagnosis diagnose oral glucose tolerance test fasting glucose concentration type first evidence level woman increased risk use high risk history impair fasting glucose impair glucose tolerance previous obesity metabolic syndrome age year disease clinical glucose may indicate first woman gestational week woman previous glucose evidence level base result adverse outcome study define fasting plasma glucose glucose case one value metabolic control woman receive blood glucose blood glucose level normal range fasting insulin therapy mortality woman glucose tolerance week year case normal glucose tolerance evidence level woman increased relative risk type follow-up weight management activity development healthy
23117052 en early diagnosis mellitus complication reduce therefore improve decrease cardiovascular evaluate chronic complication incidence prevalence complication sample patient study complication patient aged year diagnose type type mellitus little month measured datum drug treatment recent lipid profile patient included study prevalence incidence rate chronic complication respective hemoglobin value found patient blood pressure level patient cholesterol level less patient patient new complication old high BMI value well high blood pressure level great use chronic complication increasing
23039321 en aim study assess therapy insulin type mellitus group clinical trial T2DM patient control insulin therapy without patient receive treatment patient randomize week difference adjust mean change hba1c overall study population also receive without therapy well similar low incidence compare vs improve control associate weight vs insulin significant reduce hba1c patient T2DM control insulin without well profile similar result without weight increase incidence improve control
23522916 en risk factor disease well association blood pressure clinical disease patient type index analyzed year patient type well control related presence mass index previous cardiovascular patient one patient severe reduction control respective mean significant lower patient type control vs patient lower associate increased well rate lower found patient previous event negative correlate age duration hba1c assess common type cohort pressure may high value patient due may improve risk regard disease large type
24067201 en change patient type obtain patient type mellitus normal control type diabetic patient also receive insulin therapy year analysis perform analysis test decrease found type diabetic patient compare normal control insulin therapy year increased observed compare baseline level diabetic patient significant change found insulin therapy year show increased treatment compare baseline diabetic patient decrease insulin therapy change improve
24065684 en factor different cell include cell normal cell role type mellitus type mellitus T2DM recent association disease risk factor T2DM gene indicate possible association T2DM aim study investigate relationship T2DM parameter T2DM population method use patient T2DM healthy control found significant high T2DM patient control group serum level T2DM patient significant high patient increased T2DM population datum suggest related diabetic assessment T2DM
23999370 en several clinical study include two revealed patient mellitus elevated risk compare subject suggest mellitus risk observed patient high indicate patient may cause poor low increased diabetic may one common disease large study need treatment diabetic
25510087 en research level patient mellitus type obesity revealed level hemoglobin effective decrease hba1c patient treatment
23393667 en type type disease occur insulin number patient disease insulin therapy therapy early development complication type
23035602 en high risk complication association disease cardiovascular system patient type reduce development disease independent factor increase risk time time independent known risk factor cardiovascular disease event present study assessment different patient presence without status studied mean study found patient type disease patient without characteristic patient may severe development event patient datum obtain relationship glycemic
22437081 en cardiovascular risk factor contribute mortality among diabetic patient management therefore control blood glucose blood pressure obesity development complication patient evaluate status control risk factor among diabetic patient hospital type diabetic patient hospital use determine weight blood pressure fasting blood glucose lipid profile also assess use define risk poor control value group association cholesterol association clinical female mean duration mellitus DM year glycemic blood pressure control observed subject respective subject found compare mean index risk factor status control risk factor cardiovascular risk factor poor among patient need identify possible contribute factor reduce mortality patient
22389717 en aim evaluate incidence type mellitus year age new year perform retrospective review patient diagnose type new case type age diagnosis increase type incidence among per however incidence occur among age group high old group incidence new case type high new study period age group rate increase similar new type incidence increase similar change BMI diagnosis association BMI age increase type incidence among year study age diagnosis increased great incidence occur little change BMI population provide
22258959 en blood glucose found effective patient type patient type use insulin effective patient type use assess effect patient type mellitus use trial database control trial investigate effect compare care glucose patient type use insulin study use hba1c primary outcome independent datum included study evaluate study risk datum study compare whether primary outcome hba1c patient outcome fasting plasma glucose level adverse effect control trial included evaluate outcome patient intervention duration range month week month week trial compare care without one study compare one study trial compare care one study trial compare less control group study low risk study include patient duration one year show statistical significant decrease hba1c month follow-up confidence interval CI participant trial overall statistical decrease month follow-up CI participant two trial analysis effect show effect patient general general two trial reported one trial compare blood glucose glucose base per week total first year blood glucose time glucose trial reported effect trial intervention care control group less group group high follow-up group difference compare less datum effect outcome effect statistical significant study reported datum review duration one year overall effect blood glucose control patient type use insulin month month base evidence patient general general research need impact impact well impact diabetic complication
24123702 en plasma level potential obesity role type mellitus T2DM investigate therefore conduct association study identify associate level investigate whether associate development metabolic syndrome T2DM independent cohort cardiovascular disease risk factor study subject finding subject logistic regression use examine effect metabolic outcome subject significant associate level subject respective associate level risk or T2DM or determined show significant increased T2DM risk respective compare found gene significant associate level however associate T2DM risk association association T2DM
22742891 en reported associate cause type mellitus T2DM study aim role cholesterol level association T2DM analyzed fasting glucose status status level level age body mass index included analysis logistic analysis use identify factor independent associate age common factor independent associate among model multiple logistic regression analysis use identify factor independent associate T2DM identify model included subject identify independent factor odd ratio confidence interval study lipid level associate relationship T2DM individual however relationship T2DM lipid level included analysis
16735444 en important development function one potential target study examine effect function found impair response normal decrease compare protein activity found activity associate result normal treatment on similar impair response normal protein activity function
17921119 en glucose system method control therapy glucose level two glucose diabetic patient woman man mean age year patient type woman man mean age year patient type result patient population present review method day method event however period several time method lead change therapy present due case result range method base present method effective patient type present result method provide compare glycemic control type patient
23924496 en mellitus DM regard new risk factor study potential role DM well patient cohort patient treat hospital hospital diagnosis among diagnose chronic analyzed statistical according clinical metabolic analyzed logistic regression model use determine potential role patient diabetic mean duration DM year patient diabetic mean duration DM year analysis show compare patient patient high lower DM patient high high patient high value blood cell hemoglobin increased level high total level lower ratio logistic regression analysis show DM independent associate factor odd ratio CI patient compare patient similar result observed CI independent factor role may current relationship DM study
23124624 en association risk investigate however study result remain use present study relationship recent study provide evidence without individual study study identify control trial may relationship mellitus risk assess use relative risk effect effect model use analysis analysis conduct assess test test study case control cohort study case included follow-up range among included cohort study significant associate incidence analysis study CI cohort study CI however analysis statistical significant association found study CI cohort study conduct CI study follow-up year compare risk among without diabetic patient use insulin treatment reduce incidence cohort study result suggest mellitus associate decrease incidence population addition time positive associate incidence present consider however study
21510110 en study patient type mellitus without lipid studied type diabetic subject disease group diabetic subject without disease group age BMI healthy control group oral provide body three group age BMI duration significant different diabetic group ratio significant group compare group also group significant high group fasting total cholesterol level significant high group compare group fasting significant lower group vs group fasting significant three study group significant observed group group compare group different lipid parameter adjust respective fasting value observed remain significant high group group compare group level group significant high compare group level significant lower group compare group parameter show significant correlation fasting group significant correlation found glycemic insulin resistance study significant significant patient type mellitus disease may result disease type subject
24485344 en conduct retrospective cohort study assess association mellitus DM adult therapy DM patient compare patient use associate improve
24309215 en type mellitus T2DM condition aged population cardiovascular disease cause patient T2DM cardiovascular complication primary target risk factor lipid disorder hypertension however recent clinical trial aim evaluate treatment T2DM cardiovascular risk cardiovascular cardiovascular system provide new cardiovascular risk reduce overall health care T2DM therapy review cardiovascular compare clinical individual cardiovascular disease multiple related clinical outcome assess response cardiovascular system diabetic
23945844 en aim study review evidence effect type mellitus study identify different database obtain independent review two use identify study perform datum use review define study great incidence range type diabetic significant high control or confidence interval mean great diabetic control test overall effect response also statistical significant diabetic compare control group or CI diabetic patient significant high incidence little compare control mean great diabetic clinical diabetic group suggest age duration DM important role
25944078 en role system previous study show diabetic result change diabetic review examine current finding diabetic clinical diabetic diabetic include age response however mechanism cell important role recent identify diabetic model found impair potential cell new impair cell function diabetic mechanism diabetic finding diabetic
19922962 en level elevated patient cardiovascular disorder relationship metabolic syndrome studied woman study woman cardiovascular risk factor protein measured metabolic syndrome base association cholesterol treatment respective mean serum level high type mellitus without vs multiple logistic regression analysis type mellitus show significant association serum level age protein cardiovascular risk factor odd ratio confidence interval significant difference found mean serum level metabolic syndrome without metabolic syndrome mean level significant subject without hypertension glucose obesity according cholesterol treatment level significant associate independent cardiovascular risk factor woman however level correlation metabolic syndrome study determine elevated type mellitus
22760513 en review important recent finding characteristic function population possible role cell population potential cell possible type role disease recent role type significant potential cell population can also population clinical trial cell new research cell recent population function can cell cell type possible disease
24520125 en type condition cell potential target can previous show therapy investigate whether can development model effect result disease however glycemic control individual week associate increased cell less correlate treatment provide clinical clinical trial use datum treatment type diabetic patient
25269649 en association healthy factor healthy body weight healthy risk gestational cohort health study woman without chronic reported gestational diagnose medical previous first time gestational reported factor measured independent significant associate risk gestational three low risk factor week activity healthy two healthy score associate lower risk gestational compare relative risk confidence interval addition body mass index BMI low risk factor associate lower risk gestational compare relative risk compare woman low risk factor lower risk gestational relative risk population risk risk factor poor confidence interval on similar population risk observed low risk factor health datum low risk associate low risk gestational can effective gestational
24841704 en patient chronic associate age effect factor outcome study patient aim assess influence factor patient follow study age model disease score complication follow-up association baseline factor outcome follow-up test use logistic regression model respective on total patient man age year included baseline patient baseline independent associate baseline independent associate baseline independent associate development renal dysfunction follow-up
23909668 en mellitus DM common among little known role care relative DM study examine DM among DM finding indicate DM low high provide activity high care care DM care need role
23521622 en elevated level found diabetic patient indicate mellitus DM one level important role cell function protein contribute DM consider lipid cause according related may important role DM development disease complication due cell level cell system influence similar condition
21526633 en protein protein factor elevated level risk factor disease baseline level protein healthy man woman risk first diabetic increased risk disease datum study show risk clinical disease patient type compare without however datum regard diabetic study conduct among patient patient hospital protein base total subject patient type mellitus without hypertension healthy control significant difference mean blood pressure patient control fasting blood glucose protein significant high diabetic compare control positive significant correlation patient study show diabetic significant high serum protein compare control also positive significant correlation protein fasting blood glucose among patient control
24639059 en assess therapy patient randomize control trial week perform compare therapy mean difference mean hba1c change baseline odd ratio included mean hba1c change follow therapy vs vs compare therapy found can effective control use low incidence effect evidence increase risk
20683289 en mellitus medical disorder adverse may use patient mellitus remain reported study present clinical outcome patient well control type three different type follow-up clinical report use patient well control type mellitus treatment evidence clinical significant complication related treatment found patient population
22324103 en evidence association oral disease oral disease clinical condition individual medical patient oral health general health result patient patient association oral health role group common medical condition patient blood pressure plasma glucose cholesterol disease DM diabetic patient blood glucose level blood pressure well patient medical diagnose treat disease early result medical outcome role reduce incidence adverse impact
22117097 en report health medical care woman man age group case man receive treatment woman compare old old cardiovascular mellitus common increase age treat drug known significant adverse aim study difference treatment cardiovascular disease among old study on one datum medical relative well care included study aged year aged year aged year study total included present analysis study outcome medical diagnosis drug total woman large number drug man mean vs multiple logistic regression model adjust age well medical diagnosis hypertension show association female odd ratio or CI or CI or CI on similar model adjust show female associate or CI however man participant diagnose woman man use oral drug whereas difference several drug oral drug observed study old case woman drug man man undergo can difference diagnosis
25904026 en control woman gestational mellitus insulin therapy potential role review aim compare control therapy insulin database include control trial total sample study found difference control insulin group compare outcome receive therapy less weight study on number study reported lower rate one reported high rate group difference score assess risk included study diagnosis complication study one study follow-up datum trial relative sample body evidence suggest role management need
19951851 en aim study determine clinical profile mellitus DM month age aged month diagnose DM included study three case DM month age identify patient female three patient diabetic two three blood sample three patient analyzed gene gene on gene one patient diagnosis DM cell patient diagnosis patient DM treatment one clinical evidence case DM within first month condition high prevalence mean month age diagnose test diagnosis
23306648 en diagnose patient important risk factor mortality therapy due risk medical patient population complication impact metabolic control retrospective analysis perform compare effect treatment glycemic control therapy prevalence complication cardiovascular group diabetic patient population prevalence cohort diabetic patient receive therapy potential result effect patient disease rate medication high diabetic subject show define hba1c glycemic control therapy patient control lower rate complication hypertension significant diabetic patient
23948511 en mellitus DM impair activity well important related dysfunction DM several effect diabetic patient insulin whereas role therapy remain use related function can patient
26337994 en type mellitus T2DM associate condition metabolic improve complication metabolic function level weight study T2DM diabetic T2DM studied control normal potential perform relative T2DM baseline major difference group potential duration T2DM undergo incidence T2DM T2DM control control T2DM T2DM T2DM related change renal resistance T2DM diabetic patient risk event
25806677 en aim study evaluate complication follow-up population type mellitus disease cohort disease retrospective review health compare complication within year diagnosis follow-up determined year population compare population age patient significant lower weight body mass index BMI score vs high rate vs health vs rate observed group present significant perform group follow-up range first year result suggest patient possible complication negative patient follow-up may need group complication regard health
20040705 en study examine whether treatment care type mellitus among old improve medication glycemic control type mellitus large primary care care intervention care assess baseline week use medication event system assess outcome assess baseline week included test glycemic control study assess participant aged year participant great oral intervention vs care intervention vs care great intervention group care group week participant care intervention lower level hemoglobin intervention vs care mean score intervention vs care compare participant care group randomize control trial type mellitus treatment outcome among old intervention may effective
19856811 en patient mellitus chronic disease health outcome multiple parameter need include protein type control glycemic control mellitus multiple parameter mellitus chronic disease on parameter chronic disease mellitus great confidence
19920002 en outcome clinical management important assess value randomize patient type mellitus disease medical therapy need insulin insulin whether intervention use patient follow patient medical assess management medical high medical therapy significant method medical therapy intervention medical therapy also high insulin insulin factor significant independent increased included insulin use baseline female body mass index base datum medical therapy insulin insulin show medical therapy compare intervention per high confidence suggest may per lower significant increase among patient type mellitus disease medical therapy need compare among patient identify intervention
20707738 en recent study observed number type aim present study assess prevalence obesity metabolic among subject type patient type mellitus studied medical history renal function test lipid profile body oral glucose tolerance test subject plasma insulin also addition glucose oral total subject female mean age year studied among subject impair fasting glucose impair glucose tolerance mellitus glucose tolerance one subject level great low level high total cholesterol level prevalence obesity elevated plasma glucose high among old subject subject type increased risk obesity risk increase
28155315 en diabetic disease major system care study aim assess level patient type mellitus study conduct chronic hospital participant T2DM study per participant per participant hypertension disease per reported lower reported previous participant reported examine participant score mean confidence interval CI mean CI diabetic care high level less year old significant score previous care study demonstrated base current improve well patient provide T2DM patient risk factor identify
27819738 en relationship risk gestational mellitus remain study effect protein risk gestational mellitus database study statistical analyzed use study case control included identify significant risk analyzed vs odd ratio or confidence interval CI vs or CI model analysis revealed female on show reduce observed significant difference female result indicate influence determine presence
26344020 en several study reported association gene type mellitus population population therefore study reported association gene study included healthy control gene perform follow difference observed association gene significant patient healthy control or model also associate or age increase risk finding gene associate study large sample need
26542316 en evaluate relationship include lead prevalence datum study participant health sample population measured sample status determined base previous diagnosis odd ratio associate high compare low CI lead high associate great insulin resistance positive associate relative low level
27044587 en oral glucose tolerance test test time poor woman hba1c chronic hba1c test less time patient consider compare therefore test hba1c use gestational mellitus health care hba1c level result woman test gestational week on profile woman period mean age participant year range assessment hba1c cohort woman present number woman according evaluate woman use value hba1c show negative value use hba1c value result suggest woman hba1c may result significant reduction patient hba1c
25107578 en effect risk studied examine effect control patient disease without type mellitus DM patient reduce cardiovascular complication study control group age DM previous period assess use time method patient clinical status value decrease group control patient mean vs control vs change group vs control DM patient positive case control patient positive case control first report effective reduce risk patient
25073857 en determine effect insulin insulin treatment associate cardiovascular disease patient type mellitus disease trial level compare patient type mellitus disease randomize treatment concentration protein evaluate baseline one year treatment significant effect decrease increase increase change decrease change change statistical different group protein decrease effect significant great group group treatment effect profile patient type mellitus disease treatment change may treatment regard cardiovascular
26376846 en gestational mellitus increasing aim study investigate association serum concentration study conduct woman healthy woman control evaluate fasting serum lipid concentration measured week group factor compare two group use independent sample significant difference level two group mean level lower group significant correlation serum level body mass index well fasting blood glucose serum lipid profile include cholesterol concentration significant association concentration use regression model factor odd ratio low serum concentration associate woman
26288254 en aim study patient gestational mellitus evaluate relationship insulin resistance glucose determined glucose
25443800 en evaluate influence insulin normal gestational mellitus woman one normal glucose tolerance studied glucose assess oral glucose tolerance test serum concentration insulin resistance index determined blood early weight assess lower concentration control group vs negative associate presence index index positive cholesterol multiple regression analysis concentration one insulin resistance BMI low concentration cholesterol relationship found index concentration lower patient compare healthy woman low concentration associate insulin resistance finding suggest insulin resistance may new associate
25058016 en increasing body evidence suggest type common mellitus DM however risk patient DM examine risk patient retrospective cohort study use health research database compare patient new diagnose DM control without medical obesity disease hypertension age patient assess index follow-up patient incidence incidence time high patient new diagnose DM risk first control group adjust ratio CI risk oral CI CI CI significant high patient DM associate increased risk develop risk develop oral significant high patient DM
24683177 en body mass index BMI mellitus DM remain whether association level study assess effect association BMI well association BMI use datum participant among health obesity level define use primary use logistic regression investigate influence association different BMI well found positive association BMI DM level found association BMI DM large association among female increase BMI female similar increased odd DM high odd female associate DM association
25369141 en insulin therapy patient type mellitus disease patient may increased prevalence insulin resistance common insulin therapy high insulin associate effect study show may individual perform provide evidence clinical conduct study may base mellitus type outcome evaluate hemoglobin hba1c fasting plasma glucose lipid weight insulin diabetic adverse event perform use review total randomize control trial included associate reduction insulin body weight total cholesterol level level level increase risk compare treatment patient significant difference found group group hba1c level level level significant difference found group group risk severe diabetic may decrease insulin body weight lipid level however increase incidence follow-up clinical trial need
24930987 en gestational mellitus several complication include high rate study investigate association observed study woman healthy woman evaluate three evaluate serum measured blood day lower mean blood level control vs develop lower healthy group reduce associate lower blood level associate lower serum level day result show compare healthy may associate lower level measured blood effect
25056244 en aim investigate association factor level type mellitus perform study include T2DM woman healthy control measured serum measured level high T2DM control vs significant associate T2DM level lower T2DM control vs however association found serum level associate datum role increased ratio possible dysfunction
26818900 en care provide type mellitus significant health provide result however little evidence evaluate type mellitus year analysis base randomize clinical study conduct include type mellitus two group one receive receive type mellitus change hemoglobin hba1c consider primary effective body mass index blood pressure blood pressure fasting blood glucose total cholesterol level estimate base use trial evaluate three result assess per decrease hba1c three consider respective decrease hba1c analysis show type mellitus patient control treatment disease compare
26522834 en recent evidence suggest potential effect treatment type diabetic however mechanism remain investigate effect mechanism treatment model type diabetic oral body week treatment significant elevated fasting plasma insulin level insulin resistance index impair glucose tolerance insulin tolerance tolerance treatment also gene elevated gene glucose treatment cause significant increase protein decrease ratio finding suggest treatment insulin resistance model type little provide new effect type
22128781 en determine duration relationship glucose glycemic control rate adult patient database day patient use patient use patient study period age insulin use insulin significant influence hemoglobin hba1c duration use adult use significant lower hba1c severe reduce patient use use use associate significant reduction hba1c adult event reduce age
22620011 en mellitus group disease associate metabolic disorder chronic due insulin chronic diagnosis hba1c level consider blood glucose level month according recent diagnosis addition early plasma glucose value hba1c one diabetic diagnosis also evaluate glycemic control provide clinical
26496307 en study aim examine whether poor glycemic control measured hemoglobin hba1c cardiovascular risk factor diabetic patient type mellitus aged year type DM care management period included follow related factor analyzed use regression follow-up year case identify incidence rate patient hba1c level high risk adjust respective compare patient hba1c level significant incidence increasing hba1c significant patient hba1c level blood pressure high female low estimate rate type DM hba1c increased risk relationship incidence also associate poor glucose control cardiovascular risk factor hypertension low high decrease
26496267 en determine whether increase insulin measured insulin resistance model assessment insulin use gestational mellitus identify study subject included study assess analyzed method total trial participant included significant reduction gestational incidence risk ratio confidence interval CI weight mean difference CI fasting glucose oral glucose tolerance test CI glucose CI glucose CI related complication odd ratio or CI current evidence reduce development gestational mellitus although randomize control trial
23600679 en gestational mellitus time diagnose disease develop year base risk study conduct woman base risk complication recent adverse outcome study demonstrated associate risk association study group result clinical new gestational mellitus base first time outcome
22159786 en aim study determine whether metabolic syndrome individual presence type mellitus associate status estimate subject high cardiovascular risk study define according diagnosis assessment perform use show significant lower level high high index individual type mellitus T2DM show significant high show high prevalence multiple regression analysis show parameter positive associate metabolic syndrome T2DM related obesity number define first study positive association T2DM status lower measured result suggest metabolic positive effect healthy subject high risk cardiovascular disease
21864034 en aim study evaluate glycemic control individual type mellitus oral identify cohort year hemoglobin hba1c use assess glycemic control datum consider first year group identify receive oral insulin insulin oral year insulin patient receive insulin baseline hba1c decrease old baseline follow-up body mass index BMI receive insulin respective patient group compare patient group remain year patient glycemic control baseline follow-up less old receive insulin current use oral improve glucose control diagnosis mellitus
22528595 en disease cause mortality patient patient poor first effective patient type presence value risk improve management risk factor evidence use research need define potential patient may
22393122 en study evaluate impair resistance protein activity drug diabetic condition model drug oral studied result show mellitus significant increased concentration oral datum diabetic significant indicate impair datum show oral normal indicate important role significant decrease oral result revealed significant increased effective decrease suggest function may role increased oral diabetic insulin treatment change diabetic result impair activity contribute increased oral
22050532 en risk factor cardiovascular event renal correlate study evaluate independent event patient study patient patient follow month mean follow-up result event disease duration year patient mean year old mean hba1c baseline mean range ratio significant correlate ratio regression model include age estimate rate blood pressure event ratio confidence interval however value event correlate cardiovascular risk patient
25026924 en aim study determine whether serum associate risk type mellitus T2DM cohort man risk factor measured sample subject disease study association baseline level risk T2DM analysis adjust potential mean baseline age level year respective follow-up year range year new case T2DM observed association value T2DM risk subject ratio per high level result CI model adjust age body mass index blood pressure serum history T2DM association change protein activity serum insulin resistance however association found adjust baseline fasting plasma glucose cohort man found relationship risk T2DM high risk subject baseline level increased risk however independent baseline level
19262374 en increase disease type mellitus recent treatment disease condition change type mellitus disease follow new evidence suggest per development dysfunction lead cause disease contribute cardiovascular disease patient type mellitus may develop presence normal diagnosis however new method plasma intervention management recent randomize control trial suggest potential severe complication type mellitus patient may early diagnosis treatment
22842610 en blood glucose care management among patient mellitus increase current method glucose use glucose use range concentration glucose analyzed high response value factor determined high lower range glucose correlation response concentration low range glucose determined value lower blood glucose range datum new method glucose current use patient response individual several important management can measured
22641251 en dysfunction associate study investigate whether improve function patient without mellitus DM examine relationship change included control group group evaluate participant function significant similar patient patient DM improve difference whereas without DM improve time early correlate change patient DM baseline patient DM patient show similar increased without DM show great associate patient without DM
21196000 en aim study investigate possible effect mellitus clinical retrospective review clinical patient two group patient without patient two group compare profile clinical age body mass index diagnosis prevalence hypertension weight similar two group without time similar without contribute early diagnosis
26542478 en gestational mellitus disease include insulin resistance model reported effect study investigate effect model great improve glucose insulin tolerance outcome female found reduce activity female finding potential effect also
26377195 en suggest common use may lower risk examine whether use lower risk patient cohort study patient type baseline year baseline diagnosis model evaluate association use follow-up diagnosis age body mass index included patient follow year patient compare patient receive medication use associate lower risk adjust confidence interval CI association increasing total CI CI CI CI finding analysis include evaluate outcome period study suggest potential use risk patient type may lower risk reduce potential use
21983385 en syndrome one common disorder well known associate multiple disease multiple chronic disease system association disease previous reported report one case mellitus disease suggest disease patient
19795399 en previous study show addition influence type mellitus T2DM current study identify T2DM datum obtain total number individual individual analysis use perform relative T2DM group addition test perform association significant evidence observed addition total show evidence estimate high score group little identify previous result study provide evidence presence T2DM evidence provide important study population
22152777 en investigate effect group control group diabetic group group group group control group also mellitus group normal drug rate observed day respective treatment test method index day treatment rate control group high diabetic group rate treat group high diabetic group rate group high group group compare diabetic group control group increased group group high diabetic group mellitus
20656522 en several show mellitus risk however overall risk perform include cohort study study conduct included review total case reported cohort study one study total subject report risk man woman show increased risk subject compare subject or CI increase risk ratio adjust possible significant man woman adjust CI man adjust CI woman analysis revealed increased risk or CI or CI case high risk without early important management increasing prevalence health clinical
23905837 en subject on mechanism recent reported investigate whether increased patient type without renal role measured study patient control impact plasma determined sample previous randomize group study compare plasma level high patient type control study plasma correlate subject plasma independent plasma adjust age BMI body mass index hba1c randomize trial significant lower whereas change observed group similar reduction hba1c reduction plasma correlate change hba1c group suggest reduce plasma plasma increased patient type renal subject
25524438 en profile can type mellitus however study profile metabolic profile serum sample obtain cohort individual develop follow-up time year control use study regard disease logistic regression assess association several lipid association positive associate whereas high concentration reduce odd respective evidence positive association study one large profile study population finding new develop target study number potential important
21181397 en on perform assess association also gene reduce risk mellitus include type type diabetic complication include diabetic diabetic diabetic conduct identify cohort study association effect test among study among study evaluate use one analysis use potential estimate use regression test included case control also show significant association reduce risk or CI or CI or CI model also show significant association reduce risk diabetic model or CI reduce risk diabetic or CI or CI or CI gene effect risk diabetic diabetic risk need study
25868061 en assessment health associate obesity aim study compare insulin resistance index patient healthy control obesity type group year old
23875532 en examine woman mellitus type DM impact related consider risk factor dysfunction man woman although evidence woman less study conduct effect DM study conduct woman low status participant control result test use datum age woman year total score found correlate type DM treatment duration DM diagnosis complication DM level hba1c blood pressure woman woman DM determined function disease impact within finding health woman intervention
24434301 en recent research revealed low may related clinical study evaluate effect serum level diabetic subject aim low serum concentration two factor factor factor patient type fasting glucose level hba1c lipid profile patient type treat low patient type subject serum use use low patient type reduce serum concentration suggest potential effect can
24433580 en target diabetic diabetic well aim present study investigate effect metabolic profile patient healthy control use cause due perform patient healthy control concentration glucose determined use compare two concentration significant lower vs diabetic compare control group concentration found significant high vs diabetic glucose level found significant elevated three diabetic compare control group however significant change level observed three examine among two analysis indicate mellitus may cause change metabolic profile decrease concentration decrease diabetic elevated concentration related glucose
20959716 en association recent hba1c one diagnosis mellitus compare hba1c fasting plasma glucose level diagnosis among adult
24452065 en important therapy parameter well study compare total diabetic evaluate factor influence plasma protein profile obtain diabetic receive oral per day addition drug factor influence protein evaluate use model investigate influence several include glucose concentration hemoglobin body mass index age time patient value high total respective ratio total concentration high diabetic subject protein result revealed related patient can potential lead increased risk complication diabetic
23887452 en studied effect change effect compare result treatment determined medication study decrease primary effect treatment lead decrease increased number well studied two decrease number activity less effective also decrease number increased number change medication use study
18611954 en type mellitus associate function chronic condition perform review finding current association history type mellitus risk study three cohort study included review found history type mellitus positive associate overall risk however significant study study important rate ratio type mellitus found confidence interval among study confidence interval among cohort study identify included study case control control although positive association type mellitus risk evidence included study study improve control need finding
23137378 en retrospective cohort study type patient evaluate association treatment identify clinical research previous general research database include included cohort new diagnosis include occur follow-up identify cohort incidence rate estimate compare age incidence per group respective adjust potential ratio CI CI group compare group respective individual CI CI CI study provide evidence incidence first year therapy type patient drug
22841465 en difference outcome according woman gestational mellitus relationship characteristic outcome woman analysis woman studied multiple characteristic outcome compare according logistic regression analysis method perform group vs previous history body mass index diagnosis fasting plasma glucose diagnosis hemoglobin group outcome also observed difference prevalence vs large gestational age vs high group logistic regression analysis independent odd ratio range confidence interval CI CI patient adverse outcome medical history datum glycemic control independent poor outcome
19363256 en effect cause lipid lead increased however disease include mellitus DM previous study demonstrated cause mellitus type review evidence mortality rate due DM disease disease model increase chronic role insulin resistance disease potential include use reduce level use effective research assess early evidence insulin resistance
21507434 en diabetic complication mellitus prevalence related presence hypertension aim study clinical factor associate increased need patient diabetic study patient follow diabetic patient group according whether previous receive studied cardiovascular risk factor treatment receive patient control hypertension observed group receive year history cardiovascular disease lower similar patient treat significant high receive patient treat significant high receive significant difference observed control blood factor related year history cardiovascular disease disease treatment
21388440 en individual type mellitus may effect aim study compare response associate change vs type glucose level measured type two day day occur without total perform duration rate ratio blood level high vs difference trial difference reduction glucose plasma glucose level trial glucose level high vs compare associate less vs time glucose vs time decrease glucose level similar type
24502249 en several study investigate risk factor impair glucose tolerance type mellitus however normal glucose tolerance different study estimate risk influence risk factor first age year age year included analysis participant group group impair fasting glucose potential risk factor development glucose investigate age health blood pressure BMI activity history analysis conduct two first factor analysis use logistic regression influence total individual included analysis health due result factor analysis logistic regression respective risk indicate different impact different risk factor glucose estimate impact risk factor high level hypertension high BMI risk factor glucose can use identify individual increased risk develop three
24018646 en evaluate effect type T2DM metabolic risk effect show study effect rate large outcome patient T2DM undergo little follow-up assess define hemoglobin less fasting blood glucose less diabetic medication change metabolic include hypertension diabetic follow-up year range mean weight associate mean reduction rate respective whereas improve decrease without baseline remain duration T2DM high T2DM occur associate duration T2DM less weight control rate low high high hypertension respective diabetic significant T2DM metabolic risk factor severe patient intervention within year diagnosis associate high rate
23855352 en on perform assess association factor gene gestational mellitus on conduct identify cohort study association effect test among study among study evaluate use use potential estimate use regression test on total study include case control overall control significant association risk gestational mellitus observed or CI or CI model suggest associate increased risk gestational mellitus
21340138 en determine influence drug medical care control blood sample obtain glycemic control define hba1c poor poor hba1c logistic regression model use determine association factor patient medical diagnosis metabolic associate increase control on diabetic poor poor glycemic control medical care patient need
20838752 en compare lipid profile serum level mellitus group group on receive group receive cholesterol type mellitus group fasting serum level decrease diabetic group group compare control fasting serum level decrease group compare group on serum level group level decrease group datum suggest serum level may obesity type mellitus
27143381 en investigate plasma sample healthy type mellitus plasma lipid significant increase total level disease duration group disease period less year increase also decrease group disease level normal level
22196129 en woman history gestational mellitus high risk develop type within year evidence duration influence type base one retrospective study association study woman type cohort study woman recent within health care system primary assess whether compare reduce incidence type mellitus among woman study also examine whether duration effect blood glucose insulin resistance period report method study obtain clinical follow-up cohort study woman diagnose within study woman week baseline diagnose aged year great week use medication glucose tolerance within year participant type medical condition baseline type within first year datum early month month conduct obtain first large study cohort woman recent assess duration examine relationship type potential assess previous
24232813 en development important associate increased risk significant medical increased increase type woman age type diabetic sample aim mechanism development gestational several study show intervention metabolic control cardiovascular risk factor complication disease finding recent number new therapy large research clinical health negative impact research research clinical study conduct increase level evidence
24289561 en type mellitus T2DM mortality patient insulin factor insulin important role development aim characteristic protein cell case patient T2DM retrospective included without ratio protein datum relationship protein insulin show high T2DM group compare without T2DM high found negative associate T2DM group respective also found T2DM duration year difference group without study found high protein patient T2DM association early may important early event development associate
24032284 en role mellitus complication several use present study aim investigate patient compare healthy control test patient healthy control subject mean age patient year mean duration year mean level patient patient show high compare control positive correlate plasma hba1c level significant correlation duration result show significant increase patient per cell relative control group per cell significant correlation duration hba1c result suggest condition increased level may factor increased
23649196 en activity investigate effect assess result show activity cell diabetic indicate decrease incidence mellitus type potential activity type
23577069 en incidence severe type decrease new treatment risk dysfunction need studied treatment function patient type severe study randomize study use treat day two function primary response treatment associate significant reduction time less time treatment change concentration patient type treatment associate effect function time assess response
23438184 en role glucose potential target type little important development complication type mellitus renal glucose lead new mechanism complication treatment obesity patient type type glucose glucose role glucose also clinical trial treatment
23363982 en investigate clinical assess type diabetic one patient type undergo positive low respective assess use patient without without duration blood pressure ratio independent independent logistic regression analysis characteristic analysis two parameter CI respective respective duration elevated independent independent improve
24138536 en due reduce level cholesterol elevated normal level cholesterol type mellitus T2DM study evaluate compare patient diabetic control therapy
21791087 en high prevalence occur several study different found patient chronic associate type mellitus DM prevalence DM among patient therefore important identify treatment chronic study evaluate prevalence DM among patient different include chronic patient study patient old case also healthy control included include function test blood glucose level also include profile factor case diabetic healthy control diabetic found diabetic group mean age respective lower level group mean age respective high level compare diabetic group diabetic group age significant factor incidence two group significant difference regard finding although among diabetic case score high diabetic patient among diabetic diabetic patient group old history diabetic case age factor can potential contribute development type logistic regression analysis show age can associate presence significant factor
23922493 en correlate serum level factor type mellitus subject included patient type DM mellitus diabetic diabetic healthy control age year follow serum level analyzed use significant difference found serum level study group on positive correlation found level on significant positive correlation found increase serum level associate increase diabetic
23813150 en type mellitus two common disorder chronic condition follow-up control high index may associate adverse outcome treatment condition general also role management disorder
23672990 en association serum level current poor known examine association level risk patient type mellitus follow year sample type diabetic baseline on diagnosis participant year case incidence elevated level associate increased risk odd ratio confidence interval increase level age body mass index hypertension chronic disease interval use association adjust odd ratio confidence interval included risk score association result remain patient previous disease analysis finding suggest elevated level associate increased incidence patient type mellitus multiple clinical risk factor
23362628 en new diagnose type mellitus care management important develop healthy develop increase type clinical among diagnose type score related diabetic care management on use measured use assess outcome use evidence score on statistical significant increase found score datum positive relationship type found mean among similar type
24807830 en study determined can type mellitus
22578323 en determine prevalence clinical characteristic diabetic patient study prevalence duration complication complication metabolic control baseline blood glucose hba1c metabolic complication type assessment use index datum use total patient studied prevalence study included patient mean age year woman diagnosis year event common follow disease diabetic hba1c analysis perform patient level assessment rate metabolic complication diabetic syndrome oral patient use follow respective index diagnose prevalence high patient diabetic complication significant level
26070216 en identify characteristic patient type mellitus T2DM analyzed datum index clinical characteristic group patient related T2DM hospital patient clinical evidence related T2DM among cohort mean number year index three index patient time cause identify one patient multiple logistic regression analysis show compare patient without diagnosis patient T2DM odd ratio less prevalence odd ratio high number previous year odd significant patient clinical evidence due T2DM history previous year patient identify aim reduce risk
22122224 en glycemic therapy use patient base several factor one important condition renal disease disease cardiovascular disease potential lower hemoglobin possible treatment adverse effect use association clinical association develop treatment patient type include medical association also management patient care review profile drug treatment need drug patient renal disease disease cardiovascular disease
26181706 en therapy effective cardiovascular disease general population show increase risk mellitus analyzed DM study participant follow compare rate among therapy period use model examine association year risk develop DM age history body mass index therapy also adjust score patient analyzed therapy develop DM DM independent associate therapy adjust ratio per year use well old age status body mass index association use DM similar model adjust use associate increased risk DM population similar datum general population patient glucose clinical indicate cardiovascular disease risk reduction
23140077 en compare prevalence diabetic two study two patient aged year old examine two prevalence type mellitus among respective type mellitus statistical high prevalence diabetic among diabetic compare vs diabetic vs vs vs analysis diabetic significant diabetic may high prevalence type mellitus diabetic among type however found show diabetic
23545115 en high incidence cardiovascular disease one new may contribute assessment cardiovascular risk treatment one research reduction cardiovascular risk low development several characteristic patient high rate compare healthy population diabetic development review role different type development well use cardiovascular risk
22802218 en year type known disease elevated blood level associate obesity disease patient plasma glucose level hba1c diagnosis new drug old day mellitus disease large disease associate obesity activity primary treatment although remain major type new old disease treatment review recent type treatment possible new
24903995 en chronic lead complication diabetic syndrome diabetic disease aim study determine concentration factor on patient study conduct patient type without healthy control group serum concentration fasting glucose lipid profile measured plasma concentration hemoglobin hba1c significant difference observed concentration subject group control group positive correlation level negative correlation level study concentration patient healthy individual may indicate control glucose level complication on negative correlation level positive correlation level suggest lipid occur may
23894675 en study conduct assess randomize clinical trial treatment mellitus investigate current medical database treatment mellitus trial reported study study case study review two independent evaluate trial whether reported identify according method result respective three assess trial use trial result condition
23870133 en disease cause high one dysfunction studied patient relative studied use found common occur patient present patient population control present two among patient three suggest consider patient history mellitus
23795882 en may less impact risk develop mellitus DM compare conduct retrospective study investigate factor impair glucose tolerance DM two group receive treatment treatment cohort positive status elevated significant correlate diagnose DM among factor significant related diagnose DM BMI factor significant correlate level may less contribute development DM research need DM
23740755 en blood test current evaluate cardiovascular health patient study evaluate high cell health health profile measured cell population type mellitus DM healthy control use cell level significant lower concentration DM whereas level present significant high concentration DM patient one present significant lower concentration DM patient level one provide health profile may include drug development clinical risk assessment
21218510 en type mellitus study aim examine clinical total patient patient parameter test serum measured determined response subject patient patient significant high concentration plasma glucose severe low level increased level patient disease associate positive serum low little one test three patient positive response significant high patient clinical characteristic may multiple factor include drug syndrome among presence
24878859 en examine whether history treatment associate risk development mellitus DM conduct retrospective cohort study use health datum one individual adult DM aged year treatment DM patient identify DM subject history within one year treatment index subject age index year index DM subject without history within one year treatment adjust ratio confidence interval CI model association history DM patient without within one year treatment adjust among DM patient within one year treatment CI CI within one year treatment associate increased risk new treat DM patient individual status major study
24657294 en index may due occur aim determine relationship index cardiovascular disease mortality determine whether association individual clinical disease undergo participant man mean age year mean mean year follow-up association diabetic vs participant association similar status among diabetic patient relationship observed low high high risk normal range patient association low risk whereas high risk association status high low risk whereas risk high lower diabetic individual clinical disease low high high risk relationship observed status finding suggest may value individual may
25972077 en prevalence obesity major increasing mortality woman complication gestational mellitus develop cardiovascular metabolic disease obesity may associate chronic response may one mechanism woman develop adult review evidence obesity associate change obesity may associate role target obesity may disease influence function
25772210 en study determine whether management plasma glucose sample significant effect glucose body mass index first woman cohort fasting glucose level measured early cohort oral glucose tolerance test perform week sample woman cohort first sample analysis analysis sample according hospital woman fasting glucose test early result woman analysis compare woman analysis mean interval sample compare sample woman glucose tolerance test fasting glucose level woman analysis compare woman analysis interval fasting sample week oral glucose tolerance test cohort compare sample fasting glucose sample analyzed gestational mellitus woman
23051145 en patient type mellitus cardiovascular event common outcome subject intervention reduce however study show presence effect therefore aim study effect patient role plasma insulin glucose use difference control patient compare control patient studied without patient studied condition control studied without less healthy control control reduce however lower patient healthy control model however reduce study
18996811 en evaluate mean estimate year age diagnosis type type mellitus hospital participant development development current compare finding clinical datum include age hemoglobin level type body mass index also rate participant assessment compare on level great great consider study rate great rate great however participant time role age metabolic control measured hemoglobin type body mass index influence participant assess identify early
18254314 en clinical outcome mellitus
24259350 en evaluate assessment compare study patient mellitus test DM patient without clinical evidence patient change whereas value patient group high study also lower diabetic
20963262 en case study control health research model use on sample year age obtain on mellitus type health statistical analysis prevalence diagnose confidence interval CI prevalence diagnose adjust age CI difference prevalence risk factor control two consider first time research on among effective health
21222316 en associate increasing prevalence chronic disease include type mellitus chronic complication change observed mellitus treatment lower level hemoglobin prevalence patient treat insulin increased change decrease associate increasing risk severe age risk factor population year multiple chronic renal associate increased risk develop complication level care clinical low blood glucose early treatment complication associate increased hospital mortality old
20873150 en parameter studied patient type mellitus test test revealed reduction patient diabetic change patient without diabetic glycemic dysfunction patient diabetic poor study blood use research study blood glucose level examine patient mellitus
25022865 en type mellitus present diabetic report use type
26317981 en investigate blood glucose response interval mean duration type mellitus subject perform test different mean on first subject adjust insulin insulin reduce on mean blood rate measured glucose measured glucose decrease significant on compare difference found glucose response on blood on ratio on significant high compare occur use insulin lead decrease compare although mean duration high therefore can perform
26252477 en type mellitus T2DM associate reduction however evidence determine whether change associate individual T2DM study investigate association change intervention resistance individual total participant control intervention change mass change include relative time estimate metabolic change independent associate change relative estimate on significant observed change change relative month association observed change estimate result study suggest change associate great individual T2DM effect increasing individual T2DM
26083329 en aim evaluate correlation protein type mellitus T2DM complication T2DM role total T2DM patient healthy control group on T2DM patient three group base complication group presence disease group disease group subject serum level measured group increased serum level relative group group group on compare group on significant high group group group group high group high logistic regression analysis show lower index BMI cholesterol well high cholesterol level may factor T2DM high level cholesterol independent risk factor datum indicate correlation complication T2DM patient lower BMI well high level may factor T2DM high level independent risk factor T2DM
26037293 en datum impact mellitus DM risk therefore investigate impact DM risk subject analyzed subject undergo mean age year man score disease clinical outcome assess define little disease disease disease compare subject without DM DM high score vs significant vs large disease vs however significant difference significant vs disease vs vs follow-up period range month significant difference syndrome group ratio confidence interval subject DM without DM difference clinical outcome
25934190 en population associate reduce risk type mellitus T2DM investigate association T2DM risk metabolic association analysis perform T2DM study case control associate T2DM odd ratio or confidence interval however associate lower fasting plasma insulin level lower model assessment insulin resistance index fasting insulin level population
23653894 en impair severe patient mellitus little known review chronic diabetic patient treatment diabetic include glycemic control well therapy base use high pressure therapy use treatment diabetic care
25274537 en oral glucose treatment adult patient type mellitus glucose provide mechanism blood glucose several trial week duration week duration study week treatment therapy include insulin improve control reduce blood pressure adult patient type large trial therapy show week week reduction level primary well participant clinical trial adverse event treatment risk although occur insulin mechanism therapy drug include insulin provide addition management type review clinical use patient type
24830701 en report previous healthy female present new diagnose type mellitus review previous reported case may cause significant mortality population
22348239 en mellitus common disorder increasing prevalence blood cause reduce patient may impair little one diabetic may first present respective lead may consider disease intervention
25824289 en study investigate whether cell blood cell type included cell cell blood cell blood control trial database database trial one group included case therapy group case treatment hemoglobin decrease therapy compare month month month fasting plasma glucose reduce therapy group compare control follow-up therapy compare month analysis show level increased therapy compare control therapy month therapy month insulin reduction also observed patient receive therapy month therapy demonstrated glycemic control increased insulin elevated insulin cell
27166424 en aim study compare metabolic parameter type mellitus T2DM general population contribute datum sample three group T2DM T2DM prevalence prevalence type respective patient condition significant old high mean body mass index high lower mean total cholesterol lower estimate rate lower medication less association lower increased prevalence patient study define association T2DM control associate high prevalence
24675660 en patient mellitus event response impair adverse increased mortality evidence clinical study factor level include factor addition diabetic show potential different cell impair diabetic review current contribute
20835596 en evaluate effect model mellitus blood evaluate mellitus DM group mellitus treat group control level significant high DM group control group vs protein respective compare control group vs significant high control group vs respective model mellitus reduce
26382453 en mellitus normal disease cause develop total adult population treatment early high disease important disease addition parameter contribute significant disease analysis new major disease analysis provide development drug therapy disease target protein
26345823 en patient syndrome increased risk type mellitus T2DM recent demonstrated serum level also elevated T2DM patient aim study determine whether serum level associate T2DM patient study patient patient without T2DM respective serum level examine use method patient T2DM significant elevated serum level compare without T2DM vs according logistic regression analysis serum level independent T2DM patient base regression analysis serum level positive associate body mass index blood pressure serum level model assessment insulin resistance level protein fasting plasma glucose plasma glucose hba1c patient elevated serum level may new T2DM patient
26313785 en study different population cardiovascular disease patient patient obesity however datum association body mass index BMI mortality among patient patient type mellitus T2DM investigate association BMI mortality patient T2DM define body weight conduct cohort study T2DM patient mean follow-up period month use regression model BMI related risk mortality adjust association BMI mortality observed among participant significant elevated mortality compare ratio ratio ratio ratio association remain examine datum age study found relationship mortality BMI patient T2DM age function BMI regard potential important target weight management T2DM
26313783 en investigate association change incidence type mellitus T2DM within sample sample woman man aged year cohort cardiovascular disease study study health association change body weight incidence T2DM assess ratio investigate change obesity well change relative baseline value estimate adjust conduct analysis obesity status age vs year found change body weight incidence T2DM adjust analysis study sample participant body mass index baseline show lower compare woman man weight analysis found association change weight T2DM difference age study show association change weight obesity incidence T2DM healthy primary weight development T2DM
26272662 en mellitus can lead outcome without management report case outcome patient mellitus poor control present poor week show demonstrated also found on perform without improve develop treatment case demonstrated without can consider
26121402 en may influence risk develop type mellitus T2DM study evaluate determine whether include healthy activity level associate T2DM use datum study cohort study adult aged year baseline on total participant T2DM baseline undergo clinical follow-up healthy activity individual participant measured use system method score estimate ratio T2DM associate use regression model adjust age level use datum analyzed T2DM define fasting glucose level little use insulin oral follow-up year participant develop T2DM incidence rate CI per adjust model lower risk develop T2DM associate great healthy per range increase score CI activity per increase score CI association primary associate T2DM per increase score CI great activity little healthy associate lower incidence T2DM although result method may T2DM although intervention study need
25391871 en change possible role blood lipid mellitus patient total patient diagnosis disease may base diabetic also blood glucose blood lipid new positive level blood glucose lipid diabetic relationship mellitus blood lipid perform logistic positive rate high diabetic vs or CI value logistic regression adjust lower level diabetic vs correlate or CI value logistic regression correlation blood decrease may important role mellitus patient disease
24090506 en evaluate blood patient gestational mellitus examine patient healthy woman week parameter assess significant high lower treat insulin significant lower high compare change patient
24090161 en study gestational mellitus study included woman serum protein measured week patient development total woman analysis level significant high level significant lower among woman develop compare level significant different group value show respective value show respective low high respective overall important early improve overall role
22231920 en study found increased risk disease patient type mellitus T2DM aim determine whether patient T2DM diagnose disease time diagnosis finding may impact patient analysis patient perform diagnosis patient without T2DM compare use logistic regression analysis T2DM old patient T2DM lower risk disease diagnosis age BMI multiple logistic regression analysis change result individual less patient T2DM potential due improve model less early patient T2DM may lower risk diagnosis study result investigate impact medical patient type mellitus
20653745 en risk factor associate high level risk development type sample woman recent history gestational woman aged year diagnose gestational datum included risk woman response rate current diagnose type year woman low low risk develop type risk high high risk use logistic regression analysis factor associate high level risk body mass index odd ratio or confidence interval CI history or CI use insulin or CI woman known risk factor type risk high found one consider low low risk development result suggest need increased gestational type risk
27042281 en present study aim evaluate insulin patient type randomize trial patient randomize two treatment receive insulin day period day treatment blood sample obtain treatment period obtain use treatment total patient randomize man woman mean hemoglobin baseline base value total effect glucose rate one interval total mean effect interval first interval total mean effect interval duration patient type datum patient overall previous reported patient
19696205 en major health therapy important treatment intervention woman effect different type mellitus assess effect medical therapy complication control woman follow week control group medical use group woman type mellitus gestational included total reduction glucose control group receive hospital care statistical analysis included logistic regression or CI lower risk type low weight less woman gestational receive care lower woman type include glucose positive effect woman health care
26557720 en increased subject type mellitus normal however presence serum related may reduce fasting blood obtain subject age BMI control subject measured compare control subject increased subject serum significant group according mean hba1c level high subject hba1c compare hba1c regression analysis increase hba1c increased respective independent BMI group study demonstrated increased subject poor control suggest may contribute increased risk
26451383 en type mellitus T2DM disorder impair insulin resistance insulin lipid protein factor gene reported one risk factor T2DM population result study conduct base determine gene total T2DM control gene determined base time high significant difference subject age BMI hba1c significant association among subject revealed significant difference on significant difference gene consider risk factor T2DM subject among
26004082 en assess patient mellitus DM
25587719 en insulin cell potential increased serum level metabolic insulin resistance type mellitus T2DM diabetic protein lead early period chronic associate development disease include T2DM chronic early model study demonstrated association T2DM correlation early
25076074 en relationship adverse outcome glucose control risk factor complication glycemic control potential risk factor well studied investigate whether hemoglobin hba1c level independent associate complication retrospective cohort patient diagnosis mellitus study assess risk factor associate analysis show hba1c level little one associate however adjust significant factor hba1c level increasing odd factor confidence interval CI complication analysis show body mass index little one hba1c level significant factor adjust significant factor develop complication little one odd ratio CI hba1c level odd ratio CI retrospective study hba1c level association complication patient
24816041 en diabetic patient low index normal index statistical investigate whether impact risk factor different compare use database diabetic patient evaluate develop common regression model model statistical difference impact risk factor two hypertension history disease common independent risk factor decrease impact significant different impact age diabetic duration body mass index significant different two index age body mass index significant associate diabetic duration significant impact impact significant great vs population normal patient risk factor high prevalence decrease risk factor decrease diabetic patient age diabetic duration body mass index associate reduce patient normal
25856935 en study clinical profile new diagnose type mellitus patient study conduct new diagnose type mellitus patient on history clinical assess complication lipid female mean age patient year mean BMI female ratio female patient hypertension patient serum level patient total serum cholesterol patient cholesterol prevalence present study show new diagnose type diabetic normal BMI also within normal prevalence metabolic syndrome also low new diagnose patient
25243967 en compare metabolic risk factor related type mellitus T2DM development disease total T2DM DM group case T2DM group case study clinical datum analysis included level blood lipid function insulin well result oral glucose tolerance test test insulin level index body insulin index use estimate insulin insulin level index early insulin index cell function index glucose index use evaluate function cell use statistical analysis risk factor T2DM assess use logistic regression DM group group high body mass index BMI level lower age level high cholesterol group high blood glucose level vs vs vs vs group high insulin level vs vs group high level vs vs vs group high vs less lower vs vs vs logistic analysis show BMI level major risk factor T2DM or respective develop disease may early type T2DM patient severe glucose disorder
25163828 en aim examine prevalence factor associate elevated protein man woman new diagnose type mellitus DM measured patient new diagnose type DM included research type assess prevalence elevated relative risk examine association clinical factor regression use regression examine association value range total type DM patient elevated level woman man elevated among woman lower risk elevated observed patient receive adjust confidence interval CI whereas high risk patient obesity CI man primary elevated among patient activity CI previous cardiovascular disease CI elevated increased weight age year analysis show result analysis regression analysis association high increased fasting blood new diagnose type DM patient elevated level important risk factor elevated may include low activity man obesity use woman
19446110 en improve insulin resistance glycemic control may also effect patient type mellitus investigate whether influence independent cardiovascular event patient type mellitus on trial perform patient treat patient receive patient insulin patient follow-up period month evaluate use index base analysis obtain blood pressure group similar baseline great range group although therapy improve hemoglobin cholesterol decrease significant group improve patient type mellitus mechanism metabolic finding may important clinical use patient type mellitus
22205924 en impact mellitus DM aim evaluate association mellitus study assess effect mellitus mortality outcome complication risk estimate use effect effect database total study among study reported risk incidence study reported risk mortality study provide total result mortality patient study risk study reported risk patient indicate mellitus DM significant associate increased risk incidence risk confidence interval CI mortality compare patient DM increased CI risk increased risk compare without DM DM patient compare finding current suggest DM may associate elevated risk incidence mortality patient poor relative
22077156 en insulin reduce insulin on complication increase risk observed type type diabetic patient review cause risk type type mechanism type associate reduce type present type protein decrease increase risk also associate increased level contribute medical significant patient diabetic condition increase disease complication research identify provide increase treatment improve patient health
23134940 en according health type mellitus type recent age group identify age group need mass early use risk score medical identify risk develop type use score use include age history status assess blood glucose high score follow test diagnosis assess observed high low risk group respective develop type mean obesity high risk compare low risk history present mean score also two one found need early disease obesity activity
20731732 en aim study investigate care index diabetic determine correlation metabolic control insulin treatment duration study group year age type diabetic hospital healthy subject control group assess use level participant provide oral datum type duration insulin medical datum although type mellitus can potential high risk significant difference observed regard care diabetic healthy control level among diabetic however high significant lower
20523303 en high prevalence type mellitus DM risk condition may similar effect function type healthy subject healthy subject subject type subject function assess one subject studied healthy control healthy control subject DM subject DM group undergo study may type group impair compare group vs respective test group multiple regression model adjust found baseline type status negative status function impair function similar type however function treatment patient type therefore may potential improve outcome
24981292 en mellitus DM independent risk factor DM population major cause role remain new method aim study evaluate impact DM patient disease patient significant evaluate study difference consider high analysis perform determine impact DM characteristic patient DM patient DM similar compare patient without DM analysis patient DM high value analysis logistic regression analysis DM independent high or CI or CI patient DM independent whether assessment characteristic independent factor need investigate
23726071 en weight associate glycemic parameter patient also reduce presence include hypertension reduce risk cardiovascular disease change weight body weight month rate per week target decrease risk factor change associate weight however patient therefore intervention may also high effective weight reduction risk patient type use medication include recent show effective therapy management obesity patient type
26491214 en association type mellitus T2DM hypertension studied population large finding investigate association population obesity status sample total T2DM healthy sample base method follow T2DM patient respective control obesity status found associate T2DM odd ratio or hypertension odd ratio or population analyzed risk significant increased risk hypertension population odd ratio or found hypertension group or however effect obesity status association T2DM risk hypertension associate obesity status association study obesity datum also associate T2DM risk population
25488377 en assess risk factor develop type mellitus database perform use subject two independent datum use assess included study odd ratio or association determined use model analysis perform study included included total subject overall or develop T2DM confidence interval CI significant study result analysis however evidence method or risk factor T2DM
20186491 en cardiovascular disease major complication mellitus improve treatment need dysfunction contribute clinical mellitus review evidence dysfunction mellitus study investigate mechanism study current management new treatment cardiovascular disease patient mellitus
25711186 en mellitus year indicate disease type case adult population rate woman man year result mortality per year cause year increased age year can due high low activity adult mellitus result study type mellitus present factor population prevalence increased prevalence one year age study important study role cause clinical care treatment woman cause diagnosis treatment medication
25794412 en development gestational mellitus however evidence association study estimate effect aim determine association use investigate association risk two among woman individual assess time use statistical model estimate association different observed increased odd per increase CI CI CI per increase CI CI CI first well model compare model or model however or first association observed model or CI study suggest associate increased risk association gestational mellitus health
19220548 en aim study determine whether mellitus increase risk patient undergo retrospective patient undergo hospital patient diagnose blood glucose level insulin patient increased vs vs hospital compare without period patient diagnosis compare patient without patient develop patient hospital high mortality rate
22883333 en relationship glucose level diabetic complication type total type hospital included study related clinical datum within one week patient two group group group according index patient poor parameter two group duration year vs year blood pressure vs fasting plasma glucose vs hemoglobin hba1c vs protein vs ratio diabetic complication vs vs score score vs score patient treat insulin vs parameter significant high group group value multiple correlation analysis show factor hba1c duration diabetic complication insulin respective value logistic regression analysis found found correlate hba1c increasing hba1c diabetic complication significant value independent risk factor diabetic complication duration or hba1c or or or type mellitus poor blood glucose correlate complication addition poor result poor
21194579 en mellitus type increase obesity metabolic disease contribute increasing incidence prevalence cardiovascular disease metabolic cardiovascular risk factor patient type factor may one treatment treatment treatment increase risk cardiovascular mortality clinical type cardiovascular disease range cardiovascular study dysfunction dysfunction common cardiovascular disease dysfunction metabolic chronic obesity associate chronic type cardiovascular disease new research type also cardiovascular mortality associate type number trial well study demonstrated positive effect range cardiovascular disease clinical target include protein reduction elevated level also observed function large trial duration finding large trial associate significant reduction blood pressure weight
21166849 en common mellitus disease however patient without disease patient evaluate chronic patient man woman early investigate diabetic examine age year year duration year year patient type type diabetic complication investigate clinical pressure patient diagnose chronic syndrome lower treat patient also one patient treat patient follow year rate outcome treat lower increased one patient patient reported syndrome consider diagnosis patient lower result increased treatment
21139492 en aim study compare level patient type mellitus DM healthy control group level metabolic control complication patient also patient type DM body mass healthy control group included study duration DM complication DM review level normal range measured level significant high patient compare control group prevalence high level patient level positive correlate age duration number complication effect duration diabetic multiple regression analysis use regression multiple regression analysis study determine new value level patient value value patient may indicate need blood glucose complication define new value patient
22108150 en population difference impact cholesterol previous studied patient type mellitus examine relationship cholesterol patient profile patient studied cholesterol serum provide concentration show statistical significant correlation cholesterol significant positive relationship found total concentration contribute large correlation concentration remain significant associate cholesterol assess use regression model included concentration well important statistical significant association observed number cholesterol hemoglobin show significant correlation cholesterol patient control type mellitus cholesterol plasma correlate significant positive concentration total
21550079 en recent association study identify several type mellitus T2DM however study investigate whether risk development T2DM conduct study sample population health obtain clinical database risk score association analysis among subject T2DM baseline case T2DM new diagnose follow-up period mean risk score subject significant high subject remain vs although mean body mass index vs glucose vs also significant high subject develop T2DM risk score remain independent development T2DM parameter possible factor odd ratio development T2DM confidence interval type identify association study significant associate development T2DM general population sample
22750912 en study conduct evaluate impact patient disease treat intervention diabetic patient disease remain total patient disease receive undergo retrospective analyzed compare effect two treatment clinical outcome target according patient diabetic risk ratio confidence interval CI CI similar group however rate target significant high group CI incidence CI CI similar group however diabetic population incidence CI significant high compare group significant high rate group CI rate high compare diabetic impact mellitus treatment effect patient undergo patient risk high cohort whereas diabetic cohort
25391019 en study assess whether can influence tolerance patient type datum obtain patient assess base test study duration week subject effect assess week adjust effect compare result patient negative positive baseline show statistical difference two group week respective subject subject significant less subject analysis female body mass index age independent parameter associate demonstrated effect without female body mass index age independent effect
21883442 en type treatment population current provide insulin complication include increased mortality cell number current therapy review development treatment cell cell well potential use cell type therapy body research cell cell evidence cell demonstrated increase insulin new however recent cell can research present research cell treatment type
20047645 en characteristic major well general change disease association study may high association also independent study provide analysis identify mellitus analysis indicate associate mellitus difference observed suggest may disease association new diabetic identify well difference potential effect within diabetic
19180134 en cause range syndrome major health although effect well complication less well known review evidence mellitus significant increased incidence due insulin may several year however less severe without result increased risk type
21718089 en important diagnosis metabolic syndrome development disease mellitus DM estimate risk development DM age study subject undergo health conduct man aged year diagnosis base cholesterol prevalence DM occur association increased age subject subject prevalence DM among subject one two also increased age significant increase odd ratio subject significant increase odd ratio subject show high prevalence DM prevalence increased age subject
24437264 en recent study demonstrated relationship dysfunction development obesity type increase risk disorder condition chronic cause obesity type impair patient type diabetic therefore important new target obesity type
21668339 en patient type remain individual without large great risk cardiovascular disease also associate increased incidence type suggest may also contribute high rate mortality one risk factor disease glycemic control associate improve outcome patient include reduction risk cause early disease recent trial patient disease mortality glycemic control although may period therapy include intervention control hypertension lipid mortality however analysis control cardiovascular risk trial indicate may patient glycemic target therapy treatment group may increase mortality risk remain determined whether relationship whether common risk factor current healthy base weight management control complication reduce risk patient
25799433 en compare increase prevalence gestational mellitus base health risk factor period also examine change prevalence use association study group woman within week undergo glucose test gestational week woman plasma glucose undergo oral glucose tolerance test woman positive adjust prevalence cohort woman include estimate woman positive logistic regression use obtain odd ratio confidence interval use prevalence risk factor compare adjust prevalence increase use increased adjust prevalence age high body mass index high blood pressure history weight risk factor compare prevalence obesity increased age year prevalence old age increasing prevalence increased change
21194302 en associate complication patient patient time glycemic control potential cause medical little complication identify three patient due management patient disease relative provide common use diabetic medication population individual patient need provide patient outcome patient care
22420648 en determine association type mellitus disease oral assess sample subject without type measured concentration evaluate relationship clinical parameter disease analysis demonstrated disease independent positive correlate increased concentration relative association disease level great association diabetic status concentration primary associate disease presence study examine response oral assess disease mellitus independent associate oral effect disease
24476982 en aim study determine effect body mass index outcome woman gestational on retrospective study perform examine woman gestational receive intervention blood glucose without insulin therapy woman gestational three group according body mass index body mass index control group body mass index group body mass index group datum total woman participant included control woman woman gestational gestational weight high control low group prevalence chronic hypertension hypertension high group control group multiple logistic regression analysis revealed body mass index gestational weight chronic hypertension associate hypertension result hypertension prevalence age lower woman control woman present result suggest medical intervention woman gestational may contribute reduce prevalence age reduction complication
23030325 en prevalence mellitus DM increase remain number patient DM major control patient DM patient increased risk poor treatment outcome include treatment early disease medication disease DM management patient DM
22975549 en on woman week due diabetic patient normal hba1c severe negative cell low insulin associate type negative patient common type first patient type mellitus
22593714 en aim study identify effect intervention mellitus type patient mean analysis datum previous clinical trial compare effect include health care duration individual use datum patient intervention result statistical significant patient blood pressure control general regression model baseline outcome regression mean statistical significant regression model result important clinical need outcome intervention patient general health
22248301 en patient type mellitus T2DM high risk cardiovascular disease however evidence glycemic control lead improve cardiovascular outcome improve glycemic control adult T2DM evaluate trial therapy therapy improve glycemic control significant decrease hemoglobin fasting plasma glucose glucose compare control general well analysis clinical effect body weight blood pressure lipid level risk compare control on retrospective trial found evidence increase risk patient T2DM ratio CI major adverse cardiovascular event retrospective may reduce risk major adverse event on outcome trial assessment outcome patient current determine whether reduce risk T2DM
22031524 en aim study evaluate woman type mellitus woman T2DM healthy control three age group group diabetic healthy control group diabetic healthy control group diabetic healthy control participant subject day period total significant difference mean level per observed woman healthy control age group group vs group vs group vs similar mean significant lower patient T2DM healthy control age group group vs group vs group vs on statistical significant difference total observed group T2DM patient vs healthy control found negative correlate age hemoglobin fasting blood glucose study first evaluate T2DM patient lower woman compare healthy control
17474808 en conduct retrospective study assess incidence mellitus present diabetic patient disorder patient treat patient review use database clinical datum outcome incidence diabetic syndrome per patient year patient mellitus also determined incidence diabetic associate use mean hemoglobin hba1c level period patient diagnose mellitus compare general hospital population review patient identify diabetic present diabetic diabetic known mellitus syndrome syndrome known mellitus incidence present diabetic patient high reported general population per patient year patient per patient year general population per patient year general hospital population incidence diabetic drug period follow incidence patient present diabetic mean hba1c level incidence mellitus present diabetic patient high general hospital population elevated level observed suggest patient mellitus little several week diabetic
23836309 en incidence type mellitus increasing increase among year examine association early development study hospital relative individual total increased risk follow assessment develop month age month age first compare first month age diagnose early first development ratio CI CI respective adjust relative type early CI CI respective time CI also CI result suggest age increased risk month age new may reduce risk
22707890 en aim study evaluate impact mellitus DM mortality patient undergo intervention patient patient history DM group high mean age prevalence history hypertension disease high diagnosis group lower DM group also significant high incidence mortality hospital vs vs on analysis revealed independent mortality use diagnosis DM however regression analysis show DM independent mortality ratio confidence interval high association mortality mortality patient undergo therefore patient DM undergo may treatment
26847556 en associate incidence type mellitus T2DM cardiovascular disease relationship risk factor patient T2DM remain aim study identify investigate relationship potential risk factor patient study participant T2DM history analyzed use relationship identify factor analysis potential risk factor investigate logistic regression identify factor analysis three associate risk factor high associate lower use medication healthy high associate high body mass index level associate lower level blood pressure finding correlate risk factor T2DM patient
21781529 en characteristic risk factor type mellitus T2DM total subject diagnose oral glucose tolerance test base association type mellitus clinical test insulin include insulin on total T2DM difference found prevalence T2DM female respective new diagnose rate female age year old first year year female year old year year female year old year year female compare normal glucose tolerance subject new diagnose T2DM impair glucose subject high prevalence hypertension less activity statistical difference show body weight year diagnosis one year diagnosis diagnosis new diagnose T2DM compare result obtain ratio new diagnose T2DM compare difference found characteristic T2DM high prevalence obesity hypertension less activity associate T2DM
17157411 en previous report demonstrated association disease include aim association mellitus study perform database large health case patient define subject diagnose patient identify use cardiovascular respective control group included without among case control group compare test use compare parameter logistic regression model use study included patient case patient subject without control patient significant high patient compare control group odd ratio or confidence interval CI significant high patient compare control group or CI patient logistic regression model demonstrated association multiple use use medication on similar model demonstrated association use study base database diagnosis base datum therefore case case patient may on may occur due associate high individual medical care on effect diagnosis disease study previous report association study need
19321342 en mellitus one common disease number patient increase cause high pressure major complication diabetic aim study investigate effect two patient patient mellitus included present included use disease pressure measured two condition statistical analysis conduct use difference pressure found condition increased pressure show significant decrease increased revealed pressure significant lower pressure compare demonstrated use significant pressure clinical can study
20195772 en medication current drug treatment type mellitus indicate improve glycemic control use hba1c primary therapy reduction blood glucose hba1c show reduce risk chronic complication evidence clinical therapy reduce hba1c medication may increase cardiovascular risk patient population cardiovascular disease therefore role cardiovascular assessment medication develop treatment type datum evidence new treatment type result increase cardiovascular risk review event well general new cardiovascular new develop medication treatment type lead patient use therapy medication within treatment type
19145324 en effect mellitus decrease concentration glucose increased insulin study change positive effect function effect decrease number change reduction
24039941 en estimate gestational mellitus estimate function age body mass index BMI use risk population age BMI woman according health datum estimate prevalence increased CI CI woman respective woman prevalence increased CI woman estimate prevalence increased CI prevalence high prevalence
23536513 en gestational mellitus define diagnose common obesity type new increase prevalence condition diagnosis management gestational review provide regard diagnosis gestational number gestational blood glucose concentration treatment oral medication insulin management glucose period determine review provide current well current gestational care
21359582 en analysis mellitus trial report outcome patient type follow group treatment group insulin follow glucose control group treatment treatment according year use total cohort database study present mortality rate group mortality rate treatment period follow-up datum patient mortality rate cardiovascular without significant difference treatment group total number high risk group disease compare group CI CI compare group insulin treatment associate cardiovascular event or CI mortality or CI associate lower mortality rate CI lower risk CI type poor drug insulin may associate increased risk event risk
24838051 en present study perform evaluate outcome woman type type mellitus DM retrospective study conduct general hospital evaluate woman type type DM respective compare outcome two group hemoglobin level first significant studied group gestational weight lower type DM type DM although significant difference outcome group primary rate high type DM type DM multiple logistic regression analysis revealed status body mass index BMI gestational weight chronic hypertension disease include diabetic associate hypertension BMI associate need primary study demonstrated difference observed rate mortality woman type DM type DM however woman type DM high risk primary
21937504 en gestational associate adverse outcome identify woman risk type mellitus T2DM may improve glucose tolerance identify prevalence associate factor examine effect glucose compare oral glucose tolerance test result woman control normal gestational glucose tolerance datum time method result normal fasting plasma glucose impair fasting glucose impair glucose tolerance glucose T2DM glucose logistic regression use identify factor woman test compare index odd ratio or confidence interval CI history T2DM or CI gestational insulin use or CI associate prevalence significant lower woman vs vs gestational insulin use history T2DM elevated body mass index associate may metabolic effect
23656997 en role insulin year on one may one population different factor disease effect known association risk factor insulin resistance type mellitus metabolic syndrome although investigate possible related development metabolic disorder possible association studied different population result high associate one insulin resistance type mellitus metabolic syndrome lead review related insulin resistance syndrome type mellitus metabolic syndrome although present possible factor result obtain
23651509 en activity evaluate relative activity group identify lead group reduce blood glucose level diabetic model on clinical use type mellitus
22509797 en evaluate mellitus DM insulin therapy analysis total receive period day group control group time group on diabetic group group insulin group group control group group analysis group DM body weight two day DM group receive insulin day month group receive two month DM group level glucose within analysis datum analyzed significant level within normal range group on high group mean show significant difference group group related significant difference group mean show group statistical lower group mellitus impair result present lower group group low value insulin therapy found diabetic
22974360 en treatment patient characteristic within associate provide several report mellitus one negative factor low rate related little known patient overall whether known general population whether related primary disease treatment due review factor may lead development early factor may incidence positive impact rate cardiovascular risk factor occur
23322233 en activity previous study demonstrated high level associate reduce prevalence disease however relationship current patient type concentration may associate relationship baseline plasma total level event type diabetic patient intervention event study analysis treatment clinical datum analysis concentration significant associate great risk level individual lower concentration high risk first per decrease concentration CI association baseline include age status level hba1c trial treatment vs well previous cardiovascular disease diabetic diabetic per decrease concentration CI result identify significant relationship level total major datum may type
19718502 en aim present study determine whether diagnosis mellitus DM primary associate increased risk on retrospective cohort use base database patient diagnose mellitus age diagnose compare control group without history group follow first diagnosis diagnose mellitus develop disorder compare group statistical factor mellitus associate increased risk develop CI CI statistical age significant related diagnosis patient mellitus develop without history result large study base general population indicate association previous found research use several
19440027 en recent influence common patient mellitus DM risk develop aim study determine prevalence patient DM identify risk patient DM evaluate history total patient included female age year patient assess history datum compare datum overall prevalence diabetic group vs test prevalence significant high patient disease test can increased prevalence patient disease hypertension diabetic risk factor develop respective test medication lower prevalence test influence significant respective patient DM high risk compare patient without demonstrated significant high prevalence patient disease finding
23116739 en population prevalence however datum base study conduct year population aim determine prevalence mellitus metabolic syndrome population participant aged year type assess according metabolic syndrome base prevalence confidence interval CI type CI impair fasting CI impair glucose tolerance type present CI prevalence metabolic syndrome high cholesterol overall CI prevalence increased high prevalence cardiovascular disease
22293170 en investigate without type mellitus aged compare status studied patient year may sample patient without measured serum total activity adjust serum ratio level patient without significant patient without level significant lower may patient show significant negative correlate group patient correlation adjust age body mass index patient high serum lower according lower serum glucose negative correlate disease correlate patient without disorder status mechanism
18667997 en mellitus type dysfunction important role complication investigate whether level increased diabetic compare baseline plasma level diabetic patient cardiovascular perform regression analysis adjust possible total patient patient without mellitus type level significant high diabetic patient range patient range mellitus type age year current status presence use associate level mellitus type age current remain independent associate level analysis regression mellitus type regression adjust age current use mellitus type associate increased level independent clinical association may contribute diabetic
22195378 en reported low serum level risk factor serum level lower normal glucose tolerance test perform new health normal control base case result control group level serum level control statistical significant different prevalence low level serum less control study use large number adjust factor need role low serum level risk factor
27585435 en chronic age contribute diabetic complication blood glucose level age reduce target early type effect determined respective activity determined use age total activity reduce determined correlation among show great effect whereas show great effect correlate whereas correlation observed age great effect blood value negative correlate activity finding study potential type mellitus
23586846 en current study compare two different insulin insulin insulin insulin insulin insulin use primary change time included incidence glycemic trial type type clinical individual patient datum included trial randomize little two treatment duration week estimate use model assess analysis effect baseline parameter analyzed mean difference confidence interval CI high high age increased rate associate improve outcome fasting plasma glucose significant different glucose significant lower treatment compare analysis present significant level overall rate significant lower insulin provide statistical significant overall glycemic control lower rate compare
25587547 en study factor role glucose lipid aim study evaluate relationship serum level metabolic parameter patient type mellitus study included T2DM patient healthy control fasting blood sample obtain patient control group serum level measured current characteristic identify value type serum level significant high T2DM patient healthy control show positive correlation model assessment insulin resistance level blood cell logistic regression analysis age body mass index BMI protein independent associate T2DM analysis serum level high patient T2DM value finding suggest may contribute glucose lipid
25258716 en assess influence obesity patient type patient history disorder study clinical assessment evaluate related age obesity related age influence large female increased difference mean time perform test influence control condition patient type mellitus history disorder may female obesity may decrease control female
25835233 en aim study evaluate effect level patient type mellitus T2DM on total adult patient man woman mean age year control T2DM study subject month follow-up mean concentration serum significant increased man woman level decrease significant man woman addition significant increase serum level man woman respective follow-up woman significant correlation observed change baseline serum fasting glucose man significant correlation serum improve serum concentration can several parameter glucose lipid
23669362 en insulin gene lead dysfunction mellitus due model syndrome due protein clinical whereas case identify study suggest insulin function also impair
25039582 en compare development gestational mellitus treatment treatment control trial compare insulin treatment age month include weight assessment insulin treatment development age significant CI age month vs CI vs CI age month mean index significant development evaluate age month month month insulin body define regard early development
24459851 en datum effect different present result obtain use two model mellitus type similar development mellitus type show different lead effect blood plasma role system clinical
24046985 en aim study investigate difference level patient type mellitus DM without healthy subject correlation level clinical parameter also type DM diagnose present control group healthy aged year level statistical significant elevated subject type DM compare control group difference level subject type DM compare diabetic without level subject type DM correlate clinical parameter statistical elevated level subject type DM without major role development diabetic may assessment risk treatment diabetic complication
23733915 en lipid level lipid increased type mellitus may cause function investigate relationship among lipid level function effect high low level patient type mellitus patient undergo high low randomize study function assess correlate positive level concentration study low high increased low high high low whereas high high low high study finding indicate patient type mellitus change clinical trial
23254593 en increase decrease blood pressure response associate increased risk develop hypertension however response contribute change well aim determine control compare patient type mellitus T2DM response participant control T2DM undergo determine rate resistance mean change define value pressure high patient T2DM change whereas significant decrease control change correlate change control respective patient T2DM respective significant correlate change T2DM patient observed control response patient T2DM result may contribute increased cardiovascular risk associate T2DM
22256691 en regard mellitus type mellitus on sample hospital management use negative primary positive management management effective
23653275 en woman type mellitus high prevalence disorder aim study evaluate profile disorder evaluate compare healthy syndrome subject measured first significant healthy control year significant mean hba1c diagnosis profile score significant two group hba1c study mean hba1c month correlate negative level significant lower due role high lower level
23517794 en high level lipid associate type mellitus T2DM complication use insulin oral study effect serum blood pressure renal system addition effect glycemic T2DM case included study parameter estimate three month therapy significant glycemic control serum level value respective significant effect serum lipid blood pressure T2DM case three month treatment change serum level duration treatment T2DM case level lipid associate improve serum status glycemic control
23220949 en patient type mellitus T2DM level blood glucose analyzed glucose day mean blood glucose level significant without however condition therapy significant decrease mean blood glucose level period vs mean glycemic vs addition tolerance test conduct change insulin total value subject female year BMI tolerance test value respective increasing total value respective significant decrease result indicate effective blood glucose insulin effect may also body weight
26816609 en association study group gestational associate increased prevalence however remain intervention woman gestational mellitus result outcome retrospective cohort study on total woman subject subject included study intervention woman gestational mellitus two outcome increased prevalence gestational mellitus diagnosis compare diagnosis week early vs week associate reduce risk primary adjust odd ratio confidence interval one adverse outcome adjust odd ratio confidence interval include care associate improve outcome increased prevalence gestational mellitus diagnosis
26946845 en effect effective insulin resistance type model group model group group group control medication week effect glucose lipid insulin resistance investigate change use level group improve fasting blood glucose serum level glucose tolerance T2DM increased index decrease change group level group group lower model group improve increase insulin T2DM effect may little
26721008 en disease important complication cause patient type mellitus T2DM important risk factor first drug treatment DM study different different compare population study compare mean reduction serum level use among T2DM patient study finding low effective low cholesterol total patient T2DM fasting level two group patient group baseline fasting serum level obtain patient group on receive group receive week fasting level obtain compare reduction level level group on group respective follow level reduction level baseline level group on group effective reduce level type diabetic patient
26255137 en one system study evaluate patient mellitus type healthy control blood cell patient control sample assess use patient body mass index BMI blood glucose level measured result show increase patient control correlation observed BMI result increase independent blood glucose concentration BMI
26101175 en aim study investigate oral glucose multiple patient type mellitus study patient T2DM receive day day total patient man woman age year plasma concentration within plasma level increased mean value respective mean change baseline glucose day respective compare day respective compare mean change baseline fasting plasma glucose day respective compare day respective compare day mean change weight respective overall profile similar report multiple suggest patient T2DM profile similar treatment associate increase reduction compare
25924888 en research assess effect type mellitus T2DM diabetic diabetic role T2DM evaluate diabetic role chronic disease assess use control diabetic studied age week DM present age week significant high blood glucose concentration compare control significant increase total renal observed however major increase total due increased great change total renal respective observed group similar diabetic remain treatment change although group difference observed compare control increased diabetic treatment effect influence T2DM
25805666 en type management type mellitus glucose effect contribute reduce also weight blood pressure reduction several similar characteristic oral low renal drug parameter case chronic disease case may use lower patient response assess glucose increasing renal assess reduction estimate rate patient patient normal function patient may occur patient severe use regard case renal dysfunction clinical impact renal function potential influence diabetic result model
24800930 en chronic risk factor type mellitus T2DM influence chronic disease risk develop T2DM remain study investigate risk develop T2DM among patient use retrospective cohort study identify patient control health database follow cohort cohort compare incidence patient risk analyzed use regression model incidence T2DM high group patient group vs per patient high risk adjust ratio confidence interval CI baseline high patient high incidence rate ratio T2DM compare also observed increased risk T2DM patient CI compare first study report association increased risk develop T2DM among high patient
23404189 en patient mellitus DM high risk several cardiovascular disorder disease disease DM association disease increased cardiovascular mortality DM patient contribute risk subject several mechanism DM patient large DM patient show response treatment high rate adverse cardiovascular event treatment therefore new treatment DM patient reduce risk present provide current status function profile patient DM
23360660 en mellitus disease DM health DM type disease use treat condition study evaluate whether can improve DM randomize clinical trial DM conduct database included trial assess use datum analysis perform provide included analysis study trial conduct trial low study common study on conduct due poor current regard treatment DM poor trial regard treatment DM study clinical evidence need high conduct
23095432 en cardiovascular risk reduction patient relationship glycemic control outcome glucose control fasting blood glucose on number treat type mellitus evidence cardiovascular recent treatment provide glycemic control medication show study increase cardiovascular risk therefore increase range treat patient type mellitus without increasing cardiovascular risk
22621778 en on new chronic disease disease outcome major according level addition level previous two examine prevalence diabetic patient type mellitus base new study perform patient type diabetic significant common subject diabetic disease disease significant high group group one also significant great group compare evaluate risk diabetic complication
24008699 en research conduct mellitus study aim datum may observed diagnosis need change time change treatment care disease normal one different
26078843 en aim study evaluate association several factor include characteristic type medication possible factor age serum mellitus DM hypertension
25749468 en aim review gestational mellitus role development database study included study blood sample diagnosis model use mean difference compare level case potential included study study study indicate level first early lower CI whereas level high CI among woman develop woman datum finding protein identify study several include protein study assessment level first lower among woman develop woman whereas level high study assessment need association risk
26803651 en gestational mellitus define glucose tolerance first woman history risk develop type T2DM T2DM common gene study association analysis identify number associate include also associate T2DM gene also identify associate metabolic also associate metabolic general population two associate metabolic study suggest difference T2DM metabolic population
20003545 en body mass index BMI use estimate body increased BMI associate increase metabolic disease type mellitus T2DM body body impact development treatment T2DM study examine body level BMI among study improve early management risk factor weight BMI body correlation body BMI man woman analysis compare mean BMI difference without T2DM significant man without mellitus mean BMI per body body woman T2DM significant high BMI body compare woman without mellitus woman T2DM may body compare without mellitus difference increase risk T2DM diagnosis T2DM body
21680989 en within year association association study association clinical diagnosis treatment type mellitus T2DM hemoglobin hba1c base new relationship complication fasting plasma glucose level oral glucose tolerance test finding major trial glucose control patient T2DM medication treatment treatment patient diagnosis T2DM treatment respective therapy treatment insulin patient target glucose level base patient hba1c level include range therapy addition treatment include therapy patient need review recent change use current may individual patient characteristic
21371203 en present study evaluate relationship disease clinical woman gestational mellitus type mellitus perform one woman index index index clinical level index medical age body mass index fasting plasma glucose hemoglobin hba1c significant high among high similar adjust model medical evaluate effect group parameter presence disease significant high diabetic compare woman disease similar group age BMI hba1c factor related development two type mellitus
24655325 en associate gene associate type mellitus however result individual study association gene case individual study conduct odd ratio or confidence interval evaluate model on significant relationship observed gene or CI or CI or CI or CI or CI model significant association gene model or CI population among significant association found population gene significant associate increased risk
27352181 en recent year increase complication type mellitus T2DM disease aim determine risk factor T2DM patient relationship serum complication perform retrospective analysis T2DM patient hospital T2DM patient two group base whether patient also group on without case group case general patient analyzed statistical compare blood glucose fasting insulin perform logistic regression analysis determined risk factor T2DM patient significant high BMI blood pressure observed T2DM patient patient without statistical different also significant high level T2DM patient patient without statistical different significant high level observed T2DM patient without statistical significant logistic regression analysis also show high BMI independent risk factor T2DM patient level positive correlate BMI statistical significant risk factor T2DM patient BMI finding provide clinical early diagnosis T2DM patient
26179285 en study aim assess among sample patient type mellitus primary health care assess participant clinical characteristic multiple regression model use assess difference index use score vs vs vs examine compare confidence interval difference index score multiple logistic regression model use assess response demonstrated index score also demonstrated score can determined index score score significant difference found response patient report compare study provide evidence different
25637172 en use treat type mellitus T2DM population analysis perform impact clinical factor patient plasma concentration activity obtain study two two use studied value include level well factor effect parameter relationship investigate use analysis included plasma concentration patient analysis included plasma activity plasma concentration patient drug model target difference impact effect concentration analysis show investigate factor activity clinical factor include age weight
20005535 en impair insulin one important type mellitus first first study aim evaluate new diagnose type mellitus patient type mellitus patient test glucose sample glucose tolerance test method two glucose different rate follow result change plasma insulin glucose level regard use old high body mass index model assessment function lower fasting plasma glucose hemoglobin hba1c significant correlation first correlation different parameter hba1c also evaluate correlate significant hba1c respective type mellitus subject high old high body mass index time important factor determine glucose level type mellitus patient first correlate indicate also use method can without
23646921 en study assess effect cell function diabetic dysfunction group group undergo high level use potential week function pressure analysis increased group significant function positive effect treatment dysfunction
19186366 en health one major health health health also health result important health day day also response provide mellitus management include complication role provide care
23584643 en normal may study patient mellitus clinical compare result total diabetic patient included case control compare result study report patient diabetic mellitus compare high patient positive respective compare control positive respective diabetic show high negative compare group among diabetic patient positive diabetic compare without on high positive case diabetic patient different diabetic increased diabetic cause presence diabetic increased correlate diabetic
26909480 en investigate glucose oral glucose tolerance test large gestational mellitus study group woman patient metabolic disorder week follow outcome included patient age BMI BMI glucose value gestational week woman without statistical significant difference control group respective week fasting glucose level independent respective characteristic compare fasting plasma glucose plasma glucose level may
22813564 en cardiovascular disease risk factor diabetic complication subject included study group group included type DM group age control group type DM group age control group study activity high significant decrease activity type DM type DM activity significant activity show negative significant correlate type DM correlate type DM level significant increased level decrease type type associate development complication may due role also show negative correlation studied
24757888 en on study perform type patient general prevalence complication datum determine statistical significant difference prevalence complication prevalence type diabetic group disease chronic disease disease disease disease prevalence group disease chronic disease disease disease prevalence assess statistical patient disease disease disease statistical significant high prevalence type
22775412 en patient mellitus high risk possible reduce present study investigate effect diabetic renal sample diabetic total plasma concentration diabetic renal included analysis determine population estimate addition studied use obtain diabetic diabetic patient plasma concentration significant high period population model model respective drug oral population estimate rate population estimate oral oral oral respective population estimate total oral respective model indicate related related important diabetic patient time lower patient indicate significant lower patient population model status significant value concentration remain significant different diabetic sample whereas concentration significant high sample diabetic study use revealed major study provide evidence significant reduce lead increased concentration finding clinical diabetic multiple medication
24599712 en important health care health one study aim diabetic patient disease two medical conduct patient use new method datum identify base health two high level health care result research use management care type mellitus
21274328 en mellitus DM develop within first week finding include report case due diabetic treatment insulin insulin treatment insulin interval three time day blood result decrease DM due associate may present weight
24088748 en dysfunction important role development diabetic aim study evaluate dysfunction use different patient type mellitus early diabetic investigate serum level include cell dysfunction measured use evaluate study group included patient type mellitus DM healthy control subject diabetic patient two group according finding group type diabetic patient diabetic group type diabetic patient finding early diabetic serum level vs vs patient without vs vs diabetic patient vs vs control group significant difference serum level three group value diabetic patient without diabetic patient control group significant difference found early diabetic consider dysfunction
24053462 en evaluate measured week gestational mellitus study included woman week measured gestational body mass index BMI estimate according result oral glucose tolerance test perform week subject two group odd ratio or confidence interval BMI estimate characteristic woman BMI or gestational BMI or week or correlate risk week week value range show
20734573 en assess prevalence treatment control mellitus DM primary health care associate cardiovascular risk factor effective treatment estimate clinical impact DM disease study perform primary care general base population on clinical datum previous diagnosis DM medication test lipid hba1c first two adult patient day blood pressure measured DM define fasting glucose use study included individual mean age year woman identify diabetic prevalence DM adjust age primary health care high man increased age among diabetic population treat drug hba1c lower high medication obesity metabolic syndrome present history association risk factor DM woman impact DM also high woman among diabetic treat drug diabetic patient medication control although diabetic population treat total cholesterol diabetic patient treat total cholesterol management DM primary care improve patient treat control DM clinical impact due association risk high diabetic woman due first association DM risk factor woman less treatment
26675391 en investigate whether oral glucose tolerance test can outcome gestational mellitus condition blood glucose total woman care first hospital included diagnose diagnosis gestational health datum analyzed woman high age gestational weight however statistical significant group less gestational weight prevalence increased lower lower risk high risk increasing significant prevalence group prevalence significant high compare normal group prevalence two group also significant different group statistical high prevalence or CI well gestational weight or CI BMI or CI difference prevalence BMI prevalence or CI or CI well BMI gestational weight significant impact outcome blood glucose control consider
17803054 en healthy glucose tolerance fasting assess model clinical change fasting may reported conduct retrospective analysis compare fasting serum datum include blood sample healthy age female change found fasting significant increased glucose significant decrease serum metabolic significant increased blood previous associate mellitus therefore healthy may first model mellitus include metabolic change associate large ratio high system glucose similar blood assess potential mellitus
26345943 en one chronic disease previous study several show factor gene associate type T2DM present study association gene T2DM population analysis examine gene respective healthy individual subject T2DM result show significant different patient control population however statistical difference patient T2DM cohort addition patient high healthy individual or finding suggest one important factor associate T2DM individual population risk develop T2DM
21299398 en mellitus remain one cause mortality according disease control individual diagnose type mellitus disease although may age effect disease lead significant complication decrease treatment mellitus chronic insulin review current status complication
21205545 en evaluate effect control hba1c study conduct diabetic health mean age year mellitus diabetic patient regard general disease insulin therapy activity management conduct include general diabetic follow hba1c level measured baseline month compare use sample total patient trial significant decrease hba1c level mean hba1c level respective studied group improve control patient treatment diabetic care
20946010 en type mellitus T2DM patient risk increasing hypertension cardiovascular risk factor associate treatment elevated cholesterol found effect well improve glycemic control adult T2DM base several study use addition therapy use glycemic control type diabetic studied T2DM on recent study examine therapy patient T2DM recent study treatment use therapy T2DM review recent clinical study regard therapy mechanism treatment
20855567 en may contribute found studied influence fasting lipid association plasma lipid study type mellitus T2DM high level sample obtain subject lower protein however significant great correlate negative multiple regression model insulin resistance result show subject lower lipid correlate negative finding show role lipid fasting
16580609 en normal elevated plasma concentration clinical disease patient gene studied identify gene lead cell similar protein also clinical value early diagnosis treatment associate
21429061 en type mellitus risk type may influence cohort first type age year measured weight study fasting blood glucose aged year history determined age aged year assessment rate obesity remain year aged year include aged year diagnosis prevalence type cohort first woman type high reported obesity important risk factor type population may result
27935263 en treatment new glycemic control patient value hba1c complication case therapy without effect case treatment consider due effect treatment individual age duration disease risk
20305943 en evaluate plasma concentration retrospective study conduct woman mellitus undergo present mellitus plasma level medical first compare result presence finding related plasma level mean concentration respective value value one high overall found first care period perform week concentration identify significant plasma concentration revealed high result value associate identify compare lower value value overall three value possible use plasma level high risk woman finding important management woman mellitus care
24174504 en type mellitus T2DM high number primary care T2DM addition treatment complication present review effect diagnosis treatment T2DM well management complication review database association although identify research show research
20735160 en one research use known study one clinical disease level protein mellitus type population use type patient normal healthy control hospital protein analyzed use first follow mass analysis level protein found type patient compare control determined decrease whereas level protein increased respective patient compare level identify protein reported assessment level early diagnosis also mellitus type
22011804 en may influence complication diabetic study investigate association prevalence cardiovascular event hypertension hypertension obesity mellitus patient follow hospital perform compare cardiovascular disease hypertension hypertension obesity blood pressure plasma level glucose cholesterol total high low serum association presence cardiovascular disease can identify found significant patient among hypertension also high blood pressure total cholesterol result suggest mellitus patient may high develop hypertension study diabetic population finding
20711718 en gene found associate low diabetic type investigate patient type whether associate mortality mortality associate renal disease study patient type individual define control without define year assess analysis system define need chronic study patient control follow-up year patient compare patient significant mortality patient vs time increased risk year follow-up associate mortality mortality patient type patient baseline
19855919 en little management patient type mellitus clinical treatment insulin study provide clinical profile patient treatment insulin primary care on total patient diagnose oral treatment receive insulin included study datum well datum complication medical history oral treatment clinical hba1c concentration insulin treatment mean age sample year man patient diagnosis little one significant hypertension patient profile metabolic syndrome patient high incidence complication complication insulin recent mean hba1c patient treat month common treatment two oral patient observed study present elevated mean hba1c body mass index level complication related time insulin change treatment diagnosis occur hba1c level factor can contribute development complication patient profile study
20641142 en disease syndrome great health system disease mellitus multiple type mellitus T2DM common prevalence among risk factor include obesity change patient also show dysfunction insulin resistance however poor health care system patient diagnose complication complication metabolic disorder cause significant mortality high treatment T2DM increasing prevalence risk factor health care system positive response need T2DM factor population datum T2DM review provide risk factor complication treatment care T2DM
26078978 en evidence role development diabetic aim current study whether association status diabetic type two group patient patient without respective assess subject diabetic complication concentration associate presence diabetic patient lower concentration compare patient complication study association presence diabetic type study
23046397 en trial determine insulin can use
19375594 en cardiovascular dysfunction associate high mortality type mellitus patient study therefore test associate insulin resistance cardiovascular dysfunction type mellitus patient without insulin treatment base finding type mellitus patient group group year mean group year cardiovascular function assess rate plasma concentration lower group group early value lower respective rate high group group fasting plasma glucose insulin concentration model assessment index value high group group multiple logistic regression analysis revealed index associate patient result associate cardiovascular function insulin resistance index independent association patient type mellitus
19249171 en on study change serum type mellitus patient treatment perform use metabolic analysis serum sample obtain type mellitus patient without drug treatment type mellitus patient treat month datum subject analysis analysis little analysis investigate effect serum profile type mellitus patient analysis revealed increased decrease glucose lipid serum treat patient compare one positive increased decrease well treat group use study change serum type mellitus patient treatment may mechanism
21161290 en identify whether presence patient mellitus risk factor dysfunction patient mellitus undergo analyzed datum blood value measured patient identify presence addition patient undergo test day day month rate dysfunction day month age hypertension presence duration diabetic insulin therapy independent dysfunction whereas hba1c diabetic insulin therapy presence independent found presence associate dysfunction patient mellitus
21403658 en patient mellitus increased risk cardiovascular disease important insulin resistance syndrome type related risk intervention high effective reduce level cholesterol primary trial show use lead high significant reduction incidence major event on datum outcome therapy clinical population patient type therapy patient type similar patient type however therapy high risk population therapy great reduction incidence event lipid management result risk reduction reduction level cholesterol target therapy increase level low patient type effective current use clinical trial cardiovascular therapy large trial include patient test
22435949 en determine prevalence diabetic diabetic patient old type mellitus addition determine relationship risk factor condition patient study patient randomize control trial on total patient type datum show correlation risk factor different risk factor age duration pressure fasting insulin insulin treatment cholesterol ratio history disease contribute significant duration insulin treatment ratio correlate risk factor related diabetic patient type mellitus aged year different datum also show risk factor associate
26820050 en renal cause type mellitus adult age protein cell response factor cell aim study determine whether level increase diabetic time indicate renal patient healthy study renal function normal patient level measured two year result evaluate ratio mean patient group significant high control level increased significant whereas level decrease level remain significant high use diabetic respective result suggest increase time may indicate early diabetic
26683358 en study reported statistical significant association mellitus DM risk however result evidence incidence studied association DM study cohort study DM significant associate decrease risk or CI analysis DM show decrease risk or CI analysis statistical significant effect DM observed study or CI effect observed cohort study or CI analysis significant association found among DM or CI significant association found female DM or CI current evidence suggest DM significant associate decrease risk
26567123 en treatment increasing risk aim determine incidence characteristic cohort study included patient type treatment incidence per year per patient patient high blood glucose odd ratio confidence interval insulin use odd ratio confidence interval associate reduce risk odd ratio confidence interval event among patient severe odd ratio confidence interval event patient odd ratio confidence interval patient well blood glucose treatment can reduce risk treatment
23611470 en aim present study investigate possible association metabolic syndrome patient type present study patient type case without control mean age year mean duration year mean assess define according weight datum mean range patient reported lower total high total control total case high mean patient lower range range range range total range range patient without association group logistic regression model high associate or CI adjust high increased odd presence patient type may major association consider decrease
22372150 en effect insulin serum mellitus DM DM three group DM group group group normal control group drug week level determined one level insulin serum measured observed use DM show significant increase compare control group can decrease level DM show significant decrease insulin serum compare control group effect level significant increased DM significant treatment show change DM treatment can significant improve effect DM related significant
21807961 en relationship among activity factor factor woman type mellitus use datum blood pressure lipid hemoglobin function health care reported week year woman great woman woman woman woman week year intervention woman T2DM time role several factor
20808667 en assess care patient examine association care health outcome health care retrospective cohort study use health database age first diagnose mellitus hypertension chronic disease follow year mean care index hypertension mellitus care increased disease risk decrease health care health care system patient great care health care lower risk hospital use lower health care need develop improve care patient chronic disease
18280440 en study evaluate compare glycemic control role type patient type mellitus group receive insulin follow oral respective evaluate glycemic control serum insulin week poor control patient elevated serum two group receive significant improve glycemic control lower serum insulin level well improve improve glycemic control reduce insulin resistance type mellitus patient insulin therapy lead reduction reduce insulin resistance therapy significant lower elevated serum level poor control type mellitus patient type mellitus patient insulin therapy oral can need insulin therapy poor control type mellitus patient therapy patient type mellitus
20337636 en activity well study compare patient hypertension type mellitus patient two group according type mellitus two group patient effect glucose lipid renal function compare glucose lipid model assessment insulin resistance level group group significant lower regard renal function diabetic group estimate rate significant high ratio significant lower patient hypertension mellitus effect glucose lipid renal function
26858959 en aim study prevalence drug use group type cohort healthy aged year studied drug control group sample age metabolic control regard hba1c poor hba1c prevalence drug use lower among control group use follow use associate poor glycemic control hba1c report use drug little healthy use associate poor metabolic control
26628192 en identify blood cell individual subject mellitus individual without use gene identify model blood related function evaluate identify subject control independent presence level multiple test show addition subject
26579834 en analysis evaluate glucose patient type mellitus T2DM perform patient base datum three individual study three individual study baseline hba1c body weight blood pressure evaluate overall study population assess base adverse event provide reduction hba1c body weight study patient general similar overall population patient T2DM profile patient overall population high rate study include analysis datum sample patient improve glycemic control reduce body weight general well patient T2DM
26571022 en type mellitus T2DM disease patient two drug addition change glycemic control current treatment T2DM patient glycemic control addition therapy although effective reduce hemoglobin drug associate adverse effect weight case new drug treatment T2DM effective improve glycemic control increasing renal glucose clinical trial well weight low risk reduction blood pressure review clinical evidence use therapy T2DM result suggest therapy new treatment range patient T2DM result cardiovascular outcome trial need
23797928 en study effect glycemic type mellitus control patient type glycemic control hemoglobin hba1c patient treat three time week glycemic control improve week increased three time glycemic assess blood glucose day value mean assess week treatment hba1c level significant decrease mean glucose glycemic also significant improve treatment reduction value respective significant positive correlation change hba1c change study significant change present study improve glucose hba1c level patient type demonstrated also effective improve glycemic effect need
20934793 en major mortality medication decrease increase investigate association outcome recent cohort age year function year identify database may group according status year group group group group group group analysis adjust characteristic outcome regression analysis time overall mortality follow-up year day day time outcome overall group associate significant study outcome group associate high overall risk however group associate high risk group associate high mortality risk whereas group associate high cardiovascular mortality outcome relative major cardiovascular mortality first year major function little year influence outcome need
20630007 en estimate relative patient characteristic diagnosis management clinical patient present subject primary care according level patient diagnosis patient clinical study consider relative patient factor patient diagnosis factor diagnosis due factor relative patient factor total reduce health care patient increased finding suggest contribute influence may result reduce health care associate
25922340 en obesity increasing provide clinical perform review current datum base research disease may however change associate presence chronic known insulin resistance type whether role glucose lipid intervention study include provide cohort healthy subject use sample baseline identify great potential target can
19158371 en however respective investigate whether finding risk assessment relationship common baseline cardiovascular patient study evaluate patient type mellitus receive randomize treatment follow-up patient analysis patient present without risk increased respective compare patient associate increase risk increase risk patient type mellitus risk associate risk assessment
23987037 en change status mellitus DM studied reduction well reduction activity cause change DM cause significant reduction activity system well
23708985 en patient type mellitus patient provide result among renal therapy although number need method patient result two datum
23632148 en type mellitus mortality improve incidence increased remain diagnosis suggest dysfunction possible early significant outcome patient undergo treatment examine suggest possible diagnosis
23050733 en increased contribute development measured known correlate serum protein may indicate overall level body present study investigate whether serum level associate man type mellitus level risk factor measured man type DM assess obtain model analysis indicate significant positive association serum increased according serum regression analysis show serum independent associate positive relationship identify adult subject type DM independent cardiovascular risk factor study need whether contribute increased subject type DM
22974412 en study evaluate effect hemoglobin concentration insulin adult patient type mellitus randomize clinical trial patient T2DM subject receive first month month patient receive control group intervention metabolic profile include insulin concentration decrease significant vs intervention respective significant difference change baseline group vs group respective on reduction level patient insulin period show great decrease concentration group adult patient T2DM
18631864 en mellitus common metabolic complication include factor may role development target treatment include oral well insulin recent several drug treatment type use oral therapy well insulin review negative impact patient outcome
22765958 en complication cause mortality type mellitus datum subject population analyzed prevalence complication possible risk factor cohort study include patient aged diagnose little month hospital hospital patient man mean age year duration year one complication patient complication patient complication high prevalence use vs vs hypertension vs metabolic syndrome vs old duration high value hemoglobin blood pressure logistic regression analysis duration or hemoglobin level or metabolic syndrome or show independent association patient duration year vs year patient without complication high prevalence metabolic syndrome vs patient without complication receive lipid treatment vs patient without complication multiple regression model duration or CI remain independent associate patient complication time study duration metabolic syndrome two related factor chronic complication
22748474 en gestational mellitus assess woman risk type rate identify factor woman undergo general cohort study woman hospital may base datum month case medical perform woman risk type patient undergo glucose woman rate hospital significant difference although factor patient type well glucose report report type study role period need primary
25368731 en mean potential risk factor complication diabetic study aim mean type diabetic patient treatment study participant diabetic control blood diabetic diabetic control blood perform use parameter per sample include mean mean fasting blood diabetic control mean diabetic control mean diabetic control statistical significant difference diabetic healthy control mean diabetic healthy control study revealed high mean diabetic treatment diabetic control mean lower case control however parameter diabetic treatment within normal range healthy individual
21777049 en factor use woman mellitus DM identify health research large method study included woman DM woman DM analysis method woman DM use general low use woman use method need poor outcome woman DM receive little care woman
25747344 en rate use therapy patient however remain use risk patient due retrospective study studied patient age year old undergo rate estimate method association baseline characteristic assess mellitus present patient respective rate major year whereas rate time day analysis status ratio confidence interval CI serum CI CI CI base CI CI independent status low level intervention poor independent patient use risk rate
24564589 en mellitus consider common potential health number prevalence health impact individual well protein found within protein show can glycemic control
26230556 en mellitus treatment factor medical control assessment assess result patient mellitus aged year woman analyzed analysis group index obtain review factor show statistical value measured total use assess treatment patient
26068309 en patient type mellitus DM disease diabetic patient show response remain complication among diabetic patient evidence primary aim assess whether high risk diabetic patient without previous event study included diabetic patient patient without event treatment medication blood sample analyzed analysis included mean age year mean similar diabetic patient control found diabetic patient control respective similar diabetic patient control respective also found similar diabetic patient control elevated fasting plasma glucose associate increased risk mellitus patient without event normal blood profile
25896293 en mellitus metabolic disease health system general consider type mellitus model measured glucose level control insulin system present new metabolic model use model reduction method model three different model reduction method system compare result base patient three group adult show new model model model well clinical use research
23865310 en study aim evaluate function patient mellitus DM use case group patient type DM normal according hemoglobin control level case group two group include control group function perform function three include two result show statistical difference clinical baseline characteristic among three group however statistical difference mass index group compare control significant difference found among three studied group also found significant difference compare group group control found statistical difference compare group statistical difference three group control can use evaluate function can also reduction function DM patient poor blood glucose control early
23808737 en type mellitus lead known among patient type important type significant increase risk method among new diagnose patient patient evaluate among patient type mellitus change treatment significant increase large well profile potential disease lead change increase level level lower level treatment lead significant cardiovascular risk however treatment cardiovascular risk remain high
23618167 en protein glucose increasing regard new target treatment obesity insulin resistance type mellitus T2DM relationship mellitus sample group normal female female gene gene studied method two first normal female compare female gene respective difference gene female gene difference normal gene observed also difference gene result obtain research profile potential relationship mellitus
23609464 en patient type mellitus T2DM high risk development cardiovascular event serum level reported associate disease T2DM assess whether serum level correlate presence mellitus level patient T2DM undergo assess index level significant high patient T2DM without logistic regression analysis revealed serum level independent associate presence serum level positive correlate index score adjust clinical level associate presence patient T2DM
23507799 en disease metabolic syndrome condition insulin resistance common mechanism therefore associate type mellitus obesity increasing prevalence increased within important body clinical evidence suggest associate mortality also increased risk develop cardiovascular disease type mellitus review evidence suggest disease factor determine development major type mellitus cardiovascular disease
22784975 en hypertension condition associate chronic complication patient therapy current treatment hypertension due reduce however effect therapy may different examine blood pressure reduction metabolic treatment patient type mellitus hypertension randomize clinical trial included patient type mellitus hypertension within year period patient treatment week primary mean change blood pressure mean change blood pressure treatment CI within consider patient assess treatment group patient mean age year group patient mean age year group receive little study medication included population population regard mean change blood pressure difference CI mean change blood pressure significant different CI study group population however datum population suggest patient group may metabolic outcome group estimate rate CI hemoglobin CI fasting CI CI CI significant difference adverse effect group disorder group group vs study result suggest regard blood pressure reduction effect renal function glucose control level compare however adverse event reported group
27334434 en current study determine effect level glucose type woman gestational mellitus randomize clinical trial perform among woman patient week level blood woman week intervention change serum level great woman group vs result demonstrated compare result significant increase level blood woman current study demonstrated week among woman increased level compare group
20171459 en type mellitus related adjust condition current study examine difference relationship type mellitus population sample datum obtain study on total old adult aged year included study multiple logistic regression analysis use examine relationship old man woman reported significant high woman aged year age difference relationship age condition man time related woman two three time related high function difference consider relationship old adult
17362164 en compare incidence mellitus undergo renal incidence chronic renal compare mortality rate undergo renal develop mellitus identify potential risk factor development mellitus case undergo renal develop incidence year risk incidence mellitus among population chronic renal undergo renal year risk undergo renal time develop mellitus control chronic renal mortality rate among time rate among undergo renal develop age body weight change body weight found significant associate development suggest undergo renal increased risk develop mellitus compare chronic renal mortality rate high develop
17349054 en mellitus condition occur develop first week month possible adult dysfunction condition may time metabolic insulin occur early period patient less develop patient patient diagnosis lower insulin occur two group base clinical early mellitus on number condition associate level among recent insulin one case analysis found provide identify period analysis also potential important patient insulin therapy common patient mellitus follow-up care age mellitus insulin therapy high treatment insulin may age group
23343738 en disorder insulin resistance mellitus DM on decrease number function lead decrease present patient DM diagnose syndrome syndrome receive therapy result improve plasma level glucose hba1c decrease addition decrease first patient therapy effective treatment patient
22761295 en study determine baseline protein on individual individual without type mellitus on total individual individual without use on participant use determine activity measured assess protein significant lower individual control without show significant reduce negative associate two group significant high individual observed plasma individual also demonstrated high index although individual individual without lower poor activity associate result suggest response
25433204 en compare mortality low weight woman without mellitus cohort study retrospective datum adjust odd ratio confidence interval outcome mortality function DM woman DM rate DM CI significant increase observed DM receive without DM diabetic high gestational age weight mean weight gestational age status score similar significant difference two group regard syndrome mortality total mortality need rate significant lower diabetic group whereas significant high DM logistic regression analysis condition independent associate DM adjust or CI DM risk mortality early
26428701 en assess health care patient type retrospective cohort study primary care patient year first patient characteristic level clinical assess use outcome patient therapy hemoglobin hba1c body mass index BMI month according age year BMI hba1c overall patient patient hba1c BMI patient therapy month reduction hba1c therapy target reduction hba1c body weight patient therapy low however datum assess BMI medication treatment assess research general
26377953 en aim study assess major disease include type multiple type datum obtain estimate use base per value per per datum total number patient total use value datum disease associate great
26219155 en condition contribute mortality several disorder include type mellitus cardiovascular compare risk factor patient T2DM method study BMI T2DM measured fasting plasma glucose lipid serum level insulin type insulin index insulin resistance index adult great high ratio incidence hypertension value great reported among adult on association ratio correlate serum insulin plasma BMI whereas studied plasma present study demonstrated increased risk T2DM adult T2DM adult among population ratio may risk cardiovascular event
26053222 en whether diabetic patient without history disease risk event patient history remain study aim determine whether type mellitus T2DM disease need follow subject oral drug T2DM recent use database health review assessment population primary study development need among three group base status T2DM recent T2DM recent T2DM recent age patient recent time risk CI compare patient T2DM patient T2DM recent demonstrated increased risk compare subject recent CI increased risk compare subject T2DM CI risk also according analysis datum database revealed T2DM recent risk population result suggest risk diabetic patient population
25734896 en recent increasing level activity effect intervention glucose subject mellitus intervention study investigate effect intervention use level glucose plasma glucose hemoglobin hba1c adult subject type DM study characteristic finding glucose study review significant glucose found intervention group compare observed control group study hba1c level study hba1c plasma glucose level one study glucose one study study addition study found significant increase number one study show significant reduction glucose study demonstrated relationship change number glucose study show significant glucose among subject type DM study need regard use glucose increase subject
25413254 en age elevated mellitus DM development reduction cholesterol level serum poor control patient compare control individual determined mechanism lipid level analyzed treat lipid protein use gene increased mean mass observed compare little glucose cholesterol impair cell related great lipid decrease although protein decrease compare cell increased cell treatment on low reduce level occur cell gene impair cholesterol lipid contribute individual
18695867 en investigate prevalence type mellitus relationship status total man woman aged year use method use datum include status subject association type mellitus test prevalence mellitus define fasting blood prevalence man woman respective significant high prevalence among compare three less mellitus found among old age group age year less status significant related mellitus prevalence mellitus related factor within population base factor population may increasing prevalence type mellitus
18663160 en type mellitus increasing health among woman associate increased risk study however datum regard examine association weight incidence type mellitus follow-up study woman participant reported follow-up new diagnosis type present analysis included woman weight baseline identify case type mellitus follow-up outcome incidence type incidence type mellitus high high include factor incidence rate ratio per day confidence interval incidence rate ratio confidence interval association body mass index whereas association independent body mass associate increased risk type mellitus woman increasing adverse health effect little healthy
18492034 en assess whether patient treatment mellitus according clinical two aged old type mellitus health assess treatment use time patient regard medication define according patient patient old vs mellitus vs year patient reported lower patient individual treatment glucose control mean vs within group large group although mean individual group significant difference found patient compare treatment vs glucose control analysis association individual treatment cholesterol patient treatment mellitus associate old patient treatment mellitus clinical status
19016936 en examine association serum level old adult analysis year participant mellitus health body adult aged mellitus baseline serum month baseline health status include function chronic condition medication participant reported year follow-up mean baseline serum baseline serum great year adjust age body mass index activity adjust odd ratio confidence interval function chronic condition medication use association on remain reported previous serum associate old man woman mellitus aim mechanism association serum need
23666569 en target drug on clinical study conduct compare gene protein level activity diabetic diabetic included effect value gene protein level activity significant lower similar result observed study activity individual revealed lower effective concentration diabetic compare difference related several gene study indicate significant lower gene protein level activity diabetic patient clinical study large number patient whether mellitus
23518655 en increasing patient mellitus examine relationship resistance mechanism diabetic disease status patient determined follow on gene also diabetic patient significant on diabetic patient resistance mechanism
22441120 en consider development type mellitus T2DM obesity insulin resistance investigate gene association type mellitus conduct study patient T2DM control high analysis analysis hospital significant difference observed type mellitus control associate T2DM however among T2DM group patient significant increased level serum compare control group subject significant increased level compare gene associate T2DM population however may role insulin resistance
21715174 en provide also function range common complication mellitus therefore examine outcome total cohort subject cohort age BMI baseline without mellitus participant examine baseline year significant difference total range two group baseline year group significant lower total range score similar result observed year year significant increase observed diabetic group year similar result study presence mellitus lead outcome although significant difference year suggest patient remain high period
27988319 en gestational mellitus diagnose lead number woman diagnose increasing effective early risk potential provide new result increasing use study however study investigate change associate investigate plasma cohort normal mass study perform change plasma case healthy control sample statistical method plasma sample number significant lower plasma woman develop compare healthy control difference observed reduction lipid participant develop can early first change independent difference observed study well provide
24530307 en type mellitus result insulin cause disorder although control gene identify disease include profile examine profile blood cell patient compare healthy subject total patient healthy subject datum analyzed statistical statistical test characteristic examine function value database use potential target provide database use analysis found different analysis indicate patient healthy individual target indicate potential analysis target observed respective target previous associate include study indicate may potential well provide new mechanism disorder
24439487 en datum regard association gene type mellitus T2DM risk population relationship T2DM risk population perform conduct identify study identify perform statistical test perform use total T2DM case control included present result show evidence significant association gene T2DM risk vs vs vs vs vs addition significant association also found gene diabetic result suggest may associate increased risk T2DM population association study result
21532115 en include clinical one diabetic complication can multiple mechanism insulin insulin resistance however mechanism type risk increased high assessment clinical important risk assess patient risk use metabolic treatment diabetic risk
24802206 en investigate association hba1c incidence patient type treatment treatment insulin mean year
24687000 en may different effect cardiovascular event patient mellitus conduct evaluate effect mortality major event patient DM datum datum included control trial included randomize clinical trial effect DM mortality major event period little month study outcome datum individual trial analyzed use risk ratio CI model estimate difference estimate according test perform analysis identify mortality cause effect major identify trial compare drug patient compare therapy control patient compare control treatment significant reduce risk mortality CI major event include treatment significant mortality CI rate major event associate decrease risk patient DM analysis show treatment effect mortality significant baseline blood pressure trial participant type reduce mortality mortality major event patient DM whereas outcome consider therapy mortality population
27057552 en type mellitus increased risk mechanism large possible increased level show individual examine influence concentration response blood cell decrease response increased effect independent activity change activity effect increasing concentration reduce insulin resistance obesity study need determine
26525976 en study assess association gestational mellitus cohort woman measured total use week logistic regression analysis assess outcome impair fasting glucose impair glucose tolerance base oral glucose tolerance test age history BMI adjust odd ratio CI CI significant associate outcome CI independent risk
26223239 en assess whether gestational mellitus intervention woman high risk woman history BMI study week intervention group control group subject intervention group receive activity weight control study one group control group receive care diagnosis base oral glucose tolerance test week total woman included analysis incidence intervention group control group CI age BMI previous status number week gestational weight lower intervention group CI adjust woman intervention group increased time activity improve compare woman control intervention reduce incidence woman finding may major health
24972631 en type mellitus T2DM chronic disease associate complication chronic complication related T2DM health system diabetic complication associate T2DM one cause association insulin use risk also reported different obtain result relationship insulin risk recent evidence conduct include cohort study on perform database identify study on total cohort study included conduct cohort study possible association insulin use individual type major study significant association insulin use risk analysis study datum hba1c similar result also DM duration adjust result reported significant result role insulin use risk development result statistical important mechanism insulin use increase risk study study datum need found
24548654 en obesity increased prevalence type mellitus T2DM patient T2DM body weight associate risk complication major cause mortality review evidence effect weight weight show decrease risk T2DM T2DM weight show improve control severe T2DM study reduction cardiovascular risk factor weight patient T2DM however datum trial revealed weight intervention reduce rate cardiovascular event adult T2DM analysis large cardiovascular outcome trial also however cardiovascular risk weight T2DM include weight patient risk T2DM consider impact weight therapy patient
21493741 en patient undergo high cardiovascular risk reduce incidence rate cardiovascular event patient chronic disease two randomize trial patient show significant effect cardiovascular analysis conduct study investigate whether baseline cardiovascular event whether effect clinical outcome concentration increased risk mortality significant reduce rate adverse outcome high ratio confidence interval primary event cause respective decrease patient type mellitus undergo significant reduce risk event cause
19610128 en known type type associate change number poor relationship recent study reported adjust glucose concentration patient indicate relationship glucose concentration review severe condition significant severe well clinical condition also observed individual condition suggest rate blood glucose concentration high response increase blood glucose assess population review new therapy rate therapy may glucose concentration glucose
26721032 en among diabetic patient one complication system result dysfunction study determine diabetic patient associate risk case total patient mellitus dysfunction hospital three month included assess dysfunction index function system use respective factor impact function duration age patient body mass index BMI control hypertension status age patient year CI patient duration mellitus BMI statistical significant different among patient severe diabetic patient dysfunction associate risk factor duration disease body mass index
26075473 en analysis increasing medical clinical study sample subject blood sample medication use protein major method use included protein use follow use profile subject mellitus DM type patient control subject analyzed on system profile diabetic control group base analysis use characteristic high test diabetic patient compare control subject association health status may clinical provide chronic disease
22052679 en risk major increased woman mellitus whether risk increased gestational mellitus aim study perform review major woman gestational conduct study datum major woman gestational group two consider study datum use result case control cohort study on high risk major observed woman gestational relative risk ratio or confidence interval CI cohort study or case control study risk major high woman group cohort study or case control study provide high risk major woman gestational group woman factor can risk however lower woman
24751882 en on body examine risk factor cardiovascular disease woman mellitus high risk disease man mellitus on recent study provide evidence woman mellitus also increased risk
26092495 en treatment type improve oral glucose tolerance patient type man type hemoglobin randomize subject glucose blood sample glucose period assess plasma glucose insulin concentration result show plasma level increased elevated plasma level plasma glucose insulin concentration time treatment glucose insulin effect oral glucose tolerance plasma glucose concentration measured lower compare treatment vs respective improve oral glucose tolerance patient type
25199997 en study assess effect renal profile glucose patient type mellitus study patient T2DM different renal function per renal function normal renal function estimate rate renal renal severe renal receive increased increasing renal plasma concentration similar among renal function group adjust mean ratio normal renal function CI CI CI patient severe renal respective decrease renal correlate glucose decrease increasing renal correlate adjust mean change baseline patient normal renal function severe renal respective patient adverse event datum suggest patient T2DM renal increase glucose decrease increasing renal
25781527 en aim study assess status body activity level group type mellitus compare parameter determine relationship body total patient aged year included assess use body determined use activity assess mean patient protein hemoglobin hba1c significant correlate per day per day mean body female mean activity per study patient high protein low diabetic control significant correlate protein study high body age level activity
25044633 en study estimate diabetic cohort patient diagnose adult patient incidence study follow-up study year diagnosis analysis use type year patient T2DM diagnose diabetic old age diagnosis CI per year independent high BMI diagnosis CI per development diabetic age BMI hba1c significant develop diabetic year year duration high hba1c level or CI per increase blood pressure or CI per increase associate T2DM diagnose adult increased risk develop diabetic compare old age high BMI diagnosis risk development diabetic addition poor control blood pressure year follow-up risk development diabetic
25281032 en history gestational mellitus identify population female type cardiovascular disease dysfunction disorder study aim impair insulin early index woman previous control included three month undergo metabolic assessment include sample glucose tolerance test oral glucose tolerance test assess female year follow-up dysfunction assess baseline significant associate insulin well status parameter analysis revealed elevated subject according level early development disease however dysfunction female history early disorder woman high risk follow-up management provide disease
22324407 en mellitus DM chronic metabolic disease insulin insulin resistance great management prevalence recent develop new type control DM complication include protein body reported activity activity different mechanism present multiple mellitus mechanism glucose control include glucose increase insulin however evidence individual addition assess randomize control trial need diabetic patient
21033316 en protein protein factor elevated level risk factor disease baseline level protein healthy man woman risk first diabetic increased risk disease datum study show risk clinical disease patient type compare without however datum regard diabetic study determine serum protein type study conduct among patient patient hospital protein base total subject patient type mellitus without hypertension healthy control significant difference mean blood pressure patient control fasting blood glucose protein significant high diabetic compare control positive significant correlation patient study show diabetic significant high serum protein compare control also positive significant correlation protein fasting blood glucose among patient control
22338445 en diabetic one common complication type mellitus cause also conduct study diabetic known diabetic patient year diagnosis type study conduct medical health period year study group patient type mellitus medical patient diagnose type mellitus year duration included study type diagnose use statistical analysis use found total type patient year diagnosis patient diabetic patient early possible management diabetic one common cause
20583965 en improve mechanism include protein recent finding indicate metabolic occur also study glucose model treat parameter lipid protein studied mean time treatment decrease glucose concentration improve glucose tolerance increase gene protein treatment level increase protein treatment diabetic
19681367 en several use determine body determine characteristic body woman gestational mellitus woman normal glucose tolerance woman gestational mellitus normal glucose tolerance week study use glucose diagnosis oral glucose tolerance test body test use statistical total woman included diagnosis gestational mellitus normal glucose tolerance woman respective body mass index great woman mass total body similar studied group mass great woman gestational mellitus range patient range woman normal glucose tolerance range body woman week different woman gestational mellitus compare woman normal glucose tolerance woman gestational mellitus show significant increase mass without significant change mass total body
19332092 en study effect protein protein reported mellitus protein studied effect glucose level evaluate presence analyzed characteristic presence patient evaluate show significant high early increased new observed found high compare serum patient show high result show serum patient may early mellitus
20583393 en study conduct investigate condition associate poor outcome among patient mellitus analyzed datum clinical characteristic diabetic study aim assess influence mellitus characteristic identify poor outcome among diabetic patient study included patient present patient undergo three blood patient patient patient according mellitus diabetic patient old year index high difference patient without mellitus analysis mellitus identify independent mortality or CI perform patient mortality high diabetic patient mortality significant high among diabetic patient one week therapy index associate increased mortality among diabetic mellitus risk factor clinical outcome
23436340 en gestational mellitus insulin resistance cell dysfunction role intervention improve glucose tolerance insulin resistance control may therefore population activity associate glucose insulin risk reduction type mellitus T2DM T2DM treatment however regard activity review therefore provide effect intervention glucose tolerance insulin control insulin use woman evidence regard activity glucose tolerance insulin however activity may control insulin use woman major intervention study aim research role activity management develop activity management
24740573 en poor control known disorder body mass reduction protein protein large reduce activity increased rate cell therefore protein different diabetic diabetic reduction protein reduction protein associate mass protein reduction protein insulin protein reduction protein associate protein reduce activity reduction activity finding response protein compare may provide new mean diabetic
27624579 en characteristic type mellitus T2DM insulin profile relationship insulin response glucose subject T2DM follow insulin response decrease T2DM fasting concentration high T2DM compare subject decrease T2DM response response impair T2DM ratio first response decrease T2DM correlate high T2DM reduce response ratio reduce severe T2DM
26347894 en evaluate intervention woman gestational method randomize control trial woman history glucose tolerance intervention control risk factor associate development type primary outcome change fasting plasma glucose study follow-up intervention group show significant control group evidence effect intervention effect one health population intervention investigate health need develop test
22350135 en study investigate subject type patient two one compare type patient subject study compare control subject perform on fasting blood sample obtain plasma insulin glucose determined on obtain determined insulin estimate index high compare type patient control also control subject high insulin observed compare subject high type type high group significant difference group observed two high type type patient type subject overall different compare control
24083984 en cell evaluate patient type control on high found case control associate disease insulin
25315294 en oral insulin due lower patient evidence retrospective study suggest oral compare insulin use treatment woman gestational mellitus review oral treatment gestational mellitus research need evaluate study evaluate effect outcome also need
20978217 en review characteristic glycemic control patient type conduct use datum also receive study review datum treatment type mellitus treatment type mechanism however activity provide primary mechanism patient type mechanism include may also effect study included patient type trial conduct patient study duration week one trial evaluate week follow-up hemoglobin reduction plasma glucose concentration primary study statistical significant difference found use result mean reduction range result mean increase range incidence adverse effect great clinical trial cardiovascular demonstrated management type may population patient risk study duration may define role management
20809236 en type mellitus T2DM major risk factor cardiovascular disease mortality system complication addition evidence retrospective study effect development T2DM potential recent trial regard history T2DM increased mechanism potential management addition role primary patient consider development patient
26049412 en present present assessment glucose model patient type mellitus use datum blood glucose concentration model base function regression model respective development model datum patient period use model evaluate use clinical addition datum activity consider effect model investigate analysis indicate model range related activity model obtain result clinical
25542297 en number woman gestational mellitus first diagnose associate risk complication obesity recent control trial demonstrated management use blood glucose clinical remain control insulin therapy recent show reduce management insulin therapy oral medication show insulin therapy within weight insulin also consider use insulin therapy oral therefore insulin associate adverse effect although weight also oral therapy associate weight however remain whether risk show study need treatment weight provide oral
24898337 en may present significant significant disease related aim study determine influence clinical factor patient type mellitus DM compare patient without DM present syndrome use relative observed medical intervention without influence associate renal function function clinical among parameter reduce increased function activity indicate clinical parameter factor
24464596 en role obesity type mellitus T2DM gestational mellitus cardiovascular complication ratio provide method assessment status investigate value oral glucose tolerance test development woman woman without included study blood test follow within week diagnose mean level significant high woman vs respective analysis logistic regression analysis show elevated or CI independent elevated level independent result study role
21803130 en associate evidence activity reduce patient type mellitus T2DM group high incidence T2DM however regard activity T2DM patient identify gene use T2DM patient healthy control also assess activity serum vs vs activity significant lower patient compare control activity studied however activity show significant difference show significant association type significant observed among activity lower patient can lead increased lipid activity activity influence diabetic compare control may related type
20849981 en prevalence incidence type mellitus DM increase age diagnosis treatment old present evidence patient old multiple general clinical trial adverse health outcome insulin resistance DM care risk factor control syndrome type DM patient consider target hemoglobin diabetic glycemic control patient increase risk significant mean hemoglobin diabetic patient little known care multiple DM DM need care
20149550 en present factor observed type within two body pressure cause develop effect determined effect also observed research possible model development dysfunction insulin cell insulin three also observed type regard different level follow condition function insulin patient positive increased general condition level decrease medication well major use medication without treatment therapy use primary factor use primary
24860832 en aim aim study determine patient type risk factor use method presence hypertension chronic disease subject type subject risk factor group respective use assess presence score result age presence score significant high group risk factor addition age year old odd ratio CI presence hypertension odd ratio CI odd ratio CI odd ratio CI can independent high score hypertension patient type effect
22214721 en study aim investigate parameter patient mellitus type estimate relationship blood response change blood plasma examine patient mellitus type healthy age control blood measured also blood investigate response impact significant increase rate patient control found cause decrease blood increase resistance index diabetic patient mean value response index significant high group patient mellitus type increased blood value associate impair
22145391 en according evidence obtain large study incidence rate syndrome diabetic time high general population mortality high patient type mellitus high risk outcome within day year follow-up poor early treatment result diabetic mean trial review
21598465 en mellitus one major health diabetic early complication mellitus therefore treatment diagnosis estimate diabetic patient medical treatment different
21843306 en study investigate whether insulin associate metabolic type mellitus year old assess previous insulin week year insulin therapy use assessment system current hba1c level year insulin significant lower therapy level report significant three assessment significant difference therapy hba1c hba1c year insulin week type mellitus show report metabolic control year insulin
21800009 en type mellitus T2DM test effective T2DM possible due increased on study compare week treatment period patient T2DM complication response examine test blood plasma decrease compare vs response similar high show response compare difference reduce high correlate mean correlate identify patient improve response high risk T2DM patient study whether improve clinical outcome patient
24455747 en type mellitus T2DM disease factor recent year evidence correlate early factor risk adult period development factor may increase risk include healthy obesity found increase risk insulin resistance T2DM obesity also negative effect cause increased T2DM adult also potential mechanism may T2DM therefore possible risk T2DM factor
23517792 en increased impair common finding diabetic study report status type study type diabetic patient control measured determined activity significant high patient control significant lower significant difference observed however significant difference observed patient control regard activity activity patient significant high patient significant lower patient analyzed group analysis demonstrated hba1c positive correlate activity negative correlate level however patient treat group similar correlation case finding suggest activity type diabetic increased compare
20879969 en type mellitus cause significant mortality result high level glucose insulin resistance impair insulin current treatment disease glycemic control also associate effect weight new treatment target new therapy need present important role development type mellitus treatment target system recent two insulin level high undergo clinical new drug treatment type result study clinical patient type demonstrated effective well treatment type insulin profile
20070556 en hemoglobin hba1c result adult type care may improve glycemic control determine whether hba1c result type improve patient care glycemic randomize control trial year age receive hba1c result several day assessment hba1c level therapy change baseline follow-up patient studied similar baseline characteristic include hba1c vs improve hba1c month baseline study subject receive increased hba1c result month less reported vs subject rate less vs hba1c method hba1c type mellitus although glycemic control result intervention result less
27399125 en study aim compare month year adverse cardiovascular outcome associate patient type mellitus database study compare patient T2DM total adverse cardiovascular outcome reported month year consider clinical study odd ratio or confidence interval analysis perform study total number patient included associate significant high total or CI or CI or CI respective also drug mortality or CI or CI or CI or CI respective target target major adverse event also similar reported or CI or CI or CI follow-up period associate increase among patient T2DM mortality adverse cardiovascular outcome also significant different group consider effective use patient T2DM
25621798 en mellitus DM factor cell index however impact DM mortality remain perform retrospective study datum included total patient undergo first age year range compare patient without DM group patient DM DM group old disease use analysis show DM associate increased risk ratio confidence interval CI CI presence DM associate increased risk overall mortality analysis CI DM risk factor mortality improve clinical outcome patient DM control glycemic control trial
24969222 en randomize trial conduct compare effective different remain diabetic patient trial large patient include mellitus DM patient randomize base presence DM target month primary demonstrated compare vs addition month DM show vs insulin treatment associate increased rate however less group month similar rate significant month patient undergo follow-up demonstrated lower high month compare follow clinical current study DM patient addition month may treat found clinical follow-up can evaluate clinical effect new
24137986 en independent study conduct impair lipid risk factor patient type mellitus change lipid metabolic syndrome include increase level decrease influence patient type parameter reduce metabolic syndrome effect positive influence system case normal lipid profile medical treatment result due well effect
20829623 en syndrome common glucose clinical mellitus development mellitus syndrome well insulin important glucose several increase glucose insulin insulin increase contribute development insulin resistance body significant contribute insulin resistance development metabolic syndrome glucose tolerance impair insulin well level cell different insulin glucose tolerance mellitus patient syndrome
22296353 en investigate clinical clinical patient mellitus provide therapy patient mellitus DM present study patient period control group clinical datum DM group control group retrospective analyzed use mean age patient DM group year old compare control group patient ratio high control group response rate DM group lower control group patient DM group clinical ratio difference significant significant difference diabetic group control group overall rate DM group control group difference significant patient cause result overall show DM group difference statistical significant serum insulin fasting two high normal value DM group serum insulin level control group normal old patient high high clinical diabetic group patient mellitus risk poor may cause poor patient
21338304 en dysfunction large number patient mellitus DM however little known impact DM patient study man type mellitus T2DM compare man DM without patient DM compare patient clinical profile DM without use patient poor however difference two group significant contribute poor patient mellitus
20735351 en diabetic common complication mellitus primary cause renal disease factor type mellitus factor cell activity gene two normal diabetic possible model type however develop lower change possible target study treatment use diabetic patient early
21864817 en associate increased risk major adverse event intervention compare clinical outcome patient without mellitus treat randomize patient treatment diabetic diabetic follow month primary major adverse event define target included individual mortality target diabetic patient use compare associate increased risk major adverse event vs ratio confidence interval vs ratio confidence interval target vs ratio confidence interval target vs ratio confidence interval patient without difference risk decrease similar compare associate increased risk adverse event patient follow-up
21489532 en mellitus type increasing due high rate obesity also show previous study diabetic impair aim study role disease whether change can improve patient characteristic outcome patient known diabetic time time diabetic patient use high mean diabetic patient develop complication develop pressure hospital increased day day difference complication group one year function similar diabetic patient compare without finding show diabetic increased risk complication hospital general normal
24671002 en cell insulin glucose normal glucose also known cell normal type aim study type level new diagnose type concentration found increase correlate level insulin type determined elevated level increase risk cell cell finding factor cause type
26663724 en mellitus DM complication cause health large development complication DM patient DM important development drug study study effect new model DM study cause increase blood decrease treatment follow blood two effective blood diabetic decrease diabetic treatment decrease whereas increased studied significant activity new treatment DM complication
23690101 en mellitus DM metabolic disease associate disease therefore important diagnose presence early possible DM patient aim study correlation patient DM type study included DM type patient perform hospital patient two group case group group include patient control group group include patient without estimate use score define ratio patient three female mean age score case group significant high control group regression analysis revealed ratio independent base level score respective according study patient DM independent positive correlation score
23657005 en recent relationship obesity present randomize study aim evaluate blood glucose level body weight patient type mellitus T2DM mechanism T2DM study included patient receive oral week blood sample week perform treatment perform T2DM patient healthy individual use significant decrease whereas population significant increased T2DM patient compare healthy individual analysis healthy individual T2DM patient indicate significant difference healthy individual T2DM patient group general similar treatment however week therapy ratio group significant increased significant high compare group indicate improve T2DM treatment decrease blood glucose level body weight T2DM patient
23027769 en several study reported increased risk type mellitus provide important risk study examine association factor metabolic control population woman woman mean age diabetic two group mean value hemoglobin three year healthy woman control profile index perform use woman poor metabolic control show lower value compare healthy control woman metabolic control significant difference woman metabolic control healthy control lower increased although statistical significant observed patient poor metabolic control patient metabolic metabolic control may can consider woman age
26081205 en evaluate effect new body index prevalence mellitus DM fasting may total subject age year subject receive test relationship prevalence overall increased impact prevalence DM according logistic regression analysis adjust risk factor DM relative low odd ratio DM prevalence CI CI CI associate prevalence DM cohort study difference
21562065 en mellitus associate decrease reduce tolerance response type patient without well healthy control studied lower body negative pressure use assess response blood assess blood response lower compare reduce compare type patient reduce blood type patient present impair potential decrease cardiovascular
22999236 en glucose overall cardiovascular risk glycemic base duration cardiovascular disease age glycemic control show complication type type mellitus although cardiovascular disease major cause patient complication cause treatment effective management diabetic complication
22814767 en gene development mellitus include type type T2DM however result study perform investigate association database odd ratio or confidence interval use effect model study study study study study study study study study study T2DM included result indicate associate increased risk vs or CI vs or CI associate increased risk T2DM vs or CI vs or CI however significant association observed risk significant association risk found gene may increase risk may increase risk T2DM
26285328 en present study estimate effective health treatment disease patient mean age year type mellitus receive therapy include patient patient result positive clinical disease test parameter lipid status health treatment management disease patient present type mellitus lead function lipid
25961824 en oral type mellitus however little compare also common use study evidence glucose effect database randomize control trial conduct estimate glucose effect vs vs common use model method treatment estimate confidence interval total study included analysis trial reduce hemoglobin hba1c significant difference CI trial use common significant hba1c reduction CI CI glucose effect little effect little
25784223 en present case cause diabetic diagnose treat month follow patient although
22981711 en type mellitus major chronic disease management disease review effect resistance glycemic control characteristic intervention adult type mellitus perform use database study improve glycemic control great duration number among study resistance may result study effect different resistance different method whether one type great type mellitus management
24229665 en protein two major important role type mellitus study aim investigate change patient relationship clinical new diagnose patient time diagnosis one year year diagnosis follow-up clinical datum analyzed patient remain however patient patient prevalence diagnosis one year year prevalence respective diagnosis one year year respective fasting level patient high patient indicate patient less cell datum suggest diagnosis cell function patient
26340637 en prevalence obesity type mellitus T2DM well old individual risk disease increased high total increased risk associate decrease risk patient increased risk develop T2DM recent research suggest T2DM previous consider review effect relationship treatment potential intervention may decrease risk associate change insulin resistance chronic
25722016 en recent number woman gestational mellitus increasing due potential study investigate response healthy control metabolic profile use mass datum show case control metabolic three metabolic identify level revealed may lipid lipid relationship potential risk evaluate logistic regression characteristic analysis on model show great potential diagnose disorder
24823472 en examine difference patient without mellitus DM large cohort examine difference patient without retrospective review patient analysis analysis profile regression model perform compare patient without DM on patient analysis datum perform compare patient without patient study population DM DM time analysis analysis show significant high total individual DM however patient DM significant lower analysis show patient DM significant lower significant great patient without DM patient DM significant great patient without DM vs associate multiple difference analysis compare without DM include significant high lower control well may reduce patient DM
23937044 en datum role on on correlation on insulin resistance cardiovascular risk factor well increase level on patient type mellitus high cardiovascular risk metabolic without complication on
23689152 en diabetic complication lead early diagnosis treatment renal cardiovascular complication study investigate value index type diabetic patient type mellitus index less define risk factor compare patient base mean range correlation significant duration disease cardiovascular event care hypertension significant correlation odd ratio confidence interval on less cardiovascular complication also early diabetic patient patient follow-up early complication
23579541 en evaluate association year outcome type mellitus T2DM study T2DM subject undergo outcome T2DM group age body mass index glucose response test evaluate insulin insulin estimate glucose tolerance test use assess body present lower glucose response compare significant among group index insulin adjust insulin demonstrated large function subject compare body significant among study datum show subject T2DM response normal glucose tolerance datum suggest function T2DM
23453199 en patient type mellitus severe insulin recent cell cell previous observed factor may multiple cell show insulin response glucose however number associate low insulin aim determine whether cell within clinical diabetic model
23354016 en investigate whether risk mellitus metabolic syndrome disease examine prevalence metabolic syndrome among adult disease compare assess medical patient disease diagnosis hypertension body mass index BMI lipid profile level glucose hemoglobin identify metabolic syndrome patient without disease age control prevalence metabolic syndrome disease cohort compare control subject included health patient disease compare control similar prevalence metabolic syndrome significant lower among patient disease control vs mean BMI patient disease significant lower control vs however disease associate lower risk prevalence metabolic syndrome lower among patient disease control general population difference difference BMI study need determine mechanism disease risk metabolic syndrome
26883978 en evidence demonstrated chronic effect body present study investigate effect diabetic first group control group mellitus group DM treatment group per day day mellitus treatment group blood pressure blood glucose insulin tolerance determined protein associate insulin well factor show impair glucose tolerance insulin resistance addition increased however serum cholesterol decrease insulin resistance improve protein insulin increased reduce treatment effect insulin resistance diabetic
22913905 en review recent development treatment obesity type mellitus T2DM randomize control trial include intervention activity therapy show weight body weight within month treatment also reduce develop T2DM individual impair glucose tolerance activity however may less impact obesity significant health individual may treatment mean weight body weight within year well rate development patient determine medical intervention treatment obesity T2DM
22838167 en mellitus DM treatment one patient metabolic control great diabetic patient study assess effect different insulin treatment glycemic control presence complication subject type patient type DM medical group according treatment insulin insulin therapy multiple insulin insulin well index insulin treatment metabolic control assess hemoglobin hba1c lipid level presence complication statistical analysis use study included test correlation patient significant metabolic control treatment group compare one therapy hba1c vs therapy hba1c significant difference glycemic control observed patient insulin insulin glycemic control significant influence reported patient reported significant lower patient cardiovascular complication reported also lower well treatment metabolic control also
22828549 en mellitus increasing health associate on study conduct among adult type mellitus patient research metabolic disorder influence characteristic among datum measured use study found included severe severe significant common female odd ratio respective current also high odd ratio severe odd ratio among characteristic status identify follow level female primary identify significant health among adult type mellitus patient association characteristic consider diabetic patient
21805479 en study association type mellitus significant association risk mortality however can patient may lead effect different type cell study found level significant high type mellitus patient compare healthy subject diabetic cell examine cell cell addition similar diabetic diabetic also high cell indicate diabetic cell important role well cell also diabetic study demonstrated diabetic patient can lead cell large treatment diabetic patient
26281219 en effect system disease month respective obesity type mellitus influence treatment insulin studied effect obesity show respective effect activity treatment lead obesity effect observed influence condition treatment decrease effect level control lead metabolic syndrome system treatment one disease complication cardiovascular system
26201170 en two number new case type mellitus T2DM among increased study group may related study examine relationship risk T2DM activity year age health model use relationship participant risk factor T2DM health T2DM significant relationship found risk health T2DM health activity related risk activity
26159020 en blood patient syndrome type mellitus DM intervention total patient type DM treatment group control group treat treatment treatment group treatment group treat treatment patient treatment group time time per day time time per day year primary incidence included time score blood syndrome incidence evaluate treatment month incidence less treatment group control group patient treatment group patient control group incidence show treatment group statistical difference compare control group patient hospital treatment group patient treatment group statistical difference compare control group incidence significant lower treatment group month month lower control group month incidence treatment group lower control group compare treatment score lower treatment group month treatment control group month treatment lower treatment group control group month treatment treatment can reduce event improve score patient DM
26010492 en aim review assess effect therapy serum level type mellitus use control trial database trial control clinical trial evaluate effect case report trial study assess use risk assessment use effect identify potential study assess included review three low risk three risk consider high risk show statistical significant mean difference CI CI intervention result reduce serum level T2DM individual decrease important metabolic control mechanism increased risk complication T2DM
25863010 en recent datum role development well function insulin protein factor previous study suggest significant role risk type mellitus T2DM population present study investigate association healthy population use use on total patient T2DM healthy control undergo found significant association fasting plasma glucose level among analyzed significant associate fasting plasma glucose index respective healthy population
25312690 en type mellitus DM increased risk cardiovascular complication index early change recent effect blood receive therefore study aim examine association parameter patient DM study investigate relationship parameter control subject man woman patient DM man woman participant DM high blood level low rate high rate without DM different metabolic parameter compare mean value increased addition positive correlation patient DM adjust factor multiple regression analysis revealed significant increased DM however association control subject finding show increased elevated DM independent associate adjust cardiovascular risk factor early level low rate early patient DM
22965164 en type mellitus woman increase risk adverse outcome important control therapy diabetic diabetic dysfunction well review medication risk obtain control blood glucose blood pressure outcome however risk severe major although result function woman diabetic normal serum level complication woman woman normal function insulin consider use study insulin provide result insulin remain lower
22776014 en assess blood glucose control patient type mellitus control patient week randomize group show significant glucose mean glucose fasting plasma glucose value group difference group change respective mean mean respective respective increased plasma concentration compare incidence adverse event adverse event similar among group adverse improve blood glucose level without
22686944 en evaluate subject control type mellitus T2DM
22868018 en determine status well control poor control type diabetic patient compare normal healthy management hospital well control poor control type diabetic subject oral score according oral index compare control group normal healthy individual obtain status use glycemic control evaluate value use independent sample mean type age diabetic subject year control group year female great patient poor control compare well control diabetic patient control vs respective also increased poor control compare control group well control however difference statistical significant compare well control control group number mean also significant high poor control compare control group status estimate significant poor glycemic control
21348814 en aim study evaluate impact glucose level high risk hospital mortality patient studied patient care diagnosis consider association glucose mortality assess regression overall incidence patient mortality high patient vs mellitus DM present patient level patient low prevalence DM patient present glucose increase risk adjust ratio analysis show blood pressure blood cell significant increased risk high high prevalence mortality status patient present elevated glucose level consider clinical datum diabetic patient
23638123 en several study evaluate relationship mellitus DM relationship incidence may influence DM association may clinical factor aim assess clinical difference patient without system compare subject DM subject diagnose perform analysis identify factor associate presence DM among DM old positive test or CI or CI less hospital or CI develop or CI treatment or CI develop population treatment disease DM disease effect DM incidence outcome provide management disease health
21757636 en increasing management mellitus DM however little research assessment review evaluate whether relationship health care study use identify analyzed finding study revealed datum however care measured provide need related DM patient care
26495752 en prevalence gestational mellitus obesity study aim whether intervention woman whether woman outcome normal glucose tolerance retrospective cohort study woman diagnose woman therapy diagnosis multiple outcome woman adjust odd ratio confidence interval CI care CI rate lower group CI CI respective increase gestational age among woman CI woman body mass index BMI similar outcome BMI group obesity increased risk poor outcome therapy woman may rate large gestational age without increasing rate woman BMI less outcome similar suggest woman can potential treat less
18302671 en mellitus disease population individual early well intervention include individual glycemic control new medication weight insulin system old glycemic control blood pressure cholesterol management reduce disease include cardiovascular event evidence risk factor possible oral oral response may cardiovascular outcome increase mortality oral medical oral new case oral health present diagnosis risk factor management complication oral health provide care patient
25072937 en common disease mellitus may reduce contribute dysfunction reduce model therefore aim current study investigate dysfunction patient without type patient type included study assess well assess decrease patient decrease group baseline vs significant reduce patient type however high group dysfunction cause patient may treatment
25226805 en gestational mellitus define first associate several health large health impact role obesity activity effective intervention treatment known effective treatment type base study positive influence glucose insulin reduce risk however although intervention reported effective glycemic control woman develop intervention aim show effective increasing level effective reduce incidence therefore need develop effective increasing level woman high risk intervention study need determine type duration intervention effect outcome high study examine outcome body
24620446 en estimate prevalence hypertension obesity medical characteristic population among fasting glucose measured define according datum medical characteristic measured mass evaluate use blood pressure measured hypertension define according prevalence rate confidence interval general man woman impair glucose tolerance general man woman hypertension general obesity found individual mass associate man woman ratio lower man woman high prevalence obesity related recent change activity result health also indicate can increase
25693837 en retrospective analysis database increased risk gestational mellitus woman association evaluate relationship glucose cohort woman gestational glucose tolerance normal total woman undergo metabolic include oral glucose tolerance test mean week prevalence function insulin clinical risk factor compare woman female lower mean adjust function index insulin resistance vs high mean adjust blood glucose compare female woman high odd develop odd ratio CI increased relative risk risk factor age year associate poor function high increased risk potential may influence glucose
20102896 en mellitus investigate impact risk event old patient syndrome study population patient interval syndrome year age patient receive oral diabetic medication insulin year age included first event occur first mortality follow-up year age risk factor evaluate model follow-up patient first event patient patient development adult patient associate increased risk first event risk factor mortality year age interval rate mortality interval interval contribute independent mortality risk adult patient risk factor
22901562 en occur study reported effect system include mellitus DM therefore oral improve glycemic control associate risk factor patient type mellitus T2DM present clinical study therefore test patient T2DM hospital randomize control trial patient randomize control intervention group control group receive oral whereas intervention group receive oral period month hemoglobin lipid profile protein measured baseline month result month significant improve mean hemoglobin mean vs blood pressure mean vs total cholesterol mean vs total protein mean vs T2DM significant change body weight cholesterol observed oral found effective glycemic control may possible provide potential treatment management
26033074 en health value control health adult type health related due factor can identify risk poor adult type mellitus sample datum analysis value diagnosis type mellitus participant mean health value new need control type mellitus demonstrated influence level health value common impact included medication management blood glucose type control level health value influence complication associate type mellitus finding health value health result development potential research type mellitus type mellitus health value development can provide clinical assessment type mellitus patient
23205802 en mellitus DM hypertension may associate complication study determined risk patient DM hypertension undergo present study determine association DM hypertension factor development measured change method logistic regression compare status patient year age old patient history medication use DM hypertension use patient age vs number change occur adult within mean month observed follow-up time month among patient occur large associate according analysis DM patient large significant association presence hypertension patient use number association presence according analysis large mellitus factor hypertension patient use risk DM remain possible cardiovascular risk factor development
19434204 en on total diabetic control study determine relative incidence mellitus blood group current diagnosis mellitus diabetic blood group fasting blood blood determined use method type type gestational mellitus identify study obtain history subject hospital case mean age diabetic age range year mean age control age range year significant difference mean age two group blood group on significant high among diabetic diabetic blood group significant lower diabetic control population blood group on therefore mellitus
18581583 en present study investigate effect type mellitus oral health subject first group subject type mellitus female age year group healthy subject disease female age year subject evaluate two group year old year old participant examine index oral condition evaluate well index index index CI datum obtain group compare compare group observed development age diabetic group age interval group type mellitus high ratio group group type mellitus great group type mellitus control group CI value show increase group type mellitus statistical significant difference CI control type mellitus group patient finding obtain show type mellitus important oral health
18506898 en recent study suggest mellitus increase risk develop aim study risk among patient mellitus large cohort patient chronic included patient mellitus age year prevalence mellitus patient score score score multiple logistic regression analysis show increased risk mellitus patient elevated body mass index BMI odd ratio or confidence interval CI decrease risk mellitus patient high serum level or CI follow-up year range patient mellitus patient without mellitus develop CI CI respective regression analysis patient show mellitus independent associate development ratio CI patient chronic mellitus increase risk develop
24337793 en previous reported level increased determine whether investigate level subject range level subject age year year determined on relationship age level significant positive correlate base regression adjust level according show increase age normal level demonstrated regression use adult range potential treatment diabetic patient age
22521970 en hypertension independent risk factor hypertension may increase risk patient whether drug associate risk retrospective study use cohort examine incidence follow-up period regression model use estimate effect hypertension medication risk adjust several potential patient studied mean age year factor duration hypertension associate increased risk develop ratio confidence interval CI medication decrease risk range analysis patient without hypertension CI CI show hypertension associate increased risk whereas medication associate reduce risk among patient without hypertension may potential role patient
23529219 en role protein cell normal condition protein however cell factor protein glucose protein cause cell several response cell response three protein important role response factor protein protein disease include review insulin insulin resistance glucose mechanism
24430729 en datum regard gestational mellitus new number health care association new aim study investigate new review total woman undergo follow oral glucose tolerance test woman found undergo blood glucose well management insulin treatment treatment glycemic woman one two three value woman two three value need insulin treatment one value vs age gestational week diagnosis history correlate insulin treatment woman adjust odd ratio confidence interval compare outcome woman normal glucose tolerance hypertension two group datum suggest show less severe glucose risk insulin history
24649873 en although major risk factor identify study impact therapy year included define according patient datum compare cause therapy analysis patient patient develop among common risk factor high age body mass index BMI factor ratio treatment factor high relative risk impact patient decrease patient influence high patient reduce due high high rate treatment age BMI
18719629 en aim study assess whether baseline risk cardiovascular disease patient mellitus use drug use drug on retrospective study within general research database cohort included patient mellitus patient characteristic general cardiovascular characteristic medical odd ratio or confidence interval on total patient use drug case control included study cohort female receive treatment year index associate use drug or CI or CI case multiple cardiovascular risk factor compare control baseline risk disorder cardiovascular disease found high patient mellitus use drug compare patient mellitus treatment
24841896 en effect blood glucose concentration body weight investigate model group use control week change blood glucose concentration body weight week old significant difference blood glucose level group blood glucose level increased age group week blood glucose level increased rate concentration week age significant lower concentration blood glucose value week remain level week group body weight increased age treatment significant reduce blood glucose level body weight suggest therapy effective development mellitus
24788804 en evaluate effect large patient clinical outcome health rate type mellitus T2DM patient primary care sample patient T2DM general compare number T2DM patient group age hba1c level outcome hba1c level health rate include measured baseline effect clinical outcome health rate assess use estimate group group clinical outcome period on significant great patient group follow-up compare group group mean effective clinical outcome reduce general rate period T2DM patient disease care primary
24507683 en protein gestational mellitus
19570552 en major health study large report associate type mellitus individual old year large datum obtain individual include fasting blood glucose fasting insulin lipid profile weight clinical estimate level analysis determine correlation control estimate range estimate related type mellitus fasting blood glucose fasting insulin addition evidence common control analysis common fasting insulin obesity body mass index correlation fasting insulin associate type mellitus effect evidence control insulin presence insulin resistance syndrome obesity
22314123 en increase general population increase number patient type mellitus T2DM although treatment patient T2DM adult management group change renal function increased prevalence multiple individual treatment treatment patient status risk relative datum regard T2DM old adult clinical base datum population current include treatment relative status patient review treatment treatment population current management T2DM population
20737753 en cell dysfunction mellitus important role also disease treatment reduce function cell factor insulin response factor known due current type identify two insulin several study demonstrated two may increase decrease function mellitus increase case use one treatment control glucose blood level therapy current two one mellitus treatment
25220626 en mellitus DM risk factor associate poor outcome association less examine effect DM overall woman retrospective cohort study patient diagnose perform DM diagnosis datum test test use compare method test use compare DM patient diagnosis DM difference age status DM patient present although patient group BMI significant different two group vs DM vs difference base BMI diabetic patient poor vs vs compare patient use among diabetic patient patient DM poor patient without association independent obesity use outcome
23086039 en adult include adult type presence determined characteristic study conduct hospital diabetic patient year without insulin therapy month aged year measured clinical datum subject patient positive show compare type patient lower fasting less metabolic syndrome patient high different low high type less study effect difference can important risk clinical
25315629 en study group oral glucose tolerance test test gestational mellitus aim study compare health association study group total woman undergo fasting day plasma glucose measured use diagnose woman identify diagnose woman diagnose diagnose low compare diagnosis due low test fasting need possible use glucose test test follow fasting
27330731 en aim identify factor glycemic control associate mortality diabetic patient hospital care retrospective analyzed case diabetic patient hospital care undergo glucose time per day datum regard day hospital datum status glycemic mean glucose concentration hospital logistic regression analysis determine association factor mortality rate associate mortality according result adjust analysis show significant positive association mortality increasing risk odd ratio or confidence interval CI high value significant associate increased mortality increasing risk or CI or CI respective mean glucose concentration also significant associate mortality increasing risk or CI index associate mortality care mellitus patient
21625418 en on known treatment disease however regard development risk control diabetic metabolic syndrome patient effect cholesterol effect may improve insulin resistance little influence glucose factor suggest can provide treatment patient glucose mellitus clinical trial test clinical provide
18205795 en one blood group use also elevated condition include mellitus chronic disorder related study investigate level patient type metabolic patient type mellitus healthy subject study level serum measured blood test day obtain three day perform patient patient finding two parameter investigate mean level study group control group association level age patient duration body mass index metabolic control level hba1c fasting glucose serum lipid presence complication treatment level diabetic patient related evaluate patient
18612115 en protein insulin insulin study high level associate insulin resistance however association type mellitus determine whether level associate old study among aged year study retrospective measured level baseline serum among participant without participant develop mellitus follow-up develop participant participant level within high increased risk compare participant low model adjust age body weight activity blood pressure level fasting glucose level cholesterol concentration concentration protein level adjust ratio confidence interval association level adjust ratio high vs low confidence interval old serum associate independent insulin resistance
21121384 en type mellitus disease associate disorder disease one disease associate decrease insulin patient may cause glucose study review disease type diabetic correlation age duration type mellitus patient hospital history analysis fasting blood glucose level serum level perform prevalence disease type diabetic disorder patient female old year age group year age group duration disease year year disease associate type mellitus patient undergo dysfunction
22661900 en large body clinical study year duration population type mellitus review datum use base baseline hemoglobin level age patient addition although review datum mechanism diabetic population patient current impair glucose tolerance impair fasting glucose review aim define use population type mellitus receive great management disease
20804071 en estimate patient mellitus type analysis perform patient day therapy show diabetic patient associate protein cell mean result mellitus
18300524 en disease mellitus increasing major develop care increase mellitus prevalence develop disease disease on number factor cause include population obesity obesity hypertension cardiovascular risk factor associate association risk factor mellitus high due cardiovascular complication management number poor high medication poor diabetic increase prevalence mellitus need obtain number health care management health
17367830 en investigate level diabetic mellitus disease diabetic show within week insulin therapy need insulin therapy concentration measured week insulin therapy difference level found time group concentration significant lower compare control insulin insulin therapy increased significant group level different control whereas although level mellitus disease
25761720 en study examine whether related among primary care patient type mellitus DM assess patient type DM individual patient datum baseline level baseline follow assess use patient health patient high high high less compare adjust odd ratio or confidence interval CI influence may risk
25492374 en oral drug common use type mellitus T2DM patient gene gene influence glucose previous study demonstrated population result remain population study evaluate impact gene clinical T2DM patient on total new treatment T2DM patient included study patient follow week determined use treatment body mass index BMI serum lipid profile hemoglobin hba1c fasting glucose level blood pressure measured study cohort mean age year T2DM patient base hba1c level one less among vs response little vs two patient two on time great treatment on similar observed analyzed different model or CI or CI or CI or CI show significant effect BMI hba1c lipid parameter datum suggest gene associate patient T2DM
19440747 en type impair glucose tolerance increasing patient also health care system complication metabolic dysfunction one major finding target disorder development mechanism one target mechanism intervention however individual addition impact well blood glucose control consider high define blood glucose target treatment change however patient medical individual therefore consider treatment clinical study target need year due
19686306 en gene result patient insulin therapy without glycemic control among patient due finding include dysfunction known syndrome case patient syndrome function insulin treatment response severe patient mellitus month age old age diagnosis case patient month time diagnosis suggest patient age month diagnosis receive cause
26305874 en glucose treatment adult type mellitus T2DM patient lower plasma glucose level reduce renal glucose increasing glucose increased also associate lead reduction body weight blood pressure result study evaluate development patient T2DM therapy improve glycemic control provide reduction body weight study year duration general well high incidence adverse event related mechanism include related result clinical study lead effective range patient T2DM
20875901 en association plasma type mellitus study evaluate whether patient present different plasma status healthy control group examine whether clinical parameter correlation level plasma present patient type mellitus determined new develop method result show patient significant lower level healthy subject vs respective significant negative correlation revealed among clinical parameter include fasting plasma glucose hemoglobin ratio finding suggest association individual concentration presence include associate clinical parameter current whether status factor study potential method individual investigate relationship
23743942 en compare new score characteristic test health adult research regard patient age year mellitus primary care oral patient time patient assess use regard patient individual total patient mean year high significant less score adjust compare score high correlate score correlate score score correlate time care patient important provide regard patient need blood glucose control
22097345 en study effect different type mellitus T2DM model type mellitus high high diabetic model group group group group group different treatment group therapy normal control group body weight oral glucose tolerance test blood lipid level include total cholesterol high low plasma level plasma result determined weight fasting plasma glucose plasma glucose one blood glucose two plasma level activity increased model group compare normal control group plasma level decrease model group model group compare model group result blood lipid level activity improve level increased different treatment group improve different treatment group compare group plasma level elevated decrease significant group level decrease significant group level decrease significant group compare group plasma level decrease level elevated significant group decrease group different effective type mellitus effect group therapy group
21982652 en new drug mellitus need cardiovascular outcome population high risk development treatment type mellitus therapy randomize clinical study patient syndrome use assessment primary trial man woman type follow year statistical trial use evaluate ratio first base primary primary event primary event first analysis CI study CI group analysis study patient randomize examine define profile patient high risk event
22312141 en develop present evidence provide clinical effective type base evidence review evaluate identify use control trial clinical outcome evaluate included mortality cardiovascular mortality evidence use clinical system oral therapy patient diagnose type include weight improve evidence therapy treat patient type evidence treat patient control evidence
22296077 en major type function patient type studied patient year age type fasting level per per serum within month diagnosis patient receive one three study treatment two follow two primary outcome change serum level tolerance test baseline outcome included hemoglobin level mean insulin rate fasting level similar study group primary outcome month significant group group use compare insulin hemoglobin level rate adverse event three group significant significant reduce improve clinical outcome period medical number
21507365 en use datum patient disease assess risk mellitus determine whether risk event trial randomize patient presence assess study follow-up time year examine risk associate use regression model adjust baseline test whether risk patient without mellitus woman man mean age year develop observed significant use participant group increased risk adjust baseline ratio confidence interval risk ratio confidence interval use associate increased risk patient risk decrease patient treat datum suggest may risk glucose observed patient
23040240 en study evaluate association type mellitus T2DM risk participant health follow-up study baseline follow datum potential baseline adjust relationship first report estimate use event man T2DM show CI increased risk compare without adjust age BMI activity man T2DM total report compare without T2DM CI adjust risk CI mellitus associate significant great risk
22891946 en plasma cholesterol aim study examine association mortality cardiovascular parameter analysis perform study study evaluate patient type mellitus follow year association outcome use regression analysis body mass index BMI use addition value BMI serum protein concentration concentration associate presence baseline odd ratio confidence interval CI per increase follow-up association found mortality ratio CI patient BMI CI group according CI association remain significant adjust parameter associate baseline association observed less associate event level risk mortality association status
23632280 en review determine potential role treatment type mellitus
22212499 en control blood glucose reduce cardiovascular event total mortality clinical effect glucose control patient type time trial identify study included randomize control compare different level blood glucose control type diabetic patient two independent datum study use case report investigate total mortality cardiovascular event patient type use model obtain relative risk confidence interval CI included trial patient significant effect blood glucose control mortality CI cardiovascular mortality CI glucose control reduce risk CI although effect incidence CI event glucose control reduce risk CI incidence CI CI significant effect incidence CI risk severe increased glucose control CI blood glucose control reduce risk event without effect mortality cardiovascular mortality glucose control increase risk severe
20097957 en consider important role several disease mellitus DM cardiovascular complication chronic renal DM associate age different drug drug potential complication DM recent report show activity therefore examine effect base level found decrease total control well diabetic group however also found increase diabetic well control diabetic decrease plasma therefore high activity less
19542734 en chronic disease lead decrease may renal renal cell important role result type mellitus T2DM insulin resistance associate renal decrease study aim relationship among renal decrease presence T2DM well role renal randomize group normal control group group group group T2DM group group treatment group group treatment group group group T2DM group treat respective week determined use insulin group glucose rate serum level determined measured use group significant high group compare group level group high level group high group difference significant group level show negative correlation significant difference observed level level group lower group level group lower group high group level group group group level negative correlate positive correlate level group similar lower group level lower group compare group high group level group positive correlate level group show negative correlation T2DM renal may cause decrease activity renal may result significant reduction level
25469524 en increase patient metabolic complication include mellitus DM impair fasting glucose however little known incidence risk factor glycemic disorder datum clinical trial DM define fasting glucose level incidence DM risk factor DM also patient contribute follow-up incidence DM per respective analysis age adjust ratio confidence interval CI adjust CI baseline fasting glucose adjust CI associate DM high incidence DM patient receive therapy potential increased risk glycemic disorder patient age high baseline fasting glucose
26452712 en associate diabetic clinical lower treatment review use perform use mellitus diabetic dysfunction common diabetic population estimate prevalence associate diabetic complication major assessment management population include medical history follow-up diabetic patient perform according finding type dysfunction risk consider management mellitus significant impact lower function on well complication management risk diabetic patient regard complication
20875900 en potential disorder include major mortality develop gene may role type mellitus T2DM use population sample control case assess relationship several fasting insulin level fasting glucose level hemoglobin model assessment presence T2DM examine overall similar case control regression analysis adjust potential risk show evidence association test multiple logistic regression analysis show evidence association test presence T2DM multiple use show similar finding occur large present suggest gene may T2DM risk assessment
20927670 en care group well show improve care outcome disease management system health improve care include hba1c compare health within health system on disease management include health care follow determine whether care can improve disease management health patient improve significant patient remain statistical significant health include patient patient test within year health care population result significant clinical outcome reduce outcome population
20851323 en review determine relationship diagnosis adult population research individual increased incidence group individual increased prevalence great increased among individual prevalence effect population determined research relationship population need effective treatment model develop study also need determine cause effect among population
25716219 en mellitus T2DM protein effective develop effect protein less evaluate T2DM protein effective effect evaluate effect T2DM group base control mass serum parameter determined weight lower weight serum activity although lower parameter different datum suggest protein improve
25336239 en aim study evaluate whether level hba1c can outcome patient type mellitus T2DM study patient T2DM undergo first hba1c level measured model assess relationship hba1c level patient develop follow-up regression analysis revealed hba1c independent characteristic analysis demonstrated hba1c value rate patient hba1c value compare hba1c value test level hba1c associate increased risk patient T2DM undergo
21631993 en study determine effect diabetic complication protein lipid investigate relationship clinical study group type diabetic patient patient without complication patient complication research hospital healthy control subject serum sample diabetic patient healthy subject protein protein level significant high diabetic group control group significant difference level two group significant high diabetic group complication compare diabetic group without condition one cause complication mellitus study diabetic patient
19520452 en type evaluate function control subject intervention intervention effect type mellitus
23703342 en important role type mellitus T2DM test use present study aim investigate correlation status evaluate risk factor T2DM patient study included subject patient T2DM control female mean age clinical include body mass index blood pressure glucose lipid addition T2DM show significant high level control vs on multiple regression analysis revealed cholesterol independent significant correlate level patient T2DM although correlation significant control analysis show independent significant correlate level female T2DM significant correlation level present finding may control female patient T2DM well management female patient T2DM
23645245 en investigate patient type mellitus DM relationship glycemic total type DM patient patient group according score fasting plasma glucose plasma glucose hemoglobin hba1c level test difference group relationship glycemic control patient effective hba1c different level negative related hba1c glycemic control patient disease year significant different due different level patient positive related control level patient positive related control medication blood glucose hba1c level patient positive related control medication time patient receive DM use insulin disease patient important factor type DM type DM patient effective control hba1c glycemic control improve type DM patient disease treatment method effect DM
22672497 en on assessment medication medication aim study medication patient type conduct sample type medication score range high score indicate medication assess use assess review examine use factor analysis medication score respective analysis show one factor high score old lower hba1c level medication less on effect observed may assess medication patient type research can target investigate use patient population
22083554 en type mellitus may possible due increased effect insulin resistance aim study determine impact patient case included retrospective study woman undergo patient two group diabetic patient age status body mass index BMI status treatment type patient included study patient rate vs mean BMI level statistical high vs diabetic patient statistical difference rate diabetic group statistical high diabetic patient compare patient month CI patient month CI diabetic patient odd ratio significant increased decrease result suggest independent factor
24020809 en diabetic cause mortality type study function early use method therefore use determined parameter one week analysis perform use show significant reduction diabetic also show significant reduction suggest observed significant decrease cell decrease datum suggest impair one factor contribute observed decrease early
23317376 en glucose among woman recent history gestational mellitus important identify woman glucose rate review found study among study estimate prevalence glucose tolerance related care woman recent history identify health prevalence estimate clinical related use assess difference clinical provide care response rate reported woman glucose tolerance use fasting blood oral glucose tolerance test although reported woman recent history increased risk type mellitus woman reported woman group reported intervention may improve reported level use test provide identify need change may improve care woman recent
22416660 en research investigate mellitus use mellitus group normal fasting blood glucose determined group on positive control group receive respective group receive treatment group receive drug use treatment mellitus blood glucose body weight week plasma lipid total cholesterol low high blood determined week treatment result show significant reduction blood glucose group compare diabetic control treatment group increase weight treatment group compare diabetic control weight plasma cholesterol level also significant reduce treat study found reduce blood glucose plasma cholesterol level increase weight diabetic treat use treatment
20674218 en first time investigate change serum protein level type mellitus T2DM model treat normal T2DM T2DM addition serum protein profile three group perform use mass identify protein sample three group analyzed estimate protein found effect T2DM serum include serum protein level healthy treatment
25679092 en gestational mellitus define glucose first increasing related health complication recent study role several obesity correlation insulin resistance related renal sample evaluate ratio study first use perform mass range sample condition several condition ratio sample time also test regard parameter ratio mass range method sample base time mass woman woman normal glucose tolerance oral glucose tolerance test according week age week age year study determined statistical significant difference observed high value found group possible can early insulin resistance although
25666344 en gestational mellitus disease adverse outcome study aim identify disease gene profile gene database include healthy control identify value known disease man database known disease investigate gene confidence score analysis perform value database rate total identify include known disease obtain gene identify significant gene significant function consider disease include however study result
22749774 en aim study assess compare activity evaluate correlation glycemic control hba1c body mass index BMI patient type mellitus group woman man type diabetic patient treat insulin mean year T2DM year hba1c assessment use activity assessment female participant respective female respective patient demonstrated high base score show significant high hba1c BMI correlate finding indicate may potential activity assessment method result suggest activity impact glycemic control BMI type diabetic patient however study large population need
20830223 en study conduct examine relationship history type T2DM risk develop gestational mellitus perform oral glucose tolerance test woman glucose tolerance oral glucose addition review incidence T2DM analyzed association history T2DM risk subject normal diagnose compare woman history T2DM woman first history T2DM high risk T2DM odd ratio risk develop significant increased woman history T2DM relative
24507868 en study assess incidence impair glucose type adult one use datum incidence per year patient mean time month
25200039 en investigate whether syndrome patient type T2DM associate low chronic patient poor glycemic control group group T2DM case group T2DM without case control group health without index analyzed hospital serum level determined index low measured model assessment insulin resistance index group high group control group vs vs vs vs per lower group control group vs vs compare normal control level vs vs vs vs vs vs vs vs patient group increased significant correlation analysis revealed positive associate negative associate positive negative multiple regression analysis found independent associate show level chronic activity
25849542 en type mellitus T2DM chronic metabolic disease mortality impact treatment T2DM trial compare reported clinical difference glycemic control study compare effective develop model evaluate T2DM patient effective measured reduction hemoglobin hba1c base case model change hba1c medical time compare per reduction hba1c model clinical datum randomize control trial base case respective use clinical datum per reduction hba1c respective model parameter drug hba1c reduction patient treatment month adverse event rate analysis use datum level per reduction hba1c use datum result effective relative large clinical datum
25841171 en recent identify effect study determine whether association serum development disease patient type mellitus study included T2DM patient without patient lower serum concentration without logistic regression analysis indicate association serum concentration development T2DM patient or CI regression analysis show correlation serum concentration body mass index BMI model assessment insulin resistance protein index T2DM patient analysis show BMI independent correlate serum study show association serum concentration development T2DM patient
25727829 en type mellitus common chronic disease low incidence first month year old age group high incidence time base review study factor associate patient research risk factor event disease low also factor need diabetic patient effective health care intervention factor associate type mellitus
25615723 en mellitus DM associate renal woman compare man mechanism recent DM difference level type DM patient healthy control well function plasma blood pressure rate effective renal plasma measured man woman man woman plasma level general lower man woman difference statistical significant level man high compare woman man man woman correlate negative renal function man negative correlate plasma woman correlate function determine role function difference DM
25944670 en large disease study determined level diabetic individual decrease level level diabetic patient change can function mellitus subject well result decrease level result large compare on similar diabetic patient analysis revealed increased level several protein include factor whereas factor target protein also diabetic diabetic well decrease level target may one mean well function mellitus
23510051 en control associate mortality mean glucose concentration glucose incidence low glucose mellitus DM association study whether association control mortality patient without DM value low glucose cohort
23631443 en glucose renal glucose potential improve plasma glucose concentration diabetic patient use treatment type mellitus T2DM therapy effective oral use treatment randomize study subject T2DM subject randomize one two treatment receive three treatment period two interval duration treatment period subject clinical duration treatment period glucose fasting plasma glucose adverse event clinical parameter include assessment perform treatment period occur day treatment study demonstrated effect although value lower compare effect well adverse event increase well study result development treatment
23582124 en study show lead mellitus type randomize control trial recent randomize control trial compare medical treatment patient poor control perform trial show general effective medical treatment therefore consider treatment patient obesity
23572490 en mellitus independent risk factor report result patient mellitus included trial large randomize study evaluate effect conduct patient included mellitus consider present analysis study drug oral participant datum outcome analysis follow incidence primary group control group relative risk confidence interval on need day also similar group respective ratio confidence interval reduce risk clinical outcome patient mellitus undergo
23213066 en several report clinical association type mellitus DM disease however study effect type DM study study investigate effect type DM conduct cohort study man without type DM year metabolic factor include fasting glucose hemoglobin hba1c development type DM incidence rate type DM compare according normal severe model use ratio type DM incidence rate type DM increased according normal severe adjust multiple confidence interval CI type DM development high group severe group compare normal group respective development type DM potential associate normal addition independent risk factor development type DM result suggest potential early type DM
23130652 en perform evaluate renal early type DM mellitus chronic week DM level measured renal activity measured renal renal protein identify analysis renal increased DM however change DM also elevated renal activity change treatment revealed positive renal DM treatment increase three protein datum protein mechanism include
25903847 en compare outcome woman gestational mellitus new define association study group vs case health woman within week woman undergo glucose test week undergo oral glucose tolerance test result woman group define define define large gestational age hypertension compare among group logistic regression use control use woman respective new identify woman new define significant increased risk adjust or define diagnose case outcome case
20546780 en role blood decrease resistance also contribute function impair patient mellitus blood decrease cause reduce activity increased also increased factor dysfunction diabetic condition blood similar different mechanism dysfunction evidence present blood type type
22539443 en important role type mellitus T2DM complication association T2DM different population different result study association T2DM may cause effect effect review association T2DM metabolic characteristic complication T2DM population
22856232 en provide relationship factor metabolic control insulin mellitus study individual factor well report effect intervention glycemic control patient aged year analysis indicate evidence relationship individual factor metabolic control due result study suggest patient high present poor glycemic control effect intervention increasing evidence show contribute improve metabolic control suggest research include study mechanism finding body research provide include within health care
22311033 en number study examine association diabetic report two gene investigate assess possible relationship among type diabetic patient study subject type mellitus case group patient control group patient clinical diabetic type year duration on significant high found patient control analysis show significant association model odd ratio or CI presence associate CI increased risk adjust risk factor first study risk factor
21303657 en reduce hypertension cardiovascular renal disease little type mellitus DM type DM gestational mellitus respective aim study evaluate role insulin activity type DM type DM patient year disease duration receive insulin healthy individual according age use control patient year week recent diagnose insulin therapy also healthy week healthy woman control use activity estimate determined method activity difference rate activity significant high type DM control patient healthy woman healthy woman respective datum suggest insulin mechanism increased activity type DM patient respective
22161582 en type remain population incidence type increased increase obesity also consider clinical type type although patient care type treatment outcome disease well diagnosis
22167126 en insulin insulin metabolic insulin increase blood dysfunction observed insulin investigate insulin metabolic type obtain insulin participant type follow blood assess use observed positive related insulin measured insulin increased insulin participant within insulin participant change negative correlate insulin result insulin participant high level plasma insulin need insulin participant suggest insulin one metabolic insulin type
23469911 en mellitus DM associate high rate event patient syndrome undergo intervention need develop effective cardiovascular associate DM associate DM high risk complication target oral therapy year treatment patient syndrome undergo intervention however use therapy high rate cardiovascular event occur within cohort patient DM can associate impair clinical outcome DM associate high prevalence reduce therapy may contribute high rate event population finding treatment present review aim oral therapy evidence regard oral therapy include high patient DM
23468443 en patient mellitus DM known large compare patient assess patient DM according glucose subject patient DM patient hemoglobin hba1c poor control DM patient hba1c undergo DM patient vs patient high DM patient compare patient DM patient DM patient less vs less vs DM patient similar patient whereas show significant difference among DM patient similar patient group less DM patient finding suggest control important DM patient
24658008 en hemoglobin hba1c associate increased risk cardiovascular disease aim study examine relationship hba1c level among old patient mellitus retrospective study total type DM patient aged year old undergo first hba1c level measured general hospital evaluate use score subject three group according hba1c level logistic regression correlation use association measured hba1c level mean age year high hba1c level significant associate high score correlation hba1c level score addition high hba1c independent patient high score score age hypertension level logistic regression significant associate among old patient DM on high hba1c value independent prevalence study need finding
24851567 en determine association individual effect hypertension among aged year datum metabolic syndrome year among participant use number participant prevalence association hypertension found among participant hypertension hypertension CI CI CI among CI CI CI among female present study effect association hypertension health hypertension disease important among population
23820625 en mellitus DM major health severe complication significant impact disease due high prevalence severe high study first study DM type type associate complication estimate medical DM complication include medical drug medical datum health use due complication base datum obtain statistical risk use assess DM increase observed year time period medical type DM DM cause significant therefore associate high associate treatment complication hospital complication treatment time hospital treatment per year complication high compare related DM total health care DM complication total health care total DM cause health care system health care total cause complication
20725918 en method mellitus use obtain can use mellitus include glucose condition glucose concentration range glucose respective system serum study different provide
20539226 en current glycemic control less reduce complication diabetic population increase glucose reduce plasma glucose level may present glucose improve glycemic control patient type clinical change status rate associate body weight may reduce blood pressure increased increase risk may increase risk reduce plasma glucose without increased insulin clinical weight major increase glucose provide mean treat condition important remain clinical research need effect potential effect need determine also remain determined whether drug lower glucose renal cell independent may diabetic
21886308 en group high prevalence rate type gestational increased incidence include factor protein gene type protein gestational perform gene study association important protein gene gestational woman diagnose gestational control time use protein control gestational case test use test association protein gestational protein found associate gestational association suggest gestational type may previous
21573904 en decrease duration impair negative influence aim study assess characteristic patient type characteristic control assess possible risk factor impair studied adult patient type man woman duration year control characteristic assess index assess hba1c value clinical obtain medical assess hospital assess patient type poor compare control participant on high patient type increased risk vs significant association individual characteristic hba1c value logistic regression analysis score presence independent associate poor patient type mellitus high risk compare control participant syndrome type
21424847 en factor without need develop can development type mellitus examine effect development use develop diabetic model evaluate plasma glucose glucose tolerance test insulin use mass follow analysis development model demonstrated normal number insulin effect effect control lead also increased model week week development week evidence insulin model analysis demonstrated protein protein reduce insulin increased insulin reduce protein function also result suggest potential effective
21210146 en mellitus common disorder associate time diagnosis related different define prevalence disease patient type mellitus similar study perform sample patient follow medical analyzed patient female mean age year range year mean duration year range year test concentration measured subject also diabetic positive whereas patient positive patient positive female patient positive year patient evidence whereas two patient two patient two patient positive prevalence disease type diabetic patient high general population on type diabetic patient patient year duration patient positive may need assessment function interval
20580584 en retrospective study population care diagnose multiple disorder include disorder time interval diagnosis disorder medical diagnose one disorder review mean age time diagnosis first disorder year common disorder mellitus two mellitus one mellitus on mean month diagnosis first disorder study suggest multiple disorder
26039078 en recent study show gene related gestational mellitus however study remain association glucose level oral glucose tolerance test woman present study aim provide evidence association glucose level evaluate effect study woman control conduct association risk analyzed use logistic regression association glucose level assess use regression model on include present study previous report associate or associate level glucose BMI age independent risk factor perform total high risk or study demonstrated first time associate glucose level woman study provide evidence association
23999171 en insulin effect assess whether mellitus serum level insulin associate disease conduct study man undergo also undergo identify man clinical diagnosis serum level insulin fasting man without without logistic regression use estimate effect level insulin man associate adjust odd ratio or confidence interval CI among positive associate association positive associate adjust obesity level insulin or vs CI association man or positive associate or CI associate or vs CI study associate man serum insulin level associate serum associate positive associate study need man woman finding
24682908 en mellitus DM important risk factor use medication disease however patient event use known resistance aim study assess prevalence diabetic patient factor associate examine group subject diagnose type DM function test perform method blood examine subject patient patient association found age known duration BMI rate mean blood pressure risk factor current treat mean total cholesterol concentration significant high association found result test medication multiple logistic regression analysis revealed factor associate current concentration high study association poor control diabetic patient resistance diabetic patient associate lipid disorder history current
24878048 en effect reduce type mellitus T2DM patient whether impair function patient due target compare patient without T2DM level estimate type cell different evaluate level significant reduce patient T2DM compare patient analysis revealed reduce T2DM patient due decrease number cell body decrease T2DM patient cell reduce T2DM patient correlation found reduce clinical parameter include body mass index age hemoglobin disease first evidence reduce T2DM patient datum function T2DM may also result decrease target
18490524 en patient type mellitus increased risk development on event development cell cholesterol role cell previous found chronic elevated glucose reduce present study examine whether patient type mellitus decrease impair cholesterol increased cell patient without type mellitus blood cholesterol analysis perform patient type mellitus reduction cholesterol increase cholesterol relative control subject present control subject patient type mellitus similar control subject patient type mellitus patient control subject treatment reduce cell patient type cholesterol reduce patient type mellitus impair cholesterol significant correlate increased cholesterol function type mellitus can potential disease observed patient type mellitus
18219529 en patient type mellitus may increased risk chronic insulin therapy may increase risk among patient type mellitus investigate determine whether insulin therapy increase risk among clinical patient type conduct retrospective study among patient type mellitus undergo total hospital among patient number control age case show significant high rate chronic insulin therapy year control regression analysis patient receive chronic insulin therapy three time risk compare patient receive insulin odd ratio confidence interval insulin therapy associate increased risk among type mellitus patient result may provide need patient type mellitus receive chronic insulin therapy
27657457 en several study demonstrated relationship gene type mellitus T2DM risk result among population assess association database association T2DM odd ratio or confidence interval CI model assess review study control case included model demonstrated associate T2DM vs on or CI vs vs vs significant association T2DM risk target regard gene T2DM
25070044 en patient type prevalence remain evaluate prevalence patient type patient healthy control use compare two different test use patient previous patient test according consider patient test test test show dysfunction found patient present study show presence high related associate dysfunction use study need whether different may different whether may dysfunction
21562753 en association mellitus DM risk among man undergo obesity analysis man undergo first datum history DM determined review patient characteristic analyzed analysis DM risk use logistic regression adjust body mass index age year man DM DM associate high BMI DM associate risk analysis similar result found obesity analysis DM associate great risk disease association among man subject DM associate disease man DM associate risk disease man obesity DM associate great risk disease association among suggest effect DM obesity
18232276 en mellitus DM common disease major diabetic patient also general health activity diabetic study assess role activity DM patient value study reduction therapy patient study study included female patient diagnose mellitus according new health found two time according patient type mellitus whereas patient type mellitus activity day treatment patient according activity mellitus assessment level decrease activity DM type patient female respective also DM type patient decrease activity female respective female patient activity decrease level compare patient significant difference female decrease mellitus patient activity decrease level important difference type effect activity patient activity patient need important low effective activity treatment mellitus patient
17986830 en mellitus disorder first year case diagnose however low value important diagnosis age group major related diagnosis treatment follow-up diagnosis early possible important patient treat oral major obtain diagnosis follow-up patient disease syndrome type first year insulin treatment major medical
17473488 en common treatment on adverse effect however treat patient recent year period found patient mellitus compare diabetic patient patient patient mellitus control oral patient mellitus can group one group positive type mellitus group mellitus type mellitus
17074529 en mellitus one common disease target system diabetic case type relative development insulin resistance type early cause severe level insulin clinical common metabolic diabetic patient level important role development insulin disease provide review
18940155 en general hospital follow-up patient chronic disease investigate risk develop care patient included patient patient follow-up level level follow-up level follow-up care level follow-up result compare patient follow-up total patient type type included among level level level on total patient follow care care control general high risk profile model can patient follow model less patient low risk general
22074727 en associate insulin resistance aim current study determine incidence therapy effect fasting plasma glucose concentration hba1c adult patient total patient mean age year BMI analyzed mean period year range total number observed number case compare number case rate three one develop old high BMI concentration blood pressure lower concentration develop incidence per significant increased compare well population increased BMI decrease duration significant association subject develop plasma glucose concentration increased hba1c increased year incidence increased patient receive adverse risk profile baseline therefore glucose parameter patient
21245462 en protein protein high role study protein show test whether cell develop use insulin evaluate change normal function gene profile response significant normal mass insulin response high glucose low level treatment day weight significant weight identify target revealed significant among protein significant result result suggest factor
19935498 en mellitus chronic disease general population two first patient mellitus high incidence disorder may cause metabolic activity high potential cause metabolic risk high high risk associate association association management patient include baseline assessment weight blood pressure blood glucose level history obesity hypertension cardiovascular first three month weight analysis perform first three month year patient significant weight increase blood glucose level first intervention patient change
19701877 en low effect high metabolic control patient type examine study patient type receive week oral study participant test week week study blood sample clinical parameter metabolic risk patient study test well week significant reduction observed fasting blood glucose insulin insulin resistance risk factor addition significant lower concentration found female participant blood blood lipid remain reduction within significant metabolic control present study finding previous reported study subject effect low glucose patient mellitus type
20173777 en protein high response important function also clinical disease disorder type mellitus T2DM common metabolic condition cause insulin resistance cause role dysfunction addition effect system effect potential target mellitus reduce disease incidence model type mellitus clinical trial study therapy patient review patient
26173919 en oral drug improve control without cause weight increasing risk patient type mellitus T2DM include use oral mechanism similar profile patient T2DM may use oral although important may clinical patient difference include target oral plasma protein metabolic renal potential dysfunction impair drug clinical due profile low risk effect body weight disease clinical study need management T2DM potential
20196738 en type mellitus associate low cholesterol level independent cardiovascular risk factor low cholesterol concentration determined different protein include cholesterol protein cholesterol protein well different include type type mellitus also associate cholesterol well impair type mellitus first present review type mellitus activity protein different factor influence review new impact glucose cardiovascular complication
20129809 en evaluate type type mellitus T2DM datum case T2DM case occur among aged year obtain study evaluate incidence rate study within group significant within study observed T2DM evidence correlation T2DM present level level evidence correlation observed study provide evidence presence type type incidence among aged year
19926034 en mellitus recent incidence incidence remain high high rate high prevalence condition poor control time mellitus prevalence obesity evidence mellitus important risk factor disease treatment response glucose control review provide evidence role mellitus clinical response treatment addition review potential mechanism mellitus cause effect diabetic control related
22953310 en medical treatment patient type mellitus obesity body mass index great current treatment complication effective treatment weight also examine current evidence impact weight type
23320544 en demonstrated dysfunction possible increase lipid decrease serum present study investigate whether reduce lipid dysfunction man type subject control randomize concentration well score subject study serum glucose insulin concentration similar subject control reduce compare control two score significant different control mean concentration control result reduction increase dysfunction man type therefore may lead potential cardiovascular patient type mellitus
22579719 en development diabetic type mellitus T2DM associate poor control disease duration clinical however complication poor patient study test function associate T2DM study included T2DM subject without plasma assess use system indicate time decrease patient undergo clinical also measured identify use lower vs vs subject logistic analysis revealed association fasting glucose duration well insulin treatment adjust well age association impair associate T2DM patient however whether lead development presence
27269925 en determine effect serum level patient type mellitus
27258493 en use associate hypertension mellitus however relationship risk examine study investigate association use development gestational mellitus aim study determine whether use increase risk conduct study database health review assessment woman included among case case identify control included logistic regression analysis adjust drug use include case control case control subject identify drug use adjust use associate increased rate adjust odd ratio CI medication ratio associate increased risk however statistical found model adjust model use associate increase risk use associate increased risk
25097861 en woman history type previous gestational group high risk cardiovascular event change risk level well association glucose index parameter glucose insulin resistance function lipid level parameter dysfunction evaluate woman month diagnose woman woman group high lower function group group glucose correlate independent group fasting glucose effect risk woman woman high level decrease cell function associate independent index value fasting glucose important risk independent associate
22299476 en protein new possible obesity type mellitus T2DM renal condition mellitus evaluate association among renal function T2DM population serum level analyzed subject T2DM use base estimate rate per according use serum level age T2DM status subject group control per group control per group T2DM subject per group T2DM subject per T2DM control group level high subject per subject per however difference significant control group adjust age BMI presence T2DM T2DM associate plasma level result suggest among presence T2DM major serum level evaluate role insulin resistance T2DM
21862132 en insulin treatment clinical current patient type mellitus type mellitus T2DM current evidence base treatment also patient regard treatment study aim individual different insulin base develop value adult T2DM regard different therapy participant present value total participant response rate T2DM high value participant weight respective major increasing number day per week blood glucose level target range reduce number participant T2DM similar factor high first study assess insulin therapy can management however sample can result T2DM high value weight reduction number
20940076 en observed subject mellitus aim study evaluate whether mellitus increase risk subject patient female mean age year glycemic control compare well age female mean age year normal subject female mean age year subject range measured evaluate on significant reduction found subject compare one patient compare show observed diabetic datum increasing
25706868 en patient undergo develop disease complication previous reported significant lower patient healthy subject aim identify factor patient man woman mean age year duration year use level significant lower patient compare healthy control vs multiple regression analysis show independent associate duration serum concentration significant lower patient mellitus DM compare patient without DM vs patient multiple factor include duration serum concentration first report significant lower level patient DM without DM
23879031 en diabetic complication change characteristic complication lead change result different level increase concentration decrease dysfunction factor patient type mellitus reduction system use research
23705638 en type mellitus T2DM increasing major health estimate health response study aim prevalence T2DM among adult period prevalence T2DM estimate among adult aged year old period use impact model model prevalence T2DM period increase T2DM prevalence high man woman increase prevalence T2DM year year age T2DM high level T2DM estimate population aged year old T2DM
23579029 en role increased serum concentration associate disease therefore can type also serum level determined cohort patient healthy control subject observed one database gene control patient analysis perform control patient association found age diagnosis level serum concentration similar group associate serum concentration group
19811579 en result study examine difference patient mellitus undergo use diabetic patient mellitus undergo presence use score analysis regression analysis perform assess association type control insulin oral serum level glucose protein time significant lower compare vs vs method correlation analysis show high statistical significant association two correlation type control level glucose however significant correlation significant decrease compare patient mellitus undergo level glycemic control time associate serum level
26017649 en investigate blood glucose level effect patient score patient type mellitus T2DM disease without randomize study patient T2DM disease undergo oral study blood glucose level use glucose system patient randomize two group patient receive patient receive parameter blood pressure rate level also difference blood glucose level group time evaluate group demonstrated significant decrease blood glucose level time group show significant difference status cause significant impact parameter however lower blood glucose level observed first report use blood glucose show effect patient type mellitus disease
25920313 en insulin resistance define clinical known insulin increase glucose recent year increasing role type mellitus related complication aim possible role observed patient also risk factor several complication patient role studied however datum study different population show may condition diagnose woman healthy subject role relative however complication general population health disease base may factor outcome woman therefore reduce glycemic control control weight woman also
25887236 en insulin resistance role type mellitus T2DM mechanism may associate whereas ratio new investigate relationship study aim evaluate relationship determine whether sample total patient T2DM value control group age BMI healthy value diabetic patient significant high healthy control value patient value great patient value correlation analysis show significant positive correlation logistic regression analysis show risk include hba1c CI level correlate positive odd ratio increased factor CI one increase significant associate high value may
25726031 en although oral medication type mellitus T2DM patient insulin therapy glycemic control prevalence insulin use among patient T2DM study evaluate impact treatment patient treat care estimate associate use insulin therapy among patient new diagnose T2DM treat retrospective study use medical datum adult diagnosis T2DM identify first diagnosis index period index use assess treatment base treatment cohort cohort receive great medication receive insulin cohort insulin therapy duration day patient ratio base score rate use outcome assessment period compare patient insulin included analysis woman mean age year cohort per patient per month high total cohort vs difference cohort rate event per cohort per cohort less insulin therapy associate increased event increased medical great health care
25356815 en compare score may adverse cardiovascular event diabetic evaluate value assess patient type mellitus estimate rate great total patient found three patient respective great found patient respective characteristic analysis found confidence interval positive negative value respective logistic regression analysis age odd ratio or or current or great or found independent associate increased risk respective great improve status current finding suggest effective evaluate disease use patient type mellitus function
25277671 en mellitus DM associate dysfunction reduce increasing factor increased risk cardiovascular disease effect function investigate conduct randomize clinical trial study consider according study man type DM chronic function study analyzed diabetic man randomize respective evaluate mean increase CI result show high perform analysis significant improve high protein respective statistical respective significant reduce serum level CI suggest effect chronic function chronic improve serum diabetic man large study need effect chronic function
25153576 en complication mellitus DM increasing duration disease poor glycemic control age new diagnose type DM present weight day previous week patient recent DM type diagnose base serum glucose negative study patient hospital month group on diagnosis possible retrospective
27881170 en associate increased complication addition also influence parameter may rate complication management evidence hba1c can increase aim review relationship parameter conduct study study total participant type type review relationship show mean difference hba1c CI difference cholesterol CI difference cholesterol CI however statistical significant difference blood pressure two group difference hba1c statistical significant CI however revealed period year hba1c statistical significant lower hba1c lipid profile compare lead increase hba1c may reduce complication impact lipid profile
21420530 en aim result obtain clinical trial evaluate effect glycemic control complication associate type mellitus current evidence review control cardiovascular risk study group disease control trial clinical trial general study clinical management type well need clinical research
23618488 en mellitus metabolic disease increase hemoglobin hba1c disorder activity reduce patient type mellitus evaluate outcome type DM study T2DM case group study two major group group group receive three per day three month parameter hba1c glucose evaluate baseline three month statistical analysis evaluate use mean age patient female range year blood pressure result show significant difference group baseline compare receive use show significant difference concentration plasma hba1c significant difference group level show significant increased group research subject T2DM three month demonstrated significant low level hypertension decrease level blood glucose increase activity reduce insulin resistance parameter
23592065 en aim study association function medical treatment year chronic patient man year age chronic renal disease mellitus patient three group three assess function test function test relationship function patient chronic disease mellitus type medical function associate type medical treatment adult chronic renal mellitus use function important identify management function mellitus type chronic renal disease
23539399 en report case type mellitus treatment chronic man previous diagnose mellitus occur month therapy patient also type insulin resistance one year patient insulin treatment positive patient disorder test treatment
23458774 en index recent risk risk clinical factor effect evaluate function study perform investigate relationship index patient type mellitus study population patient man woman year old use parameter need pressure pressure parameter obtain include serum hba1c great elevated patient compare control independent hba1c correlation hba1c negative influence poor control function independent correlation improve association suggest association well patient
23121123 en obesity disorder type mellitus T2DM man well man may effect normal function regard clinical on high index presence assess man remain management associate study development clinical important condition
23053856 en dysfunction increased common patient mellitus DM however two factor remain aim study investigate relationship function assess patient DM mean age year man patient type DM function assess evaluate whereas assess blood pressure pressure index mean ratio ratio respective mean mean mean respective independent associate dysfunction independent related ratio dysfunction parameter associate index function patient DM therapy reduce pressure may reduce prevalence dysfunction population
26117955 en number different cell mellitus DM different investigate effect DM use two week DM different increased significant number cell plasma cell cell increased well significant cell show also on cell week DM number decrease compare week treatment however number high compare control correlation cell role well increasing
25867373 en investigate patient type mellitus T2DM investigate value on total patient T2DM patient impair fasting glucose included study health control group determined use correlation serum concentration fasting glucose analyzed use correlation analysis significant difference observed serum T2DM group group control group compare control group group statistical difference observed T2DM group statistical difference observed group compare control group patient T2DM correlation identify serum on poor correlation identify blood level show increase T2DM patient may associate disorder
25808148 en on number study effect base known blood however effect blood glucose level test report common effect model obesity type mellitus effect present diabetic increase blood glucose level effect significant
25683794 en review analysis study compare association type mellitus review clinical trial compare use treatment effective use follow hba1c fasting plasma glucose patient hba1c treatment due effective treatment need included follow weight treatment type adverse event adverse event patient type patient severe treatment due adverse effect study group treat show result effective regard difference observed great number case group treat adverse event treatment due occur case group compare group remain adverse event include mortality show difference group weight difference group consider clinical great effective association difference adverse effect severe patient treatment association due well effective may treatment patient potential population treatment
25490061 en use lower total cholesterol cholesterol level among patient type type mellitus T2DM however study among patient patient high cholesterol cholesterol may also effective compare effect among subject female T2DM female therapy week T2DM subject lower baseline respective whereas effective respective among subject show significant decrease baseline although lower respective effect lower among subject compare T2DM subject study show cholesterol less effective T2DM subject whereas cholesterol little effective among subject
25325344 en type mellitus metabolic disorder associate increased related cardiovascular complication use aim study evaluate effect mean profile blood sample patient treatment sample analyzed determine level relationship level clinical hemoglobin cholesterol evaluate change level although significant decrease level patient observed response drug found however presence gene may associate response patient whereas clinical show association drug use finding previous report patient use primary event
21989315 en mellitus DM one major health develop type DM condition patient DM common addition condition relationship disorder evidence suggest common mechanism may role DM several possible mechanism diagnosis management review common mechanism factor insulin resistance new can due complication type DM DM patient identify complication complication DM addition complication DM important diabetic patient health may overall management DM management disorder management control also reduce health complication patient
25891975 en estimate evaluate diagnosis medication identify patient use datum medical care hospital medical care assess diagnosis medication identify patient use examine difference patient characteristic use logistic regression identify adult among use analysis diagnosis medication CI respective diabetic patient year age woman diagnosis medication diabetic patient diagnosis medication glucose hemoglobin measured less diagnosis medication identify one patient
21158919 en mellitus complication renal number risk factor identify potential impact development perform retrospective study history renal define need therapy without history analysis risk factor development perform on total patient develop group group analysis age body mass index BMI use identify independent risk factor development patient group lower BMI less history disease result result study suggest impact development
19154948 en elevated factor level cardiovascular dysfunction associate high mortality rate patient type mellitus test elevated associate insulin resistance cardiovascular dysfunction patient type mellitus receive insulin treatment study group type mellitus patient high level year old group control group type mellitus patient normal level year old group cardiovascular function assess rate plasma concentration early value lower respective rate high group group fasting plasma insulin concentration model assessment index value high group group multiple regression analysis revealed level independent model assessment index value result high level associate cardiovascular function insulin resistance patient type mellitus
27149468 en previous identify association mellitus DM risk disease however result study perform investigate evidence base cohort study assess association DM risk database include identify cohort study study reported risk estimate associate DM adjust effect estimate use test well assess total cohort study individual included adjust relative risk associate DM CI effect female CI CI association similar study research study sample year duration baseline age result CI finding base cohort study indicate associate increased risk study association mechanism
23245702 en patient develop mellitus DM compare general population relative however increased rate DM reported study compare DM rate relative patient disorder control subject study prevalence DM increased relative patient compare relative healthy subject finding possible DM disorder
23273718 en diabetic possible type mellitus T2DM risk aim study association rate dysfunction T2DM patient T2DM mean age year man without mellitus complication negative result patient known disease clinical assessment insulin use association use model event follow-up period year event associate age index baseline hemoglobin mass index function model outcome model base clinical datum age overall significant improve index significant improve addition provide significant value regard association independent index function indicate role metabolic risk patient T2DM
23001157 en mellitus type associate dysfunction however relationship dysfunction patient large study evaluate whether increased increased associate dysfunction decrease assess analysis patient assess cardiovascular patient patient undergo assessment function index rate assess analysis period ratio independent sample test regression analysis use statistical analysis significant correlate function patient associate function decrease measured analysis
22991242 en type mellitus T2DM insulin resistance review recent mechanism T2DM recent T2DM include mechanism insulin resistance decrease insulin also role mechanism may normal role T2DM response T2DM may provide new treatment mellitus
21937208 en three group subject identify within sample old subject normal fasting glucose impair fasting glucose type mellitus aim present study evaluate relationship among plasma lipid metabolic factor three group role total subject aged year study included analysis factor analysis conduct man woman factor score use independent model determine factor follow-up subject major factor found man insulin resistance body total cholesterol cholesterol also woman insulin resistance total cholesterol body cholesterol man man woman cholesterol significant factor total man CI man CI man CI woman CI among woman body factor also factor total CI factor include cholesterol show mortality old man independent level woman diagnose
21165420 en mellitus increase blood level chronic mellitus associate increase blood level follow development mellitus remain disease level decrease early value mellitus change observed concentration reduce
20964461 en old population increase health two condition common occur contribute hypertension mellitus effective blood pressure control important patient population patient treatment define use two medication common patient population risk potential therapy consider possible multiple drug therapy reduce risk include review patient medication include therapy use therapy great reduction also patient demonstrated number clinical trial medication reduction complication independent reduction therapy control control outcome patient hypertension
20959501 en review effect low glycemic index glycemic risk factor type mellitus T2DM T2DM conduct use use type mellitus glycemic included randomize control study examine effect intervention low glycemic index glycemic risk factor hemoglobin plasma glucose concentration subject T2DM T2DM low glycemic index studied treatment T2DM study review randomize study randomize study randomize study individual low glycemic index improve glycemic risk factor decrease per day decrease low glycemic index glycemic index however result low glycemic index one study change study T2DM receive medication elevated concentration clinical trial need determine role low glycemic index treatment T2DM
22742209 en disease management improve health care diabetic treatment according current low rate health assess whether lead difference well determine overall cohort study compare level health associate patient year datum use datum identify patient treat medication insulin study period diabetic receive care high provide general vs vs well provide care vs increased level medical assessment treatment lower patient day hospital compare day patient treatment overall increase care medication study period lower patient vs overall patient control group health assessment show result indicate improve care well overall due lower rate due retrospective study datum research control trial provide whether include
22366881 en function may early individual type mellitus impair type assess type healthy control use baseline define time time time baseline compare high type healthy control vs lower type vs control vs difference group baseline time time impair type high cell type
24912127 en gestational mellitus important increasing health study aim investigate reported prevalence among database study prevalence two independent assess result datum risk conduct examine use analysis finding prevalence total study similar reported study great reduction within use study increased method datum assess effect factor study datum prevalence finding show high prevalence woman woman great increase prevalence age woman increase prevalence time prevalence increased two study compare although prevalence among woman due
24550580 en compare effective therapy type mellitus DM type DM patient randomize three group group on receive day group patient treat group receive week fasting plasma glucose plasma glucose body weight measured week hemoglobin hba1c week significant decrease level week compare value hba1c level three treatment group significant decrease week compare baseline value hba1c level group significant decrease compare group on week addition also significant decrease level compare analysis show statistical significant change weight study subject different significant decrease hba1c compare type DM patient
23793876 en patient mellitus DM normal may dysfunction assess whether dysfunction may time remain present assess change function analysis clinical patient type DM normal total patient type DM normal year man evaluate patient remain clinical baseline follow-up perform measured assess function rate time early rate assess function follow-up significant increase mass index significant decrease ratio observed remain analysis demonstrated significant adjust change mass index change remain significant patient type DM normal may show function assess change
20616309 en examine association association risk factor disease large association participant study regression model impact model effect status observed significant association adjust odd ratio presence CI observed impact risk presence show reported associate associate protein associate protein factor associate evidence association association potential disease outcome association
25777969 en treatment type mellitus several insulin reduce several clinical trial demonstrated control patient control type include use therapy insulin addition control effect control reduction treatment year general well clinical trial adverse event common low risk use may associate insulin effective general well treatment patient control type
25668200 en gestational mellitus found independent risk factor type mellitus cardiovascular dysfunction however datum risk renal disease study investigate whether risk renal study compare incidence renal cohort woman without previous occur period mean follow-up duration study conduct medical study population woman outcome diagnosis renal woman little previous use show woman high rate total renal vs respective odd ratio confidence interval addition found significant association use test number risk renal respective model adjust independent associate renal significant risk factor renal risk patient
17493087 en study body mass index BMI prevalence mellitus hypertension examine BMI among patient condition compare result two study improve early management risk factor health clinical datum conduct year old response receive adult participant prevalence mellitus hypertension estimate within BMI BMI level among individual disease mean BMI increased BMI associate increased prevalence mellitus hypertension study condition patient estimate prevalence mellitus hypertension similar study high study prevalence mellitus hypertension occur range BMI increased high BMI however patient metabolic disease condition prevalence may method datum relationship BMI metabolic disease
22779336 en early complication patient type mellitus metabolic complication disease significant influence range aim study evaluate hemoglobin hba1c fasting two group patient group glycemic control hba1c group poor glycemic control hba1c control group patient hypertension fasting glycemic patient three value patient test hba1c determined high group poor glycemic control lower level found group glycemic control however low level control group difference statistical significant fasting well increased group high hba1c group glycemic control hba1c group poor glycemic control significant large group hba1c increased hemoglobin fasting well influence hemoglobin
22588816 en determine prevalence disease type mellitus use retrospective hospital study conduct hospital total age year range study cohort included patient female total number positive patient patient patient less weight age age patient show association low level disease difference mean hemoglobin level insulin prevalence patient consider among high reported therefore
22553992 en mellitus DM important health impact patient DM present study evaluate incidence impact DM outcome patient patient primary receive treatment patient without DM retrospective investigate impact DM overall patient patient reported history DM current one medication patient DM significant old without DM high incidence disease high body mass index without DM significant difference type disease renal disease two group DM patient high incidence patient without DM vs high prevalence DM patient significant impact DM observed retrospective study therefore treatment patient DM patient without DM
27149499 en rate due among patient without type use hospital datum patient hospital analysis patient primary diagnosis group status diabetic incidence overall status study period period year analyzed identify patient rate due increased significant diabetic patient case per case per patient respective incidence high among patient diabetic patient time patient undergo increased group whereas patient undergo decrease increased high rate among diabetic patient incidence rate ratio confidence interval CI among patient incidence rate ratio CI mortality lower diabetic patient patient odd ratio CI incidence rate high patient increase high rate among diabetic patient diabetic patient significant lower mortality possible early diagnosis improve treatment
18426823 en protein age diabetic complication aim evaluate association mellitus DM one age sample obtain DM patient control addition investigate sample control use method examine significant high diabetic patient subject diabetic group range vs control group similar significant difference diabetic control diabetic group vs control group protein significant great diabetic patient control association diabetic model may possible protein contribute development therefore study age dysfunction potential indicate
22361981 en aim study examine association type mellitus early analysis man woman different total total lower perform type define use medication fasting plasma glucose glucose impair glucose tolerance analysis glucose logistic regression use estimate association prevalence adjust possible total individual analysis associate age weight status history total related or increase CI total or CI associate finding association prevalence type role factor determine correlate development condition
18038707 en mellitus type base compare retrospective study mellitus status type type base status presence obesity type patient type type patient significant lower BMI blood pressure type patient high insulin type type patient total cholesterol significant type type mellitus consider among present type clinical insulin high
21150617 en review provide evidence patient type mellitus T2DM may patient T2DM renal disease insulin patient result insulin improve glucose on number retrospective study outcome patient type mellitus T2DM undergo although patient T2DM include patient less year age BMI less year total insulin less fasting level less severe disease function presence datum show T2DM outcome patient undergo type may diabetic patient evaluate base well follow-up
20820904 en mellitus metabolic disease cause relative insulin result protein lipid reported associate type complication study activity diabetic complication assess complication type activity lower type group control group regard activity correlation found diabetic complication study gene population
24728128 en type associate insulin contribute level rate change test association individual rate change year follow-up individual study associate fasting glucose insulin response index glucose effective gestational mellitus or insulin difference fasting plasma insulin concentration index also associate rate change fasting glucose insulin evidence association rate change cell insulin contribute level insulin difference rate change insulin observed association rate change insulin response change insulin effect
25849480 en high rate disease reported high risk determined risk disease cohort patient type type T2DM disease health datum determined incidence adjust risk disease compare risk disease compare adult high risk T2DM adult lower incidence compare incidence low however risk relative high less may development
24746438 en insulin resistance cardiovascular disease factor reported associate insulin resistance studied association factor known patient mellitus disease positive protein negative associate patient age disease included study patient evaluate cardiovascular risk factor blood sample assessment time base patient significant lower protein total compare diabetic diabetic patient lower on significant lower diabetic patient positive protein negative correlate correlation individual show negative correlation negative correlate correlation factor insulin resistance
24851592 en study aim patient diagnosis type mellitus T2DM health related study use analysis patient T2DM duration use use datum follow identify datum management use patient diagnosis T2DM function function treatment management need patient associate
24059320 en role body function associate disease type disease recent study provide use potential target treatment disease review provide function relationship type mellitus disease potential target
21672004 en evaluate response patient assess factor associate patient type response determined patient baseline adult group group patient old age range duration lower datum show low rate low rate patient trial old patient patient duration consider measured first
25098030 en woman gestational mellitus increased risk develop patient characteristic associate glucose tolerance retrospective review included patient define fasting plasma glucose level oral glucose tolerance test patient undergo assess factor result diagnose woman diagnose early gestational age high value also therapy several model positive negative value factor result patient patient decrease risk develop compare patient
19625242 en determine prevalence cohort patient normal serum concentration primary care retrospective cohort study compare adult patient without patient old year identify use database year primary care patient hemoglobin level man year old man year old woman known cause identify compare patient patient normal serum level man woman patient old age high serum level lower estimate rate reduce serum level common patient without prevalence high patient treat insulin receive oral medication logistic regression analysis serum age use statistical prevalence patient normal serum level factor associate old age high serum level use therapy
22330753 en clinical evidence model show relationship base suggest management mellitus randomize control clinical trial conduct hospital determine effect status population period week can improve general health status several target compare control group independent sample protein level significant decrease ratio level significant improve result also finding significant difference protein ratio serum may present management risk cardiovascular disease disease condition
24980704 en gestational mellitus associate adverse effect health recent aim study evaluate new association study group prevalence risk factor oral glucose tolerance test perform woman week define according fasting plasma glucose plasma glucose fasting glucose plasma glucose glucose value included diagnosis prevalence risk factor week studied according two total prevalence high age independent associate age fasting insulin week associate increase prevalence compare risk factor use
27523286 en syndrome disorder cause gene define mellitus syndrome two two gene on present syndrome due possible activity factor patient possible activity factor year month year month respective need syndrome patient syndrome clinical improve significant suggest important syndrome can severe present previous reported patient syndrome
26334523 en type mellitus T2DM chronic metabolic disease major impact disease include number however estimate prevalence incidence associate disease well current development difference large prevalence incidence presence examine year datum large health analysis base respective datum age population total study cohort year prevalence T2DM year age range year age year old year prevalence respective incidence rate rate per disease risk odd ratio T2DM hypertension disease renal year several year early compare common increasing population high age T2DM observed well increase early year datum need include early diagnosis well health major disease T2DM
25017195 en several risk factor reported aim study among chronic disease mellitus DM hypertension risk three different evaluate retrospective use patient analysis adjust age DM hypertension current status analysis conduct logistic regression analysis revealed significant associate whereas DM associate found DM increased association hypertension significant associate significant association three high prevalence risk common three different DM well hypertension relationship risk
18806274 en case diagnose type study conduct population however may population evidence high prevalence syndrome associate high rate aim evaluate perform study analysis follow study population diabetic patient found mellitus DM compare patient identify DM protein result result major impact factor effect
26607295 en study one age study woman gestational mellitus factor contribute level potential outcome
22054905 en patient high incidence total patient without hemoglobin hba1c level blood glucose control diabetic patient on total patient undergo primary total total one hemoglobin level examine evaluate correlation control hba1c total occur diabetic patient patient diabetic patient patient diabetic patient hba1c level range mean diabetic patient hba1c level range mean hba1c level patient diabetic patient significant high risk hemoglobin level risk
25016144 en increasing number type relative odd develop diabetic patient range compare patient develop two disease need role control primary study evaluate serum level gene healthy patient result show group lower level patient low study suggest use high
26106186 en mechanism disease significant cause dysfunction cell occur also obesity cell may role type impact function dysfunction metabolic change high glucose lipid cell cell cause metabolic change target mechanism may large impact disease can effective complication current therapy impact therefore cell significant treatment type complication
19165288 en risk complication type mellitus total blood glucose level impact health individual effective method need insulin therapy normal level blood glucose patient increased severe present without provide patient one major factor treatment therefore method mass need significant cell however cell research include assess potential therefore new develop new base cell treatment mellitus type
26187848 en review examine prevalence type mellitus T2DM identify risk factor among adult database identify study include prevalence estimate T2DM estimate major T2DM included old age high level body factor hypertension prevalence rate study potential important risk factor level review prevalence T2DM suggest control disease
21224289 en recent demonstrated glucose protein increasing plasma insulin role insulin current study investigate effect patient type receive randomize study assess use plasma lipid measured mass study provide possible reduction observed increased analysis cause patient type potential plasma insulin also potential effect increasing
21512208 en although known disease possible clinical clinical analysis also sample recent method analysis analysis need sample therefore potential result patient one possible analysis may metabolic control patient mellitus provide study analysis also previous reported factor may potential mass mass develop time although include analysis use potential use metabolic condition may include mellitus clinical present factor may although method control important method blood glucose
18488152 en evidence several mellitus role disease aim present study compare level sample blood patient mellitus type mellitus type control subject age range concentration measured mean method use overall found range value result study show mean value significant reduce level high blood sample diabetic patient diabetic patient compare control subject level sample diabetic patient found high significant level found high patient healthy control result obtain study may role development mellitus
23431394 en obesity history important type population however known whether related obesity associate risk develop T2DM population present study evaluate association obesity T2DM study included patient T2DM patient impair fasting glucose impair glucose tolerance control subject include result show association T2DM age body mass index BMI or also associate or independent age BMI association found studied association analysis adjust age show associate BMI fasting plasma glucose fasting serum insulin subject without T2DM however fasting plasma glucose significant factor adjust BMI result suggest common associate T2DM independent obesity population also effect plasma glucose concentration BMI insulin
20061332 en cell increased type diabetic patient type associate high patient patient type control included use function measured total level activity level measured type mellitus high number vs lower vs high vs lower vs lower activity level vs compare control positive correlation level fasting glucose level correlate correlation number correlation number activity level multiple regression analysis show level associate elevated patient type mellitus increase glucose control
20012857 en resistance study show resistance improve control type patient type mellitus report effect health status participant type mellitus week resistance resistance control intervention outcome included health status assess score medical outcome measured measured value statistical due multiple model analysis indicate resistance lead clinical statistical significant score compare control score clinical important control compare resistance effect score overall participant included analysis adverse event study include participant group participant resistance group participant group participant control group participant included analysis trial health status patient resistance health status study health research association
22814835 en prevalence mellitus correlate among adult population population base study medical research adult year drug included outcome prevalence correlate mellitus among adult population use individual weight blood pressure measured blood fasting blood glucose blood study subject diagnose diabetic analysis age body mass index ratio hypertension total blood cholesterol found statistical significant logistic regression method analysis age body mass index ratio total blood cholesterol statistical study adult increased age high total blood cholesterol important correlate
19873688 en compare outcome mortality complication type mellitus randomize control trial patient receive use outcome research model baseline patient characteristic randomize control trial effect trial use datum outcome clinical patient type trial three cohort patient base baseline characteristic patient trial patient trial patient patient impact three treatment type incidence cardiovascular renal event estimate three time period year improve three time compare great year follow-up respective renal event lower rate first high compare high compare use model datum trial complication compare treatment type
25827194 en mellitus DM remain health care evaluate outcome DM patient present cardiovascular disease period retrospective analysis perform include patient hospital rate per patient DM diabetic year female DM vs show time compare diabetic present vs occur year early compare study period use increased however per per year DM per overall case rate DM diabetic patient year early diabetic regression analysis revealed mortality DM patient included use or CI use or CI or CI use or CI or CI age or CI remain although rate diabetic patient increasing mortality rate use medication however improve medication diabetic patient associate increased mortality need regard risk factor DM healthy great need primary diabetic patient
25742566 en according health mellitus DM year cause DM impact system body cell dysfunction protein multiple treatment DM protein target type significant target glucose well insulin resistance cell cell similar protein well oral control potential clinical outcome role effective clinical new therapy DM individual
25565158 en current insulin therapy mellitus cause patient among therapy oral great include low due poor poor review provide oral insulin
25030030 en study suggest may associate mellitus DM however result review risk conduct study assess association risk study identify database also review included study reported or association risk DM two independent datum assess study study independent report participant patient DM included on adjust or association DM risk CI analysis association DM man CI woman CI associate statistical high risk DM normal difference among significant associate increased risk DM increase significant high among man group study
27040861 en study compare therapy patient type mellitus control review randomize control trial perform two independent study datum assess risk clinical outcome cardiovascular event hba1c change baseline body weight event rate on use effect model conduct mean difference treatment effect risk ratio adult patient type glycemic control included analysis compare difference hba1c change subject whereas significant decrease rate event observed patient little one event follow-up period week body weight decrease CI compare datum assess difference risk cardiovascular review show clinical significant difference assessment analysis show significant decrease risk event patient use
26721648 en patient age low conduct trial determine whether provide study primary blood participant diabetic status receive elevated associate primary concentration included low syndrome major adverse event protein analyzed randomize participant participant receive great mean increase baseline level compare receive vs respective mean difference confidence interval CI decrease incidence vs respective relative risk CI incidence similar group participant without type mellitus significant decrease compare vs respective CI associate increase protein lower incidence event may patient condition blood study
25275713 en early change function assess patient type mellitus DM compare healthy patient type DM age year DM duration year control undergo index measured measured rate early rate mean age year mean duration year lower diabetic patient control on high time diabetic value lower ratio high diabetic rate decrease diabetic respective early rate control respective patient type DM function measured impair control function impair
20414550 en investigate relationship activity total activity analyzed type type diabetic patient weight incidence metabolic syndrome patient use activity activity show high positive correlation weight group relative activity show negative correlation present study suggest positive correlation activity mellitus insulin resistance may high value activity associate insulin resistance diabetic patient diabetic patient presence relative high lead less metabolic syndrome
20170482 en early diagnosis follow cardiovascular risk intervention may improve outcome type mellitus T2DM target evidence clinical effective intervention trial T2DM case high risk glucose tolerance T2DM effective population identify disease early care method control trial cardiovascular risk management within group trial among T2DM compare treatment intervention within general research glucose tolerance test within population individual aged year year also provide medical history health undergo lipid profile assessment primary outcome reduction model disease risk year three year identify T2DM cohort relative difference treatment group one year occur new diagnose T2DM case receive according current cardiovascular risk intervention large target T2DM risk assess T2DM disease contribute significant health care need
17151739 en two case mellitus occur association reported first case develop mellitus within week due insulin therapy two within day mellitus case diabetic severe disease diagnose day perform due within day mellitus within week remain without insulin period little two case mellitus occur association diabetic occur mellitus suggest may occur previous report however suggest case may result mellitus management insulin therapy risk insulin effect result diabetic insulin may contribute adverse outcome study regard risk
18595633 en evaluate effective mellitus disease management year complication early diagnosis population level time show diabetic patient significant value time age duration increasing time control indicate improve early diagnosis care mellitus indicate population level health health system complication
18369071 en contribute diabetic aim study parameter type mellitus without investigate relationship patient type diabetic parameter included protein protein serum measured patient mellitus without complication mellitus normal control subject concentration type mellitus DM significant high control subject concentration patient significant elevated patient without significant increase serum patient compare normal subject serum high mellitus patient without significant high serum protein type DM compare normal subject mellitus patient significant high protein compare patient without result indicate severe lipid protein may contribute mellitus important risk factor development diabetic level type serum
23377164 en diabetic occur patient type however patient type also condition aim study evaluate compare clinical characteristic outcome type type mellitus DM patient retrospective cohort study adult patient clinical characteristic patient DM compare patient DM primary outcome study cohort included patient diagnosis patient DM patient DM patient DM significant old patient DM significant patient severe group DM total mortality rate patient primary outcome significant group patient patient DM severe disease outcome compare DM age independent mortality
23811853 en effect evaluate effect glucose individual type
20701584 en diabetic complication study mechanism early change reduce high may important factor development influence concentration function renal cell well relationship concentration total review research datum condition concentration determine factor rate show high associate low concentration diabetic patient chronic on occur glucose diabetic impair similar change may occur cell glucose control insulin diabetic patient complication
22123496 en occur history study identify several factor associate include baseline factor factor effect metabolic syndrome evidence two indicate metabolic association insulin resistance mellitus develop mellitus associate poor patient outcome review risk insulin resistance risk develop one factor consider primary study suggest may provide improve response therapy reduce incidence compare insulin resistance may potential complication improve outcome
23990523 en examine whether total weight concentration measured associate risk gestational mellitus study among woman health serum sample obtain woman case subject woman develop two control subject case year blood age age number high risk increased odd ratio or CI history BMI glucose insulin concentration similar estimate observed effect total level BMI associate increased risk compare woman level or CI low concentration decrease insulin function associate reduce glucose tolerance may identify woman high risk target early intervention
22420869 en therapy result low risk weight weight type mellitus T2DM outcome use treatment conduct clinical trial one included oral datum identify review datum clinical trial use treatment impact weight evaluate patient T2DM high therapy compare therapy treatment include high general high association great weight also improve use therapy low incidence cause weight potential found clinical trial may improve clinical outcome increased treatment datum need whether case
22189894 en cause chronic mortality total one multiple include reported adult receive blood glucose group evaluate risk among adult diagnose group review mortality effective control evidence regard evaluate use assessment development value use system base group finding previous adult aged year mellitus type type possible diagnosis on datum risk among adult aged year less therefore adult aged year may assess risk response report provide use
19829176 en therapy treatment patient type mellitus weight treatment significant glycemic control found patient major weight therefore mechanism glucose control review recent treat obesity also possible treatment obesity effective mellitus mechanism effective weight reduction include effect insulin patient lower body mass index current new treatment
26757003 en gestational mellitus common condition woman may result well complication management may reduce complication general retrospective analysis outcome follow medical aim study assess clinical outcome compare two time period one result revealed increased care decrease incidence significant reduction overall rate complication show significant woman positive impact care outcome
25510748 en study show mellitus DM risk factor cardiovascular disease include however clinical characteristic impact DM patient well patient included mortality cardiovascular mortality major event prevalence DM patient compare patient diabetic patient old cardiovascular disease patient DM determined score however patient receive follow-up mortality rate DM group significant high group incidence DM independent risk factor mortality ratio confidence interval CI cardiovascular mortality CI CI CI common associate increased risk mortality cardiovascular mortality however increased risk found follow-up patient DM
25367553 en aim assess function gestational mellitus glycemic studied normal glycemic control use value obtain normal significant increased compare normal decrease significant well negative value normal increased gestational age significant correlate assess function use examine function glycemic control
25222839 en gestational mellitus condition impair glucose tolerance occur range weight risk factor study evaluate association factor identify woman high risk develop woman negative oral glucose tolerance test positive analyzed association study perform difference case control analyzed test associate high value body mass index BMI age gene associate correlate on show compare association BMI age increased significant risk result correlation age BMI on increased significant risk impair glucose tolerance
26155708 en aim study activity high analysis patient type mellitus DM show reduce effect increase influence due decrease one change effect factor cardiovascular disorder associate period suggest relationship DM normal due high period correlation clinical datum diabetic
26822459 en metabolic syndrome cardiovascular disease reduce study aim relationship metabolic syndrome type mellitus study perform type mellitus patient year old mean age fasting glucose lipid profile measured blood pressure characteristic participant evaluate use score determine participant risk metabolic syndrome woman significant high man CI associate significant lower risk metabolic syndrome CI association observed metabolic syndrome demonstrated association metabolic syndrome type mellitus patient however great diabetic
25774705 en treatment obesity need risk develop although intervention conduct clinical study base per analysis female age year history obesity type mellitus T2DM patient three on patient patient patient patient treat respective model assessment insulin resistance index year score significant reduce on significant reduce on level significant reduce on reduce although significant however index significant reduce on on significant reduction index index significant improve on associate use may reduce weight metabolic syndrome parameter history obesity T2DM
25688892 en type mellitus disease number medication review new include adverse effect potential therapy review use medication lead reduction medication also show reduce use insulin adverse effect use review drug potential role management type mellitus
25665645 en protein use new type oral drug treat disease develop can effective treat type mellitus first can protein gene per cell oral significant reduce blood glucose level type diabetic high high
25554536 en several trial cohort study show increased incidence type mellitus T2DM patient use whether patient high risk development T2DM patient present cohort study patient disease without DM baseline patient use baseline use therapy define therapy cholesterol model use estimate risk T2DM therapy therapy associate increased risk T2DM ratio confidence interval adjust age body mass index plasma cholesterol plasma level therapy related high risk T2DM compare therapy ratio confidence interval adjust age body mass index plasma cholesterol plasma level increase risk number metabolic syndrome characteristic insulin resistance present patient low baseline glucose level use increase risk T2DM patient clinical disease increase risk independent number metabolic syndrome patient low baseline glucose level
25534458 en diabetic patient consider diabetic complication study determine independent factor among clinical characteristic type study included type diabetic patient consider rate high according presence two group identify diabetic patient diabetic patient cardiovascular test test blood test perform patient statistical analysis use logistic regression included patient response measured test diabetic patient vs diabetic patient odd increased serum CI serum level CI respective diabetic patient prevalence renal diabetic patient vs diabetic patient high type diabetic patient significant related system independent factor associate high level serum renal
25207475 en occur disease status reported early previous found significant reduce adult type mellitus DM aim study investigate plasma lipid new diagnose without plasma sample DM compare healthy control analysis perform decrease value found group compare control patient compare healthy control significant difference found plasma new diagnose show reduce lipid although different different present study suggest lead plasma DM significant impact plasma
24896141 en study oral diabetic treatment woman type mellitus T2DM study compare effect insulin glycemic control outcome woman randomize control trial conduct insulin treatment T2DM primary outcome glycemic control measured hemoglobin outcome compare study woman receive receive insulin woman group glycemic control vs insulin similar rate weight care syndrome treatment group one case insulin group one case group case study glycemic control woman receive insulin large study need determine whether consider insulin woman T2DM
17021918 en aim study determine whether risk disease associate mellitus use identify event participant three study conduct year study provide year follow-up event assess mellitus risk event use mellitus common mellitus associate great risk ratio compare mellitus mellitus CI CI difference level risk factor among diabetic three group difference development mellitus develop mellitus risk high mellitus group important population risk difference may mellitus
27584552 en complication chronic common present patient may also mechanism model use year study evaluate potential therapy period model new relative increased use model study common use model type type provide index condition
23644116 en investigate correlation gene hypertension patient disease type study conduct among patient disease mellitus gene determined use according patient group group incidence hypertension risk factor hypertension pressure pressure index compare two group logistic regression analysis perform adjust effect incidence hypertension group significant high group group show significant great difference pressure pressure two group logistic regression analysis show associate increased risk hypertension high insulin level insulin gene may associate hypertension patient disease type patient on great risk develop hypertension
22584565 en drug insulin oral drug type type mellitus patient system health system patient included total patient identify mean age patient year female patient treat oral drug lower patient receive patient reduction drug oral drug according age
21163558 en recent study reported lower blood pressure improve status patient aim study evaluate effective medication therapy diabetic study included type mellitus patient group receive patient group use day blood sample baseline day day compare therapy show improve effect reduction glucose vs treatment vs vs reduction hba1c vs treatment vs vs significant reduction plasma level respective vs treatment therapy respective vs treatment plasma significant improve vs treatment therapy treatment significant observed activity patient treat effect provide effective drug may clinical effective
23703340 en prevalence gestational mellitus known status study determine prevalence risk factor associate woman care care hospital study woman estimate gestational age week care care hospital woman oral glucose tolerance test on general characteristic status level history hypertension history association use diagnose total woman study diagnose woman on value observed woman analysis risk factor found significant associate age level status weight BMI weight history hypertension history analysis presence found significant associate prevalence found per care hospital intervention control risk factor
23617762 en increasing major chronic disease datum impact health review prevalence complication include review prevalence complication conduct use prevalence range prevalence significant high common prevalence range prevalence chronic complication range important common health prevalence individual observed chronic complication common need related complication
22917499 en prevalence rate examine whether increased contribute man woman aged year history measured odd ratio type year estimate use logistic total man woman reported new diagnose year high associate increased risk type woman man odd ratio CI woman year respective association high woman woman associate risk type associate increased risk type woman
22122222 en patient type mellitus therapy two glycemic target disease review current treatment association association study association clinical therapy treatment treatment patient type hemoglobin level therapy patient base clinical factor addition therapy include drug mechanism effective target type oral however early use insulin patient target whereas early use new mechanism risk new individual patient
20662602 en drug use diabetic patient aim study effect due oral two week week revealed normal diabetic treatment reduce increased factor reduce can improve effect due
25535261 en fasting insulin concentration increasing use insulin resistance risk type T2DM although association adult outcome determine whether fasting insulin concentration associate insulin value participant cardiovascular risk study baseline age year datum adult T2DM mean age increase fasting insulin associate relative risk confidence interval CI T2DM remain significant adjust BMI history T2DM aged year increase insulin associate CI T2DM adjust BMI history T2DM age group increase BMI associate CI T2DM insulin history T2DM association BMI associate T2DM analysis T2DM high fasting insulin level early fasting insulin concentration early independent associate elevated risk T2DM
25271187 en result study association serum concentration gestational study demonstrated woman gestational mellitus lower concentration result reported aim study compare serum concentration woman woman review database control trial perform datum effect model use conduct study woman woman found compare serum concentration woman normal one revealed serum concentration lower woman compare woman CI demonstrated concentration woman lower normal woman result significant CI CI also demonstrated serum status lower woman impair glucose tolerance compare woman CI evidence suggest serum concentration significant lower woman gestational compare normal woman
25227411 en correlate different insulin resistance include gestational mellitus presence risk factor early studied value early subject without risk factor compare result patient little one risk factor patient without risk factor study risk control group respective early value measured addition fasting plasma glucose glucose test value week significant different risk control group vs respective although fasting plasma glucose level glucose test result high risk group control group vs vs respective risk factor impact early value subject
20679164 en assess relationship characteristic risk type mellitus characteristic identify may year type disease identify hospital datum control year factor included age status use body mass index weight care factor included weight gestational age gestational outcome first type mellitus adjust odd ratio estimate association characteristic type type negative associate old odd ratio or confidence interval CI lower status care or CI care or CI or CI related body mass index high or CI associate increased risk factor related decrease early obesity may associate type
23413692 en use previous develop method significant increase activity found blood plasma patient type mellitus without cardiovascular complication well disease plasma concentration measured significant high blood plasma patient on significant correlation activity concentration observed blood plasma sample healthy increased activity correlate concentration blood plasma patient result study role development determine activity blood relationship activity concentration patient blood high concentration significant parameter dysfunction cardiovascular disease development obtain result evidence cardiovascular complication associate activity may risk DM patient
22172021 en rate may use assess diabetic aim present study determine clinical rate patient type patient type age year parameter rate time interval interval mean interval difference low low high total two day relative assess correlation respective rate sample estimate clinical trial significant difference mean rate test indicate lower parameter interval lower little parameter low first correlation range sample patient per group rate range clinical rate patient type poor relative suggest great clinical diagnosis follow-up
25727954 en on model target drug develop influence fasting plasma glucose hemoglobin hba1c use model potential can hba1c period compare current use treatment mean datum type mellitus T2DM model perform use plasma profile patient T2DM well model profile high different interval first week treatment two potential can improve hba1c current use clinical treatment
25688893 en type treatment type mellitus on conduct identify study related review may use therapy relative healthy old patient type mellitus hypertension medication patient chronic disease insulin
25673447 en little role type mellitus aim assess use test association total T2DM patient healthy control age level study assess use use assessment score association hemoglobin hba1c test correlation test assess correlation analysis T2DM patient correlation analysis show score regard significant positive correlate reduce T2DM patient high hba1c level significant associate poor among T2DM datum indicate among T2DM change mechanism dysfunction suggest can T2DM patient
25627336 en study incidence among adult type mellitus T2DM high risk cardiovascular disease study T2DM cardiovascular risk cohort risk factor cohort new logistic model rate cohort year year risk factor cohort year year use significant great among new event among event T2DM risk high incidence event large study significant system
23713294 en investigate effect protein serum patient type mellitus case type mellitus patient two group control group treat oral day insulin base blood glucose level treatment group treat week fasting blood glucose blood glucose test two group patient treatment healthy case test treatment level serum patient T2DM significant high healthy case treatment group difference treatment statistical treatment difference treatment group control group statistical can significant decrease level patient T2DM can decrease blood glucose improve insulin resistance according new evaluate T2DM treatment may
23305475 en evaluate effective insulin insulin insulin insulin type mellitus T2DM patient clinical total T2DM patient T2DM oral insulin insulin insulin insulin study insulin included follow week hba1c poor week hba1c observed cohort patient insulin respective overall rate increased new insulin therapy whereas reduction observed insulin on reduction body weight cohort whereas overall lipid profile blood pressure insulin well result significant control T2DM patient
23265968 en recent associate type mellitus study investigate presence compare healthy on compare healthy response protein serum concentration also measured result show protein compare healthy datum also correlation serum activity patient protein increase concentration compare subject response patient observed may indicate role disease
23054323 en investigate whether mellitus DM associate outcome include time among man undergo clinical patient undergo follow year analyzed association mellitus outcome time examine define time total subject DM group show significant difference parameter include age DM group lower group observed difference statistical analysis DM significant associate score also significant associate result show DM man associate suggest DM may disease need DM also assess relationship potential can improve outcome patient two disease
22860716 en aim present study relationship mellitus type disorder metabolic profile diabetic diabetic patient first assessment participant year diabetic patient hba1c patient control metabolic first statistical related diabetic profile control hba1c hba1c patient significant high overall score factor analysis revealed positive association disorder metabolic profile patient patient control metabolic profile score lower although difference score level present result provide evidence mellitus type associate disorder
23723366 en cell role mellitus protein contribute diabetic cell adult type diabetic control function impair diabetic increased activity function negative protein significant diabetic increased show decrease level negative diabetic improve function also found type diabetic normal high glucose treatment related function found role increase increased contribute dysfunction diabetic
23982556 en severe cause lipid patient mellitus due serum lipid year old present show finding show serum elevated serum level cholesterol fasting blood glucose hba1c occur primary therefore history well cause
22184868 en studied change first model type mellitus DM vs normal analysis perform addition cell population examine first determined analysis found significant high DM vs normal group cell population significant lower DM vs normal therefore consider cause first
21690453 en review type mellitus conduct review use study identify metabolic rate identify randomize control trial study lead rate rate effect lead weight reduction on large patient undergo presence mellitus perform according glycemic control improve month improve type mechanism may
21467970 en type mellitus insulin resistance function mass addition factor important role study indicate increased presence may also important incidence metabolic disease on cause insulin resistance function model present blood target response cell metabolic insulin resistance adult insulin resistance metabolic addition glucose female well glucose function although evidence consider risk factor type mellitus disease related insulin resistance
19322534 en mellitus metabolic disorder glucose primary chronic population mellitus metabolic disorder known associate large number disease cardiovascular system well system also mellitus associate oral suggest patient may treatment different without therapy clinical case report present general clinical mellitus follow result disease
18259206 en assess factor associate mellitus adult population study cohort study included subject aged year rate blood sample subject mellitus define fasting plasma glucose concentration history diagnosis mellitus found subject regression analysis presence mellitus significant associate body mass index blood pressure concentration pressure presence lower lower level lower blood pressure statistical associate age presence general prevalence early mellitus associate general prevalence although mellitus significant correlate high pressure associate
21194577 en increased prevalence type mellitus primary increasing rate metabolic increasing role development cardiovascular disease type condition dysfunction insulin resistance activity elevated level disease associate type patient glycemic control target disease may also current treatment intervention follow early treatment period elevated glucose clinical current treatment type therapy early therapy current disease glycemic control time early intervention therapy control remain type increasing aim potential provide disease although remain demonstrated early therapy result disease clinical therapy great therapy potential effect function lower risk weight
20713923 en examine relationship use medication total health care patient type studied adult type health undergo period use datum use medication time interval total health care per obesity care two patient type mellitus undergo associate medication therapy patient month year year reduction use observed medication year total health care per increased year decrease year year compare observed year associate reduction use medication overall health care patient type health health
22913896 en glycemic control reduce risk complication patient type mellitus T2DM however medication major factor glycemic relative common patient T2DM prevalence severe increase insulin treatment prevalence patient type impact patient T2DM severe may associate increased risk cardiovascular event insulin insulin therapy major cause patient T2DM drug use low risk therapy type mechanism potential low risk may patient T2DM improve glycemic control
22481012 en aim study determine effect therapy patient type mellitus activity lipid profile patient type poor glycemic control normal normal cholesterol therapy improve glycemic control therapy month hemoglobin decrease mean effect lipid profile statistical significant decrease concentration increased decrease significant total activity decrease significant activity high glycemic control lead change activity patient receive previous therapy glycemic control patient type change include large decrease high activity
20170928 en treatment disease study disease mellitus associate change model mellitus evaluate oral control change activity level compare control also studied significant change parameter observed however ratio significant great control oral ratio control increase due increased level result oral due control
23922047 en clinical syndrome associate mass report outcome patient develop finding man hospital diabetic level high respective show severe two day test normal mass patient undergo revealed level occur function may cause however due factor reported patient mellitus diabetic one presence result mellitus associate factor patient
23705494 en obesity mellitus associate low elevated serum insulin level insulin decrease increase associate early severe obesity function associate similar may insulin cause insulin associate insulin resistance suggest important role insulin glucose level well
23534770 en study examine mellitus DM risk reported finding examine association conduct database perform assessment trial base perform use regression conduct included study study cohort study found association DM relative risk confidence interval CI association also observed population CI study CI statistical found association risk duration DM risk related age DM study relationship DM without duration disease age diagnosis
23446214 en clinical factor glycemic control may influence function patient type mellitus T2DM aim investigate independent factor function among clinical factor studied patient T2DM without disease finding compare diabetic patient healthy subject early on early measured assess function evaluate insulin resistance estimate rate ratio clinical characteristic addition glycemic control T2DM significant lower mass significant great control subject regression analysis independent age also independent whereas fasting plasma glucose hemoglobin level addition blood pressure ratio ratio independent dysfunction may great role glycemic control development dysfunction T2DM
22475248 en disease disorder disorder associate several syndrome disease protein associate condition mellitus disease disease present present case disease diagnose patient disease develop type one mellitus
27034205 en study examine concentration parameter gestational mellitus patient normal glucose tolerance individual also level risk among study included individual gestational week plasma insulin level analyzed gene use result show plasma level significant high impair fasting glucose group group vs plasma level correlate plasma fasting insulin level body mass index model resistance insulin index group however significant associate risk plasma level finding show high level associate large research need association gene among population
27308832 en study use type model control investigate factor weight blood glucose level response measured evaluate show significant month severe obesity month significant elevated month month revealed decrease significant analysis show suggest reduce blood model use study show early show finding chronic reduce blood
20566726 en negative impact mellitus well little known effect disease disease related insulin resistance evaluate whether adult new diagnose increased risk use health database perform retrospective cohort study group adult new diagnose without known individual year health individual disease primary study outcome development disease incidence rate disease per among new diagnose per among without ratio confidence interval CI age health care hypertension obesity cardiovascular disease ratio CI new diagnose high risk disease also known diabetic whether disease glycemic remain determined
21880549 en type mellitus high individual reduce medical obesity increasing however treatment diabetic population known assess odd complication patient without retrospective cohort study use database identify subject undergo cohort patient without age health year logistic regression analysis determined relative odd complication month mean age patient year woman complication without common complication need renal complication occur diabetic group incidence complication great period odd ratio or incidence complication great or or period incidence renal complication great period or finding individual although management renal complication population
24461589 en system role glucose important response blood glucose level may due metabolic glucose healthy subject blood glucose normal within relative range diabetic patient increase risk complication disease diabetic clinical research use positive effect treatment review current response treatment clinical
24318789 en mellitus DM increasing although major complication condition diabetic patient also profile diabetic occur obtain relative recent diabetic model include model diabetic also mean sample method found change diabetic however overall remain review aim possible current research need on can determine target treatment DM disease increasing development important use method diabetic patient
26650511 en current effective provide glycemic control case associate effect on glucose new glucose glucose review assess clinical effective T2DM on conduct randomize clinical trial total study included review outcome assess change hba1c fasting plasma therapy potential decrease control T2DM insulin independent mechanism improve glycemic control decrease body weight profile indicate lower number adverse event include event finding T2DM however datum need
25450824 en oral although condition response may also mellitus related development study mellitus DM disease oral complication also target diabetic recent year mellitus present review relationship mellitus potential mechanism development diabetic patient influence role increase risk disease mechanism demonstrated less impact disease glycemic control mechanism occur possible disease may insulin resistance similar obesity glycemic control
24402298 en high low cholesterol risk disease study examine relationship ratio mortality cause disease cardiovascular disease analysis man group ratio metabolic syndrome index disease use occur incidence type mellitus DM according ratio estimate man ratio fasting blood glucose index use follow ratio mortality risk factor mortality rate high individual high ratio low ratio man metabolic syndrome also mortality incidence DM time high man high ratio low ratio individual high ratio high incidence DM low ratio index cause mortality ratio mortality well metabolic syndrome man also high ratio DM index mortality well ratio DM incidence
23385227 en patient diabetic syndrome may need well care care poor two patient may hospital treatment whether case management system care according improve patient care addition analyzed hospital well hospital
23113652 en renal study perform patient associate type early mellitus DM patient associate type early DM result type DM revealed significant reduction high value rate presence reduce renal characteristic finding renal develop type early DM DM may renal function
22155463 en diabetic complication metabolic control type mellitus metabolic control factor among retrospective study conduct hospital clinical datum review case mean age patient year age range year female patient patient age group year year year overall mean hba1c duration patient follow-up month patient insulin insulin therapy hba1c according association duration year patient duration year mean hba1c duration year mean hba1c value metabolic control cohort less study improve metabolic control patient population
21422768 en low factor level observed patient research show increase level randomize study patient major test whether lead increased serum level whether change level associate change receive week addition therapy baseline follow-up determined serum level use found effect level change level significant associate study provide evidence improve level patient use
25730782 en disease include mellitus parameter can estimate related parameter plasma DM patient lipid measured present total cholesterol on level result show parameter common diabetic individual compare healthy individual case age great value increased level lipid potential also associate great important diagnosis diabetic patient
25687500 en group disorder metabolic dysfunction include insulin resistance increased level also observed patient obesity type mellitus study suggest multiple function include lipid lipid insulin result severe metabolic review recent evidence cause metabolic present disease model can potential common metabolic disease include obesity metabolic syndrome type
22424044 en type T2DM chronic disease insulin resistance decrease function role incidence disease increasing increase incidence T2DM change obesity cause remain define disease major cause early mortality due cardiovascular disease cause chronic renal disease insulin metabolic individual glycemic management disease increasing base function early disease may important complication T2DM glycemic management disease condition patient glycemic target presence condition age patient disease duration presence complication severe
19863847 en aim assess relationship disease obesity mellitus total number patient undergo significant patient study patient analysis perform significant found obesity three time diabetic patient without patient without without obesity significant patient obesity diabetic patient without or patient diabetic patient without or patient without vs diabetic patient without or patient without obesity vs diabetic patient without or significant association mellitus patient obesity mellitus association found
23333685 en use diagnosis clinical blood hemoglobin hba1c level patient age female without examine hospital study datum analyzed datum significant correlation blood glucose hba1c level among several group high lower hba1c level suggest group little regression analysis correlation hba1c level result high significant hba1c value subject hba1c value datum effective study effective patient high hba1c level
25509887 en study value patient mellitus DM high risk need included patient type DM type DM without DM undergo lower renal two patient without DM regression analysis show risk factor define history DM elevated level among DM patient assessment lower level renal follow-up patient without metabolic study total patient DM group patient group study rate method indicate DM patient significant group difference among without metabolic regression analysis show DM level factor associate development examine group patient DM two important factor cardiovascular renal disease
20850846 en association gene respective type mellitus examine use population study age year study significant associate hemoglobin level respective respective on association study multiple logistic regression analysis show significant association odd ratio or independent age association study sample study age year or sample association significant or subject insulin resistance model assessment insulin resistance significant insulin decrease respective glucose tolerance normal glucose tolerance glucose however subject show significant increase subject normal glucose tolerance respective glucose tolerance whereas decrease significant gene associate increase insulin resistance primary insulin
25493953 en study examine association factor incidence early chronic disease among type trial without studied define per year renal disease year factor included use activity known risk age duration body mass index blood pressure fasting plasma glucose use risk consider study develop score significant independent risk factor reduce risk compare first odd ratio show significant association significant decrease risk compare activity significant decrease risk health high cardiovascular risk
24517121 en increasing patient type mellitus suggest role aim determine compare status adult without total adult healthy control included study mean age year year among control measured serum cholesterol blood glucose compare result group control healthy group mean level significant lower adult control adult severe compare severe control group overall adult healthy prevalence among adult relative high therefore population
24373610 en diabetic effect influence plasma subject poor adult type mellitus treat day day day determined chronic day reduce concentration concentration significant increased correlate concentration time may reduce cardiovascular disease risk diabetic adult lipid mechanism
24238846 en gestational mellitus common complication high risk population associate increased outcome early management identify risk factor factor influence glucose several study show increased woman elevated also reported woman may also influence insulin resistance review current potential relationship status development
24227538 en study aim investigate effect reduce estimate rate disease among patient on total subject group according presence ratio low cardiovascular risk factor index also assess use logistic regression analysis odd ratio or related low low compare confidence interval CI CI CI respective patient type low low associate independent
21329534 en conduct determine effect patient also evidence diagnosis treatment patient insulin resistance occur patient due also develop patient patient mellitus mellitus may may lead high mortality rate among patient large due treatment patient chronic disease improve patient reduce insulin oral
25054957 en gestational mellitus common complication similar type general population cause include incidence obesity well old age woman old datum reported whereas use two time high include case new association study group high result study adverse outcome large study relationship outcome new among new old new common important
20851292 en mellitus metabolic disorder develop response relative insulin patient treat drug several study may associate complication aim study examine association patient study included patient receive diagnose gene diagnose patient significant among patient compare patient without or CI association present result suggest gene may associate risk development renal
20825145 en mellitus adult mellitus treatment method characteristic patient age treat patient age
22338420 en obesity obesity rate development cardiovascular disease increase mortality obesity mellitus well risk factor contribute disease prevalence age population therefore study aim determine prevalence mellitus patient diagnose hospital base study conduct medical hospital may on total patient diagnose disease patient female on total found diabetic mellitus significant among patient disease compare patient disease
20001615 en mellitus major occur due found adult patient significant cause management clinical patient type include occur due insulin resistance well cell review history management use may well complication early intervention may function change
21528518 en type cause age month case due protein insulin cause important treatment important cause insulin therapy oral medication
25225197 en disease diagnosis type mellitus T2DM on study perform patient patient T2DM aim evaluate multiple lower relationship different factor age duration T2DM glycemic DM treatment multiple respective found among patient T2DM age duration T2DM insulin therapy risk factor patient T2DM lower T2DM several factor determine role
19760517 en mellitus DM condition system development aim present study perform analysis patient type mellitus compare patient control two patient use evaluate oral patient present clinical without sample sample also determined diabetic patient great test patient great control group test however difference group test patient control DM condition increased
26041734 en on range prevalence disease diabetic patient estimate use pressure index clinical datum may patient also risk diabetic may well increase high level chronic disease well improve clinical
21986012 en body evidence relationship disease mellitus aim study therefore evaluate effect participant complication patient diagnose total general study less study participant reported due among diabetic patient significant complication associate factor significant associate effect health logistic regression analysis old result study indicate effect health among sample general low may outcome disease diabetic patient
26343686 en present study glucose risk type mellitus T2DM two healthy subject control group T2DM subject case group included plasma parameter method plasma significant lower case group control group negative correlate fasting glucose high plasma associate lower risk T2DM or confidence interval CI per increase significant lower case group control group positive correlate fasting glucose healthy subject correlation negative T2DM subject on significant observed fasting glucose effect significant subject lower level glucose
26011590 en show increase study suggest effect role increasing role subject mellitus type remain large aim investigate association activity subject without study adult control age mean BMI subject age year BMI studied fasting serum datum measured use time index use assess level observed significant high level subject control index positive associate control level significant high index healthy control activity observed study show association activity level healthy control subject suggest condition
25770019 en cell mechanism response among aim study assess cell effect patient obesity type mellitus analyzed patient obesity healthy subject treat cell found increased decrease patient group obesity compare control group different studied found increased different patient also positive correlation cell age BMI cell show negative correlation age BMI cholesterol increase cell patient regard group obesity control observed addition cell patient decrease treat datum suggest possible role observed patient obesity
25163771 en may disease event baseline score determined whether serum activity independent adult type mellitus T2DM patient without cardiovascular disease evaluate score assess baseline month serum activity significant high compare vs analysis demonstrated activity association risk factor association activity patient T2DM found serum activity may independent incidence
27333720 en several great number study increase type mellitus incidence age group therefore aim study assess change age aged year period primary case independent datum hospital case receive test incidence rate use regression case use method mean incidence CI compare CI incidence increased age group relative increase incidence per period large aged year CI CI respective case great number case diagnose month found occur age result indicate disease
26905353 en evaluate diabetic type mellitus base study female mean age year little year medical finding patient undergo clinical study found patient include early age duration fasting blood hemoglobin level significant difference patient without reduce observed lower patient significant high patient lower finding low common complication found type study early
26060823 en type T2DM patient include glycemic control increased risk cardiovascular disease glycemic control may reduce risk however risk factor elevated dysfunction may study evaluate impact metabolic disease T2DM subject glycemic control hba1c
24947793 en use new association study group diagnosis gestational mellitus result increased prevalence whether improve outcome evaluate diagnosis compare risk factor outcome assess woman use woman use week group receive treatment follow-up use result important increase rate vs outcome decrease rate gestational hypertension gestational age large gestational age score care estimate per woman evaluate use group diagnose use new associate increase prevalence study population well significant outcome result
19437029 en difference due reported effect development due change mellitus change may study determine whether difference diabetic normal subject duration study group include diabetic individual evaluate measured response obtain patient model statistical show significant decrease age increased significant significant high diabetic difference age related duration mean regard correlation change characteristic parameter individual patient may provide change therefore new parameter
27723022 en body management general status important
23636445 en recent association study group gestational mellitus woman syndrome known compare prevalence rate risk factor woman according analysis randomize study plasma glucose level measured use oral glucose tolerance test diagnose according prevalence rate according week week week increased insulin level correlate week less weight according diagnosis correlate less weight first year difference found prevalence two use less weight associate independent use reduce weight first year woman whether diagnosis per woman less weight mellitus
21550953 en determine among primary care regard use clinical care related patient datum result analyzed response significant relationship among well identify reported clinical management patient management insulin therapy use treatment insulin glucose on reported use clinical assessment identify need related care patient well need intervention
24406490 en review assess whether intervention effective health adult database investigate use total found study remain identify potential study use datum study identify examine positive result reported study reduce improve blood glucose improve weight management study sample use reported
26833544 en relationship body mass index BMI change early presence type mellitus T2DM study included retrospective body weight year measured BMI year BMI change define BMI BMI BMI odd ratio or T2DM associate BMI confidence interval CI CI respective BMI BMI change prevalence T2DM increased compare participant normal weight BMI or CI T2DM participant BMI increase participant BMI or CI analysis according age show similar BMI may influence T2DM prevalence independent current BMI T2DM prevalence positive associate weight related weight weight can adverse effect
26541263 en patient type mellitus T2DM high risk although high evidence patient aim study investigate association serum level man conduct study investigate relationship serum level vs presence regression analysis adjust age duration body mass index serum hba1c serum protein show serum positive associate well respective logistic regression analysis adjust revealed serum level associate presence multiple odd ratio interval per increase association significant first show high level serum associate multiple independent man T2DM
23250458 en blood pressure one important intervention reduce complication mortality patient mellitus recent study indicate blood pressure level range lower blood pressure level reduce risk diabetic associate increased cardiovascular mortality low blood pressure level patient disease disease patient mellitus need therapy first drug
19890425 en glucose different type evidence randomize control clinical trial analysis aim develop base clinical need database on also glucose clinical major type treatment treatment insulin randomize clinical trial according patient individual need characteristic type patient number per use glucose well type use base individual patient type treatment clinical characteristic type intervention
23800121 en gestational mellitus define glucose occur diagnose first time study show disorder population studied body mass index BMI incidence patient high risk develop type month patient health activity period important identify factor may impact target sample woman diagnosis cohort study week hospital can impact health period risk general health evaluate use week month multiple regression analysis perform first time research study woman recent activity level factor possible health period factor identify study study model health use intervention woman
24026995 en glycemic control diabetic patient may insulin therapy early disease poor glycemic control risk factor development diabetic complication patient insulin therapy several year disease glycemic control complication patient receive insulin therapy negative treatment cause negative study evaluate insulin among patient type study research patient type hba1c oral therapy identify study datum obtain patient use study show insulin common participant reported insulin important cause insulin among patient insulin important among patient type mellitus finding study suggest intervention aim increasing insulin use
19784428 en relationship mellitus clinical patient present study aim investigate relationship mellitus develop clinical study analyzed medical adult patient aged year diagnose mellitus compare metabolic study found statistical significant among patient mellitus compare patient control result identify study correlation mellitus therefore investigate health care provide care patient mellitus follow-up health patient group
21341513 en research result level protein blood plasma mellitus chronic present show presence mellitus chronic change blood plasma level protein glucose however protein increased chronic change mellitus change chronic influence found influence
26456345 en use management mellitus DM metabolic disorder present study evaluate effect on type model two week follow body weight oral treat body weight intervention diabetic show significant high serum glucose serum serum lipid insulin resistance lower serum insulin function glucose tolerance compare normal revealed change treatment effect compare result study suggest treatment show effect model
26537267 en score model type mellitus patient undergo evaluate compare score obtain T2DM parameter age use insulin oral hemoglobin retrospective evaluate diabetic patient undergo period datum score result fasting blood glucose hemoglobin patient T2DM found score observed patient group score show assess T2DM patient undergo
26370862 en report case man type mellitus week patient develop diabetic insulin therapy year develop treatment previous study reported case present case suggest potential association disorder consider follow-up patient
26212724 en relationship type mellitus incidence remain assess incidence patient retrospective cohort study patient health medical study subject follow incidence assess incidence ratio incidence incidence general patient identify incidence rate case per incidence rate high female patient vs case per associate significant increased confidence interval CI significant elevated female patient CI patient elevated CI show great increase among female patient patient significant increased significant increased female associate increase risk incidence patient undergo type
26050482 en parameter dysfunction patient type mellitus DM without disease examine patient DM without included medical history parameter function dysfunction patient DM related disease duration level presence chronic high associate reduction association parameter characteristic evidence possible development dysfunction patient DM
26040038 en analyzed status mellitus DM parameter potential revealed time increase compare control decrease also revealed significant increase response DM increasing found significant decrease group change
26020062 en important role insulin two previous study indicate associate risk type mellitus T2DM population respective examine association one gene risk T2DM participant use significant associate risk T2DM model include model model model associate significant decrease risk T2DM or CI age BMI associate increased risk total cholesterol control individual result show associate T2DM decrease risk T2DM population may decrease risk T2DM due insulin resistance
26016260 en type mellitus condition increasing prevalence patient present condition control complication control care patient
25786453 en on man diagnose mellitus year age poor blood glucose control period renal therefore undergo revealed mass insulin level significant elevated result fasting test lead diagnosis patient receive treatment oral glucose result case renal finding show blood glucose level
25643799 en study conduct determine whether serum concentration healthy mellitus DM new diagnose DM compare healthy serum concentration significant high diabetic healthy whereas serum concentration lower diabetic however significant difference level group serum concentration diabetic without disorder significant treatment insulin significant decrease diabetic without disorder result show clinical diabetic can concentration result disorder effect result DM
25482224 en mellitus DM risk factor develop report indicate serum concentration drug lower patient DM therefore develop model determine population parameter assess effect DM status patient evaluate use plasma sample patient DM base model DM rate body mass index BMI patient patient DM great patient patient DM great patient without DM correlate plasma concentration concentration lower patient DM great treatment patient DM compare patient without DM treatment
25262436 en study investigate difference disease well characteristic patient one hypertension mellitus DM retrospective review patient DM disease undergo normal severe score score define patient risk patient disease characteristic evaluate include positive low DM patient follow patient respective DM patient disease patient vs vs vs vs DM patient risk patient prevalence positive low high DM patient vs low patient score DM patient high patient respective significant difference observed DM patient DM patient high risk well compare patient similar high DM patient low patient
25153227 en report two type mellitus treat insulin develop severe insulin
20368224 en chronic insulin resistance present study plasma level disease type disease patient fasting plasma sample subject group patient type mellitus type patient without patient history healthy control risk factor body mass index body ratio blood pressure activity measured use plasma estimate significant difference observed level body body mass index ratio blood pressure group concentration significant correlate duration body mass index ratio blood pressure body activity level association risk factor
20232652 en estimate population disorder associate change health little studied general diabetic change type occur two major clinical type type type associate different mechanism disorder reduction occur type type study diagnose normal reduce increased healthy control found increased incidence type addition change number factor diabetic study woman type significant high risk relative risk confidence interval CI type CI mortality rate first year patient man change cause number renal function increased low mass increased difference change patient mellitus high risk type great well decrease cause change also diabetic risk factor current measured receive treatment
18292034 en well known patient disease develop one previous show disease patient type mellitus compare population disease common disease associate type mellitus general occur aim study investigate prevalence well disease patient type mellitus aim also compare prevalence disease patient type mellitus type mellitus perform patient type mellitus type mellitus disease case function disease according result significant high diabetic patient disease type mellitus type mellitus disease due also patient type mellitus increased risk need disorder patient type mellitus disease
18179506 en compare prevalence type mellitus population assess glycemic control condition health participant aged old type control measured hemoglobin less prevalence condition treatment rate blood pressure serum prevalence diagnose type mellitus population increased patient condition renal history patient treat medication increased glycemic control rate also improve great glycemic control rate patient without adjust patient characteristic include duration mellitus patient renal less control rate treatment glycemic control patient diagnose type mellitus level high patient condition may present mellitus management
17932620 en aim study evaluate prevalence clinical diagnosis mellitus type study group new diagnose mellitus type mean age year assessment perform two compare include datum hba1c plasma lipid positive found old age positive group vs year significant difference among group regard clinical characteristic presence subject new diagnose time diagnosis mellitus type association clinical status demonstrated study
21287949 en disease blood case two three development disease multiple risk factor among significant role hypertension mellitus aim evaluate presence hypertension mellitus type patient disease compare disease one total patient patient group type disease included patient disease group included patient disease group patient disease group patient disease three follow clinical age hypertension total cholesterol mellitus hypertension significant patient hypertension group normal blood pressure hypertension subject significant high disease group compare disease group female prevalence hypertension significant high group high value group compare group group vs group female found value group compare group value found group significant diabetic group difference group statistical significant found significant diabetic group difference diabetic statistical significant large diabetic man woman patient disease group hypertension type mellitus statistical high individual disease
21086616 en change patient hypertension associate type mellitus therapy change blood pressure profile metabolic control baseline clinical patient receive treatment without month examine common estimate index value glycemic control blood lipid patient increased group woman three time among without group less decrease mean mean less control group woman show increased body mass index group reduction also decrease show reduce change group control blood system index group reduction glycemic control result study suggest correlation reduction high body mass index patient woman body weight group patient
20873250 en mellitus type mellitus T2DM time incidence event disease major cause develop include chronic complication DM also medical great value result large randomize control study evaluate impact rate blood glucose control incidence outcome cardiovascular disease patient T2DM
20684233 en studied mellitus two different level decrease mellitus control new identify different well three result two show change mellitus control result demonstrated mellitus significant show mechanism glucose disease
20205108 en glucose aim therapy mellitus increase glucose level therapy type mellitus T2DM clinical significant study aim determine clinical perform blood assess glucose addition insulin test perform baseline new diagnose T2DM control subject diabetic patient test month therapy addition level assess treatment significant decrease subject T2DM cell addition increase response addition insulin control therapy result significant increase type significant decrease T2DM therapy effective therapy type related studied cell may use new mellitus
18347976 en aim study test several dysfunction patient type mellitus relative relative present mellitus individual year age without clinical disease three group type mellitus patient without complication man woman first relative type mellitus man woman control individual man woman body measured function determined glucose insulin cell cell protein plasma also studied independent significant high diabetic group control respective high group high diabetic group group correlate little diabetic group group vs control patient type relative relationship dysfunction cell patient independent
26113357 en possible complication treatment however incidence rate study incidence rate review reported database identify study patient on perform evaluate incidence rate also perform several analysis evaluate impact treatment incidence rate CI CI CI CI CI CI CI CI study provide new datum incidence rate treatment function however high study several factor may influence incidence
23448484 en mellitus associate increased risk cardiovascular disease important factor cardiovascular different mechanism protein association dysfunction contribute diabetic complication development lipid protein protein factor cause change protein therefore dysfunction role disease may also increase factor impair several also cell one factor potential current clinical evidence therapy diabetic cardiovascular complication glycemic control reduce association treatment hypertension dysfunction obesity condition also associate therefore complication mellitus
23716623 en assess effect diabetic investigate correlation diabetic subject little history mellitus DM included subject group undergo treatment little one group history perform evaluate measured group group significant difference score group datum group correlate DM correlation may potential role estimate treatment compare diabetic
25443979 en mellitus common chronic disease general mellitus relationship presence one condition increase risk mechanism relationship large group disorder lipid increase risk can result review examine relationship mellitus potential mellitus mechanism development disease effect insulin important role on model suggest important role relationship aim clinical management
19942983 en evaluate diabetic type T2DM T2DM patient evaluate according age year time diagnosis year body mass index BMI hba1c type association BMI cardiovascular can common chronic T2DM logistic regression show hba1c independent related group related can age related show type type mellitus related factor different complication may two type mellitus
23439184 en type mellitus examine weight status reported hemoglobin female year female year assess body mass index BMI prevalence reported glycemic control hba1c compare base age weight duration year hba1c use insulin therapy obesity respective BMI weight status significant associate ratio significant lower compare weight among weight status BMI positive correlate hba1c respective hemoglobin high normal weight mean respective significant high weight mean respective general population obesity among weight status influence glycemic control suggest need intervention
26669030 en aim study evaluate status patient type mellitus year perform condition included patient without patient positive characteristic year improve patient without
26424306 en disease mellitus treatment disease improve glucose control syndrome patient show glucose control treatment syndrome mass woman diagnose blood glucose poor control receive insulin therapy undergo syndrome insulin decrease insulin treatment treatment
26355928 en studied use due treatment patient clinical chronic disease type mellitus DM study included total patient type DM patient study group group control group group ratio study group patient receive treatment according day study included case history body weight clinical blood analysis study primary month month study group patient compare control group patient found statistical significant index clinical assessment decrease positive parameter according day case study group case control group day patient study control group respective time group patient day respective on due effective treatment patient present type DM
25864887 en statistical investigate whether impact cardiovascular risk factor different analyzed type diabetic patient evaluate assess develop common regression model model statistical difference impact cardiovascular risk factor two significant correlation diabetic duration hemoglobin level presence cardiovascular disease independent risk factor elevated impact age blood pressure cholesterol level significant different two cholesterol level significant associate age blood pressure significant impact impact significant great patient low age high pressure high whereas patient low impair cholesterol level high model statistical impact cardiovascular risk factor elevated patient type mellitus
25823278 en metabolic independent risk factor development also poor cardiovascular disease renal dysfunction factor due incidence type mellitus significant review consider mechanism common well presence metabolic new value cardiovascular event early diagnosis review present management patient disease
25821337 en subject type mellitus glycemic control diabetic complication current use control disease several study indicate level elevated diabetic patient
25729932 en aim study perform association study protein gene type mellitus well disease age also assess role syndrome type presence disease disease patient population one patient healthy individual use significant difference among patient healthy individual associate age however protein cell response gene role protein function population different use
25656035 en investigate insulin insulin type mechanism insulin resistance
25621468 en type mellitus early mellitus cell glucose current treatment associate cell therapy demonstrated function cause cell use cell therapy complication common associate cell treatment demonstrated clinical therapy possible mechanism model positive result clinical trial also potential method model gene therapy clinical
25524371 en reported effective type mellitus T2DM however mechanism recent reported important glucose study effect high low include perform two month plasma level different test perform investigate role can reduce weight however significant effect blood glucose level blood concentration insulin however significant improve insulin plasma relative decrease T2DM however occur significant improve insulin resistance reduce blood glucose may improve insulin T2DM important role T2DM can new target
25382134 en on correlation gene type mellitus T2DM evidence relationship remain association T2DM population include participant individual study population conduct odd ratio or confidence interval evaluate model model relationship T2DM significant or CI or CI or CI or CI model or CI or CI model significant associate T2DM population population gene may increased risk develop T2DM
25300688 en aim study investigate association factor gene type mellitus T2DM population patient T2DM control population on total patient T2DM control study found associate significant increased risk T2DM significant associate risk T2DM analysis base age result show change may contribute T2DM population
25273396 en target recent report indicate effective type mellitus well disease study indicate therapy lead disease however patient syndrome reported report case patient insulin cell week treatment adverse effect observed month addition reduction level improve function treatment period year diagnosis
25113641 en metabolic syndrome chronic disease adult population different study relationship type mellitus complication patient therefore mechanism recent research important assessment potential glycemic control may improve patient outcome recent regard cardiovascular complication mechanism review whether glycemic control patient included current aim therefore current need glycemic control patient mean reduction cardiovascular complication remain
25000923 en hypertension decrease glucose tolerance adverse lipid profile low activity level associate increased type mellitus T2DM cardiovascular disease risk high interval low reduce time high may current activity per week high provide significant risk healthy week T2DM risk include glucose tolerance blood pressure lipid measured associate change range blood cardiovascular risk response subject change associate statistical significant increase result decrease decrease blood pressure also evidence change blood lipid glucose concentration potential intervention improve blood cardiovascular health
24861008 en mellitus develop model mellitus respective change drug reported compare respective control review review change drug change due change disease drug plasma blood rate ratio drug general change drug can well three factor mechanism drug renal also drug reported present datum
22622863 en several finding use health datum conduct assessment association total woman aged follow mean year regression model use estimate ratio confidence interval association diagnose include duration associate increased risk CI CI CI CI assess duration need risk statistical significant association associate significant increased risk woman increase risk study
22717466 en study correlate cardiovascular risk factor aged year complication mean duration year blood pressure datum evaluate level assess test test perform fasting lipid hemoglobin statistical analysis correlation test body correlation among statistical significant included weight score BMI score body high compare significant significant relationship lipid profile poor control found independent body
18438542 en prevalence adult according population studied use analyzed patient year found positive without insulin although age year diagnosis without insulin month presence insulin resistance factor on insulin similar type diabetic patient identify base presence low present subject high multiple show DM high risk compare diabetic patient present high prevalence associate disease high indicate risk DM patient high may early use patient low type diabetic patient negative
18322310 en type mellitus associate disease association type mellitus therefore investigate prevalence type diabetic patient compare effect age patient type mellitus one subject type mellitus one three normal control age year method use type diabetic patient positive positive control group compare without female type diabetic patient female vs respective among type diabetic patient old high concentration patient high level duration presence type diabetic patient compare normal subject association type mellitus
22348372 en patient overall function incidence impair glucose tolerance previous risk factor identify early high risk reduce risk reduce mortality condition possible management although renal consider impact patient risk factor management impair glucose tolerance also type
20722995 en mellitus change reported base analysis analysis activity change activity reported also review change drug reported change drug review also drug change total plasma time time drug ratio total body respective drug reported drug found drug drug plasma blood rate ratio change drug drug however renal value drug study drug patient type mellitus similar different result drug obtain diabetic patient type mellitus present datum
20625236 en diabetic complication type mellitus study perform analysis normal model type mellitus normal according rate rate normal decrease normal occur two rate first respective value lower normal age relationship observed rate plasma glucose level present study suggest event occur model type mellitus
20575465 en role type mellitus without complication reported therefore estimate new diagnose patient type mellitus healthy control hba1c complication significant change level type diabetic patient compare control correlation can found level hba1c level type mellitus complication
20467177 en on patient diagnose mellitus age insulin treatment age year insulin improve glycemic control hba1c level month reduction insulin observed reduce month month also body weight reduce month without clinical treatment drug include possible glucose medication period present effect insulin effect case type mellitus
19709689 en low level associate complication patient type mellitus evidence level aim study assess effect different plasma level type mellitus patient type mellitus subject receive medical therapy week change plasma glucose hemoglobin insulin resistance model assessment total cholesterol cholesterol cholesterol evaluate baseline week week group significant increase baseline value medical therapy group type mellitus patient may contribute effect
22043070 en on diagnose mellitus glycemic control clinical insulin develop evidence finding included
23752780 en can treatment hypertension evidence trial high evaluate effect blood pressure patient type mellitus large hospital type mellitus lower aim without aim study blood pressure measured patient randomize patient intervention group patient control group study significant change blood pressure difference blood pressure CI control group difference blood pressure CI intervention group three patient intervention group adverse high study show significant effect blood pressure patient type study result one previous trial hypertension treatment
17151290 en mellitus one common disorder population number diabetic patient patient type increase number diabetic patient cause mellitus mellitus cause factor factor may lead development mellitus include drug obesity type disease increased role type factor may factor mellitus individual gene may diabetic factor increase factor increasing role cause mellitus incidence type range type prevalence type range
24429949 en patient mellitus type DM cardiovascular studied treatment result significant positive change total cholesterol cholesterol level treatment associate improve DM result influence metabolic rate studied
24167365 en role may health outcome little research examine mechanism role study aim test two serum associate type mellitus T2DM elevated hemoglobin association serum protein aged old health serum hemoglobin important included present study logistic regression analysis method test study serum concentration significant associate increased odd T2DM estimate association hemoglobin serum however effect observed sample present study previous research provide new evidence effect decrease serum concentration T2DM may increased study randomize control trial need present finding
24159791 en randomize study therapy disease mellitus type disease include estimate characteristic show reduce syndrome use therapy also significant decrease number patient elevated level change suggest patient activity high cardiovascular risk effect reduce insulin resistance improve lower cardiovascular risk patient
24093775 en association study result important type mellitus development aim study investigate role development type mellitus population group type diabetic patient group healthy control examine group patient control or CI similar negative result obtain female association type mellitus population
23984050 en result significant weight evaluate effect weight glycemic control blood pressure subject subject system study effect weight hba1c fasting blood glucose evaluate week subject year BMI mean month one adverse event week month mean weight hba1c baseline subject elevated mean pressure reduce baseline week month subject decrease baseline subject associate weight early hba1c reduction subject trial
23819328 en present review datum new drug mellitus analyzed drug use metabolic disorder dysfunction insulin resistance increased glucose
23811765 en aim study new diabetic model research group serum glucose level week high glucose level week serum glucose level group within normal range week increase week serum glucose level reduction relative week observed number normal week decrease time result indicate mellitus low weight weight week mellitus mechanism effective model may
23556170 en evaluate effect treatment metabolic control measured hba1c type mellitus patient disease treat study group patient diagnose type mellitus disease hba1c obtain month treatment test sample value less statistical total sample female mean age year old mean hba1c baseline mean reduction statistical significant treatment prevalence disease mean control treatment decrease similar previous study study glycemic control disease improve control
23548356 en hypertension metabolic type mellitus consider review target pressure level analyzed large study group drug patient mellitus present result clinical study effective patient
23365654 en study reported association protein type mellitus T2DM however study association study conduct determine whether associate T2DM study T2DM patient subject on identify study investigate association T2DM odd ratio or model analysis perform study significant T2DM group study result show associate T2DM model or CI associate disease model or CI or CI or CI however remain associate T2DM or CI or CI respective model significant association T2DM study association T2DM however significant association increased T2DM
23334075 en current treatment disorder report case woman disorder type mellitus T2DM show significant result decrease plasma glucose patient T2DM year week week follow-up first period reported significant decrease positive report month hemoglobin level decrease week case suggest potential T2DM identify result
23286208 en compare incidence cardiovascular event mortality patient type mellitus treat assessment cardiovascular patient perform datum study patient baseline included study little week duration range week datum use analysis major adverse cardiovascular event include event cardiovascular analysis perform three cohort cohort cohort study cohort study compare cohort analysis patient little reported event group group incidence rate per group group incidence rate ratio confidence interval CI analysis compare incidence rate per incidence rate ratio CI analysis compare incidence rate per incidence rate ratio CI analysis clinical trial indicate treatment increase cardiovascular risk patient type mellitus high rate event associate relative
19789948 en on female treat insulin therapy type mellitus year mellitus well control develop show finding hospital on show mass observed revealed show mass although mass show without evidence perform revealed can finding indicate therefore perform diagnosis diabetic demonstrated positive patient undergo cell observed patient
24183983 en previous show increase effect insulin independent system normal impair glucose tolerance type mellitus T2DM response define T2DM important subject receive glucose response use glucose little effect response whereas increased response normal glucose tolerance impair glucose tolerance T2DM response similar group show cell blood cell high level low level cell positive cell also observed potential increase effect
23447092 en investigate type mellitus T2DM patient mean T2DM patient healthy man perform also perform individual significant T2DM rate significant high T2DM period finding suggest T2DM patient characteristic activity due possible
27766967 en insulin management management female present mellitus insulin increased time day blood glucose high protein low important care insulin treatment may lead without insulin may glycemic control use insulin
26866601 en prevalence gestational mellitus high risk complication well obesity result prevalence change may also contribute increased prevalence risk diagnosis treatment new base study study review evidence treatment target current regard diagnosis treatment evidence study
23354371 en study evaluate association risk study association cohort study reported relative risk study show odd ratio included analysis confidence interval total study study cohort study datum study associate increased risk compare incidence CI cohort study patient statistical significant increased risk CI without significant among study control age body mass index association found CI study suggest woman increased risk
20191079 en type associate increased risk development cardiovascular disease blood incidence among patient type research hemoglobin hba1c may improve mortality datum recent study show patient type increased mortality low possible hba1c use treatment multiple factor baseline hba1c duration presence medication influence treatment result hypertension common patient type impact risk independent glycemic control risk factor provide reduce mortality patient type base result recent trial use current therapy glycemic control use therapy need individual patient need risk
19339356 en use reported cause weight aim study assess risk mellitus associate treatment examine whether risk influence treatment duration study cohort patient receive little one new datum general research database patient little year age without cohort total case mellitus subject identify compare use year recent use month high associate increased risk incidence rate risk similar use high incidence rate incidence rate treatment period lower associate increased use little associate increased risk association observed
25888735 en may role mellitus include gestational mellitus may study investigate possible association retrospective study within cohort woman participant care hospital sample review care participant sample analysis case group similar healthy without gestational complication healthy sample analysis control group lead level sample measured plasma mass possible association level risk studied subject assess logistic prevalence observed investigate participant concentration studied case significant high control age body mass index found positive associate prevalence among sample level associate adjust odd ratio CI CI CI present may contribute risk
19200253 en study investigate complication mellitus one group new interval fasting group healthy control receive similar mellitus fasting blood glucose level study different week week use blood glucose level diabetic increased significant period value blood week study diabetic however change observed body increase cell
22120488 en may increased risk mellitus related disorder several report lipid profile type DM among general population different however lipid profile type DM previous determine serum lipid profile without type type mellitus study datum included patient age weight blood pressure fasting lipid profile hospital without DM type DM control serum level significant high diabetic control vs lipid diabetic cholesterol found diabetic subject serum total cholesterol cholesterol found diabetic subject T2DM common low cholesterol reduce lipid level patient risk cardiovascular event
21556019 en disease type mellitus T2DM insulin resistance although type mellitus due relative insulin increased prevalence obesity insulin resistance population mean also common condition T2DM associate adverse outcome T2DM risk factor disease patient whereas may cardiovascular risk mortality individual T2DM present patient T2DM associate increased risk development current treatment aim improve insulin resistance weight improve insulin use reduce use show demonstrated improve remain regard use
21215511 en disease remain disease disease may disease disease mellitus present first case on man disease woman disease disease type mellitus present patient undergo therapy level blood glucose level follow improve common factor disease factor three disease may suggest factor important role disease study define disease case present patient
22888618 en reported association type mellitus group studied association type gene population on group patient type mellitus healthy subject prevalence include patient control significant high patient group relationship gene significant significant difference chronic complication relationship significant result previous study
22669803 en evaluate assess treatment type use present association study review evaluate randomize control trial included evaluate therapy patient type year result randomize study patient indicate treatment result significant glycemic weight adverse effect common lead drug treatment type study evaluate outcome cardiovascular event mortality
22217471 en evaluate risk type mellitus T2DM T2DM insulin resistance one assessment included health index diagnosis included T2DM insulin resistance score high rate function lower difference health diagnosis associate body mass index associate number care associate difference health function impair factor include obesity care influence treatment T2DM may increased
23342412 en use population study investigate method evaluate mellitus DM total participant study on characteristic analysis fasting plasma glucose hba1c diagnose DM compare base DM use also estimate correlation among hba1c clinical characteristic significant positive correlation fasting serum hba1c found participant study analysis DM similar hba1c therefore datum indicate potential DM diagnosis
23270530 en oral glucose tolerance test mellitus DM syndrome database conduct cohort study assess individual included on model use positive ratio negative ratio odd ratio use analysis study participant included study result CI CI CI CI CI respective lower diagnose DM patient CI CI value CI CI adjust interval test age show difference interval two patient provide similar patient patient previous DM use
23234272 en mellitus DM associate risk study investigate relationship DM use identify patient new diagnose control without age diagnosis year case logistic regression model estimate odd ratio or confidence interval CI associate DM age control disorder use drug DM association DM or CI significant associate or CI or CI or CI use or CI elevated risk DM patient insulin or CI or CI DM high risk however disorder drug associate risk disease
23176242 en on female evaluate weight diagnose hospital low blood glucose concentration however blood insulin concentration perform treat day year follow-up datum regard blood glucose concentration weight serum analysis revealed blood glucose concentration range day day oral weight insulin blood glucose concentration time value decrease within range insulin day treatment weight consider normal blood glucose concentration within insulin treatment mellitus report may effective diabetic
23042817 en cell status disease datum gene mellitus type contribute development mellitus however function cardiovascular system remain study aim investigate role
24273930 en type mellitus T2DM need insulin therapy common drug significant effect need insulin effect use treat mellitus treatment patient type mellitus need insulin randomize clinical trial evaluate effect one month oral drug blood level fasting glucose glucose hemoglobin hba1c blood pressure patient compare group lower blood level fasting glucose glucose hba1c significant respective without significant effect parameter compare may improve glycemic control type diabetic patient need insulin therapy
23852243 en aim study compare metabolic control level therapy type mellitus DM study perform subject type DM patient chronic disease group clinical parameter index index clinical level metabolic control fasting glucose level hba1c level baseline month patient revealed significant statistical reduction clinical parameter month DM group hba1c significant statistical increased month difference level found month group present significant reduction hba1c level therapy however level increased month suggest study investigate result study
23612534 en evaluate effect therapy poor control type mellitus retrospective report characteristic outcome patient receive individual therapy study population included participant insulin intervention group included patient mean age year intervention year datum year control group included patient mean age year observed case group control group therapy associate decrease hemoglobin intervention group compare similar control group addition therapy poor control may improve glycemic control
23574730 en contribute development patient type mellitus T2DM study compare effect glucose lipid patient T2DM patient T2DM randomize group receive serum related glucose lipid measured treatment week use test week treatment cause similar significant decrease hemoglobin mean significant increase fasting insulin level great increase observed group group addition significant decrease change glucose level observed group great decrease observed group group group also show great decrease change insulin level group lipid level show significant difference group result treatment result similar glycemic control great decrease glucose insulin level observed compare patient T2DM
23383099 en increased body mass index related incidence however outcome different type mellitus DM studied study investigate effect type DM clinical outcome retrospective analysis adult patient without type DM perform on total patient different among subject type DM patient patient type DM significant old patient mean follow-up period year patient type DM show high disease patient vs addition mortality high type DM group vs patient type DM show high primary without DM vs rate type DM group year year year respective analysis show type DM independent type DM time diagnosis increased mortality follow-up patient type DM therefore
24605588 en studied influence index condition decrease early period control relative cell whereas day increase cell period increased early mellitus one cell
22988060 en examine relationship metabolic control type mellitus mean age year group reported group group reported metabolic control assess hemoglobin hba1c value obtain medical reported significant group associate hba1c blood glucose control found associate
22595397 en study compare presence dysfunction type mellitus patient without blood pressure response perform analysis patient type mellitus aged time interval interval difference total high low low rate test blood pressure response identify blood pressure woman group blood pressure response normal blood pressure response patient significant difference group time parameter rate significant reduction blood pressure group independent correlate blood pressure included blood pressure rate patient type mellitus blood pressure response suggest dysfunction impair
23892184 en disease chronic disease occur adult occur lower one common cause difference risk factor diabetic patient remain aim study investigate difference several potential risk factor female patient type mellitus profile risk factor analyzed patient patient according significant correlation increased age hemoglobin significant positive correlation increased age diabetic patient level hemoglobin significant correlate clinical patient study first report indicate difference risk factor associate patient patient may important role disease
26156928 en aim study examine model use related type risk datum obtain database control system datum included consider age blood pressure history body mass index BMI use diagnosis develop datum use datum model identify patient age factor result high indicate model function patient individual healthy indicate high model healthy develop model use T2DM test T2DM diagnosis
26014311 en insulin insulin insulin insulin glycemic control patient clinical trial compare insulin follow-up examine health compare effect insulin retrospective study datum health insulin rate use model control outcome assess use study population included receive little oral medication insulin outcome included condition significant relationship type insulin mortality ratio mortality individual insulin CI CI difference risk remain insulin significant increased risk found difference health outcome compare use insulin insulin high insulin without clinical treatment patient
25748416 en evaluate associate woman gestational mellitus study woman large woman health complication large gestational age score woman positive associate negative associate history status woman diagnose early receive insulin treatment vs CI vs addition associate great obesity history gestational weight insulin therapy on analysis use revealed score independent associate per common woman associate early diagnosis great insulin treatment increased independent obesity gestational weight
20144180 en hemoglobin hba1c level show related complication although control poor use clinical research whether different study examine potential difference characteristic three different control poor total type mellitus aged change management on medical review recent hba1c level health care three different control demonstrated significant difference characteristic control poor control demonstrated response different glycemic control may different characteristic association among characteristic therefore individual assessment characteristic need occur independent control
24958326 en study determine patient type mellitus hemoglobin hba1c randomize response system treat week primary change baseline hba1c week included patient hba1c change baseline fasting plasma glucose body weight blood pressure week total patient randomize treat week adjust mean confidence interval CI difference vs change baseline hba1c patient hba1c baseline hba1c compare reduce body weight respective adverse event reported patient receive patient receive report adverse event event treatment week patient T2DM reduce hba1c body weight well
20857841 en incidence type increasing include factor important role aim study evaluate role factor incidence type conduct retrospective study subject diagnose type subject group subject diagnosis type study present mean age year group age increased year year weight study group influence age weight early well level group year previous study found incidence type year influence factor
20842885 en disease mellitus may lead several complication disease one major oral health patient report increased risk among diabetic aim study investigate oral health status patient mellitus type metabolic control study included sample diabetic patient two group poor control control hba1c patient medical oral health index clinical patient poor control significant high number compare control vs parameter significant high patient poor control control vs index positive correlation patient study indicate relationship poor control disease
25588398 en disease patient type mellitus severe oral effective treat one mean important patient study revealed high need care patient mellitus type week use oral index improve time index reduce decrease also
24217637 en diabetic study suggest can risk factor aim study determine relationship patient type mellitus total patient type DM included patient undergo plasma body evaluate according patient group severe significant difference group patient mean duration serum concentration significant high patient without respective serum increased diabetic study suggest body associate patient type DM
20045535 en although recent clinical study show serum level negative associate serum investigate relationship serum level total weight ratio ratio vs change one treatment type mellitus patient serum total ratio significant positive correlate change multiple regression analysis adjust age duration body body weight serum hemoglobin show serum total significant positive correlate change significant relationship found serum level hemoglobin vs change finding suggest serum total can clinical change treatment type mellitus reduction patient type mellitus
22282035 en examine relationship among patient type mellitus T2DM use model study sample patient T2DM three patient reported significant patient without result analysis suggest patient great great negative negative associate great use little use related great great overall result study relationship among patient T2DM however study relationship finding need study evaluate relationship
21442483 en evaluate association study perform compare patient study group patient without control group hospital medical incidence DM study group control group difference analysis DM independent associate risk increased DM patient duration risk duration less year year significant difference found patient without mellitus increase risk however associate mellitus
19331240 en estimate age prevalence diagnose type mellitus T2DM evaluate influence database clinical management study review medical T2DM patient number patient T2DM age population prevalence among year old prevalence increased age management T2DM base significant high database prevalence diagnose type mellitus low compare previous suggest prevalence high age group identify type group management type mellitus improve use database database
23371328 en high incidence mellitus population present provide treatment diabetic patient according current evidence
23710810 en assess value hemoglobin hba1c adult oral glucose tolerance test
23470694 en complication obesity identify risk factor body mass index BMI use obesity high BMI reported independent risk factor however influence increase BMI development follow-up retrospective study identify patient receive hospital patient included study define base association patient develop follow-up period month patient patient diagnose first year follow-up month patient diagnose month age increase BMI independent risk factor logistic analysis level BMI use first study association increase BMI development increase BMI risk factor finding BMI medical
23406063 en mellitus analysis lead activity time high value association disease disease suggest potential great condition
22966766 en reported chronic disease due aim study show impact renal function study subject total hypertension patient hypertension study cohort examine association investigate correlation multiple clinical parameter analysis show significant association total mortality prevalence cardiovascular event on show significant high prevalence mellitus DM lower estimate rate subject without subject DM on show significant lower significant correlation subject on show independent risk reduce renal function patient DM
20630070 en use among patient high prevalence use aim study prevalence use among patient mellitus examine characteristic develop sample patient age two hospital datum use test within previous month female complication use diabetic condition use use use high rate use patient two hospital also high rate use need health related use
24469234 en type mellitus multiple need glycemic control mechanism event increase risk cardiovascular disease weight mortality individual important control without weight clinical trial datum patient therapy suggest insulin may effective therapy insulin associate weight insulin associate weight weight associate therapy suggest well therapy insulin
24356795 en recent evidence suggest improve insulin randomize study investigate effect activity well fasting level subject type mellitus receive week week treatment perform fasting significant difference fasting activity datum insulin effect mean influence population clinical trial number
21394612 en investigate mellitus patient role hypertension use patient hypertension healthy included study subject group healthy mean age year patient mean age year patient mean age year patient hypertension mean age year measured mean use analysis regression model multiple use statistical analysis mean healthy patient without hypertension patient patient hypertension compare healthy control subject significant high patient hypertension patient hypertension whereas increased patient significant high patient hypertension patient finding remain factor hypertension effect patient whereas diabetic effect
26246406 en previous type determine whether risk type increased weight common analyzed individual on identify population high mean weight increased risk type early age one individual identify retrospective review medical diagnosis age year study show decrease activity clinical care potential occur population
25521597 en glucose cell fasting perform significant function glucose reported control glucose target treatment type present study large identify perform study also compare reported two drug show study contribute evidence type drug identify show high
24969141 en aim study identify factor independent associate rate type diabetic population high risk cardiovascular study type diabetic subject mean duration year undergo blood pressure assess insulin resistance presence disease subject decrease compare analysis revealed significant high ratio high also logistic regression analysis show independent type diabetic population independent associate suggest diabetic patient also may mechanism association cardiovascular event study
24040875 en prevalence type mellitus T2DM increasing T2DM associate complication disease disease disease diabetic show effect several diabetic complication well cardiovascular risk dysfunction chronic disease disease metabolic syndrome syndrome several clinical trial T2DM patient reported significant reduction event treatment however risk reported risk reduction individual overall use diabetic patient target increased risk
20570807 en case type mellitus association cell clinical datum study patient present cell patient man history poor control type mellitus diabetic diabetic hypertension therapy show patient serum cell period patient treat cell concentration cell suggest role cell may multiple target may possible role syndrome poor control hypertension
22799127 en aim study assess effect effect glucose level studied healthy control serum glucose level measured time day analysis assess level group difference level statistical significant level cause great however difference statistical significant increase glucose level diabetic glucose level diabetic diabetic study demonstrated significant serum glucose level
22150528 en estimate remain cause incidence complication diagnose type model cohort adult aged year new diagnose type treatment base study outcome included year incidence complication cause mean year without treatment year treatment year treatment lead lower incidence complication lower mortality complication renal disease vs treatment within year incidence disease increased great risk factor treatment result adult type year may severe chronic complication type clinical treatment may treatment on management include early control cardiovascular risk factor need reduce risk
21323901 en patient mellitus medication however effect drug well investigate effect diabetic protein level activity compare two reduce diabetic significant lower protein level observed diabetic protein level significant two group observed increased protein level high activity diabetic study indicate associate significant decrease activity protein level finding can clinical diabetic patient receive multiple medication effect activity clinical study diabetic patient
19175903 en type mellitus system cell found patient type mellitus may also syndrome report two severe chronic first present age month develop mellitus age present clinical age severe chronic clinical although patient chronic response high presence clinical disorder possible
21489091 en evaluate risk type T2DM value health associate body mass index BMI old T2DM insulin resistance method T2DM health reported health current health evaluate health index female old T2DM BMI old little rate T2DM complication treat renal disease little however significant lower health assess assessment current health risk T2DM rate treatment significant consider treatment T2DM T2DM also
23364030 en examine potential impact risk factor include associate metabolic syndrome risk investigate use baseline datum include level datum year use on test regression show or high level or independent associate increased risk low mellitus elevated level age lower follow-up
21222313 en old patient high risk complication increase time develop compare subject without addition diabetic patient associate major cardiovascular event include risk high within year diagnosis type mortality rate general population study analyzed clinical datum risk factor outcome diabetic patient subject high value value high clinical outcome patient case rate day severe develop medical complication hospital primary study patient control glucose associate reduction risk therefore control risk factor patient hypertension
20620425 en population individual important cardiovascular disease important on early however receive less treatment relationship investigate present important study cardiovascular risk factor study association risk factor presence change risk time risk presence large influence regard cardiovascular health population study
20071261 en mellitus chronic disease major health according current diabetic number complication year show type complication early risk several datum method use diagnosis management diagnosis use model result show provide medical outcome medical study
25668937 en prevalence increase therapy patient target oral drug insulin therapy although early insulin patient target insulin therapy time insulin insulin therapy factor control current develop aim provide base datum insulin therapy management type mellitus T2DM use insulin clinical need management T2DM insulin
22394699 en important cause mortality type mellitus DM risk factor aim present study determine related patient type patient type DM study age duration insulin major cardiovascular risk factor include metabolic parameter assess patient also perform blood subject use method perform use blood pressure increased subject according analysis adjust risk factor total cholesterol cholesterol cholesterol however found associate increase result suggest associate DM
22249968 en evaluate datum regard clinical develop patient type mellitus T2DM patient study identify use medical datum two provide care medical subject one datum diagnosis result medication obtain period first use datum positive value rate test use compare datum use age compare subject T2DM statistical datum medical subject T2DM subject identify datum use T2DM subject subject T2DM subject subject identify positive value rate respective T2DM subject respective subject age mean age female mean age female T2DM finding show use datum medical contribute finding consider develop
22160540 en glucose cell change function plasma glucose evidence reduce type measured cell response glucose model type mellitus diabetic body glucose body determined increased cell response glucose three cell type significant reduce compare significant reduce compare glucose significant increased respective datum suggest glucose cell impair
21390057 en patient type mellitus increased risk cardiovascular disease examine pressure index blood pressure parameter patient type mellitus on total patient type mellitus mean duration year follow year baseline patient undergo follow-up patient cardiovascular event analysis event follow-up ratio regression analysis adjust risk ratio event on significant two parameter found high ratio great increase ratio per increase on increase increase ratio increased adjust confidence interval event whereas similar increase increased study show ratio event type patient consider evaluate risk
19769558 en control reduce risk development complication type type general target hba1c level patient also provide target little target hba1c level hba1c target base factor type duration medication presence cardiovascular disease risk management also include control cardiovascular risk factor include weight blood pressure lipid serum level therapy
19475334 en aim study assess status mellitus DM diabetic study group control subject type DM patient without complication diabetic compare control subject decrease significant increase serum protein protein patient compare normal subject index high diabetic diabetic patient without complication significant correlation serum glucose level high significant positive correlation plasma level significant correlation level finding patient severe normal high diabetic patient without complication may important role complication
21418003 en aim present review finding study relationship incidence prevalence mortality type mellitus T2DM year on database result related prevalence incidence mortality T2DM found studied relationship prevalence T2DM two incidence three mortality two studied mortality prevalence great incidence prevalence high mortality due T2DM although association one study difference prevalence T2DM risk factor T2DM great woman man evidence T2DM incidence prevalence mortality present among woman activity healthy health reduction related
24859238 en early response protein severe model characteristic similar mellitus present study use insulin system use response on system also develop control insulin determine whether insulin cell treat result revealed increase decrease insulin therefore system may study mellitus use addition may cell cell model mellitus
26840133 en obesity associate increased risk adverse outcome study show improve outcome improve insulin patient gestational lead less weight occur trial woman without index BMI weight receive per day woman group week BMI time study week primary outcome reduction score reduction incidence outcome included gestational weight incidence gestational well incidence adverse outcome perform use analysis perform according total woman trial woman group group significant difference score group range group range gestational weight lower group group range vs range incidence vs odd ratio confidence interval incidence effect high group group significant difference incidence gestational adverse woman without BMI reduce weight weight number number
21367583 en associate increased risk disorder include disease cardiovascular disease can high mortality rate patient risk factor include hypertension obesity positive history contribute similar complication type diabetic patient subject level factor diabetic patient increased risk complication diabetic population recent complication show several clinical study increased risk patient impair glucose tolerance insulin metabolic role development patient metabolic target patient therefore review mechanism increased risk recent mellitus also potential target mechanism
25668934 en type mellitus chronic disease insulin cell case diagnose remain disease population early treatment important reduce complication disease individual insulin current patient reduce effect weight also effective use insulin insulin treatment management regard insulin use treatment patient care current develop base aim provide clinical management
19110706 en on adult female present weight increased mellitus diagnose base finding include result age obesity clinical type mellitus diagnosis glucose tolerance test treatment management insulin therapy insulin clinical type mellitus
18679158 en study investigate whether event occur type mellitus role development disease study mellitus type patient rate level evaluate serum level also measured group disease without significant high hemoglobin high serum lower serum remain diabetic patient on statistical significant positive correlation observed serum serum hemoglobin poor metabolic control elevated level decrease level occur type mellitus influence incidence disease
18347866 en metabolic syndrome risk factor cardiovascular disease contribute syndrome study aim evaluate result treatment metabolic syndrome patient type mellitus body mass index BMI lower perform patient woman man mean age year range year mean BMI range patient diagnosis type mellitus T2DM little year previous evidence treatment use oral insulin little month mean duration type mellitus year range year metabolic syndrome diagnose patient hypertension diagnose patient mean number drug patient two perform associate perform patient patient mean follow-up period month range month mean BMI patient glycemic control patient level high man high woman patient less man woman hypertension control patient control metabolic syndrome effective control metabolic syndrome type mellitus on follow-up period need
20539998 en group medical patient study group medical mellitus health care patient on present group patient patient period datum patient use analysis show change time datum use respective increased great hemoglobin revealed patient general group medical increase major group medical low patient system
26293506 en therapy type result one aim therapy diabetic cause therapy cell addition on cell therapy patient type
26524290 en clinical response great patient identify associate treatment response can mechanism little known relationship treatment response perform study identify risk factor weight sample patient previous clinical trial assess treatment obesity on cohort patient clinical study weight identify test independent cohort patient type identify may contribute weight body weight respective finding body weight respective independent cohort also identify may associate response may associate treatment finding may weight individual treat related insulin response however finding need large sample
25155146 en show effective general treatment improve control patient type mellitus control without randomize study adult patient without receive treatment primary change baseline week change baseline hba1c week significant confidence interval change baseline fasting plasma glucose group group significant high patient hba1c rate week impact weight severe observed result assessment similar group adverse event incidence rate respective without provide effective glucose general well
25124546 en event may cause reduction mellitus cause gene type investigate patient diagnose show profile normal show cause reported previous report cause event two disorder cause different mechanism
25117462 en patient high prevalence insulin resistance risk mellitus DM observed healthy control datum current prevalence change use new study patient without DM receive first therapy according clinical include define model assessment DM assess patient time less receive overall prevalence patient logistic regression analysis significant association found ratio CI per CI per evaluate DM diagnose patient patient vs overall rate DM per previous vs lower prevalence observed current patient risk factor receive new drug identify patient high risk develop DM
26120860 en level mellitus DM change year age period mortality population mortality rate impact DM use mortality rate year old increased DM man change reduction year woman reduction year period reduction man woman year DM increase man woman reduction observed health aim reduce mortality cause early treatment group
25395241 en role lipid mellitus DM influence patient hospital medical may included lipid risk factor include blood glucose hypertension DM investigate level high cholesterol decrease DM group compare group low level cholesterol patient DM logistic regression demonstrated decrease cholesterol correlate DM relative risk low cholesterol level group CI compare high level group age impact cholesterol correlate DM population aged year or low level cholesterol high risk high level group or cholesterol correlate DM population aged year
23755944 en assess patient type mellitus treat insulin compare multiple insulin study conduct assess patient treatment use related general treatment score patient therapy similar treat vs lower score vs health patient treat show high score vs value obtain high patient compare group week vs three month period vs therapy show poor although treatment treat difference related group
25504156 en patient type mellitus T2DM remain medication clinical analysis compare among adult patient two retrospective cohort study health health database adult aged year T2DM included patient year year measured use day consider measured time define day drug day therapy logistic regression model compare outcome cohort baseline sample included patient follow-up adjust odd significant great among adjust odd ratio follow-up therapy adjust significant great adjust ratio compare significant compare significant great result similar adult T2DM therapy significant compare patient
25458659 en previous study compare prevalence high type mellitus T2DM patient provide compare prevalence patient T2DM metabolic syndrome T2DM undergo disease function measured month prevalence significant high T2DM patient patient T2DM vs whereas month T2DM patient significant high prevalence vs analysis T2DM odd ratio or CI or CI previous chronic treatment or CI independent whereas T2DM or CI important independent T2DM independent therapy T2DM remain independent may clinical current therapy
25336181 en evaluate patient type mellitus DM control cardiovascular risk total patient type DM mean age year man control subject mean age year man hospital undergo included retrospective cohort study patient control group compare characteristic finding evaluate group correlate determined regression analysis among patient type DM fasting blood glucose total cholesterol cholesterol level significant high compare control group positive correlation body mass index serum level fasting blood glucose hemoglobin hba1c total cholesterol cholesterol regression analysis hba1c significant contribute finding indicate significant high value diabetic control associate positive body weight poor glycemic control hba1c level diabetic patient status hypertension
25329038 en effect glucose blood pressure adverse event evaluate use datum study patient type mellitus T2DM baseline patient medication provide reduction confidence interval CI baseline compare respective respective reduction CI reduction respective compare overall population patient elevated baseline great reduction CI respective great reduction patient baseline respective patient elevated baseline reduction CI respective change respective elevated baseline associate increased incidence increased increased vs incidence low group associate reduce patient T2DM range baseline increased incidence related reduction
25040479 en low level associate cardiovascular risk factor however relationship level function man type mellitus T2DM total man history significant lower level normal glucose vs increased risk vs significant difference level subject without among T2DM vs among vs group overall vs lower level significant associate odd ratio or or characteristic analysis level show T2DM level high value T2DM low value show level correlate T2DM level correlate man T2DM
22814841 en mellitus complication significant cause mortality evaluate potential present study evaluate serum level diabetic study subject normal healthy control diabetic diabetic patient patient without complication study group diabetic patient disease study group diabetic patient disease study group plasma glucose hemoglobin serum level estimate plasma glucose hemoglobin level significant high study group compare control however serum level significant lower diabetic patient disease significant negative correlation observed serum fasting plasma glucose hemoglobin indicate role diabetic addition therapy may diabetic complication
21484978 en regard association type mellitus insulin resistance metabolic syndrome cardiovascular disease on perform identify disease on total identify report one investigate disease on total included regard association type mellitus insulin resistance metabolic syndrome cardiovascular disease respective plasma concentration increased participant diagnose type mellitus metabolic syndrome cardiovascular disease odd ratio confidence interval CI CI CI CI respective level positive associate insulin resistance CI study found overall result analysis found test study suggest use may obesity status insulin resistance metabolic syndrome cardiovascular disease
22988932 en randomize study compare blood glucose subject type mellitus
26039918 en one common complication aim examine mellitus patient receive on two group result renal function finding evaluate one year perform according develop patient receive patient level age significant different diabetic group renal function show significant difference sample revealed significant difference diabetic group vs patient vs result indicate early development effect renal
25527236 en plasma potential cardiovascular disease insulin resistance obesity examine relationship plasma concentration metabolic syndrome patient type mellitus T2DM evaluate plasma risk diabetic patient without known plasma develop base range healthy adult plasma concentration measured T2DM patient without known disease disease mean blood pressure population plasma concentration range T2DM patient significant high concentration within group plasma significant high patient also patient compare patient without respective plasma regression analysis found independent associate BMI protein cholesterol however plasma regression analysis outcome patient high concentration plasma associate obesity status however plasma independent
25479542 en study lower pressure patient type mellitus DM health factor health factor analyzed risk score pressure patient type DM month vs body change remain assess parameter associate lower patient type DM effective clinical trial
25260537 en adult type mellitus impair rate interval compare healthy control addition result adverse change cardiovascular healthy adult adult assess rate blood pressure analyzed baseline interval adult compare healthy control result significant reduction interval change different adult healthy current study show adult impair cardiovascular function finding effect reduce cardiovascular function similar adult healthy control result suggest may cardiovascular control patient increasing risk cardiovascular mortality
25066830 en study incidence type mellitus T2DM trial participant risk T2DM reduce T2DM result trial may due sample study may also reported association due factor intervention study may study show association high status decrease incidence T2DM trial therefore may cause effect study may association study may increasing serum level perform identify examine association T2DM glucose on evidence conduct use outcome analysis high identify outcome evidence analysis consider outcome group outcome type T2DM fasting glucose glucose tolerance fasting insulin insulin insulin evidence role reduce odd T2DM incidence evidence evidence present outcome low level review significant research outcome research aim identify T2DM
23287960 en result cohort study regard association mellitus DM risk incidence mortality aim assess whether association database cohort study DM mortality outcome datum independent use relative risk confidence interval estimate use model investigate use test total cohort study case cause included analysis among study reported risk incidence study reported risk mortality show DM associate increased incidence CI test compare individual without general population analysis conduct study year type DM positive association DM risk observed analysis also show study significant influence relative risk significant found mellitus positive associate mortality CI test cohort study suggest significant association DM increased risk incidence increased risk mortality
20434886 en study test impact management intervention old adult type individual age baseline follow-up month participant significant great body mass index care group found suggest change health parameter treatment
18579465 en cardiovascular risk factor great clinical effective cardiovascular risk management well care patient type aim study estimate effective cardiovascular risk management type diabetic patient type mellitus man woman age year duration year datum medical history treatment parameter well blood pressure level activity evaluate according current patient body mass index target level patient woman man measured patient respective control level patient lipid drug use patient among target level target target level lipid target value patient drug use patient among target value regard patient current cardiovascular risk factor patient need cardiovascular risk management care adult patient type mellitus
21839662 en although disease cardiovascular disease mellitus association serum level investigate association serum conduct study man type mellitus examine relationship serum total level measured correlation analysis show patient age duration negative correlate positive body mass index BMI positive correlate negative negative correlate negative correlate hba1c respective multiple regression analysis adjust age duration BMI serum hba1c negative associate respective negative associate association significant hba1c study first time show negative association serum serum man type independent age duration BMI renal function hba1c
21221528 en aim study test effective vs care primary outcome measured score outcome control trial elevated score use diagnose group intervention patient outcome provide treatment baseline month follow-up measured use study hba1c level obtain medical score decrease baseline month group respective significant difference group hba1c significant within group patient receive increased group compare patient improve score impact compare management improve outcome patient
26562371 en evaluate identify severe gestational mellitus according health associate high risk adverse woman first hospital analyzed retrospective participant diagnose different group according different number oral glucose tolerance test result body mass index BMI participant without included group incidence adverse outcome analyzed according difference BMI number woman diagnose large gestational age group value significant high group value group also significant difference group group risk adverse outcome increased woman body mass index woman BMI group low risk adverse outcome need insulin case severe study case woman value value BMI severe treat severe
27219877 en type mellitus T2DM observed well study history datum T2DM control analyzed fasting blood glucose hba1c measured compare control high diabetic vs vs vs diabetic high diabetic among patient vs control vs patient diabetic compare patient age time study T2DM also high prevalence high control compare patient gene patient diabetic compare patient diabetic T2DM significant role T2DM associate patient T2DM diabetic different patient
22997730 en role system mellitus DM disease current poor general cause type complication system insulin however recent year evidence system development disease activity protein system well contribute significant DM case development disease factor cause dysfunction system DM insulin resistance occur result insulin therapy review system DM well relationship change system development diabetic
22071074 en previous study examine glycemic diagnosis mellitus provide result current study test hba1c participant obtain health year fasting plasma glucose hba1c mean index outcome value less great sample respective analysis age fasting insulin level year low index analysis result model new hba1c
26167475 en aim evaluate model severe mellitus effect cell diabetic one group receive DM group receive DM DM show significant parameter compare DM present change characteristic decrease DM show associate diabetic condition low number cell found DM suggest can effect DM present increased renal index decrease renal index factor level also reduce DM datum renal function
25377916 en plasma associate metabolic cardiovascular renal patient type less well type aim compare level patient vs healthy control blood pressure rate effective renal plasma evaluate patient glucose effect vs increased parameter evaluate patient glucose lower vs vs decrease increase level correlate positive negative decrease increased lower vs positive correlate negative increase study examine effect therapy impact cause important effect
25100397 en need identify gestational mellitus recent show associate investigate association level female without included mellitus hypertension oral glucose tolerance test perform diagnose use association study group measured characteristic use identify identify mean level significant high subject compare subject first multiple logistic regression analysis show significant association odd ratio or confidence interval CI adjust potential on CI identify level high female can use potential
23261861 en aim study determine type mellitus control subject study type use significant common patient control subject significant lower patient control common patient whereas control subject observed among result similar potential previous observed population
23209008 en medication treatment increased previous recent mechanism drug review mechanism medication current treat mellitus insulin mechanism factor patient mellitus
23134339 en general management type mellitus overall individual conduct determine overall effect chronic chronic control patient effect different type control condition obtain positive identify study use mean effect follow large confidence interval use total study study use study study study study control large chronic control resistance resistance decrease blood glucose level use also show significant effect chronic control although show significant result chronic control resistance significant improve chronic control although show control due resistance resistance study subject addition risk also improve level patient
23042819 en recent datum dysfunction may potential mechanism development insulin resistance examine association dysfunction type mellitus T2DM impair glucose review conduct study cohort study participant T2DM baseline included relative risk use effect model study study T2DM impair fasting glucose impair glucose tolerance relative risk T2DM case confidence interval per great dysfunction estimate dysfunction analysis estimate dysfunction relative risk T2DM per high plasma level per high plasma level per lower response per lower ratio per high ratio addition relative risk impair fasting glucose case per great datum indicate estimate dysfunction associate T2DM possible impair fasting glucose suggest role T2DM
21789690 en on body research suggest prevalence major disorder type mellitus significant high without type associate increased review current two common disease potential conduct review identify evidence suggest mechanism relationship type may include effect associate impact insulin effect chronic impact may type research determine association clinical population
18465362 en occur patient type mellitus suggest elevated level insulin cell lead cell patient type mellitus study show increased risk high risk patient treat insulin mortality increased recent evidence patient type mellitus undergo insulin therapy interval year review evidence present patient type mellitus
18040660 en aim study examine association incidence type mellitus large cohort study study woman history type mellitus cardiovascular disease study history activity assess regression model evaluate association risk type year follow-up woman diagnose type mellitus woman lower risk mellitus relative risk CI increasing duration associate reduce risk type mellitus adjust duration year analysis adjust age BMI activity level level number presence hypertension may woman develop type mellitus
21427654 en aim study assess effect patient type mellitus T2DM without patient T2DM receive month medication blood lower assess baseline month use measured parameter patient treat significant increase increase parameter significant decrease observed control group respective whereas change effect patient T2DM
21289263 en obesity type mellitus T2DM cardiovascular profile patient without T2DM baseline intervention study female T2DM female healthy week parameter T2DM group significant increased serum concentration factor protein group less profile compare T2DM group T2DM patient decrease body weight improve metabolic profile decrease increased patient without T2DM increased factor two week significant improve profile T2DM patient
19658004 en elevated concentration disease however patient without type remain poor therefore correlation association measured level patient compare result cell patient without type mellitus level significant high patient patient patient analysis show age body mass index blood pressure high cholesterol cell normal significant associate addition blood pressure cholesterol significant factor model correlation plasma patient observed without result suggest mellitus patient plasma level association plasma level may result development complication patient
23933122 en hba1c value influence mean blood glucose level base develop hba1c use datum blood glucose also hba1c diabetic patient use develop study included patient type mellitus female aged mean blood glucose value obtain datum previous week hba1c use develop compare value measured value measured value hba1c respective measured value respective positive correlation value hba1c hba1c value use develop datum general measured value use value hba1c can estimate measured datum
25200482 en chronic disease cause mortality study disease well development health mortality patient study identify health mortality patient mellitus study cohort mellitus patient diagnose follow logistic regression model develop number diagnosis number group number major group care group system use model prevalence mellitus number diagnosis associate health mortality mortality number model adjust age number number high system mortality mellitus study patient mellitus need
24447809 en investigate relationship blood gestational mellitus woman woman study serum blood level measured time association serum blood level metabolic parameter significant lower mean serum level compare control group vs mean blood level control group significant different vs significant difference found age gestational week BMI weight blood pressure group well serum level negative correlate BMI respective correlation level parameter found serum level patient significant lower compare control however significant difference found blood level patient healthy woman
24710641 en study evaluate compare effect glycemic control cardiovascular risk factor patient new diagnose type mellitus randomize clinical study patient new diagnose T2DM on total patient randomize group drug month fasting plasma glucose plasma glucose hba1c insulin lipid parameter dysfunction measured baseline month group hba1c insulin significant decrease treatment compare baseline group BMI hba1c significant decrease treatment compare baseline group hba1c significant decrease treatment compare baseline whereas increased month decrease insulin score compare effective glycemic control patient new diagnose oral T2DM cardiovascular risk factor patient therapy compare therapy also drug effective treatment patient
26234084 en review datum also analysis result research DM include type syndrome type case patient one two model clinical disease population age significant high risk significant less low risk year study show high risk group increase group low risk lower high risk year define high risk early age DM T2DM development cause gene case contribute study value new DM
25539895 en effect patient mellitus on total patient receive month blood pressure plasma measured baseline follow-up level rate measured month treatment similar significant reduction observed pressure level treatment however age body mass index duration plasma reduction show major independent factor influence reduction regression positive age plasma reduction negative body mass index duration similar finding observed pressure result patient whether reduction measured value associate increased effective reduce diabetic
25413174 en aim study determine total level subject without gestational mellitus woman week oral glucose tolerance test normal result diagnose level include total age BMI similar two group use high control group fasting blood glucose high group total level range control group range group level range control group range group study revealed relationship low total level type mellitus DM regard type DM finding suggest related however can investigate
22409964 en mellitus DM several case DM evaluate effective disease management use database investigate impact care hospital care hospital patient DM analyzed analyzed according age year presence characteristic complication insulin use intervention total analysis investigate effect complication care associate DM mortality complication rate respective significant difference age among disease great impact increasing complication significant independent care DM case
23811614 en function health mellitus DM function patient aim study identify common patient DM use study DM treatment patient patient treat conduct three use response two use first DM whereas DM factor DM DM provide effective function DM
23132330 en patient mellitus DM high risk mortality overall reduce mortality mortality patient without DM decrease time previous analysis assess recent hospital mortality patient according DM analyzed datum patient treat hospital one care hospital study patient include DM hospital mortality decrease patient remain high patient DM compare without DM study difference mortality patient without DM significant time DM time adjust odd ratio mortality associate DM confidence interval confidence interval large hospital mortality observed diabetic woman hospital mortality patient without DM significant great observed woman DM
21692625 en status effect treatment patient type mellitus disease patient type mean hemoglobin hba1c level disease study group disease included patient clinical group disease included patient clinical patient patient group patient group undergo treatment analyzed difference serum concentration metabolic parameter hemoglobin parameter protein parameter two group treatment month patient patient group patient group study significant difference index index clinical time observed cohort observed significant difference group whereas significant difference group baseline month group improve glycemic control difference level significant different time cohort significant positive association among metabolic parameter month treatment improve health patient significant reduction metabolic parameter observed period
18669811 en study medication management adult poor control type mellitus DM identify characteristic associate poor analysis baseline datum randomize control intervention conduct great study evaluate effect intervention control month medication included medication management use medication medication base medication characteristic associate poor control identify use regression subject mean mean duration DM year studied common included medication obtain DM medication DM medication significant associate high hemoglobin related study identify factor associate poor control finding identify potential medication DM provide control
23235674 en effect blood glucose lipid level provide lipid control assess effect type database among database included control trial compare without oral control intervention without oral review independent trial datum evaluate risk trial use parameter outcome datum potential range week investigate participant overall risk trial high compare effect without drug treatment one study drug treatment demonstrated statistical significant reduction fasting blood glucose mean difference confidence interval CI participant trial trial low risk also reduction hba1c CI participant trial trial low risk however trial compare participant statistical significant difference two hba1c increased demonstrated statistical significant reduction CI participant trial trial low risk observed adverse effect reported complication disease mortality show significant effect control however number study different ratio treatment assess effect management cardiovascular risk well reduction complication type mellitus datum mortality also need investigate
23089368 en study examine value patient type mellitus show outcome patient hypertension associate increased cardiovascular event measured independent mortality patient ratio index pressure perform datum patient retrospective analyzed base previous value patient group reduce patient group patient primary overall reduce significant lower vs CI increased risk mortality adjust risk factor blood pressure mortality blood pressure related dysfunction low found patient independent mortality patient normal blood pressure increased risk study evaluate clinical parameter therapy need improve clinical outcome patient
23036710 en patient type mellitus T2DM insulin resistance associate obesity response increased level condition provide mechanism T2DM analyzed blood cell patient T2DM compare subject investigate several response response obtain T2DM patient subject total datum analyzed use use gene analysis investigate significant gene study possible influence clinical gene profile show T2DM patient present significant change gene compare control group on great number T2DM among high value one associate one identify two significant related insulin resistance related addition profile influence patient age obesity age hba1c study profile provide difference T2DM patient individual contribute new disease
23541039 en common use test diagnosis include fasting plasma glucose level oral glucose tolerance test recent hemoglobin level included diagnosis association aim determine value identify patient include impair glucose tolerance impair fasting glucose among adult determine whether according age adult without history hospital on perform characteristic use evaluate diagnose value increased age year year old year similar man woman study determine whether
18301839 en although clinical diabetic clinical dysfunction type mellitus investigate clinical rate response type study patient type mellitus healthy control rate response measured subject rate response measured little datum analysis use correlation test multiple rate response lower patient mellitus control less respective age female presence independent reduce rate response independent positive correlation found rate response factor associate rate response independent duration mellitus presence hypertension disease mean rate response patient mellitus complication lower compare control less datum suggest dysfunction may complication age female reduce rate response type mellitus
20015524 en study examine effect influence rate blood pressure response oral glucose individual without type mellitus pressure measured response glucose subject group without group week assess use analysis blood pressure rate analysis glucose significant increased ratio decrease increased response reduce glucose group increased group glucose effect improve response oral glucose adult independent status change body weight body level glycemic control
22528597 en addition role development complication important role type mellitus T2DM mean effective glycemic control reduce incidence complication also metabolic contribute disease multiple effect include weight associate current therapy present glycemic control subject T2DM recent renal develop reduce plasma glucose concentration mechanism oral independent function insulin improve glycemic control weight review datum mechanism
22399236 en protein current role studied T2DM without type mellitus determined gene protein concentration insulin response glucose gene protein level lower T2DM also lower insulin high concentration on positive correlation gene negative correlation found concentration cause reduction increase concentration reduction insulin contribute insulin response glucose T2DM patient reduce increased insulin response glucose impair
22397507 en type mellitus T2DM insulin resistance dysfunction treatment disease target among recent addition T2DM increase level insulin provide clinical result therapy T2DM indicate treatment T2DM patient glycemic control result clinical trial provide evidence addition treatment association effect function profile compare datum suggest low incidence adverse event may improve patient therapy improve metabolic control
24534349 en prevalence risk factor plasma patient type patient type hospital plasma diagnose logistic regression use assess association plasma associate risk plasma diabetic obesity prevalence plasma according logistic regression analysis presence plasma associate or high high body mass index or high or high level or or or control or high prevalence plasma diabetic level hba1c body mass index control may decrease prevalence
20930001 en obesity associate patient chronic however obesity management mellitus DM common little known impact obesity patient DM therefore examine association obesity outcome cohort patient without participant chronic group trial body mass index BMI baseline DM BMI patient without DM score obesity use patient DM patient without DM baseline characteristic among patient DM mortality occur patient respective ratio obesity compare obesity confidence interval CI among patient without DM mortality occur patient respective associate obesity CI patient chronic DM obesity whether weight may improve outcome patient need investigate study
19309449 en presence type mellitus evaluate two common positive history fasting positive history negative gene factor gene cause two common clinical outcome evaluate follow-up period present diagnosis insulin two oral medication three follow-up period remain without medication hemoglobin level one develop total group fasting follow-up remain presence patient without lead analysis positive history without follow type consider
21710713 en investigate mellitus patient normal test perform mellitus patient normal healthy control system function evaluate significant difference two group mellitus patient significant lower control function system mellitus patient normal
21357278 en type mellitus associate complication hypertension impair blood pressure control type diabetic patient reduce risk may blood function determined month control type diabetic patient complication T2DM diabetic patient without complication patient lower T2DM patient mean month among group however patient control reduce T2DM month baseline month whereas reduction T2DM function change month impair type mellitus reduction diabetic patient control reduction diabetic patient complication indicate treatment disease suggest treatment aim reduction
26497775 en consider glucose examine whether associate prevalence type T2DM general studied subject man woman year old include man woman T2DM participant cohort study association T2DM analyzed multiple logistic regression potential analysis also perform body mass index investigate show significant high adjust odd ratio or T2DM among man confidence interval CI woman CI significant association first study show significant association T2DM among subject
24060315 en study whether whether relationship plasma concentration without gestational mellitus blood obtain woman woman woman sample healthy woman concentration determined woman significant high plasma concentration healthy woman period level plasma lower woman significant lower plasma healthy woman woman significant high concentration healthy woman period plasma also high woman healthy woman period plasma level decrease period level woman high healthy woman result revealed present level correlate plasma concentration
25256148 en cardiovascular model develop patient type new patient investigate study aim cardiovascular model develop datum type patient without cardiovascular disease disease cohort respective use model estimate risk disease assess datum assess observed large score different cohort model range CI CI model poor disease incidence target population observed risk observed ratio model range CI CI risk evaluate model model provide risk estimate model identify type patient low high risk develop
22932284 en recent study revealed mellitus associate increased risk type decrease however risk increased decrease type risk increased high factor major cause review review treatment high diabetic patient multiple risk
25143741 en glycemic control remain major complication related mellitus insulin therapy treatment use glycemic large population glycemic target insulin treatment may associate due event therefore event glycemic target associate multiple also remain significant insulin therapy insulin treatment patient patient change insulin new insulin insulin clinical provide similar glycemic control patient type mellitus significant lower insulin although treatment patient different type type trial result suggest may insulin therapy patient type control oral role treatment diabetic patient
22200728 en dysfunction important development complication patient type increased improve patient type test oral improve function patient type study perform patient type ratio medical patient two time per day week patient assess outcome primary change base change index change index increased mean baseline follow-up group change group change index baseline great group group blood pressure change treatment week duration improve function patient type
22179222 en disorder include type may negative control increase risk diabetic complication aim study prevalence use adult type compare risk among diabetic patient group adult year type compare control individual level datum drug hospital research database type control subject respective female receive factor association group type associate or CI high risk analysis adjust potential include age risk factor risk increase statistical or CI risk factor use similar among type diabetic patient control risk factor per contribute increased risk use adult type
20493430 en previous study patient type mellitus found significant improve insulin significant increased serum level patient investigate effect type metabolic parameter patient type total patient randomize study patient receive month datum patient blood pressure significant decrease group study decrease among group change fasting plasma glucose fasting insulin hba1c total cholesterol cholesterol protein group lower effect metabolic dysfunction patient type effect metabolic difference among treatment can due low statistical study
23367733 en population group population different different may lead disease compare population recent year population change significant increase incidence rate mellitus DM increase known risk factor common recent health provide show recent incidence rate DM population increased per per among per among female rate decrease change recent population lead increase incidence rate DM group risk factor effective intervention
19318222 en woman history gestational mellitus high risk type mellitus review study glucose tolerance test result risk factor development T2DM among woman history database medical subject T2DM datum datum sample diagnose without analysis woman case report diagnosis base oral glucose tolerance test T2DM evaluate outcome relative association incidence reported T2DM two independent review perform datum assess datum study participant characteristic T2DM diagnosis follow-up regression model association identify evaluate glucose risk T2DM woman history study found fasting blood glucose significant T2DM odd ratio or range relative risk range relative risk T2DM plasma glucose study or range glucose study or range overall study high follow-up study duration study adjust risk blood glucose glucose T2DM among woman use
20405739 en increased decrease healthy subject increased type change less type associate age complication
20922871 en type insulin treatment reduce complication related disease patient duration type treat oral drug insulin patient type age history cardiovascular disease treatment oral diabetic drug insulin profile drug use aim year several study demonstrated reduction hemoglobin patient risk result clinical event increase cardiovascular event mortality glycemic disease diabetic patient high value significant difference among drug reduce insulin resistance drug drug effective reduce cardiovascular event increase protein activity effect finding large study disease patient patient care treat insulin glycemic target mean may lead increased mortality result important management disease patient type also blood glucose concentration increase intervention blood pressure control reduce effective cardiovascular event mortality
22153416 en mellitus DM large intervention current study aim prevalence DM patient evaluate outcome intervention intervention study little patient two first DM treatment related intervention on conduct health among patient health first large study prevalence DM current prevalence DM result study provide important evidence DM
20811623 en concentration recent reported elevated several chronic disorder however study examine association concentration type mellitus case T2DM control study case control first study case control study analysis use datum datum study show plasma concentration significant increased case compare control plasma concentration significant correlate plasma glucose concentration age BMI history or high plasma concentration compare low CI remain significant fasting plasma history hypertension analysis age BMI history plasma concentration associate high or regard important role T2DM study clinical plasma diagnosis T2DM complication
20405312 en mellitus metabolic disease insulin potential cell diabetic value hba1c level recent datum plasma activity type study evaluate activity study new diagnose type mellitus age group year well healthy control subject diabetic value glucose hba1c control group value glucose hemoglobin hba1c total glucose level blood plasma hemoglobin hba1c measured use method activity blood plasma measured method activity hba1c significant increased diabetic compare control subject activity type mellitus high finding high blood hba1c level presence type mellitus activity may
23215856 en examine disease associate development impair glucose woman recent history gestational without history follow month subject undergo oral glucose tolerance test oral disease insulin fasting determined define presence clinical woman without history woman significant high fasting glucose insulin concentration increased insulin resistance decrease function although statistical significant woman high prevalence disease woman without history woman disease show great insulin resistance lower function woman disease impair glucose insulin index significant lower woman disease woman without disease show reduce insulin function month disease may contribute impair glucose risk develop
22939581 en patient without history mellitus increased level hemoglobin hba1c associate high cardiovascular risk clinical outcome intervention investigate whether patient may increased risk adverse event intervention assess patient trial randomize control trial hba1c datum patient known diabetic patient without history diabetic hba1c hba1c assessment perform clinical outcome also compare patient diabetic known diabetic diabetic rate high vs known diabetic vs analysis adjust significant high risk diabetic compare odd ratio confidence interval known diabetic odd ratio confidence interval year target rate significant high diabetic related difference target large diabetic difference statistical vs diabetic show increased risk
22544873 en evaluate function assess rate association dysfunction patient mellitus three patient DM compare normal control patient DM compare hypertension function rate index large DM group normal control vs well DM compare patient vs significant reduce DM group compare normal control vs similar correlation increasing respective diabetic group however significant difference group on logistic regression analysis demonstrated patient show significant reduction compare normal control difference increasing DM independent associate function associate dysfunction evaluate diabetic contribute patient DM
19492925 en on insulin develop insulin reported negative correlate insulin resistance diabetic subject level assess insulin gestational mellitus type mellitus type DM normal woman level high control positive normal high diabetic type DM healthy woman on high occur woman clinical insulin resistance positive association poor glycemic control
19204799 en range association mellitus recent diabetic patient level role chronic development disease use method identify cell protein also use response method test blood plasma obtain T2DM patient control result large patient compare control T2DM analysis perform cell base positive two clinical base similar test can level test diabetic patient finding
24679741 en value patient type function without remain study sample patient type man mean age year history disease patient undergo assessment normal individual patient analysis patient follow-up period month range month event occur rate subject event rate associate significant high patient without analysis ratio confidence interval ratio confidence interval independent whereas disease independent dysfunction independent outcome patient type assess dysfunction clinical
27560635 en type mellitus T2DM relative insulin insulin resistance also associate metabolic include although study studied metabolic T2DM patient metabolic syndrome assess metabolic relative aim study compare clinical T2DM subject without case control study include T2DM patient T2DM subject control use datum use assess included index ratio body mass index BMI blood pressure blood pressure serum lipid profile fasting plasma glucose hemoglobin hba1c health use diagnosis metabolic syndrome test use less statistical significant use compare mean test significant difference metabolic prevalence T2DM group control group according mean value hba1c significant high T2DM subject mean value total cholesterol cholesterol cholesterol high subject T2DM group group significant mean value BMI high group T2DM group difference BMI significant prevalence subject T2DM high clinical index high T2DM subject mean hba1c BMI significant high compare also
26910019 en aim study evaluate influence response two group diabetic day group receive day respective day analysis day response observed group day response response observed observed response observed analysis diabetic condition diabetic mellitus influence response
26517230 en aim study investigate whether change observed type mellitus T2DM patient insulin therapy study perform subject T2DM patient without control hospital patient group T2DM patient insulin T2DM patient insulin control group use assess change use research on total evaluate use datum high significant association observed well three group compare high significant association vs vs compare significant less patient compare patient vs logistic regression analysis show group less group control group or or finding show T2DM patient insulin therapy less compare T2DM patient insulin
26512030 en study conduct analysis gestational mellitus target on model assess primary outcome per year healthy outcome cohort study hospital database relative target use risk factor ratio analysis show disease prevalence rate intervention effective glycemic management impact base model datum reduce complication gestational mellitus compare target
21492413 en type mellitus blood glucose insulin develop may blood glucose control high blood glucose level related need negative effect may negative little possible impact may glycemic control function use method need aim study method assess aim whether associate glycemic control function examine study observed characteristic large two year function glycemic control hba1c obtain medical assessment intervention study impact function glycemic control
22575410 en health care patient treat type blood glucose one therapy potential little insulin study show glucose control insulin patient type effective management primary care level insulin therapy patient type review observed outcome regard insulin use type
22446033 en aim study report prevalence complication identify clinical characteristic related complication subject new diagnose type subject subject known new diagnose analyzed study among diabetic subject new diagnose remain history subject undergo diabetic pressure prevalence complication confidence interval prevalence diabetic diabetic risk factor develop complication increasing age odd ratio increasing blood pressure increasing hemoglobin risk factor diabetic diabetic increasing blood pressure increasing hemoglobin risk factor diabetic increasing age one new diagnose type subject complication
20609967 en association mellitus fasting glucose concentration risk disease major aim association range individual fasting blood glucose concentration risk factor without disease study risk factor regression adjust age blood pressure index ratio included datum outcome risk study adjust CI disease change lipid renal disease high woman man year year old disease adult prevalence estimate fasting blood glucose concentration related risk significant association compare fasting blood glucose concentration disease lower without history fasting blood glucose concentration impair fasting glucose status significant improve disease several risk risk range disease independent risk factor without fasting blood glucose concentration associate risk medical research
24795397 en independent type although correlate insulin resistance risk factor develop gestational mellitus relationship study assess whether level associate risk study conduct among woman health case patient woman develop two control subject case patient year blood age age number high low level associate increased risk odd ratio CI adjust BMI history use result adjust model assessment insulin resistance fasting status rate gestational weight significant association found among woman high associate increased level level risk level present year may identify woman increased risk
24698434 en obesity chronic disease incidence increasing adult clinical number include cause obesity time disease include review present change found mellitus obesity related syndrome clinical early diagnosis disease
19783061 en function control activity may include patient management condition compare two different population patient type mellitus T2DM studied relationship patient assess use assessment assess use activity hba1c lipid level blood pressure duration mean age patient year mean duration year mean hba1c mean fasting plasma glucose cholesterol respective mean score range normal indicate impair mean score indicate impair suggest syndrome function score correlate significant correlation hba1c duration lipid level blood pressure patient T2DM may syndrome may impact group
27833702 en consider cardiovascular risk factor type mellitus T2DM associate increase risk cardiovascular disease aim study investigate level T2DM patient association metabolic factor T2DM patient healthy control participant study level determined result analyzed use level diabetic found significant increased compare normal healthy group diabetic group level correlate significant duration level decrease total significant correlate increased protein decrease total
27594733 en renal activity show increase patient develop diabetic study aim determine activity concentration sample patient type one type diabetic subject study blood sample fasting blood glucose lipid early sample also activity concentration significant increased diabetic subject compare control positive correlation serum on negative correlation found diabetic elevated level respective activity can early renal diabetic complication
27410954 en insulin treatment important risk adjust rate risk insulin treatment increased major drug lower risk event diabetic insulin treat diabetic diabetic need insulin
27282005 en first oral patient type mellitus type resistance group drug value one resistance resistance
26998356 en risk factor identify aim clinical characteristic associate patient may patient care severe severe study lower sample management therapy provide patient according patient positive significant high history mellitus odd ratio respective correlate history chronic disease hypertension mellitus may risk factor patient severe
26819426 en relationship serum level patient type mellitus T2DM
26688531 en although mellitus DM risk factor disease little known association DM estimate association DM conduct study among recent health patient DM use hba1c use test hba1c result medical history patient included patient hba1c result overall patient DM prevalence significant high among patient DM without DM DM adjust or without DM high without DM may impair
21051047 en evaluate influence disease development metabolic parameter type mellitus datum patient aged year mean age year mean duration year number increased time patient significant vs year significant lower weight score vs vs compare patient without disease difference found hemoglobin severe patient significant lower weight found disease important
21324429 en associate event mortality patient without however known whether associate per present study included patient disease define ratio define ratio prevalence significant great patient vs logistic regression analysis adjust age hypertension cholesterol cholesterol protein body mass index estimate rate use significant associate adjust odd ratio or confidence interval CI adjust or CI CI association significant patient type or CI without or CI significant associate determined patient without type mellitus independent cardiovascular risk factor estimate rate
21186995 en status type mellitus T2DM important complication major cause renal disease study different result regard association gene T2DM diabetic study assess association T2DM case T2DM case diagnose year one healthy individual normal blood history T2DM control first report high significant odd ratio confidence indicate risk develop DM population DM group similar respective association individual history risk factor obesity hypertension impair glucose tolerance may assess
25315007 en associate type may target development intervention use multiple model investigate use effective associate blood among cell decrease result identify may potential significant change management
25295493 en several mellitus DM remain present time drug well show result patient DM review mechanism patient DM potential role population
25118849 en on review current study lower finding diabetic woman conduct include current report obesity significant associate diabetic woman effect parameter significant association clinical hba1c value presence severe diabetic patient cardiovascular risk significant association mortality diabetic high risk therapy glycemic control diabetic dysfunction undergo model trial result include cell therapy although need study
27437921 en aim activity one management mellitus effect different metabolic control remain aim review association review effect intervention without glycemic control type resistance resistance method perform use randomize control study examine effect type result association analysis potential improve glycemic control assess hba1c change hba1c range resistance respective evidence may improve glycemic control great condition duration addition important metabolic effect glycemic
20634940 en dysfunction regard important factor disease type hypertension result change include cell related complication review mechanism dysfunction may cause patient mellitus
18940899 en study investigate association mellitus DM prevalence aged year old health on total participant aged year old included also blood pressure measured blood blood sample concentration blood lipid response previous test blood pressure test use identify individual participant reported history DM logistic regression analysis use prevalence odd ratio association prevalence potential blood lipid blood pressure investigate analysis common individual DM CI CI compare participant without DM blood lipid blood pressure change result prevalence three time high patient DM compare participant
25504835 en type mellitus cause response within cell however event remain poor study individual use case show primary population cell cell cell although new datum individual cell type patient little two overall rate correlate two patient develop disease early age profile review evidence current well
25465599 en evaluate clinical early type mellitus patient T2DM two group base ratio parameter determined group serum fasting plasma glucose hemoglobin level range significant increased group compare group difference group observed fasting glucose hba1c serum level estimate rate positive correlate significant association observed hba1c serum increase diabetic suggest dysfunction present period significant positive association indicate possible clinical early T2DM
25409499 en protein glucose effect investigate concentration subject type mellitus T2DM well age BMI control subject also examine effect oral glucose tolerance test serum concentration T2DM study new diagnose first treatment T2DM control subject serum measured concentration significant lower patient T2DM compare control serum significant negative correlate glucose significant positive correlate subject subject multiple regression analysis serum significant correlation T2DM subject control subject serum significant negative correlate significant positive correlate insulin however subject multiple regression analysis serum serum concentration significant lower T2DM subject may early diagnosis T2DM patient increase level new treatment T2DM patient research need
25388240 en use treatment type mellitus T2DM however result number randomize trial effect treatment T2DM study assess effect treatment randomize control trial compare treatment T2DM database control trial clinical trial mean difference datum test use evaluate study effect hemoglobin fasting plasma glucose reduce weight blood pressure prevalence adverse event significant different CI CI CI CI great blood effect however adverse event treatment large study conduct use provide clinical
25369080 en type mellitus T2DM poor study dysfunction may identify diabetic two within gene rate studied plasma concentration factor associate associate respective concentration respective addition also associate analysis association studied gene associate dysfunction T2DM patient
25118630 en type mellitus T2DM increased obesity one important therapy plasma base datum analysis investigate effect group week treat group group week period sample plasma analyzed time mass analysis little analysis model T2DM investigate effect several metabolic identify potential T2DM found can T2DM result effect also mechanism
25027838 en function datum type mellitus study assess function dysfunction patient control studied perform on use total function total significant great control compare patient vs also great control vs regard parameter function significant different group demonstrated independent dysfunction reduction function function type mellitus associate dysfunction function
24277052 en prevalence disease metabolic syndrome increasing association metabolic factor therefore studied relationship metabolic factor study conduct examine patient disease relationship patient female patient present increased cholesterol decrease high cholesterol patient hypertension present mellitus DM increased age female body mass index positive correlate glucose control positive correlate correlation female analysis identify age DM significant risk factor significant correlation observed hypertension negative correlation serum level significant risk factor patient therefore need
23377619 en woman type mellitus hba1c target however remain therefore need period week rate renal glucose whether may use type woman evaluate woman type compare hba1c
23263796 en clinical trial compare oral drug show therapy effective control low risk associate weight reduction blood pressure base health clinical use patient type weight review aim use therapy type clinical trial database clinical trial perform use present recent association association study also clinical trial compare therapy significant great reduction hemoglobin weight effect weight difference clinical important effect show difference within two great treatment reported great hemoglobin reduction weight due great patient great compare oral effect
19058956 en remain poor recent study mellitus may risk test possible association mellitus general study general contribute datum health primary care database patient year age first diagnosis control per case age general estimate odd ratio mellitus use logistic regression role status medication case found increased risk use insulin odd ratio or confidence interval CI use drug or CI case control found association status study provide evidence association mellitus
21440764 en system reported important role mellitus hypertension addition association reported hypertension role development mellitus known investigate association development perform patient undergo renal period group develop group patient show respective compare group high group addition found significant high group patient compare group patient high may contribute high prevalence datum suggest effect risk large patient group studied
27647189 en on recent study reported positive association elevated serum level protein development type general population however relationship serum level risk develop gestational mellitus reported aim study investigate change serum concentration first determine whether conduct study cohort level measured use woman develop sample woman remain level compare use logistic regression use odd ratio develop among serum level high woman woman without vs fasting blood glucose high woman woman without vs glucose test show blood glucose high woman woman without vs on model adjust baseline characteristic medical complication gestational characteristic revealed risk develop among woman compare develop week develop serum concentration increased factor provide effective early
27606810 en gestational mellitus associate include dysfunction aim study effect factor factor examine use cell normal healthy patient use cell model study cell measured system respective analyzed use condition condition significant significant cell may impair reduce cell contribute
26813307 en gestational mellitus define first risk high among woman lead response contribute although obesity relative well mechanism define study recent year identify however current datum regard obesity woman research disease review recent study related insulin resistance
26375854 en addition blood glucose patient type mellitus show previous show cell high glucose reduce use type diabetic model potential independent glucose use glucose level use insulin diabetic treat outcome compare diabetic provide datum renal factor overall reduction reduction finding potential therapy multiple diabetic
21978840 en diabetic potential complication mellitus incidence treatment associate mortality rate high year outcome large due treatment patient present review evidence result improve patient on important factor provide effective severe metabolic condition evidence role also research need also
25638453 en cardiovascular can relative common complication mellitus DM significant role cardiovascular disease evidence indicate effect factor different disorder study investigate role possible effect can type DM model control DM group group receive group group week level measured plasma significant interval whereas significant interval plasma level treat DM group significant lower control group treatment significant reduction plasma level respective also correlation analysis show significant negative correlation study suggest effective can mean plasma level use assessment function
20026629 en mortality among mellitus whether group however examine impact mortality among retrospective cohort study compare change mortality among aged year mortality confidence interval CI CI decrease significant great high group low group group age year mortality rate ratio low high group among woman among man effect mortality old group drug difference study overall among however decrease great high group low among aged year finding increasing impact health health care study need factor difference mortality
17288897 en prevalence mellitus high patient general population significant risk factor mellitus type aim study whether significant risk factor whether whether type datum retrospective patient type treatment receive whether type patient undergo develop mellitus patient receive develop test insulin patient patient influence use analyzed patient patient treat treat develop mellitus receive patient significant risk factor develop influence treatment significant difference development mellitus found type
25438683 en mellitus DM reported increase risk complication however impact DM development remain aim whether DM independent risk factor among patient on total patient on datum clinical characteristic history retrospective review patient DM patient DM significant high ratio renal history compare patient associate low base multiple logistic regression analysis odd ratio or DM or identify independent analysis DM significant correlate patient on patient DM independent associate patient on
24222720 en aim study evaluate relationship serum factor concentration duration type mellitus one patient healthy control examine serum concentration measured use on positive association time duration high serum concentration observed similar prevalence complication increased duration logistic regression analysis show serum concentration duration disease independent risk factor development high serum concentration associate significant risk development year duration year disease effect result study indicate serum concentration one factor may impact complication
23550405 en relationship total body according patient type mellitus correlation adult T2DM studied age time mass total body index mass BMI glucose hba1c determined test compare independent mean correlation study included man woman difference compare age BMI duration T2DM blood glucose hba1c analysis show relationship BMI mass change body due mass observed chronic disease BMI correlation mass mass related patient T2DM
23378723 en aim present study evaluate role age development among type diabetic subject
23052826 en mellitus DM known impair function report reduce cause DM aim study investigate potential type DM body weight week development diabetic body weight day result show significant fasting blood glucose level lipid profile treatment increased reduce decrease lipid level plasma also significant activity level serum blood compare diabetic treat body weight diabetic datum revealed potential effect
22986731 en study aim assess cardiovascular risk individual fasting plasma glucose respective mellitus evaluate whether hba1c improve risk estimate risk score individual without regression estimate primary cardiovascular event cohort individual aged year hba1c individual score model year follow-up individual primary adjust cardiovascular risk factor one group woman whereas increased risk man woman respective score hba1c improve individual without man hba1c increased cardiovascular risk individual cardiovascular risk factor hba1c significant improve risk score individual without mellitus
22048611 en cardiovascular complication major cause mortality however patient increased risk cardiovascular disease found disease presence type mellitus T2DM aim study evaluate group T2DM patient studied patient T2DM age year assess score score well score measured patient known diabetic patient age however diabetic group high score score logistic regression analysis identify significant presence diabetic patient age significant patient type diabetic patient increased found significant diabetic patient
25730996 en syndrome common syndrome common syndrome type mellitus DM disease aim investigate effect type DM result type DM patient undergo study included patient syndrome patient DM patient type DM treat DM blood glucose level assessment use score two group compare test test confidence interval consider statistical patient type DM mean score control mean score mean status score control mean status score patient without DM mean score control mean score status score control mean status score statistical significant difference two DM patient blood glucose level without syndrome syndrome patient without DM
25675573 en intervention effect mellitus T2DM provide treat control group T2DM model T2DM model according randomize method model group medication group group group group day model model group without receive treatment medication group according body mass treat group treat respective current treatment per treatment day treatment per week week model week intervention blood sample fasting blood glucose measured week intervention method cholesterol use test serum protein fasting insulin week intervention body mass normal group increase body mass model group medication group group significant reduce compare model group group group reduce group lower medication group group group reduce significant lower medication group group significant lower group insulin index medication group group group increased medication group lower group group lower medication group group group lower medication group group can reduce level improve insulin resistance T2DM improve insulin index blood lipid
25418129 en aim study investigate value pressure index assess early change patient type mellitus T2DM complication negative group complication positive group healthy control group use conduct patient obtain patient blood pressure also measured pressure index blood pressure group among group statistical significant control group negative group positive group can use new T2DM patient early change T2DM patient
25408484 en great medication demonstrated associate improve clinical outcome however evidence therapy patient type mellitus retrospective cohort study use datum compare T2DM patient therapy index therapy patient included T2DM index year index month baseline month index follow-up study outcome index day follow-up vs vs logistic regression compare adjust potential analysis perform sample included patient value compare patient treat patient treat statistical significant great odd odd ratio vs or or significant high adjust odd compare patient difference research correlate factor clinical outcome
24710710 en on management insulin mellitus weight age present diabetic insulin patient follow develop diagnose age patient diagnose analysis revealed diagnosis syndrome patient
26338099 en change function primary mellitus however provide may study evaluate healthy control group control system use negative ratio compare group finding demonstrated group great negative reduce positive group negative ratio also great mean difference great negative may negative positive study determine influence development
26253996 en study compare individual mellitus without healthy control group subject on model use examine relative use assess group difference correlation use assess relationship individual significant reduction group individual reduce group reduce group group individual study multiple individual reduce difference individual use two analysis study determine observed profile related development
26772769 en care intervention chronic condition lead improve outcome case study aim two research first mechanism outcome care type relationship mechanism outcome care type conduct period included care type research intervention datum perform use common datum study assess method model mechanism outcome use study relationship factor level model mechanism define intervention type number chronic care model outcome effect mechanism study reported found level level due low number outcome possible relationship mechanism increased level occur level also decrease development level increasing research regard impact health outcome relationship mechanism outcome study
21445505 en study aim intervention intervention impair management diagnosis participant mellitus intervention analyzed according model intervention high care impair diagnosis disease medication disease management among activity characteristic study intervention mellitus evidence care
22565410 en study diagnose type mellitus T2DM effect T2DM related management aim study develop intervention study diagnose T2DM hospital on develop datum analyzed use research develop related identify include impact T2DM perform related cause T2DM among although negative health datum related T2DM develop study T2DM intervention research aim increase may impact
23329581 en insulin use determine insulin datum insulin compare insulin impact database related randomize control trial study perform type on included trial subject datum show significant number group CI per week CI group compare control subject reported significant reduction blood glucose value group compare control observed one adverse event blood glucose group reported trial difference hba1c within group patient treatment according treatment effective insulin positive impact glucose profile
17563021 en study elevated prevalence among subject mellitus DM mechanism association study investigate relationship DM health body study cohort study conduct analysis included subject aged year without baseline define use follow-up presence score study presence define incidence mellitus status hemoglobin hba1c level assess baseline mellitus status control hba1c level hba1c level time analysis use estimate event mean follow-up year participant DM high incidence vs vs without DM mellitus associate increased risk odd ratio or confidence interval CI or CI on relationship observed DM or CI among participant poor glycemic old adult DM associate increased risk
23698202 en investigate first factor factor study show subject type mellitus improve glucose lead significant decrease body study aim possible reduction use insulin subject type treat subject type treat insulin obtain significant reduction insulin blood glucose effect increased level improve glucose protein
23466761 en trial conduct evaluate effect medical therapy intervention individual type mellitus control metabolic parameter year year diagnosis year treat oral week period base medical therapy adult type mellitus primary outcome control hba1c level outcome included blood pressure lipid profile insulin level week subject study rate therapy result show significant reduction hba1c reduction subject high hba1c level baseline score vs significant improve medical therapy result outcome individual high hba1c level study
23121425 en identify effect health model factor among mellitus patient one important diabetic although patient study factor related use total patient two hospital diabetic health use health factor respective datum use datum use logistic regression model revealed health influence participant related identify significant role study factor influence patient use finding study health intervention aim factor mean
21913184 en use associate decrease risk mortality however effect clinical outcome define study aim evaluate association use mortality diabetic patient identify patient diagnose mellitus patient compare two group diabetic patient diabetic patient patient clinical characteristic overall mortality mortality analyzed follow-up month total among patient use compare total among patient use use associate decrease overall mortality mortality analysis clinical factor use show lower risk overall mortality CI mortality CI patient use patient associate lower risk overall mortality
26265234 en although increased level associate disease evidence increased factor patient diabetic patient undergo intervention baseline level determined follow-up perform month patient group without baseline level compare also studied diabetic month diabetic patient mean level significant high without vs on baseline value diabetic without define value analysis demonstrated correlate significant high prevalence event event diabetic patient
25895200 en study among individual type mellitus T2DM study aim assess determine associate factor among individual T2DM medical hospital subject datum history hospital measured use score obtain two group score score base group score number group major group whereas score number group include weight examine datum analysis multiple regression conduct use on total subject female age year duration year studied mean group score score respective subject group day less number group among group lower lower subject significant lower group score whereas lower lower ratio subject significant lower score high individual T2DM among lower level
25203150 en on low glycemic index glucose control patient mellitus study aim investigate influence glucose level woman gestational mellitus woman randomize receive normal diabetic control day on use group whereas total level remain group fasting glucose level determined total woman included study include group normal diabetic control group difference baseline characteristic group intervention glucose level significant reduce group control group glucose value significant reduce treatment group compare control group change baseline glucose value significant great treatment group control group significant reduce glucose level woman
23707747 en base use effect blood glucose investigate found test individual show test also individual effect factor overall effect observed total individual cell model
23759397 en insulin insulin patient type mellitus three important need blood glucose result insulin study insulin associate use use insulin insulin evaluate included insulin insulin three patient conduct day day insulin day participant general follow participant three insulin within use without conduct insulin day occur insulin intervention target insulin potential health outcome glycemic control insulin report one
23433540 en patient great estimate rate among patient type follow year several clinical common include poor medication
26045324 en define weight may normal woman woman gestational mellitus increased risk due increased insulin resistance high blood glucose result glucose body cause also large gestational age review study impact well complication outcome health
25802854 en examine association gestational mellitus total health year diagnose high prevalence high mean weight score high mean BMI age score year old diagnose impair glucose tolerance develop year high mean value score weight BMI age year old normal glucose diagnose increased risk weight year old compare normal glucose
23510547 en high metabolic effect severe disorder include disorder major disorder mortality patient due however study study time metabolic effect without cohort database large sample control cohort study patient without diagnosis medication DM follow compare age control incidence DM identify case patient patient patient age respective patient increased risk medication vs vs respective medication respective control age regression model show significant increased risk medication among patient ratio confidence interval CI CI increased risk medication also among patient CI CI patient show increased risk medication first control cohort study show increased risk medication among patient significant increased risk among patient
23323293 en patient type mellitus diabetic although reduction factor may important role diabetic major mechanism change research mechanism may major treatment type mellitus
23305017 en mellitus studied include relationship clinical disease patient primary diagnose mellitus examine clinical type age patient different role disease
23256827 en according recent study serum concentration negative associate obesity mellitus type DM aim study relationship renal function serum patient diabetic serum level investigate patient control patient diabetic group according rate three group level diabetic group show significant difference compare control group high concentration observed patient compare control group significant patient low concentration regression analysis revealed negative correlation BMI positive correlation multiple regression BMI independent factor level well independent diabetic one important role increased blood diabetic patient diabetic mellitus type obesity diabetic
23089999 en include among low glycemic index mellitus DM use lower therefore study type DM total participant type DM randomize participant increase little per day increase month primary outcome change hemoglobin hba1c value disease risk score reduce hba1c value CI high reduce hba1c value CI relative reduction hba1c value great high CI respective risk reduction CI large great relative reduction blood pressure compare high CI improve glycemic control reduce risk score type DM
23015113 en type mellitus T2DM associate high rate complication patient disease medical therapy measured T2DM patient receive day positive syndrome assess response patient T2DM control trial measured T2DM patient present great compare patient mean vs decrease among patient T2DM mean vs value vs mean vs patient T2DM per value important correlation observed value value similar among mean vs type mellitus associate increased blood among patient current medical therapy significant reduce patient independent response therapy
22986427 en retrospective study show increased risk hypertension mellitus disease however mechanism need study aim determine association index hypertension mellitus DM type lipid disorder man study man woman different use total rate group high time pressure serum lipid level blood pressure cardiovascular risk factor woman man total score associate significant DM woman odd ratio or confidence interval CI man type woman man hypertension woman man group show association total low cholesterol high total cholesterol high level associate significant man woman hypertension woman man woman man also associate several lipid group associate DM woman remain also associate significant positive DM woman female high time pressure associate significant hypertension associate positive woman associate positive DM hypertension woman study provide evidence association metabolic disorder hypertension total associate significant DM type hypertension different associate health result associate disease
23559105 en disease one common known chronic disorder relationship several disease mellitus DM increasing review provide relationship DM year examine relationship two chronic disease datum DM different clinical determine prevalence level glycemic control provide finding research conduct use control trial database primary research report relationship control treatment complication identify relationship DM effect DM effect glycemic control effect glycemic control evidence review adverse effect health adverse effect glycemic control complication research need relationship large control trial population positive influence glycemic control possible reduce complication
21913966 en compare effect cardiovascular risk intervention care type general adult without diagnose health randomize control trial case receive cardiovascular risk management care according intervention hba1c blood pressure total cholesterol primary outcome model disease risk analysis year individual significant reduction hba1c blood pressure total cholesterol baseline group mean change total study population baseline significant difference observed mean change baseline hba1c vs blood pressure vs total cholesterol vs weight vs treatment disease risk reduce respective intervention associate medication use odd ratio compare care treatment response intervention increase intervention patient identify significant reduce model disease risk treatment adverse effect
25509903 en gestational mellitus first incidence high associate development lead diagnosis condition week case risk group woman lead diagnosis case time insulin resistance clinical important risk factor metabolic adverse outcome study indicate previous use need diagnosis treatment metabolic mellitus DM clinical risk factor obesity type DM cardiovascular disease
24556638 en diabetic adverse health effect healthy individual recent demonstrated increased cardiovascular type however effect healthy diabetic evaluate impact healthy type week several measured diabetic cell show cell diabetic decrease number cell significant increase cell observed diabetic increased significant activity include reduce compare diabetic healthy show cell diabetic cell observed diabetic cell cell cause effect diabetic little observed effect
25622739 en factor associate glycemic control adult type mellitus insulin total patient aged year insulin therapy month type study two group according association hemoglobin target target compare use logistic female age year disease duration year logistic regression analysis revealed odd ratio total insulin within per or blood glucose or insulin adult patient insulin
19124170 en determine status care general conduct hospital study on total patient aged type type patient care general respective hba1c level measured method age body weight type treatment obtain patient mean hba1c level patient treat general significant lower treat vs mean hba1c level patient without insulin therapy lower treat insulin patient treat insulin therapy high general study show hba1c level patient treat general study
19118911 en estimate prevalence mellitus relationship risk factor population undergo health glucose tolerance test total sample subject undergo health aged year without known prevalence glucose tolerance adjust sample estimate use analysis value number need identify one risk factor estimate use number diabetic number diabetic prevalence among man woman respective among man woman respective lower individual risk factor BMI hypertension low individual risk factor among man woman may among individual risk factor man
23902591 en new mellitus one major metabolic complication development impair fasting glucose associate increased risk cardiovascular mortality well studied aim study evaluate incidence risk factor new mellitus impair fasting glucose study adult patient year chronic disease evaluate develop impair fasting patient found patient man woman develop new mellitus patient develop impair fasting glucose mean age patient new mellitus high patient mean fasting plasma glucose significant high diabetic patient compare patient vs vs patient new mellitus receive high medication patient plasma glucose development new mellitus age independent risk factor new mellitus patient
22508671 en compare effect vs medical therapy type mellitus syndrome hypertension patient type cohort study patient type undergo therapy follow assess diabetic month treatment obesity total patient type undergo group on total patient type undergo therapy group group on mean body mass index fasting plasma glucose level hemoglobin level respective month value respective patient regard prevalence syndrome patient reduce significant use medication hypertension group mean body mass index fasting plasma glucose level hemoglobin level respective month value respective patient remain diabetic increased level therapy regard observed increase use medication hypertension prevalence syndrome study treatment type diabetic patient compare medical treatment
24279438 en cohort study prevalence complication time type DM man woman aged year new diagnose previous type mellitus period prevalence diabetic man woman prevalence diabetic man woman base according study renal disease man woman baseline man woman cohort study rate
24249434 en aim research compare patient type mellitus T2DM receive drug randomize on tolerance test conduct group plasma concentration glucose insulin activity measured day day treatment period value analyzed change difference three treatment patient hemoglobin level fasting plasma glucose concentration plasma glucose concentration duration year mean included study compare treatment lower vs insulin response vs insulin concentration significant treatment change group index increased significant treatment vs general well control glucose effective compare drug
21218752 en evaluate risk factor dysfunction incidence patient new diagnose patient new diagnose mellitus type study use index function result less use patient diagnose mellitus type case patient compare man statistical significant difference according duration hypertension body mass index serum level hemoglobin hba1c use logistic regression model age identify significant risk new diagnose mellitus high prevalence related risk factor age hypertension body mass index
26613076 en type recent health primary increased prevalence obesity weight reduction type indicate role development recent development metabolic disease studied increase response lipid demonstrated effect treatment insulin resistance model result clinical trial
22997208 en number individual mellitus DM DM need diagnosis also intervention complication method base new clinical test protein found different body diabetic patient clinical trial clinical review provide potential DM
23326914 en obesity type mellitus treat use include increasing activity drug treatment patient although recent year treatment obesity type mellitus effective include treatment low follow-up rate poor outcome complication therefore management obesity type mellitus treatment follow-up
23322140 en weight patient type mellitus T2DM body mass index BMI study examine effect T2DM status severe patient T2DM
22858190 en aim present study evaluate independent patient type mellitus DM on total patient type DM undergo determined revealed significant subject subject significant old duration DM ratio great subject significant compare subject without significant odd ratio significant increased estimate rate odd ratio confidence interval odd ratio confidence interval associate increased risk significant independent cardiovascular risk factor characteristic analysis effect significant presence independent significant patient type DM
22270379 en increase prevalence type mellitus T2DM reported study two datum also suggest prevalence disease aim study determine prevalence previous T2DM impair fasting glucose impair glucose tolerance cohort healthy study group subject aged year body mass index oral glucose tolerance test perform subject previous T2DM impair glucose subject subject glucose present number subject need treatment obesity
22730940 en woman gestational mellitus develop type mellitus T2DM new woman T2DM previous study investigate whether use result positive change woman large woman study diagnosis control intervention group baseline assessment intervention group receive care control group receive care baseline week month follow-up outcome included body mass index follow-up intervention group compare control group significant reduce total total woman also increased activity compare control group significant change total activity level occur follow-up body mass index intervention group improve compare control intervention group show positive compare control group research effective
22558941 en among patient type mellitus medication reported low patient may treatment treatment outcome datum show case increase medication patient hemoglobin reduce little patient target poor patient significant high little lower medication patient increased poor glycemic control multiple study large care database demonstrated outcome reduction related management treatment addition patient
22374408 en also known insulin model aim assess whether patient type mellitus improve control without risk
20072961 en insulin patient type may glucose concentration fasting present study examine whether fasting test can adult patient type insulin therapy intervention study mean age year BMI mean hba1c duration year participant plasma glucose concentration blood glucose profile compare three test day hospital insulin insulin test protein according fasting test plasma glucose concentration remain test plasma glucose concentration within increase plasma glucose concentration similar three different glucose concentration significant increase patient type test determine insulin patient type
24713709 en on man type mellitus DM datum oral glucose tolerance test show diabetic disorder base insulin response glucose high however observed increased insulin evaluate glucose rate consider insulin mechanism clinical treat therapy without medication insulin assessment investigate DM insulin role clinical type DM
18436709 en effect mellitus renal cardiovascular system less effect function type type mellitus associate reduce function dysfunction disease insulin resistance significant role study effect year include response potential although research examine dysfunction patient need mechanism history complication develop treatment
19077023 en aim study determine type use among type mellitus reported medical factor associate use treatment mellitus disease therefore use among type increasing patient diagnose type little month study management included study datum use result per reported use one therapy use oral include found use result use important use effect positive adverse treatment clinical insulin treatment may provide development new oral important use effect clinical care
21837834 en treatment known mellitus DM present study revealed function examine patient DM ratio major treatment base health include result significant function activity system patient present type mellitus
22867046 en also known provide adult patient type therapy therapy oral drug patient control type treatment review clinical treatment adult patient type several week well trial significant improve control cardiovascular risk adult patient control type treatment effect therapy study year treatment overall control general observed insulin show patient treatment whereas patient provide control control general significant baseline treatment general well patient trial adverse event similar incidence occur treatment type patient individual patient management
23859808 en mellitus DM reported associate increased risk however study assess association DM total examine association history DM incidence cohort study on total man woman year old baseline follow incidence baseline man woman history on total man woman identify new diagnose ratio confidence interval CI determined use model potential man DM risk increase total compare without DM CI increased risk CI CI CI diabetic man observed woman significant increased risk total CI CI observed among diabetic subject datum suggest DM may increased risk total
22189003 en mellitus increasing associate significant one may impact however present datum suggest patient care presence mellitus associate increased mortality patient possible parameter control whether type type drug therapy result result model use clinical possible mellitus
21364066 en metabolic complication therapy patient include insulin resistance mellitus syndrome metabolic syndrome obesity glucose lipid increased risk cardiovascular disease metabolic study report prevalence mellitus metabolic syndrome among adult patient prevalence mellitus metabolic syndrome respective on therapy diagnosis syndrome significant associate metabolic
18417955 en one major factor mellitus found mellitus patient show high level investigate level relationship level clinical woman diagnose mellitus age hospital patient woman level measured patient level found among patient high value low value whereas level individual less although patient clinical mellitus level high range patient show high level clinical condition great mellitus patient may show clinical large
18289058 en prevalence mellitus increasing rate due population obesity diabetic complication complication disease disease disease also oral development complication suggest treatment target metabolic factor protein factor may effective type type diabetic model well model test potential drug also mellitus review common use model treatment diabetic complication
18271455 en increased prevalence type mellitus age group three case on woman type mellitus present gestational week receive chronic treatment oral drug due insulin therapy result control occur week due due week on woman previous gestational mellitus present first possible type mellitus insulin treatment without on woman type mellitus insulin treatment control without insulin therapy woman type mellitus therapy care similar woman type mellitus woman history gestational test type mellitus mellitus care
21717870 en diabetic cause renal disease clinical prevalence risk factor among patient type mellitus T2DM well assess prevalence patient T2DM determine associate risk study evaluate T2DM patient hospital perform three sample patient month define presence little two three test ratio less patient female year age old BMI history DM blood pressure hba1c prevalence respective prevalence diabetic T2DM respective associate risk factor duration DM hba1c level prevalence associate risk factor duration DM hba1c level hypertension
24297984 en patient diabetic compare may increased risk however whether patient also great group old adult parameter use also assess use level use great diabetic patient mean age year body mass index hemoglobin level mean participant demonstrated high base score age hemoglobin level number duration positive correlate participant great also however correlation observed level participant old adult mellitus level
24229691 en evaluate whether increase cardiovascular risk patient type mellitus review obtain study regard role model identify associate increased risk cardiovascular event type diabetic effect development cardiovascular complication
22265768 en great incidence severe resistance treatment patient mellitus compare general population diabetic patient undergo treatment general outcome patient without retrospective analyzed datum period case follow diagnosis included early individual compare outcome patient control group assess effect insulin within diabetic patient included diabetic group patient control significant range score difference diabetic control group early follow-up mean month on diabetic patient compare control patient diabetic group influence primary vs insulin vs provide management diabetic use estimate rate may
22167294 en first study determine mortality status different investigate mortality high group obtain mortality datum assess mortality use regression first mortality estimate datum mortality examine per model overall show high mortality population compare population mortality rate ratio high population CI CI man woman respective found association mortality group high mortality rate population mortality rate high association mortality suggest change may one factor
22768893 en glucose concentration type mellitus need improve glycemic control management glucose concentration concentration glucose insulin rate estimate use important glucose evaluate use statistical method model glucose glucose concentration model develop use evaluate retrospective clinical datum individual use drug metabolic provide method influence parameter method also general method provide improve model model large model base method result model glucose little model new less change condition effect parameter
22508341 en study assess relationship weight among patient type mellitus DM undergo weight patient weight management review patient sample diagnosis DM little reduction baseline value weight treatment increasing activity patient weight measured measured patient study cohort mean baseline body mass index mean age year mean patient significant mean weight study weight baseline body weight reduce respective mean month respective medication weight reduction weight potential decrease among patient type DM finding may clinical patient weight
24251641 en difference observed study obtain use aim evaluate relationship subject type compare three range month lower hba1c fasting plasma glucose weight type patient mean decrease hba1c week significant great three group compare group great decrease occur group mean decrease fasting plasma glucose baseline significant great three group group great decrease occur group body weight significant reduce group period effect hba1c fasting plasma glucose however may less effective body weight compare
26887305 en investigate impact change body mass index BMI type mellitus T2DM population cohort obtain baseline datum multiple metabolic disorder metabolic syndrome conduct subject found T2DM baseline cardiovascular follow total subject included analysis receive include difference T2DM history different group examine use range examine test difference BMI regression model investigate association year change BMI incidence T2DM also examine association BMI risk T2DM subject normal baseline BMI baseline subject subject normal baseline baseline total participant female investigate include new T2DM case female baseline incidence regression model analysis result show T2DM risk relative high high CI T2DM risk also high high BMI group CI subject obesity normal baseline incidence rate T2DM group high control group value value subject normal T2DM risk high group control group CI subject T2DM risk also high group control group CI control T2DM risk high BMI control CI can reduce risk control T2DM risk increased BMI control
26850395 en association type risk related type mellitus T2DM case case chronic disease management system incidence relative risk confidence interval CI total T2DM case respective reported among T2DM patient incidence per incidence per compare without T2DM risk incidence increased T2DM patient risk high year age group decrease increase age addition increased risk significant T2DM patient aged year study T2DM associate increased risk statistical
26467280 en protein also known association elevated serum level associate obesity insulin resistance however little known serum level drug increase patient type week treatment decrease serum concentration vs hemoglobin without significant change lipid effect however gene significant reduce treatment increased gene effect decrease gene decrease serum level little reduction
26079161 en one complication include complication major health remain common hospital disease significant result early diagnosis reduce
21516855 en present current datum prevalence mellitus DM complication include change on range associate mechanism disorder DM relationship DM role development change presence DM result study group patient DM patient treat patient follow study show number diabetic patient dysfunction increase DM type respective patient type DM type DM
18418443 en evidence review presence plasma cell type mellitus hypertension decrease cell cell cell metabolic concentration significant less normal system insulin decrease activity one system due decrease insulin resistance decrease insulin type mellitus associate disease decrease concentration type mellitus identify occur normal blood plasma decrease also result cell cell also cause also type mellitus although respective lipid disease syndrome type mellitus may population
18271458 en incidence type mellitus increasing rate related complication body weight major factor increased incidence type mellitus develop type mellitus identify patient history gestational medication index test impair fasting blood glucose level reduce risk type mellitus therapy less effective type mellitus disease treatment intervention effect effect complication type mellitus
23237394 en aim study influence mellitus DM rate patient disease retrospective analyzed hospital patient subject DM found patient group control group patient age without DM datum parameter study compare group patient compare patient control group increased respective patient DM control patient one patient without DM analysis show independent effect presence DM history among patient found patient DM similar age patient without DM patient DM conduct intervention
23227256 en role glucose obesity relationship serum concentration condition type aim study determine level large cohort subject control identify metabolic concentration possible mechanism control investigate change level response subject day subject control subject undergo clinical include serum level determined significant high serum level compare control vs subject control subject significant level concentration associate fasting blood glucose body mass index BMI index age diagnosis correlation analysis multiple regression analysis diagnosis serum level independent age BMI perform diabetic subject result significant reduction concentration compare baseline level study associate increased serum level compare subject association impair glucose provide evidence regard relationship glucose
22233951 en significant cause serum patient poor control severe important management associate severe patient diabetic case report new type mellitus present severe diabetic insulin important diagnose serum lipid profile patient present
25861982 en assess oral drug type mellitus T2DM patient glycemic analysis use datum two clinical study patient evaluate included adverse event adverse change hemoglobin hba1c adverse similar among group therapy group therapy group group therapy result decrease hba1c week show change increase week analysis provide evidence use therapy T2DM patient
25712444 en review study glucose drug treatment type mellitus use clinical trial new oral mechanism independent function insulin datum clinical trial demonstrated different patient population study result blood glucose level well reduction body weight blood pressure well associate increased risk oral use treatment include insulin treat T2DM
20957814 en clinical metabolic characteristic observed among patient early type included patient early T2DM medical blood age year woman history history obesity diagnose mean age year mean duration year patient poor glycemic control insulin common need patient year diagnosis significant related complication common patient on duration significant associate develop complication early T2DM total number diabetic patient history history obesity associate metabolic syndrome disease poor glycemic control contribute high prevalence related complication high rate mortality
20819452 en patient characteristic study investigate characteristic evaluate method control cardiovascular risk factor patient on total patient type mellitus diagnose year age group patient diagnose year age group patient difference clinical diabetic complication diagnose use medication mean fasting plasma glucose fasting insulin level significant lower group group group show significant great model assessment insulin resistance group complication insulin use significant common group insulin resistance less severe relative oral effective
20479101 en current evidence glycemic control glycemic control patient associate complication clinical trial patient type type revealed glycemic control complication however trial show glycemic control reduce incidence complication recent clinical trial found similar association association clinical control hemoglobin plasma glucose associate increased mortality use insulin insulin use insulin therapy however reduce risk glycemic control known complication current evidence suggest glycemic control possible diagnosis type type potential reduce mortality great care treat
22455092 en mellitus DM associate increased risk disease aim study determine difference presence patient without compare patient DM mean age undergo determined per high patient vs risk factor patient DM high prevalence compare subject vs vs respective patient compare without vs vs respective patient DM high prevalence significant disease individual DM high risk overall increased independent cardiovascular risk factor show study need evaluate value different observed patient
22548941 en evaluate treatment associate medication change hemoglobin retrospective database analysis patient diagnosis hemoglobin level within day hospital identify database treatment assess patient reduction change therapy compare hemoglobin hemoglobin hemoglobin hemoglobin patient included hemoglobin group hemoglobin group hemoglobin group hemoglobin significant mean age year overall patient reduction change respective hemoglobin patient hemoglobin therapy compare hemoglobin hemoglobin respective respective within insulin significant high hemoglobin hemoglobin significant high hemoglobin hemoglobin lower patient therapy change hemoglobin hemoglobin respective difference reduction high patient hemoglobin level therapy patient change therapy lower hemoglobin datum suggest may use hemoglobin treatment
26428026 en risk disease subject metabolic high low cholesterol level remain little known regard risk cholesterol level analyzed cohort aged year follow-up level without known compare incidence ratio event group use model normal normal high low woman man normal low high metabolic patient metabolic high woman man respective age hypertension use duration hemoglobin observed increased risk woman confidence interval man confidence interval metabolic compare normal subject presence metabolic adult associate increased risk effective need adult metabolic
18930061 en use treat high risk model suggest effect whereas study result indicate increased risk study examine association therapy risk patient conduct retrospective study within cohort diabetic patient care within system case subject identify time study study follow-up lower study control identify on year therapy use define medication patient included among patient undergo association prevalence adjust odd ratio or confidence interval CI however among patient without adjust or CI significant association use observed among patient undergo lower result indicate therapy associate increased risk
26692421 en DM may risk aim define role DM DM undergo analysis follow day compare DM analysis perform use clinical undergo undergo analysis high use without difference DM significant lower high patient DM impact high lower independent clinical independent use DM impact without
19150058 en gestational mellitus common complication increased however significant also woman previous high risk develop primary type risk metabolic syndrome increased woman risk year age increase development
20637376 en association association study use hba1c level diagnose mellitus diagnosis level hba1c provide chronic correlate well risk complication use hba1c method develop diagnosis test major include hba1c hba1c low result hba1c method lead significant number case addition among group study compare hba1c logistic large develop hba1c among
23156061 en study patient chronic associate mellitus revealed lipid disorder present obesity mellitus addition chronic increased lipid disorder high value lipid revealed lipid disorder female
22314122 en investigate rate impact event among patient type mellitus T2DM receive different oral drug patient T2DM impact database mean number health care due event per estimate regression model use assess risk factor event assess effect event treatment compare patient without patient T2DM included analysis estimate health care per insulin use associate increased risk develop follow use impact risk relative event associate significant increased risk treatment patient show significant high health care patient without adjust respective associate different level risk event associate high risk treatment significant increased health care
22179629 en investigate early change occur clinical evidence diabetic subject type mellitus evidence diabetic case subject mellitus control studied use influence age outcome also subject show decrease mean case compare control vs among case subject year age show reduce mean vs mean vs mean vs compare control however difference outcome case compare control duration glycemic control show significant change outcome case significant lower mean diabetic hemoglobin compare vs result suggest evidence early clinical evidence diabetic subject type mellitus
22122310 en diabetic development patient type mellitus DM also diabetic increased complication finding study investigate association glycemic control mean subject undergo analysis hba1c serum fasting blood glucose level level statistical analysis perform use correlation analysis analysis regression analysis test use statistical study included patient type DM value patient patient without difference statistical significant determined positive correlation significant difference patient hba1c level determined correlation hba1c level study determined significant positive relationship complication significant correlation identify poor glycemic control diabetic patient however association poor glycemic control type diabetic patient investigate study large sample
22001578 en patient type mellitus DM increased risk little known patient report study compare result healthy subject type mellitus healthy control subject diabetic history obtain use perform previous two overall significant difference diabetic control however diabetic different diabetic method analysis type mellitus result complication however diabetic may may presence
21034605 en whether glucose control type reduce incidence event patient perform compare glucose control glucose control randomize control include control trial index trial outcome incidence major trial patient included analysis decrease incidence major event patient glucose treatment vs control however control type show significant impact incidence cause compare control control well incidence cardiovascular control normal normal level type effective reduce incidence major event significant difference mortality cause cardiovascular two
20532521 en study aim influence chronic disease mellitus hypertension study included participant age year group group patient hypertension group included hypertension mellitus group mellitus group healthy duration group correlate group show significant difference use duration correlation parameter determine patient mellitus
20628017 en chronic disease medical patient complication study insulin control period insulin define insulin diabetic glucose level day day insulin without fasting improve glycemic control also reduce diabetic complication
24061028 en profile medical drug use treatment patient health system study conduct patient included study type medical primary care drug treatment analyzed drug according system patient identify mean age year patient year old cardiovascular drug use patient use patient medical per year primary care care care less reported datum indicate high prevalence care
24412390 en insulin therapy remain care glycemic control patient insulin therapy effective elevated fasting less reduction associate high incidence weight therapy improve without weight associate insulin therapy potential reduce cardiovascular related however increased severe adverse effect present patient insulin effect fasting plasma glucose effect plasma glucose adverse effect therapy clinical diabetic patient use insulin associate treatment type
25060414 en reduce remain patient mellitus DM common renal population analyzed mortality cardiovascular mortality month among patient outcome study trial DM status use patient DM receive compare patient DM patient receive old man renal function compare receive baseline risk factor among DM patient use associate mortality ratio confidence interval CI CI similar finding patient mortality CI CI DM therapy low overall use DM status clinical significant renal difference use associate patient reduce DM DM influence effective therapy
25862461 en control patient mellitus reduce related complication aim study determine whether control associate type assess sample diabetic health use consider individual assess association score datum logistic total score significant high negative individual significant difference found control treatment control show difference group mean age subject significant high age diabetic patient diagnose significant year negative score high associate diabetic less control disease high number control consider negative adjust or CI
23072848 en drug treatment mellitus use drug increasing health aim study determine patient characteristic drug complication common adverse drug study month diabetic general datum patient drug show insulin follow patient control therapy found therapy patient patient female common found hypertension addition patient blood remain insulin therapy also significant increase new oral drug insulin blood glucose study need patient use drug blood glucose hemoglobin hba1c level control diabetic complication
23006958 en although gene associate mellitus association known clinical risk factor hemoglobin hba1c remain poor investigate associate hba1c level examine possible
20403889 en develop increase prevalence mellitus occur study evaluate risk use health prevalence rate among man woman aged year old compare rate among rate among use logistic regression identify risk factor age level level time found compare risk elevated among odd ratio or man CI or woman CI or man CI or woman CI or man CI or woman CI increased risk early age year high high among woman compare man lower status great time also associate increased risk woman high risk compare risk early age suggest effective develop target age group
19223782 en therapy treatment significant history disease metabolic complication include insulin resistance increase risk type cardiovascular disease disease present new management review prevalence mellitus patient treat also review current mechanism type insulin resistance insulin development type mellitus
19636033 en clinical treatment type mellitus control complication trial demonstrated reduce complication therapy study clinical age therapy clinical analysis incidence complication perform patient therapy therapy patient complication study study patient study population cohort cohort therapy aim glycemic level insulin insulin therapy insulin glycemic target outcome included incidence rate level per renal cardiovascular year incidence cardiovascular disease respective treatment group respective cohort therapy group lower incidence complication patient treat lower reported
18293711 en mellitus disease studied year influence patient glycemic level disorder several study develop evidence general increase prevalence important role disease mellitus complication disease significant impair metabolic control diabetic patient treatment disease reduction oral may result diabetic condition less mechanism disease insulin resistance similar obesity glycemic control research relationship disease
21054355 en diagnosis type great disease recent year diagnose first week month remain result type analysis clinical patient diagnose first month provide evidence disease different development mellitus cause although one case large impact clinical gene insulin oral glycemic control review diagnosis subject may influence medical care subject early
19834322 en prevalence type mellitus T2DM one health associate complication cardiovascular disease disease diabetic renal result increasing reduce health T2DM disease multiple insulin insulin lead cell treatment T2DM patient effective control blood glucose blood pressure lipid elevated complication associate high glucose concentration control weight control activity treatment T2DM increasing insulin level insulin oral insulin insulin reduce rate review present mechanism effect drug adverse effect new drug include addition present drug clinical trial use treatment base evidence therapy base oral duration high however major change factor also need
25966738 en evaluate fasting plasma concentration identify individual risk type retrospective analysis datum health individual cholesterol concentration subject without concentration risk factor type man woman cholesterol concentration insulin model assessment insulin resistance associate high plasma concentration hba1c glucose healthy man woman cholesterol concentration glucose insulin risk type mellitus plasma concentration identify within population individual risk type mellitus
26824283 en recent patient mellitus datum care recent evidence
18251672 en study mellitus factor provide sample use study use disease different conduct follow-up diagnosis identify one type type female gestational impair glucose tolerance one high sample effect large weight difference large large analysis model estimate correlation body mass index BMI correlation
25160842 en risk elevated mellitus DM compare aim study compare population incidence disease adult without event identify hospital datum incidence rate without DM aged year estimate regression case study period incidence rate man confidence interval CI woman CI DM overall reduction respective reduction incidence DM adult without DM incidence significant decrease man CI woman CI incidence rate ratio man without DM CI CI CI CI woman significant reduction incidence rate adult DM however risk incidence remain great DM
24819408 en gestational mellitus week independent associate complication whether increase risk therefore independent effect outcome retrospective cohort study outcome week study group compare without control group study group significant high incidence include positive pressure care hospital duration logistic regression analysis independent risk factor CI CI care CI result demonstrated independent effect risk severe complication intervention management
24163121 en evidence regard effective patient undergo intervention therefore patient disease mellitus DM undergo randomize receive within control baseline clinical characteristic similar group level incidence type group significant different control group can show significant effect level type incidence patient DM undergo
23677911 en diabetic patient therapy patient disease healthy individual evaluate effect activity patient severe DM compare result healthy individual although DM group significant difference concentration value activity patient DM healthy individual independent activity patient DM
24938715 en evidence suggest one mellitus DM large however impact current study improve regard role DM level examine normal cell cell cell well cell glucose obtain cell DM normal observed result demonstrated level cell significant high normal cell level cell significant high cell cell lead DM compare cell result indicate high level may DM
22570973 en effect prevalence disease glycemic control mellitus known aim determine whether dysfunction associate impair associate impair glycemic control type type analyzed measured hba1c level clinical parameter T2DM subject age year month duration regression use association use T2DM patient compare patient subject T2DM significant elevated vs vs compare patient demonstrated significant relationship hba1c level compare subject association elevated suggest dysfunction can impair negative impact glycemic control T2DM
25495002 en compare clinical outcome adult type mellitus T2DM model datum randomize trial database analysis model care included clinical impact clinical model clinical hemoglobin use base case body mass index blood pressure cholesterol database analysis drug adverse event base case compare treatment result patient similar finding found difference range range remain may T2DM treatment patient due lower overall
25402385 en syndrome resistance elevated serum presence level resistance normal negative mechanism resistance within determine whether clinical associate condition include disorder however decrease mass recent patient present report mellitus first report regard association one year therapy observed reduction level insulin resistance possible disorder
25360775 en perform review regard treatment type mellitus T2DM patient severe renal trial assess compare treatment drug identify use clinical two independent datum model estimate report study total participant included analysis compare treatment reduce hba1c significant increased risk weight show difference hba1c effect CI lower incidence without mortality adverse event however evidence low assess use system effective hba1c T2DM patient severe renal also potential risk adverse event regard low evidence according randomize trial need
25297916 en rate increase risk develop type mellitus T2DM however whether rate can use risk T2DM therefore study examine association rate T2DM evaluate use rate identify risk conduct rate measured fasting blood sample obtain blood glucose use method analyzed characteristic study included subject aged year rate significant associate T2DM rate adjust odd ratio T2DM female subject respective subject rate can T2DM female subject T2DM CI CI female subject rate associate increased risk T2DM female subject however rate potential high risk T2DM adult
25246411 en study oral may lower level determine whether use compare associate increased risk low level patient type clinical research identify patient receive patient treat follow use model evaluate association low level compare total patient treat patient included among patient treat event low level observed follow-up incidence rate group event low level observed incidence rate compare associate increased risk low level patient treat incidence rate adjust ratio confidence interval CI high risk day adjust CI association observed patient adjust CI study use associate increased incidence low level patient treat patient clinical need
24905061 en associate increased type mellitus one cell
24557635 en increasing prevalence mellitus renal disease diabetic new early change present first study renal mean evaluate patient without compare healthy high significant patient compare healthy reduction compare within mean renal DM
24170184 en prevalence mellitus DM increasing present study examine relationship increase participant undergo health diagnose use DM define use medication DM fasting blood glucose level hemoglobin level logistic regression analysis datum participant man woman revealed association DM independent age body odd ratio or confidence interval CI man or CI woman participant DM follow independent DM or CI man woman prevalence DM increased significant period examine among man woman increased prevalence among man woman independent present DM may important role recent increase prevalence DM
25224328 en diabetic patient age year current patient insulin therapy mellitus adult BMI hba1c duration duration insulin therapy presence examine patient insulin therapy patient receive insulin therapy evidence patient high mean hba1c mean duration mean duration insulin patient evidence patient patient increasing important population
23757052 en mellitus DM associate risk complication system aim study DM patient correlate finding clinical patient year type DM healthy control studied use base method assess include total also change difference patient control found regard number overall revealed reduce patient associate duration age hba1c patient show reduce compare patient without type show related overall can possible associate presence change change reported study
20167685 en study aim investigate development mellitus study group age year patient remain control age year examine baseline possible month prevalence insulin index insulin index estimate use oral glucose tolerance test plasma glucose plasma year present compare control group group month increase significant change occur control use logistic regression age odd ratio year present patient cause increase insulin resistance observed insulin
24986803 en study investigate concentration protein whether early concentration change diagnosis gestational mellitus study control woman age body mass index serum measured week week difference group compare model analysis diagnosis use estimate model general health outcome also compare high woman vs control whereas serum different increased time however serum early change concentration early development significant difference activity score control elevated woman large trial evaluate role development
24503044 en on retrospective study conduct year include patient type mellitus show female significant high prevalence diabetic baseline female independent risk factor development
25906524 en potential cause mellitus among report case use primary drug result multiple develop type mellitus
25620182 en type mellitus T2DM associate high risk presence normal increased study evaluate risk assess change parameter group woman type mellitus T2DM compare control group woman T2DM healthy control aged year research subject baseline follow-up medical history current drug therapy risk factor patient analyzed parameter time baseline found statistical significant difference T2DM patient parameter follow-up significant high decrease parameter found T2DM group decrease significant high control datum difference risk T2DM woman compare control study suggest T2DM woman present high increased compare control respective show high decrease lower decrease
25344747 en effect cardiovascular risk patient type mellitus DM effect incidence event mortality patient database identify study also review two independent model model assess effect treatment patient randomize control study included total participant overall treatment patient DM associate statistical significant reduction event ratio confidence interval CI reduction mortality CI associate result significant reduction event mortality patient DM
25338824 en may type mellitus T2DM aim determine association without sample T2DM healthy control characteristic include pressure include index include regression use study association two group adjust age T2DM year healthy individual year T2DM associate healthy participant associate associate association associate T2DM healthy individual mechanism change may healthy individual T2DM
19101899 en aim assess effect different type mellitus DM patient receive total patient DM without DM study characteristic patient outcome assess compare group without DM patient type DM type DM patient DM diagnose type DM type DM DM respective diabetic patient significant high rate function compare control group patient rate significant lower patient DM DM type compare patient respective type DM significant adverse effect patient patient DM relative patient compare type DM type found DM DM patient rate compare finding suggest patient present type DM follow
18809649 en oral health health metabolic disorder oral health oral health may review mellitus DM provide care patient DM general negative also evidence presence disease associate increased cardiovascular patient chronic metabolic disorder relative common condition one may
18847481 en disease risk high risk population patient mellitus study determined value cardiovascular event patient included patient mellitus man woman age year study study patient history disease addition patient show disease determined score mean period year patient event rate period patient patient score patient significant high compare without event score associate significant high event rate cardiovascular event event observed patient compare risk score score score show significant high respective patient risk can identify within high risk group patient mellitus event can patient without
26060262 en previous demonstrated disorder mellitus type individual little known regard impact mellitus type outcome population analyzed baseline datum patient mellitus type examine relationship glucose control measured hemoglobin score overall baseline datum treatment study individual mellitus type compare individual without disorder compare hemoglobin level group assess relationship management mellitus type conduct similar analysis use number diagnosis association overall medical measured disorder individual mellitus type associate increased decrease function hemoglobin level significant different without multiple disorder associate difference mellitus type control however significant associate high hemoglobin level significant associate overall medical three mellitus type significant associate level hemoglobin previous study need relationship health management mellitus type
25042298 en multiple system study determine whether diabetic compare conduct potential analysis healthy control mellitus DM patient without patient patient significant increase mean duration mean duration rate little mean duration rate show little among different group individual value little mean duration rate may analysis
19635170 en prevalence increasing individual high risk cardiovascular disorder patient subject intervention also outcome patient patient without factor although improve outcome diabetic diabetic lead mechanism diabetic different glucose show influence outcome current datum indicate result compare insulin however large trial effect glucose associate improve review effect glucose
25755231 en mellitus present first month aim clinical characteristic large cohort patient estimate incidence rate patient present hospital patient follow-up type mellitus month age analysis patient diagnose analysis identify patient undergo analysis patient cause included patient identify dysfunction observed patient patient oral on associate identify patient incidence one common cause cohort high rate new target increased within cohort
25650264 en early hypertension control reduce risk cardiovascular complication among patient mellitus need improve hypertension management among patient aim evaluate rate association hypertension diagnosis treatment among patient mellitus retrospective analysis health year old mellitus hypertension receive primary care large group use identify case hypertension analysis estimate receive hypertension diagnosis medication time model CI identify association time hypertension diagnosis patient mellitus clinical hypertension receive diagnosis receive medication use receive diagnosis receive medication associate diagnosis rate disease primary care associate diagnosis rate associate treatment rate disease medication diagnosis treatment hypertension similar use patient mellitus use remain hypertension intervention target patient multiple improve hypertension clinical care
27181125 en use relative common among patient type mellitus T2DM high incidence T2DM use treatment study therapy among patient T2DM relationship study T2DM diabetic hospital may patient use mean age patient year prevalence use use use therapy factor found use therapy among patient T2DM age year participant effective study estimate prevalence use revealed positive found three significant use among patient T2DM datum on research large sample target T2DM population need
23250464 en disorder common patient mellitus increase associate glycemic control increased mortality disorder associate mellitus disorder disease disorder mellitus influence metabolic control complication outcome health system health care reduce mortality patient group
23942987 en intervention aim increase drug treatment need individual patient on intervention develop improve type evaluate new care intervention use group include assess patient intervention patient intervention intervention cause studied type mellitus patient evaluate mean group included patient patient develop intervention general patient assess mean intervention patient consider intervention factor poor time well factor patient intervention reported follow intervention poor receive
23873403 en use hemoglobin hba1c gestational mellitus aim present study determine hba1c level patient possible hba1c study included patient perform week according gestational mellitus therapy history hypertension known history previous consider disease condition hba1c determined diagnosis hba1c level great hba1c value result range increased on significant correlation hba1c value diagnosis individual BMI observed present negative outcome increased increasing hba1c level hba1c level hba1c patient hba1c level hba1c level analysis show hba1c diagnosis result adverse present result indicate hba1c level can adverse event
27013182 en population diagnose mellitus DM large disease large population factor present effect DM health adult population DM complication effect review provide evidence diabetic condition case similar complication include related disease dysfunction well disorder mortality metabolic cell change associate lead review diagnosis metabolic cell
20956395 en need test type mellitus T2DM patient identify early hba1c T2DM impair glucose also include impair fasting glucose impair glucose tolerance hba1c T2DM different use hba1c however association use hba1c new method hba1c value per use hba1c use oral glucose tolerance test patient need need hba1c result less recent however whether hba1c fasting plasma glucose two test different individual T2DM use hba1c medical condition result hba1c control month include disorder renal chronic
23700798 en mellitus examine activity high activity value respective identify activity examine effect result revealed show activity significant activity addition relationship base mellitus related activity group activity two characteristic activity
25539716 en study aim evaluate association body disease patient type ratio index body index BMI ratio measured risk estimate according risk score patient high risk risk risk group multiple logistic regression model perform association risk outcome total patient type year female hba1c evaluate high risk group great elevated BMI value patient risk difference observed multiple logistic regression model value associate risk or CI adjust diabetic serum duration association risk body associate high risk patient type
26211283 en mellitus type type two type case two adult aged risk present type subject outcome insulin therefore insulin important review new care patient
24495681 en investigate relationship different type gestational mellitus total case receive first hospital perform oral glucose tolerance test gestational week group normal blood glucose result fasting plasma glucose glucose glucose normal gestational mellitus group group result time group on on mean fasting plasma glucose normal plasma glucose glucose plasma glucose normal effect different number result outcome group mean one blood glucose result two blood glucose blood glucose analyzed outcome among case case diagnose group case treat case normal blood glucose normal blood glucose group group rate respective significant high normal blood glucose group statistical significant difference rate normal blood glucose group group on case case case incidence significant high normal blood glucose group compare on statistical group case case case compare normal blood glucose group significant high incidence significant high incidence among case patient fasting blood glucose case diagnose group high incidence adverse outcome woman fasting blood glucose low rate adverse outcome among
24267259 en serum on response protein type associate chronic study investigate change level type diabetic patient evaluate relationship serum cholesterol two known cholesterol type patient type mellitus control measured cholesterol serum determined cell cell test serum significant increased diabetic patient cholesterol serum significant impair three group diabetic patient correlate cholesterol correlate cholesterol regression analysis show presence significant independent cholesterol increased type diabetic patient associate cholesterol serum
24116738 en common complication cause patient therapy aim study review outcome effect age study database factor associate treatment mortality analyzed logistic regression overall rate one per old patient lower remain patient diabetic subject high risk age odd ratio or mellitus or or independent age or or age mellitus two major risk factor adverse outcome although result suggest patient need care occur
27079336 en major health however provide mechanism provide develop health care type increase care develop health primary health care regard mellitus health care provide patient care management primary care obtain low development new target lead care risk decrease mortality complication
27056389 en disease associate impair glucose mellitus disease syndrome associate impair glucose tolerance finding syndrome among drug observed drug addition disease cause well syndrome syndrome syndrome syndrome syndrome
20920426 en presence body cause change may study investigate change glucose patient type mellitus type mellitus use model glucose T2DM patient included glucose protein day period blood glucose ratio increased first several day patient although glucose level change observed analysis sample concentration glucose increasing increased presence T2DM significant high possible dysfunction T2DM T2DM high healthy insulin resistance insulin also high patient mellitus compare healthy protein known insulin therefore insulin resistance may high level first glucose metabolic change change glucose glucose similar T2DM however difference indicate metabolic activity two patient group observed difference base insulin dysfunction T2DM
23021699 en insulin woman type mellitus use insulin increase hemoglobin retrospective study woman type mellitus hemoglobin use insulin primary outcome change insulin insulin increased rate increase insulin insulin increased total insulin total insulin week type mellitus insulin increased week increase rate control
23021330 en aim study examine effect metabolic syndrome type mellitus finding increased risk outcome known whether risk cohort study examine year age year presence low cholesterol high high glucose high blood pressure high body mass index previous show adult outcome define define participant according status baseline follow-up examine risk high time risk confidence interval high time risk confidence interval T2DM compare whereas status show similar risk increased risk adult high T2DM datum indicate risk level
22902096 en plasma level cardiovascular disease impact target determined response type mellitus assess relationship change study three treatment period type diabetic patient plasma mass measured decrease response baseline treatment similar compare change lipid treatment period related positive baseline level high protein cholesterol total cholesterol ratio less baseline response correlate change cholesterol total cholesterol ratio treatment type mellitus plasma lower treatment severe may response lipid treatment decrease lipid treatment may mellitus
22767380 en medical treatment type mellitus DM insulin control without effect weight develop new drug glycemic control little effect drug treatment type DM review potential role treatment type DM major datum included use type mellitus year increase insulin cell also decrease new study role decrease effect drug type DM treatment study need
22483688 en significant function development dysfunction include important effect development cardiovascular disease increased event contribute development complication mellitus present review role potential target treatment condition
22037802 en prevalence among man woman aged year period
16949516 en although test diabetic patient assess study measured use patient type mellitus diabetic patient patient type mellitus multiple regression analysis show independent associate related diabetic patient show diabetic patient recent develop study clinical diabetic patient
24566596 en mellitus DM care different factor may adverse glycemic control patient may test relative hospital significant patient study evaluate effect hospital care patient DM within day hospital one patient DM medical primary care primary care randomize control intervention group hospital subject intervention group subject day subject control group intervention group within day control subject intervention patient medical condition follow-up period significant among patient control group intervention group follow-up may effective patient primary care patient DM medical large randomize control trial need finding
22218444 en common disease among medical treatment patient increase rate related consider common complication associate early prevalence high adult patient high prevalence early risk recent year several study condition treatment new well current diagnosis follow-up present study
22086798 en reported significant role mellitus DM population investigate whether gene associate mellitus renal use diagnose according association patient diagnose follow-up period month duration diagnosis range month month significant difference group age vs year BMI vs significant different group patient different difference development overall result association
22048882 en conduct review study diabetic patient within total study study included review conduct result study indicate diabetic without three indicate intervention lead improve health day result two analysis indicate day compare care evaluate associate increased health care diabetic patient treatment intervention aim treatment increase time great care
23758409 en role also known associate association level ratio use study serum level determined subject type mellitus body mass association parameter serum ratio studied use multiple regression regression analysis subject indicate significant positive association level serum on major statistical association observed analysis included serum level ratio associate suggest serum may
22429713 en mellitus type potential characteristic define study aim clinical parameter patient identify associate individual hypertension hospital fasting plasma glucose serum lipid measured medical history status activity patient mean female aged year mean year known patient medication hypertension diabetic complication occur body mass index increased body female ratio female occur respective increased cholesterol high general low factor independent associate included history adjust odd ratio confidence interval increased also several low study patient low status hypertension management need risk profile population
21883438 en investigate vs patient type clinical trial compare vs clinical trial compare vs patient included analysis model use outcome vs vs patient treatment effect trial outcome per health system result respective mean increase year vs year vs associate high vs vs patient ratio per year vs per year vs treatment type
24112518 en prevalence increasing however datum serum level adult cardiovascular complication study measured serum level examine relationship complication adult three group analysis subject normal glucose impair glucose fasting plasma glucose plasma glucose hemoglobin hba1c serum level measured datum included index level group significant decrease compare group vs vs serum level significant increased vs multiple regression show serum level group negative correlate hba1c serum level positive correlate hba1c diabetic subject serum level decrease subject estimate rate analysis serum level subject diabetic complication significant decrease compare diabetic subject without complication effect possible level decrease subject observed increase level correlate increasing glucose level diabetic patient complication lower serum level complication
24142614 en mellitus chronic metabolic disorder result factor type mellitus T2DM disease one common chronic complication correlation T2DM total patient T2DM patient T2DM study use gene clinical datum also significant difference T2DM group T2DM group different group significant difference age BMI blood lipid fasting blood glucose ratio patient T2DM group protein level significant high on value less gene important role patient T2DM change level protein therefore result role T2DM identify several potential disease
23632200 en factor multiple effect therapy however potential recent examine use effect reported glycemic control healthy oral glucose tolerance test follow insulin glucose base study type mellitus overall effect glucose level level test period significant reduction glucose total compare baseline control healthy associate reduction glucose significant increase insulin treatment lead significant reduction glucose total significant reduction serum glucose compare baseline control insulin treatment therefore role great potential use
27690318 en estimate prevalence diagnose evaluate care among year study study base review datum obtain medical diagnosis included study prevalence use population first population care determined use prevalence among aged CI significant lower prevalence among age group CI blood pressure blood pressure measured within year difference care observed high prevalence diagnose observed among compare major difference observed care two group overall prevalence diagnose increased compare early study prevalence care
21752046 en mellitus relative treatment high rate diabetic patient aim present study investigate effect model significant change protein evaluate week healthy cause change significant reduce diabetic group week increased diabetic group time whereas reduce diabetic control negative finding diabetic patient therapy
23814097 en treatment increased gestational mellitus compare factor increased compare age multiple independent associate increased age treatment high high multiple rate treatment treatment associate increased risk population retrospective cohort study use datum treatment study included prevalence compare logistic regression use assess association treatment odd ratio or adjust or confidence interval CI large aged year compare prevalence high prevalence overall increased compare CI high odd CI significant difference among CI aged year age high odd compare possible investigate associate increased risk risk can BMI large may reduce study datum suggest cause important role increased multiple may risk related treatment
26972374 en treatment patient well known syndrome however whether remain aim study evaluate impact identify patient undergo undergo function test mortality compare two analysis revealed cause severe severe diabetic patient identify lower incidence high incidence analysis independent cause complication level identify factor severe associate increased level presence
23114390 en prevalence risk factor development mellitus previous reported present study indicate prevalence possible risk factor diabetic database hospital study healthy control age on activity obesity prevalence year base result hospital present study per diabetic year old disease among case common vs female case reported time diagnosis year compare control age time diagnosis case control respective case control age time study year significant high number control age control vs case on significant high case time diagnosis time study compare control similar age time diagnosis case compare control similar time control high compare case vs DM respective case less compare control respective result indicate perform low activity can identify risk factor well study population
22862965 en examine presence cell factor compare patient type mellitus DM without DM revealed presence group significant cell significant large patient DM cell number cell negative correlate serum level glucose hemoglobin whereas positive correlate level serum glucose cell high level patient type DM can
22494469 en type mellitus disease association study aim investigate high patient control result indicate positive association negative association analysis revealed significant patient control positive effect development analysis demonstrated provide major effect develop method method identify three also determine impact show risk develop
21692847 en present study investigate effect oral therapy different diabetic parameter studied included hemoglobin fasting plasma level cholesterol cholesterol cholesterol diabetic normal present study can increase effect effect according finding similar result obtain lipid parameter whereas oral therapy blood glucose total cholesterol cholesterol therapy different
22550962 en determine prevalence syndrome population association disease hypertension mellitus study participant aged year population determined little one datum blood analysis blood pressure use determine DM weight base population age syndrome estimate population rate high subject subject rate DM cholesterol level statistical significant association test found high rate subject high rate subject subject syndrome increased odd time blood pressure high group group association can adjust age duration increased odd syndrome increase risk syndrome prevalence high association DM effect age
23890345 en investigate effect gestational mellitus weight body mass index BMI compare BMI value present BMI also woman little one studied age weight health care compare value weight weight high age high BMI age age increased weight high BMI age on similar observed normal BMI follow-up high risk obesity due factor BMI found normal however study can role factor early intervention
21655874 en insulin resistance reduce response dysfunction glucose associate factor factor correlate obesity type mellitus hypertension however clinical factor insulin resistance present type known syndrome type mellitus resistance insulin condition insulin resistance use normal normal treatment related complication report two case female patient different related type associate complication without treatment insulin possible treatment report research medical
21276585 en previous study reported difference present characteristic woman man undergo disease examine patient type mellitus known trial patient woman man woman man vs vs woman reported vs high compare man vs woman man vs woman lower mean index vs number total significant vs vs odd high woman man odd ratio confidence interval odd ratio confidence interval group patient known mellitus woman man less datum suggest factor influence woman population
23153979 en dysfunction significant risk factor cardiovascular disease study determined role plasma level disease patient type mellitus study included patient type DM patient healthy without major cardiovascular risk factor control estimate method gene studied studied use diabetic patient patient control high group compare diabetic control group level significant lower patient diabetic patient compare control increased incidence diabetic patient
22047939 en study examine whether use glucose reduce individual type mellitus participant low glucose condition day treatment study participant three well treatment reduce incidence relative time baseline treatment respective blood glucose level blood glucose less use clinical significant effect possible due low blood glucose level
23907137 en research relationship parameter development mellitus DM patient treat patient undergo include retrospective review on total patient follow little year included analysis parameter mean receive obtain treatment receive little statistical significant factor development DM respective value respective value factor event associate development DM analysis factor statistical whereas show independent factor associate development may function development DM patient receive
24523311 en mellitus DM risk factor development disease new clinical associate factor disease type old age high hemoglobin level duration high insulin therapy low less severe impair less impair characteristic may addition insulin resistance elevated associate type may
24232664 en evaluate association study group association diagnose gestational mellitus woman undergo oral glucose tolerance test week use diagnosis adverse outcome include low weight diagnose woman respective odd ratio confidence interval CI CI increase diagnosis diagnose associate although impact need
26643420 en impact resistance patient type mellitus T2DM
23943142 en insulin less weight patient type mellitus however insulin insulin weight effect increased one mechanism weight insulin however study compare patient use insulin use insulin also study compare protein chronic disease patient use insulin insulin aim current study compare effect insulin insulin protein patient type clinical datum evaluate patient score protein also total patient insulin insulin included study difference protein patient group also group use insulin insulin related protein regression difference insulin insulin protein type diabetic patient study need patient normal renal function mechanism regard weight effect insulin
20191842 en show use model mellitus body mass body mass two day period week perform test determine body mass index control diabetic diabetic measured show significant decrease diabetic receive treatment difference statistical show high difference follow diabetic receive treatment decrease body compare analyzed sample high difference found diabetic overall high difference diabetic body index studied group low diabetic regression due use chronic complication mellitus
19575688 en woman history gestational mellitus high risk type mellitus review test type woman gestational database two independent review perform datum independent assess confidence interval use study test oral glucose tolerance test study use study fasting blood glucose range study use health study use may due number difference population high follow-up compare reported test type woman history gestational study need history glucose woman history gestational type population outcome
20095517 en recent study indicate prevalence mellitus DM type increasing chronic DM associate dysfunction addition increased risk cardiovascular disease time early diagnosis can development diabetic complication aim study risk development disease patient evaluate use new study included participant without diagnosis DM hypertension disease two year study patient fasting plasma cholesterol cholesterol cholesterol group oral glucose tolerance test perform analyzed blood also measured body mass analyzed prevalence prevalence impair fasting glucose impair glucose tolerance DM age female year respective healthy population high vs population obesity vs hypertension vs vs lower vs risk factor healthy subject without diagnosis DM high risk factor disease
27989876 en use mellitus DM complication aim study investigate effect DM model DM low high week evaluate estimate relative weight rate level activity general diabetic renal function parameter also determined mechanism base effective general DM include weight elevated blood glucose level low serum insulin level reduce serum protein also increasing weight ratio rate level decrease show effect increase level activity decrease cell ratio increased age protein level DM also well DM may related
27966735 en common type disease type mellitus T2DM factor contribute development T2DM study investigate role gene development T2DM population blood sample obtain T2DM patient control subject hospital obtain datum statistical analyzed test revealed statistical significant difference patient control regression analysis indicate associate increased risk T2DM compare adjust odd ratio or confidence interval CI respective model correlate high risk T2DM or model show high risk develop T2DM high risk develop T2DM therefore may early T2DM population
25687568 en may health recent trial use among healthy woman potential improve glycemic control aim study investigate effect intervention metabolic parameter outcome among woman gestational randomize trial woman new diagnosis gestational impair glucose tolerance glucose tolerance test woman randomize diagnosis fasting blood sample baseline week analysis glucose insulin lipid primary outcome difference fasting glucose first analyzed follow analysis woman therapy insulin outcome change insulin model assessment lipid therapy woman randomize difference group fasting glucose vs therapy vs vs among woman fasting plasma glucose decrease significant within group level group total cholesterol vs group vs total cholesterol vs cholesterol difference group metabolic parameter intervention among woman glucose tolerance impact glycemic control observed normal total cholesterol treatment group risk metabolic syndrome
25648911 en potential renal examine association development diabetic subject type system concentration measured baseline sample subject undergo baseline year sample concentration analysis relationship assess use multiple regression age duration hba1c mean pressure rate rate model examine change baseline value also mean age year mean duration year mean association found high associate high baseline year woman baseline man baseline associate concentration measured clinical finding woman associate change suggest may early change
22952989 en aim study type mellitus use two different examine characteristic associate base method use subject risk factor disease logistic regression model use investigate factor associate mean age subject year female year known duration patient reported mean score CI CI respective female lower duration year lower associate high logistic regression model factor addition significant associate lower level regression analysis study finding indicate patient relative poor therefore identify management diabetic patient
21957900 en evaluate association body mass index BMI large gestational age woman analysis type type prevalence type type diabetic large gestational age respective respective BMI associate increased odd woman type however type diabetic increase weight result increased odd type diabetic odd decrease increase insulin known association obesity woman found woman type type increased odd however insulin type weight type significant associate odd
21342625 en investigate prevalence type mellitus T2DM clinical datum new diagnose mellitus DM obesity retrospective total new case diagnose DM year diagnose T2DM prevalence T2DM duration increased significant compare first duration vs number case type mellitus T2DM increased respective duration on total patient receive oral glucose tolerance test case diagnose T2DM case case disease prevalence rate T2DM increased significant year prevalence T2DM increased significant high prevalence obesity high risk T2DM cardiovascular disease
21411463 en study determine effect mellitus DM renal outcome outcome associate patient reported adjust DM analyzed primary outcome mortality major complication treatment rate study show great negative influence outcome previous use patient DM negative impact outcome study show may less risk previous control treatment patient DM
21168629 en risk factor mellitus effect parameter function retrospective analyzed patient follow-up year patient mellitus DM develop mellitus year rate month respective incidence first year early day patient risk factor age year history DM body mass index therapy risk factor age therapy group receive number drug similar level influence parameter group reduce function compare subject use rate estimate rate high among plasma glucose early period among patient function use influence function
19573885 en healthy adult level factor increase response glucose increase positive correlate function high activity system associate increased risk severe patient type mellitus system possible mechanism studied impact plasma patient type mellitus high low activity analyzed association level function patient type high low study function assess assessment test plasma glucose control study plasma change plasma increased group group difference group on association reduce function low response observed plasma level increase patient type mellitus response activity associate function previous association low activity
27832993 en review aim recent finding role important complication although treatment mellitus recent glycemic control increase risk weight therefore therapy may potential related include range function cardiovascular renal effect three include system well review provide evidence important role mellitus related complication include disorder early diagnosis risk assessment intervention complication may improve care
26541516 en type mellitus T2DM chronic condition primary treatment control hba1c patient receive high care within clinical treatment aim study assess compare treatment patient T2DM control previous model use treatment effect parameter review system year use present outcome ratio analysis assess model associate mean confidence interval CI CI result estimate per analysis determined parameter treatment effect weight impact however per estimate per show treatment system patient T2DM control
20646646 en investigate clinical risk factor renal patient type datum retrospective study chronic complication type diabetic on total patient type group year group year patient also three group according rate group group group estimate study clinical parameter patient renal group type patient significant high patient vs vs respective type diabetic patient renal duration vs year blood pressure vs blood pressure vs hypertension vs diabetic vs cardiovascular disease vs disease vs significant high group group multiple logistic regression analysis revealed duration blood pressure independent associate renal type diabetic patient whereas blood pressure blood glucose independent risk factor renal type diabetic patient renal lower rate patient blood pressure risk factor type decrease renal function blood pressure may renal function
20522067 en woman gestational mellitus increased risk develop type early management type important reduce associate complication evaluate follow-up woman diagnose two hospital include hospital woman increased risk develop type blood glucose also included woman woman woman diagnose hospital woman first undergo glucose test two woman reported develop type result increased early group therefore early intervention treatment reduce complication
20353144 en base type mellitus type mellitus cause diagnosis base level fasting blood glucose level oral glucose tolerance although patient hypertension risk high negative value define patient test may type need insulin include cell function level cell cell insulin value
26279321 en aim evaluate impact mortality patient use datum datum health system define primary cause occur hospital association study outcome evaluate two cohort without score use model among diagnosis primary prevalence increased prevalence primary remain primary associate reduce mortality odd ratio or confidence interval CI significant decrease time ratio CI associate increased mortality or CI significant increase time CI prevalence increasing patient associate increased mortality hospital
24420910 en type reduce renal glucose increasing glucose management type mellitus reduce without value weight blood pressure may use drug review potential regard three study perform healthy assess assess plasma concentration test significant influence cardiovascular common use patient type medication influence parameter change consider clinical however drug can metabolic may result significant change show potential patient type receive chronic treatment individual treat several medication patient renal
24528351 en association important assess DM perform two group mean one month participant two day participant weight statistical study female group group mean age year old mean body mass index BMI participant year year similar group intervention intervention group significant high difference assessment test group vs effective DM perform
20734163 en mellitus associate poor outcome patient impact mellitus treatment one effect patient without mellitus patient undergo response assess cell evaluate effect different concentration insulin glucose diabetic condition patient included patient lower rate disease vs time significant compare diabetic day vs day cell insulin glucose important cell drug resistance study show less effective diabetic patient rate time disease
20649628 en risk factor patient type mellitus T2DM however assess risk factor T2DM general research database T2DM use estimate incidence T2DM relative adjust disease obesity use regression analysis adjust risk factor index use estimate ratio confidence interval patient T2DM patient without develop patient T2DM high risk compare patient without CI patient T2DM significant high rate vs condition vs history obesity disease use significant adjust factor age risk develop remain elevated patient T2DM adjust CI adjust risk factor patient T2DM elevated risk compare patient without increased risk patient T2DM
19700362 en increased risk develop disorder well treatment diabetic control high risk female disorder impair function also reported among early diagnosis year severe type mellitus contribute development relationship negative however insulin improve patient metabolic control metabolic control also addition role important identify patient high risk develop disorder health high risk patient disorder low status health therapy medical group also present review prevalence among risk factor development management
22519904 en associate risk association population remain analyzed risk study conduct study included oral renal cell case hospital control odd ratio or subject compare major identify factor consider logistic regression significant elevated oral or or or or or or or oral risk diagnosis datum association suggest first time may also increase risk
22442692 en develop test risk score population high cardiovascular risk score individual three study sample regression model use risk factor score included status history type hypertension score included also high blood glucose test score cohort sample risk score risk score score assess score study individual develop follow-up score whereas score sample significant high identify risk factor develop score determine individual high risk develop individual high cardiovascular risk score significant high also use
22257365 en type chronic condition result decrease increased health change development patient risk new increase patient change development randomize control trial assess clinical type risk risk assessment perform primary care two primary care one three study risk randomize receive risk assessment type risk factor result risk participant risk receive test receive risk provide study fasting plasma glucose insulin level body mass index BMI measured baseline month patient response risk primary outcome change insulin resistance BMI month outcome include change activity risk develop provide patient risk common chronic disease primary care remain study whether provide type risk primary care improve patient clinical outcome risk healthy change addition study use risk can development care model use individual risk primary
21958333 en type mellitus associate increase glucose decrease insulin insulin however patient type system impair effect well possible reduction may role management type current therapy effective treatment type however may type increase therapy target cell can possible effective treatment potential new patient type include show increased insulin improve glucose tolerance similar study demonstrated increased improve glucose level insulin resistance addition show increase decrease glucose level patient type result suggest effect may due increase level evidence suggest may new management type
19667949 en fasting plasma glucose identify mellitus oral glucose tolerance test high aim assess hemoglobin hba1c patient undergo week renal total renal without undergo week characteristic analysis use identify test on level diagnose patient identify plasma glucose characteristic analysis revealed confidence interval confidence interval hba1c patient hba1c patient test respective hba1c provide similar patient hba1c hba1c early period undergo
21168630 en mellitus associate evaluate related renal due cause diabetic related renal evaluate characteristic glycemic profile fasting level plasma insulin level insulin resistance among patient develop mellitus year age history impair glucose tolerance time correlate development mellitus period
20051882 en evaluate association mellitus compare age healthy study included subject one per subject one diabetic patient study group healthy control study group diabetic diabetic diabetic determined patient treatment history statistical analysis perform analysis test correlation analysis perform assess association disease duration hemoglobin level among characteristic study control group similar mean significant great study group compare control group addition mean found great compare difference statistical also significant correlation level hemoglobin disease duration among found diabetic patient compare patient associate mellitus obtain pressure diabetic
20465096 en mellitus DM define significant high risk well risk patient type time high change patient type include change decrease activity increased risk insulin resistance syndrome study evaluate patient risk patient result subject analysis difference treatment patient disease therapy diabetic patient clinical less
19436948 en relationship serum factor level parameter dysfunction patient mellitus type without investigate diabetic patient two blood control group serum plasma factor measured use subject significant high compare control difference control statistical significant correlate observed significant increase serum level suggest serum can dysfunction type
18979202 en role system potential effect condition well insulin possible also insulin resistance increased potential role control diabetic condition condition associate also study may decrease incidence possible also mellitus may improve metabolic control however mechanism effect need
22136979 en current population aged year
22002336 en renal system patient mellitus contribute risk recent plasma also provide risk study examine system control mechanism patient individual type mellitus individual system randomize treatment lower blood pressure plasma increased renal plasma rate increased plasma decrease plasma whereas plasma increase chronic treatment day renal effect without significant change plasma time plasma whereas lower relative resistance renal response chronic system renal system level cell diabetic patient high system renal system
24595351 en clinical value rate clinical study potential gene profile risk among subject study use datum base datum base datum identify level associate type rate analysis associate function analysis datum identify model gene subject ratio result suggest may potential gene risk clinical subject
18080918 en well known patient mellitus patient mellitus chronic severe due status aim study determine association type mellitus population case control study type mellitus group study conduct primary health care period study included type mellitus patient assess profile among type mellitus patient mean age type mellitus patient year compare year subject on positive found diabetic subject compare subject high prevalence diabetic patient subject vs chronic common diabetic patient present study suggest significant association type mellitus significant high diabetic patient subject
20384711 en aim study investigate clinical well risk factor mellitus retrospective evaluate define fasting blood glucose little two oral drug insulin patient according time early vs duration vs analysis age use independent risk factor among patient perform vs vs significant severe patient incidence patient severe patient significant cardiovascular event patient early patient show rate compare patient whereas difference outcome early independent risk factor negative impact patient time duration
24125565 en gestational mellitus common medical complication high weight develop metabolic disease adult status health disease new disease mechanism mechanism may provide aim review role development insulin resistance metabolic disease adverse change mechanism may early event metabolic disease study contribute effect disease treatment change
26825666 en although several study found gestational mellitus evidence use diagnose large aim study assess effect glucose index weight change woman new diagnose woman randomize clinical trial receive week weight glucose index first week study weight similar group however week study weight group significant lower group fasting blood decrease intervention control group significant decrease group significant high group insulin resistance index group reduction study period group however increase insulin resistance index observed change insulin resistance statistical significant insulin index increased group insulin index group significant different adjust baseline glucose weight among woman need value can
26289515 en investigate common risk factor present woman undergo oral glucose tolerance test determine relationship time woman metabolic period review datum included age gestational age weight risk factor gestational mellitus woman subject study study population woman test week woman little one common risk factor history previous obesity among history previous significant associate week common presence risk factor early risk factor need early woman risk
25177939 en within associate mellitus finding correlation risk among population finding therefore odd ratio or confidence interval current study within database on total study patient control included analysis study revealed significant associate increased risk model vs vs vs vs vs analysis however significant associate identify significant association risk although association among man different
24062093 en impact mellitus DM use patient treat remain retrospective evaluate patient undergo clinical regression model association DM use patient diagnosis DM DM associate value within follow-up month range month patient diabetic patient without use diabetic patient use regression analysis group DM without use CI DM use CI associate on analysis status significant association DM use risk found association DM use patient treat effect DM complication overall need assess similar cohort
25194081 en examine activity hemoglobin patient type mellitus subject hba1c level can perform activity activity glycemic control assess hba1c level well age duration DM activity age mean time study patient year month range respective activity time per month range compare mean change hba1c found study also revealed activity associate reduction present study demonstrated activity associate hba1c reduction clinical important patient type DM
24913240 en perform effect body mass index BMI weight mellitus DM compare year on total case study analyzed patient receive significant lower BMI high compare receive BMI mean difference confidence interval CI CI rate DM difference two type CI effect body weight show similar effect DM
24519713 en role factor gestational age weight type mellitus study woman assess concentration week vs vs respective first serum concentration similar vs group datum range vs respective on lower concentration observed vs group vs group concentration first vs respective group concentration significant high gestational age week compare week vs serum concentration well increase level early may development woman
24026142 en primary metabolic parameter mellitus study drug risk reduce total patient metabolic syndrome mellitus randomize group group group group pressure decrease group group difference effective significant difference metabolic parameter trial cholesterol level decrease group group hypertension treatment effective datum current reduce cardiovascular risk
21219422 en treatment type period lower insulin follow increased insulin improve insulin associate patient type follow year insulin hba1c plasma glucose concentration determined diagnosis month studied define insulin hba1c within normal range plasma concentration observed per patient one time high level lower ratio indicate compare also associate high value patient man high BMI diagnosis baseline compare patient diagnosis type associate lower ratio suggest lower indicate insulin control glucose
21265645 en woman history gestational mellitus increased risk develop type T2DM follow-up care follow-up care woman recent conduct two independent identify use datum analysis age year mean body mass index BMI identify general follow-up care due adjust new receive diagnosis identify care among recent report multiple follow-up care result development intervention improve care woman reduce risk
20890173 en plasma patient type high lipid evaluate association activity cholesterol total patient body mass healthy adult fasting blood sample obtain plasma glucose lipid profile insulin activity measured model assessment insulin resistance also compare healthy participant significant high lower activity high level activity activity significant correlation patient healthy participant activity significant decrease type lower activity type mechanism may adverse reduce activity
18931370 en several evidence elevated blood may insulin resistance type mellitus glucose insulin metabolic test analyzed datum adult aged year participant risk study blood estimate use base total plasma protein baseline baseline estimate blood independent associate several metabolic syndrome model adjust known estimate blood type mellitus compare low adult high blood ratio confidence interval ratio confidence interval develop therefore elevated blood risk factor insulin resistance type mellitus
19776333 en identify rate health need adult obtain care datum determine relationship sample patient sample adult included patient health prevalence health health prevalence great level sample found level health found reduce among presence on significant increase rate found among period significant difference found among compare among adult found high rate reported study population result study need develop health treatment
19641163 en woman recent gestational mellitus remain glucose however rate oral glucose tolerance test low aim study develop model risk assessment target woman high risk woman glucose datum glucose datum perform week total woman impair fasting glucose impair glucose tolerance independent risk factor BMI prevalence vs gestational age diagnosis week vs value vs insulin therapy vs prevalence assess according number risk factor subject according significant increase prevalence risk low risk subject risk factor odd ratio risk risk factor high risk risk factor group included risk factor high risk diagnose within group target woman base risk assessment use risk factor reduce number case
22231975 en evaluate presence mellitus DM cohort patient patient assess disease control DM hba1c diabetic patient vs use vs regression analysis hypertension associate odd ratio or CI control associate presence or CI presence DM associate presence hypertension however level patient without
18510382 en mellitus major individual cause potential complication disease early intervention early therefore mortality current method include oral glucose tolerance test fasting plasma glucose hemoglobin hba1c patient measured found elevated patient glucose early condition use glucose mellitus early disease test base method use clinical trial result test can use mellitus also impair fasting glucose impair glucose tolerance normal glucose tolerance
17617163 en difference mellitus suggest disease little evidence type type disease response major important determine type test major known associate on total diabetic control type association found three show association population common can difference prevalence different evidence also associate suggest can common
25799813 en mellitus common health may cause disease complication may cause diabetic complication study aim effect type diabetic patient serum total index estimate index measured index case control study conduct health chronic type mellitus patient age normal healthy control included study plasma found diabetic case compare healthy control on significant increase level case control significant decrease case control case control observed
25511492 en mortality risk without type mellitus T2DM period subject patient year old undergo health hospital incidence risk factor analyzed method total subject T2DM group DM group follow-up mortality rate cause DM group group major mortality cause disease cardiovascular disease analysis revealed mortality cause cardiovascular DM significant independent mortality risk factor T2DM CI cardiovascular disease CI base mellitus independent risk factor increased mortality risk
25335333 en study effect cell level mechanism mellitus DM model total body weight group blood glucose level low high model group group group group group normal glucose age control group intervention week fasting blood glucose body weight hemoglobin hba1c total cholesterol determined determined determined level analyzed time control group body weight decrease increased model group blood glucose high model group control group compare model group body weight increased level significant lower high group compare group body weight body weight lower increased group statistical difference level among group model group significant severe control group group compare model group group severe group model group group range group group level significant lower group model group group group effect blood glucose blood lipid effective role DM function
25272521 en resistance use insulin condition patient type mellitus T2DM use insulin determine population regard insulin current medication several patient T2DM year old insulin treatment evaluate patient use insulin determine insulin current medication patient group use insulin insulin current medication group positive negative mean age year year duration T2DM female one use insulin patient show lower positive negative insulin current treatment negative insulin increased time risk without study time increase risk compare group high patient T2DM found show low positive high negative insulin use improve T2DM patient
25244264 en evidence association blood group aim study investigate association blood group mellitus DM study diabetic blood medical study included diabetic patient healthy control on total adult patient year age diabetic hospital patient study response rate on total healthy adult year age blood individual study response rate blood group subject database blood datum revealed blood group significant common diabetic patient compare healthy population vs blood group significant less common diabetic patient compare vs among diabetic man blood group significant high among diabetic woman on vs vs respective significant high compare healthy finding study suggest associate DM DM common individual blood group
25168549 en relationship mellitus DM man lower adjust impact age obtain database patient may patient DM control age difference rate group whereas significant high DM patient control vs total score significant high DM patient control vs vs vs score high DM patient control whereas group similar score among DM patient high score similar score score also significant high DM patient difference due high patient great age control
25074545 en glucose protein blood early age age contribute significant complication mellitus disease however current early diagnosis report identify relative protein plasma sample obtain type mellitus T2DM patient individual use analyzed mass among studied protein statistical significant high level T2DM control T2DM within new early diagnosis T2DM control may indicate early metabolic change T2DM
25073564 en increased patient type mellitus DM diabetic define dysfunction patient type DM hypertension disease disease assess level type DM patient without on total DM blood sample day undergo plasma concentration measured baseline diagnose presence define early early ratio prevalence level high patient compare without vs respective assess use regression analysis odd ratio confidence interval independent result characteristic show patient type DM
23759393 en medication high rate cell provide medication cell intervention population range patient cell intervention system include response medication adult type mellitus report result use patient target population use intervention one three type related provide value patient also value obtain method datum provide datum use result provide potential patient population
23412605 en high pressure cause renal model determine whether renal hypertension associate increased patient type pressure renal function rate effective renal plasma respective sample obtain individual type determined use healthy control individual clinical characteristic protein blood pressure level similar diabetic healthy control group addition hba1c level similar two diabetic group baseline high diabetic patient healthy control patient vs respective renal blood also high renal resistance lower patient diabetic patient high rate factor factor protein normal also high vs diabetic individual elevated diabetic individual vs healthy control associate increased patient type
23086559 en consider first clinical dysfunction associate poor renal cardiovascular type patient develop may effective intervention assess value risk score development conduct study case control renal disease study case define follow-up year control age status on model use base independent associate or CI development estimate characteristic increase index show significant different case relative sample result suggest analysis early renal risk assessment patient role renal
21129801 en aim evaluate association diabetic cardiovascular disease risk patient new diagnose type total new diagnose type diabetic undergo diabetic assess risk estimate use study risk found subject rate hypertension diabetic significant high among patient risk significant increased subject old age hypertension presence diabetic show significant association body mass index status hba1c cholesterol cholesterol presence diabetic study show diabetic independent risk patient new diagnose type suggest diagnosis diabetic may cardiovascular assessment early
16919215 en study compare range individual without mellitus use effect range individual mellitus individual similar age profile revealed individual mellitus significant lower range high individual individual mellitus positive relationship glycemic control duration mellitus respective decrease range increased mellitus population clinical first study finding individual mellitus one control factor difference range mean change significant range change range may important
25225211 en cardiovascular event risk factor identify however dysfunction one type mellitus impair glucose insulin resistance may development cardiovascular disease therefore investigate dysfunction type mellitus insulin resistance regard risk cardiovascular event cohort year woman type mellitus dysfunction glucose tolerance oral glucose tolerance test insulin model assessment insulin resistance determined follow-up year participant cardiovascular event less associate cardiovascular event type mellitus ratio confidence interval among high normal glucose among lower type mellitus insulin resistance present relative risk cause dysfunction type mellitus insulin resistance increase cardiovascular event risk identify dysfunction target individual
27124041 en aim study compare medical treatment type mellitus T2DM T2DM patient perform one common treatment patient T2DM compare medical treatment identify randomize control trial evaluate medical treatment T2DM patient conduct database clinical trial review perform according review primary outcome T2DM analysis hemoglobin hba1c fasting plasma glucose body mass index BMI serum lipid level blood pressure medication use adverse event present odd ratio or mean difference confidence interval total T2DM patient included follow-up range month associate high T2DM rate or CI serum level cholesterol CI medical treatment hba1c CI BMI CI CI CI cholesterol CI blood pressure CI lower however CI total cholesterol CI blood pressure CI significant different treatment group use improve group medical treatment T2DM metabolic condition cardiovascular risk factor patient T2DM
26914659 en previous reported drug improve glycemic control disease patient type mellitus T2DM however effect aim study effective treatment patient T2DM retrospective patient T2DM treat among patient normal level remain patient normal level study addition compare change datum include level body weight patient remain patient period day follow-up body weight hemoglobin level decrease significant serum level also decrease significant index patient serum lead glycemic control also reduction body weight level reduction index patient therapy
26512024 en type may develop perform year age study control subject two time month mean hba1c level time relative control subject significant less significant less population change blood glucose level time time negative correlate change suggest glucose level may associate addition glycemic significant negative correlate development result type effect blood glucose level well within current treatment management
21472660 en gestational mellitus metabolic condition cause severe early diagnosis treatment significant investigate compare prevalence gestational mellitus woman control study conduct research hospital woman without risk factor examine first on glucose test test positive oral glucose tolerance test perform week diagnose according association prevalence compare woman without woman ratio woman without woman time woman without among woman ratio woman difference ratio found statistical significant base result woman time woman without may risk factor large study early complication disease woman
23578350 en cause mellitus DM disease little known prevalence develop compare prevalence DM control group develop assessment study participant DM participant individual risk factor subject undergo test study included DM control participant among participant similar DM control vs on significant high DM group compare control vs participant whereas without model DM independent associate odd ratio confidence interval woman less man vs woman large study DM participant control group less woman man
25297911 en treatment adult type mellitus several on also review management type aim therapy base recent datum randomize control trial oral improve control use include insulin control also show patient renal include severe aged year first primary use without patient renal general well associate low risk effect datum indicate may effect cardiovascular renal profile patient type datum need low risk may provide important patient group include impair patient
24531925 en estimate gestational mellitus obesity hospital datum obtain woman type mellitus diagnosis reported little one datum relative risk confidence interval use model use population body mass index BMI woman adjust age gestational weight status use hypertension hypertension overall adjust time high among woman compare woman woman high among woman woman case obesity among among among woman case obesity group BMI case among woman respective result indicate significant increased risk among woman association case weight group
23336845 en study evaluate datum clinical outcome difference patient type mellitus T2DM use insulin retrospective study analyzed medical impact database adult T2DM treat insulin evaluate clinical outcome year compare individual patient use patient cohort use score total patient identify cohort patient group baseline characteristic similar group treatment significant high vs medication ratio also significant high among vs insulin use glycemic control similar group total also similar group high among lower overall insulin result improve treatment clinical outcome
16896570 en primary care management patient mellitus investigate prevalence mellitus type type type drug treatment association presence diabetic complication metabolic control sample general response rate total patient assess study use assessment addition mellitus disease among disease disease disease disease diabetic prevalence mellitus type type respective type type patient complication receive treatment receive treatment receive oral drug insulin two compare diabetic without complication treatment significant high patient complication odd ratio or complication or hba1c previous study diabetic drug treatment increased patient receive drug blood control improve well
26215009 en syndrome system body therefore study compare parameter diabetic study subject type diabetic subject study sample analyzed concentration diabetic group concentration normal group concentration normal indicate effect type mellitus parameter
24863523 en target gestational mellitus mean plasma protein on analysis blood level sample control first study control sample mellitus significant lower concentration control retrospective one level significant lower control increased diabetic woman independent early
25918235 en mass dysfunction development type T2DM recent show presence factor cell investigate whether also occur whether related presence observed time increased insulin cell cell time increased compare control group increase cell also found diabetic high cell cell correlate presence datum indicate occur T2DM can contribute decrease mass potential function
18813413 en determine prevalence type mellitus among year old conduct year define prevalence chronic disease mellitus base recent population use included datum evidence mellitus prevalence estimate per per age identify type mellitus prevalence rate per female ratio female prevalence type mellitus show high low also group age prevalence prevalence prevalence prevalence prevalence type mellitus per
21937865 en identify factor among group aged patient mellitus retrospective review perform diabetic subject aged year old independent base review age diagnosis diabetic control complication assessment perform obtain include function status diabetic patient consider high age duration high insulin use lower function lower patient diabetic patient independent treat subject diabetic patient clinical patient high age high serum high prevalence diabetic patient logistic regression analysis follow function score score characteristic analysis revealed diabetic model low hospital well datum analyzed among diabetic
21879657 en present mellitus patient different result study present show outcome patient control review consider patient therapy metabolic control complication according datum define also blood glucose period evaluate
21441696 en although major clinical mechanism well known patient complication disease also disorder disorder consider one mechanism observed diabetic patient model evidence dysfunction reported observed patient study decrease level protein increase activity however several report indicate occur therefore association recent disease dysfunction blood may disorder also disorder
20473853 en study suggest associate decrease risk population base investigate association duration report study within treatment study man aged year base test man datum analysis within year general control prevalence case control associate reduce risk odd ratio confidence interval evidence association great poor association change increasing duration associate decrease risk datum evidence association
26112044 en gestational mellitus remain compare impact three intervention healthy activity risk randomize woman risk BMI oral glucose tolerance test week without randomize woman receive base on gestational weight target receive intervention primary outcome fasting glucose insulin trial participant develop week woman less CI lower fasting glucose group week significant difference group intervention associate less lower fasting glucose compare finding large trial use early intervention woman
23045421 en evaluate parameter change parameter mellitus type perform year old disease duration less year year year case patient two group group patient complication duration disease less year group patient diagnose complication diabetic diabetic diabetic level hemoglobin level glucose control group included healthy age group less disorder found group case disorder revealed group change number blood group prevalence one mellitus type perform early change treatment time
26171400 en elevated pressure independent mortality diabetic DM patient on gene show major therefore test may develop elevated DM due decrease test type perform patient elevated normal group evaluate whether significant association type elevated decrease define low plasma found statistical significant type DM prevalence elevated lower mean level elevated low level significant DM individual type associate elevated level low plasma level patient DM
24438478 en risk associate gestational mellitus well increasing evidence treatment condition however group whether base risk factor level glucose treatment outcome treatment possible health care well response trial determine diagnosis management control trial investigate rate clinical effective primary care control trial target population include woman present first week two hospital hospital general hospital participant week primary care care primary outcome rate outcome include clinical effective primary include gestational week time time woman diagnose outcome woman addition conduct trial period first hospital week control trial
24251432 en evaluate measured type without diabetic study diabetic without diabetic healthy subject measured correlation diabetic parameter fasting glucose level hba1c age duration also mean value control group correlate fasting glucose level hba1c age duration study show diabetic similar healthy control addition fasting glucose level hba1c age duration
24016490 en glucose lipid effect lipid profile cardiovascular risk trial examine whether addition medical therapy reduce risk cardiovascular mortality patient type mellitus recent randomize trial on total patient randomize addition medical therapy primary time first event cardiovascular due change renal function treatment patient follow little year primary event whether improve cardiovascular outcome patient disease
20682688 en common associate high fasting glucose type population however association glucose level oral glucose tolerance test assess large sample associate analyzed association outcome week cohort also test association associate high fasting glucose glucose glucose also associate high weight mass associate three glucose outcome fasting glucose respective population associate high odd gestational mellitus according new association study group associate glucose level known increased risk adverse outcome woman without study important determine glucose known
24328511 en tolerance test conduct fasting type mellitus T2DM patient difference glycemic response conduct examine effect response day T2DM patient conduct T2DM patient week treatment profile measured compare baseline treatment significant reduce insulin significant decrease compare insulin level significant increased also significant increased level reduce level significant level compare baseline treatment improve response T2DM patient
27183782 en great group cell cell first found glucose insulin control well cell new target treatment type
26488176 en study aim relationship syndrome gestational mellitus health research database use study use diagnosis blood test diagnosis woman diagnose year age diagnose mellitus woman previous diagnosis woman without odd ratio or risk logistic regression analysis status woman diagnosis occur among woman history compare without vs logistic regression analysis revealed associate adjust or among patient use medication treat oral significant difference development medication medication use reduce risk adjust or history significant independent risk factor development medication use reduce risk woman follow weight control complication due
26051417 en incidence increasing study demonstrated within gene can associate type mellitus study conduct association T2DM population study included patient diabetic base health healthy control blood use logistic regression compare odd ratio risk develop T2DM without age significant high diabetic subject compare normal subject significant CI increased risk T2DM three type age BMI significant CI risk T2DM two significant association fasting insulin value decrease level gene T2DM addition may role development cardiovascular disease metabolic syndrome insulin level
27461213 en patient type mellitus T2DM improve glycemic control profile related mechanism adverse event reported patient include recent report investigate characteristic include potential trial include patient reported similar patient vs vs respective common event patient result patient lower observed vs trial overall population vs less patient vs finding analysis indicate lead increased risk potential event among patient T2DM include patient outcome study provide
22721433 en base mellitus method study aim type diabetic patient time intervention group undergo group control datum one three month intervention range score test score poor assess use DM effective evaluate base increasing number participant level group show increasing number participant level score significant improve test score significant improve increasing number participant DM effective improve diabetic patient need impact
25316228 en association study group new gestational mellitus analysis adverse outcome study datum study evaluate diagnosis large study conduct review medical total woman undergo diagnosis first hospital prevalence gestational glucose according different value define datum group incidence adverse outcome related value prevalence gestational glucose respective prevalence vs vs vs vs prevalence significant lower prevalence hypertension also high group normal group prevalence high result indicate woman identify related significant lower risk multiple adverse outcome finding provide
24450389 en gestational mellitus first important health adverse outcome type treatment care follow-up however remain investigate care diagnosis treatment follow-up database identify study subject study test correlation health care health system characteristic study indicate woman change health treatment little known health system factor improve on number related health care characteristic identify study woman healthy lower health care health system related identify study identify care high
21923457 en assess effective high insulin patient type mellitus cohort management adult poor control type insulin resistance therapy large insulin clinical datum medical system insulin resistance define insulin primary outcome change hemoglobin type insulin high insulin outcome change number insulin insulin body weight use insulin patient reduction mean number decrease insulin use insulin change body weight change insulin statistical significant vs patient insulin study severe patient use insulin provide glucose control compare insulin reduce although drug treatment use patient management
21406489 en study investigate effect hemoglobin hba1c body mass index BMI blood pressure trial conduct hospital patient randomize control group intervention group receive include factor metabolic control primary outcome included hba1c BMI week significant decrease hba1c mean value intervention group also significant decrease compare increase addition result demonstrated improve number patient baseline BMI change significant group study finding show may effective hba1c level control
24171882 en aim study determine prevalence metabolic syndrome type mellitus T2DM cholesterol health use metabolic syndrome also three use identify metabolic study type diabetic subject subject age group included study type diabetic chronic metabolic disorder study fasting blood glucose blood lipid assess blood pressure measured prevalence metabolic syndrome found respective use three prevalence high woman age group show compare high prevalence observed observed prevalence metabolic syndrome follow diagnosis show different use
26019384 en disease high patient mellitus DM remain common cause among population significant diabetic associate among diabetic prevalence high range mortality significant high potential use among DM individual however recent clinical trial two study randomize total diabetic use mean follow year trial show lower event rate reduce major cardiovascular event group compare care result trial current use DM individual however study important potential negative result
25513744 en insulin function use aim assess association insulin function blood glucose insulin therapy insulin datum period glycemic control patient control hemoglobin hba1c level less adult less base hba1c level studied use duration blood glucose use patient age year year adult respective blood glucose control control adult respective respective use per day show control control adult control vs vs difference change adult blood glucose use association glycemic control significant group datum show patient control
25307511 en evaluate effect therapy cardiovascular risk function type mellitus diabetic randomize trial participant system week week therapy period primary change plasma rate obtain intervention rate estimate measured plasma rate mean age participant year baseline mean CI rate mean hba1c mean estimate rate mean blood pressure compare therapy therapy significant effect plasma concentration rate reduce estimate rate reduce measured rate reduce therapy plasma concentration type diabetic however rate significant lower
23761589 en study examine rate estimate rate period associate risk factor type mellitus T2DM patient medical T2DM patient rate renal disease use analysis perform determine factor associate function on total patient mean age year female mean rate baseline hemoglobin level duration T2DM associate great function cohort treatment early function patient T2DM
23480340 en evaluate woman gestational mellitus compare change month woman undergo test week study group included woman diagnose undergo month control group included healthy total serum perform concentration woman significant lower woman without among significant lower concentration woman found control concentration group significant increase total concentration found woman history found negative correlate body mass index well weight negative correlate significant decrease level function total negative correlation body mass index indicate total
22309596 en type mellitus T2DM group metabolic disorder include impair insulin insulin obesity T2DM compare subject total body body correlate metabolic increase risk cardiovascular disease patient T2DM poor glycemic control complication hypertension major therapy T2DM low insulin weight reduction include activity major therapy T2DM insulin insulin clinical rate T2DM may important T2DM subject without obesity management group
19805636 en early dysfunction type mellitus study population patient insulin treatment age year year time analysis interval pressure provide index period control age group pressure great patient control significant reduce patient similar change profile control patient on study year show pressure low datum patient type mellitus show significant increase pressure reduce period increase pressure control increase on study year show increase suggest early dysfunction
26104579 en diabetic complication type type lead renal disease therefore early great disease management aim study evaluate level protein type diabetic patient different diabetic assess value early type diabetic patient healthy control included study level evaluate on significant level found diabetic patient compare diabetic patient control subject correlation study revealed significant positive correlate ratio respective serum respective serum respective significant correlate rate respective characteristic analysis level early diagnosis revealed value whereas value finding present study suggest may consider potential early diabetic
26951536 en compare parameter patient mellitus DM healthy control clinical trial included patient type DM healthy perform hemoglobin hba1c level DM case obtain test test test correlation test use statistical mean age DM year mean age healthy year age mean mean lower mean DM case statistical significant significant difference group respective also found significant negative correlation hba1c level DM may parameter cause lower effect may change status consider
27163882 en development complication mellitus DM include diabetic factor include impair study effect known several protein model DM mean protein development DM significant protein decrease increased gene diabetic protein diabetic gene without impact protein development DM follow significant increase normal level gene also found increased diabetic protein found protein gene level effect diabetic observed
21574441 en study included patient aged year chronic mellitus DM examine analysis change included patient change less patient present diabetic development DM patient
21350421 en patient clinical diabetic examine patient group patient control one clinical diabetic evaluate difference first use change dysfunction score change test effective treatment estimate disorder patient mellitus type effective treatment diabetic disorder
22379876 en influence diabetic studied group patient severe diabetic mellitus type disorder range patient group receive therapy diabetic group therapy group patient receive therapy group therapy use status estimate day treatment function result show use drug include patient within function patient mellitus high level day
26631737 en elevated concentration diabetic disease associate increased risk renal disease cardiovascular event mechanism conduct association study independent individual without follow study known association ratio overall sample demonstrated effect individual without change per use diabetic control show high concentration reduce cell control relative high patient diabetic disease compare control subject identify known influence
17091057 en mellitus disorder may occur age mellitus define present within first week disorder may result mellitus although reported report condition may present report case mellitus present diabetic review condition
22857780 en assess effective treat dysfunction man study conduct randomize man dysfunction receive assess change man duration profile man index function function mean change baseline study index function function score significant improve analysis indicate can less adverse event common reported treatment effective dysfunction man effective early adverse event similar
22549560 en test patient mellitus DM develop cell significant less compare prevalence DM patient positive patient negative retrospective study patient undergo patient patient DM diagnosis medical history oral medication insulin time addition perform previous total case patient status diabetic case patient cohort diabetic time patient negative DM prevalence DM among case range study included diabetic patient total case low positive diabetic consider index patient possible research need DM
26733478 en development diabetic study use assessment outcome therefore aim investigate association different individual assess individual recent diagnose type type baseline cohort study score well association score estimate use multiple regression type high serum associate presence reduce high level weight total ratio associate whereas association observed protein type total show positive association result recent diagnose type association type type study whether may difference type
22354153 en treatment base total cholesterol time cholesterol evaluate concentration change impact cardiovascular risk reduction diabetic patient cohort study use database studied diabetic patient little two patient group according use status follow-up outcome concentration change baseline event mortality follow-up regression model assess outcome concentration decrease patient without disease patient baseline respective use reduce event respective adjust ratio confidence interval CI CI per reduction mortality adjust CI primary CI use effective diabetic patient care clinical trial primary change use cholesterol diabetic patient
19656320 en cause mellitus patient insulin report blood glucose day therapy glucose well control normal month on also insulin patient receive oral important one current reported range lower insulin model well control lower may insulin early intervention effective patient early intervention
21946614 en aim study evaluate patient mellitus show normal function test result use investigate relationship duration glycemic control presence total patient man woman age year duration year included study ratio ratio result compare ratio normal control patient ratio significant high patient control group correlation observed ratio presence diabetic complication glycemic control method patient due age glycemic control presence complication
22538147 en glycemic control may important glycemic control diabetic complication blood glucose may use time retrospective analyzed glycemic time glucose patient type mellitus identify datum time identify time within correlation patient included datum mean time mean time significant patient correlation time general regard value
22214722 en study aim investigate relationship parameter rate patient mellitus type include blood plasma rate examine patient mellitus type control subject undergo rate interval time parameter datum perform use significant increase patient control found within range rate diabetic patient decrease total low mean increase low ratio patient mellitus type increased blood associate reduce
22185022 en addition prevalence metabolic syndrome type mellitus role insulin resistance glucose development complication metabolic syndrome mellitus present evidence clinical trial treatment metabolic syndrome mellitus cardiovascular complication diabetic demonstrated positive effect insulin resistance body mass obesity lipid cell blood pressure diabetic complication improve cardiovascular system condition duration
21778617 en type mellitus T2DM adverse health cause complication respective recent clinical study show disorder related multiple clinical study show risk T2DM patient increased although patient risk T2DM patient also increased assess risk finding suggest T2DM mass reduction need assess risk T2DM patient related well may show DM important assess risk T2DM patient evaluate history use respective
21765850 en early one month age diabetic cell mellitus within month development may occur diabetic analyzed identify group according according profile activity develop revealed tolerance response
21672313 en study examine cell blood patient without mellitus DM clinical significant high among diabetic patient cell blood significant increased diabetic patient compare patient may due general high diabetic patient cell blood cell patient without DM significant increased compare level diabetic patient healthy control cell blood potential
21220623 en examine relationship diabetic type type mellitus new undergo follow-up obtain baseline determine examine incidence mean mean correlate analysis estimate show large significant associate characteristic adjust baseline clinical risk factor significant association baseline present also baseline characteristic independent early characteristic type mellitus
22792745 en cell patient mellitus type aim study evaluate dysfunction patient mellitus type measured plasma activity factor plasma activity significant elevated index group compare patient hypertension control correlation day activity dysfunction revealed well
21142408 en need several oral drug study evaluate relationship type mellitus patient undergo study use type mellitus patient undergo treat high define on total patient treatment remain patient drug significant high patient treatment compare patient without treatment vs adjust vs adjust use associate increased risk high or CI CI treatment associate decrease type mellitus patient therapy undergo
21094815 en mellitus major complication renal study demonstrated factor associate mellitus investigate association renal use gene among diabetic subject patient patient show high value body weight body mass index BMI group however significant association observed incidence age follow-up duration BMI type
26754041 en insulin resistance associate among mellitus determine effect insulin whether analysis included participant study baseline study estimate use hba1c fasting serum regression analysis perform assess effect ratio type determined use regression within type association type statistical evidence effect score group type type analysis negative association type type association include effect
23338579 en research aim evaluate care mellitus health datum type type may analysis result relationship patient
27449710 en on number type identify metabolic syndrome known datum prevalence aim study estimate prevalence assess association mellitus presence complication define obesity hypertension multiple logistic regression analysis perform identify association present show significant disease diabetic syndrome also disease increased increased independent glucose control patient metabolic control hba1c show significant less disease independent important risk factor develop therefore patient identify development study need effect insulin resistance patient
20480725 en evaluate factor influence mellitus risk care status history type status independent great risk weight status history type may clinical
20408439 en type cell number patient on decrease cell addition cell cell characteristic finding type revealed high blood glucose level normal hemoglobin serum disease factor associate type hba1c lower disease indicate new hba1c association study type medical type type disease
19248096 en disease type mellitus DM reported individual study association investigate population level study patient diagnose control subject population subject test presence factor history obtain medical review prevalence type DM type DM compare patient control subject presence risk DM associate increased risk odd ratio or confidence interval CI association or CI presence risk patient type DM or CI association type DM association type DM risk develop patient type DM may presence suggest risk factor may common disease
19563681 en study suggest renal disease incidence mortality rate among patient chronic disease age association mellitus hypertension adult well use determine association risk factor age year define estimate rate ratio adult year age prevalence ratio confidence interval associate hypertension respective prevalence ratio confidence interval respective diagnose mellitus respective mellitus prevalence ratio associate hypertension diagnose mellitus lower old age adult mellitus hypertension associate age however association age
19421971 en one common disease new case reported diabetic year disease high prevalence treatment disease current medical therapy cause type mellitus glucose occur within several week weight early datum patient impair glucose tolerance effective treatment primary therapy type mellitus remain medical review glucose well research mechanism may one day important management type mellitus
21029887 en compare patient mellitus subject without case response factor measured diabetic patient subject use response pressure also measured difference determined use analysis diabetic parameter also diabetic patient subject evaluate significant great diabetic patient mean difference confidence interval CI significant difference group mean difference CI mean difference CI correlate blood glucose concentration CI CI multiple regression analysis effect blood glucose concentration reduce age significant diabetic patient may related blood glucose concentration study effect poor glucose control diabetic patient response
20303129 en associate high independent cardiovascular risk factor common lipid mellitus DM investigate association DM study subject woman metabolic healthy control DM subject association DM odd ratio or parameter fasting glucose lipid profile measured high lower cholesterol healthy control DM patient age body mass index associate increased risk DM or confidence interval CI fasting cholesterol little significant increased risk DM CI CI respective DM patient show positive correlation fasting glucose significant correlation observed healthy woman regard found study population test may contribute increased DM woman addition positive correlation fasting glucose DM patient may risk cardiovascular disease
19838876 en study show mortality diabetic individual compare general population datum assess cardiovascular mortality patient type type compare general population patient type type man follow year patient increased mortality compare general population CI mortality ratio high type compare type diabetic patient vs cardiovascular CI according type cardiovascular mortality significant high woman compare man type type type significant decrease two type type increased mortality compare general population mortality high type compare type woman compare man type decrease two
20724017 en on number patient high day high day insulin management treat patient high insulin without insulin on patient diagnosis therapy improve outcome patient provide review diagnosis management patient review insulin insulin resistance insulin diagnosis clinical patient general management condition
21924513 en case control study aim investigate relationship body mass index BMI insulin type T2DM healthy control T2DM patient clinical datum participant reported serum level fasting blood glucose blood glucose lipid measured method insulin level insulin significant high significant lower patient control insulin resistance found patient show positive correlation control negative correlation BMI patient positive correlation found insulin model assessment insulin resistance patient result may important mechanism T2DM patient
19390093 en large provide case management patient chronic condition lower care examine effective intervention clinical management old medical patient patient on randomize control trial conduct compare case management care outcome aged year medical new intervention case management care outcome primary assess year follow-up hemoglobin low cholesterol blood pressure level result model show overall reduction year follow-up primary blood pressure estimate difference CI year cholesterol blood pressure intervention group care group ratio case management result blood pressure level year medical mortality different group although trial
18424578 en study prevalence risk factor can interval diagnose can patient study conduct among patient diabetic prevalence can among patient type type mellitus assess function test can score patient relationship interval possible influence age duration can also prevalence can analysis show significant association can high age odd ratio or or duration disease year or patient type significant risk can among patient type or or high age or disease duration year or analysis show independent risk analysis disease duration year result significant case type type positive value diagnosis can type type respective high can score correlate interval correlation prevalence can mellitus high high age duration significant risk factor interval use diagnose can positive value
25295795 en assess impact weight change use treatment among patient type mellitus retrospective T2DM patient included insulin datum clinical datum patient cohort base relative change body weight three cohort weight decrease weight change weight increase difference treatment evaluate use statistical model adjust baseline total patient weight weight weight included mean age year woman baseline weight cohort significant lower per year compare cohort lower medical reduce weight reduction associate lower respective patient weight less therapy weight associate significant increase per year compare cohort however difference rate among patient T2DM associate decrease lower rate treatment treatment reduce patient T2DM
24859808 en present study evaluate insulin insulin insulin oral drug patient type mellitus T2DM patient examine base function patient T2DM treat insulin insulin week two group according function group on ratio whereas group ratio week insulin significant decrease fasting blood glucose blood glucose hba1c observed two group effective rate respective on reduction insulin group decrease group on observed group decrease hba1c group on large number patient group compare group on difference incidence change body weight observed insulin patient T2DM demonstrated improve blood glucose control reduce insulin result revealed patient T2DM insulin patient T2DM increased level
26954355 en different study result regard association mellitus analysis base sample association mellitus use analysis participant without previous diagnose included diagnose use oral glucose tolerance test cohort included current glucose concentration significant lower fasting current vs vs respective age status activity history logistic regression revealed significant negative association normal weight BMI adjust odd ratio obesity compare current less elevated less elevated among normal weight significant association metabolic disorder among normal weight lower among lower
25414152 en evaluate whether treatment gestational mellitus health include lower study age woman trial treatment treatment weight blood pressure fasting glucose fasting insulin cholesterol baseline characteristic similar follow-up treat group BMI significant different treat association observed BMI score cholesterol blood pressure insulin resistance effect treatment different fasting glucose respective year outcome female treat woman significant lower fasting glucose treatment associate reduction obesity metabolic dysfunction treat woman found however female woman treat lower fasting glucose
21913493 en prevalence chronic disease increasing rate one control complication disease disease disease diabetic patient cause mortality increasing large increase develop great develop well develop medication may reduce prevalence oral important role management oral drug effect also effect may important role case use may reduce mortality due complication related
17989836 en although type mellitus also population different obtain mean review database addition subject mechanism clinical treatment age group type mellitus type mellitus disease disease associate drug related primary mechanism present treatment metabolic control complication
23506375 en risk important factor management type type T2DM mellitus common incidence high T2DM patient use insulin patient duration cause response glucose level dysfunction also cause normal response reduction insulin T2DM increase T2DM increase also cause syndrome glucose increase also large glucose result glycemic response result without increase risk severe associate mortality effect severe cause may include adverse cardiovascular outcome reduce impact important identify patient risk use medication new insulin insulin therapy cause insulin may reduce risk
26459271 en study aim evaluate whether intervention woman gestational mellitus gestational weight month analysis woman without hospital participant datum intervention condition medical individual medical level statistical woman diagnose receive intervention time gestational week woman intervention low BMI increase woman without intervention vs woman vs group significant lower risk vs low weight vs vs group include factor analysis woman without intervention high risk CI woman intervention high risk low weight or CI however woman intervention low rate intervention weight improve outcome woman
20712864 en also show also use also result base activity great increased case elevated level identify cause disease clinical show diabetic common chronic complication mellitus whether level base patient study compare plasma base level healthy diabetic individual level high diabetic group whereas significant different plasma level lower diabetic group on show primary present result suggest plasma elevated level diabetic patient also contribute diabetic complication
23511759 en effect insulin therapy major type mellitus DM datum subject population perform study prevalence patient type DM evaluate related study included patient aged diagnose type DM little month hospital hospital patient patient compare without old year vs year duration year vs year high body mass index vs vs blood pressure vs analysis show independent association duration or CI level or CI or CI hypertension or CI one patient type DM presence associate duration concentration hypertension
23684449 en impair type mellitus T2DM mechanism aim study investigate role response patient response test assess man woman parameter mean assess index perform significant decrease compare control condition however overall evaluate significant improve compare response suggest diabetic patient reduce
21424210 en evidence indicate diabetic individual may increased risk several however relationship risk remain provide assessment relationship identify study relative risk confidence interval study cohort study found associate increased risk compare CI significant among study positive association also found risk significant finding increased risk
24547967 en change normal response insulin resistance therefore gestational mellitus may cause system study examine role cell development use analysis total protein different high compare healthy within total cell different patient however activity total significant reduce patient total decrease significant patient patient increased significant patient increased significant patient finding parameter related development function may cause reduction total patient however analysis result
25101985 en whether high body mass index BMI effect diabetic type mellitus DM patient chronic disease remain study aim investigate relationship BMI renal function type DM patient total type DM patient study patient group according BMI follow normal group BMI group BMI group BMI primary serum level measured interval baseline value need regression analysis method increase BMI lead increase estimate rate confidence interval CI study period regression analysis show compare group normal BMI group ratio CI primary outcome adjust study show BMI factor renal function type DM patient
24845558 en type mellitus disease factor however mechanism development remain large body evidence important role review datum influence level status risk development model also current regard level status factor among result reduce level
20668832 en investigate effect renal function cardiovascular outcome patient intervention event year renal status examine clinical characteristic outcome included total cardiovascular disease estimate vs risk factor total event CI adjust characteristic increased risk increasing total respective risk renal status change first year analysis effect effect ratio low elevated blood independent risk factor cardiovascular event mortality rate population independent risk risk factor consider remain clinical risk related number characteristic therefore consider assess treatment patient included risk model
27858842 en factor found associate risk gestational mellitus however association study provide result aim review relationship risk
22145456 en type recent identify new found adult aim study investigate well clinical characteristic type among type patient new diagnose type year included patient three hospital patient two female patient type negative patient type old age lower hba1c patient type addition patient type increased serum level decrease fasting serum level type among patient new diagnose type age although type common disease possible type may common
21519740 en effect overall cardiovascular risk factor well known however whether reduce incidence type evaluate effect risk develop type mellitus large cohort follow participant year assess baseline previous outcome type diagnose review medical report odd ratio type use low assess use logistic regression baseline mean age year BMI two new case mellitus diagnose follow-up adjust odd ratio high vs low CI found association incidence type association can number observed case study follow-up high baseline risk need evaluate association
18039190 en investigate serum concentration protein patient type mellitus female age healthy subject concentration determined use result show serum concentration patient type mellitus statistical significant high compare control group healthy subject body mass index BMI correlate significant serum concentration patient type mellitus statistical significant positive correlation also found ratio serum concentration patient type mellitus elevated serum concentration patient type mellitus cause presence chronic patient possible determined increase concentration system patient type mellitus association serum level type mellitus remain
22124957 en treatment diabetic primary care patient perform system aim early potential complication chronic disease case management case management mean important clinical parameter patient interval mean treatment also large development development similar chronic disease
23729552 en different change glucose patient syndrome treatment result patient syndrome develop on syndrome follow-up diagnose syndrome year old therapy month treatment age therapy on observed treatment period hospital age year therapy time weight blood glucose insulin hba1c age receive therapy year weight revealed fasting blood glucose fasting insulin hba1c primary insulin therapy diagnosis type insulin therapy oral therapy year normal level insulin therapy month hba1c treatment therapy blood glucose profile impair therapy observed obesity cause type patient oral change may develop patient
23024256 en type may diabetic control investigate type diabetic control assess hba1c among individual compare aged two hospital type care hba1c result use assess diabetic per patient high mean hba1c value control associate study health association management improve diabetic control
20677607 en patient mellitus time increased risk cardiovascular disease patient however risk cardiovascular risk factor hypertension obesity also associate identify independent risk factor cardiovascular disease associate cardiovascular risk factor study hospital medical medical on total patient patient patient disease patient disease patient control disease found significant high patient control significant high diabetic patient disease patient disease
26680319 en incidence mellitus rate health therefore diagnose important management hemoglobin hba1c mean diagnose use use hba1c diagnose review use
25200659 en cardiovascular mortality rate increased type poor cohort analyzed study patient health follow-up study man health study woman serum mortality man ratio CI per woman first report high increased mortality man woman type study mechanism influence mortality
23299036 en study history rate population old patient aged year type mellitus
19267355 en type mellitus insulin cause treat disease one effect intervention cause recent show effect cell model also recent possible type result model lead clinical trial patient type result review on analysis adult study revealed significant insulin effect patient high treatment glycemic control treat patient treat patient study year medical patient cause treatment type insulin disease
26207051 en obesity gestational mellitus increase age status risk metabolic syndrome mechanism poor health risk metabolic disease model obesity impact effect metabolic system change result suggest gestational health risk whether change disease risk control study identify intervention need healthy
20723099 en aim study impact care study female mean age range mean duration range patient medical intervention effect evaluate month positive effect observed clinical status reduction number increased blood glucose mean hba1c reduce change mean change however little effect study care
23108748 en study aim possible relationship level protein mellitus type patient disease individual
23067919 en diabetic patient disease remain randomize trial trial compare intervention diabetic patient medical total diabetic participant randomize trial mean follow-up year year relative reduction present baseline characteristic patient randomize provide trial diabetic randomize cohort year old female duration year disease medication insulin therapy hypertension mean hemoglobin mean blood pressure mean score trial participant baseline characteristic similar trial trial diabetic cohort follow-up include risk factor control contribute significant diabetic patient
21877209 en type mellitus management population study first decrease health population patient group conduct hba1c hba1c type DM well disease effect treatment common group included finding provide assess level control suggest change need care identify need provide care population
22074122 en evaluate effect compare duration patient type total aged year hypertension type treat week according group week treatment blood pressure plasma significant reduce blood pressure blood pressure value vs vs respective statistical difference two drug significant reduce interval week week vs well similar effect reduce duration related mechanism diabetic patient
23140079 en evidence high rate type investigate prevalence risk factor among patient treat health new database patient aged year treat conduct retrospective review patient patient diagnosis compare compare group diabetic patient significant found high prevalence type among patient population studied found characteristic compare group finding among patient response finding include health clinical group develop control among
25349017 en control trial whether improve outcome gestational mellitus diagnose association study group test effective care outcome woman without range gestational week receive care group receive individual group perform blood glucose compare one group outcome define weight hypertension group similar gestational week weight group lower group vs rate group compare group relative risk CI rate compare score lower high use system improve outcome woman
26603531 en plasma risk factor development complication assess study use control complication trial intervention complication cohort subject type level plasma activity measured plasma subject type year common measured year plasma level positive significant associate BMI hemoglobin blood pressure total cholesterol cholesterol age duration cholesterol statistical model risk factor demonstrated positive association plasma analysis use general model show plasma significant associate value addition mean level high subject plasma level high compare subject plasma level lower finding plasma risk factor disease type
26558681 en disease remain major complication new target study investigate role protein protein target development control use low model decrease plasma insulin insulin resistance well major dysfunction associate protein remain show improve analysis lipid increased level body also lipid result lipid metabolic change well dysfunction result new potential target dysfunction
23245808 en type mellitus consider one important chronic significant number severe complication elevated index mortality several insulin resistance relative factor major development obesity correlate development resistance metabolic response may role may relationship resistance insulin may complication review association increased level associate chronic condition
25579434 en datum regard effect type mellitus T2DM review aim current datum randomize control trial conduct assess effect diabetic included obtain related study database study study conduct type DM woman outcome fasting blood hemoglobin hba1c according effect model use included also study due severe study can datum show significant effect mean difference confidence interval CI effect hba1c CI effect respective also effect hba1c study positive effect reduction diabetic however due evidence number use
25177708 en compare patient type mellitus DM healthy control investigate association patient type DM control included lipid DM individual undergo mean age score significant DM control group lipid significant lower DM group also reduce DM group associate total score DM group significant reduce lipid relative control group negative correlation parameter total score suggest occur diabetic
27514509 en one model type mellitus change activity important study investigate major obtain type sample mass system study metabolic three determine activity metabolic compare normal control estimate lower estimate high significant difference metabolic datum suggest activity decrease activity increased
25475973 en study gestational due clinical aim determine current new diagnosis lower level investigate management woman clinical response rate clinical lower glucose tolerance value diagnosis fasting datum use revealed significant increase woman diagnose clinical management similar increase prevalence major health care
16898084 en clinical diagnosis mellitus base blood glucose level day disease analysis gene gene insulin important result type mellitus adult disease population type present type
19602103 en disease disorder associate mellitus study diabetic correlate protein present study investigate association mellitus oral test evaluate status insulin patient different investigate influence insulin found difference group patient large group control individual assess however insulin significant reduce high compare cell datum indicate insulin within range normal found adult influence insulin increased risk among patient although result glucose tolerance patient patient also model regard
21235455 en mechanism cause effect mellitus reduce cause increased decrease decrease concentration reduce result important decrease cell therefore lead reduce major effect consider improve cause decrease therefore treatment base mechanism treatment
26067361 en need associate insulin resistance lipid study aim investigate role gestational mellitus study included three woman normal glucose tolerance three type mellitus measured study gene great woman mean lower compare significant group compare woman protein level found lower woman vs woman relative decrease impair decrease
24423035 en diagnosis gestational mellitus base review evidence regard identify test evaluate assess effect different outcome determine treatment diagnosis database may include control trial group trial independent conduct study assessment one datum datum included randomize control trial retrospective cohort study compare test test woman woman group receive treatment treatment treatment conduct analysis study outcome included weight metabolic outcome identify included study randomize control trial cohort study retrospective cohort study prevalence study association datum group health diagnosis little evidence remain oral glucose test glucose improve reduce high negative value positive value range prevalence evidence diagnose less week three study one study compare association study group two study examine effect health outcome one retrospective cohort study show group on within cohort study found incidence group group study examine health outcome woman different undergo treatment study show positive relationship increasing glucose level incidence primary one study also found significant case clinical woman without compare among study case observed woman woman positive weight show difference study show difference woman health impair glucose tolerance woman without woman diagnose base datum group compare woman without case group without compare oral glucose tolerance test datum group datum group positive health impair glucose tolerance case found among patient group without compare obesity patient group study compare glucose insulin need treatment evidence show case treat group evidence weight evidence found less treatment low evidence show difference treat evidence show treatment reduction evidence metabolic outcome among study provide datum difference found gestational age care significant among evidence positive association increasing plasma glucose oral glucose tolerance test primary increased risk found oral glucose test high treatment result less current evidence show treatment effect poor metabolic outcome little evidence increased research need metabolic outcome result treatment effect treatment use care
22996090 en estimate incidence gestational mellitus according association study group complication woman consider diabetic according association estimate rate according conduct review compare outcome woman according association group woman according group result odd ratio or adjust or confidence interval CI study statistical difference large gestational age level rate use CI group present similar rate compare adjust or CI complication compare or CI compare adjust or CI compare or CI complication compare or CI metabolic complication compare or CI compare group association consider according similar outcome woman without randomize study analysis need
24101400 en increased cardiovascular risk type mellitus result disorder system include impair aim study blood individual disease study included individual among patient group individual group mellitus control group blood analyzed level protein concentration determined mean assess high control mean significant compare individual group however significant high group on related fasting concentration glucose concentration protein significant difference observed regard although significant relationship clinical different associate concentration high blood individual fasting glucose concentration concentration one
24054927 en man well known high risk woman cardiovascular disease recent year however study show adult man also high risk type important clinical health datum examine potential mechanism include change insulin resistance role clinical
22977863 en type mellitus determined disease week lead development body weight mellitus
22977857 en hemoglobin studied type mellitus increased significant disease year hemoglobin significant remain change hemoglobin hemoglobin studied hemoglobin increased significant patient history type mellitus significant correlation cholesterol found clinical parameter positive correlate measured
22854241 en present case type mellitus diagnose base however patient hospital treatment revealed high level blood glucose glucose level normal normal revealed
22795925 en glucose clinical development treatment patient type mellitus primary evaluate profile therapy patient T2DM on evaluate effect patient T2DM therapy randomize receive day profile include event adverse event assess study determined plasma mean ratio CI plasma concentration day day assess glucose observed group patient observed group patient reported patient receive patient receive event blood glucose level per observed mean ratio CI CI respective treatment day significant high group baseline treatment day well patient without addition therapy result clinical change
22750288 en study relationship diabetic study revealed diabetic significant high time target compare control group serum level high control group positive correlate level serum glucose blood group level significant increased whereas significant decrease cell study show significant increased increased whereas decrease datum suggest possible dysfunction associate mellitus may level
22525877 en on method develop insulin plasma on rate within concentration range relative insulin plasma less respective insulin respective also determine parameter insulin mellitus patient
22400810 en on potential lipid profile found patient type mellitus T2DM include increased concentration decrease concentration lower cholesterol level concentration evaluate baseline week use datum randomize study include patient T2DM treat increased week significant reduce increased level compare decrease concentration concentration decrease confidence interval CI whereas large decrease CI total mean plasma concentration decrease CI compare large concentration large increased CI whereas concentration decrease CI patient T2DM profile potential less reduce concentration increased large plasma concentration
22282049 en associate increased cardiovascular risk on low improve cardiovascular risk profile patient type mellitus T2DM metabolic profile function however effect aim study therefore assess effect month follow-up T2DM patient included patient T2DM mean age year BMI measured use follow-up without intervention on reduce body weight baseline value respective month follow-up reduction body weight respective baseline value weight T2DM patient decrease weight
25316147 en common medical cause therefore increase insulin well known therapy treatment base therapy new develop treatment well review aim addition therapy use treatment therapy
25133192 en two effect study reported level correlate decrease rate increased therefore evaluate level renal patient without T2DM serum level measured subject without T2DM analysis group subject presence found serum level significant high patient subject without however statistical difference diabetic patient without subject serum level also high individual subject without serum level show significant difference diabetic patient subject without serum level lower patient T2DM individual without T2DM datum T2DM renal correlate serum level however serum level show significant difference individual renal without renal
25097860 en study relationship hemoglobin type mellitus T2DM patient patient known disease undergo measured time blood blood analysis patient significant lower patient significant correlation however known relationship significant use value normal significant increased risk adjust odd ratio CI glycemic control associate determined T2DM patient risk
24637304 en incidence type mellitus factor although factor study need factor reported study aim define incidence prevalence characteristic year one study included patient aged year diagnose hospital hospital patient review general population datum year age group also total patient female incidence respective prevalence year respective patient present year age group month first study incidence prevalence found show increase year incidence prevalence high female case found
23349368 en whether mellitus DM adverse factor chronic total reduce observed mean day total cardiovascular mortality potential total patient DM group patient DM receive therapy great DM associate adjust risk total cardiovascular mortality association outcome patient similar management DM remain major adverse
19283352 en prevalence adult estimate poor glucose control presence complication diabetic diabetic common regard risk factor mortality determine renal cardiovascular complication glycemic control due change treatment effect patient general evidence glycemic base datum clinical trial according range plasma glucose
25002067 en woman previous gestational group development metabolic syndrome cardiovascular disease new association study group significant increase number woman diagnose metabolic outcome woman determine prevalence metabolic syndrome use adult treatment insulin resistance use woman previous use cohort woman two woman previous value population mean age year woman compare control group woman mean age year known normal glucose tolerance period on total woman previous metabolic syndrome compare woman vs year prevalence high woman previous vs woman previous great prevalence metabolic syndrome compare woman intervention period
23424763 en determine outcome year patient associate study group patient without complication month patient included study duration year week observed decrease year decrease due diabetic decrease patient due diabetic
22115011 en effective cholesterol risk profile remain determined concentration patient type elevated cardiovascular risk randomize study investigate effect concentration plasma patient type patient randomize patient study total cholesterol respective reduce concentration whereas reduce respective respective however reduce concentration patient type
24349098 en recent study protein obesity type aim determine whether concentration patient gestational mellitus compare normal glucose tolerance control investigate relationship metabolic parameter study woman control hospital plasma level factor insulin determined woman high lower subject difference found level low subject insulin index correlate positive BMI insulin glucose fasting blood cell negative adjust gestational age correlate correlation correlation blood pressure significant correlation analysis regression analysis independent negative level correlate significant may also correlate independent insulin resistance indicate potential role
25719588 en associate risk factor diabetic among type mellitus study conduct among aged year diabetic may medical use include clinical participant one compare hemoglobin hba1c mean difference found among hba1c similar insulin high insulin major follow among insulin treatment reported reported regression analysis revealed high hba1c level presence independent risk factor significant great high hba1c level insulin treatment control risk factor patient
25511640 en aim case study examine insulin treatment patient type mellitus glucose perform type baseline datum day day day day blood plasma glucose serum plasma total total result glycemic control day three patient total different medication patient suggest difference response may effect
22460500 en study relationship health system mellitus regard use treatment population health current health model role mellitus need include
22432726 en on use management mellitus develop characteristic studied use well profile also assess result show low due addition contribute significant three test time without time result show less drug management mellitus
21644010 en use hba1c control patient mellitus high level remain blood study hba1c compare evaluate whether control patient study included patient age diagnosis day insulin therapy patient level hba1c measured month plasma glucose use blood glucose elevated respective hba1c within normal diagnosis treatment decrease age whereas hba1c increased positive correlate hba1c show correlation significant correlate control patient whereas hba1c influence change control
21574908 en investigate level evaluate relationship mellitus DM study included man healthy subject mean age year subject without DM year DM patient year plasma concentration total determined cell measured concentration significant lower DM group healthy group show among healthy DM group difference significant negative correlate blood glucose positive correlate negative correlate DM logistic multiple regression analysis revealed age ratio potential risk factor level may potential risk factor DM man
18690594 en mellitus DM renal show associate lower patient disease presence DM associate whereas patient mean age year woman DM DM without DM undergo analyzed different use score well patient DM patient mean total high compare vs vs respective however rate little one significant lower patient compare control vs respective whereas patient control vs rate control patient DM respective previous DM associate high present presence however associate lower compare presence DM patient
22187345 en plasma protein reduce patient obesity type increase level improve insulin study investigate association type two gene investigate whether response patient type participant patient type patient treat week compare parameter two group fasting blood significant individual different treatment mean decrease ratio treatment also significant individual different control patient patient control patient significant different patient control group gene may important type population however significant associate response sample
26813668 en examine association age risk gestational mellitus cohort study woman health study adjust risk ratio age year CI respective analysis effect indicate association finding early significant associate increased risk association large body
26694998 en compare incidence woman diagnose gestational mellitus early evaluate associate total woman care week diagnose week early diagnose week normal test incidence compare factor associate outcome group baseline characteristic group weight great less glycemic control incidence complication include significant different group logistic regression analysis demonstrated diagnosis significant associate less gestational weight decrease risk adjust odd ratio or confidence interval CI gestational weight great risk adjust or CI glycemic control also reduce risk adjust or CI weight glycemic control diagnosis independent associate woman woman diagnose early similar rate woman diagnose
24469558 en hemoglobin use diagnose glucose blood subject several blood glucose patient diabetic hba1c value
23677380 en patient chronic disease mellitus DM increased risk event compare one whether change among DM studied patient undergo intervention function test perform assess use system high define patient group presence DM among without DM DM DM mean level respective prevalence respective association DM odd associate DM remain significant or CI presence DM impact compare condition whether may improve outcome among patient
23988079 en estimate rate clinical assessment method develop function assess method patient determined renal also estimate analysis indicate estimate two method group patient however difference estimate great two estimate indicate great patient difference estimate significant lower estimate significant high estimate indicate estimate provide great patient mellitus provide group patient however estimate great high indicate determined renal
23937662 en use define normal function large cohort healthy evaluate patient type perform healthy year age patient year age duration disease year participant undergo three relative increase blood total relative response determined addition time first healthy control independent age value per parameter datum healthy control use lower define normal function diabetic patient show significant reduce response whereas response cohort patient compare control significant high impair response response one parameter significant high dysfunction present type diabetic patient type little one year study need assess value dysfunction development cardiovascular patient
23896839 en investigate effect three group control diabetic diabetic treat according time day glucose level receive group evaluate level blood sample reduction cell increased group day compare group day group also show high concentration group diabetic
22749805 en major individual mellitus DM major function protein hemoglobin previous demonstrated DM renal cell primary study determine cell assess potential demonstrated cell DM use perform analysis demonstrated associate lipid DM result significant decrease renal may major role development diabetic may target renal disease
22990153 en study use health patient care mellitus datum use result show use within group use use within group patient regard group use care individual mellitus
22405830 en gene therapy use insulin potential provide low treatment method mellitus on cell primary well gene on gene gene cell include cell insulin use insulin cell insulin insulin positive cell insulin present cell insulin assessment presence insulin present study provide cell insulin gene can develop provide mellitus treatment provide insulin well current treatment
22435941 en assess effect intervention trial investigate relationship overall mortality observed among case study follow-up study type diabetic analysis factor number lead three healthy type type type relationship overall mortality investigate although statistical significant lower overall mortality healthy type overall mortality analyzed age mortality rate type healthy type high type high mortality rate reported type lower mortality rate reported healthy type ratio regression analysis type healthy type CI increased lower mortality overall mortality significant decrease type increased lead poor type diabetic patient healthy type similar hypertension improve
23515667 en increase type obesity develop factor evidence suggest adverse associate increased risk disease adult disease gestational mellitus present associate increased mortality also increased risk obesity metabolic cardiovascular disease evidence suggest similar lead change important influence function important early development adverse factor period may important adult disease adult on primary define outcome also health status
21514559 en study evaluate intervention increasing rate follow-up woman gestational mellitus retrospective cohort study patient conduct primary outcome obtain cohort obtain cohort receive week statistical test cohort compare cohort increased rate decrease follow-up development type increase need obtain
24768206 en increased reduce may contribute development reduce cause related weight woman complication control group gene analysis weight significant high group vs control index group lower control significant use found significant decrease increased role significant compare control result gene may little
22002004 en determine profile disease type datum diabetic patient studied type diabetic mean age year female patient mean duration year patient patient positive patient positive patient positive patient known case perform two patient one result normal whereas demonstrated change group whereas patient addition prevalence present study type diabetic population high compare study first time population similar regard role important factor development
22020667 en recent identify however role remain aim present study investigate plasma level association plasma level metabolic parameter subject new diagnose type mellitus subject impair glucose tolerance subject normal glucose tolerance study plasma level measured level elevated subject compare control vs regression analysis show subject plasma correlate positive body mass index BMI hemoglobin hba1c fasting blood glucose blood glucose glucose fasting plasma insulin model assessment insulin resistance logistic regression analysis revealed plasma significant associate difference concentration found elevated subject related several clinical parameter known associate insulin resistance
21812894 en obesity type mellitus T2DM factor increasing prevalence study factor treatment important increasing although obesity associate change metabolic function remain review development adult change response factor influence study use model aim finding obesity T2DM
22838102 en new association study group increase prevalence gestational mellitus important system on analysis estimate gestational mellitus use new activity identify database group treatment care care care individual value use datum total estimate CI per case CI total per case treat CI research determine effective
22348857 en evaluate prevalence type review clinical type follow-up hospital year aged year type also prevalence time great prevalence general population occur type general population
21195376 en patient type mellitus T2DM dysfunction identify examine correlate response patient T2DM dysfunction healthy patient T2DM man year use early rate baseline index define clinical metabolic datum dysfunction baseline independent associate weight odd ratio or hemoglobin or group impair response independent associate reduce or index or dysfunction identify remain subject finding associate or lower rate or metabolic control metabolic patient T2DM associate dysfunction response association response factor include rate suggest potential role patient diabetic disease
22815030 en mellitus DM define DM first month type DM disorder development mass function DM case cause protein respective insulin insulin therapy report three case DM two patient blood glucose profile patient DM undergo patient gene oral consider
21852675 en study obesity gestational mellitus obesity obesity analyzed primary cell treat insulin glucose factor measured factor protein use potential primary cell compare whereas obesity significant effect analysis metabolic parameter plasma revealed significant increased insulin well increased glucose value group cell identify glucose insulin occur may occur two different whereas high increased concentration
20734138 en evaluate care control clinical parameter fasting patient type study conduct health study conduct participant two group care group control group patient within group patient fasting value fasting care group significant reduce reduction control group time on significant reduction level patient care group increase observed control group follow-up intervention group contribute drug therapy provide patient type mellitus increase treatment reduce drug therapy control
24881568 en medication treatment type mellitus T2DM remain significant need new effective oral improve glycemic control profile regard target recent year show glucose insulin cell also cell current review development clinical datum research potential effective treatment T2DM
21969406 en patient type mellitus glycemic control intervention however regard therapy patient control increased use new incidence type significant health care system conduct analysis determine relative treatment type use study outcome model complication therapy adult type control obtain clinical datum review treatment obtain perform analysis test result associate estimate per relative treatment include estimate compare result patient type control addition therapy
22127492 en compare development profile prevalence disorder type mellitus age range prevalence disorder found respective respective significant associate index cause investigate group due low serum level due disorder associate also disorder common although present group profile two group primary due decrease serum level whereas due increased
25916018 en high possible disease mellitus DM determine DM prevalence rate study conduct within on total drug DM use test statistical analysis perform use test DM vs study subject DM old high high hypertension compare subject without DM DM found also DM occur study demonstrated potential DM therefore important two disease patient change disease develop
20739883 en type mellitus T2DM metabolic syndrome recent finding suggest T2DM less can new association study provide evidence common factor factor factor factor T2DM metabolic presence insulin resistance show patient increased risk develop T2DM indicate insulin resistance new finding patient can also therapy study demonstrated study suggest patient increased risk develop T2DM important clinical study evaluate whether patient T2DM cardiovascular event therapy
20579862 en contribute mellitus therefore test effect activity gene well renal mellitus treat day week decrease activity three vs control vs control vs control treatment activity gene three day control diabetic treat control diabetic treat control diabetic treat study effect renal may related increase activity gene addition system important mechanism result show may consider potential treatment diabetic
26597212 en study aim assess complication among mellitus DM conduct retrospective cohort study patient hospital clinical datum obtain patient case age current age duration DM year outcome renal datum mean duration year year year adjust cardiovascular risk factor remain significant associate respective effect mortality adverse outcome associate observed outcome result may care target group
26384673 en insulin insulin oral patient insulin insulin insulin level randomize trial trial type patient provide hba1c compare insulin although associate less hba1c provide significant lower fasting plasma glucose level significant less compare insulin randomize trial trial type T2DM patient provide hba1c compare common occur adverse event study analysis datum study common occur adverse event T2DM patient however general decrease time addition treatment associate positive outcome insulin effective general treatment T2DM patient may provide insulin
21176489 en study clinical mellitus case clinical review weight case age diagnosis month mean blood glucose diagnosis case mellitus include body weight common clinical finding included case complication blood dysfunction respective insulin test case one case negative hemoglobin increased case insulin treatment case blood glucose blood glucose decrease significant within case develop blood glucose case develop blood glucose well control among case follow case age month insulin diagnosis management may lead blood glucose method cause
20880180 en serum common use recent study indicate level range normal adverse outcome mellitus DM metabolic syndrome aim study define man woman may analyzed large health cohort healthy subject evidence disease baseline level identify develop DM within elevated baseline serum value significant associate development DM odd ratio compare high lower study population on analysis revealed baseline value high among woman among man significant associate increased risk DM level value high associate increased risk DM relative high baseline level DM compare age cholesterol study value high woman man respective may DM suggest value normal healthy lower value individual increased risk DM
22011463 en aim study determine incidence type mellitus female system general population primary datum report statistical patient case incidence rate per per year confidence interval CI statistical significant high among per per year CI female per CI rate ratio CI result regression model show incidence type female decrease time datum demonstrated primary incidence type mellitus population incidence type mellitus female decrease
21805298 en type mellitus review evaluate evidence control clinical trial effective type conduct database without population characteristic outcome consider change fasting blood glucose hba1c clinical trial two control clinical trial three trial compare effect show effective hba1c test effect compare type show effect mean difference CI study compare treatment report significant difference control group evidence suggest effective therapy type current trial
21707174 en study examine relationship outcome datum new diagnose type factor blood sample assess control hba1c month total time month included control positive negative outcome age BMI included control estimate analysis two model test model association value outcome change model examine change time outcome control hba1c associate control outcome change change control change negative outcome regard associate hba1c change negative outcome change hba1c however change result indicate target intervention improve
17346451 en risk relative mellitus also risk relative mellitus risk disease risk factor obesity relative two risk factor high develop mellitus relative one risk develop patient relative can among risk factor risk mellitus significant statistical among high risk mellitus associate age obesity patient relative high risk develop mellitus similar patient suggest different identify risk previous parameter health
21826136 en study relationship mellitus DM adult obtain use oral participant group chronic base patient severe group among subject chronic prevalence type DM impair fasting glucose respective group prevalence type DM compare group prevalence impair fasting glucose group respective logistic regression analysis revealed severe risk factor DM or or logistic regression analysis show independent associate DM or datum revealed prevalence DM high patient individual without consider independent risk factor type DM
25601734 en gestational mellitus study evaluate impact early medical provide datum without estimate first gestational week base model hospital regression model estimate relative risk per range increase concentration adjust study age CI associate increased risk risk estimate remain elevated first associate lower risk risk increased first week associate increased risk increase risk association early time common
25093258 en aim study investigate association serum level patient hypertension mellitus DM on total patient diagnosis DM study patient three group follow diabetic diabetic serum level negative correlate group whereas significant positive correlation serum level index significant negative correlation serum level patient correlation serum serum level investigate individual patient group negative correlation found group respective on significant relationship plasma level parameter found patient DM suggest mechanism development subject impair function may change
25062844 en study evaluate factor protein type mellitus T2DM obesity T2DM whether independent risk factor T2DM population conduct study total subject include T2DM patient control common studied perform gene analysis perform use multiple logistic regression association T2DM cohort found subject body mass index BMI on increased risk develop T2DM analysis present study provide datum suggest effect T2DM subject population
24988213 en hemoglobin hba1c clinical cardiovascular disease cardiovascular mortality however relationship hba1c intervention patient type mellitus DM study assess relationship hba1c patient type studied cohort diabetic patient disease undergo evaluate analysis association hba1c level value within normal respective model high hba1c level associate less risk odd ratio or confidence interval CI high hba1c level associate less risk or CI hba1c associate risk or CI present study provide first evidence high hba1c level associate less risk diabetic patient
24899268 en remain role type mellitus determine randomize clinical trial compare outcome weight T2DM participant include participant aged year body mass index weight weight intervention outcome cohort effective measured weight glycemic potential participant undergo randomize among randomize participant obesity woman mean age year hemoglobin level participant undergo intervention participant current participant undergo rate respective cohort multiple datum participant great mean weight baseline CI compare CI CI T2DM respective group respective group group group significant reduction use occur group adverse event included treat medical group study several potential large treatment T2DM obesity patient body mass index include associate randomize patient vs intervention result show effective treatment follow weight T2DM outcome
18713133 en mellitus medical include weight occur patient poor control mellitus
19646184 en compare clinical characteristic patient type mellitus conduct use database clinical datum diabetic patient year age case clinical patient diagnose T2DM case diagnosis base clinical finding subject three examine age diagnosis patient body mass index T2DM significant high compare risk factor hypertension T2DM patient hypertension control within target hba1c T2DM prevalence lower T2DM age group hypertension less compare T2DM patient occur
19520874 en examine prevalence correlate diagnose among type type mellitus study conduct use hospital database medical datum multiple logistic regression use model difference diagnose related factor analysis conduct type type prevalence type type respective risk factor type included female related complication type risk factor included age related complication insulin use addition significant diagnose compare odd ratio or confidence interval CI analysis revealed evidence association according factor examine finding body regard difference among type high adjust odd diagnose compare may due difference two group
23250459 en prevalence increasing addition patient diagnose current association type base current evidence
22817678 en aim study assess level related care among woman age type mellitus woman aged year related care participant undergo intervention intervention participant care remain participant reported care response rate participant intervention participant reported care increased event statistical significant increase score complication need female patient
25253014 en evaluate function patient type mellitus DM total patient diagnosis DM group case normal control group measured show difference among group however significant lower DM group control group parameter show significant difference among function reduce function patient type mellitus
25176072 en evaluate early patient type mellitus use obtain patient type mellitus normal control subject analysis perform use type diabetic patient decrease compare normal control decrease found diabetic patient patient show reduce decrease multiple reduce type diabetic patient
25052177 en decrease blood glucose level cell diabetic however study show result association type mellitus T2DM risk aim study conduct association incidence T2DM
25008445 en on woman type mellitus reported plasma glucose first use effect complication adverse effect important patient mellitus patient
24824210 en high associate reduce risk type mellitus T2DM improve function factor also determine risk study investigate whether association risk T2DM glucose man fasting plasma glucose insulin hemoglobin hba1c level measured man age function insulin resistance evaluate respective assess subject low high group within age group according associate T2DM analyzed use risk score subject low high group high group high hba1c level low group low high group individual high lower low multiple regression analysis although significant hba1c also associate hba1c independent result suggest associate hba1c level independent however association increased hba1c impair function
24201223 en type mellitus T2DM adult case study datum gene disease protein compare cause T2DM datum little datum
20336164 en may glycemic control type mellitus within day effect change body weight therefore treat type mellitus patient current
25260269 en identify risk patient undergo patient undergo primary investigate included follow-up year total follow-up analysis perform assess effect hospital outcome adjust patient characteristic associate lower mortality confidence however also associate mortality overall risk factor female increased risk high body mass index increased risk per medical treat increased risk previous increased risk disease increased risk similar result similar hospital outcome however associate lower mortality confidence patient undergo use patient risk low diabetic woman great risk develop
21274512 en associate increased risk several association perform review examine association incidence study identify review included cohort study estimate CI datum association incidence use cohort study analysis study show compare individual without patient statistical significant increased risk CI among study association woman CI man CI analysis study adjust body mass index CI CI indicate positive association risk research whether association
17320348 en type mellitus insulin cell however disease response large function cell analyzed blood gene use datum cell patient new patient type T2DM healthy control subject possible influence glucose finding analyzed change datum show cell function cell gene also reduce cell show impair function include response may lead
20022651 en develop model base clinical datum assess risk type among impair glucose tolerance study mellitus investigate treatment individual use develop model time model use datum cardiovascular risk factor model included treatment serum level fasting plasma glucose history cardiovascular disease hypertension model population normal glucose tolerance respective model identify individual type management early treatment
26796386 en diagnose mellitus DM risk factor patient
21144198 en prevalence chronic disease primary care patient hypertension assess prevalence patient hypertension identify whether age hypertension associate primary health care aged year known type hypertension rate assess patient patient blood presence determined rate estimate clinical characteristic rate hypertension respective increased prevalence hypertension presence independent associate odd ratio or confidence interval CI decrease estimate or CI age show association decrease or CI primary care patient patient hypertension high prevalence follow-up evaluate whether cardiovascular risk management primary care population
19340390 en cause common glucose contribute development patient increased risk included patient syndrome history impair glucose group glucose group patient follow year follow-up patient group develop type group patient follow-up develop type relative risk period patient development type patient diagnose consider population increased risk develop
25266849 en gestational mellitus associate elevated risk adverse health outcome type cardiovascular disease increasing use whether correlation elevated review study assess relationship included mean difference use study total subject included analysis confidence interval CI regression analysis found association large associate weight control may cardiovascular disease patient
17894523 en type mellitus among health identify risk factor development type mellitus study identify risk factor group obesity elevated blood pressure elevated blood glucose elevated total cholesterol presence development type mellitus without history health present two identify risk factor type mellitus presence multiple risk factor participant positive history mellitus history statistical significant base study result factor history may development type mellitus
20923517 en oral plasma on therapy may aim present study system plasma level management respective subject perform diabetic mean respective potential respective drug respective respective blood glucose level reduce significant normal level compare difference two treatment group however whereas effective period effective result present study show effective type mellitus week can use improve patient drug treatment result decrease
24972471 en assess effect age increase DM prevalence DM prevalence datum health perform age population adjust prevalence rate age year method population one adjust increase also period DM prevalence increase population period although different two adjust prevalence rate also show increasing population factor increase prevalence rate known
18794603 en prevalence increased history poor impact glycemic control aim change status glycemic control among population sample patient chronic obtain baseline month change chronic glycemic control improve glycemic control assess fasting plasma glucose chronic glycemic control follow-up datum individual mean age year type syndrome overall reported change large change syndrome change month increased mean fasting plasma glucose poor glycemic control associate less glycemic control significant related association glycemic control
24595824 en dysfunction change function contribute increased cardiovascular type mellitus study aim investigate change high protein cell level also test association early change study included diagnosis healthy subject age body mass index serum lipid hba1c interval function assess use use response interval significant high diabetic patient control subject finding show dysfunction significant lower early decrease ratio increased early time time significant lower response increased lower level high high compare control subject on positive correlation hba1c found function dysfunction may early association early change change glycemic control poor early function may reduce risk complication
25279441 en chronic disease patient clinical aim study determine early hospital day datum patient period two hospital base patient serum hospital day datum clinical also model protein presence previous year significant risk factor presence risk factor identify patient positive negative value CI on clinical parameter identify patient risk early
17896900 en indicate treatment type mellitus lower blood glucose level insulin increasing therapy result weight insulin resistance drug patient report use man type patient weight drug weight lead insulin resistance development type characteristic type therapy body mass index hemoglobin value month therapy patient body weight hemoglobin value insulin reduce use insulin addition patient improve weight first case report use patient type mellitus may patient type
17686482 en develop mellitus significant also elevated blood glucose observed on new found factor may cause glucose normal aim present study investigate characteristic consider female glucose tolerance test diabetic week age early increased serum insulin level test day day week insulin insulin glucose difference can observed normal well elevated insulin observed day indicate dysfunction among diabetic can change increased serum insulin level increased insulin may suggest develop type condition lead increased
26857652 en study evaluate effect insulin compare insulin type mellitus T2DM test treat day insulin insulin also evaluate weight treat show impair glucose tolerance chronic treatment show effect diabetic lower weight diabetic insulin reduce T2DM impair glucose tolerance result show insulin effect effective reduce weight treatment major disorder patient T2DM
23282259 en type mellitus T2DM patient studied adult woman mean age year receive patient T2DM confidence interval mean prevalence among patient negative case vs respective among disease patient vs respective patient receive treatment response T2DM T2DM patient old without vs year analysis age significant associate diagnosis high among patient chronic age important determine factor
22932288 en patient mellitus hypertension well known increased risk observed mellitus report indicate increased risk hypertension disease similar on number factor reported multiple cell type among blood factor activity however effective treatment review recent research blood present finding
20369724 en on hospital undergo care severe hypertension several per day blood test show revealed among parameter time history clinical diagnosis syndrome control week total treatment perform week week glucose blood level high first day insulin therapy perform day day renal function blood hypertension factor event increased blood concentration may result mellitus complication syndrome evidence positive elevated level reduction blood concentration negative history follow glucose concentration normal glucose test response function decrease serum
21454245 en review use system type mellitus cardiovascular event clinical datum evaluate relationship identify clinical datum mechanism insulin resistance type may include impair blood activity increased insulin effect demonstrated reduce incidence patient hypertension cardiovascular population however impact mortality on recent trial evaluate cardiovascular outcome primary trial therapy reduce incidence relative follow-up period cardiovascular outcome however significant treatment may number potential factor include low rate cardiovascular disease baseline patient use number potential influence insulin resistance type clinical trial show reduce risk however recent result trial show addition reduce risk improve cardiovascular outcome
24374946 en mellitus major health several study show significant number diabetic patient regard well aim study determine use among type mellitus T2DM patient impact study T2DM patient different hospital health hospital use use among patient found use use common use poor therapy therapy patient poor glycemic control high rate complication associate use among T2DM patient significant impact therapy associate complication increasing patient medical
26916684 en assess effect insulin treatment change patient type trial conduct hospital participant type hba1c body mass index addition insulin treatment month aim hba1c primary outcome change mean cardiovascular disease hba1c insulin weight adverse event mean significant group difference CI hba1c reduce group difference CI significant lower insulin trial group CI compare CI group less weight difference CI group regard number patient severe adverse event group vs insulin reduce large reduction hba1c less weight insulin compare insulin however trial sample may therefore result
18042359 en respective role may provide estimate study investigate development type studied individual test baseline mean time diagnose type mellitus high associate lower risk early finding high associate increased risk whereas associate BMI hba1c activity significant factor risk previous study result indicate development type mellitus association two previous show new finding
26370526 en increasing study suggest gestational mellitus mellitus may associate increased risk major determine whether associate increased risk perform cohort study review included study use result relative risk confidence interval model model study assess use on total cohort study included analysis study show associate increased risk respective high risk major woman group however risk lower woman cohort study need test effect risk
26132858 en type mellitus metabolic disease high blood complication cardiovascular renal disorder poor blood development impair glucose tolerance change use drug obtain great drug review use well mechanism effect glucose glucose mechanism protein activity gene activity glucose reduction mechanism also review clinical trial perform high potential
26060825 en use insulin may improve glycemic control insulin type T2DM patient insulin study evaluate potential T2DM subject insulin receive week subject little one hba1c analyzed change baseline hba1c glucose tolerance test baseline hba1c decrease decrease decrease treatment period hba1c observed week remain study study therapy improve glycemic control tolerance reduce insulin T2DM subject poor control insulin therapy
23697958 en examine patient mellitus patient diabetic study included individual mean age year range perform include assessment diabetic blood sample subject subject diagnosis mellitus subject diabetic mean significant patient mellitus subject vs patient diabetic subject without vs age associate high hemoglobin hba1c value regression confidence interval CI presence mellitus CI presence diabetic diabetic adjust age body mass index blood pressure level mellitus associate presence diabetic diabetic associate significant adjust body mass index blood pressure level adjust blood glucose concentration hba1c value diagnosis mellitus blood pressure mellitus statistical significant whereas presence diabetic associate whereas mellitus disease lead diabetic disorder associate adjust presence
24260557 en factor consider improve glucose tolerance insulin current study investigate serum level patient gestational mellitus relationship level determined patient healthy control gestational age serum level correlate metabolic level significant reduce patient relative healthy subject whereas level increased patient serum level independent correlate insulin resistance increased model assessment insulin resistance positive related serum group serum level independent positive correlate insulin resistance serum related serum addition population group woman syndrome history low level significant lower patient without history control without level reduce patient level serum level related insulin resistance serum level different suggest reduce serum level can increased serum level can response disease
27083284 en factor factor cause mellitus dysfunction role analyzed compare show decrease indicate major due decrease identify several respective show cell cell can cell increase individual compare healthy control patient mellitus role finding provide new renal individual
19449745 en found relative number mellitus case among general health mean incidence rate total period increase incidence rate year analysis provide medical great number patient provide also influence overall health care datum show high treatment patient mellitus compare treatment diagnosis show also relationship presence mellitus complication medical system also important health patient influence care high patient treatment change little increase care control role health demonstrated development drug general health target year also include increase care high well
24355893 en prevalence obesity increase recent incidence prevalence metabolic obesity type mellitus although adult one identify risk may normal status change medication intervention known reduce risk review factor known influence risk develop treatment trial potential datum analysis clinical datum large population development estimate individual risk
23861950 en patient type mellitus DM renal also include dysfunction effect renal blood pressure less therefore measured renal function system type DM patient healthy control renal associate high elevated level
23659561 en assess treatment compare patient type mellitus fasting cohort study conduct patient day therapy follow week patient treatment study include one patient provide patient one patient total patient total mean number per patient mean fasting respective significant mean difference CI patient compare patient receive reported event one patient reported fasting treatment result treatment compare patient type mellitus study sample datum
23629823 en although great improve recent year mechanism type mellitus T2DM remain cell cell major increased T2DM patient cell system decrease within increased may contribute recent datum diabetic cardiovascular complication response include also T2DM patient evidence suggest target may reduce complication
20062952 en clinical present diabetic patient relative common complication mellitus can complication mellitus case consider similar case
23683111 en investigate risk assessment management individual without type mellitus T2DM primary care primary care assessment management patient year old clinical evidence cardiovascular disease diagnose little one risk individual T2DM without hypertension individual T2DM hba1c individual cholesterol T2DM without individual hypertension T2DM target whereas without target blood pressure target outcome individual T2DM individual T2DM without increase activity without T2DM elevated primary care low lipid target healthy change patient
26916685 en assess effect insulin change patient type trial conduct hospital type hba1c body mass index addition month insulin time insulin time insulin insulin aim hba1c outcome change mean cardiovascular disease hba1c insulin weight adverse event change group CI CI CI hba1c reduce CI compare CI CI group weight high CI CI compare group CI insulin high CI compare CI CI number participant severe adverse event change insulin difference hba1c weight insulin trial sample may therefore
22911280 en rate reduction blood pressure little normal patient type mellitus type DM function cause risk development disease great diabetic patient patient normal level aim study investigate whether difference level patient type compare female type DM healthy individual female control group blood pressure perform level measured found patient type DM control group diabetic control individual level high respective subject respective significant difference two group respective group level high participant significant difference group high level increase cardiovascular risk therefore relationship blood pressure change level investigate large study
22144118 en evaluate effect glycemic control diabetic complication associate patient type mellitus present study patient hospital medical patient effect glycemic control patient blood glucose significant female patient mean hba1c use glycemic control insulin per body weight also diabetic significant high female glycemic control high incidence female patient glycemic control female patient according clinical management
25771793 en evidence show type T2DM patient BMI datum investigate change metabolic T2DM patient BMI
25633883 en several study examine association on gestational mellitus however result perform study investigate whether on correlate population conduct previous patient control may subject use difference patient control investigate study on study conduct study related association on identify association on assess use study show on associate population previous reported study included perform show on associate study on may associate population provide evidence result risk on may increase risk
25572333 en several study disease aim study evaluate relationship concentration presence early type patient previous history patient age year disease duration year hba1c body mass index BMI control age BMI studied define value on determine presence subject show high vs patient control score great patient vs compare control subject show difference result according patient lower concentration prevalence control association concentration
25356602 en glucose show improve glycemic control type mellitus T2DM study aim characteristic treatment outcome patient treat within first month retrospective cohort study use large health database patient aged T2DM patient month baseline period month follow-up period first patient study mean age year female among patient datum baseline follow-up mean hba1c decrease baseline follow-up patient hba1c decrease baseline follow-up patient receive little one baseline among receive two receive three compare baseline follow-up lower insulin treat first poor control hba1c level baseline receive multiple first hba1c level use study result profile patient receive outcome follow-up time hba1c datum patient research outcome
24397174 en population prevalence mellitus increasing therefore clinical management diabetic diabetic patient increasing important therefore clinical diabetic disease review assess include clinical change well treatment patient present multiple complication consider management
19824187 en study evaluate medical type mellitus without complication determine impact complication type diabetic perform study type major study population total hospital use subject medical per patient estimate mean difference medical patient without complication vs also significant different patient without complication medical significant among patient disease high medical disease without correlation statistical significant number complication medical high complication system need intervention development complication among diabetic population development complication body system
19560451 en early patient risk develop mellitus develop insulin develop measured healthy patient use sample little high use level patient significant high healthy may evaluate risk
19402848 en health care associate treatment review identify difference among report relationship patient review study level patient total study identify included study analyzed datum base database low medication ratio associate high important difference found use identify patient diagnosis datum period datum associate statistical clinical outcome among estimate within study population compare estimate study difference result important estimate use model
20840299 en clinical mellitus study medical identify duration diabetic new diagnose cohort study datum include history profile duration define without insulin week studied logistic regression factor associate duration analyzed time day range study duration day range day range high age or CI less increased serum cholesterol or CI high body weight CI high blood glucose CI body weight cholesterol glucose level duration diabetic old develop may outcome possible suggest disease
20680411 en group protein lipid age development diabetic complication related disease mellitus metabolic change lipid protein change age development chronic complication related disease disease disease review aim occur different age mellitus disease
23900469 en blood glucose conduct control trial assess primary care control trial conduct primary care patient type mellitus age range year time study receive care group patient receive similar care total patient type mellitus intervention control group respective month hba1c level intervention group show statistical significant confidence interval relative control group undergo care patient hba1c treatment target control intervention group improve control possible due great intervention group
23764734 en effect glucose may contribute effect whether effect different obesity type T2DM examine significant glucose condition effect impair T2DM effect glucose increase blood impair obesity associate evidence observed treatment activity datum provide evidence indicate effect obesity T2DM mechanism may impair
23664596 en diabetic effect possible effect subject poor adult type mellitus treat day day reduce participant participant week although correlate positive individual correlation observed may reduce adult mellitus
23485142 en healthy participant type T2DM compare response glucose insulin known influence glucose determine effect fasting glucose lipid participant T2DM blood sample baseline study participant one fasting blood sample day day plasma change lead change glucose insulin concentration significant correlation observed fasting concentration response several examine correlation present healthy participant group T2DM group effect one week fasting glucose lipid healthy participant
23466101 en low level blood contribute increased risk cardiovascular disease patient type mellitus T2DM determine mechanism cardiovascular disease patient investigate effect cholesterol diabetic patient healthy subject study patient mellitus cholesterol treatment cell diabetic subject increase cholesterol treatment significant increased protein level without protein include diabetic suggest lipid addition diabetic patient cell positive correlation decrease serum level impair cholesterol diabetic patient present study identify reduce mechanism increased cell cardiovascular disease diabetic subject
23273663 en study difference characteristic glycemic control type without sample mean year without associate great high glucose level great study suggest negative outcome research need determine
22122223 en treatment patient type mellitus oral drug treatment provide glycemic control patient insulin disease cell one important care patient type insulin therapy health care insulin management patient type treatment use therapy include insulin addition multiple insulin treatment include addition insulin oral drug patient insulin treatment role insulin therapy provide management patient type insulin treatment
21631239 en examine outcome woman gestational mellitus treat compare insulin retrospective cohort study woman diagnose gestational mellitus therapy woman compare woman treat insulin outcome compare use test logistic regression model statistical indicate confidence interval woman medical therapy study receive receive insulin compare insulin therapy oral treatment associate increased risk CI care woman gestational care compare treat insulin finding examine large trial
18654064 en type mellitus obesity relationship increased prevalence review evaluate effect therapy weight glycemic control type mellitus population on conduct identify randomize control trial reported weight effect treatment new therapy include drug treatment potential patient type mellitus include also examine therapy weight insulin resistance glucose profile however significant body weight reduction improve glycemic control weight drug effective patient type mellitus may use patient associate improve glycemic value decrease mortality clinical evidence effect effect patient type mellitus evidence clinical drug datum need evaluate
17804264 en mellitus common cause disorder although poor little mechanism mellitus method possible type change investigate adult female examine diabetic subject diabetic increase diabetic study show significant large diabetic time respective profile significant large time respective compare diabetic although study suggest diabetic associate remain whether can mechanism mellitus
22913898 en outcome associate therapy may potential influence patient characteristic therapy health outcome patient drug known disease characteristic base several different medication increasing potential therapy treatment type review datum association patient characteristic outcome treatment medical suggest general important therapy disease treatment response risk current datum patient characteristic treatment response number known influence include factor age body mass index patient disease duration baseline hemoglobin level hemoglobin level value correlate treatment response recent treatment influence outcome associate medication include effect treatment
22913894 en relative new oral improve glycemic control patient type mellitus increase level insulin clinical trial show provide significant reduction hemoglobin level low risk model study suggest cardiovascular system possible effect may therapy clinical trial datum show increase major adverse cardiovascular event suggest potential cardiovascular therapy cardiovascular trial current define cardiovascular impact therapy patient type mellitus
22547676 en gene case mellitus present low insulin target cell identify factor target gene cell reduce protein insulin cell diabetic improve diabetic study mechanism contribute insulin new therapy
24393280 en disease one disease aim study evaluate mortality rate patient according age determine studied patient hospital cohort included patient patient year age without mellitus patient year age mellitus patient year age without mellitus patient year age mellitus control subject without disease patient age year mellitus status outcome mortality rate year patient year age vs control subject risk ratio confidence interval CI diabetic patient year age vs control subject CI patient year age vs control subject CI diabetic patient year age regression analysis cardiovascular risk factor disease clinical several found independent outcome patient year age protein CI diabetic patient year age CI patient year age CI CI diabetic patient year age CI CI rate year among patient according age among patient study included result develop treatment patient
22311265 en gene associate increased risk previous reported associate high rate among patient history compare without history whereas rate difference history time outcome body mass index BMI mellitus DM retrospective review identify female history BMI DM diagnosis relationship BMI well prevalence DM group patient history high prevalence DM vs high BMI vs compare without patient difference potential influence metabolic profile female associate female show relative great clinical metabolic profile history little one history
22266735 en association study group recent new diagnose gestational mellitus study determine whether compare current develop analysis model compare three identify current glucose test week follow glucose tolerance test indicate included woman diagnose receive risk woman reduce risk primary outcome ratio model care reduce incidence woman compare current per care result glucose model patient identify use intervention
18663202 en general gestational risk factor type however condition remain determine incidence mellitus diagnosis gestational use database identify period diagnosis gestational database hospital examine database woman time total year determined presence mellitus according database identify woman woman diagnosis gestational incidence gestational significant study period develop gestational month year age whether woman previous whether woman hypertension index primary care level index significant risk factor gestational index ratio confidence interval age lower also important factor analyzed year rate development high among woman gestational among early year large study rate development gestational increased time year estimate use woman target woman
25433844 en assess relationship high lower disease lead individual without mellitus without study subject new diagnose lead therapy control without clinical lead analysis perform method lead subject total level well level decrease respective significant high relationship within cholesterol finding reduction increase may consider important cardiovascular disease use identify presence high concentration patient potential
25203338 en disease consider one major complication disorder mellitus DM DM present chronic glucose DM consider common finding present review change occur diabetic disorder complication present review several diabetic disease present potential improve DM review also effective use complication diabetic disease
23990231 en aim study determine influence mellitus DM patient undergo primary study population patient first treat primary evaluate use well method define increase base individual patient study population two group according presence DM show significant high rate vs lower incidence vs compare similar incidence DM group vs significant diabetic patient vs vs respective patient incidence similar compare patient DM associate development
24102694 en aim study compare parameter diabetic sample level study period may found mellitus glucose hemoglobin level case found study group period undergo treatment disorder week found control group analysis health test test test case body mass index measured difference mean age body mass index two group significant difference found parameter total cell per total cell per normal test normal mellitus level cause
21947435 en mean plasma glucose concentration week determined value assess diagnosis type mellitus general studied man woman mean age year range year health hba1c fasting plasma concentration glucose measured participant hba1c diagnose level significant correlate hba1c level presence significant high participant level three increased level characteristic analysis indicate level investigate potential use research clinical
22997507 en aim study investigate association factor type diabetic analyzed control diabetic patient hba1c diabetic patient hba1c characteristic assess characteristic measured blood sample study one year diabetic patient use first diabetic patient statistical significant positive relationship level observed control diabetic patient statistical significant negative relationship well score observed assessment value decrease patient control metabolic association may T2DM
22474429 en high risk type mellitus T2DM cardiovascular disease BMI assess reduction may factor metabolic profile associate obesity metabolic status factor contribute therefore assess two age cohort T2DM determine effect BMI lipid profile obtain cohort datum measured finding indicate effect reduce T2DM man compare man T2DM man correlate total cholesterol reduce T2DM man correlate total cholesterol study among T2DM man change lipid BMI suggest lipid BMI may contribute
21741060 en assess association factor insulin resistance type mellitus T2DM metabolic syndrome subject normal glucose tolerance T2DM study factor measured serum insulin estimate use insulin resistance use model assessment subject T2DM significant decrease level compare subject significant lower subject measured model assessment compare subject without regression analysis show significant association adjust age body mass index hemoglobin type mellitus significant associate adjust age body mass index level decrease increasing number metabolic logistic regression analysis show negative association adjust age odd ratio confidence interval among lower level subject T2DM
